FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Grahammer, F
   Haenisch, N
   Steinhardt, F
   Sander, L
   Roerden, M
   Arnold, F
   Cordts, T
   Wanner, N
   Reichardt, W
   Kerjaschki, D
   Ruegg, MA
   Hall, MN
   Moulin, P
   Busch, H
   Boerries, M
   Walz, G
   Artunc, F
   Huber, TB
AF Grahammer, Florian
   Haenisch, Nora
   Steinhardt, Frederic
   Sander, Lukas
   Roerden, Malte
   Arnold, Frederic
   Cordts, Tomke
   Wanner, Nicola
   Reichardt, Wilfried
   Kerjaschki, Dontscho
   Ruegg, Markus A.
   Hall, Michael N.
   Moulin, Pierre
   Busch, Hauke
   Boerries, Melanie
   Walz, Gerd
   Artunc, Ferruh
   Huber, Tobias B.
TI mTORC1 maintains renal tubular homeostasis and is essential in response
   to ischemic stress
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE mTOR; mitochondrial biogenesis; acute kidney injury; tubular transport;
   urinary concentration mechanism
ID OXYGEN-CONSUMPTION; SODIUM-TRANSPORT; BINDING PARTNER; RAPAMYCIN;
   KIDNEY; RAPTOR; PATHWAY; COMPLEX; MICE; GROWTH
AB Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell metabolism and autophagy. Despite widespread clinical use of mTORC1 inhibitors, the role of mTORC1 in renal tubular function and kidney homeostasis remains elusive. By using constitutive and inducible deletion of conditional Raptor alleles in renal tubular epithelial cells, we discovered that mTORC1 deficiency caused a marked concentrating defect, loss of tubular cells, and slowly progressive renal fibrosis. Transcriptional profiling revealed that mTORC1 maintains renal tubular homeostasis by controlling mitochondrial metabolism and biogenesis as well as transcellular transport processes involved in countercurrent multiplication and urine concentration. Although mTORC2 partially compensated for the loss of mTORC1, exposure to ischemia and reperfusion injury exaggerated the tubular damage in mTORC1-deficient mice and caused pronounced apoptosis, diminished proliferation rates, and delayed recovery. These findings identify mTORC1 as an important regulator of tubular energy metabolism and as a crucial component of ischemic stress responses.
C1 [Grahammer, Florian; Steinhardt, Frederic; Sander, Lukas; Arnold, Frederic; Cordts, Tomke; Wanner, Nicola; Walz, Gerd; Huber, Tobias B.] Univ Med Ctr Freiburg, Div Renal, D-79106 Freiburg, Germany.
   [Haenisch, Nora; Roerden, Malte; Artunc, Ferruh] Univ Tubingen Hosp, Div Renal, D-72076 Tubingen, Germany.
   [Wanner, Nicola; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany.
   [Wanner, Nicola] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
   [Busch, Hauke; Boerries, Melanie] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany.
   [Huber, Tobias B.] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.
   [Reichardt, Wilfried] Univ Med Ctr Freiburg, Dept Med Phys, D-79106 Freiburg, Germany.
   [Kerjaschki, Dontscho] Univ Vienna, Dept Pathol, A-1090 Vienna, Austria.
   [Ruegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland.
   [Moulin, Pierre] Novartis Inst Biomed Res Preclin Safety Discovery, CH-4002 Basel, Switzerland.
   [Busch, Hauke; Boerries, Melanie] German Canc Consortium, D-69120 Heidelberg, Germany.
   [Busch, Hauke; Boerries, Melanie] German Canc Res Ctr, D-69120 Heidelberg, Germany.
RP Huber, TB (corresponding author), Univ Med Ctr Freiburg, Div Renal, D-79106 Freiburg, Germany.
EM tobias.huber@uniklinik-freiburg.de
RI Ruegg, Markus/X-7256-2019; Busch, Hauke/R-6452-2016; Reichardt,
   Wilfried/K-6727-2013
OI Ruegg, Markus/0000-0002-4974-9384; Busch, Hauke/0000-0003-4763-4521;
   Huber, Tobias B./0000-0001-7175-5062
FU Deutsche Forschungsgemeinschaft (DFG) "Polycystic Kidney Disease-From
   Model Organisms to Novel Therapies" [KFO 201]; DFG Heisenberg
   ProgramGerman Research Foundation (DFG); DFG Collaborative Research
   Center 992; European Research CouncilEuropean Research Council (ERC);
   Excellence Initiative of the German Federal Government Spemann Graduate
   School [EXC294, GSC-4]; Excellence Initiative of the German State
   Government Spemann Graduate School [EXC294, GSC-4]; Federal Ministry of
   Education and Research Joint Transnational Grant [01KU1215];
   GerontoSys2-Project NephAge; Pfizer Pharma GmbHPfizer
FX We thank Betina Kiefer, Charlotte Meyer, Temel Kilic, Helga Schachner,
   Evelyn Watzig, and Annette Merkle for expert technical assistance and
   all members of our laboratories for helpful discussions and support.
   This study was supported by grants from Deutsche Forschungsgemeinschaft
   (DFG) "Polycystic Kidney Disease-From Model Organisms to Novel
   Therapies" (KFO 201) (to F.G., W.R., G.W., and T.B.H.), DFG Heisenberg
   Program (to T.B.H.), and Collaborative Research Center 992 (to T.B.H.);
   by European Research Council Grant Project DNCure (to T.B.H.); by the
   Excellence Initiative of the German Federal and State Governments
   (EXC294, to T.B.H.; GSC-4) Spemann Graduate School (to N.W. and T.B.H.);
   by the Federal Ministry of Education and Research Joint Transnational
   Grant 01KU1215 (to T.B.H.) and GerontoSys2-Project NephAge (to H.B.,
   M.B., and T.B.H.); and by project-specific grant support by Pfizer
   Pharma GmbH (formerly Wyeth GmbH) (to T.B.H.).
CR Artunc F, 2009, KIDNEY BLOOD PRESS R, V32, P119, DOI 10.1159/000214439
   AVNER ED, 1983, J UROLOGY, V129, P660, DOI 10.1016/S0022-5347(17)52273-9
   Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bissler JJ, 2013, LANCET, V381, P817, DOI 10.1016/S0140-6736(12)61767-X
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313
   Committee on Care and Use of Laboratory Animals, 1985, DHHS PUBL NIH
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Devuyst O, 2012, ANN ENDOCRINOL-PARIS, V73, P128, DOI 10.1016/j.ando.2012.03.032
   Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330
   Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   GOLBAEKDAL K, 1994, TRANSPLANTATION, V58, P1153, DOI 10.1097/00007890-199412270-00002
   Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Haller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039229
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827
   Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kempe DS, 2010, NEPHROL DIAL TRANSPL, V25, P2938, DOI 10.1093/ndt/gfq172
   Kezic A, 2013, AM J NEPHROL, V37, P291, DOI 10.1159/000348496
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lieberthal W, 2006, TRANSPLANTATION, V82, P17, DOI 10.1097/01.tp.0000225772.22757.5e
   Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161
   MANDEL LJ, 1981, AM J PHYSIOL, V240, pF357
   MANDEL LJ, 1986, KIDNEY INT, V29, P3, DOI 10.1038/ki.1986.2
   Mercier-Zuber A, 2011, CURR OPIN NEPHROL HY, V20, P534, DOI 10.1097/MNH.0b013e3283484b06
   Morales JM, 2003, TRANSPL P, V35, p154S, DOI 10.1016/S0041-1345(03)00224-0
   Morales JM, 2002, AM J TRANSPLANT, V2, P436, DOI 10.1034/j.1600-6143.2002.20507.x
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50
   Smith KD, 2003, J AM SOC NEPHROL, V14, P1037, DOI 10.1097/01.ASN.0000057542.86377.5A
   SOLTOFF SP, 1986, ANNU REV PHYSIOL, V48, P9
   Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297
   Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 43
TC 48
Z9 48
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 8
PY 2014
VL 111
IS 27
BP E2817
EP E2826
DI 10.1073/pnas.1402352111
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK6CH
UT WOS:000338514800007
PM 24958889
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Singh, P
   Nair, AR
   Cabernard, C
AF Singh, Priyanka
   Nair, Anjana Ramdas
   Cabernard, Clemens
TI The Centriolar Protein Bld10/Cep135 Is Required to Establish Centrosome
   Asymmetry in Drosophila Neuroblasts
SO CURRENT BIOLOGY
LA English
DT Article
ID SPINDLE ORIENTATION; BASAL BODY; INHERITANCE; CEP135; LOCALIZATION;
   CARTWHEEL; MOTHER; ENSURE; BLD10P; CYCLE
AB Centrosome asymmetry has been implicated in stem cell fate maintenance in both flies and vertebrates [1, 2]. Drosophila neuroblasts, the neural precursors of the fly's central nervous system [3], contain molecularly and physically asymmetric centrosomes, established through differences in pericentriolar matrix (PCM) retention [4-7]. For instance, the daughter centriole maintains PCM and thus microtubule-organizing center (MTOC) activity through Polo-mediated phosphorylation of Centrobin (Cnb) [7, 8]. The mother centriole, however, quickly downregulates PCM and moves away from the apical cortex, randomly migrating through the cytoplasm until maturation sets in at prophase [4-6, 8]. How PCM downregulation is molecularly controlled is currently unknown, but it involves Pericentrin (PCNT)-like protein (PLP) to prevent premature Polo localization and thus MTOC activity [9]. Here, we report that the centriolar protein Bld10, the fly ortholog of Cep135, is required to establish centrosome asymmetry in Drosophila neuroblasts through shedding of Polo from the mother centrosome. bld10 mutants fail to downregulate Polo and PCM, generating two active, improperly positioned MTOCs. Failure to shed Polo and PCM causes spindle alignment and centrosome segregation defects, resulting in neuroblasts incorrectly retaining the older mother centrosome. Since Cep135 is implicated in primary microcephaly, we speculate that perturbed centrosome asymmetry could contribute to this rare neurodevelopmental disease.
C1 [Singh, Priyanka; Nair, Anjana Ramdas; Cabernard, Clemens] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cabernard, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM clemens.cabernard@unibas.ch
RI singh, priyanka/N-1372-2018
OI singh, priyanka/0000-0003-0841-1544; Singh,
   Priyanka/0000-0002-5928-6280; Cabernard, Clemens/0000-0003-3706-6401
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF); Novartis Foundation for Biomedical Research;
   EMBOEuropean Molecular Biology Organization (EMBO)
FX We thank Tri Thanh Pham for custom-made MATLAB codes and Andreas Merdes,
   Chris Doe, and members of the C.C. and Nigg lab for helpful discussions
   and critical reading of the manuscript. We are grateful to Tim Megraw,
   Jordan Raff, Renata Basto, Juergen Knoblich, Cayetano Gonzalez, Monica
   Bettencourt-Dias, Tomer Avidor-Reiss, Chris Doe, Fumio Matsuzaki, and
   Nasser Rusan for flies and antibodies. We also thank the member of the
   Imaging Core Facility (IMCF) for technical support. This work was
   supported by the Swiss National Science Foundation (SNSF) and the
   Novartis Foundation for Biomedical Research. P.S. is supported by an
   EMBO long-term postdoctoral fellowship.
CR Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141
   Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961
   Cabernard Clemens, 2013, Cold Spring Harb Protoc, V2013, P970, DOI 10.1101/pdb.prot078162
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   Carvalho-Santos Z, 2012, DEV CELL, V23, P412, DOI 10.1016/j.devcel.2012.06.001
   Conduit PT, 2010, CURR BIOL, V20, P2187, DOI 10.1016/j.cub.2010.11.055
   Conduit PT, 2010, CURR BIOL, V20, P2178, DOI 10.1016/j.cub.2010.11.011
   Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224
   Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191
   Hallen MA, 2008, BIOPHYS J, V95, P3048, DOI 10.1529/biophysj.108.134593
   Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021
   Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Januschke J, 2013, NAT CELL BIOL, V15, P241, DOI 10.1038/ncb2671
   Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245
   Karpova N, 2006, CELL MOTIL CYTOSKEL, V63, P301, DOI 10.1002/cm.20124
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Lerit DA, 2013, J CELL BIOL, V202, P1013, DOI 10.1083/jcb.201303141
   Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56
   Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627
   Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022
   Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134
   Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115
   Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8
   Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088
   Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312
   Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036
   Pelletier L, 2012, CURR OPIN CELL BIOL, V24, P541, DOI 10.1016/j.ceb.2012.05.005
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Roque H, 2012, J CELL SCI, V125, P5881, DOI 10.1242/jcs.113506
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910
NR 37
TC 26
Z9 26
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD JUL 7
PY 2014
VL 24
IS 13
BP 1548
EP 1555
DI 10.1016/j.cub.2014.05.050
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AL0EI
UT WOS:000338799800032
PM 24954048
OA Bronze
DA 2021-01-25
ER

PT J
AU Flici, H
   Cattenoz, PB
   Komonyi, O
   Laneve, P
   Erkosar, B
   Karatas, OF
   Reichert, H
   Berzsenyi, S
   Giangrande, A
AF Flici, Hakima
   Cattenoz, Pierre B.
   Komonyi, Orban
   Laneve, Pietro
   Erkosar, Berra
   Karatas, Omer F.
   Reichert, Heinrich
   Berzsenyi, Sara
   Giangrande, Angela
TI Interlocked loops trigger lineage specification and stable fates in the
   Drosophila nervous system
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GLIAL-CELLS; TRANSCRIPTIONAL ACTIVITY; ASYMMETRIC DIVISION;
   TUMOR-METASTASIS; FEEDBACK LOOP; GENE REPO; PROTEIN; DIFFERENTIATION;
   ACETYLATION; CBP
AB Multipotent precursors are plastic cells that generate different, stable fates at the correct number, place and time, to allow tissue and organ formation. While fate determinants are known to trigger specific transcriptional programs, the molecular pathway driving the progression from multipotent precursors towards stable and specific identities remains poorly understood. Here we demonstrate that, in Drosophila neural precursors, the glial determinant glial cell missing (Gcm) acts as a 'time bomb' and triggers its own degradation once the glial programme is stably activated. This requires a sequence of transcriptional and post-transcriptional loops, whereby a Gcm target first affects the expression and then acetylation of the fate determinant, thus controlling Gcm levels and stability over time. Defective homeostasis between the loops alters the neuron: glia ratio and freezes cells in an intermediate glial/neuronal phenotype. In sum, we identify an efficient strategy triggering cell identity, a process altered in pathological conditions such as cancer.
C1 [Flici, Hakima; Cattenoz, Pierre B.; Komonyi, Orban; Laneve, Pietro; Erkosar, Berra; Karatas, Omer F.; Berzsenyi, Sara; Giangrande, Angela] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.
   [Flici, Hakima; Cattenoz, Pierre B.; Komonyi, Orban; Laneve, Pietro; Erkosar, Berra; Karatas, Omer F.; Berzsenyi, Sara; Giangrande, Angela] CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France.
   [Flici, Hakima; Cattenoz, Pierre B.; Komonyi, Orban; Laneve, Pietro; Erkosar, Berra; Karatas, Omer F.; Berzsenyi, Sara; Giangrande, Angela] INSERM, U964, F-67404 Illkirch Graffenstaden, France.
   [Flici, Hakima; Cattenoz, Pierre B.; Komonyi, Orban; Laneve, Pietro; Erkosar, Berra; Karatas, Omer F.; Berzsenyi, Sara; Giangrande, Angela] Univ Strasbourg, F-67404 Illkirch Graffenstaden, France.
   [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Karatas, Omer F.] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, Istanbul, Turkey.
RP Giangrande, A (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.
EM angela@igbmc.fr
RI laneve, pietro/ABD-1633-2020; Karatas, Omer/I-5103-2013; Flici,
   Hakima/L-6894-2017; laneve, pietro/M-3386-2014
OI Flici, Hakima/0000-0002-7185-4543; Cattenoz, Pierre/0000-0001-5301-1975;
   Erkosar, Berra/0000-0003-1152-6772; Karatas, Omer/0000-0002-0379-2088;
   laneve, pietro/0000-0002-8865-4038
FU Institut National de la Sante et de la Recherche MedicaleInstitut
   National de la Sante et de la Recherche Medicale (Inserm); Centre
   National de la Recherche ScientifiqueCentre National de la Recherche
   Scientifique (CNRS); Universite de Strasbourg; Hospital de Strasbourg;
   Association pour la Recherche sur le CancerFondation ARC pour la
   Recherche sur le CancerAustralian Research Council; Institut National du
   CancerAgence Nationale de la Recherche (ANR)French National Research
   Agency (ANR); Region AlsaceRegion Grand-Est; FRM fellowships; French
   State fund [ANR-10-LABX-0030-INRT]; Agence Nationale de la Recherche
   under the frame programme Investissements d'Avenir labelledFrench
   National Research Agency (ANR) [ANR-10-IDEX-0002-02]
FX We thank J. Skeath, J. Kumar, M. Mannervik, C. Gonzalez, B. Altenhein,
   B. J. Jones, the Bloomington Stock Center for reagents and all lab
   members for suggestions. We thank Pei-Yi Chen for help with mutant
   constructs, C. Diebold, C. Delaporte, N. Arbogast and H. Dietrich for
   technical assistance, as well as the imaging, the cell culture and the
   mass spectrometry facilities. We thank C. Romier for advice on the 3D
   structure of the Gcm-DBD and on the mutagenesis, This work was supported
   by: Institut National de la Sante et de la Recherche Medicale, Centre
   National de la Recherche Scientifique, Universite de Strasbourg,
   Hospital de Strasbourg, Association pour la Recherche sur le Cancer,
   Institut National du Cancer, Agence Nationale de la Recherche (ANR) and
   Region Alsace. F.H., O.K., P.L. and S.B. were supported by FRM
   fellowships, B.E by ARC, P. B. C. by ANR and Neurex Network (TriNeuron
   Programme Interreg IV Upper Rhine). The work was also is supported by
   the grant ANR-10-LABX-0030-INRT, a French State fund managed by the
   Agence Nationale de la Recherche under the frame programme
   Investissements d'Avenir labelled ANR-10-IDEX-0002-02.
CR Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0
   Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967
   Altenhein B, 2006, DEV BIOL, V296, P545, DOI 10.1016/j.ydbio.2006.04.460
   Beaucher M, 2007, DEV BIOL, V301, P287, DOI 10.1016/j.ydbio.2006.09.019
   Bedford DC, 2012, AGING-US, V4, P247, DOI 10.18632/aging.100453
   Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449
   Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372
   Bernardoni R, 1998, DEVELOPMENT, V125, P3189
   Bernardoni R, 1997, DEV BIOL, V191, P118
   Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006
   Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107
   CAMPBELL G, 1994, DEVELOPMENT, V120, P2957
   CAMPOSORTEGA JA, 1993, J NEUROBIOL, V24, P1305, DOI 10.1002/neu.480241005
   Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005
   Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422
   De Iaco R, 2006, EMBO J, V25, P244, DOI 10.1038/sj.emboj.7600907
   Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09
   Dittrich R, 1997, DEVELOPMENT, V124, P2515
   Egger B, 2002, DEVELOPMENT, V129, P3295
   Flici H, 2011, DEVELOPMENT, V138, P4167, DOI 10.1242/dev.070391
   Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7
   Fujimoto H, 2012, J COMPUT CHEM, V33, P239, DOI 10.1002/jcc.21956
   Giesen K, 1997, DEVELOPMENT, V124, P2307
   Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   Ho MSC, 2009, P NATL ACAD SCI USA, V106, P6778, DOI 10.1073/pnas.0808899106
   HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3
   Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124
   Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362
   JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5
   Kamieniarz K, 2009, CHEM BIOL, V16, P1027, DOI 10.1016/j.chembiol.2009.10.002
   Kimbrel EA, 2009, J BIOL CHEM, V284, P13033, DOI 10.1074/jbc.M901248200
   Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850
   Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085
   Laneve P, 2013, DEV BIOL, V375, P65, DOI 10.1016/j.ydbio.2012.12.014
   Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002
   Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P404, DOI 10.1016/j.bbrc.2012.03.007
   LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4
   Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002
   Lilja T, 2007, DEV BIOL, V305, P650, DOI 10.1016/j.ydbio.2007.01.036
   Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530
   Miller AA, 1998, EMBO J, V17, P6316, DOI 10.1093/emboj/17.21.6316
   Nguyen DX, 2004, EMBO J, V23, P1609, DOI 10.1038/sj.emboj.7600176
   Popkova A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003159
   Schmidt I, 2011, GLIA, V59, P1264, DOI 10.1002/glia.21123
   Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032
   Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099
   Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688
   Vincent S, 1996, DEVELOPMENT, V122, P131
   Wang HY, 2005, BIOL CELL, V97, P63
   Wu JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-131
   XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981
   Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009
   Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468
   Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357
NR 59
TC 12
Z9 12
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL
PY 2014
VL 5
AR 4484
DI 10.1038/ncomms5484
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN5IF
UT WOS:000340623400029
PM 25066644
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Schmidt, T
   Bergner, A
   Schwede, T
AF Schmidt, Tobias
   Bergner, Andreas
   Schwede, Torsten
TI Modelling three-dimensional protein structures for applications in drug
   design
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID STRUCTURE-BASED PREDICTION; HOMOLOGY MODELS; LIGAND INTERACTIONS;
   CRYSTAL-STRUCTURES; COMPUTATIONAL ANALYSIS; SOFTWARE FRAMEWORK; TARGET
   FLEXIBILITY; QUALITY ASSESSMENT; MOLECULAR DOCKING; ABC TRANSPORTERS
AB A structural perspective of drug target and anti-target proteins, and their molecular interactions with biologically active molecules, largely advances many areas of drug discovery, including target validation, hit and lead finding and lead optimisation. In the absence of experimental 3D structures, protein structure prediction often offers a suitable alternative to facilitate structure-based studies. This review outlines recent methodical advances in homology modelling, with a focus on those techniques that necessitate consideration of ligand binding. In this context, model quality estimation deserves special attention because the accuracy and reliability of different structure prediction techniques vary considerably, and the quality of a model ultimately determines its usefulness for structure-based drug discovery. Examples of G-protein-coupled receptors (GPCRs) and ADMET-related proteins were selected to illustrate recent progress and current limitations of protein structure prediction. Basic guidelines for good modelling practice are also provided.
C1 [Schmidt, Tobias; Bergner, Andreas; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schmidt, Tobias; Bergner, Andreas; Schwede, Torsten] SIB, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Torsten.Schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Bergner,
   Andreas/0000-0002-5843-4325
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324] Funding Source: NIH RePORTER; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U01 GM093324] Funding Source: Medline
CR ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503
   Abrol R, 2011, METHODS, V55, P405, DOI 10.1016/j.ymeth.2011.12.005
   Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Beier C, 2010, EXPERT OPIN DRUG DIS, V5, P347, DOI 10.1517/17460441003713462
   Ben Nasr N, 2013, J CHEM INF MODEL, V53, P293, DOI 10.1021/ci3004557
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323
   Bergner A, 2001, BIOPOLYMERS, V61, P99, DOI 10.1002/1097-0282(2001/2002)61:2<99::AID-BIP10075>3.0.CO;2-8
   Berman HM, 2013, BIOPOLYMERS, V99, P218, DOI 10.1002/bip.22132
   Beuming T, 2012, J CHEM INF MODEL, V52, P3263, DOI [10.1021/ci300411b, 10.1021/ci3004111]
   Biasini M, 2013, ACTA CRYSTALLOGR D, V69, P701, DOI 10.1107/S0907444913007051
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Brylinski M, 2010, J CHEM INF MODEL, V50, P1839, DOI 10.1021/ci100235n
   Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m
   Cavasotto CN, 2011, CURR TOP MED CHEM, V11, P1528
   Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006
   Chen L, 2012, DRUG DISCOV TODAY, V17, P343, DOI 10.1016/j.drudis.2011.11.003
   Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d
   Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884
   Dalton JAR, 2010, J MOL BIOL, V399, P645, DOI 10.1016/j.jmb.2010.04.047
   de Graaf C, 2008, PROTEINS, V71, P599, DOI 10.1002/prot.21724
   Demel MA, 2009, CHEM BIODIVERS, V6, P1960, DOI 10.1002/cbdv.200900138
   Dong D, 2012, DRUG METAB REV, V44, P192, DOI 10.3109/03602532.2011.645580
   Du-Cuny L, 2011, J CHEM INF MODEL, V51, P2948, DOI 10.1021/ci200271d
   Durrant JD, 2010, CURR OPIN PHARMACOL, V10, P770, DOI 10.1016/j.coph.2010.09.001
   Ecker GF, 2008, DRUG DISCOV TODAY, V13, P311, DOI 10.1016/j.drudis.2007.12.012
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032
   Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706
   Fauman EB, 2011, CURR OPIN CHEM BIOL, V15, P463, DOI 10.1016/j.cbpa.2011.05.020
   Fernandes MX, 2004, J CHEM INF COMP SCI, V44, P1961, DOI 10.1021/ci049803m
   Ferrara P, 2007, J MOL MODEL, V13, P897, DOI 10.1007/s00894-007-0207-6
   Fujioka M, 2012, DRUG DISCOV TODAY, V17, P1133, DOI 10.1016/j.drudis.2012.06.010
   Goldfeld DA, 2013, PROTEINS, V81, P214, DOI 10.1002/prot.24178
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706
   Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Heinke R, 2011, BIOORGAN MED CHEM, V19, P3605, DOI 10.1016/j.bmc.2011.01.029
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Jacobson M, 2004, ANNU REP MED CHEM, V39, P259, DOI 10.1016/S0065-7743(04)39020-2
   Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590
   Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c
   Katritch Vsevolod, 2012, Methods Mol Biol, V857, P189, DOI 10.1007/978-1-61779-588-6_8
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012
   Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036
   Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253
   Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7
   Kryshtafovych A., 2013, PROTEINS
   Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012
   Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024
   Langer T, 2009, CURR OPIN PHARMACOL, V9, P589, DOI 10.1016/j.coph.2009.06.001
   Larsson P, 2009, PROTEINS, V77, P167, DOI 10.1002/prot.22476
   MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131
   Maffeo C, 2012, CHEM REV, V112, P6250, DOI 10.1021/cr3002609
   Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330
   McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294
   McGuffin LJ, 2011, PROTEINS, V79, P137, DOI 10.1002/prot.23120
   Medina-Franco JL, 2011, DRUG DISCOV TODAY, V16, P418, DOI 10.1016/j.drudis.2011.02.003
   Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023
   Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]
   Mullins JGL, 2012, ADV PROTEIN CHEM STR, V89, P117, DOI 10.1016/B978-0-12-394287-6.00005-7
   Nikiforovich GV, 2010, PROTEINS, V78, P271, DOI 10.1002/prot.22537
   Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005
   O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]
   Oshiro C, 2004, J MED CHEM, V47, P764, DOI 10.1021/jm0300781
   Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199
   Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024
   Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Ravna Aina Westrheim, 2012, Methods Mol Biol, V857, P281, DOI 10.1007/978-1-61779-588-6_12
   Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z
   Rua F, 2012, BIOTECHNOL APPL BIOC, V59, P479, DOI 10.1002/bab.1051
   Rueda M, 2012, J CHEM INF MODEL, V52, P2705, DOI [10.1021/ci30010881, 10.1021/ci3001088]
   Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710
   Schultes S, 2013, MEDCHEMCOMM, V4, P193, DOI 10.1039/c2md20212c
   Schultes S, 2013, CHEMMEDCHEM, V8, P49, DOI 10.1002/cmdc.201200412
   Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007
   Singh DV, 2013, J MOL MODEL, V19, P227, DOI 10.1007/s00894-012-1535-8
   Stary A, 2010, CHEMMEDCHEM, V5, P455, DOI 10.1002/cmdc.200900461
   Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859
   Stoll F, 2011, DRUG DISCOV TODAY, V16, P530, DOI 10.1016/j.drudis.2011.04.008
   Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010
   Tang H, 2012, PROTEINS, V80, P1503, DOI 10.1002/prot.24035
   Tautermann Christofer S, 2012, Methods Mol Biol, V914, P255, DOI 10.1007/978-1-62703-023-6_15
   Thai KM, 2010, CHEMMEDCHEM, V5, P436, DOI 10.1002/cmdc.200900374
   Thorsteinsdottir HB, 2006, PROTEINS, V65, P407, DOI 10.1002/prot.21096
   Toschi L, 2006, CHEMMEDCHEM, V1, P1237, DOI 10.1002/cmdc.200600183
   Unwalla RJ, 2010, J COMPUT AID MOL DES, V24, P237, DOI 10.1007/s10822-010-9336-6
   Vakser IA, 2013, CURR OPIN STRUC BIOL, V23, P198, DOI 10.1016/j.sbi.2012.12.003
   Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896
   Waszkowycz B, 2002, CURR OPIN DRUG DISC, V5, P407
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z
   Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503
NR 106
TC 71
Z9 73
U1 3
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD JUL
PY 2014
VL 19
IS 7
BP 890
EP 897
DI 10.1016/j.drudis.2013.10.027
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AL5BO
UT WOS:000339148700012
PM 24216321
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Svensson, K
   Handschin, C
AF Svensson, Kristoffer
   Handschin, Christoph
TI Modulation of PGC-1 alpha activity as a treatment for metabolic and
   muscle-related diseases
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID DUCHENNE MUSCULAR-DYSTROPHY; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA;
   SKELETAL-MUSCLE; MDX MOUSE; RESVERATROL SUPPLEMENTATION; INSULIN
   SENSITIVITY; FIBER-TYPE; MITOCHONDRIAL BIOGENESIS; EXERCISE MIMETICS;
   PHYSICAL-ACTIVITY
C1 [Svensson, Kristoffer; Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USAMuscular Dystrophy
   Association; SwissLife 'Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung'; Swiss Society for Research on Muscle Diseases;
   Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation (UMDF); Association Francaise contre
   les MyopathiesAssociation Francaise contre les Myopathies; Neuromuscular
   Research Association Basel; Gebert-Ruf Foundation 'Rare Diseases'
   Program; University of Basel, Biozentrum
FX Research in our laboratory is supported by the Swiss National Science
   Foundation, the Muscular Dystrophy Association USA, the SwissLife
   'Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung', the
   Swiss Society for Research on Muscle Diseases, the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation (UMDF), the Association Francaise contre les
   Myopathies, the Neuromuscular Research Association Basel, the Gebert-Ruf
   Foundation 'Rare Diseases' Program, the University of Basel and the
   Biozentrum.
CR Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Babraj JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1042, DOI 10.1152/ajpendo.90811.2008
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003
   Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Bueno CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045699
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Carey AL, 2009, DIABETOLOGIA, V52, P2015, DOI 10.1007/s00125-009-1420-x
   Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019
   Dolinsky VW, 2012, J PHYSIOL-LONDON, V590, P2783, DOI 10.1113/jphysiol.2012.230490
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31
   Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley JA, 2009, NUTR REV, V67, P172, DOI 10.1111/j.1753-4887.2009.00185.x
   Hollinger K, 2013, AM J PHYSIOL-REG I, V305, pR13, DOI 10.1152/ajpregu.00221.2012
   Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9
   Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210
   Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047
   Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16
   Jamurtas AZ, 2004, EUR J APPL PHYSIOL, V92, P393, DOI 10.1007/s00421-004-1156-8
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lee-Young RS, 2011, INT J OBESITY, V35, P982, DOI 10.1038/ijo.2010.220
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009
   Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265
   Maddocks Matthew, 2012, Critical Reviews in Oncogenesis, V17, P285
   Markert CD, 2011, MUSCLE NERVE, V43, P464, DOI 10.1002/mus.21987
   McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533
   Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155
   Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063
   Shadfar S, 2011, NUTR CANCER, V63, P749, DOI 10.1080/01635581.2011.563032
   Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119
   Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x
   Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110
   Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839
   Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033426
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012
NR 64
TC 6
Z9 7
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD JUL
PY 2014
VL 19
IS 7
BP 1024
EP 1029
DI 10.1016/j.drudis.2014.02.013
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AL5BO
UT WOS:000339148700032
PM 24631683
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Schleicher, KD
   Dettmer, SL
   Kapinos, LE
   Pagliara, S
   Keyser, UF
   Jeney, S
   Lim, RYH
AF Schleicher, Kai D.
   Dettmer, Simon L.
   Kapinos, Larisa E.
   Pagliara, Stefano
   Keyser, Ulrich F.
   Jeney, Sylvia
   Lim, Roderick Y. H.
TI Selective transport control on molecular velcro made from intrinsically
   disordered proteins
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID NUCLEAR-PORE COMPLEX; FG-NUCLEOPORINS; REPEAT REGIONS; IMPORTIN-BETA;
   DIFFUSION; BINDING; MOTION; DYNAMICS
AB The selectivity and speed of many biological transport processes(1) transpire from a 'reduction of dimensionality'(2) that confines diffusion to one or two dimensions instead of three(3). This behaviour remains highly sought after on polymeric surfaces(4) as a means to expedite diffusional search processes in molecular engineered systems. Here, we have reconstituted the two-dimensional diffusion of colloidal particles on a molecular brush surface. The surface is composed of phenylalanineglycine nucleoporins (FG Nups)(5)-intrinsically disordered proteins that facilitate selective transport through nuclear pore complexes in eukaryotic cells(6). Local and ensemble-level experiments involving optical trapping using a photonic force microscope(7) and particle tracking by video microscopy(8), respectively, reveal that 1-mu m-sized colloidal particles bearing nuclear transport receptors(9) called karyopherins can exhibit behaviour that varies from highly localized to unhindered two-dimensional diffusion. Particle diffusivity is controlled by varying the amount of free karyopherins in solution, which modulates the multivalency of Kap-binding sites within the molecular brush(10). We conclude that the FG Nups resemble stimuli-responsive(11) molecular 'velcro', which can impart 'reduction of dimensionality' as a means of biomimetic transport control in artificial environments.
C1 [Schleicher, Kai D.; Kapinos, Larisa E.; Jeney, Sylvia; Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schleicher, Kai D.; Kapinos, Larisa E.; Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Dettmer, Simon L.; Pagliara, Stefano; Keyser, Ulrich F.] Univ Cambridge, Cavendish Lab, Cambridge CB3 OHE, England.
   [Jeney, Sylvia] Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
RI Pagliara, Stefano/F-2888-2012; Keyser, Ulrich/E-7696-2012
OI Pagliara, Stefano/0000-0001-9796-1956; Keyser,
   Ulrich/0000-0003-3188-5414; Dettmer, Simon Lee/0000-0003-2972-5147; Lim,
   Roderick/0000-0001-5015-6087
FU National Centre of Competence in Research 'Molecular Systems
   Engineering'; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Biozentrum; Swiss Nanoscience Institute; Swiss
   National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [206021_121396, 200021_143703]; ERCEuropean Research Council
   (ERC); Leverhulme; Newton Trust through an Early Career Fellowship
FX The authors thank R.L. Schoch, M. Grimm and F.M. Mor for assistance and
   discussions. RY.H.L., K.D.S. and L.E.K. acknowledge support from the
   National Centre of Competence in Research 'Molecular Systems
   Engineering', the Swiss National Science Foundation, the Biozentrum and
   the Swiss Nanoscience Institute. S.J. acknowledges support from the
   Swiss National Science Foundation (SNF grant nos R'Equip 206021_121396
   and 200021_143703). S.L.D. acknowledges the German Academic Exchange
   Service and the German National Academic Foundation. S.P. and U.F.K.
   acknowledge support from an ERC starting grant. S.P. also acknowledges
   support from the Leverhulme and Newton Trust through an Early Career
   Fellowship.
CR Alberts B., 2002, MOL BIOL CELL
   BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023
   Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923
   Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dettmer SL, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4865552
   Eichmann SL, 2013, LANGMUIR, V29, P2299, DOI 10.1021/la304355t
   Elbaum M, 2006, SCIENCE, V314, P766, DOI 10.1126/science.1135924
   Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318
   Happel J., 1983, LOW REYNOLDS NUMBER
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   JACOBSON K, 1987, ANNU REV PHYSIOL, V49, P163, DOI 10.1146/annurev.ph.49.030187.001115
   Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Kapinos LE, 2014, BIOPHYS J, V106, P1751, DOI 10.1016/j.bpj.2014.02.021
   Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/NNANO.2011.88, 10.1038/nnano.2011.88]
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Martinez-Veracoechea FJ, 2011, P NATL ACAD SCI USA, V108, P10963, DOI 10.1073/pnas.1105351108
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Perl A, 2011, NAT CHEM, V3, P317, DOI [10.1038/nchem.1005, 10.1038/NCHEM.1005]
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   PIERRES A, 1995, J BIOL CHEM, V270, P26586, DOI 10.1074/jbc.270.44.26586
   Rich A., 1968, STRUCTURAL CHEM MOL, P198
   Santer S, 2004, POLYMER, V45, P8279, DOI 10.1016/j.polymer.2004.09.085
   Srinivasan N, 2012, WIRES NANOMED NANOBI, V4, P204, DOI 10.1002/wnan.1160
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239
   Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001
   van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
NR 33
TC 27
Z9 29
U1 1
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
EI 1748-3395
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD JUL
PY 2014
VL 9
IS 7
BP 525
EP 530
DI 10.1038/NNANO.2014.103
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AL4GT
UT WOS:000339091600012
PM 24929341
DA 2021-01-25
ER

PT J
AU Liu, QX
   Wang, XF
   Ikeo, K
   Hirose, S
   Gehring, WJ
   Gojobori, T
AF Liu, Qing-Xin
   Wang, Xian-Feng
   Ikeo, Kazuho
   Hirose, Susumu
   Gehring, Walter J.
   Gojobori, Takashi
TI Evolutionarily conserved transcription factor Apontic controls the G1/S
   progression by inducing cyclin E during eye development
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DEVELOPING DROSOPHILA EYE; CELL-PROLIFERATION; IMAGINAL DISC;
   PATTERN-FORMATION; EGF RECEPTOR; S-PHASE; GENE; EMBRYOGENESIS; HEDGEHOG;
   GROWTH
AB During Drosophila eye development, differentiation initiates in the posterior region of the eye disk and progresses anteriorly as a wave marked by the morphogenetic furrow (MF), which demarcates the boundary between anterior undifferentiated cells and posterior differentiated photoreceptors. However, the mechanism underlying the regulation of gene expression immediately before the onset of differentiation remains unclear. Here, we show that Apontic (Apt), which is an evolutionarily conserved transcription factor, is expressed in the differentiating cells posterior to the MF. Moreover, it directly induces the expression of cyclin E and is also required for the G1-to-S phase transition, which is known to be essential for the initiation of cell differentiation at the MF. These observations identify a pathway crucial for eye development, governed by a mechanism in which Cyclin E promotes the G1-to-S phase transition when regulated by Apt.
C1 [Liu, Qing-Xin; Wang, Xian-Feng] Shandong Agr Univ, Lab Dev Genet, Tai An 271018, Shandong, Peoples R China.
   [Liu, Qing-Xin; Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan.
   [Hirose, Susumu] Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan.
   [Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Gojobori, Takashi] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia.
   [Gojobori, Takashi] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan.
RP Liu, QX (corresponding author), Shandong Agr Univ, Lab Dev Genet, Tai An 271018, Shandong, Peoples R China.
EM liuqingxin@sdau.edu.cn; takashi.gojobori@kaust.edu.sa
RI Hirose, Susumu/I-8865-2019
FU National Basic Research Program of ChinaNational Basic Research Program
   of China [2012CB114600]; Ministry of Education, Culture, Sports, Science
   and Technology of JapanMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT)
FX We thank Helena Richardson for Cyclin E antibody and Yash Hiromi for
   valuable suggestions. This work was supported by National Basic Research
   Program of China Grant 2012CB114600 (to Q.-X. L. and X.-F.W.), a Grant
   in Aid for Scientific Research (to S. H.), and a Research Grant for the
   Cell Innovation Project from the Ministry of Education, Culture, Sports,
   Science and Technology of Japan (to K.I. and T.G.).
CR BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K
   Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502
   Crack D, 2002, DEV BIOL, V241, P157, DOI 10.1006/dbio.2001.0496
   DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983
   Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a
   Eulenberg KG, 1997, EMBO J, V16, P7156, DOI 10.1093/emboj/16.23.7156
   Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017
   Gehring WJ, 2011, GENOME BIOL EVOL
   Gellon G, 1997, DEVELOPMENT, V124, P3321
   HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0
   Hwang HC, 2005, ONCOGENE
   Jones L, 2000, DEVELOPMENT, V127, P4619
   Kim KY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-283
   KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9
   Kumar JP, 1998, DEVELOPMENT, V125, P3875
   Lau KF, 2010, NEUROREPORT, V21, P761, DOI 10.1097/WNR.0b013e32833bfca0
   Liu QX, 2009, GENE DEV, V23, P1165, DOI 10.1101/gad.1774209
   Liu QX, 2003, DEVELOPMENT, V130, P719, DOI 10.1242/dev.00297
   McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6
   RICHARDSON H, 1995, DEVELOPMENT, V121, P3371
   Secombe J, 1998, GENETICS, V149, P1867
   Starz-Gaiano M, 2008, DEV CELL, V14, P726, DOI 10.1016/j.devcel.2008.03.005
   Su MT, 1999, MECH DEVELOP, V80, P125, DOI 10.1016/S0925-4773(98)00197-X
   Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4
   Thomas BI, 1999, TRENDS GENET, V15, P184, DOI 10.1016/S0168-9525(99)01720-5
   THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5
   Tio M, 1997, DEVELOPMENT, V124, P343
   TOMLINSON A, 1988, DEVELOPMENT, V104, P183
   Turkel N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003627
   Woodhouse EC, 2003, P NATL ACAD SCI USA, V100, P11463, DOI 10.1073/pnas.2031202100
   XU T, 1993, DEVELOPMENT, V117, P1223
NR 33
TC 11
Z9 11
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 1
PY 2014
VL 111
IS 26
BP 9497
EP 9502
DI 10.1073/pnas.1407145111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK0QG
UT WOS:000338118900046
PM 24979795
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Siegmund, K
   Lee, WY
   Tchang, VS
   Stiess, M
   Terracciano, L
   Kubes, P
   Pieters, J
AF Siegmund, Kerstin
   Lee, Woo-Yong
   Tchang, Vincent S.
   Stiess, Michael
   Terracciano, Luigi
   Kubes, Paul
   Pieters, Jean
TI Coronin 1 is dispensable for leukocyte recruitment and liver injury in
   concanavalin A-induced hepatitis (vol 153, pg 62, 2013 )
SO IMMUNOLOGY LETTERS
LA English
DT Correction
C1 [Siegmund, Kerstin; Tchang, Vincent S.; Stiess, Michael; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, Mol Pathol Div, CH-4003 Basel, Switzerland.
   [Siegmund, Kerstin; Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada.
RP Siegmund, K (corresponding author), Med Univ Innsbruck, Div Translat Cell Genet, Dept Med Genet Mol & Clin Pharmacol, Peter Mayr Str 1a, A-6020 Innsbruck, Austria.
EM Kerstin.siegmund@i-med.ac.at; jean.pieters@unibas.ch
RI Stiess, Michael/ABF-9835-2020
OI Stiess, Michael/0000-0001-5363-0389
CR Siegmund K, 2013, IMMUNOL LETT, V153, P62, DOI 10.1016/j.imlet.2013.06.005
NR 1
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUL
PY 2014
VL 160
IS 1
BP 105
EP 105
DI 10.1016/j.imlet.2014.04.002
PG 1
WC Immunology
SC Immunology
GA AI8WR
UT WOS:000337208200017
PM 28859836
DA 2021-01-25
ER

PT J
AU Umemura, A
   Park, EJ
   Taniguchi, K
   Lee, JH
   Shalapour, S
   Valasek, MA
   Aghajan, M
   Nakagawa, H
   Seki, E
   Hall, MN
   Karin, M
AF Umemura, Atsushi
   Park, Eek Joong
   Taniguchi, Koji
   Lee, Jun Hee
   Shalapour, Shabnam
   Valasek, Mark A.
   Aghajan, Mariam
   Nakagawa, Hayato
   Seki, Ekihiro
   Hall, Michael N.
   Karin, Michael
TI Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent
   mTORC1 Inhibition
SO CELL METABOLISM
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; COMPLEX 1; LIFE-SPAN;
   RAPAMYCIN; CANCER; ACTIVATION; TRANSPLANTATION; PROLIFERATION;
   PROGRESSION
AB Obesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH) and increases liver cancer risk. Obesity-induced insulin resistance depends, in part, on chronic activation of mammalian target of rapamycin complex 1 (mTORC1), which also occurs in human and mouse hepatocellular carcinoma (HCC), a frequently fatal liver cancer. Correspondingly, mTORC1 inhibitors have been considered as potential NASH and HCC treatments. Using a mouse model in which high-fat diet enhances HCC induction by the hepatic carcinogen DEN, we examined whether mTORC1 inhibition attenuates liver inflammation and tumorigenesis. Notably, rapamycin treatment or hepatocyte-specific ablation of the specific mTORC1 subunit Raptor resulted in elevated interleukin-6 (IL-6) production, activation of signal transducer and activator of transcription 3 (STAT3), and enhanced HCC development, despite a transient reduction in hepatosteatosis. These results suggest that long-term rapamycin treatment, which also increases IL-6 production in humans, is unsuitable for prevention or treatment of obesity-promoted liver cancer.
C1 [Umemura, Atsushi; Taniguchi, Koji; Shalapour, Shabnam; Aghajan, Mariam; Nakagawa, Hayato; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.
   [Park, Eek Joong; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
   [Lee, Jun Hee] Univ Michigan, Dept Mol & Integrat Physiol, Geriatr Ctr, Ann Arbor, MI 48109 USA.
   [Valasek, Mark A.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA.
   [Nakagawa, Hayato] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM karinoffice@ucsd.edu
RI Seki, Ekihiro/K-2481-2016; Nakagawa, Hayato/I-2837-2012
OI Seki, Ekihiro/0000-0002-9472-6085; Nakagawa, Hayato/0000-0002-6973-5094;
   Valasek, Mark/0000-0003-1721-3451; Lee, Jun Hee/0000-0002-2200-6011;
   Umemura, Atsushi/0000-0002-7433-8501
FU Rotary Foundation; Japan Society for the Promotion of ScienceMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of Science; Uehara Memorial Foundation
   Fellowship; Elison Medical Foundation [NS-0932-12]; German Research
   Foundation (DFG)German Research Foundation (DFG) [SH721/1-1]; Daiichi
   Sankyo Foundation for Life Science; Astellas Foundation for Research on
   Metabolic Disorders; NCIUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI); Superfund Basic Research Program [P42ES010337]; Elison
   Medical Foundation; American Association for Study of Liver
   Diseases/American Liver Foundation; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, R01CA118165, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, R01CA118165, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, R01CA155120,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, R01CA118165, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, R01CA118165, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, R01CA155120, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, R01CA118165, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, R01CA155120, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, R01CA155120, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA155120, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, R01CA118165, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, R01CA118165, P30CA023100, P30CA023100,
   P30CA023100, P30CA023100, P30CA023100, P30CA023100, P30CA023100,
   R01CA118165, P30CA023100, P30CA023100, P30CA023100] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572, P30DK020572, P30DK020572,
   P30DK020572, P30DK020572, P30DK020572] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337, P42ES010337, P42ES010337, P42ES010337, P42ES010337,
   P42ES010337] Funding Source: NIH RePORTER
FX A.U. was supported by a Global Grant Scholarship from The Rotary
   Foundation; K.T. was supported by Postdoctoral Fellowship for Research
   Abroad, Research Fellowship for Young Scientists from the Japan Society
   for the Promotion of Science, and the Uehara Memorial Foundation
   Fellowship; J.H.L. was supported by The Elison Medical Foundation
   (NS-0932-12); S. S was supported by the German Research Foundation (DFG,
   SH721/1-1); H.N. was supported by Daiichi Sankyo Foundation for Life
   Science and Astellas Foundation for Research on Metabolic Disorders. M.
   K. is an American Cancer Society Research Professor and the Ben and
   Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases. Research
   was supported by grants from the NCI, the Superfund Basic Research
   Program (P42ES010337 to M. K. and E. S.), The Elison Medical Foundation,
   and the American Association for Study of Liver Diseases/American Liver
   Foundation.
CR Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798
   Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bhat M, 2013, HEPATOLOGY, V58, P810, DOI 10.1002/hep.26323
   Buron F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053078
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015
   Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203
   Faloppi L, 2011, CANCER TREAT REV, V37, P169, DOI 10.1016/j.ctrv.2010.08.001
   Galluzzi L, 2012, METHODS MOL BIOL, V821, P125, DOI 10.1007/978-1-61779-430-8_9
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Leffert H L, 1979, Methods Enzymol, V58, P536
   LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Massoud O, 2012, J HEPATOL, V56, P288, DOI 10.1016/j.jhep.2011.06.012
   Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031
   Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352
   Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739
   Mercalli A, 2013, IMMUNOLOGY, V140, P179, DOI 10.1111/imm.12126
   Merlen G, 2014, J HEPATOL, V60, P152, DOI 10.1016/j.jhep.2013.08.025
   Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223
   Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674
   Novartis, 2013, GLOB STUD LOOK COMB
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Peddi VR, 2013, TRANSPLANT REV-ORLAN, V27, P97, DOI 10.1016/j.trre.2013.06.001
   Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09
   Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   Watt KD, 2012, LIVER TRANSPLANT, V18, pS52, DOI 10.1002/lt.23515
   Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yamanaka K, 2013, CANCER MED-US, V2, P862, DOI 10.1002/cam4.150
   Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124
   Zhu AX, 2011, CANCER-AM CANCER SOC, V117, P5094, DOI 10.1002/cncr.26165
NR 48
TC 83
Z9 84
U1 1
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JUL 1
PY 2014
VL 20
IS 1
BP 133
EP 144
DI 10.1016/j.cmet.2014.05.001
PG 12
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA AO5QZ
UT WOS:000341401300015
PM 24910242
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Biasini, M
   Bienert, S
   Waterhouse, A
   Arnold, K
   Studer, G
   Schmidt, T
   Kiefer, F
   Cassarino, TG
   Bertoni, M
   Bordoli, L
   Schwede, T
AF Biasini, Marco
   Bienert, Stefan
   Waterhouse, Andrew
   Arnold, Konstantin
   Studer, Gabriel
   Schmidt, Tobias
   Kiefer, Florian
   Cassarino, Tiziano Gallo
   Bertoni, Martino
   Bordoli, Lorenza
   Schwede, Torsten
TI SWISS-MODEL: modelling protein tertiary and quaternary structure using
   evolutionary information
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID STRUCTURE PREDICTION; SECONDARY STRUCTURE; QUALITY; WEB; RECOGNITION;
   ENVIRONMENT; PDBVIEWER; SINGLE; SERVER; SCORE
AB Protein structure homology modelling has become a routine technique to generate 3D models for proteins when experimental structures are not available. Fully automated servers such as SWISS-MODEL with user-friendly web interfaces generate reliable models without the need for complex software packages or downloading large databases. Here, we describe the latest version of the SWISS-MODEL expert system for protein structure modelling. The SWISS-MODEL template library provides annotation of quaternary structure and essential ligands and co-factors to allow for building of complete structural models, including their oligomeric structure. The improved SWISS-MODEL pipeline makes extensive use of model quality estimation for selection of the most suitable templates and provides estimates of the expected accuracy of the resulting models. The accuracy of the models generated by SWISS-MODEL is continuously evaluated by the CAMEO system. The new web site allows users to interactively search for templates, cluster them by sequence similarity, structurally compare alternative templates and select the ones to be used for model building. In cases where multiple alternative template structures are available for a protein of interest, a user-guided template selection step allows building models in different functional states.
C1 [Biasini, Marco; Bienert, Stefan; Waterhouse, Andrew; Arnold, Konstantin; Studer, Gabriel; Schmidt, Tobias; Kiefer, Florian; Cassarino, Tiziano Gallo; Bertoni, Martino; Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Biasini, Marco; Bienert, Stefan; Waterhouse, Andrew; Arnold, Konstantin; Studer, Gabriel; Schmidt, Tobias; Kiefer, Florian; Cassarino, Tiziano Gallo; Bertoni, Martino; Bordoli, Lorenza; Schwede, Torsten] SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Cassarino, Tiziano Gallo/AAM-2845-2020
OI Schwede, Torsten/0000-0003-2715-335X; Cassarino, Tiziano
   Gallo/0000-0001-9220-2360; Bertoni, Martino/0000-0003-0720-1027; Studer,
   Gabriel/0000-0003-0462-1456
FU Swiss Institute of Bioinformatics (SIB); Swiss Foundation for Excellence
   and Talent in Biomedical Research; Biozentrum University of Basel
   international PhD program; Werner von Siemens Foundation
FX Swiss Institute of Bioinformatics (SIB); PhD fellowship of the SIB by
   the 'Swiss Foundation for Excellence and Talent in Biomedical Research'
   [to G.S.]; fellowship for the Biozentrum University of Basel
   international PhD program by the Werner von Siemens Foundation [to
   M.Be.]. Funding for open access charge: SIB Swiss Institute of
   Bioinformatics.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Biasini M, 2013, ACTA CRYSTALLOGR D, V69, P701, DOI 10.1107/S0907444913007051
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Buenavista MT, 2012, BIOINFORMATICS, V28, P1851, DOI 10.1093/bioinformatics/bts292
   Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Haas J, 2013, DATABASE-OXFORD, V2013, DOI DOI 10.1093/DATABASE/BAT031
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468
   Kryshtafovych A, 2014, PROTEINS, V82, P112, DOI 10.1002/prot.24347
   Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172
   Poupon A, 2010, METHODS MOL BIOL, V609, P349, DOI 10.1007/978-1-60327-241-4_20
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
   Rykunov Dmitry, 2009, Journal of Structural and Functional Genomics, V10, P95, DOI 10.1007/s10969-008-9044-9
   Sadowski MI, 2007, PROTEINS, V69, P476, DOI 10.1002/prot.21531
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schmidt T., 2013, DRUG DISCOV TODAY
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Schwede T., 2008, COMPUTATIONAL STRUCT, P3
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350
NR 35
TC 2849
Z9 2933
U1 11
U2 237
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2014
VL 42
IS W1
BP W252
EP W258
DI 10.1093/nar/gku340
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AM2XN
UT WOS:000339715000042
PM 24782522
OA DOAJ Gold, Green Published, Green Accepted
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Lepore, M
   de Lalla, C
   Gundimeda, SR
   Gsellinger, H
   Consonni, M
   Garavaglia, C
   Sansano, S
   Piccolo, F
   Scelfo, A
   Haussinger, D
   Montagna, D
   Locatelli, F
   Bonini, C
   Bondanza, A
   Forcina, A
   Li, ZY
   Ni, GH
   Ciceri, F
   Jeno, P
   Xia, CF
   Mori, L
   Dellabona, P
   Casorati, G
   De Libero, G
AF Lepore, Marco
   de Lalla, Claudia
   Gundimeda, S. Ramanjaneyulu
   Gsellinger, Heiko
   Consonni, Michela
   Garavaglia, Claudio
   Sansano, Sebastiano
   Piccolo, Francesco
   Scelfo, Andrea
   Haeussinger, Daniel
   Montagna, Daniela
   Locatelli, Franco
   Bonini, Chiara
   Bondanza, Attilio
   Forcina, Alessandra
   Li, Zhiyuan
   Ni, Guanghui
   Ciceri, Fabio
   Jenoe, Paul
   Xia, Chengfeng
   Mori, Lucia
   Dellabona, Paolo
   Casorati, Giulia
   De Libero, Gennaro
TI A novel self-lipid antigen targets human T cells against CD1c(+)
   leukemias
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID ACUTE MYELOID-LEUKEMIA; NKT CELLS; MASS-SPECTROMETRY;
   MYCOBACTERIUM-TUBERCULOSIS; ELECTROSPRAY-IONIZATION; LYSOPHOSPHATIDIC
   ACID; DONOR LYMPHOCYTES; IMMUNE-RESPONSES; CANCER; GLYCOLIPIDS
AB T cells that recognize self-lipids presented by CD1c are frequent in the peripheral blood of healthy individuals and kill transformed hematopoietic cells, but little is known about their antigen specificity and potential antileukemia effects. We report that CD1c self-reactive T cells recognize a novel class of self-lipids, identified as methyl-lysophosphatidic acids (mLPAs), which are accumulated in leukemia cells. Primary acute myeloid and B cell acute leukemia blasts express CD1 molecules. mLPA-specific T cells efficiently kill CD1c(+) acute leukemia cells, poorly recognize nontransformed CD1c-expressing cells, and protect immuno-deficient mice against CD1c+ human leukemia cells. The identification of immunogenic self-lipid antigens accumulated in leukemia cells and the observed leukemia control by lipid-specific T cells in vivo provide a new conceptual framework for leukemia immune surveillance and possible immunotherapy.
C1 [Lepore, Marco; Gundimeda, S. Ramanjaneyulu; Sansano, Sebastiano; Mori, Lucia; De Libero, Gennaro] Univ Basel, Univ Hosp Basel, Dept Biomed, CH-4056 Basel, Switzerland.
   [Gsellinger, Heiko; Haeussinger, Daniel] Univ Basel, Dept Chem, Nucl Magnet Resonance Lab, CH-4056 Basel, Switzerland.
   [Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   [Lepore, Marco; de Lalla, Claudia; Consonni, Michela; Garavaglia, Claudio; Piccolo, Francesco; Scelfo, Andrea; Dellabona, Paolo; Casorati, Giulia] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Expt Immunol Unit, I-20132 Milan, Italy.
   [Bonini, Chiara; Bondanza, Attilio] Ist Sci San Raffaele, Expt Hematol Unit, I-20132 Milan, Italy.
   [Forcina, Alessandra; Ciceri, Fabio] Ist Sci San Raffaele, Bone Marrow Transplantat Unit, I-20132 Milan, Italy.
   [Montagna, Daniela] Univ Pavia, Dipartimento Pediat, Immunol Lab, I-27100 Pavia, Italy.
   [Montagna, Daniela] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy.
   [Locatelli, Franco] IRCCS Bambino Gesu Hosp, Dept Pediat Hematol Oncol, I-00165 Rome, Italy.
   [Li, Zhiyuan; Ni, Guanghui; Xia, Chengfeng] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochemistry & Plant Resources We, Kunming 650201, Peoples R China.
   [Mori, Lucia; De Libero, Gennaro] Singapore Immunol Network SIgN Agcy Sci Tech & Re, Singapore 138648, Singapore.
RP De Libero, G (corresponding author), Univ Basel, Univ Hosp Basel, Dept Biomed, CH-4056 Basel, Switzerland.
EM lucia_mori@immunol.a-star.edu.sg; dellabona.paolo@hsr.it;
   casorati.giulia@hsr.it; gennaro.delibero@unibas.ch
RI Montagna, Daniela/AAK-9380-2020; Dellabona, Paolo/G-5416-2012; Casorati,
   Giulia/J-7141-2018; Consonni, Michela/AAN-7695-2020; Haussinger,
   Daniel/C-6617-2016; garavaglia, claudio/AAO-2748-2020; bonini,
   chiara/I-9202-2012
OI Dellabona, Paolo/0000-0002-1414-633X; Casorati,
   Giulia/0000-0002-5102-4112; Consonni, Michela/0000-0003-1224-6449;
   Haussinger, Daniel/0000-0002-4798-0072; garavaglia,
   claudio/0000-0003-2299-2883; BONINI, Maria Chiara/0000-0002-0772-1674;
   Lepore, Marco/0000-0003-1353-8224; MONTAGNA, DANIELA/0000-0002-1533-579X
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100AO-122464/1, Sinergia CRS133-124819]; Association for International
   Cancer Research; Italian Ministry of HealthMinistry of Health, Italy;
   Italian Association for Cancer Research (Special Program 5x1000
   9965)Associazione Italiana per la Ricerca sul Cancro (AIRC)
   [AIRC-IG-5804, AIRC-IG-11523]; AIRC Special Program 5x1000
   9962Associazione Italiana per la Ricerca sul Cancro (AIRC); Yunnan
   High-End Technology Professionals Introduction Program [2010CI117]
FX This work was supported by grants from the Swiss National Foundation
   (3100AO-122464/1 and Sinergia CRS133-124819) awarded to G. De Libero,
   Oncosuisse awards to L. Mori and G. De Libero, grants from the
   Association for International Cancer Research to P. Dellabona, G.
   Casorati, L. Mori, and G. De Libero, grants from the Italian Ministry of
   Health and the Italian Association for Cancer Research (AIRC-IG-5804,
   AIRC-IG-11523, Special Program 5x1000 9965) to P. Dellabona and G.
   Casorati, AIRC Special Program 5x1000 9962 to F. Locatelli, and Yunnan
   High-End Technology Professionals Introduction Program (2010CI117) to C.
   Xia.
CR Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704
   Berzofsky JA, 2009, CURR MOL MED, V9, P667, DOI 10.2174/156652409788970706
   Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716
   Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733
   Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608
   Canderan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012014
   Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451
   Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93
   Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831
   Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9
   de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956
   de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211
   De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013
   DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763
   Dhodapkar MV, 2011, CLIN IMMUNOL, V140, P160, DOI 10.1016/j.clim.2010.12.010
   Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358
   Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069
   Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006
   Endo T, 2009, J BIOCHEM, V146, P283, DOI 10.1093/jb/mvp068
   Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245
   Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244
   Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097
   Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0
   Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P2065, DOI 10.1016/j.jasms.2007.08.019
   Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021
   Jager D, 2001, J CLIN PATHOL, V54, P669, DOI 10.1136/jcp.54.9.669
   Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070
   Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407
   Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974
   Manolova V, 2003, EUR J IMMUNOL, V33, P29, DOI 10.1002/immu.200390004
   Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755
   Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408
   Metelitsa LS, 2011, CLIN IMMUNOL, V140, P119, DOI 10.1016/j.clim.2010.10.005
   Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143
   Montagna D, 2006, BLOOD, V108, P3843, DOI 10.1182/blood-2006-05-021535
   Montamat-Sicotte DJ, 2011, J CLIN INVEST, V121, P2493, DOI 10.1172/JCI46216
   Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353
   Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119
   Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027
   Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585
   Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297
   Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700
   Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001
   Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405
   Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061
   Rubnitz JE, 2008, PEDIATR CLIN N AM, V55, P21, DOI 10.1016/j.pcl.2007.11.003
   Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006
   Seremet T, 2011, CANCER J, V17, P325, DOI 10.1097/PPO.0b013e3182326004
   Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X
   Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963
   Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U
   Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669
   Speiser DE, 2010, SEMIN IMMUNOL, V22, P144, DOI 10.1016/j.smim.2010.03.004
   Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157
   Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036
   van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001
   Vidriales MB, 2003, BLOOD, V101, P4695, DOI 10.1182/blood-2002-08-2613
   Vincent MS, 2005, J IMMUNOL, V175, P6344, DOI 10.4049/jimmunol.175.10.6344
   Vincent MS, 2002, NAT IMMUNOL, V3, P1163, DOI 10.1038/ni851
   Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001
   Wingard JR, 2011, J CLIN ONCOL, V29, P2230, DOI 10.1200/JCO.2010.33.7212
   Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102
   Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446
   Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503
NR 66
TC 58
Z9 58
U1 0
U2 17
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD JUN 30
PY 2014
VL 211
IS 7
BP 1360
EP 1374
DI 10.1084/jem.20140410
PG 15
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA AL2AD
UT WOS:000338927200009
PM 24935257
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Siamer, S
   Guillas, I
   Shimobayashi, M
   Kunz, C
   Hall, MN
   Barny, MA
AF Siamer, Sabrina
   Guillas, Isabelle
   Shimobayashi, Mitsugu
   Kunz, Caroline
   Hall, Michael N.
   Barny, Marie-Anne
TI Expression of the Bacterial Type III Effector DspA/E in Saccharomyces
   cerevisiae Down-regulates the Sphingolipid Biosynthetic Pathway Leading
   to Growth Arrest
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID STEWARTII SUBSP STEWARTII; CHAIN FATTY-ACIDS; HRP GENE-CLUSTER;
   ERWINIA-AMYLOVORA; CELL-DEATH; PSEUDOMONAS-SYRINGAE;
   ARABIDOPSIS-THALIANA; SERINE PALMITOYLTRANSFERASE; CERAMIDE SYNTHESIS;
   CATALYTIC SUBUNIT
AB Erwinia amylovora, the bacterium responsible for fire blight, relies on a type III secretion system and a single injected effector, DspA/E, to induce disease in host plants. DspA/E belongs to the widespread AvrE family of type III effectors that suppress plant defense responses and promote bacterial growth following infection. Ectopic expression of DspA/E in plant or in Saccharomyces cerevisiae is toxic, indicating that DspA/E likely targets a cellular process conserved between yeast and plant. To unravel the mode of action of DspA/E, we screened the Euroscarf S. cerevisiae library for mutants resistant to DspA/E-induced growth arrest. The most resistant mutants (Delta sur4,Delta fen1,Delta ipt1,Delta skn1,Delta csg1, Delta csg2,Delta orm1, and Delta orm2) were impaired in the sphingolipid biosynthetic pathway. Exogenously supplied sphingolipid precursors such as the long chain bases (LCBs) phytosphingosine and dihydrosphingosine also suppressed the DspA/E-induced yeast growth defect. Expression of DspA/E in yeast down-regulated LCB biosynthesis and induced a rapid decrease in LCB levels, indicating that serine palmitoyltransferase (SPT), the first and rate-limiting enzyme of the sphingolipid biosynthetic pathway, was repressed. SPT down-regulation was mediated by dephosphorylation and activation of Orm proteins that negatively regulate SPT. A Delta cdc55 mutation affecting Cdc55-PP2A protein phosphatase activity prevented Orm dephosphorylation and suppressed DspA/E-induced growth arrest.
C1 [Siamer, Sabrina; Barny, Marie-Anne] Univ Paris 06, INRA UMR1392, IEES, F-75252 Paris, France.
   [Guillas, Isabelle] Univ Paris 06, Sorbonne Univ, UMR1166, INSERM,Pitie Salpetriere Univ Hosp, F-75013 Paris, France.
   [Siamer, Sabrina; Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kunz, Caroline] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France.
   [Kunz, Caroline] Museum Natl Hist Nat, UMR7245, F-75005 Paris, France.
RP Barny, MA (corresponding author), Univ Paris 06, INRA UMR1392, IEES, Bat A-7eme Etage Case 237,7 Quai St Bernard, F-75252 Paris, France.
EM barny@agroparistech.fr
OI Shimobayashi, Mitsugu/0000-0002-6936-0990; marie-anne,
   barny/0000-0002-2005-1388; Guillas, Isabelle/0000-0002-6073-0529
FU Agence Nationale de la Recherche Jeune Chercheur DspCellDeath
   grantFrench National Research Agency (ANR); Contrat Jeune Scientifique
   "Institut National de la Recherche Agronomique" Ph.D. fellowship;
   European Molecular Biology OrganizationEuropean Molecular Biology
   Organization (EMBO)
FX This work was supported in part by the Agence Nationale de la Recherche
   Jeune Chercheur DspCellDeath grant.; Recipient of a Contrat Jeune
   Scientifique "Institut National de la Recherche Agronomique" Ph.D.
   fellowship and a European Molecular Biology Organization short term
   fellowship.
CR Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003
   Bach L, 2011, J CELL SCI, V124, P3223, DOI 10.1242/jcs.074575
   Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099
   Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132
   BARNY MA, 1990, MOL MICROBIOL, V4, P777, DOI 10.1111/j.1365-2958.1990.tb00648.x
   Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480
   Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356
   Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007
   Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325
   Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016
   Boureau T, 2011, MOL PLANT MICROBE IN, V24, P577, DOI 10.1094/MPMI-09-10-0212
   Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72
   Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961
   Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005
   Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787
   Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606
   Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774
   Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x
   Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004
   Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x
   DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101
   Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076
   Degrave A, 2013, MOL PLANT PATHOL, V14, P506, DOI 10.1111/mpp.12022
   Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004
   Dietrich CR, 2008, PLANT J, V54, P284, DOI 10.1111/j.1365-313X.2008.03420.x
   Dutton MF, 1996, PHARMACOL THERAPEUT, V70, P137, DOI 10.1016/0163-7258(96)00006-X
   Frederick RD, 2001, MOL PLANT MICROBE IN, V14, P1213, DOI 10.1094/MPMI.2001.14.10.1213
   Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008
   Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI [10.1111/j.1364-3703.2008.00489.x, 10.1111/J.1364-3703.2008.00489.X]
   Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943
   Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021
   Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388
   Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368
   Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931
   Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473
   Mor H, 2001, MOL PLANT MICROBE IN, V14, P431, DOI 10.1094/MPMI.2001.14.3.431
   Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809
   Oh CS, 2007, MOL PLANT PATHOL, V8, P255, DOI 10.1111/j.1364-3703.2007.00390.X
   Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376
   Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108
   Saucedo-Garcia M, 2011, NEW PHYTOL, V191, P943, DOI 10.1111/j.1469-8137.2011.03727.x
   Shi LH, 2007, CELL RES, V17, P1030, DOI 10.1038/cr.2007.100
   Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006
   Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753
   Siamer S, 2011, FEBS OPEN BIO, V1, P23, DOI 10.1016/j.fob.2011.11.001
   Siamer S, 2013, FEMS MICROBIOL LETT, V342, P54, DOI 10.1111/1574-6968.12108
   Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209
   Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030
   Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562
   Voynova NS, 2012, BIOCHEM J, V447, P103, DOI 10.1042/BJ20120712
   Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
NR 60
TC 11
Z9 12
U1 1
U2 24
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 27
PY 2014
VL 289
IS 26
BP 18466
EP 18477
DI 10.1074/jbc.M114.562769
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AJ9OM
UT WOS:000338042000043
PM 24828506
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Lebrun-Julien, F
   Bachmann, L
   Norrmen, C
   Trotzmuller, M
   Kofeler, H
   Ruegg, MA
   Hall, MN
   Suter, U
AF Lebrun-Julien, Frederic
   Bachmann, Lea
   Norrmen, Camilla
   Troetzmueller, Martin
   Koefeler, Harald
   Rueegg, Markus A.
   Hall, Michael N.
   Suter, Ueli
TI Balanced mTORC1 Activity in Oligodendrocytes Is Required for Accurate
   CNS Myelination
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE mTOR; myelin; oligodendrocytes; TSC1; TSC2; tuberous sclerosis
ID MAMMALIAN TARGET; TUBEROUS SCLEROSIS; TSC1-TSC2 COMPLEX; RAPAMYCIN
   PATHWAY; AXONAL INTEGRITY; MESSENGER-RNA; SCHWANN-CELLS; MOUSE MODEL;
   AKT; CHOLESTEROL
AB The mammalian target of rapamycin (mTOR) pathway integrates multiple signals and regulates crucial cell functions via the molecular complexes mTORC1 and mTORC2. These complexes are functionally dependent on their raptor (mTORC1) or rictor (mTORC2) subunits. mTOR has been associated with oligodendrocyte differentiation and myelination downstream of the PI3K/Akt pathway, but the functional contributions of individual complexes are largely unknown. We show, by oligodendrocyte-specific genetic deletion of Rptor and/or Rictor in the mouse, that CNS myelination is mainly dependent on mTORC1 function, with minor mTORC2 contributions. Myelin-associated lipogenesis and protein gene regulation are strongly reliant on mTORC1. We found that also oligodendrocyte-specific overactivation of mTORC1, via ablation of tuberous sclerosis complex 1 (TSC1), causes hypomyelination characterized by downregulation of Akt signaling and lipogenic pathways. Our data demonstrate that a delicately balanced regulation of mTORC1 activation and action in oligodendrocytes is essential for CNS myelination, which has practical overtones for understanding CNS myelin disorders.
C1 [Lebrun-Julien, Frederic; Bachmann, Lea; Norrmen, Camilla; Suter, Ueli] ETH, Dept Biol, Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.
   [Troetzmueller, Martin; Koefeler, Harald] Med Univ Graz, Core Facil Mass Spectrometry Lipid, Med Res Ctr, A-8010 Graz, Austria.
   [Troetzmueller, Martin; Koefeler, Harald] Omics Ctr Graz, A-8010 Graz, Austria.
   [Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Suter, U (corresponding author), ETH, Dept Biol, Swiss Fed Inst Technol, Otto Stern Weg 7,HPL F36, CH-8093 Zurich, Switzerland.
EM usuter@cell.biol.ethz.ch
RI Norrmen, Camilla/B-6406-2016; Ruegg, Markus/X-7256-2019; Suter,
   Ueli/A-1624-2010
OI Norrmen, Camilla/0000-0001-9045-8864; Ruegg, Markus/0000-0002-4974-9384;
   Kofeler, Harald/0000-0002-2725-9616; Trotzmuller,
   Martin/0000-0003-0545-9892
FU Marie Curie International Incoming Fellowship within the 7th European
   Community frameworkEuropean Union (EU); Swiss Federal Institute of
   Technology (ETH) fellowship; Marie Curie Intra European Fellowship
   within the 7th European Community framework; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); National Center of
   Competence in Research "Neural Plasticity and Repair."Swiss National
   Science Foundation (SNSF)
FX F. L. J. was supported by a Marie Curie International Incoming
   Fellowship within the 7th European Community framework and a Swiss
   Federal Institute of Technology (ETH) fellowship. C. N. was supported by
   a Marie Curie Intra European Fellowship within the 7th European
   Community framework. Work in the laboratory of U. S. is funded by the
   Swiss National Science Foundation and the National Center of Competence
   in Research "Neural Plasticity and Repair." We thank Klaus-Armin Nave
   for providing CNP-cre mice, Mario Pende and Karim Nadra for providing
   processed tissues of S6K1; S6K2 double-null mice, Nahum Sonenberg and
   Arkady Khoutorsky for providing processed tissue of Eif4ebp1; Eif4ebp2
   double-null mice, Steven Scherer and Werner Kovacs for antibodies, the
   Electron Microscopy and Light Microscopy Centers of the ETH Zurich,
   members of the Suter laboratory for fruitful discussions, Ned Mantei for
   critically reading the manuscript, and Jorge Pereira for support and
   input.
CR Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609
   Ando S, 2003, NEUROCHEM RES, V28, P5, DOI 10.1023/A:1021635826032
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6
   Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014
   Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668
   Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041
   Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024
   Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015
   Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323
   Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009
   Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629
   Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550
   Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008
   Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002
   Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010
   Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108
   Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281
   Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090
   Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08
   Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217
   HUETHER G, 1986, NEUROCHEM RES, V11, P1303, DOI 10.1007/BF00966124
   Ishii A, 2012, J NEUROSCI, V32, P8855, DOI 10.1523/JNEUROSCI.0137-12.2012
   Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002
   Laplante M, 2012, COLD SPRING HARB PER, P4
   Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107
   Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0
   Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495
   Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506
   Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200
   Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007
   Mietzsch U, 2013, J COMP NEUROL, V521, P3817, DOI 10.1002/cne.23380
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Morrison BM, 2013, TRENDS CELL BIOL, V23, P644, DOI 10.1016/j.tcb.2013.07.007
   Napolioni V, 2009, BRAIN DEV-JPN, V31, P104, DOI 10.1016/j.braindev.2008.09.013
   Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Roux P.P., 2012, COLD SPRING HARB PER, V4
   Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426
   Saher G, 2010, SUBCELL BIOCHEM, V51, P489, DOI 10.1007/978-90-481-8622-8_18
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012
   Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649
   Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930
   Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330
   Tyler WA, 2011, GLIA, V59, P1754, DOI 10.1002/glia.21221
   Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009
   van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053
   Verheijen MHG, 2009, P NATL ACAD SCI USA, V106, P21383, DOI 10.1073/pnas.0905633106
   Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014
   Wood TL, 2013, ASN NEURO, V5, P63, DOI 10.1042/AN20120092
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006
   Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222
   Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020
NR 69
TC 76
Z9 78
U1 0
U2 8
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUN 18
PY 2014
VL 34
IS 25
BP 8432
EP 8448
DI 10.1523/JNEUROSCI.1105-14.2014
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA AK5FD
UT WOS:000338449200006
PM 24948799
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Kanca, O
   Ochoa-Espinosa, A
   Affolter, M
AF Kanca, Oguz
   Ochoa-Espinosa, Amanda
   Affolter, Markus
TI IV. Tools and methods for studying cell migration and cell rearrangement
   in tissue and organ development
SO METHODS
LA English
DT Article
DE Imaging; Drosophila; Cell migration; Techniques
ID TRACHEAL BRANCHING MORPHOGENESIS; DOUBLE-STRANDED-RNA;
   DROSOPHILA-MELANOGASTER; IN-VIVO; TRANSGENIC RNAI; GENETIC-CONTROL;
   FUSION PROTEIN; APICAL CONSTRICTION; ADHERENS JUNCTIONS; LIVING
   DROSOPHILA
AB A vast diversity of biological systems, ranging from prokaryotes to multicellular organisms, show cell migration behavior. Many of the basic cellular and molecular concepts in cell migration apply to diverse model organisms. Drosophila, with its vast repertoire of tools for imaging and for manipulation, is one of the favorite organisms to study cell migration. Moreover, distinct Drosophila tissues and organs offer diverse cell migration models that are amenable to live imaging and genetic manipulations. In this review, we will provide an overview of the fruit fly toolbox that is of particular interest for the analysis of cell migration. We provide examples to highlight how those tools were used in diverse migration systems, with an emphasis on tracheal morphogenesis, a process that combines morphogenesis with cell migration. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kanca, Oguz; Ochoa-Espinosa, Amanda; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Kanca, Oguz/I-6672-2015
OI Kanca, Oguz/0000-0001-5438-0879; Ochoa-Espinosa,
   Amanda/0000-0003-1943-790X; Affolter, Markus/0000-0002-5171-0016
CR Abramoff D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024
   BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930
   Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088
   Batz T, 2014, DEVELOPMENT, V141, P899, DOI 10.1242/dev.102160
   Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930
   Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942
   Caussinus E., 2013, CURR PROTOC PROTEIN, V73
   Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890
   Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567
   Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178
   Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935
   Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903
   DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251
   Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1
   Fernandez-Espartero CH, 2013, J CELL SCI, V126, P2285, DOI 10.1242/jcs.124438
   Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3
   Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087
   Gratz S.J., 2013, FLY AUSTIN, P7
   Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105
   Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567
   Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566
   Harder B, 2008, BIOTECHNIQUES, V44, P765, DOI 10.2144/000112884
   Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/NNM.13.86, 10.2217/nnm.13.86]
   Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426
   Ikeya T, 1999, DEVELOPMENT, V126, P4455
   Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012
   Kamiyama D, 2009, SCIENCE, V324, P1338, DOI 10.1126/science.1170615
   Kanca O, 2014, DEVELOPMENT, V141, P472, DOI 10.1242/dev.102913
   Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531
   Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471
   Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727
   Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018
   Kondo T, 2013, NATURE, V494, P125, DOI 10.1038/nature11792
   Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X
   Lebreton G, 2014, J CELL SCI, V127, P465, DOI 10.1242/jcs.142737
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293
   Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179
   Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536
   Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522
   Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003
   McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035
   Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001
   Monier B., 2010, NAT CELL BIOL, V60, P1
   Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006
   Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198
   Myat MM, 2005, DEV BIOL, V281, P38, DOI 10.1016/j.ydbio.2005.02.005
   Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146
   Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]
   Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630
   Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080
   Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397
   Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450
   Oda H, 2001, J CELL SCI, V114, P493
   Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246
   Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298
   Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663
   Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009
   Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447
   Perrimon N, 2007, FLY, V1, P1
   Pichler Garwin, 2012, Methods Mol Biol, V911, P475, DOI 10.1007/978-1-61779-968-6_29
   Pitsouli C, 2010, DEVELOPMENT, V137, P3615, DOI 10.1242/dev.056408
   Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566
   Raychaudhuri N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001434
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Roper K, 2012, DEV CELL, V23, P939, DOI 10.1016/j.devcel.2012.09.013
   Rolls MM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-7
   Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998
   Romer T, 2011, CURR OPIN BIOTECH, V22, P882, DOI 10.1016/j.copbio.2011.06.007
   Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231
   Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953
   Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x
   Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110
   St Johnston D, 2013, WIRES DEV BIOL, V2, P587, DOI 10.1002/wdev.101
   Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130
   Tanaka H, 2004, DEV BIOL, V274, P413, DOI 10.1016/j.ydbio.2004.07.035
   Taxis C, 2012, METHODS MOL BIOL, V832, P611, DOI 10.1007/978-1-61779-474-2_43
   Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25
   Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553
   Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061
   Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712
   Worley MI, 2013, DEVELOPMENT, V140, P3275, DOI 10.1242/dev.096057
   Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049
   Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979
NR 104
TC 0
Z9 0
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD JUN 15
PY 2014
VL 68
IS 1
BP 228
EP 232
DI 10.1016/j.ymeth.2014.03.004
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AJ3FG
UT WOS:000337551300025
PM 24631575
DA 2021-01-25
ER

PT J
AU Kuert, PA
   Hartenstein, V
   Bello, BC
   Lovick, JK
   Reichert, H
AF Kuert, Philipp A.
   Hartenstein, Volker
   Bello, Bruno C.
   Lovick, Jennifer K.
   Reichert, Heinrich
TI Neuroblast lineage identification and lineage-specific Hox gene action
   during postembryonic development of the subesophageal ganglion in the
   Drosophila central brain
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Neuroblast; lineage; Hox; Dfd; Scr; Antp
ID CENTRAL-NERVOUS-SYSTEM; REPRESSIBLE CELL MARKER; MOLECULAR MARKERS;
   MOSAIC ANALYSIS; PATTERN; ORGANIZATION; PROLIFERATION; NEUROGENESIS;
   MELANOGASTER; ARCHITECTURE
AB The central brain of Drosophila consists of the supraesophageal ganglion (SPG) and the subesophageal ganglion (SEG), both of which are generated by neural stem cell-like neuroblasts during embryonic and postembryonic development. Considerable information has been obtained on postembryonic development of the neuroblasts and their lineages in the SPG. In contrast, very little is known about neuroblasts, neural lineages, or any other aspect of the postembryonic development in the SEG. Here we characterize the neuroanatomy of the larval SEG in terms of tracts, commissures, and other landmark features as compared to a thoracic ganglion. We then use clonal MARCM labeling to identify all adult-specific neuroblast lineages in the late larval SEG and find a surprisingly small number of neuroblast lineages, 13 paired and one unpaired. The Hox genes Dfd, Scr, and Antp are expressed in a lineage-specific manner in these lineages during postembryonic development. Hox gene loss-of-function causes lineage-specific defects in axonal targeting and reduction in neural cell numbers. Moreover, it results in the formation of novel ectopic neuroblast lineages. Apoptosis block also results in ectopic lineages suggesting that Hox genes are required for lineage-specific termination of proliferation through programmed cell death. Taken together, our findings show that postembryonic development in the SEG is mediated by a surprisingly small set of identified lineages and requires lineage-specific Hox gene action to ensure the correct formation of adult-specific neurons in the Drosophila brain. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kuert, Philipp A.; Bello, Bruno C.; Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hartenstein, Volker; Lovick, Jennifer K.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA.
RP Kuert, PA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM philipp.kuert@unibas.ch; volkerh@mcdb.ucla.edu; jlovick@ucla.edu;
   heinrich.reichert@unibas.ch
RI Lovick, Jennifer/Q-3886-2019
FU Swiss NSFSwiss National Science Foundation (SNSF); Sinergia Program
   [CRSII3 136307]
FX We thank Rolf Urbach, Amelia Younossi-Hartenstein and Susanne Flister.
   Supported by the Swiss NSF and the Sinergia Program CRSII3 136307.
CR Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   Brierley DJ, 2012, J COMP NEUROL, V520, P1629, DOI 10.1002/cne.23003
   Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762
   Cardona A, 2009, J COMP NEUROL, V515, P427, DOI 10.1002/cne.22086
   Condie JM, 1991, DROSOPHILA INFORMATI, V70, P52
   del Toro ED, 2001, J NEUROSCI, V21, P5637
   DOE CQ, 1992, DEVELOPMENT, V116, P855
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4
   Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015
   Kuert PA, 2012, BIOL OPEN, V1, P1006, DOI 10.1242/bio.20121966
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x
   Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699
   Lovick JK, 2013, DEV BIOL, V384, P228, DOI 10.1016/j.ydbio.2013.07.008
   Marin EC, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-31
   Monastirioti M, 2010, DEVELOPMENT, V137, P191, DOI 10.1242/dev.043604
   Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482
   Patel N. H, 1994, DROSOPHILA MELANOGAS
   Percival-Smith A, 1997, DEVELOPMENT, V124, P5049
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Peterson C, 2002, DEVELOPMENT, V129, P1467
   PFLUGER HJ, 1988, PHILOS T ROY SOC B, V321, P1, DOI 10.1098/rstb.1988.0090
   POWER ME, 1948, J COMP NEUROL, V88, P347, DOI 10.1002/cne.900880303
   Schmid A, 1999, DEVELOPMENT, V126, P4653
   Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660
   Siebert M, 2009, GENE DEV, V23, P1052, DOI 10.1101/gad.520509
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   TYRER NM, 1982, PHILOS T R SOC B, V297, P91, DOI 10.1098/rstb.1982.0035
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   VieilleGrosjean I, 1997, DEV BIOL, V183, P49, DOI 10.1006/dbio.1996.8450
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0
   Wong DC, 2013, DEV BIOL, V384, P258, DOI 10.1016/j.ydbio.2013.07.009
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057
NR 50
TC 18
Z9 18
U1 0
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD JUN 15
PY 2014
VL 390
IS 2
BP 102
EP 115
DI 10.1016/j.ydbio.2014.03.021
PG 14
WC Developmental Biology
SC Developmental Biology
GA AG6PG
UT WOS:000335540300002
PM 24713419
OA Bronze
DA 2021-01-25
ER

PT J
AU Maze, A
   Glatter, T
   Bumann, D
AF Maze, Alain
   Glatter, Timo
   Bumann, Dirk
TI The Central Metabolism Regulator EIIA(Glc) Switches Salmonella from
   Growth Arrest to Acute Virulence through Activation of Virulence Factor
   Secretion
SO CELL REPORTS
LA English
DT Article
ID ESCHERICHIA-COLI; CARBOHYDRATE-METABOLISM; PROTEIN; SYSTEM; ENZYME;
   PHOSPHOENOLPYRUVATE; TYPHIMURIUM; EXPRESSION; ENTERICA; HOST
AB The ability of Salmonella to cause disease depends on metabolic activities and virulence factors. Here, we show that a key metabolic protein, EIIA(Glc), is absolutely essential for acute infection, but not for Salmonella survival, in a mouse typhoid fever model. Surprisingly, phosphorylation-dependent EIIA Glc functions, including carbohydrate transport and activation of adenylate cyclase for global regulation, do not explain this virulence phenotype. Instead, biochemical studies, in vitro secretion and translocation assays, and in vivo genetic epistasis experiments suggest that EIIA Glc binds to the type three secretion system 2 (TTSS-2) involved in systemic virulence, stabilizes its cytoplasmic part including the crucial TTSS-2 ATPase, and activates virulence factor secretion. This unexpected role of EIIA Glc reveals a striking direct link between central Salmonella metabolism and a crucial virulence mechanism.
C1 [Maze, Alain; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Maze, Alain] Univ Strasbourg, ESBS, UMR7242, F-67412 Illkirch Graffenstaden, France.
   [Glatter, Timo] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
EM dirk.bumann@unibas.ch
OI Maze, Alain/0000-0003-0873-3690; Glatter, Timo/0000-0001-8716-8516
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [31003A-121834]
FX We thank N. Figueroa-Bossi for providing pSUB11, K. Bettenbrock for
   pSC26-scrYp, M. Hensel for p3181, and K. Jahreis for a polyclonal
   antibody to EIIA<SUP>Glc</SUP>. We thank B. Claudi, N. Burton, M. Rosas
   Ballina, and C. Kasper for their help with experimental methods. This
   project was in part funded by Swiss National Foundation (31003A-121834).
CR Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001
   Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09
   BUHR A, 1994, J BIOL CHEM, V269, P23437
   Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232
   Choi J, 2010, P NATL ACAD SCI USA, V107, P20506, DOI 10.1073/pnas.1000759107
   Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007
   Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751
   CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06
   DORSCHUG M, 1984, EUR J BIOCHEM, V144, P113, DOI 10.1111/j.1432-1033.1984.tb08438.x
   Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679
   Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932
   Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x
   Koo BM, 2004, J BIOL CHEM, V279, P31613, DOI 10.1074/jbc.M405048200
   Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z
   Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060
   Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970
   McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037
   NELSON SO, 1982, J BACTERIOL, V150, P604, DOI 10.1128/JB.150.2.604-615.1982
   Pickering BS, 2012, MBIO, V3, DOI 10.1128/mBio.00228-12
   Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374
   Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185
   Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027
   Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2
   Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593
   Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301
   VOGLER AP, 1988, MOL GEN GENET, V213, P175, DOI 10.1007/BF00333417
   Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x
   Wang GS, 2000, J BIOL CHEM, V275, P39811, DOI 10.1074/jbc.C000709200
   Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x
   WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382
   Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347
   You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446
   Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000
NR 41
TC 16
Z9 16
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 12
PY 2014
VL 7
IS 5
BP 1426
EP 1433
DI 10.1016/j.celrep.2014.04.022
PG 8
WC Cell Biology
SC Cell Biology
GA AK3LA
UT WOS:000338324200011
PM 24835993
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Schilling, J
   Schoppel, J
   Sauer, E
   Pluckthun, A
AF Schilling, Johannes
   Schoppe, Jendrik
   Sauer, Evelyn
   Plueckthun, Andreas
TI Co-Crystallization with Conformation-Specific Designed Ankyrin Repeat
   Proteins Explains the Conformational Flexibility of BCL-W
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE apoptosis; anti-apoptotic BCL-2 family; BCL-W; ligand binding-competent
   conformation; DARPins
ID SMALL-MOLECULE INHIBITORS; CELL-DEATH; IN-VITRO; APOPTOSIS; FAMILY;
   EXPRESSION; DISCOVERY; REGULATORS; COMPOUND; BCL-X(L)
AB BCL-W is a member of the BCL-2 family of anti-apoptotic proteins. A key event in the regulation of apoptosis is the heterodimerization between anti-apoptotic and pro-apoptotic family members, which involves a conserved surface-exposed groove on the anti-apoptotic proteins. Crystal structures of the ligand binding-competent conformation exist for all anti-apoptotic family members, with the exception of BCL-W, due to the flexibility of the BCL-W groove region. Existing structures had suggested major deviations of the BCL-W groove region from the otherwise structurally highly related remaining anti-apoptotic family members. To capture its ligand binding-competent conformation by counteracting the conformational flexibility of the BCL-W groove, we had selected high-affinity groove-binding designed ankyrin repeat proteins (DARPins) using ribosome display. We now determined two high-resolution crystal structures of human BCL-W in complex with different DARPins at resolutions 1.5 and 1.85 angstrom, in which the structure of BCL-W is virtually identical, and BCL-W adopts a conformation extremely similar to the ligand-free conformation of its closest relative BCL-XL in both structures. However, distinct differences to all previous BCL-W structures are evident, notably in the ligand-binding region. We provide the first structural explanation for the conformational flexibility of the BCL-W groove region in comparison to other BCL-2 family members. Due to the importance of the anti-apoptotic BCL-2 family as drug targets, the presented crystal structure of ligand binding-competent BCL-W may serve as a valuable basis for structure-based drug design in the future and provides a missing piece for the structural characterization of this protein family. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Schilling, Johannes; Schoppe, Jendrik; Plueckthun, Andreas] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.
   [Sauer, Evelyn] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pluckthun, A (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM plueckthun@bioc.uzh.ch
RI Pluckthun, Andreas/C-2746-2009
OI Pluckthun, Andreas/0000-0003-4191-5306; Schoppe,
   Jendrik/0000-0002-2689-5549
FU Forschungskredit of the University of Zurich; European Research
   CouncilEuropean Research Council (ERC) [268621]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [3100A_146278/1]
FX We thank Celine Stutz-Ducommun and Beat Blattmann for help in protein
   crystallization and the staff of beamline PXIII at the Swiss Light
   Source for support during data collection. We also thank the members of
   the Pluckthun laboratory for valuable discussions. J. Schilling was
   supported by a pre-doctoral fellowship of the Forschungskredit of the
   University of Zurich. This work was supported by European Research
   Council grant 268621 (NEXT-BINDERS) and the Swiss National Science
   Foundation grant 3100A_146278/1 (both to A.P.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bairey O, 1999, CLIN CANCER RES, V5, P2860
   Becattini B, 2004, CHEM BIOL, V11, P389, DOI 10.1016/j.chembiol.2004.02.020
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665
   Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030
   Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105
   Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663
   Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200
   Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085
   Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f
   Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329
   Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7
   Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799
   Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455
   Jager R, 1997, ONCOGENE, V15, P1787, DOI 10.1038/sj.onc.1201353
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z
   Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023
   Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149
   Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k
   Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015
   Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7
   Liang H, 1997, J MOL BIOL, V274, P291, DOI 10.1006/jmbi.1997.1415
   Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012
   Rutledge SE, 2002, CURR OPIN CHEM BIOL, V6, P479, DOI 10.1016/S1367-5931(02)00352-6
   Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983
   Schilling J, 2014, J MOL BIOL, V426, P691, DOI 10.1016/j.jmb.2013.10.026
   Shigemasa K, 2002, JPN J CANCER RES, V93, P542, DOI 10.1111/j.1349-7006.2002.tb01289.x
   Troy CM, 2002, J NEUROSCI RES, V69, P145, DOI 10.1002/jnr.10294
   Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095
   Voutsadakis IA, 2000, ACTA ONCOL, V39, P151, DOI 10.1080/028418600430707
   Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191
   Walker LSK, 2002, NAT REV IMMUNOL, V2, P11, DOI 10.1038/nri701
   Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124
   Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897
   Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003
   Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885
NR 53
TC 6
Z9 6
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 12
PY 2014
VL 426
IS 12
BP 2346
EP 2362
DI 10.1016/j.jmb.2014.04.010
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AI8YV
UT WOS:000337213800006
PM 24747052
DA 2021-01-25
ER

PT J
AU Moharana, K
   Zabeau, L
   Peelman, F
   Ringler, P
   Stahlberg, H
   Tavernier, J
   Savvides, SN
AF Moharana, Kedar
   Zabeau, Lennart
   Peelman, Frank
   Ringler, Philippe
   Stahlberg, Henning
   Tavernier, Jan
   Savvides, Savvas N.
TI Structural and Mechanistic Paradigm of Leptin Receptor Activation
   Revealed by Complexes with Wild-Type and Antagonist Leptins
SO STRUCTURE
LA English
DT Article
ID SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; JANUS KINASE/SIGNAL
   TRANSDUCER; BINDING-SITE-III; CYTOKINE RECEPTOR; BREAST-CANCER;
   EXTRACELLULAR DOMAIN; CELL PROLIFERATION; CYTOPLASMIC DOMAIN;
   CRYSTAL-STRUCTURE
AB Leptin activates its cognate receptor (LR) to regulate body weight and metabolically costly processes, such as reproduction and immune responses. Despite such benevolent pleiotropy, leptin-mediated signaling has been implicated in autoimmune diseases and breast cancer, thereby rejuvenating interest in leptin antagonism. We present comparative biochemical and structural studies of the LR ectodomain (LRecto) in complex with wild-type and antagonist leptin variants. We show that high-affinity binding of leptin to the cytokine receptor homology 2 domain of LRecto primes interactions with the Ig-domain (LRIg) of another leptin-bound LRecto to establish a quaternary assembly. In contrast, antagonist leptin variants carrying mutations at the LRIg binding site only enable binary complexes with LRecto. Acetylation of free cysteines in LRecto also abrogates quaternary complexes, suggesting a functional role for intrareceptor disulfides. We propose a revised conceptual framework for LR activation whereby leptin activates predimerized LR at the cell surface to seed higher order complexes with 4:4 stoichiometry.
C1 [Moharana, Kedar; Savvides, Savvas N.] Univ Ghent, Lab Prot Biochem & Biomol Engn L ProBE, Unit Struct Biol, B-9000 Ghent, Belgium.
   [Zabeau, Lennart; Peelman, Frank; Tavernier, Jan] Univ Ghent, Flanders Inst Biotechnol VIB, B-9000 Ghent, Belgium.
   [Zabeau, Lennart; Peelman, Frank; Tavernier, Jan] Univ Ghent, Dept Med Prot Res, B-9000 Ghent, Belgium.
   [Ringler, Philippe; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4003 Basel, Switzerland.
RP Tavernier, J (corresponding author), Univ Ghent, Flanders Inst Biotechnol VIB, B-9000 Ghent, Belgium.
EM jan.tavernier@vib-ugent.be; savvas.savvides@ugent.be
RI Stahlberg, Henning/H-1868-2011; Tavernier, Jan/AAG-3636-2019
OI Stahlberg, Henning/0000-0002-1185-4592; 
FU Methusalem grant (Ghent University, Ghent, Belgium); Fonds
   Wetenschappelijk Onderzoek (Brussels, Belgium); ERCEuropean Research
   Council (ERC) [340941]
FX This work was supported by a Methusalem grant (Ghent University, Ghent,
   Belgium) and by Fonds Wetenschappelijk Onderzoek (Brussels, Belgium).
   J.T. is holder of an ERC Advanced Grant (340941). We are grateful to the
   ESRF, SOLEIL, and Deutsches Elektronen-Synchrotron/European Molecular
   Biology Laboratory for access to synchrotron facilities and data
   collection support. We thank the SWITCH laboratory (Vlaams Instituut
   voor Biotechnologie [VIB], Ghent, Belgium) and Dr. Rodrigo Gallardo
   (VIB) for access to and assistance with MALS measurements. Prof.
   Georgios Skiniotis (University of Michigan) kindly provided the EM map
   derived for the leptin-LR quaternary complex for comparison purposes.
CR Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184
   Artac M, 2012, MED ONCOL, V29, P1510, DOI 10.1007/s12032-011-0056-0
   Bacart J, 2010, FEBS LETT, V584, P2213, DOI 10.1016/j.febslet.2010.03.033
   Bahrenberg G, 2002, MOL ENDOCRINOL, V16, P859, DOI 10.1210/me.16.4.859
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Biener E, 2005, BIOL CELL, V97, P905
   Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385
   Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901
   Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798
   Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018
   Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019
   Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011
   Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200
   Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108
   David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288
   De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011
   Devos R, 1997, J BIOL CHEM, V272, P18304, DOI 10.1074/jbc.272.29.18304
   Elegheert J, 2012, NAT STRUCT MOL BIOL, V19, P938, DOI 10.1038/nsmb.2367
   Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5
   Felix J, 2013, STRUCTURE, V21, P528, DOI 10.1016/j.str.2013.01.018
   Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076
   Fong TM, 1998, MOL PHARMACOL, V53, P234
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299
   Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006
   Ghilardi N, 1997, MOL ENDOCRINOL, V11, P393, DOI 10.1210/me.11.4.393
   Graupner M, 1999, BIOPHYS J, V77, P493, DOI 10.1016/S0006-3495(99)76906-7
   Guo SC, 2012, BBA-REV CANCER, V1825, P207, DOI 10.1016/j.bbcan.2012.01.002
   Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Haniu M, 1998, J BIOL CHEM, V273, P28691, DOI 10.1074/jbc.273.44.28691
   Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053
   Hausman GJ, 2012, BIOCHIMIE, V94, P2075, DOI 10.1016/j.biochi.2012.02.022
   Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104
   Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201
   Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987
   Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010
   Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003
   Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036
   Motyl KJ, 2012, BIOCHIMIE, V94, P2089, DOI 10.1016/j.biochi.2012.04.015
   Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457
   Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018
   Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17
   Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200
   Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012
   Ramachandrappa S, 2011, J CLIN INVEST, V121, P2080, DOI 10.1172/JCI46044
   Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449
   Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572
   Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174
   Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107
   Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893
   Wauman J, 2008, MOL ENDOCRINOL, V22, P965, DOI 10.1210/me.2007-0414
   White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065
   White DW, 1999, J CELL BIOCHEM, V73, P278, DOI 10.1002/(SICI)1097-4644(19990501)73:2<278::AID-JCB13>3.3.CO;2-N
   Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183
   Zabeau L, 2005, J BIOL CHEM, V280, P22632, DOI 10.1074/jbc.M413308200
   Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078
   Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0
NR 73
TC 21
Z9 23
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD JUN 10
PY 2014
VL 22
IS 6
BP 866
EP 877
DI 10.1016/j.str.2014.04.012
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AK1VP
UT WOS:000338206200009
PM 24882746
OA Bronze
DA 2021-01-25
ER

PT J
AU Schmidt, T
   Schwede, T
   Meuwly, M
AF Schmidt, Tobias
   Schwede, Torsten
   Meuwly, Markus
TI Computational Analysis of Methyl Transfer Reactions in Dengue Virus
   Methyltransferase
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ADENOSYL-L-METHIONINE; MESSENGER-RNA; ATOMISTIC SIMULATION;
   MOLECULAR-DYNAMICS; CATALYTIC LYSINE; CAP; NS5; PROTEIN; TARGET;
   MECHANISM
AB S-Adenosyl-L-methionine (SAM) dependent methyltransferases (MTases) play crucial roles in many biological processes. The MTase of the dengue virus is of particular interest for the development of antiviral drugs against flaviviruses. It catalyzes two distinct methylation reactions at the N7 and the 2'O position of the viral RNA cap structure. Based on density functional theory (DFT) electronic structure calculations, the molecular basis of the underlying chemical reactions involved in the N7 and the 2'O methyl transfer reactions of this enzyme were investigated using model systems. Calculations in the condensed phase show that both reactions are exergonic with significant activation barriers of 13.7 and 17.6 kcal/mol and stable product states, stabilized by 23.5 and 16.9 kcal/mol compared to the reactant states for the N7 and the 2'O reaction, respectively. We find that the reaction rate for the 2'O reaction is significantly enhanced in the presence of the native proton acceptor group, which lowers the activation barrier in the catalyzed reaction by 3.8 kcal/mol compared to the uncatalyzed reaction in aqueous solution. Furthermore, the 2'O reaction involves a methyl and a proton transfer reaction. Our results suggest that these two reactions occur in a concerted fashion in which the methyl group and the proton are transferred simultaneously. From a therapeutic viewpoint, SAM analogues stable under physiological conditions are particularly relevant. One such compound in MeAzaSAM, an isostructural mimic of SAM, for which the present calculations suggest that the methyl transfer reaction is unlikely to occur under biologically relevant conditions.
C1 [Meuwly, Markus] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Schmidt, Tobias; Schwede, Torsten] Univ Basel, Switzerland Biozentrum, SIB, CH-4056 Basel, Switzerland.
RP Meuwly, M (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM m.meuwly@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [200021-117810]; NCCR-MUST
FX The authors would like to thank Dr. Juergen Haas for numerous fruitful
   discussions. Financial support from the Swiss National Science
   Foundation (SNF) through grants 200021-117810 (to MM) and the NCCR-MUST
   (to MM) is gratefully acknowledged.
CR BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251
   CANTONI GL, 1952, J AM CHEM SOC, V74, P2942, DOI 10.1021/ja01131a519
   Castejon H, 1999, J AM CHEM SOC, V121, P2139, DOI 10.1021/ja983736t
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974
   Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189
   Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109
   Danielsson J, 2008, J CHEM THEORY COMPUT, V4, P1083, DOI 10.1021/ct800066q
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260
   Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604
   Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7
   Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007
   FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605
   Frisch M. J., 2004, GAUSSIAN 03 REV D 02, V03
   Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9
   Hager J, 2002, J BIOL CHEM, V277, P41978, DOI 10.1074/jbc.M205423200
   Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1
   Joce C, 2009, ORG BIOMOL CHEM, V7, P635, DOI 10.1039/b816495a
   Klimasauskas S, 2007, WILEY ENCY CHEM BIOL
   Li C, 2006, BIOCHEMISTRY-US, V45, P907, DOI 10.1021/bi051736h
   Li C, 2004, BIOCHEMISTRY-US, V43, P5680, DOI 10.1021/bi0359980
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lutz S, 2011, J BIOL CHEM, V286, P23679, DOI 10.1074/jbc.M111.230003
   Mannisto PT, 1999, PHARMACOL REV, V51, P593
   Meuwly M, 2006, CHEMPHYSCHEM, V7, P2061, DOI 10.1002/cphc.200600304
   Mishra S, 2010, J AM CHEM SOC, V132, P2968, DOI 10.1021/ja9078144
   Nagy T, 2014, J CHEM THEORY COMPUT, V10, P1366, DOI 10.1021/ct400953f
   Nienhaus K, 2013, CHEM-EUR J, V19, P3558, DOI 10.1002/chem.201203558
   Nutt DR, 2006, BIOPHYS J, V90, P1191, DOI 10.1529/biophysj.105.071522
   Ochterski JW, 1996, J CHEM PHYS, V104, P2598, DOI 10.1063/1.470985
   PENG CY, 1993, ISR J CHEM, V33, P449
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486
   Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2
   Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0
   Thompson MJ, 1996, CHEM COMMUN, P791, DOI 10.1039/cc9960000791
   Thompson MJ, 1999, J ORG CHEM, V64, P7467, DOI 10.1021/jo9907742
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   Zhao Y, 2005, J PHYS CHEM A, V109, P2012, DOI 10.1021/jp045141s
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 47
TC 8
Z9 8
U1 1
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 5
PY 2014
VL 118
IS 22
BP 5882
EP 5890
DI 10.1021/jp5028564
PG 9
WC Chemistry, Physical
SC Chemistry
GA AI6UB
UT WOS:000337011400009
PM 24809209
DA 2021-01-25
ER

PT J
AU Okujava, R
   Guye, P
   Lu, YY
   Mistl, C
   Polus, F
   Vayssier-Taussat, M
   Halin, C
   Rolink, AG
   Dehio, C
AF Okujava, Rusudan
   Guye, Patrick
   Lu, Yun-Yueh
   Mistl, Claudia
   Polus, Florine
   Vayssier-Taussat, Muriel
   Halin, Cornelia
   Rolink, Antonius G.
   Dehio, Christoph
TI A Translocated Effector Required for Bartonella Dissemination from Derma
   to Blood Safeguards Migratory Host Cells from Damage by Co-translocated
   Effectors
SO PLOS PATHOGENS
LA English
DT Article
ID IV SECRETION SYSTEM; LEADING-EDGE; ENDOTHELIAL-CELLS; HENSELAE; PROTEIN;
   RHOA; RETRACTION; INFECTION; INVASION; PATHOGEN
AB Numerous bacterial pathogens secrete multiple effectors to modulate host cellular functions. These effectors may interfere with each other to efficiently control the infection process. Bartonellae are Gram-negative, facultative intracellular bacteria using a VirB type IV secretion system to translocate a cocktail of Bartonella effector proteins (Beps) into host cells. Based on in vitro infection models we demonstrate here that BepE protects infected migratory cells from injurious effects triggered by BepC and is required for in vivo dissemination of bacteria from the dermal site of inoculation to blood. Human endothelial cells (HUVECs) infected with a Delta bepE mutant of B. henselae (Bhe) displayed a cell fragmentation phenotype resulting from Bep-dependent disturbance of rear edge detachment during migration. A Delta bepCE mutant did not show cell fragmentation, indicating that BepC is critical for triggering this deleterious phenotype. Complementation of Delta bepE with BepE(Bhe) or its homologues from other Bartonella species abolished cell fragmentation. This cyto-protective activity is confined to the C-terminal Bartonella intracellular delivery (BID) domain of BepE(Bhe) (BID2.E-Bhe). Ectopic expression of BID2.E-Bhe impeded the disruption of actin stress fibers by Rho Inhibitor 1, indicating that BepE restores normal cell migration via the RhoA signaling pathway, a major regulator of rear edge retraction. An intradermal (i.d.) model for B. tribocorum (Btr) infection in the rat reservoir host mimicking the natural route of infection by blood sucking arthropods allowed demonstrating a vital role for BepE in bacterial dissemination from derma to blood. While the Btr mutant Delta bepDE was abacteremic following i.d. inoculation, complementation with BepE(Btr), BepE(Bhe) or BIDs.E-Bhe restored bacteremia. Given that we observed a similar protective effect of BepE(Bhe) on infected bone marrow-derived dendritic cells migrating through a monolayer of lymphatic endothelial cells we propose that infected dermal dendritic cells may be involved in disseminating Bartonella towards the blood stream in a BepE-dependent manner.
C1 [Okujava, Rusudan; Guye, Patrick; Lu, Yun-Yueh; Mistl, Claudia; Polus, Florine; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Vayssier-Taussat, Muriel] INRA, Unite Contrat Bartonella, Maisons Alfort, France.
   [Halin, Cornelia] ETH, Inst Pharmaceut Sci, Zurich, Switzerland.
   [Rolink, Antonius G.] Univ Basel, Dept Biomed DBM, Basel, Switzerland.
RP Okujava, R (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Halin, Cornelia/0000-0002-7899-2850
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A-132979]; Research and Technology Development
   (RTD) project InfectX in the frame of SystemsX.ch [51RT 0_126008]; Swiss
   Initiative for Systems Biology
FX This work was supported by grant 31003A-132979 from the Swiss National
   Science Foundation (SNSF, www.snf.ch) and grant 51RT 0_126008 for the
   Research and Technology Development (RTD) project InfectX in the frame
   of SystemsX.ch (www.systemsx.ch), the Swiss Initiative for Systems
   Biology (both to CD). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4
   Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006
   Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009
   Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039
   Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x
   Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010
   Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295
   Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713
   Foil L, 1998, J MED ENTOMOL, V35, P625, DOI 10.1093/jmedent/35.5.625
   Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007
   Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146
   Heasman SJ, 2010, J CELL BIOL, V190, P553, DOI 10.1083/jcb.201002067
   Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336
   Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012
   Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941
   Jermy A, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2509
   Kido M, 2011, BIOCHEM BIOPH RES CO, V412, P266, DOI 10.1016/j.bbrc.2011.07.081
   Kim MJ, 2012, BIOCHEM BIOPH RES CO, V418, P500, DOI 10.1016/j.bbrc.2012.01.053
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3
   Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e
   Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199
   Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786
   Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008
   Marignac G, 2010, COMP IMMUNOL MICROB, V33, P95, DOI 10.1016/j.cimid.2008.07.011
   Miao L, 2003, SCIENCE, V302, P1405, DOI 10.1126/science.1089129
   Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955
   Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533
   Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254
   Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Rid R, 2005, CELL MOTIL CYTOSKEL, V61, P161, DOI 10.1002/cm.20076
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Shames SR, 2012, TRENDS MICROBIOL, V20, P214, DOI 10.1016/j.tim.2012.02.007
   Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Skinner JA, 2005, J IMMUNOL, V175, P4647, DOI 10.4049/jimmunol.175.7.4647
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447
   Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8
   Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048
   Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792
   Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84
NR 64
TC 16
Z9 16
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2014
VL 10
IS 6
AR e1004187
DI 10.1371/journal.ppat.1004187
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AK1SV
UT WOS:000338197400024
PM 24945914
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Hutter, CAJ
   Lehner, R
   Wirth, C
   Condemine, G
   Peneff, C
   Schirmer, T
AF Hutter, C. A. J.
   Lehner, R.
   Wirth, Ch
   Condemine, G.
   Peneff, C.
   Schirmer, T.
TI Structure of the oligogalacturonate-specific KdgM porin
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID ERWINIA-CHRYSANTHEMI 3937; OUTER-MEMBRANE CHANNELS; CRYSTAL-STRUCTURES;
   SECRETION; FAMILY; LYASE
AB The phytopathogenic Gram-negative bacterium Dickeya dadantii (Erwinia chrysanthemi) feeds on plant cell walls by secreting pectinases and utilizing the oligogalacturanate products. An outer membrane porin, KdgM, is indispensable for the uptake of these acidic oligosaccharides. Here, the crystal structure of KdgM determined to 1.9 angstrom resolution is presented. KdgM is folded into a regular 12-stranded antiparallel beta-barrel with a circular cross-section defining a transmembrane pore with a minimal radius of 3.1 angstrom. Most of the loops that would face the cell exterior in vivo are disordered, but nevertheless mediate contact between densely packed membrane-like layers in the crystal. The channel is lined by two tracks of arginine residues facing each other across the pore, a feature that is conserved within the KdgM family and is likely to facilitate the diffusion of acidic oligosaccharides.
C1 [Hutter, C. A. J.; Lehner, R.; Wirth, Ch; Peneff, C.; Schirmer, T.] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Condemine, G.] Univ Lyon, F-69003 Lyon, France.
   [Condemine, G.] Univ Lyon 1, F-69622 Villeurbanne, France.
   [Condemine, G.] Inst Natl Sci Appl, F-69621 Villeurbanne, France.
   [Condemine, G.] CNRS, Microbiol Adaptat & Pathogenie UMR5240, F-75700 Paris, France.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
OI Condemine, Guy/0000-0002-3256-3815; Lehner, Roman/0000-0002-0478-5445;
   Wirth, Christophe/0000-0001-8864-6508
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AO-105587]
FX We would like to thank the team at the Swiss Light Source, Villigen,
   Switzerland for their excellent support. This work was supported by
   Swiss National Science Foundation grant No. 3100AO-105587 to TS.
CR Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200
   Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   CONDEMINE G, 1992, MOL MICROBIOL, V6, P3199, DOI 10.1111/j.1365-2958.1992.tb01775.x
   Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07
   Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008
   Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1113, DOI 10.1046/j.1365-2958.2001.02564.x
   HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213
   Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814
   Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107
   MANEEWANNAKUL S, 1994, PLASMID, V31, P300, DOI 10.1006/plas.1994.1032
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7
   Seyedarabi A, 2010, BIOCHEMISTRY-US, V49, P539, DOI 10.1021/bi901503g
   Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999
   Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X
   Subbarao GV, 2006, J MOL BIOL, V360, P750, DOI 10.1016/j.jmb.2006.05.045
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wirth C, 2009, J MOL BIOL, V394, P718, DOI 10.1016/j.jmb.2009.09.054
NR 24
TC 6
Z9 6
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0907-4449
EI 1399-0047
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD JUN
PY 2014
VL 70
BP 1770
EP 1778
DI 10.1107/S1399004714007147
PN 6
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA AK0PW
UT WOS:000338117800027
PM 24914987
DA 2021-01-25
ER

PT J
AU Miloslavski, R
   Cohen, E
   Avraham, A
   Iluz, Y
   Hayouka, Z
   Kasir, J
   Mudhasani, R
   Jones, SN
   Cybulski, N
   Ruegg, MA
   Larsson, O
   Gandin, V
   Rajakumar, A
   Topisirovic, I
   Meyuhas, O
AF Miloslavski, Rachel
   Cohen, Elad
   Avraham, Adam
   Iluz, Yifat
   Hayouka, Zvi
   Kasir, Judith
   Mudhasani, Rajini
   Jones, Stephen N.
   Cybulski, Nadine
   Rueegg, Markus A.
   Larsson, Ola
   Gandin, Valentina
   Rajakumar, Arjuna
   Topisirovic, Ivan
   Meyuhas, Oded
TI Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR
   pathway in a 4E-BP-independent manner
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Article
DE hypoxia; mTOR; TOP mRNAs; translational control; 4E-BP
ID MOUSE EMBRYONIC FIBROBLASTS; ACTIVATED PROTEIN-KINASE; CELL-GROWTH; S6
   KINASE; RPS6 PHOSPHORYLATION; GLUCOSE-HOMEOSTASIS; INDEPENDENT MANNER;
   MAMMALIAN TARGET; PYRIMIDINE TRACT; QUIESCENT CELLS
AB Cells encountering hypoxic stress conserve resources and energy by downregulating the protein synthesis. Here we demonstrate that one mechanism in this response is the translational repression of TOP mRNAs that encode components of the translational apparatus. This mode of regulation involves TSC and Rheb, as knockout of TSC1 or TSC2 or overexpression of Rheb rescued TOP mRNA translation in oxygen-deprived cells. Stress-induced translational repression of these mRNAs closely correlates with the hypophosphorylated state of 4E-BP, a translational repressor. However, a series of 4E-BP loss-and gain-of-function experiments disprove a cause-and-effect relationship between the phosphorylation status of 4E-BP and the translational repression of TOP mRNAs under oxygen or growth factor deprivation. Furthermore, the repressive effect of anoxia is similar to that attained by the very efficient inhibition of mTOR activity by Torin 1, but much more pronounced than raptor or rictor knockout. Likewise, deficiency of raptor or rictor, even though it mildly downregulated basal translation efficiency of TOP mRNAs, failed to suppress the oxygen-mediated translational activation of TOP mRNAs. Finally, co-knockdown of TIA-1 and TIAR, two RNA-binding proteins previously implicated in translational repression of TOP mRNAs in amino acid-starved cells, failed to relieve TOP mRNA translation under other stress conditions. Thus, the nature of the proximal translational regulator of TOP mRNAs remains elusive.
C1 [Miloslavski, Rachel; Cohen, Elad; Avraham, Adam; Iluz, Yifat; Hayouka, Zvi; Kasir, Judith; Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.
   [Mudhasani, Rajini; Jones, Stephen N.] Univ Massachusetts, Sch Med, Dept Cell Biol, North Worcester, MA 01655 USA.
   [Cybulski, Nadine; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, SE-17176 Stockholm, Sweden.
   [Gandin, Valentina; Rajakumar, Arjuna; Topisirovic, Ivan] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.
   [Gandin, Valentina; Rajakumar, Arjuna; Topisirovic, Ivan] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada.
RP Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.
EM meyuhas@cc.huji.ac.il
RI Ruegg, Markus/X-7256-2019; Topisirovic, Ivan/A-9426-2008
OI Ruegg, Markus/0000-0002-4974-9384; Topisirovic,
   Ivan/0000-0002-5510-9762; Larsson, Ola/0000-0003-1412-1308; Rajakumar,
   Arjuna/0000-0001-5937-0856; Mudhasani, Rajini/0000-0001-7824-6949
FU Israel Science FoundationIsrael Science Foundation [559/09]; Otto
   Stieber Foundation; Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR) [CIHR MOP-115195]
FX This work was supported by the Israel Science Foundation (grant number
   559/09 to O.M.), the Otto Stieber Foundation (to O.M.), and the Canadian
   Institutes of Health Research (grant number CIHR MOP-115195 to I.T.).
CR AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822
   Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06
   Caldarola S, 2009, FEBS J, V276, P3199, DOI 10.1111/j.1742-4658.2009.07036.x
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105
   Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16
   Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112
   Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311
   Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911
   DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Granneman S, 2007, CURR BIOL, V17, pR415, DOI 10.1016/j.cub.2007.04.011
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x
   KASPAR RL, 1992, J BIOL CHEM, V267, P508
   KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06
   Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319
   Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200
   Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010
   Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5
   Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105
   Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075
   Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
   Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368
   Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608
   Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605
   Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9
   SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3
   Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   Shama Silvian, 1995, Gene Expression, V4, P241
   Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002
   Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005
   Stolovich M, 2005, J BIOL CHEM, V280, P5336, DOI 10.1074/jbc.M412434200
   Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002
   Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621
   Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222
   Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168
NR 62
TC 56
Z9 57
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD JUN
PY 2014
VL 6
IS 3
SI SI
BP 255
EP 266
DI 10.1093/jmcb/mju008
PG 12
WC Cell Biology
SC Cell Biology
GA AI7JR
UT WOS:000337065700009
PM 24627160
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Brummer, A
   Hausser, J
AF Bruemmer, Anneke
   Hausser, Jean
TI MicroRNA binding sites in the coding region of mRNAs: Extending the
   repertoire of post-transcriptional gene regulation
SO BIOESSAYS
LA English
DT Article
DE 3 ' UTR; CDS; miRNAs; mRNA degradation; post-transcriptional regulation;
   RBPs; translation
ID TRANSCRIPTOME-WIDE IDENTIFICATION; 3' UNTRANSLATED REGIONS; EMBRYONIC
   STEM-CELLS; TARGET SITES; C-ELEGANS; IN-VIVO; TRANSLATIONAL REPRESSION;
   ALTERNATIVE POLYADENYLATION; CAENORHABDITIS-ELEGANS; EXPRESSION PROFILES
AB It is well established that microRNAs (miRNAs) induce mRNA degradation by binding to 3' untranslated regions (UTRs). The functionality of sites in the coding domain sequence (CDS), on the other hand, remains under discussion. Such sites have limited impact on target mRNA abundance and recent work suggests that miRNAs bind in the CDS to inhibit translation. What then could be the regulatory benefits of translation inhibition through CDS targeting compared to mRNA degradation following 3' UTR binding? We propose that these domain-dependent effects serve to diversify the functional repertoire of post-transcriptional gene expression control. Possible regulatory benefits may include tuning the time-scale and magnitude of post-transcriptional regulation, regulating protein abundance depending on or independently of the cellular state, and regulation of the protein abundance of alternative splice variants. Finally, we review emerging evidence that these ideas may generalize to RNA-binding proteins beyond miRNAs and Argonaute proteins.
C1 [Bruemmer, Anneke] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hausser, Jean] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
RP Hausser, J (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
EM jean@hausser.org
OI Brummer, Anneke/0000-0002-3576-0750; Hausser, Jean/0000-0002-3321-7199
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PBBSP3_146961]; EMBOEuropean Molecular Biology Organization
   (EMBO) [ALTF 1160-2012]
FX We thank Andreas Gruber from the Zavolan lab (University of Basel),
   Julien Roux (University of Chicago), Tabitha Bucher (Weizmann Institute
   of Science), and Marie Hausser for constructive comments on the
   scientific and graphical aspects of the manuscript. J.H. acknowledges
   the support of the Swiss National Science Foundation (PBBSP3_146961) and
   EMBO (ALTF 1160-2012).
CR Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565
   Alon U., 2007, INTRO SYSTEMS BIOL D
   Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704
   Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501
   Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82
   Brummer A, 2013, RNA, V19, P1317, DOI 10.1261/rna.037531.112
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008
   Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784
   EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547
   Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067
   Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105
   Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246
   Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542
   Friend K, 2012, NAT STRUCT MOL BIOL, V19, P176, DOI 10.1038/nsmb.2214
   Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709
   Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   HARGROVE JL, 1989, FASEB J, V3, P2360
   Hausser J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.68
   Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Hurst LD, 2006, J MOL EVOL, V63, P174, DOI 10.1007/s00239-005-0273-2
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106
   Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293
   Jovanovic M, 2012, GENOME RES, V22, P1360, DOI 10.1101/gr.133330.111
   Jung HM, 2013, MOL BIOL CELL, V24, P1638, DOI 10.1091/mbc.E12-12-0891
   Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Kapeli K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00144
   Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89
   Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404
   Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Li F, 2012, PLANT CELL, V24, P4346, DOI 10.1105/tpc.112.104232
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Marin RM, 2013, RNA, V19, P467, DOI 10.1261/rna.035634.112
   Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016
   Nelson PT, 2011, NUCLEIC ACIDS RES, V39, P8163, DOI 10.1093/nar/gkr532
   Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207
   Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693
   Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101
   Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411
   Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429
   Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861
   Racher H, 2010, GENOME, V53, P83, DOI [10.1139/G09-090, 10.1139/g09-090]
   Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311
   Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Scheckel C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002742
   Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111
   Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131
   Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015
   Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292
   Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007
   Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100
   Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635
NR 87
TC 91
Z9 92
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD JUN
PY 2014
VL 36
IS 6
BP 617
EP 626
DI 10.1002/bies.201300104
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA AI0IH
UT WOS:000336529800014
PM 24737341
DA 2021-01-25
ER

PT J
AU Neves, RC
   Kristensen, RM
AF Neves, Ricardo Cardoso
   Kristensen, Reinhardt Mobjerg
TI A new type of loriciferan larva (Shira larva) from the deep sea of
   Shatsky Rise, Pacific Ocean
SO ORGANISMS DIVERSITY & EVOLUTION
LA English
DT Article
DE Loricifera; Lifecycle; Morphology; Taxonomy; Systematics; Evolution
ID NANALORICIDAE; ARMORLORICUS; NORTH; GENUS
AB Loricifera is a phylum of minute animals that live exclusively in marine sediments. A total of 33 species have been described so far in this phylum; however, several more are already known from preliminary observations. Loriciferans are characterised by a complex life cycle, which involves a succession of several adult and larval stages. Here, we describe a new type of loriciferan larval stage: the Shira larva. The gross morphology of this larva is generally similar to that of the most prominent larval type of Loricifera, the so-called Higgins larva. However, the Shira larva possesses a number of unique features, namely (1) a single pair of anteroventral setae is present in the most anterior region of the abdomen, (2) the bases of the anteroventral setae are very large and swollen, (3) the thorax and abdomen are thinner than the introvert and (4) the abdominal region is divided into five sub-regions. Accordingly, we described the new species, Tenuiloricus shirayamai gen. nov. et sp. nov. (incertae sedis). The new findings are discussed from a comparative perspective with the Higgins larva as well as with the fossil of a putative loriciferan larval stage from the Middle Cambrian.
C1 [Neves, Ricardo Cardoso] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kristensen, Reinhardt Mobjerg] Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark.
RP Neves, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM ricardon.6@gmail.com
RI Neves, Ricardo Cardoso/J-9822-2014; Kristensen, Reinhardt M/A-8772-2013
OI Neves, Ricardo Cardoso/0000-0002-9219-9066; Kristensen, Reinhardt
   M/0000-0001-9549-1188
FU EU research exchange programme SYNTHESYS
FX We are particularly grateful to Prof. Dr. Y. Shirayama (Japan Agency for
   Marine-Earth Science and Technology, Kyoto University), for the material
   offered to the Natural History Museum of Denmark. Funding to study the
   holotype described here was provided partially by EU research exchange
   programme SYNTHESYS. We thank Prof. Dr. Heinrich Reichert for reading a
   preliminary version of this article.
CR Bang-Berthelsen IH, 2012, HDB ZOOLOGY GASTROTR, V1, P307
   Gad G, 2004, HELGOLAND MAR RES, V58, P40, DOI 10.1007/s10152-003-0167-x
   Gad G, 2005, THESIS C VONOSSIETZK
   Gad G., 2005, ORG DIVERS EVOL, V5, P44
   Gad G., 2005, BERICHTE POLAR MEERE, V507, P140
   Gad G., 2000, THESIS C VONOSSIETZK
   Gad G, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2096.1.6
   Gad G, 2009, ZOOTAXA, P33, DOI 10.11646/zootaxa.2096.1.5
   Gad Gunner, 2003, Deep-Sea Newsletter, V32, P4
   Heiner Bang-Berthelsen I., 2008, THESIS U COPENHAGEN
   Heiner I, 2004, HELGOLAND MAR RES, V58, P192, DOI 10.1007/s10152-004-0185-3
   Heiner I, 2008, SYST BIODIVERS, V6, P225, DOI 10.1017/S147720000800265X
   Heiner I, 2007, HELGOLAND MAR RES, V61, P167, DOI 10.1007/s10152-007-0064-9
   Heiner I, 2009, MAR BIOL RES, V5, P529, DOI 10.1080/17451000902933009
   Heiner I, 2009, J MORPHOL, V270, P129, DOI 10.1002/jmor.10671
   Higgins R.P., 1986, SMITHSONIAN CONTRIB, V438, P1
   Higgins RP., 1988, INTRO STUDY MEIOFAUN
   Kristensen R.M., 1991, P351
   Kristensen Reinhardt M., 2002, P179
   Kristensen RM, 2013, CAH BIOL MAR, V54, P161
   KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163
   Kristensen RM, 2004, CAH BIOL MAR, V45, P121
   KRISTENSEN RM, 1991, VERH DTSCH ZOOL GES, V84, P231
   Maas A, 2009, MEM ASSOC AUSTRALAS, V37, P281
   Neves RC, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-19
   Pardos F, 2013, HELGOLAND MAR RES, V67, P623, DOI 10.1007/s10152-013-0349-0
   SHIRAYAMA Y, 1984, OCEANOL ACTA, V7, P113
NR 27
TC 8
Z9 8
U1 0
U2 17
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1439-6092
EI 1618-1077
J9 ORG DIVERS EVOL
JI Org. Divers. Evol.
PD JUN
PY 2014
VL 14
IS 2
BP 163
EP 171
DI 10.1007/s13127-013-0160-4
PG 9
WC Evolutionary Biology; Zoology
SC Evolutionary Biology; Zoology
GA AH4EY
UT WOS:000336080900002
DA 2021-01-25
ER

PT J
AU Erhard, F
   Haas, J
   Lieber, D
   Malterer, G
   Jaskiewicz, L
   Zavolan, M
   Dolken, L
   Zimmer, R
AF Erhard, Florian
   Haas, Juergen
   Lieber, Diana
   Malterer, Georg
   Jaskiewicz, Lukasz
   Zavolan, Mihaela
   Doelken, Lars
   Zimmer, Ralf
TI Widespread context dependency of microRNA-mediated regulation
SO GENOME RESEARCH
LA English
DT Article
ID DIFFERENTIAL EXPRESSION ANALYSIS; TARGET MESSENGER-RNA; GENE-EXPRESSION;
   TRANSLATIONAL REPRESSION; TRANSCRIPTION FACTORS; BINDING PROTEINS;
   PAR-CLIP; IDENTIFICATION; SITES; RECOGNITION
AB Gene expression is regulated in a context-dependent, cell-type-specific manner. Condition-specific transcription is dependent on the presence of transcription factors (TFs) that can activate or inhibit its target genes (global context). Additional factors, such as chromatin structure, histone, or DNA modifications, also influence the activity of individual target genes (individual context). The role of the global and individual context for post-transcriptional regulation has not systematically been investigated on a large scale and is poorly understood. Here we show that global and individual context dependency is a pervasive feature of microRNA-mediated regulation. Our comprehensive and highly consistent data set from several high-throughput technologies (PAR-CLIP, RIP-chip, 4sU-tagging, and SILAC) provides strong evidence that context-dependent microRNA target sites (CDTS) are as frequent and functionally relevant as constitutive target sites (CTS). Furthermore, we found the global context to be insufficient to explain the CDTS, and that flanking sequence motifs provide individual context that is an equally important factor. Our results demonstrate that, similar to TF-mediated regulation, global and individual context dependency are prevalent in microRNA-mediated gene regulation, implying a much more complex post-transcriptional regulatory network than is currently known. The necessary tools to unravel post-transcriptional regulations and mechanisms need to be much more involved, and much more data will be needed for particular cell types and cellular conditions in order to understand microRNA-mediated regulation and the context-dependent post-transcriptional regulatory network.
C1 [Erhard, Florian; Zimmer, Ralf] Univ Munich, Inst Informat, D-80333 Munich, Germany.
   [Haas, Juergen; Lieber, Diana; Malterer, Georg] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany.
   [Haas, Juergen] Univ Edinburgh, Div Pathway Med, Edinburgh EH17 8TR, Midlothian, Scotland.
   [Lieber, Diana] Univ Ulm Klinikum, Inst Virol, D-89081 Ulm, Germany.
   [Jaskiewicz, Lukasz; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jaskiewicz, Lukasz; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Doelken, Lars] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
RP Dolken, L (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
EM ld408@medschl.cam.ac.uk; zimmer@bio.ifi.lmu.de
RI Zavolan, Mihaela/S-3888-2016; Zimmer, Ralf/L-9295-2019
OI Zavolan, Mihaela/0000-0002-8832-2041
FU BMBFFederal Ministry of Education & Research (BMBF) [01GS0801];
   MRCMedical Research Council UK (MRC) [G1002523]; NHSBT [WP11-05]; Swiss
   Cancer League [KFS 02477-08-2009]; Medical Research CouncilMedical
   Research Council UK (MRC) [G1002523] Funding Source: researchfish
FX This work was supported by grants from BMBF (NGFN-Plus #01GS0801 to
   R.Z., L.D., and J.H.), MRC (G1002523 to L. D.), NHSBT (WP11-05 to L.D.),
   and Swiss Cancer League (#KFS 02477-08-2009 to M.Z.).
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Carroll AP, 2013, J MOL CELL BIOL, V5, P73, DOI 10.1093/jmcb/mjt004
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611
   Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138
   Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108
   Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Erhard F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r79
   Erhard F, 2013, BIOINFORMATICS, V29, P77, DOI 10.1093/bioinformatics/bts631
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Haecker I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002884
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651
   Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109
   Jaskiewicz L, 2012, METHODS, V58, P106, DOI 10.1016/j.ymeth.2012.09.006
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Kozak M, 2008, GENE, V423, P108, DOI 10.1016/j.gene.2008.07.013
   Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197
   Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109
   Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905
   Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040
   Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162
   Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63
   Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954
   Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484
   Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921
   Vens C, 2011, BIOINFORMATICS, V27, P1231, DOI 10.1093/bioinformatics/btr110
   Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111
   Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112
   Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111
NR 51
TC 69
Z9 70
U1 0
U2 9
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD JUN
PY 2014
VL 24
IS 6
BP 906
EP 919
DI 10.1101/gr.166702.113
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA AI2BQ
UT WOS:000336662200003
PM 24668909
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Latreille, M
   Hausser, J
   Stutzer, I
   Zhang, Q
   Hastoy, B
   Gargani, S
   Kerr-Conte, J
   Pattou, F
   Zavolan, M
   Esguerra, JLS
   Eliasson, L
   Rulicke, T
   Rorsman, P
   Stoffel, M
AF Latreille, Mathieu
   Hausser, Jean
   Stuetzer, Ina
   Zhang, Quan
   Hastoy, Benoit
   Gargani, Sofia
   Kerr-Conte, Julie
   Pattou, Francois
   Zavolan, Mihaela
   Esguerra, Jonathan L. S.
   Eliasson, Lena
   Ruelicke, Thomas
   Rorsman, Patrik
   Stoffel, Markus
TI MicroRNA-7a regulates pancreatic beta cell function
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID INSULIN GENE-EXPRESSION; B-CELLS; DECREASED EXPRESSION; ANALYSIS
   REVEALS; MOUSE PANCREAS; SECRETION; PROTEIN; ALPHA; EXOCYTOSIS; ISLETS
AB Dysfunctional microRNA (miRNA) networks contribute to inappropriate responses following pathological stress and are the underlying cause of several disease conditions. In pancreatic beta cells, miRNAs have been largely unstudied and little is known about how specific miRNAs regulate glucose-stimulated insulin secretion (GSIS) or impact the adaptation of beta cell function to metabolic stress. In this study, we determined that miR-7 is a negative regulator of GSIS in beta cells. Using Mir7a2 deficient mice, we revealed that miR-7a2 regulates beta cell function by directly regulating genes that control late stages of insulin granule fusion with the plasma membrane and ternary SNARE complex activity. Transgenic mice overexpressing miR-7a in beta cells developed diabetes due to impaired insulin secretion and beta cell dedifferentiation. Interestingly, perturbation of miR-7a expression in beta cells did not affect proliferation and apoptosis, indicating that miR-7 is dispensable for the maintenance of endocrine beta cell mass. Furthermore, we found that miR-7a levels are decreased in obese/ diabetic mouse models and human islets from obese and moderately diabetic individuals with compensated beta cell function. Our results reveal an interconnecting miR-7 genomic circuit that regulates insulin granule exocytosis in pancreatic beta cells and support a role for miR-7 in the adaptation of pancreatic p cell function in obesity and type 2 diabetes.
C1 [Latreille, Mathieu; Stuetzer, Ina; Stoffel, Markus] ETH, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.
   [Latreille, Mathieu; Stuetzer, Ina; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Zhang, Quan; Hastoy, Benoit; Rorsman, Patrik] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Headington, England.
   [Gargani, Sofia; Kerr-Conte, Julie; Pattou, Francois] Univ Lille 2, CHRU Lille, INSERM, European Genom Inst Diabet, Lille, France.
   [Esguerra, Jonathan L. S.; Eliasson, Lena] Lund Univ, Ctr Diabet, Dept Clin Sci Malmo, Malmo, Sweden.
   [Ruelicke, Thomas] Vetmeduni Vienna, Inst Lab Anim Sci, Vienna, Austria.
   [Stoffel, Markus] Univ Zurich, Fac Med, Zurich, Switzerland.
RP Stoffel, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Schafmattstr 22,HPL H36, CH-8093 Zurich, Switzerland.
EM stoffel@biol.ethz.ch
RI Pattou, Francois/O-6151-2017; Esguerra, Jonathan/M-2366-2014; Rorsman,
   Patrik/A-4331-2016; Pattou, Francois/Y-8448-2019; Eliasson,
   Lena/E-9294-2012; Zavolan, Mihaela/S-3888-2016
OI Pattou, Francois/0000-0001-8388-3766; Esguerra,
   Jonathan/0000-0001-8454-6606; Rorsman, Patrik/0000-0001-7578-0767;
   Eliasson, Lena/0000-0002-6467-5029; Zavolan,
   Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199;
   Latreille, Mathieu/0000-0001-8542-749X; HASTOY,
   Benoit/0000-0003-1244-7857
FU Swedish Research CouncilSwedish Research Council; Region Skane ALP;
   Swedish Diabetes Foundation; EFSD-Lily Research Fellowship; Crafoord
   Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg
   Foundation; JDRFJuvenile Diabetes Research Foundation; ERCEuropean
   Research Council (ERC); Austrian Genome Research Program; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
   [31003A_127307]; European Genomic Institute for Diabetes (EGID)
   [ANR-10-LABX-46]; L'Agence de la BioMedecine and Fondation de l'Avenir;
   Wellcome Trust Senior Investigator AwardWellcome Trust; Medical Research
   CouncilMedical Research Council UK (MRC) [G0801995] Funding Source:
   researchfish; Wellcome TrustWellcome Trust [095531/Z/11/Z] Funding
   Source: researchfish
FX We thank M. Muller, B. Kubsch, F. Nunez Villena, and K. Hermann (ETH
   Zurich) for technical support; K. Ahmed and D. Esterhazy for reading the
   manuscript; P. Lefebvre and J. Thevenet (Lille) for help with Affymetrix
   expression analysis and the human islet obesity mouse model,
   respectively; and T. Kolbe (Biomodels Austria, University of Veterinary
   Medicine Vienna) for pronuclei and blastocyst injections. The project
   was supported by The Swedish Research Council (to L. Eliasson), Region
   Skane ALP (to L. Eliasson), The Swedish Diabetes Foundation (to L.
   Eliasson), EFSD-Lily Research Fellowship grant (to J.L.S. Esguerra), the
   Crafoord Foundation (to J.L.S. Esguerra), and The Knut and Alice
   Wallenberg Foundation. This work was supported by grants from the JDRF
   (Scholar grant to M. Stoffel), ERC (Metabolomirs to M. Stoffel), the
   Austrian Genome Research Program (GEN-AU II and III, Austromouse, to T.
   Rulicke), the Swiss National Science Foundation (grant no. 31003A_127307
   to M. Stoffel and M. Zavolan), European Genomic Institute for Diabetes
   (EGID; ANR-10-LABX-46), and L'Agence de la BioMedecine and Fondation de
   l'Avenir (to F. Pattou and J. Kerr-Conte). Q. Zhang was supported by a
   Wellcome Trust Senior Investigator Award to P. Rorsman.
CR Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009
   Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029
   Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200
   Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9
   Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4
   Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004
   Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991
   Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052
   Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227
   Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240
   Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028
   Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112
   de Chevigny A, 2012, NAT NEUROSCI, V15, P1120, DOI 10.1038/nn.3142
   De Franco E, 2013, DIABETES, V62, P993, DOI 10.2337/db12-0885
   Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108
   Dumortier O, 2013, CELL METAB, V18, P312, DOI 10.1016/j.cmet.2013.06.004
   Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613
   Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237
   Gargani S, 2013, DIABETOLOGIA, V56, P350, DOI 10.1007/s00125-012-2775-y
   Gopel S, 1999, J PHYSIOL-LONDON, V521, P717, DOI 10.1111/j.1469-7793.1999.00717.x
   Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708
   Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200
   Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173
   Herrera PL, 2000, DEVELOPMENT, V127, P2317
   Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kanno T, 2002, J PHYSIOL-LONDON, V545, P501, DOI 10.1113/jphysiol.2002.031344
   Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007
   Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499
   Kredo-Russo S, 2012, DEVELOPMENT, V139, P3021, DOI 10.1242/dev.080127
   Kredo-Russo S, 2012, EXP DIABETES RES, DOI 10.1155/2012/695214
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175
   Mandelbaum AD, 2012, EXP DIABETES RES, DOI 10.1155/2012/470302
   Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361
   Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928
   Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005
   Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367
   Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014
   Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5
   Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575
   Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200
   Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160
   Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10
   Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x
   Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516
   Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662
   Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104
   Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008
   Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16
   Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045
   StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0
   Sudhof TC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005637
   Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029
   Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041
   Wang YW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/401723
   Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451
   Wang YL, 2013, MOL CELL BIOL, V33, P1233, DOI 10.1128/MCB.01604-12
   Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352
NR 63
TC 149
Z9 160
U1 1
U2 35
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUN
PY 2014
VL 124
IS 6
BP 2722
EP 2735
DI 10.1172/JCI73066
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AI4XC
UT WOS:000336868800042
PM 24789908
OA Bronze, Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Fumeaux, C
   Radhakrishnan, SK
   Ardissone, S
   Theraulaz, L
   Frandi, A
   Martins, D
   Nesper, J
   Abel, S
   Jenal, U
   Viollier, PH
AF Fumeaux, Coralie
   Radhakrishnan, Sunish Kumar
   Ardissone, Silvia
   Theraulaz, Laurence
   Frandi, Antonio
   Martins, Daniel
   Nesper, Jutta
   Abel, Soeren
   Jenal, Urs
   Viollier, Patrick H.
TI Cell cycle transition from S-phase to G1 in Caulobacter is mediated by
   ancestral virulence regulators
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SINORHIZOBIUM-MELILOTI; ALPHA-PROTEOBACTERIA; AGROBACTERIUM-TUMEFACIENS;
   TRANSCRIPTION FACTOR; HISTIDINE KINASE; MASTER REGULATOR; GENE-CLUSTER;
   CRESCENTUS; IDENTIFICATION; DIVISION
AB Zinc-finger domain transcriptional regulators regulate a myriad of functions in eukaryotes. Interestingly, ancestral versions (MucR) from Alpha-proteobacteria control bacterial virulence/symbiosis. Whether virulence regulators can also control cell cycle transcription is unknown. Here we report that MucR proteins implement a hitherto elusive primordial S -> G1 transcriptional switch. After charting G1-specific promoters in the cell cycle model Caulobacter crescentus by comparative ChIP-seq, we use one such promoter as genetic proxy to unearth two MucR paralogs, MucR1/2, as constituents of a quadripartite and homeostatic regulatory module directing the S -> G1 transcriptional switch. Surprisingly, MucR orthologues that regulate virulence and symbiosis gene transcription in Brucella, Agrobacterium or Sinorhizobium support this S -> G1 switch in Caulobacter. Pan-genomic ChIP-seq analyses in Sinorhizobium and Caulobacter show that this module indeed targets orthologous genes. We propose that MucR proteins and possibly other virulence regulators primarily control bacterial cell cycle (G1-phase) transcription, rendering expression of target (virulence) genes periodic and in tune with the cell cycle.
C1 [Fumeaux, Coralie; Radhakrishnan, Sunish Kumar; Ardissone, Silvia; Theraulaz, Laurence; Frandi, Antonio; Martins, Daniel; Viollier, Patrick H.] Univ Geneva, Inst Genet & Genom Geneva iGE3, Fac Med CMU, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland.
   [Nesper, Jutta; Abel, Soeren; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Viollier, PH (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, Fac Med CMU, Dept Microbiol & Mol Med, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.
EM Patrick.Viollier@unige.ch
RI Frandi, Antonio/ABE-7216-2020
OI Fumeaux, Coralie/0000-0002-6969-3111; Abel, Soren/0000-0002-4041-6989;
   Viollier, Patrick/0000-0002-5249-9910; Radhakrishnan,
   Sunish/0000-0001-8729-263X; Frandi, Antonio/0000-0003-4626-7619;
   Ardissone, Silvia/0000-0003-4346-8124
FU SNF [31003A_143660, 31003A_130469]
FX This work was supported by SNF grants no. 31003A_143660 to P.H.V. and
   no. 31003A_130469 to U.J. We thank Lucy Shapiro, Jim Gober, Mike Laub,
   Jean-Jacques Letesson, Xavier de Bolle and Matteo Brilli for materials
   and/or discussions.
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Ardissone S, 2012, FRONT BIOSCI-LANDMRK, V17, P1695, DOI 10.2741/4013
   Bahlawane C, 2008, MOL PLANT MICROBE IN, V21, P1498, DOI 10.1094/MPMI-21-11-1498
   Bahlawane C, 2008, J BACTERIOL, V190, P3456, DOI 10.1128/JB.00062-08
   Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52
   Chen JC, 2006, EMBO J, V25, P377, DOI 10.1038/sj.emboj.7600935
   Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x
   Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658
   D'Souza JA, 2002, GENE, V297, P123, DOI 10.1016/S0378-1119(02)00876-4
   Davis NJ, 2011, FEMS MICROBIOL LETT, V319, P146, DOI 10.1111/j.1574-6968.2011.02275.x
   De Nisco NJ, 2014, P NATL ACAD SCI USA, V111, P3217, DOI 10.1073/pnas.1400421111
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977
   Fiebig A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004101
   Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x
   Gora KG, 2013, MOL MICROBIOL, V87, P1277, DOI 10.1111/mmi.12166
   Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   HAHNENBERGER KM, 1987, J MOL BIOL, V194, P91, DOI 10.1016/0022-2836(87)90718-2
   Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002
   Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x
   Kado CI, 2002, PLASMID, V48, P179, DOI 10.1016/S0147-619X(02)00116-6
   Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001
   Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056
   Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346
   Lee JS, 2011, J BACTERIOL, V193, P1681, DOI 10.1128/JB.01541-10
   Llewellyn M, 2005, MOL MICROBIOL, V57, P1127, DOI 10.1111/j.1365-2958.2005.04745.x
   Malgieri G, 2007, P NATL ACAD SCI USA, V104, P17341, DOI 10.1073/pnas.0706659104
   Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10
   McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Mirabella A, 2013, J BACTERIOL, V195, P453, DOI 10.1128/JB.01336-12
   Mohr CD, 1996, J BACTERIOL, V178, P675, DOI 10.1128/jb.178.3.675-682.1996
   Murray SM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001749
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808
   Radhakrishnan SK, 2010, DEV CELL, V18, P90, DOI 10.1016/j.devcel.2009.10.024
   Rockey D. D., 1999, CHLAMYDIAL DEV CYCLE, P403
   Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470
   Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223
   Suh SJ, 2004, J MICROBIOL METH, V58, P203, DOI 10.1016/j.mimet.2004.03.018
   Tan MH, 2010, P NATL ACAD SCI USA, V107, P18985, DOI 10.1073/pnas.1014395107
   Tsokos CG, 2012, CURR OPIN MICROBIOL, V15, P744, DOI 10.1016/j.mib.2012.10.011
   Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101
   Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x
   Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x
NR 52
TC 48
Z9 48
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2014
VL 5
AR 4081
DI 10.1038/ncomms5081
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AL0SV
UT WOS:000338838000025
PM 24939058
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Schnarwiler, F
   Niemann, M
   Doiron, N
   Harsman, A
   Kaser, S
   Mani, J
   Chanfon, A
   Dewar, CE
   Oeljeklaus, S
   Jackson, CB
   Pusnik, M
   Schmidt, O
   Meisinger, C
   Hiller, S
   Warscheid, B
   Schnaufer, AC
   Ochsenreiter, T
   Schneider, A
AF Schnarwiler, Felix
   Niemann, Moritz
   Doiron, Nicholas
   Harsman, Anke
   Kaeser, Sandro
   Mani, Jan
   Chanfon, Astrid
   Dewar, Caroline E.
   Oeljeklaus, Silke
   Jackson, Christopher B.
   Pusnik, Mascha
   Schmidt, Oliver
   Meisinger, Chris
   Hiller, Sebastian
   Warscheid, Bettina
   Schnaufer, Achim C.
   Ochsenreiter, Torsten
   Schneider, Andre
TI Trypanosomal TAC40 constitutes a novel subclass of mitochondrial
   beta-barrel proteins specialized in mitochondrial genome inheritance
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE organelle; parasitic protozoa
ID OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; BACTERIAL ORIGIN; CELL-CYCLE;
   BRUCEI; DNA; SEGREGATION; ER; MAINTENANCE; MORPHOLOGY
AB Mitochondria cannot form de novo but require mechanisms allowing their inheritance to daughter cells. In contrast to most other eukaryotes Trypanosoma brucei has a single mitochondrion whose single-unit genome is physically connected to the flagellum. Here we identify a beta-barrel mitochondrial outer membrane protein, termed tripartite attachment complex 40 (TAC40), that localizes to this connection. TAC40 is essential for mitochondrial DNA inheritance and belongs to the mitochondrial porin protein family. However, it is not specifically related to any of the three subclasses of mitochondrial porins represented by the metabolite transporter voltage-dependent anion channel (VDAC), the protein translocator of the outer membrane 40 (TOM40), or the fungi-specific MDM10, a component of the endoplasmic reticulum-mitochondria encounter structure (ERMES). MDM10 and TAC40 mediate cellular architecture and participate in transmembrane complexes that are essential for mitochondrial DNA inheritance. In yeast MDM10, in the context of the ERMES, is postulated to connect the mitochondrial genomes to actin filaments, whereas in trypanosomes TAC40 mediates the linkage of the mitochondrial DNA to the basal body of the flagellum. However, TAC40 does not colocalize with trypanosomal orthologs of ERMES components and, unlike MDM10, it regulates neither mitochondrial morphology nor the assembly of the protein translocase. TAC40 therefore defines a novel subclass of mitochondrial porins that is distinct from VDAC, TOM40, and MDM10. However, whereas the architecture of the TAC40-containing complex in trypanosomes and the MDM10-containing ERMES in yeast is very different, both are organized around a beta-barrel protein of the mitochondrial porin family that mediates a DNA-cytoskeleton linkage that is essential for mitochondrial DNA inheritance.
C1 [Schnarwiler, Felix; Niemann, Moritz; Harsman, Anke; Kaeser, Sandro; Mani, Jan; Chanfon, Astrid; Pusnik, Mascha; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
   [Doiron, Nicholas; Ochsenreiter, Torsten] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland.
   [Dewar, Caroline E.; Schnaufer, Achim C.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland.
   [Dewar, Caroline E.; Schnaufer, Achim C.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.
   [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
   [Oeljeklaus, Silke; Schmidt, Oliver; Meisinger, Chris; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.
   [Jackson, Christopher B.] Univ Bern, Inselspital, Dept Paediat & Clin Res, Div Human Genet, CH-3010 Bern, Switzerland.
   [Schmidt, Oliver; Meisinger, Chris] Univ Freiburg, Zentrum Biochem & Mol Zellforsch, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.
   [Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
EM andre.schneider@dcb.unibe.ch
RI Ochsenreiter, Torsten/E-6040-2010; Hiller, Sebastian/B-3573-2008;
   Jackson, Christopher B./M-3222-2013; Meisinger, Chris/J-1110-2014
OI Hiller, Sebastian/0000-0002-6709-4684; Jackson, Christopher
   B./0000-0003-1035-6417; Meisinger, Chris/0000-0002-8326-3548; Schmidt,
   Oliver/0000-0002-7921-4663; Schnaufer, Achim/0000-0003-2132-5560; Kaser,
   Sandro/0000-0002-2775-9469; Warscheid, Bettina/0000-0001-5096-1975
FU Peter und Traudl Engelhorn Foundation; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG); Excellence
   Initiative of the German Federal and State Governments (Exzellenzcluster
   294 BIOSS Centre for Biological Signalling Studies); Swiss National
   FoundationSwiss National Science Foundation (SNSF) [138355]; Medical
   Research CouncilMedical Research Council UK (MRC) [G0600129] Funding
   Source: researchfish
FX We thank J. Wideman for communicating the accession numbers of
   trypanosomal MDM12 and MDM34 candidates to us. M.N. and A. H. gratefully
   acknowledge fellowships from the Peter und Traudl Engelhorn Foundation.
   Research in the groups of C. M. and B. W. was funded by grants from the
   Deutsche Forschungsgemeinschaft and the Excellence Initiative of the
   German Federal and State Governments (Exzellenzcluster 294 BIOSS Centre
   for Biological Signalling Studies). Research in the laboratory of A. S.
   was supported by Grant 138355 of the Swiss National Foundation.
CR Bay DC, 2012, BBA-BIOMEMBRANES, V1818, P1502, DOI 10.1016/j.bbamem.2011.11.027
   Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200
   Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x
   Dacks JB, 2008, PARASITOL INT, V57, P97, DOI 10.1016/j.parint.2007.11.004
   Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110
   Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030
   Flinner N, 2012, BIOL LETTERS, V8, P446, DOI 10.1098/rsbl.2011.1121
   Gheiratmand L, 2013, J BIOL CHEM, V288, P3489, DOI 10.1074/jbc.M112.417428
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118
   Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057
   JUKES T, 1969, EVOLUTION PROTEIN MO
   Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636
   Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088
   McCulloch Richard, 2004, Methods Mol Biol, V262, P53
   McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010
   Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040
   Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003
   Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x
   Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093
   Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002
   Ochsenreiter T, 2008, MOL CELL BIOL, V28, P5595, DOI 10.1128/MCB.00637-08
   Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525
   Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288
   Pusnik M, 2012, MOL BIOL CELL, V23, P3420, DOI 10.1091/mbc.E12-02-0107
   Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060
   ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0
   SASSE R, 1988, J CELL SCI, V90, P577
   Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862
   SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431
   Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5
   Scott SV, 2003, CURR OPIN CELL BIOL, V15, P482, DOI 10.1016/S0955-0674(03)00070-X
   Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361
   Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x
   Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wideman JG, 2013, MOL BIOL EVOL, V30, P2044, DOI 10.1093/molbev/mst120
   Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844
   Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X
   Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012
   Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057
   Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956
NR 46
TC 24
Z9 24
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 27
PY 2014
VL 111
IS 21
BP 7624
EP 7629
DI 10.1073/pnas.1404854111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AH8TO
UT WOS:000336411300037
PM 24821793
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Giss, D
   Kemmerling, S
   Dandey, V
   Stahlberg, H
   Braun, T
AF Giss, Dominic
   Kemmerling, Simon
   Dandey, Venkata
   Stahlberg, Henning
   Braun, Thomas
TI Exploring the Interactome: Microfluidic Isolation of Proteins and
   Interacting Partners for Quantitative Analysis by Electron Microscopy
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID TOMOGRAPHY; PROTEOMICS; SELECTION
AB Multimolecular protein complexes are important for many cellular processes. However, the stochastic nature of the cellular interactome makes the experimental detection of complex protein assemblies difficult and quantitative analysis at the single molecule level essential. Here, we present a fast and simple microfluidic method for (i) the quantitative isolation of endogenous levels of untagged protein complexes from minute volumes of cell lysates under close to physiological conditions and (ii) the labeling of specific components constituting these complexes. The method presented uses specific antibodies that are conjugated via a photocleavable linker to magnetic beads that are trapped in microcapillaries to immobilize the target proteins. Proteins are released by photocleavage, eluted, and subsequently analyzed by quantitative transmission electron microscopy at the single molecule level. Additionally, before photocleavage, immunogold can be employed to label proteins that interact with the primary target protein. Thus, the presented method provides a new way to study the interactome and, in combination with single molecule transmission electron microscopy, to structurally characterize the large, dynamic, heterogeneous multimolecular protein complexes formed.
C1 [Giss, Dominic; Kemmerling, Simon; Dandey, Venkata; Stahlberg, Henning; Braun, Thomas] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4056 Basel, Switzerland.
RP Braun, T (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4056 Basel, Switzerland.
EM Thomas.braun@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU SNF SystemsX.ch (CINA); NCCR NanoscienceSwiss National Science
   Foundation (SNSF)
FX We thank Shirley Muller and Benjamin Bircher (C-CINA, University of
   Basel, Switzerland) for carefully reading the manuscript and expert
   discussions. The project was supported by the SNF SystemsX.ch (CINA,
   granted to H.S.) and the NCCR Nanoscience.
CR Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020
   Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9
   Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097
   Bouchet-Marquis C, 2012, J STRUCT BIOL, V177, P119, DOI 10.1016/j.jsb.2011.10.007
   BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8
   Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x
   Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001
   Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   Engel A, 2010, SPRINGER SERIES CHEM, V96, P417, DOI 10.1007/978-3-642-02597-6_21
   FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0
   Kemmerling S, 2013, J STRUCT BIOL, V183, P467, DOI 10.1016/j.jsb.2013.06.012
   Kemmerling S, 2012, J STRUCT BIOL, V177, P128, DOI 10.1016/j.jsb.2011.11.001
   Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585
   Koster AJ, 2003, NAT REV MOL CELL BIO, pSS6, DOI 10.1038/nrm1194
   Kourkoutis LF, 2012, ANNU REV MATER RES, V42, P33, DOI 10.1146/annurev-matsci-070511-155004
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Leis A, 2009, TRENDS BIOCHEM SCI, V34, P60, DOI 10.1016/j.tibs.2008.10.011
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Lim M, 2008, ANAL BIOCHEM, V383, P103, DOI 10.1016/j.ab.2008.07.038
   Martin-Benito J, 2007, EMBO REP, V8, P252, DOI 10.1038/sj.embor.7400894
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   O'Mahony FC, 2013, JOVE-J VIS EXP, DOI 10.3791/50221
   Ramadan Q, 2011, ANALYST, V136, P1157, DOI 10.1039/c0an00654h
   Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007
   Rudashevskaya EL, 2013, NAT PROTOC, V8, P75, DOI 10.1038/nprot.2012.133
   Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]
   Stengel F, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.014027
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Uzoma Ijeoma, 2013, Genomics Proteomics & Bioinformatics, V11, P18, DOI 10.1016/j.gpb.2012.12.005
   Vanhecke D, 2011, J MICROSC-OXFORD, V242, P221, DOI 10.1111/j.1365-2818.2010.03478.x
   Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016
   Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052
NR 39
TC 8
Z9 8
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD MAY 20
PY 2014
VL 86
IS 10
BP 4680
EP 4687
DI 10.1021/ac4027803
PG 8
WC Chemistry, Analytical
SC Chemistry
GA AH8WJ
UT WOS:000336418600009
PM 24773394
DA 2021-01-25
ER

PT J
AU Zhang, Y
   Teo, BM
   Goldie, KN
   Stadler, B
AF Zhang, Yan
   Teo, Boon M.
   Goldie, Kenneth N.
   Stadler, Brigitte
TI Poly(N-isopropylacrylamide)/Poly(dopamine) Capsules
SO LANGMUIR
LA English
DT Article
ID POLYMER HYDROGEL CAPSULES; POLYELECTROLYTE MULTILAYER CAPSULES;
   POLYDOPAMINE NANOCAPSULES; DOPAMINE; RELEASE; FILMS; PH; IMMOBILIZATION;
   VERSATILE; DELIVERY
AB Polymer capsules are an interesting concept considered in nanobiotechnology. Approaches that facilitate their assembly remain sought after. Poly(dopamine) (PDA) has been considered and successfully applied in this context. We recently demonstrated that PDA could be copolymerized with different types of poly(N-isopropylacrylamide) (pNiPAAm) to assemble mixed films on planar substrates. Herein, we transferred this approach onto colloidal substrates and characterized the film thickness depending on the film composition and template particles size. While the membrane of capsules assembled using 5 mu m template particles exhibited strong dependency on the film composition, smaller templates led to capsules with similar membrane thickness. We then compared the permeability of different capsules using fluorescently labeled dextran and fluorescein. We found that the permeability of capsules was heavily dependent on the polymer composition and the template particle size. These fundamental findings contribute to the potential of these capsules, assembled in one-step, for biomedical applications.
C1 [Zhang, Yan; Teo, Boon M.; Stadler, Brigitte] Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, Aarhus, Denmark.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
RP Stadler, B (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr INANO, Aarhus, Denmark.
EM bstadler@inano.au.dk
OI Stadler, Brigitte/0000-0002-7335-3945
FU Danish Council for Independent Research, Technology and Production
   Sciences, DenmarkDet Frie Forskningsrad (DFF)
FX This work was supported by a Sapere Aude Starting Grant from the Danish
   Council for Independent Research, Technology and Production Sciences,
   Denmark.
CR An JH, 2011, POLYM INT, V60, P1581, DOI 10.1002/pi.3116
   Angelatos AS, 2007, LANGMUIR, V23, P4554, DOI 10.1021/la063674h
   Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Becker AL, 2009, LANGMUIR, V25, P14079, DOI 10.1021/la901687a
   Cheng FF, 2013, J BIOMED NANOTECHNOL, V9, P1155, DOI 10.1166/jbn.2013.1611
   Chong SF, 2011, LANGMUIR, V27, P1724, DOI 10.1021/la104510e
   Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r
   De Geest BG, 2012, ANGEW CHEM INT EDIT, V51, P3862, DOI 10.1002/anie.201200048
   De Koker S, 2012, CHEM SOC REV, V41, P2867, DOI 10.1039/c2cs15296g
   De Koker S, 2010, J IMMUNOL, V184, P203, DOI 10.4049/jimmunol.0803591
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Dierendonck M, 2012, J CONTROL RELEASE, V161, P592, DOI 10.1016/j.jconrel.2012.03.001
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Driever CD, 2011, SOFT MATTER, V7, P4257, DOI 10.1039/c0sm01410a
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Hosta-Rigau L, 2013, SMALL, V9, P3573, DOI 10.1002/smll.201300125
   Ibarz G, 2001, ADV MATER, V13, P1324, DOI 10.1002/1521-4095(200109)13:17<1324::AID-ADMA1324>3.0.CO;2-L
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Kim K, 2013, BIOMATER SCI-UK, V1, P783, DOI 10.1039/c3bm00004d
   Kulygin O, 2010, SMALL, V6, P1558, DOI 10.1002/smll.201000453
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Liu QZ, 2011, MACROMOL BIOSCI, V11, P1227, DOI 10.1002/mabi.201100061
   Liu Y., 2014, CHEM REV IN PRESS
   Lomas H, 2011, SMALL, V7, P2109, DOI 10.1002/smll.201100744
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Ochs CJ, 2011, CHEM MATER, V23, P3141, DOI 10.1021/cm201390e
   Postma A, 2009, CHEM MATER, V21, P3042, DOI 10.1021/cm901293e
   Price AD, 2010, ADV MATER, V22, P720, DOI 10.1002/adma.200903411
   Saiz-Poseu J, 2013, ADV MATER, V25, P2066, DOI 10.1002/adma.201204383
   Sexton A, 2009, ACS NANO, V3, P3391, DOI 10.1021/nn900715g
   Stadler B, 2009, NANOSCALE, V1, P68, DOI 10.1039/b9nr00143c
   Such GK, 2012, PROG POLYM SCI, V37, P985, DOI 10.1016/j.progpolymsci.2011.12.002
   Tong WJ, 2012, CHEM SOC REV, V41, P6103, DOI 10.1039/c2cs35088b
   Tsai WB, 2011, ACTA BIOMATER, V7, P2518, DOI 10.1016/j.actbio.2011.03.010
   Yeroslavsky G, 2013, CHEM COMMUN, V49, P5721, DOI 10.1039/c3cc37762h
   Yu B, 2009, CHEM COMMUN, P6789, DOI 10.1039/b910679k
   Zelikin AN, 2010, SMALL, V6, P2201, DOI 10.1002/smll.201000765
   Zhang L, 2011, GREEN CHEM, V13, P300, DOI 10.1039/c0gc00432d
   Zhang Y, 2013, J PHYS CHEM B, V117, P10504, DOI 10.1021/jp407106z
   Zhang Y, 2013, LANGMUIR, V29, P10213, DOI 10.1021/la402118u
   Zhang Y, 2012, LANGMUIR, V28, P17585, DOI 10.1021/la304080c
NR 43
TC 15
Z9 15
U1 1
U2 177
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 20
PY 2014
VL 30
IS 19
BP 5592
EP 5598
DI 10.1021/la5005227
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AH8UU
UT WOS:000336414500031
PM 24761831
DA 2021-01-25
ER

PT J
AU Fribourg, PF
   Chami, M
   Sorzano, COS
   Gubellini, F
   Marabini, R
   Marco, S
   Jault, JM
   Levy, D
AF Fribourg, Pierre Frederic
   Chami, Mohamed
   Sorzano, Carlos Oscar S.
   Gubellini, Francesca
   Marabini, Roberto
   Marco, Sergio
   Jault, Jean-Michel
   Levy, Daniel
TI 3D Cryo-Electron Reconstruction of BmrA, a Bacterial Multidrug ABC
   Transporter in an Inward-Facing Conformation and in a Lipidic
   Environment
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
ID BINDING CASSETTE TRANSPORTER; ELECTRON-ELECTRON RESONANCE; ATP-BINDING;
   P-GLYCOPROTEIN; MEMBRANE-PROTEINS; BACILLUS-SUBTILIS; ALTERNATING
   ACCESS; 2D CRYSTALLIZATION; MICROSCOPY; MSBA
AB ABC (ATP-binding cassette) membrane exporters are efflux transporters of a wide diversity of molecule across the membrane at the expense of ATP. A key issue regarding their catalytic cycle is whether or not their nucleotide-binding domains (NBDs) are physically disengaged in the resting state. To settle this controversy, we obtained structural data on BmrA, a bacterial multidrug homodimeric ABC transporter, in a membrane-embedded state. BmrA in the apostate was reconstituted in lipid bilayers forming a mixture of ring-shaped structures of 24 or 39 homodimers. Three-dimensional models of the ring-shaped structures of 24 or 39 homodimers were calculated at 2.3 nm and 2.5 nm resolution from cryo-electron microscopy, respectively. In these structures, BmrA adopts an inward-facing open conformation similar to that found in mouse P-glycoprotein structure with the NBDs separated by 3 nnn. Both lipidic leaflets delimiting the transmembrane domains of BmrA were clearly resolved. In planar membrane sheets, the NBDs were even more separated. BmrA in an ATP-bound conformation was determined from two-dimensional crystals grown in the presence of ATP and vanadate. A projection map calculated at 1.6 nm resolution shows an open outward-facing conformation. Overall, the data are consistent with a mechanism of drug transport involving large conformational changes of BmrA and show that a bacterial ABC exporter can adopt at least two open inward conformations in lipid membrane. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Fribourg, Pierre Frederic; Gubellini, Francesca; Marco, Sergio; Levy, Daniel] Inst Curie, Ctr Rech, F-75231 Paris 05, France.
   [Fribourg, Pierre Frederic; Gubellini, Francesca; Levy, Daniel] CNRS, UMR 168, F-75231 Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
   [Sorzano, Carlos Oscar S.; Marabini, Roberto] Ctr Nacl Biotecnol, Unidad Bioinformat, Madrid 28049, Spain.
   [Marco, Sergio] Ctr Univ Orsay, INSERM, Ctr Rech, Inst Curie,U759, F-91405 Orsay, France.
   [Jault, Jean-Michel] Univ Grenoble 1, CEA, CNRS, Inst Biol Struct,UMR 5075, F-38027 Grenoble 1, France.
   [Levy, Daniel] Inst Curie, Biolmaging Cell & Tissue Core Facil, F-75231 Paris 05, France.
RP Levy, D (corresponding author), Inst Curie, UMR 168, 11 Rue Pierre & Marie Curie, F-75231 Paris 05, France.
EM jean-michel.jault@ibcp.fr
RI jault, jean-michel/G-2086-2012; marco, SERGIO/E-4875-2017; Sorzano,
   Carlos Oscar S S./F-2639-2016; Marabini, Roberto/B-6141-2014
OI jault, jean-michel/0000-0003-1743-2777; Sorzano, Carlos Oscar S
   S./0000-0002-9473-283X; levy, daniel/0000-0002-8949-4072; Gubellini,
   Francesca/0000-0002-2155-9765; Marabini, Roberto/0000-0001-7876-1684
FU Institut Curie; Centre National de la Recherche ScientifiqueCentre
   National de la Recherche Scientifique (CNRS); Agence Nationale de la
   RechercheFrench National Research Agency (ANR) [ANR-06-Blan-0420]
FX We thank A. Di Cicco and J. Manzi for technical support. We thank Dr. J.
   Busselez for fruitful discussion and Dr. H. Stahlberg and Dr. A. Engel
   for their continuous support. This work was supported by Institut Curie
   and Centre National de la Recherche Scientifique and by the Agence
   Nationale de la Recherche Grant No. ANR-06-Blan-0420 (to D.L. and
   J.M.J.).
CR Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309
   Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976
   Dalmas O, 2005, BIOCHEMISTRY-US, V44, P4312, DOI 10.1021/bi0482809
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155
   Dezi M, 2011, J STRUCT BIOL, V174, P307, DOI 10.1016/j.jsb.2010.12.001
   Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200
   Ganesan B, 2007, APPL ENVIRON MICROB, V73, P2498, DOI 10.1128/AEM.01832-06
   George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546
   Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836
   Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630
   Hirst SJ, 2011, J STRUCT BIOL, V173, P506, DOI 10.1016/j.jsb.2010.10.013
   Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448
   Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x
   KRIAT M, 1992, BIOCHIMIE, V74, P949, DOI 10.1016/0300-9084(92)90079-T
   Krugel H, 2010, FEMS MICROBIOL LETT, V313, P155, DOI 10.1111/j.1574-6968.2010.02143.x
   Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200
   Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200
   Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155
   Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010
   Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125
   Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110
   Matsuno K, 1999, J BACTERIOL, V181, P3382, DOI 10.1128/JB.181.11.3382-3391.1999
   Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109
   Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s
   Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]
   Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646
   Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62
   Seantier B, 2011, J MOL RECOGNIT, V24, P461, DOI 10.1002/jmr.1070
   SETLOW P, 1970, J BIOL CHEM, V245, P3637
   Shimano F, 2006, PHYTOCHEMISTRY, V67, P132, DOI 10.1016/j.phytochem.2005.10.013
   Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018
   Tao HC, 2013, NAT METHODS, V10, P759, DOI [10.1038/NMETH.2533, 10.1038/nmeth.2533]
   Thomsson E, 2005, YEAST, V22, P615, DOI 10.1002/yea.1219
   Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151
   Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104
   Ward A, 2009, J STRUCT BIOL, V165, P169, DOI 10.1016/j.jsb.2008.11.006
   Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110
   Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114
   Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/BSE0500043, 10.1042/bse0500043]
   Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193
   Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051
   Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050
NR 50
TC 18
Z9 18
U1 0
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 15
PY 2014
VL 426
IS 10
BP 2059
EP 2069
DI 10.1016/j.jmb.2014.03.002
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AH7XP
UT WOS:000336349000004
PM 24630999
DA 2021-01-25
ER

PT J
AU Meunier, E
   Dick, MS
   Dreier, RF
   Schurmann, N
   Broz, DK
   Warming, S
   Roose-Girma, M
   Bumann, D
   Kayagaki, N
   Takeda, K
   Yamamoto, M
   Broz, P
AF Meunier, Etienne
   Dick, Mathias S.
   Dreier, Roland F.
   Schuermann, Nura
   Broz, Daniela Kenzelmann
   Warming, Soren
   Roose-Girma, Merone
   Bumann, Dirk
   Kayagaki, Nobuhiko
   Takeda, Kiyoshi
   Yamamoto, Masahiro
   Broz, Petr
TI Caspase-11 activation requires lysis of pathogen-containing vacuoles by
   IFN-induced GTPases
SO NATURE
LA English
DT Article
ID NONCANONICAL INFLAMMASOME ACTIVATION; TOXOPLASMA-GONDII; HOST-DEFENSE;
   IMMUNITY; SALMONELLA; INFECTION; AUTOPHAGY; NLRP3; RESISTANCE; PROTECTS
AB Lipopolysaccharide from Gram-negative bacteria is sensed in the host cell cytoplasm by a non-canonical inflammasome pathway that ultimately results in caspase-11 activation and cell death(1-3). In mouse macrophages, activation of this pathway requires the production of type-I interferons(4,5), indicating that interferon-induced genes have a critical role in initiating this pathway. Here we report that a cluster of small interferon-inducible GTPases, the so-called guanylate-binding proteins, is required for the full activity of the non-canonical caspase-11 inflammasome during infections with vacuolar Gram-negative bacteria. We show that guanylate-binding proteins are recruited to intracellular bacterial pathogens and are necessary to induce the lysis of the pathogen-containing vacuole. Lysis of the vacuole releases bacteria into the cytosol, thus allowing the detection of their lipopolysaccharide by a yet unknown lipopolysaccharide sensor. Moreover, recognition of the lysed vacuole by the danger sensor galectin-8 initiates the uptake of bacteria into autophagosomes, which results in a reduction of caspase-11 activation. These results indicate that host-mediated lysis of pathogen-containing vacuoles is an essential immune function and is necessary for efficient recognition of pathogens by inflammasome complexes in the cytosol.
C1 [Meunier, Etienne; Dick, Mathias S.; Dreier, Roland F.; Schuermann, Nura; Bumann, Dirk; Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Broz, Daniela Kenzelmann] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland.
   [Warming, Soren; Roose-Girma, Merone; Kayagaki, Nobuhiko] Genentech Inc, San Francisco, CA 94080 USA.
   [Takeda, Kiyoshi; Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan.
RP Broz, P (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
EM petr.broz@unibas.ch
RI Takeda, Kiyoshi/C-9331-2009; Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790; Dick, Mathias/0000-0002-4070-9749;
   Warming, Soren/0000-0002-5721-0741
FU SNSFSwiss National Science Foundation (SNSF) [PP00P3_139120/1];
   University of Basel [ID2153162]; Marie Heim-Voegtlin Fellowship
   [145516]; Grants-in-Aid for Scientific ResearchMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [23689029, 25670201] Funding Source: KAKEN
FX We thank N. Mizushima and S. Virgin for Atg5-deficient BMDMs, K. Pfeffer
   for Gbp2-deficient BMDMs, J. Frey for B. thailandensis, the Biozentrum
   Proteomics and Imaging Core Facilities for technical assistance, K.
   Anderson, T. Soukup, R. Schwingendorf, J. C. Cox, V. M. Dixit for
   reagents and N. Personnic for discussions. This work was supported by an
   SNSF Professorship PP00P3_139120/1, University of Basel project grant
   ID2153162 to P. B. and a Marie Heim-Voegtlin Fellowship 145516 to D.K.B.
CR Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751
   Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419
   Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257
   Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006
   Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110
   Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400
   Coers J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003538
   Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988
   Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414
   Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176
   Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711
   Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664
   Paetzold S, 2007, INFECT IMMUN, V75, P4826, DOI 10.1128/IAI.00454-07
   Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007
   Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141
   Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744
   Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967
   VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227
   Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009
   Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003
NR 26
TC 252
Z9 258
U1 2
U2 68
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 15
PY 2014
VL 509
IS 7500
BP 366
EP +
DI 10.1038/nature13157
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AH4TM
UT WOS:000336121200040
PM 24739961
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Callon, M
   Burmann, BM
   Hiller, S
AF Callon, Morgane
   Burmann, Bjoern M.
   Hiller, Sebastian
TI Structural Mapping of a Chaperone- Substrate Interaction Surface**
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE chaperone proteins; membrane proteins; NMR spectroscopy; protein
   ensembles; protein-protein interactions
ID ESCHERICHIA-COLI; NMR CHARACTERIZATION; DENATURED STATES; PROTEIN P53;
   GROEL; SKP; DOMAIN; HSP90; BINDING; MODEL
AB NMR spectroscopy is used to detect site-specific intermolecular short-range contacts in a membrane-protein-chaperone complex. This is achieved by an orthogonal isotope-labeling scheme that permits the unambiguous detection of intermolecular NOEs between the well-folded chaperone and the unfolded substrate ensemble. The residues involved in these contacts are part of the chaperone-substrate contact interface. The approach is demonstrated for the 70kDa bacterial Skp-tOmpA complex.
C1 [Callon, Morgane; Burmann, Bjoern M.; Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sebastian.hiller@unibas.ch
RI Burmann, Bjorn/M-8913-2015; Burmann, Bjorn/AAR-7399-2020; Hiller,
   Sebastian/B-3573-2008
OI Burmann, Bjorn/0000-0002-3135-7964; Hiller,
   Sebastian/0000-0002-6709-4684
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3_128419]; European Research CouncilEuropean Research
   Council (ERC) [MOMP 281764]; Werner-Siemens Foundation
FX This work was supported by grants from the Swiss National Science
   Foundation (Grant PP00P3_128419) and the European Research Council (FP7
   contract MOMP 281764) to S. H., and by a personal fellowship from the
   Werner-Siemens Foundation to M.C.
CR Barbar E, 1999, BIOPOLYMERS, V51, P191, DOI 10.1002/(SICI)1097-0282(1999)51:3<191::AID-BIP3>3.0.CO;2-B
   Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011
   Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677
   Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p
   Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660
   ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541
   Ernst R.R., 1987, PRINCIPLES NUCL MAGN
   Fiebig KM, 1996, J PHYS CHEM-US, V100, P2661, DOI 10.1021/jp952747v
   Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039
   Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236
   Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114
   Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102
   Jarchow S, 2008, PROTEOMICS, V8, P4987, DOI 10.1002/pmic.200800288
   Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442
   Koculi E, 2011, PROTEIN SCI, V20, P1380, DOI 10.1002/pro.665
   Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828
   Libich DS, 2013, P NATL ACAD SCI USA, V110, P11361, DOI 10.1073/pnas.1305715110
   Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045
   Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066
   Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322
   Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007
   Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103
   Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200
   Tzeng SR, 2012, METHODS MOL BIOL, V831, P133, DOI 10.1007/978-1-61779-480-3_8
   Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106
   Wang ZL, 1999, BIOCHEMISTRY-US, V38, P12537, DOI 10.1021/bi991070p
   WUTHRICH K, 1994, CURR OPIN STRUC BIOL, V4, P93, DOI 10.1016/S0959-440X(94)90065-5
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yagi-Utsumi M, 2013, FEBS LETT, V587, P1605, DOI 10.1016/j.febslet.2013.04.007
NR 30
TC 19
Z9 19
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD MAY 12
PY 2014
VL 53
IS 20
BP 5069
EP 5072
DI 10.1002/anie.201310963
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA AG5RO
UT WOS:000335476400010
PM 24700611
DA 2021-01-25
ER

PT J
AU Yasugi, T
   Fischer, A
   Jiang, YR
   Reichert, H
   Knoblich, JA
AF Yasugi, Tetsuo
   Fischer, Anja
   Jiang, Yanrui
   Reichert, Heinrich
   Knoblich, Juergen A.
TI A Regulatory Transcriptional Loop Controls Proliferation and
   Differentiation in Drosophila Neural Stem Cells
SO PLOS ONE
LA English
DT Article
ID PRONEURAL GENE-EXPRESSION; NEUROBLAST SELF-RENEWAL;
   CENTRAL-NERVOUS-SYSTEM; ACHAETE-SCUTE; OPTIC LOBE; SPINDLE ORIENTATION;
   ASYMMETRIC DIVISION; BRAIN-DEVELOPMENT; TUMOR-SUPPRESSOR; DNA-BINDING
AB Neurogenesis is initiated by a set of basic Helix-Loop-Helix (bHLH) transcription factors that specify neural progenitors and allow them to generate neurons in multiple rounds of asymmetric cell division. The Drosophila Daughterless (Da) protein and its mammalian counterparts (E12/E47) act as heterodimerization factors for proneural genes and are therefore critically required for neurogenesis. Here, we demonstrate that Da can also be an inhibitor of the neural progenitor fate whose absence leads to stem cell overproliferation and tumor formation. We explain this paradox by demonstrating that Da induces the differentiation factor Prospero (Pros) whose asymmetric segregation is essential for differentiation in one of the two daughter cells. Da co-operates with the bHLH transcription factor Asense, whereas the other proneural genes are dispensible. After mitosis, Pros terminates Asense expression in one of the two daughter cells. In da mutants, pros is not expressed, leading to the formation of lethal transplantable brain tumors. Our results define a transcriptional feedback loop that regulates the balance between self-renewal and differentiation in Drosophila optic lobe neuroblasts. They indicate that initiation of a neural differentiation program in stem cells is essential to prevent tumorigenesis.
C1 [Yasugi, Tetsuo; Fischer, Anja; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.
   [Jiang, Yanrui; Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
RP Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.
EM juergen.knoblich@imba.oeaw.ac.at
RI Yasugi, Tetsuo/N-4913-2015; Knoblich, Juergen A/C-2974-2015
OI Knoblich, Juergen A/0000-0002-6751-3404
FU Austrian Academy of Sciences; Austrian Science F [I1281-B19, Z_153_B09];
   European Research Council (ERC)European Research Council (ERC); EMBO
   long-term fellowshipEuropean Molecular Biology Organization (EMBO); JSPS
   Postdoctoral FellowshipMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT)Japan Society for the Promotion of Science;
   Austrian Science Fund (FWF)Austrian Science Fund (FWF) [Z 153] Funding
   Source: researchfish
FX Work in J.A.K.'s laboratory is supported by the Austrian Academy of
   Sciences, the Austrian Science Fund (FWF, grants I1281-B19 and
   Z_153_B09) and an advanced grant of the European Research Council (ERC).
   Support for T.Y. was provided by EMBO long-term fellowship and JSPS
   Postdoctoral Fellowship for Research Abroad. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   BRAND M, 1993, DEVELOPMENT, V119, P1
   CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x
   CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X
   CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U
   CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205
   Cheng XY, 2009, J CELL MOL MED, V13, P4377, DOI 10.1111/j.1582-4934.2008.00664.x
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Colonques J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019342
   CRONMILLER C, 1987, CELL, V48, P479, DOI 10.1016/0092-8674(87)90198-X
   CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I
   DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640
   Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Heng JIT, 2003, BIOESSAYS, V25, P709, DOI 10.1002/bies.10299
   HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0
   Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515
   JARMAN AP, 1993, DEVELOPMENT, V119, P19
   Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445
   MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X
   MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0
   Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022
   Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232
   Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   SKEATH JB, 1992, DEVELOPMENT, V114, P939
   Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005
   Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309
   Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898
   Torii MA, 1999, DEVELOPMENT, V126, P443
   VAESSIN H, 1994, DEVELOPMENT, V120, P935
   VANDOREN M, 1991, DEVELOPMENT, V113, P245
   Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506
   Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117
   Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058
NR 50
TC 5
Z9 6
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 7
PY 2014
VL 9
IS 5
AR e97034
DI 10.1371/journal.pone.0097034
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG9HB
UT WOS:000335728900132
PM 24804774
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Hultin, S
   Zheng, Y
   Mojallal, M
   Vertuani, S
   Gentili, C
   Balland, M
   Milloud, R
   Belting, HG
   Affolter, M
   Helker, CSM
   Adams, RH
   Herzog, W
   Uhlen, P
   Majumdar, A
   Holmgren, L
AF Hultin, Sara
   Zheng, Yujuan
   Mojallal, Mahdi
   Vertuani, Simona
   Gentili, Christian
   Balland, Martial
   Milloud, Rachel
   Belting, Heinz-Georg
   Affolter, Markus
   Helker, Christian S. M.
   Adams, Ralf H.
   Herzog, Wiebke
   Uhlen, Per
   Majumdar, Arindam
   Holmgren, Lars
TI AmotL2 links VE-cadherin to contractile actin fibres necessary for
   aortic lumen expansion
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VASCULAR ENDOTHELIAL-CADHERIN; ADHERENS JUNCTIONS; VESSEL FUSION; CELLS;
   MECHANISMS; GENE; MORPHOGENESIS; MIGRATION; INTERACTS; ADHESION
AB The assembly of individual endothelial cells into multicellular tubes is a complex morphogenetic event in vascular development. Extracellular matrix cues and cell-cell junctional communication are fundamental to tube formation. Together they determine the shape of endothelial cells and the tubular structures that they ultimately form. Little is known regarding how mechanical signals are transmitted between cells to control cell shape changes during morphogenesis. Here we provide evidence that the scaffold protein amotL2 is needed for aortic vessel lumen expansion. Using gene inactivation strategies in zebrafish, mouse and endothelial cell culture systems, we show that amotL2 associates to the VE-cadherin adhesion complex where it couples adherens junctions to contractile actin fibres. Inactivation of amotL2 dissociates VE-cadherin from cytoskeletal tensile forces that affect endothelial cell shape. We propose that the VE-cadherin/amotL2 complex is responsible for transmitting mechanical force between endothelial cells for the coordination of cellular morphogenesis consistent with aortic lumen expansion and function.
C1 [Hultin, Sara; Zheng, Yujuan; Mojallal, Mahdi; Vertuani, Simona; Gentili, Christian; Majumdar, Arindam; Holmgren, Lars] Karolinska Univ Hosp, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden.
   [Balland, Martial; Milloud, Rachel] Univ Grenoble 1, Lab Interdisciplinaire Phys, F-38402 Grenoble 9, France.
   [Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   [Helker, Christian S. M.; Herzog, Wiebke] Univ Munster, Fac Biol, D-48149 Munster, Germany.
   [Adams, Ralf H.; Herzog, Wiebke] Max Planck Inst Mol Biomed, D-48149 Munster, Germany.
   [Herzog, Wiebke] Cluster Excellence EXC 1003, D-48149 Munster, Germany.
   [Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
RP Holmgren, L (corresponding author), Karolinska Univ Hosp, Canc Ctr Karolinska, Dept Pathol & Oncol, S-17176 Stockholm, Sweden.
EM lars.holmgren@ki.se
RI Adams, Ralf H/AAE-9274-2019
OI Uhlen, Per/0000-0003-1446-1062; Balland, martial/0000-0002-6585-9735;
   Helker, Christian/0000-0003-0427-5338; Affolter,
   Markus/0000-0002-5171-0016; Belting, Heinz-Georg/0000-0002-1538-4364;
   Herzog, Wiebke/0000-0002-9843-3458
FU Swedish Cancer Society, Swedish Research Council, Cancer Society of
   Stockholm; NRW return fellowship
FX This work has been supported by grants from the Swedish Cancer Society,
   Swedish Research Council, Cancer Society of Stockholm. C. H. and W. H.
   were funded by the NRW return fellowship. We would like to thank Jeffrey
   Essner for the Tg(kdrl:msna-EGFP)<SUP>is1</SUP> transgenic line and
   Stefan Schulte-Merker for the double transgenic fish
   Tg(kdrl:EGFP)<SUP>s843</SUP>; Tg(gata1:dsRed)<SUP>sd2</SUP> transgenic
   line. We are indebted to Dannel McCollum for sharing amotL2 constructs.
   Thanks to the Karolinska fish facility for providing embryos and raising
   fish strains. We thank the Knut and Alice Wallenberg Foundation (CLICK)
   and the Uppsala SciLife BioVis bio-imaging facility for providing
   microscopy facilities. Thanks to Bertrand Joseph for supportive
   discussions. We are grateful to Mattias Karlen for help with graphics.
CR Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007
   Axnick J, 2012, CURR OPIN HEMATOL, V19, P192, DOI 10.1097/MOH.0b013e3283523ebc
   Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109
   Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200
   Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9
   Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881
   Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x
   Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874
   Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230
   Gory-Faure S, 1999, DEVELOPMENT, V126, P2093
   Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006
   Helker CSM, 2013, DEVELOPMENT, V140, P2776, DOI 10.1242/dev.091876
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782
   Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120
   Ingber DE, 2008, J BODYW MOV THER, V12, P198, DOI 10.1016/j.jbmt.2008.04.038
   Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003
   Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010
   Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107
   Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012
   Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108
   Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11
   Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772
   Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679
   Nelson W James, 2005, Novartis Found Symp, V269, P159
   NELSON WJ, 2005, NOVART FDN SYMP, V269, P168
   Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011
   Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113
   Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647
   Schnittler HJ, 1997, AM J PHYSIOL-HEART C, V273, pH2396
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f
   Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806
   Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785
   Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001
   Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010
   Zeeb M, 2010, CURR OPIN CELL BIOL, V22, P626, DOI 10.1016/j.ceb.2010.07.003
   Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156
   Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006
NR 58
TC 49
Z9 51
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY
PY 2014
VL 5
AR 3743
DI 10.1038/ncomms4743
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AJ0SN
UT WOS:000337366400001
PM 24806444
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Svensson, K
   Handschin, C
AF Svensson, Kristoffer
   Handschin, Christoph
TI MicroRNAs Emerge as Modulators of NAD plus - Dependent Energy Metabolism
   in Skeletal Muscle
SO DIABETES
LA English
DT Editorial Material
ID SIRT1 ACTIVATION; PROTECTS; DISEASE; PARP-1; TRANSCRIPTION; PGC-1-ALPHA;
   MICE
C1 [Svensson, Kristoffer; Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009
   Bai P, 2007, J BIOL CHEM, V282, P37738, DOI 10.1074/jbc.M701021200
   Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016
   Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017
   Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x
   Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364
   Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610
   Sakamaki J, 2009, BIOCHEM BIOPH RES CO, V382, P497, DOI 10.1016/j.bbrc.2009.03.022
   Underhill C, 2011, ANN ONCOL, V22, P268, DOI 10.1093/annonc/mdq322
   Vinciguerra M, 2010, DIS MODEL MECH, V3, P298, DOI 10.1242/dmm.004655
   Williams CB, 2012, APPL CLIN GENET, V5, P81, DOI 10.2147/TACG.S31276
   Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
NR 19
TC 3
Z9 4
U1 0
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD MAY
PY 2014
VL 63
IS 5
BP 1451
EP 1453
DI 10.2337/db14-0166
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF6AK
UT WOS:000334796600008
PM 24757196
OA Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Weidner, J
   Wang, CW
   Prescianotto-Baschong, C
   Estrada, AF
   Spang, A
AF Weidner, Julie
   Wang, Congwei
   Prescianotto-Baschong, Cristina
   Estrada, Alejandro F.
   Spang, Anne
TI The polysome-associated proteins Scp160 and Bfr1 prevent P body
   formation under normal growth conditions
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Processing bodies; mRNA; mRNA metabolism; Endoplasmic reticulum;
   Translation; Saccharomyces cerevisiae; mRNA-binding proteins; mRNA
   decay; Stress response; Ribonucleotide particles; Stress granules
ID KH-DOMAIN PROTEIN; FRAGILE-X-SYNDROME; MESSENGER-RNA;
   SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; ENDOPLASMIC-RETICULUM;
   PROCESSING BODIES; STRESS GRANULES; MRNP COMPLEXES; BUDDING YEAST
AB Numerous mRNAs are degraded in processing bodies (P bodies) in Saccharomyces cerevisiae. In logarithmically growing cells, only 0-1 P bodies per cell are detectable. However, the number and appearance of P bodies change once the cell encounters stress. Here, we show that the polysome-associated mRNA-binding protein Scp160 interacts with P body components, such as the decapping protein Dcp2 and the scaffold protein Pat1, presumably, on polysomes. Loss of either Scp160 or its interaction partner Bfr1 caused the formation of Dcp2-positive structures. These Dcp2-positive foci contained mRNA, because their formation was inhibited by the presence of cycloheximide. In addition, Scp160 was required for proper P body formation because only a subset of bona fide P body components could assemble into the Dcp2-positive foci in Delta scp160 cells. In either Delta bfr1 or Dscp160 cells, P body formation was uncoupled from translational attenuation as the polysome profile remained unchanged. Collectively, our data suggest that Bfr1 and Scp160 prevent P body formation under normal growth conditions.
C1 [Weidner, Julie; Wang, Congwei; Prescianotto-Baschong, Cristina; Estrada, Alejandro F.; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Weidner, Julie/AAS-6673-2020; Spang, Anne/A-7029-2008; Spang,
   Anne/M-7223-2019
OI Weidner, Julie/0000-0002-7140-8666; Spang, Anne/0000-0002-2387-6203;
   Spang, Anne/0000-0002-2387-6203
FU Werner-Siemens Fellowships; Human Frontiers Science ProgramHuman
   Frontier Science Program [RGP0031/ 2009-C]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31003A_ 141207];
   University of Basel
FX This work was supported by Werner-Siemens Fellowships (to J.W. and
   C.W.), the Human Frontiers Science Program [grant number RGP0031/
   2009-C], the Swiss National Science Foundation [grant number 31003A_
   141207] and the University of Basel (to A.S.).
CR Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044
   Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737
   Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833
   Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962
   Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791
   Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Cao WM, 2004, CANCER RES, V64, P1515, DOI 10.1158/0008-5472.CAN-03-0675
   Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012
   Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000
   Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497
   Currie JR, 1999, AM J MED GENET, V84, P272, DOI 10.1002/(SICI)1096-8628(19990528)84:3<272::AID-AJMG21>3.3.CO;2-4
   delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201
   Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X
   Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001
   Gelin-Licht R, 2012, CELL REP, V1, P483, DOI 10.1016/j.celrep.2012.03.004
   Goolsby KM, 2003, NUCLEIC ACIDS RES, V31, P5644, DOI 10.1093/nar/gkg768
   Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1
   Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226
   Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255
   Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158
   JACKSON CL, 1994, GENETICS, V137, P423
   Jain S, 2013, ADV EXP MED BIOL, V768, P23, DOI 10.1007/978-1-4614-5107-5_3
   Kilchert C, 2010, MOL BIOL CELL, V21, P2624, DOI 10.1091/mbc.E10-02-0099
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Lang BD, 2000, NUCLEIC ACIDS RES, V28, P1576, DOI 10.1093/nar/28.7.1576
   Lang BD, 2001, NUCLEIC ACIDS RES, V29, P2567, DOI 10.1093/nar/29.12.2567
   LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6
   Li AM, 2003, NUCLEIC ACIDS RES, V31, P1830, DOI 10.1093/nar/gkg284
   Marsellach FX, 2006, J BIOL CHEM, V281, P18227, DOI 10.1074/jbc.M601671200
   Mendelsohn BA, 2003, NUCLEIC ACIDS RES, V31, P5838, DOI 10.1093/nar/gkg810
   Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468
   MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145
   Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011
   Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07
   Prescianotto-Baschong C, 2002, TRAFFIC, V3, P37, DOI 10.1034/j.1600-0854.2002.30106.x
   Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976
   Ritz A. M., 2014, CELL REP, DOI [10.1016/j.celrep.2014.02.026, DOI 10.1016/J.CELREP.2014.02.026.]
   Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025
   Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299
   Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301
   SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200
   Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505
   Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199
   Trautwein M, 2004, MOL BIOL CELL, V15, P5021, DOI 10.1091/mbc.E04-05-0411
   Vollbrandt T, 2004, INT J BIOCHEM CELL B, V36, P1306, DOI 10.1016/j.biocel.2003.11.006
   Weber V, 1997, EUR J BIOCHEM, V249, P309, DOI 10.1111/j.1432-1033.1997.00309.x
   WINTERSBERGER U, 1995, YEAST, V11, P929, DOI 10.1002/yea.320111004
   Woo HH, 2011, MOL CELL BIOL, V31, P215, DOI 10.1128/MCB.01031-10
   Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019
NR 56
TC 26
Z9 26
U1 0
U2 9
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 1
PY 2014
VL 127
IS 9
BP 1992
EP 2004
DI 10.1242/jcs.142083
PG 13
WC Cell Biology
SC Cell Biology
GA AH0MU
UT WOS:000335814800012
PM 24569876
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Scherer, S
   Kowal, J
   Chami, M
   Dandey, V
   Arheit, M
   Ler, PR
   Stahlberg, H
AF Scherer, Sebastian
   Kowal, Julia
   Chami, Mohamed
   Dandey, Venkata
   Arheit, Marcel
   Ler, Philippe Ring
   Stahlberg, Henning
TI 2dx_automator: Implementation of a semiautomatic high-throughput
   high-resolution cryo-electron crystallography pipeline
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE 2dx; Image processing automation; Cryo-EM; Direct electron detector;
   High-throughput electron microscopy; Membrane proteins
ID BEAM-INDUCED MOTION; ELECTRON CRYOMICROSCOPY; CRYSTAL IMAGES; CRYO-EM;
   MICROSCOPY; DETECTORS; SPECIMEN
AB The introduction of direct electron detectors (DED) to cryo-electron microscopy has tremendously increased the signal-to-noise ratio (SNR) and quality of the recorded images. We discuss the optimal use of DEDs for cryo-electron crystallography, introduce a new automatic image processing pipeline, and demonstrate the vast improvement in the resolution achieved by the use of both together, especially for highly tilted samples. The new processing pipeline (now included in the software package 2dx) exploits the high SNR and frame readout frequency of DEDs to automatically correct for beam-induced sample movement, and reliably processes individual crystal images without human interaction as data are being acquired. A new graphical user interface (GUI) condenses all information required for quality assessment in one window, allowing the imaging conditions to be verified and adjusted during the data collection session. With this new pipeline an automatically generated unit cell projection map of each recorded 2D crystal is available less than 5 min after the image was recorded. The entire processing procedure yielded a three-dimensional reconstruction of the 2D-crystallized ion-channel membrane protein Ml0K1 with a much-improved resolution of 5 angstrom in-plane and 7 angstrom in the z-direction, within 2 days of data acquisition and simultaneous processing. The results obtained are superior to those delivered by conventional photographic film-based methodology of the same sample, and demonstrate the importance of drift-correction. (c) 2014 The Authors. Published by Elsevier Inc.
C1 [Scherer, Sebastian; Kowal, Julia; Chami, Mohamed; Dandey, Venkata; Arheit, Marcel; Ler, Philippe Ring; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
RP Stahlberg, H (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, WRO 1058,Mattenstr 26, CH-4058 Basel, Switzerland.
EM henning.stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Kowal, Julia/0000-0003-4694-1896
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [315230_146929, 205320_144427]
FX We thank Shirley A. Muller for insightful discussions and critically
   reading of the paper, and Pawel A. Penczek, Werner Kuhl-brandt, Cristina
   Paulino, and Deryck Mills for fruitful discussions. This work was
   supported by the Swiss National Science Foundation (grants
   315230_146929, 205320_144427, and the NCCR Trans-Cure). We acknowledge
   generous support by the FAG Basel.
CR Arheit Marcel, 2013, Methods Mol Biol, V955, P313, DOI 10.1007/978-1-62703-176-9_18
   Arheit Marcel, 2013, Methods Mol Biol, V955, P171, DOI 10.1007/978-1-62703-176-9_10
   Arheit Marcel, 2013, Methods Mol Biol, V955, P195, DOI 10.1007/978-1-62703-176-9_11
   Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008
   Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003
   Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Glaeser RM, 2011, ULTRAMICROSCOPY, V111, P90, DOI 10.1016/j.ultramic.2010.10.010
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Kowal J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4106
   Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822
   McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002
   Milazzo AC, 2011, J STRUCT BIOL, V176, P404, DOI 10.1016/j.jsb.2011.09.002
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009
   Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016
   Scherer S., 2013, J STRUCT BIOL
   Veesler D, 2013, J STRUCT BIOL, V184, P193, DOI 10.1016/j.jsb.2013.09.003
   Zeng X, 2007, J STRUCT BIOL, V160, P353, DOI 10.1016/j.jsb.2007.08.008
NR 22
TC 17
Z9 17
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2014
VL 186
IS 2
BP 302
EP 307
DI 10.1016/j.jsb.2014.03.016
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AG8YV
UT WOS:000335705700011
PM 24680783
OA Other Gold
DA 2021-01-25
ER

PT J
AU Balwierz, PJ
   Pachkov, M
   Arnold, P
   Gruber, AJ
   Zavolan, M
   van Nimwegen, E
AF Balwierz, Piotr J.
   Pachkov, Mikhail
   Arnold, Phil
   Gruber, Andreas J.
   Zavolan, Mihaela
   van Nimwegen, Erik
TI ISMARA: automated modeling of genomic signals as a democracy of
   regulatory motifs
SO GENOME RESEARCH
LA English
DT Article
ID NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION
   FACTOR-BINDING; UNFOLDED PROTEIN RESPONSE; GENE-EXPRESSION;
   MESSENGER-RNA; MASTER REGULATOR; CELL STATES; ER STRESS; MOUSE
AB Accurate reconstruction of the regulatory networks that control gene expression is one of the key current challenges in molecular biology. Although gene expression and chromatin state dynamics are ultimately encoded by constellations of binding sites recognized by regulators such as transcriptions factors (TFs) and microRNAs (miRNAs), our understanding of this regulatory code and its context-dependent read-out remains very limited. Given that there are thousands of potential regulators in mammals, it is not practical to use direct experimentation to identify which of these play a key role for a particular system of interest. We developed a methodology that models gene expression or chromatin modifications in terms of genome-wide predictions of regulatory sites and completely automated it into a web-based tool called ISMARA (Integrated System for Motif Activity Response Analysis). Given only gene expression or chromatin state data across a set of samples as input, ISMARA identifies the key TFs and miRNAs driving expression/chromatin changes and makes detailed predictions regarding their regulatory roles. These include predicted activities of the regulators across the samples, their genome-wide targets, enriched gene categories among the targets, and direct interactions between the regulators. Applying ISMARA to data sets from well-studied systems, we show that it consistently identifies known key regulators ab initio. We also present a number of novel predictions including regulatory interactions in innate immunity, a master regulator of mucociliary differentiation, TFs consistently disregulated in cancer, and TFs that mediate specific chromatin modifications.
C1 [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Balwierz, Piotr J/AAG-4187-2020; Zavolan, Mihaela/S-3888-2016
OI Balwierz, Piotr J/0000-0002-1548-4605; van Nimwegen,
   Erik/0000-0001-6338-1312; Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF 3100A0-118318]; Swiss Initiative in Systems Biology, through
   the CellPlasticity project; Werner Siemens-Foundation; Swiss Institute
   of Bioinformatics
FX We would like to thank Jean Hausser for help in the probewise processing
   of microarray data and members of the van Nimwegen research group for
   helpful discussions.E.v.N., P.A., and P.J.B.were supported by Grant SNF
   3100A0-118318 from the Swiss National Science Foundation and by
   SystemsX.ch, the Swiss Initiative in Systems Biology, through the
   CellPlasticity project.A.J.G.was supported by the Werner
   Siemens-Foundation.M.P.was supported by a grant from the Swiss Institute
   of Bioinformatics.
CR Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508
   Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112
   Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartoov-Shifman R, 2002, J BIOL CHEM, V277, P25914, DOI 10.1074/jbc.M201582200
   Bauer DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-366
   Bochkis IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002770
   Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398
   Bolcun-Filas E, 2011, DEVELOPMENT, V138, P3319, DOI 10.1242/dev.067645
   Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004
   Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014
   Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015
   Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a
   Campanero MR, 1999, MOL CELL BIOL, V19, P8442
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711
   COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089
   de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   El Zein L, 2009, J CELL SCI, V122, P3180, DOI 10.1242/jcs.048348
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gan Q, 2011, J BIOL CHEM, V286, P21853, DOI 10.1074/jbc.M111.233098
   Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31
   Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1
   Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388
   HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500
   Hasegawa R, 2013, EXP CELL RES, V319, P68, DOI 10.1016/j.yexcr.2012.11.003
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803
   Horvath GC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-63
   Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107
   Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021
   Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621
   Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171
   Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281
   Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005
   KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729
   Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241
   Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419
   Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360
   Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004
   Okamoto K, 2006, BRAIN RES, V1081, P19, DOI 10.1016/j.brainres.2006.01.081
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   PIAGGIO G, 1994, NUCLEIC ACIDS RES, V22, P4284, DOI 10.1093/nar/22.20.4284
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266
   Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8
   Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029
   Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036
   Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005
   SERFAS MS, 1993, AM J PHYSIOL, V265, pG506
   Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37
   Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243
   Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Summers KM, 2010, EUR J HUM GENET, V18, P1209, DOI 10.1038/ejhg.2010.91
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474
   TEN RM, 1993, CR ACAD SCI III-VIE, V316, P496
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23
   Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020
   Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329
   Tomaru Y, 2009, NUCLEIC ACIDS RES, V37, P1049, DOI 10.1093/nar/gkn1028
   Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238
   Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315
   Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0
   Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200
   Zhou YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-396
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 108
TC 107
Z9 107
U1 0
U2 6
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD MAY
PY 2014
VL 24
IS 5
BP 869
EP 884
DI 10.1101/gr.169508.113
PG 16
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA AG4CA
UT WOS:000335365600016
PM 24515121
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Fengos, G
   Schmidt, A
   Martin, K
   Fluri, E
   Aebersold, R
   Iber, D
   Pertz, O
AF Fengos, Georgios
   Schmidt, Alexander
   Martin, Katrin
   Fluri, Erika
   Aebersold, Ruedi
   Iber, Dagmar
   Pertz, Olivier
TI Spatial proteomic and phospho-proteomic organization in three
   prototypical cell migration modes
SO PROTEOME SCIENCE
LA English
DT Article
DE Fibroblast; Directional cell migration; Signaling; Proteomics;
   Phosphorylation
ID STATISTICAL-MODEL; PROTEINS; PHOSPHORYLATION; MICROTUBULES; ACTIVATION;
   INTEGRINS; DYNAMICS; DATABASE; REVEALS; ACTIN
AB Background: Tight spatio-temporal signaling of cytoskeletal and adhesion dynamics is required for localized membrane protrusion that drives directed cell migration. Different ensembles of proteins are therefore likely to get recruited and phosphorylated in membrane protrusions in response to specific cues.
   Results: Here, we use an assay that allows to biochemically purify extending protrusions of cells migrating in response to three prototypical receptors: integrins, recepor tyrosine kinases and G-coupled protein receptors. Using quantitative proteomics and phospho-proteomics approaches, we provide evidence for the existence of cue-specific, spatially distinct protein networks in the different cell migration modes.
   Conclusions: The integrated analysis of the large-scale experimental data with protein information from databases allows us to understand some emergent properties of spatial regulation of signaling during cell migration. This provides the cell migration community with a large-scale view of the distribution of proteins and phospho-proteins regulating directed cell migration.
C1 [Fengos, Georgios; Iber, Dagmar] Swiss Fed Inst Technol, D BSSE, CH-4058 Basel, Switzerland.
   [Schmidt, Alexander] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Martin, Katrin; Fluri, Erika; Pertz, Olivier] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
   [Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
RP Iber, D (corresponding author), Swiss Fed Inst Technol, D BSSE, Mattenstr 26, CH-4058 Basel, Switzerland.
EM dagmar.iber@bsse.ethz.ch; olivier.pertz@unibas.ch
RI Iber, Dagmar/V-2846-2019
OI Iber, Dagmar/0000-0001-8051-1035; pertz, olivier/0000-0001-8579-4919
FU iPhD SystemsX; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF)
FX This research was supported by an iPhD SystemsX grant to Olivier Pertz
   and Dagmar Iber, and by a Swiss National Science Foundation grant to
   Olivier Pertz. We are grateful to Ioannis Xenarios, Anne Niknejad and
   Mark Ibberson for valuable input on the project.
CR Beato M, 1993, GENE EXPRESSION, P43
   Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005
   BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349
   Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x
   Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032
   Daaka Y, 2002, BBA-MOL CELL BIOL L, V1582, P265, DOI 10.1016/S1388-1981(02)00180-4
   Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79
   Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#
   Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904
   Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142
   Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0
   Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242
   Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665
   Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105
   Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7
   Wittmann T, 2001, J CELL SCI, V114, P3795
NR 26
TC 3
Z9 3
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-5956
J9 PROTEOME SCI
JI Proteome Sci.
PD MAY 1
PY 2014
VL 12
AR 23
DI 10.1186/1477-5956-12-23
PG 18
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AG7LF
UT WOS:000335598800001
PM 24987309
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Pieles, K
   Glatter, T
   Harms, A
   Schmidt, A
   Dehio, C
AF Pieles, Kathrin
   Glatter, Timo
   Harms, Alexander
   Schmidt, Alexander
   Dehio, Christoph
TI An experimental strategy for the identification of AMPylation targets
   from complex protein samples
SO PROTEOMICS
LA English
DT Article
DE Adenylylation; AMPylation; Fic proteins; Isotopic labeling;
   Microbiology; Vimentin
ID MASS-SPECTROMETRY; FIC PROTEINS; ADENYLYLATION; BARTONELLA; BINDING
AB AMPylation is a posttranslational modification (PTM) that has recently caught much attention in the context of bacterial infections as pathogens were shown to secrete Fic proteins that AMPylate Rho GTPases and thus interfere with host cell signaling processes. Although Fic proteins are widespread and found in all kingdoms of life, only a small number of AMPylation targets are known to date. A major obstacle to target identification is the limited availability of generic strategies allowing sensitive and robust identification of AMPylation events. Here, we present an unbiased MS-based approach utilizing stable isotope-labeled ATP. The ATP isotopes are transferred onto target proteins in crude cell lysates by in vitro AMPylation introducing specific reporter ion clusters that allow detection of AMPylated peptides in complex biological samples by MS analysis. Applying this strategy on the secreted Fic protein Bep2 of Bartonella rochalimae, we identified the filamenting protein vimentin as an AMPylation target that was confirmed by independent assays. Vimentin represents a new class of target proteins and its identification emphasizes our method as a valuable tool to systematically uncover AMPylation targets. Furthermore, the approach can be generically adapted to study targets of other PTMs that allow incorporation of isotopically labeled substrates.
C1 [Pieles, Kathrin; Glatter, Timo; Harms, Alexander; Schmidt, Alexander; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Harms, Alexander/J-5710-2019; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Harms,
   Alexander/0000-0003-2106-1286; Dehio, Christoph/0000-0001-7288-1052;
   Glatter, Timo/0000-0001-8716-8516
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A-132979]; Biozentrum, University of Basel; 
   [51RT 0_126008]
FX Research was supported by grant 31003A-132979 of the Swiss National
   Science Foundation (SNSF), grant 51RT 0_126008 for the Research and
   Technology Development (RTD) project InfectX in the frame of SystemsX.ch
   (both to Christoph Dehio). Work of K. P. was supported by the
   International Ph. D. Program "Fellowships for Excellence" of the
   Biozentrum, University of Basel.
CR Broncel M, 2012, CHEMBIOCHEM, V13, P183, DOI 10.1002/cbic.201100743
   BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949
   Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729
   Grammel M, 2011, J AM CHEM SOC, V133, P17103, DOI 10.1021/ja205137d
   Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603
   Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681
   Pimenova T, 2008, J MASS SPECTROM, V43, P185, DOI 10.1002/jms.1280
   Rinner O, 2008, NAT METHODS, V5, P748, DOI 10.1038/nmeth0808-748a
   Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
NR 18
TC 17
Z9 17
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAY
PY 2014
VL 14
IS 9
BP 1048
EP 1052
DI 10.1002/pmic.201300470
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE8ZC
UT WOS:000334290600013
PM 24677795
DA 2021-01-25
ER

PT J
AU Zhang, LJ
   Ruegg, M
   Hall, M
   Mach, JP
   Romero, P
   Donda, A
AF Zhang, Lianjun
   Ruegg, Markus
   Hall, Michael
   Mach, Jean-Pierre
   Romero, Pedro
   Donda, Alena
TI mTOR signaling controls iNKT cell differentiation and effector function
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Zhang, Lianjun; Romero, Pedro; Donda, Alena] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland.
   [Ruegg, Markus; Hall, Michael] Univ Basel, Biozentrum, Basel, Switzerland.
   [Mach, Jean-Pierre] Univ Lausanne, Dept Biochem, Lausanne, Switzerland.
RI Zhang, Lianjun/AAE-6795-2020; Coll, Lluis Fajas/C-8567-2014; Ruegg,
   Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2014
VL 192
SU 1
MA HEM3P.278
PG 1
WC Immunology
SC Immunology
GA V44RB
UT WOS:000209765001120
DA 2021-01-25
ER

PT J
AU Bertels, F
   Silander, OK
   Pachkov, M
   Rainey, PB
   van Nimwegen, E
AF Bertels, Frederic
   Silander, Olin K.
   Pachkov, Mikhail
   Rainey, Paul B.
   van Nimwegen, Erik
TI Automated Reconstruction of Whole-Genome Phylogenies from Short-Sequence
   Reads
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE next-generation sequencing; Escherichia coli; Pseudomonas syringae
ID RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LIKELIHOOD APPROACH;
   EVOLUTION; TRANSMISSION; ADAPTATION; MECHANISM; ALIGNMENT; SPREAD; TREES
AB Studies of microbial evolutionary dynamics are being transformed by the availability of affordable high-throughput sequencing technologies, which allow whole-genome sequencing of hundreds of related taxa in a single study. Reconstructing a phylogenetic tree of these taxa is generally a crucial step in any evolutionary analysis. Instead of constructing genome assemblies for all taxa, annotating these assemblies, and aligning orthologous genes, many recent studies 1) directly map raw sequencing reads to a single reference sequence, 2) extract single nucleotide polymorphisms (SNPs), and 3) infer the phylogenetic tree using maximum likelihood methods from the aligned SNP positions. However, here we show that, when using such methods to reconstruct phylogenies from sets of simulated sequences, both the exclusion of nonpolymorphic positions and the alignment to a single reference genome, introduce systematic biases and errors in phylogeny reconstruction. To address these problems, we developed a new method that combines alignments from mappings to multiple reference sequences and show that this successfully removes biases from the reconstructed phylogenies. We implemented this method as a web server named REALPHY (Reference sequence Alignment-based Phylogeny builder), which fully automates phylogenetic reconstruction from raw sequencing reads.
C1 [Bertels, Frederic; Silander, Olin K.; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Bertels, Frederic; Silander, Olin K.; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
   [Bertels, Frederic; Rainey, Paul B.] Massey Univ Albany, New Zealand Inst Adv Study, Auckland, New Zealand.
   [Bertels, Frederic; Rainey, Paul B.] Massey Univ Albany, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand.
   [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany.
RP Bertels, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM frederic.bertels@gmail.com
RI Rainey, Paul/A-3207-2008
OI Rainey, Paul/0000-0003-0879-5795; Silander, Olin/0000-0003-4105-8316;
   van Nimwegen, Erik/0000-0001-6338-1312; Bertels,
   Frederic/0000-0001-6222-4139
FU Royal Society of New ZealandRoyal Society of New Zealand; James Cook
   Research Fellowship; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Ambizione Fellowship [PZ00P3-144605]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [31003A_135397]
FX The authors thank Chris Field for helpful discussions. This work was
   supported by the Royal Society of New Zealand with a James Cook Research
   Fellowship to P. B. R.; and the Swiss National Science Foundation with
   an Ambizione Fellowship (grant number PZ00P3-144605) to O.K.S., and a
   Swiss National Science Foundation Grant (grant number 31003A_135397) to
   E.v.N. Funding for open access charge: Swiss National Science Foundation
   Grant (grant number 31003A_135397).
CR Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106
   Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545
   Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110
   Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002
   Epstein B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002868
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Felsenstein J, 2005, PHYLIP PHYLOGENY INF
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   Grievink LS, 2013, GENOME BIOL EVOL, V5, P681, DOI 10.1093/gbe/evt032
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214
   Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395
   Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006
   Jukes T. H., 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404
   Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368
   Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876
   Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108
   McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109
   McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503
   Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392
   Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344
   Nei M, 2000, MOL EVOLUTION PHYLOG
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106
   Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423
   Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5
   Rocha EPC, 2006, TRENDS GENET, V22, P412, DOI 10.1016/j.tig.2006.06.004
   Rodriguez-R LM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-43
   Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894
   Spencer M, 2007, SYST BIOL, V56, P25, DOI 10.1080/10635150601156313
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
NR 36
TC 174
Z9 178
U1 0
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD MAY
PY 2014
VL 31
IS 5
BP 1077
EP 1088
DI 10.1093/molbev/msu088
PG 12
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA AH1XF
UT WOS:000335914400003
PM 24600054
OA Green Published
DA 2021-01-25
ER

PT J
AU Harrisberger, F
   Spalek, K
   Smieskova, R
   Schmidt, A
   Coynel, D
   Milnik, A
   Fastenrath, M
   Freytag, V
   Gschwind, L
   Walter, A
   Vogel, T
   Bendfeldt, K
   de Quervain, DJF
   Papassotiropoulos, A
   Borgwardt, S
AF Harrisberger, F.
   Spalek, K.
   Smieskova, R.
   Schmidt, A.
   Coynel, D.
   Milnik, A.
   Fastenrath, M.
   Freytag, V.
   Gschwind, L.
   Walter, A.
   Vogel, T.
   Bendfeldt, K.
   de Quervain, D. J. -F.
   Papassotiropoulos, A.
   Borgwardt, S.
TI The association of the BDNF Va166Met polymorphism and the hippocampal
   volumes in healthy humans: A joint meta-analysis of published and new
   data
SO NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
LA English
DT Review
DE BDNF Va166Met; rs6265; Brain-derived neurotrophic factor; BDNF; MRI;
   Hippocampus; sMRI; Structural
ID FACTOR VAL66MET POLYMORPHISM; GRAY-MATTER VOLUME; ACTIVITY-DEPENDENT
   SECRETION; NEUROTROPHIC FACTOR GENE; BRAIN MORPHOLOGY; HUMAN-MEMORY;
   VAL(66)MET POLYMORPHISM; AUTOMATED SEGMENTATION; COGNITIVE NEUROSCIENCE;
   AGING HIPPOCAMPUS
AB Background: The brain-derived neurotrophic factor (BDNF) Va166Met polymorphism (refSNP Cluster Report: rs6265) is a common and functionally relevant single nucleotide polymorphism (SNP). The gene itself, as well as the SNP rs6265, have been implicated in hippocampal learning and memory. However, imaging genetic studies have produced controversial results about the impact of this SNP on hippocampal volumes in healthy subjects.
   Methods: We examined the association between the rs6265 polymorphism and hippocampal volume in 643 healthy young subjects using automatic segmentation and subsequently included these data in a meta-analysis based on published studies with 5298 healthy subjects in total.
   Results: We found no significant association between SNP rs6265 and hippocampal volumes in our sample (g= 0.05, p =0.58). The meta-analysis revealed a small, albeit significant difference in hippocampal volumes between genotype groups, such that Met-carriers had slightly smaller hippocampal volumes than Val/Val homozygotes (g=0.09, p=0.04), an association that was only evident when manual (g=0.22, p = 0.01) but not automatic tracing approaches (g=0.04, p = 0.38) were used. Studies using manual tracing showed evidence for publication bias and a significant decrease in effect size over the years with increasing sample sizes.
   Conclusions: This study does not support the association between SNP rs6265 and hippocampal volume in healthy individuals. The weakly significant effect observed in the meta-analysis is mainly driven by studies with small sample sizes. In contrast, our original data and the meta-analysis of automatically segmented hippocampal volumes, which was based on studies with large samples sizes, revealed no significant genotype effect. Thus, meta-analyses of the association between rs6265 and hippocampal volumes should consider possible biases related to measuring technique and sample size. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Harrisberger, F.; Smieskova, R.; Schmidt, A.; Walter, A.; Vogel, T.; de Quervain, D. J. -F.; Papassotiropoulos, A.; Borgwardt, S.] Univ Basel, Dept Psychiat UPK, CH-4056 Basel, Switzerland.
   [Harrisberger, F.; Smieskova, R.; Schmidt, A.; Bendfeldt, K.; Borgwardt, S.] Univ Basel Hosp, Med Image Anal Ctr, CH-4031 Basel, Switzerland.
   [Spalek, K.; Coynel, D.; Fastenrath, M.; Gschwind, L.; de Quervain, D. J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Coynel, D.; Milnik, A.; Freytag, V.; Papassotiropoulos, A.] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, A.] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Borgwardt, S.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London SE5 8AF, England.
RP Borgwardt, S (corresponding author), Psychiat Univ Hosp Basel, Wilhelm Klein Str 27, CH-4056 Basel, Switzerland.
EM stefan.borgwardt@upkbs.ch
RI bendfeldt, kerstin/AAZ-2197-2020; Coynel, David/H-9189-2019; Borgwardt,
   Stefan/Q-6168-2018; Schmidt, Andre/C-2948-2014
OI Coynel, David/0000-0001-5028-5807; Borgwardt,
   Stefan/0000-0002-5792-3987; Schmidt, Andre/0000-0001-6055-8397; Milnik,
   Annette/0000-0002-3933-3289; de Quervain, Dominique/0000-0001-7131-2464;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
CR Agartz I, 2006, AM J MED GENET B, V141B, P513, DOI 10.1002/ajmg.b.30338
   Baj G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00188
   BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x
   Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599
   Bergouignan L, 2009, NEUROIMAGE, V45, P29, DOI 10.1016/j.neuroimage.2008.11.006
   Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107
   Brandys M.K., 2011, WIRELESS INTELLIGENT, P1
   Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707
   Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022
   Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909
   Cerasa A, 2008, NEUROREPORT, V19, P405, DOI 10.1097/WNR.0b013e3282f5f784
   Cerasa A, 2010, BEHAV BRAIN RES, V207, P377, DOI 10.1016/j.bbr.2009.10.022
   Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663
   Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004
   Chepenik LG, 2009, NEUROPSYCHOPHARMACOL, V34, P944, DOI 10.1038/npp.2008.107
   Cole J, 2011, GENES BRAIN BEHAV, V10, P756, DOI 10.1111/j.1601-183X.2011.00714.x
   Cooper H., 2009, HDB RES SYNTHESIS ME
   Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010
   de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   Donohoe G, 2011, NEUROIMAGE, V54, P2132, DOI 10.1016/j.neuroimage.2010.09.089
   Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473
   Driscoll I, 2003, CEREB CORTEX, V13, P1344, DOI 10.1093/cercor/bhg081
   Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046
   Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010
   Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x
   Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410
   Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001
   Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592
   Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143
   Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51
   Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579
   Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006
   Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490
   Gonul AS, 2011, WORLD J BIOL PSYCHIA, V12, P110, DOI 10.3109/15622975.2010.507786
   Goodro M, 2012, PSYCHIAT RES-NEUROIM, V203, P38, DOI 10.1016/j.pscychresns.2011.09.014
   Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6
   Hajek T, 2012, WORLD J BIOL PSYCHIA, V13, P178, DOI 10.3109/15622975.2011.580005
   Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003
   Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Honea R, 2009, NEUROIMAGE, V45, P44, DOI 10.1016/j.neuroimage.2008.10.064
   Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841
   Jessen F, 2009, PSYCHIAT GENET, V19, P99, DOI 10.1097/YPG.0b013e32832080ce
   Joffe RT, 2009, HUM BRAIN MAPP, V30, P1246, DOI 10.1002/hbm.20592
   Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Karnik MS, 2010, PSYCHIAT RES, V178, P425, DOI 10.1016/j.psychres.2009.09.008
   Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851
   Knickmeyer RC, 2013, CEREB CORTEX
   Koolschijn PCMP, 2010, HIPPOCAMPUS, V20, P1010, DOI 10.1002/hipo.20699
   KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856
   Lipsey M, 2000, PRACTICAL METAANALYS
   Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028
   Lu B, 2000, PROG BRAIN RES, V128, P231
   Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505
   Malykhin NV, 2008, NEUROREPORT, V19, P543, DOI 10.1097/WNR.0b013e3282f8b18c
   Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x
   Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3
   Moher D, 2009, PLOS MED, V6, DOI [10.1016/j.ijsu.2010.02.007, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535]
   Molendijk ML, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.72
   Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078
   Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509
   Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033
   Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016
   Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808
   Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067
   Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010
   Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135
   Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379
   Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657
   Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398
   Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004
   R Core Team, 2012, R LANG ENV STAT COMP
   Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020
   Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8
   Ruigrok A.N.V., 2013, NEUROSCI BIOBEHAV RE
   Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47
   Schofield PR, 2009, BIOL PSYCHOL, V80, P176, DOI 10.1016/j.biopsycho.2008.09.001
   Smieskova R, 2010, NEUROSCI BIOBEHAV R, V34, P1207, DOI 10.1016/j.neubiorev.2010.01.016
   Smieskova R, 2009, CURR PHARM DESIGN, V15, P2535, DOI 10.2174/138161209788957456
   Smith GN, 2012, SCHIZOPHR RES, V134, P253, DOI 10.1016/j.schres.2011.11.022
   Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886
   Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720
   Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250
   Stern AJ, 2008, BIOL PSYCHIAT, V64, P856, DOI 10.1016/j.biopsych.2008.07.009
   Sullivan EV, 2001, HIPPOCAMPUS, V11, P754, DOI 10.1002/hipo.1091
   Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187
   Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656
   Takahashi T, 2008, NEUROSCI LETT, V435, P34, DOI 10.1016/j.neulet.2008.02.004
   Taylor WD, 2007, PSYCHIAT RES-NEUROIM, V155, P173, DOI 10.1016/j.pscychresns.2007.01.005
   Toro R, 2009, BRAIN STRUCT FUNCT, V213, P501, DOI 10.1007/s00429-009-0203-y
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   von Bohlen O, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00036
   Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013
   Walter A, 2012, SCHIZOPHR RES, V142, P217, DOI 10.1016/j.schres.2012.10.013
   Wei QL, 2012, PROG NEURO-PSYCHOPH, V36, P122, DOI 10.1016/j.pnpbp.2011.08.021
   Westfall PH, 1993, RESAMPLING BASED MUL
   Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037777
NR 106
TC 46
Z9 47
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0149-7634
EI 1873-7528
J9 NEUROSCI BIOBEHAV R
JI Neurosci. Biobehav. Rev.
PD MAY
PY 2014
VL 42
BP 267
EP 278
DI 10.1016/j.neubiorev.2014.03.011
PG 12
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA AH9LO
UT WOS:000336464100017
PM 24674929
OA Other Gold
DA 2021-01-25
ER

PT J
AU Thomson, AS
   Heer, FT
   Smith, FJ
   Hendron, E
   Berneche, S
   Rothberg, BS
AF Thomson, Andrew S.
   Heer, Florian T.
   Smith, Frank J.
   Hendron, Eunan
   Berneche, Simon
   Rothberg, Brad S.
TI Initial steps of inactivation at the K+ channel selectivity filter
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE calcium; gating; permeation; dynamics; energetics
ID C-TYPE INACTIVATION; MOLECULAR-DYNAMICS SIMULATIONS; POTASSIUM-CHANNEL;
   COMPUTER-SIMULATIONS; VOLTAGE SENSITIVITY; POTENTIAL FUNCTIONS; SLOW
   INACTIVATION; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; ION CONDUCTION
AB K+ efflux through K+ channels can be controlled by C-type inactivation, which is thought to arise from a conformational change near the channel's selectivity filter. Inactivation is modulated by ion binding near the selectivity filter; however, the molecular forces that initiate inactivation remain unclear. We probe these driving forces by electrophysiology and molecular simulation of MthK, a prototypical K+ channel. Either Mg2+ or Ca2+ can reduce K+ efflux through MthK channels. However, Ca2+, but not Mg2+, can enhance entry to the inactivated state. Molecular simulations illustrate that, in the MthK pore, Ca2+ ions can partially dehydrate, enabling selective accessibility of Ca2+ to a site at the entry to the selectivity filter. Ca2+ binding at the site interacts with K+ ions in the selectivity filter, facilitating a conformational change within the filter and subsequent inactivation. These results support an ionic mechanism that precedes changes in channel conformation to initiate inactivation.
C1 [Thomson, Andrew S.; Smith, Frank J.; Hendron, Eunan; Rothberg, Brad S.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA.
   [Heer, Florian T.; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Heer, Florian T.; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Berneche, S (corresponding author), Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
EM simon.berneche@unibas.ch; rothberg@temple.edu
OI Rothberg, Brad/0000-0003-1982-2269
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3-139205]; US National Science FoundationNational Science
   Foundation (NSF) [MCB-1243803]
FX The authors thank Victor Pau and Carol Deutsch for helpful discussions
   and critical reading of the manuscript. Computational resources were
   provided by the Basel Computational Biology Center. This work is
   supported by grants from the Swiss National Science Foundation
   (Professorship no. PP00P3-139205 to S.B.) and the US National Science
   Foundation (MCB-1243803 to B.S.R.).
CR BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X
   Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653
   BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711
   Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100
   Boiteux C, 2011, STRUCTURE, V19, P70, DOI 10.1016/j.str.2010.10.008
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069
   Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309
   Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073
   Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153
   Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n
   Dvir H, 2010, J STRUCT BIOL, V171, P231, DOI 10.1016/j.jsb.2010.03.020
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   FERGUSON WB, 1991, J GEN PHYSIOL, V98, P163, DOI 10.1085/jgp.98.1.163
   Halgren TA, 2001, CURR OPIN STRUC BIOL, V11, P236, DOI 10.1016/S0959-440X(00)00196-2
   HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2
   Hille B., 2001, ION CHANNELS EXCITAB, P814
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9
   Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888
   Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a
   Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a
   Jiao D, 2006, J PHYS CHEM B, V110, P18553, DOI 10.1021/jp062230r
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Kuo MMC, 2007, P NATL ACAD SCI USA, V104, P2151, DOI 10.1073/pnas.0609085104
   Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4
   Levy DI, 1996, BIOPHYS J, V71, P3157, DOI 10.1016/S0006-3495(96)79509-7
   Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106
   Li Y, 2007, J GEN PHYSIOL, V129, P109, DOI 10.1085/jgp.200609655
   Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3
   LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Moscoso C, 2012, BIOPHYS J, V103, P1198, DOI 10.1016/j.bpj.2012.08.015
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67
   Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670
   Parfenova LV, 2006, J BIOL CHEM, V281, P21131, DOI 10.1074/jbc.M603109200
   Pau VPT, 2011, P NATL ACAD SCI USA, V108, P17684, DOI 10.1073/pnas.1107229108
   Pau VPT, 2010, J GEN PHYSIOL, V135, P509, DOI 10.1085/jgp.200910387
   Posson DJ, 2013, NAT STRUCT MOL BIOL, V20, P159, DOI 10.1038/nsmb.2473
   Ray EC, 2006, J GEN PHYSIOL, V128, P203, DOI 10.1085/jgp.200609561
   Roux B, 2002, BIOPHYS J, V82, P1681, DOI 10.1016/S0006-3495(02)75520-3
   Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499
   Shin HG, 2005, J GEN PHYSIOL, V125, P413, DOI 10.1085/jgp.200409242
   Smith FJ, 2012, STRUCTURE, V20, P2038, DOI 10.1016/j.str.2012.09.014
   Thomson AS, 2010, J GEN PHYSIOL, V136, P569, DOI 10.1085/jgp.201010507
   Wojtas-Niziurski W, 2013, J CHEM THEORY COMPUT, V9, P1885, DOI 10.1021/ct300978b
   WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687
   WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631
   Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717
   Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865
   YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4
   Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239
NR 58
TC 13
Z9 13
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 29
PY 2014
VL 111
IS 17
BP E1713
EP E1722
DI 10.1073/pnas.1317573111
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG1TL
UT WOS:000335199000009
PM 24733889
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schmidl, C
   Hansmann, L
   Lassmann, T
   Balwierz, PJ
   Kawaji, H
   Itoh, M
   Kawai, J
   Nagao-Sato, S
   Suzuki, H
   Andreesen, R
   Hayashizaki, Y
   Forrest, ARR
   Carninci, P
   Hoffmann, P
   Edinger, M
   Rehli, M
AF Schmidl, Christian
   Hansmann, Leo
   Lassmann, Timo
   Balwierz, Piotr J.
   Kawaji, Hideya
   Itoh, Masayoshi
   Kawai, Jun
   Nagao-Sato, Sayaka
   Suzuki, Harukazu
   Andreesen, Reinhard
   Hayashizaki, Yoshihide
   Forrest, Alistair R. R.
   Carninci, Piero
   Hoffmann, Petra
   Edinger, Matthias
   Rehli, Michael
CA FANTOM Consortium
TI The enhancer and promoter landscape of human regulatory and conventional
   T-cell subpopulations
SO BLOOD
LA English
DT Article
ID VERSUS-HOST-DISEASE; SUPPRESSIVE FUNCTION; FOXP3 EXPRESSION; EX-VIVO;
   GENE-EXPRESSION; TRANSCRIPTION; EFFECTOR; DIFFERENTIATION; METHYLATION;
   EXPANSION
AB CD4(+)CD25(+)FOXP3(+) human regulatory T cells (Tregs) are essential for self-tolerance and immune homeostasis. Here, we describe the promoterome of CD4(+)CD25(high)CD45RA(+) naive and CD4(+)CD25(high)CD45RA(-) memory Tregs and their CD25(-) conventional T-cell (Tconv) counterparts both before and after in vitro expansion by cap analysis of gene expression (CAGE) adapted to single-molecule sequencing (HeliScopeCAGE). We performed comprehensive comparative digital gene expression analyses and revealed novel transcription start sites, of which several were validated as alternative promoters of known genes. For all in vitro expanded subsets, we additionally generated global maps of poised and active enhancer elements marked by histone H3 lysine 4 monomethylation and histone H3 lysine 27 acetylation, describe their cell type-specific motif signatures, and evaluate the role of candidate transcription factors STAT5, FOXP3, RUNX1, and ETS1 in both Treg- and Tconv-specific enhancer architectures. Network analyses of gene expression data revealed additional candidate transcription factors contributing to cell type specificity and a transcription factor network in Tregs that is dominated by FOXP3 interaction partners and targets. In summary, we provide a comprehensive and easily accessible resource of gene expression and gene regulation in human Treg and Tconv subpopulations.
C1 [Schmidl, Christian; Hansmann, Leo; Andreesen, Reinhard; Hoffmann, Petra; Edinger, Matthias; Rehli, Michael] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany.
   [Lassmann, Timo; Kawaji, Hideya; Itoh, Masayoshi; Kawai, Jun; Nagao-Sato, Sayaka; Suzuki, Harukazu; Hayashizaki, Yoshihide; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan.
   [Lassmann, Timo; Kawaji, Hideya; Itoh, Masayoshi; Suzuki, Harukazu; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.
   [Balwierz, Piotr J.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Balwierz, Piotr J.] Swiss Inst Bioinformat, Basel, Switzerland.
   [Kawaji, Hideya; Itoh, Masayoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan.
   [Andreesen, Reinhard; Hoffmann, Petra; Edinger, Matthias; Rehli, Michael] Regensburg Ctr Intervent Immunol, Regensburg, Germany.
RP Rehli, M (corresponding author), Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany.
EM michael.rehli@ukr.de
RI Kawai, Jun/A-6451-2016; Carninci, Piero/K-1568-2014; Balwierz, Piotr
   J/AAG-4187-2020; Kawaji, Hideya/N-5116-2015; Hayashizaki,
   Yoshihide/N-6590-2015; Suzuki, Harukazu/N-9553-2015; Rehli,
   Michael/E-9093-2011; Hansmann, Leo/V-3748-2019; Lassmann,
   Timo/A-8271-2008; Itoh, Masayoshi/N-5363-2015
OI Carninci, Piero/0000-0001-7202-7243; Balwierz, Piotr
   J/0000-0002-1548-4605; Kawaji, Hideya/0000-0002-0575-0308; Suzuki,
   Harukazu/0000-0002-8087-0836; Rehli, Michael/0000-0003-3992-932X;
   Hansmann, Leo/0000-0003-3790-0128; Lassmann, Timo/0000-0002-0138-2691;
   Itoh, Masayoshi/0000-0002-1772-318X; Edinger,
   Matthias/0000-0003-2889-2533; Schmidl, Christian/0000-0002-0522-202X;
   Winteringham, Louise/0000-0002-8117-5069; Forrest,
   Alistair/0000-0003-4543-1675
FU Ministry of Education, Culture, Sports, Science and Technology
   (MEXT)Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); MEXTMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT); Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [[KFO] 146]; BayImmuNet grant; Jose Carreras Foundation
   (FACS-Sorting Facility); Rudolf Bartling Foundation; Innovative Cell
   Biology
FX This work was supported by a research grant from the Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) to RIKEN
   Center for Life Science Technologies and from MEXT to RIKEN Preventive
   Medicine and Diagnosis Innovation Program, by grants from the Deutsche
   Forschungsgemeinschaft (M. R., M. E., and P. H.; Clinical Research Unit
   [KFO] 146), a BayImmuNet grant (M. E.), a grant from the Jose Carreras
   Foundation (FACS-Sorting Facility), and a grant from the Rudolf Bartling
   Foundation (M. R.). FANTOM5 was made possible by a research grant for
   RIKEN Omics Science Center from MEXT (Y.H.) and a grant from Innovative
   Cell Biology by Innovative Technology (Cell Innovation Program) from the
   MEXT (Y.H.).
CR Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787
   Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Bennett CL, 2001, NAT GENET, V27, P20
   Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084
   Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444
   Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784
   Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226
   Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x
   Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916
   Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461
   Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702
   Collier FM, 2004, BIOCHEM BIOPH RES CO, V324, P1360, DOI 10.1016/j.bbrc.2004.09.205
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324
   Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915
   Edinger M, 2011, CURR OPIN IMMUNOL, V23, P679, DOI 10.1016/j.coi.2011.06.006
   Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107
   Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182
   Hansmann L, 2012, J IMMUNOL, V188, P1275, DOI 10.4049/jimmunol.1102288
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399
   Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086
   Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409
   Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904
   Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776
   Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110
   Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003
   Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731
   Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32
   Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772
   Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012
   Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019
   Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153
   Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154
   Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1
   Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053
   Schmidl C, 2014, BLOOD, V123, pE90, DOI 10.1182/blood-2013-02-484188
   Schmidl C, 2011, EUR J IMMUNOL, V41, P1491, DOI 10.1002/eji.201041067
   Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109
   Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453
   Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963
   Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756
   Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674
   Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747
NR 53
TC 46
Z9 46
U1 0
U2 13
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 24
PY 2014
VL 123
IS 17
BP E68
EP E78
DI 10.1182/blood-2013-02-486944
PG 11
WC Hematology
SC Hematology
GA AH1QK
UT WOS:000335895800003
PM 24671953
DA 2021-01-25
ER

PT J
AU Schmidl, C
   Renner, K
   Peter, K
   Eder, R
   Lassmann, T
   Balwierz, PJ
   Itoh, M
   Nagao-Sato, S
   Kawaji, H
   Carninci, P
   Suzuki, H
   Hayashizaki, Y
   Andreesen, R
   Hume, DA
   Hoffmann, P
   Forrest, ARR
   Kreutz, MP
   Edinger, M
   Rehli, M
AF Schmidl, Christian
   Renner, Kathrin
   Peter, Katrin
   Eder, Ruediger
   Lassmann, Timo
   Balwierz, Piotr J.
   Itoh, Masayoshi
   Nagao-Sato, Sayaka
   Kawaji, Hideya
   Carninci, Piero
   Suzuki, Harukazu
   Hayashizaki, Yoshihide
   Andreesen, Reinhard
   Hume, David A.
   Hoffmann, Petra
   Forrest, Alistair R. R.
   Kreutz, Marina P.
   Edinger, Matthias
   Rehli, Michael
CA FANTOM Consortium
TI Transcription and enhancer profiling in human monocyte subsets
SO BLOOD
LA English
DT Article
ID GENE-EXPRESSION; DIFFERENTIATION; HETEROGENEITY; MACROPHAGE; SIGNATURES;
   DISTINCT; REVEALS; APOPTOSIS; PROTEINS; CELLS
AB Human blood monocytes comprise at least 3 subpopulations that differ in phenotype and function. Here, we present the first in-depth regulome analysis of human classical (CD14(++)CD16(-)), intermediate (CD14(+)CD16(+)), and nonclassical (CD14(dim)CD16(+)) monocytes. Cap analysis of gene expression adapted to Helicos single-molecule sequencing was used to map transcription start sites throughout the genome in all 3 subsets. In addition, global maps of H3K4me1 and H3K27ac deposition were generated for classical and nonclassical monocytes defining enhanceosomes of the 2 major subsets. We identified differential regulatory elements (including promoters and putative enhancers) that were associated with subset-specific motif signatures corresponding to different transcription factor activities and exemplarily validated novel downstream enhancer elements at the CD14 locus. In addition to known subset-specific features, pathway analysis revealed marked differences in metabolic gene signatures. Whereas classical monocytes expressed higher levels of genes involved in carbohydrate metabolism, priming them for anaerobic energy production, nonclassical monocytes expressed higher levels of oxidative pathway components and showed a higher mitochondrial routine activity. Our findings describe promoter/enhancer landscapes and provide novel insights into the specific biology of human monocyte subsets.
C1 [Schmidl, Christian; Renner, Kathrin; Peter, Katrin; Eder, Ruediger; Hoffmann, Petra; Kreutz, Marina P.; Edinger, Matthias; Rehli, Michael] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany.
   [Lassmann, Timo; Itoh, Masayoshi; Nagao-Sato, Sayaka; Kawaji, Hideya; Carninci, Piero; Suzuki, Harukazu; Hayashizaki, Yoshihide; Forrest, Alistair R. R.] RIKEN Omics Sci Ctr, Yokohama Inst, Yokohama, Kanagawa, Japan.
   [Lassmann, Timo; Itoh, Masayoshi; Kawaji, Hideya; Carninci, Piero; Suzuki, Harukazu; Forrest, Alistair R. R.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.
   [Balwierz, Piotr J.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Balwierz, Piotr J.] Swiss Inst Bioinformat, Basel, Switzerland.
   [Itoh, Masayoshi; Kawaji, Hideya; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan.
   [Andreesen, Reinhard; Hoffmann, Petra; Kreutz, Marina P.; Edinger, Matthias; Rehli, Michael] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany.
   [Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.
   [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland.
RP Rehli, M (corresponding author), Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany.
EM michael.rehli@ukr.de
RI Itoh, Masayoshi/N-5363-2015; Kawaji, Hideya/N-5116-2015; Carninci,
   Piero/K-1568-2014; Hayashizaki, Yoshihide/N-6590-2015; Rehli,
   Michael/E-9093-2011; Suzuki, Harukazu/N-9553-2015; Balwierz, Piotr
   J/AAG-4187-2020; Lassmann, Timo/A-8271-2008
OI Itoh, Masayoshi/0000-0002-1772-318X; Kawaji, Hideya/0000-0002-0575-0308;
   Carninci, Piero/0000-0001-7202-7243; Rehli, Michael/0000-0003-3992-932X;
   Suzuki, Harukazu/0000-0002-8087-0836; Balwierz, Piotr
   J/0000-0002-1548-4605; Lassmann, Timo/0000-0002-0138-2691; Hume,
   David/0000-0002-2615-1478; Schmidl, Christian/0000-0002-0522-202X;
   Winteringham, Louise/0000-0002-8117-5069; Edinger,
   Matthias/0000-0003-2889-2533; Forrest, Alistair/0000-0003-4543-1675
FU MEXTMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); MEXT, JapanMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT); Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [DFG Re1310/9, Re1310/13]; BayImmuNet; Jose
   Carreras Foundation (FACS-Sorting Facility); Rudolf Bartling Foundation;
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BBS/E/D/20251969,
   BB/I024801/1] Funding Source: researchfish
FX FANTOM5 was made possible by a research grant for RIKEN Omics Science
   Center from MEXT (Y.H.) and an Innovative Cell Biology by Innovative
   Technology (Cell Innovation Program) grant from MEXT, Japan (Y.H.). This
   work was also supported by a research grant from MEXT to RIKEN Center
   for Life Science Technologies and from MEXT to RIKEN Preventive Medicine
   and Diagnosis Innovation Program. This project was funded by grants from
   the Deutsche Forschungsgemeinschaft (DFG Re1310/9, /13) (M. R.),
   BayImmuNet (M. E.), the Jose Carreras Foundation (FACS-Sorting
   Facility), and the Rudolf Bartling Foundation (M.R.).
CR Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403
   Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787
   Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009
   Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182
   Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907
   Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331
   Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11
   Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063
   Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hetherington CJ, 1999, J IMMUNOL, V162, P503
   HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3
   HOOD DA, 1989, EUR J BIOCHEM, V179, P275, DOI 10.1111/j.1432-1033.1989.tb14551.x
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36
   Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214
   Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776
   Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028
   Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110
   Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658
   Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958
   Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200
   Pham TH, 2007, J BIOL CHEM, V282, P21924, DOI 10.1074/jbc.M611618200
   Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692
   Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773
   Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sauter KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054935
   Schmidl C, 2014, BLOOD, V123, pE68, DOI 10.1182/blood-2013-02-486944
   Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109
   Stadlmann S, 2006, CELL BIOCHEM BIOPHYS, V44, P179, DOI 10.1385/CBB:44:2:179
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453
   Weber C, 2000, J LEUKOCYTE BIOL, V67, P699
   Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3
   Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355
   Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80
   Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827
   Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111
   Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69
   Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558
NR 52
TC 71
Z9 72
U1 0
U2 18
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 24
PY 2014
VL 123
IS 17
BP E90
EP E99
DI 10.1182/blood-2013-02-484188
PG 10
WC Hematology
SC Hematology
GA AH1QK
UT WOS:000335895800005
PM 24671955
DA 2021-01-25
ER

PT J
AU Esposito, MS
   Capelli, P
   Arber, S
AF Esposito, Maria Soledad
   Capelli, Paolo
   Arber, Silvia
TI Brainstem nucleus MdV mediates skilled forelimb motor tasks
SO NATURE
LA English
DT Article
DE Translating the behavioural output of the nervous system into movement
   involves interaction between brain and spinal; cord. The brainstem
   provides an essential bridge between the two structures; but
   circuit-level organization and function; of this intermediary system
   remain poorly understood. Here we use intersectional virus tracing and
   genetic strategies in; mice to reveal a selective synaptic connectivity
   matrix between brainstem substructures and functionally distinct spinal;
   motor neurons that regulate limb movement. The brainstem nucleus
   medullary reticular formation ventral part (MdV); stands out as
   specifically targeting subpopulations of forelimb-innervating motor
   neurons. Its glutamatergic premotor; neurons receive synaptic input from
   key upper motor centres and are recruited during motor tasks. Selective
   neuronal; ablation or silencing experiments reveal that MdV is
   critically important specifically for skilled motor behaviour;
   including; accelerating rotarod and single-food-pellet reaching tasks.
   Our results indicate that distinct premotor brainstem; nuclei access
   spinal subcircuits to mediate task-specific aspects of motor programs.
ID MESENCEPHALIC LOCOMOTOR REGION; SPINAL-CORD; GABAERGIC NEURONS;
   ORGANIZATION; ACTIVATION; MOVEMENTS; CIRCUITS; SPECIFICITY; RECOVERY;
   SINGLE
C1 [Esposito, Maria Soledad; Capelli, Paolo; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland.
   [Esposito, Maria Soledad; Capelli, Paolo; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Esposito, Maria Soledad/0000-0003-0673-4219; Arber,
   Silvia/0000-0002-6261-250X
FU Human Frontier Science ProgramHuman Frontier Science Program; European
   Research Council Advanced GrantEuropean Research Council (ERC); Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   Kanton Basel-Stadt; Novartis Research Foundation
FX We are grateful to M. Mielich, B. Rapp, D. Salvador and M. Sigrist for
   expert technical help, L. Gelman, A. Ponti, N. Ehrenfeuchter, M.
   Kirschmann and R. Thierry for help and advice with image acquisition and
   analysis, and to P. Caroni for discussions and comments on the
   manuscript. We thank F. Donato, Y. Zuo, A. Takeoka, P. Tovote and P.
   Botta for advice on design of behavioral experiments, and S. Sternson
   for providing PSEM<SUP>308</SUP> and advice for neuronal silencing
   experiments. M.S.E. was supported by a long-term fellowship of the Human
   Frontier Science Program, and all authors by a European Research Council
   Advanced Grant, the Swiss National Science Foundation, the Kanton
   Basel-Stadt and the Novartis Research Foundation.
CR Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527
   Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270
   Blanco JE, 2007, EXP NEUROL, V203, P333, DOI 10.1016/j.expneurol.2006.08.017
   Bretzner F, 2013, J NEUROSCI, V33, P14681, DOI 10.1523/JNEUROSCI.5231-12.2013
   Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762
   Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007
   Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001
   Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053
   Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2
   GARCIARILL E, 1987, BRAIN RES, V411, P1, DOI 10.1016/0006-8993(87)90675-5
   Gorski JA, 2002, J NEUROSCI, V22, P6309
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Greene E.C., 1935, ANATOMY RAT
   Grillner S, 1972, Prog Brain Res, V37, P243, DOI 10.1016/S0079-6123(08)63906-0
   Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008
   Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59
   HOLMQVIST B, 1961, Acta Physiol Scand Suppl, V186, P1
   Hyland BI, 1997, BEHAV BRAIN RES, V85, P175, DOI 10.1016/S0166-4328(97)87582-1
   Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0
   Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392
   Jankowska E, 2003, J NEUROSCI, V23, P1867
   Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019
   Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004
   Kuypers H, 1981, HDB PHYSL, P597
   Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547
   Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606
   McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3
   MORI S, 1989, BRAIN RES, V505, P66, DOI 10.1016/0006-8993(89)90116-9
   Noga BR, 2003, J NEUROPHYSIOL, V90, P1464, DOI 10.1152/jn.00034.2003
   Orlovsky G. N., 1999, NEURONAL CONTROL LOC
   Paxinos G., 2012, MOUSE BRAIN STEREOTA
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106
   Roh J, 2011, J NEUROPHYSIOL, V106, P1363, DOI 10.1152/jn.00842.2010
   Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946
   SHIK ML, 1976, PHYSIOL REV, V56, P465
   SKINNER RD, 1984, BRAIN RES, V323, P385, DOI 10.1016/0006-8993(84)90319-6
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001
   Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028
   Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107
   WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248
   Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389
   Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010
   Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577
   Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349
NR 49
TC 108
Z9 109
U1 3
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD APR 17
PY 2014
VL 508
IS 7496
BP 351
EP +
DI 10.1038/nature13023
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AF0KP
UT WOS:000334403000043
PM 24487621
DA 2021-01-25
ER

PT J
AU Kapinos, LE
   Schoch, RL
   Wagner, RS
   Schleicher, KD
   Lim, RYH
AF Kapinos, Larisa E.
   Schoch, Rafael L.
   Wagner, Raphael S.
   Schleicher, Kai D.
   Lim, Roderick Y. H.
TI Karyopherin-Centric Control of Nuclear Pores Based on Molecular
   Occupancy and Kinetic Analysis of Multivalent Binding with FG
   Nucleoporins
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID SURFACE-PLASMON RESONANCE; IMPORTIN-BETA; SINGLE-MOLECULE; DOMAIN
   TOPOLOGY; NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL BASIS; REPEAT REGIONS;
   PROTEIN IMPORT; COMPLEX; ARCHITECTURE
AB Intrinsically disordered Phe-Gly nucleoporins (FG Nups) within nuclear pore complexes exert multivalent interactions with transport receptors (Karyopherins (Kaps)) that orchestrate nucleocytoplasmic transport. Current FG-centric views reason that selective Kap translocation is promoted by alterations in the barrier-like FG Nup conformations. However, the strong binding of Kaps with the FG Nups due to avidity contradicts rapid Kap translocation in vivo. Here, using surface plasmon resonance, we innovate a means to correlate in situ mechanistic (molecular occupancy and conformational changes) with equilibrium (binding affinity) and kinetic (multivalent binding kinetics) aspects of Karyopherin beta 1 (Kap beta 1) binding to four different FG Nups. A general feature of the FxFG domains of Nup214, Nup62, and Nup153 is their capacity to extend and accommodate large numbers of Kap beta 1 molecules at physiological Kap,61 concentrations. A notable exception is the GLFG domain of Nup98, which forms a partially penetrable cohesive layer. Interestingly, we find that a slowly exchanging Kap beta 1 phase forms an integral constituent within the FG Nups that coexists with a fast phase, which dominates transport kinetics due to limited binding with the pre-occupied FG Nups at physiological Kap beta 1 concentrations. Altogether, our data reveal an emergent Kap-centric barrier mechanism that may underlie mechanistic and kinetic control in the nuclear pore complex.
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Basel, Swiss Nanosci Inst, Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Schoch, Rafael/0000-0003-1799-2272; Lim, Roderick/0000-0001-5015-6087
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Biozentnun; Swiss Nanoscience Institute
FX This work is supported by the Swiss National Science Foundation, the
   Biozentnun, and the Swiss Nanoscience Institute.
CR Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831
   Atkinson CE, 2013, BIOPHYS J, V104, P37, DOI 10.1016/j.bpj.2012.11.3823
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bright JN, 2001, PROG BIOPHYS MOL BIO, V76, P131, DOI 10.1016/S0079-6107(01)00012-8
   Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004
   Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014
   Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114
   Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199
   Gjelstrup LC, 2012, J IMMUNOL, V188, P1292, DOI 10.4049/jimmunol.1103012
   GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0
   Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]
   Hansen PC, 2007, NUMER ALGORITHMS, V46, P189, DOI 10.1007/s11075-007-9136-9
   Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9
   Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/NNANO.2011.88, 10.1038/nnano.2011.88]
   Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302
   Landi G, 2006, APPL MATH COMPUT, V175, P715, DOI 10.1016/j.amc.2005.07.037
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760
   Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109
   Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Munoz EM, 2013, J AM CHEM SOC, V135, P5966, DOI 10.1021/ja400951g
   Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204
   Opferman MG, 2013, LANGMUIR, V29, P8584, DOI 10.1021/la4013922
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Schoch RL, 2013, LANGMUIR, V29, P4068, DOI 10.1021/la3049289
   Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109
   Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030
   Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7
   Svitel J, 2007, BIOPHYS J, V92, P1742, DOI 10.1529/biophysj.106.094615
   Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110
   Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09
   Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656
   Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171
   Xu SL, 2013, MOL BIOL CELL, V24, P1222, DOI 10.1091/mbc.E12-08-0585
   Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
   Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125
NR 68
TC 62
Z9 62
U1 1
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR 15
PY 2014
VL 106
IS 8
BP 1751
EP 1762
DI 10.1016/j.bpj.2014.02.021
PG 12
WC Biophysics
SC Biophysics
GA AF2UF
UT WOS:000334567300026
PM 24739174
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Spiess, M
AF Spiess, Martin
TI Protein Translocation: The Sec61/SecYEG Translocon Caught in the Act
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; CONDUCTING CHANNEL; ER
   MEMBRANE; INSERTION; YEAST; RECOGNITION; INTEGRATION; RIBOSOME; SEGMENTS
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535
   Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019
   du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200
   Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107
   Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026
   Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Lycklama A., 2011, J BIOL CHEM, V286, P43881
   Lycklama A., 2010, J BIOL CHEM, V285, P23747
   MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5
   McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6
   Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720
   Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]
   Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9
   Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994
   Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125
   Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
NR 20
TC 3
Z9 3
U1 0
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD APR 14
PY 2014
VL 24
IS 8
BP R317
EP R319
DI 10.1016/j.cub.2014.02.051
PG 4
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AE8SQ
UT WOS:000334272700010
PM 24735854
OA Bronze
DA 2021-01-25
ER

PT J
AU Guilvout, I
   Chami, M
   Disconzi, E
   Bayan, N
   Pugsley, AP
   Huysmans, GHM
AF Guilvout, Ingrid
   Chami, Mohamed
   Disconzi, Elena
   Bayan, Nicolas
   Pugsley, Anthony P.
   Huysmans, Gerard H. M.
TI Independent Domain Assembly in a Trapped Folding Intermediate of
   Multimeric Outer Membrane Secretins
SO STRUCTURE
LA English
DT Article
ID STRUCTURAL-CHARACTERIZATION; PORE FORMATION; PROTEIN; INSERTION; STATE;
   PULD; INSIGHTS; PILQ; PILIATION; MECHANISM
AB The outer membrane portal of the Klebsiella oxytoca type II secretion system, PulD, is a prototype of a family of proteins, the secretins, which are essential components of many bacterial secretion and pilus assembly machines. PulD is a homododecamer with a periplasmic vestibule and an outer chamber on either side of a membrane-spanning region that is poorly resolved by electron microscopy. Membrane insertion involves the formation of a dodecameric membrane-embedded intermediate. Here, we describe an amino acid substitution in PulD that blocks its assembly at this intermediate "prepore'' stage. Electron microscopy indicated that the prepore has an apparently normal periplasmic vestibule but a poorly organized outer chamber. A peptide loop around this amino acid appears to be important for the formation/stability of the fully folded complex. A similar assembly intermediate results from creation of the same amino acid substitution in the Pseudomonas aeruginosa secretin XcpQ.
C1 [Guilvout, Ingrid; Disconzi, Elena; Pugsley, Anthony P.; Huysmans, Gerard H. M.] Inst Pasteur, Dept Microbiol, Mol Genet Unit, F-75724 Paris 15, France.
   [Guilvout, Ingrid; Disconzi, Elena; Pugsley, Anthony P.; Huysmans, Gerard H. M.] Inst Pasteur, Dept Struct Biol & Chem, F-75724 Paris 15, France.
   [Guilvout, Ingrid; Disconzi, Elena; Pugsley, Anthony P.; Huysmans, Gerard H. M.] CNRS, ERL3526, F-75724 Paris 15, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, C CINA Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
   [Disconzi, Elena; Bayan, Nicolas] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France.
RP Pugsley, AP (corresponding author), Inst Pasteur, Dept Microbiol, Mol Genet Unit, Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr; ghuysman@pasteur.fr
RI Huysmans, Gerard/AAJ-6285-2020; Bayan, Nicolas/AAI-5034-2020
OI Bayan, Nicolas/0000-0001-7760-0811
FU French National Research Agency (ANR)French National Research Agency
   (ANR) [09-BLAN-0291]; Marie Curie Intra-European FellowshipEuropean
   Union (EU) [PIEF-GA-2010-272611]; EMBO-Pasteur fellowship [ALTF
   1088-2010]; Swiss National Science Foundation (SystemsX.ch RTD
   CINA)Swiss National Science Foundation (SNSF)
FX We thank Patrick England and Bruno Baron for assistance with circular
   dichroism and Prof. Henning Stahlberg (Biozentrum, University of Basel)
   for his continued support. This work was funded in part by the French
   National Research Agency (ANR grant number 09-BLAN-0291). G. H. M. H.
   was a recipient of a Marie Curie Intra-European Fellowship
   (PIEF-GA-2010-272611) and an EMBO-Pasteur fellowship (ALTF 1088-2010).
   The EM work was supported in part by the Swiss National Science
   Foundation (SystemsX.ch RTD CINA).
CR Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Chen CJ, 2004, J BACTERIOL, V186, P730, DOI 10.1128/JB.186.3.730-739.2004
   Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]
   Disconzi E, 2014, J BACTERIOL, V196, P121, DOI 10.1128/JB.00750-13
   Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008
   Frye SA, 2006, MICROBIOL-SGM, V152, P3751, DOI 10.1099/mic.0.2006/000315-0
   Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956
   Gromiha MM, 2005, BIOINFORMATICS, V21, P961, DOI 10.1093/bioinformatics/bti126
   Gsponer J, 2006, P NATL ACAD SCI USA, V103, P99, DOI 10.1073/pnas.0508667102
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06
   Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11
   Huysmans GHM, 2013, J BIOL CHEM, V288, P30700, DOI 10.1074/jbc.M113.489112
   Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107
   Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b
   Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762
   Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011
   Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102
   McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005
   Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108
   Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023
   MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985
   Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203
   Nickerson NN, 2012, J BACTERIOL, V194, P4951, DOI 10.1128/JB.00798-12
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Pernot L., 2008, FOLD DES, V1778, P1611
   Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910
   Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054
   RODIONOVA NA, 1995, BIOCHEMISTRY-US, V34, P1921, DOI 10.1021/bi00006a013
   Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008
   Vallee-Belisle A, 2012, NAT STRUCT MOL BIOL, V19, P731, DOI 10.1038/nsmb.2322
   Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096
NR 41
TC 10
Z9 10
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD APR 8
PY 2014
VL 22
IS 4
BP 582
EP 589
DI 10.1016/j.str.2014.02.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AE8WF
UT WOS:000334283000011
PM 24657091
OA Bronze
DA 2021-01-25
ER

PT J
AU Herranz, M
   Boyle, MJ
   Pardos, F
   Neves, RC
AF Herranz, Maria
   Boyle, Michael J.
   Pardos, Fernando
   Neves, Ricardo C.
TI Comparative myoanatomy of Echinoderes (Kinorhyncha): a comprehensive
   investigation by CLSM AND 3D reconstruction
SO FRONTIERS IN ZOOLOGY
LA English
DT Article
DE Ecdysozoa; Scalidophora; Segmentation; Phalloidin; Organ system;
   Circular muscle; Introvert; Pharynx
ID POSTEMBRYONIC DEVELOPMENT; PHYLOGENETIC-RELATIONSHIPS; COMPARATIVE
   MORPHOLOGY; NERVOUS-SYSTEM; SISTER-GROUP; ULTRASTRUCTURE; CYCLORHAGIDA;
   LORICIFERA; ECDYSOZOA; SEGMENTATION
AB Introduction: Kinorhyncha is a clade of marine invertebrate meiofauna. Their body plan includes a retractable introvert bearing rings of cuticular spines, and a limbless trunk with distinct segmentation of nervous, muscular and epidermal organ systems. As derived members within the basal branch of Ecdysozoa, kinorhynchs may provide an important example of convergence on the evolution of segmentation within one of three bilaterian superclades. We describe the myoanatomy of Echinoderes, the most specious kinorhynch genus, and build upon historical studies of kinorhynch ultrastructure and gross morphology. This is the first multi-species comparison of a complete organ system by confocal microscopy and three-dimensional reconstruction within Kinorhyncha.
   Results: Myoanatomy of adult Echinoderes is composed of the following: Head with two mouth cone circular muscles, nine pairs of oral style muscles, ten introvert retractors, one introvert circular muscle, and fourteen introvert circular muscle retractors; Neck with one circular muscle; Trunk showing distinct pairs of ventral and dorsal muscles within segments 1-10, dorsoventral muscles within segments 3-10, diagonal muscles within segments 1-8, longitudinal fibers spanning segments 1-9, three pairs of terminal spine muscles, and one pair of male penile spine muscles; Gut showing a pharynx with ten alternating rings of radial and circular muscle fibers enclosed in a complex sheath of protractors and retractors, an orthogonal grid of longitudinal and circular fibers surrounding the intestine, and paired hindgut dilators.
   Conclusions: Myoanatomy is highly conserved between species of Echinoderes. Interspecific variation is observed in the arrangement and number of introvert fibers and the composition of pharyngeal muscles. Segmented trunk musculature facilitates the movements of articulated cuticular plates along the anterior-posterior axis. Intersegmental muscle fibers assist with dorsoventral and lateral trunk movements. Protractors, retractors and circular muscles coordinate eversion and retraction of the introvert and mouth cone, and relocation of the pharynx during locomotion and feeding behaviors. Pairs of posterior fibers suggest independent movements of terminal spines, and male penile spines. Within Scalidophora, myoanatomy is more similar between Kinorhyncha and Loricifera, than either group is to Priapulida. Kinorhynch myoanatomy may reflect a convergent transition from vermiform to segmented body plans during the early radiation of Ecdysozoa.
C1 [Herranz, Maria; Pardos, Fernando] Univ Complutense Madrid, Fac Biol, Dpto Zool & Antropol Fis Zool Invertebrados, E-28040 Madrid, Spain.
   [Boyle, Michael J.] Smithsonian Trop Res Inst, Naos Marine Labs, Panama City 084303092, Panama.
   [Neves, Ricardo C.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Herranz, M (corresponding author), Univ Complutense Madrid, Fac Biol, Dpto Zool & Antropol Fis Zool Invertebrados, C Jose Antonio Novais 2, E-28040 Madrid, Spain.
EM mariaherranz@bio.ucm.es
RI Herranz, Maria/J-8042-2014; Neves, Ricardo Cardoso/J-9822-2014;
   MARTINEZ, FERNANDO PARDOS/I-5218-2017; Herranz, Maria/AAT-6007-2020
OI Herranz, Maria/0000-0002-3020-6072; Neves, Ricardo
   Cardoso/0000-0002-9219-9066; MARTINEZ, FERNANDO
   PARDOS/0000-0002-6292-9793; Herranz, Maria/0000-0002-3020-6072
FU Ministerio de Ciencia y Tecnolog a, Government of Spain [2009-08928];
   Smithsonian Institution/Link Foundation Graduate Fellowship; ASSEMBLE
   [227799]
FX MH is grateful to Dr. Mary Rice and Dr. Jon Norenburg for sponsorship
   and scientific advisement, and to Dr. Valerie Paul and technical staff
   at the Smithsonian Marine Station at Fort Pierce (SMSFP). We acknowledge
   technical and field staff at CCMAR (Portugal). MH is very grateful to
   Dr. Heinrich Reichert, and staff at the Imaging Core Facility at
   Biozentrum, University of Basel (Switzerland). Dr. Reinhardt Mobjerg
   Kristensen generously loaned us unpublished TEM images. Part of this
   research was funded by Project CGL 2009-08928 (Ministerio de Ciencia y
   Tecnologia, Government of Spain) to FP. Field collection, imaging and
   research in Florida (USA) was funded by a Smithsonian Institution/Link
   Foundation Graduate Fellowship to MH. Field collection and imaging in
   Faro (Portugal) was funded by ASSEMBLE Grant No. 227799 to RCN and MH.
   This publication is Smithsonian Marine Station contribution no. 948.
CR Adrianov A.V., 1991, Ekologiya Morya, V39, P57
   Adrianov AV, 1994, KINORHYNCHA STRUCTUR
   Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0
   Ahlrichs WH, 1995, ULTRASTRUKTUR PHYLOG
   Bang-Berthelsen I, 2013, HDB ZOOLOGY GASTROTR, V1, P77
   BROWN R, 1989, ZOOL SCR, V18, P471
   Brown R., 1985, THESIS MACQUARIE U S
   Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890
   Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108
   Claparede ARE, 1863, KENNTNIS GATTUNG ECH
   Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4
   Garey JR, 2001, ZOOL ANZ, V240, P321, DOI 10.1078/0044-5231-00039
   Giribet G, 2008, PHILOS T R SOC B, V363, P1513, DOI 10.1098/rstb.2007.2241
   Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124
   HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451
   Hannibal RL, 2013, EVO DEVO IN PRESS
   Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896
   Herranz M, 2013, ZOOL ANZ, V253, P93, DOI 10.1016/j.jcz.2013.09.005
   Herranz M, 2013, J MORPHOL, V274, P258, DOI 10.1002/jmor.20089
   Higgins R.P., 1988, P328
   Higgins R. P., 1983, SMITHSON CONTRIB MAR, V18, P1, DOI DOI 10.5479/SI.01960768.18.1
   Higgins R.P., 1990, SMITHSON CONTR ZOOL, V500, P1, DOI DOI 10.5479/SI.00810282.500
   HIGGINS RP, 1968, T AM MICROSC SOC, V87, P21, DOI 10.2307/3224334
   Janssen R, 2010, EVOL DEV, V12, P363, DOI 10.1111/j.1525-142X.2010.00423.x
   KOZLOFF EN, 1972, T AM MICROSC SOC, V91, P119, DOI 10.2307/3225404
   Kristensen R.M., 1991, P351
   Kristensen R.M., 1991, P377
   Lang K, 1963, LOWER METAZOA COMP B
   Lemburg Christian, 1995, Microfauna Marina, V10, P7
   Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021
   Muller MCM, 2004, ZOOMORPHOLOGY, V123, P45, DOI 10.1007/s00435-003-0088-x
   Muller MCM, 2003, J MORPHOL, V256, P103, DOI 10.1002/jmor.10058
   NEBELSICK M, 1993, ZOOMORPHOLOGY, V113, P211, DOI 10.1007/BF00403313
   Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619
   Neuhaus B, 2013, HDB ZOOLOGY GASTROTR, P77
   Neuhaus Birger, 1993, Microfauna Marina, V8, P163
   Neuhaus Birger, 1994, Microfauna Marina, V9, P61
   Neves RC, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-19
   Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1
   Nielsen C, 2013, INVERTEBR BIOL, V132, P1, DOI 10.1111/ivb.12010
   NYHOLM K-G, 1976, ZOON (Uppsala), V4, P121
   Ordonez DG, 2000, J MORPHOL, V246, P161
   Pardos F, 1998, ZOOL ANZ, V237, P195
   Park JK, 2006, ZOOL SCI, V23, P943, DOI 10.2108/zsj.23.943
   Remane A., 1936, KLASSEN ORDNUNGEN TI, V4, P243
   Remane A, 1929, HDB ZOOLOGIE
   Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030
   Rothe B. H., 2004, MEIOFAUNA MAR, V13, P21
   Ruppert E.E., 2004, INVERTEBRATE ZOOLOGY
   Schmidt-Rhaesa A, 2006, INTEGR COMP BIOL, V46, P144, DOI 10.1093/icb/icj019
   Schmidt-Rhaesa A, 2013, HDB ZOOLOGY GASTROTR, V1, P77
   Schmidt-Rhaesa A, 2007, EVOLUTION ORGAN SYST
   Seaver EC, 2003, INT J DEV BIOL, V47, P583
   Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x
   Sorensen MV, 2010, J MORPHOL, V271, P863, DOI 10.1002/jmor.10844
   Sorensen Martin V., 2008, Meiofauna Marina, V16, P21
   Sorensen MV, 2005, P BIOL SOC WASH, V118, P499, DOI 10.2988/0006-324X(2005)118[499:ANSOEF]2.0.CO;2
   Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243
   Yamasaki H, 2013, MOL PHYLOGENET EVOL, V67, P303, DOI 10.1016/j.ympev.2013.02.016
   Zelinka C., 1928, MONOGRAPHIE ECHINODE
NR 60
TC 14
Z9 14
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-9994
J9 FRONT ZOOL
JI Front. Zool.
PD APR 5
PY 2014
VL 11
AR 31
DI 10.1186/1742-9994-11-31
PG 26
WC Zoology
SC Zoology
GA AF2HN
UT WOS:000334533300001
PM 24708877
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU McCoy, JG
   Rusinova, R
   Kim, DM
   Kowal, J
   Banerjee, S
   Cartagena, AJ
   Thompson, AN
   Kolmakova-Partensky, L
   Stahlberg, H
   Andersen, OS
   Nimigean, CM
AF McCoy, Jason G.
   Rusinova, Radda
   Kim, Dorothy M.
   Kowal, Julia
   Banerjee, Sourabh
   Cartagena, Alexis Jaramillo
   Thompson, Ameer N.
   Kolmakova-Partensky, Ludmila
   Stahlberg, Henning
   Andersen, Olaf S.
   Nimigean, Crina M.
TI A KcsA/MloK1 Chimeric Ion Channel Has Lipid-dependent Ligand-binding
   Energetics*
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Electron Microscopy (EM); Energetics; Fluorescence; Gating; Ion
   Channels; Isothermal Titration Calorimetry; Nanodisc; Single-channel
   Recording
ID NUCLEOTIDE-GATED CHANNELS; HYPERPOLARIZATION-ACTIVATED CHANNEL;
   PROKARYOTIC K+ CHANNEL; LOTI K1 CHANNEL; POTASSIUM-CHANNEL; STRUCTURAL
   BASIS; PACEMAKER CHANNELS; SELECTIVITY FILTER; HCN CHANNELS; CAMP
AB Background: The mechanism of ligand gating in physiologically important cyclic nucleotide-modulated channels is unknown. Results: We constructed and purified a chimeric ion channel with activity modulated by cAMP and used it to measure ligand-binding energetics. Conclusion: cAMP binds with high lipid-dependent affinity to the chimeric channel. Significance: The availability of a good protein preparation enables assays that shed light on ligand gating.
   Cyclic nucleotide-modulated ion channels play crucial roles in signal transduction in eukaryotes. The molecular mechanism by which ligand binding leads to channel opening remains poorly understood, due in part to the lack of a robust method for preparing sufficient amounts of purified, stable protein required for structural and biochemical characterization. To overcome this limitation, we designed a stable, highly expressed chimeric ion channel consisting of the transmembrane domains of the well characterized potassium channel KcsA and the cyclic nucleotide-binding domains of the prokaryotic cyclic nucleotide-modulated channel MloK1. This chimera demonstrates KcsA-like pH-sensitive activity which is modulated by cAMP, reminiscent of the dual modulation in hyperpolarization-activated and cyclic nucleotide-gated channels that display voltage-dependent activity that is also modulated by cAMP. Using this chimeric construct, we were able to measure for the first time the binding thermodynamics of cAMP to an intact cyclic nucleotide-modulated ion channel using isothermal titration calorimetry. The energetics of ligand binding to channels reconstituted in lipid bilayers are substantially different from those observed in detergent micelles, suggesting that the conformation of the chimera's transmembrane domain is sensitive to its (lipid or lipid-mimetic) environment and that ligand binding induces conformational changes in the transmembrane domain. Nevertheless, because cAMP on its own does not activate these chimeric channels, cAMP binding likely has a smaller energetic contribution to gating than proton binding suggesting that there is only a small difference in cAMP binding energy between the open and closed states of the channel.
C1 [McCoy, Jason G.; Rusinova, Radda; Kim, Dorothy M.; Banerjee, Sourabh; Thompson, Ameer N.; Nimigean, Crina M.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA.
   [Rusinova, Radda; Thompson, Ameer N.; Andersen, Olaf S.; Nimigean, Crina M.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.
   [Nimigean, Crina M.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.
   [Cartagena, Alexis Jaramillo; Andersen, Olaf S.; Nimigean, Crina M.] Weill Cornell Med Coll, Tri Inst Program Chem Biol, New York, NY 10065 USA.
   [Kolmakova-Partensky, Ludmila] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.
   [Kowal, Julia; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland.
RP Nimigean, CM (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave, New York, NY 10065 USA.
EM crn2002@med.cornell.edu
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Nimigean,
   Crina/0000-0002-6254-4447; Kowal, Julia/0000-0003-4694-1896
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM077560, GM021342];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [315230]; National Center of Competence in Research TransCure;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM021342,
   R01GM021342, R01GM021342, R01GM021342, R01GM077560, R01GM021342,
   R01GM021342, R01GM021342, R01GM021342, R01GM021342, R01GM077560,
   R01GM021342, R01GM021342, R01GM021342, R01GM021342, R01GM021342,
   R01GM021342, R01GM021342, R01GM021342, R01GM021342, R01GM021342,
   R01GM021342, R01GM021342, R01GM077560, R01GM021342, R01GM077560,
   R01GM077560, R01GM021342, R01GM021342, R01GM021342, R01GM077560,
   R01GM021342, R01GM021342, R01GM021342, R01GM021342, R01GM021342,
   R01GM021342, R01GM021342, R01GM021342, R01GM021342] Funding Source: NIH
   RePORTER
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants GM077560 (to C. M. N.) and GM021342 (to O. S. A.). This
   work was also supported by Swiss National Science Foundation Grant
   315230 and National Center of Competence in Research TransCure (to H.
   S.).
CR Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9
   Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066
   Banerjee S, 2011, J GEN PHYSIOL, V137, P217, DOI 10.1085/jgp.201010558
   Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019
   Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237
   Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020
   Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563
   Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105
   Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030
   Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069
   Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728
   Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003
   Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008
   Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102
   Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248
   Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741
   Hirano M, 2011, BIOPHYS J, V101, P2157, DOI 10.1016/j.bpj.2011.09.024
   Ingolfsson HI, 2010, ASSAY DRUG DEV TECHN, V8, P427, DOI 10.1089/adt.2009.0250
   Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580
   Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a
   Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002
   Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235
   Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747
   Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022
   LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303
   Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606
   Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255
   Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107
   Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110
   Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133
   Nimigean CM, 2007, J MOL BIOL, V371, P1325, DOI 10.1016/j.jmb.2007.06.030
   Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050
   Peuker S, 2013, BIOPHYS J, V104, P63, DOI 10.1016/j.bpj.2012.11.3816
   Posson DJ, 2013, J GEN PHYSIOL, V142, P613, DOI 10.1085/jgp.201311057
   Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197
   Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106
   Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734
   Rusinova R, 2014, BIOPHYS J, V106, P1070, DOI 10.1016/j.bpj.2014.01.027
   Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8
   SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x
   Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108
   Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68
   Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391
   SHABB JB, 1992, J BIOL CHEM, V267, P5723
   Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341
   Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105
   Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034
   Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033
   Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978
   Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207
   Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922
   Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315
NR 54
TC 7
Z9 7
U1 1
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 4
PY 2014
VL 289
IS 14
BP 9535
EP 9546
DI 10.1074/jbc.M113.543389
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE2MK
UT WOS:000333807000010
PM 24515111
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Perez-Schindler, J
   Vargas-Fernandez, E
   Santos, G
   Svensson, K
   Wahli, W
   Handschin, C
AF Perez-Schindler, Joaquin
   Vargas-Fernandez, Elyzabeth
   Santos, Gesa
   Svensson, Kristoffer
   Wahli, Walter
   Handschin, Christoph
TI PPAR beta/delta is not required by PGC-1 alpha to enhance skeletal
   muscle oxidative metabolism
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Perez-Schindler, Joaquin; Vargas-Fernandez, Elyzabeth; Santos, Gesa; Svensson, Kristoffer; Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
   [Wahli, Walter] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, Lausanne, Switzerland.
RI Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; Handschin,
   Christoph/E-6886-2015
OI Wahli, Walter/0000-0002-5966-9089; Handschin,
   Christoph/0000-0003-0603-1097
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2014
VL 28
IS 1
SU S
MA 1164.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AX0OG
UT WOS:000346651002227
DA 2021-01-25
ER

PT J
AU Arnold, AS
   Gill, J
   Christe, M
   Ruiz, R
   McGuirk, S
   St-Pierre, J
   Tabares, L
   Handschin, C
AF Arnold, Anne-Sophie
   Gill, Jonathan
   Christe, Martine
   Ruiz, Rocio
   McGuirk, Shawn
   St-Pierre, Julie
   Tabares, Lucia
   Handschin, Christoph
TI Morphological and functional remodelling of the neuromuscular junction
   by skeletal muscle PGC-1 alpha
SO NATURE COMMUNICATIONS
LA English
DT Article
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; SLOW-TWITCH; RAT FAST;
   GLUCOSE-HOMEOSTASIS; NERVE; EXPRESSION; EXERCISE; DIFFERENTIATION;
   TRANSMISSION; ADAPTATIONS
AB The neuromuscular junction (NMJ) exhibits high morphological and functional plasticity. In the mature muscle, the relative levels of physical activity are the major determinants of NMJ function. Classically, motor neuron-mediated activation patterns of skeletal muscle have been thought of as the major drivers of NMJ plasticity and the ensuing fibre-type determination in muscle. Here we use muscle-specific transgenic animals for the peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1 alpha) as a genetic model for trained mice to elucidate the contribution of skeletal muscle to activity-induced adaptation of the NMJ. We find that muscle-specific expression of PGC-1 alpha promotes a remodelling of the NMJ, even in the absence of increased physical activity. Importantly, these plastic changes are not restricted to post-synaptic structures, but extended to modulation of presynaptic cell morphology and function. Therefore, our data indicate that skeletal muscle significantly contributes to the adaptation of the NMJ subsequent to physical activity.
C1 [Arnold, Anne-Sophie; Gill, Jonathan; Christe, Martine; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   [Ruiz, Rocio; Tabares, Lucia] Univ Seville, Sch Med, Dept Med Physiol & Biophys, E-41009 Seville, Spain.
   [McGuirk, Shawn; St-Pierre, Julie] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Ruiz, Rocio/B-9306-2013; Tabares, Lucia/K-8768-2015; Handschin,
   Christoph/E-6886-2015
OI Ruiz, Rocio/0000-0001-5142-9972; Tabares, Lucia/0000-0002-4027-4044;
   Handschin, Christoph/0000-0003-0603-1097; McGuirk,
   Shawn/0000-0002-7183-7962; St-Pierre, Julie/0000-0002-2815-7099
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USA (MDA)Muscular Dystrophy
   Association; SwissLife Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung; Swiss Society for Research on Muscle Diseases
   (SSEM); Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation (UMDF); Association Francaise contre
   les Myopathies (AFM)Association Francaise contre les Myopathies;
   Gebert-Ru f Foundation Rare Diseases Program; Neuromuscular Research
   Association Basel (NeRAB); University of Basel; Canadian Institutes of
   Health ResearchCanadian Institutes of Health Research (CIHR)
   [MOP-106603]; Terry Fox Foundation [TFF-116128]; molecular oncology
   research; Spanish Ministry of Science and InnovationSpanish Government
   [BFU2010- 21648]
FX This project was funded by the Swiss National Science Foundation, the
   Muscular Dystrophy Association USA (MDA), the SwissLife
   'Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung', the
   Swiss Society for Research on Muscle Diseases (SSEM), the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation (UMDF), the Association Francaise contre les
   Myopathies (AFM), the Gebert-Ruf Foundation 'Rare Diseases' Program, the
   Neuromuscular Research Association Basel (NeRAB), the University of
   Basel and the Spanish Ministry of Science and Innovation BFU2010- 21648.
   Research in J. St- P. laboratory is funded by grants from the Canadian
   Institutes of Health Research (MOP-106603) and Terry Fox Foundation
   (TFF-116128). J. St- P. is a FRSQ research scholar. Shawn McGuirk is
   supported by a Michael D'Avirro fellowship in molecular oncology
   research (McGill University).
CR Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883
   Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608
   Bewick GS, 2004, EUR J NEUROSCI, V19, P2967, DOI 10.1111/j.0953-816X.2004.03418.x
   Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348
   Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019
   Desaulniers P, 2001, J APPL PHYSIOL, V90, P1041
   Deschenes MR, 2011, NEUROSCIENCE, V190, P56, DOI 10.1016/j.neuroscience.2011.05.070
   Deschenes MR, 2006, NEUROSCIENCE, V137, P1277, DOI 10.1016/j.neuroscience.2005.10.042
   Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968
   Frank CA, 2014, NEUROPHARMACOLOGY, V78, P63, DOI 10.1016/j.neuropharm.2013.06.015
   Froemming GR, 2000, BBA-BIOMEMBRANES, V1466, P151, DOI 10.1016/S0005-2736(00)00195-4
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008
   Hirsch NP, 2007, BRIT J ANAESTH, V99, P132, DOI 10.1093/bja/aem144
   Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722
   Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026
   Krieger F, 2013, NEUROBIOL DIS, V54, P169, DOI 10.1016/j.nbd.2012.12.010
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110
   Reid B, 1999, J NEUROSCI, V19, P2511
   Ruiz R, 2011, J NEUROSCI, V31, P2000, DOI 10.1523/JNEUROSCI.4663-10.2011
   Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Shi L, 2012, TRENDS NEUROSCI, V35, P441, DOI 10.1016/j.tins.2012.04.005
   Slater CR, 2008, ANN NY ACAD SCI, V1132, P1, DOI 10.1196/annals.1405.003
   Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004
   Summermatter S, 2013, DIABETES, V62, P85, DOI 10.2337/db12-0291
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   TOMAS J, 1990, J ANAT, V168, P123
   Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107
   VATINE J J, 1990, Electromyography and Clinical Neurophysiology, V30, P19
   Weibel E. R., 1979, STEREOLOGICAL METHOD
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007
   Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Yumoto N, 2012, NATURE, V489, P438, DOI 10.1038/nature11348
NR 44
TC 30
Z9 30
U1 1
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR
PY 2014
VL 5
AR 3569
DI 10.1038/ncomms4569
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG2BM
UT WOS:000335220300005
PM 24686533
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Ritz, AM
   Trautwein, M
   Grassinger, F
   Spang, A
AF Ritz, Alicja M.
   Trautwein, Mark
   Grassinger, Franziska
   Spang, Anne
TI The Prion-like Domain in the Exomer-Dependent Cargo Pin2 Serves as a
   trans-Golgi Retention Motif
SO CELL REPORTS
LA English
DT Article
ID PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE;
   CHS3P; YEAST; CHS5P; LOCALIZATION; APPEARANCE; HOMOLOGY; SEQUENCE
AB Prion and prion-like domains (PLDs) are found in many proteins throughout the animal kingdom. We found that the PLD in the S. cerevisiae exomer-dependent cargo protein Pin2 is involved in the regulation of protein transport and localization. The domain serves as a Pin2 retention signal in the trans-Golgi network (TGN). Pin2 is localized in a polarized fashion at the plasma membrane of the bud early in the cell cycle and the bud neck at cytokinesis. This polarized localization is dependent on both exo- and endocytosis. Upon environmental stress, Pin2 is rapidly endocytosed, and the PLD aggregates and causes sequestration of Pin2. The aggregation of Pin2 is reversible upon stress removal and Pin2 is rapidly re-exported to the plasma membrane. Altogether, these data uncover a role for PLDs as protein localization elements.
C1 [Ritz, Alicja M.; Trautwein, Mark; Grassinger, Franziska; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Boehringer Ingelheim FundBoehringer Ingelheim; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31003AB-126021,
   31003A-141207]; University of Basel
FX We thank I. Derkatch, S. Liebman, J. Shorter, S. Nothwehr, and M. Hall
   for strains and reagents. I. G. Macara is acknowledged for comments on
   the manuscript. We thank P. Jeno and S. Moes (Mass Spectrometry
   Facility) and T. Sharpe (Biophysics Facility) from the Biozentrum for
   support. This work was supported by the Boehringer Ingelheim Fund (to A.
   M. R.), the Swiss National Science Foundation (31003AB-126021 and
   31003A-141207 to A. S.), and the University of Basel.
CR Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044
   Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324
   Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072
   Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182
   Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200
   Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597
   Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147
   Derkatch IL, 1997, GENETICS, V147, P507
   Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5
   Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715
   GROFFEN J, 1983, NATURE, V304, P167, DOI 10.1038/304167a0
   Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013
   Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200
   King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016
   KUSHNIROV VV, 1988, GENE, V66, P45, DOI 10.1016/0378-1119(88)90223-5
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Liu JJ, 1999, NATURE, V400, P573
   Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003
   Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910
   MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622
   OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928
   Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1
   Paczkowski JE, 2012, EMBO J, V31, P4191, DOI 10.1038/emboj.2012.268
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124
   Rockenbauch U, 2012, MOL BIOL CELL, V23, P4402, DOI 10.1091/mbc.E11-12-1015
   Sadowski I, 2013, PHOSPHOGRID SACCHARO, V2013
   Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210
   Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95
   Schindler C, 2009, TRAFFIC, V10, P1362, DOI 10.1111/j.1600-0854.2009.00952.x
   Schlecht U, 2012, P NATL ACAD SCI USA, V109, P9213, DOI 10.1073/pnas.1204952109
   Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016
   SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Starr TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046386
   Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380
   Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878
   Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081
   Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007
   Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100
   Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2
   Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006
   Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235
   Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106
   Zanolari B, 2011, J CELL SCI, V124, P1055, DOI 10.1242/jcs.072371
   Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565
   Ziman M, 1996, MOL BIOL CELL, V7, P1909
NR 49
TC 16
Z9 17
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR
PY 2014
VL 7
IS 1
BP 249
EP 260
DI 10.1016/j.celrep.2014.02.026
PG 12
WC Cell Biology
SC Cell Biology
GA AE9BG
UT WOS:000334298200024
PM 24656818
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Vigano, MA
   Ivanek, R
   Balwierz, P
   Berninger, P
   van Nimwegen, E
   Karjalainen, K
   Rolink, A
AF Vigano, Maria Alessandra
   Ivanek, Robert
   Balwierz, Piotr
   Berninger, Philipp
   van Nimwegen, Erik
   Karjalainen, Klaus
   Rolink, Antonius
TI An epigenetic profile of early T-cell development from multipotent
   progenitors to committed T- cell descendants
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Development; Epigenetics; Genome-wide; T cells
ID HEMATOPOIETIC STEM-CELLS; IMMUNE-SYSTEM; TRANSCRIPTIONAL CONTROL;
   LINEAGE; DIFFERENTIATION; NOTCH; IL-7; RESTRICTION; PLURIPOTENT;
   PLASTICITY
AB Cellular differentiation of the T-cell branch of the immune system begins with the HSC, which undergoes a series of stages characterized by progressive restriction in multipotency and acquisition of specific lineage identity At the molecular level, the restriction of cell potential, commitment, and differentiation to a specific lineage is achieved through the coordinated control of gene expression and epigenetic mechanisms. Here, we analyzed and compared the gene expression profiles and the genome-wide histone modification marks H3K4me3 (H3 lysine 4 trimethylation) and H3K27me3 (H3 lysine 27 trimethylation) in (i) in vitro propagated HSCs, (ii) in vitro generated and propagated pro-T cells derived from these stem cells, and (iii) double-positive thymocytes derived from these pro-T cells after injection into Rag-deficient mice. The combined analyses of the different datasets in this unique experimental system highlighted the importance of both transcriptional and epigenetic repression in shaping the early phases of T-cell development.
C1 [Vigano, Maria Alessandra; Rolink, Antonius] Univ Basel, Dev & Mol Immunol Grp, Dept Biomed, CH-4058 Basel, Switzerland.
   [Ivanek, Robert] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
   [Ivanek, Robert; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
   [Balwierz, Piotr; Berninger, Philipp; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4058 Basel, Switzerland.
   [Balwierz, Piotr] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London, England.
   [Balwierz, Piotr] MRC Clin Sci Ctr, London, England.
   [Karjalainen, Klaus] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
RP Rolink, A (corresponding author), Univ Basel, Dev & Mol Immunol Grp, Dept Biomed, Mattenstr 28, CH-4058 Basel, Switzerland.
EM antonious.rolink@unibas.ch
RI Balwierz, Piotr J/AAG-4187-2020; Karjalainen, Klaus/A-2206-2011; Ivanek,
   Robert/A-8852-2008
OI Balwierz, Piotr J/0000-0002-1548-4605; vigano, maria
   alessandra/0000-0003-2009-0384; van Nimwegen, Erik/0000-0001-6338-1312;
   Ivanek, Robert/0000-0002-8403-056X
FU SystemsX.ch RTD project Cell Plasticity; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX We would like to thank Sophie Dessus-Babus and Manuel Kohler for
   technical assistance in the ChIP-seq experiments; Philippe Demougin for
   the Affymetrix gene expression facility; Lukas Burger, Michael Stadler,
   Patrick Matthias, Dirk Schuebeler and Fraser McBlane for the very
   helpful discussion. Antonius Rolink is the holder of the chair in
   Immunology endowed by F. Hoffman-La Roche Ltd., Basel. This work was
   supported by the SystemsX.ch RTD project Cell Plasticity and Swiss
   National Science Foundation.
CR Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]
   Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112
   Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822
   Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009
   Bhandoola A, 2006, NAT REV IMMUNOL, V6, P117, DOI 10.1038/nri1778
   Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009
   Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991
   Ceredig R, 2012, SEMIN IMMUNOL, V24, P159, DOI 10.1016/j.smim.2012.02.004
   Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525
   Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003
   Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011
   De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9
   Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018
   Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995
   Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016
   Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587
   Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x
   Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484
   Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590
   Miranda-Saavedra D, 2008, CURR OPIN GENET DEV, V18, P530, DOI 10.1016/j.gde.2008.09.001
   Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007
   Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005
   Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078
   Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295
   Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004
   Radtke F, 2000, J EXP MED, V191, P1085, DOI 10.1084/jem.191.7.1085
   Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004
   Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232
   Ruedl C, 2008, INT IMMUNOL, V20, P1211, DOI 10.1093/intimm/dxn079
   Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005
   Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86
   Tussiwand R, 2011, EUR J IMMUNOL, V41, P3371, DOI 10.1002/eji.201141824
   Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375
   Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009
   Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176
   Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404
   Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056
   Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905
NR 42
TC 17
Z9 18
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD APR
PY 2014
VL 44
IS 4
BP 1181
EP 1193
DI 10.1002/eji.201344022
PG 13
WC Immunology
SC Immunology
GA AE7JR
UT WOS:000334174400029
PM 24374622
OA Bronze
DA 2021-01-25
ER

PT J
AU Luisier, R
   Unterberger, EB
   Goodman, JI
   Schwarz, M
   Moggs, J
   Terranova, R
   van Nimwegen, E
AF Luisier, Raphaelle
   Unterberger, Elif B.
   Goodman, Jay I.
   Schwarz, Michael
   Moggs, Jonathan
   Terranova, Remi
   van Nimwegen, Erik
TI Computational modeling identifies key gene regulatory interactions
   underlying phenobarbital-mediated tumor promotion
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; MOUSE-CELL LINES; BETA-CATENIN;
   TRANSCRIPTION FACTORS; ANDROSTANE RECEPTOR; NUCLEAR RECEPTOR;
   LIVER-CANCER; WNT/BETA-CATENIN; DNA-REPLICATION; HUMAN HCC
AB Gene regulatory interactions underlying the early stages of non-genotoxic carcinogenesis are poorly understood. Here, we have identified key candidate regulators of phenobarbital (PB)-mediated mouse liver tumorigenesis, a well-characterized model of non-genotoxic carcinogenesis, by applying a new computational modeling approach to a comprehensive collection of in vivo gene expression studies. We have combined our previously developed motif activity response analysis (MARA), which models gene expression patterns in terms of computationally predicted transcription factor binding sites with singular value decomposition (SVD) of the inferred motif activities, to disentangle the roles that different transcriptional regulators play in specific biological pathways of tumor promotion. Furthermore, transgenic mouse models enabled us to identify which of these regulatory activities was downstream of constitutive androstane receptor and beta-catenin signaling, both crucial components of PB-mediated liver tumorigenesis. We propose novel roles for E2F and ZFP161 in PB-mediated hepatocyte proliferation and suggest that PB-mediated suppression of ESR1 activity contributes to the development of a tumor-prone environment. Our study shows that combining MARA with SVD allows for automated identification of independent transcription regulatory programs within a complex in vivo tissue environment and provides novel mechanistic insights into PB-mediated hepatocarcinogenesis.
C1 [Luisier, Raphaelle; Moggs, Jonathan; Terranova, Remi] Novartis Inst Biomed Res, CH-4057 Basel, Switzerland.
   [Unterberger, Elif B.; Schwarz, Michael] Univ Tubingen, Inst Expt & Clin Pharmacol & Toxicol, Dept Toxicol, D-72074 Tubingen, Germany.
   [Goodman, Jay I.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM remi.terranova@novartis.com; erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
FU Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001];
   NovartisNovartis; Swiss Systems Biology Initiative SystemsX.ch within
   the network "Cellplasticity"; University of Basel
FX Innovative Medicine Initiative Joint Undertaking (IMI JU) (115001)
   (MARCAR project; http://www.imi-marcar. eu/); Novartis. EvN was
   supported by the Swiss Systems Biology Initiative SystemsX.ch within the
   network "Cellplasticity". Funding for open access charge: University of
   Basel.
CR Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645
   Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508
   Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112
   Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982
   Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102
   Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179
   Calvisi DF, 2009, GUT, V58, P679, DOI 10.1136/gut.2008.152652
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537
   Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309
   Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038
   Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885
   Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6
   Cunningham ML, 1996, MUTAT RES-REV GENET, V365, P59, DOI 10.1016/S0165-1110(96)90012-3
   DIWAN BA, 1992, CARCINOGENESIS, V13, P1893, DOI 10.1093/carcin/13.10.1893
   Eagon PK, 1996, GASTROENTEROLOGY, V110, P1199, DOI 10.1053/gast.1996.v110.pm8613010
   Eisele PS, 2013, J BIOL CHEM, V288, P6589, DOI 10.1074/jbc.A112.375253
   El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200
   Garcia-Rostan G, 1999, CANCER RES, V59, P1811
   Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X
   Giera S, 2010, TOXICOL SCI, V115, P22, DOI 10.1093/toxsci/kfq033
   Gonzales AJ, 1998, CARCINOGENESIS, V19, P1173, DOI 10.1093/carcin/19.7.1173
   Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082
   Hasegawa R, 2013, EXP CELL RES, V319, P68, DOI 10.1016/j.yexcr.2012.11.003
   Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520
   JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200
   LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003
   Ledda-Columbano GM, 2011, MOL PATHOL LIB, V5, P791, DOI 10.1007/978-1-4419-7107-4_54
   Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350
   Lee GH, 2000, TOXICOL PATHOL, V28, P215, DOI 10.1177/019262330002800201
   Lempiainen H, 2013, TOXICOL SCI, V131, P375, DOI 10.1093/toxsci/kfs303
   Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026
   Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135
   Malz M, 2009, HEPATOLOGY, V50, P1130, DOI 10.1002/hep.23051
   MARSMAN DS, 1988, CANCER RES, V48, P6739
   Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07
   Meier-Abt F, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3419
   MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825
   Meserve JH, 2012, NAT CELL BIOL, V14, P1124, DOI 10.1038/ncb2609
   Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P
   Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034
   Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705
   Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   NUMOTO M, 1993, NUCLEIC ACIDS RES, V21, P3767, DOI 10.1093/nar/21.16.3767
   NUMOTO M, 1995, JPN J CANCER RES, V86, P277, DOI 10.1111/j.1349-7006.1995.tb03051.x
   Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368
   Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145
   Palacios J, 1998, CANCER RES, V58, P1344
   Palaiologou M, 2012, VIRCHOWS ARCH, V460, P439, DOI 10.1007/s00428-012-1220-4
   Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585
   PERAINO C, 1973, JNCI-J NATL CANCER I, V51, P1349, DOI 10.1093/jnci/51.4.1349
   PERAINO C, 1971, CANCER RES, V31, P1506
   Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12
   Phillips JM, 2007, TOXICOL SCI, V96, P72, DOI 10.1093/toxsci/kfl188
   Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108
   Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102
   R Core Team, 2013, R LANG ENV STAT COMP
   Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226
   Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118
   Shimizu I, 1998, GUT, V42, P112, DOI 10.1136/gut.42.1.112
   SobekKlocke I, 1997, GENOMICS, V43, P156, DOI 10.1006/geno.1997.4784
   Summers KM, 2010, EUR J HUM GENET, V18, P1209, DOI 10.1038/ejhg.2010.91
   Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474
   Thomson JP, 2013, NUCLEIC ACIDS RES, V41, P5639, DOI 10.1093/nar/gkt232
   TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254
   Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593
   Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020
   Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329
   TSUTSUI S, 1992, VIRCHOWS ARCH B, V62, P371, DOI 10.1007/BF02899706
   Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238
   Williams GM, 2008, TOXICOL LETT, V180, P75, DOI 10.1016/j.toxlet.2008.05.021
   Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593
   YAMAMOTO R, 1991, INT J CANCER, V49, P83, DOI 10.1002/ijc.2910490116
   Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459
NR 83
TC 11
Z9 12
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR
PY 2014
VL 42
IS 7
BP 4180
EP 4195
DI 10.1093/nar/gkt1415
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AF5NV
UT WOS:000334761100015
PM 24464994
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Diepenbruck, M
   Waldmeier, L
   Ivanek, R
   Berninger, P
   Arnold, P
   van Nimwegen, E
   Christofori, G
AF Diepenbruck, Maren
   Waldmeier, Lorenz
   Ivanek, Robert
   Berninger, Philipp
   Arnold, Phil
   van Nimwegen, Erik
   Christofori, Gerhard
TI Tead2 expression levels control the subcellular distribution of Yap and
   Taz, zyxin expression and epithelial-mesenchymal transition
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Breast cancer; EMT; metastasis; Taz; Tead; Yap; Zyxin
ID TRANSCRIPTION FACTORS; CELL-PROLIFERATION; ORGAN SIZE; CANCER; PATHWAY;
   ENHANCER; EMT; GROWTH; FAMILY; DIFFERENTIATION
AB The cellular changes during an epithelial-mesenchymal transition (EMT) largely rely on global changes in gene expression orchestrated by transcription factors. Tead transcription factors and their transcriptional co-activators Yap and Taz have been previously implicated in promoting an EMT; however, their direct transcriptional target genes and their functional role during EMT have remained elusive. We have uncovered a previously unanticipated role of the transcription factor Tead2 during EMT. During EMT in mammary gland epithelial cells and breast cancer cells, levels of Tead2 increase in the nucleus of cells, thereby directing a predominant nuclear localization of its co-factors Yap and Taz via the formation of Tead2-Yap-Taz complexes. Genome-wide chromatin immunoprecipitation and next generation sequencing in combination with gene expression profiling revealed the transcriptional targets of Tead2 during EMT. Among these, zyxin contributes to the migratory and invasive phenotype evoked by Tead2. The results demonstrate that Tead transcription factors are crucial regulators of the cellular distribution of Yap and Taz, and together they control the expression of genes critical for EMT and metastasis.
C1 [Diepenbruck, Maren; Waldmeier, Lorenz; Ivanek, Robert; Christofori, Gerhard] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
   [Berninger, Philipp; Arnold, Phil; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Berninger, Philipp; Arnold, Phil; van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Christofori, G (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
EM Gerhard.christofori@unibas.ch
OI Ivanek, Robert/0000-0002-8403-056X; van Nimwegen,
   Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss Initiative for Systems Biology (RTD Cellplasticity);
   EU-FP7 framework program [TuMIC 2008-201662]; Swiss Cancer League
FX This research has been supported by the Swiss National Science
   Foundation; the Swiss Initiative for Systems Biology (RTD
   Cellplasticity), the EU-FP7 framework program [grant number TuMIC
   2008-201662]; and the Swiss Cancer League. Deposited in PMC for
   immediate release.
CR Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019
   Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103
   Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036
   Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104
   Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696
   Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621
   Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310
   DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0
   De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192
   Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004
   Ikeda Y, 2009, WORLD J GASTRO SURG, V1, P49, DOI 10.4240/wjgs.v1.i1.49
   Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7
   Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129
   Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711
   Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Larkin SB, 1996, MOL CELL BIOL, V16, P3742
   Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178
   Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07
   Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810
   Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634
   Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003
   Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434
   Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975
   Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346
   Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046
   Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151
   Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2
   Sawada A, 2005, DEVELOPMENT, V132, P4719, DOI 10.1242/dev.02059
   Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07
   Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823
   Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107
   Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020
   Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013
   Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012
   Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007
   Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601
   Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651
   Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223
   Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0
   Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108
   Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408
   Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111
   Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210
   Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001
NR 63
TC 76
Z9 76
U1 0
U2 23
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR 1
PY 2014
VL 127
IS 7
BP 1523
EP 1536
DI 10.1242/jcs.139865
PG 14
WC Cell Biology
SC Cell Biology
GA AE3UY
UT WOS:000333905100015
PM 24554433
OA Green Accepted, Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Jorjani, H
   Zavolan, M
AF Jorjani, Hadi
   Zavolan, Mihaela
TI TSSer: an automated method to identify transcription start sites in
   prokaryotic genomes from differential RNA sequencing data
SO BIOINFORMATICS
LA English
DT Article
AB Motivation: Accurate identification of transcription start sites (TSSs) is an essential step in the analysis of transcription regulatory networks. In higher eukaryotes, the capped analysis of gene expression technology enabled comprehensive annotation of TSSs in genomes such as those of mice and humans. In bacteria, an equivalent approach, termed differential RNA sequencing (dRNA-seq), has recently been proposed, but the application of this approach to a large number of genomes is hindered by the paucity of computational analysis methods. With few exceptions, when the method has been used, annotation of TSSs has been largely done manually.
   Results: In this work, we present a computational method called 'TSSer' that enables the automatic inference of TSSs from dRNA-seq data. The method rests on a probabilistic framework for identifying both genomic positions that are preferentially enriched in the dRNA-seq data as well as preferentially captured relative to neighboring genomic regions. Evaluating our approach for TSS calling on several publicly available datasets, we find that TSSer achieves high consistency with the curated lists of annotated TSSs, but identifies many additional TSSs. Therefore, TSSer can accelerate genome-wide identification of TSSs in bacterial genomes and can aid in further characterization of bacterial transcription regulatory networks.
C1 [Jorjani, Hadi; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31003A_147013]
FX Work in the Zavolan laboratory is supported by the University of Basel
   and the Swiss National Science Foundation (grant number 31003A_147013).
CR Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98
   Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582
   Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495
   Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10
   Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109
   Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137
   Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756
   Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100
   Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043
NR 10
TC 18
Z9 19
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD APR 1
PY 2014
VL 30
IS 7
BP 971
EP 974
DI 10.1093/bioinformatics/btt752
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA AE6DC
UT WOS:000334078300011
PM 24371151
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Baudouin, SJ
AF Baudouin, Stephane J.
TI Heterogeneity and convergence: the synaptic pathophysiology of autism
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE metabotropic glutamate receptor type I; pathophysiology; genetic mouse
   models; Neuroligin; Prosap/Shank; autism spectrum disorders
ID METABOTROPIC GLUTAMATE-RECEPTOR; FRAGILE-X; MOUSE MODEL; POSTSYNAPTIC
   DENSITY; SOCIAL-INTERACTION; SHANK FAMILY; PROTEIN; NEUROLIGIN-3;
   MUTATIONS; PLASTICITY
AB Autism is a developmental disorder characterised by a high heterogeneity of clinical diagnoses and genetic associations. This heterogeneity is a challenge for the identification of the pathophysiology of the disease and for the development of new therapeutic strategies. New conceptual approaches are being used to try to challenge this complexity and gene cluster analysis studies suggest that the pathophysiology of autism is associated with a dysregulation of specific cellular mechanisms. This review will present the experimental evidence for a convergence of synaptic pathophysiology between syndromic and non-syndromic forms of autism, grouped under the generic term of autism spectrum disorders. In particular I will highlight the results from genetic mouse models identifying a convergence of dysregulation of the synaptic type I metabotropic glutamate receptor pathway in mouse models for autism spectrum disorders. These results help to build a new conceptual framework for the study of the synaptic phenotype of autism, which is important for the identification of new therapeutic strategies.
C1 [Baudouin, Stephane J.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Baudouin, Stephane J.] Cardiff Univ, Sch Biosci, Neurosci Div, Cardiff CF10 3AX, S Glam, Wales.
RP Baudouin, SJ (corresponding author), Cardiff Univ, Sch Biosci, Neurosci Div, Cardiff CF10 3AX, S Glam, Wales.
EM BaudouinS@cardiff.ac.uk
OI baudouin, stephane/0000-0001-6902-6071
FU National Center for Competence in Research - Synapsy; EU-AIMS (European
   Autism Interventions) initiative
FX I am grateful to Peter Scheiffele, Emily Sylwestrak and Harald Witte for
   comments on the manuscript. My work was supported by grants from the
   National Center for Competence in Research - Synapsy and the EU-AIMS
   (European Autism Interventions) initiative attributed to Peter
   Scheiffele.
CR Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005
   Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012
   Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658
   Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011
   Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006
   Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489
   Boeckers TM, 1999, J NEUROSCI, V19, P6506
   Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x
   Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003
   Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110
   Busquets-Garcia A, 2013, NAT MED, V19, P603, DOI 10.1038/nm.3127
   Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036
   Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108
   Ey E, 2012, GENES BRAIN BEHAV, V11, P928, DOI 10.1111/j.1601-183X.2012.00849.x
   Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036
   Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021
   Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628
   Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035
   Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108
   Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004
   Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005
   Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699
   Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107
   Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105
   Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016
   Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045
   Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270
   Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510
   McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038
   Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023
   Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009
   Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012
   Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011
   Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010
   Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965
   Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013
   Potter WB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001627
   Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x
   Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166
   Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015
   Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010
   Sheng M, 2000, J CELL SCI, V113, P1851
   Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221
   Takeuchi K, 2013, P NATL ACAD SCI USA, V110, P4738, DOI 10.1073/pnas.1222803110
   Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310
   Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212
   Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208
   Xu Jun-Yu, 2012, Shengli Xuebao, V64, P550
   Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012
   Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108
   Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X
NR 67
TC 14
Z9 14
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD APR
PY 2014
VL 39
IS 7
SI SI
BP 1107
EP 1113
DI 10.1111/ejn.12498
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA AE3PE
UT WOS:000333887600006
PM 24712990
DA 2021-01-25
ER

PT J
AU Dill, MT
   Makowska, Z
   Trincucci, G
   Gruber, AJ
   Vogt, JE
   Filipowicz, M
   Calabrese, D
   Krol, I
   Lau, DT
   Terracciano, L
   van Nimwegen, E
   Roth, V
   Heim, MH
AF Dill, Michael T.
   Makowska, Zuzanna
   Trincucci, Gaia
   Gruber, Andreas J.
   Vogt, Julia E.
   Filipowicz, Magdalena
   Calabrese, Diego
   Krol, Ilona
   Lau, Daryl T.
   Terracciano, Luigi
   van Nimwegen, Erik
   Roth, Volker
   Heim, Markus H.
TI Pegylated IFN-alpha regulates hepatic gene expression through transient
   Jak/STAT activation
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID INTERFERON-ALPHA; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; TRANSCRIPTION
   FACTORS; COMBINATION THERAPY; INITIAL TREATMENT; INDUCTION; RESPONSES;
   PATHWAYS; SUPPRESSOR
AB The use of pegylated interferon-alpha (pegIFN-alpha) has replaced unmodified recombinant IFN-alpha for the treatment of chronic viral hepatitis. While the superior antiviral efficacy of pegIFN-alpha is generally attributed to improved pharmacokinetic properties, the pharmacodynamic effects of pegIFN-alpha in the liver have not been studied. Here, we analyzed pegIFN-alpha-induced signaling and gene regulation in paired liver biopsies obtained prior to treatment and during the first week following pegIFN-alpha injection in 18 patients with chronic hepatitis C. Despite sustained high concentrations of pegIFN-alpha in serum, the Jak/STAT pathway was activated in hepatocytes only on the first day after pegIFN-alpha administration. Evaluation of liver biopsies revealed that pegIFN-alpha induces hundreds of genes that can be classified into four clusters based on different temporal expression profiles. In all clusters, gene transcription was mainly driven by IFN-stimulated gene factor 3 (ISGF3). Compared with conventional IFN-alpha therapy, pegIFN-alpha induced a broader spectrum of gene expression, including many genes involved in cellular immunity. IFN-induced secondary transcription factors did not result in additional waves of gene expression. Our data indicate that the superior antiviral efficacy of pegIFN-alpha is not the result of prolonged Jak/STAT pathway activation in hepatocytes, but rather is due to induction of additional genes that are involved in cellular immune responses.
C1 [Dill, Michael T.; Makowska, Zuzanna; Trincucci, Gaia; Filipowicz, Magdalena; Calabrese, Diego; Krol, Ilona; Heim, Markus H.] Univ Basel, Hepatol Lab, Dept Biomed, CH-4031 Basel, Switzerland.
   [Dill, Michael T.; Filipowicz, Magdalena; Heim, Markus H.] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland.
   [Gruber, Andreas J.; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4031 Basel, Switzerland.
   [Gruber, Andreas J.; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
   [Vogt, Julia E.; Roth, Volker] Univ Basel, Comp Sci Dept, CH-4031 Basel, Switzerland.
   [Lau, Daryl T.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Liver Ctr,Dept Med, Boston, MA 02215 USA.
   [Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
RP Heim, MH (corresponding author), Univ Basel, Dept Biomed, Zentrum Lehre & Forsch, Hebelstr 20, CH-4031 Basel, Switzerland.
EM markus.heim@unibas.ch
RI lau, daryl/AAH-5057-2020; Roth, Volker/Q-4025-2017; Dill, Michael
   T/G-6253-2010; Heim, Markus/A-7526-2008
OI Roth, Volker/0000-0003-0991-0273; Dill, Michael T/0000-0002-1926-4204;
   Heim, Markus/0000-0002-7523-4894; Calabrese, Diego/0000-0002-0259-8611;
   Filipowicz, Magdalena/0000-0002-0356-8836; Vogt, Julia
   E./0000-0002-6004-7770; van Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [320030-130243]; SNF [323500-123714]; Werner Siemens-Foundation
FX This work was supported by Swiss National Science Foundation (SNF) grant
   320030-130243 (to M.H. Heim) and SNF grant 323500-123714 (to M.T. Dill).
   A.J. Gruber was supported by a Fellowship of the Werner
   Siemens-Foundation.
CR Aberle JH, 2007, J INFECT DIS, V195, P1315, DOI 10.1086/513278
   Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611
   Barnes E, 2002, HEPATOLOGY, V36, P743, DOI 10.1053/jhep.2002.35344
   Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059
   Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106
   Claassen MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049389
   Cramp ME, 2000, GASTROENTEROLOGY, V118, P346, DOI 10.1016/S0016-5085(00)70217-4
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853
   Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287
   Foster GR, 2010, DRUGS, V70, P147, DOI 10.2165/11531990-000000000-00000
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699
   Heim MH, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P189, DOI 10.1007/978-3-642-00150-5_12
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503
   Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Kamal SM, 2002, GASTROENTEROLOGY, V123, P1070, DOI 10.1053/gast.2002.36045
   Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167
   LARNER AC, 1986, J BIOL CHEM, V261, P453
   Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107
   Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371
   Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963
   Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660
   Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000
   McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010
   Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908
   MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376
   MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x
   Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105
   Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Silva M, 2006, J HEPATOL, V45, P204, DOI 10.1016/j.jhep.2006.03.008
   Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400
   Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200
   Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013
   Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770
   Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066
   Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301
NR 53
TC 29
Z9 31
U1 1
U2 5
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD APR
PY 2014
VL 124
IS 4
BP 1568
EP 1581
DI 10.1172/JCI70408
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AE1IQ
UT WOS:000333723400019
PM 24569457
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Dill, MT
   Makowska, Z
   Trincucci, G
   Gruber, AJ
   Vogt, JE
   Filipowicz, M
   Calabrese, D
   Krol, I
   Lau, DT
   Terracciano, L
   van Nimwegen, E
   Roth, V
   Heim, MH
AF Dill, M. T.
   Makowska, Z.
   Trincucci, G.
   Gruber, A. J.
   Vogt, J. E.
   Filipowicz, M.
   Calabrese, D.
   Krol, I.
   Lau, D. T.
   Terracciano, L.
   van Nimwegen, E.
   Roth, V.
   Heim, M. H.
TI PEGYLATED INTERFERON-ALPHA INDUCES SUSTAINED TRANSCRIPTIONAL RESPONSE IN
   LIVER INFILTRATING IMMUNE CELLS BUT NOT IN HEPATOCYTES IN THE LIVER OF
   PATIENTS WITH CHRONIC HEPATITIS C
SO JOURNAL OF HEPATOLOGY
LA English
DT Meeting Abstract
CT 49th Annual International Liver Congress of the
   European-Association-for-the-Study-of-the-Liver
CY APR 09-13, 2014
CL London, ENGLAND
SP European Assoc Study Liver
C1 [Dill, M. T.; Makowska, Z.; Trincucci, G.; Filipowicz, M.; Calabrese, D.; Krol, I.; Heim, M. H.] Univ Basel, Dept Biomed, Hepatol Lab, Basel, Switzerland.
   [Dill, M. T.; Filipowicz, M.; Heim, M. H.] Univ Basel, Univ Basel Hosp, Div Gastroenterol & Hepatol, Basel, Switzerland.
   [Gruber, A. J.; van Nimwegen, E.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gruber, A. J.; van Nimwegen, E.] Univ Basel, Swiss Inst Bioinformat, Basel, Switzerland.
   [Vogt, J. E.; Roth, V.] Univ Basel, Dept Comp Sci, Basel, Switzerland.
   [Lau, D. T.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Liver, Boston, MA 02215 USA.
   [Terracciano, L.] Univ Basel, Inst Pathol, Basel, Switzerland.
EM michael.dill@unibas.ch
RI Roth, Volker/Q-4025-2017; lau, daryl/AAH-5057-2020
OI Roth, Volker/0000-0003-0991-0273; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD APR
PY 2014
VL 60
IS 1
SU S
MA 047
BP S20
EP S20
DI 10.1016/S0168-8278(14)60049-0
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CS3HB
UT WOS:000361961700048
DA 2021-01-25
ER

PT J
AU Stohr, S
   Sandmann, L
   Pfander, S
   Dazert, E
   Manns, MP
   Steinmann, E
   von Hahn, T
   Ciesek, S
AF Stoehr, S.
   Sandmann, L.
   Pfaender, S.
   Dazert, E.
   Manns, M. P.
   Steinmann, E.
   von Hahn, T.
   Ciesek, S.
TI HOST mTORC1 SIGNALING IS REQUIRED FOR HEPATITIS C VIRUS (HCV) RNA
   REPLICATION
SO JOURNAL OF HEPATOLOGY
LA English
DT Meeting Abstract
CT 49th Annual International Liver Congress of the
   European-Association-for-the-Study-of-the-Liver
CY APR 09-13, 2014
CL London, ENGLAND
SP European Assoc Study Liver
C1 [Stoehr, S.; Sandmann, L.; Manns, M. P.; von Hahn, T.; Ciesek, S.] Hannover Med Sch, Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
   [Pfaender, S.; Steinmann, E.] Ctr Expt & Clin Infect Res, Div Expt Virol, Twincore, Hannover, Germany.
   [Dazert, E.] Univ Basel, Cell Growth & Dev Biozentrum, Basel, Switzerland.
EM steffi.stoehr@gmx.net
RI Sandmann, Lisa/ABD-1803-2020; Ciesek, Sandra/AAO-4719-2020
OI Ciesek, Sandra/0000-0002-1802-7565
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD APR
PY 2014
VL 60
IS 1
SU S
MA P211
BP S136
EP S136
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA CS3HB
UT WOS:000361961700372
DA 2021-01-25
ER

PT J
AU Pantelic, RS
   Fu, WY
   Schoenenberger, C
   Stahlberg, H
AF Pantelic, Radosav S.
   Fu, Wangyang
   Schoenenberger, Christian
   Stahlberg, Henning
TI Rendering graphene supports hydrophilic with non-covalent aromatic
   functionalization for transmission electron microscopy
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID BIOLOGICAL MACROMOLECULES; SPECIMEN PREPARATION; CARBON NANOTUBES;
   RESOLUTION; FILMS; OXIDE; REDUCTION; CONTRAST; IMAGES; LAYER
AB Amorphous carbon films have been routinely used to enhance the preparation of frozen-hydrated samples for transmission electron microscopy (TEM), either in retaining protein concentration, providing mechanical stability or dissipating sample charge. However, strong background signal from the amorphous carbon support obstructs that of the sample, and the insulating properties of thin amorphous carbon films preclude any efficiency in dispersing charge. Graphene addresses the limitations of amorphous carbon. Graphene is a crystalline material with virtually no phase or amplitude contrast and unparalleled, high electrical carrier mobility. However, the hydrophobic properties of graphene have prevented its routine application in Cryo-TEM. This Letter reports a method for rendering graphene TEM supports hydrophilic-a convenient approach maintaining graphene's structural and electrical properties based on non-covalent, aromatic functionalization. (C) 2014 AIP Publishing LLC.
C1 [Pantelic, Radosav S.] NCI, Bethesda, MD 20892 USA.
   [Fu, Wangyang; Schoenenberger, Christian] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   [Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
RP Pantelic, RS (corresponding author), NCI, 50 South Dr,Bldg 50,Room 4306, Bethesda, MD 20892 USA.
EM pantelic@imbb.forth.gr
RI Stahlberg, Henning/H-1868-2011; Schoenenberger, Christian/N-3187-2017
OI Stahlberg, Henning/0000-0002-1185-4592; Schoenenberger,
   Christian/0000-0002-5652-460X
FU National Cancer Institute/National Institutes for Health at the National
   Institutes for Health (NIH); NFS Nanoscience and Nanotechnology;
   Nano-Tera.ch; Swiss Nanoscience Institute; ESF-Eurographene
FX Dr Radosav Pantelic wishes to thank Dr Sriram Subramaniam (National
   Cancer Institute/National Institutes for Health) as sponsor of his
   fellowship at the National Institutes for Health (NIH) and access to TEM
   resources. Professor Henning Stahlberg appreciates the support of the
   Swiss National Science Foundation (NCCR Nano and Structural Biology) and
   Swiss Initiative for Systems Biology (SystemsX.ch, RTD CINA). Professor
   Christian Schoenenberger and DrWangyang Fu gratefully acknowledge
   Funding from NFS Nanoscience and Nanotechnology, Nano-Tera.ch, Swiss
   Nanoscience Institute, and ESF-Eurographene.
CR Abeyrathne PD, 2010, METHOD ENZYMOL, V481, P25, DOI 10.1016/S0076-6879(10)81001-8
   An XH, 2010, NANO LETT, V10, P4295, DOI 10.1021/nl903557p
   Benesch JLP, 2010, J STRUCT BIOL, V172, P161, DOI 10.1016/j.jsb.2010.03.004
   Brink J, 1998, J MICROSC-OXFORD, V191, P67
   Buckhout-White S, 2013, SOFT MATTER, V9, P1414, DOI 10.1039/c2sm26950c
   Casiraghi C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818692
   Cerf A, 2011, NANO LETT, V11, P4232, DOI 10.1021/nl202219w
   Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Cheng HC, 2011, ACS NANO, V5, P2051, DOI 10.1021/nn103221v
   Dong XC, 2009, SMALL, V5, P1422, DOI 10.1002/smll.200801711
   Dong XC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.135501
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Fu WY, 2011, NANO LETT, V11, P3597, DOI 10.1021/nl201332c
   Ghosh S, 2012, J PHYS CHEM C, V116, P20688, DOI 10.1021/jp303339f
   Glaeser RM, 2004, MICROSC MICROANAL, V10, P790, DOI 10.1017/S1431927604040668
   Glaeser RM, 2011, BIOPHYS J, V100, P2331, DOI 10.1016/j.bpj.2011.04.018
   Gopalakrishnan K, 2011, CHEM PHYS LETT, V511, P304, DOI 10.1016/j.cplett.2011.06.033
   Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555
   HENDERSON R, 1992, ULTRAMICROSCOPY, V46, P1, DOI 10.1016/0304-3991(92)90003-3
   Hunter CA, 2001, J CHEM SOC PERK T 2, P651, DOI 10.1039/b008495f
   JAKUBOWSKI U, 1989, ULTRAMICROSCOPY, V31, P351, DOI 10.1016/0304-3991(89)90333-1
   Jeon J, 2013, BBA-GEN SUBJECTS, V1830, P3807, DOI 10.1016/j.bbagen.2013.03.002
   Larson DM, 2011, J STRUCT BIOL, V174, P420, DOI 10.1016/j.jsb.2011.02.005
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Liu ZF, 2010, ADV FUNCT MATER, V20, P2857, DOI 10.1002/adfm.201000761
   Massover WH, 2011, MICRON, V42, P141, DOI 10.1016/j.micron.2010.05.006
   Mitsuoka K, 2011, MICRON, V42, P100, DOI 10.1016/j.micron.2010.08.006
   Miyajima Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3224834
   Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721
   Mutus JY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063011
   Pantelic RS, 2012, SOLID STATE COMMUN, V152, P1375, DOI 10.1016/j.ssc.2012.04.038
   Pantelic RS, 2011, NANO LETT, V11, P4319, DOI 10.1021/nl202386p
   Pantelic RS, 2011, J STRUCT BIOL, V174, P234, DOI 10.1016/j.jsb.2010.10.002
   Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020
   Parviz D, 2012, ACS NANO, V6, P8857, DOI 10.1021/nn302784m
   Rhinow D, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3645010
   Rhinow D, 2011, ULTRAMICROSCOPY, V111, P342, DOI 10.1016/j.ultramic.2011.01.028
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Sader K, 2013, J STRUCT BIOL, V183, P531, DOI 10.1016/j.jsb.2013.04.014
   Simmons TJ, 2009, ACS NANO, V3, P865, DOI 10.1021/nn800860m
   Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235
   Ziegler K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266802
NR 45
TC 15
Z9 15
U1 1
U2 41
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAR 31
PY 2014
VL 104
IS 13
AR 134103
DI 10.1063/1.4870531
PG 5
WC Physics, Applied
SC Physics
GA AF0MK
UT WOS:000334408500079
OA Bronze
DA 2021-01-25
ER

PT J
AU Forrest, ARR
   Kawaji, H
   Rehli, M
   Baillie, JK
   de Hoon, MJL
   Haberle, V
   Lassmann, T
   Kulakovskiy, IV
   Lizio, M
   Itoh, M
   Andersson, R
   Mungall, CJ
   Meehan, TF
   Schmeier, S
   Bertin, N
   Jorgensen, M
   Dimont, E
   Arner, E
   Schmidl, C
   Schaefer, U
   Medvedeva, YA
   Plessy, C
   Vitezic, M
   Severin, J
   Semple, CA
   Ishizu, Y
   Young, RS
   Francescatto, M
   Alam, I
   Albanese, D
   Altschuler, GM
   Arakawa, T
   Archer, JAC
   Arner, P
   Babina, M
   Rennie, S
   Balwierz, PJ
   Beckhouse, AG
   Pradhan-Bhatt, S
   Blake, JA
   Blumenthal, A
   Bodega, B
   Bonetti, A
   Briggs, J
   Brombacher, F
   Burroughs, AM
   Califano, A
   Cannistraci, CV
   Carbajo, D
   Chen, Y
   Chierici, M
   Ciani, Y
   Clevers, HC
   Dalla, E
   Davis, CA
   Detmar, M
   Diehl, AD
   Dohi, T
   Drablos, F
   Edge, ASB
   Edinger, M
   Ekwall, K
   Endoh, M
   Enomoto, H
   Fagiolini, M
   Fairbairn, L
   Fang, H
   Farach-Carson, MC
   Faulkner, GJ
   Favorov, AV
   Fisher, ME
   Frith, MC
   Fujita, R
   Fukuda, S
   Furlanello, C
   Furuno, M
   Furusawa, J
   Geijtenbeek, TB
   Gibson, AP
   Gingeras, T
   Goldowitz, D
   Gough, J
   Guhl, S
   Guler, R
   Gustincich, S
   Ha, TJ
   Hamaguchi, M
   Hara, M
   Harbers, M
   Harshbarger, J
   Hasegawa, A
   Hasegawa, Y
   Hashimoto, T
   Herlyn, M
   Hitchens, KJ
   Sui, SJH
   Hofmann, OM
   Hoof, I
   Hori, F
   Huminiecki, L
   Iida, K
   Ikawa, T
   Jankovic, BR
   Jia, H
   Joshi, A
   Jurman, G
   Kaczkowski, B
   Kai, C
   Kaida, K
   Kaiho, A
   Kajiyama, K
   Kanamori-Katayama, M
   Kasianov, A
   Kasukawa, T
   Katayama, S
   Kato, S
   Kawaguchi, S
   Kawamoto, H
   Kawamura, YI
   Kawashima, T
   Kempfle, JS
   Kenna, TJ
   Kere, J
   Khachigian, LM
   Kitamura, T
   Klinken, SP
   Knox, AJ
   Kojima, M
   Kojima, S
   Kondo, N
   Koseki, H
   Koyasu, S
   Krampitz, S
   Kubosaki, A
   Kwon, AT
   Laros, JFJ
   Lee, W
   Lennartsson, A
   Li, K
   Lilje, B
   Lipovich, L
   Mackay-sim, A
   Manabe, R
   Mar, JC
   Marchand, B
   Mathelier, A
   Mejhert, N
   Meynert, A
   Mizuno, Y
   Morais, DAD
   Morikawa, H
   Morimoto, M
   Moro, K
   Motakis, E
   Motohashi, H
   Mummery, CL
   Murata, M
   Nagao-Sato, S
   Nakachi, Y
   Nakahara, F
   Nakamura, T
   Nakamura, Y
   Nakazato, K
   Van Nimwegen, E
   Ninomiya, N
   Nishiyori, H
   Noma, S
   Nozaki, T
   Ogishima, S
   Ohkura, N
   Ohmiya, H
   Ohno, H
   Ohshima, M
   Okada-Hatakeyama, M
   Okazaki, Y
   Orlando, V
   Ovchinnikov, DA
   Pain, A
   Passier, R
   Patrikakis, M
   Persson, H
   Piazza, S
   Prendergast, JGD
   Rackham, OJL
   Ramilowski, JA
   Rashid, M
   Ravasi, T
   Rizzu, P
   Roncador, M
   Roy, S
   Rye, MB
   Saijyo, E
   Sajantila, A
   Saka, A
   Sakaguchi, S
   Sakai, M
   Sato, H
   Satoh, H
   Savvi, S
   Saxena, A
   Schneider, C
   Schultes, EA
   Schulze-Tanzil, GG
   Schwegmann, A
   Sengstag, T
   Sheng, GJ
   Shimoji, H
   Shimoni, Y
   Shin, JW
   Simon, C
   Sugiyama, D
   Sugiyama, T
   Suzuki, M
   Suzuki, N
   Swoboda, RK
   't Hoen, PAC
   Tagami, M
   Takahashi, N
   Takai, J
   Tanaka, H
   Tatsukawa, H
   Tatum, Z
   Thompson, M
   Toyoda, H
   Toyoda, T
   Valen, E
   van de Wetering, M
   van den Berg, LM
   Verardo, R
   Vijayan, D
   Vorontsov, IE
   Wasserman, WW
   Watanabe, S
   Wells, CA
   Winteringham, LN
   Wolvetang, E
   Wood, EJ
   Yamaguchi, Y
   Yamamoto, M
   Yoneda, M
   Yonekura, Y
   Yoshida, S
   Zabierowski, SE
   Zhang, PG
   Zhao, XB
   Zucchelli, S
   Summers, KM
   Suzuki, H
   Daub, CO
   Kawai, J
   Heutink, P
   Hide, W
   Freeman, TC
   Lenhard, B
   Bajic, VB
   Taylor, MS
   Makeev, VJ
   Sandelin, A
   Hume, DA
   Carninci, P
   Hayashizaki, Y
AF Forrest, Alistair R. R.
   Kawaji, Hideya
   Rehli, Michael
   Baillie, J. Kenneth
   de Hoon, Michiel J. L.
   Haberle, Vanja
   Lassmann, Timo
   Kulakovskiy, Ivan V.
   Lizio, Marina
   Itoh, Masayoshi
   Andersson, Robin
   Mungall, Christopher J.
   Meehan, Terrence F.
   Schmeier, Sebastian
   Bertin, Nicolas
   Jorgensen, Mette
   Dimont, Emmanuel
   Arner, Erik
   Schmidl, Christian
   Schaefer, Ulf
   Medvedeva, Yulia A.
   Plessy, Charles
   Vitezic, Morana
   Severin, Jessica
   Semple, Colin A.
   Ishizu, Yuri
   Young, Robert S.
   Francescatto, Margherita
   Alam, Intikhab
   Albanese, Davide
   Altschuler, Gabriel M.
   Arakawa, Takahiro
   Archer, John A. C.
   Arner, Peter
   Babina, Magda
   Rennie, Sarah
   Balwierz, Piotr J.
   Beckhouse, Anthony G.
   Pradhan-Bhatt, Swati
   Blake, Judith A.
   Blumenthal, Antje
   Bodega, Beatrice
   Bonetti, Alessandro
   Briggs, James
   Brombacher, Frank
   Burroughs, A. Maxwell
   Califano, Andrea
   Cannistraci, Carlo V.
   Carbajo, Daniel
   Chen, Yun
   Chierici, Marco
   Ciani, Yari
   Clevers, Hans C.
   Dalla, Emiliano
   Davis, Carrie A.
   Detmar, Michael
   Diehl, Alexander D.
   Dohi, Taeko
   Drablos, Finn
   Edge, Albert S. B.
   Edinger, Matthias
   Ekwall, Karl
   Endoh, Mitsuhiro
   Enomoto, Hideki
   Fagiolini, Michela
   Fairbairn, Lynsey
   Fang, Hai
   Farach-Carson, Mary C.
   Faulkner, Geoffrey J.
   Favorov, Alexander V.
   Fisher, Malcolm E.
   Frith, Martin C.
   Fujita, Rie
   Fukuda, Shiro
   Furlanello, Cesare
   Furuno, Masaaki
   Furusawa, Jun-ichi
   Geijtenbeek, Teunis B.
   Gibson, Andrew P.
   Gingeras, Thomas
   Goldowitz, Daniel
   Gough, Julian
   Guhl, Sven
   Guler, Reto
   Gustincich, Stefano
   Ha, Thomas J.
   Hamaguchi, Masahide
   Hara, Mitsuko
   Harbers, Matthias
   Harshbarger, Jayson
   Hasegawa, Akira
   Hasegawa, Yuki
   Hashimoto, Takehiro
   Herlyn, Meenhard
   Hitchens, Kelly J.
   Sui, Shannan J. Ho
   Hofmann, Oliver M.
   Hoof, Ilka
   Hori, Fumi
   Huminiecki, Lukasz
   Iida, Kei
   Ikawa, Tomokatsu
   Jankovic, Boris R.
   Jia, Hui
   Joshi, Anagha
   Jurman, Giuseppe
   Kaczkowski, Bogumil
   Kai, Chieko
   Kaida, Kaoru
   Kaiho, Ai
   Kajiyama, Kazuhiro
   Kanamori-Katayama, Mutsumi
   Kasianov, ArtemS.
   Kasukawa, Takeya
   Katayama, Shintaro
   Kato, Sachi
   Kawaguchi, Shuji
   Kawamoto, Hiroshi
   Kawamura, Yuki I.
   Kawashima, Tsugumi
   Kempfle, Judith S.
   Kenna, Tony J.
   Kere, Juha
   Khachigian, Levon M.
   Kitamura, Toshio
   Klinken, S. Peter
   Knox, Alan J.
   Kojima, Miki
   Kojima, Soichi
   Kondo, Naoto
   Koseki, Haruhiko
   Koyasu, Shigeo
   Krampitz, Sarah
   Kubosaki, Atsutaka
   Kwon, Andrew T.
   Laros, Jeroen F. J.
   Lee, Weonju
   Lennartsson, Andreas
   Li, Kang
   Lilje, Berit
   Lipovich, Leonard
   Mackay-sim, Alan
   Manabe, Ri-ichiroh
   Mar, Jessica C.
   Marchand, Benoit
   Mathelier, Anthony
   Mejhert, Niklas
   Meynert, Alison
   Mizuno, Yosuke
   Morais, David A. de Lima
   Morikawa, Hiromasa
   Morimoto, Mitsuru
   Moro, Kazuyo
   Motakis, Efthymios
   Motohashi, Hozumi
   Mummery, Christine L.
   Murata, Mitsuyoshi
   Nagao-Sato, Sayaka
   Nakachi, Yutaka
   Nakahara, Fumio
   Nakamura, Toshiyuki
   Nakamura, Yukio
   Nakazato, Kenichi
   Van Nimwegen, Erik
   Ninomiya, Noriko
   Nishiyori, Hiromi
   Noma, Shohei
   Nozaki, Tadasuke
   Ogishima, Soichi
   Ohkura, Naganari
   Ohmiya, Hiroko
   Ohno, Hiroshi
   Ohshima, Mitsuhiro
   Okada-Hatakeyama, Mariko
   Okazaki, Yasushi
   Orlando, Valerio
   Ovchinnikov, Dmitry A.
   Pain, Arnab
   Passier, Robert
   Patrikakis, Margaret
   Persson, Helena
   Piazza, Silvano
   Prendergast, James G. D.
   Rackham, Owen J. L.
   Ramilowski, Jordan A.
   Rashid, Mamoon
   Ravasi, Timothy
   Rizzu, Patrizia
   Roncador, Marco
   Roy, Sugata
   Rye, Morten B.
   Saijyo, Eri
   Sajantila, Antti
   Saka, Akiko
   Sakaguchi, Shimon
   Sakai, Mizuho
   Sato, Hiroki
   Satoh, Hironori
   Savvi, Suzana
   Saxena, Alka
   Schneider, Claudio
   Schultes, Erik A.
   Schulze-Tanzil, Gundula G.
   Schwegmann, Anita
   Sengstag, Thierry
   Sheng, Guojun
   Shimoji, Hisashi
   Shimoni, Yishai
   Shin, Jay W.
   Simon, Christophe
   Sugiyama, Daisuke
   Sugiyama, Takaaki
   Suzuki, Masanori
   Suzuki, Naoko
   Swoboda, Rolf K.
   't Hoen, Peter A. C.
   Tagami, Michihira
   Takahashi, Naoko
   Takai, Jun
   Tanaka, Hiroshi
   Tatsukawa, Hideki
   Tatum, Zuotian
   Thompson, Mark
   Toyoda, Hiroo
   Toyoda, Tetsuro
   Valen, Eivind
   van de Wetering, Marc
   van den Berg, Linda M.
   Verardo, Roberto
   Vijayan, Dipti
   Vorontsov, Ilya E.
   Wasserman, Wyeth W.
   Watanabe, Shoko
   Wells, Christine A.
   Winteringham, Louise N.
   Wolvetang, Ernst
   Wood, Emily J.
   Yamaguchi, Yoko
   Yamamoto, Masayuki
   Yoneda, Misako
   Yonekura, Yohei
   Yoshida, Shigehiro
   Zabierowski, Susan E.
   Zhang, Peter G.
   Zhao, Xiaobei
   Zucchelli, Silvia
   Summers, Kim M.
   Suzuki, Harukazu
   Daub, Carsten O.
   Kawai, Jun
   Heutink, Peter
   Hide, Winston
   Freeman, Tom C.
   Lenhard, Boris
   Bajic, Vladimir B.
   Taylor, Martin S.
   Makeev, Vsevolod J.
   Sandelin, Albin
   Hume, David A.
   Carninci, Piero
   Hayashizaki, Yoshihide
CA FANTOM Consortium
   RIKEN PMI CLST DGT
TI A promoter-level mammalian expression atlas
SO NATURE
LA English
DT Article
ID TRANSCRIPTION FACTOR; GENE-EXPRESSION; HOMEOBOX GENE; MICE LACKING;
   DIFFERENTIATION; MOUSE; CLASSIFICATION; SIGNATURES; MUTATIONS; DEAFNESS
AB Regulated transcription controls the diversity, developmental pathways and spatial organization of the hundreds of cell types that make up a mammal. Using single-molecule cDNA sequencing, we mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body. We find that few genes are truly 'housekeeping', whereas many mammalian promoters are composite entities composed of several closely separated TSSs, with independent cell-type-specific expression profiles. TSSs specific to different cell types evolve at different rates, whereas promoters of broadly expressed genes are the most conserved. Promoter-based expression analysis revealskey transcription factors defining cell states and links them to binding-site motifs. The functions of identified novel transcripts can be predicted by coexpression and sample ontology enrichment analyses. The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.
C1 [Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Vitezic, Morana; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Burroughs, A. Maxwell; Fukuda, Shiro; Furuno, Masaaki; Harbers, Matthias; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hashimoto, Takehiro; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kaiho, Ai; Kajiyama, Kazuhiro; Kanamori-Katayama, Mutsumi; Katayama, Shintaro; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kubosaki, Atsutaka; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nagao-Sato, Sayaka; Nakazato, Kenichi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Saijyo, Eri; Saka, Akiko; Sakai, Mizuho; Saxena, Alka; Sengstag, Thierry; Shimoji, Hisashi; Shin, Jay W.; Simon, Christophe; Suzuki, Masanori; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Watanabe, Shoko; Yoshida, Shigehiro; Suzuki, Harukazu; Daub, Carsten O.; Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, OSC, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kajiyama, Kazuhiro; Kasukawa, Takeya; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Sakai, Mizuho; Shin, Jay W.; Simon, Christophe; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Yoshida, Shigehiro; Suzuki, Harukazu; Carninci, Piero] RIKEN, CLST, DGT, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Kawaji, Hideya; Itoh, Masayoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program PMI, Wako, Saitama 3510198, Japan.
   [Rehli, Michael; Schmidl, Christian; Edinger, Matthias] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany.
   [Rehli, Michael; Edinger, Matthias] Regensburg Ctr Intervent Immunol RCI, D-93042 Regensburg, Germany.
   [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland.
   [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland.
   [Haberle, Vanja] Univ Bergen, Dept Biol, NO-5006 Bergen, Norway.
   [Haberle, Vanja; Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, MRC Clin Sci Ctr, London W12 0NN, England.
   [Kulakovskiy, Ivan V.; Makeev, Vsevolod J.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
   [Kulakovskiy, Ivan V.; Medvedeva, Yulia A.; Favorov, Alexander V.; Kasianov, ArtemS.; Vorontsov, Ilya E.; Makeev, Vsevolod J.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia.
   [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2200 Copenhagen, Denmark.
   [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark.
   [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA.
   [Meehan, Terrence F.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.
   [Schmeier, Sebastian; Schaefer, Ulf; Medvedeva, Yulia A.; Alam, Intikhab; Archer, John A. C.; Jankovic, Boris R.; Marchand, Benoit; Pain, Arnab; Rashid, Mamoon; Bajic, Vladimir B.] KAUST, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia.
   [Schmeier, Sebastian] Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, Auckland 0745, New Zealand.
   [Dimont, Emmanuel; Altschuler, Gabriel M.; Sui, Shannan J. Ho; Hofmann, Oliver M.; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Vitezic, Morana; Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.
   [Semple, Colin A.; Young, Robert S.; Rennie, Sarah; Meynert, Alison; Prendergast, James G. D.; Taylor, Martin S.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland.
   [Francescatto, Margherita; Rizzu, Patrizia; Heutink, Peter] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr Amsterdam, NL-1081 BT Amsterdam, Netherlands.
   [Francescatto, Margherita] Univ Porto, Grad Program Areas Basic & Appl Biol, Abel Salazar Biomed Sci Inst, P-4050313 Oporto, Portugal.
   [Albanese, Davide; Chierici, Marco; Furlanello, Cesare; Jurman, Giuseppe; Roncador, Marco] Fdn Bruno Kessler, I-38123 Trento, Italy.
   [Arner, Peter; Mejhert, Niklas] Karolinska Inst, Dept Med, Karolinska Univ Hosp, SE-14186 Huddinge, Sweden.
   [Babina, Magda; Guhl, Sven] Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany.
   [Balwierz, Piotr J.; Van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Beckhouse, Anthony G.; Briggs, James; Hitchens, Kelly J.; Ovchinnikov, Dmitry A.; Vijayan, Dipti; Wells, Christine A.; Wolvetang, Ernst] Univ Queensland, AIBN, St Lucia, Qld 4072, Australia.
   [Beckhouse, Anthony G.; Blumenthal, Antje; Hitchens, Kelly J.; Vijayan, Dipti; Wells, Christine A.] Univ Queensland, Australian Infect Dis Res Ctr AID, St Lucia, Qld 4072, Australia.
   [Pradhan-Bhatt, Swati] Univ Delaware, Dept Biol Sci, Newark, DE 19713 USA.
   [Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA.
   [Blumenthal, Antje; Kenna, Tony J.] Univ Queensland, Diamantina Inst, St Lucia, Qld 4072, Australia.
   [Bodega, Beatrice; Orlando, Valerio] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy.
   [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Int Ctr Genet Engn & Biotechnol ICGEB Cape Town C, ZA-7925 Cape Town, South Africa.
   [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa.
   [Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA.
   [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
   [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA.
   [Califano, Andrea; Shimoni, Yishai] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, New York, NY 10032 USA.
   [Cannistraci, Carlo V.; Orlando, Valerio; Pain, Arnab; Rashid, Mamoon; Ravasi, Timothy] KAUST, Biol & Environm Sci & Engn Div, Thuwal 239556900, Saudi Arabia.
   [Cannistraci, Carlo V.; Ravasi, Timothy] KAUST, Appl Math & Computat Sci Program, Thuwal 239556900, Saudi Arabia.
   [Carbajo, Daniel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA.
   [Ciani, Yari; Dalla, Emiliano; Piazza, Silvano; Schneider, Claudio; Verardo, Roberto] LNCIB, I-34149 Trieste, Italy.
   [Clevers, Hans C.; van de Wetering, Marc] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.
   [Clevers, Hans C.] Royal Netherlands Acad Arts & Sci, NL-1000 GC Amsterdam, Netherlands.
   [Clevers, Hans C.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands.
   [Davis, Carrie A.; Gingeras, Thomas] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11797 USA.
   [Detmar, Michael; Krampitz, Sarah] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
   [Diehl, Alexander D.] SUNY Buffalo, Dept Neurol, Sch Med & Biomed Sci, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA.
   [Dohi, Taeko; Kawamura, Yuki I.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol Res Inst, Ichikawa, Chiba 2728516, Japan.
   [Drablos, Finn; Rye, Morten B.] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway.
   [Edge, Albert S. B.; Kempfle, Judith S.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA.
   [Ekwall, Karl; Kere, Juha; Lennartsson, Andreas; Persson, Helena] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, SE-14183 Huddinge, Sweden.
   [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Enomoto, Hideki; Morimoto, Mitsuru; Sheng, Guojun; Yonekura, Yohei] RIKEN, CDB, Chuo Ku, Kobe, Hyogo 6500047, Japan.
   [Fagiolini, Michela] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA.
   [Fang, Hai; Gough, Julian; Rackham, Owen J. L.] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England.
   [Farach-Carson, Mary C.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA.
   [Faulkner, Geoffrey J.] Mater Med Res Inst, Cancer Biol Program, South Brisbane, Qld 4101, Australia.
   [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Oncol Biostat & Bioinformat, Baltimore, MD 21205 USA.
   [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia.
   [Frith, Martin C.] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan.
   [Fujita, Rie; Satoh, Hironori; Takai, Jun; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Furusawa, Jun-ichi; Koyasu, Shigeo; Moro, Kazuyo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan.
   [Geijtenbeek, Teunis B.; van den Berg, Linda M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
   [Gibson, Andrew P.; Laros, Jeroen F. J.; Schultes, Erik A.; 't Hoen, Peter A. C.; Tatum, Zuotian; Thompson, Mark] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands.
   [Goldowitz, Daniel; Ha, Thomas J.; Mathelier, Anthony; Wasserman, Wyeth W.; Zhang, Peter G.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada.
   [Gustincich, Stefano; Zucchelli, Silvia] SISSA, I-34136 Trieste, Italy.
   [Hamaguchi, Masahide; Morikawa, Hiromasa; Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.
   [Hara, Mitsuko; Kojima, Soichi] RIKEN, ASI, Wako, Saitama 3510198, Japan.
   [Herlyn, Meenhard; Swoboda, Rolf K.; Zabierowski, Susan E.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA.
   [Iida, Kei; Kawaguchi, Shuji; Toyoda, Tetsuro] RIKEN, Bioinformat & Syst Engn Div BASE, Yokohama, Kanagawa 2300045, Japan.
   [Jia, Hui; Lipovich, Leonard; Wood, Emily J.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA.
   [Kai, Chieko; Nakamura, Toshiyuki; Sato, Hiroki; Sugiyama, Takaaki; Yoneda, Misako] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan.
   [Kere, Juha] Sci Life Lab, SE-17121 Solna, Sweden.
   [Khachigian, Levon M.; Patrikakis, Margaret] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.
   [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan.
   [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Stem Cell Signaling, Inst Med Sci, Tokyo 1088639, Japan.
   [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Perth, WA 6009, Australia.
   [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Med Res Ctr, QEII Med Ctr, Perth, WA 6009, Australia.
   [Knox, Alan J.] Univ Nottingham, City Hosp, Nottingham NG5 1PB, England.
   [Lee, Weonju] Kyungpook Natl Univ, Sch Med, Dept Dermatol, Taegu 700721, South Korea.
   [Mackay-sim, Alan] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.
   [Mizuno, Yosuke; Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan.
   [Morais, David A. de Lima] Univ Bristol, Fac Engn, Clifton BS81UB, England.
   [Moro, Kazuyo] Japanese Sci & Technol Agcy JST, PRESTO, Tokyo 1020076, Japan.
   [Motohashi, Hozumi] Tohoku Univ, Ctr Radioisotope Sci, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Mummery, Christine L.; Passier, Robert] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands.
   [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan.
   [Nakamura, Yukio] RIKEN, BioResource Ctr BRC, Tsukuba, Ibaraki 3050074, Japan.
   [Nozaki, Tadasuke; Toyoda, Hiroo] Tokyo Univ Pharm & Life Sci, Dept Clin Mol Genet, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
   [Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan.
   [Ohshima, Mitsuhiro] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan.
   [Sajantila, Antti] Univ Helsinki, Dept Forens Med, Hjelt Inst, Helsinki 003000, Finland.
   [Schneider, Claudio] Univ Udine, DSMB, I-33100 Udine, Italy.
   [Schulze-Tanzil, Gundula G.] Charite, Dept Orthoped Trauma & Reconstruct Surg, D-14195 Berlin, Germany.
   [Sugiyama, Daisuke] Kyushu Univ Hosp, Ctr Clin & Translat Reseach, Higashi Ku, Fukuoka 8128582, Japan.
   [Tatsukawa, Hideki] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.
   [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.
   [Yamaguchi, Yoko] Nihon Univ, Dept Biochem, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan.
   [Lenhard, Boris] Univ Bergen, Dept Informat, NO-5008 Bergen, Norway.
   [Makeev, Vsevolod J.] MIPT, Dept Biol & Med Phys, Dolgoprudnyi 141700, Moscow Region, Russia.
RP Forrest, ARR (corresponding author), RIKEN, OSC, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.
EM alistair.forrest@gmail.com; carninci@riken.jp; yosihide@gsc.riken.jp
RI Schmeier, Sebastian/D-4731-2011; Wolvetang, Ernst jurgen/D-6644-2017;
   Hide, Winston/R-3815-2019; Motakis, Efthymios/AAL-6863-2020; Edge,
   Albert/Q-5448-2019; Vitezic, Morana/A-6165-2013; Pain,
   Arnab/L-5766-2015; Kere, Juha/A-9179-2008; Nakachi, Yutaka/M-2446-2013;
   Severin, Jessica/AAQ-2723-2020; Drablos, Finn/L-4970-2019; Nakamura,
   Yukio/A-5263-2016; Taylor, Martin S/C-3825-2009; Kenna,
   Tony/A-6035-2011; Mungall, Chris/I-6006-2019; Bertin,
   Nicolas/O-9602-2019; Kasukawa, Takeya/N-5070-2015; Vorontsov, Ilya
   E/C-6333-2014; Kawai, Jun/A-6451-2016; Bajic, Vladimir/D-2810-2009;
   Summers, Kim M/M-4086-2015; Diehl, Alexander/G-9883-2016; Ovchinnikov,
   Dmitry/J-7963-2014; Khachigian, Levon/AAZ-7458-2020; Lassmann,
   Timo/A-8271-2008; Hoen, Peter A 't/D-3950-2018; Morikawa,
   Hiromasa/AAU-9261-2020; Arner, Erik/A-1895-2010; Sandelin,
   Albin/G-2881-2011; Hayashizaki, Yoshihide/N-6590-2015; Carninci,
   Piero/K-1568-2014; Ramilowski, Jordan A./Z-3103-2019; Ravasi,
   Timothy/B-8777-2008; KONDO, NAOTO/A-5829-2016; Blumenthal,
   Antje/A-3608-2011; Daub, Carsten O/A-7436-2010; Hitchens,
   Kelly/D-4320-2009; Valen, Eivind/A-8617-2011; Itoh,
   Masayoshi/N-5363-2015; Archer, John/D-5200-2012; de Hoon,
   Michiel/A-6443-2013; Lipovich, Leonard/B-2355-2019; Motohashi,
   Hozumi/AAZ-2628-2020; Sheng, Guojun/G-4116-2014; Kitamura,
   Toshio/AAA-2071-2021; Bodega, Beatrice/I-4644-2018; Kulakovskiy,
   Ivan/A-1462-2014; Sakaguchi, Shimon/C-9535-2009; Kwon,
   Andrew/D-4625-2017; Baillie, John Kenneth/F-3124-2011; Koyasu,
   Shigeo/J-5583-2015; Tatsukawa, Hideki/AAE-8377-2020; Moro,
   Kazuyo/A-5987-2016; Plessy, Charles/N-5054-2015; Hide, Winston
   Hide/C-7217-2009; Albanese, Davide/AAA-7295-2021; Kawaji,
   Hideya/N-5116-2015; Yamamoto, Masayuki/A-4873-2010; Zhao,
   Xiaobei/G-3567-2014; Kojima, Soichi/N-7104-2015; Koseki,
   Haruhiko/I-3825-2014; Kasianov, Artem S/R-3495-2016; Morikawa,
   Hiromasa/H-5958-2013; Cannistraci, Carlo Vittorio/G-1710-2014;
   Kaczkowski, Bogumil/D-5336-2017; Wasserman, Wyeth/I-4866-2015; Rehli,
   Michael/E-9093-2011; Medvedva, Yulia A/H-5947-2016; Suzuki,
   Harukazu/N-9553-2015; Dalla, Emiliano/AAH-3039-2020; Andersson,
   Robin/B-5311-2009; Ohno, Hiroshi/L-7899-2014; Sheng, Guojun/I-4900-2015;
   Bertin, Nicolas/C-3025-2008; Semple, Colin A M/A-5613-2009; Persson,
   Helena/ABE-5003-2020; Faulkner, Geoffrey J/M-3168-2014; Mackay-Sim,
   Alan/C-3431-2008; Mathelier, Anthony/Y-4693-2019; Katayama,
   Shintaro/F-2958-2010; Hide, Winston A/V-2727-2017; Beckhouse, Anthony
   G/A-2601-2010; Tomic, Nevena/AAA-2135-2021; Chierici, Marco/P-9949-2019;
   Schultes, Erik/B-6035-2012; Makeev, Vsevolod/E-8015-2013; Hofmann,
   Oliver/F-1800-2013; Wells, Christine/A-5071-2010
OI Schmeier, Sebastian/0000-0002-3947-8226; Wolvetang, Ernst
   jurgen/0000-0002-2146-6614; Hide, Winston/0000-0002-8621-3271; Vitezic,
   Morana/0000-0002-7994-9600; Pain, Arnab/0000-0002-1755-2819; Kere,
   Juha/0000-0003-1974-0271; Nakachi, Yutaka/0000-0003-1964-2495; Severin,
   Jessica/0000-0003-1274-208X; Drablos, Finn/0000-0001-5794-828X;
   Nakamura, Yukio/0000-0001-8056-4946; Taylor, Martin
   S/0000-0001-7656-330X; Mungall, Chris/0000-0002-6601-2165; Bertin,
   Nicolas/0000-0002-9835-9606; Kasukawa, Takeya/0000-0001-5085-0802;
   Vorontsov, Ilya E/0000-0001-8888-0804; Bajic,
   Vladimir/0000-0001-5435-4750; Summers, Kim M/0000-0002-7084-4386; Diehl,
   Alexander/0000-0001-9990-8331; Ovchinnikov, Dmitry/0000-0001-9603-8385;
   Lassmann, Timo/0000-0002-0138-2691; Hoen, Peter A
   't/0000-0003-4450-3112; Morikawa, Hiromasa/0000-0002-6793-5885; Arner,
   Erik/0000-0003-1225-4908; Sandelin, Albin/0000-0002-7109-7378; Carninci,
   Piero/0000-0001-7202-7243; Ramilowski, Jordan A./0000-0002-3156-6416;
   KONDO, NAOTO/0000-0001-9576-7615; Blumenthal, Antje/0000-0003-3673-7015;
   Daub, Carsten O/0000-0002-3295-8729; Hitchens,
   Kelly/0000-0002-8777-6332; Itoh, Masayoshi/0000-0002-1772-318X;
   Lipovich, Leonard/0000-0002-0531-3570; Bodega,
   Beatrice/0000-0003-0527-9234; Kulakovskiy, Ivan/0000-0002-6554-8128;
   Kwon, Andrew/0000-0001-5019-8156; Baillie, John
   Kenneth/0000-0001-5258-793X; Koyasu, Shigeo/0000-0001-9585-3038; Plessy,
   Charles/0000-0001-7410-6295; Hide, Winston Hide/0000-0002-8621-3271;
   Albanese, Davide/0000-0002-9493-3850; Kawaji,
   Hideya/0000-0002-0575-0308; Zhao, Xiaobei/0000-0002-5277-0846; Kojima,
   Soichi/0000-0002-5252-1612; Koseki, Haruhiko/0000-0001-8424-5854;
   Kasianov, Artem S/0000-0001-8086-392X; Morikawa,
   Hiromasa/0000-0002-6793-5885; Cannistraci, Carlo
   Vittorio/0000-0003-0100-8410; Kaczkowski, Bogumil/0000-0001-6554-5608;
   Rehli, Michael/0000-0003-3992-932X; Medvedva, Yulia
   A/0000-0002-7587-1666; Suzuki, Harukazu/0000-0002-8087-0836; Dalla,
   Emiliano/0000-0002-4687-6011; Andersson, Robin/0000-0003-1516-879X;
   Ohno, Hiroshi/0000-0001-8776-9661; Bertin, Nicolas/0000-0002-9835-9606;
   Semple, Colin A M/0000-0003-1765-4118; Faulkner, Geoffrey
   J/0000-0001-5769-4494; Mackay-Sim, Alan/0000-0003-4446-5371; Mathelier,
   Anthony/0000-0001-5127-5459; Katayama, Shintaro/0000-0001-7581-5157;
   Hide, Winston A/0000-0002-8621-3271; Beckhouse, Anthony
   G/0000-0002-5141-8250; Chierici, Marco/0000-0001-9791-9301; Piazza,
   Silvano/0000-0002-7156-5434; Meehan, Terrence/0000-0003-1980-3228;
   Gingeras, Thomas/0000-0001-9106-3573; Furlanello,
   Cesare/0000-0002-5384-3605; Edinger, Matthias/0000-0003-2889-2533; Alam,
   Intikhab/0000-0001-5306-847X; van Nimwegen, Erik/0000-0001-6338-1312;
   Ravasi, Timothy/0000-0002-9950-465X; Heutink, Peter/0000-0001-5218-1737;
   Rashid, Mamoon/0000-0003-4851-4994; Schultes, Erik/0000-0001-8888-635X;
   Okazaki, Yasushi/0000-0003-3241-5502; Babina, Magda/0000-0002-4500-7615;
   Farach-Carson, Mary/0000-0002-4526-3088; Kenna,
   Tony/0000-0001-6844-3463; Mejhert, Niklas/0000-0003-1785-833X;
   Khachigian, Levon/0000-0003-3446-0323; fagiolini,
   michela/0000-0003-2807-803X; Makeev, Vsevolod/0000-0001-9405-9748; IIDA,
   Kei/0000-0001-7130-8705; Roy, Sugata/0000-0001-7183-7957; Harbers,
   Matthias/0000-0002-5613-7220; Frith, Martin/0000-0003-0998-2859;
   Prendergast, James/0000-0001-8916-018X; Hume, David/0000-0002-2615-1478;
   Hofmann, Oliver/0000-0002-7738-1513; /0000-0002-6191-4709; Laros, Jeroen
   F.J./0000-0002-8715-7371; Persson, Helena/0000-0002-5187-6446; Haberle,
   Vanja/0000-0003-4191-3714; Rashid, Mamoon/0000-0003-1457-477X;
   Sajantila, Antti/0000-0003-4117-5248; Wells,
   Christine/0000-0003-3133-3628; Mummery, Christine/0000-0002-4549-6535;
   Ekwall, Karl/0000-0002-3029-4041; Mar, Jessica/0000-0002-5147-9299;
   Forrest, Alistair/0000-0003-4543-1675; Freeman,
   Thomas/0000-0001-5235-8483; Califano, Andrea/0000-0003-4742-3679;
   Jorgensen, Mette/0000-0002-2804-0560; Schmidl,
   Christian/0000-0002-0522-202X; Fisher, Malcolm/0000-0003-1074-8103;
   Ciani, Yari/0000-0002-9635-2830; Nakahara, Fumio/0000-0003-1515-8284;
   Zucchelli, Silvia/0000-0003-4556-2990; Francescatto,
   Margherita/0000-0003-1232-7302; Winteringham,
   Louise/0000-0002-8117-5069; Knox, Alan/0000-0002-5906-4143; Huminiecki,
   Lukasz/0000-0003-1943-4450; Hamaguchi, Masahide/0000-0002-8651-4445;
   Lenhard, Boris/0000-0002-1114-1509; Goldowitz,
   Daniel/0000-0003-4756-4017; Rackham, Owen/0000-0002-4390-0872; Jurman,
   Giuseppe/0000-0002-2705-5728; Sengstag, Thierry/0000-0002-7516-6246;
   Moro, Kazuyo/0000-0002-7377-1303; Endoh, Mitsuhiro/0000-0003-0715-1701;
   Wasserman, Wyeth/0000-0001-6098-6412; Lennartsson,
   Andreas/0000-0002-3272-2505; Burroughs, A. Max/0000-0002-2229-8771;
   Valen, Eivind/0000-0003-1840-6108
FU MEXTMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); MEXT, JapanMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT); Research Grants for RIKEN Preventive
   Medicine and Diagnosis Innovation Program(RIKEN PMI); RIKEN Centre for
   Life Science Technologies, Division of Genomic Technologies (RIKEN CLST
   (DGT)) from the MEXT, Japan; Grants-in-Aid for Scientific
   ResearchMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for
   Scientific Research (KAKENHI) [22118001, 23790791, 22228005, 22122005,
   23689044, 22118002, 26713029] Funding Source: KAKEN; NATIONAL INSTITUTE
   OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Dental & Craniofacial Research (NIDCR) [R01DE022969,
   R01DE022969, R01DE022969, R01DE022969, R01DE022969] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM084875, R01GM084875, R01GM084875] Funding Source: NIH RePORTER;
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BBS/E/D/20211551,
   BB/F003722/1, BBS/E/D/20231759, BB/I024801/1, BB/I025018/1,
   BBS/E/D/20251969, BBS/E/D/20211552, BBS/E/D/20211550, BB/G022771/1,
   BB/I001107/1] Funding Source: researchfish; Lundbeck
   FoundationLundbeckfonden [R82-2010-6779] Funding Source: researchfish;
   Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_U127597124, MC_UP_1102/1] Funding Source: researchfish; Novo
   Nordisk FondenNovo Nordisk Foundation [NNF12OC1016371] Funding Source:
   researchfish; Wellcome TrustWellcome Trust [103258/Z/13/Z] Funding
   Source: researchfish
FX FANTOM5 was made possible by a Research Grant for RIKEN Omics Science
   Center from MEXT to Y. Hayashizaki and a grant of the Innovative Cell
   Biology by Innovative Technology (Cell Innovation Program) from the
   MEXT, Japan to Y. Hayashizaki. It was also supported by Research Grants
   for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN
   PMI) to Y. Hayashizaki and RIKEN Centre for Life Science Technologies,
   Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT,
   Japan. Extended acknowledgements are provided in the Supplementary
   Information.
CR Acampora D, 1999, DEVELOPMENT, V126, P3795
   Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121
   Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Chabchoub E, 2012, CLIN GENET, V81, P584, DOI 10.1111/j.1399-0004.2011.01684.x
   Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695
   DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145
   Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759
   Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206
   Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355
   He GY, 2010, DEV BIOL, V344, P720, DOI 10.1016/j.ydbio.2010.05.509
   Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186
   Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110
   Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110
   Kapoor S, 2011, INDIAN PEDIATR, V48, P727, DOI 10.1007/s13312-011-0108-8
   Kawaji H., 2014, GENOME RES
   Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487
   Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009
   Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440
   Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0
   Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163
   Lu MF, 1999, DEVELOPMENT, V126, P495
   McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567
   Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6
   Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5
   Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963
   Oja E., 2001, INDEPENDENT COMPONEN
   Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6
   PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2
   Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171
   Pringle IA, 2012, J MOL MED, V90, P1487, DOI 10.1007/s00109-012-0928-6
   Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176
   Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33
   Severin J., 2014, NATURE BIOTECHNOL
   Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018
   Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45
   ten Berge D, 1998, DEVELOPMENT, V125, P3831
   Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453
   Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043
   Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487
   Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068
   Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628
NR 54
TC 945
Z9 948
U1 6
U2 246
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 27
PY 2014
VL 507
IS 7493
BP 462
EP +
DI 10.1038/nature13182
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6WN
UT WOS:000333402000033
PM 24670764
OA Green Published, Green Accepted
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Ramakrishnan, C
   Bieri, A
   Sauter, N
   Roizard, S
   Ringler, P
   Muller, SA
   Goldie, KN
   Enimanev, K
   Stahlberg, H
   Rinn, B
   Braun, T
AF Ramakrishnan, Chandrasekhar
   Bieri, Andrej
   Sauter, Nora
   Roizard, Sophie
   Ringler, Philippe
   Mueller, Shirley A.
   Goldie, Kenneth N.
   Enimanev, Kaloyan
   Stahlberg, Henning
   Rinn, Bernd
   Braun, Thomas
TI openBEB: open biological experiment browser for correlative measurements
SO BMC BIOINFORMATICS
LA English
DT Article
ID ELECTRON-MICROSCOPY
AB Background: New experimental methods must be developed to study interaction networks in systems biology. To reduce biological noise, individual subjects, such as single cells, should be analyzed using high throughput approaches. The measurement of several correlative physical properties would further improve data consistency. Accordingly, a considerable quantity of data must be acquired, correlated, catalogued and stored in a database for subsequent analysis.
   Results: We have developed openBEB (open Biological Experiment Browser), a software framework for data acquisition, coordination, annotation and synchronization with database solutions such as openBIS. OpenBEB consists of two main parts: A core program and a plug-in manager. Whereas the data-type independent core of openBEB maintains a local container of raw-data and metadata and provides annotation and data management tools, all data-specific tasks are performed by plug-ins. The open architecture of openBEB enables the fast integration of plug-ins, e.g., for data acquisition or visualization. A macro-interpreter allows the automation and coordination of the different modules. An update and deployment mechanism keeps the core program, the plug-ins and the metadata definition files in sync with a central repository.
   Conclusions: The versatility, the simple deployment and update mechanism, and the scalability in terms of module integration offered by openBEB make this software interesting for a large scientific community. OpenBEB targets three types of researcher, ideally working closely together: (i) Engineers and scientists developing new methods and instruments, e.g., for systems-biology, (ii) scientists performing biological experiments, (iii) theoreticians and mathematicians analyzing data. The design of openBEB enables the rapid development of plug-ins, which will inherently benefit from the "house keeping" abilities of the core program. We report the use of openBEB to combine live cell microscopy, microfluidic control and visual proteomics. In this example, measurements from diverse complementary techniques are combined and correlated.
C1 [Bieri, Andrej; Sauter, Nora; Ringler, Philippe; Mueller, Shirley A.; Goldie, Kenneth N.; Stahlberg, Henning; Braun, Thomas] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, Basel, Switzerland.
   [Ramakrishnan, Chandrasekhar; Enimanev, Kaloyan; Rinn, Bernd] Swiss Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, Ctr Informat Sci & Databases C ISD, Basel, Switzerland.
   [Ramakrishnan, Chandrasekhar; Rinn, Bernd] Univ Basel, Biozentrum, Swiss Inst Bioinformat, Basel, Switzerland.
   [Roizard, Sophie] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes LCPPM, Lausanne, Switzerland.
RP Braun, T (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, Basel, Switzerland.
EM Thomas.Braun@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU SystemsX.ch initiative (CINA); SNF [200020_146619]; SNI PhD school
FX We thank Stefan Arnold, Christoph von Arx, Benjamin Bircher, Dominic
   Giss, Simon Kemmerling (C-CINA, University Basel) for testing the
   openBEB software. We thank Christophe Salzmann (EPFL, Lausanne,
   Switzerland) for providing the LabView Quicktime libraries. The project
   is supported by the SystemsX.ch initiative (CINA, granted to HS), the
   SNF (200020_146619, granted to TB) and the SNI PhD school.
CR Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020
   Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]
   Bauch A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-468
   Engel A, 2009, ADV IMAG ELECT PHYS, V159, P357, DOI 10.1016/S1076-5670(09)59009-X
   Kemmerling S, 2013, J STRUCT BIOL, V183, P467, DOI 10.1016/j.jsb.2013.06.012
   Kemmerling S, 2012, J STRUCT BIOL, V177, P128, DOI 10.1016/j.jsb.2011.11.001
   Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
NR 9
TC 8
Z9 8
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAR 26
PY 2014
VL 15
AR 84
DI 10.1186/1471-2105-15-84
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA AF2NK
UT WOS:000334548600001
PM 24666611
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Montani, L
   Petrinovic, MM
AF Montani, Laura
   Petrinovic, Marija M.
TI Targeting Axonal Regeneration: The Growth Cone Takes the Lead
SO JOURNAL OF NEUROSCIENCE
LA English
DT Editorial Material
ID NERVOUS-SYSTEM; MYELIN
C1 [Montani, Laura] ETH, Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.
   [Petrinovic, Marija M.] F Hoffmann La Roche, DTA Neurosci Ophthalmol & Rare Dis, Pharma Res & Early Dev, pRED, CH-4070 Basel, Switzerland.
   [Petrinovic, Marija M.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Petrinovic, MM (corresponding author), F Hoffmann La Roche, DTA Neurosci Ophthalmol & Rare Dis, Pharma Res & Early Dev, pRED, Bldg 68,Room 327,Grenzacherstr 124, CH-4070 Basel, Switzerland.
EM laura.montani@biol.ethz.ch; marija-magdalena.petrinovic@roche.com
RI Petrinovic, Marija/T-2349-2019; Montani, Laura/M-9583-2017
OI Petrinovic, Marija/0000-0002-0894-8424; Montani,
   Laura/0000-0002-8243-6734
CR Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176
   Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006
   Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19
   Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004
   Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200
   Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700
   Stern S, 2013, J NEUROSCI, V33, P18836, DOI 10.1523/JNEUROSCI.3029-13.2013
   Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]
NR 8
TC 6
Z9 6
U1 0
U2 5
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD MAR 26
PY 2014
VL 34
IS 13
BP 4443
EP 4444
DI 10.1523/JNEUROSCI.0320-14.2014
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA AE0RP
UT WOS:000333674200001
PM 24671990
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Barth, L
   Sutterlin, R
   Nenniger, M
   Vogt, KE
AF Barth, Lydia
   Suetterlin, Rosmarie
   Nenniger, Markus
   Vogt, Kaspar E.
TI Reduced synaptic activity in neuronal networks derived from embryonic
   stem cells of murine Rett syndrome model
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE Rett syndrome; stem cell-derived neurons; neurodevelopment;
   electrophysiology; excitability; synaptic activity
ID CPG-BINDING PROTEIN-2; MOUSE MODEL; MECP2-DEFICIENT MICE; DELAYED
   MATURATION; NEURAL DEVELOPMENT; PYRAMIDAL NEURONS; MECP2; DEFICIENCY;
   DYSFUNCTION; EXPRESSION
AB Neurodevelopmental diseases such as the Rett syndrome (RTT) have received renewed attention, since the mechanisms involved may underlie a broad range of neuropsychiatric disorders such as schizophrenia and autism. In vertebrates early stages in the functional development of neurons and neuronal networks are difficult to study. Embryonic stem cell-derived neurons provide an easily accessible tool to investigate neuronal differentiation and early network formation. We used in vitro cultures of neurons derived from murine embryonic stem cells missing the methyl-CpG-binding protein 2 (MECP2) gene (MeCP2-/y) and from wild type cells of the corresponding background. Cultures were assessed using whole-cell patch-clamp electrophysiology and immunofluorescence. We studied the functional maturation of developing neurons and the activity of the synaptic connections they formed. Neurons exhibited minor differences in the developmental patterns for their intrinsic parameters, such as resting membrane potential and excitability; with the MeCP2-/y cells showing a slightly accelerated development, with shorter action potential half-widths at early stages. There was no difference in the early phase of synapse development, but as the cultures matured, significant deficits became apparent, particularly for inhibitory synaptic activity. MeCP2-/y embryonic stem cell-derived neuronal cultures show clear developmental deficits that match phenotypes observed in slice preparations and thus provide a compelling tool to further investigate the mechanisms behind RTT pathophysiology.
C1 [Barth, Lydia; Suetterlin, Rosmarie; Nenniger, Markus; Vogt, Kaspar E.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Vogt, KE (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM kaspar.vogt@unibas.ch
OI Vogt, Kaspar/0000-0002-0859-876X
CR Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Baschong W, 1999, METHOD ENZYMOL, V307, P173
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027
   Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018
   Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582
   Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906
   Colic S, 2013, NEURAL NETWORKS, V46, P109, DOI 10.1016/j.neunet.2013.05.002
   Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009
   Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102
   Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004
   Farra N, 2012, MOL PSYCHIATR, V17, P1261, DOI 10.1038/mp.2011.180
   Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537
   Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899
   Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389
   Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5
   Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009
   Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062
   Nissenkorn A, 2010, EPILEPSIA, V51, P1252, DOI 10.1111/j.1528-1167.2010.02597.x
   Noutel J, 2011, NEURON, V70, P35, DOI 10.1016/j.neuron.2011.03.001
   Okabe Y, 2010, BRAIN RES, V1360, P17, DOI 10.1016/j.brainres.2010.08.090
   Rett A, 1966, Wien Med Wochenschr, V116, P723
   Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7
   Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005
   Wood L, 2009, J NEUROSCI, V29, P12440, DOI 10.1523/JNEUROSCI.3321-09.2009
   Zhang XL, 2010, AM J PHYSIOL-CELL PH, V298, pC635, DOI 10.1152/ajpcell.00442.2009
   Zhang ZW, 2010, J NEUROPHYSIOL, V103, P2470, DOI 10.1152/jn.00601.2009
   Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037
   Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071
NR 32
TC 3
Z9 3
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAR 26
PY 2014
VL 8
AR 79
DI 10.3389/fncel.2014.00079
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA AD7BP
UT WOS:000333416400001
PM 24723848
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Franceschini, A
   Meier, R
   Casanova, A
   Kreibich, S
   Daga, N
   Andritschke, D
   Dilling, S
   Ramo, P
   Emmenlauer, M
   Kaufmann, A
   Conde-Alvarez, R
   Low, SH
   Pelkmans, L
   Helenius, A
   Hardt, WD
   Dehio, C
   von Mering, C
AF Franceschini, Andrea
   Meier, Roger
   Casanova, Alain
   Kreibich, Saskia
   Daga, Neha
   Andritschke, Daniel
   Dilling, Sabrina
   Raemoe, Pauli
   Emmenlauer, Mario
   Kaufmann, Andreas
   Conde-Alvarez, Raquel
   Low, Shyan Huey
   Pelkmans, Lucas
   Helenius, Ari
   Hardt, Wolf-Dietrich
   Dehio, Christoph
   von Mering, Christian
TI Specific inhibition of diverse pathogens in human cells by synthetic
   microRNA-like oligonucleotides inferred from RNAi screens
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE high-throughput RNAi screening; antimicrobials
ID WEST-NILE-VIRUS; TARGET; GENOME; IDENTIFICATION
AB Systematic genetic perturbation screening in human cells remains technically challenging. Typically, large libraries of chemically synthesized siRNA oligonucleotides are used, each designed to degrade a specific cellular mRNA via the RNA interference (RNAi) mechanism. Here, we report on data from three genome-wide siRNA screens, conducted to uncover host factors required for infection of human cells by two bacterial and one viral pathogen. We find that the majority of phenotypic effects of siRNAs are unrelated to the intended "on-target" mechanism, defined by full complementarity of the 21-nt siRNA sequence to a target mRNA. Instead, phenotypes are largely dictated by "off-target" effects resulting from partial complementarity of siRNAs to multiple mRNAs via the "seed" region (i.e., nucleotides 2-8), reminiscent of the way specificity is determined for endogenous microRNAs. Quantitative analysis enabled the prediction of seeds that strongly and specifically block infection, independent of the intended on-target effect. This prediction was confirmed experimentally by designing oligos that do not have any on-target sequence match at all, yet can strongly reproduce the predicted phenotypes. Our results suggest that published RNAi screens have primarily, and unintentionally, screened the sequence space of microRNA seeds instead of the intended on-target space of protein-coding genes. This helps to explain why previously published RNAi screens have exhibited relatively little overlap. Our analysis suggests a possible way of identifying "seed reagents" for controlling phenotypes of interest and establishes a general strategy for extracting valuable untapped information from past and future RNAi screens.
C1 [Franceschini, Andrea; Daga, Neha; von Mering, Christian] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
   [Franceschini, Andrea; Daga, Neha; von Mering, Christian] Univ Zurich, Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland.
   [Meier, Roger; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Casanova, Alain; Raemoe, Pauli; Emmenlauer, Mario; Kaufmann, Andreas; Conde-Alvarez, Raquel; Low, Shyan Huey; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kreibich, Saskia; Andritschke, Daniel; Dilling, Sabrina; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.
   [Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
RP Helenius, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
EM ari.helenius@bc.biol.ethz.ch; mering@imls.uzh.ch
RI Franceschini, Andrea/AAE-8362-2019; Dehio, Christoph/AAD-5572-2019; von
   Mering, Christian/B-3300-2008; Conde-Alvarez, Raquel/K-5854-2014; Dehio,
   Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; von Mering,
   Christian/0000-0001-7734-9102; Conde-Alvarez,
   Raquel/0000-0003-0046-3577; Dehio, Christoph/0000-0001-7288-1052;
   Pelkmans, Lucas/0000-0002-6754-9730; Hardt,
   Wolf-Dietrich/0000-0002-9892-6420
FU SystemsX.ch, the Swiss Initiative for Systems Biology [51RT 0_126008];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Vontobel Foundation; European Research CouncilEuropean Research
   Council (ERC); International PhD Program "Fellowships for Excellence" of
   Biozentrum Basel;  [31003A-132979];  [310030-132997/1];  [31003A-135688]
FX We acknowledge support from Grant 51RT 0_126008 ("InfectX") from
   SystemsX.ch, the Swiss Initiative for Systems Biology. From the Swiss
   National Science Foundation, C.D. acknowledges Grant 31003A-132979,
   W.-D.H. acknowledges Grant 310030-132997/1, and C.v.M. acknowledges
   Grant 31003A-135688. Work by W.-D.H and D.A was supported by a grant
   from the Vontobel Foundation, work by R.M. and A.H. by an Advanced Grant
   from the European Research Council, and work by A.C. and S.H.L by the
   International PhD Program "Fellowships for Excellence" of Biozentrum
   Basel.
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428
   Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437
   Clemente R, 2010, J VIROL, V84, P3562, DOI 10.1128/JVI.02274-09
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300
   Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706
   Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348
   Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7
   Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110
   Nagy A, 2003, NAT GENET, V33, P276, DOI 10.1038/ng1115
   Schmaljohn CS, 2007, FIELDS VIROLOGY, P1741
   Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170
   Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3
   Shamu CE, 2012, NAT CELL BIOL, V14, P115, DOI 10.1038/ncb2435
   Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]
   Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901
   Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775
   Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004
NR 33
TC 43
Z9 44
U1 0
U2 19
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 25
PY 2014
VL 111
IS 12
BP 4548
EP 4553
DI 10.1073/pnas.1402353111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6CK
UT WOS:000333341100052
PM 24616511
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Braissant, O
   Bonkat, G
   Bachmann, A
AF Braissant, O.
   Bonkat, G.
   Bachmann, A.
TI Do lymphocytes really like radix roots? A reality check of
   microcalorimetric data and a reply to Liu et al. (2013)
SO THERMOCHIMICA ACTA
LA English
DT Article
DE Lymphocytes; Isothermal microcalorimetry; Radix
ID ISOTHERMAL MICROCALORIMETRY; CALORIMETRY; GROWTH; CELLS
AB Isothermal microcalorimetry measures the heat produced or consumed by any physical, chemical or biological process. When studying biological processes it is often helpful to perform parallel experiments and controls using other techniques to interpret the calorimetric signal and discriminate the biological contribution from other heat releasing processes. If such parallel measurements are not possible, a reality check can also help in making sense of the data. Here we perform such reality check on the data presented in a recent paper and propose an alternative interpretation of the data keeping in mind the biological limitation of the cells tested. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Braissant, O.; Bonkat, G.; Bachmann, A.] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Braissant, O.; Bonkat, G.] Univ Basel, Fac Med, Biozentrum, Pharmazentrum,Lab Biomechan & Biocalorimetry LOB2, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Fac Med, Biozentrum, Pharmazentrum,Lab Biomechan & Biocalorimetry LOB2, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR American Type Culture Collection (ATCC), 2013, ATCC AN CELL LIN
   Bonkat G, 2013, UROLOGE, V52, P1092, DOI 10.1007/s00120-013-3169-6
   Braissant O, 2013, THERMOCHIM ACTA, V555, P64, DOI 10.1016/j.tca.2012.12.005
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   CAPALBO EE, 1964, J IMMUNOL, V92, P234
   HOWARD M, 1981, P NATL ACAD SCI-BIOL, V78, P5788, DOI 10.1073/pnas.78.9.5788
   Kemp RB, 2000, THERMOCHIM ACTA, V349, P23, DOI 10.1016/S0040-6031(99)00493-1
   Kemp RB, 2000, THERMOCHIM ACTA, V348, P1, DOI 10.1016/S0040-6031(00)00428-7
   Liu TT, 2013, THERMOCHIM ACTA, V571, P1, DOI 10.1016/j.tca.2013.07.031
   Murigande C, 2009, IMMUNOL INVEST, V38, P67, DOI 10.1080/08820130802572160
   Rodriguez D, 2011, J APPL MICROBIOL, V111, P1016, DOI 10.1111/j.1365-2672.2011.05117.x
   TA Instruments, 2011, TAM AIR CAL OP MAN
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wadso L., 2005, CEMENT INT, V3, P94
   Wadso L, 2009, FOOD CONTROL, V20, P956, DOI 10.1016/j.foodcont.2008.11.008
   XIE CL, 1988, THERMOCHIM ACTA, V123, P33
NR 16
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD MAR 20
PY 2014
VL 580
BP 63
EP 65
DI 10.1016/j.tca.2014.02.003
PG 3
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA AF5BF
UT WOS:000334728300009
DA 2021-01-25
ER

PT J
AU Stekhoven, DJ
   Omasits, U
   Quebatte, M
   Dehio, C
   Ahrens, CH
AF Stekhoven, Daniel J.
   Omasits, Ulrich
   Quebatte, Maxime
   Dehio, Christoph
   Ahrens, Christian H.
TI Proteome-wide identification of predominant subcellular protein
   localizations in a bacterial model organism
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Subcellular localization; Experimental proteomics data; Outer membrane
   proteome; Machine learning; Localization change; Prokaryote
ID GRAM-NEGATIVE BACTERIA; INNER MEMBRANE PROTEOME; IV SECRETION SYSTEM;
   BARTONELLA-HENSELAE; OUTER-MEMBRANE; ESCHERICHIA-COLI;
   PSEUDOMONAS-AERUGINOSA; GLOBAL ANALYSIS; COMPLEX-I; PREDICTION
AB Proteomics data provide unique insights into biological systems, including the predominant subcellular localization (SCL) of proteins, which can reveal important clues about their functions. Here we analyzed data of a complete prokaryotic proteome expressed under two conditions mimicking interaction of the emerging pathogen Bartonella henselae with its mammalian host. Normalized spectral count data from cytoplasmic, total membrane, inner and outer membrane fractions allowed us to identify the predominant SCL for 82% of the identified proteins. The spectral count proportion of total membrane versus cytoplasmic fractions indicated the propensity of cytoplasmic proteins to co-fractionate with the inner membrane, and enabled us to distinguish cytoplasmic, peripheral inner membrane and bona fide inner membrane proteins. Principal component analysis and k-nearest neighbor classification training on selected marker proteins or predominantly localized proteins, allowed us to determine an extensive catalog of at least 74 expressed outer membrane proteins, and to extend the SCL assignment to 94% of the identified proteins, including 18% where in silico methods gave no prediction. Suitable experimental proteomics data combined with straightforward computational approaches can thus identify the predominant SCL on a proteome-wide scale. Finally, we present a conceptual approach to identify proteins potentially changing their SCL in a condition-dependent fashion.
   Biological significance
   The work presented here describes the first prokaryotic proteome-wide subcellular localization (SCL) dataset for the emerging pathogen B. henselae (Bhen). The study indicates that suitable subcellular fractionation experiments combined with straight-forward computational analysis approaches assessing the proportion of spectral counts observed in different subcellular fractions are powerful for determining the predominant SCL of a large percentage of the experimentally observed proteins. This includes numerous cases where in silico prediction methods do not provide any prediction. Avoiding a treatment with harsh conditions, cytoplasmic proteins tend to co-fractionate with proteins of the inner membrane fraction, indicative of close functional interactions. The spectral count proportion (SCP) of total membrane versus cytoplasmic fractions allowed us to obtain a good indication about the relative proximity of individual protein complex members to the inner membrane. Using principal component analysis and k-nearest neighbor approaches, we were able to extend the percentage of proteins with a predominant experimental localization to over 90% of all expressed proteins and identified a set of at least 74 outer membrane (OM) proteins. In general, OM proteins represent a rich source of candidates for the development of urgently needed new therapeutics in combat of resurgence of infectious disease and multi-drug resistant bacteria. Finally, by comparing the data from two infection biology relevant conditions, we conceptually explore methods to identify and visualize potential candidates that may partially change their SCL in these different conditions. The data are made available to researchers as a SCL compendium for Bhen and as an assistance in further improving in silico SCL prediction algorithms. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Stekhoven, Daniel J.; Omasits, Ulrich; Ahrens, Christian H.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
   [Omasits, Ulrich] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Quebatte, Maxime; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Stekhoven, DJ (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM stekhoven@quantik.ch; christian.ahrens@agroscope.admin.ch
RI Stekhoven, Daniel J./K-1887-2019; Dehio, Christoph/R-8277-2016; Ahrens,
   Christian H./F-4656-2011; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Ahrens, Christian
   H./0000-0002-8148-7257; Dehio, Christoph/0000-0001-7288-1052; Quebatte,
   Maxime/0000-0002-3733-1511; Goldmann, Ulrich/0000-0003-1120-6912;
   Stekhoven, Daniel/0000-0003-3163-3161
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A_130723]; SystemsX.ch [51RT 0_126008]; Swiss
   Initiative for Systems Biology under IPP grant [2011/121]; SNSFSwiss
   National Science Foundation (SNSF) [31003A-132979]; Department of
   Energy's Office of Biological and Environmental ResearchUnited States
   Department of Energy (DOE)
FX We thank Gabriella Pessi (University of Zurich) for critical reading of
   the manuscript and Ljiljana Pasa-Tolic and Sisi Wu from the Pacific
   Northwest National Laboratory for expert help and fruitful discussions.
   CHA acknowledges support from the Swiss National Science Foundation
   (SNSF) under grant 31003A_130723 and from SystemsX.ch, the Swiss
   Initiative for Systems Biology under IPP grant 2011/121. CD acknowledges
   support from the SNSF under grant 31003A-132979 and from SystemsX.ch
   under grant 51RT 0_126008 (RTD project InfectX). We thank Ralph
   Schlapbach for access to the mass spectrometry facility of the
   Functional Genomics Center Zurich. A part of the research was performed
   using EMSL, a national scientific user facility sponsored by the
   Department of Energy's Office of Biological and Environmental Research
   and located at the Pacific Northwest National Laboratory.
CR Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973
   Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207
   Aseev LV, 2011, MOL BIOL+, V45, P739, DOI 10.1134/S0026893311050025
   Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778
   Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351
   Brown Roslyn N, 2012, Int J Proteomics, V2012, P123076, DOI 10.1155/2012/123076
   Brown RN, 2010, J PROTEOME RES, V9, P4454, DOI 10.1021/pr100215h
   Bumann D, 2010, J PROTEOMICS, V73, P2267, DOI 10.1016/j.jprot.2010.08.004
   Casabona MG, 2013, PROTEOMICS, V13, P2419, DOI 10.1002/pmic.201200565
   Chenoweth MR, 2004, INFECT IMMUN, V72, P3097, DOI 10.1128/IAI.72.6.3097-3105.2004
   Chenoweth MR, 2004, APPL ENVIRON MICROB, V70, P656, DOI 10.1128/AEM.70.2.656-663.2004
   Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191
   Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216
   Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524
   Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730
   Dumetz F, 2008, MICROBIOL-SGM, V154, P1793, DOI 10.1099/mic.0.2008/016600-0
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973
   Franz B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-54
   Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101
   Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057
   Gatto L, 2010, PROTEOMICS, V10, P3957, DOI 10.1002/pmic.201000244
   Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390
   Han MJ, 2011, PROTEOMICS, V11, P1213, DOI 10.1002/pmic.201000191
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11
   Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618
   Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703
   Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731
   Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902
   Lee K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn619
   Li DM, 2011, GENET MOL RES, V10, P1789, DOI 10.4238/vol10-3gmr1153
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Lu YY, 2013, CELL MICROBIOL, V15, P759, DOI 10.1111/cmi.12070
   Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447
   Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658
   Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222
   Mintz-Oron S, 2009, BIOINFORMATICS, V25, pI247, DOI 10.1093/bioinformatics/btp209
   Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x
   Nair Rajesh, 2002, Bioinformatics, V18 Suppl 1, pS78
   Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607
   Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Papanastasiou M, 2013, MOL CELL PROTEOMICS, V12, P599, DOI 10.1074/mcp.M112.024711
   Pieper R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-5
   Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019
   Pulliainen AT, 2012, P NATL ACAD SCI USA, V109, P9581, DOI 10.1073/pnas.1117651109
   Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Riedel K, 2006, PROTEOMICS, V6, P207, DOI 10.1002/pmic.200500097
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Sadowski PG, 2006, NAT PROTOC, V1, P1778, DOI 10.1038/nprot.2006.254
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Shatkay H, 2007, BIOINFORMATICS, V23, P1410, DOI 10.1093/bioinformatics/btm115
   STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x
   Werner JA, 2006, CLIN VACCINE IMMUNOL, V13, P830, DOI 10.1128/CVI.00135-06
   Wu S, 2013, INT J PROTEOMICS, V2013
   Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
NR 66
TC 20
Z9 20
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD MAR 17
PY 2014
VL 99
BP 123
EP 137
DI 10.1016/j.jprot.2014.01.015
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AE5EH
UT WOS:000334010100009
PM 24486812
DA 2021-01-25
ER

PT J
AU Hadziselimovic, N
   Vukojevic, V
   Peter, F
   Milnik, A
   Fastenrath, M
   Fenyves, BG
   Hieber, P
   Demougin, P
   Vogler, C
   de Quervain, DJF
   Papassotiropoulos, A
   Stetak, A
AF Hadziselimovic, Nils
   Vukojevic, Vanja
   Peter, Fabian
   Milnik, Annette
   Fastenrath, Matthias
   Fenyves, Bank Gabor
   Hieber, Petra
   Demougin, Philippe
   Vogler, Christian
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
   Stetak, Attila
TI Forgetting Is Regulated via Musashi-Mediated Translational Control of
   the Arp2/3 Complex
SO CELL
LA English
DT Article
ID RNA-BINDING PROTEIN; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; ACTIN
   POLYMERIZATION; C. ELEGANS; MEMORY; MECHANISMS; PLASTICITY; DROSOPHILA;
   DYNAMICS
AB A plastic nervous system requires the ability not only to acquire and store but also to forget. Here, we report that musashi (msi-1) is necessary for time-dependent memory loss in C. elegans. Tissue-specific rescue demonstrates that MSI-1 function is necessary in the AVA interneuron. Using RNA-binding protein immunoprecipitation (IP), we found that MSI-1 binds to mRNAs of three subunits of the Arp2/3 actin branching regulator complex in vivo and downregulates ARX-1, ARX-2, and ARX-3 translation upon associative learning. The role of msi-1 in forgetting is also reflected by the persistence of learning-induced GLR-1 synaptic size increase in msi-1 mutants. We demonstrate that memory length is regulated cooperatively through the activation of adducin (add-1) and by the inhibitory effect of msi-1. Thus, a GLR-1/MSI-1/Arp2/3 pathway induces forgetting and represents a novel mechanism of memory decay by linking translational control to the structure of the actin cytoskeleton in neurons.
C1 [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Fastenrath, Matthias; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Fenyves, Bank Gabor] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary.
   [Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Univ Psychiat Clin, CH-4055 Basel, Switzerland.
RP Stetak, A (corresponding author), Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM a.stetak@unibas.ch
OI Vukojevic, Vanja/0000-0001-5303-9492; de Quervain,
   Dominique/0000-0001-7131-2464; Milnik, Annette/0000-0002-3933-3289;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler,
   Christian/0000-0003-3922-109X
FU National Institutes of Health Office of Research Infrastructure Programs
   [P40 OD010440]; Forschungsfonds of the University of Basel [DPE2112];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSIK0_122691, CRSI33_130080]
FX We are grateful to Anne Spang and Jean Pieters for generously sharing
   methods, reagents, and instruments and to Alex Hajnal for his valuable
   comments on the manuscript and for laser ablation tools. We also like to
   thank the Caenorhabditis Genetic Center (supported by the National
   Institutes of Health Office of Research Infrastructure Programs grant
   P40 OD010440) for providing nematode strains. The Forschungsfonds of the
   University of Basel (DPE2112 to A.S.) and the Swiss National Science
   Foundation (Sinergia grants CRSIK0_122691 and CRSI33_130080 to
   D.J.-F.d.Q. and A.P.) supported this work.
CR Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200
   BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H
   Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003
   Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007
   Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002
   BRENNER S, 1974, GENETICS, V77, P71
   Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005
   CHALFIE M, 1985, J NEUROSCI, V5, P956
   Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159
   Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634
   Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4
   Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488
   Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045
   Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046
   Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001
   Inoue A, 2013, CELL REP, V3, P808, DOI 10.1016/j.celrep.2013.02.019
   Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615
   Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372
   Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340
   Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596
   Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3
   McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200
   Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181
   Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231
   Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699
   Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139
   Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311
   Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2
   Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012
   Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499
   Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044
   Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019
   Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14
   Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004
   Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686
   Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555
   Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397
   Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x
NR 40
TC 48
Z9 50
U1 0
U2 27
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 13
PY 2014
VL 156
IS 6
BP 1153
EP 1166
DI 10.1016/j.cell.2014.01.054
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AD0ST
UT WOS:000332945100007
PM 24630719
OA Bronze
DA 2021-01-25
ER

PT J
AU Eroglu, E
   Burkard, TR
   Jiang, YR
   Saini, N
   Homem, CCF
   Reichert, H
   Knoblich, JA
AF Eroglu, Elif
   Burkard, Thomas R.
   Jiang, Yanrui
   Saini, Nidhi
   Homem, Catarina C. F.
   Reichert, Heinrich
   Knoblich, Juergen A.
TI SWI/SNF Complex Prevents Lineage Reversion and Induces Temporal
   Patterning in Neural Stem Cells
SO CELL
LA English
DT Article
ID CHROMATIN-REMODELING COMPLEX; DROSOPHILA-BRAIN-TUMOR; REGULATES
   SELF-RENEWAL; TRANSCRIPTION FACTORS; PROGENITOR CELLS; NEUROBLAST
   LINEAGES; FACS PURIFICATION; MOSAIC ANALYSIS; DOMAIN PROTEIN;
   NERVOUS-SYSTEM
AB Members of the SWI/SNF chromatin-remodeling complex are among the most frequently mutated genes in human cancer, but how they suppress tumorigenesis is currently unclear. Here, we use Drosophila neuroblasts to demonstrate that the SWI/SNF component Osa (ARID1) prevents tumorigenesis by ensuring correct lineage progression in stem cell lineages. We show that Osa induces a transcriptional program in the transit-amplifying population that initiates temporal patterning, limits self-renewal, and prevents dedifferentiation. We identify the Prdm protein Hamlet as a key component of this program. Hamlet is directly induced by Osa and regulates the progression of progenitors through distinct transcriptional states to limit the number of transit-amplifying divisions. Our data provide a mechanistic explanation for the widespread tumor suppressor activity of SWI/SNF. Because the Hamlet homologs Evi1 and Prdm16 are frequently mutated in cancer, this mechanism could well be conserved in human stem cell lineages.
C1 [Eroglu, Elif; Burkard, Thomas R.; Homem, Catarina C. F.; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria.
   [Jiang, Yanrui; Saini, Nidhi; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.
EM juergen.knoblich@imba.oeaw.ac.at
RI Knoblich, Juergen A/C-2974-2015
OI Knoblich, Juergen A/0000-0002-6751-3404; Eroglu,
   Elif/0000-0003-3952-3178; Homem, Catarina/0000-0003-4243-0298; Burkard,
   Thomas/0000-0002-0884-2929
FU Austrian Academy of Sciences; Austrian Science Fund (FWF)Austrian
   Science Fund (FWF) [I_552-B19, I_1281_B19, Z_153_B09]; European Research
   CouncilEuropean Research Council (ERC); Austrian Science Fund
   (FWF)Austrian Science Fund (FWF) [Z 153, I 1281] Funding Source:
   researchfish
FX We thank I. Reichardt, M. Lancaster, and H. Harzer for critical comments
   on the manuscript; A. W. Moore, C.Y. Lee, Y.N. Jan, S. Thor, S.X. Hou,
   U. Walldorf, the Bloomington Drosophila Stock Center, the Vienna
   Drosophila RNAi Center, the Developmental Studies Hybridoma Bank, and
   TriP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks
   and reagents; F. Mauri for the help with generating Dpn antibody; H.
   Harzer for generating the rabbit Pros antibody; J. Steinmann for the
   help with the shmiR design; M. Madalinski for peptide synthesis and
   affinity purification; G. Schmauss and T. Lendl for FACS support; P.
   Pasierbek for bio-optics support; and CSF NGS unit for next-generation
   sequencing. Work in J.A.K.'s lab is supported by the Austrian Academy of
   Sciences, the Austrian Science Fund (FWF, grants I_552-B19, I_1281_B19,
   and Z_153_B09), and an advanced grant of the European Research Council.
CR Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706
   Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032
   Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061
   BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011
   Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029
   Crosby MA, 1999, MOL CELL BIOL, V19, P1159
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   DINGWALL AK, 1995, MOL BIOL CELL, V6, P777
   Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344
   Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998
   Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107
   Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012
   Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461
   Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019
   Harzer H, 2013, NAT PROTOC, V8, P1088, DOI 10.1038/nprot.2013.062
   Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106
   Homem CCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079588
   Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515
   Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272
   JENNINGS B, 1994, DEVELOPMENT, V120, P3537
   Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628
   Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710
   Klein T, 1997, DEVELOPMENT, V124, P3123
   Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049
   Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98
   Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019
   Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012
   Liu C, 2012, CURR OPIN NEUROBIOL, V22, P844, DOI 10.1016/j.conb.2012.04.012
   Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Ma Y, 1998, MECH DEVELOP, V73, P169, DOI 10.1016/S0925-4773(98)00050-1
   Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044
   Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034
   McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6
   Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005
   Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387
   Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904
   Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06
   Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022
   Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410
   Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006
   Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048
   Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21
   Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4
   Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306
   Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413
   Russell SRH, 1996, DEVELOPMENT, V122, P3669
   Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007
   Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135
   Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005
   Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012
   Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548
   Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119
   Song Y, 2011, GENE DEV, V25, P2644, DOI 10.1101/gad.171959.111
   Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801
   Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309
   TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E
   Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5
   Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051
   Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8
   Vazquez M, 1999, DEVELOPMENT, V126, P733
   Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068
   Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021
   Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009
   Xiao Q, 2012, DEVELOPMENT, V139, P2670, DOI 10.1242/dev.081687
   Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003
   Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006
   Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008
   Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779
   Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891
   Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045
   Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109
NR 94
TC 78
Z9 80
U1 0
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 13
PY 2014
VL 156
IS 6
BP 1259
EP 1273
DI 10.1016/j.cell.2014.01.053
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AD0ST
UT WOS:000332945100015
PM 24630726
OA Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Sundriyal, A
   Massa, C
   Samoray, D
   Zehender, F
   Sharpe, T
   Jenal, U
   Schirmer, T
AF Sundriyal, Amit
   Massa, Claudia
   Samoray, Dietrich
   Zehender, Fabian
   Sharpe, Timothy
   Jenal, Urs
   Schirmer, Tilman
TI Inherent Regulation of EAL Domain-catalyzed Hydrolysis of Second
   Messenger Cyclic di-GMP
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Allosteric Regulation; Bacterial Signal Transduction; Chromatography;
   Crystal Structure; Phosphodiesterases; c-di-GMP Signaling; Second
   Messenger
ID ESCHERICHIA-COLI; MECHANISM; PROTEIN; PHOSPHODIESTERASE; ACTIVATION;
   ROCR
AB Background: The bacterial second messenger cyclic di-GMP (c-di-GMP) is degraded by EAL phosphodiesterases. Results: The isolated EAL domain is active only as a homodimer. Substrate binding is coupled with EAL dimerization. Conclusion: Activity of many full-length EAL phosphodiesterases may be regulated by catalytic domain dimerization. Significance: A generic mechanism for the regulation of a central node of c-di-GMP signaling is provided.
   The universal second messenger cyclic di-GMP (cdG) is involved in the regulation of a diverse range of cellular processes in bacteria. The intracellular concentration of the dinucleotide is determined by the opposing actions of diguanylate cyclases and cdG-specific phosphodiesterases (PDEs). Whereas most PDEs have accessory domains that are involved in the regulation of their activity, the regulatory mechanism of this class of enzymes has remained unclear. Here, we use biophysical and functional analyses to show that the isolated EAL domain of a PDE from Escherichia coli (YahA) is in a fast thermodynamic monomer-dimer equilibrium, and that the domain is active only in its dimeric state. Furthermore, our data indicate thermodynamic coupling between substrate binding and EAL dimerization with the dimerization affinity being increased about 100-fold upon substrate binding. Crystal structures of the YahA-EAL domain determined under various conditions (apo, Mg2+, cdGCa(2+) complex) confirm structural coupling between the dimer interface and the catalytic center. The built-in regulatory properties of the EAL domain probably facilitate its modular, functional combination with the diverse repertoire of accessory domains.
C1 [Sundriyal, Amit; Massa, Claudia; Samoray, Dietrich; Zehender, Fabian; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Sharpe, Timothy] Univ Basel, Biozentrum, Biophys Facil, CH-4056 Basel, Switzerland.
   [Jenal, Urs] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
OI Sharpe, Timothy/0000-0002-4980-1330
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_138414, 31003A_130469]
FX This work was supported by Swiss National Science Foundation Grants
   31003A_138414 (to T. Sch.) and 31003A_130469 (to U. J.).
CR Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966
   Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009
   Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702
   Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588
   Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08
   Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09
   Robert-Paganin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052424
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005
   Tarnawski M, 2013, ACTA CRYSTALLOGR D, V69, P1045, DOI 10.1107/S0907444913004423
   Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050
   WALKER GM, 1994, CRIT REV BIOTECHNOL, V14, P311, DOI 10.3109/07388559409063643
   WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026
   Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x
NR 37
TC 42
Z9 45
U1 1
U2 18
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 7
PY 2014
VL 289
IS 10
BP 6978
EP 6990
DI 10.1074/jbc.M113.516195
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AC3BG
UT WOS:000332389400058
PM 24451384
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Heck, A
   Fastenrath, M
   Ackermann, S
   Auschra, B
   Bickel, H
   Coynel, D
   Gschwind, L
   Jessen, F
   Kaduszkiewicz, H
   Maier, W
   Milnik, A
   Pentzek, M
   Riedel-Heller, SG
   Ripke, S
   Spalek, K
   Sullivan, P
   Vogler, C
   Wagner, M
   Weyerer, S
   Wolfsgruber, S
   de Quervain, DJF
   Papassotiropoulos, A
AF Heck, Angela
   Fastenrath, Matthias
   Ackermann, Sandra
   Auschra, Bianca
   Bickel, Horst
   Coynel, David
   Gschwind, Leo
   Jessen, Frank
   Kaduszkiewicz, Hanna
   Maier, Wolfgang
   Milnik, Annette
   Pentzek, Michael
   Riedel-Heller, Steffi G.
   Ripke, Stephan
   Spalek, Klara
   Sullivan, Patrick
   Vogler, Christian
   Wagner, Michael
   Weyerer, Siegfried
   Wolfsgruber, Steffen
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
TI Converging Genetic and Functional Brain Imaging Evidence Links Neuronal
   Excitability to Working Memory, Psychiatric Disease, and Brain Activity
SO NEURON
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; SET ANALYSIS; RISK LOCI;
   SCHIZOPHRENIA; SYSTEM; CEREBELLUM; REGISTRATION; CIRCUITRY; COGNITION
AB Working memory, the capacity of actively maintaining task-relevant information during a cognitive task, is a heritable trait. Working memory deficits are characteristic for many psychiatric disorders. We performed genome-wide gene set enrichment analyses in multiple independent data sets of young and aged cognitively healthy subjects (n = 2,824) and in a large schizophrenia case-control sample (n = 32,143). The voltage-gated cation channel activity gene set, consisting of genes related to neuronal excitability, was robustly linked to performance in working memory-related tasks across ages and to schizophrenia. Functional brain imaging in 707 healthy participants linked this gene set also to working memory-related activity in the parietal cortex and the cerebellum. Gene set analyses may help to dissect the molecular underpinnings of cognitive dimensions, brain activity, and psychopathology.
C1 [Heck, Angela; Fastenrath, Matthias; Ackermann, Sandra; Auschra, Bianca; Coynel, David; Gschwind, Leo; Milnik, Annette; Vogler, Christian; Weyerer, Siegfried; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Heck, Angela; Milnik, Annette; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Fastenrath, Matthias; Coynel, David; Gschwind, Leo; Spalek, Klara; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Bickel, Horst] Tech Univ Munich, Dept Psychiat, D-85748 Munich, Germany.
   [Jessen, Frank; Maier, Wolfgang; Wagner, Michael; Wolfsgruber, Steffen] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany.
   [Jessen, Frank; Maier, Wolfgang; Wagner, Michael; Wolfsgruber, Steffen] German Ctr Neurogenerat Dis, DZNE, D-53105 Bonn, Germany.
   [Kaduszkiewicz, Hanna] Univ Med Ctr Hamburg Eppendorf, Ctr Psychosocial Med, Dept Primary Med Care, D-20246 Hamburg, Germany.
   [Pentzek, Michael] Univ Dusseldorf, Fac Med, Inst Gen Practice, D-40225 Dusseldorf, Germany.
   [Riedel-Heller, Steffi G.] Univ Leipzig, Fac Med, Inst Social Med Occupat Hlth & Publ Hlth, D-04103 Leipzig, Germany.
   [Ripke, Stephan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Sullivan, Patrick] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.
   [Weyerer, Siegfried] Cent Inst Mental Hlth, D-68159 Mannheim, Germany.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Transfac Res Platform, CH-4012 Basel, Switzerland.
RP Heck, A (corresponding author), Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
EM angela.heck@unibas.ch; andreas.papas@unibas.ch
RI Wagner, Michael/E-2325-2011; Coynel, David/H-9189-2019; Jessen,
   Frank/AAK-6170-2020
OI Wagner, Michael/0000-0003-2589-6440; Coynel, David/0000-0001-5028-5807;
   Vogler, Christian/0000-0003-3922-109X; de Quervain,
   Dominique/0000-0001-7131-2464; Milnik, Annette/0000-0002-3933-3289;
   Heck, Angela/0000-0002-1543-3197; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Spalek, Klara/0000-0002-4244-6495
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSI33_130080]; European UnionEuropean Union (EU)
   [HEALTH-F4-2009-242257]; National Center for Competence in Research
   SYNAPSY; German Research Network on Dementia (KND); German Research
   Network on Degenerative Dementia (KNDD), German Federal Ministry of
   Education and Research [01GI0420, 01GI0711]; NATIONAL INSTITUTE OF
   MENTAL HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH059160, R01MH059160, R01MH059160] Funding Source: NIH
   RePORTER
FX We thank Elmar Merkle, Christoph Stippich, and Oliver Bieri for granting
   access to the fMRI facilities of the University Hospital Basel. This
   work was funded by the Swiss National Science Foundation (Sinergia grant
   CRSI33_130080 to D.J.-F.d.Q. and A.P.), by the 7th framework programme
   of the European Union (ADAMS project, HEALTH-F4-2009-242257), by the
   National Center for Competence in Research SYNAPSY, and by the German
   Research Network on Dementia (KND) and the German Research Network on
   Degenerative Dementia (KNDD), German Federal Ministry of Education and
   Research grants 01GI0420 and 01GI0711.
CR Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Balanza-Martinez V, 2008, NEUROSCI BIOBEHAV R, V32, P1426, DOI 10.1016/j.neubiorev.2008.05.019
   Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959
   Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2
   D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056
   Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21
   Erk S, 2010, ARCH GEN PSYCHIAT, V67, P803, DOI 10.1001/archgenpsychiatry.2010.94
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107
   GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G
   GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473
   Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011
   Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489
   Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962
   Karlsgodt KH, 2011, BEHAV BRAIN RES, V225, P610, DOI 10.1016/j.bbr.2011.08.016
   Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037
   Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178
   Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191
   LEINER HC, 1991, BEHAV BRAIN RES, V44, P113, DOI 10.1016/S0166-4328(05)80016-6
   LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497
   Luck T, 2007, DEMENT GERIATR COGN, V24, P307, DOI 10.1159/000108099
   Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428
   O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7
   O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131
   Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742
   Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940
   Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074
   Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058
   Shah P., 1999, MODELS WORKING MEMOR, V1, P1
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943
   Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1
   Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255
   Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884
   Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006
   Wechsler D., 1987, WECHSLER MEMORY SCAL
   WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609
   Wiser AK, 1998, NEUROREPORT, V9, P1895, DOI 10.1097/00001756-199806010-00042
   Zhang QM, 2012, NEUROPSYCHOPHARMACOL, V37, P677, DOI 10.1038/npp.2011.242
NR 51
TC 58
Z9 59
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD MAR 5
PY 2014
VL 81
IS 5
BP 1203
EP 1213
DI 10.1016/j.neuron.2014.01.010
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA AC4YH
UT WOS:000332526700021
PM 24529980
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU de Abreu, DAF
   Caballero, A
   Fardel, P
   Stroustrup, N
   Chen, ZA
   Lee, K
   Keyes, WD
   Nash, ZM
   Lopez-Moyado, IF
   Vaggi, F
   Cornils, A
   Regenass, M
   Neagu, A
   Ostojic, I
   Liu, C
   Cho, YM
   Sifoglu, D
   Shen, Y
   Fontana, W
   Lu, H
   Csikasz-Nagy, A
   Murphy, CT
   Antebi, A
   Blanc, E
   Apfeld, J
   Zhang, Y
   Alcedo, J
   Ch'ng, Q
AF de Abreu, Diana Andrea Fernandes
   Caballero, Antonio
   Fardel, Pascal
   Stroustrup, Nicholas
   Chen, Zhunan
   Lee, KyungHwa
   Keyes, William D.
   Nash, Zachary M.
   Lopez-Moyado, Isaac F.
   Vaggi, Federico
   Cornils, Astrid
   Regenass, Martin
   Neagu, Anca
   Ostojic, Ivan
   Liu, Chang
   Cho, Yongmin
   Sifoglu, Deniz
   Shen, Yu
   Fontana, Walter
   Lu, Hang
   Csikasz-Nagy, Attila
   Murphy, Coleen T.
   Antebi, Adam
   Blanc, Eric
   Apfeld, Javier
   Zhang, Yun
   Alcedo, Joy
   Ch'ng, QueeLim
TI An Insulin-to-Insulin Regulatory Network Orchestrates Phenotypic
   Specificity in Development and Physiology
SO PLOS GENETICS
LA English
DT Article
ID LIFE-SPAN; C-ELEGANS; TRANSCRIPTION FACTOR; DAUER FORMATION; GROWTH;
   EXPRESSION; GENE; PEPTIDE; DAF-2; LONGEVITY
AB Insulin-like peptides (ILPs) play highly conserved roles in development and physiology. Most animal genomes encode multiple ILPs. Here we identify mechanisms for how the forty Caenorhabditis elegans ILPs coordinate diverse processes, including development, reproduction, longevity and several specific stress responses. Our systematic studies identify an ILP-based combinatorial code for these phenotypes characterized by substantial functional specificity and diversity rather than global redundancy. Notably, we show that ILPs regulate each other transcriptionally, uncovering an ILP-to-ILP regulatory network that underlies the combinatorial phenotypic coding by the ILP family. Extensive analyses of genetic interactions among ILPs reveal how their signals are integrated. A combined analysis of these functional and regulatory ILP interactions identifies local genetic circuits that act in parallel and interact by crosstalk, feedback and compensation. This organization provides emergent mechanisms for phenotypic specificity and graded regulation for the combinatorial phenotypic coding we observe. Our findings also provide insights into how large hormonal networks regulate diverse traits.
C1 [de Abreu, Diana Andrea Fernandes; Caballero, Antonio; Liu, Chang; Blanc, Eric; Ch'ng, QueeLim] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.
   [Fardel, Pascal; Cornils, Astrid; Regenass, Martin; Neagu, Anca; Ostojic, Ivan; Alcedo, Joy] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Fardel, Pascal; Neagu, Anca] Univ Basel, Biozentrum, Basel, Switzerland.
   [Stroustrup, Nicholas; Nash, Zachary M.; Lopez-Moyado, Isaac F.; Fontana, Walter; Apfeld, Javier] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.
   [Chen, Zhunan; Shen, Yu; Zhang, Yun] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.
   [Lee, KyungHwa; Keyes, William D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.
   [Lee, KyungHwa; Keyes, William D.; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
   [Vaggi, Federico; Csikasz-Nagy, Attila] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.
   [Cho, Yongmin; Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Sifoglu, Deniz; Alcedo, Joy] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
   [Csikasz-Nagy, Attila] Kings Coll London, Inst Math & Mol Biomed, London WC2R 2LS, England.
   [Csikasz-Nagy, Attila] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.
   [Antebi, Adam] Max Planck Inst Biol Ageing, Cologne, Germany.
RP de Abreu, DAF (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England.
EM Antebi@age.mpg.de; eric.blanc@kcl.ac; javier_apfeld@hms.harvard.edu;
   yzhang@oeb.harvard.edu; joy.alcedo@wayne.edu; queelim@kcl.ac.uk
RI Stroustrup, Nicholas/K-6412-2017; Stroustrup, Nicholas/ABG-6402-2020;
   Csikasz-Nagy, Attila/A-3487-2009; Stroustrup, Nicholas/S-1425-2019;
   Caballero, Antonio/I-8510-2014; Ch'ng, QueeLim/C-5348-2009
OI Stroustrup, Nicholas/0000-0001-9530-7301; Csikasz-Nagy,
   Attila/0000-0002-2919-5601; Stroustrup, Nicholas/0000-0001-9530-7301;
   Caballero, Antonio/0000-0001-6042-9245; Ch'ng,
   QueeLim/0000-0003-1941-3828; Lu, Hang/0000-0002-6881-660X; Cho,
   Yongmin/0000-0002-8361-9612; Alcedo, Joy/0000-0002-5279-6640; Apfeld,
   Javier/0000-0001-9897-5671; Lopez-Moyado, Isaac/0000-0002-3720-0722
FU ERCEuropean Research Council (ERC) [NeuroAge 242666]; Research Councils
   UK FellowshipResearch Councils UK (RCUK); University of London Central
   Research Fund; Novartis Research Foundation; Wayne State University;
   Esther A. and Joseph Klingenstein Fund; March of Dimes FoundationMarch
   of Dimes; Alfred P. Sloan FoundationAlfred P. Sloan Foundation; John
   Merck Fund; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 DC009852, R03
   AG032481, R01 AG034994, DP2 OD004402-01, R01AG035317, R21EB012803,
   R01GM088333]; Max Planck SocietyMax Planck Society; Sybacol/Bundes
   Ministerium fur Bildung und Forschung; CECAD/Deutch Forschung
   Gemeinschaft; NSFNational Science Foundation (NSF) [CBET 0954578];
   Medical Research CouncilMedical Research Council UK (MRC) [G0901899]
   Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING
   AND BIOENGINEERINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Biomedical Imaging & Bioengineering (NIBIB) [R21EB012803,
   R21EB012803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM088333, R01GM088333,
   R01GM088333, R01GM088333, R01GM088333, R01GM088333, R01GM088333,
   R01GM088333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R03AG032481, R01AG034994, R01AG034994, R01AG035317, R01AG035317,
   R01AG035317, R01AG034994, R03AG032481, R01AG034994, R03AG032481,
   R01AG034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON
   DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Deafness & Other Communication Disorders (NIDCD)
   [R01DC009852, R01DC009852, R01DC009852, R01DC009852, R01DC009852,
   R01DC009852, R01DC009852, R01DC009852, R01DC009852] Funding Source: NIH
   RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P40OD010440, P40OD010440, P40OD010440, P40OD010440,
   P40OD010440, P40OD010440, P40OD010440, DP2OD004402, P40OD010440,
   P40OD010440, P40OD010440, P40OD010440, P40OD010440] Funding Source: NIH
   RePORTER
FX QC is funded by an ERC Starting Investigator Grant (NeuroAge 242666), a
   Research Councils UK Fellowship and the University of London Central
   Research Fund. JAl is funded by the Novartis Research Foundation and
   Wayne State University. YZ is funded by The Esther A. and Joseph
   Klingenstein Fund, March of Dimes Foundation, The Alfred P. Sloan
   Foundation, The John Merck Fund and NIH (R01 DC009852). JAp and WF are
   funded by NIH (R03 AG032481 and R01 AG034994). AA is funded by the Max
   Planck Society, Sybacol/Bundes Ministerium fur Bildung und Forschung,
   and CECAD/Deutch Forschung Gemeinschaft. CTM is funded by a NIH New
   Innovator Grant (DP2 OD004402-01). HL is funded by the Alfred P. Sloan
   Foundation, NIH (R01AG035317, R21EB012803, R01GM088333), and NSF (CBET
   0954578). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Alcedo J, 2010, ADV EXP MED BIOL, V694, P197
   Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000
   Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006
   Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185
   Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830
   Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086
   Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9
   Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721
   Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526
   Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025
   Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689
   Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905
   Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113
   DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347
   Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508
   Flores CO, 2013, ISME J, V7, P520, DOI 10.1038/ismej.2012.135
   Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108
   Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248
   Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865
   Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004
   Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735
   Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147
   Gems D, 1998, GENETICS, V150, P129
   GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X
   Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857
   Hagberg A., 2008, 7 PYTH SCI C SCIPY20, P11
   Hahm JH, 2011, AGING CELL, V10, P208, DOI 10.1111/j.1474-9726.2010.00655.x
   Houthoofd K, 2005, AGING CELL, V4, P87, DOI 10.1111/j.1474-9726.2005.00150.x
   Hristova M, 2005, MOL CELL BIOL, V25, P11059, DOI 10.1128/MCB.25.24.11059-11072.2005
   Hsu SYT, 2005, ANN NY ACAD SCI, V1041, P520, DOI 10.1196/annals.1282.078
   Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003
   Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051
   Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006
   Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6
   JOHNSON TR, 1989, MOL ENDOCRINOL, V3, P580, DOI 10.1210/mend-3-3-580
   Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027
   Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031
   Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971
   Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906
   Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013
   Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789
   Maier W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000376
   Matsunaga Y, 2012, BIOCHEM BIOPH RES CO, V423, P478, DOI 10.1016/j.bbrc.2012.05.145
   McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004
   Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523
   Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108
   Nelson DW, 2003, GENE DEV, V17, P813, DOI 10.1101/gad.1090203
   Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301
   Ritter AD, 2013, GENOME RES, V23, P954, DOI 10.1101/gr.150466.112
   Ruaud AF, 2011, GENETICS, V187, P337, DOI 10.1534/genetics.110.123323
   Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058
   Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933
   Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013
   Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809
   Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009
   Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]
   Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533
   Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408
   Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024
   Vaggi F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002732
   VOWELS JJ, 1992, GENETICS, V130, P105
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
NR 76
TC 39
Z9 39
U1 1
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD MAR
PY 2014
VL 10
IS 3
AR e1004225
DI 10.1371/journal.pgen.1004225
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA AI8FM
UT WOS:000337144700049
PM 24675767
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Franke, B
   Gasch, A
   Rodriguez, D
   Chami, M
   Khan, MM
   Rudolf, R
   Bibby, J
   Hanashima, A
   Bogomolovas, J
   von Castelmur, E
   Rigden, DJ
   Uson, I
   Labeit, S
   Mayans, O
AF Franke, Barbara
   Gasch, Alexander
   Rodriguez, Dayte
   Chami, Mohamed
   Khan, Muzamil M.
   Rudolf, Ruediger
   Bibby, Jaclyn
   Hanashima, Akira
   Bogomolovas, Julijus
   von Castelmur, Eleonore
   Rigden, Daniel J.
   Uson, Isabel
   Labeit, Siegfried
   Mayans, Olga
TI Molecular basis for the fold organization and sarcomeric targeting of
   the muscle atrogin MuRF1
SO OPEN BIOLOGY
LA English
DT Article
DE RBCC/TRIM fold; coiled-coil; COS-box; X-ray crystallography; electron
   microscopy; ab initio modelling
ID E3 LIGASE MURF1; UBIQUITIN LIGASES; TRIM PROTEINS; RING FINGER-1;
   COILED-COILS; M-LINE; FAMILY; IDENTIFICATION; REVEALS; PROGRAM
AB MuRF1 is an E3 ubiquitin ligase central to muscle catabolism. It belongs to the TRIM protein family characterized by a tripartite fold of RING, B-box and coiled-coil (CC) motifs, followed by variable C-terminal domains. The CC motif is hypothesized to be responsible for domain organization in the fold as well as for high-order assembly into functional entities. But data on CC from this family that can clarify the structural significance of this motif are scarce. We have characterized the helical region from MuRF1 and show that, contrary to expectations, its CC domain assembles unproductively, being the B2- and COS-boxes in the fold (respectively flanking the CC) that promote a native quaternary structure. In particular, the C-terminal COS-box seemingly forms an a-hairpin that packs against the CC, influencing its dimerization. This shows that a C-terminal variable domain can be tightly integrated within the conserved TRIM fold to modulate its structure and function. Furthermore, data from transfected muscle show that in MuRF1 the COS-box mediates the in vivo targeting of sarcoskeletal structures and points to the pharmacological relevance of the COS domain for treating MuRF1-mediated muscle atrophy.
C1 [Franke, Barbara; Bibby, Jaclyn; Bogomolovas, Julijus; von Castelmur, Eleonore; Rigden, Daniel J.; Mayans, Olga] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Gasch, Alexander; Hanashima, Akira; Bogomolovas, Julijus; Labeit, Siegfried] Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intens Med, D-68167 Mannheim, Germany.
   [Rodriguez, Dayte; Uson, Isabel] Inst Biol Mol Barcelona, Barcelona, Spain.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt C CINA, Basel, Switzerland.
   [Khan, Muzamil M.; Rudolf, Ruediger] Karlsruhe Inst Technol, Inst Toxikol & Genet, D-76344 Eggenstein Leopoldshafen, Germany.
   [Rudolf, Ruediger] Univ Appl Sci Mannheim, Inst Zell & Mol Biol, D-68163 Mannheim, Germany.
RP Mayans, O (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.
EM olga.mayans@liv.ac.uk
RI Khan, Muzami Majid/P-7813-2014; Bogomolovas, Julius/AAS-3642-2020;
   Rudolf, Rudiger/A-6476-2009; Khan, Muzamil Maijd/O-2444-2019
OI Khan, Muzami Majid/0000-0002-8188-0251; Bogomolovas,
   Julius/0000-0001-8344-1909; Rudolf, Rudiger/0000-0002-0833-1053; Khan,
   Muzamil Maijd/0000-0002-8188-0251; Mayans, Olga/0000-0001-6876-8532; von
   Castelmur, Eleonore/0000-0001-7061-4890; Rigden,
   Daniel/0000-0002-7565-8937
FU Royal SocietyRoyal Society of London [291834/SarcoSi]; Association
   Francaise contre les MyopathiesAssociation Francaise contre les
   Myopathies; BBSRC DTG programme; SNSFSwiss National Science Foundation
   (SNSF); Grants-in-Aid for Scientific ResearchMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [13J10667] Funding Source: KAKEN
FX We acknowledge the support of the Royal Society (O.M.),
   FP7-PEOPLE-2011-IRSES (#291834/SarcoSi), Association Francaise contre
   les Myopathies and the BBSRC DTG programme. The EM work was supported in
   part by the SNSF.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Bell JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037470
   Bibby J, 2012, ACTA CRYSTALLOGR D, V68, P1622, DOI 10.1107/S0907444912039194
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   Cambiaghi V, 2012, ADV EXP MED BIOL, V770, P77
   Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448
   Chen SN, 2012, CIRC RES, V111, P907, DOI 10.1161/CIRCRESAHA.112.270207
   Choi KR, 2012, J CELL SCI, V125, P714, DOI 10.1242/jcs.092361
   Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009
   Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   Cox TC, 2012, ADV EXP MED BIOL, V770, P105
   Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032
   Eddins MJ, 2011, CELL BIOCHEM BIOPHYS, V60, P113, DOI 10.1007/s12013-011-9175-7
   Elkins JM, 2009, PROTEIN SCI, V18, P782, DOI 10.1002/pro.82
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827
   Garcia P, 2006, FASEB J, V20, P1142, DOI 10.1096/fj.05-5262com
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kapinos LE, 2011, J MOL BIOL, V408, P135, DOI 10.1016/j.jmb.2011.02.037
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Le Rumeur E, 2012, FEBS LETT, V586, P2717, DOI 10.1016/j.febslet.2012.05.004
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mayans O, 2012, ADV EXP MED BIOL, V770, P119
   McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089
   Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304
   Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001
   Mrosek M, 2008, BIOCHEMISTRY-US, V47, P10722, DOI 10.1021/bi800733z
   Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com
   Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011
   Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580
   Ojima K, 2010, J CLIN INVEST, V120, P2672, DOI 10.1172/JCI40658
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   Perera S, 2012, J MUSCLE RES CELL M, V33, P107, DOI 10.1007/s10974-012-9288-7
   Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131
   Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140
   Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]
   Rudolf R, 2013, AGE, V35, P1663, DOI 10.1007/s11357-012-9468-9
   Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225
   SEO J, 1993, PROTEINS, V15, P223, DOI 10.1002/prot.340150302
   Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200
   Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959
   Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952
   Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Woodsmith J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016162
   Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2
   Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065
NR 54
TC 14
Z9 15
U1 0
U2 11
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2046-2441
J9 OPEN BIOL
JI Open Biol
PD MAR
PY 2014
VL 4
IS 3
AR 130172
DI 10.1098/rsob.130172
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE3VM
UT WOS:000333906500002
PM 24671946
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Nigg, EA
AF Nigg, Erich A.
TI Seventy-five years of Chromosoma: Ivory Towers, citation metrics, and
   longevity of research
SO CHROMOSOMA
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-5915
EI 1432-0886
J9 CHROMOSOMA
JI Chromosoma
PD MAR
PY 2014
VL 123
IS 1-2
BP 1
EP 2
DI 10.1007/s00412-014-0453-1
PG 2
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AD8OH
UT WOS:000333525000001
PM 24535086
OA Bronze
DA 2021-01-25
ER

PT J
AU Naden, LN
   Pham, TT
   Shirts, MR
AF Naden, Levi N.
   Pham, Tri T.
   Shirts, Michael R.
TI Linear Basis Function Approach to Efficient Alchemical Free Energy
   Calculations. 1. Removal of Uncharged Atomic Sites
SO JOURNAL OF CHEMICAL THEORY AND COMPUTATION
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; HISTOGRAM ANALYSIS METHOD; HYDRATION
   FREE-ENERGIES; SIDE-CHAIN ANALOGS; THERMODYNAMIC INTEGRATION; EXPLICIT
   SOLVENT; WATER MODELS; FORCE-FIELDS; BINDING; BIOMOLECULES
AB We present a general approach to transform between molecular potential functions during free energy calculations using a variance minimized linear basis functional form. This approach splits the potential energy function into a sum of pairs of basis functions, which depend on coordinates, and 'alchemical' switches, which depend only on the coupling variable. The power of this approach is that, first, the calculation of the coupling parameter dependent terms is removed from inner loop force calculation routines, second, the flexibility in specifying basis functions and alchemical switches allows users to choose transformation pathways that maximize statistical efficiency, and third, it is possible to predict entirely in postprocessing, without any additional energy evaluations, the thermodynamic properties along any alchemical path with moderate overlap from an initial simulation that uses the same basis functions. This allows construction of optimized, minimum variance alchemical switches from a single simulation with fixed basis functions and trial alchemical switching functions. We describe how to construct these linear basis potentials for real molecular systems of different sizes and shapes, considering particularly the problems of eliminating singularities and minimizing variance of particle removal in dense fluids. The statistical error in free energy calculations using the optimized basis functions is lower than standard soft core models, and approach the minimum variance possible over all pair potentials. We recommend an optimized set of basis functions and alchemical switches for standard molecular free energy calculations.
C1 [Naden, Levi N.; Shirts, Michael R.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22902 USA.
   [Pham, Tri T.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Shirts, MR (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22902 USA.
EM michael.shirts@virginia.edu
OI Pham, Tri/0000-0003-1026-2146; Shirts, Michael/0000-0003-3249-1097
FU National Science FoundationNational Science Foundation (NSF)
   [CHE-1152786]; Division Of ChemistryNational Science Foundation (NSF)NSF
   - Directorate for Mathematical & Physical Sciences (MPS) [1152786]
   Funding Source: National Science Foundation
FX The authors acknowledge funding from the National Science Foundation
   through grant CHE-1152786 and helpful discussions from John Chodera
   (Memorial Sloan-Kettering Cancer Center), Peter Eastman (Stanford), and
   the rest of the OpenMM team. We thank Jacob Monroe (University of
   Virginia) for making available simulation data on the efficiency of
   host-guest molecular transformations.
CR Aqvist J, 2004, CHEM PHYS LETT, V384, P288, DOI 10.1016/j.cplett.2003.12.039
   Bemporad D, 2004, BIOPHYS J, V87, P1, DOI 10.1529/biophysj.103.030601
   BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4
   BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1
   Blondel A, 2004, J COMPUT CHEM, V25, P985, DOI 10.1002/jcc.20025
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Buelens F. P., 2011, J COMPUT CHEM, P25
   Case D. A., 2014, AMBER 14 U CALIFORNI
   Chodera JD, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3660669
   CHOW KH, 1995, COMPUT PHYS COMMUN, V91, P283, DOI 10.1016/0010-4655(95)00059-O
   Crooks GE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.100602
   de Ruiter A, 2012, J CHEM THEORY COMPUT, V8, P3686, DOI 10.1021/ct200750p
   Deng YQ, 2004, J PHYS CHEM B, V108, P16567, DOI 10.1021/jp048502c
   Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192
   Eastman P, 2010, COMPUT SCI ENG, V12, P34, DOI 10.1109/MCSE.2010.27
   Eastman P, 2010, J COMPUT CHEM, V31, P1268, DOI 10.1002/jcc.21413
   Eastman P, 2010, J CHEM THEORY COMPUT, V6, P434, DOI 10.1021/ct900463w
   Efron B, 1993, INTRO BOOTSTRAP, Vxvi, P436
   Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209
   FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021
   FRITSCH FN, 1984, SIAM J SCI STAT COMP, V5, P300, DOI 10.1137/0905021
   Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510
   Gelman A, 1998, STAT SCI, V13, P163
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Hritz J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2888998
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mobley DL, 2007, J PHYS CHEM B, V111, P2242, DOI 10.1021/jp0667442
   Mobley DL, 2009, J CHEM THEORY COMPUT, V5, P350, DOI 10.1021/ct800409d
   Monroe JI, 2014, J COMPUT AID MOL DES, V28, P401, DOI 10.1007/s10822-014-9716-4
   Paliwal H, 2011, J CHEM THEORY COMPUT, V7, P4115, DOI 10.1021/ct2003995
   Paluch AS, 2011, J CHEM ENG DATA, V56, P1587, DOI 10.1021/je101251n
   Pham TT, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3697833
   Pham TT, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3607597
   Pitera JW, 2002, MOL SIMULAT, V28, P45, DOI 10.1080/08927020211973
   Powell M. J. D., 1994, ADV OPTIMIZATION NUM, P51, DOI DOI 10.1007/978-94-015-8330-5_4
   Riniker S, 2011, J PHYS CHEM B, V115, P13570, DOI 10.1021/jp204303a
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Shenfeld DK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046705
   Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987
   Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177
   Shirts MR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1877132
   Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119
   Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191
   Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301
   Wang K, 2013, J COMPUT AID MOL DES, V27, P989, DOI 10.1007/s10822-013-9689-8
   WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820
   ZACHARIAS M, 1994, J CHEM PHYS, V100, P9025, DOI 10.1063/1.466707
NR 50
TC 25
Z9 25
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9618
EI 1549-9626
J9 J CHEM THEORY COMPUT
JI J. Chem. Theory Comput.
PD MAR
PY 2014
VL 10
IS 3
BP 1128
EP 1149
DI 10.1021/ct4009188
PG 22
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA AD0GW
UT WOS:000332913500024
PM 26580188
DA 2021-01-25
ER

PT J
AU Scherer, S
   Arheit, M
   Kowal, J
   Zeng, XY
   Stahlberg, H
AF Scherer, Sebastian
   Arheit, Marcel
   Kowal, Julia
   Zeng, Xiangyan
   Stahlberg, Henning
TI Single particle 3D reconstruction for 2D crystal images of membrane
   proteins
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Cryo-electron crystallography; Membrane proteins; Single-particle
   analysis; High performance computing; GPGPU; 2dx
ID EM STRUCTURE DETERMINATION; ELECTRON-MICROSCOPY; CRYO-EM; 2-DIMENSIONAL
   CRYSTALS; RESOLUTION; REFINEMENT; SOFTWARE; SYSTEM; TILT
AB In cases where ultra-flat cryo-preparations of well-ordered two-dimensional (2D) crystals are available, electron crystallography is a powerful method for the determination of the high-resolution structures of membrane and soluble proteins. However, crystal unbending and Fourier-filtering methods in electron crystallography three-dimensional (3D) image processing are generally limited in their performance for 2D crystals that are badly ordered or non-flat. Here we present a single particle image processing approach, which is implemented as an extension of the 2D crystallographic pipeline realized in the 2dx software package, for the determination of high-resolution 3D structures of membrane proteins. The algorithm presented, addresses the low single-to-noise ratio (SNR) of 2D crystal images by exploiting neighborhood correlation between adjacent proteins in the 2D crystal. Compared with conventional single particle processing for randomly oriented particles, the computational costs are greatly reduced due to the crystal-induced limited search space, which allows a much finer search space compared to classical single particle processing. To reduce the considerable computational costs, our software features a hybrid parallelization scheme for multi-CPU clusters and computer with high-end graphic processing units (GPUs). We successfully apply the new refinement method to the structure of the potassium channel MloK1. The calculated 3D reconstruction shows more structural details and contains less noise than the map obtained by conventional Fourier-filtering based processing of the same 2D crystal images. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.
C1 [Scherer, Sebastian; Arheit, Marcel; Kowal, Julia; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland.
   [Zeng, Xiangyan] Ft Valley State Univ, Ft Valley, GA 31030 USA.
RP Stahlberg, H (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, WRO 1058,Mattenstr 26, CH-4058 Basel, Switzerland.
EM henning.stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Kowal, Julia/0000-0003-4694-1896
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [315230_146929, 205320_144427]; Swiss National Science Foundation
   (NCCR TransCure)Swiss National Science Foundation (SNSF); Swiss National
   Supercomputing Centre (CSCS) [d19]
FX We thank D. Castano-Diez and S.A. Muller for insightful discussions and
   critically reading of the manuscript. We thank T. Robinson (Swiss
   National Supercompting Center, CSCS), U. Borstnik (ETH Zurich,
   Informatikdienste, Cluster-support) and M. Jacquout (University Basel,
   Universitatsrechenzentrum) for their support and discussion in context
   of the high-performance realization of the here presented procedure.
   This work was supported by the Swiss National Science Foundation (Grants
   315230_146929, 205320_144427, and the NCCR TransCure) and by a grant
   from the Swiss National Supercomputing Centre (CSCS) under project ID
   d19.
CR ANDERSON TW, 1985, LINEAR ALGEBRA APPL, V70, P147, DOI 10.1016/0024-3795(85)90049-7
   Arheit M., 2013, ELECT CRYSTALLOGRAPH, V955, P195
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Castano-Diez D, 2008, J STRUCT BIOL, V164, P153, DOI 10.1016/j.jsb.2008.07.006
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313
   Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010
   FRANK J, 1975, ULTRAMICROSCOPY, V1, P159, DOI 10.1016/S0304-3991(75)80020-9
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004
   Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339
   Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003
   Jost G., 2003, P EWOMP 3
   Kowal J., 2013, NAT COMMUN
   Kunji ERS, 2000, P NATL ACAD SCI USA, V97, P4637, DOI 10.1073/pnas.080064697
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Lyumkis D., 2013, J STRUCT BIOL
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115
   Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Unger Vinzenz M, 2013, Methods Mol Biol, V955, P211, DOI 10.1007/978-1-62703-176-9_12
   Zeng X, 2007, J STRUCT BIOL, V160, P362, DOI 10.1016/j.jsb.2007.09.013
   Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004
NR 33
TC 9
Z9 9
U1 0
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAR
PY 2014
VL 185
IS 3
BP 267
EP 277
DI 10.1016/j.jsb.2013.12.011
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AC8WI
UT WOS:000332815400004
PM 24382495
OA Other Gold
DA 2021-01-25
ER

PT J
AU Quebatte, G
   Kitas, E
   Seelig, J
AF Quebatte, Gabriela
   Kitas, Eric
   Seelig, Joachim
TI riDOM, a cell penetrating peptide. Interaction with phospholipid
   bilayers
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Cell penetrating peptide; Transfection; Peptide-membrane interaction;
   Pore formation; Melittin; Thermodynamic
ID MAGAININ 2 AMIDE; PORE FORMATION; GENE DELIVERY; PHOSPHATIDYLCHOLINE
   MEMBRANES; TITRATION CALORIMETRY; CIRCULAR-DICHROISM; MELITTIN BINDING;
   MAMMALIAN-CELLS; LIPID-BINDING; THERMODYNAMICS
AB Melittin is an amphipathic peptide which has received much attention as a model peptide for peptide-membrane interactions. It is however not suited as a transfection agent due to its cytolytic and toxicological effects. Retro-inverso-melittin, when covalently linked to the lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (riDOM), eliminates these shortcomings. The interaction of riDOM with phospholipid membranes was investigated with circular dichroism (CD) spectroscopy, dynamic light scattering, zeta-potential measurements, and high-sensitivity isothermal titration calorimetry. riDOM forms cationic nanoparticles with a diameter of similar to 13 nm which are well soluble in water and bind with high affinity to DNA and lipid membranes. When dissolved in bilayer membranes, riDOM nanoparticles dissociate and form transient pores. riDOM-induced membrane leakiness is however much reduced compared to that of authentic melittin. The secondary structure of the ri-melittin is not changed when riDOM is transferred from water to the membrane and displays a large fraction of beta-structure. The P-31 NMR spectrum of the nanoparticle is however transformed into a typical bilayer spectrum. The Gibbs free energy of riDOM binding to bilayer membranes is -8.0 to -10.0 kcal/mol which corresponds to the partition energy of just one fatty acyl chain. Half of the hydrophobic surface of the riDOM lipid extension with its 2 oleic acyl chains is therefore involved in a lipid-peptide interaction. This packing arrangement guarantees a good solubility of riDOM both in the aqueous and in the membrane phase. The membrane binding enthalpy is small and riDOM binding is thus entropy-driven. (C) 2013 Published by Elsevier B.V.
C1 [Quebatte, Gabriela; Seelig, Joachim] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   [Kitas, Eric] F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev Discovery Chem, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM gabriela.quebatte@unibas.ch; eric_a.kitas@roche.com;
   joachim.seelig@unibas.ch
OI Quebatte, Gabriela/0000-0002-2530-5527
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX This work was supported by the Swiss National Science Foundation grant #
   31003A-129701.
CR Aveyard Robert, 1973, INTRO PRINCIPLES SUR
   BERGETHON PR, 1990, BIOPHYSICAL CHEM MOL
   BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007
   Boeckle S, 2005, J GENE MED, V7, P1335, DOI 10.1002/jgm.783
   Boeckle S, 2006, J CONTROL RELEASE, V112, P240, DOI 10.1016/j.jconrel.2006.02.002
   Chen CP, 2006, BIOCONJUGATE CHEM, V17, P1057, DOI 10.1021/bc060028l
   CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4
   Coles DJ, 2008, BIOPOLYMERS, V90, P651, DOI 10.1002/bip.21019
   Coles DJ, 2010, TETRAHEDRON, V66, P5435, DOI 10.1016/j.tet.2010.05.031
   Ehtezazi T, 2003, LANGMUIR, V19, P9387, DOI 10.1021/la0268799
   Fletcher MD, 1998, CHEM REV, V98, P763, DOI 10.1021/cr970468t
   Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x
   GOTO Y, 1992, BIOCHEMISTRY-US, V31, P732, DOI 10.1021/bi00118a014
   HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314
   Keller S, 2005, ANGEW CHEM INT EDIT, V44, P5252, DOI 10.1002/anie.200500519
   Klocek G, 2008, BIOCHEMISTRY-US, V47, P2841, DOI 10.1021/bi702258z
   Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h
   KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014
   Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105
   LEGENDRE JY, 1995, BIOCHEM BIOPH RES CO, V217, P179, DOI 10.1006/bbrc.1995.2761
   Legendre JY, 1997, BIOCONJUGATE CHEM, V8, P57, DOI 10.1021/bc960076d
   Matulis D, 2002, J AM CHEM SOC, V124, P7331, DOI 10.1021/ja0124055
   Mazzuca C, 2010, BIOPHYS J, V99, P1791, DOI 10.1016/j.bpj.2010.07.010
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Meyer M, 2007, J GENE MED, V9, P797, DOI 10.1002/jgm.1075
   Ogris M, 2001, J BIOL CHEM, V276, P47550, DOI 10.1074/jbc.M108331200
   PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020
   Pozharski E, 2003, BIOPHYS J, V85, P3969, DOI 10.1016/S0006-3495(03)74811-5
   Prata CAH, 2008, BIOCONJUGATE CHEM, V19, P418, DOI 10.1021/bc700451b
   QUAY SC, 1983, BIOCHEMISTRY-US, V22, P695, DOI 10.1021/bi00272a026
   Quebatte G, 2013, J PHYS CHEM B, V117, P10807, DOI 10.1021/jp404979y
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   Rex S, 1998, BIOCHEMISTRY-US, V37, P2336, DOI 10.1021/bi971009p
   RICHIERI GV, 1995, J BIOL CHEM, V270, P15076, DOI 10.1074/jbc.270.25.15076
   Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033
   Sauder R, 2011, METHODS MOL BIOL, V683, P129, DOI 10.1007/978-1-60761-919-2_10
   Schlaeger EJ, 2003, CYTOTECHNOLOGY, V42, P47, DOI 10.1023/A:1026125016602
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e
   VOGEL H, 1981, FEBS LETT, V134, P37, DOI 10.1016/0014-5793(81)80545-5
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wieprecht T, 2000, BIOPHYS CHEM, V85, P187, DOI 10.1016/S0301-4622(00)00120-4
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   WILCOX W, 1992, PROTEIN SCI, V1, P641, DOI 10.1002/pro.5560010510
   Zhang SB, 2010, BIOCONJUGATE CHEM, V21, P1003, DOI 10.1021/bc900261c
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h
   Ziegler A, 2011, BIOCHEMISTRY-US, V50, P4650, DOI 10.1021/bi1019429
NR 51
TC 11
Z9 11
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAR
PY 2014
VL 1838
IS 3
BP 968
EP 977
DI 10.1016/j.bbamem.2013.10.017
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB2ZT
UT WOS:000331661800027
PM 24184424
OA Bronze
DA 2021-01-25
ER

PT J
AU Hassaine, G
   Deluz, C
   Tol, MB
   Li, XD
   Graff, A
   Vogel, H
   Nury, H
AF Hassaine, Gherici
   Deluz, Cedric
   Tol, Menno B.
   Li, Xiao-Dan
   Graff, Alexandra
   Vogel, Horst
   Nury, Hugues
TI Large scale expression and purification of the mouse 5-HT3 receptor (vol
   1828, pg 2544, 2013)
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Correction
C1 [Hassaine, Gherici; Deluz, Cedric; Tol, Menno B.; Vogel, Horst; Nury, Hugues] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers Membranes, CH-1015 Lausanne, Switzerland.
   [Li, Xiao-Dan] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   [Graff, Alexandra] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4085 Basel, Switzerland.
RP Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers Membranes, CH-1015 Lausanne, Switzerland.
EM horst.vogel@epfl.ch; hugues.nury@epfl.ch
OI li, xiaodan/0000-0001-8647-7317
CR Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAR
PY 2014
VL 1838
IS 3
BP 1055
EP 1055
DI 10.1016/j.bbamem.2013.09.002
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB2ZT
UT WOS:000331661800036
OA Bronze
DA 2021-01-25
ER

PT J
AU Kleijer, KTE
   Schmeisser, MJ
   Krueger, DD
   Boeckers, TM
   Scheiffele, P
   Bourgeron, T
   Brose, N
   Burbach, JPH
AF Kleijer, Kristel T. E.
   Schmeisser, Michael J.
   Krueger, Dilja D.
   Boeckers, Tobias M.
   Scheiffele, Peter
   Bourgeron, Thomas
   Brose, Nils
   Burbach, J. Peter H.
TI Neurobiology of autism gene products: towards pathogenesis and drug
   targets
SO PSYCHOPHARMACOLOGY
LA English
DT Review
DE Autism spectrum disorders; Autism genetics; Dendritic protein synthesis;
   Autism drug targets; Neurexin; Neuroligin; SHANK; CNTNAP2; PTEN; Fragile
   X syndrome mousemodels
ID FRAGILE-X-SYNDROME; TUMOR-SUPPRESSOR GENE; SCAFFOLDING PROTEIN SHANK3;
   COPY NUMBER VARIATION; DE-NOVO MUTATIONS; MOUSE MODEL; SPECTRUM
   DISORDERS; MICE LACKING; NEURODEVELOPMENTAL DISORDERS;
   SYNAPTIC-TRANSMISSION
AB The genetic heterogeneity of autism spectrum disorders (ASDs) is enormous, and the neurobiology of proteins encoded by genes associated with ASD is very diverse. Revealing the mechanisms on which different neurobiological pathways in ASD pathogenesis converge may lead to the identification of drug targets.
   The main objective is firstly to outline the main molecular networks and neuronal mechanisms in which ASD gene products participate and secondly to answer the question how these converge. Finally, we aim to pinpoint drug targets within these mechanisms.
   Literature review of the neurobiological properties of ASD gene products with a special focus on the developmental consequences of genetic defects and the possibility to reverse these by genetic or pharmacological interventions.
   The regulation of activity-dependent protein synthesis appears central in the pathogenesis of ASD. Through sequential consequences for axodendritic function, neuronal disabilities arise expressed as behavioral abnormalities and autistic symptoms in ASD patients. Several known ASD gene products have their effect on this central process by affecting protein synthesis intrinsically, e.g., through enhancing the mammalian target of rapamycin (mTOR) signal transduction pathway or through impairing synaptic function in general. These are interrelated processes and can be targeted by compounds from various directions: inhibition of protein synthesis through Lovastatin, mTOR inhibition using rapamycin, or mGluR-related modulation of synaptic activity.
   ASD gene products may all feed into a central process of translational control that is important for adequate glutamatergic regulation of dendritic properties. This process can be modulated by available compounds but may also be targeted by yet unexplored routes.
C1 [Kleijer, Kristel T. E.; Burbach, J. Peter H.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, NL-3984 CG Utrecht, Netherlands.
   [Schmeisser, Michael J.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany.
   [Krueger, Dilja D.; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.
   [Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bourgeron, Thomas] Inst Pasteur, F-75724 Paris 15, France.
RP Burbach, JPH (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Univ Sweg 100, NL-3984 CG Utrecht, Netherlands.
EM j.p.h.burbach@umcutrecht.nl
RI Schmeisser, Michael/S-6347-2019
OI Bourgeron, Thomas/0000-0001-8164-9220; Krueger-Burg,
   Dilja/0000-0001-5597-6287
FU EU-AIMS (European Autism Interventions); Innovative Medicines Initiative
   [115300]; European Union from the European Federation of Pharmaceutical
   Industries Associations companies' [P7/2007-2013]; Autism Speaks;
   European Commission EUROSPIN; SynSys Consortia [FP7HEALTHF22009241498,
   FP7HEALTH F22009242167]; Alexander von Humboldt FoundationAlexander von
   Humboldt Foundation; European CommissionEuropean CommissionEuropean
   Commission Joint Research Centre; Deutsche Forschungsgemeinschaft
   (DFG)German Research Foundation (DFG) [BO1718/4-1]; Ulm University
   [L.SBN.0081]
FX Authors of this review were supported by EU-AIMS (European Autism
   Interventions), which receives support from the Innovative Medicines
   Initiative Joint Undertaking under grant agreement no. 115300, the
   resources of which are composed of financial contributions from the
   European Union's Seventh Framework Programme (grant P7/2007-2013), from
   the European Federation of Pharmaceutical Industries and Associations
   companies' in-kind contributions, and from Autism Speaks, resulting in a
   total of (sic)29.6 million. N.B. was supported by the European
   Commission EUROSPIN and SynSys Consortia (FP7HEALTHF22009241498,
   FP7HEALTH F22009242167). D. D. K. is a recipient of a fellowship of the
   Alexander von Humboldt Foundation and a Marie Curie International
   Reintegration Grant of the European Commission. Research is further
   supported by the Deutsche Forschungsgemeinschaft (DFG, BO1718/4-1 to T.
   M. B.) and by the Baustein program of Ulm University (L.SBN.0081 to
   M.J.S.).
CR Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47
   Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009
   Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005
   Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291
   ANDERSON GR, 2012, CANDIDATE AUTISM GEN, DOI DOI 10.1073/PNAS.1216398109
   Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004
   Argyropoulos A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00417
   Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012
   Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737
   Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658
   Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782
   Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610
   Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697
   Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035
   Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005
   Berkel S, 2012, HUM MOL GENET, V21, P344, DOI 10.1093/hmg/ddr470
   Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589
   Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701
   Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078
   Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003
   Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022
   Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004
   Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387
   Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162
   Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010
   Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175
   Boeckers TM, 1999, J NEUROSCI, V19, P6506
   Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x
   Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005
   Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9
   Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Busquets-Garcia A, 2013, NAT MED, V19, P603, DOI 10.1038/nm.3127
   Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646
   Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493
   Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008
   Caglayan AO, 2010, DEV MED CHILD NEUROL, V52, P130, DOI 10.1111/j.1469-8749.2009.03523.x
   Camacho-Garcia RJ, 2012, NEUROBIOL DIS, V47, P135, DOI 10.1016/j.nbd.2012.03.031
   Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27
   Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chaste P., 2012, DIALOGUES CLIN NEURO, V14, P281, DOI DOI 10.2217/EPI.11.19
   Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470
   Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158
   Chiliana B, 2013, CLIN GENET, V84, P560, DOI 10.1111/cge.12105
   Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063
   Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200
   Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004
   Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909
   Crawley Jacqueline N, 2012, Dialogues Clin Neurosci, V14, P293
   Daoud H, 2009, BIOL PSYCHIAT, V66, P906, DOI 10.1016/j.biopsych.2009.05.008
   Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013
   Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193
   Denayer A, 2012, MOL SYNDROMOL, V3, P14, DOI 10.1159/000339119
   Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002
   Di Cristofano A, 1998, NAT GENET, V19, P348
   Diaz-Ruiz O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007027
   Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001
   Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958
   Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838
   Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305
   Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57
   Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933
   Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860
   EDGE L, 2012, CELL, V149, P955, DOI DOI 10.1016/J.CELL.2012.05.011
   Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x
   Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788
   Ehninger D, 2013, NEUROPHARMACOLOGY, V68, P97, DOI 10.1016/j.neuropharm.2012.05.015
   Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002
   Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007
   El-Kordi A, 2013, BEHAV BRAIN RES, V251, P41, DOI 10.1016/j.bbr.2012.11.016
   Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239
   Erickson CA, 2013, PSYCHOPHARMACOLOGY, V228, P75, DOI 10.1007/s00213-013-3022-z
   Erickson CA, 2011, J CHILD ADOL PSYCHOP, V21, P565, DOI 10.1089/cap.2011.0034
   Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108
   Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106
   Ey E, 2012, GENES BRAIN BEHAV, V11, P928, DOI 10.1111/j.1601-183X.2012.00849.x
   Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017
   Fernandez TV, 2008, AM J MED GENET A, V146A, P2746, DOI 10.1002/ajmg.a.32533
   Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036
   Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048
   Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487
   Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008
   Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107
   Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822
   Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021
   Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628
   Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118
   Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003
   Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336
   Grayton HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067114
   Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518
   Gutierrez RC, 2009, NEUROSCIENCE, V162, P208, DOI 10.1016/j.neuroscience.2009.04.062
   Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389
   Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001
   HANSSEN AMN, 1995, J MED GENET, V32, P117, DOI 10.1136/jmg.32.2.117
   Herman GE, 2007, AM J MED GENET A, V143A, P589, DOI 10.1002/ajmg.a.31619
   Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea
   Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108
   Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008
   Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008
   Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708
   Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327
   Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136
   Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105
   Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016
   Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008
   Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1125, DOI 10.1007/s00213-013-3268-5
   Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017
   King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504
   Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012
   Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042
   Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781
   Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100
   Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023
   Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256
   Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3
   Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521
   Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05
   Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124
   Lemonnier E, 2010, ACTA PAEDIATR, V99, P1885, DOI 10.1111/j.1651-2227.2010.01933.x
   Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036
   Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825
   Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016
   Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943
   Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871
   Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247
   Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6
   Marino S, 2002, DEVELOPMENT, V129, P3513
   McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132
   Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009
   Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015
   Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590
   Murphy D, 2012, NAT REV DRUG DISCOV, V11, P815, DOI 10.1038/nrd3881
   Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0
   Napoli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042504
   Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031
   Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852
   Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014
   O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835
   Olexova L, 2012, NEUROSCI RES, V74, P184, DOI 10.1016/j.neures.2012.10.004
   Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237
   Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034
   Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010
   Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965
   Penagarikano O, 2012, TRENDS MOL MED, V18, P156, DOI 10.1016/j.molmed.2012.01.003
   Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040
   Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260
   Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146
   Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1
   Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253
   Pop AS, 2014, PSYCHOPHARMACOLOGY, V231, P1227, DOI 10.1007/s00213-012-2947-y
   Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808
   Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x
   Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024
   Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351
   Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008
   Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945
   Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002
   Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782
   Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017
   Schaaf CP, 2012, EUR J HUM GENET, V20, P1240, DOI 10.1038/ejhg.2012.95
   Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheng M, 2000, J CELL SCI, V113, P1851
   Shinoda Y, 2013, EXP ANIM TOKYO, V62, P71, DOI 10.1538/expanim.62.71
   Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026
   Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851
   Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010
   Sperow M, 2012, J PHYSIOL-LONDON, V590, P777, DOI 10.1113/jphysiol.2011.220236
   Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004
   State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924
   Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356
   Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2
   Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5
   Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221
   TAKEUCHI K, 2013, DYSREGULATION SYNAPT, DOI DOI 10.1073/PNAS.1222803110
   Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009
   Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442
   Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106
   van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324
   Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852
   van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8
   Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2
   Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205
   Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212
   Wohr M, 2013, BEHAV BRAIN RES, V251, P50, DOI 10.1016/j.bbr.2012.07.024
   Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631
   Won H, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00019
   Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208
   Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479
   Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629
   Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012
   Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891
   Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009
   Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004
   Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009
   Zhu G, 2012, DEVELOPMENT, V139, P3422, DOI 10.1242/dev.083154
   Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886
   Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071
NR 209
TC 45
Z9 48
U1 1
U2 50
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0033-3158
EI 1432-2072
J9 PSYCHOPHARMACOLOGY
JI Psychopharmacology
PD MAR
PY 2014
VL 231
IS 6
BP 1037
EP 1062
DI 10.1007/s00213-013-3403-3
PG 26
WC Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA AB8FL
UT WOS:000332025500006
PM 24419271
DA 2021-01-25
ER

PT J
AU Gruber, AR
   Martin, G
   Keller, W
   Zavolan, M
AF Gruber, Andreas R.
   Martin, Georges
   Keller, Walter
   Zavolan, Mihaela
TI Means to an end: mechanisms of alternative polyadenylation of messenger
   RNA precursors
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
ID CLEAVAGE FACTOR-I; 3' UNTRANSLATED REGIONS; BINDING-PROTEIN; U1 SNRNP;
   NUCLEOTIDE-RESOLUTION; MOLECULAR-MECHANISMS; INTERACTION SITES;
   NONCODING RNA; CLIP; TRANSCRIPTION
AB Expression of mature messenger RNAs (mRNAs) requires appropriate transcription initiation and termination, as well as pre-mRNA processing by capping, splicing, cleavage, and polyadenylation. Acore 3'-end processing complex carries out the cleavage and polyadenylation reactions, but many proteins have been implicated in the selection of polyadenylation sites among the multiple alternatives that eukaryotic genes typically have. In recent years, high-throughput approaches to map both the 3'-end processing sites as well as the binding sites of proteins that are involved in the selection of cleavage sites and in the processing reactions have been developed. Here, we review these approaches as well as the insights into themechanisms of polyadenylation that emerged from genome-wide studies of polyadenylation across a range of cell types and states. (C) 2013 The Authors. WIREs RNA published by JohnWiley & Sons, Ltd.
C1 [Gruber, Andreas R.; Martin, Georges; Keller, Walter; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Gruber,
   Andreas/0000-0003-1219-4239
FU University of Basel; Louis-Jeantet Foundation for Medicine; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [31003A-143977]
FX The work was supported by the University of Basel, the Louis-Jeantet
   Foundation for Medicine, and the Swiss National Science Foundation
   (grant no. 31003A-143977 to W.K.).
CR Akhtar MN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-646
   Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349
   Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112
   Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001
   Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI [10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkt1030]
   Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029
   Beyer K, 1997, J BIOL CHEM, V272, P26769, DOI 10.1074/jbc.272.42.26769
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Charlesworth A, 2013, WIRES RNA, V4, P437, DOI 10.1002/wrna.1171
   Cheng YM, 2006, BIOINFORMATICS, V22, P2320, DOI 10.1093/bioinformatics/btl394
   Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79
   Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932
   Darmon SK, 2012, RNA BIOL, V9, P1255, DOI 10.4161/rna.21957
   DARNELL JC, 2012, COLD SPRING HARB PER, V4
   de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655
   de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001
   Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hans H, 2000, MOL CELL BIOL, V20, P2926, DOI 10.1128/MCB.20.8.2926-2932.2000
   HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0
   Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]
   Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112
   Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616
   Jaskiewicz L, 2012, METHODS, V58, P106, DOI 10.1016/j.ymeth.2012.09.006
   Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022
   Ji XJ, 2013, MOL CELL BIOL, V33, P2560, DOI 10.1128/MCB.01380-12
   Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69
   Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106
   Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479
   Kalkatawi M, 2012, BIOINFORMATICS, V28, P127, DOI 10.1093/bioinformatics/btr602
   Katahira J, 2013, NUCLEIC ACIDS RES, V41, P7060, DOI 10.1093/nar/gkt414
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x
   Khaladkar M, 2011, RNA BIOL, V8, P529, DOI 10.4161/rna.8.3.15194
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105
   Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008
   Lee CY, 2013, BIOINFORMATICS, V29, P1713, DOI 10.1093/bioinformatics/btt288
   Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870
   Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637
   Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3
   Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a
   Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003
   Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010
   Masuda T, 2012, P NATL ACAD SCI USA, V109, P10885, DOI 10.1073/pnas.1121524109
   Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016
   Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176
   Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470
   Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112
   Mueller AA, 2013, CURR OPIN CELL BIOL, V25, P222, DOI 10.1016/j.ceb.2012.12.008
   Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022
   Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251
   Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640
   Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42
   Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020
   Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018
   Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007
   Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2
   Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311
   Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004
   Ruepp MD, 2010, NUCLEIC ACIDS RES, V38, P7637, DOI 10.1093/nar/gkq613
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799
   Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711
   Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028
   Sievers C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks697
   Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67
   Sun Y, 2012, J MOL CELL BIOL, V4, P352, DOI 10.1093/jmcb/mjs041
   Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Wang L, 2013, RNA, V19, P413, DOI 10.1261/rna.035360.112
   Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012
   Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040
   Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109
   Yoon OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002882
   Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907
   Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873
   Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055
   Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100
NR 96
TC 52
Z9 53
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD MAR
PY 2014
VL 5
IS 2
BP 183
EP 196
DI 10.1002/wrna.1206
PG 14
WC Cell Biology
SC Cell Biology
GA AA6LV
UT WOS:000331210700002
PM 24243805
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Vinet, AF
   Fiedler, T
   Studer, V
   Froquet, R
   Dardel, A
   Cosson, P
   Pieters, J
AF Vinet, Adrien F.
   Fiedler, Thomas
   Studer, Vera
   Froquet, Romain
   Dardel, Anna
   Cosson, Pierre
   Pieters, Jean
TI Initiation of multicellular differentiation in Dictyostelium discoideum
   is regulated by coronin A
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID DENSITY-SENSING FACTOR; PROTEIN-COUPLED RECEPTOR; SIGNAL-TRANSDUCTION;
   GENE-EXPRESSION; MOLECULAR-GENETICS; GROWING-CELLS; FOLIC-ACID; IN-VIVO;
   CAMP; CHEMOTAXIS
AB Many biological systems respond to environmental changes by activating intracellular signaling cascades, resulting in an appropriate response. One such system is represented by the social amoeba Dictyostelium discoideum. When food sources become scarce, these unicellular cells can initiate a cAMP-driven multicellular aggregation program to ensure long-term survival. On starvation, the cells secrete conditioned medium factors that initiate cAMP signal transduction by inducing expression of genes such as cAMP receptors and adenylate cyclase. The mechanisms involved in the activation of the first pulses of cAMP release have been unclear. We here show a crucial role for the evolutionarily conserved protein coronin A in the initiation of the cAMP response. On starvation, coronin A-deficient cells failed to up-regulate the expression of cAMP-regulated genes, thereby failing to initiate development, despite a normal prestarvation response. Of importance, external addition of cAMP to coronin A-deficient cells resulted in normal chemotaxis and aggregate formation, thereby restoring the developmental program and suggesting a functional cAMP relay in the absence of coronin A. These results suggest that coronin A is dispensable for cAMP sensing, chemotaxis, and development per se but is part of a signal transduction cascade essential for system initiation leading to multicellular development in Dictyostelium.
C1 [Vinet, Adrien F.; Fiedler, Thomas; Studer, Vera; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Froquet, Romain; Dardel, Anna; Cosson, Pierre] Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel; Long Term EMBO FellowshipEuropean Molecular
   Biology Organization (EMBO)
FX We thank the Dictyostelium Stock Center for strains and reagents,
   Richard Gomer for antibodies, Richard Gomer and Derrik Brazill for
   discussions, Philippe Demougin for the quantitative PCR analysis, and
   members of the laboratory for discussions. This study was financed by
   grants from the Swiss National Science Foundation (J.P. and P. C.) and
   the Canton of Basel. A. F. V. is a recipient of a Long Term EMBO
   Fellowship.
CR Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03
   Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013
   Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469
   Bakthavatsalam D, 2007, CURR BIOL, V17, P892, DOI 10.1016/j.cub.2007.04.029
   BONNER JT, 1947, J EXP ZOOL, V106, P1, DOI 10.1002/jez.1401060102
   Brazill DT, 1998, J BIOL CHEM, V273, P8161, DOI 10.1074/jbc.273.14.8161
   Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427
   Clarke M, 1995, EXPERIENTIA, V51, P1124, DOI 10.1007/BF01944730
   CLARKE M, 1988, DEV GENET, V9, P315, DOI 10.1002/dvg.1020090413
   Clemen Christoph S, 2008, Subcell Biochem, V48, P1, DOI 10.1007/978-0-387-09595-0_1
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812
   CORNILLON S, 1994, J CELL SCI, V107, P2691
   Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200
   DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   Deery WJ, 2002, J BIOL CHEM, V277, P31972, DOI 10.1074/jbc.M204539200
   Deery WJ, 1999, J BIOL CHEM, V274, P34476, DOI 10.1074/jbc.274.48.34476
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337
   DEVREOTES PN, 1983, DEV BIOL, V95, P154, DOI 10.1016/0012-1606(83)90014-3
   DEWIT RJW, 1986, DIFFERENTIATION, V32, P192, DOI 10.1111/j.1432-0436.1986.tb00573.x
   Eckert C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-268
   EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R
   Faix J, 1992, J CELL SCI, V102, P2203
   Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#
   Froquet R, 2012, MOL BIOL CELL, V23, P679, DOI 10.1091/mbc.E11-04-0338
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   GERISCH G, 1982, ANNU REV PHYSIOL, V44, P535, DOI 10.1146/annurev.ph.44.030182.002535
   Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415
   GROSS JD, 1976, J CELL SCI, V22, P645
   INSALL RH, 1994, MOL BIOL CELL, V5, P703
   Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003
   JAIN R, 1994, J BIOL CHEM, V269, P9128
   JAIN R, 1992, GENE DEV, V6, P390, DOI 10.1101/gad.6.3.390
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   JOHNSON RL, 1992, COLD SPRING HARB SYM, V57, P169, DOI 10.1101/SQB.1992.057.01.022
   KAY RR, 1982, P NATL ACAD SCI-BIOL, V79, P3228, DOI 10.1073/pnas.79.10.3228
   Kimmel AR, 1991, CURR OPIN GENET DEV, V1, P383, DOI 10.1016/S0959-437X(05)80304-1
   Kimmel AR, 2004, CURR OPIN GENET DEV, V14, P540, DOI 10.1016/j.gde.2004.08.001
   Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105
   KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lim CJ, 2005, EXP CELL RES, V306, P47, DOI 10.1016/j.yexcr.2005.02.002
   Lucas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005012
   Maeda M, 1997, J BIOL CHEM, V272, P23690, DOI 10.1074/jbc.272.38.23690
   Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   MANN SKO, 1987, MOL CELL BIOL, V7, P458, DOI 10.1128/MCB.7.1.458
   MANN SKO, 1991, MECH DEVELOP, V35, P89, DOI 10.1016/0925-4773(91)90060-J
   Mantzouranis L, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-79
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   Parent CA, 1996, ANNU REV BIOCHEM, V65, P411
   Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5
   Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465
   PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5
   Puta F, 1998, FOLIA BIOL-PRAGUE, V44, P185
   RATHI A, 1992, MECH DEVELOP, V36, P173, DOI 10.1016/0925-4773(92)90068-U
   RATHI A, 1991, DEV GENET, V12, P82, DOI 10.1002/dvg.1020120115
   Ray S, 2011, CELL SIGNAL, V23, P335, DOI 10.1016/j.cellsig.2010.09.017
   RILEY BB, 1990, P NATL ACAD SCI USA, V87, P4746, DOI 10.1073/pnas.87.12.4746
   Schafer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054172
   Schafer E, 2011, SMALL, V7, P723, DOI 10.1002/smll.201001955
   Shina MC, 2011, CELL MOL LIFE SCI, V68, P303, DOI 10.1007/s00018-010-0455-y
   Shu S, 2012, MOL BIOL CELL, V23, P390, DOI 10.1091/mbc.E11-09-0764
   Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228
   SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2
   Teo R, 2010, MOL BIOL CELL, V21, P2788, DOI 10.1091/mbc.E09-10-0891
   VANHAASTERT PJM, 1983, J BIOL CHEM, V258, P9636
   VANHAASTERT PJM, 1981, J BACTERIOL, V147, P170, DOI 10.1128/JB.147.1.170-175.1981
   Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251
   WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171
   Weijer CJ, 1999, SEMIN CELL DEV BIOL, V10, P609, DOI 10.1006/scdb.1999.0344
   YUEN IS, 1995, J CELL BIOL, V129, P1251, DOI 10.1083/jcb.129.5.1251
NR 77
TC 22
Z9 22
U1 0
U2 10
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR 1
PY 2014
VL 25
IS 5
BP 688
EP 701
DI 10.1091/mbc.E13-04-0219
PG 14
WC Cell Biology
SC Cell Biology
GA AM1SR
UT WOS:000339629100013
PM 24403600
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Shimobayashi, M
   Hall, MN
AF Shimobayashi, Mitsugu
   Hall, Michael N.
TI Making new contacts: the mTOR network in metabolism and signalling
   crosstalk
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID AMINO-ACID LEVELS; RAG GTPASES; TRANSLATION INITIATION;
   CELL-PROLIFERATION; TUMOR-SUPPRESSOR; SIZE-CONTROL; COMPLEX;
   PHOSPHORYLATION; AUTOPHAGY; AKT
AB More than 20 years after its discovery, our understanding of target of rapamycin (TOR) signalling continues to grow. Recent global 'omics' studies have revealed physiological roles of mammalian TOR (mTOR) in protein, nucleotide and lipid synthesis. Furthermore, emerging evidence provides new insight into the control of mTOR by other pathways such as Hippo, WNT and Notch signalling. Together, this progress has expanded the list of downstream effectors and upstream regulators of mTOR signalling.
C1 [Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Shimobayashi, Mitsugu/0000-0002-6936-0990
FU Louis-Jeantet Foundation; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Canton of Basel
FX The authors acknowledge support from the Louis-Jeantet Foundation, the
   Swiss National Science Foundation and the Canton of Basel.
CR Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044
   Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032
   Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606
   Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112
   Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465
   Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017
   Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024
   Hosokawa N., MOL BIOL CELL, V20
   Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912
   Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249
   Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566
   Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003
   Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041
   Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888
   Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006
   Mieulet V, 2010, TRENDS MOL MED, V16, P329, DOI 10.1016/j.molmed.2010.05.001
   Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259
   Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112
   Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193
   Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5
   Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771
   Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790
   Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32
   Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016
   Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615
   Valvezan AJ, 2014, DIS MODEL MECH, V7, P63, DOI 10.1242/dmm.012625
   Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335
   Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076
   Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484
   Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058
   Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854
   Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
NR 85
TC 616
Z9 637
U1 7
U2 206
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD MAR
PY 2014
VL 15
IS 3
BP 155
EP 162
DI 10.1038/nrm3757
PG 8
WC Cell Biology
SC Cell Biology
GA AB7VZ
UT WOS:000332000300009
PM 24556838
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Jayachandran, R
   Liu, XL
   BoseDasgupta, S
   Muller, P
   Zhang, CL
   Moshous, D
   Studer, V
   Schneider, J
   Genoud, C
   Fossoud, C
   Gambino, F
   Khelfaoui, M
   Muller, C
   Bartholdi, D
   Rossez, H
   Stiess, M
   Houbaert, X
   Jaussi, R
   Frey, D
   Kammerer, RA
   Deupi, X
   de Villartay, JP
   Luthi, A
   Humeau, Y
   Pieters, J
AF Jayachandran, Rajesh
   Liu, Xiaolong
   BoseDasgupta, Somdeb
   Mueller, Philipp
   Zhang, Chun-Lei
   Moshous, Despina
   Studer, Vera
   Schneider, Jacques
   Genoud, Christel
   Fossoud, Catherine
   Gambino, Frederic
   Khelfaoui, Malik
   Mueller, Christian
   Bartholdi, Deborah
   Rossez, Helene
   Stiess, Michael
   Houbaert, Xander
   Jaussi, Rolf
   Frey, Daniel
   Kammerer, Richard A.
   Deupi, Xavier
   de Villartay, Jean-Pierre
   Luethi, Andreas
   Humeau, Yann
   Pieters, Jean
TI Coronin 1 Regulates Cognition and Behavior through Modulation of
   cAMP/Protein Kinase A Signaling
SO PLOS BIOLOGY
LA English
DT Article
ID LONG-TERM POTENTIATION; CYCLIC-AMP ACCUMULATION; ADENYLYL-CYCLASE;
   SUBUNIT DISSOCIATION; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; MOUSE MODELS;
   PROTEIN; ACTIVATION; AUTISM
AB Cognitive and behavioral disorders are thought to be a result of neuronal dysfunction, but the underlying molecular defects remain largely unknown. An important signaling pathway involved in the regulation of neuronal function is the cyclic AMP/Protein kinase A pathway. We here show an essential role for coronin 1, which is encoded in a genomic region associated with neurobehavioral dysfunction, in the modulation of cyclic AMP/PKA signaling. We found that coronin 1 is specifically expressed in excitatory but not inhibitory neurons and that coronin 1 deficiency results in loss of excitatory synapses and severe neurobehavioral disabilities, including reduced anxiety, social deficits, increased aggression, and learning defects. Electrophysiological analysis of excitatory synaptic transmission in amygdala revealed that coronin 1 was essential for cyclic-AMP-protein kinase A-dependent presynaptic plasticity. We further show that upon cell surface stimulation, coronin 1 interacted with the G protein subtype Gs to stimulate the cAMP/PKA pathway. The absence of coronin 1 or expression of coronin 1 mutants unable to interact with Gs resulted in a marked reduction in cAMP signaling. Strikingly, synaptic plasticity and behavioral defects of coronin 1-deficient mice were restored by in vivo infusion of a membrane-permeable cAMP analogue. Together these results identify coronin 1 as being important for cognition and behavior through its activity in promoting cAMP/PKA-dependent synaptic plasticity and may open novel avenues for the dissection of signal transduction pathways involved in neurobehavioral processes.
   Author Summary Memory and behavior depend on the proper transduction of signals in the brain, but the underlying molecular mechanisms remain largely unknown. Coronin 1 is a member of a highly conserved family of proteins, and although its gene lies in a chromosome region associated with neurobehavioral dysfunction in mice and men, it has never been directly ascribed a specific function in the brain. Here we show that coronin 1 plays an important role in cognition and behavior by regulating the cyclic AMP (cAMP) signaling pathway. We find that when cell surface receptors are activated, coronin 1 stimulates cAMP production and activation of protein kinase A. Coronin 1 deficiency resulted in severe functional defects at excitatory synapses. Furthermore, in both mice and humans, deletion or mutation of coronin 1 causes severe neurobehavioral defects, including social deficits, increased aggression, and learning disabilities. Strikingly, treatment with a membrane-permeable analogue of cAMP restored synaptic plasticity and behavioral defects in mice lacking coronin 1. Together this work not only shows a critical role for coronin 1 in neurobehavior but also defines a role for the coronin family in regulating the transmission of signals within cells.
C1 [Jayachandran, Rajesh; Liu, Xiaolong; BoseDasgupta, Somdeb; Mueller, Philipp; Studer, Vera; Rossez, Helene; Stiess, Michael; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
   [Zhang, Chun-Lei; Gambino, Frederic; Khelfaoui, Malik; Houbaert, Xander; Humeau, Yann] Interdisciplinary Inst Neurosci, Bordeaux, France.
   [Moshous, Despina; de Villartay, Jean-Pierre] Hop Necker Enfants Malad, Paris, France.
   [Schneider, Jacques] Univ Children Hosp, Dept Radiol, UKBB, Basel, Switzerland.
   [Genoud, Christel] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland.
   [Fossoud, Catherine] CHU Nice, F-06202 Nice, France.
   [Genoud, Christel; Mueller, Christian; Luethi, Andreas] Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
   [Bartholdi, Deborah] Univ Basel Hosp, CH-4031 Basel, Switzerland.
   [Jaussi, Rolf; Frey, Daniel; Kammerer, Richard A.; Deupi, Xavier] Paul Scherrer Inst, Biomol Res Lab, Villigen, Switzerland.
   [Deupi, Xavier] Paul Scherrer Inst, Villigen, Switzerland.
RP Jayachandran, R (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM yann.humeau@u-bordeaux.fr; jean.pieters@unibas.ch
RI de Villartay, jean pierre/H-9353-2017; Moshous, Despina/B-7507-2017;
   Deupi, Xavier/B-2424-2009; Stiess, Michael/ABF-9835-2020
OI de Villartay, jean pierre/0000-0001-5987-0463; Moshous,
   Despina/0000-0001-6719-3693; Deupi, Xavier/0000-0003-4572-9316; Stiess,
   Michael/0000-0001-5363-0389; Pieters, Jean/0000-0002-5284-9757; gambino,
   frederic/0000-0002-2981-5030; Kammerer, Richard/0000-0003-4570-5197;
   liu, xiaolong/0000-0002-3096-4981
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel; Optimus Foundation; ETH ZurichETH Zurich;
   Agence Nationale pour la RechercheFrench National Research Agency (ANR);
   Novartis Research Foundation; HFSP Fellowship; EMBO Long Term
   FellowshipEuropean Molecular Biology Organization (EMBO); Cloetta
   Medical Fellowship; Robert A. Good/Jeffrey Modell Fellowship in
   Transplantation and Immunodeficiency
FX This work was supported by the Swiss National Science Foundation, the
   Canton of Basel, the Optimus Foundation, the ETH Zurich within the
   framework of the National Center for Competence in Research in
   Structural Biology Program, the Agence Nationale pour la Recherche, and
   the Novartis Research Foundation. Michael Stiess is a recipient of an
   HFSP Fellowship, Michael Stiess and Somdeb BoseDasgupta are recipients
   of an EMBO Long Term Fellowship, Rajesh Jayachandran is a recipient of a
   Cloetta Medical Fellowship, and Despina Moshous received a Robert A.
   Good/Jeffrey Modell Fellowship in Transplantation and Immunodeficiency.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47
   Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013
   Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92
   Blaeser F, 2006, MOL CELL BIOL, V26, P9105, DOI 10.1128/MCB.01452-06
   Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011
   Brown GP, 2000, J NEUROSCI, V20, P7880
   Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100
   CASEY PJ, 1988, COLD SPRING HARB SYM, V53, P203, DOI 10.1101/SQB.1988.053.01.026
   Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015
   Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Crawley J. N., 2007, WHATS WRONG MY MOUSE
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a
   DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Ferry B, 1999, J NEUROSCI, V19, P5119
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105
   Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134
   Gambino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011399
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009
   Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225
   GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151
   Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x
   GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330
   Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108
   HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4
   Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019
   Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007
   Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9
   Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883
   INSEL PA, 1982, J BIOL CHEM, V257, P9717
   JASPER JR, 1995, J PHARMACOL EXP THER, V274, P937
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kelly MP, 2009, MOL PSYCHIATR, V14, P398, DOI 10.1038/mp.2008.124
   Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3
   KOOLHAAS JM, 1980, PROG NEUROBIOL, V15, P247, DOI 10.1016/0301-0082(80)90024-6
   Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5
   Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E
   Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007
   Makranz C, 2006, GLIA, V53, P441, DOI 10.1002/glia.20303
   McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474
   Mironov SL, 1999, J NEUROPHYSIOL, V81, P247
   Morris AJ, 1999, PHYSIOL REV, V79, P1373
   Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042
   Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022
   Ngai J, 2008, EUR J IMMUNOL, V38, P3208, DOI 10.1002/eji.200838195
   Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56
   Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397
   Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014
   Parmigiani S, 1998, NEUROSCI BIOBEHAV R, V23, P143, DOI 10.1016/S0149-7634(98)00016-5
   Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465
   Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4
   Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146
   Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457
   Rebois RV, 1997, CELL SIGNAL, V9, P141, DOI 10.1016/S0898-6568(96)00133-7
   Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x
   Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4
   Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002
   Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851
   Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024
   Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627
   SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302
   Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221
   Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vianna MRM, 1999, BEHAV PHARMACOL, V10, P223, DOI 10.1097/00008877-199903000-00011
   Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212
   Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974
   WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482
   Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208
   Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2
   Yee BK, 2013, CELL TISSUE RES, V354, P221, DOI 10.1007/s00441-013-1611-0
   Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200
NR 90
TC 45
Z9 46
U1 0
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAR
PY 2014
VL 12
IS 3
AR e1001820
DI 10.1371/journal.pbio.1001820
PG 21
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA AD6YF
UT WOS:000333406800011
PM 24667537
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Blank, D
   Wolf, L
   Ackermann, M
   Silander, OK
AF Blank, Diana
   Wolf, Luise
   Ackermann, Martin
   Silander, Olin K.
TI The predictability of molecular evolution during functional innovation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE adaptation; transcription; compensatory mutation; biosynthesis
ID ESCHERICHIA-COLI; ADAPTIVE EVOLUTION; THREESPINE STICKLEBACKS;
   DEVELOPMENTAL BIOLOGY; KEY INNOVATION; BINDING-SITES; EVO-DEVO;
   MUTATIONS; GENES; ADAPTATION
AB Determining the molecular changes that give rise to functional innovations is a major unresolved problem in biology. The paucity of examples has served as a significant hindrance in furthering our understanding of this process. Here we used experimental evolution with the bacterium Escherichia coli to quantify the molecular changes underlying functional innovation in 68 independent instances ranging over 22 different metabolic functions. Using whole-genome sequencing, we show that the relative contribution of regulatory and structural mutations depends on the cellular context of the metabolic function. In addition, we find that regulatory mutations affect genes that act in pathways relevant to the novel function, whereas structural mutations affect genes that act in unrelated pathways. Finally, we use population genetic modeling to show that the relative contributions of regulatory and structural mutations during functional innovation may be affected by population size. These results provide a predictive framework for the molecular basis of evolutionary innovation, which is essential for anticipating future evolutionary trajectories in the face of rapid environmental change.
C1 [Blank, Diana; Wolf, Luise; Silander, Olin K.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Ackermann, Martin] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.
   [Ackermann, Martin] Eawag, Dept Environm Microbiol, CH-8600 Dubendorf, Switzerland.
RP Silander, OK (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM olinsilander@gmail.com
RI Ackermann, Martin/V-4554-2017
OI Ackermann, Martin/0000-0003-0087-4819; Silander,
   Olin/0000-0003-4105-8316
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [PZ00P3_126617, PZ00P3_144605, 31003A_130735]
FX We thank C. Bigosch for genotyping assistance; E. van Nimwegen for input
   on calculating transcriptional output; F. Bertels, C. Field, F. Geier,
   and O. Tenaillon for comments and suggestions; and T. Bollenbach for
   sharing the pNDL1 plasmid. D. B. and O. K. S. were supported by grants
   from the Swiss National Foundation (PZ00P3_126617 and PZ00P3_144605). M.
   A. was supported by Swiss National Foundation Grant 31003A_130735.
CR Ando H, 2014, MOL MICROBIOL, V91, P538, DOI 10.1111/mmi.12476
   ARONSON BD, 1989, J BACTERIOL, V171, P5503, DOI 10.1128/jb.171.10.5503-5511.1989
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480
   Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504
   BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8
   Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104
   Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514
   Bosma T, 2002, APPL ENVIRON MICROB, V68, P3582, DOI 10.1128/AEM.68.7.3582-3587.2002
   Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811
   Brilli M, 2004, GENE, V339, P149, DOI 10.1016/j.gene.2004.06.033
   Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030
   Dabizzi S, 2001, RES MICROBIOL, V152, P539, DOI 10.1016/S0923-2508(01)01228-1
   Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088
   Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003
   Haag ES, 2011, DEVELOPMENT, V138, P2633, DOI 10.1242/dev.066928
   Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x
   Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121
   JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944
   Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134
   Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012
   Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997
   LIN ECC, 1976, BIOSCIENCE, V26, P548, DOI 10.2307/1297270
   Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879
   McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39
   Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449
   MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922
   Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521
   Ohno S., 1970, EVOLUTION GENE DUPLI
   R Core Team, 2013, R LANG ENV STAT COMP
   Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568
   Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540
   Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/omi.1.2000.5.205
   Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415
   Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042
   Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x
   Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997
   Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2
   Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986
   Walkiewicz K, 2012, P NATL ACAD SCI USA, V109, P21408, DOI 10.1073/pnas.1209335110
   Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063
   Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852
NR 44
TC 40
Z9 40
U1 1
U2 41
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 25
PY 2014
VL 111
IS 8
BP 3044
EP 3049
DI 10.1073/pnas.1318797111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC0JP
UT WOS:000332180900041
PM 24516157
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Barth, L
   Suetterlin, R
   Nenniger, M
   Vogt, KE
AF Barth, Lydia
   Suetterlin, Rosmarie
   Nenniger, Markus
   Vogt, Kaspar E.
TI Functional differentiation of stem cell-derived neurons from different
   murine backgrounds
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Article
DE embryonic stem cells; neurons; electrophysiology; development; synaptic
   transmission
AB Murine stem cell-derived neurons have been used to study a wide variety of neuropsychiatric diseases with a hereditary component, ranging from autism to Alzheimer's. While a significant amount of data on their molecular biology has been generated, there is little data on the physiology of these cultures. Different mouse strains show clear differences in behavioral and other neurobiologically relevant readouts. We have studied the physiology of early differentiation and network formation in neuronal cultures derived from three different mouse embryonic stem cell lines. We have found largely overlapping patterns with some significant differences in the timing of the functional milestones. Neurons from R1 showed the fastest development of intrinsic excitability, while E14Tg2a and J1 were slower. This was also reflected in an earlier appearance of synaptic activity in R1 cultures, while E14Tg2a and J1 were delayed by up to 2 days. In conclusion, stem cells from all backgrounds could be successfully differentiated into functioning neural networks with similar developmental patterns. Differences in the timing of specific milestones, suggest that control cell lines and time-points should be carefully chosen when investigating genetic alterations that lead to subtle deficits in neuronal function.
C1 [Barth, Lydia; Suetterlin, Rosmarie; Nenniger, Markus; Vogt, Kaspar E.] Univ Basel, Dept Neurobiol Pharmacol, Biozentrum, CH-4056 Basel, Switzerland.
RP Vogt, KE (corresponding author), Univ Basel, Dept Neurobiol Pharmacol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM kaspar.vogt@unibas.ch
OI Vogt, Kaspar/0000-0002-0859-876X
CR Bahrey HLP, 2003, J NEUROPHYSIOL, V89, P1761, DOI 10.1152/jn.00972.2002
   Barkus Christopher, 2013, Curr Top Behav Neurosci, V14, P55, DOI 10.1007/7854_2012_224
   Baschong W, 1999, METHOD ENZYMOL, V307, P173
   Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Biella G, 2007, NEUROSCIENCE, V149, P38, DOI 10.1016/j.neuroscience.2007.07.021
   Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860
   LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F
   NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424
   Scharf SH, 2012, CURR PSYCHIAT REP, V14, P159, DOI 10.1007/s11920-012-0256-0
   Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064
NR 11
TC 2
Z9 2
U1 0
U2 3
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD FEB 20
PY 2014
VL 8
AR 49
DI 10.3389/fncel.2014.00049
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA AB5GU
UT WOS:000331817700002
PM 24600351
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Arquint, C
   Nigg, EA
AF Arquint, Christian
   Nigg, Erich A.
TI STIL Microcephaly Mutations Interfere with APC/C-Mediated Degradation
   and Cause Centriole Amplification
SO CURRENT BIOLOGY
LA English
DT Article
ID HUMAN-CELLS; SIL GENE; CENTROSOME AMPLIFICATION; MITOTIC ENTRY; PROTEIN;
   DUPLICATION; CPAP; PROCENTRIOLE; ARCHITECTURE; CHECKPOINT
AB Background: STIL is a centriole duplication factor that localizes to the procentriolar cartwheel region, and mutations in STIL are associated with autosomal recessive primary microcephaly (MCPH). Excess STIL triggers centriole amplification, raising the question of how STIL levels are regulated.
   Results: Using fluorescence time-lapse imaging, we identified a two-step process that culminates in the elimination of STIL at the end of mitosis. First, at nuclear envelope breakdown, Cdk1 triggers the translocation of STIL from centrosomes to the cytoplasm. Subsequently, the cytoplasmic bulk of STIL is degraded via the anaphase-promoting complex/cyclosome (APC/C)-proteasome pathway. We identify a C-terminal KEN box as critical for STIL degradation. Remarkably, this KEN box is deleted in MCPH mutants of STIL, rendering STIL resistant to proteasomal degradation and causing centriole amplification.
   Conclusions: Our results reveal a role for Cdk1 in STIL dissociation from centrosomes during early mitosis, with implications for the timing of cartwheel disassembly. Additionally, we propose that centriole amplification triggered by STIL stabilization is the underlying cause of microcephaly in human patients with corresponding STIL mutations.
C1 [Arquint, Christian; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
OI nigg, erich/0000-0003-4835-5719
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310030B_149641/1]; Werner Siemens-Foundation (Zug, Switzerland)
FX We are grateful to Stephen C. Blacklow (Harvard Medical School), Jeff
   Parvin (Ohio State University Medical Center), and Peter Jackson
   (Genentech) for sharing cell lines and reagents. We thank Alexia
   Ferrand, Niko Ehrenfeuchter, and Oliver Biehlmaier (Imaging Core
   Facility, Biozentrum, University of Basel) for assistance with
   microscopy and Thorsten Schmidt, Elisabeth Burgelt, and Elena Nigg for
   providing anti-CP110 monoclonal antibodies. We further thank Elena Nigg
   for technical assistance and Alwin Kramer (DKFZ, Heidelberg) as well as
   members of the Kramer and Nigg laboratories for helpful discussions.
   This work was supported by the Swiss National Science Foundation (grant
   310030B_149641/1). C.A. was funded by a PhD fellowship from the Werner
   Siemens-Foundation (Zug, Switzerland).
CR Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431
   APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462
   Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887
   Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163
   Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017
   Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005
   Cottee MA, 2013, ELIFE, V2, DOI 10.7554/eLife.01071
   Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373
   Gurden MDJ, 2010, J CELL SCI, V123, P321, DOI 10.1242/jcs.062075
   Hatzopoulos GN, 2013, STRUCTURE, V21, P2069, DOI 10.1016/j.str.2013.08.019
   Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429
   Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171
   Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002
   Kitagawa D, 2011, J CELL SCI, V124, P3884, DOI 10.1242/jcs.089888
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245
   Papari E, 2013, CLIN GENET, V83, P488, DOI 10.1111/j.1399-0004.2012.01949.x
   Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988
   Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07
   Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337
   Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109
   Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128
   Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001
NR 37
TC 65
Z9 67
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD FEB 17
PY 2014
VL 24
IS 4
BP 351
EP 360
DI 10.1016/j.cub.2013.12.016
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AB3VS
UT WOS:000331718900017
PM 24485834
OA Bronze
DA 2021-01-25
ER

PT J
AU Benjamin, D
   Hall, MN
AF Benjamin, Don
   Hall, Michael N.
TI mTORC1: Turning Off Is Just as Important as Turning On
SO CELL
LA English
DT Editorial Material
ID RAG GTPASES
AB mTORC1 is activated primarily on the lysosome. Menon et al. and Demetriades et al. show that mTORC1 deactivation on the lysosome is determined by recruitment of its negative regulator, the tumor suppressor complex TSC1-TSC2. These reports highlight the importance of subcellular localization in the regulation of mTORC1.
C1 [Benjamin, Don; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
CR Bar-Peled L, 2012, CELL, V151, P1390, DOI 10.1016/j.cell.2012.11.038
   Benjamin D, 2013, NAT CELL BIOL, V15, P1135, DOI 10.1038/ncb2849
   Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041
   Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822
NR 8
TC 13
Z9 15
U1 1
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD FEB 13
PY 2014
VL 156
IS 4
BP 627
EP 628
DI 10.1016/j.cell.2014.01.057
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AA8YB
UT WOS:000331379800002
PM 24529368
OA Bronze
DA 2021-01-25
ER

PT J
AU Schwan, C
   Kruppke, AS
   Noelke, T
   Schumacher, L
   Koch-Nolte, F
   Kudryashev, M
   Stahlberg, H
   Aktories, K
AF Schwan, Carsten
   Kruppke, Anna S.
   Noelke, Thilo
   Schumacher, Lucas
   Koch-Nolte, Friedrich
   Kudryashev, Mikhail
   Stahlberg, Henning
   Aktories, Klaus
TI Clostridium difficile toxin CDT hijacks microtubule organization and
   reroutes vesicle traffic to increase pathogen adherence
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID ADP-RIBOSYLTRANSFERASE; ACTIN-FILAMENTS; PROTEINS; BINDING; EXOCYTOSIS;
   MEMBRANE; CYTOSKELETON; FIBRONECTIN; LAMININ; CELLS
AB Clostridium difficile causes antibiotic-associated diarrhea and pseudomembranous colitis by the actions of Rho-glucosylating toxins A and B. Recently identified hypervirulent strains, which are associated with increased morbidity and mortality, additionally produce the actin-ADP-ribosylating toxin C. difficile transferase (CDT). CDT depolymerizes actin, causes formation of microtubule-based protrusions, and increases pathogen adherence. Here we show that CDT-induced protrusions allow vesicle traffic and contain endoplasmic reticulum tubules, connected to microtubules via the calcium sensor Stim1. The toxin reroutes Rab11-positive vesicles containing fibronectin, which is involved in bacterial adherence, from basolateral to the apical membrane sides in a microtubule-and Stim1-dependent manner. The data yield a model of C. difficile adherence regulated by actin depolymerization, microtubule restructuring, subsequent Stim1-dependent Ca2+ signaling, vesicle rerouting, and secretion of ECM proteins to increase bacterial adherence.
C1 [Schwan, Carsten; Kruppke, Anna S.; Noelke, Thilo; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.
   [Schumacher, Lucas; Koch-Nolte, Friedrich] Univ Klinikum Hamburg Eppendorf, Inst Immunol, D-20246 Hamburg, Germany.
   [Kudryashev, Mikhail; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland.
   [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany.
RP Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.
EM Klaus.Aktories@pharmakol.uni-freiburg.de
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Koch-Nolte,
   Friedrich/0000-0003-1730-6674; Schwan, Carsten/0000-0003-3876-8739;
   Kudryashev, Misha/0000-0003-3550-6274
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [AK
   6/20-1]; Swiss initiative for Systems Biology (SystemsX.ch) [CINA];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [NCCR Nano, NCCR TransCure]
FX We thank Richard Pagano, Ari Helenius, Rick Horwitz, and Tobias Meyer
   for Addgene plasmids. We thank Christoph Romanin for Stim1-CFP and
   Orai1-YFP Plasmids. We thank Winfried Romer for mcherry-Rab4. We thank
   Neil Fairweather for antisera against C. difficile 630. We thank Holger
   Rohde and Hans-Willi Mittrucker for help in animal experiments. We thank
   Elke Heitzmann and Gerhard Wetterer for technical assistance and Andrew
   Karalewitz for reading the manuscript. The study was supported by the
   Deutsche Forschungsgemeinschaft (AK 6/20-1 to K.A.). M.K. and H.S are
   supported by the Swiss initiative for Systems Biology (SystemsX.ch,
   Grant CINA) and Swiss National Science Foundation (Grants NCCR Nano and
   NCCR TransCure).
CR Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x
   AUNIS D, 1988, J EXP BIOL, V139, P253
   Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0
   Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev
   BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449
   Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002
   Durrbach A, 2000, TRAFFIC, V1, P411, DOI 10.1034/j.1600-0854.2000.010506.x
   ERMERT L, 1995, AM J PHYSIOL-LUNG C, V268, pL753
   Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050
   Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001
   Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0
   JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0
   Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500
   KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071
   Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017
   KREUTZ C, 1995, ZBL BAKT-INT J MED M, V282, P442
   LI GD, 1994, MOL BIOL CELL, V5, P1199
   Lin YP, 2011, J BIOL CHEM, V286, P3957, DOI 10.1074/jbc.M110.184523
   Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004
   McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590
   MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589
   Muik M, 2012, CELL MOL LIFE SCI, V69, P4163, DOI 10.1007/s00018-012-1072-8
   Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909
   OHISHI I, 1984, INFECT IMMUN, V43, P54, DOI 10.1128/IAI.43.1.54-58.1984
   Onodera K, 2013, J MEMBRANE BIOL, V246, P271, DOI 10.1007/s00232-013-9528-9
   Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002
   Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216
   Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997
   Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x
   Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626
   Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320
   Shen WW, 2011, BIOL CELL, V103, P365, DOI 10.1042/BC20100152
   Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x
NR 33
TC 51
Z9 53
U1 0
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 11
PY 2014
VL 111
IS 6
BP 2313
EP 2318
DI 10.1073/pnas.1311589111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA3NO
UT WOS:000330999600059
PM 24469807
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lima, WC
   Vinet, A
   Pieters, J
   Cosson, P
AF Lima, Wanessa C.
   Vinet, Adrien
   Pieters, Jean
   Cosson, Pierre
TI Role of PKD2 in Rheotaxis in Dictyostelium
SO PLOS ONE
LA English
DT Article
ID MOLECULAR-MECHANISMS; POLYCYSTIN-2; MEMBRANE; PROTEIN; EXOCYTOSIS;
   CALCIUM; CHANNEL; CA2+; DISCOIDEUM; RECEPTOR
AB The sensing of mechanical forces modulates several cellular responses as adhesion, migration and differentiation. Transient elevations of calcium concentration play a key role in the activation of cells following mechanical stress, but it is still unclear how eukaryotic cells convert a mechanical signal into an ion flux. In this study, we used the model organism Dictyostelium discoideum to assess systematically the role of individual calcium channels in mechanosensing. Our results indicate that PKD2 is the major player in the cell response to rheotaxis (i.e., shear-flow induced mechanical motility), while other putative calcium channels play at most minor roles. Mutant pkd2 KO cells lose the ability to orient relative to a shear flow, whereas their ability to move towards a chemoattractant is unaffected. PKD2 is also important for calcium-induced lysosome exocytosis: WT cells show a transient, 2-fold increase in lysosome secretion upon sudden exposure to high levels of extracellular calcium, but pkd2 KO cells do not. In Dictyostelium, PKD2 is specifically localized at the plasma membrane, where it may generate calcium influxes in response to mechanical stress or extracellular calcium changes.
C1 [Lima, Wanessa C.; Cosson, Pierre] Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, Geneva, Switzerland.
   [Vinet, Adrien; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
RP Lima, WC (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, Geneva, Switzerland.
EM Wanessa.deLima@unige.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Foundation for Scientific ResearchSwiss National Science
   Foundation (SNSF) [31003A-135789]; Doerenkamp-Zbinden Foundation;
   Fondation Egon Naef pour la Recherche in Vitro
FX The PC lab was supported by the Swiss National Foundation for Scientific
   Research (grant 31003A-135789), the Doerenkamp-Zbinden Foundation and
   the Fondation Egon Naef pour la Recherche in Vitro. WCL was partially
   funded during this project with a Telethon Action Suisse grant. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765
   Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836
   Benghezal M, 2001, IMMUNOGENETICS, V52, P284
   Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557
   Charette SJ, 2006, TRAFFIC, V7, P1528, DOI 10.1111/j.1600-0854.2006.00478.x
   Charette SJ, 2006, FEBS LETT, V580, P4923, DOI 10.1016/j.febslet.2006.08.009
   Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200
   Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701
   Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726
   Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993
   Drummond IA, 2011, BBA-MOL BASIS DIS, V1812, P1322, DOI 10.1016/j.bbadis.2011.03.003
   Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006
   Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461
   Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926
   Hadwiger JA, 1999, DIFFERENTIATION, V64, P195, DOI 10.1046/j.1432-0436.1999.6440195.x
   Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005
   Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006
   Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154
   King JS, 2011, AUTOPHAGY, V7, P1490, DOI 10.4161/auto.7.12.17924
   Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023
   Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124
   Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960
   Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167
   Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792
   Lima Wanessa C, 2013, Methods Mol Biol, V983, P445, DOI 10.1007/978-1-62703-302-2_25
   Lima WC, 2012, J CELL SCI, V125, P2315, DOI 10.1242/jcs.100362
   Lombardi ML, 2008, EXP CELL RES, V314, P1850, DOI 10.1016/j.yexcr.2008.02.001
   Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662
   Lusche DF, 2012, J CELL SCI, V125, P1770, DOI 10.1242/jcs.098301
   MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6
   Mennesson E, 2006, J CONTROL RELEASE, V114, P389, DOI 10.1016/j.jconrel.2006.06.006
   Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190
   Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003
   Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069
   Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076
   Patel A, 2010, NAT REV NEPHROL, V6, P530, DOI 10.1038/nrneph.2010.97
   Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8
   Qian F, 2005, PFLUG ARCH EUR J PHY, V451, P277, DOI 10.1007/s00424-005-1469-4
   Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179
   Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215
   Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4
   Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93
   Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248
   Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045
   Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103
   Su ZW, 2009, PFLUG ARCH EUR J PHY, V458, P861, DOI 10.1007/s00424-009-0680-0
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Traynor D, 2000, EMBO J, V19, P4846, DOI 10.1093/emboj/19.17.4846
   Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934
   Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819
   Wilczynska Z, 2005, EUKARYOT CELL, V4, P1513, DOI 10.1128/EC.4.9.1513-1525.2005
   Witzgall R, 2005, N-S ARCH PHARMACOL, V371, P342, DOI 10.1007/s00210-005-1027-9
   Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437
   Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x
   Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus
NR 57
TC 13
Z9 13
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2014
VL 9
IS 2
AR e88682
DI 10.1371/journal.pone.0088682
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7CL
UT WOS:000331254600105
PM 24520414
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hettwer, S
   Lin, S
   Kucsera, S
   Haubitz, M
   Oliveri, F
   Fariello, RG
   Ruegg, MA
   Vrijbloed, JW
AF Hettwer, Stefan
   Lin, Shuo
   Kucsera, Stefan
   Haubitz, Monika
   Oliveri, Filippo
   Fariello, Ruggero G.
   Ruegg, Markus A.
   Vrijbloed, Jan W.
TI Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably
   Improves the Muscle Pathology Caused by the Disassembly of the
   Neuromuscular Junction
SO PLOS ONE
LA English
DT Article
ID RECEPTOR TYROSINE KINASE; PROTEOLYTIC CLEAVAGE; SKELETAL-MUSCLE;
   DISTINCT ROLES; ISOFORMS; MUSK; NEUROTRYPSIN; DIFFER; NERVE
AB Treatment of neuromuscular diseases is still an unsolved problem. Evidence over the last years strongly indicates the involvement of malformation and dysfunction of neuromuscular junctions in the development of such medical conditions. Stabilization of NMJs thus seems to be a promising approach to attenuate the disease progression of muscle wasting diseases. An important pathway for the formation and maintenance of NMJs is the agrin/Lrp4/MuSK pathway. Here we demonstrate that the agrin biologic NT-1654 is capable of activating the agrin/Lrp4/MuSK system in vivo, leading to an almost full reversal of the sarcopenia-like phenotype in neurotrypsin-overexpressing (SARCO) mice. We also show that injection of NT-1654 accelerates muscle re-innervation after nerve crush. This report demonstrates that a systemically administered agrin fragment has the potential to counteract the symptoms of neuromuscular disorders.
C1 [Hettwer, Stefan; Kucsera, Stefan; Haubitz, Monika; Fariello, Ruggero G.; Vrijbloed, Jan W.] Neurotune AG, Zurich, Switzerland.
   [Lin, Shuo; Oliveri, Filippo; Ruegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hettwer, S (corresponding author), Neurotune AG, Zurich, Switzerland.
EM stefan.hettwer@neurotune.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Swiss Commission for Technology and Innovation (CTI) [12887.1]
FX This work was supported by the Swiss Commission for Technology and
   Innovation (CTI), project number 12887.1. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bogdanik LP, 2011, HUM MOL GENET, V20, P4617, DOI 10.1093/hmg/ddr396
   Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090
   Butikofer L, 2011, FASEB J, V25, P4378, DOI 10.1096/fj.11-191262
   Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Cenacchi G, 2011, J NEUROL, V258, P746, DOI 10.1007/s00415-010-5823-x
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007
   Deschenes MR, 2004, SPORTS MED, V34, P809, DOI 10.2165/00007256-200434120-00002
   Dupuis L, 2010, CURR DRUG TARGETS, V11, P1250, DOI 10.2174/1389450111007011250
   Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791
   FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Hettwer S, 2013, EXP GERONTOL, V48, P69, DOI 10.1016/j.exger.2012.03.002
   Ko IK, 2013, BIOMATERIALS, VS0142-9612
   Koneczny I, 2013, J ANAT, DOI [10.1111/joa. 12034, DOI 10.1111/J0A.12034]
   Krakora D, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/379657
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Motomura Masakatsu, 2013, Brain Nerve, V65, P433
   Murray LM, 2013, NEUROBIOL DIS, V49, P57, DOI 10.1016/j.nbd.2012.08.019
   NOVIKOFF AB, 1980, J HISTOCHEM CYTOCHEM, V28, P1036, DOI 10.1177/28.9.7410815
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006
   Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004
   Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, P31
   Punga AR, 2011, EUR J NEUROSCI, V33, P890, DOI 10.1111/j.1460-9568.2010.07569.x
   Reif R, 2008, PROTEIN EXPRES PURIF, V61, P13, DOI 10.1016/j.pep.2008.06.003
   Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   Samuel MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046663
   SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810
   Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200
   Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008
   TSUJI S, 1984, HISTOCHEMISTRY, V81, P129, DOI 10.1007/BF00490105
   Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107
   Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696
   Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033
NR 42
TC 31
Z9 31
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 10
PY 2014
VL 9
IS 2
AR e88739
DI 10.1371/journal.pone.0088739
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA7CL
UT WOS:000331254600111
PM 24520420
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Vasquez, D
   Milusheva, R
   Baumann, P
   Constantin, D
   Chami, M
   Palivan, CG
AF Vasquez, Daniela
   Milusheva, Rakiya
   Baumann, Patric
   Constantin, Doru
   Chami, Mohamed
   Palivan, Cornelia G.
TI The Amine Content of PEGylated Chitosan Bombyx mori Nanoparticles Acts
   as a Trigger for Protein Delivery
SO LANGMUIR
LA English
DT Article
ID PEG-GRAFTED CHITOSAN; DRUG-DELIVERY; INTRACELLULAR DELIVERY; TARGETED
   DELIVERY; RELEASE; GLYCOL); ALBUMIN; MICROSPHERES; AGGREGATION;
   DERIVATIVES
AB In modern medicine, effective protein therapy is a major challenge to which a significant contribution can be expected from nanoscience through the development of novel delivery systems. Here we present the effect of the amine content of nanoparticles based on PEGylated chitosan Bombyx mori (PEG-O-ChsBm) copolymers on the entrapment of molecules in a search for highly efficient,nanocarriers. PEG-O-ChsBm copolymers were synthesized with amine contents from 1.12% to 0.70%, and nanoparticles were generated by self-assembly in dilute aqueous solutions. These nanoparticles successfully entrapped molecules with a wide range of sizes, the efficiency of which was dependent on their amine contents. While hydrophobic molecules were entrapped with high efficiency in all types of nanoparticle, hydrophilic molecules were entrapped only in those with low amine content. Bovine serum albumin, selected as a model protein, was entrapped in nanoparticles and efficiently released in acidic conditions. The triggered entrapment of molecules in PEG-O-ChsBm nanoparticles by selection of the appropriate amine content represents a straightforward way to modulate their delivery by fine changes in the properties of nanocarriers.
C1 [Vasquez, Daniela; Baumann, Patric; Palivan, Cornelia G.] Univ Basel, Dept Phys Chem, CH-4056 Basel, Switzerland.
   [Milusheva, Rakiya] Acad Sci Uzbek, Inst Polymer Chem & Phys, Tashkent, Uzbekistan.
   [Constantin, Doru] Univ Paris 11, CNRS, Lab Phys Solides, UMR 8502, F-91405 Orsay, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
RP Palivan, CG (corresponding author), Univ Basel, Dept Phys Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM cornelia.palivan@unibas.ch
RI Constantin, Doru/H-8495-2013
OI Constantin, Doru/0000-0001-5623-9633
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); National Center of Competence in Nanoscale Science
FX Financial support was provided by the Swiss National Science Foundation
   and the National Center of Competence in Nanoscale Science and is
   gratefully acknowledged. C.P. thanks Prof. W. Meier from the University
   of Basel for fruitful discussions. R.M. thanks the Swiss National
   Foundation for the International Short Visit fellowship, which served
   for the synthesis of the copolymers. D.V. acknowledges Gabriele Persy
   (University of Basel) for TEM measurements, and Patrick Judeinstein from
   Laboratoire Leon Brillouin (LLB) of the CEA-Saclay, for SANS
   experiments. D.V. thanks Adrian Najer (University of Basel) for the
   analysis of FCS experimental data. Authors thank Dr. B.A. Goodman for
   editing the manuscript.
CR Bae K, 2009, PHARM RES-DORDR, V26, P93, DOI 10.1007/s11095-008-9713-1
   Bentley MD, 2003, Patent No. [US 6,602,952 B1, 6602952]
   Brown Larry R, 2005, Expert Opin Drug Deliv, V2, P29, DOI 10.1517/17425247.2.1.29
   Casettari L, 2012, PROG POLYM SCI, V37, P659, DOI 10.1016/j.progpolymsci.2011.10.001
   Chavda H, 2010, J PHARM BIOALLIED SC, V2, P124, DOI 10.4103/0975-7406.67010
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Falabella CA, 2009, J BIOMAT SCI-POLYM E, V20, P903, DOI 10.1163/156856209X444330
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gorochovceva N, 2004, EUR POLYM J, V40, P685, DOI 10.1016/j.eurpolymj.2003.12.005
   Hu Y, 2003, BIOMATERIALS, V24, P2395, DOI 10.1016/S0142-9612(03)00021-8
   Hu YQ, 2005, CARBOHYD POLYM, V61, P472, DOI 10.1016/j.carbpol.2005.06.022
   Huang M, 2004, PHARM RES-DORDR, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jeong YI, 2006, J PHARM SCI-US, V95, P2348, DOI 10.1002/jps.20586
   Jiang X, 2006, J GENE MED, V8, P477, DOI 10.1002/jgm.868
   Kim JY, 2013, BIOMATERIALS, V34, P1170, DOI 10.1016/j.biomaterials.2012.09.047
   Kolhe P, 2003, BIOMACROMOLECULES, V4, P173, DOI 10.1021/bm025689+
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Malhotra M, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S43683
   Malhotra M, 2011, INT J NANOMED, V6, P485, DOI 10.2147/IJN.S17190
   Mao S, 2005, PHARM RES-DORDR, V22, P2058, DOI 10.1007/s11095-005-8175-y
   Margarson MP, 2004, BRIT J ANAESTH, V92, P821, DOI 10.1093/bja/aeh111
   Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001
   Ouchi T, 1998, POLYMER, V39, P5171, DOI 10.1016/S0032-3861(97)10020-9
   Papadimitriou SA, 2012, INT J PHARMACEUT, V430, P318, DOI 10.1016/j.ijpharm.2012.04.004
   Park IK, 2001, J CONTROL RELEASE, V76, P349, DOI 10.1016/S0168-3659(01)00448-5
   Prego C, 2006, J CONTROL RELEASE, V111, P299, DOI 10.1016/j.jconrel.2005.12.015
   Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030
   Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720
   Rashidova S. S., 2004, CHROMATOGRAPHIA, V59, P11
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Shanthi C. N., 2010, INT J PHARMTECH RES, V2, P675
   Silva SS, 2003, EUR POLYM J, V39, P1515, DOI 10.1016/S0014-3057(03)00013-2
   Sinha VR, 2004, INT J PHARMACEUT, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Stauch O, 2002, BIOMACROMOLECULES, V3, P565, DOI 10.1021/bm0200074
   Sun W, 2010, INT J PHARMACEUT, V386, P275, DOI 10.1016/j.ijpharm.2009.11.025
   Tanner P, 2011, FEBS LETT, V585, P1699, DOI 10.1016/j.febslet.2011.05.003
   VANSAARLOOS W, 1987, PHYSICA A, V147, P280, DOI 10.1016/0378-4371(87)90111-7
   WILTZIUS P, 1987, PHYS REV LETT, V59, P2123, DOI 10.1103/PhysRevLett.59.2123
   Wu Y, 2005, INT J PHARMACEUT, V295, P235, DOI 10.1016/j.ijpharm.2005.01.042
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   YADAV G, 2013, MIDDLE EAST J SCI RE, V16, P782, DOI DOI 10.5829/idosi.mejsr.2013.16.06.75176
   Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]
   Yang XD, 2008, COLLOID SURFACE B, V61, P125, DOI 10.1016/j.colsurfb.2007.07.012
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang XG, 2008, J MATER SCI-MATER M, V19, P3525, DOI 10.1007/s10856-008-3500-8
   Zhang XG, 2008, EUR J PHARM BIOPHARM, V68, P526, DOI 10.1016/j.ejpb.2007.08.009
NR 48
TC 14
Z9 15
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 4
PY 2014
VL 30
IS 4
BP 965
EP 975
DI 10.1021/la404558g
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AA3TO
UT WOS:000331015600002
PM 24422910
DA 2021-01-25
ER

PT J
AU Iijima, T
   Iijima, Y
   Witte, H
   Scheiffele, P
AF Iijima, Takatoshi
   Iijima, Yoko
   Witte, Harald
   Scheiffele, Peter
TI Neuronal cell type-specific alternative splicing is regulated by the KH
   domain protein SLM1
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID SYNAPSE FORMATION; TRANSSYNAPTIC INTERACTION; CEREBELLAR DEVELOPMENT;
   GERM-CELLS; NEUREXIN; SAM68; NEUROLIGINS; BINDING; SPERMATOGENESIS;
   HIPPOCAMPUS
AB The unique functional properties and molecular identity of neuronal cell populations rely on cell type-specific gene expression programs. Alternative splicing represents a powerful mechanism for expanding the capacity of genomes to generate molecular diversity. Neuronal cells exhibit particularly extensive alternative splicing regulation. We report a highly selective expression of the KH domain-containing splicing regulators SLM1 and SLM2 in the mouse brain. Conditional ablation of SLM1 resulted in a severe defect in the neuronal isoform content of the polymorphic synaptic receptors neurexin-1, -2, and -3. Thus, cell type-specific expression of SLM1 provides a mechanism for shaping the molecular repertoires of synaptic adhesion molecules in neuronal populations in vivo.
C1 [Iijima, Takatoshi; Iijima, Yoko; Witte, Harald; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kanton Basel-Stadt; Uehara Memorial FoundationUehara Memorial
   Foundation; KANAE Foundation for the Promotion of Medical Science;
   Astellas Foundation for Research on Metabolic Disorders
FX This work was supported by funds to P. Scheiffele from the Swiss
   National Science Foundation and the Kanton Basel-Stadt. T. Iijima was
   supported by the Uehara Memorial Foundation, KANAE Foundation for the
   Promotion of Medical Science, and Astellas Foundation for Research on
   Metabolic Disorders.
CR Altman J., 1997, RELATION ITS EVOLUTI, P230
   Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060
   Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024
   Beck ES, 2012, J NEUROSCI, V32, P7058, DOI 10.1523/JNEUROSCI.3717-11.2012
   Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026
   Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005
   Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011
   de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019
   Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710
   Ehrmann I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003474
   Fisette JF, 2010, RNA, V16, P228, DOI 10.1261/rna.1890310
   Futai K, 2013, J NEUROSCI, V33, P3612, DOI 10.1523/JNEUROSCI.1811-12.2013
   Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47
   Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111
   Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006
   Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549
   HAWLEY RG, 1994, GENE THER, V1, P136
   Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028
   Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x
   Klein ME, 2013, P NATL ACAD SCI USA, V110, P3125, DOI 10.1073/pnas.1209811110
   Kuroyanagi H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003337
   Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380
   Lawrence JJ, 2008, TRENDS NEUROSCI, V31, P317, DOI 10.1016/j.tins.2008.03.008
   Lipscombe D, 2013, BBA-BIOMEMBRANES, V1828, P1522, DOI 10.1016/j.bbamem.2012.09.018
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035
   Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x
   Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185
   Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3
   Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011
   Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138
   Rajan P, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-82
   Richard S, 2005, PLOS GENET, V1, P676, DOI 10.1371/journal.pgen.0010074
   Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007
   Saito H, 2005, BIOCHEM BIOPH RES CO, V331, P1216, DOI 10.1016/j.bbrc.2005.04.043
   Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080
   Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302
   Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010
   Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011
   Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007
   Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026
   Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035
   Venables JP, 1999, HUM MOL GENET, V8, P959, DOI 10.1093/hmg/8.6.959
   Zheng S, 2013, TRENDS GENET, V29, P442, DOI 10.1016/j.tig.2013.04.003
   Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009
NR 48
TC 44
Z9 48
U1 0
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD FEB 3
PY 2014
VL 204
IS 3
BP 331
EP 342
DI 10.1083/jcb.201310136
PG 12
WC Cell Biology
SC Cell Biology
GA AA2IR
UT WOS:000330918800007
PM 24469635
OA Other Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Irvine, AG
   Slynko, V
   Nikolaev, Y
   Senthamarai, RRP
   Pervushin, K
AF Irvine, Alistair G.
   Slynko, Vadim
   Nikolaev, Yaroslav
   Senthamarai, Russell R. P.
   Pervushin, Konstantin
TI Collaborative development for setup, execution, sharing and analytics of
   complex NMR experiments
SO JOURNAL OF MAGNETIC RESONANCE
LA English
DT Article
DE NMR experiment database; NMR Wiki; Collaborative development; Pulse
   program optimisation; Spin dynamics analysis; Signal-to-noise prediction
ID SIMULATION; PROGRAM; RESONANCE
AB Factory settings of NMR pulse sequences are rarely ideal for every scenario in which they are utilised. The optimisation of NMR experiments has for many years been performed locally, with implementations often specific to an individual spectrometer. Furthermore, these optimised experiments are normally retained solely for the use of an individual laboratory, spectrometer or even single user. Here we introduce a web-based service that provides a database for the deposition, annotation and optimisation. of NMR experiments. The application uses a Wiki environment to enable the collaborative development of pulse sequences. It also provides a flexible mechanism to automatically generate NMR experiments from deposited sequences.
   Multidimensional NMR experiments of proteins and other macromolecules consume significant resources, in terms of both spectrometer time and effort required to analyse the results. Systematic analysis of simulated experiments can enable optimal allocation of NMR resources for structural analysis of proteins. Our web-based application (http://nmrplus.org) provides all the necessary information, includes the auxiliaries (waveforms, decoupling sequences etc.), for analysis of experiments by accurate numerical simulation of multidimensional NMR experiments. The online database of the NMR experiments, together with a systematic evaluation of their sensitivity, provides a framework for selection of the most efficient pulse sequences. The development of such a framework provides a basis for the collaborative optimisation of pulse sequences by the NMR community, with the benefits of this collective effort being available to the whole community. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Irvine, Alistair G.; Senthamarai, Russell R. P.; Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Slynko, Vadim; Nikolaev, Yaroslav; Pervushin, Konstantin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM kpervushin@ntu.edu.sg
RI Pervushin, Konstantin/AAJ-6580-2020; Nikolaev, Yaroslav/I-1976-2013
OI Pervushin, Konstantin/0000-0002-6393-4340; Nikolaev,
   Yaroslav/0000-0002-1479-7474
FU Singapore National Research FoundationSingapore National Research
   Foundation; Singapore Ministry of EducationMinistry of Education,
   Singapore; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); NRF CRPSingapore National Research Foundation; MOE
   ARC; SNF
FX The authors thank Singapore National Research Foundation, Singapore
   Ministry of Education as well as Swiss National Science Foundation for
   financial support (NRF CRP, MOE ARC Tier-2 grants and SNF grant to
   Konstantin Pervushin, respectively). The authors would like to thank
   RIKEN NMR facility (japan) for the production of truncated constructs of
   beta-catenin and acquisition of triple-resonance spectra.
CR Allman T, 1996, J MAGN RESON SER A, V123, P26, DOI 10.1006/jmra.1996.0210
   Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179
   Blanton WB, 2003, J MAGN RESON, V162, P269, DOI 10.1016/S1090-7807(03)00035-1
   de la Roche M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1680
   DEBOUREGAS FS, 1992, J MAGN RESON, V96, P280, DOI 10.1016/0022-2364(92)90081-H
   Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253
   Kuprov I, 2008, J MAGN RESON, V195, P45, DOI 10.1016/j.jmr.2008.08.008
   Kuprov I, 2007, J MAGN RESON, V189, P241, DOI 10.1016/j.jmr.2007.09.014
   Kuprov I, 2007, J MAGN RESON, V184, P196, DOI 10.1016/j.jmr.2006.09.023
   Nicholas P, 2000, J MAGN RESON, V145, P262, DOI 10.1006/jmre.2000.2108
   Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7
   Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690
   Senthamarai RRP, 2010, J MAGN RESON, V203, P129, DOI 10.1016/j.jmr.2009.12.008
   SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008
   Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975
NR 15
TC 2
Z9 2
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1090-7807
EI 1096-0856
J9 J MAGN RESON
JI J. Magn. Reson.
PD FEB
PY 2014
VL 239
BP 121
EP 129
DI 10.1016/j.jmr.2013.12.004
PG 9
WC Biochemical Research Methods; Physics, Atomic, Molecular & Chemical;
   Spectroscopy
SC Biochemistry & Molecular Biology; Physics; Spectroscopy
GA AB5UV
UT WOS:000331855100018
PM 24472492
DA 2021-01-25
ER

PT J
AU Astasov-Frauenhoffer, M
   Braissant, O
   Hauser-Gerspach, I
   Weiger, R
   Walter, C
   Zitzmann, NU
   Waltimo, T
AF Astasov-Frauenhoffer, Monika
   Braissant, Olivier
   Hauser-Gerspach, Irmgard
   Weiger, Roland
   Walter, Clemens
   Zitzmann, Nicola U.
   Waltimo, Tuomas
TI Microcalorimetric Determination of the Effects of Amoxicillin,
   Metronidazole, and Their Combination on In Vitro Biofilm
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Amoxicillin; biofilms; calorimetry; metronidazole; microbial sensitivity
   tests; peri-implantitis
ID ISOTHERMAL MICROCALORIMETRY; STAPHYLOCOCCUS-AUREUS; SUSCEPTIBILITY;
   PERIODONTITIS; VANCOMYCIN; THERAPY; GROWTH; RESISTANCE
AB Background: The mechanism of action of adjuvant antibiotic therapy in the treatment of peri-implantitis is not well understood. The aim of this study is to investigate antibiotic susceptibility of an in vitro biofilm by isothermal microcalorimetry (IMC).
   Methods: Titanium disks containing a 72-hour three-species biofilm (Streptococcus sanguinis DSM20068, Fusobacterium nucleatum ATCC10953, and Porphyromonas gingivalis DSM20709) were placed in a series of IMC ampoules with nutrient agar supplemented with increasing concentrations of amoxicillin, metronidazole, or their combination and incubated anaerobically for 10 days. Lag time and maximum growth rate were determined from continuous heat-flow recordings of metabolic activity. To validate the IMC biofilm results, adherent S. sanguinis and P. gingivalis were incubated anaerobically in medium supplemented with antibiotics at 37 degrees C for 24 hours, and their vitality was determined by live/dead staining, conventional culturing, and IMC.
   Results: In all biofilm samples incubated with antibiotics, a prolonged lag phase was observed compared with controls (P < 0.05). Maximum growth rate was significantly lower for samples treated with either amoxicillin or metronidazole compared with controls (P < 0.05). Combining the antibiotics did not improve this effect. Concentrations exceeding 10 times the minimum inhibitory concentration completely inhibited the growth of adherent S. sanguinis and P. gingivalis, whereas lower concentrations resulted in only a delay in the lag phase. A poor correlation was observed between live/dead staining and conventional culturing.
   Conclusions: IMC gives new evidence about antibiotic effects on oral biofilms and is more informative than conventional culture and live/dead assays. The combination of antibiotics was found to be more efficient than metronidazole alone; however, only minor differences in growth inhibition were detected compared with amoxicillin alone.
C1 [Astasov-Frauenhoffer, Monika; Hauser-Gerspach, Irmgard; Waltimo, Tuomas] Univ Basel, Clin Prevent Dent & Oral Microbiol, Sch Dent Med, CH-4056 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Weiger, Roland; Walter, Clemens; Zitzmann, Nicola U.] Univ Basel, Dept Periodontol Endodontol & Cariol, CH-4056 Basel, Switzerland.
RP Astasov-Frauenhoffer, M (corresponding author), Univ Basel, Clin Prevent Dent & Oral Microbiol, Sch Dent Med, Hebelstr 3, CH-4056 Basel, Switzerland.
EM m.astasov-frauenhoffer@unibas.ch
RI Walter, Clemens/H-3353-2011; Braissant, Olivier/AAO-2371-2020;
   Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X; Astasov-Frauenhoffer,
   Monika/0000-0001-9638-3939
CR Albrektsson T, 1993, P 1 EUR WORKSH PER, P365
   Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007
   Astasov-Frauenhoffer M, 2011, J MATER SCI-MATER M, V22, P2045, DOI 10.1007/s10856-011-4377-5
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   Braissant O, 2013, THERMOCHIM ACTA, V555, P64, DOI 10.1016/j.tca.2012.12.005
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Clinical and Laboratory Standards Institute, 1999, METH DET BACT ACT AN
   Gilbert P, 2002, ADV MICROB PHYSIOL, V46, P203, DOI 10.1016/S0065-2911(02)46005-5
   Guerrero A, 2005, J CLIN PERIODONTOL, V32, P1096, DOI 10.1111/j.1600-051X.2005.00814.x
   Haffajee AD, 2006, PERIODONTOL 2000, V42, P219, DOI 10.1111/j.1600-0757.2006.00191.x
   Heitz-Mayfield LJA, 2012, CLIN ORAL IMPLAN RES, V23, P205, DOI 10.1111/j.1600-0501.2011.02276.x
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Howell M, 2012, J CLIN MICROBIOL, V50, P16, DOI 10.1128/JCM.05556-11
   Huang Q, 2012, ORTHOPEDICS, V35, pE53, DOI 10.3928/01477447-20111122-11
   Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08
   Kabanova N, 2012, FOOD MICROBIOL, V29, P67, DOI 10.1016/j.fm.2011.08.018
   Krayer Joe W, 2010, Dent Clin North Am, V54, P13, DOI 10.1016/j.cden.2009.08.010
   Mihhalevski A, 2011, J APPL MICROBIOL, V110, P529, DOI 10.1111/j.1365-2672.2010.04904.x
   Mouratidou A, 2011, J PERIODONTOL, V82, P1360, DOI 10.1902/jop.2011.100657
   Nguyen AH, 2012, ANTIMICROB AGENTS CH, V56, P3776, DOI 10.1128/AAC.00114-12
   Persson Leif G, 2004, Clin Implant Dent Relat Res, V6, P230, DOI 10.1111/j.1708-8208.2004.tb00039.x
   Shen Y, 2010, J ENDODONT, V36, P1820, DOI 10.1016/j.joen.2010.08.029
   Skucaite N, 2010, J ENDODONT, V36, P1611, DOI 10.1016/j.joen.2010.04.009
   Stephens C, 2002, CURR BIOL, V12, pR132, DOI 10.1016/S0960-9822(02)00706-6
   Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838
   Tafin UF, 2012, CLIN MICROBIOL INFEC, V18, pE241, DOI 10.1111/j.1469-0691.2012.03854.x
   Tafin UF, 2011, ANTIMICROB AGENTS CH, V55, P4821, DOI 10.1128/AAC.00141-11
   Teles RP, 2006, PERIODONTOL 2000, V42, P180, DOI 10.1111/j.1600-0757.2006.00192.x
   Trampuz A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-116
   VANWINKELHOFF AJ, 1989, J CLIN PERIODONTOL, V16, P128
   VANWINKELHOFF AJ, 1992, J PERIODONTOL, V63, P52, DOI 10.1902/jop.1992.63.1.52
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   Walter Clemens, 2011, J Int Acad Periodontol, V13, P11
   Winkel EG, 2001, J CLIN PERIODONTOL, V28, P296, DOI 10.1034/j.1600-051x.2001.028004296.x
   Wohlfahrt JC, 2012, INT J ORAL MAX IMPL, V27, P401
NR 36
TC 24
Z9 25
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2014
VL 85
IS 2
BP 349
EP 357
DI 10.1902/jop.2013.120733
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AA5LI
UT WOS:000331140100020
PM 23594193
DA 2021-01-25
ER

PT J
AU Galhardo, M
   Sinkkonen, L
   Berninger, P
   Lin, J
   Sauter, T
   Heinaniemi, M
AF Galhardo, Mafalda
   Sinkkonen, Lasse
   Berninger, Philipp
   Lin, Jake
   Sauter, Thomas
   Heinaniemi, Merja
TI Integrated analysis of transcript-level regulation of metabolism reveals
   disease-relevant nodes of the human metabolic network
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; GENOME-WIDE ANALYSIS; LIVER X RECEPTOR;
   ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; BINDING-SITES; GLOBAL
   RECONSTRUCTION; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; GAMMA
AB Metabolic diseases and comorbidities represent an ever-growing epidemic where multiple cell types impact tissue homeostasis. Here, the link between the metabolic and gene regulatory networks was studied through experimental and computational analysis. Integrating gene regulation data with a human metabolic network prompted the establishment of an open-sourced web portal, IDARE (Integrated Data Nodes of Regulation), for visualizing various gene-related data in context of metabolic pathways. Motivated by increasing availability of deep sequencing studies, we obtained ChIP-seq data from widely studied human umbilical vein endothelial cells. Interestingly, we found that association of metabolic genes with multiple transcription factors (TFs) enriched disease-associated genes. To demonstrate further extensions enabled by examining these networks together, constraint-based modeling was applied to data from human preadipocyte differentiation. In parallel, data on gene expression, genome-wide ChIP-seq profiles for peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer binding protein (CEBP) alpha, liver X receptor (LXR) and H3K4me3 and microRNA target identification for miR-27a, miR-29a and miR-222 were collected. Disease-relevant key nodes, including mitochondrial glycerol-3-phosphate acyltransferase (GPAM), were exposed from metabolic pathways predicted to change activity by focusing on association with multiple regulators. In both cell types, our analysis reveals the convergence of microRNAs and TFs within the branched chain amino acid (BCAA) metabolic pathway, possibly providing an explanation for its downregulation in obese and diabetic conditions.
C1 [Galhardo, Mafalda; Sinkkonen, Lasse; Sauter, Thomas; Heinaniemi, Merja] Univ Luxembourg, Life Sci Res Unit, L-1511 Luxembourg, Luxembourg.
   [Berninger, Philipp] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Berninger, Philipp] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Lin, Jake] Inst Syst Biol, Seattle, WA 98109 USA.
   [Lin, Jake] Univ Luxembourg, Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg.
   [Heinaniemi, Merja] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FI-70211 Kuopio, Finland.
RP Heinaniemi, M (corresponding author), Univ Luxembourg, Life Sci Res Unit, 162a Ave Faiencerie, L-1511 Luxembourg, Luxembourg.
EM thomas.sauter@uni.lu; merja.heinaniemi@uef.fi
RI Heinaniemi, Merja/AAS-4530-2020
OI Heinaniemi, Merja/0000-0001-6190-3439; Galhardo,
   Mafalda/0000-0001-8911-1660; Lin, Jake/0000-0001-9928-1663
FU Fonds National de la Recherche Luxembourg [AFR]Luxembourg National
   Research Fund [AM2c, C08/BM/01]; University of Eastern Finland;
   Fondation du Pelican de Mie et Pierre Hippert-Faber under the aegis of
   Fondation de Luxembourg; University of Luxembourg
FX Fonds National de la Recherche Luxembourg [AFR, AM2c and C08/BM/01];
   funding from the University of Eastern Finland and the Fondation du
   Pelican de Mie et Pierre Hippert-Faber under the aegis of Fondation de
   Luxembourg. Funding for open access charge: University of Luxembourg.
CR Basel-Vanagaite L, 2012, AM J HUM GENET, V90, P49, DOI 10.1016/j.ajhg.2011.11.028
   Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538
   Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002
   Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299
   Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11
   Brockmoller SF, 2012, J PROTEOME RES, V11, P850, DOI 10.1021/pr200685r
   Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312
   Castoldi M, 2008, NAT PROTOC, V3, P321, DOI 10.1038/nprot.2008.4
   Cho N, 2008, CURR TOP MED CHEM, V8, P1483, DOI 10.2174/156802608786413474
   Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1
   Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9
   Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Feldmann R, 2013, NUCLEIC ACIDS RES, V41, P3518, DOI 10.1093/nar/gkt034
   FRANCKE U, 1984, P NATL ACAD SCI-BIOL, V81, P2826, DOI 10.1073/pnas.81.9.2826
   Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411
   GIBSON DM, 1982, ADV ENZYME REGUL, V20, P263, DOI 10.1016/0065-2571(82)90020-6
   Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939
   Gregersen LH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-232
   HARLAN WR, 1967, J CLIN INVEST, V46, P239, DOI 10.1172/JCI105526
   He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167
   Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226
   Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184
   Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2
   Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010
   IGNARRO LJ, 1989, PHARMACEUT RES, V6, P651, DOI 10.1023/A:1015926119947
   John E., 2012, NUCLEIC ACIDS RES, V40, P1
   Kanter JE, 2012, BBA-MOL CELL BIOL L, V1821, P358, DOI 10.1016/j.bbalip.2011.10.008
   Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098
   Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012
   Kwee SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046591
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09
   Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024
   Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x
   Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042
   McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   MCNAMARA JP, 1982, AM J PHYSIOL, V243, pR258
   McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447
   Mersey BD, 2005, HUM MOL GENET, V14, P3371, DOI 10.1093/hmg/ddi368
   Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006
   Mudhasani R, 2010, J CELL BIOCHEM, V110, P812, DOI 10.1002/jcb.22625
   Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024
   Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117
   Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010
   Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108
   Ono K, 2012, J CARDIOL, V60, P339, DOI 10.1016/j.jjcc.2012.07.014
   Peterfy M, 2001, NAT GENET, V27, P121
   Qin Y, 2009, BBA-MOL CELL BIOL L, V1791, P140, DOI 10.1016/j.bbalip.2008.12.003
   Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155
   Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008
   Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313
   Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152
   Shiraki T, 2005, J BIOL CHEM, V280, P14145, DOI 10.1074/jbc.M500901200
   Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487
   Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12
   Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454
   Suarez RK, 2012, J EXP BIOL, V215, P2351, DOI 10.1242/jeb.059725
   Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298
   Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702
   Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488
   Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246
   Vickers K.C., 2012, HEPATOLOGY, V01, P1
   Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520
   Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105
   Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538
   Wessely F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.46
   World Health Organization, 2000, GLOB STAT REP NONC D
   Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974
NR 75
TC 25
Z9 26
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB
PY 2014
VL 42
IS 3
BP 1474
EP 1496
DI 10.1093/nar/gkt989
PG 23
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AA5KX
UT WOS:000331138800013
PM 24198249
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kryshtafovych, A
   Barbato, A
   Fidelis, K
   Monastyrskyy, B
   Schwede, T
   Tramontano, A
AF Kryshtafovych, Andriy
   Barbato, Alessandro
   Fidelis, Krzysztof
   Monastyrskyy, Bohdan
   Schwede, Torsten
   Tramontano, Anna
TI Assessment of the assessment: Evaluation of the model quality estimates
   in CASP10
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
ID PROTEIN-STRUCTURE PREDICTION; ABSOLUTE QUALITY; RECOGNITION; SERVER; WEB
C1 [Kryshtafovych, Andriy; Fidelis, Krzysztof; Monastyrskyy, Bohdan] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Barbato, Alessandro; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Barbato, Alessandro; Schwede, Torsten] SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Tramontano, Anna] Sapienza Univ Rome, Dept Phys, I-00185 Rome, Italy.
RP Kryshtafovych, A (corresponding author), Univ Calif Davis, Genome Ctr, 451 Hlth Sci Dr, Davis, CA 95616 USA.
EM akryshtafovych@ucdavis.edu
RI Schwede, Torsten/A-4650-2008; Tramontano, anna/D-5378-2009
OI Schwede, Torsten/0000-0003-2715-335X; Tramontano,
   anna/0000-0002-5610-3338; Monastyrskyy, Bohdan/0000-0002-4803-0378;
   Kryshtafoych, Andriy/0000-0001-5066-7178
FU US National Institute of General Medical Sciences (NIGMS/NIH)
   [R01GM100482]; KAUST Award [KUK-I1-012-43]; EMBOEuropean Molecular
   Biology Organization (EMBO); NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM100482, R01GM100482, R01GM100482,
   R01GM100482, R01GM100482, R01GM100482, R01GM100482, R01GM100482,
   R01GM100482] Funding Source: NIH RePORTER
FX Grant sponsor: US National Institute of General Medical Sciences
   (NIGMS/NIH); Grant number: R01GM100482; Grant sponsor: KAUST Award;
   Grant numbers: KUK-I1-012-43; EMBO.
CR Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182
   Kryshtafovych A, 2011, PROTEINS, V79, P91, DOI 10.1002/prot.23180
   Kryshtafovych A, 2009, DRUG DISCOV TODAY, V14, P386, DOI 10.1016/j.drudis.2008.11.010
   Larsson P, 2009, PROTEINS
   Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014
   McGuffin LJ, 2010, BIOINFORMATICS, V26, P182, DOI 10.1093/bioinformatics/btp629
   McGuffin LJ, 2009, PROTEINS, V77, P185, DOI 10.1002/prot.22491
   Moult J, 2008, STRUCTURE, V16, P14, DOI 10.1016/j.str.2007.12.001
   Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200
   Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091
   Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224
   Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Tramontano A, 2006, FEBS LETT, V580, P2928, DOI 10.1016/j.febslet.2006.04.011
   Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319
   Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774
   Wang QG, 2011, PROTEINS, V79, P185, DOI 10.1002/prot.23185
   Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012
NR 29
TC 78
Z9 80
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2014
VL 82
SU 2
SI SI
BP 112
EP 126
DI 10.1002/prot.24347
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AA5NY
UT WOS:000331147900009
PM 23780644
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Cassarino, TG
   Bordoli, L
   Schwede, T
AF Cassarino, Tiziano Gallo
   Bordoli, Lorenza
   Schwede, Torsten
TI Assessment of ligand binding site predictions in CASP10
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
ID FUNCTIONALLY IMPORTANT RESIDUES; SOFTWARE FRAMEWORK; PROTEINS; DATABASE;
   IDENTIFICATION; OPENSTRUCTURE; TEMPLATES; SEQUENCE; DOMAINS; DNA
C1 [Cassarino, Tiziano Gallo; Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Biozentrum, Basel, Switzerland.
   [Cassarino, Tiziano Gallo; Bordoli, Lorenza; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Biozentrum Univ Basel, SIB Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Cassarino, Tiziano Gallo/AAM-2845-2020
OI Schwede, Torsten/0000-0003-2715-335X; Cassarino, Tiziano
   Gallo/0000-0001-9220-2360
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U01
   GM093324-01]; SIB Swiss Institute of Bioinformatics; NATIONAL INSTITUTE
   OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324] Funding Source: NIH RePORTER
FX Grant sponsor: National Institute of General Medical Sciences; grant
   number: U01 GM093324-01; Grant sponsor: SIB Swiss Institute of
   Bioinformatics.
CR Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Biasini M, 2013, ACTA CRYSTALLOGR D, V69, P701, DOI 10.1107/S0907444913007051
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Binkowski TA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-45
   Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12
   Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105
   Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270
   Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585
   Chauviac FX, 2012, J BIOL CHEM, V287, P44372, DOI 10.1074/jbc.M112.406264
   Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626
   Ghersi D, 2009, BIOINFORMATICS, V25, P3185, DOI 10.1093/bioinformatics/btp562
   Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769
   Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19
   Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005
   Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x
   Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181
   Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753
   Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489
   Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109
   Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315
   Lopez G, 2007, NUCLEIC ACIDS RES, V35, pW573, DOI 10.1093/nar/gkm297
   Lopez G, 2007, PROTEINS, V69, P165, DOI 10.1002/prot.21651
   Lopez G, 2007, NUCLEIC ACIDS RES, V35, pD219, DOI 10.1093/nar/gkl897
   Lopez G, 2009, PROTEINS, V77, P138, DOI 10.1002/prot.22557
   Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009
   Mao B, 2013, PROTEINS
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Ponting CP, 1997, PROTEIN SCI, V6, P464
   Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5
   RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183
   Roche DB, 2010, BIOINFORMATICS, V26, P2920, DOI 10.1093/bioinformatics/btq543
   Roy A, 2012, EMBO C CRIT ASS PROT, P57
   Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174
   Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007
   Soro S, 2005, PROTEINS, V61, P201, DOI 10.1002/prot.20738
   Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005
   Tai CH, 2013, PROTEINS
   Taylor TJ, 2013, PROTEINS
   Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406
   Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059
   Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966
   Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200
   Zhang J., 2012, PLOS ONE, V7, pe3035, DOI 10.1371/journal.pone.0030355
NR 45
TC 20
Z9 20
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2014
VL 82
SU 2
SI SI
BP 154
EP 163
DI 10.1002/prot.24495
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AA5NY
UT WOS:000331147900012
PM 24339001
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU van der Woude, AD
   Stoop, EJM
   Stiess, M
   Wang, S
   Ummels, R
   van Stempvoort, G
   Piersma, SR
   Cascioferro, A
   Jimenez, CR
   Houben, ENG
   Luirink, J
   Pieters, J
   van der Sar, AM
   Bitter, W
AF van der Woude, Aniek D.
   Stoop, Esther J. M.
   Stiess, Michael
   Wang, Sen
   Ummels, Roy
   van Stempvoort, Gunny
   Piersma, Sander R.
   Cascioferro, Alessandro
   Jimenez, Connie R.
   Houben, Edith N. G.
   Luirink, Joen
   Pieters, Jean
   van der Sar, Astrid M.
   Bitter, Wilbert
TI Analysis of SecA2-dependent substrates in Mycobacterium marinum
   identifies protein kinase G (PknG) as a virulence effector
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID PATHOGENIC MYCOBACTERIA; SUPEROXIDE-DISMUTASE; VII SECRETION; SECA2
   SYSTEM; LABEL-FREE; TUBERCULOSIS; HOST; GROWTH; MACROPHAGES; PERSISTENCE
AB The pathogenicity of mycobacteria is closely associated with their ability to export virulence factors. For this purpose, mycobacteria possess different protein secretion systems, including the accessory Sec translocation pathway, SecA2. Although this pathway is associated with intracellular survival and virulence, the SecA2-dependent effector proteins remain largely undefined. In this work, we studied a Mycobacterium marinumsecA2 mutant with an impaired capacity to initiate granuloma formation in zebrafish embryos. By comparing the proteomic profile of cell envelope fractions from the secA2 mutant with wild type M.marinum, we identified putative SecA2-dependent substrates. Immunoblotting procedures confirmed SecA2-dependent membrane localization for several of these proteins, including the virulence factor protein kinase G (PknG). Interestingly, phenotypical defects of the secA2 mutant are similar to those described for pknG, including phagosomal maturation. Overexpression of PknG in the secA2 mutant restored its localization to the cell envelope. Importantly, PknG-overexpression also partially restored the virulence of the secA2 mutant, as indicated by enhanced infectivity in zebrafish embryos and restored inhibition of phagosomal maturation. These results suggest that SecA2-dependent membrane localization of PknG is an important determinant for M.marinum virulence.
C1 [van der Woude, Aniek D.; Stoop, Esther J. M.; Ummels, Roy; van Stempvoort, Gunny; Houben, Edith N. G.; van der Sar, Astrid M.; Bitter, Wilbert] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, NL-1081 BT Amsterdam, Netherlands.
   [van der Woude, Aniek D.; Houben, Edith N. G.; Luirink, Joen; Bitter, Wilbert] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands.
   [Stiess, Michael; Wang, Sen; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Piersma, Sander R.; Jimenez, Connie R.] Vrije Univ Amsterdam Med Ctr, OncoProte Lab, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands.
   [Cascioferro, Alessandro] Inst Pasteur Pathogenom Mycobacterienne Integree, F-75724 Paris, France.
RP Bitter, W (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM w.bitter@vumc.nl
RI Houben, Edith N.G./B-2110-2015; Stiess, Michael/ABF-9835-2020; Jimenez,
   Connie/AAI-3763-2020; Bitter, Wilbert/ABG-3726-2020; Bitter,
   Wilbert/AAA-6872-2019; Luirink, Joen/AAB-8658-2021; van der Sar,
   Astrid/A-3698-2008; Cascioferro, Alessandro/E-3445-2017
OI Houben, Edith N.G./0000-0002-8805-2002; Stiess,
   Michael/0000-0001-5363-0389; Bitter, Wilbert/0000-0001-8347-6511; van
   der Sar, Astrid/0000-0001-5790-5036; Luirink, J./0000-0001-8431-0804;
   Cascioferro, Alessandro/0000-0001-7751-7348; Pieters,
   Jean/0000-0002-5284-9757; Stoop, Esther/0000-0001-5149-5734
FU ECHO grant from the Netherlands Organization for Scientific Research;
   Smart Mix Programme of the Netherlands Ministry of Economic
   AffairsMinistry of Economic Affairs, Netherlands; Netherlands Ministry
   of Education, Culture and Science; EMBOEuropean Molecular Biology
   Organization (EMBO); Human Frontiers Science ProgramHuman Frontier
   Science Program; Canton Basel; Optimus Foundation; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
FX This work was supported by funding from an ECHO grant from the
   Netherlands Organization for Scientific Research to A.D.vdW., the Smart
   Mix Programme of the Netherlands Ministry of Economic Affairs and the
   Netherlands Ministry of Education, Culture and Science to E.J.M.S., an
   EMBO and a Human Frontiers Science Program long term fellowship to M.
   S., and the Canton Basel, the Optimus Foundation and the Swiss National
   Science Foundation to J.P. We are grateful to Prof. Paul Martin
   (University of Bristol) for providing the L-plastin antibody. We thank
   Helen O'Hare for fruitful discussions and Lisanne van Leeuwen, Theo
   Verboom, Thang Pham and Wim Schouten for technical assistance.
CR Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x
   Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773
   Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200
   Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x
   Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x
   Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001
   Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596
   Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966
   Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014
   Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2
   Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016
   Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889
   Feltcher ME, 2013, J BACTERIOL, V195, P672, DOI 10.1128/JB.02032-12
   Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006
   Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07
   Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x
   Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001
   Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857
   Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x
   Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x
   Jensen K, 2012, CLIN VACCINE IMMUNOL, V19, P1170, DOI 10.1128/CVI.00184-12
   Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006
   Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558
   Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x
   Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06
   Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100
   Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x
   Ligon LS, 2013, J BACTERIOL, V195, P4456, DOI 10.1128/JB.00630-13
   Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005
   O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x
   Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105
   Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003
   Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]
   Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677
   Piersma SR, 2010, J PROTEOME RES, V9, P1913, DOI 10.1021/pr901072h
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   PUTTINAOWARAT S, 2000, FISH VET J, V5, P6
   Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016
   Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x
   Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200
   Rosenkrands I, 2000, ELECTROPHORESIS, V21, P935, DOI 10.1002/(SICI)1522-2683(20000301)21:5<935::AID-ELPS935>3.3.CO;2-G
   Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09
   Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676
   Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11
   TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493
   Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095
   van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082
   van der Woude AD, 2013, J BACTERIOL, V195, P2050, DOI 10.1128/JB.02236-12
   Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Watkins BY, 2012, INFECT IMMUN, V80, P3512, DOI 10.1128/IAI.00686-12
   WHO, 2011, 2011 2012 TUB GLOB F
   Wolff KA, 2009, ANTIMICROB AGENTS CH, V53, P3515, DOI 10.1128/AAC.00012-09
NR 61
TC 35
Z9 35
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD FEB
PY 2014
VL 16
IS 2
BP 280
EP 295
DI 10.1111/cmi.12221
PG 16
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 287MY
UT WOS:000329547100009
PM 24119166
DA 2021-01-25
ER

PT J
AU Moult, J
   Fidelis, K
   Kryshtafovych, A
   Schwede, T
   Tramontano, A
AF Moult, John
   Fidelis, Krzysztof
   Kryshtafovych, Andriy
   Schwede, Torsten
   Tramontano, Anna
TI Critical assessment of methods of protein structure prediction (CASP) -
   round x
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
ID MASS-SPECTROMETRY; UCSF CHIMERA; MODELS; PROGRESS; ROSETTA; SYSTEM;
   SCORE
C1 [Moult, John] Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.
   [Moult, John] Univ Maryland, Dept Cell Biol & Mol Genet, Rockville, MD 20850 USA.
   [Fidelis, Krzysztof; Kryshtafovych, Andriy] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Schwede, Torsten] Univ Basel, Biozentrum, Basel, Switzerland.
   [Schwede, Torsten] SIB, Basel, Switzerland.
   [Tramontano, Anna] Sapienza Univ Rome, Dept Phys, I-00185 Rome, Italy.
   [Tramontano, Anna] Sapienza Univ Rome, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy.
RP Moult, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.
EM jmoult@umd.edu
RI Schwede, Torsten/A-4650-2008; Tramontano, anna/D-5378-2009
OI Schwede, Torsten/0000-0003-2715-335X; Tramontano,
   anna/0000-0002-5610-3338; Moult, John/0000-0002-3012-2282; Kryshtafoych,
   Andriy/0000-0001-5066-7178
FU US National Institute of General Medical Sciences (NIGMS/NIH)
   [R01GM100482]; KAUST Award [KUK-I1-012-43]; EMBOEuropean Molecular
   Biology Organization (EMBO); NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM100482, R01GM100482, R01GM100482,
   R01GM100482, R01GM100482, R01GM100482, R01GM100482, R01GM100482,
   R01GM100482] Funding Source: NIH RePORTER
FX Grant sponsor: the US National Institute of General Medical Sciences
   (NIGMS/NIH); Grant number: R01GM100482 (to KF); Grant sponsors: KAUST
   Award KUK-I1-012-43 (to AT) and by EMBO.
CR Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5
   Cassarino TG, 2014, PROTEINS, V82, P154, DOI 10.1002/prot.24495
   Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414
   Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488
   Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190
   Kiselar JG, 2010, J MASS SPECTROM, V45, P1373, DOI 10.1002/jms.1808
   Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   Kryshtafovych A, 2014, PROTEINS, V82, P112, DOI 10.1002/prot.24347
   Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489
   Kryshtafovych A, 2014, PROTEINS, V82, P164, DOI 10.1002/prot.24448
   Kryshtafovych A, 2014, PROTEINS, V82, P7, DOI 10.1002/prot.24399
   Kryshtafovych A, 2009, PROTEINS, V77, P217, DOI 10.1002/prot.22562
   Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109
   Levitt M, 1997, ANNU REV BIOCHEM, V66, P549, DOI 10.1146/annurev.biochem.66.1.549
   Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106
   Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473
   Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336
   MONASTYRSKYY B, 2014, PROTEINS S2, V82, P127
   Monastyrskyy B, 2014, PROTEINS, V82, P138, DOI 10.1002/prot.24340
   Moult J, 2005, PROTEINS, V61, P3, DOI 10.1002/prot.20716
   Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556
   Moult J, 2001, PROTEINS, P2
   Moult J, 1999, PROTEINS, P2
   MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303
   Moult J, 1997, PROTEINS, P2
   Moult J, 2008, STRUCTURE, V16, P14, DOI 10.1016/j.str.2007.12.001
   Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767
   Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200
   Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589
   Nugent T, 2014, PROTEINS, V82, P98, DOI 10.1002/prot.24377
   Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172
   Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091
   Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007
   Snyder DA, 2014, PROTEINS, V82, P219, DOI 10.1002/prot.24490
   Tai CH, 2014, PROTEINS, V82, P57, DOI 10.1002/prot.24470
   Taylor TJ, 2014, PROTEINS, V82, P84, DOI 10.1002/prot.24367
   Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261
   Venclovas C, 2001, PROTEINS, P163
   Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
NR 49
TC 239
Z9 245
U1 2
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2014
VL 82
SU 2
SI SI
BP 1
EP 6
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AA5NY
UT WOS:000331147900001
PM 24344053
OA Green Published, Green Accepted, Bronze
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Kryshtafovych, A
   Moult, J
   Bales, P
   Bazan, JF
   Biasini, M
   Burgin, A
   Chen, C
   Cochran, FV
   Craig, TK
   Das, R
   Fass, D
   Garcia-Doval, C
   Herzberg, O
   Lorimer, D
   Luecke, H
   Ma, XL
   Nelson, DC
   van Raaij, MJ
   Rohwer, F
   Segall, A
   Seguritan, V
   Zeth, K
   Schwede, T
AF Kryshtafovych, Andriy
   Moult, John
   Bales, Patrick
   Bazan, J. Fernando
   Biasini, Marco
   Burgin, Alex
   Chen, Chen
   Cochran, Frank V.
   Craig, Timothy K.
   Das, Rhiju
   Fass, Deborah
   Garcia-Doval, Carmela
   Herzberg, Osnat
   Lorimer, Donald
   Luecke, Hartmut
   Ma, Xiaolei
   Nelson, Daniel C.
   van Raaij, Mark J.
   Rohwer, Forest
   Segall, Anca
   Seguritan, Victor
   Zeth, Kornelius
   Schwede, Torsten
TI Challenging the state of the art in protein structure prediction:
   Highlights of experimental target structures for the 10th Critical
   Assessment of Techniques for Protein Structure Prediction Experiment
   CASP10
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
ID GATED UREA CHANNEL; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; CYTOKINES
   IL-34; TERMINAL DOMAIN; GIANT VIRUSES; RECEPTOR; TAILSPIKE;
   BACTERIOPHAGES; RECOGNITION
C1 [Kryshtafovych, Andriy] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Moult, John] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
   [Moult, John; Bales, Patrick; Nelson, Daniel C.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.
   [Bazan, J. Fernando; Ma, Xiaolei] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA.
   [Bazan, J. Fernando; Ma, Xiaolei] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA.
   [Biasini, Marco; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Biasini, Marco; Schwede, Torsten] SIB, CH-4056 Basel, Switzerland.
   [Burgin, Alex] Broad Inst, Cambridge, MA 02142 USA.
   [Cochran, Frank V.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.
   [Craig, Timothy K.; Lorimer, Donald] Emerald Bio, Bainbridge Isle, WA 98110 USA.
   [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA.
   [Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.
   [Garcia-Doval, Carmela; van Raaij, Mark J.] CSIC, CNB, E-28049 Madrid, Spain.
   [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   [Luecke, Hartmut] Univ Calif Irvine, Ctr Biomembrane Syst, Dept Biochem & Biophys, Irvine, CA 92697 USA.
   [Luecke, Hartmut] Univ Calif Irvine, Ctr Biomembrane Syst, Dept Comp Sci, Irvine, CA 92697 USA.
   [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
   [Rohwer, Forest; Segall, Anca; Seguritan, Victor] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.
   [Luecke, Hartmut; Zeth, Kornelius] Univ Basque Country, CSIC, Unidad Biofis, Bizkaia, Spain.
   [Luecke, Hartmut; Zeth, Kornelius] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Torsten.Schwede@unibas.ch
RI Rohwer, Forest/AAC-5315-2019; van Raaij, Mark J/B-3678-2009; Nelson,
   Daniel C./I-2198-2012; Schwede, Torsten/A-4650-2008
OI van Raaij, Mark J/0000-0002-4781-1375; Nelson, Daniel
   C./0000-0003-3248-4831; Schwede, Torsten/0000-0003-2715-335X; Garcia
   Doval, Carmela/0000-0002-3422-9490; Das, Rhiju/0000-0001-7497-0972;
   Kryshtafoych, Andriy/0000-0001-5066-7178; Moult,
   John/0000-0002-3012-2282; Segall, Anca/0000-0002-8454-5248; Craig,
   Timothy/0000-0002-4625-444X; Herzberg, Osnat/0000-0003-2823-7627
FU US National Institutes of Health (NIH)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01AI78000];
   Spanish Ministry of Economy and Competitiveness [BFU2011-24843]; US
   National Institutes of General Medical Sciences (NIGMS/NIH)
   [R01GM100482]; UC Irvine Center for Biomembrane Systems, Spanish
   Ministry of Education; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI078000, R01AI078000, R01AI078000,
   R01AI078000, R01AI078000, R01AI078000, R01AI078000, R01AI078000,
   R01AI078000, R01AI078000] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM100482, R01GM100482,
   R01GM100482, R01GM100482, R01GM100482, R01GM100482, R01GM100482,
   R01GM100482, R01GM100482] Funding Source: NIH RePORTER
FX Grant sponsor: US National Institutes of Health (NIH); Grant number:
   R01AI78000; Grant sponsor: Spanish Ministry of Economy and
   Competitiveness; Grant number: BFU2011-24843; Grant sponsor: US National
   Institutes of General Medical Sciences (NIGMS/NIH); Grant number:
   R01GM100482; Grant sponsors: UC Irvine Center for Biomembrane Systems,
   Spanish Ministry of Education.
CR Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7
   Ackermann HW, 1999, ADV VIRUS RES, V51, P135
   Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5
   Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x
   BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z
   Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877
   Browning C, 2012, STRUCTURE, V20, P326, DOI 10.1016/j.str.2011.12.009
   Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7
   Cassarino TG, 2014, PROTEINS, V82, P154, DOI 10.1002/prot.24495
   Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105
   Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044
   DOVER GA, 1991, CELL, V65, P9, DOI 10.1016/0092-8674(91)90401-J
   Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009
   Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003
   Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109
   Garcia-Doval C, 2012, ACTA CRYSTALLOGR F, V68, P166, DOI 10.1107/S1744309111051049
   Hakim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050649
   Haq IU, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-9
   Heineman RH, 2008, AM NAT, V171, pE149, DOI 10.1086/528962
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   Holm L, 2006, CURR PROTOC BIOINFOR
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887
   Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441
   Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495
   Kolmar H, 2011, CURR PHARM DESIGN, V17, P4329, DOI 10.2174/138161211798999465
   Kouril T, 2008, ARCH MICROBIOL, V190, P355, DOI 10.1007/s00203-008-0377-3
   Kratzner R, 2005, ACTA CRYSTALLOGR D, V61, P1255, DOI 10.1107/S0907444905021207
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Kryshtafovych A, 2014, PROTEINS, V82, P7, DOI 10.1002/prot.24399
   Kryshtafovych A, 2011, PROTEINS, V79, P6, DOI 10.1002/prot.23196
   Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430
   Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370
   Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012
   Long CM, 2009, VIROLOGY, V388, P231, DOI 10.1016/j.virol.2009.04.006
   Luecke H., 2013, INT INNOVATION, V20, P104
   Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010
   Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473
   McNulty R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3900
   Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452
   Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019
   Nugent T, 2014, PROTEINS, V82, P98, DOI 10.1002/prot.24377
   Ogata H, 2007, GENOME RES, V17, P1353, DOI 10.1101/gr.6358607
   Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172
   Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703
   POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33
   Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103
   Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006
   ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533
   ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Seguritan V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002657
   Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997
   Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130
   SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6
   Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584
   STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X
   Strugatsky D, 2013, NATURE, V493, P255, DOI 10.1038/nature11684
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750
   Tai CH, 2013, PROTEINS
   Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332
   Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371
   VOLKIN E, 1958, VIROLOGY, V6, P545, DOI 10.1016/0042-6822(58)90101-6
   Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07
   Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482
   Willits D, 2003, VIROLOGY, V306, P280, DOI 10.1016/S0042-6822(02)00054-5
   Xiang Y, 2009, MOL CELL, V34, P375, DOI 10.1016/j.molcel.2009.04.009
   Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109
   Yoshida T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-427
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
NR 73
TC 37
Z9 37
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD FEB
PY 2014
VL 82
SU 2
SI SI
BP 26
EP 42
DI 10.1002/prot.24489
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AA5NY
UT WOS:000331147900004
PM 24318984
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Pivetta, C
   Esposito, MS
   Sigrist, M
   Arber, S
AF Pivetta, Chiara
   Esposito, Maria Soledad
   Sigrist, Markus
   Arber, Silvia
TI Motor-Circuit Communication Matrix from Spinal Cord to Brainstem Neurons
   Revealed by Developmental Origin
SO CELL
LA English
DT Article
ID LATERAL RETICULAR NUCLEUS; SPINOCEREBELLAR TRACT NEURONS; C3-C4
   PROPRIOSPINAL NEURONS; FUNCTIONAL-ORGANIZATION; CEREBELLAR CORTEX; MOSSY
   FIBERS; CAT; RAT; PROJECTION; PATHWAYS
AB Accurate motor-task execution relies on continuous comparison of planned and performed actions. Motor-output pathways establish internal circuit collaterals for this purpose. Here we focus on motor collateral organization between spinal cord and upstream neurons in the brainstem. We used a newly developed mouse genetic tool intersectionally with viruses to uncover the connectivity rules of these ascending pathways by capturing the transient expression of neuronal subpopulation determinants. We reveal a widespread and diverse network of spinal dual-axon neurons, with coincident input to forelimb motor neurons and the lateral reticular nucleus (LRN) in the brainstem. Spinal information to the LRN is not segregated by motor pool or neurotransmitter identity. Instead, it is organized according to the developmental domain origin of the progenitor cells. Thus, excerpts of most spinal information destined for action are relayed to supraspinal centers through exquisitely organized ascending connectivity modules, enabling precise communication between command and execution centers of movement.
C1 [Pivetta, Chiara; Esposito, Maria Soledad; Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Pivetta, Chiara; Esposito, Maria Soledad; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X; Esposito, Maria
   Soledad/0000-0003-0673-4219
FU ERC Advanced Grant; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Kanton Basel-Stad; Novartis Research
   Foundation; Human Frontier Science Foundation (HFSP) program
FX We are grateful to M. Mielich for technical support; E. Kremer for
   advice on production of Cav-Cre virus and material; A. Ponti, M.
   Kirschmann, M. Stadler, and R. Thierry for help and advice with image
   acquisition, processing, and statistical analysis; P. Kopp, J. F. Spetz,
   and B. Kuchemann for help with the generation of transgenic mice; M.
   Goulding for sharing unpublished data on Gata3 neurons; and P. Caroni
   and P. Scheiffele for discussions and comments on the manuscript. All
   authors were supported by an ERC Advanced Grant, the Swiss National
   Science Foundation, the Kanton Basel-Stadt, and the Novartis Research
   Foundation. M. S. E. was supported by a long-term fellowship from the
   Human Frontier Science Foundation (HFSP) program.
CR Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038
   ALSTERMARK B, 1991, EXP BRAIN RES, V84, P561
   ALSTERMARK B, 1985, J PHYSIOL-LONDON, V363, P287, DOI 10.1113/jphysiol.1985.sp015710
   Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x
   ALSTERMARK B, 1984, EXP BRAIN RES, V56, P279, DOI 10.1007/BF00236284
   Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527
   Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011
   ARSHAVSKY YI, 1978, BRAIN RES, V151, P479, DOI 10.1016/0006-8993(78)91081-8
   ARSHAVSKY YI, 1986, CEREBELLUM RHYTHMICA
   Azim E., 2014, NATURE
   BRODAL A, 1949, J COMP NEUROL, V91, P259, DOI 10.1002/cne.900910206
   Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007
   CAMPBELL SK, 1974, BRAIN RES, V77, P1, DOI 10.1016/0006-8993(74)90801-4
   CLENDENIN M, 1974, EXP BRAIN RES, V21, P487
   CLENDENIN M, 1974, EXP BRAIN RES, V21, P473
   Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457
   EKEROT CF, 1990, EXP BRAIN RES, V79, P129, DOI 10.1007/BF00228881
   Ezure K, 1997, EXP BRAIN RES, V113, P230, DOI 10.1007/BF02450321
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011
   HINMAN A, 1959, J COMP NEUROL, V113, P61, DOI 10.1002/cne.901130104
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006
   Jankowska E, 2010, J NEUROPHYSIOL, V104, P1872, DOI 10.1152/jn.00408.2010
   Jankowska E, 2013, J PHYSIOL-LONDON, V591, P5445, DOI 10.1113/jphysiol.2012.248740
   Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004
   KOEKKOEK SKE, 1995, NEUROSCI LETT, V200, P13, DOI 10.1016/0304-3940(95)12077-H
   KUNZLE H, 1973, J COMP NEUROL, V149, P103, DOI 10.1002/cne.901490107
   LUNDBERG A, 1971, EXP BRAIN RES, V12, P317
   Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4
   Orlovsky G. N., 1999, NEURONAL CONTROL LOC
   OSCARSSON O, 1965, PHYSIOL REV, V45, P495
   Paxinos G., 2012, MOUSE BRAIN STEREOTA
   Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005
   RAJAKUMAR N, 1992, ANAT EMBRYOL, V185, P25, DOI 10.1007/BF00213598
   ROSEN I, 1969, BRAIN RES, V16, P55, DOI 10.1016/0006-8993(69)90085-7
   SANTARCANGELO E, 1981, ARCH ITAL BIOL, V119, P324
   Shinoda Y, 2000, PROG BRAIN RES, V124, P173
   SHOKUNBI MT, 1985, J COMP NEUROL, V239, P216, DOI 10.1002/cne.902390208
   Shrestha SS, 2012, NEUROSCIENCE, V226, P253, DOI 10.1016/j.neuroscience.2012.09.015
   Shrestha SS, 2012, J PHYSIOL-LONDON, V590, P1737, DOI 10.1113/jphysiol.2011.226852
   Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001
   Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028
   WALBERG F, 1958, J COMP NEUROL, V109, P363, DOI 10.1002/cne.901090304
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O
   Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027
NR 50
TC 67
Z9 67
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JAN 30
PY 2014
VL 156
IS 3
BP 537
EP 548
DI 10.1016/j.cell.2013.12.014
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 302DD
UT WOS:000330580800019
PM 24485459
OA Bronze
DA 2021-01-25
ER

PT J
AU Lopez, R
   Mosca, B
   Bergamelli, L
   Ruegg, MA
   Bentzinger, FC
   Hall, MN
   Treves, S
   Zorzato, F
AF Lopez, Ruben
   Mosca, Barbara
   Bergamelli, Leda
   Ruegg, Markus A.
   Bentzinger, Florian C.
   Hall, Michael N.
   Treves, Susan
   Zorzato, Francesco
TI Raptor Ablation in Skeletal Muscle Affects the Structure and Function of
   the Excitation-Contraction Coupling Macromolecular Complex
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Lopez, Ruben; Treves, Susan; Zorzato, Francesco] Univ Basel Hosp, CH-4031 Basel, Switzerland.
   [Mosca, Barbara; Bergamelli, Leda; Treves, Susan; Zorzato, Francesco] Univ Ferrara, I-44100 Ferrara, Italy.
   [Ruegg, Markus A.; Bentzinger, Florian C.; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Lopez Dicuru, Ruben
   Jose/0000-0002-3802-3158
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 123A
EP 123A
DI 10.1016/j.bpj.2013.11.733
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000400618
OA Bronze
DA 2021-01-25
ER

PT J
AU Xu, YY
   Liang, CW
   Basilio, D
   Accardi, A
   Berneche, S
AF Xu, Yanyan
   Liang, Chungwen
   Basilio, Daniel
   Accardi, Alessio
   Berneche, Simon
TI Conformational Changes Required for Chloride Ion Permeation in the
   CLC-ec1 Exchanger
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Xu, Yanyan; Liang, Chungwen; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
   [Basilio, Daniel; Accardi, Alessio] Weill Cornell Med Coll, New York, NY USA.
RI Basilio, Daniel/Q-6909-2019
OI Basilio, Daniel/0000-0002-5346-8921
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 145A
EP 146A
DI 10.1016/j.bpj.2013.11.841
PG 2
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000400722
OA Bronze
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Aebi, U
AF Herrmann, Harald
   Aebi, Ueli
TI Intermediate Filament Structure, Assembly and Nanomechanics
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Herrmann, Harald] German Canc Res Ctr, Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 174A
EP 174A
DI 10.1016/j.bpj.2013.11.990
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000400866
OA Bronze
DA 2021-01-25
ER

PT J
AU Berneche, S
   Wojtas-Niziurski, W
   Heer, F
AF Berneche, Simon
   Wojtas-Niziurski, Wojciech
   Heer, Florian
TI Regulation of ion Permeation in the Selectivity Filter of Potassium
   Channels
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Berneche, Simon; Wojtas-Niziurski, Wojciech; Heer, Florian] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 234A
EP 234A
DI 10.1016/j.bpj.2013.11.1369
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000401298
OA Bronze
DA 2021-01-25
ER

PT J
AU Thomson, AS
   Heer, FT
   Smith, FJ
   Berneche, S
   Rothberg, BS
AF Thomson, Andrew S.
   Heer, Florian T.
   Smith, Frank J.
   Berneche, Simon
   Rothberg, Brad S.
TI Initial Steps of Inactivation at the K+ Channel Selectivity Filter
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Thomson, Andrew S.; Smith, Frank J.; Rothberg, Brad S.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19122 USA.
   [Heer, Florian T.; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 234A
EP 234A
DI 10.1016/j.bpj.2013.11.1370
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000401299
OA Bronze
DA 2021-01-25
ER

PT J
AU Heer, FT
   Thomson, AS
   Rothberg, BS
   Berneeche, S
AF Heer, Florian T.
   Thomson, Andrew S.
   Rothberg, Brad S.
   Berneeche, Simon
TI Microscopic Mechanisms Underlying Inactivation in the KcsA and MTHK K+
   Channels
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Heer, Florian T.; Berneeche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
   [Thomson, Andrew S.; Rothberg, Brad S.] Temple Univ Sch Med, Dept Biochem, Philadelphia, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 542A
EP 542A
DI 10.1016/j.bpj.2013.11.3021
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000403087
OA Bronze
DA 2021-01-25
ER

PT J
AU Seelig, A
   Zwick, M
AF Seelig, Anna
   Zwick, Matthias
TI Enhancing the ATPase Activity of the Cystic Fibrosis Transmembrane
   Conductance Regulator CFTR in Live Cells Reduces Chloride Flux
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Seelig, Anna; Zwick, Matthias] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 751A
EP 751A
DI 10.1016/j.bpj.2013.11.4135
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000404253
OA Bronze
DA 2021-01-25
ER

PT J
AU Wu, XM
   Gehring, W
AF Wu, Xiaomo
   Gehring, Walter
TI Cellular uptake of the Antennapedia homeodomain polypeptide by
   macropinocytosis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Antennapedia homeodomain; Penetratin; Cell-Penetrating Peptides (CPPs)
ID CELLS IN-VITRO; PENETRATING PEPTIDES; FUNCTIONAL PROTEINS; 3RD HELIX;
   DELIVERY; CARRIERS; VIRUS; VIVO
AB Antennapedia homeodomain has been shown to be able to translocate from extracellular space into the cytoplasm of cells in a receptor-independent manner. Its third alpha-helix domain, designated as "Penetratin", was proposed to be the functional transduction domain that is responsible for the translocation, and it is widely used for intracellular delivery of various exogenous proteins. Although Penetratin has been regarded to be the only element conferring the capacity on its parent polypeptide to penetrate through the plasma membrane, we found that the complete Antennapedia homeodomain exhibits an appreciably higher level of translocation efficiency as compared to Penetratin. Pharmacological analysis demonstrated that macropinocytic endocytosis plays a significant role underlying the process of the homeodomain internalization, and this is consistent with the observation that internalized polypeptide co-localizes with a fluid phase dye. Our results identify macropinocytosis as a major mechanism by which Antennapedia homeodomain obtains the access to the interior of cells, providing a novel perspective in the field of protein translocation and transduction. (C) 2014 The Authors. Published by Elsevier Inc. All rights reserved.
C1 [Wu, Xiaomo; Gehring, Walter] Univ Basel, Biozentrum, Growth & Dev, CH-4056 Basel, Switzerland.
RP Gehring, W (corresponding author), Univ Basel, Biozentrum, Growth & Dev, CH-4056 Basel, Switzerland.
EM Walter.Gehring@unibas.ch
OI Wu, xiaomo/0000-0001-6515-1588
CR Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009
   Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138
   Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003
   Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Duncan D, 2010, DEV BIOL, V347, P82, DOI 10.1016/j.ydbio.2010.08.012
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200
   Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x
   JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864
   Kerkis A, 2006, IUBMB LIFE, V58, P7, DOI 10.1080/15216540500494508
   Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20
   Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   QIAN YQ, 1994, P NATL ACAD SCI USA, V91, P4091, DOI 10.1073/pnas.91.9.4091
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281
NR 19
TC 13
Z9 13
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 24
PY 2014
VL 443
IS 4
BP 1136
EP 1140
DI 10.1016/j.bbrc.2013.12.062
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB6TD
UT WOS:000331921500002
PM 24361959
OA Other Gold
DA 2021-01-25
ER

PT J
AU Kanca, O
   Caussinus, E
   Denes, AS
   Percival-Smith, A
   Affolter, M
AF Kanca, Oguz
   Caussinus, Emmanuel
   Denes, Alexandru S.
   Percival-Smith, Anthony
   Affolter, Markus
TI Raeppli: a whole-tissue labeling tool for live imaging of Drosophila
   development
SO DEVELOPMENT
LA English
DT Article
DE Drosophila; Live imaging; Lineage tracing; Multicolor labeling;
   Organogenesis; Whole-tissue labeling
ID FLUORESCENT PROTEINS; CELL-PROLIFERATION; SYSTEM; MELANOGASTER;
   RECOMBINASE; EXPRESSION; GROWTH; DISC; MORPHOGENESIS; DYNAMICS
AB Observation of how cells divide, grow, migrate and form different parts of a developing organism is crucial for understanding developmental programs. Here, we describe a multicolor imaging tool named Raeppli (after the colorful confetti used at the carnival in Basel). Raeppli allows whole-tissue labeling such that the descendants of the majority of cells in a single organ are labeled and can be followed simultaneously relative to one another. We tested the use of Raeppli in the Drosophila melanogaster wing imaginal disc. Induction of Raeppli during larval stages irreversibly labels >90% of the cells with one of four spectrally separable, bright fluorescent proteins with low bias of selection. To understand the global growth characteristics of imaginal discs better, we induced Raeppli at various stages of development, imaged multiple fixed discs at the end of their larval development and estimated the size of their pouch primordium at those developmental stages. We also imaged the same wing disc through the larval cuticle at different stages of its development; the clones marked by Raeppli provide landmarks that can be correlated between multiple time points. Finally, we used Raeppli for continuous live imaging of prepupal eversion of the wing disc.
C1 [Kanca, Oguz; Caussinus, Emmanuel; Denes, Alexandru S.; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Percival-Smith, Anthony] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Kanca, Oguz/I-6672-2015
OI Kanca, Oguz/0000-0001-5438-0879; Affolter, Markus/0000-0002-5171-0016
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Cantons Basel-Stadt and Basel-Land; National Sciences and
   Engineering Research Council of CanadaNatural Sciences and Engineering
   Research Council of Canada; SystemsX.ch initiative within the framework
   of the WingX Project; European Molecular Biology Organization
   fellowshipEuropean Molecular Biology Organization (EMBO)
FX This work was supported by grants from the Swiss National Science
   Foundation and from Cantons Basel-Stadt and Basel-Land (M. A.) and from
   the National Sciences and Engineering Research Council of Canada
   (A.P.-S.). O.K. and E. C. were funded by the SystemsX.ch initiative
   within the framework of the WingX Project, A. S. D. was partially
   supported by a European Molecular Biology Organization fellowship.
   Deposited in PMC for immediate release.
CR Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874
   Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X
   Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016
   COHEN B, 1993, DEVELOPMENT, V117, P597
   Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034
   FRISTROM D, 1993, DEV DROSOPHILA MELAN, V2, P843
   GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9
   GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1
   Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567
   Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566
   Johnston LA, 2003, NAT CELL BIOL, V5, P827, DOI 10.1038/ncb1041
   Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002
   Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293
   Lu JJ, 2011, TRANSGENIC RES, V20, P183, DOI 10.1007/s11248-010-9394-5
   MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459
   Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406
   Merriam J R, 1978, Results Probl Cell Differ, V9, P71
   Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640
   Nienhaus U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047594
   Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168
   Sangiorgi E, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn627
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949
   Strack RL, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-32
   Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006
   Taylor J, 2008, DEV BIOL, V313, P739, DOI 10.1016/j.ydbio.2007.11.009
   Thorpe HM, 2000, MOL MICROBIOL, V38, P232, DOI 10.1046/j.1365-2958.2000.02142.x
   Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505
   Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037
   Weigmann K, 1999, DEVELOPMENT, V126, P3823
   Worley MI, 2013, DEVELOPMENT, V140, P3275, DOI 10.1242/dev.096057
   Yagi R, 2010, P NATL ACAD SCI USA, V107, P16166, DOI 10.1073/pnas.1005957107
NR 38
TC 29
Z9 29
U1 0
U2 17
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JAN 15
PY 2014
VL 141
IS 2
BP 472
EP 480
DI 10.1242/dev.102913
PG 9
WC Developmental Biology
SC Developmental Biology
GA 282JI
UT WOS:000329166700023
PM 24335257
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Burton, NA
   Schurmann, N
   Casse, O
   Steeb, AK
   Claudi, B
   Zankl, J
   Schmidt, A
   Bumann, D
AF Burton, Neil A.
   Schuermann, Nura
   Casse, Olivier
   Steeb, Anne K.
   Claudi, Beatrice
   Zankl, Janine
   Schmidt, Alexander
   Bumann, Dirk
TI Disparate Impact of Oxidative Host Defenses Determines the Fate of
   Salmonella during Systemic Infection in Mice
SO CELL HOST & MICROBE
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; NITRIC-OXIDE SYNTHASE; PERIPLASMIC
   SUPEROXIDE-DISMUTASE; NADPH PHAGOCYTE OXIDASE; ESCHERICHIA-COLI;
   ANTIMICROBIAL ACTIONS; PROTECTS SALMONELLA; REACTIVE OXYGEN; IN-VIVO;
   MACROPHAGES
AB Reactive oxygen and nitrogen species function in host defense via mechanisms that remain controversial. Pathogens might encounter varying levels of these species, but bulk measurements cannot resolve such heterogeneity. We used single-cell approaches to determine the impact of oxidative and nitrosative stresses on individual Salmonella during early infection in mouse spleen. Salmonella encounter and respond to both stresses, but the levels and impact vary widely. Neutrophils and inflammatory monocytes kill Salmonella by generating overwhelming oxidative stress through NADPH oxidase and myeloperoxidase. This controls Salmonella within inflammatory lesions but does not prevent their spread to more permissive resident red pulp macrophages, which generate only sublethal oxidative bursts. Regional host expression of inducible nitric oxide synthase exposes some Salmonella to nitrosative stress, triggering effective local Salmonella detoxification through nitric oxide denitrosylase. Thus, reactive oxygen and nitrogen species influence dramatically different outcomes of disparate Salmonella-host cell encounters, which together determine overall disease progression.
C1 [Burton, Neil A.; Schuermann, Nura; Casse, Olivier; Steeb, Anne K.; Claudi, Beatrice; Bumann, Dirk] Univ Basel, CH-4056 Basel, Switzerland.
   [Zankl, Janine] Univ Basel, FACS Core Facil, CH-4056 Basel, Switzerland.
   [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, CH-4056 Basel, Switzerland.
EM dirk.bumann@unibas.ch
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [31003A-121834]; Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [SPP1316 Bu971/6]
FX We thank Mauricio Rosas Ballina for help with preparing figures, and the
   Swiss National Foundation (31003A-121834) and Deutsche
   Forschungsgemeinschaft (SPP1316 Bu971/6) for funding.
CR Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067
   Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x
   Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200
   Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966
   BENJAMIN WH, 1990, J IMMUNOL, V144, P3143
   Bower JM, 2006, J BACTERIOL, V188, P928, DOI 10.1128/JB.188.3.928-933.2006
   Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419
   Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547
   Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997
   Craig M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004975
   Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997
   Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913
   Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103
   Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12
   Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004
   Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11
   Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200
   Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200
   Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0
   Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998
   Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074
   Gulig PA, 1997, INFECT IMMUN, V65, P5191, DOI 10.1128/IAI.65.12.5191-5197.1997
   Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698
   Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107
   Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   HORMAECHE CE, 1980, IMMUNOLOGY, V41, P973
   Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818
   Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008
   Imlay J.A., 2009, OXIDATIVE STRESS
   Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200
   Khan SA, 2001, MICROB PATHOGENESIS, V30, P29, DOI 10.1006/mpat.2000.0405
   Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003
   Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349
   Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x
   Leone AM, 1996, BIOCHEM BIOPH RES CO, V221, P37, DOI 10.1006/bbrc.1996.0557
   Li XJ, 2009, MOL BIOL CELL, V20, P1520, DOI 10.1091/mbc.E08-06-0620
   LIN FR, 1987, BRIT J EXP PATHOL, V68, P539
   Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014
   Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0
   MUOTIALA A, 1992, VACCINE, V10, P243, DOI 10.1016/0264-410X(92)90159-H
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193
   NUSRAT AR, 1988, J EXP MED, V168, P1505, DOI 10.1084/jem.168.4.1505
   PACELLI R, 1995, J EXP MED, V182, P1469, DOI 10.1084/jem.182.5.1469
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102
   Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211
   Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004
   RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569
   Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101
   Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789
   Rydstrom A, 2009, EUR J IMMUNOL, V39, P3019, DOI 10.1002/eji.200939483
   Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001
   Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x
   Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x
   Spiro S, 2006, BIOCHEM SOC T, V34, P200, DOI 10.1042/BST0340200
   Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301
   Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304
   Tan SM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003282
   Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623
   Umezawa K, 1997, INFECT IMMUN, V65, P2932, DOI 10.1128/IAI.65.7.2932-2940.1997
   Uzzau S, 2002, MOL MICROBIOL, V46, P147, DOI 10.1046/j.1365-2958.2002.03145.x
   VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227
   VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2009.00877.x, 10.1111/j.1600-0854.2008.00877.x]
   Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676
   Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655
   Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227
   White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546
   Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200
   Wolfe MT, 2002, J BACTERIOL, V184, P5898, DOI 10.1128/JB.184.21.5898-5902.2002
   Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009
NR 77
TC 90
Z9 92
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JAN 15
PY 2014
VL 15
IS 1
BP 72
EP 83
DI 10.1016/j.chom.2013.12.006
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AA1KC
UT WOS:000330854100010
PM 24439899
OA Bronze
DA 2021-01-25
ER

PT J
AU Yang, Q
   Nausch, LWM
   Martin, G
   Keller, W
   Doublie, S
AF Yang, Qin
   Nausch, Lydia W. M.
   Martin, Georges
   Keller, Walter
   Doublie, Sylvie
TI Crystal Structure of Human Poly(A) Polymerase Gamma Reveals a Conserved
   Catalytic Core for Canonical Poly(A) Polymerases
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE nnRNA processing; 3' end processing; polyadenylation; poly(A) polymerase
   gamma; neo-PAP
ID PRE-MESSENGER-RNA; ALTERNATIVE CLEAVAGE; SEQUENCE ALIGNMENT;
   DNA-POLYMERASE; PROTEIN; POLYADENYLATION; COMPLEX; MECHANISM; BINDING;
   SPECIFICITY
AB In eukaryotes, the poly(A) tail added at the 3 ' end of an mRNA precursor is essential for the regulation of mRNA stability and the initiation of translation. Poly(A) polymerase (PAP) is the enzyme that catalyzes the poly(A) addition reaction. Multiple isoforms of PAP have been identified in vertebrates, which originate from gene duplication, alternative splicing or post-translational modifications. The complexity of PAP isoforms suggests that they might play different roles in the cell. Phylogenetic studies indicate that vertebrate PAPs are grouped into three clades termed alpha, beta and gamma, which originated from two gene duplication events. To date, all the available PAP structures are from the PAP alpha clade. Here, we present the crystal structure of the first representative of the PAP gamma clade, human PAP gamma bound to cordycepin triphosphate (3 ' dATP) and Ca2+. The structure revealed that PAP gamma closely resembles its PAP alpha ortholog. An analysis of residue conservation reveals a conserved catalytic binding pocket, whereas residues at the surface of the polymerase are more divergent. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Yang, Qin; Nausch, Lydia W. M.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.
   [Martin, Georges; Keller, Walter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Yang, Q (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.
EM yang@crystal.harvard.edu; sdoublie@uvm.edu
OI Yang, Qin/0000-0003-4038-2464; Doublie, Sylvie/0000-0002-6294-5304
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM62239]; University
   of Basel; Swiss National Science FundSwiss National Science Foundation
   (SNSF) [3100-053897, 31003A-143977]; Louis-Jeantet Foundation for
   Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM062239, R01GM062239, R01GM062239, R01GM062239, R01GM062239]
   Funding Source: NIH RePORTER
FX The authors gratefully acknowledge Drs. Ramiro Barrantes-Reynolds and
   Jeffrey Bond for help with the phylogenetic study and Dr. Mark Rould for
   help with crystallographic data analysis. This work was supported by the
   National Institutes of Health award GM62239 (to S.D.). W.K. and G.M.
   were supported by the University of Basel, the Swiss National Science
   Fund (grants numbers 3100-053897 and 31003A-143977) and the
   Louis-Jeantet Foundation for Medicine.
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Balbo PB, 2007, STRUCTURE, V15, P1117, DOI 10.1016/j.str.2007.07.010
   Balbo PB, 2007, J MOL BIOL, V366, P1401, DOI 10.1016/j.jmb.2006.12.030
   Balbo PB, 2005, BIOCHEMISTRY-US, V44, P7777, DOI 10.1021/bi050089r
   Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346
   Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011
   Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110
   Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0
   Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4
   Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3
   Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Ezeokonkwo C, 2012, FEBS LETT, V586, P1173, DOI 10.1016/j.febslet.2012.03.036
   Felsenstein J, 2001, PHYLIP 3 6A2
   Franceschetti M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002441
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633
   Kai W, 2011, GENOME BIOL EVOL, V3, P424, DOI 10.1093/gbe/evr041
   Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226
   Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008
   Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200
   Lee SH, 2008, NUCLEIC ACIDS RES, V36, P803, DOI 10.1093/nar/gkm1091
   Lee YJ, 2000, FEBS LETT, V487, P287, DOI 10.1016/S0014-5793(00)02367-X
   LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0
   Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3
   Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069
   Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193
   Martin G, 2008, BBA-GENE REGUL MECH, V1779, P206, DOI 10.1016/j.bbagrm.2007.12.003
   Meinke G, 2008, BIOCHEMISTRY-US, V47, P6859, DOI 10.1021/bi800204k
   Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991
   Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176
   Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Perumal K, 2001, J BIOL CHEM, V276, P21791, DOI 10.1074/jbc.M101905200
   Pezet-Valdez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067977
   Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2
   RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0
   Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST
   Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028
   Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200
   Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395
   Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005
   Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001
   Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040
   Yang Q, 2011, WIRES RNA, V2, P732, DOI 10.1002/wrna.88
   Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021
   Yang Q, 2011, ACTA CRYSTALLOGR F, V67, P241, DOI 10.1107/S1744309110051110
   Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107
   Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 61
TC 14
Z9 15
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 9
PY 2014
VL 426
IS 1
BP 43
EP 50
DI 10.1016/j.jmb.2013.09.025
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 303NN
UT WOS:000330681300008
PM 24076191
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Tattikota, SG
   Rathjen, T
   McAnulty, SJ
   Wessels, HH
   Akerman, I
   van de Bunt, M
   Hausser, J
   Esguerra, JLS
   Musahl, A
   Pandey, AK
   You, XT
   Chen, W
   Herrera, PL
   Johnson, PR
   O'Carroll, D
   Eliasson, L
   Zavolan, M
   Gloyn, AL
   Ferrer, J
   Shalom-Feuerstein, R
   Aberdam, D
   Poy, MN
AF Tattikota, Sudhir G.
   Rathjen, Thomas
   McAnulty, Sarah J.
   Wessels, Hans-Hermann
   Akerman, Ildem
   van de Bunt, Martijn
   Hausser, Jean
   Esguerra, Jonathan L. S.
   Musahl, Anne
   Pandey, Amit K.
   You, Xintian
   Chen, Wei
   Herrera, Pedro L.
   Johnson, Paul R.
   O'Carroll, Donal
   Eliasson, Lena
   Zavolan, Mihaela
   Gloyn, Anna L.
   Ferrer, Jorge
   Shalom-Feuerstein, Ruby
   Aberdam, Daniel
   Poy, Matthew N.
TI Argonaute2 Mediates Compensatory Expansion of the Pancreatic beta Cell
SO CELL METABOLISM
LA English
DT Article
ID MESSENGER-RNAS; INSULIN; MICRORNAS; REVEALS; MICE; METABOLISM;
   MECHANISMS; CROSSTALK; TARGETS; ROLES
AB Pancreatic beta cells adapt to compensate for increased metabolic demand during insulin resistance. Although the microRNA pathway has an essential role in beta cell proliferation, the extent of its contribution is unclear. Here, we report that miR-184 is silenced in the pancreatic islets of insulin-resistant mouse models and type 2 diabetic human subjects. Reduction of miR-184 promotes the expression of its target Argonaute2 (Ago2), a component of the microRNA-induced silencing complex. Moreover, restoration of miR-184 in leptin-deficient ob/ob mice decreased Ago2 and prevented compensatory beta cell expansion. Loss of Ago2 during insulin resistance blocked beta cell growth and relieved the regulation of miR-375-targeted genes, including the growth suppressor Cadm1. Lastly, administration of a ketogenic diet to ob/ob mice rescued insulin sensitivity and miR-184 expression and restored Ago2 and beta cell mass. This study identifies the targeting of Ago2 by miR-184 as an essential component of the compensatory response to regulate proliferation according to insulin sensitivity.
C1 [Tattikota, Sudhir G.; Rathjen, Thomas; McAnulty, Sarah J.; Musahl, Anne; Pandey, Amit K.; You, Xintian; Chen, Wei; Poy, Matthew N.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
   [Aberdam, Daniel] INSERM, UMR S 976, F-75475 Paris, France.
   [Aberdam, Daniel] Univ Paris Diderot, Skin Res Ctr, F-75013 Paris, France.
   [Shalom-Feuerstein, Ruby] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Anat & Cell Biol, IL-31096 Haifa, Israel.
   [Akerman, Ildem; Ferrer, Jorge] Inst Invest Biomed August Pi I Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona 08036, Spain.
   [Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England.
   [van de Bunt, Martijn; Johnson, Paul R.; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Esguerra, Jonathan L. S.; Eliasson, Lena] Lund Univ, Malmo Univ Hosp, Ctr Diabet, Dept Clin Sci, SE-20502 Malmo, Sweden.
   [Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.
   [Johnson, Paul R.; Gloyn, Anna L.] Churchill Hosp, OCDEM, ORH Trust, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England.
   [Johnson, Paul R.] Univ Oxford, Nuffield Dept Surg, Oxford OX3 9DU, England.
   [O'Carroll, Donal] European Mol Biol Lab, I-00015 Monterotondo, Italy.
RP Poy, MN (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
EM matthew.poy@mdc-berlin.de
RI Eliasson, Lena/E-9294-2012; Zavolan, Mihaela/S-3888-2016; Tattikota,
   Sudhir Gopal/K-4830-2018; Pandey, Amit/AAY-2887-2020; Poy,
   Matthew/F-6914-2017; Aberdam, Daniel/G-3299-2013; Chen, Wei/C-1273-2011;
   Esguerra, Jonathan/M-2366-2014; Ferrer, Jorge/A-3176-2012
OI Eliasson, Lena/0000-0002-6467-5029; Tattikota, Sudhir
   Gopal/0000-0003-0318-5533; Pandey, Amit/0000-0002-8886-1694; Poy,
   Matthew/0000-0002-4904-2426; Esguerra, Jonathan/0000-0001-8454-6606;
   Ferrer, Jorge/0000-0002-5959-5729; Akerman, Ildem/0000-0002-9875-1421;
   Hausser, Jean/0000-0002-3321-7199; Gloyn, Anna/0000-0003-1205-1844;
   Herrera Merino, Pedro Luis/0000-0003-0771-9504; O'Carroll,
   Donal/0000-0002-8626-2217; YOU, Xintian/0000-0002-1684-7084; Zavolan,
   Mihaela/0000-0002-8832-2041; Aberdam, Daniel/0000-0002-4019-5418; van de
   Bunt, Martijn/0000-0002-6744-6125
FU Helmholtz GemeinschaftHelmholtz Association; ERC Starting Grant
   [IsletVasc 260744]; Fritz Thyssen Stiftung; Deutsches Zentrum fuer
   Herz-Kreislauf Forschung, E.V. (DZHK); Swedish Diabetes Association;
   Swedish Research CouncilSwedish Research Council; Wellcome TrustWellcome
   Trust [095101/Z/10/Z, 101033/Z/13/Z];  [ANR11-03 erare2-SkinDev];
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [U01DK089572, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, U01DK089572, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, U01DK089572, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, U01DK089572, P30DK020593, P30DK020593,
   P30DK020593, P30DK020593, P30DK020593, U01DK089572] Funding Source: NIH
   RePORTER
FX This work was funded by the Helmholtz Gemeinschaft, an ERC Starting
   Grant (IsletVasc 260744), the Fritz Thyssen Stiftung, the Deutsches
   Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK), ANR11-03
   erare2-SkinDev (to D.A.), Swedish Diabetes Association, Swedish Research
   Council, and the Wellcome Trust (095101/Z/10/Z [to A.L.G.] and
   101033/Z/13/Z [to J.F.]). The authors thank L.v.d. Weyden for providing
   the Cadm1 knockout mouse and T. Horvath, M. Landthaler, T. Willnow, M.
   Gotthardt, F. Spagnoli, R. Schweiker, K.L. Brayman, H.P. Rahn, M.
   Richter, A. Sporbert, and the MDC Microscopy Core Facility for
   assistance in conducting this work.
CR Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024
   Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495
   Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645
   Dumortier O, 2013, CELL METAB, V18, P312, DOI 10.1016/j.cmet.2013.06.004
   Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005
   El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614
   Floyd PD, 1999, J NEUROSCI, V19, P7732
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002
   Herrera PL, 2000, DEVELOPMENT, V127, P2317
   Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210
   Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151
   Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47
   Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039
   Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635
   Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016
   Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103
   Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027
   Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653
   Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005
   Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010
   Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327
   Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959
   O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607
   ORLAND MJ, 1985, J CLIN INVEST, V75, P2047, DOI 10.1172/JCI111924
   Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029
   Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345
   Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144
   Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680
   Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028
   Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788
   Tattikota SG, 2013, MOL CELL PROTEOMICS, V12, P1214, DOI 10.1074/mcp.M112.024786
   van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272
   van der Weyden L, 2006, MOL CELL BIOL, V26, P3595, DOI 10.1128/MCB.26.9.3595-3609.2006
   van der Weyden L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-29
   Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111
   Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355
   Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2
   Zhu YX, 2013, DIABETES, V62, P3194, DOI 10.2337/db13-0151
NR 45
TC 92
Z9 96
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 7
PY 2014
VL 19
IS 1
BP 122
EP 134
DI 10.1016/j.cmet.2013.11.015
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 285YO
UT WOS:000329431200014
PM 24361012
OA Other Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Luksys, G
   Ackermann, S
   Coynel, D
   Fastenrath, M
   Gschwind, L
   Heck, A
   Rasch, B
   Spalek, K
   Vogler, C
   Papassotiropoulos, A
   de Quervain, D
AF Luksys, Gediminas
   Ackermann, Sandra
   Coynel, David
   Fastenrath, Matthias
   Gschwind, Leo
   Heck, Angela
   Rasch, Bjoern
   Spalek, Klara
   Vogler, Christian
   Papassotiropoulos, Andreas
   de Quervain, Dominique
TI BAIAP2 Is Related to Emotional Modulation of Human Memory Strength
SO PLOS ONE
LA English
DT Article
ID EPISODIC MEMORY; COGNITIVE NEUROSCIENCE; DECISION-MAKING; ASSOCIATION;
   GENES; METAANALYSIS; EXPERIENCE; PREDICTS; IRSP53; STRESS
AB Memory performance is the result of many distinct mental processes, such as memory encoding, forgetting, and modulation of memory strength by emotional arousal. These processes, which are subserved by partly distinct molecular profiles, are not always amenable to direct observation. Therefore, computational models can be used to make inferences about specific mental processes and to study their genetic underpinnings. Here we combined a computational model-based analysis of memory-related processes with high density genetic information derived from a genome-wide study in healthy young adults. After identifying the best-fitting model for a verbal memory task and estimating the best-fitting individual cognitive parameters, we found a common variant in the gene encoding the brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) that was related to the model parameter reflecting modulation of verbal memory strength by negative valence. We also observed an association between the same genetic variant and a similar emotional modulation phenotype in a different population performing a picture memory task. Furthermore, using functional neuroimaging we found robust genotype-dependent differences in activity of the parahippocampal cortex that were specifically related to successful memory encoding of negative versus neutral information. Finally, we analyzed cortical gene expression data of 193 deceased subjects and detected significant BAIAP2 genotype-dependent differences in BAIAP2 mRNA levels. Our findings suggest that model-based dissociation of specific cognitive parameters can improve the understanding of genetic underpinnings of human learning and memory.
C1 [Luksys, Gediminas; Ackermann, Sandra; Coynel, David; Gschwind, Leo; Heck, Angela; Rasch, Bjoern; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
   [Luksys, Gediminas; Coynel, David; Fastenrath, Matthias; Rasch, Bjoern; Spalek, Klara; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland.
   [Ackermann, Sandra; Rasch, Bjoern] Univ Zurich, Dept Psychol, Dept Psychol, Zurich, Switzerland.
   [Papassotiropoulos, Andreas; de Quervain, Dominique] Univ Basel, Psychiat Univ Clin, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland.
RP Luksys, G (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
EM gedi.luksys@unibas.ch; andreas.papas@unibas.ch;
   dominique.dequervain@unibas.ch
RI Rasch, Bjorn/A-3119-2015; Coynel, David/H-9189-2019
OI Rasch, Bjorn/0000-0001-7607-3415; Coynel, David/0000-0001-5028-5807;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Heck,
   Angela/0000-0002-1543-3197; de Quervain, Dominique/0000-0001-7131-2464;
   Spalek, Klara/0000-0002-4244-6495; Vogler, Christian/0000-0003-3922-109X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSIK0_122691, CRSI33_130080, CRSII1_136227]; 7th framework
   programme of the European Union (ADAMS project) [HEALTH-F4-2009-242257];
   National Center for Competence in Research SYNAPSY
FX This work was funded by the Swiss National Science Foundation (Sinergia
   grants CRSIK0_122691, CRSI33_130080, CRSII1_136227 to DQ and AP), by the
   7th framework programme of the European Union (ADAMS project,
   HEALTH-F4-2009-242257) and by the National Center for Competence in
   Research SYNAPSY. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954
   Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185
   Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007
   Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105
   Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104
   Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342
   Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461
   Hager W., 1994, HDB DEUTSCHSPRACHIGE
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009
   Kolsch H, 2009, J NEURAL TRANSM, V116, P897, DOI 10.1007/s00702-009-0238-5
   LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825
   Lang PJ, 2008, INT AFFECTIVE PICTUR
   Luksys G, 2011, CURR OPIN NEUROBIOL, V21, P502, DOI 10.1016/j.conb.2011.03.003
   Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248
   Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101
   Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030
   Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16
   Nassar MR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003015
   Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219
   PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6
   Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3
   Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Ribases M, 2009, BIOL PSYCHIAT, V66, P926, DOI 10.1016/j.biopsych.2009.06.024
   Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008
   SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195
   Teukolsky S A, 1992, NUMERICAL RECIPES C
   Toma C, 2011, J PSYCHIATR RES, V45, P280, DOI 10.1016/j.jpsychires.2010.09.001
   Tulving E., 1972, ORG MEMORY, P381, DOI DOI 10.1017/S0140525X00047257
NR 41
TC 10
Z9 10
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 2
PY 2014
VL 9
IS 1
AR e83707
DI 10.1371/journal.pone.0083707
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 286ID
UT WOS:000329460100016
PM 24392092
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Baudouin, S
   Burkle, L
   Scheiffele, P
AF Baudouin, S.
   Burkle, L.
   Scheiffele, P.
TI Targeting MAP-Kinase Interacting Kinases Restores Protein Synthesis
   Homeostasis and Improves Behavioral Deficits in Neuroligin-3 Mouse Model
   of Autism
SO CURRENT NEUROPHARMACOLOGY
LA English
DT Meeting Abstract
ID FRAGILE-X-SYNDROME; RARE DE-NOVO; TRANSLATION; SYNAPSES; LOCI
C1 [Baudouin, S.; Burkle, L.; Scheiffele, P.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Baudouin, S.] Cardiff Univ, Sch Biosci, Neurosci Div, Cardiff CF10 3AX, S Glam, Wales.
EM BaudouinS@cardiff.ac.uk
CR Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Darnell JC, 2013, NAT NEUROSCI, V16, P1530, DOI 10.1038/nn.3379
   Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021
   Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017
   Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015
   Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9
   Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985
   Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778
NR 9
TC 0
Z9 0
U1 0
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-159X
EI 1875-6190
J9 CURR NEUROPHARMACOL
JI Curr. Neuropharmacol.
PY 2014
VL 12
SU 1
MA 6
BP 2
EP 3
PG 2
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA CP5SJ
UT WOS:000359944100007
DA 2021-01-25
ER

PT B
AU Hausser, J
   Zavolan, M
AF Hausser, Jean
   Zavolan, Mihaela
BE Hartmann, RK
   Bindereif, A
   Schon, A
   Westhof, E
TI Characterization and Prediction of miRNA Targets
SO HANDBOOK OF RNA BIOCHEMISTRY, VOLS 1 AND 2, 2ND EDITION
LA English
DT Article; Book Chapter
ID MICRORNA EXPRESSION ATLAS; POSTTRANSCRIPTIONAL REGULATION; SYSTEMATIC
   IDENTIFICATION; MICROARRAY ANALYSIS; SITE ACCESSIBILITY;
   GENE-EXPRESSION; MESSENGER-RNAS; CELL-CYCLE; IN-VIVO; PROTEIN
C1 [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Hausser, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Zavolan, Mihaela/S-3888-2016
OI Hausser, Jean/0000-0002-3321-7199
CR Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037
   Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012
   Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119
   Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
   Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Duda R.O., 2000, PATTERN CLASSIFICATI, V2nd
   Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079
   Enright AJ, 2004, GENOME BIOL, V5
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105
   Friedman J, 2001, ELEMENTS STAT LEARNI
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7
   Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247
   Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952
   Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109
   Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126
   Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543
   Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152
   Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68
   Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702
   Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007
   Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207
   O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104
   Olson A J, 2008, Pac Symp Biocomput, P126
   Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607
   Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2
   Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102
   Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102
   Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065
   Schagat T., 2007, CELL NOTES, V19, P4
   Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060
   Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576
   Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229
   Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014
   Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030
NR 100
TC 0
Z9 0
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-527-65055-2; 978-3-527-32764-5
PY 2014
BP 833
EP 859
D2 10.1002/9783527647064
PG 27
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BD0PU
UT WOS:000357533800038
DA 2021-01-25
ER

PT B
AU Hoell, JI
   Hafner, M
   Landthaler, M
   Ascano, M
   Farazi, TA
   Wardle, G
   Nusbaum, J
   Cekan, P
   Khorshid, M
   Burger, L
   Zavolan, M
   Tuschl, T
AF Hoell, Jessica I.
   Hafner, Markus
   Landthaler, Markus
   Ascano, Manuel
   Farazi, Thalia A.
   Wardle, Greg
   Nusbaum, Jeff
   Cekan, Pavol
   Khorshid, Mohsen
   Burger, Lukas
   Zavolan, Mihaela
   Tuschl, Thomas
BE Hartmann, RK
   Bindereif, A
   Schon, A
   Westhof, E
TI Transcriptome-Wide Identification of Protein Binding Sites on RNA by
   PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking and
   Immunoprecipitation)
SO HANDBOOK OF RNA BIOCHEMISTRY, VOLS 1 AND 2, 2ND EDITION
LA English
DT Article; Book Chapter
ID RIBONUCLEOPROTEIN COMPLEXES; MESSENGER-RNAS; 4-THIOURIDINE; NETWORKS;
   BRAIN
C1 [Hoell, Jessica I.; Hafner, Markus; Ascano, Manuel; Farazi, Thalia A.; Wardle, Greg; Nusbaum, Jeff; Cekan, Pavol; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA.
   [Landthaler, Markus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany.
   [Khorshid, Mohsen; Burger, Lukas; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Khorshid, Mohsen; Burger, Lukas; Zavolan, Mihaela] SIB, CH-4056 Basel, Switzerland.
RP Hoell, JI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10065 USA.
RI Zavolan, Mihaela/S-3888-2016; Hafner, Markus/O-7100-2018; Ascano,
   Manuel/ABA-3586-2020; Landthaler, Markus/A-1427-2010
OI Hafner, Markus/0000-0002-4336-6518; Ascano, Manuel/0000-0002-9370-5493;
   Landthaler, Markus/0000-0002-1075-8734
CR Andrus A, 2001, Curr Protoc Nucleic Acid Chem, VChapter 10, DOI 10.1002/0471142700.nc1005s01
   BEZERRA R, 1990, BIOCHEM BIOPH RES CO, V166, P29, DOI 10.1016/0006-291X(90)91907-A
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9
   Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673
   Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178
   McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14
   Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
NR 13
TC 1
Z9 1
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-527-65055-2; 978-3-527-32764-5
PY 2014
BP 877
EP 898
D2 10.1002/9783527647064
PG 22
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BD0PU
UT WOS:000357533800040
DA 2021-01-25
ER

PT J
AU Uda, NR
   Upert, G
   Angelici, G
   Nicolet, S
   Schmidt, T
   Schwede, T
   Creus, M
AF Uda, Narasimha Rao
   Upert, Gregory
   Angelici, Gaetano
   Nicolet, Stefan
   Schmidt, Tobias
   Schwede, Torsten
   Creus, Marc
TI Zinc-selective inhibition of the promiscuous bacterial amide-hydrolase
   DapE: implications of metal heterogeneity for evolution and antibiotic
   drug design
SO METALLOMICS
LA English
DT Article
ID N-SUCCINYL-L,L-DIAMINOPIMELIC ACID DESUCCINYLASE; COMPUTATIONAL
   STRUCTURAL BIOLOGY; ANGIOTENSIN-CONVERTING ENZYME; PEPTIDE DEFORMYLASE;
   METHIONINE AMINOPEPTIDASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI;
   HAEMOPHILUS-INFLUENZAE; DIAMINOPIMELIC ACID; LYSINE BIOSYNTHESIS
AB The development of resistance to virtually all current antibiotics makes the discovery of new antimicrobial compounds with novel protein targets an urgent challenge. The dapE-encoded N-succinyl-L, L-diaminopimelic acid desuccinylase (DapE) is an essential metallo-enzyme for growth and proliferation in many bacteria, acting in the desuccinylation of N-succinyl-L, L-diaminopimelic acid (SDAP) in a late stage of the anabolic pathway towards both lysine and a crucial building block of the peptidoglycan cell wall. L-Captopril, which has been shown to exhibit very promising inhibitory activity in vitro against DapE and has attractive drug-like properties, nevertheless does not target DapE in bacteria effectively. Here we show that L-captopril targets only the Zn2+-metallo-isoform of the enzyme, whereas the Mn2+-enzyme, which is also a physiologically relevant isoform in bacteria, is not inhibited. Our finding provides a rationale for the failure of this promising lead-compound to exhibit any significant antibiotic activity in bacteria and underlines the importance of addressing metallo-isoform heterogeneity in future drug design. Moreover, to our knowledge, this is the first example of metallo-isoform heterogeneity in vivo that provides an evolutionary advantage to bacteria upon drug-challenge.
C1 [Uda, Narasimha Rao; Upert, Gregory; Angelici, Gaetano; Nicolet, Stefan; Creus, Marc] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Schmidt, Tobias; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Creus, M (corresponding author), Univ Basel, Dept Chem, Spitalstr 51, CH-4056 Basel, Switzerland.
EM marc.creus@unibas.ch
RI Creus, Marc/E-8397-2012; Schwede, Torsten/A-4650-2008; Upert,
   Gregory/H-3475-2011; Angelici, Gaetano/T-4630-2017
OI Schwede, Torsten/0000-0003-2715-335X; Upert,
   Gregory/0000-0003-1849-9973; Angelici, Gaetano/0000-0002-4397-3449; Uda,
   Narasimha Rao/0000-0001-5967-6118
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200021-116344, CR22I3_143770]; State Secretariat for Education
   and Research [C11.0054]; COST ActionsEuropean Cooperation in Science and
   Technology (COST) [TD0905, CM0902]; Holcim Foundation; Novartis
   FoundationNovartis
FX The authors would like to thank the financial support from the Swiss
   National Science Foundation (Grants 200021-116344 and CR22I3_143770),
   the State Secretariat for Education and Research (Grant C11.0054) and
   COST Actions TD0905 and CM0902. MC is particularly grateful for the
   support from the Holcim Foundation and GA from the Novartis Foundation.
   The authors would also like to acknowledge Prof. Thomas R. Ward for
   general encouragement and for allowing the use of laboratory space and
   facilities, as well as thank Prof. Charles G. Miller (University of
   Illinois) for his generous donation of valuable research materials and
   insights.
CR [Anonymous], 2012, SUITE 2012 MAESTRO V
   [Anonymous], 2012, MACROMODEL VERSION 9
   Arnold F. H., 1996, PROTEIN ENG, V9, P78
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587
   Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541
   Biasini M, 2013, ACTA CRYSTALLOGR D, V69, P701, DOI 10.1107/S0907444913007051
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Bienvenue DL, 2003, BIOCHEMISTRY-US, V42, P10756, DOI 10.1021/bi034845+
   Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960
   Born TL, 1998, BIOCHEMISTRY-US, V37, P10478, DOI 10.1021/bi9806807
   Broder DH, 2003, J BACTERIOL, V185, P4748, DOI 10.1128/JB.185.16.4748-4754.2003
   Chai SC, 2008, J BIOL CHEM, V283, P26879, DOI 10.1074/jbc.M804345200
   Chai SC, 2011, EUR J MED CHEM, V46, P3537, DOI 10.1016/j.ejmech.2011.04.056
   Chowdhury AR, 2005, TETRAHEDRON LETT, V46, P1675, DOI 10.1016/j.tetlet.2005.01.062
   Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423
   ECDC/EMEA, 2009, ECDC EMEA THE BACTER
   Giglione C, 2000, MOL MICROBIOL, V36, P1197, DOI 10.1046/j.1365-2958.2000.01908.x
   Gillner D, 2009, BIOORG MED CHEM LETT, V19, P6350, DOI 10.1016/j.bmcl.2009.09.077
   Gillner DM, 2013, J BIOL INORG CHEM, V18, P155, DOI 10.1007/s00775-012-0965-1
   GILVARG C, 1959, J BIOL CHEM, V234, P2955
   Girish TS, 2010, J BIOL CHEM, V285, P29406, DOI 10.1074/jbc.M110.147579
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797
   Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g
   Huguet F, 2012, CHEMMEDCHEM, V7, P1020, DOI 10.1002/cmdc.201200076
   Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570
   Leeds JA, 2006, CURR OPIN PHARMACOL, V6, P445, DOI 10.1016/j.coph.2006.06.003
   Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46
   Luo QL, 2003, J MED CHEM, V46, P2631, DOI 10.1021/jm0300532
   Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059
   Maret W, 2010, METALLOMICS, V2, P117, DOI 10.1039/b915804a
   MEINNEL T, 1995, J MOL BIOL, V254, P175, DOI 10.1006/jmbi.1995.0609
   Nguyen KT, 2007, ARCH BIOCHEM BIOPHYS, V468, P217, DOI 10.1016/j.abb.2007.09.023
   Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062
   Oefner C, 2003, J MOL BIOL, V332, P13, DOI 10.1016/S0022-2836(03)00862-3
   ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908
   Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305
   Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279
   Schiffmann R, 2005, ANGEW CHEM INT EDIT, V44, P3620, DOI 10.1002/anie.200500592
   Supuran C. T., 2013, EXPERT OPIN THER PAT, P1
   Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441
   Uda NR, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/306465
   Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300
   WHO, 2002, FACT SHEET NO 194
   Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j
   Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636
   You L, 1996, PROTEIN ENG, V9, P719, DOI 10.1093/protein/9.8.719
   Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006
NR 49
TC 16
Z9 17
U1 0
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1756-5901
EI 1756-591X
J9 METALLOMICS
JI Metallomics
PY 2014
VL 6
IS 1
BP 88
EP 95
DI 10.1039/c3mt00125c
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 278LF
UT WOS:000328891100008
PM 24057071
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Gruber, AJ
   Grandy, WA
   Balwierz, PJ
   Dimitrova, YA
   Pachkov, M
   Ciaudo, C
   van Nimwegen, E
   Zavolan, M
AF Gruber, Andreas J.
   Grandy, William A.
   Balwierz, Piotr J.
   Dimitrova, Yoana A.
   Pachkov, Mikhail
   Ciaudo, Constance
   van Nimwegen, Erik
   Zavolan, Mihaela
TI Embryonic stem cell-specific microRNAs contribute to pluripotency by
   inhibiting regulators of multiple differentiation pathways
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID CHROMATIN REMODELING COMPLEX; NF-KAPPA-B; SELF-RENEWAL; TRANSCRIPTIONAL
   REPRESSORS; MESSENGER-RNAS; PROBE LEVEL; MOUSE; EXPRESSION; NETWORK;
   TARGETS
AB The findings that microRNAs (miRNAs) are essential for early development in many species and that embryonic miRNAs can reprogram somatic cells into induced pluripotent stem cells suggest that these miRNAs act directly on transcriptional and chromatin regulators of pluripotency. To elucidate the transcription regulatory networks immediately downstream of embryonic miRNAs, we extended the motif activity response analysis approach that infers the regulatory impact of both transcription factors (TFs) and miRNAs from genome-wide expression states. Applying this approach to multiple experimental data sets generated from mouse embryonic stem cells (ESCs) that did or did not express miRNAs of the ESC-specific miR-290-295 cluster, we identified multiple TFs that are direct miRNA targets, some of which are known to be active during cell differentiation. Our results provide new insights into the transcription regulatory network downstream of ESC-specific miRNAs, indicating that these miRNAs act on cell cycle and chromatin regulators at several levels and downregulate TFs that are involved in the innate immune response.
C1 [Gruber, Andreas J.; Grandy, William A.; Balwierz, Piotr J.; Dimitrova, Yoana A.; Pachkov, Mikhail; van Nimwegen, Erik; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Ciaudo, Constance] ETH, CH-8093 Zurich, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelberstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Ciaudo, Constance/A-2014-2012; Balwierz, Piotr J/AAG-4187-2020; Zavolan,
   Mihaela/S-3888-2016
OI Ciaudo, Constance/0000-0002-0857-4506; Balwierz, Piotr
   J/0000-0002-1548-4605; van Nimwegen, Erik/0000-0001-6338-1312; Zavolan,
   Mihaela/0000-0002-8832-2041
FU Swiss National ScienceSwiss National Science Foundation (SNSF)
   [31003A_127307]; European Research Council Starting GrantEuropean
   Research Council (ERC); Werner Siemens fellowship at the Biozentrum;
   Biozentrum, University of Basel
FX Swiss National Science [#31003A_127307]; European Research Council
   Starting Grant [to M.Z.]. Werner Siemens fellowship at the Biozentrum
   [to A.J.G.]. Source of open access funding: Biozentrum, University of
   Basel.
CR Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001
   AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110
   Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308
   Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792
   Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136
   Ciaudo C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003791
   Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620
   Fraley C, 2009, MCLUST MODEL BASED C
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Granadino B, 2000, MECH DEVELOP, V97, P157, DOI 10.1016/S0925-4773(00)00410-X
   Gruber AJ, 2013, EPIGENOMICS-UK, V5, P671, DOI 10.2217/epi.13.65
   Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316
   Hanina SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001163
   He L, 2012, STEM CELL REV REP, V8, P128, DOI 10.1007/s12015-011-9285-z
   Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106
   Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009
   HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Kuo CH, 2012, BIOCHEM BIOPH RES CO, V417, P11, DOI 10.1016/j.bbrc.2011.11.058
   Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033
   Martin-de-Lara F, 2008, TRANSGENIC RES, V17, P1131, DOI 10.1007/s11248-008-9214-3
   Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725
   Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909
   Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102
   Queva C, 2001, MOL CELL BIOL, V21, P703, DOI 10.1128/MCB.21.3.703-712.2001
   Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37
   Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Skinner MK, 2010, DIFFERENTIATION, V80, P1, DOI 10.1016/j.diff.2010.02.003
   Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79
   Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680
   Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007
   Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969
   Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250
   Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107
   Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006
   Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054
NR 56
TC 21
Z9 24
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 2014
VL 42
IS 14
BP 9313
EP 9326
DI 10.1093/nar/gku544
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AQ9ZH
UT WOS:000343219200047
PM 25030899
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Panneerselvam, K
   Mena-Hernando, S
   Teo, BM
   Goldie, KN
   Stadler, B
AF Panneerselvam, Karthiga
   Mena-Hernando, Sofia
   Teo, Boon M.
   Goldie, Kenneth N.
   Stadler, Brigitte
TI Liposomes equipped with poly(N-isopropyl acryl amide)-containing
   coatings as potential drug carriers
SO RSC ADVANCES
LA English
DT Article
ID CONVECTIVE FLOW; MYOBLAST CELLS; DELIVERY; FILMS; NANOCAPSULES;
   ASSEMBLIES; DEPOSITION; LIPOPLEX
AB Polymer coated liposomes are promising drug delivery candidates. Herein, we report on the coating of liposomes with mixed films containing poly(dopamine) (PDA) and different types of poly(N-isopropyl acryl amide) (pNiPAAm). Their potential as drug carriers from solution in the presence of shear stress or in a substrate-mediated manner using macrophages is assessed. Although we found no difference in the cell mean fluorescence (CMF) when applying shear stress when employing fluorescently labeled liposomes, macrophages exposed to liposomes coated with a mixture of PDA and highly-branched pNiPAAm (L-D/HB) exhibited significantly higher CMF after 2.5 h compared to liposomes coated with only PDA (L-D) or with a mixture of PDA and aminated pNiPAAm (L-2(D/pNH)). The coated liposomes did not affect the cell viability in the time frame tested, but the application of shear stress reduced the number of surface-adherent macrophages. L-D, L-2(D/pNH) or L-D/pHB could be immobilized to poly(L lysine) pre-coated silica substrates. All substrates were equally suited for macrophages to adhere. The CMF of the adhering macrophages was found to be independent of the coating of the surface-immobilized liposomes when using fluorescently labeled liposomes in the coatings. Taken together, we demonstrate that mixed PDA-based coatings can be used to affect the interaction of liposomes with macrophages with potential in drug delivery.
C1 [Panneerselvam, Karthiga; Mena-Hernando, Sofia; Teo, Boon M.; Stadler, Brigitte] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
RP Stadler, B (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.
EM bstadler@inano.au.dk
OI Stadler, Brigitte/0000-0002-7335-3945
FU Sapere Aude Starting Grant from the Danish Council for Independent
   Research, Technology and Production Sciences, Denmark
FX This work was supported by a Sapere Aude Starting Grant from the Danish
   Council for Independent Research, Technology and Production Sciences,
   Denmark. We acknowledge Associate Prof. R. Meyer (iNANO, Aarhus
   University, Denmark) for access to CLSM, and Associate Prof. A. Zelikin
   (Department of Chemistry, Aarhus University, Denmark) for access to the
   DLS, plate reader and flow cytometer.
CR Aguirre G, 2014, POLYM CHEM-UK, V5, P4569, DOI 10.1039/c4py00297k
   Ali SI, 2011, SOFT MATTER, V7, P5382, DOI 10.1039/c1sm05266g
   Ali SI, 2010, LANGMUIR, V26, P7848, DOI 10.1021/la904709c
   An JH, 2011, POLYM INT, V60, P1581, DOI 10.1002/pi.3116
   Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644
   Bhowmick T, 2012, J CONTROL RELEASE, V157, P485, DOI 10.1016/j.jconrel.2011.09.067
   Bjornmalm M, 2014, J CONTROL RELEASE, V190, P139, DOI 10.1016/j.jconrel.2014.04.030
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q
   Fejerskov B, 2014, SMALL, V10, P1314, DOI 10.1002/smll.201303101
   Fillafer C, 2009, LAB CHIP, V9, P2782, DOI 10.1039/b906006e
   Fujiwara T, 2006, BIOL PHARM BULL, V29, P1511, DOI 10.1248/bpb.29.1511
   Fukui Y, 2009, LANGMUIR, V25, P10020, DOI 10.1021/la9008834
   Gao WW, 2013, J MATER CHEM B, V1, P6569, DOI [10.1039/C3TB21238F, 10.1039/c3tb21238f]
   Graf N, 2012, SOFT MATTER, V8, P3641, DOI 10.1039/c2sm07272f
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Harris SS, 2005, GENE THER, V12, P512, DOI 10.1038/sj.gt.3302397
   Hosta-Rigau L, 2014, ACS APPL MATER INTER, V6, P12771, DOI 10.1021/am502743z
   Hosta-Rigau L, 2013, MOL PHARMACEUT, V10, P2707, DOI 10.1021/mp4001298
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kim K, 2013, BIOMATER SCI-UK, V1, P783, DOI 10.1039/c3bm00004d
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Liu YX, 2014, LANGMUIR, V30, P3118, DOI 10.1021/la500006e
   Lynge ME, 2013, BIOMATER SCI-UK, V1, P1181, DOI 10.1039/c3bm60107b
   Lynge ME, 2013, ACS APPL MATER INTER, V5, P2967, DOI 10.1021/am4006868
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Ochs CJ, 2011, CHEM MATER, V23, P3141, DOI 10.1021/cm201390e
   Saiz-Poseu J, 2013, ADV MATER, V25, P2066, DOI 10.1002/adma.201204383
   Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008
   Teo BM, 2014, NANOSCALE, V6, P6426, DOI 10.1039/c4nr00459k
   Teo BM, 2013, BBA-GEN SUBJECTS, V1830, P4838, DOI 10.1016/j.bbagen.2013.06.022
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Tsai WB, 2011, ACTA BIOMATER, V7, P2518, DOI 10.1016/j.actbio.2011.03.010
   van der Westen R, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0008-4
   Yamamoto S, 2011, LANGMUIR, V27, P9576, DOI 10.1021/la201500b
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhang Y, 2014, LANGMUIR, V30, P5592, DOI 10.1021/la5005227
   Zhang Y, 2013, J PHYS CHEM B, V117, P10504, DOI 10.1021/jp407106z
   Zhang Y, 2013, LANGMUIR, V29, P10213, DOI 10.1021/la402118u
   Zhang Y, 2012, LANGMUIR, V28, P17585, DOI 10.1021/la304080c
NR 41
TC 10
Z9 10
U1 1
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 84
BP 44769
EP 44776
DI 10.1039/c4ra07720b
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AQ7KP
UT WOS:000342993800062
DA 2021-01-25
ER

PT S
AU Goldie, KN
   Abeyrathne, P
   Kebbel, F
   Chami, M
   Ringler, P
   Stahlberg, H
AF Goldie, Kenneth N.
   Abeyrathne, Priyanka
   Kebbel, Fabian
   Chami, Mohamed
   Ringler, Philippe
   Stahlberg, Henning
BE Kuo, J
TI Cryo-electron Microscopy of Membrane Proteins
SO ELECTRON MICROSCOPY: METHODS AND PROTOCOLS, 3RD EDITION
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE 2D membrane protein crystals; Back injection; Sandwich method;
   Spot-scanning; Carbon flatness; Low dose; Cryo-electron microscopy
ID IMAGE-PROCESSING LIBRARY; ELECTRON-MICROSCOPY; 2D CRYSTALLIZATION;
   2-DIMENSIONAL CRYSTALLIZATION; BIOLOGICAL MACROMOLECULES; SPECIMEN
   FLATNESS; RADIATION-DAMAGE; PURPLE MEMBRANE; RESOLUTION; CRYSTALLOGRAPHY
AB Electron crystallography is used to study membrane proteins in the form of planar, two-dimensional (2D) crystals, or other crystalline arrays such as tubular crystals. This method has been used to determine the atomic resolution structures of bacteriorhodopsin, tubulin, aquaporins, and several other membrane proteins. In addition, a large number of membrane protein structures were studied at a slightly lower resolution, whereby at least secondary structure motifs could be identified.
   In order to conserve the structural details of delicate crystalline arrays, cryo-electron microscopy (cryo-EM) allows imaging and/or electron diffraction of membrane proteins in their close-to-native state within a lipid bilayer membrane.
   To achieve ultimate high-resolution structural information of 2D crystals, meticulous sample preparation for electron crystallography is of outmost importance. Beam-induced specimen drift and lack of specimen flatness can severely affect the attainable resolution of images for tilted samples. Sample preparations that sandwich the 2D crystals between symmetrical carbon films reduce the beam-induced specimen drift, and the flatness of the preparations can be optimized by the choice of the grid material and the preparation protocol.
   Data collection in the cryo-electron microscope using either the imaging or the electron diffraction mode has to be performed applying low-dose procedures. Spot-scanning further reduces the effects of beam-induced drift. Data collection using automated acquisition schemes, along with improved and user-friendlier data processing software, is increasingly being used and is likely to bring the technique to a wider user base.
C1 [Goldie, Kenneth N.; Abeyrathne, Priyanka; Kebbel, Fabian; Chami, Mohamed; Ringler, Philippe; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, Basel, Switzerland.
RP Goldie, KN (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
CR Abeyrathne PD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 1: BIOPHYSICAL TECHNIQUES FOR STRUCTURAL CHARACTERIZATION OF MACROMOLECULES, P277, DOI 10.1016/B978-0-12-374920-8.00119-3
   Abeyrathne PD, 2010, METHOD ENZYMOL, V481, P25, DOI 10.1016/S0076-6879(10)81001-8
   AEBI U, 1973, Journal of Supramolecular Structure, V1, P498, DOI 10.1002/jss.400010606
   AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183
   Arheit Marcel, 2013, Methods Mol Biol, V955, P313, DOI 10.1007/978-1-62703-176-9_18
   Arheit Marcel, 2013, Methods Mol Biol, V955, P171, DOI 10.1007/978-1-62703-176-9_10
   Arheit Marcel, 2013, Methods Mol Biol, V955, P195, DOI 10.1007/978-1-62703-176-9_11
   Bammes BE, 2010, J STRUCT BIOL, V169, P331, DOI 10.1016/j.jsb.2009.11.001
   BOOY FP, 1993, ULTRAMICROSCOPY, V48, P273, DOI 10.1016/0304-3991(93)90101-3
   Comolli LR, 2005, J STRUCT BIOL, V152, P149, DOI 10.1016/j.jsb.2005.08.004
   Coudray N, 2011, J STRUCT BIOL, V173, P365, DOI 10.1016/j.jsb.2010.09.019
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   DOWNING KH, 1991, SCIENCE, V251, P53, DOI 10.1126/science.1846047
   Downing KH, 1999, ULTRAMICROSCOPY, V75, P215, DOI 10.1016/S0304-3991(98)00065-5
   Downing KH, 2001, MICROSC MICROANAL, V7, P407, DOI 10.1017/S1431927601010406
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Fujiyoshi Y, 2008, CURR OPIN STRUC BIOL, V18, P587, DOI 10.1016/j.sbi.2008.07.005
   Gipson B, 2008, MICROSC MICROANAL, V14, P1290
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Glaeser RM, 2004, MICROSC MICROANAL, V10, P790, DOI 10.1017/S1431927604040668
   GLAESER RM, 1992, ULTRAMICROSCOPY, V46, P33, DOI 10.1016/0304-3991(92)90006-6
   GLAESER RM, 1992, ULTRAMICROSCOPY, V47, P256, DOI 10.1016/0304-3991(92)90201-T
   Glaeser RM, 2008, J STRUCT BIOL, V163, P271, DOI 10.1016/j.jsb.2008.06.001
   Glaeser RM, 2011, BIOPHYS J, V100, P2331, DOI 10.1016/j.bpj.2011.04.018
   Glaeser RM, 2011, J STRUCT BIOL, V174, P1, DOI 10.1016/j.jsb.2010.12.005
   Golas MM, 2005, MOL CELL, V17, P869, DOI 10.1016/j.molcel.2005.02.016
   Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   Hasler L, 1998, J STRUCT BIOL, V121, P162, DOI 10.1006/jsbi.1998.3960
   HENDERSON R, 1992, ULTRAMICROSCOPY, V46, P1, DOI 10.1016/0304-3991(92)90003-3
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081
   Hu MH, 2010, J STRUCT BIOL, V171, P102, DOI 10.1016/j.jsb.2010.02.018
   Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001
   Iancu CV, 2006, J STRUCT BIOL, V153, P231, DOI 10.1016/j.jsb.2005.12.004
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   Schenk AD, 2010, METHOD ENZYMOL, V482, P101, DOI 10.1016/S0076-6879(10)82004-X
   Schmidt-Krey I, 2013, METHODS MOL BIOL, V95
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317
   Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049
   TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036
   TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   Vonck J, 2000, ULTRAMICROSCOPY, V85, P123, DOI 10.1016/S0304-3991(00)00052-8
   Walz T, 1998, J STRUCT BIOL, V121, P142, DOI 10.1006/jsbi.1998.3945
   Zeng X, 2007, J STRUCT BIOL, V160, P362, DOI 10.1016/j.jsb.2007.09.013
   Zeng X, 2007, J STRUCT BIOL, V160, P353, DOI 10.1016/j.jsb.2007.08.008
   Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004
NR 68
TC 21
Z9 21
U1 1
U2 27
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-62703-776-1; 978-1-62703-775-4
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2014
VL 1117
BP 325
EP 341
DI 10.1007/978-1-62703-776-1_15
D2 10.1007/978-1-62703-776-1
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Microscopy
SC Biochemistry & Molecular Biology; Microscopy
GA BB1KV
UT WOS:000341167200016
PM 24357370
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Gyurko, DM
   Soti, C
   Stetak, A
   Csermely, P
AF Gyurko, David M.
   Soti, Csaba
   Stetak, Attila
   Csermely, Peter
TI System Level Mechanisms of Adaptation, Learning, Memory Formation and
   Evolvability: The Role of Chaperone and Other Networks
SO CURRENT PROTEIN & PEPTIDE SCIENCE
LA English
DT Review
DE Adaptation; chaperones; evolution; heat shock proteins; learning;
   memory; protein structure networks; protein-protein interaction
   networks; stress
ID HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; CELLULAR NETWORKS; SIGNALING
   PATHWAYS; STRESS-PROTEINS; HSP90; DYNAMICS; EXPRESSION; GROEL; EVOLUTION
AB During the last decade, network approaches became a powerful tool to describe protein structure and dynamics. Here, we describe first the protein structure networks of molecular chaperones, then characterize chaperone containing sub-networks of interactomes called as chaperone-networks or chaperomes. We review the role of molecular chaperones in short-term adaptation of cellular networks in response to stress, and in long-term adaptation discussing their putative functions in the regulation of evolvability. We provide a general overview of possible network mechanisms of adaptation, learning and memory formation. We propose that changes of network rigidity play a key role in learning and memory formation processes. Flexible network topology provides 'learning-competent' state. Here, networks may have much less modular boundaries than locally rigid, highly modular networks, where the learnt information has already been consolidated in a memory formation process. Since modular boundaries are efficient filters of information, in the 'learning-competent' state information filtering may be much smaller, than after memory formation. This mechanism restricts high information transfer to the 'learning competent' state. After memory formation, modular boundary-induced segregation and information filtering protect the stored information. The flexible networks of young organisms are generally in a 'learning competent' state. On the contrary, locally rigid networks of old organisms have lost their 'learning competent' state, but store and protect their learnt information efficiently. We anticipate that the above mechanism may operate at the level of both protein-protein interaction and neuronal networks.
C1 [Gyurko, David M.; Soti, Csaba; Csermely, Peter] Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary.
   [Stetak, Attila] Univ Basel, Life Sci Training Facil, Fac Psychol, Div Mol Neurosci, Basel, Switzerland.
   [Stetak, Attila] Univ Basel, Life Sci Training Facil, Biozentrum, Basel, Switzerland.
RP Csermely, P (corresponding author), Semmelweis Univ, Dept Med Chem, POB 260, H-1444 Budapest, Hungary.
EM csermely.peter@med.semmelweis-univ.hu
RI Csermely, Peter/J-2067-2017; Soti, Csaba/O-6070-2017
OI Csermely, Peter/0000-0001-9234-0659; Soti, Csaba/0000-0002-4057-7678;
   Gyurko, David Marton/0000-0002-2997-9799
FU Hungarian National Science Foundation [OTKA-K83314]; EUEuropean Union
   (EU) [TAMOP-4.2.2/B-10/1-2010-0013]
FX Authors would like to thank members of the LINK-group (www.linkgroup.hu)
   and the Stress-group of the Department of Medical Chemistry at the
   Semmelweis University, Budapest, Hungary for helpful suggestions. Work
   in the authors' laboratory was supported by research grants from the
   Hungarian National Science Foundation (OTKA-K83314), from the EU
   (TAMOP-4.2.2/B-10/1-2010-0013) and by a residence at the Rockefeller
   Foundation Bellagio Center (PC).
CR Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004
   Agnati LF, 2007, J NEURAL TRANSM, V114, P3, DOI 10.1007/s00702-006-0563-x
   Agnati LF, 2004, CELL MOL NEUROBIOL, V24, P501, DOI 10.1023/B:CEMN.0000023626.35717.5d
   Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039
   Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054
   Ambrosini MV, 2005, HIPPOCAMPUS, V15, P413, DOI 10.1002/hipo.20069
   Ammon-Treiber S, 2008, NEUROBIOL LEARN MEM, V90, P358, DOI 10.1016/j.nlm.2008.04.006
   Armstrong JD, 2012, ADV EXP MED BIOL, V736, P119, DOI 10.1007/978-1-4419-7210-1_6
   Arslan MA, 2006, BIOGERONTOLOGY, V7, P383, DOI 10.1007/s10522-006-9053-7
   Arslan MA, 2012, FASEB J, V26, P766, DOI 10.1096/fj.11-186197
   ARTYMIUK PJ, 1990, PROTEIN ENG, V4, P39, DOI 10.1093/protein/4.1.39
   Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108
   Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317
   Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725
   Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025
   Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765
   BLACKSTROM L, 2011, 4 DEGREES SEPARATION
   Bobula J, 2006, GENETICS, V174, P937, DOI 10.1534/genetics.106.061564
   Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009
   Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021
   Bogumil D, 2012, GENOME BIOL EVOL, V4, P618, DOI 10.1093/gbe/evs025
   Chen BS, 2011, EVOL BIOINFORM, V7, P201, DOI 10.4137/EBO.S8123
   Chen WQ, 2008, BBA-PROTEINS PROTEOM, V1784, P555, DOI 10.1016/j.bbapap.2008.01.002
   Cheng J, 2012, J MOL NEUROSCI, V48, P441, DOI 10.1007/s12031-012-9724-6
   Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k
   Chennubhotla C, 2007, J COMPUT BIOL, V14, P765, DOI 10.1089/cmb.2007.R015
   Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075
   Chevallier N, 2011, J PSYCHOPHARMACOL, V25, P960, DOI 10.1177/0269881111400648
   Cho HJ, 2011, J AM CHEM SOC, V133, P20267, DOI 10.1021/ja206762p
   Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370
   Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112
   Csermely P, 2001, TRENDS GENET, V17, P701, DOI 10.1016/S0168-9525(01)02495-7
   Csermely P, 2004, TRENDS BIOCHEM SCI, V29, P331, DOI 10.1016/j.tibs.2004.05.004
   CSERMELY P, 1994, BIOCHEM BIOPH RES CO, V202, P1657, DOI 10.1006/bbrc.1994.2124
   Csermely P, 1998, CURR SCI INDIA, V74, P442
   Csermely P, 2009, WEAK LINKS UNIVERSAL
   Csermely P., 2013, TALENT DEV EXCELLENC, V5, P115
   Csermely P, 2007, ADV EXP MED BIOL, V594, P55
   Csermely P, 2012, CURR PROTEIN PEPT SC, V13, P19, DOI 10.2174/138920312799277992
   Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009
   Csermely Peter, 2008, Novartis Found Symp, V291, P45
   Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006
   De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807
   Di Paola V, 2004, BIOSYSTEMS, V74, P29, DOI 10.1016/j.biosystems.2004.01.003
   Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562
   Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605
   Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004
   Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002
   Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694
   Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101
   Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044
   Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011
   Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029
   Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675
   Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a
   Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950
   Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1
   Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121
   Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743
   Gaspar ME, 2012, BRIEF FUNCT GENOMICS, V11, P443, DOI 10.1093/bfgp/els023
   Gerges NZ, 2004, J NEUROSCI, V24, P4758, DOI 10.1523/JNEUROSCI.0594-04.2004
   Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030
   Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514
   Gong YC, 2011, METHODS MOL BIOL, V787, P189, DOI 10.1007/978-1-61779-295-3_15
   Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26
   Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061
   Hadziselimovic N, 2014, CELL, V156, P1153, DOI 10.1016/j.cell.2014.01.054
   Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555
   Han ZG, 2007, J THEOR BIOL, V246, P755, DOI 10.1016/j.jtbi.2007.01.022
   Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013
   HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2
   Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012
   Houry WA, 1999, NATURE, V402, P147
   Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913
   Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028
   Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058
   Keskin O, 2002, BIOCHEMISTRY-US, V41, P491, DOI 10.1021/bi011393x
   Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174
   Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489
   Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420
   Kiss HJM, 2009, BIOESSAYS, V31, P651, DOI 10.1002/bies.200800224
   Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149
   Korcsmaros T, 2007, J BIOSCIENCES, V32, P441, DOI 10.1007/s12038-007-0043-y
   Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528
   Krishnan A, 2008, CURR PROTEIN PEPT SC, V9, P28
   Kumar M, 2012, MOL MICROBIOL, V84, P736, DOI 10.1111/j.1365-2958.2012.08054.x
   Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025
   Lee JB, 2012, J PHYSIOL-LONDON, V590, P1535, DOI 10.1113/jphysiol.2011.224907
   Leil TA, 2003, J NEUROSCI RES, V71, P763, DOI 10.1002/jnr.10541
   Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264
   Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007
   Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014
   Li KW, 2010, ANAL BIOANAL CHEM, V397, P3195, DOI 10.1007/s00216-010-3658-z
   Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011
   Liu Y, 2010, BIOCOMPUT-PAC SYM, P269, DOI 10.1142/9789814295291_0029
   Liu Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000931
   Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109
   Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1
   MATSUSHITA T, 1995, BIOL CYBERN, V72, P497, DOI 10.1007/s004220050152
   McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036
   Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187
   Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799
   Nardai G, 2002, EXP GERONTOL, V37, P1257, DOI 10.1016/S0531-5565(02)00134-1
   Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000
   Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]
   Ng A, 2006, NUCLEIC ACIDS RES, V34, pD527, DOI 10.1093/nar/gkj044
   Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6
   Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109
   Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2
   Ogasawara H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-181
   Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550
   Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491
   Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8
   Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168
   Pizarro JM, 2003, NEUROBIOL LEARN MEM, V79, P142, DOI 10.1016/S1074-7427(02)00008-4
   Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105
   Prinsloo E, 2012, IUBMB LIFE, V64, P266, DOI 10.1002/iub.607
   Prinsloo E, 2009, BIOESSAYS, V31, P370, DOI 10.1002/bies.200800158
   Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749
   Quinta HR, 2011, CELL SIGNAL, V23, P1907, DOI 10.1016/j.cellsig.2011.07.023
   Rajapakse I, 2011, P NATL ACAD SCI USA, V108, P17257, DOI 10.1073/pnas.1113249108
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139
   Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935
   Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207
   Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550
   Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041
   Rutherford S, 2007, CRIT REV BIOCHEM MOL, V42, P355, DOI 10.1080/10409230701597782
   Rutherford S, 2007, ADV EXP MED BIOL, V594, P190
   Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104
   Sardiu ME, 2011, J BIOL CHEM, V286, P23645, DOI 10.1074/jbc.R110.174052
   Sgro CM, 2010, P ROY SOC B-BIOL SCI, V277, P2049, DOI 10.1098/rspb.2010.0008
   Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067
   Song H, 2006, BIOPHYS J, V90, P2309, DOI 10.1529/biophysj.105.074500
   Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6
   Sorokina O, 2011, MOL BIOSYST, V7, P2813, DOI 10.1039/c1mb05152k
   Sossin WS, 2008, TRENDS NEUROSCI, V31, P170, DOI 10.1016/j.tins.2008.01.001
   Soti C, 2007, EXP GERONTOL, V42, P113, DOI 10.1016/j.exger.2006.05.017
   Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012
   Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007
   Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739
   Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116
   Suzuki T, 1999, BRAIN RES, V816, P99, DOI 10.1016/S0006-8993(98)01083-X
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Szalay MS, 2007, FEBS LETT, V581, P3675, DOI 10.1016/j.febslet.2007.03.083
   Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352
   Takahashi KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017295
   Takahashi KH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-284
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tehver R, 2009, J MOL BIOL, V387, P390, DOI 10.1016/j.jmb.2008.12.032
   Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09
   Tomala K, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-5
   Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192
   Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498
   Tsigelny IF, 2004, CELL BIOCHEM BIOPHYS, V40, P263, DOI 10.1385/CBB:40:3:263
   Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399
   Vishveshwara S, 2009, CURR PROTEIN PEPT SC, V10, P146, DOI 10.2174/138920309787847590
   Volkert LG, 2003, BIOSYSTEMS, V69, P127, DOI 10.1016/S0303-2647(02)00136-3
   Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14
   Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Wong P, 2004, J STRUCT BIOL, V146, P79, DOI 10.1016/j.jsb.2003.11.006
   Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492
   Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024
   Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270
   Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707
NR 173
TC 6
Z9 6
U1 0
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2037
EI 1875-5550
J9 CURR PROTEIN PEPT SC
JI Curr. Protein Pept. Sci.
PY 2014
VL 15
IS 3
BP 171
EP 188
DI 10.2174/1389203715666140331110522
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AN8TQ
UT WOS:000340877800002
PM 24694371
DA 2021-01-25
ER

PT J
AU Daubner, GM
   Brummer, A
   Tocchini, C
   Gerhardy, S
   Ciosk, R
   Zavolan, M
   Allain, FHT
AF Daubner, Gerrit M.
   Bruemmer, Anneke
   Tocchini, Cristina
   Gerhardy, Stefan
   Ciosk, Rafal
   Zavolan, Mihaela
   Allain, Frederic H. -T.
TI Structural and functional implications of the QUA2 domain on RNA
   recognition by GLD-1
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID NMR STRUCTURE DETERMINATION; TUMOR-SUPPRESSOR GENE;
   CAENORHABDITIS-ELEGANS; TRANSLATIONAL REPRESSION; BINDING PROTEIN; STAR
   PROTEIN; BIOLOGICAL FUNCTION; CHEMICAL-SHIFTS; MOLECULAR-BASIS; KH
   DOMAINS
AB The STAR family comprises ribonucleic acid (RNA)-binding proteins that play key roles in RNA-regulatory processes. RNA recognition is achieved by a KH domain with an additional alpha-helix (QUA2) that seems to extend the RNA-binding surface to six nucleotides for SF1 (Homo sapiens) and seven nucleotides for GLD-1 (Caenorhabditis elegans). To understand the structural basis of this probable difference in specificity, we determined the solution structure of GLD-1 KH-QUA2 with the complete consensus sequence identified in the tra-2 gene. Compared to SF1, the GLD-1 KH-QUA2 interface adopts a different conformation resulting indeed in an additional sequence-specific binding pocket for a uracil at the 5'end. The functional relevance of this binding pocket is emphasized by our bioinformatics analysis showing that GLD-1 binding sites with this 5'end uracil are more predictive for the functional response of the messenger RNAs to gld-1 knockout. We further reveal the importance of the KH-QUA2 interface in vitro and that its alteration in vivo affects the level of translational repression dependent on the sequence of the GLD-1 binding motif. In conclusion, we demonstrate that the QUA2 domain distinguishes GLD-1 from other members of the STAR family and contributes more generally to the modulation of RNA-binding affinity and specificity of KH domain containing proteins.
C1 [Daubner, Gerrit M.; Gerhardy, Stefan; Allain, Frederic H. -T.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
   [Bruemmer, Anneke; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Tocchini, Cristina; Ciosk, Rafal] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland.
RP Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
EM allain@mol.biol.ethz.ch
RI Zavolan, Mihaela/S-3888-2016; Gerhardy, Stefan/ABI-7973-2020
OI Brummer, Anneke/0000-0002-3576-0750; Ciosk, Rafal/0000-0003-2234-6216;
   Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSII3_127454, 31003A_149402]
FX Swiss National Science Foundation [CRSII3_127454 to M.Z., F.H.-T.A.;
   31003A_149402 to R.C]. Funding for open access charge: Swiss National
   Science Foundation [CR-SII3 127454 to M.Z., F.H.-T.A.; 31003A_149402 to
   R.C].
CR Artzt K, 2010, ADV EXP MED BIOL, V693, P1
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027
   Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016
   Biedermann B, 2009, DEV CELL, V17, P355, DOI 10.1016/j.devcel.2009.08.003
   Bockbrader K, 2008, FUTUR NEUROL, V3, P655, DOI 10.2217/14796708.3.6.655
   Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352
   BRENNER S, 1974, GENETICS, V77, P71
   Brummer A, 2013, RNA, V19, P1317, DOI 10.1261/rna.037531.112
   Carmel AB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-48
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109
   Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006
   Doreleijers JF, 2012, NUCLEIC ACIDS RES, V40, pD519, DOI 10.1093/nar/gkr1134
   FRANCIS R, 1995, GENETICS, V139, P579
   Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963
   Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47
   Garrey SM, 2008, RNA, V14, P78, DOI 10.1261/rna.633808
   GODDARD TD, 2007, SPARKY, V3
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P627
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432
   Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258
   Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293
   JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491
   Kadyk LC, 1998, DEVELOPMENT, V125, P1803
   Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lee MH, 2010, ADV EXP MED BIOL, V693, P106
   LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3
   Lehmann-Blount KA, 2005, J MOL BIOL, V346, P91, DOI 10.1016/j.jmb.2004.11.049
   Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6
   Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719
   Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058
   Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x
   McInnes LA, 2006, NEUROSCI BIOBEHAV R, V30, P551, DOI 10.1016/j.neubiorev.2005.10.003
   Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013
   Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185
   Navarro RE, 2001, DEVELOPMENT, V128, P3221
   Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11
   PELTON JG, 1993, PROTEIN SCI, V2, P543
   Peterson RD, 2004, J BIOMOL NMR, V28, P59, DOI 10.1023/B:JNMR.0000012861.95939.05
   Ryder SP, 2010, ADV EXP MED BIOL, V693, P37
   Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504
   Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706
   Sanchez-Jimenez F, 2013, INT J MOL SCI, V14, P23402, DOI 10.3390/ijms141223402
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Scheckel C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002742
   Schubert M, 2006, J BIOMOL NMR, V35, P167, DOI 10.1007/s10858-006-9025-x
   Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Teplova M, 2013, GENE DEV, V27, P928, DOI 10.1101/gad.216531.113
   Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002
   Tiwari Abhishek, 2007, In Silico Biology, V7, P651
   Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024
   Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F
   Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213
   Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334
   Yang GD, 2010, GASTROENTEROLOGY, V138, P231, DOI 10.1053/j.gastro.2009.08.001
   Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790
NR 66
TC 6
Z9 7
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 2014
VL 42
IS 12
BP 8092
EP 8105
DI 10.1093/nar/gku445
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AM2XA
UT WOS:000339713200050
PM 24838563
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT S
AU Solinger, JA
   Poteryaev, D
   Spang, A
AF Solinger, Jachen A.
   Poteryaev, Dmitry
   Spang, Anne
BE Ivanov, AI
TI Application of RNAi Technology and Fluorescent Protein Markers to Study
   Membrane Traffic in C. elegans
SO EXOCYTOSIS AND ENDOCYTOSIS, 2ND EDITION
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE C. elegans; Confocal microscopy; Embryo; Endocytosis; Endoplasmic
   reticulum; GFP; Membrane dynamics; Membrane trafficking; Protein
   transport; RNAi
ID RECEPTOR-MEDIATED ENDOCYTOSIS; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS;
   DOMAIN PROTEIN; TRANSPORT; COMPLEX; CYTOSKELETON; CYTOKINESIS;
   MATURATION; SECRETION
AB RNA interference (RNAi) is a powerful tool to study the intracellular membrane transport and membrane organelle behavior in the nematode Caenorhabditis elegans. This model organism has gained popularity in the trafficking field because of its relative simplicity, yet being multicellular. C. elegans is fully sequenced and has an annotated genome, it is easy to maintain, and a growing number of transgenic strains bearing markers for different membrane compartments are available. C. elegans is particularly well suited for protein downregulation by RNAi because of the simple but efficient methods of dsRNA delivery. The phenomenon of systemic RNAi in the worm further facilitates this approach. In this chapter we describe methods and applications of RNAi in the field of membrane traffic. We summarize the fluorescent markers used as a readout for the effects of gene knockdown in different cells and tissues and give details for data acquisition and analysis.
C1 [Solinger, Jachen A.; Poteryaev, Dmitry; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
RP Solinger, JA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Poteryaev, Dmitry/0000-0003-2695-8869
CR Ackema KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067076
   Ahringer J., 2006, REVERSE GENETICS
   Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124
   Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]
   Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787
   Chen DD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003517
   Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840
   Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605
   Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/NMETH.2641, 10.1038/nmeth.2641]
   Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x
   Fares H, 2001, GENETICS, V159, P133
   Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/88281
   Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312
   Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825
   Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311
   Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549
   Guo PF, 2010, P NATL ACAD SCI USA, V107, P18016, DOI 10.1073/pnas.1008946107
   Halder G, 1999, METH MOL B, V122, P373
   Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060
   Huang J, 2012, DEVELOPMENT, V139, P4613, DOI 10.1242/dev.086769
   Hutter Harald, 2006, V351, P155
   Isik Meltem, 2013, Methods Mol Biol, V940, P77, DOI 10.1007/978-1-62703-110-3_7
   Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419
   Kimura K, 2012, J CELL SCI, V125, P5897, DOI 10.1242/jcs.116400
   Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718
   Koushika SP, 2000, CURR OPIN CELL BIOL, V12, P517, DOI 10.1016/S0955-0674(00)00125-3
   Kubota Y, 2006, DEVELOPMENT, V133, P263, DOI 10.1242/dev.02195
   Lamitina Todd, 2006, V351, P127
   Larsen MK, 2006, MOL BIOL CELL, V17, P4318, DOI 10.1091/mbc.E06-01-0035
   Lehner BB, 2005, CORD C P, V1, P1617
   Li Zao, 2013, Methods Mol Biol, V1004, P183, DOI 10.1007/978-1-62703-383-1_14
   Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072
   Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245
   Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170
   Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725
   Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Nakae I, 2010, MOL BIOL CELL, V21, P2434, DOI 10.1091/mbc.E09-12-1010
   Nicot AS, 2006, MOL BIOL CELL, V17, P3062
   O'Connell KF, 2014, METHODS MOL BIOL, V1075, P257, DOI 10.1007/978-1-60761-847-8_13
   Ohkumo Tsuyoshi, 2008, V442, P129, DOI 10.1007/978-1-59745-191-8_10
   Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986
   Patton A, 2005, CURR BIOL, V15, P1045, DOI 10.1016/j.cub.2005.04.057
   Paupard MC, 2001, J HISTOCHEM CYTOCHEM, V49, P949, DOI 10.1177/002215540104900803
   Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606
   Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726
   Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838
   Robert Valerie J P, 2012, Methods Mol Biol, V859, P189, DOI 10.1007/978-1-61779-603-6_11
   Roudier N, 2005, TRAFFIC, V6, P695, DOI 10.1111/j.1600-0854.2005.00309.x
   Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211
   Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106
   Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54
   Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045
   Shi AB, 2012, P NATL ACAD SCI USA, V109, pE2306, DOI 10.1073/pnas.1205278109
   Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149
   Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7
   Timmons Lisa, 2006, V351, P119
   Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101
   Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225
   Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011
NR 59
TC 3
Z9 3
U1 0
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-4939-0944-5; 978-1-4939-0943-8
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2014
VL 1174
BP 329
EP 347
DI 10.1007/978-1-4939-0944-5_23
D2 10.1007/978-1-4939-0944-5
PG 19
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BA8RE
UT WOS:000338503100024
PM 24947393
DA 2021-01-25
ER

PT J
AU Bindschedler, S
   Cailleau, G
   Braissant, O
   Milliere, L
   Job, D
   Verrecchia, EP
AF Bindschedler, S.
   Cailleau, G.
   Braissant, O.
   Milliere, L.
   Job, D.
   Verrecchia, E. P.
TI Unravelling the enigmatic origin of calcitic nanofibres in soils and
   caves: purely physicochemical or biogenic processes?
SO BIOGEOSCIENCES
LA English
DT Article
ID NEEDLE-FIBER CALCITE; FUNGAL CELL-WALL; PUTATIVE NANOBACTERIA; CALCIFIED
   FILAMENTS; SOUTH-AUSTRALIA; CARBONATE; CRYSTALS; MORPHOLOGY; MOONMILK;
   BACTERIA
AB Calcitic nanofibres are ubiquitous habits of secondary calcium carbonate (CaCO3) accumulations observed in calcareous vadose environments. Despite their widespread occurrence, the origin of these nanofeatures remains enigmatic. Three possible mechanisms fuel the debate: (i) purely physicochemical processes, (ii) mineralization of rod-shaped bacteria, and (iii) crystal precipitation on organic templates. Nanofibres can be either mineral (calcitic) or organic in nature. They are very often observed in association with needle fibre calcite (NFC), another typical secondary CaCO3 habit in terrestrial environments. This association has contributed to some confusion between both habits, however they are truly two distinct calcitic features and their recurrent association is likely to be an important fact to help understanding the origin of nanofibres. In this paper the different hypotheses that currently exist to explain the origin of calcitic nanofibres are critically reviewed. In addition to this, a new hypothesis for the origin of nanofibres is proposed based on the fact that current knowledge attributes a fungal origin to NFC. As this feature and nanofibres are recurrently observed together, a possible fungal origin for nanofibres which are associated with NFC is investigated. Sequential enzymatic digestion of the fungal cell wall of selected fungal species demonstrates that the fungal cell wall can be a source of organic nanofibres. The obtained organic nanofibres show a striking morphological resemblance when compared to their natural counterparts, emphasizing a fungal origin for part of the organic nanofibres observed in association with NFC. It is further hypothesized that these organic nanofibres may act as templates for calcite nucleation in a biologically influenced mineralization process, generating calcitic nanofibres. This highlights the possible involvement of fungi in CaCO3 biomineralization processes, a role still poorly documented. Moreover, on a global scale, the organomineralization of organic nanofibres into calcitic nanofibres might be an overlooked process deserving more attention to specify its impact on the biogeochemical cycles of both Ca and C.
C1 [Bindschedler, S.; Cailleau, G.; Milliere, L.; Verrecchia, E. P.] Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland.
   [Bindschedler, S.; Job, D.] Univ Neuchatel, Microbiol Lab, Inst Biol, CH-2009 Neuchatel, Switzerland.
   [Braissant, O.] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Bindschedler, S (corresponding author), Univ Neuchatel, Microbiol Lab, Inst Biol, Rue Emile Argand 11, CH-2009 Neuchatel, Switzerland.
EM saskia.bindschedler@unine.ch
RI Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [FN 646 205320-109497/1, FN 205320-122171]
FX The authors would like to thank: Andre Villard and Michele Vlimant for
   their technical assistance during sample preparation for TEM purposes;
   Massoud Dadras, Vladislav Spassov and Mireille Leboeuf from CSEM and
   Pierre Vonlanthen at UNIL for their assistance in using electron
   microscopy; The Swiss Federal Research Institute WSL, CH-8903
   Birmensdorf, for providing the Boletus edulis strain (23.01); and Karin
   Verrecchia for improving the English of the paper. This work was
   supported by the Swiss National Science Foundation, grant nos. FN 646
   205320-109497/1 and FN 205320-122171.
CR Alonso-Zarza AM, 2007, GEOL ACTA, V5, P77
   Anand RR, 1997, AUST J EARTH SCI, V44, P87, DOI 10.1080/08120099708728296
   ARONSON JM, 1960, PROC R SOC SER B-BIO, V152, P346, DOI 10.1098/rspb.1960.0043
   Bajnoczi B, 2006, CHEM ERDE-GEOCHEM, V66, P203, DOI 10.1016/j.chemer.2005.11.002
   Banerjee S, 2013, P NATL A SCI INDIA B, V83, P277, DOI 10.1007/s40011-012-0149-3
   BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511
   Benzerara K, 2005, GEOCHIM COSMOCHIM AC, V69, P1413, DOI 10.1016/j.gca.2004.09.008
   Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100
   BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776
   Bindschedler S, 2012, GEOMICROBIOL J, V29, P301, DOI 10.1080/01490451.2011.558565
   Bindschedler S, 2010, GEOL SOC SPEC PUBL, V336, P225, DOI 10.1144/SP336.11
   Blyth AJ, 2008, GEOMICROBIOL J, V25, P101, DOI 10.1080/01490450801934938
   BOQUET E, 1973, NATURE, V246, P527, DOI 10.1038/246527a0
   Borsato A, 2000, J SEDIMENT RES, V70, P1171, DOI 10.1306/032300701171
   Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441
   Braissant O, 2009, FEMS MICROBIOL ECOL, V67, P293, DOI 10.1111/j.1574-6941.2008.00614.x
   Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   BUCKLEY HE, 1951, CRYSTAL GROWTH
   BURNETT JH, 1979, FUNGAL WALLS HYPHAL, P1
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Cailleau G, 2009, SEDIMENTOLOGY, V56, P1858, DOI 10.1111/j.1365-3091.2009.01060.x
   Cailleau G, 2009, J CRYST GROWTH, V311, P2490, DOI 10.1016/j.jcrysgro.2009.02.029
   CALLOT G, 1985, AGRONOMIE, V5, P209, DOI 10.1051/agro:19850303
   CALLOT G, 1985, AGRONOMIE, V5, P143, DOI 10.1051/agro:19850207
   Canaveras JC, 1999, GEOMICROBIOL J, V16, P9, DOI 10.1080/014904599270712
   Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3
   Canaveras JC, 2001, GEOMICROBIOL J, V18, P223
   Carlile M. J., 2001, FUNGI
   CHESTERS CG, 1963, BIOCHEM J, V86, P38, DOI 10.1042/bj0860038
   Coleman D. C., 2004, FUNDAMENTALS SOIL EC
   Cromme P, 2007, MAT SCI ENG C-BIO S, V27, P1, DOI 10.1016/j.msec.2005.11.001
   Curry MD, 2009, INT J SPELEOL, V38, P111, DOI 10.5038/1827-806X.38.2.3
   Dalas E, 2000, J COLLOID INTERF SCI, V224, P56, DOI 10.1006/jcis.1999.6670
   DEY S, 1989, J MICROSC-OXFORD, V156, P259, DOI 10.1111/j.1365-2818.1989.tb02925.x
   Dubroeucq D., 1996, MEM 3 S INT SUEL VOL
   Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008
   Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Fan PP, 2010, OECOLOGIA, V163, P509, DOI 10.1007/s00442-009-1541-4
   FARKAS V, 1979, MICROBIOL REV, V43, P117, DOI 10.1128/MMBR.43.2.117-144.1979
   Farkas V, 2003, FOLIA MICROBIOL, V48, P469, DOI 10.1007/BF02931327
   FOLK RL, 1993, J SEDIMENT PETROL, V63, P990, DOI 10.1306/D4267C67-2B26-11D7-8648000102C1865D
   Folk RL, 2001, SEDIMENTOLOGY, V48, P215, DOI 10.1046/j.1365-3091.2001.00354.x
   Fontaine T, 1997, BIOCHEM SOC T, V25, P194, DOI 10.1042/bst0250194
   Fontaine T, 2000, J BIOL CHEM, V275, P27594
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   Gillet P, 2000, EARTH PLANET SC LETT, V175, P161, DOI 10.1016/S0012-821X(99)00291-5
   Giraud-Guille MM, 2004, CR PALEVOL, V3, P503, DOI 10.1016/j.crpv.2004.07.004
   GOBAT JM, 2003, SOL VIVANT
   Gradzinski M, 1997, P 12 INT C SPEL, V1, P275
   Gradzinski M, 2012, ANN SOC GEOL POL, V82, P361
   Guggenberger G, 1999, SOIL SCI SOC AM J, V63, P1188, DOI 10.2136/sssaj1999.6351188x
   Homeijer SJ, 2008, J CRYST GROWTH, V310, P2938, DOI 10.1016/j.jcrysgro.2008.02.009
   HUNSLEY D, 1970, J GEN MICROBIOL, V62, P203, DOI 10.1099/00221287-62-2-203
   IUSS Working Group WRB, 2006, WORLD REF BAS RES 20
   IWANOFF L. L., 1906, ANN GEOLOGIE MINERAL, V8, P23
   Jeong GY, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028280
   JONES B, 1988, J SEDIMENT PETROL, V58, P457
   JONES B, 1993, J SEDIMENT PETROL, V63, P1018
   Kellermeier M, 2012, ADV CHEM PHYS, V151, P277
   Khormali F, 2006, GEODERMA, V132, P31, DOI 10.1016/j.geoderma.2005.04.024
   Kieft TL, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P19
   Kirkland BL, 1999, GEOLOGY, V27, P347, DOI 10.1130/0091-7613(1999)027<0347:AOFNLO>2.3.CO;2
   KLAPPA CF, 1979, J SEDIMENT PETROL, V49, P955, DOI 10.2110/jsr.49.955
   Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x
   Loisy C, 1999, SEDIMENT GEOL, V126, P193, DOI 10.1016/S0037-0738(99)00040-8
   Lowenstam H. A., 1989, BIOMINERALIZATION
   Maniloff J, 1997, SCIENCE, V276, P1776
   Mann S, 2000, ANGEW CHEM INT EDIT, V39, P3393
   Manoli F, 1997, J CRYST GROWTH, V182, P116, DOI 10.1016/S0022-0248(97)00318-7
   Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105
   MARX DH, 1971, FOREST SCI, V17, P37
   Milliere L, 2011, ISOT ENVIRON HEALT S, V47, P341, DOI 10.1080/10256016.2011.601305
   Milliere L, 2011, GEODERMA, V161, P74, DOI 10.1016/j.geoderma.2010.12.009
   Mugge O., 1914, ZBL MINERAL GEOL PAL, V1914, P673
   Newman BD, 1996, CHEM GEOL, V132, P205, DOI 10.1016/S0009-2541(96)00057-5
   Olszta MJ, 2004, CHEM MATER, V16, P2355, DOI 10.1021/cm035161r
   Ould Mohamed S., 1994, FRANC 9 INT WORK M S
   Pacton M., 2011, ENCY GEOBIOLOGY, P677, DOI [10.1007/978-1-4020-9212-1_154, DOI 10.1007/978-1-4020-9212-1_154]
   Paul E.A., 2007, SOIL MICROBIOLOGY EC
   Pearson V. K., 2004, MICROSC ANAL, P5
   Perry RS, 2007, SEDIMENT GEOL, V201, P157, DOI 10.1016/j.sedgeo.2007.05.014
   PHILLIPS SE, 1987, AUST J SOIL RES, V25, P405, DOI 10.1071/SR9870405
   PHILLIPS SE, 1987, AUST J SOIL RES, V25, P429, DOI 10.1071/SR9870429
   R Development Core Team, 2010, R LANG ENV STAT COMP
   RAPP P, 1989, J GEN MICROBIOL, V135, P2847
   Richter DK, 2008, SEDIMENTOLOGY, V55, P487, DOI 10.1111/j.1365-3091.2007.00915.x
   Ruiz-Herrera J., 1992, FUNGAL CELL WALL STR
   Schieber J, 2003, GEOLOGY, V31, P717, DOI 10.1130/G19663.1
   Shankar N, 2007, QUATERN INT, V175, P140, DOI 10.1016/j.quaint.2007.05.017
   Simkiss K., 1989, BIOMINERALIZATION CE
   Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x
   STOOPS GJ, 1976, AM MINERAL, V61, P172
   STRONG GE, 1992, SEDIMENTOLOGY, V39, P333, DOI 10.1111/j.1365-3091.1992.tb01042.x
   Turner BL, 2010, APPL ENVIRON MICROB, V76, P6485, DOI 10.1128/AEM.00560-10
   Turner BR, 2005, PALAEOGEOGR PALAEOCL, V229, P230, DOI 10.1016/j.palaeo.2005.06.024
   VERGES V, 1982, B MINERAL, V105, P351
   VERRECCHIA EP, 1994, J SEDIMENT RES A, V64, P650
   Verrecchia EP, 1996, BIOGEOCHEMISTRY, V35, P447, DOI 10.1007/BF02183036
   Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016
   WAINWRIGHT SA, 1963, Q J MICROSC SCI, V104, P169
   Webster J, 2007, INTRO FUNGI
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   WRIGHT VP, 1986, SEDIMENTOLOGY, V33, P831, DOI 10.1111/j.1365-3091.1986.tb00985.x
   WRIGHT VP, 1984, GEOL J, V19, P23
   Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417
   Zhou J, 2009, SEDIMENT GEOL, V222, P207, DOI 10.1016/j.sedgeo.2009.09.003
   Zhu JH, 2009, CRYSTENGCOMM, V11, P539, DOI 10.1039/b817535g
NR 108
TC 16
Z9 18
U1 0
U2 26
PU COPERNICUS GESELLSCHAFT MBH
PI GOTTINGEN
PA BAHNHOFSALLEE 1E, GOTTINGEN, 37081, GERMANY
SN 1726-4170
EI 1726-4189
J9 BIOGEOSCIENCES
JI Biogeosciences
PY 2014
VL 11
IS 10
BP 2809
EP 2825
DI 10.5194/bg-11-2809-2014
PG 17
WC Ecology; Geosciences, Multidisciplinary
SC Environmental Sciences & Ecology; Geology
GA AJ8IU
UT WOS:000337947500017
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Gour, N
   Abraham, JN
   Chami, M
   Castillo, A
   Verma, S
   Vebert-Nardin, C
AF Gour, Nidhi
   Abraham, Jancy Nixon
   Chami, Mohamed
   Castillo, Axel
   Verma, Sandeep
   Vebert-Nardin, Corinne
TI Label-free, optical sensing of the supramolecular assembly into fibrils
   of a ditryptophan-DNA hybrid
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID SOFT SPHERICAL STRUCTURES; MORPHOLOGICAL CONSEQUENCES; PEPTIDE;
   TRYPTOPHAN
AB The grafting of a short nucleic acid strand to ditryptophan dipeptide (WW) results in a peptide-DNA hybrid, which assembles into fibrils under controlled aggregation conditions as evidenced by label free optical sensing owing to the intrinsic fluorescence of the dipeptide.
C1 [Gour, Nidhi; Abraham, Jancy Nixon; Castillo, Axel; Vebert-Nardin, Corinne] Univ Geneva, Fac Sci, Dept Inorgan & Analyt Chem, CH-1211 Geneva 4, Switzerland.
   [Chami, Mohamed] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland.
   [Verma, Sandeep] Indian Inst Technol, Ctr Environm Sci & Engn, Dept Chem, DST Themat Unit Excellence Soft Nanofabricat, Kanpur 208016, Uttar Pradesh, India.
RP Vebert-Nardin, C (corresponding author), Univ Geneva, Fac Sci, Dept Inorgan & Analyt Chem, CH-1211 Geneva 4, Switzerland.
EM mohamed.chami@unibas.ch; sverma@iitk.ac.in; corinne.vebert@unige.ch
FU University of Geneva; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [PPOOP2-12838]
FX Dr Apurba K Barman is greatly acknowledged for experimental support. The
   University of Geneva and the Swiss National Science Foundation for
   Research (PPOOP2-12838) are acknowledged for financial support.
CR ABEL E, 1995, J AM CHEM SOC, V117, P1265, DOI 10.1021/ja00109a010
   Amdursky N, 2013, PHYS CHEM CHEM PHYS, V15, P13479, DOI 10.1039/c3cp51748a
   Barman AK, 2010, CHEM COMMUN, V46, P6992, DOI 10.1039/c0cc02604b
   Castelletto V, 2009, BIOPHYS CHEM, V141, P169, DOI 10.1016/j.bpc.2009.01.008
   Ghosh S, 2008, TETRAHEDRON, V64, P1250, DOI 10.1016/j.tet.2007.11.077
   Ghosh S, 2007, ANGEW CHEM INT EDIT, V46, P2002, DOI 10.1002/anie.200604383
   Gour N, 2012, CHEM COMMUN, V48, P5440, DOI 10.1039/c2cc31458d
   Hamley IW, 2007, ANGEW CHEM INT EDIT, V46, P8128, DOI 10.1002/anie.200700861
   Joshi KB, 2008, ANGEW CHEM INT EDIT, V47, P2860, DOI 10.1002/anie.200705012
   Joshi KB, 2009, BIOPHYS CHEM, V140, P129, DOI 10.1016/j.bpc.2008.11.016
   Ku TH, 2011, J AM CHEM SOC, V133, P8392, DOI 10.1021/ja2004736
   Mondal S, 2010, TETRAHEDRON LETT, V51, P856, DOI 10.1016/j.tetlet.2009.12.019
   Reches M, 2004, NANO LETT, V4, P581, DOI 10.1021/nl035159z
   Schuster TB, 2010, SOFT MATTER, V6, P5596, DOI 10.1039/c0sm00442a
   Schweizer S, 2008, BIOPHYS J, V95, P3381, DOI 10.1529/biophysj.107.126375
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
NR 16
TC 14
Z9 14
U1 0
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PY 2014
VL 50
IS 52
BP 6863
EP 6865
DI 10.1039/c4cc02631d
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AI7SQ
UT WOS:000337099100011
PM 24837840
OA Other Gold
DA 2021-01-25
ER

PT J
AU Chen, JQ
   Tu, XL
   Esen, E
   Joeng, KS
   Lin, CX
   Arbeit, JM
   Ruegg, MA
   Hall, MN
   Ma, L
   Long, FX
AF Chen, Jianquan
   Tu, Xiaolin
   Esen, Emel
   Joeng, Kyu Sang
   Lin, Congxin
   Arbeit, Jeffrey M.
   Rueegg, Markus A.
   Hall, Michael N.
   Ma, Liang
   Long, Fanxin
TI WNT7B Promotes Bone Formation in part through mTORC1
SO PLOS GENETICS
LA English
DT Article
ID OSTEOGENESIS IMPERFECTA; MUTATIONS; OSTEOBLAST; MASS; GENE;
   DIFFERENTIATION; MICE; LRP5; PROLIFERATION; DELETION
AB WNT signaling has been implicated in both embryonic and postnatal bone formation. However, the pertinent WNT ligands and their downstream signaling mechanisms are not well understood. To investigate the osteogenic capacity of WNT7B and WNT5A, both normally expressed in the developing bone, we engineered mouse strains to express either protein in a Cre-dependent manner. Targeted induction of WNT7B, but not WNT5A, in the osteoblast lineage dramatically enhanced bone mass due to increased osteoblast number and activity; this phenotype began in the late-stage embryo and intensified postnatally. Similarly, postnatal induction of WNT7B in Runx2-lineage cells greatly stimulated bone formation. WNT7B activated mTORC1 through PI3K-AKT signaling. Genetic disruption of mTORC1 signaling by deleting Raptor in the osteoblast lineage alleviated the WNT7B-induced high-bone-mass phenotype. Thus, WNT7B promotes bone formation in part through mTORC1 activation.
C1 [Chen, Jianquan; Esen, Emel; Long, Fanxin] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.
   [Tu, Xiaolin; Joeng, Kyu Sang; Lin, Congxin; Ma, Liang; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Esen, Emel; Joeng, Kyu Sang; Ma, Liang; Long, Fanxin] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA.
   [Arbeit, Jeffrey M.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.
   [Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Ma, Liang; Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA.
RP Chen, JQ (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA.
EM longf@wudosis.wustl.edu
RI Arbeit, Jeffrey/K-6920-2019; Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Washington University Musculoskeletal Research Center from NIAMS/NIH
   [R01 AR060456, R01 DK065789, R01 ES01659701, P30 AR057235]; NATIONAL
   INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal
   & Skin Diseases (NIAMS) [P30AR057235, P30AR057235, P30AR057235,
   R01AR060456, P30AR057235, P30AR057235, P30AR057235, R01AR060456,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, R01AR060456, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, R01AR060456, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, R01AR060456, P30AR057235, P30AR057235, R01AR060456,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, R01AR060456, P30AR057235, R01AR060456, P30AR057235,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235, P30AR057235,
   P30AR057235, P30AR057235, P30AR057235, P30AR057235] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK065789, R01DK065789,
   R01DK065789, R01DK065789, R01DK065789, R01DK065789, R01DK065789,
   R01DK065789, R01DK065789, R01DK065789, R01DK065789, R01DK065789] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [R01ES016597, R01ES016597, R01ES016597,
   R01ES016597, R01ES016597] Funding Source: NIH RePORTER
FX The work was supported by grants R01 AR060456, R01 DK065789 (FL), R01
   ES01659701 (LM) and P30 AR057235 (Washington University Musculoskeletal
   Research Center) from NIAMS/NIH. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005
   Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960
   Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91
   Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537
   Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444
   Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017
   Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834
   Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012
   Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1
   Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388
   Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3
   DasGupta R, 1999, DEVELOPMENT, V126, P4557
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   Esen E, 2013, CELL METAB IN PRESS
   Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567
   Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013
   Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025
   Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270
   Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020
   Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624
   Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089
   Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010
   Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Li XD, 2008, J BONE MINER RES, V23, P860, DOI [10.1359/jbmr.080216, 10.1359/JBMR.080216]
   Lin CX, 2009, GENESIS, V47, P352, DOI 10.1002/dvg.20506
   Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653
   Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515
   Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901
   Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034
   Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Pyott SM, 2013, AM J HUM GENET, V92, P590, DOI 10.1016/j.ajhg.2013.02.009
   Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480
   Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200
   Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108
   Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694
   Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003
   Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324
NR 54
TC 30
Z9 37
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7390
EI 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JAN
PY 2014
VL 10
IS 1
AR e1004145
DI 10.1371/journal.pgen.1004145
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA AI0GU
UT WOS:000336525000076
PM 24497849
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Walter, D
   Matter, A
   Fahrenkrog, B
AF Walter, David
   Matter, Anja
   Fahrenkrog, Birthe
TI Loss of Histone H3 Methylation at Lysine 4 Triggers Apoptosis in
   Saccharomyces cerevisiae
SO PLOS GENETICS
LA English
DT Article
ID CHRONOLOGICAL LIFE-SPAN; DNA-DAMAGE CHECKPOINT; BASIC BIOLOGICAL
   PHENOMENON; WIDE-RANGING IMPLICATIONS; DOUBLE-STRAND BREAKS; BUDDING
   YEAST; REGULATES APOPTOSIS; CELL-DEATH; STERILE-20 KINASE;
   GENE-EXPRESSION
AB Monoubiquitination of histone H2B lysine 123 regulates methylation of histone H3 lysine 4 (H3K4) and 79 (H3K79) and the lack of H2B ubiquitination in Saccharomyces cerevisiae coincides with metacaspase-dependent apoptosis. Here, we discovered that loss of H3K4 methylation due to depletion of the methyltransferase Set1p (or the two COMPASS subunits Spp1p and Bre2p, respectively) leads to enhanced cell death during chronological aging and increased sensitivity to apoptosis induction. In contrast, loss of H3K79 methylation due to DOT1 disruption only slightly affects yeast survival. SET1 depleted cells accumulate DNA damage and co-disruption of Dot1p, the DNA damage adaptor protein Rad9p, the endonuclease Nuc1p, and the metacaspase Yca1p, respectively, impedes their early death. Furthermore, aged and dying wild-type cells lose H3K4 methylation, whereas depletion of the H3K4 demethylase Jhd2p improves survival, indicating that loss of H3K4 methylation is an important trigger for cell death in S. cerevisiae. Given the evolutionary conservation of H3K4 methylation this likely plays a role in apoptosis regulation in a wide range of organisms.
C1 [Walter, David; Matter, Anja; Fahrenkrog, Birthe] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Fahrenkrog, Birthe] Univ Libre Brussels, Inst Mol Biol & Med, Charleroi, Belgium.
RP Walter, D (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.
EM bfahrenk@ulb.ac.be
OI Walter, David/0000-0003-4363-0339; Fahrenkrog,
   Birthe/0000-0003-4080-9413
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_118404]; Fonds Nationale de Recherche Scientifique
   BelgiumFonds de la Recherche Scientifique - FNRS [F.6006.10]; Fondation
   Brachet
FX This work was supported by the Swiss National Science Foundation (grant
   number 31003A_118404; www.snf.ch), the Fonds Nationale de Recherche
   Scientifique Belgium (grant number F.6006.10; http://www.frs-fnrs.be/),
   and the Fondation Brachet. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016
   Ahn SH, 2006, MOL CELL, V24, P211, DOI 10.1016/j.molcel.2006.09.008
   Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439
   Ajiro K, 2010, CELL DEATH DIFFER, V17, P984, DOI 10.1038/cdd.2009.199
   Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030
   Belanger KD, 2009, J CELL SCI, V122, P3931, DOI 10.1242/jcs.056887
   Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499
   Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010
   Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105
   Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970
   Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201
   Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2
   Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098
   Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219
   Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314
   Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106
   Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6
   Cox JS, 1997, MOL BIOL CELL, V8, P1805
   Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017
   Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x
   Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082
   Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247
   Fink Ga, 1991, METHOD ENZYMOL, V194, P1
   Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58
   Game JC, 2006, GENETICS, V173, P1951, DOI 10.1534/genetics.106.057794
   Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114
   Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2
   Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 2009, BIOCHEM BIOPH RES CO, V382, P227, DOI 10.1016/j.bbrc.2009.02.117
   Mazzoni C, 2005, EMBO REP, V6, P1076, DOI 10.1038/sj.embor.7400514
   McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103
   Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3
   Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100
   Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421
   Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Ren Q, 2005, MUTAT RES-FUND MOL M, V570, P163, DOI 10.1016/j.mrfmmm.2004.11.014
   Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501
   Rockenfeller P, 2008, EXP GERONTOL, V43, P876, DOI 10.1016/j.exger.2008.08.044
   Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390
   Ruckenstuhl C, 2010, AGING-US, V2, P643, DOI 10.18632/aging.100223
   Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080
   Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024
   Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4
   Singer MS, 1998, GENETICS, V150, P613
   Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X
   Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883
   Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Walter D, 2010, J CELL SCI, V123, P1931, DOI 10.1242/jcs.065938
   Watanabe K, 2002, EUKARYOT CELL, V1, P200, DOI 10.1128/EC.1.2.200-212.2002
   Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477
   Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Wood A, 2005, BIOCHEM CELL BIOL, V83, P460, DOI 10.1139/O05-116
   Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005
NR 70
TC 21
Z9 21
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7390
EI 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JAN
PY 2014
VL 10
IS 1
AR e1004095
DI 10.1371/journal.pgen.1004095
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA AI0GU
UT WOS:000336525000054
PM 24497836
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schulze, C
   Neves, RC
   Schmidt-Rhaesa, A
AF Schulze, Corinna
   Neves, Ricardo C.
   Schmidt-Rhaesa, Andreas
TI Comparative immunohistochemical investigation on the nervous system of
   two species of Arthrotardigrada (Heterotardigrada, Tardigrada)
SO ZOOLOGISCHER ANZEIGER
LA English
DT Article
DE lmmunohistochemistry; Tripartite brain; Subpharyngeal ganglion;
   Evolution; Ecdysozoa; Panarthropoda
ID FINE-STRUCTURE; 3-DIMENSIONAL RECONSTRUCTION; PHYLOGENETIC POSITION;
   SEGMENTAL GANGLIA; VELVET WORMS; EVOLUTION; ONYCHOPHORA; INSIGHTS;
   BRAIN; PHYLOGENOMICS
AB The question whether tardigrades possess a tripartite, segmented brain and a subpharyngeal ganglion or not is a matter of ongoing debate. This study sets out to analyze the structure of the nervous system of Batillipes pennaki and Actinarctus doryphorus ocellatus in order to provide new insights specially into the organization of the tardigrade brain. Based on the assumption that tardigrades are members of the taxon Panarthropoda rather than of the taxon Cycloneuralia, insights into the organization of their brain could help to clarify their relationship within Panarthropoda. Our results indicate that B. pennaki and A. doryphorus ocellatus neither possess a tripartite brain nor a subpharyngeal ganglion. The implications of these findings are discussed and compared with reference to previous studies. (C) 2013 Elsevier GmbH. All rights reserved.
C1 [Schulze, Corinna; Schmidt-Rhaesa, Andreas] Zool Museum Hamburg, D-20146 Hamburg, Germany.
   [Neves, Ricardo C.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schmidt-Rhaesa, A (corresponding author), Zool Museum Hamburg, Martin Luther King Pl 3, D-20146 Hamburg, Germany.
EM andreas.schmidt-rhaesa@uni-hamburg.de
RI Neves, Ricardo Cardoso/J-9822-2014
OI Neves, Ricardo Cardoso/0000-0002-9219-9066
FU University Hamburg; German Science Foundation (DFG)German Research
   Foundation (DFG); EUEuropean Union (EU) [227799]
FX Special thanks go to the staff of the "Station Biologique Roscoff' for
   their great help with sample taking and the supply of lab space. We also
   want to thank Prof. Dr. Jorg Oehlmann and Prof. Dr. Gunter Purschke a
   lot for sending sediment from Roscoff. Stephan Henne and Dr. Birgen
   Rothe is thanked for their help of sorting specimens of B. pennaki.
   Renate Walter is thanked a lot for the processing of the specimens from
   70% ethanol on, and her great service on the scanning electron
   microscope. We also want to thank Stephan Henne and Sebastian Bilke for
   helpful comments on the manuscript. CS was partly funded by the
   University Hamburg and the German Science Foundation (DFG). Funding to
   support the collection in Roscoff was provided to RCN by EU programme
   ASSEMBLE-grant agreement no. 227799.
CR Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0
   Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108
   Crittenden SL, 1999, METH MOL B, V122, P141
   CROWE JH, 1970, T AM MICROSC SOC, V89, P316, DOI 10.2307/3224393
   DEWEL RA, 1973, TISSUE CELL, V5, P161, DOI 10.1016/S0040-8166(73)80013-8
   DEWEL RA, 1973, TISSUE CELL, V5, P147, DOI 10.1016/S0040-8166(73)80012-6
   Dewel RA, 1999, ZOOL ANZ, V238, P191
   DEWEL RA, 1973, TISSUE CELL, V5, P133, DOI 10.1016/S0040-8166(73)80011-4
   Dewel RA, 1996, ZOOL J LINN SOC-LOND, V116, P35
   Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614
   Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5
   Giribet G, 2003, ZOOLOGY, V106, P303, DOI 10.1078/0944-2006-00131
   Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659
   GREVEN H, 1972, Z ZELLFORSCH MIK ANA, V132, P131, DOI 10.1007/BF00310301
   Hanstrom B, 1928, VERGLEICHENDE ANATOM
   KRISTENSEN R M, 1984, Smithsonian Contributions to Zoology, V391, P1
   Kristensen R. M., 1987, SELECTED S MONOGRAPH, P261
   KRISTENSEN RM, 1984, T AM MICROSC SOC, V103, P295, DOI 10.2307/3226191
   KRISTENSEN RM, 1982, Z ZOOL SYST EVOL, V20, P249
   Marcus E., 1929, KLASSEN ORDNUNGEN 1, V5
   Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603
   Mayer G, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-118
   Mayer G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-230
   Mayer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059090
   Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255
   Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011
   Persson D., 2013, J MORPHOL
   Persson DK, 2012, J MORPHOL, V273, P1227, DOI 10.1002/jmor.20054
   Plate L., 1888, ZOOLOGISCHE JB, V3, P487, DOI [10.5962/bhl.part.1265, DOI 10.5962/BHL.PART.1265, 10.5962/bhl.part.1265.]
   Ramazzotti G., 1983, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V41, P1
   Renaud-Mornant J, 1971, Bulletin Mus natn Hist nat Paris, V42, P957
   Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29
   Riggin T. G., 1962, Tech Bull Va agric Exp Stn No 152, V1962, P1
   Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590
   Rothe BH, 2010, INVERTEBR BIOL, V129, P39, DOI 10.1111/j.1744-7410.2010.00185.x
   Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L
   Schmidt-Rhaesa A, 2001, ZOOL ANZ, V240, P549, DOI 10.1078/0044-5231-00066
   Schulze C, 2013, J LIMNOL, V72, P44, DOI 10.4081/jlimnol.2013.s1.e6
   Walz B., 1979, Zeszyty Naukowe Uniwersytetu Jagiellonskiego Prace Zoologiczne, V25, P161
   Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006
   Wiederhoft H, 1996, ZOOL J LINN SOC-LOND, V116, P71
   Zantke J, 2008, ZOOMORPHOLOGY, V127, P21, DOI 10.1007/s00435-007-0045-1
NR 42
TC 24
Z9 24
U1 0
U2 9
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0044-5231
J9 ZOOL ANZ
JI Zool. Anz.
PY 2014
VL 253
IS 3
BP 225
EP 235
DI 10.1016/j.jcz.2013.11.001
PG 11
WC Zoology
SC Zoology
GA AG2WP
UT WOS:000335278100006
DA 2021-01-25
ER

PT J
AU Mittal, N
   Zavolan, M
AF Mittal, Nitish
   Zavolan, Mihaela
TI Seq and CLIP through the miRNA world
SO GENOME BIOLOGY
LA English
DT Review
ID TRANSCRIPTOME-WIDE IDENTIFICATION; RNA-BINDING PROTEIN; CIRCULAR RNAS;
   NUCLEOTIDE-RESOLUTION; BIOGENESIS PATHWAY; REGULATORY RNAS;
   MESSENGER-RNAS; IN-VIVO; MICRORNA; REVEALS
AB High-throughput sequencing of RNAs crosslinked to Argonaute proteins reveals not only a multitude of atypical miRNA binding sites but also of miRNA targets with atypical functions, and can be used to infer quantitative models of miRNA-target interaction strength.
C1 [Mittal, Nitish; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
CR Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916
   Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Broughton JP, 2013, METHODS, V63, P119, DOI 10.1016/j.ymeth.2013.03.033
   Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214
   Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300
   CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y
   Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197
   Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092
   Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126
   COCQUERELLE C, 1993, FASEB J, V7, P155
   Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409
   Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705
   Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079
   Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052
   Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017
   Enright AJ, 2004, GENOME BIOL, V5
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917
   Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823
   Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112
   Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772
   Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009
   Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027
   Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113
   Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kishore S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r45
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Knouf EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069630
   Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139
   Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108
   Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108
   Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Lagos-Quintana M, 2001, SCIENCE
   Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020
   Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164
   Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248
   Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006
   Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002
   Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344
   Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510
   Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110
   Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928
   Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508
   Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195
   NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S
   Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028
   Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556
   Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144
   Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003
   Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607
   Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777
   Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733
   Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005
   Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727
   Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67
   Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841
   Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010
   Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002
   Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110
   Xue ZH, 2012, MOL CELL, V46, P299, DOI 10.1016/j.molcel.2012.03.019
   Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106
   Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536
   Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873
   Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017
NR 91
TC 11
Z9 11
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2014
VL 15
IS 1
SI SI
AR 202
DI 10.1186/gb4151
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA AD0MC
UT WOS:000332927100026
PM 24460822
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Pieters, J
   McKinney, J
AF Pieters, Jean
   McKinney, John
BE Pieters, J
   McKinney, JD
TI Pathogenesis of Mycobacterium tuberculosis and its Interaction with the
   Host Organism Preface
SO PATHOGENESIS OF MYCOBACTERIUM TUBERCULOSIS AND ITS INTERACTION WITH THE
   HOST ORGANISM
SE Current Topics in Microbiology and Immunology
LA English
DT Editorial Material; Book Chapter
C1 [Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
   [McKinney, John] Swiss Fed Inst Technol Lausanne EPFL, Lab Microbiol & Microsyst, Lausanne, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
OI Pieters, Jean/0000-0002-5284-9757
NR 0
TC 1
Z9 1
U1 0
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
BN 978-3-642-40232-6; 978-3-642-40231-9
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2014
VL 374
BP V
EP VI
D2 10.1007/978-3-642-40232-6
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA BJU03
UT WOS:000330368100001
PM 24669377
DA 2021-01-25
ER

PT J
AU Kowal, J
   Chami, M
   Baumgartner, P
   Arheit, M
   Chiu, PL
   Rangl, M
   Scheuring, S
   Schroder, GF
   Nimigean, CM
   Stahlberg, H
AF Kowal, Julia
   Chami, Mohamed
   Baumgartner, Paul
   Arheit, Marcel
   Chiu, Po-Lin
   Rangl, Martina
   Scheuring, Simon
   Schroeder, Gunnar F.
   Nimigean, Crina M.
   Stahlberg, Henning
TI Ligand-induced structural changes in the cyclic nucleotide-modulated
   potassium channel MloK1
SO NATURE COMMUNICATIONS
LA English
DT Article
ID HCN CHANNELS; K+-CHANNEL; ACTIVATION GATE; BINDING DOMAIN;
   REARRANGEMENTS; MECHANISM; CRYSTALLOGRAPHY; HYDRATION; TERMINUS; COMPLEX
AB Cyclic nucleotide-modulated ion channels are important for signal transduction and pacemaking in eukaryotes. The molecular determinants of ligand gating in these channels are still unknown, mainly because of a lack of direct structural information. Here we report ligand-induced conformational changes in full-length MloK1, a cyclic nucleotide-modulated potassium channel from the bacterium Mesorhizobium loti, analysed by electron crystallography and atomic force microscopy. Upon cAMP binding, the cyclic nucleotide-binding domains move vertically towards the membrane, and directly contact the S1-S4 voltage sensor domains. This is accompanied by a significant shift and tilt of the voltage sensor domain helices. In both states, the inner pore-lining helices are in an 'open' conformation. We propose a mechanism in which ligand binding can favour pore opening via a direct interaction between the cyclic nucleotide-binding domains and voltage sensors. This offers a simple mechanistic hypothesis for the coupling between ligand gating and voltage sensing in eukaryotic HCN channels.
C1 [Kowal, Julia; Chami, Mohamed; Baumgartner, Paul; Arheit, Marcel; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
   [Chiu, Po-Lin] Univ Calif Davis, CBS, Davis, CA 95616 USA.
   [Rangl, Martina; Scheuring, Simon] Aix Marseille Univ, INSERM, U1006, F-13009 Marseille, France.
   [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst, ICS Struct Biochem 6, D-52425 Julich, Germany.
   [Schroeder, Gunnar F.] Univ Dusseldorf, Dept Phys, D-40225 Dusseldorf, Germany.
   [Stahlberg, Henning] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA.
   [Stahlberg, Henning] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.
   [Stahlberg, Henning] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA.
RP Nimigean, CM (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave, New York, NY 10065 USA.
EM crn2002@med.cornell.edu; henning.stahlberg@unibas.ch
RI Schroder, Gunnar F/H-5261-2013; Stahlberg, Henning/H-1868-2011;
   Scheuring, Simon/L-9843-2018; Chiu, Po-Lin/D-2762-2013
OI Schroder, Gunnar F/0000-0003-1803-5431; Stahlberg,
   Henning/0000-0002-1185-4592; Scheuring, Simon/0000-0003-3534-069X; Chiu,
   Po-Lin/0000-0001-8608-7650; Kowal, Julia/0000-0003-4694-1896; Nimigean,
   Crina/0000-0002-6254-4447
FU Swiss National Science Foundation (National Centers for Competence in
   Research Structural Biology and TransCure) [SNF 315230_127545]; Swiss
   Initiative for Systems Biology (SystemsX.ch); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH GM077560]; European Research
   Council GrantEuropean Research Council (ERC) [310080]; Agence National
   de la Recherche (ANR) GrantsFrench National Research Agency (ANR)
   [ANR-12-BS10-009-01, ANR-12-BSV8-0006-01]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM077560, R01GM077560,
   R01GM077560, R01GM077560, R01GM077560, R01GM077560] Funding Source: NIH
   RePORTER
FX We acknowledge expert technical assistance of B. Anderson and K. Goldie.
   We thank S.A. Muller for insightful discussions and critically reading
   of the manuscript. We thank P. Jenoe and S. Moes (Proteomics Core
   Facility, Biozentrum, University of Basel) for LC/MS measurement. This
   work was supported by the Swiss National Science Foundation (SNF
   315230_127545, National Centers for Competence in Research Structural
   Biology and TransCure), the Swiss Initiative for Systems Biology
   (SystemsX.ch) and National Institutes of Health (NIH GM077560) (to
   C.M.N.). Work in the Scheuring lab was supported by a European Research
   Council Grant (#310080), and Agence National de la Recherche (ANR)
   Grants (# ANR-12-BS10-009-01 and ANR-12-BSV8-0006-01).
CR AGARD DA, 1983, J MOL BIOL, V167, P849, DOI 10.1016/S0022-2836(83)80114-4
   Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011
   Appel M, 2009, J MOL BIOL, V386, P351, DOI 10.1016/j.jmb.2008.12.042
   Arheit Marcel, 2013, Methods Mol Biol, V955, P171, DOI 10.1007/978-1-62703-176-9_10
   Arheit Marcel, 2013, Methods Mol Biol, V955, P195, DOI 10.1007/978-1-62703-176-9_11
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Biskup C, 2007, NATURE, V446, P440, DOI 10.1038/nature05596
   Bruening-Wright A, 2002, J NEUROSCI, V22, P6499
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4
   Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020
   Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563
   Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105
   Clayton GM, 2009, J STRUCT BIOL, V167, P220, DOI 10.1016/j.jsb.2009.06.012
   Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030
   Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153
   Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025
   Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599
   del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Falkner B, 2013, P NATL ACAD SCI USA, V110, P8930, DOI 10.1073/pnas.1119041110
   Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008
   Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533
   Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580
   Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002
   Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235
   Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908
   Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027
   Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747
   Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022
   Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606
   Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265
   Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693
   Mari SA, 2011, P NATL ACAD SCI USA, V108, P20802, DOI 10.1073/pnas.1111149108
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133
   Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17
   Papazian DM, 1997, NEWS PHYSIOL SCI, V12, P203
   Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238
   Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Peuker S, 2013, BIOPHYS J, V104, P63, DOI 10.1016/j.bpj.2012.11.3816
   Posson DJ, 2013, NAT STRUCT MOL BIOL, V20, P159, DOI 10.1038/nsmb.2473
   Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734
   Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83
   Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873
   Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005
   Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021
   Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108
   Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68
   Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341
   Tsai CJ, 2013, J MOL BIOL, V425, P4074, DOI 10.1016/j.jmb.2013.06.036
   VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445
   Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0
   Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237
   Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579
   WILLIAMS M, 1984, PROG NEURO-PSYCHOPH, V8, P209, DOI 10.1016/0278-5846(84)90160-X
   Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033
   Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448
   Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922
   Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
NR 68
TC 41
Z9 41
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN
PY 2014
VL 5
AR 3106
DI 10.1038/ncomms4106
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA4RS
UT WOS:000331084400015
PM 24469021
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Eisele, PS
   Handschin, C
AF Eisele, Petra S.
   Handschin, Christoph
TI Functional crosstalk of PGC-1 coactivators and inflammation in skeletal
   muscle pathophysiology
SO SEMINARS IN IMMUNOPATHOLOGY
LA English
DT Review
DE Skeletal muscle; Metabolism; Metabolic disorders; Inflammation; PGC-1;
   NF-kappa B; Macrophages
ID NF-KAPPA-B; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; FATTY-ACID OXIDATION;
   ENDOPLASMIC-RETICULUM STRESS; NUCLEAR HORMONE-RECEPTORS; AORTIC
   SMOOTH-MUSCLE; DIET-INDUCED OBESITY; REGULATORY T-CELLS; TRANSCRIPTIONAL
   COACTIVATOR; PPAR-GAMMA
AB Skeletal muscle is an organ involved in whole body movement and energy metabolism with the ability to dynamically adapt to different states of (dis-)use. At a molecular level, the peroxisome proliferator-activated receptor gamma coactivators 1 (PGC-1s) are important mediators of oxidative metabolism in skeletal muscle and in other organs. Musculoskeletal disorders as well as obesity and its sequelae are associated with PGC-1 dysregulation in muscle with a concomitant local or systemic inflammatory reaction. In this review, we outline the function of PGC-1 coactivators in physiological and pathological conditions as well as the complex interplay of metabolic dysregulation and inflammation in obesity with special focus on skeletal muscle. We further put forward the hypothesis that, in this tissue, oxidative metabolism and inflammatory processes mutually antagonize each other. The nuclear factor kappa B (NF-kappa B) pathway thereby plays a key role in linking metabolic and inflammatory programs in muscle cells. We conclude this review with a perspective about the consequences of such a negative crosstalk on the immune system and the possibilities this opens for clinical applications.
C1 [Eisele, Petra S.; Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USA (MDA)Muscular Dystrophy
   Association; SwissLife 'Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung'; Swiss Society for Research on Muscle Diseases
   (SSEM); Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation (UMDF); Association Francaise contre
   les Myopathies (AFM)Association Francaise contre les Myopathies;
   Gebert-Ruf Foundation "Rare Diseases" Program; University of Basel;
   Biozentrum
FX This review is dedicated to the memory of Dr. Martine Christe. Research
   in our laboratory is supported by the Swiss National Science Foundation,
   the Muscular Dystrophy Association USA (MDA), the SwissLife
   'Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung', the
   Swiss Society for Research on Muscle Diseases (SSEM), the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation (UMDF), the Association Francaise contre les
   Myopathies (AFM), the Gebert-Ruf Foundation "Rare Diseases" Program, the
   University of Basel, and the Biozentrum.
CR Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200
   Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080
   Andersen G, 2005, J MED GENET, V42, P402, DOI 10.1136/jmg.2004.026278
   Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x
   Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185
   AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286
   Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585
   Bagattin A, 2010, P NATL ACAD SCI USA, V107, P20376, DOI 10.1073/pnas.1009176107
   Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179
   Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118
   Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011
   Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200
   Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200
   Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0
   BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532
   Buler M, 2012, J BIOL CHEM, V287, P1847, DOI 10.1074/jbc.M111.302356
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Canicio J, 2001, J BIOL CHEM, V276, P20228, DOI 10.1074/jbc.M100718200
   Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200
   Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404
   Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121
   Chang JH, 2006, ENDOCRINOLOGY, V147, P3093, DOI 10.1210/en.2005-1317
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046
   Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842
   Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494
   Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R
   Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542
   Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976
   Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642
   Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5
   Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Delerive P, 2002, MOL ENDOCRINOL, V16, P1029, DOI 10.1210/me.16.5.1029
   Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200
   Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200
   Egger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031272
   Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023
   Eisele PS, 2013, J BIOL CHEM, V288, P6589, DOI 10.1074/jbc.A112.375253
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204
   Feingold K, 2004, AM J PHYSIOL-ENDOC M, V286, pE201, DOI 10.1152/ajpendo.00205.2003
   Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x
   Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022
   Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9
   Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111
   Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004
   Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070
   Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775
   Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200
   Ikeda S, 2013, BIOCHEM BIOPH RES CO, V441, P36, DOI 10.1016/j.bbrc.2013.10.005
   Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107
   Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910
   Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000
   Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466
   Ito S, 1999, BLOOD, V93, P1456, DOI 10.1182/blood.V93.5.1456
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Ji LL, 2004, FASEB J, V18, P1499, DOI 10.1096/fj.04-1846com
   Jiang CY, 1998, NATURE, V391, P82
   JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U
   Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108
   Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200
   Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100
   Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6
   Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002
   Kassel O, 2004, GENE DEV, V18, P2518, DOI 10.1101/gad.322404
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102
   Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje
   Kien CL, 2009, CURR DIABETES REP, V9, P43, DOI 10.1007/s11892-009-0009-6
   Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456
   Kim JH, 2005, DIABETOLOGIA, V48, P1323, DOI 10.1007/s00125-005-1793-4
   Kim MS, 2005, J LIPID RES, V46, P2282, DOI 10.1194/jlr.M500217-JLR200
   Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Lacquemant C, 2002, DIABETOLOGIA, V45, P602, DOI 10.1007/s00125-002-0783-z
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708
   Lancaster GI, 2005, J PHYSIOL-LONDON, V563, P945, DOI 10.1113/jphysiol.2004.081224
   Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350
   Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   LeMoine CMR, 2010, J MOL EVOL, V70, P492, DOI 10.1007/s00239-010-9347-x
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013
   Li SM, 2009, AM J PHYSIOL-ENDOC M, V296, pE543, DOI 10.1152/ajpendo.90719.2008
   Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Liang HY, 2011, MUSCLE NERVE, V44, P947, DOI 10.1002/mus.22217
   Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008
   Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5
   Ling C, 2007, DIABETOLOGIA, V50, P1615, DOI 10.1007/s00125-007-0729-6
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   Lodish H, 2007, MOL CELL BIOL, P479
   Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Ma D, 2010, J BIOL CHEM, V285, P39087, DOI 10.1074/jbc.M110.151688
   Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014
   Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501
   Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125
   Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324
   Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200
   Menconi MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE533, DOI 10.1152/ajpendo.00596.2009
   Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x
   Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466
   Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9
   Moore ML, 2003, J BIOL CHEM, V278, P17263, DOI 10.1074/jbc.M210486200
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morari J, 2010, METABOLISM, V59, P215, DOI 10.1016/j.metabol.2009.07.020
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4
   Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721
   Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900
   Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385
   Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665
   Oberkofler H, 2009, J MOL MED, V87, P299, DOI 10.1007/s00109-008-0425-0
   Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138
   Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029
   Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708
   Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222
   Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200
   Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pagel-Langenickel I, 2008, J BIOL CHEM, V283, P22464, DOI 10.1074/jbc.M800842200
   Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327
   Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051
   Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976
   Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988
   Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007
   Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Planavila A, 2005, BBA-MOL CELL BIOL L, V1736, P120, DOI 10.1016/j.bbalip.2005.08.001
   Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Remels AHV, 2013, BBA-MOL BASIS DIS, V1832, P1313, DOI 10.1016/j.bbadis.2013.03.018
   Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964
   Rieusset J, 2012, BIOCHEM BIOPH RES CO, V417, P439, DOI 10.1016/j.bbrc.2011.11.135
   Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599
   Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x
   Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8
   Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943
   Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006
   Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com
   Sadana P, 2007, BIOCHEM J, V403, P511, DOI 10.1042/BJ20061526
   Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W
   Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002
   Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677
   Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011
   Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507
   Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402
   Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010
   Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200
   Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011
   Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007
   Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104
   Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje
   Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003
   Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x
   STPIERRE BA, 1994, AM J PATHOL, V145, P1463
   Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290
   Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955
   Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200
   Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1
   Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005
   Thews G, 1999, ANATOMIE PHYSL PATHO, P553
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330
   Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4
   Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267
   Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523
   Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x
   Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5
   Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75
   Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06
   Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010
   Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794
   Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001
   Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200
   Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475
   Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3
   Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08
   Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3
   Yu XX, 2000, AM J PHYSIOL-ENDOC M, V279, pE433
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zhang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001137
   Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104
   Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556
NR 310
TC 28
Z9 30
U1 0
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1863-2297
EI 1863-2300
J9 SEMIN IMMUNOPATHOL
JI Semin. Immunopathol.
PD JAN
PY 2014
VL 36
IS 1
BP 27
EP 53
DI 10.1007/s00281-013-0406-4
PG 27
WC Immunology; Pathology
SC Immunology; Pathology
GA AA2YI
UT WOS:000330959700004
PM 24258516
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, Walter J.
TI 21The evolution of vision
SO WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY
LA English
DT Review
ID SENSORY RHODOPSIN-II; BLUE-LIGHT PHOTORECEPTOR; CIRCADIAN CLOCK PROTEIN;
   DOMAIN-DNA COMPLEX; CRYSTAL-STRUCTURE; EYE DEVELOPMENT; VISUAL-SYSTEM;
   PAIRED DOMAIN; COLOR-VISION; SINE-OCULIS
AB In this review, the evolution of vision is retraced from its putative origins in cyanobacteria to humans. Circadian oscillatory clocks, phototropism, and phototaxis require the capability to detect light. Photosensory proteins allow us to reconstruct molecular phylogenetic trees. The evolution of animal eyes leading from an ancestral prototype to highly complex image forming eyes can be deciphered on the basis of evolutionary developmental genetic experiments and comparative genomics. As all bilaterian animals share the same master control gene, Pax6, and the same retinal and pigment cell determination genes, we conclude that the different eye-types originated monophyletically and subsequently diversified by divergent, parallel, or convergent evolution. (C) 2012 Wiley Periodicals, Inc.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM Walter.Gehring@unibas.ch
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF)
FX The research contribution of all the members of my team, and the
   financial support by the University of Basel and the Swiss National
   Science Foundation is acknowledged. Special thanks go to Greta Backhaus
   for processing the manuscript and Annette Roulier for producing the
   figures.
CR AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0
   Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0
   Albertano P, 2000, MICRON, V31, P27, DOI 10.1016/S0968-4328(99)00063-3
   Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764
   Arnheiter H, 1998, NATURE, V391, P632, DOI 10.1038/35487
   Bamann C, 2010, CURR OPIN NEUROBIOL, V20, P610, DOI 10.1016/j.conb.2010.07.003
   Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450
   BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613
   Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051
   Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254
   BERGMAN K, 1969, BACTERIOL REV, V33, P99, DOI 10.1128/MMBR.33.1.99-157.1969
   BERGMAN K, 1973, MOL GEN GENET, V123, P1, DOI 10.1007/BF00282984
   Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919
   Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x
   Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x
   Blanco J, 2005, DEVELOPMENT, V132, P1895, DOI 10.1242/dev.01738
   Blanco J, 2008, GENE EXPR PATTERNS, V8, P523, DOI 10.1016/j.gep.2008.06.002
   Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a
   Brown LS, 2001, J BIOL CHEM, V276, P32495, DOI 10.1074/jbc.M102652200
   Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406
   Bunning E., 1967, HEIDELBERG SCI LIB
   CAMPUZANO V, 1995, CURR GENET, V27, P524, DOI 10.1007/BF00314442
   Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503
   Charlton-Perkins M, 2011, MOL GENET GENOMICS, V286, P189, DOI 10.1007/s00438-011-0643-y
   Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759
   CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5
   Clements J, 2008, P NATL ACAD SCI USA, V105, P8968, DOI 10.1073/pnas.0803254105
   Codutti L, 2008, J BIOL CHEM, V283, P33321, DOI 10.1074/jbc.M805717200
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   CZERNY T, 1995, MOL CELL BIOL, V15, P2858
   DARWIN C, 1882, ORIGIN SPECIES MEANS, P143
   DODGE JD, 1983, BIOSYSTEMS, V16, P259, DOI 10.1016/0303-2647(83)90009-6
   Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003
   Dunlap JC, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P371, DOI 10.1002/352760510X.ch18
   Eakin R.M., 1982, P91
   EAKIN RM, 1981, ZOOMORPHOLOGY, V98, P1, DOI 10.1007/BF00310317
   EAKIN RM, 1979, AM ZOOL, V19, P647
   FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0
   Feuda R, P NAT ACAD IN PRESS
   Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0
   FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0
   FRANCIS D, 1967, J EXP BIOL, V47, P495
   Frisch K.v., 1949, Experientia Basel, V5, P142, DOI 10.1007/BF02174424
   Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681
   Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719
   Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8
   Gehring W, 2010, ITAL J ZOOL, V77, P124, DOI 10.1080/11250001003795350
   Gehring WJ, 2011, GENOME BIOL EVOL, V3, P1053, DOI 10.1093/gbe/evr061
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 2001, ZOOL-ANAL COMPLEX SY, V104, P171, DOI 10.1078/0944-2006-00022
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Gerhart John, 1997, CELLS EMBRYOS EVOLUT
   Glardon S, 1997, DEVELOPMENT, V124, P817
   Glossop NRJ, 2011, ESSAYS BIOCHEM, V49, P19, DOI [10.1042/BSE0490019, 10.1042/bse0490019]
   GOMEZ MD, 1994, J GEN PHYSIOL, V104, P487, DOI 10.1085/jgp.104.3.487
   Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109
   GREUET C, 1965, CR HEBD ACAD SCI, V261, P1904
   Greuet C., 1969, THESIS U NICE
   Gunhaga L, 2011, PHILOS T R SOC B, V366, P1193, DOI 10.1098/rstb.2010.0175
   HADER DP, 1987, MICROBIOL REV, V51, P1
   HADER DP, 1987, ARCH MICROBIOL, V147, P179, DOI 10.1007/BF00415281
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233
   Hamblen MJ, 1998, GENETICS, V149, P165
   HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0
   Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609
   Henderson SR, 2000, J PHYSIOL-LONDON, V524, P179, DOI 10.1111/j.1469-7793.2000.00179.x
   Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984
   Hesse R., 1897, Z WISS ZOOL, V62, P527
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T
   Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223
   Hoge MA, 1915, AM NAT, V49, P47, DOI 10.1086/279455
   HONIG B, 1979, P NATL ACAD SCI USA, V76, P2503, DOI 10.1073/pnas.76.6.2503
   Hou XG, CAMBRIAN FOSSILS CHE
   Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243
   HUGHES MJ, 1993, J BIOL CHEM, V268, P20687
   Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519
   JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170
   Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590
   Jekely G, 2009, PHILOS T R SOC B, V364, P2795, DOI 10.1098/rstb.2009.0072
   Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916
   Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x
   Kamachi Y, 2001, GENE DEV, V15, P1272, DOI 10.1101/gad.887101
   Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004
   KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871
   KONDO T, 1994, J BACTERIOL, V176, P1881, DOI 10.1128/jb.176.7.1881-1885.1994
   Kondou Y, 2002, PLANT CELL PHYSIOL, V43, P1585, DOI 10.1093/pcp/pcf176
   KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112
   Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105
   Kumauchi M, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P43, DOI 10.1002/352760510X.ch3
   Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117
   Land MF, 2002, ANIMAL EYES, P201
   Lesser MP, 2011, P ROY SOC B-BIOL SCI, V278, P3371, DOI 10.1098/rspb.2011.0336
   LEWIS EB, 1992, JAMA-J AM MED ASSOC, V267, P1524, DOI 10.1001/jama.267.11.1524
   Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611
   Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106
   LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620
   Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379
   Lister JA, 1999, DEVELOPMENT, V126, P3757
   Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977
   Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105
   Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Mayr E., 2001, WHAT EVOLUTION IS
   MCREYNOLDS JS, 1970, J GEN PHYSIOL, V56, P376, DOI 10.1085/jgp.56.3.376
   Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100
   Muller WEG, 2009, CELL MOL LIFE SCI, V66, P537, DOI 10.1007/s00018-008-8492-5
   Muller WEG, 2010, FEBS J, V277, P1182, DOI 10.1111/j.1742-4658.2009.07552.x
   Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925
   Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068
   Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100
   Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032
   Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451
   Nakamichi N, 2011, PLANT CELL PHYSIOL, V52, P1709, DOI 10.1093/pcp/pcr118
   Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3
   NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223
   NULTSCH W, 1980, ARCH MICROBIOL, V125, P181, DOI 10.1007/BF00403217
   Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0
   Ogura A, 2004, GENOME RES, V14, P1555, DOI 10.1101/gr.2268104
   Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X
   Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Parkefelt L, 2005, J COMP NEUROL, V492, P251, DOI 10.1002/cne.20658
   Passamaneck YJ, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-6
   PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2
   Pichaud F, 1999, CURR OPIN NEUROBIOL, V9, P622, DOI 10.1016/S0959-4388(99)00014-8
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pittendrigh C.S., 1981, HDB BEHAVIORAL NEURO, P57
   Plachetzki DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001054
   Plachetzki DC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-17
   Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632
   Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819
   Punzo C, 2002, DEVELOPMENT, V129, P625
   Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401
   Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361
   Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588
   Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134
   Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997
   Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X
   Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894
   Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062
   RUDOLPH J, 1995, EMBO J, V14, P4249, DOI 10.1002/j.1460-2075.1995.tb00099.x
   SALVINIPLAWEN LV, 1977, EVOLUTION PHOTORECEP
   SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001
   Santschi F., 1923, Memoires de la Societe Vaudoise des Sciences Naturelles Lausanne, V1923, P137
   Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106
   Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0
   Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x
   Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906
   Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050
   SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0
   SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686
   SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640
   SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036
   Semm P, PROGR BIOMETEROLOGY, V8
   SERIKAKU MA, 1994, GENETICS, V138, P1137
   Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904
   Shen WP, 1997, DEVELOPMENT, V124, P45
   Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8
   Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399
   Somers DE, 1998, DEVELOPMENT, V125, P485
   Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108
   Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365
   Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005
   Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1
   Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201
   Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059
   Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107
   Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6
   TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7
   Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50
   Takeda H, 2009, ZOOL SCI, V26, P805, DOI 10.2108/zsj.26.805
   Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Thimann KV, 1934, P K AKAD WET-AMSTERD, V37, P456
   Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109
   Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421
   TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6
   Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108
   Varo G, 2000, BBA-BIOENERGETICS, V1460, P220, DOI 10.1016/S0005-2728(00)00141-9
   WALTHER C, 1991, DEVELOPMENT, V113, P1435
   Wang SL, 2011, J MOL BIOL, V411, P449, DOI 10.1016/j.jmb.2011.06.002
   Wehner Rudiger, 1994, Progress in Zoology, V39, P103
   Wehner R, 2006, INVERTEBRATE VISION, P291
   WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434
   Wiens M, 2010, J CELL BIOCHEM, V111, P1377, DOI 10.1002/jcb.22866
   Williams SB, 2007, ADV MICROB PHYSIOL, V52, P229, DOI 10.1016/S0065-2911(06)52004-1
   WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62
   Wiltschko W, 1996, J EXP BIOL, V199, P29
   Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263
   XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9
   Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009
   YAN B, 1990, BIOPHYS J, V57, P807, DOI 10.1016/S0006-3495(90)82600-X
   Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660
   YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915
   YEANDLE S, 1973, J GEN PHYSIOL, V61, P552, DOI 10.1085/jgp.61.5.552
   Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505
   Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279
   Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228
   Yoshida MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-180
   Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214
   Yoshihara S, 2004, PHOTOCH PHOTOBIO SCI, V3, P512, DOI 10.1039/b402320j
   Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086
   YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784
   Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135
NR 220
TC 57
Z9 59
U1 5
U2 167
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1759-7684
EI 1759-7692
J9 WIRES DEV BIOL
JI Wiley Interdiscip. Rev.-Dev. Biol.
PD JAN-FEB
PY 2014
VL 3
IS 1
BP 1
EP 40
DI 10.1002/wdev.96
PG 40
WC Developmental Biology
SC Developmental Biology
GA AA4GE
UT WOS:000331053100001
PM 24902832
DA 2021-01-25
ER

PT J
AU Kishore, S
   Piscuoglio, S
   Kovac, MB
   Gylling, A
   Wenzel, F
   Trapani, F
   Altermatt, HJ
   Mele, V
   Marra, G
   Peltomaki, P
   Terracciano, L
   Zavolan, M
   Heinimann, K
AF Kishore, Shivendra
   Piscuoglio, Salvatore
   Kovac, Michal B.
   Gylling, Annette
   Wenzel, Friedel
   Trapani, Francesca
   Altermatt, Hans Joerg
   Mele, Valentina
   Marra, Giancarlo
   Peltomaki, Paivi
   Terracciano, Luigi
   Zavolan, Mihaela
   Heinimann, Karl
TI 3 '-UTR Poly(T/U) Tract Deletions and Altered Expression of EWSR1 Are a
   Hallmark of Mismatch Repair-Deficient Cancers
SO CANCER RESEARCH
LA English
DT Article
ID RNA-POLYMERASE-II; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY;
   3'-UNTRANSLATED REGION; MESSENGER-RNAS; LYNCH-SYNDROME; EWING SARCOMA;
   SPLICING FACTOR; BREAST-CANCER; GENE
AB The genome-wide accumulation of DNA replication errors known as microsatellite instability (MSI) is the hallmark lesion of DNA mismatch repair (MMR)-deficient cancers. Although testing for MSI is widely used to guide clinical management, the contribution of MSI at distinct genic loci to the phenotype remains largely unexplored. Here, we report that a mononucleotide (T/U)(16) tract located in the 30 untranslated region (3'-UTR) of the Ewing sarcoma breakpoint region 1 (EWSR1) gene is a novel MSI target locus that shows perfect sensitivity and specificity in detecting mismatch repair-deficient cancers in two independent populations. We further found a striking relocalization of the EWSR1 protein from nucleus to cytoplasm in MMR-deficient cancers and that the nonprotein-coding MSI target locus itself has a modulatory effect on EWSR1 gene expression through alternative 30 end processing of the EWSR1 gene. Our results point to a MSI target gene-specific effect in MMR-deficient cancers. (C)2013 AACR.
C1 [Kishore, Shivendra; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4058 Basel, Switzerland.
   [Piscuoglio, Salvatore; Kovac, Michal B.; Wenzel, Friedel; Heinimann, Karl] Univ Basel, Dept Biomed, Res Grp Human Genet, CH-4058 Basel, Switzerland.
   [Piscuoglio, Salvatore; Kovac, Michal B.; Wenzel, Friedel; Heinimann, Karl] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland.
   [Mele, Valentina] Univ Basel, Inst Surg Res & Hosp Management, CH-4058 Basel, Switzerland.
   [Mele, Valentina] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
   [Trapani, Francesca; Mele, Valentina; Terracciano, Luigi] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
   [Altermatt, Hans Joerg] Pathol Laenggasse Bern, Bern, Switzerland.
   [Marra, Giancarlo] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland.
   [Gylling, Annette; Peltomaki, Paivi] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland.
   [Trapani, Francesca] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England.
RP Heinimann, K (corresponding author), Univ Basel, Dept Biomed, Res Grp Human Genet, Mattenstr 28, CH-4058 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch; karl.heinimann@unibas.ch
RI Kovac, Michal/AAF-9605-2020; Piscuoglio, Salvatore/F-9248-2014; Kovac,
   Michal/A-4027-2011; Zavolan, Mihaela/S-3888-2016
OI Kovac, Michal/0000-0003-4526-1071; Piscuoglio,
   Salvatore/0000-0003-2686-2939; Peltomaki, Paivi/0000-0001-8819-2980;
   Zavolan, Mihaela/0000-0002-8832-2041
FU European Molecular Biology OrganizationEuropean Molecular Biology
   Organization (EMBO) [184-2009]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31003A-141225]; Academy of
   FinlandAcademy of Finland; Finnish Cancer Organizations; Sigrid Juselius
   FoundationSigrid Juselius Foundation; Biocentrum Helsinki; European
   Research CouncilEuropean Research Council (ERC); University of Basel;
   Krebsliga beider Basel; Krebsliga Zentralschweiz; Oncosuisse
FX This study was supported by grants from the European Molecular Biology
   Organization (long-term fellowship 184-2009 to S. Kishore), Swiss
   National Science Foundation grant no. 31003A-141225 (G. Marra), the
   Academy of Finland (P. Peltomaki), the Finnish Cancer Organizations (P.
   Peltomaki), the Sigrid Juselius Foundation (P. Peltomaki), Biocentrum
   Helsinki (P. Peltomaki), the European Research Council FP7-ERC-232635
   (P. Peltomaki), the University of Basel (M. Zavolan), the Krebsliga
   beider Basel (K. Heinimann), the Krebsliga Zentralschweiz (K.
   Heinimann), and Oncosuisse (K. Heinimann).
CR Allred DC, 1998, MODERN PATHOL, V11, P155
   Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018
   Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489
   Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064
   Chansky HA, 2001, CANCER RES, V61, P3586
   Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104
   de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208
   de Silanes IL, 2007, CELL ONCOL, V29, P1
   DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0
   Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028
   Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912
   Duval A, 2002, CANCER RES, V62, P2447
   Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005
   Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120
   Hampel H, 2011, CANCER PREV RES, V4, P1, DOI 10.1158/1940-6207.CAPR-10-0345
   Heinimann K, 2001, CANCER RES, V61, P7616
   Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200
   Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861
   Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d
   Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117
   Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183
   Mao G, 2008, J BIOL CHEM, V283, P3211, DOI 10.1074/jbc.M709276200
   Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003
   Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016
   Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9
   Paronetto MP, 2011, MOL CELL, V43, P353, DOI 10.1016/j.molcel.2011.05.035
   Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715
   Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964
   Pietschmann A, 2005, J CANCER RES CLIN, V131, P552, DOI 10.1007/s00432-005-0678-8
   Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086
   Ruggiero T, 2003, NUCLEIC ACIDS RES, V31, P6561, DOI 10.1093/nar/gkg858
   Sanchez G, 2008, CELL CYCLE, V7, P2299, DOI 10.4161/cc.6445
   Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008
   Shin JG, 2007, SURGERY, V142, P222, DOI 10.1016/j.surg.2007.04.002
   Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034
   Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884
   Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859
   Win AK, 2012, JNCI-J NATL CANCER I, V104, P1363, DOI 10.1093/jnci/djs351
   Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086
   ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513
   Zlobec I, 2010, BRIT J CANCER, V102, P151, DOI 10.1038/sj.bjc.6605452
   ZUCMAN J, 1992, GENE CHROMOSOME CANC, V5, P271, DOI 10.1002/gcc.2870050402
NR 44
TC 4
Z9 4
U1 0
U2 10
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JAN 1
PY 2014
VL 74
IS 1
BP 224
EP 234
DI 10.1158/0008-5472.CAN-13-2100
PG 11
WC Oncology
SC Oncology
GA 284DZ
UT WOS:000329297600022
PM 24158095
OA Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Sengupta, S
   Kaufmann, A
   Chandra, TS
AF Sengupta, Sudeshna
   Kaufmann, Andreas
   Chandra, T. S.
TI Live cell fluorescence imaging for early expression and localization of
   RIB1 and RIB3 genes in Ashbya gossypii
SO JOURNAL OF BASIC MICROBIOLOGY
LA English
DT Article
DE Ashbya gossypii; Fluorescent imaging; RIB1 and RIB3 genes; Gene
   expression
ID STRAINS
AB Ashbya gossypii is a riboflavin overproducing filamentous fungus. RIB1 and RIB3 genes encode GTP-cyclohydrolase II (GCH II) and DHBP synthase, respectively, the two rate limiting enzymes of the riboflavin biosynthetic pathway. The genes encoding yeast enhanced green fluorescent protein (yEGFP) and mCherry were fused with RIB1 and RIB3 genes, under their native promoters by PCR-based gene tagging method for their early in vivo expression and cellular localization in A. gossypii. In the integrative transformants, the fusion proteins were expressed as cytoplasmic proteins from the germ bubble stage, in all the cells throughout the hypha. This was evident from the observation that mCherry fusion proteins were seen outside the vacuoles in the cytoplasm. The older matured cells of 14h hyphae developed large vacuoles which showed green autofluorescence due to riboflavin. It is concluded that RIB1 and RIB3 genes are constitutively expressed in all the cells of this multicellular multinucleate fungus.
C1 [Sengupta, Sudeshna; Chandra, T. S.] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
   [Kaufmann, Andreas] Univ Basel, Biozentrum, Inst Appl Microbiol, Basel, Switzerland.
RP Sengupta, S (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM sudeshnaiitm@gmail.com
FU Dept. of Biotechnology (DBT) Govt. of IndiaDepartment of Biotechnology
   (DBT) India; DST-ISJRP
FX We thank Dept. of Biotechnology (DBT) Govt. of India for funding this
   project and Prof. Peter Philippsen, Biozentrum, Basel for hosting
   Sudeshna under DST-ISJRP grant (EPFL, Switzerland).
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Rischatsch R., 2007, THESIS U BASEL SWITZ
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schlosser T, 2007, APPL MICROBIOL BIOT, V76, P569, DOI 10.1007/s00253-007-1075-9
   Schlosser T, 2001, MICROBIOL-SGM, V147, P3377, DOI 10.1099/00221287-147-12-3377
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107
NR 14
TC 1
Z9 1
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0233-111X
EI 1521-4028
J9 J BASIC MICROB
JI J. Basic Microbiol.
PD JAN
PY 2014
VL 54
IS 1
SI SI
BP 81
EP 87
DI 10.1002/jobm.201200292
PG 7
WC Microbiology
SC Microbiology
GA 282JW
UT WOS:000329168300010
PM 23553441
DA 2021-01-25
ER

PT J
AU Peters, LW
   Molle, KD
   Thiemeyer, A
   Knopf, A
   Goxe, M
   Guerry, P
   Brodbeck, D
   Colombi, M
   Hall, MN
   Moroni, C
   Regenass, U
AF Peters, Lorenza Wyder
   Molle, Klaus D.
   Thiemeyer, Anke
   Knopf, Agnes
   Goxe, Marie
   Guerry, Philippe
   Brodbeck, Daniela
   Colombi, Marco
   Hall, Michael N.
   Moroni, Christoph
   Regenass, Urs
TI An Isogenic Cell Panel Identifies Compounds That Inhibit Proliferation
   of mTOR-Pathway Addicted Cells by Different Mechanisms
SO JOURNAL OF BIOMOLECULAR SCREENING
LA English
DT Article
DE synthetic lethality; oncogene addiction; isogenic cell lines; mTOR;
   farnesylation
ID HUMAN CANCER-CELLS; POLY(ADP-RIBOSE) POLYMERASE; HYDROGEN-PEROXIDE;
   LEUKEMIA-CELLS; CYCLIN-D; H-RAS; PTEN; APOPTOSIS; DETERMINES; EXPRESSION
AB The mTOR pathway is a critical integrator of nutrient and growth factor signaling. Once activated, mTOR promotes cell growth and proliferation. Several components of the mTOR pathway are frequently deregulated in tumors, leading to constitutive activation of the pathway and thus contribute to uncontrolled cell growth. We performed a high-throughput screen with an isogenic cell line system to identify compounds specifically inhibiting proliferation of PTEN/mTOR-pathway addicted cells. We show here the characterization and mode of action of two such compound classes. One compound class inhibits components of the PTEN/mTOR signaling pathway, such as S6 ribosomal protein phosphorylation, and leads to cyclin D3 downregulation. These compounds are not adenosine triphosphate competitive inhibitors for kinases in the pathway, nor do they require FKBP12 for activity like rapamycin. The other compound class turned out to be a farnesylation inhibitor, blocking the activity of GTPases, as well as an inducer of oxidative stress. Our results demonstrate that an isogenic cell system with few specific mutations in oncogenes and tumor suppressor genes can identify different classes of compounds selectively inhibiting proliferation of PTEN/mTOR pathway-addicted isogenic clones. The identified mechanisms are in line with the known cellular signaling networks activated by the altered oncogenes and suppressor genes in the isogenic system.
C1 [Peters, Lorenza Wyder; Knopf, Agnes; Goxe, Marie; Guerry, Philippe; Regenass, Urs] Actel Pharmaceut Ltd, CH-4123 Allschwil, Switzerland.
   [Molle, Klaus D.; Thiemeyer, Anke; Colombi, Marco; Hall, Michael N.; Moroni, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
   [Brodbeck, Daniela] BioFocus, Allschwil, Switzerland.
RP Peters, LW (corresponding author), Actel Pharmaceut Ltd, Gewerbestr 16, CH-4123 Allschwil, Switzerland.
EM lorenza.wyder@actelion.com
FU Swiss Commission for Technology and Innovation (CTI) [8963]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This project
   was supported by a grant from the Swiss Commission for Technology and
   Innovation (CTI) [grant number #8963] to CM, MNH, and UR.
CR Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200
   Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443
   Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220
   Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374
   Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001
   Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539
   Diao LR, 2007, CELL RES, V17, P291, DOI 10.1038/cr.2007.24
   Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3
   Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Ji ZY, 2009, FRONT BIOSCI-LANDMRK, V14, P2904, DOI 10.2741/3421
   Kiser KF, 2006, ONCOGENE, V25, P6595, DOI 10.1038/sj.onc.1209673
   KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833
   Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296
   Li HF, 2011, J BIOMOL SCREEN, V16, P383, DOI 10.1177/1087057110397357
   Matkar SS, 2008, ARCH BIOCHEM BIOPHYS, V477, P43, DOI 10.1016/j.abb.2008.05.019
   McAuliffe PF, 2010, CLIN BREAST CANCER, V10, pS59, DOI 10.3816/CBC.2010.s.013
   Mills GB, 2001, P NATL ACAD SCI USA, V98, P10031, DOI 10.1073/pnas.191379498
   Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206
   Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090
   NAIR APK, 1992, ONCOGENE, V7, P1963
   Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798
   Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003
   Pallet N, 2005, KIDNEY INT, V67, P2422, DOI 10.1111/j.1523-1755.2005.00350.x
   PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x
   Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009
   Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28
   Schult C, 2012, ANTICANCER RES, V32, P463
   Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556
   Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940
   Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009
   Wang R, 2007, CANCER RES, V67, P7856, DOI 10.1158/0008-5472.CAN-07-0151
   Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42
NR 35
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1087-0571
EI 1552-454X
J9 J BIOMOL SCREEN
JI J. Biomol. Screen
PD JAN
PY 2014
VL 19
IS 1
SI SI
BP 131
EP 144
DI 10.1177/1087057113497798
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry
GA 272GC
UT WOS:000328447300012
PM 23954931
OA Bronze
DA 2021-01-25
ER

PT J
AU Schicktanz, N
   Schwegler, K
   Fastenrath, M
   Spalek, K
   Milnik, A
   Papassotiropoulos, A
   Nyffeler, T
   de Quervain, DJF
AF Schicktanz, Nathalie
   Schwegler, Kyrill
   Fastenrath, Matthias
   Spalek, Klara
   Milnik, Annette
   Papassotiropoulos, Andreas
   Nyffeler, Thomas
   de Quervain, Dominique J. -F.
TI Motor threshold predicts working memory performance in healthy humans
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
AB Cognitive functions, such as working memory, depend on neuronal excitability in a distributed network of cortical regions. It is not known, however, if inter-individual differences in cortical excitability are related to differences in working memory performance. In the present transcranial magnetic stimulation study, which included 188 healthy young subjects, we show that participants with lower resting motor threshold, which is related to higher corticospinal excitability, had increased 2-back working memory performance. The findings may help to better understand the link between cortical excitability and cognitive functions and may also have important clinical implications with regard to conditions of altered cortical excitability.
C1 [Schicktanz, Nathalie; Schwegler, Kyrill; Fastenrath, Matthias; Spalek, Klara; de Quervain, Dominique J. -F.] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland.
   [Schicktanz, Nathalie; Schwegler, Kyrill; Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, Basel, Switzerland.
   [Milnik, Annette; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, Basel, Switzerland.
   [Nyffeler, Thomas] Univ Bern, Univ Hosp Bern, Dept Neurol, Percept & Eye Movement Lab,Inselspital, Bern, Switzerland.
   [Nyffeler, Thomas] Univ Bern, Univ Hosp Bern, Dept Clin Res, Percept & Eye Movement Lab,Inselspital, Bern, Switzerland.
   [Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabil, Luzern, Switzerland.
RP de Quervain, DJF (corresponding author), Div Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM dominique.dequervain@unibas.ch
OI Milnik, Annette/0000-0002-3933-3289; de Quervain,
   Dominique/0000-0001-7131-2464; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Nyffeler, Thomas/0000-0003-2504-8935;
   Spalek, Klara/0000-0002-4244-6495
CR Balanza-Martinez V, 2008, NEUROSCI BIOBEHAV R, V32, P1426, DOI 10.1016/j.neubiorev.2008.05.019
   Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959
   Bijsterbosch JD, 2012, MED BIOL ENG COMPUT, V50, P671, DOI 10.1007/s11517-012-0922-8
   Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294
   Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515
   Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010
   Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427
   Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21
   GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G
   GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473
   Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649
   Johnson JS, 2012, J NEUROPHYSIOL, V107, P2383, DOI 10.1152/jn.00707.2011
   Laux L, 1981, DTSCH VERSION STATE
   Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005
   Mufti MA, 2010, BRAIN STIMUL, V3, P177, DOI 10.1016/j.brs.2009.08.001
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Park SP, 2008, J CLIN NEUROL, V4, P99, DOI 10.3988/jcn.2008.4.3.99
   Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002
   Perkins KA, 2013, DRUG ALCOHOL DEPEN, V133, P283, DOI 10.1016/j.drugalcdep.2013.05.003
   Pompili A, 2012, PSYCHONEUROENDOCRINO, V37, P1379, DOI 10.1016/j.psyneuen.2012.01.007
   Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229
   Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016
   Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005
   Scheider L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021676
   Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180
   Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704
   Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012
   Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016
   Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X
   Wassermann EM, 2001, BIOL PSYCHIAT, V50, P377, DOI 10.1016/S0006-3223(01)01210-0
   Woolley CS, 1998, EPILEPSIA, V39, pS2, DOI 10.1111/j.1528-1157.1998.tb02601.x
NR 31
TC 5
Z9 5
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JAN
PY 2014
VL 1
IS 1
BP 69
EP 73
DI 10.1002/acn3.22
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA V45KC
UT WOS:000209814500010
PM 25356384
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Rumisha, SF
   Smith, T
   Abdulla, S
   Masanja, H
   Vounatsou, P
AF Rumisha, Susan Fred
   Smith, Thomas
   Abdulla, Salim
   Masanja, Honorath
   Vounatsou, Penelope
TI Modelling heterogeneity in malaria transmission using large sparse
   spatio-temporal entomological data
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE approximate spatial process; malaria transmission; seasonality; MCMC;
   INDEPTH-MTIMBA
ID INFLATED POISSON REGRESSION; INOCULATION RATES; ANOPHELES-FUNESTUS;
   MOSQUITO DENSITY; BINOMIAL MODEL; WESTERN KENYA; COUNT DATA; AFRICA;
   TANZANIA; RISK
AB Background: Malaria transmission is measured using entomological inoculation rate (EIR), number of infective mosquito bites/person/unit time. Understanding heterogeneity of malaria transmission has been difficult due to a lack of appropriate data. A comprehensive entomological database compiled by the Malaria Transmission Intensity and Mortality Burden across Africa (MTIMBA) project (2001-2004) at several sites is the most suitable dataset for studying malaria transmission mortality relations. The data are sparse and large, with small-scale spatial-temporal variation.
   Objective: This work demonstrates a rigorous approach for analysing large and highly variable entomological data for the study of malaria transmission heterogeneity, measured by EIR, within the Rufiji Demographic Surveillance System (DSS), MTIMBA project site in Tanzania.
   Design: Bayesian geostatistical binomial and negative binomial models with zero inflation were fitted for sporozoite rates (SRs) and mosquito density, respectively. The spatial process was approximated from a subset of locations. The models were adjusted for environmental effects, seasonality and temporal correlations and assessed based on their predictive ability. EIR was calculated using model-based predictions of SR and density.
   Results: Malaria transmission was mostly influenced by rain and temperature, which significantly reduces the probability of observing zero mosquitoes. High transmission was observed at the onset of heavy rains. Transmission intensity reduced significantly during Year 2 and 3, contrary to the Year 1, pronouncing high seasonality and spatial variability. The southern part of the DSS showed high transmission throughout the years. A spatial shift of transmission intensity was observed where an increase in households with very low transmission intensity and significant reduction of locations with high transmission were observed over time. Over 68 and 85% of the locations selected for validation for SR and density, respectively, were correctly predicted within 95% credible interval indicating good performance of the models.
   Conclusion: Methodology introduced here has the potential for efficient assessment of the contribution of malaria transmission in mortality and monitoring performance of control and intervention strategies.
C1 [Rumisha, Susan Fred; Smith, Thomas; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.
   [Rumisha, Susan Fred; Smith, Thomas; Vounatsou, Penelope] Univ Basel, Dept Biozentrum, Basel, Switzerland.
   [Rumisha, Susan Fred] Natl Inst Med Res, Dept Dis Surveillance & Geog Informat Syst, Dar Es Salaam, Tanzania.
   [Abdulla, Salim; Masanja, Honorath] Ifakara Hlth Inst, Dar Es Salaam, Tanzania.
RP Vounatsou, P (corresponding author), Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland.
EM Penelope.Vounatsou@unibas.ch
RI Smith, Thomas/B-5569-2015
OI Smith, Thomas/0000-0002-3650-9381; Vounatsou,
   Penelope/0000-0002-4904-5352
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [Nr 325200-118379/1]
FX We are grateful to the community in the RDSS and staff from IHI who
   devoted their time and enormous energy to the study. The study received
   funding from the Swiss National Science Foundation (Nr 325200-118379/1).
CR Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388
   Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990
   Alexander N, 2000, Biostatistics, V1, P453, DOI 10.1093/biostatistics/1.4.453
   Amek N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-86
   Amek N, 2011, SPAT SPATIO-TEMPORAL, V2, P283, DOI 10.1016/j.sste.2011.08.001
   Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108
   Banerjee S, 2008, J R STAT SOC B, V70, P825, DOI 10.1111/j.1467-9868.2008.00663.x
   Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109
   Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088
   Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136
   Brogan R, 1992, DESIGNING LONGITUDIN
   Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726
   Charlwood JD, 2001, ACTA TROP, V80, P1, DOI 10.1016/S0001-706X(01)00152-8
   Chase JM, 2009, ECOL ENTOMOL, V34, P741, DOI 10.1111/j.1365-2311.2009.01128.x
   Cressie N., 1993, STAT SPATIAL DATA
   Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113
   Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669
   Eidsvik J, 2012, COMPUT STAT DATA AN, V56, P1362, DOI 10.1016/j.csda.2011.10.022
   Finley AO, 2009, COMPUT STAT DATA AN, V53, P2873, DOI 10.1016/j.csda.2008.09.008
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X
   Gatton M, 2010, LANCET INFECT DIS, V10, P15
   GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378
   Giardina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032625
   Gillies MT, 1968, PUBL S AFR I MED RES, V54
   Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287
   Gosoniu L, 2008, DEV BAYESIAN GEOSTAT
   Greene WH, 1994, TECHNICAL REPORT
   Guelbeogo WM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-239
   HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97
   Hay J L, 2001, Biostatistics, V2, P433, DOI 10.1093/biostatistics/2.4.433
   Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3
   Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473
   Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048
   JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B
   Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63
   Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19
   Kent RJ, 2006, MED VET ENTOMOL, V20, P459, DOI 10.1111/j.1365-2915.2006.00646.x
   Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121
   Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535
   Kweka EJ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-75
   LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547
   Lee Hee-Il, 2001, Korean Journal of Parasitology, V39, P185, DOI 10.3347/kjp.2001.39.2.185
   Leisnham PT, 2007, NEW ZEAL J ZOOL, V34, P203, DOI 10.1080/03014220709510079
   LINES JD, 1991, PARASITOLOGY, V102, P167, DOI 10.1017/S0031182000062454
   Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180
   Mboera LEG, 2010, GEOSPATIAL HEALTH, V4, P167, DOI 10.4081/gh.2010.198
   Metropolis N., 1987, LOS ALAMOS SCI, V15, P125, DOI DOI 10.1128/JCM.05092-11
   Michael E, 2001, AM J TROP MED HYG, V65, P722, DOI 10.4269/ajtmh.2001.65.722
   Mwageni E, 2002, INDEPTH MONOGRAPH SE
   NEDELMAN J, 1983, BIOMETRICS, V39, P1009, DOI 10.2307/2531335
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Rau R., 2006, SEASONALITY HUMAN MO
   Reid H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-150
   Ridout M, 2001, BIOMETRICS, V57, P219, DOI 10.1111/j.0006-341X.2001.00219.x
   Rumisha SF, 2013, THESIS U BASEL BASEL
   Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143
   Sankoh OA, 2005, ENV CHANGE MALARIA R
   Seeger Matthias, 2003, BAYESIAN GAUSSIAN PR
   Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122
   SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M
   Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6
   Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818
   Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2
   Sogoba N, 2007, AM J TROP MED HYG, V76, P1009, DOI 10.4269/ajtmh.2007.76.1009
   Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083
   Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235
   Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8
   Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214
   Thomson MC, 2001, TRENDS PARASITOL, V17, P438, DOI 10.1016/S1471-4922(01)02077-3
   Warrell D, 2003, ESSENTIAL MALARIOLOG
   Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Xia G, 2005, TECHNICAL REPORT
   Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024
NR 77
TC 9
Z9 9
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2014
VL 7
AR 22682
DI 10.3402/gha.v7.22682
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AL2OZ
UT WOS:000338966200001
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Disconzi, E
   Guilvout, I
   Chami, M
   Masi, M
   Huysmans, GHM
   Pugsley, AP
   Bayan, N
AF Disconzi, Elena
   Guilvout, Ingrid
   Chami, Mohamed
   Masi, Muriel
   Huysmans, Gerard H. M.
   Pugsley, Anthony P.
   Bayan, Nicolas
TI Bacterial Secretins Form Constitutively Open Pores Akin to General
   Porins
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MECHANOSENSITIVE CHANNEL MSCL; ESCHERICHIA-COLI; OUTER-MEMBRANE;
   PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ERWINIA-CHRYSANTHEMI;
   ALPHA-HEMOLYSIN; TERMINAL DOMAIN; INNER MEMBRANE; IN-VITRO
AB Proteins called secretins form large multimeric complexes that are essential for macromolecular transit across the outer membrane of Gram-negative bacteria. Evidence suggests that the channels formed by some secretin complexes are not tightly closed, but their permeability properties have not been well characterized. Here, we used cell-free synthesis coupled with spontaneous insertion into liposomes to investigate the permeability of the secretin PulD. Leakage assays using preloaded liposomes indicated that PulD allows the efflux of small fluorescent molecules with a permeation cutoff similar to that of general porins. Other secretins were also found to form similar pores. To define the polypeptide region involved in determining the pore size, we analyzed a collection of PulD variants and studied the roles of gates 1 and 2, which were previously reported to affect the pore size of filamentous phage f1 secretin pIV, in assembly and pore formation. Liposome leakage and a novel in vivo assay showed that replacement of the conserved proline residue at position 443 in PulD by leucine increased the apparent size of the pore. The in vitro approach described here could be used to study the pore properties of membrane proteins whose production in vivo is toxic.
C1 [Disconzi, Elena; Masi, Muriel; Bayan, Nicolas] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.
   [Disconzi, Elena; Masi, Muriel; Bayan, Nicolas] Ctr Natl Rech Sci, UMR 8619, Orsay, France.
   [Disconzi, Elena; Guilvout, Ingrid; Huysmans, Gerard H. M.; Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, Paris, France.
   [Disconzi, Elena; Guilvout, Ingrid; Huysmans, Gerard H. M.; Pugsley, Anthony P.] Ctr Natl Rech Sci ERA3625, Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, C CINA Ctr Imaging & NanoAnalyt, Basel, Switzerland.
RP Bayan, N (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.
EM nicolas.bayan@u-psud.fr
RI Bayan, Nicolas/AAI-5034-2020; Masi, Muriel/N-6758-2018; Huysmans,
   Gerard/AAJ-6285-2020
OI Masi, Muriel/0000-0002-1444-7511; Bayan, Nicolas/0000-0001-7760-0811
FU Marie-Curie FellowshipEuropean Union (EU) [PIEF-GA-2010-272611]; 
   [ANR-09-BLAN-0291]
FX This work was supported in part by grant ANR-09-BLAN-0291 and by a
   Marie-Curie Fellowship to G. H. M. H. (PIEF-GA-2010-272611).
CR Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670
   Berrier C, 2011, BBA-BIOMEMBRANES, V1808, P41, DOI 10.1016/j.bbamem.2010.09.018
   Berry JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002923
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003
   Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959
   GUDMUNDSDOTTIR A, 1988, J BIOL CHEM, V263, P14224
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11
   KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x
   KILLMANN H, 1994, FEMS MICROBIOL LETT, V119, P71
   Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037
   Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228
   Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002
   Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011
   Krehenbrink M, 2008, J MOL BIOL, V383, P1058, DOI 10.1016/j.jmb.2008.09.016
   Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x
   Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x
   Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516
   Miller JH, 1972, EXPT MOL GENETICS
   Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104
   Nickerson NN, 2012, J BACTERIOL, V194, P4951, DOI 10.1128/JB.00798-12
   Nickerson NN, 2011, J BIOL CHEM, V286, P38833, DOI 10.1074/jbc.M111.279851
   NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Powl AM, 2008, BIOCHEMISTRY-US, V47, P12175, DOI 10.1021/bi801352a
   Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910
   Smith DL, 1998, J BACTERIOL, V180, P2531, DOI 10.1128/JB.180.9.2531-2540.1998
   Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Tosi T, 2011, MOL MICROBIOL, V82, P1422, DOI 10.1111/j.1365-2958.2011.07896.x
   Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096
   WALKER B, 1992, J BIOL CHEM, V267, P10902
   Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338
   YOSHIHARA E, 1989, J BIOL CHEM, V264, P6297
NR 41
TC 14
Z9 14
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JAN
PY 2014
VL 196
IS 1
BP 121
EP 128
DI 10.1128/JB.00750-13
PG 8
WC Microbiology
SC Microbiology
GA AB4XG
UT WOS:000331792600013
PM 24142256
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Zivanovic, Y
   Confalonieri, F
   Ponchon, L
   Lurz, R
   Chami, M
   Flayhan, A
   Renouard, M
   Huet, A
   Decottignies, P
   Davidson, AR
   Breyton, C
   Boulanger, P
AF Zivanovic, Yvan
   Confalonieri, Fabrice
   Ponchon, Luc
   Lurz, Rudi
   Chami, Mohamed
   Flayhan, Ali
   Renouard, Madalena
   Huet, Alexis
   Decottignies, Paulette
   Davidson, Alan R.
   Breyton, Cecile
   Boulanger, Pascale
TI Insights into Bacteriophage T5 Structure from Analysis of Its
   Morphogenesis Genes and Protein Components
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID COMPLETE GENOME SEQUENCE; RECEPTOR-BINDING PROTEIN; LONG-TAILED PHAGES;
   ESCHERICHIA-COLI; STRUCTURE REVEALS; PROHEAD PROTEASE; OUTER-MEMBRANE;
   DNA; LAMBDA; FIBER
AB Bacteriophage T5 represents a large family of lytic Siphoviridae infecting Gram-negative bacteria. The low-resolution structure of T5 showed the T = 13 geometry of the capsid and the unusual trimeric organization of the tail tube, and the assembly pathway of the capsid was established. Although major structural proteins of T5 have been identified in these studies, most of the genes encoding the morphogenesis proteins remained to be identified. Here, we combine a proteomic analysis of T5 particles with a bioinformatic study and electron microscopic immunolocalization to assign function to the genes encoding the structural proteins, the packaging proteins, and other nonstructural components required for T5 assembly. A head maturation protease that likely accounts for the cleavage of the different capsid proteins is identified. Two other proteins involved in capsid maturation add originality to the T5 capsid assembly mechanism: the single head-to-tail joining protein, which closes the T5 capsid after DNA packaging, and the nicking endonuclease responsible for the single-strand interruptions in the T5 genome. We localize most of the tail proteins that were hitherto uncharacterized and provide a detailed description of the tail tip composition. Our findings highlight novel variations of viral assembly strategies and of virion particle architecture. They further recommend T5 for exploring phage structure and assembly and for deciphering conformational rearrangements that accompany DNA transfer from the capsid to the host cytoplasm.
C1 [Renouard, Madalena; Huet, Alexis; Decottignies, Paulette; Boulanger, Pascale] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR CNRS 8619, Orsay, France.
   [Zivanovic, Yvan; Confalonieri, Fabrice] Univ Paris 11, Inst Genet & Microbiol, UMR CNRS 8621, F-91405 Orsay, France.
   [Ponchon, Luc] Univ Paris 05, CNRS UMR 8015, Paris, France.
   [Lurz, Rudi] Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4003 Basel, Switzerland.
   [Flayhan, Ali; Breyton, Cecile] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS UMR 5075, Grenoble, France.
   [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.
RP Boulanger, P (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR CNRS 8619, Orsay, France.
EM pascale.boulanger@u-psud.fr
OI Huet, Alexis/0000-0001-6069-4460; ponchon, Luc/0000-0002-4094-4853
FU RoBioMol platform of the Grenoble Instruct center (ISBG) [UMS 3518
   CNRS-CEA-UJF-EMBL]; FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble
   Partnership for Structural Biology [ANR-10-LABX-49-01]; French National
   Research AgencyFrench National Research Agency (ANR) [ANR-06-PCVI-0002];
   Institut Federatif de Recherche 115; European CommunityEuropean
   Community (EC) [211800]; Swiss National Science Foundation (SystemsX.ch
   RTD CINA)Swiss National Science Foundation (SNSF)
FX We used the RoBioMol platform of the Grenoble Instruct center (ISBG; UMS
   3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and
   GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural
   Biology. This work was supported by funding from the French National
   Research Agency (ANR-06-PCVI-0002), the Institut Federatif de Recherche
   115, and the European Community's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement 211800. The EM work was supported
   in part by the Swiss National Science Foundation (SystemsX.ch RTD CINA).
CR Auzat I, 2008, MOL MICROBIOL, V70, P557, DOI 10.1111/j.1365-2958.2008.06435.x
   Bartual SG, 2010, P NATL ACAD SCI USA, V107, P20287, DOI 10.1073/pnas.1011218107
   Black LW, 1993, MOL BIOL BACTERIOPHA
   Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9
   Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673
   Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200
   Boulanger Pascale, 2009, V502, P227, DOI 10.1007/978-1-60327-565-1_13
   Breyton C, 2013, J BIOL CHEM, V288, P30763, DOI 10.1074/jbc.M113.501536
   Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109
   Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067
   Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632
   Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429
   Cheng H, 2004, PROTEIN SCI, V13, P2260, DOI 10.1110/ps.04726004
   Davidson AR, 2012, ADV EXP MED BIOL, V726, P115, DOI 10.1007/978-1-4614-0980-9_6
   Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636
   Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98
   Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081
   Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106
   FEUCHT A, 1990, J BIOL CHEM, V265, P18561
   Flayhan A, 2014, J VIROL, V88, P820, DOI 10.1128/JVI.02135-13
   Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021
   Fokine A, 2013, J MOL BIOL, V425, P1731, DOI 10.1016/j.jmb.2013.02.012
   Garcia-Doval C, 2012, ACTA CRYSTALLOGR F, V68, P166, DOI 10.1107/S1744309111051049
   GENTZ R, 1985, J BACTERIOL, V164, P70, DOI 10.1128/JB.164.1.70-77.1985
   Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360
   Harlow E, 1988, ANTIBODIES LAB MANUA
   HELLER K, 1982, J VIROL, V41, P222, DOI 10.1128/JVI.41.1.222-227.1982
   HELLER KJ, 1984, J VIROL, V49, P20, DOI 10.1128/JVI.49.1.20-25.1984
   HELLER KJ, 1985, J BACTERIOL, V162, P621, DOI 10.1128/JB.162.2.621-625.1985
   HENDRICKSON HE, 1971, J VIROL, V7, P612, DOI 10.1128/JVI.7.5.612-618.1971
   Hendrix R.W., 2006, BACTERIOPHAGES, P409
   Hong J, 2008, FEMS MICROBIOL LETT, V289, P202, DOI 10.1111/j.1574-6968.2008.01397.x
   Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887
   Huang RK, 2011, J MOL BIOL, V408, P541, DOI 10.1016/j.jmb.2011.01.016
   Huet A, 2010, J VIROL, V84, P9350, DOI 10.1128/JVI.00942-10
   KALIMAN AV, 1995, FEBS LETT, V366, P46, DOI 10.1016/0014-5793(95)00482-O
   Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a
   KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4
   Kim JH, 2012, J VIROL, V86, P7013, DOI 10.1128/JVI.00742-12
   Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10
   Kondou Y, 2005, J MOL BIOL, V352, P976, DOI 10.1016/j.jmb.2005.07.044
   KRAUEL V, 1991, J BACTERIOL, V173, P1287, DOI 10.1128/jb.173.3.1287-1297.1991
   Lambert O, 1998, MOL MICROBIOL, V30, P761, DOI 10.1046/j.1365-2958.1998.01107.x
   LANNI YT, 1958, VIROLOGY, V5, P481, DOI 10.1016/0042-6822(58)90041-2
   Lee DH, 2012, J VIROL, V86, P11410, DOI 10.1128/JVI.01987-12
   Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106
   Liu J, 2004, J BACTERIOL, V186, P4369, DOI 10.1128/JB.186.13.4369-4375.2004
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   MARVIK OJ, 1994, VIROLOGY, V200, P702, DOI 10.1006/viro.1994.1234
   MCCORQUODALE JD, 1988, VIRUSES, V1, P439
   Medina E, 2010, J MOL BIOL, V401, P813, DOI 10.1016/j.jmb.2010.06.060
   Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604
   Mondigler M, 1996, VIROLOGY, V219, P19, DOI 10.1006/viro.1996.0218
   Niu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034585
   Noirclerc-Savoye M, 2010, BIOTECHNOL J, V5, P978, DOI 10.1002/biot.201000132
   Pell LG, 2010, J MOL BIOL, V403, P468, DOI 10.1016/j.jmb.2010.08.044
   Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072
   Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106
   Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X
   Ponchon L, 2006, J BIOL CHEM, V281, P5829, DOI 10.1074/jbc.M511817200
   Preux O, 2013, J MOL BIOL, V425, P1999, DOI 10.1016/j.jmb.2013.03.002
   Rabsch W, 2007, J BACTERIOL, V189, P5658, DOI 10.1128/JB.00437-07
   ROGERS SG, 1979, J VIROL, V29, P716, DOI 10.1128/JVI.29.2.716-725.1979
   SAIGO K, 1978, VIROLOGY, V85, P422, DOI 10.1016/0042-6822(78)90449-X
   Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200
   SCHEIBLE PP, 1975, J VIROL, V15, P1276, DOI 10.1128/JVI.15.5.1276-1280.1975
   Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200
   Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107
   STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X
   Tam W, 2013, J MOL BIOL, V425, P2450, DOI 10.1016/j.jmb.2013.03.032
   Tavares P, 2012, ADV EXP MED BIOL, V726, P585, DOI 10.1007/978-1-4614-0980-9_25
   Thomas JA, 2012, MOL MICROBIOL, V84, P324, DOI 10.1111/j.1365-2958.2012.08025.x
   Vinga I, 2012, MOL MICROBIOL, V83, P289, DOI 10.1111/j.1365-2958.2011.07931.x
   Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049
   Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006
   Xu J, 2013, J MOL BIOL, V425, P3476, DOI 10.1016/j.jmb.2013.07.002
   ZWEIG M, 1973, VIROLOGY, V51, P443, DOI 10.1016/0042-6822(73)90443-1
NR 77
TC 36
Z9 78
U1 0
U2 29
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2014
VL 88
IS 2
BP 1162
EP 1174
DI 10.1128/JVI.02262-13
PG 13
WC Virology
SC Virology
GA 282SY
UT WOS:000329194900037
PM 24198424
OA Green Published, Bronze
DA 2021-01-25
ER

PT S
AU Spitzer, J
   Hafner, M
   Landthaler, M
   Ascano, M
   Farazi, T
   Wardle, G
   Nusbaum, J
   Khorshid, M
   Burger, L
   Zavolan, M
   Tuschl, T
AF Spitzer, Jessica
   Hafner, Markus
   Landthaler, Markus
   Ascano, Manuel
   Farazi, Thalia
   Wardle, Greg
   Nusbaum, Jeff
   Khorshid, Mohsen
   Burger, Lukas
   Zavolan, Mihaela
   Tuschl, Thomas
BE Lorsch, J
TI PAR-CLIP (Photoactivatable Ribonucleoside-Enhanced Crosslinking and
   Immunoprecipitation): a Step-By-Step Protocol to the Transcriptome-Wide
   Identification of Binding Sites of RNA-Binding Proteins
SO LABORATORY METHODS IN ENZYMOLOGY: PROTEIN, PT B
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID RIBONUCLEOPROTEIN COMPLEXES; GENOME-WIDE; 4-THIOURIDINE
AB We recently developed a protocol for the transcriptome-wide isolation of RNA recognition elements readily applicable to any protein or ribonucleoprotein complex directly contacting RNA (including RNA helicases, polymerases, or nucleases) expressed in cell culture models either naturally or ectopically (Hafner et al., 2010).
   Briefly, immunoprecipitation of the RNA-binding protein of interest is followed by isolation of the crosslinked and coimmunoprecipitated RNA. In the course of lysate preparation and immunoprecipitation, the mRNAs are partially degraded using Ribonuclease T1. The isolated crosslinked RNA fragments are converted into a cDNA library and deep-sequenced using Solexa technology (see Explanatory Chapter: Next Generation Sequencing). By introducing photoreactive nucleosides that generate characteristic sequence changes upon crosslinking (see below), our protocol allows one to separate RNA segments bound by the protein of interest from the background uncrosslinked RNAs.
C1 [Spitzer, Jessica; Hafner, Markus; Ascano, Manuel; Farazi, Thalia; Wardle, Greg; Nusbaum, Jeff; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   [Khorshid, Mohsen; Burger, Lukas; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Khorshid, Mohsen; Burger, Lukas; Zavolan, Mihaela] SIB, Basel, Switzerland.
RP Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
EM ttuschl@rockefeller.edu
RI Hafner, Markus/O-7100-2018; Landthaler, Markus/A-1427-2010; Zavolan,
   Mihaela/S-3888-2016; Ascano, Manuel/ABA-3586-2020
OI Hafner, Markus/0000-0002-4336-6518; Landthaler,
   Markus/0000-0002-1075-8734; Ascano, Manuel/0000-0002-9370-5493; Zavolan,
   Mihaela/0000-0002-8832-2041
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline; Intramural NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [Z99 AR999999,
   ZIA AR041201-01, ZIA AR041200-01] Funding Source: Medline
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   BEZERRA R, 1990, BIOCHEM BIOPH RES CO, V166, P29, DOI 10.1016/0006-291X(90)91907-A
   FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9
   Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103
   Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kuimelis R. G., 2001, CURRENT PROTOCCOLS N, V10, P16
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
NR 14
TC 49
Z9 49
U1 0
U2 22
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-420120-0
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2014
VL 539
BP 113
EP 161
DI 10.1016/B978-0-12-420120-0.00008-6
PG 49
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BA2GY
UT WOS:000333380800008
PM 24581442
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Abad, MA
   Medina, B
   Santamaria, A
   Zou, J
   Plasberg-Hill, C
   Madhumalar, A
   Jayachandran, U
   Redli, PM
   Rappsilber, J
   Nigg, EA
   Jeyaprakash, AA
AF Abad, Maria Alba
   Medina, Bethan
   Santamaria, Anna
   Zou, Juan
   Plasberg-Hill, Carla
   Madhumalar, Arumugam
   Jayachandran, Uma
   Redli, Patrick Marc
   Rappsilber, Juri
   Nigg, Erich A.
   Jeyaprakash, A. Arockia
TI Structural basis for microtubule recognition by the human kinetochore
   Ska complex
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CROSS-LINKING; RING COMPLEX; BINDING; PROTEIN; DAM1; DEPOLYMERIZATION;
   ARCHITECTURE; COMPONENT; SPINDLE; ORGANIZATION
AB The ability of kinetochores (KTs) to maintain stable attachments to dynamic microtubule structures ('straight' during microtubule polymerization and 'curved' during microtubule depolymerization) is an essential requirement for accurate chromosome segregation. Here we show that the kinetochore-associated Ska complex interacts with tubulin monomers via the carboxy-terminal winged-helix domain of Ska1, providing the structural basis for the ability to bind both straight and curved microtubule structures. This contrasts with the Ndc80 complex, which binds straight microtubules by recognizing the dimeric interface of tubulin. The Ska1 microtubule-binding domain interacts with tubulins using multiple contact sites that allow the Ska complex to bind microtubules in multiple modes. Disrupting either the flexibility or the tubulin contact sites of the Ska1 microtubule-binding domain perturbs normal mitotic progression, explaining the critical role of the Ska complex in maintaining a firm grip on dynamic microtubules.
C1 [Abad, Maria Alba; Medina, Bethan; Zou, Juan; Plasberg-Hill, Carla; Jayachandran, Uma; Rappsilber, Juri; Jeyaprakash, A. Arockia] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
   [Santamaria, Anna; Redli, Patrick Marc; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Madhumalar, Arumugam] Natl Inst Immunol, New Delhi 110067, India.
   [Rappsilber, Juri] Tech Univ Berlin, Dept Biotechnol, D-13353 Berlin, Germany.
RP Jeyaprakash, AA (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.
EM jeyaprakash.arulanandam@ed.ac.uk
RI Arulanandam, Arockia Jeyaprakash/Y-5885-2019; Rappsilber,
   Juri/B-7265-2015; Rappsilber, Juri/ABF-3328-2020
OI Arulanandam, Arockia Jeyaprakash/0000-0002-1889-8635; Rappsilber,
   Juri/0000-0001-5999-1310; Madhumalar, Arumugam/0000-0001-5314-7194;
   nigg, erich/0000-0003-4835-5719; Zou, Juan/0000-0003-2594-6217
FU Wellcome Trust through a Wellcome Trust Career Development Grant
   [095822]; Wellcome Trust Centre Core GrantWellcome Trust [092076,
   091020]; ECEuropean CommissionEuropean Commission Joint Research
   CentreEuropean Community (EC); University of Basel; Swiss Cancer League
   [02657-08-2010]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [310030B_149641]; Department of Biotechnology (DBT),
   IndiaDepartment of Biotechnology (DBT) India
FX We thank Elena Conti for her generous support during the initial stages
   of the project. We thank the staff of Diamond Light Source for
   assistance during data collection and staff of Edinburgh protein
   production facility for the access. We furthermore thank Zhuo Angel
   Chen, Lauri Peil, Lutz Fischer, Colin Combe, Salman Tahir and Jimi-Carlo
   Bukowski-Wills for support during the crosslink/MS analysis. A. M.
   acknowledges the computational facilities of Bioinformatics Center, NII
   for providing access to their computational resources. We also thank
   Bill Earnshaw, Kevin Hardwick, Sutapa Chakrabarti, Lakxmi Subramanian
   and Esben Lorentzen for critical reading of the manuscript. The Wellcome
   Trust generously supported this work through a Wellcome Trust Career
   Development Grant to A.A.J. (095822), a Senior Research Fellowship to
   J.R. (084229), a Wellcome Trust Centre Core Grant (092076) and an
   instrument grant (091020). A.A.J. also acknowledges the support by the
   EC for the Marie-Curie career integration grant (FP7). A. S. and E.A.N.
   acknowledge support from the University of Basel, the Swiss Cancer
   League (02657-08-2010) and the Swiss National Science Foundation
   (310030B_149641). A. M. thanks the Department of Biotechnology (DBT),
   India, for funding.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411
   Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108
   Case D. A., 2014, AMBER 14 U CALIFORNI
   Chan YW, 2012, J CELL BIOL, V196, P563, DOI 10.1083/jcb.201109001
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401
   Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200
   Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020
   Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017
   DeLuca JG, 2012, CURR OPIN CELL BIOL, V24, P48, DOI 10.1016/j.ceb.2011.11.003
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107
   Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494
   Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96
   Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3
   Gascoigne KE, 2011, CURR OPIN CELL BIOL, V23, P102, DOI 10.1016/j.ceb.2010.07.007
   Gloyd M, 2011, J MOL BIOL, V412, P578, DOI 10.1016/j.jmb.2011.08.009
   Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353
   Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132
   Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030
   Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jeyaprakash AA, 2012, MOL CELL, V46, P274, DOI 10.1016/j.molcel.2012.03.005
   Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010
   KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0
   Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043761
   la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062
   Lampert F, 2013, J CELL BIOL, V200, P21, DOI 10.1083/jcb.201210091
   Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021
   Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007
   Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f
   Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200
   Malvezzi F, 2013, EMBO J, V32, P409, DOI 10.1038/emboj.2012.356
   Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049
   Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896
   Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047
   Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045
   Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Soares DC, 2012, J BIOL CHEM, V287, P32381, DOI 10.1074/jbc.M112.393439
   Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141
   Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7
   Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114
   Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142
   Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109
   Wang HW, 2007, NAT STRUCT MOL BIOL, V14, P721, DOI 10.1038/nsmb1274
   Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011
   Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409
   Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607
   Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a
NR 61
TC 53
Z9 54
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN
PY 2014
VL 5
AR 2964
DI 10.1038/ncomms3964
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AA4QA
UT WOS:000331079700001
PM 24413531
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT S
AU Jayachandran, R
   BoseDasgupta, S
   Pieters, J
AF Jayachandran, Rajesh
   BoseDasgupta, Somdeb
   Pieters, Jean
BE Pieters, J
   McKinney, JD
TI Surviving the Macrophage: Tools and Tricks Employed by Mycobacterium
   tuberculosis
SO PATHOGENESIS OF MYCOBACTERIUM TUBERCULOSIS AND ITS INTERACTION WITH THE
   HOST ORGANISM
SE Current Topics in Microbiology and Immunology
LA English
DT Review; Book Chapter
ID PHAGOSOME MATURATION ARREST; SER/THR PROTEIN-KINASES;
   PSEUDOMONAS-AERUGINOSA; SALMONELLA-ENTERICA; PATHOGENIC MYCOBACTERIA;
   VIRULENCE FACTOR; PHAGOLYSOSOME BIOGENESIS; SERINE/THREONINE KINASE;
   NONOPSONIC PHAGOCYTOSIS; INTRACELLULAR SURVIVAL
AB Mycobacterium tuberculosis has evolved to withstand one of the most inhospitable cells within the human body, namely the macrophage, a cell that is normally geared toward the destruction of any invading microbe. How M. tuberculosis achieves this is still incompletely understood; however, a number of mechanisms are now known that provide advantages to M. tuberculosis for its survival and proliferation inside the macrophage. While some of these mechanisms are mediated by factors released by M. tuberculosis, others rely on host components that are being hijacked to benefit survival of M. tuberculosis within the macrophage as well to avoid the generation of an effective immune response. Here, we describe several of these mechanisms, also pointing out the potential usage of this knowledge toward the development of novel strategies to treat tuberculosis. Furthermore, we attempt to put the 'macrophage niche' into context with other intracellular pathogens and discuss some of the generalities as well as specializations that M. tuberculosis employs to survive.
C1 [Jayachandran, Rajesh; BoseDasgupta, Somdeb; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773
   Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Av-Gay Y, 2000, CAN J MICROBIOL, V46, P826, DOI 10.1139/cjm-46-9-826
   Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008
   Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7
   Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x
   Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200
   CHAKRABORTY P, 1994, METHOD CELL BIOL, V45, P261
   Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x
   Chen JM, 2012, J BACTERIOL, V194, P884, DOI 10.1128/JB.06417-11
   Cheng Y, 2010, J MOL CELL BIOL, V2, P173, DOI 10.1093/jmcb/mjp053
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993
   de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07
   Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221
   Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x
   Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061
   Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7
   Ehlers S, 2010, EUR J CELL BIOL, V89, P95, DOI 10.1016/j.ejcb.2009.10.004
   Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102
   Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Ganaie AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027590
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Gatfield J, 2003, ADV IMMUNOL, V81, P45, DOI 10.1016/S0065-2776(03)81002-7
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x
   Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021
   Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049
   Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010
   Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405
   Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5
   Han GN, 2001, FEMS MICROBIOL LETT, V200, P79, DOI 10.1111/j.1574-6968.2001.tb10696.x
   Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Hassett DJ, 1996, J BACTERIOL, V178, P7322, DOI 10.1128/jb.178.24.7322-7325.1996
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963
   Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x
   Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014
   Hughes EA, 2002, IMMUNITY, V16, P325, DOI 10.1016/S1074-7613(02)00293-5
   Hunn JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001008
   Hurme R, 1999, ADV CELL MOL BIOL ME, V6, P59, DOI 10.1016/S1874-5172(99)80006-6
   Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777
   Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105
   KAYE PM, 1994, EUR J IMMUNOL, V24, P2850, DOI 10.1002/eji.1830241140
   Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711
   Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109
   Kima PE, 1996, EUR J IMMUNOL, V26, P3163, DOI 10.1002/eji.1830261249
   Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x
   Klepp LI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-3
   Lahiri A, 2010, VIRULENCE, V1, P325, DOI 10.4161/viru.1.4.12361
   Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483
   Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000
   Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003
   LEMELAND JF, 1974, PATHOL BIOL, V22, P763
   Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357
   Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318
   Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955
   Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076
   Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570
   Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287
   Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003
   MAUEL J, 1990, J LEUKOCYTE BIOL, V47, P187
   Meresse S, 1999, NAT CELL BIOL, V1, pE183
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004
   Nathan C, 2006, SCIENCE, V312, P1874
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   NORTH RJ, 1974, INFECT IMMUN, V10, P66, DOI 10.1128/IAI.10.1.66-71.1974
   Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x
   Pieters J, 2003, SCIENCE, V302, P1900, DOI 10.1126/science.1092873
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827
   Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259
   Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003
   Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334
   Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x
   Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005
   Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Ryffel B., 2006, NOVART FDN SYMP, V279, P139
   Ryffel Bernhard, 2006, Novartis Found Symp, V279, P127
   Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Schafer G, 2009, J INNATE IMMUN, V1, P231, DOI 10.1159/000173703
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09
   Scherr N, 2009, INDIAN J EXP BIOL, V47, P401
   Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091
   Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141
   Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X
   Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230
   SIBLEY LD, 1990, CLIN EXP IMMUNOL, V80, P141
   SIBLEY LD, 1988, INFECT IMMUN, V56, P1232, DOI 10.1128/IAI.56.5.1232-1236.1988
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08
   Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x
   Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003
   Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270
   Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234
   Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200
   TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597
   Togbe D, 2006, NOVART FDN SYMP, V279, P216
   Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805
   Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001
   Tracy Tan WLLDCASGJL, 2006, CELLULAR MICROBIOLOG, V8, P1417
   Uematsu Satoshi, 2006, Virus (Nagoya), V56, P1
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
   Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753
   Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282
   Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006
   Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000
   Welin A, 2011, TUBERCULOSIS EDINB
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
   Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406
   Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x
NR 153
TC 12
Z9 14
U1 0
U2 18
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
EI 2196-9965
BN 978-3-642-40232-6; 978-3-642-40231-9
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2014
VL 374
BP 189
EP 209
DI 10.1007/82_2012_273
D2 10.1007/978-3-642-40232-6
PG 21
WC Immunology; Microbiology
SC Immunology; Microbiology
GA BJU03
UT WOS:000330368100009
PM 23154833
DA 2021-01-25
ER

PT J
AU BoseDasgupta, S
   Pieters, J
AF BoseDasgupta, Somdeb
   Pieters, Jean
TI Inflammatory Stimuli Reprogram Macrophage Phagocytosis to
   Macropinocytosis for the Rapid Elimination of Pathogens
SO PLOS PATHOGENS
LA English
DT Article
ID PROTEIN-KINASE-C; MYCOBACTERIUM-TUBERCULOSIS; ALVEOLAR MACROPHAGES;
   PHAGOSOMAL MEMBRANES; PLASMA-MEMBRANE; CELL BIOLOGY; BONE-MARROW;
   IFN-GAMMA; SURVIVAL; MECHANISMS
AB Following an infectious challenge, macrophages have to be activated in order to allow efficient clearance of infectious pathogens, but how macrophage activation is coupled to increased clearance remains largely unknown. We here describe that inflammatory stimuli induced the reprogramming of the macrophage endocytic machinery from receptor-mediated phagocytosis to macropinocytosis, allowing the rapid transfer of internalized cargo to lysosomes in a receptor-independent manner. Reprogramming occurred through protein kinase C-mediated phosphorylation of the macrophage protein coronin 1, thereby activating phosphoinositol (PI)-3-kinase activity necessary for macropinocytic uptake. Expression of a phosphomimetic form of coronin 1 was sufficient to induce PI3-kinase activation and macropinocytosis even in the absence of inflammatory stimuli. Together these results suggest a hitherto unknown mechanism to regulate the internalization and degradation of infectious material during inflammation.
   Author Summary The main cells that are involved in cleaning up microbial pathogens are macrophages. Upon an infection, macrophages are being recruited to the site of infection by a number of different stimuli. In addition, during an infection, macrophages are also activated by cytokines such as interferon- and tumor necrosis factor- that is released from other immune cells. Such macrophage activation is important to achieve a rapid and efficient clearance of microbial pathogens. In this study, we found that macrophage activation induces uptake through macropinocytosis rather than receptor-mediate phagocytosis. As a consequence, microbial material as well as particles can be internalized far more efficiently; In addition, the internalized cargo is rapidly destroyed within lysosomes. We also provide the mechanisms for the switch from phagocytosis to macropinocytosis, which turned out to be the cytokine-induced phosphorylation of the host protein coronin 1. Phosphorylated coronin 1 activated the lipid kinase phosphoinositide 3-kinase, which is known to be responsible for the entry of cargo through macropinocytosis. Together these results provide evidence for a hitherto unrecognized mechanisms to regulate the internalization and degradation of infectious material during an infection.
C1 [BoseDasgupta, Somdeb; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
RP BoseDasgupta, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU long term EMBO FellowshipEuropean Molecular Biology Organization (EMBO);
   Optimus Foundation; Canton of Basel; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX This work was supported by a long term EMBO Fellowship to Somdeb
   BoseDasgupta, the Optimus Foundation, the Canton of Basel and the Swiss
   National Science Foundation. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Albrecht I, 2006, INT IMMUNOL, V18, P755, DOI 10.1093/intimm/dxl013
   ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601
   Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221
   DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x
   Didichenko SA, 2000, FEBS LETT, V485, P147, DOI 10.1016/S0014-5793(00)02220-1
   Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540
   Edwards JL, 2000, INFECT IMMUN, V68, P5354, DOI 10.1128/IAI.68.9.5354-5363.2000
   Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713
   Grimmer S, 2002, J CELL SCI, V115, P2953
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   HAMILTON TA, 1985, J BIOL CHEM, V260, P1378
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689
   Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837
   Jayachandran R, CURRENT TOPICS MIROB, V374, P189
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jiang J, 2010, CYTOSKELETON, V67, P32, DOI 10.1002/cm.20419
   Kerr MC, 2006, J CELL SCI, V119, P3967, DOI 10.1242/jcs.03167
   Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469
   Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711
   Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086
   Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012
   LEAKE ES, 1984, INFECT IMMUN, V45, P443, DOI 10.1128/IAI.45.2.443-446.1984
   Lim JP, 2012, BIOL OPEN, V1, P904, DOI 10.1242/bio.20122204
   Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20
   Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855
   Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6
   Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619
   Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510
   Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561
   Montaner LJ, 1999, J IMMUNOL, V162, P4606
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322
   Navarro-Garcia F, 2007, MICROBIOL-SGM, V153, P2828, DOI 10.1099/mic.0.2007/007088-0
   Nedela V, 2007, MICROSC RES TECHNIQ, V70, P95, DOI 10.1002/jemt.20390
   Nguyen Liem, 2006, Discov Med, V6, P82
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465
   RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635
   RUSSELL DG, 1995, TRENDS CELL BIOL, V5, P125, DOI 10.1016/S0962-8924(00)88963-1
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866
   Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007
   Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Stanley SA, 2014, CURR TOP MICROBIOL, V374, P211, DOI 10.1007/82_2013_332
   STEINBERG TH, 1988, J CELL BIOL, V107, P887, DOI 10.1083/jcb.107.3.887
   SWANSON JA, 1989, J CELL SCI, V94, P135
   SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1
   Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Veettil MV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001238
   Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015
   Vergne I, 2006, AUTOPHAGY, V2, P175, DOI 10.4161/auto.2830
   WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731
   Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207
NR 71
TC 43
Z9 45
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JAN
PY 2014
VL 10
IS 1
AR e1003879
DI 10.1371/journal.ppat.1003879
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AC6NQ
UT WOS:000332640900027
PM 24497827
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Viktorin, G
AF Viktorin, Gudrun
BE Sprecher, SG
TI Using MARCM to Study Drosophila Brain Development
SO BRAIN DEVELOPMENT: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE Drosophila; MARCM; Twin spot generator; Flp-out; Clones; Somatic
   recombination; Protocol; Brain development; Cell labeling; Neuroblast
   lineage
ID REPRESSIBLE CELL MARKER; SITE-SPECIFIC RECOMBINATION; MOSAIC ANALYSIS;
   POSTEMBRYONIC DEVELOPMENT; NEUROBLAST LINEAGES; MUSHROOM BODY;
   GENE-FUNCTION; PROTEIN; EYE; PROLIFERATION
AB Mosaic analysis with a repressible cell marker (MARCM) generates positively labeled, wild-type or mutant mitotic clones by unequally distributing a repressor of a cell lineage marker, originally tubP-driven GAL80 repressing the GAL4/UAS system. Variations of the technique include labeling of both sister clones (twin spot MARCM), the simultaneous use of two different drivers within the same clone (dual MARCM), as well as the use of different repressible transcription systems (Q-MARCM). MARCM can be combined with any UAS-based construct, such as localized GFP fusions to visualize subcellular compartments, genes for rescue and ectopic expression, and modifiers of neural activity. A related technique, the twin spot generator, generates positively labeled clones without the use of a repressor, thus minimizing the lag time between clone induction and appearance of label. The present protocol provides a detailed description of a standard MARCM analysis of brain development that includes generation of MARCM stocks and crosses, induction of clones, brain dissection at various stages of development, immunohistochemistry, and confocal microscopy, and can be modified for similar experiments involving mitotic clones.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Viktorin, G (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
CR Amanai K, 2001, DEVELOPMENT, V128, P5119
   ASHBURNER M, 2000, DROSOPHILA PROTOCOLS, P585
   Ashburner M, 2005, DROSOPHILA LAB MANUA
   Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008
   BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9
   Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774
   Blair SS, 2000, DROSOPHILA PROTOCOLS, P159
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Cabernard C, 2011, IMAGING DEV BIOL LAB, P217
   CHOU TB, 1992, GENETICS, V131, P643
   deCelis JF, 1997, DEVELOPMENT, V124, P3241
   Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/NMETH.2084, 10.1038/nmeth.2084]
   GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0
   GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025
   Greenspan R. J., 1997, FLY PUSHING THEORY P
   Griffin R, 2009, NAT METHODS, V6, P600, DOI 10.1038/nmeth.1349
   Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567
   Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566
   Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108
   HORTSCH M, 1990, DEVELOPMENT, V110, P1327
   Ito K, 2003, MICROSC RES TECHNIQ, V62, P170, DOI 10.1002/jemt.10369
   Ito K, 1997, DEVELOPMENT, V124, P761
   Ito K, 1999, DISSECT DROSOPHILA B
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Jiang YR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-3
   Kao CFLT, 2010, DROSPHILA NEUROBIOLO, P125
   Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017
   Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Kunz T, 2012, DEVELOPMENT, V139, P2510, DOI 10.1242/dev.077883
   Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681
   Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015
   Lattao R, 2011, FLY AUSTIN, V5
   Lee T, 1999, DEVELOPMENT, V126, P4065
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2007, DEVELOPMENT, V134, P1291, DOI 10.1242/dev.02814
   LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0
   Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699
   Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011
   Morante J, 2010, DROSOPHILA NEUROBIOL, P157
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107
   North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103
   Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376
   Pignoni F, 1997, DEVELOPMENT, V124, P271
   Pina C, 2012, GENESIS, V50, P119, DOI 10.1002/dvg.20801
   Potter CJ, 2011, NAT PROTOC, V6, P1105, DOI 10.1038/nprot.2011.347
   Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5
   Rooke JE, 2000, METH MOL B, V137, P15
   Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007
   Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3
   Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983
   Stork Tobias, 2012, Cold Spring Harb Protoc, V2012, P1, DOI 10.1101/pdb.top067587
   STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X
   Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591
   Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6
   Williamson W. R., 2010, JOVE-J VIS EXP, V37, P1936, DOI [10.3791/1936, DOI 10.3791/1936]
   WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201
   Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9
   Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336
   Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320
   XU T, 1993, DEVELOPMENT, V117, P1223
   Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461
   Yu XM, 2009, DROSOPHILA ADULT BRA
   Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144
   Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2
   Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045
NR 80
TC 2
Z9 2
U1 0
U2 14
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
EI 1940-6029
BN 978-1-62703-654-2; 978-1-62703-655-9
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2014
VL 1082
BP 79
EP 96
DI 10.1007/978-1-62703-655-9_6
D2 10.1007/978-1-62703-655-9
PG 18
WC Neurosciences
SC Neurosciences & Neurology
GA BHK55
UT WOS:000325721100007
PM 24048928
DA 2021-01-25
ER

PT J
AU Lamooki, GRR
   Maleki, F
   Hajihosseini, A
AF Lamooki, Gholam Reza Rokni
   Maleki, Farzaneh
   Hajihosseini, Amirhossein
TI A mathematical model for the admission process in intensive care units
SO COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION
LA English
DT Article
DE ICU; Admission process; Bistability; Hysteresis; Bifurcation; Cusp point
ID DECISION-MAKING; BED-OCCUPANCY; HOSPITALS; CAPACITIES; MANAGEMENT;
   MORTALITY; DELAYS; ICU
AB A mathematical model is given for the admission process in Intensive Care Units (ICUs). It is shown that the model exhibits bistability for certain values of its parameters. In particular, it is observed that in a two-dimensional parameter space, two saddle-node bifurcation curves terminate at a single point of the cusp bifurcation, creating an enclosed region in which the model has one unstable and two stable states. It is shown that in the presence of bistability, variations in the value of parameters may lead to undesired outcomes in the admission process as the value of state variables abruptly changes. Using numerical simulations, it is also discussed how such outcomes can be avoided by appropriately adjusting the parameter values. (c) 2013 Elsevier B.V. All rights reserved.
C1 Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran 1417614411, Iran.
   Inst Res Fundamental Sci IPM, Sch Math, Tehran 193955746, Iran.
RP Hajihosseini, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM rokni@khayam.ut.ac.ir; farzaneh.maleki@unibas.ch;
   amirhossein.hajihosseini@unibas.ch
FU IPM [90920125]
FX This research was in part supported by a grant from IPM (No. 90920125).
CR Barado J, 2012, CRIT CARE MED, V40, P1098, DOI 10.1097/CCM.0b013e3182374828
   Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376
   Gorunescu F, 2002, J OPER RES SOC, V53, P19, DOI 10.1057/palgrave/jors/2601244
   Guckenheimer J., 1990, NONLINEAR OSCILLATIO
   Harper PR, 2002, J OPER RES SOC, V53, P11, DOI 10.1057/palgrave.jors.2601278
   Hassard B., 1981, THEORY APPL HOPF BIF
   Jones CKRT, 1995, LECT NOTES MATH, V1609, P44
   Kaboli PJ, 2003, J GEN INTERN MED, V18, P155, DOI 10.1046/j.1525-1497.2003.21217.x
   Kolker A, 2009, J MED SYST, V33, P27, DOI 10.1007/s10916-008-9161-9
   Kreke Jennifer E, 2004, Curr Opin Crit Care, V10, P395, DOI 10.1097/01.ccx.0000139361.30327.20
   Kuznetsov Y. A, 1998, ELEMENTS APPL BIFURC
   Levin PD, 2003, J CRIT CARE, V18, P206, DOI 10.1016/j.jcrc.2003.10.003
   Lin F, 2009, AUST CRIT CARE, V22, P29, DOI 10.1016/j.aucc.2008.11.001
   Litvak N, 2008, EUR J OPER RES, V185, P998, DOI 10.1016/j.ejor.2006.08.021
   Liu Q. M., 2012, HOPF BIFURCATION ANA, V218, P2850
   Murray J.D., 2002, MATH BIOL
   Perko L, 2001, DIFFERENTIAL EQUATIO
   Ridge JC, 1998, EUR J OPER RES, V105, P346, DOI 10.1016/S0377-2217(97)00240-3
   Roberts MS, 1999, DECISION MAKING HLTH
   Shahani AK, 2008, ANAESTHESIA, V63, P1074, DOI 10.1111/j.1365-2044.2008.05577.x
   SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409
   Watts Rosemary, 2005, Intensive Crit Care Nurs, V21, P302, DOI 10.1016/j.iccn.2005.01.005
   Whittaker J, 2000, Intensive Crit Care Nurs, V16, P135, DOI 10.1054/iccn.2000.1488
   Wiggins S, 2003, INTRO APPL NONLINEAR
   WILLIAMS SV, 1983, CRIT CARE MED, V11, P412, DOI 10.1097/00003246-198306000-00002
   Williams Teresa, 2004, Aust Health Rev, V28, P87
   Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x
NR 27
TC 3
Z9 3
U1 0
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1007-5704
J9 COMMUN NONLINEAR SCI
JI Commun. Nonlinear Sci. Numer. Simul.
PD JAN
PY 2014
VL 19
IS 1
BP 8
EP 18
DI 10.1016/j.cnsns.2013.05.031
PG 11
WC Mathematics, Applied; Mathematics, Interdisciplinary Applications;
   Mechanics; Physics, Fluids & Plasmas; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA 218YX
UT WOS:000324470300002
DA 2021-01-25
ER

PT J
AU Perez-Schindler, J
   Summermatter, S
   Santos, G
   Zorzato, F
   Handschin, C
AF Perez-Schindler, Joaquin
   Summermatter, Serge
   Santos, Gesa
   Zorzato, Francesco
   Handschin, Christoph
TI The transcriptional coactivator PGC-1 alpha is dispensable for chronic
   overload-induced skeletal muscle hypertrophy and metabolic remodeling
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE muscle overload; transcriptional regulation; resistance training
ID RESISTANCE EXERCISE; MITOCHONDRIAL-FUNCTION; OXIDATIVE FUNCTION;
   MAMMALIAN TARGET; GENE-EXPRESSION; MTOR; ACTIVATION; SARCOPENIA;
   PROTECTS; MYOPATHY
AB Skeletal muscle mass loss and dysfunction have been linked to many diseases. Conversely, resistance exercise, mainly by activating mammalian target of rapamycin complex 1 (mTORC1), promotes skeletal muscle hypertrophy and exerts several therapeutic effects. Moreover, mTORC1, along with peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), regulates skeletal muscle metabolism. However, it is unclear whether PGC-1 alpha is required for skeletal muscle adaptations after overload. Here we show that although chronic overload of skeletal muscle via synergist ablation (SA) strongly induces hypertrophy and a switch toward a slow-contractile phenotype, these effects were independent of PGC-1 alpha. In fact, SA down-regulated PGC-1 alpha expression and led to a repression of energy metabolism. Interestingly, however, PGC-1 alpha deletion preserved peak force after SA. Taken together, our data suggest that PGC-1 alpha is not involved in skeletal muscle remodeling induced by SA.
C1 [Perez-Schindler, Joaquin; Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Zorzato, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097; Perez-Schindler,
   Joaquin/0000-0003-3141-8859
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USAMuscular Dystrophy
   Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung"; Swiss Society for Research on Muscle Diseases;
   Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation; Association Francaise contre les
   MyopathiesAssociation Francaise contre les Myopathies; Neuromuscular
   Research Association Basel; Gebert-Ruf Foundation "Rare Diseases"
   Program; University of Basel; Biozentrum
FX We thank Dr. Shuo Lin (Biozentrum, University of Basel) for his help
   with SA. This project was funded by the Swiss National Science
   Foundation, the Muscular Dystrophy Association USA, the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung," the
   Swiss Society for Research on Muscle Diseases, the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation, the Association Francaise contre les Myopathies, the
   Neuromuscular Research Association Basel, the Gebert-Ruf Foundation
   "Rare Diseases" Program, the University of Basel, and the Biozentrum.
CR Apro W, 2013, AM J PHYSIOL-ENDOC M, V305, pE22, DOI 10.1152/ajpendo.00091.2013
   Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6
   Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12
   Bodine SC, 2012, METHODS MOL BIOL, V798, P213, DOI 10.1007/978-1-61779-343-1_12
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Donges CE, 2012, J APPL PHYSIOL, V112, P1992, DOI 10.1152/japplphysiol.00166.2012
   Drexler HCA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010801
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x
   Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Item F, 2013, EUR J APPL PHYSIOL, V113, P1081, DOI 10.1007/s00421-012-2524-4
   Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697
   KANDARIAN SC, 1989, J APPL PHYSIOL, V67, P2600
   KANDARIAN SC, 1990, J APPL PHYSIOL, V69, P861
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Liu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-659
   Lowe DA, 2002, J ORTHOP SPORT PHYS, V32, P36, DOI 10.2519/jospt.2002.32.2.36
   Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685
   Perez-Schindler J., 2013, DRUG DISCOV TODAY DI, V10, pe79, DOI DOI 10.1016/J.DDMOD.2012.12.002
   Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12
   Philp A, 2011, J APPL PHYSIOL, V110, P561, DOI 10.1152/japplphysiol.00941.2010
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Romanino K, 2011, P NATL ACAD SCI USA, V108, P20808, DOI 10.1073/pnas.1111448109
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Salvadego D, 2013, J APPL PHYSIOL, V114, P1527, DOI 10.1152/japplphysiol.00883.2012
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Stepto NK, 2009, MED SCI SPORT EXER, V41, P546, DOI 10.1249/MSS.0b013e31818c6be9
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   von Haehling S, 2012, J CACHEXIA SARCOPENI, V3, P213, DOI 10.1007/s13539-012-0089-z
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
NR 43
TC 32
Z9 34
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 10
PY 2013
VL 110
IS 50
BP 20314
EP 20319
DI 10.1073/pnas.1312039110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 266YY
UT WOS:000328061700078
PM 24277823
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Wiktor, M
   Hartley, O
   Grzesiek, S
AF Wiktor, Maciej
   Hartley, Oliver
   Grzesiek, Stephan
TI Characterization of Structure, Dynamics, and Detergent Interactions of
   the Anti-HIV Chemokine Variant 5P12-RANTES
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID OPTICAL ROTATORY DISPERSION; LINEAR EXTRAPOLATION METHOD; VIRUS TYPE-1
   INFECTION; HIGHLY POTENT; ANTI-HIV-1 ACTIVITY; CRYSTAL-STRUCTURE; ENTRY
   INHIBITORS; FOLDING PATHWAY; T-CELLS; VMIP-II
AB RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with the G-protein coupled receptor CCR5, which is also the primary coreceptor used together with CD4 by HIV to enter and infect target cells. Ligands of CCR5, including chemokines and chemokine analogs, are capable of blocking HIV entry, and studies of their structures and interactions with CCR5 will be key to understanding and optimizing HIV inhibition. The RANTES derivative 5P12-RANTES is a highly potent HIV entry inhibitor that is being developed as a topical HIV prevention agent (microbicide). We have characterized the structure and dynamics of 5P12-RANTES by solution NMR. With the exception of the nine flexible N-terminal residues, 5P12-RANTES has the same structure as wild-type RANTES but unlike the wild-type, does not dimerize via its N-terminus. To prepare the ground for interaction studies with detergent-solubilized CCR5, we have also investigated the interaction of RANTES and 5P12-RANTES with various commonly used detergents. Both RANTES variants are stable in Cymal-5, DHPC, Anzergent-3-12, dodecyltrimethylammonium chloride, and a DDM/CHAPS/CHS mixture. Fos-Cholines, dodecyldimethylglycine, and sodium dodecyl-sulfate denature both RANTES variants at low pH, whereas at neutral pH the stability is considerably higher. The onset of Fos-Choline-12-induced denaturation and the denatured state were characterized by circular dichroism and NMR. The detergent interaction starts below the critical micelle concentration at a well-defined mixed hydrophobic/positive surface region of the chemokine, which overlaps with the dimer interface. An increase of Fos-Choline-12 concentration above the critical micelle concentration causes a transition to a denatured state with a high alpha-helical content.
C1 [Wiktor, Maciej; Grzesiek, Stephan] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland.
   [Hartley, Oliver] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU EUEuropean Union (EU) [FP7]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31-132857]
FX This work was supported by the EU grant No. FP7 Combined Highly Active
   Anti-Retroviral Microbicides (CHAARM) and Swiss National Science
   Foundation grant No. 31-132857.
CR Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529
   Alvares RDA, 2013, BBA-BIOMEMBRANES, V1828, P373, DOI 10.1016/j.bbamem.2012.09.024
   Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505
   ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0
   Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873
   BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902
   Cerini F, 2008, JAIDS-J ACQ IMM DEF, V49, P472, DOI 10.1097/QAI.0b013e31818c953f
   CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005
   CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996
   Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077
   De Simone A, 2009, J AM CHEM SOC, V131, P16332, DOI 10.1021/ja904937a
   Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   Fernandez EJ, 2000, BIOCHEMISTRY-US, V39, P12837, DOI 10.1021/bi001166f
   Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838
   Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105
   Garrett Daniel S, 2011, J Magn Reson, V213, P357, DOI 10.1016/j.jmr.2011.09.007
   Goddard T. D., SPARKY 3
   Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999
   Grace RCR, 2003, BIOPHYS J, V84, P655, DOI 10.1016/S0006-3495(03)74885-1
   GRZESIEK S, 1986, BIOPHYS J, V50, P265, DOI 10.1016/S0006-3495(86)83460-9
   Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101
   Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003
   Hauge HH, 1999, J BACTERIOL, V181, P740, DOI 10.1128/JB.181.3.740-747.1999
   Hoover DM, 2000, PROTEIN PEPTIDE LETT, V7, P73
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JIRGENSON B, 1961, ARCH BIOCHEM BIOPHYS, V94, P59, DOI 10.1016/0003-9861(61)90011-X
   JIRGENSONS B, 1963, J BIOL CHEM, V238, P2716
   JIRGENSONS B, 1966, J BIOL CHEM, V241, P4855
   Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2
   Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x
   Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w
   Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288
   Lim JK, 2006, J LEUKOCYTE BIOL, V80, P1395, DOI 10.1189/jlb.0406290
   Liwang AC, 1999, PROTEIN SCI, V8, P2270
   LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838
   Lusso P, 2011, FASEB J, V25, P1230, DOI 10.1096/fj.10-167627
   Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215
   Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318
   Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449
   Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999
   Murphy PM, 2000, PHARMACOL REV, V52, P145
   Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017
   Nicholson EM, 1996, BIOCHEMISTRY-US, V35, P11369, DOI 10.1021/bi960863y
   Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865
   PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5
   PATEL SR, 1993, BIOCHEMISTRY-US, V32, P5466, DOI 10.1021/bi00071a024
   Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E
   Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222
   Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599
   Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509
   Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Sarac B, 2009, J COLLOID INTERF SCI, V338, P216, DOI 10.1016/j.jcis.2009.06.027
   Schneider GF, 2008, J AM CHEM SOC, V130, P17384, DOI 10.1021/ja804736t
   Schnur E, 2013, FEBS J, V280, P2068, DOI 10.1111/febs.12230
   Schols D, 1998, ANTIVIR RES, V39, P175, DOI 10.1016/S0166-3542(98)00039-4
   Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Secchi M, 2012, CHEM BIOL, V19, P1579, DOI 10.1016/j.chembiol.2012.10.007
   Shaw BF, 2011, J AM CHEM SOC, V133, P17681, DOI 10.1021/ja205735q
   Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276
   Singarapu KK, 2011, J BIOL CHEM, V286, P43447, DOI 10.1074/jbc.M111.306464
   SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004
   Struyf S, 1998, EUR J IMMUNOL, V28, P1262, DOI 10.1002/(SICI)1521-4141(199804)28:04<1262::AID-IMMU1262>3.0.CO;2-G
   SUCHANEK G, 1977, P NATL ACAD SCI USA, V74, P975, DOI 10.1073/pnas.74.3.975
   Szabo MC, 1997, EUR J IMMUNOL, V27, P1061, DOI 10.1002/eji.1830270504
   TURRO NJ, 1978, J AM CHEM SOC, V100, P5951, DOI 10.1021/ja00486a062
   Vajpai N, 2013, P NATL ACAD SCI USA, V110, pE368, DOI 10.1073/pnas.1212222110
   Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001
   Wiktor M, 2013, J BIOMOL NMR, V55, P79, DOI 10.1007/s10858-012-9688-4
   Ylisastigui L, 1998, AIDS, V12, P977, DOI 10.1097/00002030-199809000-00003
NR 76
TC 8
Z9 8
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD DEC 3
PY 2013
VL 105
IS 11
BP 2586
EP 2597
DI 10.1016/j.bpj.2013.10.025
PG 12
WC Biophysics
SC Biophysics
GA 265HG
UT WOS:000327940400016
PM 24314089
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kowal, J
   Chami, M
   Ringler, P
   Muller, SA
   Kudryashev, M
   Castano-Diez, D
   Amstutz, M
   Cornelis, GR
   Stahlberg, H
   Engel, A
AF Kowal, Julia
   Chami, Mohamed
   Ringler, Philippe
   Mueller, Shirley A.
   Kudryashev, Mikhail
   Castano-Diez, Daniel
   Amstutz, Marlise
   Cornelis, Guy R.
   Stahlberg, Henning
   Engel, Andreas
TI Structure of the Dodecameric Yersinia enterocolitica Secretin YscC and
   Its Trypsin-Resistant Core
SO STRUCTURE
LA English
DT Article
ID OUTER-MEMBRANE; NEEDLE COMPLEX; PROTEIN-TRANSPORT; INSIGHTS; EXPORT;
   PILQ; COMPONENTS; INSERTION; SYSTEM; DOMAIN
AB The type Ill secretion system machinery, also known as the injectisome, delivers bacterial effector proteins into eukaryotic cells during infection. The outer membrane YscC secretin is a major part of Yersinia enterocolitica's injectisome and is among the first components to assemble, solely assisted by its pilotin, YscW. We have determined the three-dimensional structures of the native complex and its protease-resistant core to 12 A resolution by cryo-electron microscopy (cryo-EM) and show that YscC forms a dodecameric complex. Cryo-EM of YscC reconstituted into proteoliposomes defines the secretin's membrane-spanning region. Native YscC consists of an outer membrane ring connected via a thin cylindrical wall to a conical, periplasmic region that exposes N-terminal petals connected by flexible linkers. These petals harbor the binding site of YscD, a component of the inner membrane ring. A change in their orientation adapts the length of the YscC secretin and facilitates its interaction with YscD.
C1 [Kowal, Julia; Chami, Mohamed; Ringler, Philippe; Mueller, Shirley A.; Kudryashev, Mikhail; Castano-Diez, Daniel; Stahlberg, Henning] Univ Basel, C CINA, Biozentrum, CH-4058 Basel, Switzerland.
   [Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Engel, Andreas] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Engel, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
EM andreas.engel@case.edu
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Kowal,
   Julia/0000-0003-4694-1896; Kudryashev, Misha/0000-0003-3550-6274
FU Maurice Muller Foundation of Switzerland [SNF 3100AOB-128659,
   CRSII3_125110]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Swiss Initiative for Systems Biology (SystemsX.ch);
   Swiss Federal Government; Maurice E. Mueller Foundation
FX The authors gratefully acknowledge the expert technical assistance of B.
   Anderson and K. Goldie. This work was supported by the Maurice Muller
   Foundation of Switzerland, the Swiss National Science Foundation (SNF
   3100AOB-128659, SNF Sinergia CRSII3_125110, NCCR Structural Biology),
   and the Swiss Initiative for Systems Biology (SystemsX.ch). The work has
   been supported by grants from the Swiss Federal Government and the
   Maurice E. Mueller Foundation.
CR Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x
   Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108
   Bergeron JRC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003307
   Berry JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002923
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Burkhardt J, 2012, J BIOL CHEM, V287, P8484, DOI 10.1074/jbc.M111.334912
   Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688
   Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091
   Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x
   Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84
   DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x
   Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016624
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X
   Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002
   Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011
   Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792
   Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079
   Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369
   Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   Ross JA, 2011, J BACTERIOL, V193, P2276, DOI 10.1128/JB.01137-10
   Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10
   Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096
   Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107
   Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338
NR 48
TC 26
Z9 26
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD DEC 3
PY 2013
VL 21
IS 12
BP 2152
EP 2161
DI 10.1016/j.str.2013.09.012
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 278UH
UT WOS:000328914900009
PM 24207124
OA Bronze
DA 2021-01-25
ER

PT J
AU Ozaki, S
   Matsuda, Y
   Keyamura, K
   Kawakami, H
   Noguchi, Y
   Kasho, K
   Masuda, T
   Sakiyama, Y
   Katayama, T
AF Ozaki, Shogo
   Matsuda, Yusaku
   Keyamura, Kenji
   Kawakami, Hironori
   Noguchi, Yasunori
   Kasho, Kazutoshi
   Masuda, Tamami
   Sakiyama, Yukari
   Katayama, Tsutomu
TI Novel mechanism coupling between replication and partition of the
   chromosome in E. coli
SO GENES & GENETIC SYSTEMS
LA English
DT Meeting Abstract
C1 [Ozaki, Shogo; Matsuda, Yusaku; Keyamura, Kenji; Kawakami, Hironori; Noguchi, Yasunori; Kasho, Kazutoshi; Masuda, Tamami; Sakiyama, Yukari; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharm Sci, Dept Mol Biol, Fukuoka 812, Japan.
   [Ozaki, Shogo] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Matsuda, Yusaku] Ribomic Co, Tokyo, Japan.
   [Keyamura, Kenji] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo 171, Japan.
RI Kawakami, Hironori/H-6792-2017
OI Kawakami, Hironori/0000-0001-8971-1914
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOC JAPAN
PI SHIZUOKA-KEN
PA NATIONAL INST GENETICS YATA 1111, MISHIMA, SHIZUOKA-KEN, 411-8540, JAPAN
SN 1341-7568
EI 1880-5779
J9 GENES GENET SYST
JI Genes Genet. Syst.
PD DEC
PY 2013
VL 88
IS 6
MA WS6-4
BP 344
EP 344
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA AJ3FW
UT WOS:000337552900054
DA 2021-01-25
ER

PT J
AU Valdes-Ferrer, SI
   Rosas-Ballina, M
   Olofsson, PS
   Lu, B
   Dancho, ME
   Li, JH
   Yang, H
   Pavlov, VA
   Chavan, SS
   Tracey, KJ
AF Valdes-Ferrer, Sergio I.
   Rosas-Ballina, Mauricio
   Olofsson, Peder S.
   Lu, Ben
   Dancho, Meghan E.
   Li, JianHua
   Yang, Huan
   Pavlov, Valentin A.
   Chavan, Sangeeta S.
   Tracey, Kevin J.
TI HIGH-MOBILITY GROUP BOX 1 MEDIATES PERSISTENT SPLENOCYTE PRIMING IN
   SEPSIS SURVIVORS: EVIDENCE FROM A MURINE MODEL
SO SHOCK
LA English
DT Article
DE HMGB1; splenocyte dysregulation; priming
ID INTENSIVE-CARE; UNITED-STATES; WHOLE-BLOOD; HMGB1; RECEPTOR;
   PATHOPHYSIOLOGY; EPIDEMIOLOGY; INFLAMMATION; ENDOTOXEMIA; MONOCYTES
AB Severe sepsis is a life-threatening complication of infection and injury affecting more than 700,000 people in the United States each year. Two thirds of patients with severe sepsis will survive to be discharged. Survivors have high incidence of cognitive impairment, immune dysregulation, functional impairments with marked disability, and 5-year mortality rates of 82%. High-mobility group box 1 (HMGB1) is necessary and sufficient mediator of sepsis pathogenesis in experimental models of this syndrome. The spleen is a crucial organ in the immune response to severe infection, and splenocyte dysfunction occurs in sepsis survivors. We hypothesized that HMGB1 plays a key role in mediating the immune dysfunction of splenocytes in sepsis survivors. Mice that survived cecal ligation and puncture-induced sepsis develop persistent splenomegaly; furthermore, splenocytes derived from sepsis survivors had enhanced responses to lipopolysaccharide ex vivo. Administration of neutralizing anti-HMGB1 antibody to sepsis survivors attenuated development of splenomegaly and reversed splenocyte priming. Splenocytes exposed to HMGB1 and subsequently challenged with cognate ligands to Toll-like receptor 2 (TLR2,) TLR4, TLR9, and RAGE (receptor for advanced glycation end product) receptors had enhanced cytokine release as compared with splenocytes not previously exposed to HMGB1. Exposure of TLR2(-/-), TLR9(-/-), or RAGE(-/-) splenocytes to HMGB1 enhanced responses to other TLR receptor ligands; in contrast, HMGB1 failed to prime TLR4(-/-) splenocytes. These findings indicate that exposure to HMGB1 enhances splenocyte responses to secondary inflammatory challenges, a priming effect dependent on TLR4, and that anti-HMGB1 monoclonal antibody may be beneficial in sepsis survivors.
C1 [Valdes-Ferrer, Sergio I.; Rosas-Ballina, Mauricio; Olofsson, Peder S.; Lu, Ben; Dancho, Meghan E.; Li, JianHua; Yang, Huan; Pavlov, Valentin A.; Chavan, Sangeeta S.; Tracey, Kevin J.] Feinstein Inst Med Res, Manhasset, NY USA.
   [Rosas-Ballina, Mauricio] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
RP Tracey, KJ (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY USA.
EM kjtracey@nshs.edu
RI Valdes-Ferrer, Sergio Ivan/ABD-1057-2020
OI Valdes-Ferrer, Sergio Ivan/0000-0002-4863-6484; Tracey, Kevin
   J/0000-0003-1884-6314; Pavlov, Valentin/0000-0002-1994-2853
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM062508] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM062508,
   R01GM062508, R01GM062508, R01GM062508, R01GM062508, R01GM062508,
   R01GM062508, R01GM062508, R01GM062508, R01GM062508, R01GM062508,
   R01GM062508] Funding Source: NIH RePORTER
CR Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323
   Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI [10.1097/00003246-200107000-00002, 10.1097/00003246-200107001-00035]
   Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A
   Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195
   Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326
   Cuenca AG, 2010, CURR PROTOC IMMUNOL, V19, P13
   Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Huang LF, 2011, CYTOKINE, V53, P29, DOI 10.1016/j.cyto.2010.09.010
   Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x
   Lantos J, 2010, SHOCK, V33, P562, DOI 10.1097/SHK.0b013e3181cd8c88
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Matera G, 2013, CRIT CARE, V17, DOI 10.1186/cc12596
   Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96
   Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872
   Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004
   Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105
   Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039
   Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]
   Valdes-Ferrer SI, 2013, J INTERN MED, V274, P381, DOI 10.1111/joim.12104
   van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d
   Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B
   Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405
   Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1
   Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b
   Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82
NR 26
TC 33
Z9 34
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1073-2322
EI 1540-0514
J9 SHOCK
JI Shock
PD DEC
PY 2013
VL 40
IS 6
BP 492
EP 495
DI 10.1097/SHK.0000000000000050
PG 4
WC Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease
SC General & Internal Medicine; Hematology; Surgery; Cardiovascular System
   & Cardiology
GA 297IL
UT WOS:000330249000008
PM 24089009
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Roy, S
   Boiteux, C
   Alijevic, O
   Liang, CW
   Berneche, S
   Kellenberger, S
AF Roy, Sophie
   Boiteux, Celine
   Alijevic, Omar
   Liang, Chungwen
   Berneche, Simon
   Kellenberger, Stephan
TI Molecular determinants of desensitization in an ENaC/degenerin channel
SO FASEB JOURNAL
LA English
DT Article
DE acid-sensing ion channel; channel gating; molecular dynamics; pH
ID ACID-SENSING ION-CHANNEL-1; EXTRACELLULAR DOMAIN; DEG/ENAC CHANNEL;
   SODIUM-CHANNEL; ION CHANNELS; ASIC1; LINKER; PORE; CONFORMATION;
   ACTIVATION
AB Epithelial Na+ channel (ENaC)/degenerin family members are involved in mechanosensation, blood pressure control, pain sensation, and the expression of fear. Several of these channel types display a form of desensitization that allows the channel to limit Na+ influx during prolonged stimulation. We used site-directed mutagenesis and chemical modification, functional analysis, and molecular dynamics simulations to investigate the role of the lower palm domain of the acid-sensing ion channel 1, a member of the ENaC/degenerin family. The lower palm domains of this trimeric channel are arranged around a central vestibule, at similar to 20 angstrom above the plasma membrane and are covalently linked to the transmembrane channel parts. We show that the lower palm domains approach one another during desensitization. Residues in the palm co-determine the pH dependence of desensitization, its kinetics, and the stability of the desensitized state. Mutations of palm residues impair desensitization by preventing the closing movement of the palm. Overexpression of desensitization-impaired channel mutants in central neurons allowed-in contrast to overexpression of wild type-a sustained signaling response to rapid pH fluctuations. We identify and describe here the function of an important regulatory domain that most likely has a conserved role in ENaC/degenerin channels.
C1 [Roy, Sophie; Alijevic, Omar; Kellenberger, Stephan] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland.
   [Boiteux, Celine; Liang, Chungwen; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, Basel, Switzerland.
   [Boiteux, Celine; Liang, Chungwen; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
RP Kellenberger, S (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.
EM stephan.kellenberger@unil.ch
OI Kellenberger, Stephan/0000-0003-1755-6198
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310030_135542, P3_139205]; Swiss National Supercomputing Center
   [s241]
FX The authors thank Maxime Blanchard for the experiments with excised
   patches and Laurent Schild, Miguel van Bemmelen, Olivier Staub, Karolina
   Gwiazda, Gaetano Bonifacio, and Claudia Suenaga-Lelli for their comments
   on a previous version of the manuscript. This work was supported by
   grant 310030_135542 (S. K.) and professorship P3_139205 (S. B.) from the
   Swiss National Science Foundation, and Project s241 of the Swiss
   National Supercomputing Center (S.B).
CR Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200
   Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375
   Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200
   Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757
   Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917
   Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964
   Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459
   Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218
   HORISBERGER JD, 2004, NEPHRON PHYSIOL, V96, P37, DOI DOI 10.1159/000076406
   Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163
   Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098
   Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409
   Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382
   Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114
   Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200
   Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015
   LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0
   O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362
   Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014
   Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200
   Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X
   Smart OS, 1996, J MOL GRAPHICS, V14, P376, DOI [10.1016/S0263-7855119000009-21, DOI 10.1016/S0263-7855(97)00009-X]
   Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797
   Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529
NR 31
TC 19
Z9 19
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD DEC
PY 2013
VL 27
IS 12
BP 5034
EP 5045
DI 10.1096/fj.13-230680
PG 12
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 293UK
UT WOS:000329999000036
PM 24018065
DA 2021-01-25
ER

PT J
AU Sommer, N
   Junne, T
   Kalies, KU
   Spiess, M
   Hartmann, E
AF Sommer, Nicole
   Junne, Tina
   Kalies, Kai-Uwe
   Spiess, Martin
   Hartmann, Enno
TI TRAP assists membrane protein topogenesis at the mammalian ER membrane
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Article
DE Sec61 complex; Translocon associated proteins; Endoplasmic reticulum;
   Membrane protein topogenesis; RNA interference
ID SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE;
   TRANSLOCATION CHANNEL; ANCHOR PROTEINS; TRANSMEMBRANE ORIENTATION;
   SACCHAROMYCES-CEREVISIAE; SEQUENCE ORIENTATION; PRION PROTEIN; COMPLEX;
   SEC61P
AB Membrane protein insertion and topogenesis generally occur at the Sec61 translocon in the endoplasmic reticulum membrane. During this process, membrane spanning segments may adopt two distinct orientations with either their N- or C-terminus translocated into the ER lumen. While different topogenic determinants in membrane proteins, such as flanking charges, polypeptide folding, and hydrophobicity, have been identified, it is not well understood how the translocon and/or associated components decode them. Here we present evidence that the translocon-associated protein (TRAP) complex is involved in membrane protein topogenesis in vivo. Small interfering RNA (siRNA)-mediated silencing of the TRAP complex in HeLa cells enhanced the topology effect of mutating the flanking charges of a signal-anchor, but not of increasing signal hydrophobicity. The results suggest a role of the TRAP complex in moderating the 'positive-inside' rule. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Sommer, Nicole; Kalies, Kai-Uwe; Hartmann, Enno] Univ Lubeck, Inst Biol, CSCM, D-23538 Lubeck, Germany.
   [Junne, Tina; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Sommer, N (corresponding author), Univ Lubeck, Inst Biol, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
EM sommer@bio.uni-luebeck.de
RI Hartmann, Enno/C-5687-2013
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-125423]; German Research FoundationGerman Research
   Foundation (DFG) [Ka1444/1-3]
FX We are grateful to H. Bostelmann for excellent technical support. This
   work was supported by the Swiss National Science Foundation (grant
   31003A-125423 to M.S.) and by the German Research Foundation
   (Ka1444/1-3).
CR BELTZER JP, 1991, J BIOL CHEM, V266, P973
   Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633
   Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004
   Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x
   Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095
   GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470
   Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0
   GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7
   GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G
   Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013
   HANN BC, 1989, J CELL BIOL, V109, P3223, DOI 10.1083/jcb.109.6.3223
   HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x
   Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1
   Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060
   Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887
   Kocik L, 2012, J MOL BIOL, V424, P368, DOI 10.1016/j.jmb.2012.10.010
   KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0
   Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003
   Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228
   Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727
   Liu L, 2002, J BIOL CHEM, V277, P47348, DOI 10.1074/jbc.M207736200
   Mary C, 2010, RNA, V16, P969, DOI 10.1261/rna.2040410
   Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003
   Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053
   MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0
   Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550
   Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214
   Pfeffer S, 2012, STRUCTURE, V20, P1508, DOI 10.1016/j.str.2012.06.010
   PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0
   Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002
   Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009
   Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.E04-03-0184
   Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001
   Sanchez R, 2005, EXP PARASITOL, V109, P241, DOI 10.1016/j.exppara.2004.12.011
   Schroder K, 1999, EMBO J, V18, P4804, DOI 10.1093/emboj/18.17.4804
   Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8
   TAJIMA S, 1986, J CELL BIOL, V103, P1167, DOI 10.1083/jcb.103.4.1167
   Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25
   VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557
   WIEDMANN M, 1987, NATURE, V328, P830, DOI 10.1038/328830a0
   WIEDMANN M, 1989, FEBS LETT, V257, P263, DOI 10.1016/0014-5793(89)81549-2
   Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195
   YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0
   Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015
NR 58
TC 34
Z9 34
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 0006-3002
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD DEC
PY 2013
VL 1833
IS 12
BP 3104
EP 3111
DI 10.1016/j.bbamcr.2013.08.018
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 288FA
UT WOS:000329596200053
PM 24013069
OA Bronze
DA 2021-01-25
ER

PT J
AU Hausser, J
   Syed, AP
   Selevsek, N
   van Nimwegen, E
   Jaskiewicz, L
   Aebersold, R
   Zavolan, M
AF Hausser, Jean
   Syed, Afzal Pasha
   Selevsek, Nathalie
   van Nimwegen, Erik
   Jaskiewicz, Lukasz
   Aebersold, Ruedi
   Zavolan, Mihaela
TI Timescales and bottlenecks in miRNA-dependent gene regulation
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE gene expression regulation; kinetics; miRNAs; modeling; protein turnover
ID MESSENGER-RNA; TRANSLATIONAL REPRESSION; MIR-16 FAMILY; IN-VIVO;
   MICRORNA; EXPRESSION; CELLS; IDENTIFICATION; BIOGENESIS; STABILITY
AB MiRNAs are post-transcriptional regulators that contribute to the establishment and maintenance of gene expression patterns. Although their biogenesis and decay appear to be under complex control, the implications of miRNA expression dynamics for the processes that they regulate are not well understood. We derived a mathematical model of miRNA-mediated gene regulation, inferred its parameters from experimental data sets, and found that the model describes well time-dependent changes in mRNA, protein and ribosome density levels measured upon miRNA transfection and induction. The inferred parameters indicate that the timescale of miRNA-dependent regulation is slower than initially thought. Delays in miRNA loading into Argonaute proteins and the slow decay of proteins relative to mRNAs can explain the typically small changes in protein levels observed upon miRNA transfection. For miRNAs to regulate protein expression on the timescale of a day, as miRNAs involved in cell-cycle regulation do, accelerated miRNA turnover is necessary.
C1 [Hausser, Jean; Syed, Afzal Pasha; van Nimwegen, Erik; Jaskiewicz, Lukasz; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hausser, Jean; Syed, Afzal Pasha; van Nimwegen, Erik; Jaskiewicz, Lukasz; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Selevsek, Nathalie; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.
RP Hausser, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.hausser@weizmann.ac.il; mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Hausser, Jean/0000-0002-3321-7199; Zavolan, Mihaela/0000-0002-8832-2041;
   van Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PBBSP3_146961, 31003A_127307]; EMBOEuropean Molecular Biology
   Organization (EMBO) [ALTF 1160-2012]; European Research CouncilEuropean
   Research Council (ERC) [ERC-2008-AdG 233226]; SystemsX.ch; Swiss
   Initiative for Systems Biology
FX We thank Lukas Burger (Bioinformatics platform, FMI Basel), Julien
   Bethune (Filipowicz lab, FMI Basel), Annecke Brummer and members of the
   Zavolan and van Nimwegen group for input and stimulating discussions. We
   also thank Nitish Mittal for valuable input in the design and analysis
   of the reporter experiments and Helge Grosshans (FMI Basel) for
   constructive comments on the manuscript. JH acknowledges the support of
   the Swiss National Science Foundation (PBBSP3_146961) and EMBO (ALTF
   1160-2012). Work in the Zavolan laboratory was supported by the Swiss
   National Science foundation grant #31003A_127307. RA is supported by the
   European Research Council (ERC-2008-AdG 233226). MZ and RA were further
   supported by SystemsX.ch, the Swiss Initiative for Systems Biology.
CR Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82
   Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137
   Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50
   Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k
   Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008
   Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349
   Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390
   Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605
   Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107
   De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009
   Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   HARGROVE JL, 1989, FASEB J, V3, P2360
   Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002
   Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543
   KHANIN R, 2009, HDB STAT SYSTEMS BIO, pCH10
   Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490
   Kishore S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r45
   Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693
   Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   R Development Core Team, 2006, R LANG ENV STAT COMP
   Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021
   Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181
   Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015
   Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52
   Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
NR 54
TC 33
Z9 34
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD DEC
PY 2013
VL 9
AR 711
DI 10.1038/msb.2013.68
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 284UV
UT WOS:000329347600002
PM 24301800
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Gruber, AJ
   Zavolan, M
AF Gruber, Andreas J.
   Zavolan, Mihaela
TI Modulation of epigenetic regulators and cell fate decisions by miRNAs
SO EPIGENOMICS
LA English
DT Review
DE BAF; epigenetic regulator; epigenetics; iPSC; miR-290-295; miRNA;
   pluripotent stem cell; reprogramming; transcription factor
ID CHROMATIN REMODELING COMPLEX; MICRORNA EXPRESSION ATLAS; EMBRYONIC
   STEM-CELLS; LONG NONCODING RNA; GROUP PROTEIN EZH2; DNA METHYLATION;
   TUMOR-SUPPRESSOR; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL
   REPRESSION; LYSINE-27 METHYLATION
AB Mammalian gene expression is controlled at multiple levels by a variety of regulators, including chromatin modifiers, transcription factors and miRNAs. The latter are small, ncRNAs that inhibit the expression of target mRNAs by reducing both their stability and translation rate. In this review, we summarize the recent work towards characterizing miRNA targets that are themselves involved in the regulation of gene expression at the epigenetic level. Epigenetic regulators are strongly enriched among the predicted targets of miRNAs, which may contribute to the documented importance of miRNAs for pluripotency, organism development and somatic cell reprogramming.
C1 [Gruber, Andreas J.; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gruber, Andreas J.; Zavolan, Mihaela] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
FU Werner-Siemens fellowship
FX AJ Gruber is supported by a Werner-Siemens fellowship. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001
   Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112
   Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106
   Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273
   Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704
   Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399
   Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518
   Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253
   Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9
   Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014
   Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381
   Braun JE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012328
   Brown SJ, 2012, HUM MOL GENET, V21, pR90, DOI 10.1093/hmg/dds353
   Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615
   CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8
   Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709
   Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725
   Chen XY, 2013, INVEST OPHTH VIS SCI, V54, P2248, DOI 10.1167/iovs.12-10977
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996
   Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8
   Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036
   Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008
   Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005
   Enright AJ, 2004, GENOME BIOL, V5
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Friedman JM, 2009, CELL CYCLE, V8, P2313, DOI 10.4161/cc.8.15.9168
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426
   Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002
   Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629
   Acuna LIG, 2013, WIRES RNA, V4, P77, DOI 10.1002/wrna.1142
   Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120
   Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887
   Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975
   Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034
   Hao H, 2012, ADV EXP MED BIOL, V723, P753, DOI 10.1007/978-1-4614-0631-0_96
   Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112
   Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412
   He L, 2012, STEM CELL REV REP, V8, P128, DOI 10.1007/s12015-011-9285-z
   Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014
   Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010
   Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]
   Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285
   Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106
   Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106
   Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278
   Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561
   Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008
   Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535
   Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667
   Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068
   Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]
   Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242
   Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003
   Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10366, DOI 10.1073/pnas.93.19.10366
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960
   Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015
   Malousi A, 2008, EPIGENETICS-US, V3, P69, DOI 10.4161/epi.3.2.6066
   Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020
   Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067
   McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158
   Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725
   Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102
   Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101
   Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003
   Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589
   Perera RJ, 2012, EPIGENOMICS-UK, V4, P81, DOI [10.2217/epi.11.114, 10.2217/EPI.11.114]
   Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274
   Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039
   Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h
   Ricci EP, 2013, NUCLEIC ACIDS RES, V41, P586, DOI 10.1093/nar/gks1076
   Rivera RM, 2013, PROG BIOPHYS MOL BIO, V113, P423, DOI 10.1016/j.pbiomolbio.2013.02.001
   Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108
   Rouhi A, 2008, MAMM GENOME, V19, P517, DOI 10.1007/s00335-008-9133-x
   Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759
   Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345
   Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645
   Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3
   Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718
   Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397
   Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083
   Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013
   Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020
   Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003
   Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013
   Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862
   Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151
   Tang HS, 2013, INT J MOL MED, V32, P381, DOI 10.3892/ijmm.2013.1400
   Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029
   Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002
   Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001
   Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395
   Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161
   Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717
   Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431
   Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040
   Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985
   Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969
   Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250
   Wang ZF, 2013, CANCER LETT, V331, P1, DOI 10.1016/j.canlet.2012.12.006
   Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3
   WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998
   Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046
   Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068
   Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964
   Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625
   Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022
   Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599
   Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139
   Zhang P, 2013, BIOCHEM BIOPH RES CO, V437, P368, DOI 10.1016/j.bbrc.2013.06.082
   Zhang ZK, 2002, MOL CELL BIOL, V22, P5975, DOI 10.1128/MCB.22.16.5975-5988.2002
   Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045
   Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004
   Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607
NR 158
TC 30
Z9 30
U1 0
U2 17
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1750-1911
EI 1750-192X
J9 EPIGENOMICS-UK
JI Epigenomics
PD DEC
PY 2013
VL 5
IS 6
BP 671
EP 683
DI 10.2217/epi.13.65
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 258PH
UT WOS:000327470700011
PM 24283881
DA 2021-01-25
ER

PT J
AU Bonkat, G
   Muller, G
   Braissant, O
   Frei, R
   Tschudin-Suter, S
   Rieken, M
   Wyler, S
   Gasser, TC
   Bachmann, A
   Widmer, AF
AF Bonkat, G.
   Mueller, G.
   Braissant, O.
   Frei, R.
   Tschudin-Suter, S.
   Rieken, M.
   Wyler, S.
   Gasser, T. C.
   Bachmann, A.
   Widmer, A. F.
TI Increasing prevalence of ciprofloxacin resistance in
   extended-spectrum-beta-lactamase-producing Escherichia coli urinary
   isolates
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE Epidemiology; ESBL; Escherichia coli; Urinary tract infection; Urology
ID ANTIMICROBIAL RESISTANCE; INFECTIOUS-DISEASES; ENTEROBACTERIACEAE;
   FOSFOMYCIN; EPIDEMIOLOGY; ERTAPENEM; CYSTITIS; SOCIETY; UPDATE
AB To describe the incidence and drug susceptibility profiles of uropathogenic extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) during a 10-year period and to identify differences in resistance patterns between urological and non-urological ESBL-EC isolates.
   Retrospective analysis of 191,564 urine samples obtained during 2001 to 2010 at the University Hospital Basel, Switzerland. The computerized database of the Clinical Microbiology Laboratory and the Division of Infectious Diseases and Hospital Epidemiology was used to identify ESBL-EC positive urine samples. ESBL-EC isolates were stratified according their origin into two groups: Urology and non-Urology isolates.
   The rate of ESBL-EC positive urine samples increased significantly during the study period (3 in 2001 compared to 55 in 2010, p < 0.05). The most active agents were imipenem, meropenem, and fosfomycin (100 %), followed by amikacin (99.1 %) and nitrofurantoin (84 %). The least active substances were ampicillin-clavulanate (20 %), sulfamethoxazole (28 %), and ciprofloxacin (29.6 %). ESBL-EC isolates from urological and non-urological patients showed similar susceptibility profiles. However, ESBL-EC isolates from urological patients were significantly less susceptible to ciprofloxacin compared to non-urological isolates (14.7 vs. 32.7 %, p < 0.05).
   The rate of urinary ESBL-EC isolates is increasing. Their susceptibility to nitrofurantoin, fosfomycin, and carbapenems is excellent, whereas ampicillin-clavulanate, sulfamethoxazole, and ciprofloxacin demonstrate only low susceptibility. In particular, the use of ciprofloxacin should be strictly avoided in urologic patients with suspicion for an ESBL-EC urinary tract infection as well as routine antibiotic prophylaxis prior to urological interventions if not explicit indicated by current international guidelines or local resistance patterns.
C1 [Bonkat, G.; Mueller, G.; Braissant, O.; Rieken, M.; Wyler, S.; Gasser, T. C.; Bachmann, A.] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Bonkat, G.; Braissant, O.] Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   [Frei, R.] Univ Basel Hosp, Clin Microbiol Lab, CH-4031 Basel, Switzerland.
   [Tschudin-Suter, S.; Widmer, A. F.] Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland.
   [Tschudin-Suter, S.; Widmer, A. F.] Univ Basel Hosp, Hosp Epidemiol, CH-4031 Basel, Switzerland.
RP Bonkat, G (corresponding author), Univ Basel Hosp, Dept Urol, Spitalstr 21, CH-4031 Basel, Switzerland.
EM bonkatg@uhbs.ch
RI Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X
CR Alhambra A, 2004, J ANTIMICROB CHEMOTH, V53, P1090, DOI 10.1093/jac/dkh218
   Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713
   Blaettler L, 2009, INFECTION, V37, P534, DOI 10.1007/s15010-009-8457-0
   de Cueto M, 2006, ENFERM INFEC MICR CL, V24, P613, DOI 10.1157/13095372
   Estebanez A, 2009, EUR J CLIN MICROBIOL, V28, P1457, DOI 10.1007/s10096-009-0805-6
   Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1
   Garau J, 2008, CLIN MICROBIOL INFEC, V14, P198, DOI 10.1111/j.1469-0691.2007.01852.x
   Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372
   Grabe M, 2012, EUR ASS UROL
   Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012
   Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI 10.1093/cid/ciq257
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2
   Kuster SP, 2010, INFECTION, V38, P33, DOI 10.1007/s15010-009-9207-z
   Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856
   Mody Rupal M, 2007, Ann Clin Microbiol Antimicrob, V6, P6, DOI 10.1186/1476-0711-6-6
   Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010
   Oteo J, 2010, J ANTIMICROB CHEMOTH, V65, P2459, DOI 10.1093/jac/dkq346
   Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P712, DOI 10.1093/jac/dkp288
   Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209
   Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0
   Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004
   Ronald A, 2002, AM J MED, V113, p14S
   Schito GC, 2003, INT J ANTIMICROB AG, V22, pS79, DOI 10.1016/S0924-8579(03)00231-0
   Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819
   Tamayo J, 2007, REV ESP QUIM, V20, P334
   Thomson KS, 2001, ANTIMICROB AGENTS CH, V45, P3548, DOI 10.1128/AAC.45.12.3548-3554.2001
   Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770
   Wagenlehner FM, 2012, EUR UROL
   Wolf Jr J. S., 2012, BEST PRACTICE POLICY
NR 29
TC 30
Z9 30
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0724-4983
EI 1433-8726
J9 WORLD J UROL
JI World J. Urol.
PD DEC
PY 2013
VL 31
IS 6
BP 1427
EP 1432
DI 10.1007/s00345-013-1031-5
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 253ZY
UT WOS:000327130700016
PM 23358791
DA 2021-01-25
ER

PT J
AU Blazek, M
   Betz, C
   Hall, MN
   Reth, M
   Zengerle, R
   Meier, M
AF Blazek, Matthias
   Betz, Charles
   Hall, Michael Nip
   Reth, Michael
   Zengerle, Roland
   Meier, Matthias
TI Proximity Ligation Assay for High-content Profiling of Cell Signaling
   Pathways on a Microfluidic Chip
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID PROTEIN-KINASE-B; GROWTH-FACTOR PDGF; FLUORESCENCE MICROSCOPY;
   TRANSCRIPTION FACTOR; MAMMALIAN TARGET; IN-SITU; PHOSPHORYLATION;
   FIBROBLASTS; ACTIVATION; INSULIN
C1 [Blazek, Matthias; Meier, Matthias] Univ Freiburg, IMTEK Dept Microsyst Engn, D-79110 Freiburg, Germany.
   [Blazek, Matthias; Zengerle, Roland] Univ Freiburg, IMTEK Dept Microsyst Engn, Lab MEMS Applicat, D-79110 Freiburg, Germany.
   [Blazek, Matthias; Reth, Michael; Zengerle, Roland; Meier, Matthias] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79108 Freiburg, Germany.
   [Betz, Charles; Hall, Michael Nip] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Reth, Michael] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.
   [Reth, Michael] Univ Freiburg, Fac Biol, D-79108 Freiburg, Germany.
RP Meier, M (corresponding author), Univ Freiburg, IMTEK Dept Microsyst Engn, Georges Koehler Allee 103, D-79110 Freiburg, Germany.
EM Matthias.meier@imtek.de
RI Zengerle, Roland/B-2451-2012; Betz, Charles/B-7444-2008
OI Betz, Charles/0000-0002-9837-6916
FU German Excellence Initiative (BIOSS-Project C7); German Research
   Foundation (Emmy-Noether Grant) [ME3823/1-1]
FX This study was supported by the German Excellence Initiative
   (BIOSS-Project C7) and by the German Research Foundation (Emmy-Noether
   Grant ME3823/1-1).
CR Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x
   Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006
   Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020
   Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421
   Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Cheong R, 2009, MOL CELL PROTEOMICS, V8, P433, DOI 10.1074/mcp.M800291-MCP200
   Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16
   Dalle Pezze P., 2012, SCI SIGNAL, V5, pra25
   Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0
   Herman B., 1998, FLUORESCENCE MICROSC
   Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200
   Hughes AJ, 2012, P NATL ACAD SCI USA, V109, P21450, DOI 10.1073/pnas.1207754110
   Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200
   KELLY JD, 1991, J BIOL CHEM, V266, P8987
   KIM HRC, 1995, P NATL ACAD SCI USA, V92, P9500, DOI 10.1073/pnas.92.21.9500
   KRIEG J, 1988, J BIOL CHEM, V263, P11473
   Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200
   Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]
   Ma HR, 2012, J AM CHEM SOC, V134, P2488, DOI 10.1021/ja2101592
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Meier M, 2012, ANAL CHEM, V84, P9572, DOI 10.1021/ac302436y
   Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408
   Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200
   Razmara M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-3
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510
   Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947
   Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299
NR 36
TC 19
Z9 19
U1 0
U2 13
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD DEC
PY 2013
VL 12
IS 12
BP 3898
EP 3907
DI 10.1074/mcp.M113.032821
PG 10
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 293SI
UT WOS:000329993600036
PM 24072685
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Tchang, VSY
   Mekker, A
   Siegmund, K
   Karrer, U
   Pieters, J
AF Tchang, Vincent Sam Yong
   Mekker, Andrea
   Siegmund, Kerstin
   Karrer, Urs
   Pieters, Jean
TI Diverging role for coronin 1 in antiviral CD4(+) and CD8(+) T cell
   responses
SO MOLECULAR IMMUNOLOGY
LA English
DT Article
DE Coronin 1; Viral infection; T cells
ID VESICULAR STOMATITIS-VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
   MEMORY-LIKE PHENOTYPE; MHC CLASS-II; B-CELLS; IMMUNE-RESPONSES; CUTTING
   EDGE; INFECTION; MACROPHAGES; SURVIVAL
AB Coronin 1 is a member of the evolutionary conserved WD repeat protein family and is highly expressed in hematopoietic cells. Coronin 1 is essential for Ca2+ mobilization upon T cell receptor (TCR) stimulation providing a pro-survival signal for naive peripheral T cells. Both in mouse and in human, coronin 1 deficiency is associated with severe T cell lymphopenia. In this work, we have analyzed antiviral T cell-mediated immunity in the presence and absence of coronin 1 in vivo after infection with lymphocytic choriomenigitis virus (LCMV) and vesicular stomatitis virus (VSV) in mice. Despite low peripheral T cell numbers we found that LCMV-specific CD8(+) T cell responses were normal in the absence of coronin 1 and kinetics of LCMV-clearance were similar compared to wild type mice. In contrast, CD4(+) T cell responses were profoundly decreased after LCMV- and VSV-infection. We propose that coronin 1 plays a differential role in CD8(+) versus CD4(+) T cell responses and activation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tchang, Vincent Sam Yong; Siegmund, Kerstin; Pieters, Jean] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Tchang, Vincent Sam Yong; Mekker, Andrea; Karrer, Urs] Univ Hosp rich, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland.
   [Karrer, Urs] Cantonal Hosp Winterthur, Div Infect Dis, CH-8401 Winterthur 5, Switzerland.
RP Karrer, U (corresponding author), Cantonal Hosp Winterthur, Div Infect Dis, Brauerstr 15, CH-8401 Winterthur 5, Switzerland.
EM Vincent.Tchang@unibas.ch; smilepanther@yahoo.com;
   kerstin.siegmund@gmx.ch; urs.karrer@ksw.ch; jean.pieters@unibas.ch
RI Bellaire-Siegmund, Kerstin/D-4774-2018; Bellaire-Siegmund,
   Kerstin/AAA-9702-2021
OI Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Bellaire-Siegmund,
   Kerstin/0000-0002-3654-1170; Pieters, Jean/0000-0002-5284-9757
FU Canton of Basel (Switzerland); Swiss National Science Foundation
   (Switzerland)Swiss National Science Foundation (SNSF) [PP0033-110737];
   Heuberg Foundation (Zurich) (Switzerland); Aetas Foundation (Geneva)
   (Switzerland); Promedica Foundation (Switzerland)
FX We would like to thank the members of the research groups of Prof.
   Annette Oxenius (ETH Zurich, Switzerland) for invaluable discussions and
   sharing of reagents, Lea Haberli for expert technical assistance and PD
   Dr. Annelies Zinkernagel and Prof. Dr. med. Nicolas Muller for providing
   laboratory space and general support. This work was supported by the
   Canton of Basel, by the Swiss National Science Foundation to UK (grant
   PP0033-110737) and JP, by the Heuberg Foundation (Zurich), by the Aetas
   Foundation (Geneva) and by the Promedica Foundation (Chur; all from
   Switzerland).
CR Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94
   Andersen C, 1999, INT IMMUNOL, V11, P2035, DOI 10.1093/intimm/11.12.2035
   BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U
   Battegay M, 1996, CELL IMMUNOL, V167, P115, DOI 10.1006/cimm.1996.0014
   CHARAN S, 1986, J VIROL, V57, P1139, DOI 10.1128/JVI.57.3.1139-1144.1986
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   FREER G, 1994, J VIROL, V68, P3650, DOI 10.1128/JVI.68.6.3650-3655.1994
   FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425
   Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   HUNIG T, 1987, NATURE, V326, P298, DOI 10.1038/326298a0
   Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018
   Landais E, 2004, BLOOD, V103, P1408, DOI 10.1182/blood-2003-03-0930
   LEIST TP, 1987, J IMMUNOL, V138, P2278
   Long HM, 2005, J VIROL, V79, P4896, DOI 10.1128/JVI.79.8.4896-4907.2005
   Marshall NA, 2007, BRIT J HAEMATOL, V139, P81, DOI 10.1111/j.1365-2141.2007.06765.x
   Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013
   Moshous D., 2013, J ALLERGY C IN PRESS
   MOSKOPHIDIS D, 1989, P NATL ACAD SCI USA, V86, P3291, DOI 10.1073/pnas.86.9.3291
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733
   Nagy N, 2012, P NATL ACAD SCI USA, V109, P1512, DOI 10.1073/pnas.1120587109
   Oxenius A, 1996, J EXP MED, V183, P2209, DOI 10.1084/jem.183.5.2209
   Pieters J., 2013, NATURE REV IN PRESS
   Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002
   Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491
   Steeg C, 1997, EUR J IMMUNOL, V27, P2233, DOI 10.1002/eji.1830270917
   Sur JH, 2003, VET PATHOL, V40, P512, DOI 10.1354/vp.40-5-512
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Tanchot C, 2002, J IMMUNOL, V168, P5042, DOI 10.4049/jimmunol.168.10.5042
   Thomsen AR, 1996, J IMMUNOL, V157, P3074
   Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757
   Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166
   Wong P, 2004, J IMMUNOL, V172, P2171, DOI 10.4049/jimmunol.172.4.2171
NR 44
TC 12
Z9 12
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD DEC
PY 2013
VL 56
IS 4
BP 683
EP 692
DI 10.1016/j.molimm.2013.05.003
PG 10
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 241XZ
UT WOS:000326203300043
PM 23933558
DA 2021-01-25
ER

PT J
AU Vanneschi, L
   Mondini, M
   Bertoni, M
   Ronchi, A
   Stefano, M
AF Vanneschi, Leonardo
   Mondini, Matteo
   Bertoni, Martino
   Ronchi, Alberto
   Stefano, Mattia
TI Gene regulatory networks reconstruction from time series datasets using
   genetic programming: a comparison between tree-based and graph-based
   approaches
SO GENETIC PROGRAMMING AND EVOLVABLE MACHINES
LA English
DT Article
DE Genetic programming; Gene regulatory networks; Tree-based GP;
   Graph-based GP
ID IN-VIVO; EVOLUTION; DYNAMICS; MODEL
AB Genetic programming researchers have shown a growing interest in the study of gene regulatory networks in the last few years. Our team has also contributed to the field, by defining two systems for the automatic reverse engineering of gene regulatory networks called GRNGen and GeNet. In this paper, we revise this work by describing in detail the two approaches and empirically comparing them. The results we report, and in particular the fact that GeNet can be used on large networks while GRNGen cannot, encourage us to pursue the study of GeNet in the future. We conclude the paper by discussing the main research directions that we are planning to investigate to improve GeNet.
C1 [Vanneschi, Leonardo] Univ Nova Lisboa, ISEGI, P-1070312 Lisbon, Portugal.
   [Vanneschi, Leonardo] Univ Tecn Lisboa, IST, INESC ID, P-1000029 Lisbon, Portugal.
   [Vanneschi, Leonardo] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz DISCo, I-20126 Milan, Italy.
   [Mondini, Matteo] Mario Negri Inst Pharmacol Res, Ranica, Italy.
   [Bertoni, Martino] Univ Basel, Biozentrum, Basel, Switzerland.
   [Ronchi, Alberto] IIT, Ctr Genom Sci, SEMM, I-20139 Milan, Italy.
   [Stefano, Mattia] Univ Milano Bicocca, I-20126 Milan, Italy.
RP Vanneschi, L (corresponding author), Univ Nova Lisboa, ISEGI, P-1070312 Lisbon, Portugal.
EM lvanneschi@isegi.unl.pt; bedrosian.baol@gmail.com;
   martino.bertoni@gmail.com; alberto.ronchi@iit.it;
   mattiastefano.ms@gmail.com
OI Vanneschi, Leonardo/0000-0003-4732-3328; Bertoni,
   Martino/0000-0003-0720-1027
CR Banzhaf W, 2003, GENET PROGR SER, V6, P43
   Banzhaf W, 2004, LECT NOTES ARTIF INT, V3139, P284
   Barabasi A.-L., 2003, LINKED EVERYTHING IS
   Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104
   CAI XY, 2007, P 9 ANN C GEN EV COM, P1750
   Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055
   Clerc M., 2006, PARTICLE SWARM OPTIM
   Damiani C, 2010, LECT NOTES COMPUT SC, V6350, P1
   Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107
   Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127
   Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008
   Farinaccio A, 2011, LECT NOTES COMPUT SC, V6623, P13, DOI 10.1007/978-3-642-20389-3_2
   Floares AG, 2007, PROCEDINGS OF THE 11TH IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND SOFT COMPUTING, P238
   Foster J.A., 2006, SIGEVOLUTION, V1, P23
   Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900
   Greene CS, 2008, SIGEVOLUTION, V3, P2
   Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118
   Kauffman S. A., 1993, ORIGINS ORDER
   KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0
   Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968
   Koza JR, 1992, GENETIC PROGRAMMING
   Kuo PD, 2006, BIOSYSTEMS, V85, P177, DOI 10.1016/j.biosystems.2006.01.004
   Leier A, 2006, LECT NOTES COMPUT SC, V3905, P290
   Lopes RL, 2012, GENET PROGRAM EVOL M, V13, P339, DOI 10.1007/s10710-012-9160-y
   Nicolau M, 2009, BIOSYSTEMS, V98, P137, DOI 10.1016/j.biosystems.2009.06.006
   Niehaus J, 2007, EVOL COMPUT, V15, P199, DOI 10.1162/evco.2007.15.2.199
   Poli R., 2008, FIELD GUIDE GENETIC
   Qian L., 2011, APPL STAT NETWORK BI, DOI DOI 10.1002/9783527
   Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576
   Serra R., 2006, SYSTEMICS EMERGENCE, P625
   Serra R, 2008, LECT NOTES COMPUT SC, V5191, P315, DOI 10.1007/978-3-540-79992-4_40
   Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335
   Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021
   Streichert F, 2004, LECT NOTES COMPUT SC, V3102, P471
   Szallasi Z., 2006, SYST MOD CELL BIOL
   Vanneschi Leonardo, 2012, Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Proceedings of the 10th European Conference, EvoBIO 2012, P97, DOI 10.1007/978-3-642-29066-4_9
   Wang HX, 2006, IEEE INT WORK GENOM, P27, DOI 10.1109/GENSIPS.2006.353139
   Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448
NR 38
TC 0
Z9 0
U1 0
U2 27
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-2576
EI 1573-7632
J9 GENET PROGRAM EVOL M
JI Genet. Program. Evol. Mach.
PD DEC
PY 2013
VL 14
IS 4
BP 431
EP 455
DI 10.1007/s10710-013-9183-z
PG 25
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA 194HE
UT WOS:000322621000003
DA 2021-01-25
ER

PT J
AU Ramon-Garcia, S
   Ng, C
   Jensen, PR
   Dosanjh, M
   Burian, J
   Morris, RP
   Folcher, M
   Eltis, LD
   Grzesiek, S
   Nguyen, L
   Thompson, CJ
AF Ramon-Garcia, Santiago
   Ng, Carol
   Jensen, Pernille R.
   Dosanjh, Manisha
   Burian, Jan
   Morris, Rowan P.
   Folcher, Marc
   Eltis, Lindsay D.
   Grzesiek, Stephan
   Liem Nguyen
   Thompson, Charles J.
TI WhiB7, an Fe-S-dependent Transcription Factor That Activates
   Species-specific Repertoires of Drug Resistance Determinants in
   Actinobacteria
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Actinobacteria; Antibiotic Resistance; Gene Regulation; Iron-Sulfur
   Protein; Transcription; AT-hook; Iron-Sulfur Cluster; Regulation
ID MYCOBACTERIUM-TUBERCULOSIS H37RV; IRON-SULFUR CLUSTER; SP STRAIN RHA1;
   ESCHERICHIA-COLI; 4FE-4S CLUSTER; ANTIBIOTIC-RESISTANCE; EFFLUX PUMP;
   IN-VIVO; MOLECULAR-CLONING; BINDING PROTEIN
AB Background: WhiB7 is essential for antibiotic resistance in M. tuberculosis. Results: WhiB7 requires conserved residues, including a redox-sensitive center and DNA-binding motif, to coordinate transcription of species-specific drug resistance genes in diverse Actinobacteria. Conclusion: WhiB7 activates species-specific drug resistance genes in Actinobacteria. Significance: Understanding WhiB7 activity may allow the development of drugs that sensitize bacteria to antibiotics.
   WhiB-like (Wbl) proteins are well known for their diverse roles in actinobacterial morphogenesis, cell division, virulence, primary and secondary metabolism, and intrinsic antibiotic resistance. Gene disruption experiments showed that three different Actinobacteria (Mycobacterium smegmatis, Streptomyces lividans, and Rhodococcus jostii) each exhibited a different whiB7-dependent resistance profile. Heterologous expression of whiB7 genes showed these resistance profiles reflected the host's repertoire of endogenous whiB7-dependent genes. Transcriptional activation of two resistance genes in the whiB7 regulon, tap (a multidrug transporter) and erm(37) (a ribosomal methyltransferase), required interaction of WhiB7 with their promoters. Furthermore, heterologous expression of tap genes isolated from Mycobacterium species demonstrated that divergencies in drug specificity of homologous structural proteins contribute to the variation of WhiB7-dependent drug resistance. WhiB7 has a specific tryptophan/glycine-rich region and four conserved cysteine residues; it also has a peptide sequence (AT-hook) at its C terminus that binds AT-rich DNA sequence motifs upstream of the promoters it activates. Targeted mutagenesis showed that these motifs were required to provide antibiotic resistance in vivo. Anaerobically purified WhiB7 from S. lividans was dimeric and contained 2.1 +/- 0.3 and 2.2 +/- 0.3 mol of iron and sulfur, respectively, per protomer (consistent with the presence of a 2Fe-2S cluster). However, the properties of the dimer's absorption spectrum were most consistent with the presence of an oxygen-labile 4Fe-4S cluster, suggesting 50% occupancy. These data provide the first insights into WhiB7 iron-sulfur clusters as they exist in vivo, a major unresolved issue in studies of Wbl proteins.
C1 [Ramon-Garcia, Santiago; Ng, Carol; Dosanjh, Manisha; Burian, Jan; Eltis, Lindsay D.; Thompson, Charles J.] Univ British Columbia, Dept Microbiol & Immunol, Ctr TB Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada.
   [Jensen, Pernille R.; Folcher, Marc; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Morris, Rowan P.] Anim Hlth & Vet Labs Agcy, Starcross EX6 8PE, England.
   [Liem Nguyen] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
RP Nguyen, L (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM liem.nguyen@case.edu; charles.thompson@ubc.ca
RI Ramon Garcia, Santiago/V-8242-2017; Jensen, Pernille Rose/J-8648-2016;
   Eltis, Lindsay D/J-8272-2015; Jensen, Pernille Rose/AAX-5696-2020;
   ramon, santi/C-6077-2013
OI Ramon Garcia, Santiago/0000-0002-8480-0325; Jensen, Pernille
   Rose/0000-0003-4359-848X; Eltis, Lindsay D/0000-0002-6774-8158; Jensen,
   Pernille Rose/0000-0003-4359-848X; ramon, santi/0000-0002-8480-0325;
   Grzesiek, Stephan/0000-0003-1998-4225
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI087903];
   Canadian Institute of Health ResearchCanadian Institutes of Health
   Research (CIHR) [MOP-82855]; British Columbia Lung Association; Case
   Western Reserve University/University Hospitals Center for AIDS Research
   [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   R01AI087903, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, R01AI087903, P30AI036219,
   P30AI036219, R01AI087903, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   R01AI087903, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   R01AI087903, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219, P30AI036219,
   P30AI036219, P30AI036219, P30AI036219, P30AI036219] Funding Source: NIH
   RePORTER
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant R01 AI087903 (to L. N.), Canadian Institute of Health
   Research Grant MOP-82855 (to C. J. T.), the British Columbia Lung
   Association (to C. J. T.), and Case Western Reserve
   University/University Hospitals Center for AIDS Research Grant P30
   AI036219 (to L. N.).
CR Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8
   Ainsa JA, 1998, J BACTERIOL, V180, P5836
   Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x
   Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x
   Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412
   Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413
   Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007
   Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x
   Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1
   Burian J., 2013, NUCL ACIDS RES, DOI 10.1093/nar/gkt751
   Burian J, 2012, EXPERT REV ANTI-INFE, V10, P1037, DOI [10.1586/eri.12.90, 10.1586/ERI.12.90]
   Burian J, 2012, J BIOL CHEM, V287, P299, DOI 10.1074/jbc.M111.302588
   Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004
   Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003
   Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x
   Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x
   CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6
   CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003
   Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511
   Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v
   D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800
   EVANS JNS, 1995, INT J PEPT PROT RES, V45, P554
   Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204
   Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0
   Galbis-Martinez M, 2004, GENETICS, V167, P1585, DOI 10.1534/genetics.104.029207
   Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06
   Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x
   Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003
   Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705
   HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908
   Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157
   Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988
   Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657
   Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200
   Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292
   Kazda J, 2009, ECOLOGY OF MYCOBACTERIA: IMPACT ON ANIMAL'S AND HUMAN'S HEALTH, 2ND EDITION, P1, DOI 10.1007/978-1-4020-9413-2
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0
   Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109
   Konar M, 2012, FEBS J, V279, P2781, DOI 10.1111/j.1742-4658.2012.08662.x
   Larsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037516
   Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200
   Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032
   LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178
   McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142
   Montoro E, 2005, J ANTIMICROB CHEMOTH, V55, P500, DOI 10.1093/jac/dki023
   Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102
   MURAKAMI T, 1986, MOL GEN GENET, V205, P42, DOI 10.1007/BF02428031
   Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004
   Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881
   Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363
   Patrauchan MA, 2005, J BACTERIOL, V187, P4050, DOI 10.1128/JB.187.12.4050-4063.2005
   Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0
   Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06
   Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568
   Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436
   Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11
   Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9
   Reeves R, 1999, METHOD ENZYMOL, V304, P155
   Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8
   Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x
   Saini V, 2012, CURR OPIN CHEM BIOL, V16, P45, DOI 10.1016/j.cbpa.2012.03.004
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995
   Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419
   Singh A., 2009, PLOS PATHOG, V5
   Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104
   Smith LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040407
   Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440
   SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x
   Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333
   Stapleton MR, 2012, TUBERCULOSIS, V92, P328, DOI 10.1016/j.tube.2012.03.001
   Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399
   Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3
   STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0
   Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535
   Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069
   Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   Warren R, 2004, J BACTERIOL, V186, P7783, DOI 10.1128/JB.186.22.7783-7795.2004
   ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012
   Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106
NR 83
TC 24
Z9 28
U1 0
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 29
PY 2013
VL 288
IS 48
BP 34514
EP 34528
DI 10.1074/jbc.M113.516385
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 291FH
UT WOS:000329812800021
PM 24126912
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Bhattacharya, I
   Dragert, K
   Albert, V
   Humar, R
   Hall, MN
   Battegay, EJ
   Haas, E
AF Bhattacharya, Indranil
   Draegert, Katja
   Albert, Verena
   Humar, Rok
   Hall, Michael N.
   Battegay, Edouard J.
   Haas, Elvira
TI Rictor in Perivascular Adipose Tissue Reduces Aortic Contraction by
   Controlling Inflammation
SO CIRCULATION
LA English
DT Meeting Abstract
CT Scientific Sessions and Resuscitation Science Symposium of the
   American-Heart-Association
CY NOV 16-17, 2013
CL Dallas, TX
SP Amer Heart Assoc
DE Inflammation; Nitric oxide synthase; Adipose; Contractility
C1 [Bhattacharya, Indranil; Draegert, Katja; Battegay, Edouard J.; Haas, Elvira] Univ Zurich Hosp, Div Internal Med, Rsch Unit, CH-8091 Zurich, Switzerland.
   [Albert, Verena; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Humar, Rok] Univ Zurich Hosp, Rsch Unit, Div Internal Medicin, CH-8091 Zurich, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD NOV 26
PY 2013
VL 128
IS 22
SU S
MA 17895
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AC0CR
UT WOS:000332162907119
DA 2021-01-25
ER

PT J
AU Betz, C
   Hall, MN
AF Betz, Charles
   Hall, Michael N.
TI Where is mTOR and what is it doing there?
SO JOURNAL OF CELL BIOLOGY
LA English
DT Review
ID ENDOPLASMIC-RETICULUM MEMBRANES; SMALL GTPASE-RHEB; MAMMALIAN TARGET;
   TUBEROUS SCLEROSIS; RAG GTPASES; RAPAMYCIN MTOR;
   SUBCELLULAR-LOCALIZATION; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN;
   MITOCHONDRIAL LOCALIZATION; TRANSCRIPTIONAL REGULATOR
AB Target of rapamycin (TOR) forms two conserved, structurally distinct kinase complexes termed TOR complex 1 (TORC1) and TORC2. Each complex phosphorylates a different set of substrates to regulate cell growth. In mammals, mTOR is stimulated by nutrients and growth factors and inhibited by stress to ensure that cells grow only during favorable conditions. Studies in different organisms have reported localization of TOR to several distinct subcellular compartments. Notably, the finding that mTORC1 is localized to the lysosome has significantly enhanced our understanding of mTORC1 regulation. Subcellular localization may be a general principle used by TOR to enact precise spatial and temporal control of cell growth.
C1 [Betz, Charles; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Betz, Charles/B-7444-2008
OI Betz, Charles/0000-0002-9837-6916
FU Leslie Misrock Foundation; Louis Jeantet Foundation; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF); Canton of
   Basel
FX We acknowledge support from the Leslie Misrock Foundation, the Louis
   Jeantet Foundation, the Swiss National Science Foundation, and the
   Canton of Basel.
CR Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523
   Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006
   Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274
   Asian J. E., 2009, MOL CELL, V34, P497, DOI DOI 10.1016/J.M0LCE1.2009.04.011
   Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887
   Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044
   Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204
   Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792
   Benjamin D, 2013, NAT CELL BIOL, V15, P1135, DOI 10.1038/ncb2849
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029
   Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110
   Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x
   Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033
   Blazek M, 2013, MOL CELL PROTEOMICS, V12, P3898, DOI 10.1074/mcp.M113.032821
   Bononi A, 2013, CELL DEATH DIFFER
   Bononi A, 2012, ADV EXP MED BIOL, V740, P411, DOI 10.1007/978-94-007-2888-2_17
   Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034
   Bridges D, 2012, MOL BIOL CELL, V23, P2955, DOI 10.1091/mbc.E11-12-1034
   Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220
   Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250
   Chen CH, 2013, J BIOL CHEM, V288, P27019, DOI 10.1074/jbc.M113.498055
   Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731
   Clippinger AJ, 2011, J VIROL, V85, P3930, DOI 10.1128/JVI.01913-10
   Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539
   Cordas E, 2007, AM J PHYSIOL-CELL PH, V292, pC1971, DOI 10.1152/ajpcell.00399.2006
   Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96
   Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112
   Daniele N, 1999, J BIOL CHEM, V274, P3597, DOI 10.1074/jbc.274.6.3597
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698
   Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07
   Diaz-Troya S, 2011, PLANT PHYSIOL, V157, P730, DOI 10.1104/pp.111.179861
   Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009
   Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338
   Duran R. V., 2012, ONCOGENE
   Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Engelsberg A, 2006, BIOCHEM J, V399, P69, DOI 10.1042/BJ20060386
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022
   Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200
   Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157
   Goh ETH, 2010, J BIOL CHEM, V285, P17065, DOI 10.1074/jbc.M109.078782
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Han BK, 2011, GENE DEV, V25, P984, DOI 10.1101/gad.1998611
   Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189
   Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140
   Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535
   Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9
   Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024
   Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052
   Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   Ishikawa-Ankerhold HC, 2012, MOLECULES, V17, P4047, DOI 10.3390/molecules17044047
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699
   Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107
   Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200
   Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898
   Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003
   Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699
   Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088
   Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058
   Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017
   Leemand J, 2012, EXP DIABETES RES, DOI 10.1155/2012/242984
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089
   Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100
   Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020
   Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363
   Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424
   Malik AR, 2013, BBA-PROTEINS PROTEOM, V1834, P1434, DOI 10.1016/j.bbapap.2012.12.010
   Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45
   Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086
   Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352
   Michel AH, 2012, BIOCHEM SOC T, V40, P445, DOI 10.1042/BST20110758
   Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285
   Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390
   Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200
   Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647
   Noonan DJ, 2002, ARCH BIOCHEM BIOPHYS, V398, P132, DOI 10.1006/abbi.2001.2682
   Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616
   Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083
   Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112
   Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084
   Plank TL, 1998, CANCER RES, V58, P4766
   Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018
   Poston CN, 2011, BIOCHEM BIOPH RES CO, V415, P355, DOI 10.1016/j.bbrc.2011.10.072
   Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Ramirez-Rangel I, 2011, MOL CELL BIOL, V31, P1657, DOI 10.1128/MCB.00824-10
   Raturi A, 2012, BIOCH BIOPHYS ACTA
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039
   Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771
   Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106
   Rosner M, 2007, AMINO ACIDS, V33, P575, DOI 10.1007/s00726-007-0541-0
   Rosner M, 2007, ONCOGENE, V26, P521, DOI 10.1038/sj.onc.1209812
   Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192
   Rosner M, 2012, METHODS MOL BIOL, V821, P105, DOI 10.1007/978-1-61779-430-8_8
   Rosner M, 2011, CELL CYCLE, V10, P3608, DOI 10.4161/cc.10.20.17855
   RUBY JR, 1969, Z ZELLFORSCH MIK ANA, V97, P30, DOI 10.1007/BF00331868
   Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639
   Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559
   Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009
   Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Su CC, 2012, AM J PHYSIOL-HEART C, V302, pH716, DOI 10.1152/ajpheart.00455.2011
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105
   Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542
   Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019
   Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052
   Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004
   Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031
   Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876
   TSUN ZY, 2013, MOL CELL
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   Wang YB, 2010, J BIOL CHEM, V285, P15611, DOI 10.1074/jbc.M109.095778
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033
   Wu ZH, 2013, GENE DEV, V27, P157, DOI 10.1101/gad.203406.112
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yadav RB, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-3
   Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07
   Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076
   Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854
   Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894
   Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207
   Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005678
   Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
   Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5
   Zinzalla V, 2008, NATURE, V454, P287, DOI 10.1038/454287a
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
   Zu LY, 2011, AM J PHYSIOL-HEART C, V300, pH2177, DOI 10.1152/ajpheart.01138.2010
NR 177
TC 297
Z9 298
U1 0
U2 44
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD NOV 25
PY 2013
VL 203
IS 4
BP 563
EP 574
DI 10.1083/jcb.201306041
PG 12
WC Cell Biology
SC Cell Biology
GA 260EV
UT WOS:000327578700003
PM 24385483
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Dougherty, KJ
   Zagoraiou, L
   Satoh, D
   Rozani, I
   Doobar, S
   Arber, S
   Jessell, TM
   Kiehn, O
AF Dougherty, Kimberly J.
   Zagoraiou, Laskaro
   Satoh, Daisuke
   Rozani, Ismini
   Doobar, Staceyann
   Arber, Silvia
   Jessell, Thomas M.
   Kiehn, Ole
TI Locomotor Rhythm Generation Linked to the Output of Spinal Shox2
   Excitatory Interneurons
SO NEURON
LA English
DT Article
ID LEFT-RIGHT COORDINATION; V2A INTERNEURONS; COMMISSURAL INTERNEURONS;
   V2-DERIVED INTERNEURONS; CIRCUITS; NETWORKS; CORD; SPECIFICATION;
   ORGANIZATION; IDENTIFICATION
AB Locomotion is controlled by spinal networks that generate rhythm and coordinate left-right and flexor-extensor patterning. Defined populations of spinal interneurons have been linked to patterning circuits; however, neurons comprising the rhythm-generating kernel have remained elusive. Here, we identify an ipsilaterally projecting excitatory interneuron population, marked by the expression of Shox2 that overlaps partially with V2a interneurons. Optogenetic silencing or blocking synaptic output of Shox2 interneurons (INs) in transgenic mice perturbed rhythm without an effect on pattern generation, whereas ablation of the Shox2 IN subset coinciding with the V2a population was without effect. Most Shox2 INs are rhythmically active during locomotion and analysis of synaptic connectivity showed that Shox2 INs contact other Shox2 INs, commissural neurons, and motor neurons, with preference for flexor motor neurons. Our findings focus attention on a subset of Shox2 INs that appear to participate in the rhythm-generating kernel for spinal locomotion.
C1 [Dougherty, Kimberly J.; Kiehn, Ole] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.
   [Zagoraiou, Laskaro; Doobar, Staceyann; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci & Biochem, New York, NY 10032 USA.
   [Zagoraiou, Laskaro; Doobar, Staceyann; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Mol Biophys, New York, NY 10032 USA.
   [Zagoraiou, Laskaro; Rozani, Ismini] Acad Athens, Biomed Res Fdn, Athens 11527, Greece.
   [Satoh, Daisuke; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Satoh, Daisuke; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Zagoraiou, L (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci & Biochem, New York, NY 10032 USA.
EM lzagoraiou@bioacademy.gr; ole.kiehn@ki.se
RI kiehn, ole/AAB-1262-2019
OI Satoh, Daisuke/0000-0002-4039-1670; Dougherty,
   Kimberly/0000-0002-0807-574X; Arber, Silvia/0000-0002-6261-250X; Kiehn,
   Ole/0000-0002-5954-469X
FU Swedish Research CouncilSwedish Research Council; ERCEuropean Research
   Council (ERC); Torsten and Ragnar Soderberg Foundations; StratNeuro;
   NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS); ProjectALS; HHMIHoward Hughes Medical
   Institute; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Novartis Research Foundation; Kanton Basel-Stadt;
   National Science Foundation IRFP; Helen Hay Whitney Foundation; BRFAA;
   Marie Curie Reintegration GrantEuropean Union (EU)
FX This work was supported by the Swedish Research Council (to O.K.), ERC
   advanced grants (to O.K. and S.A.), the Torsten and Ragnar Soderberg
   Foundations (to O.K.), StratNeuro (to O.K.), a NINDS grant (to T.M.J.),
   ProjectALS (to T.M.J.), the HHMI (to T.M.J.), a Swiss National Science
   Foundation grant (to S.A. and D.S.), the Novartis Research Foundation
   (to S.A.), Kanton Basel-Stadt (to S.A.), National Science Foundation
   IRFP (to K.J.D.), the Helen Hay Whitney Foundation (to L.Z.), BRFAA (to
   L.Z.), and a Marie Curie Reintegration Grant (to L.Z.). We are grateful
   to Dr. Thomas Hnasko for providing the vGluT2<SUP>lox/lox</SUP> mice, to
   Kama Sharma for providing Chx10/n/DTA mice, and to Ann-Charlotte
   Westerdahl and Natalie Sleiers for technical assistance.
CR Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x
   BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512
   Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007
   Butt SJB, 2003, NEURON, V38, P953, DOI 10.1016/S0896-6273(03)00353-2
   Butt SJB, 2002, BRAIN RES REV, V40, P107, DOI 10.1016/S0165-0173(02)00194-7
   Butt SJB, 2002, J NEUROSCI, V22, P9961
   Cazalets JR, 2005, J PHYSIOL-LONDON, V568, P583, DOI 10.1113/jphysiol.2005.086850
   Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009
   Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009
   Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x
   Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010
   Endo T, 2008, J NEUROPHYSIOL, V100, P3043, DOI 10.1152/jn.90729.2008
   Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2
   Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137
   Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008
   Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011
   Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2
   Hinckley CA, 2006, J NEUROSCI, V26, P8477, DOI 10.1523/JNEUROSCI.0395-06.2006
   Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419
   Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x
   Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910
   Li WC, 2006, J NEUROSCI, V26, P4026, DOI 10.1523/JNEUROSCI.4727-05.2006
   Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x
   Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078
   McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225
   Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X
   Panayi H, 2010, J NEUROSCI, V30, P12274, DOI 10.1523/JNEUROSCI.2402-10.2010
   Parker D, 2000, EUR J NEUROSCI, V12, P2135, DOI 10.1046/j.1460-9568.2000.00095.x
   Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019
   Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007
   Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286
   Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002
   Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005
   Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017
   Zhong GS, 2006, J NEUROSCI, V26, P6509, DOI 10.1523/JNEUROSCI.1410-06.2006
   Zhong GS, 2010, J NEUROSCI, V30, P170, DOI 10.1523/JNEUROSCI.4849-09.2010
NR 44
TC 96
Z9 97
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD NOV 20
PY 2013
VL 80
IS 4
BP 920
EP 933
DI 10.1016/j.neuron.2013.08.015
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 256AD
UT WOS:000327281200010
PM 24267650
OA Bronze
DA 2021-01-25
ER

PT J
AU Skora, L
   Mestan, J
   Fabbro, D
   Jahnke, W
   Grzesiek, S
AF Skora, Lukasz
   Mestan, Juergen
   Fabbro, Doriano
   Jahnke, Wolfgang
   Grzesiek, Stephan
TI NMR reveals the allosteric opening and closing of Abelson tyrosine
   kinase by ATP-site and myristoyl pocket inhibitors
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE CML; heteronuclear NMR; protein dynamics
ID CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; RESIDUAL DIPOLAR
   COUPLINGS; SMALL-MOLECULE INHIBITORS; X-RAY-SCATTERING; REGULATES C-ABL;
   BCR-ABL; BINDING-SITE; SELECTIVE INHIBITOR; T315I MUTANT
AB Successful treatment of chronic myelogenous leukemia is based on inhibitors binding to the ATP site of the deregulated breakpoint cluster region (Bcr)-Abelson tyrosine kinase (Abl) fusion protein. Recently, a new type of allosteric inhibitors targeting the Abl myristoyl pocket was shown in preclinical studies to overcome ATP-site inhibitor resistance arising in some patients. Using NMR and smallangle X-ray scattering, we have analyzed the solution conformations of apo Abelson tyrosine kinase (c-Abl) and c-Abl complexes with ATP-site and allosteric inhibitors. Binding of the ATP-site inhibitor imatinib leads to an unexpected open conformation of the multidomain SH3-SH2-kinase c-Abl core, whose relevance is confirmed by cellular assays on Bcr-Abl. The combination of imatinib with the allosteric inhibitor GNF-5 restores the closed, inactivated state. Our data provide detailed insights on the poorly understood combined effect of the two inhibitor types, which is able to overcome drug resistance.
C1 [Skora, Lukasz; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mestan, Juergen; Fabbro, Doriano; Jahnke, Wolfgang] Novartis Inst Biomed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-132857]
FX We thank Gabriele Fendrich, Ines Hertel, and Dominique Kempf for help
   with sample preparation and the phosphorylation assay; Andreas Menzel
   for assistance with SAXS data acquisition; Alex Grishaev, Charles
   Schwieters, and Yun-Xing Wang for help with SAXS analysis; and Sandra
   Cowan-Jacob for fruitful discussions. This work was supported by Swiss
   National Science Foundation Grant 31-132857 (to S.G.).
CR Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760
   Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110
   Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9
   Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280
   Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006
   Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200
   Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003
   DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561
   Fabbro D, 2010, BBA-PROTEINS PROTEOM, V1804, P454, DOI 10.1016/j.bbapap.2009.12.009
   Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047
   Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001
   Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9
   Fushman D, 2000, J AM CHEM SOC, V122, P10640, DOI 10.1021/ja001128j
   Goddard T. D., 2008, SPARKY 3
   Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538
   Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046
   Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m
   Grzesiek S, 2009, CURR OPIN STRUC BIOL, V19, P585, DOI 10.1016/j.sbi.2009.07.015
   Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280
   Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0
   Honndorf VS, 2008, ANGEW CHEM INT EDIT, V47, P3548, DOI 10.1002/anie.200705614
   Jahnke W, 2010, J AM CHEM SOC, V132, P7043, DOI 10.1021/ja101837n
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Manley PW, 2008, CHIMIA, V62, P579
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108
   MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587
   Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035
   Nagar B, 2002, CANCER RES, V62, P4236
   Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6
   O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936
   O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028
   Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312
   Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2
   Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567
   Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706
   Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b
   Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108
   Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890
   Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480
   Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Thomas M, 2011, BIOORG MED CHEM LETT, V21, P3743, DOI 10.1016/j.bmcl.2011.04.060
   Vajpai N, 2008, BIOMOL NMR ASSIGM, V2, P41, DOI 10.1007/s12104-008-9079-7
   Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200
   Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770
   Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007
   Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315
   Xu R, 1999, J BIOMOL NMR, V14, P187, DOI 10.1023/A:1008350823354
   Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013
   Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675
NR 58
TC 62
Z9 63
U1 0
U2 30
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 19
PY 2013
VL 110
IS 47
BP E4437
EP E4445
DI 10.1073/pnas.1314712110
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 253PD
UT WOS:000327100600008
PM 24191057
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Demirci, E
   Junne, T
   Baday, S
   Berneche, S
   Spiess, M
AF Demirci, Erhan
   Junne, Tina
   Baday, Sefer
   Berneche, Simon
   Spiess, Martin
TI Functional asymmetry within the Sec61p translocon
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE protein translocation; transmembrane helix
ID ENDOPLASMIC-RETICULUM; TRANSMEMBRANE SEGMENTS; PLUG DOMAIN; PROTEIN
   TRANSLOCATION; MOLECULAR CODE; MEMBRANE; DYNAMICS; INTEGRATION;
   RECOGNITION; INSERTION
AB The Sec61 translocon forms a pore to translocate polypeptide sequences across the membrane and offers a lateral gate for membrane integration of hydrophobic (H) segments. A central constriction of six apolar residues has been shown to form a seal, but also to determine the hydrophobicity threshold for membrane integration: Mutation of these residues in yeast Sec61p to glycines, serines, aspartates, or lysines lowered the hydrophobicity required for integration; mutation to alanines increased it. Whereas four leucines distributed in an oligo-alanine H segment were sufficient for 50% integration, we now find four leucines in the N-terminal half of the H segment to produce significantly more integration than in the C-terminal half, suggesting functional asymmetry within the translocon. Scanning a cluster of three leucines through an oligo-alanine H segment showed high integration levels, except around the position matching that of the hydrophobic constriction in the pore where integration was strongly reduced. Both asymmetry and the position effect of H-segment integration disappeared upon mutation of the constriction residues to glycines or serines, demonstrating that hydrophobicity at this position within the translocon is responsible for the phenomenon. Asymmetry was largely retained, however, when constriction residues were replaced by alanines. These results reflect on the integration mechanism of transmembrane domains and show that membrane insertion of H segments strongly depends not only on their intrinsic hydrophobicity but also on the local conditions in the translocon interior. Thus, the contribution of hydrophobic residues in the H segment is not simply additive and displays cooperativeness depending on their relative position.
C1 [Demirci, Erhan; Junne, Tina; Baday, Sefer; Berneche, Simon; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
RI baday, sefer/ABA-9111-2020
OI baday, sefer/0000-0002-2913-6687; Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A-144111]; SNSF Professorship [PP00P3-139205];
   Basel Computational Biology Center
FX This work was supported by Swiss National Science Foundation (SNSF)
   Grant 31003A-144111 (to M. S.) and SNSF Professorship PP00P3-139205 (to
   S. Bernsche). Computational resources were provided through Swiss
   National Supercomputing Centre Grant under Project ID s241and by the
   Basel Computational Biology Center.
CR Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107
   Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026
   Gumbart J, 2011, J AM CHEM SOC, V133, P7602, DOI 10.1021/ja2019299
   Gumbart JC, 2013, J AM CHEM SOC, V135, P2291, DOI 10.1021/ja310777k
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387
   Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027
   Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003
   Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060
   Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117
   Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118
   Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200
   McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6
   Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507
   Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636
   Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]
   Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540
   Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902
   Rychkova A, 2013, P NATL ACAD SCI USA, V110, P495, DOI 10.1073/pnas.1220361110
   Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994
   Siwiak M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000865
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y
   Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039
   Zhang B, 2012, J AM CHEM SOC, V134, P13700, DOI 10.1021/ja3034526
   Zhang B, 2010, P NATL ACAD SCI USA, V107, P5399, DOI 10.1073/pnas.0914752107
NR 33
TC 16
Z9 16
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 19
PY 2013
VL 110
IS 47
BP 18856
EP 18861
DI 10.1073/pnas.1318432110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 253PD
UT WOS:000327100600045
PM 24191046
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Yang, YK
   Neef, T
   Mittelholzer, C
   Garayoa, EG
   Blauenstein, P
   Schibli, R
   Aebi, U
   Burkhard, P
AF Yang, Yongkun
   Neef, Tobias
   Mittelholzer, Christian
   Garayoa, Elisa Garcia
   Blauenstein, Peter
   Schibli, Roger
   Aebi, Ueli
   Burkhard, Peter
TI The biodistribution of self-assembling protein nanoparticles shows they
   are promising vaccine platforms
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Self-assembly; Nanoparticle; Bombesin; Drug-targeting; Vaccine;
   Biodistribution; Technetium
ID PEPTIDE NANOPARTICLES; DRUG-DELIVERY; COILED-COIL; DISPLAY; DESIGN;
   SERVE
AB Background: Because of the need to limit side-effects, nanoparticles are increasingly being studied as drug-carrying and targeting tools. We have previously reported on a scheme to produce protein-based self-assembling nanoparticles that can act as antigen display platforms. Here we attempted to use the same system for cancer-targeting, making use of a C-terminal bombesin peptide that has high affinity for a receptor known to be overexpressed in certain tumors, as well as an N-terminal polyhistidine tag that can be used for radiolabeling with technetium tricarbonyl.
   Results: In order to increase circulation time, we experimented with PEGylated and unPEGylated varities typo particle. We also tested the effect of incorporating different numbers of bombesins per nanoparticle. Biophysical characterization determined that all configurations assemble into regular particles with relatively monodisperse size distributions, having peaks of about 33 - 36 nm. The carbonyl method used for labeling produced approximately 80% labeled nanoparticles. In vitro, the nanoparticles showed high binding, both specific and non-specific, to PC-3 prostate cancer cells. In vivo, high uptake was observed for all nanoparticle types in the spleens of CD-1 nu/nu mice, decreasing significantly over the course of 24 hours. High uptake was also observed in the liver, while only low uptake was seen in both the pancreas and a tumor xenograft.
   Conclusions: The data suggest that the nanoparticles are non-specifically taken up by the reticuloendothelial system. Low uptake in the pancreas and tumor indicate that there is little or no specific targeting. PEGylation or increasing the amount of bombesins per nanoparticle did not significantly improve targeting. In particular, the uptake in the spleen, which is a primary organ of the immune system, highlights the potential of the nanoparticles as vaccine carriers. Also, the decrease in liver and spleen radioactivity with time implies that the nanoparticles are broken down and cleared. This is an important finding, as it shows that the nanoparticles can be safely used as a vaccine platform without the risk of prolonged side effects. Furthermore, it demonstrates that technetium carbonyl radiolabeling of our protein-based nanoparticles can be used to evaluate their pharmacokinetic properties in vivo.
C1 [Yang, Yongkun; Neef, Tobias; Burkhard, Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06250 USA.
   [Yang, Yongkun; Neef, Tobias; Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06250 USA.
   [Garayoa, Elisa Garcia; Blauenstein, Peter; Schibli, Roger] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, Villigen, Switzerland.
   [Mittelholzer, Christian; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Burkhard, P (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 97 N Eagleville Rd, Storrs, CT 06250 USA.
EM peter.burkhard@uconn.edu
OI Schibli, Roger/0000-0002-1537-3833
FU Swiss Nanoscience Institute (award NanoPER-SPECT); UConn Research
   Foundation
FX Support by the Swiss Nanoscience Institute (award NanoPER-SPECT) and the
   UConn Research Foundation for this work is gratefully acknowledged.
CR Alberto R, 1998, J AM CHEM SOC, V120, P7987, DOI 10.1021/ja980745t
   Babapoor Sankhiros, 2011, Influenza Res Treat, V2011, P126794, DOI 10.1155/2011/126794
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Carrio I, 2011, EUR J NUCL MED MOL I, V38, P378, DOI 10.1007/s00259-010-1698-4
   Cavadas M, 2011, NANOMED-NANOTECHNOL, V7, P730, DOI 10.1016/j.nano.2011.04.006
   Collins L, 2010, ACS NANO, V4, P2856, DOI 10.1021/nn901414q
   Doll TAPF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0740
   G.vS, 2003, CLIN MOL AN IM PET P, P19106
   Garayoa EG, 2008, BIOCONJUGATE CHEM, V19, P2409, DOI 10.1021/bc800262m
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304
   Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957
   Kaul G, 2004, J DRUG TARGET, V12, P585, DOI 10.1080/10611860400013451
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004
   Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761
   Mariani G, 2010, EUR J NUCL MED MOL I, V37, P1959, DOI 10.1007/s00259-010-1390-8
   Murphy PS, 2009, CURR PHARM DESIGN, V15, P957, DOI 10.2174/138161209787581977
   Pimentel TAPF, 2009, CHEM BIOL DRUG DES, V73, P53, DOI 10.1111/j.1747-0285.2008.00746.x
   Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   Schibli R, 2002, EUR J NUCL MED MOL I, V29, P1529, DOI 10.1007/s00259-002-0900-8
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Schweinsberg C, 2008, BIOCONJUGATE CHEM, V19, P2432, DOI 10.1021/bc800319g
   Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009
   TROSTER SD, 1992, J CONTROL RELEASE, V20, P247, DOI 10.1016/0168-3659(92)90127-D
   Wahome N, 2012, CHEM BIOL DRUG DES, V80, P349, DOI 10.1111/j.1747-0285.2012.01423.x
   Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890
   Yang YK, 2012, J STRUCT BIOL, V177, P168, DOI 10.1016/j.jsb.2011.11.011
NR 29
TC 15
Z9 15
U1 0
U2 35
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD NOV 12
PY 2013
VL 11
AR 36
DI 10.1186/1477-3155-11-36
PG 10
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 267QK
UT WOS:000328112400001
PM 24219600
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Papassotiropoulos, A
   Gerhards, C
   Heck, A
   Ackermann, S
   Aerni, A
   Schicktanz, N
   Auschra, B
   Demougin, P
   Mumme, E
   Elbert, T
   Ertl, V
   Gschwind, L
   Hanser, E
   Huynh, KD
   Jessen, F
   Kolassa, IT
   Milnik, A
   Paganetti, P
   Spalek, K
   Vogler, C
   Muhs, A
   Pfeifer, A
   de Quervain, DJF
AF Papassotiropoulos, Andreas
   Gerhards, Christiane
   Heck, Angela
   Ackermann, Sandra
   Aerni, Amanda
   Schicktanz, Nathalie
   Auschra, Bianca
   Demougin, Philippe
   Mumme, Eva
   Elbert, Thomas
   Ertl, Verena
   Gschwind, Leo
   Hanser, Edveena
   Huynh, Kim-Dung
   Jessen, Frank
   Kolassa, Iris-Tatjana
   Milnik, Annette
   Paganetti, Paolo
   Spalek, Klara
   Vogler, Christian
   Muhs, Andreas
   Pfeifer, Andrea
   de Quervain, Dominique J. -F.
TI Human genome-guided identification of memory-modulating drugs
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE emotional memory; pharmacology; PTSD
ID POSTTRAUMATIC-STRESS-DISORDER; GENE SET ANALYSIS; WIDE ASSOCIATION;
   RECONSOLIDATION BLOCKADE; GSA-SNP; RISK; SEDATION; DIPHENHYDRAMINE;
   PERFORMANCE; ACTIVATION
AB In the last decade there has been an exponential increase in knowledge about the genetic basis of complex human traits, including neuropsychiatric disorders. It is not clear, however, to what extent this knowledge can be used as a starting point for drug identification, one of the central hopes of the human genome project. The aim of the present study was to identify memory-modulating compounds through the use of human genetic information. We performed a multinational collaborative study, which included assessment of aversive memory-a trait central to posttraumatic stress disorder-and a gene-set analysis in healthy individuals. We identified 20 potential drug target genes in two genomewide-corrected gene sets: the neuroactive ligand-receptor interaction and the long-term depression gene set. In a subsequent double-blind, placebo-controlled study in healthy volunteers, we aimed at providing a proof of concept for the genome-guided identification of memory modulating compounds. Pharmacological intervention at the neuroactive ligand-receptor interaction gene set led to significant reduction of aversive memory. The findings demonstrate that genome information, along with appropriate data mining methodology, can be used as a starting point for the identification of memory-modulating compounds.
C1 [Papassotiropoulos, Andreas; Heck, Angela; Ackermann, Sandra; Auschra, Bianca; Demougin, Philippe; Gschwind, Leo; Hanser, Edveena; Huynh, Kim-Dung; Milnik, Annette; Vogler, Christian] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, Andreas; Heck, Angela; Aerni, Amanda; Schicktanz, Nathalie; Vogler, Christian; de Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, Andreas; Heck, Angela; Vogler, Christian; de Quervain, Dominique J. -F.] Univ Basel, Transfac Res Platform, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, Andreas; Demougin, Philippe; Hanser, Edveena; Huynh, Kim-Dung] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   [Gerhards, Christiane; Aerni, Amanda; Schicktanz, Nathalie; Mumme, Eva; Gschwind, Leo; Spalek, Klara; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Elbert, Thomas; Ertl, Verena; Kolassa, Iris-Tatjana] Univ Konstanz, D-78464 Constance, Germany.
   [Jessen, Frank] Univ Bonn, Sch Med, Dept Psychiat & Psychotherapy, D-53113 Bonn, Germany.
   [Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, D-89081 Ulm, Germany.
   [Milnik, Annette] Univ Magdeburg, Dept Neurol, D-39120 Magdeburg, Germany.
   [Paganetti, Paolo; Muhs, Andreas; Pfeifer, Andrea] ACImmune SA, CH-1015 Lausanne, Switzerland.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
EM andreas.papas@unibas.ch; dominique.dequervain@unibas.ch
RI Kolassa, Iris Tatjana/Y-3032-2018; Jessen, Frank/AAK-6170-2020;
   Paganetti, Paolo/AAF-8039-2020; Elbert, Thomas/C-8556-2009
OI Elbert, Thomas/0000-0003-1332-4939; Milnik, Annette/0000-0002-3933-3289;
   Spalek, Klara/0000-0002-4244-6495; Paganetti, Paolo/0000-0003-1896-6324;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler,
   Christian/0000-0003-3922-109X; de Quervain,
   Dominique/0000-0001-7131-2464; Heck, Angela/0000-0002-1543-3197
FU Swiss National Science Foundation SinergiaSwiss National Science
   Foundation (SNSF) [CRSIK0_122691, CRSI33_130080]; German Research
   Foundation (Deutsche Forschungsgemeinschaft)German Research Foundation
   (DFG)
FX This work was funded by Swiss National Science Foundation Sinergia
   Grants CRSIK0_122691 and CRSI33_130080 (to D.J.-F.d.Q. and A.
   Papassotiropoulos) and by grants from the German Research Foundation
   (Deutsche Forschungsgemeinschaft; to I.-T.K. and T.E.).
CR Brignell CM, 2007, J PSYCHOPHARMACOL, V21, P673, DOI 10.1177/0269881107077351
   Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354
   Curran HV, 1998, PSYCHOPHARMACOLOGY, V135, P27, DOI 10.1007/s002130050482
   de Quervain DJF, 2008, EUR J PHARMACOL, V583, P365, DOI 10.1016/j.ejphar.2007.11.068
   de Quervain DJF, 2012, P NATL ACAD SCI USA, V109, P8746, DOI 10.1073/pnas.1200857109
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Gamache K, 2012, NEUROPSYCHOPHARMACOL, V37, P2789, DOI 10.1038/npp.2012.145
   Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326
   Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011
   Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454
   Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142
   Kamboj SK, 2006, PSYCHOPHARMACOLOGY, V188, P482, DOI 10.1007/s00213-006-0552-7
   Kay GG, 1997, ARCH INTERN MED, V157, P2350, DOI 10.1001/archinte.157.20.2350
   Kwon Ji-sun, 2012, Genomics & Informatics, V10, P123, DOI 10.5808/GI.2012.10.2.123
   Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792
   LIEBERMAN HR, 1984, BRAIN RES, V323, P201, DOI 10.1016/0006-8993(84)90290-7
   Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772
   Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980
   McGaugh JL, 2003, MAKING LASTING MEMOR
   Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007
   Muglia P, 2011, CURR OPIN PHARMACOL, V11, P563, DOI 10.1016/j.coph.2011.08.003
   Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428
   O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7
   Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025
   PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4
   Pitman RK, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00011
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   REINER PB, 1994, NEUROSCIENCE, V59, P579, DOI 10.1016/0306-4522(94)90178-3
   Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151
   Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943
   Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582
   Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551
   Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907
   Turner C, 2006, J PSYCHOPHARMACOL, V20, P506, DOI 10.1177/0269881106059804
   Verster JC, 2003, J ALLERGY CLIN IMMUN, V111, P623, DOI 10.1067/mai.2003.63
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884
   Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324
NR 38
TC 14
Z9 14
U1 0
U2 20
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 12
PY 2013
VL 110
IS 46
BP E4369
EP E4374
DI 10.1073/pnas.1314478110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 250DQ
UT WOS:000326830900016
PM 24145423
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lenard, A
   Affolter, M
AF Lenard, Anna
   Affolter, Markus
TI Tugging Organs into Place
SO DEVELOPMENTAL CELL
LA English
DT Editorial Material
C1 [Lenard, Anna; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
CR Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996
   Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750
   Weavers H, 2013, DEV CELL, V27, P331, DOI 10.1016/j.devcel.2013.09.020
NR 6
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD NOV 11
PY 2013
VL 27
IS 3
BP 243
EP 244
DI 10.1016/j.devcel.2013.10.021
PG 2
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 257VZ
UT WOS:000327417200001
PM 24229640
OA Bronze
DA 2021-01-25
ER

PT J
AU Willadt, S
   Nenniger, M
   Vogt, KE
AF Willadt, Silvia
   Nenniger, Markus
   Vogt, Kaspar E.
TI Hippocampal Feedforward Inhibition Focuses Excitatory Synaptic Signals
   into Distinct Dendritic Compartments
SO PLOS ONE
LA English
DT Article
ID PYRAMIDAL NEURONS; BASAL DENDRITES; CORTEX; VOLTAGE; RAT; ORGANIZATION;
   PROJECTIONS; INTEGRATION; DYNAMICS; CALCIUM
AB Feedforward inhibition controls the time window for synaptic integration and ensures temporal precision in cortical circuits. There is little information whether feedforward inhibition affects neurons uniformly, or whether it contributes to computational refinement within the dendritic tree. Here we demonstrate that feedforward inhibition crucially shapes the integration of synaptic signals in pyramidal cell dendrites. Using voltage-sensitive dye imaging we studied the transmembrane voltage patterns in CA1 pyramidal neurons after Schaffer collateral stimulation in acute brain slices from mice. We observed a high degree of variability in the excitation-inhibition ratio between different branches of the dendritic tree. Many dendritic segments showed no depolarizing signal at all, especially the basal dendrites that received predominantly inhibitory signals. Application of the GABAA receptor antagonist bicuculline resulted in the spread of depolarizing signals throughout the dendritic tree. Tetanic stimulation of Schaffer collateral inputs induced significant alterations in the patterns of excitation/inhibition, indicating that they are modified by synaptic plasticity. In summary, we show that feedforward inhibition restricts the occurrence of depolarizing signals within the dendritic tree of CA1 pyramidal neurons and thus refines signal integration spatially.
C1 [Willadt, Silvia; Nenniger, Markus; Vogt, Kaspar E.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Vogt, KE (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM kaspar.vogt@unibas.ch
OI Vogt, Kaspar/0000-0002-0859-876X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-118352]
FX Funding came from the Swiss National Science Foundation Grant #
   31003A-118352. www.snf.ch. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Antic S, 1999, J NEUROPHYSIOL, V82, P1615
   Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130
   BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6
   Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   Derdikman D, 2003, J NEUROSCI, V23, P3100
   Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I
   Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022
   Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144
   Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7
   HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651
   ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407
   Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011
   Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381
   Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206
   Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826
   Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022
   Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342
   Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094
   STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303
   Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905
   Tominaga Y, 2009, NEUROSCI RES, V64, P152, DOI 10.1016/j.neures.2009.02.007
   Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116
   WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0
   Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y
   Zhou D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053508
   Zhou WL, 2012, J PHYSIOL-LONDON, V590, P3891, DOI 10.1113/jphysiol.2011.227157
NR 27
TC 8
Z9 8
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 11
PY 2013
VL 8
IS 11
AR e80984
DI 10.1371/journal.pone.0080984
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255EG
UT WOS:000327221600218
PM 24244727
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Dekkers, MPJ
   Nikoletopoulou, V
   Barde, YA
AF Dekkers, Martijn P. J.
   Nikoletopoulou, Vassiliki
   Barde, Yves-Alain
TI Death of developing neurons: New insights and implications for
   connectivity
SO JOURNAL OF CELL BIOLOGY
LA English
DT Review
ID PROGRAMMED CELL-DEATH; NERVE GROWTH-FACTOR; DEVELOPING AVIAN
   MOTONEURONS; LONG-TERM DEPRESSION; BASSOON-MUTANT MICE; NEUROTROPHIC
   FACTOR; AXON DEGENERATION; CASPASE ACTIVITY; CHICK-EMBRYO; SPINAL-CORD
AB The concept that target tissues determine the survival of neurons has inspired much of the thinking on neuronal development in vertebrates, not least because it is supported by decades of research on nerve growth factor (NGF) in the peripheral nervous system (PNS). Recent discoveries now help to understand why only some developing neurons selectively depend on NGF. They also indicate that the survival of most neurons in the central nervous system (CNS) is not simply regulated by single growth factors like in the PNS. Additionally, components of the cell death machinery have begun to be recognized as regulators of selective axonal degeneration and synaptic function, thus playing a critical role in wiring up the nervous system.
C1 [Dekkers, Martijn P. J.; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Nikoletopoulou, Vassiliki] Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Crete, Greece.
RP Barde, YA (corresponding author), Cardiff Univ, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales.
EM bardey@cardiff.ac.uk
OI Nikoletopoulou, Vassiliki/0000-0003-3646-992X; Barde,
   Yves/0000-0002-7627-461X
CR Angenstein F, 2007, CEREB CORTEX, V17, P28, DOI 10.1093/cercer/bhj121
   Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043
   Banks GB, 2005, J NEUROSCI, V25, P1249, DOI 10.1523/JNEUROSCI.1786-04.2005
   BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8
   Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616
   Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680
   Buss RR, 2006, J NEUROSCI, V26, P13413, DOI 10.1523/JNEUROSCI.3528-06.2006
   Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800
   CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516
   Chen SK, 2013, NEURON, V77, P503, DOI 10.1016/j.neuron.2012.11.028
   Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533
   Corty Megan M, 2013, J Cell Biol, V203, P395, DOI 10.1083/jcb.201306099
   CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6
   Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910
   Davis AR, 2007, J NEUROTRAUM, V24, P823, DOI 10.1089/neu.2006.0227
   DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8
   Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846
   Dekkers MPJ, 2013, SCIENCE, V340, P39, DOI 10.1126/science.1236152
   EDWARDS RH, 1989, CELL, V58, P161, DOI 10.1016/0092-8674(89)90412-1
   ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8
   ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0
   ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4
   ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5
   ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5
   Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065
   FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0
   Finn JT, 2000, J NEUROSCI, V20, P1333
   Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596
   Furne C, 2006, P NATL ACAD SCI USA, V103, P4128, DOI 10.1073/pnas.0507864103
   Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300
   Gohlke JM, 2004, DEV BRAIN RES, V151, P43, DOI 10.1016/j.devbrainres.2004.03.020
   Grimes ML, 1996, J NEUROSCI, V16, P7950
   HAMBURGER V, 1981, J NEUROSCI, V1, P60
   HAMBURGER V, 1992, J NEUROBIOL, V23, P1116, DOI 10.1002/neu.480230904
   Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013
   Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835
   Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008
   HARTIKKA J, 1988, J NEUROSCI RES, V21, P352, DOI 10.1002/jnr.490210227
   Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165
   HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664
   Heyden A, 2011, CELL TISSUE RES, V346, P11, DOI 10.1007/s00441-011-1233-3
   Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013
   Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8
   Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228
   Iscru E, 2013, NEUROSCIENCE, V231, P413, DOI 10.1016/j.neuroscience.2012.10.049
   Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004
   Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785
   JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8
   Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203
   Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103
   Kim WR, 2007, J NEUROSCI, V27, P14392, DOI 10.1523/JNEUROSCI.3903-07.2007
   Kim WR, 2009, EUR J NEUROSCI, V29, P1408, DOI 10.1111/j.1460-9568.2009.06693.x
   KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513
   Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014
   Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035
   Lavebratt C, 2006, NEUROBIOL DIS, V24, P374, DOI 10.1016/j.nbd.2006.07.018
   LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187
   Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673
   Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010
   Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105
   Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023
   Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053
   LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0
   LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x
   Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632
   MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0
   MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683
   MILLER MW, 1995, J COMP NEUROL, V355, P6, DOI 10.1002/cne.903550104
   Muller M, 2012, J NEUROSCI, V32, P14885, DOI 10.1523/JNEUROSCI.2849-12.2012
   Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767
   Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336
   Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007
   Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004
   O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012
   OKADO N, 1984, J NEUROSCI, V4, P1639
   Oppenheim RW, 2008, DEV NEUROBIOL, V68, P972, DOI 10.1002/dneu.20636
   OPPENHEIM RW, 1992, NATURE, V360, P755, DOI 10.1038/360755a0
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186
   Petreanu L, 2002, J NEUROSCI, V22, P6106
   PITTMAN RH, 1978, NATURE, V271, P364, DOI 10.1038/271364a0
   Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897
   Purves D., 1984, PRINCIPLES NEURAL DE, P131
   Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6
   Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027
   Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153
   Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012
   Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541
   SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0
   Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012
   SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0
   SOBREVIELA T, 1994, J COMP NEUROL, V350, P587, DOI 10.1002/cne.903500407
   Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896
   Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512
   Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104
   Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776
   Tremblay R, 1999, J NEUROCHEM, V72, P102, DOI 10.1046/j.1471-4159.1999.0720102.x
   Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015
   Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200
   Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621
   Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100
   Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010
   Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111
   Wang X, 2005, MOL CELL BIOL, V25, P4742, DOI 10.1128/MCB.25.11.4742-4751.2005
   Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012
   Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774
   Wu CB, 2001, J NEUROSCI, V21, P5406
   YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
NR 116
TC 91
Z9 96
U1 1
U2 21
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD NOV 11
PY 2013
VL 203
IS 3
BP 385
EP 393
DI 10.1083/jcb.201306136
PG 9
WC Cell Biology
SC Cell Biology
GA 251FD
UT WOS:000326912300004
PM 24217616
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Sylwestrak, E
   Scheiffele, P
AF Sylwestrak, Emily
   Scheiffele, Peter
TI NEUROSCIENCE Sculpting neuronal connectivity
SO NATURE
LA English
DT Editorial Material
C1 [Sylwestrak, Emily; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sylwestrak, Emily] F Hoffmann La Roche, Pharma Res & Early Dev, DTA Neurosci, Basel, Switzerland.
RP Sylwestrak, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
CR Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5
   Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743
   Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038
   Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I
   Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319
   Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009
   Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342
   Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026
   Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736
   Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008
   West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987
NR 11
TC 1
Z9 1
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 7
PY 2013
VL 503
IS 7474
BP 42
EP 43
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 247AS
UT WOS:000326585600025
PM 24201274
DA 2021-01-25
ER

PT J
AU Harris, KD
   Mrsic-Flogel, TD
AF Harris, Kenneth D.
   Mrsic-Flogel, Thomas D.
TI Cortical connectivity and sensory coding
SO NATURE
LA English
DT Review
ID PRIMARY VISUAL-CORTEX; PRIMARY SOMATOSENSORY CORTEX; CALLOSAL PROJECTION
   NEURONS; INHIBITORY NEURONS; IN-VIVO; PYRAMIDAL NEURONS;
   AUDITORY-CORTEX; GABAERGIC NEURONS; BARREL CORTEX; LAYER-V
AB The sensory cortex contains a wide array of neuronal types, which are connected together into complex but partially stereotyped circuits. Sensory stimuli trigger cascades of electrical activity through these circuits, causing specific features of sensory scenes to be encoded in the firing patterns of cortical populations. Recent research is beginning to reveal how the connectivity of individual neurons relates to the sensory features they encode, how differences in the connectivity patterns of different cortical cell classes enable them to encode information using different strategies, and how feedback connections from higher-order cortex allow sensory information to be integrated with behavioural context.
C1 [Harris, Kenneth D.] UCL Inst Neurol, London WC1N 3BG, England.
   [Harris, Kenneth D.; Mrsic-Flogel, Thomas D.] UCL Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England.
   [Mrsic-Flogel, Thomas D.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Harris, KD (corresponding author), UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM kenneth.harris@ucl.ac.uk; thomas.mrsic-flogel@unibas.ch
OI Mrsic-Flogel, Tom/0000-0002-8947-408X; Harris,
   Kenneth/0000-0002-5930-6456
FU Wellcome TrustWellcome Trust; Engineering and Physical Sciences Research
   CouncilEngineering & Physical Sciences Research Council (EPSRC); US
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; European Research
   CouncilEuropean Research Council (ERC); Engineering and Physical
   Sciences Research CouncilEngineering & Physical Sciences Research
   Council (EPSRC) [EP/I005102/1, EP/K015141/1, EP/I005102/2] Funding
   Source: researchfish
FX We thank B. Rudy, G. Buzsaki, M. Hausser, B. Haider, S. Hofer, R. Bruno
   and M. Carandini for comments on the manuscript. K. D. H. is supported
   by the Wellcome Trust, Engineering and Physical Sciences Research
   Council and US National Institutes of Health. T.M.-F. is supported by
   the Wellcome Trust and European Research Council.
CR Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526
   Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935
   Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301
   Bathellier B, 2012, NEURON, V76, P435, DOI 10.1016/j.neuron.2012.07.008
   Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306
   Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802
   Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465
   Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818
   Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658
   Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233
   Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011
   Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000
   Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007
   Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030
   Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236
   Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354
   Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005
   Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107
   Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479
   Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029
   Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425
   Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861
   de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321
   DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624
   Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152
   Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516
   Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817
   Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025
   Gao P, 2013, DEVELOPMENT, V140, P2645, DOI 10.1242/dev.087668
   GARDNERMEDWIN AR, 1976, PROC R SOC SER B-BIO, V194, P375, DOI 10.1098/rspb.1976.0084
   Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051
   GILBERT CD, 1989, J NEUROSCI, V9, P2432
   Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033
   Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152
   Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665
   Harris KD, 2008, TRENDS NEUROSCI, V31, P130, DOI 10.1016/j.tins.2007.12.002
   Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009
   Hebb D., 1949, ORG BEHAV
   Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626
   Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876
   Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039
   Jabaudon D, 2012, CEREB CORTEX, V22, P996, DOI 10.1093/cercor/bhr182
   Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688
   Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947
   Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305
   Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798
   Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909
   Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040
   Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002
   Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]
   Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015
   Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880
   Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686
   Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065
   Lee CC, 2009, CEREB CORTEX, V19, P2281, DOI 10.1093/cercor/bhn246
   Lee S., NATURE NEUR IN PRESS
   Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020
   Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674
   Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648
   Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493
   Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494
   Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488
   Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017
   Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009
   Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391
   Maruoka H, 2011, J NEUROSCI, V31, P18522, DOI 10.1523/JNEUROSCI.3117-11.2011
   Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028
   Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797
   Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108
   Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009
   Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498
   Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341
   Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663
   Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012
   Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008
   Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033
   O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026
   Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274
   Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503
   Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835
   Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007
   Otsuka T, 2011, J NEUROSCI, V31, P3862, DOI 10.1523/JNEUROSCI.5795-10.2011
   Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011
   Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108
   Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321
   Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709
   Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446
   Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464
   Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150
   Quiroga RQ, 2013, PRINCIPLES OF NEURAL CODING, P1, DOI 10.1201/b14756
   Reiner A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00142
   Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002
   Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853
   Runyan CA, 2013, J NEUROSCI, V33, P11724, DOI 10.1523/JNEUROSCI.2196-12.2013
   Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020
   Saleem A. B., NATURE NEUR IN PRESS
   Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701
   Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z
   Sherman SM, 2012, CURR OPIN NEUROBIOL, V22, P575, DOI 10.1016/j.conb.2012.03.005
   Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513
   Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012
   Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008
   Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682
   Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007
   Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068
   Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109
   Stroh A, 2013, NEURON, V77, P1136, DOI 10.1016/j.neuron.2013.01.031
   Sun YJ, 2013, J NEUROSCI, V33, P5326, DOI 10.1523/JNEUROSCI.4810-12.2013
   SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288
   Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482
   Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011
   Taniguchi H, 2011, NEURON, V72, P1091, DOI 10.1016/j.neuron.2011.12.010
   Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007
   Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013
   Van Hooser SD, 2006, J NEUROSCI, V26, P7680, DOI 10.1523/JNEUROSCI.0108-06.2006
   Watakabe A, 2012, J COMP NEUROL, V520, P3553, DOI 10.1002/cne.23160
   Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999
   Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302
   Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035
   Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004
   Yger P., PLOS COMPUT IN PRESS
   Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252
   Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958
NR 125
TC 258
Z9 259
U1 3
U2 155
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 7
PY 2013
VL 503
IS 7474
BP 51
EP 58
DI 10.1038/nature12654
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 247AS
UT WOS:000326585600031
PM 24201278
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Quebatte, M
   Dick, MS
   Kaever, V
   Schmidt, A
   Dehio, C
AF Quebatte, Maxime
   Dick, Mathias S.
   Kaever, Volkhard
   Schmidt, Alexander
   Dehio, Christoph
TI Dual input control: activation of the Bartonella henselae VirB/D4 type
   IV secretion system by the stringent sigma factor RpoH1 and the
   BatR/BatS two-component system
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID STRESS-RESPONSE; RNA-POLYMERASE; ESCHERICHIA-COLI; BACTERIAL VIRULENCE;
   DEPENDENT RESPONSE; GENE FAMILY; PPGPP; PROTEIN; TRANSCRIPTION; HOST
AB The co-ordinated expression of virulence factors is a critical process for any bacterial pathogen to colonize its host. Here we investigated the mechanisms of niche adaptation of the zoonotic pathogen Bartonella henselae by combining genetic approaches and shotgun proteomics. We demonstrated that expression of the VirB/D4 type IV secretion system (T4SS) and its secreted effector proteins require the alternative sigma factor RpoH1, which levels are controlled by the stringent response (SR) components DksA and SpoT. The RpoH1-dependent activation requires an active BatR/BatS two-component system (TCS) while BatR expression is controlled by RpoH1 and the SR components. Deletion of spoT results in a strong attenuation of VirB/D4 T4SS expression whereas dksA, rpoH1 or batR deletion fully abolishes its activity. In contrast to their activating effect on the VirB/D4 T4SS, which is critical at the early stage of host infection, SpoT and DksA negatively regulate the Trw T4SS, which mediates host-specific erythrocyte infection at a later stage of the colonization process. Our findings support a model where the SR signalling and the physiological pH-induced BatR/BatS TCS conjointly control the spatiotemporal expression of B.henselae adaptation factors during host infection.
C1 [Quebatte, Maxime; Dick, Mathias S.; Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, Res Core Unit Mass Spectrometry Metabol, Hannover, Germany.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Kaever, Volkhard/G-3280-2013; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Quebatte, Maxime/0000-0002-3733-1511;
   Dick, Mathias/0000-0002-4070-9749
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A-132979, 51RT 0_126008]
FX We specially want to thank Alexander Harms and Dr Simone Eicher for
   helpful comments and critical reading of the manuscript. We also thank
   Dr Simone Eicher for assistance with image acquisition as well as Mario
   Emmenlauer and Dr Pauli Ramo for assistance with image analysis. We are
   thankful to Annette Garbe for ppGpp measurements. We thank Marius Liesch
   for providing the unpublished plasmid pML001 and Dr Patrick Guye for
   plasmids pPG611 and pPG612. We acknowledge support by Grant
   31003A-132979 from the Swiss National Science Foundation (SNSF) and
   Grant 51RT 0_126008 for the Research and Technology Development (RTD)
   project InfectX in the frame of SystemsX.ch, the Swiss Initiative for
   Systems Biology (both to C.D.).
CR Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x
   Aberg A, 2009, J BACTERIOL, V191, P3226, DOI 10.1128/JB.01410-08
   Abromaitis S, 2013, J BACTERIOL, V195, P2662, DOI 10.1128/JB.01972-12
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3
   Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5
   Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479
   Barnett MJ, 2012, J BACTERIOL, V194, P4983, DOI 10.1128/JB.00449-12
   Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x
   Battisti JM, 2007, INFECT IMMUN, V75, P4373, DOI 10.1128/IAI.00497-07
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005
   Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546
   Boudko DY, 2001, P NATL ACAD SCI USA, V98, P15354, DOI 10.1073/pnas.261253998
   Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002
   Boutte CC, 2011, MOL MICROBIOL, V80, P695, DOI 10.1111/j.1365-2958.2011.07602.x
   Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006
   Brown SA, 2008, NAT REV MICROBIOL, V6, P657, DOI 10.1038/nrmicro1955
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519
   Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06
   Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09
   Dufour YS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002929
   Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x
   Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351
   Furman R, 2012, NUCLEIC ACIDS RES, V40, P3392, DOI 10.1093/nar/gkr1273
   Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g
   Green HA, 2006, J BACTERIOL, V188, P5712, DOI 10.1128/JB.00405-06
   GROSS R, 1993, FEMS MICROBIOL LETT, V104, P301, DOI 10.1016/0378-1097(93)90602-X
   GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8
   Guy L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003393
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001
   Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0
   Karls RK, 1998, J BACTERIOL, V180, P10, DOI 10.1128/JB.180.1.10-19.1998
   Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005
   Krol E, 2011, MOL MICROBIOL, V81, P1233, DOI 10.1111/j.1365-2958.2011.07752.x
   Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Lu YY, 2013, CELL MICROBIOL, V15, P759, DOI 10.1111/cmi.12070
   Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07
   Martinez-Salazar JM, 2009, MICROBIOL-SGM, V155, P386, DOI 10.1099/mic.0.021428-0
   McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688
   Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585
   MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   Nuss AM, 2009, J BACTERIOL, V191, P220, DOI 10.1128/JB.00925-08
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   Oke V, 2001, MICROBIOL-SGM, V147, P2399, DOI 10.1099/00221287-147-9-2399
   Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112
   Ono Y, 2001, MOL GEN GENET, V264, P902, DOI 10.1007/s004380000380
   Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219
   Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009
   Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030
   Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x
   Potrykus K, 2006, J BIOL CHEM, V281, P15238, DOI 10.1074/jbc.M601531200
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Roden JA, 2012, INFECT IMMUN, V80, P929, DOI 10.1128/IAI.05769-11
   Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803
   Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021
   Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Santos VC, 2011, J EXP BIOL, V214, P1411, DOI 10.1242/jeb.051490
   Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   Shingler V, 2011, FEMS MICROBIOL REV, V35, P425, DOI 10.1111/j.1574-6976.2010.00255.x
   Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020
   Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Vercruysse M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r17
   Vinella D, 2012, J BACTERIOL, V194, P261, DOI 10.1128/JB.06238-11
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505
   Wolf YI, 1999, GENOME RES, V9, P689
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020
NR 85
TC 9
Z9 9
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2013
VL 90
IS 4
BP 756
EP 775
DI 10.1111/mmi.12396
PG 20
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 295HU
UT WOS:000330108000007
PM 24033511
OA Bronze
DA 2021-01-25
ER

PT J
AU Bircher, BA
   Duempelmann, L
   Lang, HP
   Gerber, C
   Braun, T
AF Bircher, Benjamin Andreas
   Duempelmann, Luc
   Lang, Hans Peter
   Gerber, Christoph
   Braun, Thomas
TI Photothermal excitation of microcantilevers in liquid: effect of the
   excitation laser position on temperature and vibrational amplitude
SO MICRO & NANO LETTERS
LA English
DT Article
DE atomic force microscopy; cantilevers; intensity modulation; optical
   modulation; optimisation; photothermal effects; optimisation; flexural
   modes; laser intensity modulation; magnetic excitation; cantilever
   sensing applications; dynamic scanning force microscopy; vibrational
   amplitude; excitation laser position; microcantilevers; photothermal
   excitation
ID ATOMIC-FORCE MICROSCOPY; CANTILEVER; SENSORS
AB Demands to improve the sensitivity and measurement speed of dynamic scanning force microscopy and cantilever sensing applications necessitate the development of smaller cantilever sensors. As a result, methods to directly drive cantilevers, such as photothermal or magnetic excitation, are gaining in importance. Presented is a report on the effect of photothermal excitation of microcantilevers on the increase in steady-state temperature and the dynamics of higher mode vibrations. First, the local temperature increase upon continuous irradiation with laser light at different positions along the cantilever was measured and compared with finite element analysis data. The temperature increase was highest when the heating laser was positioned at the free end of the cantilever. Next, the laser intensity was modulated to drive higher flexural modes to resonance. The dependence of the cantilever dynamics on the excitation laser position was assessed and was in good agreement with the analytical expressions. An optimal position to simultaneously excite all flexural modes of vibration with negligible heating was found at the clamped end of the cantilever. The reports findings are essential for optimisation of the excitation efficiency to minimise the rise in temperature and avoid damaging delicate samples or functionalisation layers.
C1 [Bircher, Benjamin Andreas; Duempelmann, Luc; Braun, Thomas] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland.
   [Lang, Hans Peter; Gerber, Christoph] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Bircher, BA (corresponding author), Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland.
EM thomas.braun@unibas.ch
RI Duempelmann, Luc/M-4046-2017; Duempelmann, Luc/P-6061-2019; Bircher,
   Benjamin/AAW-2668-2020
OI Duempelmann, Luc/0000-0002-7552-543X; Duempelmann,
   Luc/0000-0002-7552-543X; Bircher, Benjamin/0000-0002-1494-6732
FU SNF [200021/130594]; NCCR Nano; ARGOVIA project NoViDeMo
FX The authors acknowledge H. Stahlberg (C-CINA, University of Basel,
   Switzerland) for providing infrastructure and facilities; S.A. Muller
   (C-CINA) for critically reading the manuscript; M. Despont and U.
   Drechsler (IBM Research GmbH, Rueschlikon, Switzerland) for providing
   cantilever arrays; K.N. Goldie (C-CINA) for determining the cantilever
   dimensions by scanning electron microscopy. This work was supported by
   SNF grant 200021/130594, NCCR Nano and ARGOVIA project NoViDeMo.
CR Asakawa H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3238484
   BARNES JR, 1994, REV SCI INSTRUM, V65, P3793, DOI 10.1063/1.1144509
   Bircher BA, 2013, ANAL CHEM, V85, P8676, DOI 10.1021/ac4014918
   Burke BG, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4776197
   Canetta C, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795625
   de Araujo MAC, 2009, APPL OPTICS, V48, P393, DOI 10.1364/AO.48.000393
   Han WH, 1996, APPL PHYS LETT, V69, P4111, DOI 10.1063/1.117835
   Ilic B, 2010, J APPL PHYS, V107, DOI 10.1063/1.3305464
   INABA S, 1993, J APPL PHYS, V73, P2654, DOI 10.1063/1.353060
   Jalili N, 2004, MECHATRONICS, V14, P907, DOI 10.1016/j.mechatronics.2004.04.005
   Johnson BN, 2012, BIOSENS BIOELECTRON, V32, P1, DOI 10.1016/j.bios.2011.10.054
   Kim S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240737
   Kiracofe D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3518965
   Labuda A, 2011, AIP ADV, V1, DOI 10.1063/1.3601872
   Labuda A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4712286
   Liu C, 2009, MICRO NANO LETT, V4, P9, DOI 10.1049/mnl:20080044
   Maali A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196052
   Mishra R, 2012, J SENSORS, V2012, DOI 10.1155/2012/617386
   Moulin AM, 1997, J VAC SCI TECHNOL B, V15, P590, DOI 10.1116/1.589297
   Nishida S, 2009, J VAC SCI TECHNOL B, V27, P964, DOI 10.1116/1.3077487
   Paolino P, 2009, J APPL PHYS, V106, DOI 10.1063/1.3245394
   Ramos D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2205409
   Ramos D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917718
   Ramos D, 2007, SENSORS-BASEL, V7, P1757, DOI 10.3390/s7091757
   Ratcliff GC, 1998, APPL PHYS LETT, V72, P1911, DOI 10.1063/1.121224
   Schaffer TE, 1996, J APPL PHYS, V80, P3622, DOI 10.1063/1.363308
   Shen S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2829999
   Stahl S. W., 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3157466
   Vassalli M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497074
   VENKATESH S, 1985, ELECTRON LETT, V21, P315, DOI 10.1049/el:19850223
   Wang SQ, 2009, OPTIK, V120, P676, DOI 10.1016/j.ijleo.2008.02.019
NR 31
TC 10
Z9 10
U1 0
U2 25
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD NOV
PY 2013
VL 8
IS 11
BP 770
EP 774
DI 10.1049/mnl.2013.0352
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 257ZC
UT WOS:000327425500005
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Wernli, L
   Bonkat, G
   Gasser, TC
   Bachmann, A
   Braissant, O
AF Wernli, L.
   Bonkat, G.
   Gasser, T. C.
   Bachmann, A.
   Braissant, O.
TI Use of isothermal microcalorimetry to quantify the influence of glucose
   and antifungals on the growth of Candida albicans in urine
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE disease processes; infection; metabolism; mycology; yeast
ID TRACT-INFECTIONS; SUSCEPTIBILITY; CURVES; SPP.
AB AimsUrinary tract infection (UTI) caused by Candida spp. is an increasing problem in clinical practice. Risk factors include diabetes mellitus, extremes of age, urinary tract abnormalities and indwelling catheters. Here, we determined the applicability of isothermal microcalorimetry (IMC) for the detection and antifungal drug susceptibility testing of Candida albicans in artificial urine.
   Methods and ResultsIsothermal microcalorimetry was used to monitor the metabolic heat production rates of C.albicans at 37 degrees C (W=Js(-1)). The influence of increasing concentrations of glucose and antifungal drugs on the growth of C.albicans was investigated. The growth rate increased linearly from 00240010 to 02030006h(-1) with increasing concentration of glucose from 20 to 1640mgl(-1). The minimum inhibitory concentrations (MIC) against C.albicans were determined at a fixed glucose concentration of 560mgl(-1). These MIC were 05gml(-1) for amphotericin B, 5gml(-1) for flucytosine, 08gml(-1) for fluconazole and 05gml(-1) for tioconazole, respectively.
   ConclusionsIMC is able to detect and quantify growth of C.albicans in artificial urine and to determine the MIC of antifungal drugs against C.albicans. This study demonstrated that IMC can be used for basic research on Candida-UTI and opens promising avenue for the use of IMC as rapid drug resistance screening tool and diagnostic tool.
   Significance and Impact of StudyLittle is known on the growth of C.albicans in urine. Our study provides measurements of the growth rate of this yeast in urine with various glucose concentrations. Thus, important insights are gathered for risk group such as patients with diabetes or patients with prolonged parenteral nutrition resulting in higher urinary glucose concentration.
C1 [Wernli, L.; Bonkat, G.; Gasser, T. C.; Bachmann, A.; Braissant, O.] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Bonkat, G.; Braissant, O.] Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, Biozentrum,Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124
   Astasov-Frauenhoffer M, 2011, J MATER SCI-MATER M, V22, P2045, DOI 10.1007/s10856-011-4377-5
   Aubert R. E., 1996, DIABETES AM, P782
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   Beezer A. E., 1974, SCI TOOLS, V21, P13
   Beezer A. E., 1978, SCI TOOLS, V25, P2510
   BERMUDEZ J, 1988, CAN J MICROBIOL, V34, P1058, DOI 10.1139/m88-186
   Bonkat G, 2013, WORLD J UROL, V31, P553, DOI 10.1007/s00345-012-0913-2
   Bonkat G, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.04.050
   Bonkat G, 2012, BJU INT, V110, P892, DOI 10.1111/j.1464-410X.2011.10902.x
   Bonkat G, 2011, WORLD J UROL, V29, P133, DOI 10.1007/s00345-010-0535-5
   Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29
   Braissant O, 2013, THERMOCHIM ACTA, V555, P64, DOI 10.1016/j.tca.2012.12.005
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Chaturvedi AK, 2009, J FORENSIC SCI, V54, P715, DOI 10.1111/j.1556-4029.2009.01011.x
   Clancy CJ, 2005, ANTIMICROB AGENTS CH, V49, P3171, DOI 10.1128/AAC.49.8.3171-3177.2005
   Febre N, 1999, J CLIN MICROBIOL, V37, P1584
   Fisher JF, 2011, CLIN INFECT DIS, V52, pS457, DOI 10.1093/cid/cir112
   Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110
   Furustrand U, 2011, MYCOSES, V54, P168
   GALGIANI JN, 1978, ANTIMICROB AGENTS CH, V13, P249, DOI 10.1128/AAC.13.2.249
   Gautam G, 2006, J ENDOUROL, V20, P522, DOI 10.1089/end.2006.20.522
   Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761
   GRIFFIN NK, 1979, ARCH DIS CHILD, V54, P371, DOI 10.1136/adc.54.5.371
   GUINET R, 1988, J CLIN MICROBIOL, V26, P2307, DOI 10.1128/JCM.26.11.2307-2312.1988
   HESSE A, 1986, CLIN CHIM ACTA, V160, P79, DOI 10.1016/0009-8981(86)90126-9
   Howell M, 2012, J CLIN MICROBIOL, V50, P16, DOI 10.1128/JCM.05556-11
   JONES RN, 1993, DIAGN MICR INFEC DIS, V17, P45, DOI 10.1016/0732-8893(93)90069-J
   Kahm M, 2010, J STAT SOFTW, V33, P1
   Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Lockhart SR, 2011, J CLIN MICROBIOL, V49, P4322, DOI 10.1128/JCM.05479-11
   LOPEZ D, 1987, CAN J MICROBIOL, V33, P6, DOI 10.1139/m87-002
   Malani AN, 2007, EXPERT REV ANTI-INFE, V5, P277, DOI 10.1586/14787210.5.2.277
   PANG SYM, 2012, INT J BIOL LIFE SCI, V8, P80
   Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757
   Porte L, 2012, REV CHIL INFECTOL, V29, P149, DOI 10.4067/S0716-10182012000200005
   Puntnam F. D., 1971, CR1802 NASA
   R Core Team, 2017, R LANG ENV STAT COMP
   SAVAGE N, 1971, INFECT IMMUN, V3, P141, DOI 10.1128/IAI.3.1.141-148.1971
   Shin JH, 2002, J CLIN MICROBIOL, V40, P1244, DOI 10.1128/JCM.40.4.1244-1248.2002
   Sobel J. D., 2002, INFECT DIS, V4, P81
   Sobel JD, 2011, CLIN INFECT DIS, V52, pS433, DOI 10.1093/cid/cir109
   Taylor EN, 2007, J AM SOC NEPHROL, V18, P654, DOI 10.1681/ASN.2006080854
   Trampuz A, 2007, TRANSFUSION, V47, P1643, DOI 10.1111/j.1537-2995.2007.01336.x
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9
   Williams DW, 2000, ORAL DIS, V6, P3, DOI 10.1111/j.1601-0825.2000.tb00314.x
   Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1
   YOUNG DS, 1970, CLIN CHEM, V16, P954
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 53
TC 9
Z9 9
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD NOV
PY 2013
VL 115
IS 5
BP 1186
EP 1193
DI 10.1111/jam.12306
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 269ET
UT WOS:000328225000009
PM 23865534
OA Bronze
DA 2021-01-25
ER

PT J
AU Alghisi, E
   Distel, M
   Malagola, M
   Anelli, V
   Santoriello, C
   Herwig, L
   Krudewig, A
   Henkel, CV
   Russo, D
   Mione, MC
AF Alghisi, E.
   Distel, M.
   Malagola, M.
   Anelli, V.
   Santoriello, C.
   Herwig, L.
   Krudewig, A.
   Henkel, C. V.
   Russo, D.
   Mione, M. C.
TI Targeting oncogene expression to endothelial cells induces proliferation
   of the myelo-erythroid lineage by repressing the notch pathway
SO LEUKEMIA
LA English
DT Article
DE myeloid leukemia model; hemogenic endothelium; RAS; myelo-erythroid
   proliferative neoplasm; zebrafish
ID HEMATOPOIETIC STEM-CELLS; IN-VIVO; DEFINITIVE HEMATOPOIESIS; AORTIC
   ENDOTHELIUM; GENE-EXPRESSION; ZEBRAFISH; BLOOD; MECHANISMS; TUMORS;
   MODEL
AB Human oncogenes involved in the development of hematological malignancies have been widely used to model experimental leukemia. However, models of myeloid leukemia rarely reproduce the human disease in full, due to genetic complexity or to difficulties in targeting leukemia initiating cells. Here, we used a zebrafish genetic model to induce the expression of oncogenic RAS in endothelial cells, including the hemogenic endothelium of the dorsal aorta that generates hematopoietic cells, and observed the development of a myelo-erythroid proliferative disorder. In larvae, the phenotype is characterized by disruption of the vascular system and prominent expansion of the caudal hematopoietic tissue. In few surviving juveniles, increased number of immature hematopoietic cells and arrest of myeloid maturation was found in kidney marrow. Peripheral blood showed increased erythroblasts and myeloid progenitors. We found that the abnormal phenotype is associated with a downregulation of the Notch pathway, whereas overexpressing an activated form of Notch together with the oncogene prevents the expansion of the myeloerythroid compartment. This study identifies the downregulation of the Notch pathway following an oncogenic event in the hemogenic endothelium as an important step in the pathogenesis of myelo-erythroid disorders and describes a number of potential effectors of this transformation.
C1 [Alghisi, E.; Malagola, M.; Russo, D.] Univ Brescia, Sch Med, Chair Hematol, Brescia, Italy.
   [Alghisi, E.; Malagola, M.; Russo, D.] Univ Brescia, Sch Med, Unit Blood Dis & Stem Cell Transplantat, Dept Clin & Expt Sci, Brescia, Italy.
   [Alghisi, E.; Mione, M. C.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany.
   [Distel, M.] UCSD, La Jolla, CA USA.
   [Anelli, V.] Weill Cornell Med Coll, Dept Surg, New York, NY USA.
   Weill Cornell Med Coll, Dept Med, New York, NY USA.
   [Anelli, V.] New York Presbyterian Hosp, New York, NY USA.
   [Santoriello, C.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Herwig, L.; Krudewig, A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Henkel, C. V.] ZF Screens BV, Leiden, Netherlands.
RP Mione, MC (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, ITG B304,Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
EM maria.mione@kit.edu
RI Distel, Martin/AAN-6408-2020
OI Distel, Martin/0000-0001-5942-0817; Henkel,
   Christiaan/0000-0001-9838-8215; ANELLI, Viviana
   Vittoria/0000-0003-1964-3252; Mione, Maria Caterina/0000-0002-9040-3705
FU German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch
   Dienst (DAAD); EMBO fellowshipEuropean Molecular Biology Organization
   (EMBO); BCC Pompiano e Franciacorta and Lions Bassa Bresciana
   Foundation; Helmholtz research programme BioInterfaces; 
   [COST-STSM-BM0804-040712-019714]
FX We are grateful to D Traver, K Kawakami, R Koester, M Tada, M Affolter,
   N Lawson, G Lieschke, L Zon and member of his lab, for plasmids,
   transgenic lines and suggestions in the course of this project. ZF
   Screen for carrying out the deep sequencing. EA was supported by a
   COST-STSM-BM0804-040712-019714 travel fellowship; MD by a postdoctoral
   fellowship of the German Academic Exchange Service (DAAD) and an EMBO
   fellowship. EA, MM and DR were partially supported by BCC Pompiano e
   Franciacorta and Lions Bassa Bresciana Foundation. MCM was supported by
   the Helmholtz research programme BioInterfaces.
CR Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105
   Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297
   Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385
   Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590
   Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738
   Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225
   Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251
   Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003
   Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107
   Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106
   Forrester A Michael, 2012, Adv Hematol, V2012, P358518, DOI 10.1155/2012/358518
   Forrester AM, 2011, BRIT J HAEMATOL, V155, P167, DOI 10.1111/j.1365-2141.2011.08810.x
   Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272
   Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732
   Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Hirschi KK, 2012, BLOOD, V119, P4823, DOI 10.1182/blood-2011-12-353466
   Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791
   Kato H, 1997, DEVELOPMENT, V124, P4133
   Kawakami K, 2004, METHOD CELL BIOL, V77, P201
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761
   Lancrin C, 2010, J MOL MED, V88, P167, DOI 10.1007/s00109-009-0554-0
   Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104
   Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048
   Martin CS, 2011, GENOME MED, V3, DOI 10.1186/gm299
   McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012
   Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998
   Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002
   Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812
   Payne E, 2009, BRIT J HAEMATOL, V146, P247, DOI 10.1111/j.1365-2141.2009.07705.x
   Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133
   Santoriello C, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00973.x
   Santoriello C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015170
   Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Teittinen KJ, 2012, LEUKEMIA RES, V36, P1082, DOI 10.1016/j.leukres.2012.06.001
   Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009
   Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147
   Zhang CX, 2013, BBA-GEN SUBJECTS, V1830, P2370, DOI 10.1016/j.bbagen.2012.06.008
NR 42
TC 18
Z9 19
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0887-6924
EI 1476-5551
J9 LEUKEMIA
JI Leukemia
PD NOV
PY 2013
VL 27
IS 11
BP 2229
EP 2241
DI 10.1038/leu.2013.132
PG 13
WC Oncology; Hematology
SC Oncology; Hematology
GA 250UV
UT WOS:000326882500014
PM 23625115
OA Bronze
DA 2021-01-25
ER

PT J
AU Gruss, F
   Zahringer, F
   Jakob, RP
   Burmann, BM
   Hiller, S
   Maier, T
AF Gruss, Fabian
   Zaehringer, Franziska
   Jakob, Roman P.
   Burmann, Bjoern M.
   Hiller, Sebastian
   Maier, Timm
TI The structural basis of autotransporter translocation by TamA
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID BARREL MEMBRANE-PROTEINS; OUTER-MEMBRANE; 2-PARTNER SECRETION;
   ESCHERICHIA-COLI; FHAC; MEMBER; CONSERVATION; SUPERFAMILY; BIOGENESIS;
   COMPONENT
AB TamA is an Escherichia coli Omp85 protein involved in autotransporter biogenesis. It comprises a 16-stranded transmembrane. beta-barrel and three POTRA domains. The 2.3-angstrom crystal structure reveals that the TamA barrel is closed at the extracellular face by a conserved lid loop. The C-terminal beta-strand of the barrel forms an unusual inward kink, which weakens the lateral barrel wall and creates a gate for substrate access to the lipid bilayer.
C1 [Gruss, Fabian; Zaehringer, Franziska; Jakob, Roman P.; Burmann, Bjoern M.; Hiller, Sebastian; Maier, Timm] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM sebastian.hiller@unibas.ch; timm.maier@unibas.ch
RI Burmann, Bjorn/AAR-7399-2020; Burmann, Bjorn/M-8913-2015; Hiller,
   Sebastian/B-3573-2008; Maier, Timm/A-8835-2016
OI Burmann, Bjorn/0000-0002-3135-7964; Hiller,
   Sebastian/0000-0002-6709-4684; Maier, Timm/0000-0002-7459-1363; Jakob,
   Roman/0000-0002-6451-8656
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3_128419]; European Research CouncilEuropean Research
   Council (ERC) [MOMP 281764]; Werner-Siemens Foundation
FX Crystallographic experiments were performed at PXIII (Swiss Light
   Source, Paul Scherrer Institute, Switzerland). We thank M. Wang and V.
   Olieric for support at the beamline, T. Schirmer for discussion and L.
   Betancor and P. F. Leadlay (University of Cambridge) for the pL1SL2
   plasmid. This work was supported by the Swiss National Science
   Foundation (Grant PP00P3_ 128419 to S. H.) and the European Research
   Council (FP7 contract MOMP 281764 to S. H.). F. G. acknowledges a
   fellowship by the Werner-Siemens Foundation.
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007
   Betancor L, 2008, CHEMBIOCHEM, V9, P2962, DOI 10.1002/cbic.200800475
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860
   Delattre AS, 2011, MOL MICROBIOL, V81, P99, DOI 10.1111/j.1365-2958.2011.07680.x
   Delattre AS, 2010, FEBS J, V277, P4755, DOI 10.1111/j.1742-4658.2010.07881.x
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fan E, 2012, J BIOL CHEM, V287, P2591, DOI 10.1074/jbc.M111.293068
   Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Guedin S, 2000, J BIOL CHEM, V275, P30202, DOI 10.1074/jbc.M005515200
   Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611
   Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521
   Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110
   Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700
   Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060
   Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047
   Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261
   Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004
   van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061
   VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0
   Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z
   Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753
NR 31
TC 88
Z9 89
U1 0
U2 25
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD NOV
PY 2013
VL 20
IS 11
BP 1318
EP U247
DI 10.1038/nsmb.2689
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 250VH
UT WOS:000326883900013
PM 24056943
DA 2021-01-25
ER

PT J
AU Gibeaux, R
   Hoepfner, D
   Schlatter, I
   Antony, C
   Philippsen, P
AF Gibeaux, Romain
   Hoepfner, Dominic
   Schlatter, Ivan
   Antony, Claude
   Philippsen, Peter
TI Organization of Organelles within Hyphae of Ashbya gossypii Revealed by
   Electron Tomography
SO EUKARYOTIC CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; MULTINUCLEATED HYPHAE; MITOCHONDRIAL
   MORPHOLOGY; CYTOPLASMIC MICROTUBULES; PEROXISOME ABUNDANCE; DYNAMICS;
   YEAST; GROWTH; NUCLEI; ACTIN
AB Ashbya gossypii grows as multinucleated and constantly elongating hyphae. Nuclei are in continuous forward and backward motion, also move during mitosis, and frequently bypass each other. Whereas these nuclear movements are well documented, comparatively little is known about the density and morphology of organelles which very likely influence these movements. To understand the three-dimensional subcellular organization of hyphae at high resolution, we performed large-scale electron tomography of the tip regions in A. gossypii. Here, we present a comprehensive space-filling model in which most membrane-limited organelles including nuclei, mitochondria, endosomes, multivesicular bodies, vacuoles, autophagosomes, peroxisomes, and vesicles are modeled. Nuclei revealed different morphologies and protrusions filled by the nucleolus. Mitochondria are very abundant and form a tubular network with a polarized spherical fraction. The organelles of the degradative pathways show a clustered organization. By analyzing vesicle-like bodies, we identified three size classes of electron-dense vesicles (similar to 200, similar to 150, and similar to 100 nm) homogeneously distributed in the cytoplasm which most likely represent peroxisomes. Finally, coated and un-coated vesicles with approximately 40-nm diameters show a polarized distribution toward the hyphal tip with the coated vesicles preferentially localizing at the hyphal periphery.
C1 [Gibeaux, Romain; Antony, Claude] European Mol Biol Lab, D-69012 Heidelberg, Germany.
   [Hoepfner, Dominic; Schlatter, Ivan; Philippsen, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM peter.philippsen@unibas.ch
RI antony, claude/K-5342-2013; Gibeaux, Romain/E-2920-2019
OI Gibeaux, Romain/0000-0001-5081-1985
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-112688]
FX Part of the work was supported by the Swiss National Science Foundation
   (grant 3100A0-112688 to P.P.).
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09
   Chang CC, 1999, J CELL SCI, V112, P1579
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4
   Gerstenberger JP, 2012, EUKARYOT CELL, V11, P353, DOI 10.1128/EC.05257-11
   Gibeaux R, 2012, J CELL SCI, V125, P5830, DOI 10.1242/jcs.111005
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Grava S, 2011, EUKARYOT CELL, V10, P902, DOI 10.1128/EC.05095-11
   Grava S, 2010, MOL BIOL CELL, V21, P3680, DOI 10.1091/mbc.E10-06-0527
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hickey PC, 2009, MED MYCOL, V47, pS110, DOI 10.1080/13693780802546541
   Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020
   Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Hohmann-Marriott MF, 2006, NEW PHYTOL, V172, P208, DOI 10.1111/j.1469-8137.2006.01868.x
   HOWARD RJ, 1981, J CELL SCI, V48, P89
   Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3
   Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363
   Kunze M, 2002, EUR J BIOCHEM, V269, P915, DOI 10.1046/j.0014-2956.2001.02727.x
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   Maeting I, 1999, FEBS LETT, V444, P15, DOI 10.1016/S0014-5793(99)00017-4
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09
   Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010
   Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464
   Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377
   Webster MT, 2010, J CELL BIOL, V191, P1079, DOI 10.1083/jcb.201006083
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010
NR 36
TC 6
Z9 6
U1 2
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
EI 1535-9786
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD NOV
PY 2013
VL 12
IS 11
BP 1423
EP 1432
DI 10.1128/EC.00106-13
PG 10
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 241IK
UT WOS:000326159800002
PM 23771903
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Hassaine, G
   Deluz, C
   Li, XD
   Graff, A
   Vogel, H
   Nury, H
AF Hassaine, Gherici
   Deluz, Cedric
   Li, Xiao-Dan
   Graff, Alexandra
   Vogel, Horst
   Nury, Hugues
TI Large scale expression and purification of the mouse 5-HT3 receptor
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Cys-loop receptor; Pentameric ligand-gated ion channel; Heterologous
   expression; X-ray diffraction
ID GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; SIZE-EXCLUSION
   CHROMATOGRAPHY; HIGH-LEVEL EXPRESSION; MAMMALIAN-CELL LINE;
   X-RAY-STRUCTURE; N-GLYCOSYLATION; 2D CRYSTALLIZATION; MEMBRANE-PROTEINS;
   LIGAND-BINDING
AB Receptors of the Cys-loop family are central to neurotransmission and primary therapeutic targets. In order to decipher their gating and modulation mechanisms, structural data is essential. However, structural studies require large amounts of pure, functional receptors. Here, we present the expression and purification of the mouse serotonin 5-HT3 receptor to high purity and homogeneity levels. Inducible expression in human embryonic kidney 293 cells in suspension cultures with orbital shaking resulted in yields of 6-8 mg receptor per liter of culture. Affinity purification using a strep tag provided pure protein in active form. Further deglycosylation and removal of the purification tag led to a pentameric receptor after size-exclusion chromatography, at the milligram scale. This material is suitable for crystallography, as demonstrated by X-ray diffraction of receptor crystals at low resolution. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Hassaine, Gherici; Deluz, Cedric; Vogel, Horst; Nury, Hugues] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland.
   [Li, Xiao-Dan] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   [Graff, Alexandra] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4085 Basel, Switzerland.
RP Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland.
EM horst.vogel@epfl.ch; hugues.nury@epfl.ch
OI li, xiaodan/0000-0001-8647-7317; Nury, Hugues/0000-0002-3433-256X
FU Swiss National Science Foundation (the SystemsX program); Swiss National
   Science Foundation (SNF Grant) [31003A-118148]; Ecole Polytechnique
   Federale de Lausanne; EMBOEuropean Molecular Biology Organization
   (EMBO); Human Science Frontier ProgramHuman Frontier Science Program
FX This work as supported by the Swiss National Science Foundation (the
   SystemsX program and SNF Grant 31003A-118148), and internal funds of the
   Ecole Polytechnique Federale de Lausanne. H.N was supported by EMBO and
   Human Science Frontier Program postdoc fellowships.
CR AAPRO MS, 1991, DRUGS, V42, P551, DOI 10.2165/00003495-199142040-00002
   Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003
   Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833
   Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462
   BOESS FG, 1995, J NEUROCHEM, V64, P1401
   Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1
   daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944
   DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0
   Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456
   GREEN T, 1995, J BIOL CHEM, V270, P6056, DOI 10.1074/jbc.270.11.6056
   Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107
   Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009
   Hendershot L.M., 2007, MT SINAI J MED, V71, P3641
   Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139
   Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717
   Hovius R, 1998, J NEUROCHEM, V70, P824
   Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001
   Ilegems E, 2004, J BIOL CHEM, V279, P53346, DOI 10.1074/jbc.M407467200
   Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896
   Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013
   Liu SP, 2011, PROTEIN EXPRES PURIF, V79, P102, DOI 10.1016/j.pep.2011.05.019
   Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496
   MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042
   Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015
   Monk SA, 2004, BIOCHEM PHARMACOL, V68, P1787, DOI 10.1016/j.bcp.2004.06.034
   Muller N, 2005, BIOTECHNOL BIOENG, V89, P400, DOI 10.1002/bit.20358
   Na JH, 2013, PROTEIN EXPRES PURIF, V88, P190, DOI 10.1016/j.pep.2013.01.001
   O'Malley MA, 2009, PROTEIN SCI, V18, P2356, DOI 10.1002/pro.246
   Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307
   Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185
   Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299
   Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624
   Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795
   Tairi AP, 1998, BIOCHEMISTRY-US, V37, P15850, DOI 10.1021/bi981812z
   Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527
   Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168
   Tol MB, 2013, J BIOL CHEM, V288, P5756, DOI 10.1074/jbc.M112.422287
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001
   Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200
   Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746
   Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939
NR 44
TC 17
Z9 17
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD NOV
PY 2013
VL 1828
IS 11
BP 2544
EP 2552
DI 10.1016/j.bbamem.2013.05.028
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 241CE
UT WOS:000326143200022
PM 23747684
OA Bronze
DA 2021-01-25
ER

PT J
AU Alperi, A
   Larrea, D
   Fernandez-Gonzalez, E
   Dehio, C
   Zechner, EL
   Llosa, M
AF Alperi, Anabel
   Larrea, Delfina
   Fernandez-Gonzalez, Esther
   Dehio, Christoph
   Zechner, Ellen L.
   Llosa, Matxalen
TI A Translocation Motif in Relaxase TrwC Specifically Affects Recruitment
   by Its Conjugative Type IV Secretion System
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID SITE-SPECIFIC RECOMBINATION; DNA TRANSFER; PLASMID R388;
   BARTONELLA-HENSELAE; PROTEIN; SIGNAL; BACTERIAL; TRANSPORT;
   ORGANIZATION; RECOGNITION
AB Type IV secretion system (T4SS) substrates are recruited through a translocation signal that is poorly defined for conjugative relaxases. The relaxase TrwC of plasmid R388 is translocated by its cognate conjugative T4SS, and it can also be translocated by the VirB/D4 T4SS of Bartonella henselae, causing DNA transfer to human cells. In this work, we constructed a series of TrwC variants and assayed them for DNA transfer to bacteria and human cells to compare recruitment requirements by both T4SSs. Comparison with other reported relaxase translocation signals allowed us to determine two putative translocation sequence (TS) motifs, TS1 and TS2. Mutations affecting TS1 drastically affected conjugation frequencies, while mutations affecting either motif had only a mild effect on DNA transfer rates through the VirB/D4 T4SS of B. henselae. These results indicate that a single substrate can be recruited by two different T4SSs through different signals. The C terminus affected DNA transfer rates through both T4SSs tested, but no specific sequence requirement was detected. The addition of a Bartonella intracellular delivery (BID) domain, the translocation signal for the Bartonella VirB/D4 T4SS, increased DNA transfer up to 4% of infected human cells, providing an excellent tool for DNA delivery to specific cell types. We show that the R388 coupling protein TrwB is also required for this high-efficiency TrwC-BID translocation. Other elements apart from the coupling protein may also be involved in substrate recognition by T4SSs.
C1 [Alperi, Anabel; Larrea, Delfina; Fernandez-Gonzalez, Esther; Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.
   [Alperi, Anabel; Larrea, Delfina; Fernandez-Gonzalez, Esther; Llosa, Matxalen] UC SODERCAN CSIC, IBBTEC, Santander, Spain.
   [Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Zechner, Ellen L.] Graz Univ, Inst Mol Biosci, Graz, Austria.
RP Llosa, M (corresponding author), Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.
EM llosam@unican.es
RI Dehio, Christoph/R-8277-2016; Fernandez Gonzalez, Esther/I-6457-2015; ,
   matxalen/ABG-5541-2020; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Fernandez Gonzalez,
   Esther/0000-0001-5586-4373; , matxalen/0000-0002-4826-2240; Dehio,
   Christoph/0000-0001-7288-1052; Zechner, Ellen L./0000-0003-2035-1898
FU Consejo Superior de Investigaciones Cientificas (CSIC, Spain)Consejo
   Superior de Investigaciones Cientificas (CSIC); Spanish Ministry of
   Science and InnovationSpanish Government [BIO2010-11623-E]; Austrian
   Science Fund (FWF)Austrian Science Fund (FWF) [P 24016] Funding Source:
   researchfish
FX A.A. and D. L. were supported by a JAE-Doc and a JAE-Predoc fellowship,
   respectively, from the Consejo Superior de Investigaciones Cientificas
   (CSIC, Spain). This work was supported by grant BIO2010-11623-E from the
   Spanish Ministry of Science and Innovation to M.L.
CR Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047
   Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10
   Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09
   Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696
   BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990
   Cesar CE, 2007, J BACTERIOL, V189, P9037, DOI 10.1128/JB.01152-07
   DATTA N, 1972, J GEN MICROBIOL, V72, P349, DOI 10.1099/00221287-72-2-349
   de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x
   de Paz HD, 2010, J BACTERIOL, V192, P2655, DOI 10.1128/JB.01692-09
   Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102
   Fernandez-Gonzalez E, 2011, J BACTERIOL, V193, P6257, DOI 10.1128/JB.05905-11
   Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002
   GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x
   Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425
   GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645
   Guo ML, 2007, P NATL ACAD SCI USA, V104, P20019, DOI 10.1073/pnas.0701738104
   Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x
   Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10
   Lang SV, 2012, PLASMID, V67, P128, DOI 10.1016/j.plasmid.2011.12.014
   Lang S, 2010, MOL MICROBIOL, V78, P1539, DOI 10.1111/j.1365-2958.2010.07423.x
   LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005
   Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008
   Llosa M, 2012, TRENDS MICROBIOL, V20, P355, DOI 10.1016/j.tim.2012.05.008
   Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x
   Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101
   Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x
   Parker C, 2007, MOL MICROBIOL, V66, P252, DOI 10.1111/j.1365-2958.2007.05925.x
   Redzej A, 2013, MOL MICROBIOL, V89, P324, DOI 10.1111/mmi.12275
   SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0
   Sambrook J., 2001, MOL CLONING LAB MANU
   SARKAR G, 1990, BIOTECHNIQUES, V8, P404
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102
   Vergunst AC, 2003, PLANT PHYSIOL, V133, P978, DOI 10.1104/pp.103.029223
   Wilkins BM, 2000, MOL MICROBIOL, V38, P650, DOI 10.1046/j.1365-2958.2000.02164.x
NR 37
TC 20
Z9 20
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD NOV
PY 2013
VL 195
IS 22
BP 4999
EP 5006
DI 10.1128/JB.00367-13
PG 8
WC Microbiology
SC Microbiology
GA 240JR
UT WOS:000326092400003
PM 23995644
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Artner, D
   Oblak, A
   Ittig, S
   Garate, JA
   Horvat, S
   Arrieumerlou, C
   Hofinger, A
   Oostenbrink, C
   Jerala, R
   Kosma, P
   Zamyatina, A
AF Artner, Daniel
   Oblak, Alja
   Ittig, Simon
   Garate, Jose Antonio
   Horvat, Simon
   Arrieumerlou, Cecile
   Hofinger, Andreas
   Oostenbrink, Chris
   Jerala, Roman
   Kosma, Paul
   Zamyatina, Alla
TI Conformationally Constrained Lipid A Mimetics for Exploration of
   Structural Basis of TLR4/MD-2 Activation by Lipopolysaccharide
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID INNATE IMMUNE-RESPONSES; DIFFERENTIAL INDUCTION; RECEPTOR 4; HUMAN MD-2;
   ENDOTOXIN; TLR4; TOLL-LIKE-RECEPTOR-4; RECOGNITION; ANALOGS; ROLES
AB Recognition of the lipopolysaccharicle (LPS), a major component of the outer membrane of Gram-negative bacteria, by the Toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD-2) complex is essential for the control of bacterial infection. A pro-inflammatory signaling cascade is initiated upon binding of membrane-associated portion of LPS, a glycophospholipid Lipid A, by a coreceptor protein MD-2, which results in a protective host innate immune response. However, activation of TLR4 signaling by LPS may lead to the dysregulated immune response resulting in a variety of inflammatory conditions including sepsis syndrome. Understanding of structural requirements for Lipid A endotoxicity would ensure the development of effective anti-inflammatory medications. Herein, we report on design, synthesis, and biological activities of a series of conformationally confined Lipid A mimetics based on beta,alpha-trehalose-type scaffold. Replacement of the flexible three-bond beta(1 -> 46) linkage in diglucosamine backbone of Lipid A by a two-bond beta,alpha(1 <-> 1) glycosidic linkage afforded novel potent TLR4 antagonists. Synthetic tetraacylated bisphosphorylated Lipid A mimetics based on a beta-GlcN(1 <-> 1)alpha-GlcN scaffold selectively block the LPS binding site on both human and murine MD-2 and completely abolish lipopolysaccharide-induced pro-inflammatory signaling, thereby serving as antisepsis drug candidates. In contrast to their natural counterpart lipid IVa, conformationally constrained Lipid A mimetics do not activate mouse TLR4. The structural basis for high antagonistic activity of novel Lipid A mimetics was confirmed by molecular dynamics simulation. Our findings suggest that besides the chemical structure, also the three-dimensional arrangement of the diglucosamine backbone of MD-2-bound Lipid A determines endotoxic effects on TLR4.
C1 [Artner, Daniel; Hofinger, Andreas; Kosma, Paul; Zamyatina, Alla] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria.
   [Garate, Jose Antonio; Oostenbrink, Chris] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, A-1190 Vienna, Austria.
   [Oblak, Alja; Horvat, Simon; Jerala, Roman] Univ Ljubljana, Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia.
   [Ittig, Simon; Arrieumerlou, Cecile] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Zamyatina, A (corresponding author), Univ Nat Resources & Life Sci, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.
EM alla.zamyatina@boku.ac.ath
RI Zamyatina, Alla/N-8411-2014; Kosma, Paul/Y-7443-2019; Oostenbrink,
   Chris/S-8002-2019
OI Zamyatina, Alla/0000-0002-4001-3522; Kosma, Paul/0000-0001-5342-7161;
   Oostenbrink, Chris/0000-0002-4232-2556; ARRIEUMERLOU,
   Cecile/0000-0002-6463-2897; Garate, Jose Antonio/0000-0002-8345-968X
FU Austrian Science Foundation (FWF)Austrian Science Fund (FWF) [FWF
   P-22116]; Slovenian Research AgencySlovenian Research Agency - Slovenia;
   COST actionEuropean Cooperation in Science and Technology (COST)
   [BM1003]; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P
   22116] Funding Source: researchfish
FX Financial support from Austrian Science Foundation (FWF) (Grant No. FWF
   P-22116), Slovenian Research Agency, and COST action BM1003 is
   gratefully acknowledged.
CR Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848
   Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057
   Akamatsu M, 2006, BIOORGAN MED CHEM, V14, P6759, DOI 10.1016/j.bmc.2006.05.051
   Barochia A, 2011, EXPERT OPIN DRUG MET, V7, P479, DOI 10.1517/17425255.2011.558190
   Bazin HG, 2008, BIOORG MED CHEM LETT, V18, P5350, DOI 10.1016/j.bmcl.2008.09.060
   CHRIST WJ, 1994, J AM CHEM SOC, V116, P3637, DOI 10.1021/ja00087a075
   DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003
   DOWD MK, 1992, J COMPUT CHEM, V13, P102, DOI 10.1002/jcc.540130113
   Fleischer JG, 2012, INNATE IMMUN-LONDON, V18, P171, DOI 10.1177/1753425910394395
   Fujimoto Y, 2005, J ENDOTOXIN RES, V11, P340, DOI 10.1179/096805105X76841
   Fukase K, 1998, TETRAHEDRON, V54, P4033, DOI 10.1016/S0040-4020(98)00133-1
   Gaekwad J, 2010, J BIOL CHEM, V285, P29375, DOI 10.1074/jbc.M110.115204
   Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946
   Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123
   Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002
   Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668
   Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127
   Meng J, 2011, SCI CHINA PHYS CHEM, V54, P187, DOI 10.1007/s11433-010-4225-5
   Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807
   Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07
   Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111
   Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109
   Oikawa M, 2004, ORG BIOMOL CHEM, V2, P3557, DOI 10.1039/b410544c
   Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006
   Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830
   Park SH, 2012, PHARMACOL THERAPEUT, V133, P291, DOI 10.1016/j.pharmthera.2011.11.001
   Peric-Hassler L, 2010, CARBOHYD RES, V345, P1781, DOI 10.1016/j.carres.2010.05.026
   Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200
   RAO VSR, 1998, CONFORMATION CARBOHY, P91
   Reisser D, 2009, ADV EXP MED BIOL, V667, P101
   Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200
   Seydel U, 2000, EUR J BIOCHEM, V267, P3032
   Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118
   Taga T, 1997, ACTA CRYSTALLOGR C, V53, P234, DOI 10.1107/S0108270196012693
   TAKAYAMA K, 1989, INFECT IMMUN, V57, P1336, DOI 10.1128/IAI.57.4.1336-1338.1989
   Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200
   Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825
   Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245
   Wang W, 2008, ANGEW CHEM INT EDIT, V47, P9870, DOI 10.1002/anie.200803474
   Yu LP, 2012, J BIOL CHEM, V287, P16346, DOI 10.1074/jbc.M112.343467
   Zhang YH, 2007, J AM CHEM SOC, V129, P5200, DOI 10.1021/ja068922a
   Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005
NR 42
TC 30
Z9 31
U1 1
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD NOV
PY 2013
VL 8
IS 11
BP 2423
EP 2432
DI 10.1021/cb4003199
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 254OP
UT WOS:000327175300011
PM 23952219
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Mariani, V
   Biasini, M
   Barbato, A
   Schwede, T
AF Mariani, Valerio
   Biasini, Marco
   Barbato, Alessandro
   Schwede, Torsten
TI lDDT: a local superposition-free score for comparing protein structures
   and models using distance difference tests
SO BIOINFORMATICS
LA English
DT Article
ID PREDICTIONS; VALIDATION; ACCURACY
AB Motivation: The assessment of protein structure prediction techniques requires objective criteria to measure the similarity between a computational model and the experimentally determined reference structure. Conventional similarity measures based on a global superposition of carbon alpha atoms are strongly influenced by domain motions and do not assess the accuracy of local atomic details in the model.
   Results: The Local Distance Difference Test (lDDT) is a superpositionfree score that evaluates local distance differences of all atoms in a model, including validation of stereochemical plausibility. The reference can be a single structure, or an ensemble of equivalent structures. We demonstrate that lDDT is well suited to assess local model quality, even in the presence of domain movements, while maintaining good correlation with global measures. These properties make lDDT a robust tool for the automated assessment of structure prediction servers without manual intervention.
C1 [Mariani, Valerio; Biasini, Marco; Barbato, Alessandro; Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mariani, Valerio; Biasini, Marco; Barbato, Alessandro; Schwede, Torsten] SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU SIB Swiss Institute of Bioinformatics
FX The authors gratefully acknowledge the financial support by the SIB
   Swiss Institute of Bioinformatics.
CR Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Bordogna A, 2011, J COMPUT CHEM, V32, P81, DOI 10.1002/jcc.21601
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Clarke ND, 2007, PROTEINS, V69, P10, DOI 10.1002/prot.21686
   Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001
   Engh R.A., 2006, INT TABLES CRYSTALLO, VF, P382, DOI DOI 10.1107/97809553602060000695
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   Flory P.J., 1969, STAT MECH CHAIN MOL
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Huang YJ, 2012, NUCLEIC ACIDS RES, V40, pW542, DOI 10.1093/nar/gks373
   Hubbard TJP, 1999, PROTEINS, P15
   Huggins M.L, 1958, PHYS CHEM HIGH POLYM
   Jones TA, 1999, PROTEINS, P30
   Keedy DA, 2009, PROTEINS, V77, P29, DOI 10.1002/prot.22551
   Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190
   Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753
   Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488
   Kryshtafovych A, 2013, PROTEINS, V81
   MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131
   Mao BC, 2011, STRUCTURE, V19, P757, DOI 10.1016/j.str.2011.04.005
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Martin ACR, 1997, PROTEINS, P14
   MOSIMANN S, 1995, PROTEINS, V23, P301, DOI 10.1002/prot.340230305
   Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011
   Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200
   Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172
   Perez A, 2012, J CHEM THEORY COMPUT, V8, P3985, DOI 10.1021/ct300148f
   Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006
   Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Shi SY, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap003
   Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776
   Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040
   Vendruscolo M., 1999, STAT PROPERTIES CONT
   Zemla A, 2001, PROTEINS, P13
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264
NR 39
TC 73
Z9 73
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD NOV 1
PY 2013
VL 29
IS 21
BP 2722
EP 2728
DI 10.1093/bioinformatics/btt473
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 239BW
UT WOS:000325997500008
PM 23986568
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bhattacharjee, M
   Schultz-Thater, E
   Trella, E
   Miot, S
   Das, S
   Loparic, M
   Ray, AR
   Martin, I
   Spagnoli, GC
   Ghosh, S
AF Bhattacharjee, Maumita
   Schultz-Thater, Elke
   Trella, Emanuele
   Miot, Sylvie
   Das, Sanskrita
   Loparic, Marko
   Ray, Alok R.
   Martin, Ivan
   Spagnoli, Giulio C.
   Ghosh, Sourabh
TI The role of 3D structure and protein conformation on the innate and
   adaptive immune responses to silk-based biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Silk-based biomaterials; Structural architectures; Biocompatibility;
   Monocyte activation; Cytokines
ID IN-VITRO; INFLAMMATORY RESPONSES; INFRARED-SPECTROSCOPY; FILMS; FIBROIN;
   VIVO; IMMUNOGENICITY; ACTIVATION; SUTURES; ORIENTATION
AB We have investigated monocyte and T cell responsiveness to silk based biomaterials of different physicochemical characteristics. Here we report that untransformed CD14+ human monocytes respond to overnight exposure to silk fibroin-based biomaterials in tridimensional form by IL-1 beta and IL-6, but not IL-10 gene expression and protein production. In contrast, fibroin based materials in bidimensional form are unable to stimulate monocyte responsiveness. The elicitation of these effects critically requires contact between biomaterials and responding cells, is not sustained and becomes undetectable in longer term cultures. We also observed that NF-kappa beta and p38 MAP kinase play key roles in monocyte activation by silk-based biomaterials. On the other hand, fibroin based materials, irrespective of their physico-chemical characteristics appeared to be unable to induce the activation of peripheral blood T cells from healthy donors, as evaluated by the expression of activation markers and IFN-gamma gene. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
C1 [Bhattacharjee, Maumita; Das, Sanskrita; Ghosh, Sourabh] Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
   [Bhattacharjee, Maumita; Schultz-Thater, Elke; Trella, Emanuele; Miot, Sylvie; Martin, Ivan; Spagnoli, Giulio C.] Univ Basel, Dept Surg, Univ Basel Hosp, CH-4003 Basel, Switzerland.
   [Bhattacharjee, Maumita; Schultz-Thater, Elke; Trella, Emanuele; Miot, Sylvie; Martin, Ivan; Spagnoli, Giulio C.] Univ Basel, Dept Biomed, Univ Basel Hosp, CH-4003 Basel, Switzerland.
   [Bhattacharjee, Maumita; Das, Sanskrita; Ray, Alok R.] IIT Delhi, Ctr Biomed Engn, New Delhi, India.
   [Bhattacharjee, Maumita; Das, Sanskrita; Ray, Alok R.] All India Inst Med Sci, New Delhi, India.
   [Loparic, Marko] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Loparic, Marko] Univ Basel, Swiss Nanosci Inst, CH-4003 Basel, Switzerland.
RP Ghosh, S (corresponding author), Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
EM gspagnoli@usb.ch; sghosh08@textile.iitd.ac.in
RI Martin, Ivan/K-9286-2016; ray, alok/N-9901-2019
OI Martin, Ivan/0000-0001-6493-0432
FU Indo-Swiss Joint Research Programme [ISJRP 123 003]; Indian Council of
   Medical Research project [09/NCD-1]
FX We thank Elisabetta Padovan (Basel, Switzerland) for advice on monocyte
   and T cell activation assays and for critical reading of the manuscript.
   This work was supported by the Indo-Swiss Joint Research Programme
   (ISJRP 123 003) and Indian Council of Medical Research project
   (09/NCD-1).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bainbridge JA, 2001, J BIOMED MATER RES, V54, P328
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Bhattacharjee M, 2012, ACTA BIOMATER, V8, P3313, DOI 10.1016/j.actbio.2012.05.023
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kurosaki S, 1999, Nihon Ika Daigaku Zasshi, V66, P41, DOI 10.1272/jnms.66.41
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Maas C, 2007, J BIOL CHEM, V282, P2229, DOI 10.1074/jbc.M605984200
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nogueira GM, 2010, BIORESOURCE TECHNOL, V101, P8446, DOI 10.1016/j.biortech.2010.06.064
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107
   SALTHOUSE TN, 1980, OTOLARYNG HEAD NECK, V88, P658, DOI 10.1177/019459988008800606
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schultz-Thater E, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-58
   Seo YK, 2009, CELL BIOL TOXICOL, V25, P513, DOI 10.1007/s10565-008-9105-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wen ZM, 1996, J INVEST ALLERG CLIN, V6, P237
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Young TH, 2000, J BIOMED MATER RES, V50, P490, DOI 10.1002/(SICI)1097-4636(20000615)50:4<490::AID-JBM4>3.0.CO;2-N
   ZIMECKI M, 1978, CLIN IMMUNOL IMMUNOP, V9, P75, DOI 10.1016/0090-1229(78)90123-X
NR 43
TC 52
Z9 54
U1 1
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2013
VL 34
IS 33
BP 8161
EP 8171
DI 10.1016/j.biomaterials.2013.07.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 222HB
UT WOS:000324720700016
PM 23896003
DA 2021-01-25
ER

PT J
AU Fukuhara, K
   Imai, F
   Ladle, DR
   Katayama, KI
   Leslie, JR
   Arber, S
   Jessell, TM
   Yoshida, Y
AF Fukuhara, Kaori
   Imai, Fumiyasu
   Ladle, David R.
   Katayama, Kei-ichi
   Leslie, Jennifer R.
   Arber, Silvia
   Jessell, Thomas M.
   Yoshida, Yutaka
TI Specificity of Monosynaptic Sensory-Motor Connections Imposed by
   Repellent Sema3E-PlexinD1 Signaling
SO CELL REPORTS
LA English
DT Article
ID DEVELOPING SPINAL-CORD; SYNAPTIC SPECIFICITY; NEURONS; AFFERENTS;
   EXPRESSION; MOUSE; TRANSMISSION; SEGREGATION; MECHANISMS; CIRCUITS
AB In mammalian spinal cord, group Ia proprioceptive afferents form selective monosynaptic connections with a select group of motor pool targets. The extent to which sensory recognition of motor neurons contributes to the selectivity of sensory-motor connections remains unclear. We show here that proprioceptive sensory afferents that express PlexinD1 avoid forming monosynaptic connections with neurons in Sema3E(+) motor pools yet are able to form direct connections with neurons in Sema3E(off) motor pools. Anatomical and electrophysiological analysis of mice in which Sema3E-PlexinD1 signaling has been deregulated or inactivated genetically reveals that repellent signaling underlies aspects of the specificity of monosynaptic sensory-motor connectivity in these reflex arcs. A semaphorin-based system of motor neuron recognition and repulsion therefore contributes to the formation of specific sensory-motor connections in mammalian spinal cord.
C1 [Fukuhara, Kaori; Imai, Fumiyasu; Katayama, Kei-ichi; Leslie, Jennifer R.; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
   [Ladle, David R.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.
   [Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Arber, Silvia] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   [Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, Kavli Inst Brain Sci, New York, NY 10032 USA.
   [Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Kavli Inst Brain Sci, New York, NY 10032 USA.
RP Yoshida, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
EM yutaka.yoshida@cchmc.org
RI Katayama, Kei-ichi/J-4699-2013
OI Katayama, Kei-ichi/0000-0003-0527-4644; Arber,
   Silvia/0000-0002-6261-250X
FU March of Dimes FoundationMarch of Dimes [5-FY09-106]; NINDSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [NS065048]; JSPSMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of Science;
   EUEuropean Union (EU); Harold and Leila Mathers Foundation; Wellcome
   TrustWellcome Trust; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); ERCEuropean Research Council (ERC); Kanton
   Basel-Stadt; Novartis Research Foundation; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01NS065048,
   R01NS065048, R01NS065048, R01NS065048, R01NS065048] Funding Source: NIH
   RePORTER
FX We thank M. Mendelsohn, J. Kirkland, and B. Han for help in the
   generation of lsl-Sema3E mice. K. Campbell, F.J. Alvarez, B. Gebelein,
   C. Gu, A. Kania, T. Kuwajima, R. Matsuoka, M. Nakafuku, M. O'Donovan,
   and H. Umemori provided comments on the manuscript. Y.Y. was supported
   by grants from the March of Dimes Foundation (5-FY09-106) and NINDS
   (NS065048). K.K. was supported by JSPS Postdoctoral Fellowships for
   Research Abroad. T.M.J. is an HHMI Investigator and is supported by
   grants from NINDS, EU Framework Program 7, Project ALS, The Harold and
   Leila Mathers Foundation, and The Wellcome Trust. S.A. was supported by
   the Swiss National Science Foundation, an ERC advanced grant, the Kanton
   Basel-Stadt, EU Framework Program 7, and the Novartis Research
   Foundation.
CR Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027
   BROWN AG, 1981, ORG SPINAL CORD
   Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019
   Clandinin TR, 2009, CURR OPIN NEUROBIOL, V19, P174, DOI 10.1016/j.conb.2009.04.011
   Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x
   Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3
   Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347
   Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003
   Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   FRANK E, 1990, J NEUROBIOL, V21, P33, DOI 10.1002/neu.480210104
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q
   Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013
   Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5
   Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004
   Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302
   Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019
   Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007
   Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032
   Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031
   Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135
NR 38
TC 34
Z9 34
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV
PY 2013
VL 5
IS 3
BP 748
EP 758
DI 10.1016/j.celrep.2013.10.005
PG 11
WC Cell Biology
SC Cell Biology
GA 269SY
UT WOS:000328263400020
PM 24210822
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Omasits, U
   Quebatte, M
   Stekhoven, DJ
   Fortes, C
   Roschitzki, B
   Robinson, MD
   Dehio, C
   Ahrens, CH
AF Omasits, Ulrich
   Quebatte, Maxime
   Stekhoven, Daniel J.
   Fortes, Claudia
   Roschitzki, Bernd
   Robinson, Mark D.
   Dehio, Christoph
   Ahrens, Christian H.
TI Directed shotgun proteomics guided by saturated RNA-seq identifies a
   complete expressed prokaryotic proteome
SO GENOME RESEARCH
LA English
DT Article
ID LOW-ABUNDANCE PROTEINS; TANDEM MASS-SPECTRA; BARTONELLA-HENSELAE;
   MEMBRANE-PROTEINS; HUMAN PATHOGEN; PEPTIDE IDENTIFICATION;
   MESSENGER-RNA; QUANTIFICATION; SYSTEM; GENOME
AB Prokaryotes, due to their moderate complexity, are particularly amenable to the comprehensive identification of the protein repertoire expressed under different conditions. We applied a generic strategy to identify a complete expressed prokaryotic proteome, which is based on the analysis of RNA and proteins extracted from matched samples. Saturated transcriptome profiling by RNA-seq provided an endpoint estimate of the protein-coding genes expressed under two conditions which mimic the interaction of Bartonella henselae with its mammalian host. Directed shotgun proteomics experiments were carried out on four subcellular fractions. By specifically targeting proteins which are short, basic, low abundant, and membrane localized, we could eliminate their initial underrepresentation compared to the estimated endpoint. A total of 1250 proteins were identified with an estimated false discovery rate below 1%. This represents 85% of all distinct annotated proteins and similar to 90% of the expressed protein-coding genes. Genes that were detected at the transcript but not protein level, were found to be highly enriched in several genomic islands. Furthermore, genes that lacked an ortholog and a functional annotation were not detected at the protein level; these may represent examples of overprediction in genome annotations. A dramatic membrane proteome reorganizationwas observed, including differential regulation of autotransporters, adhesins, and hemin binding proteins. Particularly noteworthy was the complete membrane proteome coverage, which included expression of all members of the VirB/D4 type IV secretion system, a key virulence factor.
C1 [Omasits, Ulrich; Stekhoven, Daniel J.; Robinson, Mark D.; Ahrens, Christian H.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
   [Omasits, Ulrich] Zurich Life Sci Grad Sch Program Syst Biol, CH-8057 Zurich, Switzerland.
   [Quebatte, Maxime; Dehio, Christoph] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland.
   [Fortes, Claudia; Roschitzki, Bernd] ETH, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland.
   [Fortes, Claudia; Roschitzki, Bernd] Univ Zurich, CH-8057 Zurich, Switzerland.
   [Robinson, Mark D.] Univ Zurich, SIB Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland.
RP Ahrens, CH (corresponding author), Agr Res Stn Agroscope, Res Grp Mol Diagnost Genom & Bioinformat, Schloss 1, CH-8802 Wadenswil, Switzerland.
EM christian.ahrens@imls.uzh.ch
RI Robinson, Mark D/A-6432-2015; Robinson, Mark D./O-2254-2019; Dehio,
   Christoph/R-8277-2016; Stekhoven, Daniel J./K-1887-2019; Ahrens,
   Christian H./F-4656-2011; Dehio, Christoph/AAD-5572-2019
OI Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark
   D./0000-0002-3048-5518; Dehio, Christoph/0000-0001-7288-1052; Ahrens,
   Christian H./0000-0002-8148-7257; Dehio, Christoph/0000-0001-7288-1052;
   Stekhoven, Daniel/0000-0003-3163-3161; Quebatte,
   Maxime/0000-0002-3733-1511; Goldmann, Ulrich/0000-0003-1120-6912
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [31003A-130723]; SNSFSwiss National Science Foundation
   (SNSF) [31003A_ 132979]; SystemsX.ch [51RT 0-126008]
FX We thank Dr. Ermir Qeli for initial work on the project, Sisi Wu and Dr.
   Ljiljana Pasa-Tolic (PNNL, USA) for helpful discussions, Dr. Sangtae Kim
   (PNNL, USA) for the MS-GF+ software, and Drs. Bernd Wollscheid (IMSB,
   ETHZurich), Aurelien Carlier, and Gabriella Pessi (Institute of Plant
   Biology, UZH) for critical reading of the manuscript. C.H.A.
   acknowledges support from the Swiss National Science Foundation (SNSF)
   under grant 31003A-130723. C.D. acknowledges support from the SNSF under
   grant 31003A_ 132979 and from SystemsX.ch under grant 51RT 0-126008 (RTD
   InfectX). A part of the research was performed using EMSL, a national
   scientific user facility sponsored by the Department of Energy's Office
   of Biological and Environmental Research and located at Pacific
   Northwest National Laboratory.
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519
   Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Balgley BM, 2007, MOL CELL PROTEOMICS, V6, P1599, DOI 10.1074/mcp.M600469-MCP200
   Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176
   Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s
   Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300
   Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710
   Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06
   Eberhardt C, 2009, PROTEOMICS, V9, P1967, DOI 10.1002/pmic.200700670
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Fischer F, 2006, MOL CELL PROTEOMICS, V5, P444, DOI 10.1074/mcp.M500234-MCP200
   Fonslow BR, 2011, J PROTEOME RES, V10, P3690, DOI 10.1021/pr200304u
   Franz B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-54
   Giannone RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022942
   Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108
   Guerrier L, 2008, NAT PROTOC, V3, P883, DOI 10.1038/nprot.2008.59
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   Helbig AO, 2010, J PROTEOMICS, V73, P868, DOI 10.1016/j.jprot.2010.01.005
   Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892
   Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004
   Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x
   Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244
   Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731
   Kristensen DB, 2004, MOL CELL PROTEOMICS, V3, P1023, DOI 10.1074/mcp.T400004-MCP200
   Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683
   Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931
   Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733
   Li DM, 2011, GENET MOL RES, V10, P1789, DOI 10.4238/vol10-3gmr1153
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38
   Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029
   Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009
   Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1
   Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]
   Poetsch A, 2008, PROTEOMICS, V8, P4100, DOI 10.1002/pmic.200800273
   Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060
   Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Roden JA, 2012, INFECT IMMUN, V80, P929, DOI 10.1128/IAI.05769-11
   Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597
   Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Venter E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027587
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
NR 65
TC 41
Z9 41
U1 0
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV
PY 2013
VL 23
IS 11
BP 1916
EP 1927
DI 10.1101/gr.151035.112
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 247TA
UT WOS:000326642500015
PM 23878158
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Burmann, BM
   Wang, CW
   Hiller, S
AF Burmann, Bjoern M.
   Wang, Congwei
   Hiller, Sebastian
TI Conformation and dynamics of the periplasmic membrane-protein- chaperone
   complexes OmpX-Skp and tOmpA-Skp
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID NUCLEAR-MAGNETIC-RESONANCE; SUBSTRATE-BINDING; QUALITY-CONTROL;
   RELAXATION; TRANSLOCATION; SPECTROSCOPY; ASSIGNMENT; STABILITY;
   INSERTION; REVEALS
AB The biogenesis of integral outer-membrane proteins (OMPs) in Gram-negative bacteria requires molecular chaperones that prevent the aggregation of OMP polypeptides in the aqueous periplasmic space. How these energy-independent chaperones interact with their substrates is not well understood. We have used high-resolution NMR spectroscopy to examine the conformation and dynamics of the Escherichia coli periplasmic chaperone Skp and two of its complexes with OMPs. The Skp trimer constitutes a flexible architectural scaffold that becomes more rigid upon substrate binding. The OMP substrates populate a dynamic conformational ensemble with structural interconversion rates on the submillisecond timescale. The global lifetime of the chaperone-substrate complex is seven orders of magnitude longer, emerging from the short local lifetimes by avidity. The dynamic state allows for energy-independent substrate release and provides a general paradigm for the conformation of OMP polypeptides bound to energy-independent chaperones.
C1 [Burmann, Bjoern M.; Wang, Congwei; Hiller, Sebastian] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM sebastian.hiller@unibas.ch
RI Burmann, Bjorn/AAR-7399-2020; Burmann, Bjorn/M-8913-2015; Hiller,
   Sebastian/B-3573-2008
OI Burmann, Bjorn/0000-0002-3135-7964; Hiller,
   Sebastian/0000-0002-6709-4684
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3_ 128419]; European Research CommissionEuropean
   CommissionEuropean Commission Joint Research Centre [MOMP 281764];
   Novartis FoundationNovartis; Werner-Siemens Foundation
FX We thank R. Horst, P. Schanda, A. Gossert and G. Wider for discussions
   and D. Kahne (Harvard University) for the SurA plasmid. This work was
   supported by grants from the Swiss National Science Foundation (grant
   PP00P3_ 128419) and from the European Research Commission (FP7 contract
   MOMP 281764) to S. H. and by personal fellowships from the Novartis
   Foundation to B. M. B. and from the Werner-Siemens Foundation to C.W.
CR BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486
   Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h
   Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c
   BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1
   BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684
   Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429
   Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200
   BULL HB, 1974, ARCH BIOCHEM BIOPHYS, V161, P665, DOI 10.1016/0003-9861(74)90352-X
   Burmann BM, 2012, CHIMIA, V66, P759, DOI 10.2533/chimia.2012.759
   Burmann BM, 2011, BIOCHEM J, V435, P783, DOI 10.1042/BJ20101679
   Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x
   Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a
   Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047
   Denoncin K, 2012, PROTEOMICS, V12, P1391, DOI 10.1002/pmic.201100633
   Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747
   Dyson HJ, 2001, METHOD ENZYMOL, V339, P258
   Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697
   Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105
   Fleming P.J., 2004, PROTEIN FOLDING HDB, P706
   Flory P. J., 1989, STAT MECH CHAIN MOL
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850
   Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611
   Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919
   Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565
   Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367
   Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101
   Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102
   Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106
   Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356
   Jarchow S, 2008, PROTEOMICS, V8, P4987, DOI 10.1002/pmic.200800288
   Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2
   Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069
   Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828
   Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028
   Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014
   Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1
   MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004
   MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152
   Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925
   Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044
   Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020
   Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027
   SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559
   Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029
   SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151
   Tafer H, 2004, BIOCHEMISTRY-US, V43, P860, DOI 10.1021/bi0356606
   Teilum K, 2002, J MOL BIOL, V324, P349, DOI 10.1016/S0022-2836(02)01039-2
   Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a
   Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023
   Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106
   Wu S, 2011, BIOCHEM J, V438, P505, DOI 10.1042/BJ20110264
   WUTHRICH K, 1994, CURR OPIN STRUC BIOL, V4, P93, DOI 10.1016/S0959-440X(94)90065-5
   Xia YL, 2000, J BIOMOL NMR, V18, P261, DOI 10.1023/A:1026590201757
   Xue Y, 2009, PROTEIN SCI, V18, P1401, DOI 10.1002/pro.153
   Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022
   Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335
   ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008
NR 74
TC 76
Z9 76
U1 1
U2 25
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD NOV
PY 2013
VL 20
IS 11
BP 1265
EP U186
DI 10.1038/nsmb.2677
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 250VH
UT WOS:000326883900006
PM 24077225
DA 2021-01-25
ER

PT J
AU Breyton, C
   Flayhan, A
   Gabel, F
   Lethier, M
   Durand, G
   Boulanger, P
   Chami, M
   Ebel, C
AF Breyton, Cecile
   Flayhan, Ali
   Gabel, Frank
   Lethier, Mathilde
   Durand, Gregory
   Boulanger, Pascale
   Chami, Mohamed
   Ebel, Christine
TI Assessing the Conformational Changes of pb5, the Receptor-binding
   Protein of Phage T5, upon Binding to Its Escherichia coli Receptor FhuA
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Bacteriophage; Biophysics; Electron Microscopy (EM); Membrane Proteins;
   Viral Protein; Fluorinated Surfactant; Small Angle Neutron Scattering
ID LOW-RESOLUTION STRUCTURE; OUTER-MEMBRANE PROTEIN; TAIL FIBER PROTEIN;
   X-RAY; BACTERIOPHAGE-LAMBDA; NEUTRON-SCATTERING; STRUCTURAL-CHANGES;
   SURFACTANTS; HOST; PURIFICATION
AB Background: Little is known about the very first steps of infection of bacterial viruses. Results: We specifically access the structure of phage T5 receptor-binding protein bound to its membrane receptor using specific techniques in small angle neutron scattering. Conclusion: There are no large conformational changes. Significance: Signal transduction within T5 appears different from that of phages binding cell wall saccharides.
   Within tailed bacteriophages, interaction of the receptor-binding protein (RBP) with the target cell triggers viral DNA ejection into the host cytoplasm. In the case of phage T5, the RBP pb5 and the receptor FhuA, an outer membrane protein of Escherichia coli, have been identified. Here, we use small angle neutron scattering and electron microscopy to investigate the FhuA-pb5 complex. Specific deuteration of one of the partners allows the complete masking in small angle neutron scattering of the surfactant and unlabeled proteins when the complex is solubilized in the fluorinated surfactant F-6-DigluM. Thus, individual structures within a membrane protein complex can be described. The solution structure of FhuA agrees with its crystal structure; that of pb5 shows an elongated shape. Neither displays significant conformational changes upon interaction. The mechanism of signal transduction within phage T5 thus appears different from that of phages binding cell wall saccharides, for which structural information is available.
C1 [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] Univ Grenoble Alpes, IBS, F-38027 Grenoble, France.
   [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CNRS, IBS, UMR5075, F-38027 Grenoble, France.
   [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CEA, DSV, IBS, F-38027 Grenoble, France.
   [Durand, Gregory] Univ Avignon, Equipe Chim Bioorgan & Syst Amphiphiles, F-84029 Avignon, France.
   [Durand, Gregory] Inst Biomol Max Mousseron, UMR 5247, F-34093 Montpellier, France.
   [Boulanger, Pascale] Univ Paris 11, UMR CNRS 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France.
   [Chami, Mohamed] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland.
RP Breyton, C (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble 01, France.
EM Cecile.Breyton@ibs.fr
OI Gabel, Frank/0000-0003-3446-2601; Ebel, Christine/0000-0002-6912-500X;
   Durand, Gregory/0000-0001-6680-2821
FU FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]
FX We are grateful to H. Stahlberg (Center for Cellular Imaging and
   NanoAnalytics) for support. We thank A. Le Roy (IBS) for performing AUC
   experiments and S. Raynal (University of Avignon) for the synthesis of
   F<INF>6</INF>-DigluM. We also thank the Laue-Langevin Institute for BAG
   beamtime on D22, P. Callow and G. Zaccai for local contacting, and the
   European Synchrotron Radiation Facility for BAG beamtime on ID14-3. This
   work used the Analytical Ultracentrifugation, Surface Plasmon Resonance,
   Mass Spectrometry, and Membrane Protein Purification platforms of the
   Grenoble Instruct Centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support
   from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the
   Grenoble Partnership for Structural Biology (PSB).
CR Abla M, 2008, J ORG CHEM, V73, P8142, DOI 10.1021/jo801379e
   Abla M, 2012, J FLUORINE CHEM, V134, P63, DOI 10.1016/j.jfluchem.2011.05.015
   Basit H, 2012, CHEM COMMUN, V48, P6037, DOI 10.1039/c2cc31107k
   Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016
   Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9
   Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673
   Braun V, 2009, J BACTERIOL, V191, P3431, DOI 10.1128/JB.00106-09
   Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6
   Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14
   Breyton C, 2009, BIOPHYS J, V97, P1077, DOI 10.1016/j.bpj.2009.05.053
   Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209
   Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058
   Cho KH, 2013, CHEMBIOCHEM, V14, P452, DOI 10.1002/cbic.201200759
   Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901
   Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533
   Dai W, 2010, P NATL ACAD SCI USA, V107, P4347, DOI 10.1073/pnas.0915008107
   Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003
   Ferguson AD, 1998, PROTEIN SCI, V7, P1636, DOI 10.1002/pro.5560070719
   Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Ghosh R., 2006, COMPUTING GUIDE SMAL, P35
   Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360
   HELLER KJ, 1984, J VIROL, V49, P20, DOI 10.1128/JVI.49.1.20-25.1984
   JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001
   JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355
   Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1
   Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012
   MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989
   Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015
   Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X
   Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786
   Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301
   ROESSNER CA, 1983, J BIOL CHEM, V258, P643
   Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3
   Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200
   Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107
   Soto CM, 2010, CURR OPIN BIOTECH, V21, P426, DOI 10.1016/j.copbio.2010.07.004
   Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071
   Stone R, 2002, SCIENCE, V298, P730, DOI 10.1126/science.298.5594.730
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267
   Talbot JC, 2009, J BIOENERG BIOMEMBR, V41, P349, DOI 10.1007/s10863-009-9235-5
   TIMMINS PA, 1988, EUR BIOPHYS J BIOPHY, V15, P257, DOI 10.1007/BF00256476
   Udho E, 2012, BIOCHEMISTRY-US, V51, P6753, DOI 10.1021/bi300493u
   Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109
   Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11
   Vinga I, 2012, MOL MICROBIOL, V83, P289, DOI 10.1111/j.1365-2958.2011.07931.x
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000
   Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772
NR 54
TC 30
Z9 31
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 18
PY 2013
VL 288
IS 42
BP 30763
EP 30772
DI 10.1074/jbc.M113.501536
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 291YF
UT WOS:000329868100076
PM 24014030
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Knott, G
   Genoud, C
AF Knott, Graham
   Genoud, Christel
TI Is EM dead?
SO JOURNAL OF CELL SCIENCE
LA English
DT Editorial Material
DE Electron microscopy; EM; Scanning electron microscopy; SEM; Transmission
   electron microscopy; TEM
ID ELECTRON-MICROSCOPY; CELLS; ICE; RECONSTRUCTION; TOMOGRAPHY; CIRCUITS
AB Since electron microscopy (EM) first appeared in the 1930s, it has held centre stage as the primary tool for the exploration of biological structure. Yet, with the recent developments of light microscopy techniques that overcome the limitations imposed by the diffraction boundary, the question arises as to whether the importance of EM in on the wane. This Commentary describes some of the pioneering studies that have shaped our understanding of cell structure. These include the development of cryo-EM techniques that have given researchers the ability to capture images of native structures and at the molecular level. It also describes how a number of recent developments significantly increase the ability of EM to visualise biological systems across a range of length scales, and in 3D, ensuring that EM will remain at the forefront of biology research for the foreseeable future.
C1 [Knott, Graham] Ecole Polytech Fed Lausanne, Ctr Interdisciplinaire Microscopie Elect, BioEM Facil, CH-1015 Lausanne, Switzerland.
   [Genoud, Christel] Friedrich Miescher Inst BioMed Res, CH-4058 Basel, Switzerland.
   [Genoud, Christel] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
RP Knott, G (corresponding author), Ecole Polytech Fed Lausanne, Ctr Interdisciplinaire Microscopie Elect, BioEM Facil, CH-1015 Lausanne, Switzerland.
EM Graham.Knott@epfl.ch
OI Knott, Graham W/0000-0002-2956-9052
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994
   Ballerini M, 1997, EUR J HISTOCHEM, V41, P89
   BERNHARD W, 1956, CR HEBD ACAD SCI, V242, P288
   Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/nmeth.1622, 10.1038/NMETH.1622]
   Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802
   Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818
   CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641
   DALTON AJ, 1954, AM J ANAT, V94, P171, DOI 10.1002/aja.1000940202
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47
   EVERHART TE, 1960, J SCI INSTRUM, V37, P246, DOI 10.1088/0950-7671/37/7/307
   FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081
   FRANK J, 1991, J CELL BIOL, V115, P597, DOI 10.1083/jcb.115.3.597
   Friedrich RW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00071
   Grigorieff N, 2013, ELIFE, V2, DOI 10.7554/eLife.00573
   Grimm R, 1997, BIOPHYS J, V72, P482, DOI 10.1016/S0006-3495(97)78689-2
   Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872
   Hayworth K., 2006, MICROSC MICROANAL, V12, P86, DOI DOI 10.1017/S1431927606066268
   Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346
   Hoppa MB, 2012, DIABETOLOGIA, V55, P1001, DOI 10.1007/s00125-011-2400-5
   HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631
   Knoll M., 1935, Zeitschrift fur Technische Physik, V16, P467
   Knoll M, 1932, Z PHYS, V78, P318, DOI 10.1007/BF01342199
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899
   Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046
   Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433
   Maco B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057405
   Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375
   McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226
   MCDOWALL AW, 1983, J MICROSC-OXFORD, V131, P1, DOI 10.1111/j.1365-2818.1983.tb04225.x
   Nagayama K., 2009, BIOPHYS REV, V1, P37
   NAGLER FPO, 1948, J BACTERIOL, V55, P45, DOI 10.1128/JB.55.1.45-51.1948
   NEWMAN SB, 1949, SCIENCE, V110, P66, DOI 10.1126/science.110.2846.66
   PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304
   PALADE GE, 1954, J EXP MED, V100, P641, DOI 10.1084/jem.100.6.641
   PALAY SL, 1955, J BIOPHYS BIOCHEM CY, V1, P69, DOI 10.1083/jcb.1.1.69
   PARSONS DF, 1974, SCIENCE, V186, P407, DOI 10.1126/science.186.4162.407
   Perkins GA, 2000, MICRON, V31, P97, DOI 10.1016/S0968-4328(99)00065-7
   Peters A, 2002, J NEUROCYTOL, V31, P183, DOI 10.1023/A:1024157522651
   PORTER KR, 1953, ANAT REC, V117, P685, DOI 10.1002/ar.1091170403
   PORTER KR, 1945, J EXP MED, V81, P233, DOI 10.1084/jem.81.3.233
   Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   RIS H, 1961, CAN J GENET CYTOL, V3, P95, DOI 10.1139/g61-015
   RUSKA HELMUT, 1939, ARCH GES VIRUSFORSCH, V1, P155, DOI 10.1007/BF01243399
   Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041
   SINGER SJ, 1961, J BIOPHYS BIOCHEM CY, V9, P519, DOI 10.1083/jcb.9.3.519
   Straehle CN, 2011, LECT NOTES COMPUT SC, V6891, P653, DOI 10.1007/978-3-642-23623-5_82
   Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273
   Van ROOYEN C. E., 1948, CANADIAN JOUR PUBL HEALTH, V39, P467
   Wang K, 2012, J STRUCT BIOL, V180, P318, DOI 10.1016/j.jsb.2012.07.003
   WHITE EL, 1981, J COMP NEUROL, V195, P265, DOI 10.1002/cne.901950207
   WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056
   Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041
NR 56
TC 39
Z9 39
U1 1
U2 48
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD OCT 15
PY 2013
VL 126
IS 20
BP 4545
EP 4552
DI 10.1242/jcs.124123
PG 8
WC Cell Biology
SC Cell Biology
GA 236NC
UT WOS:000325803200002
PM 24124192
OA Bronze
DA 2021-01-25
ER

PT J
AU Kochhan, E
   Lenard, A
   Ellertsdottir, E
   Herwig, L
   Affolter, M
   Belting, HG
   Siekmann, AF
AF Kochhan, Eva
   Lenard, Anna
   Ellertsdottir, Elin
   Herwig, Lukas
   Affolter, Markus
   Belting, Heinz-Georg
   Siekmann, Arndt F.
TI Blood Flow Changes Coincide with Cellular Rearrangements during Blood
   Vessel Pruning in Zebrafish Embryos
SO PLOS ONE
LA English
DT Article
ID PROGRAMMED CAPILLARY REGRESSION; IN-VIVO; TRANSGENIC ZEBRAFISH;
   APOPTOSIS; ANGIOGENESIS; LYMPHANGIOGENESIS; MACROPHAGES; NETWORK;
   PATHWAY; DEATH
AB After the initial formation of a highly branched vascular plexus, blood vessel pruning generates a hierarchically structured network with improved flow characteristics. We report here on the cellular events that occur during the pruning of a defined blood vessel in the eye of developing zebrafish embryos. Time-lapse imaging reveals that the connection of a new blood vessel sprout with a previously perfused multicellular endothelial tube leads to the formation of a branched, Y-shaped structure. Subsequently, endothelial cells in parts of the previously perfused branch rearrange from a multicellular into a unicellular tube, followed by blood vessel detachment. This process is accompanied by endothelial cell death. Finally, we show that differences in blood flow between neighboring vessels are important for the completion of the pruning process. Our data suggest that flow induced changes in tubular architecture ensure proper blood vessel pruning.
C1 [Kochhan, Eva; Siekmann, Arndt F.] Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany.
   [Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Affolter, Markus; Belting, Heinz-Georg] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland.
RP Siekmann, AF (corresponding author), Max Planck Inst Mol Biomed, Lab Cardiovasc Patterning, Munster, Germany.
EM arndt.siekmann@mpi-muenster.mpg.de
OI Belting, Heinz-Georg/0000-0002-1538-4364; Affolter,
   Markus/0000-0002-5171-0016
FU Max Planck SocietyMax Planck Society; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG
   SI-1374/3-1]; European Research CouncilEuropean Research Council (ERC)
   [260794-ZebrafishAngio]
FX This work was funded by the Max Planck Society (www.mpg.de; AFS), the
   Deutsche Forschungsgemeinschaft (DFG SI-1374/3-1; www.dfg.de; AFS) and
   an European Research Council starting grant (260794-ZebrafishAngio;
   erc.europa.eu; AFS). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005
   Baluk P, 2004, AM J PATHOL, V165, P1071, DOI 10.1016/S0002-9440(10)63369-X
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881
   Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374
   Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467
   DiezRoux G, 1997, DEVELOPMENT, V124, P3633
   Fujita M, 2011, DEVELOPMENT, V138, P1705, DOI 10.1242/dev.058776
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   LANG R, 1994, DEVELOPMENT, V120, P3395
   LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104
   Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010
   Liu TX, 2003, DEV CELL, V5, P903, DOI 10.1016/S1534-5807(03)00339-3
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293
   Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928
   Lobov IB, 2011, BLOOD, V117, P6728, DOI 10.1182/blood-2010-08-302067
   Meeson A, 1996, DEVELOPMENT, V122, P3929
   Meeson AP, 1999, DEVELOPMENT, V126, P1407
   Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014
   Roman BL, 2002, DEVELOPMENT, V129, P3009
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   Westerfield M., 1993, ZEBRAFISH BOOK
   Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254
   Zanella C, 2010, IEEE T IMAGE PROCESS, V19, P770, DOI 10.1109/TIP.2009.2033629
NR 36
TC 61
Z9 61
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2013
VL 8
IS 10
AR e75060
DI 10.1371/journal.pone.0075060
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 236SL
UT WOS:000325819400006
PM 24146748
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Baday, S
   Wang, SH
   Lamoureux, G
   Berneche, S
AF Baday, Sefer
   Wang, Shihao
   Lamoureux, Guillaume
   Berneche, Simon
TI Different Hydration Patterns in the Pores of AmtB and RhCG Could
   Determine Their Transport Mechanisms
SO BIOCHEMISTRY
LA English
DT Article
ID ESCHERICHIA-COLI; AMMONIUM TRANSPORTERS; MOLECULAR-DYNAMICS; CHANNEL;
   THERMODYNAMICS; AFFINITY; NH4+; FLUX
AB The ammonium transporters of the Amt/Rh family facilitate the diffusion of ammonium across cellular membranes. Functional data suggest that Amt proteins, notably found in plants, transport the ammonium ion (NH4+), whereas human Rhesus (Rh) proteins transport ammonia (NH3). Comparison between the X-ray structures of the prokaryotic AmtB, assumed to be representative of Amt proteins, and the human RhCG reveals important differences at the level of their pore. Despite these important functional and structural differences between Amt and Rh proteins, studies of the AmtB transporter have led to the suggestion that proteins of both subfamilies work according to the same mechanism and transport ammonia. We performed molecular dynamics simulations of the ArntB and RhCG proteins under different water and ammonia occupancy states of their pore. Free energy calculations suggest that the probability of finding NH3 molecules in the pore of AmtB is negligible in comparison to finding water. The presence of water in the pore of AmtB could support the transport of proton. The pore lumen of RhCG is found to be more hydrophobic due to the presence of a phenylalanine conserved among Rh proteins. Simulations of RhCG also reveal that the signature histidine dyad is occasionally exposed to the extracellular bulk, which is never observed in AmtB. These different hydration patterns are consistent with the idea that Amt and Rh proteins are not functionally equivalent and that permeation takes place according to two distinct mechanisms.
C1 [Baday, Sefer; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Baday, Sefer; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Wang, Shihao; Lamoureux, Guillaume] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada.
   [Wang, Shihao; Lamoureux, Guillaume] Concordia Univ, Ctr Res Mol Modeling CERMM, Montreal, PQ H4B 1R6, Canada.
RP Lamoureux, G (corresponding author), Concordia Univ, Dept Chem & Biochem, 7141 Sherbrooke St West, Montreal, PQ H4B 1R6, Canada.
EM guillaume.lamoureux@concordia.ca; simon.berneche@unibas.ch
RI baday, sefer/ABA-9111-2020; Lamoureux, Guillaume/K-4038-2013
OI baday, sefer/0000-0002-2913-6687; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [139205]; FQRNT Nouveaux chercheurs grantFQRNT; Swiss National
   Supercomputing Centre (CSCS) [s241]
FX This work was supported by a grant from the Swiss National Science
   Foundation to S. Berneche (SNF Professorship No. 139205) and by an FQRNT
   Nouveaux chercheurs grant to G.L. Computational resources were provided
   through a grant from the Swiss National Supercomputing Centre (CSCS)
   under project ID s241, by the Basel Computational Biology Center, and
   through an allocation from Calcul Quebec.
CR BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140
   Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104
   GAO JL, 1993, J PHYS CHEM-US, V97, P9241, DOI 10.1021/j100138a028
   Genetet S, 2012, AM J PHYSIOL-CELL PH, V302, pC419, DOI 10.1152/ajpcell.00092.2011
   Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107
   Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200
   Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Liu P, 2012, J CHEM THEORY COMPUT, V8, P2606, DOI 10.1021/ct300242f
   Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921
   NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x
   Orabi EA, 2012, J CHEM THEORY COMPUT, V8, P182, DOI 10.1021/ct200569x
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101
   Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Ullmann RT, 2012, J PHYS CHEM B, V116, P9690, DOI 10.1021/jp305440f
   Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050
   Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zidi-Yahiaoui N, 2009, AM J PHYSIOL-CELL PH, V297, pC537, DOI 10.1152/ajpcell.00137.2009
   ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409
NR 35
TC 11
Z9 11
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 8
PY 2013
VL 52
IS 40
BP 7091
EP 7098
DI 10.1021/bi400015f
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 243YY
UT WOS:000326355500017
PM 24021113
DA 2021-01-25
ER

PT J
AU Matena, A
   Sinnen, C
   van den Boom, J
   Wilms, C
   Dybowski, JN
   Maltaner, R
   Mueller, JW
   Link, NM
   Hoffmann, D
   Bayer, P
AF Matena, Anja
   Sinnen, Christian
   van den Boom, Johannes
   Wilms, Christoph
   Dybowski, J. Nikolaj
   Maltaner, Ricarda
   Mueller, Jonathan W.
   Link, Nina M.
   Hoffmann, Daniel
   Bayer, Peter
TI Transient Domain Interactions Enhance the Affinity of the Mitotic
   Regulator Pin1 toward Phosphorylated Peptide Ligands
SO STRUCTURE
LA English
DT Article
ID PROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; SUBSTRATE RECOGNITION;
   STRUCTURAL-ANALYSIS; WW DOMAINS; BINDING; PROTEIN; DYNAMICS; NMR;
   INHIBITORS
AB The mitotic regulator Pin1 plays an important role in protein quality control and age-related medical conditions such as Alzheimer disease and Parkinson disease. Although its cellular role has been thoroughly investigated during the past decade, the molecular mechanisms underlying its function remain elusive. We provide evidence for interactions between the two domains of Pin1. Several residues displayed unequivocal peak splits in nuclear magnetic resonance spectra, indicative of two different conformational states in equilibrium. Pareto analysis of paramagnetic relaxation enhancement data demonstrates that the two domains approach each other upon addition of a nonpeptidic ligand. Titration experiments with phosphorylated peptides monitored by fluorescence anisotropy and chemical shift perturbation indicate that domain interactions increase Pin1's affinity toward peptide ligands. We propose this interplay of the domains and ligands to be a general mechanism for a large class of two-domain proteins.
C1 [Matena, Anja; van den Boom, Johannes; Maltaner, Ricarda; Mueller, Jonathan W.; Link, Nina M.; Bayer, Peter] Univ Duisburg Essen, ZMB, Res Grp Struct & Med Biochem, D-45117 Essen, Germany.
   [Wilms, Christoph; Hoffmann, Daniel] Univ Duisburg Essen, ZMB, Res Grp Bioinformat, D-45117 Essen, Germany.
   [Sinnen, Christian] Solupharm Pharmazeut Erzeugnisse GmbH, D-34212 Melsungen, Germany.
   [Dybowski, J. Nikolaj] Evotec Munich GmbH, D-82152 Martinsried, Germany.
   [Mueller, Jonathan W.] Univ Birmingham, Inst Biomed Res, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab CEDAM, Birmingham B15 2TT, W Midlands, England.
   [Link, Nina M.] Univ Basel, Biozentrum, Res Grp Computat & Syst Biol, CH-4056 Basel, Switzerland.
RP Bayer, P (corresponding author), Univ Duisburg Essen, ZMB, Res Grp Struct & Med Biochem, D-45117 Essen, Germany.
EM peter.bayer@uni-due.de
RI Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018; Bayer,
   Peter/B-8803-2009; Mueller, Jonathan Wolf/D-1632-2010
OI Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann,
   Daniel/0000-0003-2973-7869; Bayer, Peter/0000-0003-0435-7202; Mueller,
   Jonathan Wolf/0000-0003-1212-189X
CR ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005
   Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756
   Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h
   Bayer E, 2005, CHEM COMMUN, P516, DOI 10.1039/b414037k
   Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200
   Chen CH, 2011, MOL CELL BIOL, V31, P2984, DOI 10.1128/MCB.05043-11
   Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009
   Duncan KE, 2011, J MED CHEM, V54, P3854, DOI 10.1021/jm200156c
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071
   Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463
   Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364
   Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039
   Guo CX, 2009, BIOORG MED CHEM LETT, V19, P5613, DOI 10.1016/j.bmcl.2009.08.034
   Heidecker G, 2007, J VIROL, V81, P9769, DOI 10.1128/JVI.00642-07
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005
   Innes BT, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00018
   Jacobs DM, 2003, J BIOL CHEM, V278, P26174, DOI 10.1074/jbc.M300796200
   Jager M, 2008, BIOPOLYMERS, V90, P751, DOI 10.1002/bip.21101
   James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731
   Jaremko L, 2011, J BIOL CHEM, V286, P6554, DOI 10.1074/jbc.M110.160713
   KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98
   Kovermann M, 2011, BBA-PROTEINS PROTEOM, V1814, P873, DOI 10.1016/j.bbapap.2011.03.016
   Kuhlewein A, 2004, PROTEIN SCI, V13, P2378, DOI 10.1110/ps.04756704
   Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092
   Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l
   Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001
   Liu C, 2012, BIOORGAN MED CHEM, V20, P2992, DOI 10.1016/j.bmc.2012.03.005
   Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v
   Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261
   Madl T, 2011, ANGEW CHEM INT EDIT, V50, P3993, DOI 10.1002/anie.201007168
   McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532
   Morcos F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001015
   Mueller JW, 2011, J AM CHEM SOC, V133, P20096, DOI 10.1021/ja2086195
   Mueller JW, 2008, PERSPECT MED CHEM, V2, P11
   Namanja AT, 2007, STRUCTURE, V15, P313, DOI 10.1016/j.str.2007.01.014
   Namanja AT, 2011, P NATL ACAD SCI USA, V108, P12289, DOI 10.1073/pnas.1019382108
   Peng JW, 2009, J BIOMOL NMR, V45, P171, DOI 10.1007/s10858-009-9349-4
   Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1
   Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Sekerina E, 2000, J MOL BIOL, V301, P1003, DOI 10.1006/jmbi.2000.4013
   Smet C, 2005, FEBS LETT, V579, P4159, DOI 10.1016/j.febslet.2005.06.048
   Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8
   Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232
   Urata S, 2010, J GEN VIROL, V91, P228, DOI 10.1099/vir.0.015495-0
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941
   Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929
   Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429
   Xu GYG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044226
   Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107
   Zhang Y, 2007, ACS CHEM BIOL, V2, P320, DOI 10.1021/cb7000044
NR 56
TC 15
Z9 15
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD OCT 8
PY 2013
VL 21
IS 10
BP 1769
EP 1777
DI 10.1016/j.str.2013.07.016
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 244TQ
UT WOS:000326413500008
PM 23972472
OA Bronze
DA 2021-01-25
ER

PT J
AU Schmutz, C
   Ahrne, E
   Kasper, CA
   Tschon, T
   Sorg, I
   Dreier, RF
   Schmidt, A
   Arrieumerlou, C
AF Schmutz, Christoph
   Ahrne, Erik
   Kasper, Christoph A.
   Tschon, Therese
   Sorg, Isabel
   Dreier, Roland F.
   Schmidt, Alexander
   Arrieumerlou, Cecile
TI Systems- Level Overview of Host Protein Phosphorylation During Shigella
   flexneri Infection Revealed by Phosphoproteomics
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID NF-KAPPA-B; EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; BACTERIAL INVASION;
   ACTIVATION; APOPTOSIS; IDENTIFICATION; GTPASES; INNATE; ENTRY
AB The enteroinvasive bacterium Shigella flexneri invades the intestinal epithelium of humans. During infection, several injected effector proteins promote bacterial internalization, and interfere with multiple host cell responses. To obtain a systems-level overview of host signaling during infection, we analyzed the global dynamics of protein phosphorylation by liquid chromatography-tandem MS and identified several hundred of proteins undergoing a phosphorylation change during the first hours of infection. Functional bioinformatic analysis revealed that they were mostly related to the cytoskeleton, transcription, signal transduction, and cell cycle. Fuzzy c-means clustering identified six temporal profiles of phosphorylation and a functional module composed of ATM-phosphorylated proteins related to genotoxic stress. Pathway enrichment analysis defined mTOR as the most overrepresented pathway. We showed that mTOR complex 1 and 2 were required for S6 kinase and AKT activation, respectively. Comparison with a published phosphoproteome of Salmonella typhimurium-infected cells revealed a large subset of coregulated phosphoproteins. Finally, we showed that S. flexneri effector OspF affected the phosphorylation of several hundred proteins, thereby demonstrating the wide-reaching impact of a single bacterial effector on the host signaling network.
C1 [Schmutz, Christoph; Ahrne, Erik; Kasper, Christoph A.; Tschon, Therese; Sorg, Isabel; Dreier, Roland F.; Schmidt, Alexander; Arrieumerlou, Cecile] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arrieumerlou, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cecile.arrieumerlou@unibas.ch
OI ARRIEUMERLOU, Cecile/0000-0002-6463-2897
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310030-138377/1]; SystemsX.ch
FX This work was supported by the Swiss National Science Foundation (grant
   310030-138377/1 to C. A.) and the InfectX and BattleX projects from
   SystemsX.ch.
CR Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423
   Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741
   Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026
   Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034
   Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013
   BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0
   Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867
   Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005
   Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2
   Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a
   Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16
   Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319
   Eyrich B, 2011, PROTEOMICS, V11, P554, DOI 10.1002/pmic.201000489
   Faherty CS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-272
   Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375
   Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155
   Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677
   Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g
   GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572
   HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015
   Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621
   Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692
   Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538
   Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200
   Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002
   Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651
   Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960
   Liang Y, 2011, CURR OPIN CELL BIOL, V23, P65, DOI 10.1016/j.ceb.2010.09.008
   Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009
   Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196
   Mounier J, 1999, J CELL SCI, V112, P2069
   MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Nonaka T, 2003, MICROBIOL-SGM, V149, P2513, DOI 10.1099/mic.0.26341-0
   O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200
   Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002
   Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200
   Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ramel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001619
   Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112
   Reiterer V, 2011, CELL SIGNAL, V23, P1188, DOI 10.1016/j.cellsig.2011.03.006
   Ridley A. J. H. A., 1992, COLD SPRING HARB SYM, V57, P10
   Rogers LD, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001668
   Sakaguchi T, 2002, CELL MICROBIOL, V4, P367, DOI 10.1046/j.1462-5822.2002.00197.x
   SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986
   Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5
   Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996
   Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999
   Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Schmidt A., 2011, MOL SYST BIOL, V7
   Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x
   Smyth, 2004, STAT APPL GENET MOL, V3
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012
   Ting L, 2009, MOL CELL PROTEOMICS, V8, P2227, DOI 10.1074/mcp.M800462-MCP200
   Van Nhieu GT, 2005, CURR OPIN MICROBIOL, V8, P16, DOI 10.1016/j.mib.2004.12.006
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182
   WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989
   Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011
   ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452
   ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0
NR 86
TC 35
Z9 35
U1 0
U2 18
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD OCT
PY 2013
VL 12
IS 10
BP 2952
EP 2968
DI 10.1074/mcp.M113.029918
PG 17
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 301MS
UT WOS:000330537000022
PM 23828894
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Sakurai, K
   Akiyama, M
   Cai, B
   Scott, A
   Han, BX
   Takatoh, J
   Sigrist, M
   Arber, S
   Wang, F
AF Sakurai, Katsuyasu
   Akiyama, Masahiro
   Cai, Bin
   Scott, Alexandra
   Han, Bao-Xia
   Takatoh, Jun
   Sigrist, Markus
   Arber, Silvia
   Wang, Fan
TI The Organization of Submodality-Specific Touch Afferent Inputs in the
   Vibrissa Column
SO CELL REPORTS
LA English
DT Article
ID SENSORY INNERVATION; MYSTACIAL PAD; AREA 3B; NEURONS; RAT;
   MECHANORECEPTORS; RESPONSES; SKIN; IDENTIFICATION; MORPHOLOGY
AB The rodent tactile vibrissae are innervated by several different types of touch sensory neurons. The central afferents of all touch neurons from one vibrissa collectively project to a columnar structure called a barrelette in the brainstem. Delineating how distinct types of sensors connect to second-order neurons within each barrelette is critical for understanding tactile information coding and processing. Using genetic and viral techniques, we labeled slowly adapting (SA) mechanosensory neurons, rapidly adapting (RA) mechanosensory neurons, afferent synapses, and second-order projection neurons with four different fluorescent markers to examine their connectivity. We discovered that within each vibrissa column, individual sensory neurons project collaterals to multiply distributed locations, inputs from SA and RA afferents are spatially intermixed without any discernible stereotypy or topography, and second-order projection neurons receive convergent SA and RA inputs. Our findings reveal a "one-to-many and many-to-one" connectivity scheme and the circuit architecture for tactile information processing at the first-order synapses.
C1 [Sakurai, Katsuyasu; Akiyama, Masahiro; Scott, Alexandra; Han, Bao-Xia; Takatoh, Jun; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.
   [Akiyama, Masahiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058571, Japan.
   [Akiyama, Masahiro] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058571, Japan.
   [Cai, Bin] E China Normal Univ, Inst Cognit Neurosci, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China.
   [Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Wang, F (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.
EM fan.wang@duke.edu
OI Takatoh, Jun/0000-0002-0976-7684; Arber, Silvia/0000-0002-6261-250X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 DE019440, NS077986]; Swiss
   National FoundationSwiss National Science Foundation (SNSF); Kanton
   Basel-Stadt; ERCEuropean Research Council (ERC); Novartis Research
   Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Dental & Craniofacial
   Research (NIDCR) [R01DE019440, R01DE019440, R01DE019440] Funding Source:
   NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Dental & Craniofacial
   Research (NIDCR) [R01DE019440, R01DE019440, R01DE019440] Funding Source:
   NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS077986, R01NS077986, R01NS077986,
   R01NS077986, R01NS077986, R01NS077986, R01NS077986] Funding Source: NIH
   RePORTER
FX We thank Duke Cancer Center transgenic facility for blastocyst
   injections that generated Chodl<SUP>PLAP/+</SUP> mice. We thank Dr.
   Kosuke Hamaguchi for help with custom-written programs in MATLAB. We
   thank Duke Light Microscopy Core facility for help with confocal imaging
   and 3D reconstruction. This work is supported by NIH RO1 DE019440 and
   NS077986 (to F. W.), the Swiss National Foundation, Kanton Basel-Stadt,
   an ERC Advanced Grant, and the Novartis Research Foundation (to S.A.).
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Arenkiel BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029423
   Bellavance MA, 2010, J NEUROSCI, V30, P1057, DOI 10.1523/JNEUROSCI.4805-09.2010
   BENNETTCLARKE CA, 1992, J COMP NEUROL, V320, P323, DOI 10.1002/cne.903200305
   Bosman LWJ, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00053
   CARVELL GE, 1990, J NEUROSCI, V10, P2638
   Chen LM, 2001, J NEUROPHYSIOL, V86, P3011
   da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108
   Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277
   Enjin A, 2010, J COMP NEUROL, V518, P2284, DOI 10.1002/cne.22332
   ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5
   Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804
   Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101
   Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007
   HAYASHI H, 1985, J COMP NEUROL, V237, P195, DOI 10.1002/cne.902370205
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196
   Ichikawa H, 2003, BRAIN RES, V970, P226, DOI 10.1016/S0006-8993(03)02292-3
   JACQUIN MF, 1986, J COMP NEUROL, V243, P266, DOI 10.1002/cne.902430209
   JACQUIN MF, 1993, J NEUROPHYSIOL, V70, P1911
   Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621
   KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S
   Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027
   LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697
   Lumpkin EA, 2010, J CELL BIOL, V191, P237, DOI 10.1083/jcb.201006074
   Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003
   Mackevicius EL, 2012, J NEUROSCI, V32, P15309, DOI 10.1523/JNEUROSCI.2161-12.2012
   Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002
   Pei YC, 2009, J NEUROPHYSIOL, V102, P1843, DOI 10.1152/jn.00235.2009
   Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105
   Ratte S, 2013, NEURON, V78, P758, DOI 10.1016/j.neuron.2013.05.030
   RICE FL, 1986, J COMP NEUROL, V252, P154, DOI 10.1002/cne.902520203
   Rice FL, 1997, J COMP NEUROL, V385, P149
   SUR M, 1984, J NEUROPHYSIOL, V51, P724
   Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8
   WELKER E, 1986, J NEUROSCI, V6, P3355
   Weng L, 2003, GENE, V308, P21, DOI 10.1016/S0378-1119(03)00425-6
   Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999
   Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517
   Woodbury CJ, 2001, J COMP NEUROL, V436, P304
   WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X
   Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015
NR 42
TC 35
Z9 35
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD OCT
PY 2013
VL 5
IS 1
BP 87
EP 98
DI 10.1016/j.celrep.2013.08.051
PG 12
WC Cell Biology
SC Cell Biology
GA 241FP
UT WOS:000326152100012
PM 24120861
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Blache, U
   Silvan, U
   Plodinec, M
   Suetterlin, R
   Jakob, R
   Klebba, I
   Bentires-Alj, M
   Aebi, U
   Schoenenberger, CA
AF Blache, Ulrich
   Silvan, Unai
   Plodinec, Marija
   Suetterlin, Rosmarie
   Jakob, Roman
   Klebba, Ina
   Bentires-Alj, Mohamed
   Aebi, Ueli
   Schoenenberger, Cora-Ann
TI A Tumorigenic Actin Mutant Alters Fibroblast Morphology and
   Multicellular Assembly Properties
SO CYTOSKELETON
LA English
DT Article
DE actin mutation; membrane ruffling; multicellular spheroids; tumorigenic;
   transformation; actin polymerization
ID CIRCULAR DORSAL RUFFLES; BETA-ACTIN; NEOPLASTIC TRANSFORMATION; HEARING
   IMPAIRMENT; ACTG1 MUTATIONS; CELL-MIGRATION; GENES; EXPRESSION; CULTURE;
   POLYMERIZATION
AB Tumor initiation and progression are accompanied by complex changes in the cytoarchitecture that at the cellular level involve remodeling of the cytoskeleton. We report on the impact of a mutant -actin (G245D-actin) on cell structure and multicellular assembly properties. To appreciate the effects of the Gly245Asp substitution on the organization of the actin cytoskeleton, we examined the polymerization properties of G245D-actin in vitro by pyrene polymerization assays and total internal reflection fluorescence microscopy (TIRF). The mutant actin on its own has a significantly reduced polymerization efficiency compared to native actin but also modifies the polymerization of actin in copolymerization experiments. Comparison of the structure of Rat-2 fibroblasts and a stably transfected derivate called Rat-2-sm9 revealed the effects of G245D-actin in a cellular environment. The overall actin levels in Rat-2-sm9 show a 1.6-fold increase with similar amounts of mutant and wild-type actin. G245D-actin expression renders Rat-2-sm9 cells highly tumorigenic in nude mice. In Rat-2-sm9 monolayers, G245D-actin triggers the formation of extensive membrane ruffles, which is a characteristic feature of many transformed cells. To approximate complex cell-cell and cell-matrix interactions that occur in tumors and might modulate the effects of G245D-actin, we extended our studies to scaffold-free 3D spheroid cultures. Bright field and scanning electron microscopy (SEM) show that Rat-2-sm9 and Rat-2 cells share essential features of spheroid formation and compaction. However, the resulting spheroids exhibit distinct phenotypes that differ mainly in surface structure and size. The systematic comparison of transformed and normal spheroids by SEM provides new insights into scaffold-free fibroblast spheroid formation. (c) 2013 Wiley Periodicals, Inc.
C1 [Blache, Ulrich; Silvan, Unai; Plodinec, Marija; Suetterlin, Rosmarie; Jakob, Roman; Aebi, Ueli; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Klebba, Ina; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM cora-ann.schoenenberger@unibas.ch
RI Mohamed, Bentires-Alj/F-4484-2015
OI Mohamed, Bentires-Alj/0000-0001-6344-1127; Silvan,
   Unai/0000-0003-0757-3621; Blache, Ulrich/0000-0003-4233-2268; Jakob,
   Roman/0000-0002-6451-8656
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_127014]; National Centre of Competence in Research
   "Nanoscale Science"; M.E. Muller Foundation; German Federal Ministry of
   Education and ResearchFederal Ministry of Education & Research (BMBF)
FX We gratefully acknowledge Evi Bieler (Center for Microscopy, University
   of Basel) for help with scanning electron microscopy, Janne Hyotyla
   (Biozentrum, University of Basel) for advice on TIRF microscopy, and
   Brigitte M. Jockusch (TU Braunschweig) for fruitful discussions. We
   thank John Leavitt for kindly providing Rat-2 and Rat-2-sm9 cell lines.
   This work was supported by Swiss National Science Foundation (grant
   31003A_127014 to CAS), the National Centre of Competence in Research
   "Nanoscale Science," and the M.E. Muller Foundation. UB received a
   Scholarship from the German Federal Ministry of Education and Research.
CR ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9
   Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453
   ASPENSTROM P, 1992, EUR J BIOCHEM, V207, P315, DOI 10.1111/j.1432-1033.1992.tb17052.x
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110
   Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648
   Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14
   Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075
   Gonsior SM, 1999, J CELL SCI, V112, P797
   Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003
   Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1
   Heckman CA, 2012, CELL SIGNAL, V24, P189, DOI 10.1016/j.cellsig.2011.08.023
   Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473
   Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12
   Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684
   Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006
   Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810
   KAKUNAGA T, 1978, P NATL ACAD SCI USA, V75, P1334, DOI 10.1073/pnas.75.3.1334
   LEAVITT J, 1984, MOL CELL BIOL, V4, P1961, DOI 10.1128/MCB.4.10.1961
   LEAVITT J, 1982, CLIN CHEM, V28, P850
   LEAVITT J, 1987, MOL CELL BIOL, V7, P2467, DOI 10.1128/MCB.7.7.2467
   LEAVITT J, 1987, MOL CELL BIOL, V7, P2457, DOI 10.1128/MCB.7.7.2457
   LEAVITT J, 1980, J BIOL CHEM, V255, P1650
   LIN CS, 1985, P NATL ACAD SCI USA, V82, P6995, DOI 10.1073/pnas.82.20.6995
   Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228
   Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249
   Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5
   Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693
   Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Peckham M, 2001, J CELL SCI, V114, P1367
   Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271
   Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44
   Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670
   RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8
   Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091
   SCHEVZOV G, 1993, J CELL BIOL, V121, P811, DOI 10.1083/jcb.121.4.811
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002
   Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129
   Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1
   TAKEZAWA T, 1993, EXP CELL RES, V208, P430, DOI 10.1006/excr.1993.1265
   TANIGUCHI S, 1988, J BIOCHEM-TOKYO, V103, P707, DOI 10.1093/oxfordjournals.jbchem.a122333
   TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9
   Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2
   VANDEKERCKHOVE J, 1980, CELL, V22, P893, DOI 10.1016/0092-8674(80)90566-8
   Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286
NR 53
TC 1
Z9 1
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1949-3584
EI 1949-3592
J9 CYTOSKELETON
JI Cytoskeleton
PD OCT
PY 2013
VL 70
IS 10
SI SI
BP 635
EP 650
DI 10.1002/cm.21120
PG 16
WC Cell Biology
SC Cell Biology
GA 241EX
UT WOS:000326150300008
PM 23804571
DA 2021-01-25
ER

PT J
AU Sacristan, C
   Manzano-Lopez, J
   Reyes, A
   Spang, A
   Muniz, M
   Roncero, C
AF Sacristan, Carlos
   Manzano-Lopez, Javier
   Reyes, Abigail
   Spang, Anne
   Muniz, Manuel
   Roncero, Cesar
TI Oligomerization of the chitin synthase Chs3 is monitored at the Golgi
   and affects its endocytic recycling
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RETRIEVAL RECEPTOR;
   PLASMA-MEMBRANE; ER EXIT; YEAST; COMPLEX; GROWTH; RETENTION; CARGO
AB Chs3, the catalytic subunit of chitin synthase III in Saccharomyces cerevisiae, is a complex polytopic membrane protein whose plasma membrane expression is tightly controlled: export from the ER requires interaction with Chs7; exit from the Golgi is dependent on the exomer complex, and precise bud neck localization relies on endocytosis. Moreover, Chs3 is efficiently recycled from endosomes to the TGN in an AP-1-dependent manner. Here we show that the export of Chs3 requires the cargo receptor Erv14, in a step that is independent of Chs7. Chs3 oligomerized in the ER through its N-terminal cytosolic region. However, the truncated (126)Chs3 was still exported by Erv14, but was sent back from the Golgi to the ER in a COPI- and Rer1-dependent manner. A subset of the oligomerization-deficient Chs3 proteins evaded Golgi quality control and reached the plasma membrane, where they were enzymatically active but poorly endocytosed. This resulted in high CSIII levels, but calcofluor white resistance, explained by the reduced intercalation of calcofluor white between nascent chitin fibres. Our data show that the oligomerization of Chs3 through its N-terminus is essential for proper protein trafficking and chitin synthesis and is therefore monitored intracellularly.
C1 [Sacristan, Carlos; Reyes, Abigail; Roncero, Cesar] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain.
   [Sacristan, Carlos; Reyes, Abigail; Roncero, Cesar] Univ Salamanca, CSIC, Dept Genet & Microbiol, E-37008 Salamanca, Spain.
   [Manzano-Lopez, Javier; Muniz, Manuel] Univ Seville, Dept Biol Celular, Seville, Spain.
   [Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
RP Roncero, C (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain.
EM crm@usal.es
RI Spang, Anne/A-7029-2008; Manzano-Lopez, Javier/ABH-9468-2020; Roncero,
   Cesar/M-9028-2019; muniz, manuel/Q-2890-2019; IBIS,
   EUCARIONTES/H-7494-2016; Roncero, Cesar/B-5200-2017; Spang,
   Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Roncero, Cesar/0000-0001-5964-3252;
   muniz, manuel/0000-0001-8011-6991; Roncero, Cesar/0000-0001-5964-3252;
   Spang, Anne/0000-0002-2387-6203; Manzano-Lopez,
   Javier/0000-0002-7149-1690; Sacristan, Carlos/0000-0003-1312-2341
FU MEC; EMBOEuropean Molecular Biology Organization (EMBO); JCyL Grant
   [GR231]; University of Seville; University of Basel; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF); Spanish
   CICYTConsejo Interinstitucional de Ciencia y Tecnologia (CICYT)
   [BIO2007-60779, BFU2010-18632, BFU2008-04119, BFU2011-24513]; Junta de
   Andalucia GrantJunta de Andalucia [P09-CVI-4503]
FX We thank R. Valle and V. Casquero for technical assistance, and M.
   Trautwein for his generous help with the MS analysis. C.S. is grateful
   to P.O. Ljungdahl for materials and helpful discussions. We acknowledge
   support of C.S. by a FPU fellowship from the MEC. A.R. was supported by
   a EMBO short-term fellowship and by the JCyL Grant GR231, and J.M.-L. by
   an University of Seville fellowship. Work in the Spang Lab was supported
   by the University of Basel and the Swiss National Science Foundation.
   This research was supported by the Spanish CICYT Grants BIO2007-60779
   and BFU2010-18632 to C.R. and BFU2008-04119 and BFU2011-24513 to M.M.,
   and by the Junta de Andalucia Grant P09-CVI-4503 to M.M.
CR Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200
   Atanassov II, 2009, J BIOL CHEM, V284, P3833, DOI 10.1074/jbc.M807456200
   Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005
   Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324
   Breidenbach MA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015339
   CABIB E, 1989, J CELL BIOL, V108, P1665, DOI 10.1083/jcb.108.5.1665
   Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x
   CHOI WJ, 1994, ANAL BIOCHEM, V219, P368, DOI 10.1006/abio.1994.1278
   Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000
   Cos T, 1998, EUR J BIOCHEM, V256, P419, DOI 10.1046/j.1432-1327.1998.2560419.x
   Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319
   DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75
   HARPER JW, 1993, CELL, V75, P805
   Herzig Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001329
   Holthuis JCM, 1998, MOL BIOL CELL, V9, P3383, DOI 10.1091/mbc.9.12.3383
   Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103
   Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106
   Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100
   Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049
   Lenardon MD, 2010, J CELL SCI, V123, P2199, DOI 10.1242/jcs.060210
   LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Maue L, 2009, INSECT BIOCHEM MOLEC, V39, P654, DOI 10.1016/j.ibmb.2009.06.005
   Meissner D, 2010, MOL BIOL CELL, V21, P2425, DOI 10.1091/mbc.E10-01-0080
   Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27
   Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849
   Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124
   Rockenbauch U, 2012, MOL BIOL CELL, V23, P4402, DOI 10.1091/mbc.E11-12-1015
   RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985
   Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7
   Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779
   Rose M.D., 1990, METHODS YEAST GENETI
   Sacristan C, 2012, MOL MICROBIOL, V83, P1124, DOI 10.1111/j.1365-2958.2012.07995.x
   Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210
   Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777
   Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935
   Sato M, 2004, MOL BIOL CELL, V15, P1417, DOI 10.1091/mbc.E03-10-0765
   SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0
   SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7
   SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111
   Starr TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046386
   Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007
   Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153
   Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100
   Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2
   VALDIVIESO MH, 1991, J CELL BIOL, V114, P101, DOI 10.1083/jcb.114.1.101
   Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108
   Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106
   Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200
   Zanolari B, 2011, J CELL SCI, V124, P1055, DOI 10.1242/jcs.072371
   Ziman M, 1996, MOL BIOL CELL, V7, P1909
NR 53
TC 15
Z9 15
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD OCT
PY 2013
VL 90
IS 2
BP 252
EP 266
DI 10.1111/mmi.12360
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 232IG
UT WOS:000325486100005
PM 23926947
DA 2021-01-25
ER

PT J
AU Benjamin, D
   Hall, MN
AF Benjamin, Don
   Hall, Michael N.
TI TSC on the peroxisome controls mTORC1
SO NATURE CELL BIOLOGY
LA English
DT Editorial Material
ID ACTIVATION; STRESS
AB mTOR is a central controller that integrates many inputs to regulate cell growth and ensure cellular homeostasis. The mTORC1 inhibitor TSC (tuberous sclerosis complex) on the peroxisome is found to inhibit mTORC1 in response to endogenous reactive oxygen species. Thus, mTOR may avoid confounding different inputs by sensing them at different cellular locations.
C1 [Benjamin, Don; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Benjamin, D (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
CR Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107
   Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110
   Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220
   Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033
   Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822
NR 10
TC 11
Z9 11
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD OCT
PY 2013
VL 15
IS 10
BP 1135
EP 1136
DI 10.1038/ncb2849
PG 2
WC Cell Biology
SC Cell Biology
GA 228QC
UT WOS:000325200300003
PM 24084861
DA 2021-01-25
ER

PT J
AU Ruegg, MA
   Meinen, S
   Maier, G
   Lin, S
   Yurchenco, PG
AF Ruegg, M. A.
   Meinen, S.
   Maier, G.
   Lin, S.
   Yurchenco, P. G.
TI The role of laminins in myomatrix assembly and skeletal muscle stability
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 18th International Congress of the World-Muscle-Society (WMS)
CY OCT 01-05, 2013
CL CA
SP World Muscle Soc
C1 [Ruegg, M. A.; Meinen, S.; Maier, G.; Lin, S.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Yurchenco, P. G.] Robert Wood Johnson Med Sch, Piscataway, NJ USA.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2013
VL 23
IS 9-10
BP 738
EP 739
DI 10.1016/j.nmd.2013.06.377
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 225OP
UT WOS:000324972500004
DA 2021-01-25
ER

PT J
AU Yurchenco, PD
   Crosson, S
   McKee, KK
   Ruegg, MA
AF Yurchenco, P. D.
   Crosson, S.
   McKee, K. K.
   Ruegg, M. A.
TI Mechanism of laminin assembly: Insight for structural repairs of MDC1A
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 18th International Congress of the World-Muscle-Society (WMS)
CY OCT 01-05, 2013
CL CA
SP World Muscle Soc
C1 [Yurchenco, P. D.; Crosson, S.; McKee, K. K.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.
   [Ruegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2013
VL 23
IS 9-10
BP 738
EP 738
DI 10.1016/j.nmd.2013.06.375
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 225OP
UT WOS:000324972500002
DA 2021-01-25
ER

PT J
AU Brummer, A
   Kishore, S
   Subasic, D
   Hengartner, M
   Zavolan, M
AF Bruemmer, Anneke
   Kishore, Shivendra
   Subasic, Deni
   Hengartner, Michael
   Zavolan, Mihaela
TI Modeling the binding specificity of the RNA-binding protein GLD-1
   suggests a function of coding region-located sites in translational
   repression
SO RNA
LA English
DT Article
DE RNA-binding protein (RBP); GLD-1; binding site prediction;
   accessibility; translation repression; stabilization
ID TRANSCRIPTOME-WIDE IDENTIFICATION; MIRNA TARGET SITES; MESSENGER-RNA;
   STAR PROTEIN; IN-VIVO; CLIP; RECOGNITION; REGULATOR; SEQUENCE; MOTIF
AB To understand the function of the hundreds of RNA-binding proteins (RBPs) that are encoded in animal genomes it is important to identify their target RNAs. Although it is generally accepted that the binding specificity of an RBP is well described in terms of the nucleotide sequence of its binding sites, other factors such as the structural accessibility of binding sites or their clustering, to enable binding of RBP multimers, are also believed to play a role. Here we focus on GLD-1, a translational regulator of Caenorhabditis elegans, whose binding specificity and targets have been studied with a variety of methods such as CLIP (crosslinking and immunoprecipitation), RIP-Chip (microarray measurement of RNAs associated with an immunoprecipitated protein), profiling of polysome-associated mRNAs and biophysical determination of binding affinities of GLD-1 for short nucleotide sequences. We show that a simple biophysical model explains the binding of GLD-1 to mRNA targets to a large extent, and that taking into account the accessibility of putative target sites significantly improves the prediction of GLD-1 binding, particularly due to a more accurate prediction of binding in transcript coding regions. Relating GLD-1 binding to translational repression and stabilization of its target transcripts we find that binding sites along the entire transcripts contribute to functional responses, and that CDS-located sites contribute most to translational repression. Finally, biophysical measurements of GLD-1 affinity for a small number of oligonucleotides appear to allow an accurate reconstruction of the sequence specificity of the protein. This approach can be applied to uncover the specificity and function of other RBPs.
C1 [Bruemmer, Anneke; Kishore, Shivendra; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Subasic, Deni; Hengartner, Michael] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Brummer,
   Anneke/0000-0002-3576-0750; Hengartner, Michael/0000-0002-7584-596X
FU SNF Sinergia [CRSII3_127454]
FX We thank Erik van Nimwegen and the whole Zavolan group for discussions.
   This work was supported by the SNF Sinergia grant CRSII3_127454.
CR Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014
   Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016
   Biedermann B, 2009, DEV CELL, V17, P355, DOI 10.1016/j.devcel.2009.08.003
   Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112
   Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109
   Hofacker IL, 2010, METHODS MOL BIOL, V623, P137, DOI 10.1007/978-1-60761-588-0_9
   Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258
   Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009
   Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008
   Lee MH, 2004, GENE DEV, V18, P1047, DOI 10.1101/gad.1188404
   Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901
   Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486
   Mootz D, 2004, DEVELOPMENT, V131, P3263, DOI 10.1242/dev.01196
   Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550
   Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706
   Scheckel C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002742
   Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Wang X, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S8
   Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213
   Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334
   Xu L, 2001, GENETICS, V159, P1007
   Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545
   Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150
   Zisoulis DG, 2011, METHODS MOL BIOL, V732, P169, DOI 10.1007/978-1-61779-083-6_13
NR 41
TC 15
Z9 16
U1 0
U2 6
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD OCT
PY 2013
VL 19
IS 10
BP 1317
EP 1326
DI 10.1261/rna.037531.112
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 219QV
UT WOS:000324524300001
PM 23974436
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Valdes-Ferrer, SI
   Rosas-Ballina, M
   Olofsson, PS
   Lu, B
   Dancho, ME
   Ochani, M
   Li, JH
   Scheinerman, JA
   Katz, DA
   Levine, YA
   Hudson, LK
   Yang, H
   Pavlov, VA
   Roth, J
   Blanc, L
   Antoine, DJ
   Chavan, SS
   Andersson, U
   Diamond, B
   Tracey, KJ
AF Valdes-Ferrer, S. I.
   Rosas-Ballina, M.
   Olofsson, P. S.
   Lu, B.
   Dancho, M. E.
   Ochani, M.
   Li, J. H.
   Scheinerman, J. A.
   Katz, D. A.
   Levine, Y. A.
   Hudson, L. K.
   Yang, H.
   Pavlov, V. A.
   Roth, J.
   Blanc, L.
   Antoine, D. J.
   Chavan, S. S.
   Andersson, U.
   Diamond, B.
   Tracey, K. J.
TI HMGB1 mediates splenomegaly and expansion of splenic CD11b+Ly-6C(high)
   inflammatory monocytes in murine sepsis survivors
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE anti-HMGB1; CD11b+Ly-6C(high); HMGB1; sepsis survivors; splenomegaly
ID MOBILITY GROUP BOX-1; COGNITIVE IMPAIRMENT; UNITED-STATES; IN-VIVO;
   CARE; EPIDEMIOLOGY; LETHALITY; RELEASE; PROTEIN
AB Background More than 500,000 hospitalized patients survive severe sepsis annually in the USA. Recent epidemiological evidence, however, demonstrated that these survivors have significant morbidity and mortality, with 3-year fatality rates higher than 70%. To investigate the mechanisms underlying persistent functional impairment in sepsis survivors, here we developed a model to study severe sepsis survivors following cecal ligation and puncture (CLP).
   Methods Sepsis was induced in mice by CLP and survivors were followed for twelve weeks. Spleen and blood were collected and analyzed at different time points post-sepsis.
   Results We observed that sepsis survivors developed significant splenomegaly. Analysis of the splenic cellular compartments revealed a major expansion of the inflammatory CD11b+ Ly-6CHigh pool. Serum high-mobility group box 1 (HMGB1) levels in the sepsis surviving mice were significantly elevated for 4-6 weeks after post-sepsis, and administration of an anti-HMGB1 monoclonal antibody significantly attenuated splenomegaly as well as splenocyte priming. Administration of recombinant HMGB1 to naive mice induced similar splenomegaly, leukocytosis and splenocyte priming as observed in sepsis survivors. Interestingly analysis of circulating HMGB1 from sepsis survivors by mass spectroscopy demonstrated a stepwise increase of reduced form of HMGB1 (with known chemo-attractant properties) during the first 3 weeks, followed by disulphide form (with known inflammatory properties) 4-8 weeks after CLP.
   Discussion Our results indicate that prolonged elevation of HMGB1 is a necessary and sufficient mediator of splenomegaly and splenocyte expansion, as well as splenocyte inflammatory priming in murine severe sepsis survivors.
C1 [Valdes-Ferrer, S. I.; Olofsson, P. S.; Lu, B.; Dancho, M. E.; Ochani, M.; Li, J. H.; Scheinerman, J. A.; Katz, D. A.; Hudson, L. K.; Yang, H.; Pavlov, V. A.; Roth, J.; Blanc, L.; Chavan, S. S.; Diamond, B.; Tracey, K. J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA.
   [Valdes-Ferrer, S. I.; Lu, B.] Elmezzi Grad Sch Mol Med, Manhasset, NY USA.
   [Rosas-Ballina, M.] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Levine, Y. A.] Valen Inc, SetPoint Med, Valencia, CA USA.
   [Antoine, D. J.] Univ Liverpool, MRC, Ctr Drug Safety Sci Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.
   [Andersson, U.] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.
   [Andersson, U.] Karolinska Univ Hosp, Stockholm, Sweden.
RP Tracey, KJ (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.
EM kjtracey@nshs.edu
RI Valdes-Ferrer, Sergio Ivan/ABD-1057-2020; Levine, Yaakov/AAA-2578-2020
OI Valdes-Ferrer, Sergio Ivan/0000-0002-4863-6484; chavan,
   sangeeta/0000-0002-4822-3356; Andersson, Ulf/0000-0003-0316-3860; Blanc,
   Lionel/0000-0002-0185-6260; Tracey, Kevin J/0000-0003-1884-6314; Pavlov,
   Valentin/0000-0002-1994-2853
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01-GM57726,
   R01-GM62508]; Wellcome TrustWellcome Trust; NATIONAL INSTITUTE OF
   GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM062508, R01GM062508,
   R43GM057726, R01GM062508, R01GM062508, R01GM062508, R01GM062508,
   R01GM062508, R01GM062508, R01GM062508, R01GM062508, R01GM062508,
   R01GM062508] Funding Source: NIH RePORTER; Medical Research
   CouncilMedical Research Council UK (MRC) [G0700654B] Funding Source:
   researchfish
FX This work was supported by the National Institute of General Medical
   Sciences (grants R01-GM57726 and R01-GM62508 to KJT). DJA is supported
   by a Wellcome Trust Research Fellowship.
CR Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI [10.1097/00003246-200107000-00002, 10.1097/00003246-200107001-00035]
   Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A
   Angus DC, 2010, JAMA-J AM MED ASSOC, V304, P1833, DOI 10.1001/jama.2010.1546
   Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235
   Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195
   Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602
   FABRY Z, 1993, J NEUROIMMUNOL, V47, P23, DOI 10.1016/0165-5728(93)90281-3
   Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019
   Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Osler W, 1908, BRIT MED J, V1908, P1470
   Pozo AL, 2009, BLOOD REV, V23, P105, DOI 10.1016/j.blre.2008.10.001
   Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203
   Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058
   Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105
   Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039
   Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   van Zoelen MAD, 2009, SHOCK, V31, P280, DOI 10.1097/SHK.0b013e318186262d
   Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B
   Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405
   Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100
   Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389
NR 27
TC 52
Z9 53
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
J9 J INTERN MED
JI J. Intern. Med.
PD OCT
PY 2013
VL 274
IS 4
BP 381
EP 390
DI 10.1111/joim.12104
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 213OZ
UT WOS:000324068800010
PM 23808943
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Degiacomi, MT
   Lacovache, I
   Pernot, L
   Chami, M
   Kudryashev, M
   Stahlberg, H
   van der Goot, FG
   Dal Peraro, M
AF Degiacomi, Matteo T.
   Lacovache, Ioan
   Pernot, Lucile
   Chami, Mohamed
   Kudryashev, Misha
   Stahlberg, Henning
   van der Goot, F. Gisou
   Dal Peraro, Matteo
TI Molecular assembly of the aerolysin pore reveals a swirling
   membrane-insertion mechanism
SO NATURE CHEMICAL BIOLOGY
LA English
DT Article
ID GPI-ANCHORED PROTEINS; CRYSTAL-STRUCTURE; FORMING PROTEINS; TOXIN;
   CHANNEL; RECEPTOR; BINDING; HEPTAMERIZATION; IDENTIFICATION;
   TRANSMEMBRANE
AB Aerolysin is the founding member of a superfamily of (beta-pore-forming toxins whose pore structure is unknown. We have combined X-ray crystallography, cryo-EM, molecular dynamics and computational modeling to determine the structures of aerolysin mutants in their monomeric and heptameric forms, trapped at various stages of the pore formation process. A dynamic modeling approach based on swarm intelligence was applied, whereby the intrinsic flexibility of aerolysin extracted from new X-ray structures was used to fully exploit the cryo-EM spatial restraints. Using this integrated strategy, we obtained a radically new arrangement of the prepore conformation and a near-atomistic structure of the aerolysin pore, which is fully consistent with all of the biochemical data available so far. Upon transition from the prepore to pore, the aerolysin heptamer shows a unique concerted swirling movement, accompanied by a vertical collapse of the complex, ultimately leading to the insertion of a transmembrane beta-barrel.
C1 [Degiacomi, Matteo T.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.
   [Lacovache, Ioan; Pernot, Lucile; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland.
   [Kudryashev, Misha; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Basel, Switzerland.
   [Dal Peraro, Matteo] Swiss Inst Bioinformat, Lausanne, Switzerland.
RP Degiacomi, MT (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Oxford, England.
EM gisou.vandergoot@epfl.ch; matteo.dalperaro@epfl.ch
RI Stahlberg, Henning/H-1868-2011; Degiacomi, Matteo/M-4342-2017; van der
   Goot, Gisou/B-2279-2012
OI Stahlberg, Henning/0000-0002-1185-4592; Degiacomi,
   Matteo/0000-0003-4672-471X; van der Goot, Gisou/0000-0002-8522-274X;
   Kudryashev, Misha/0000-0003-3550-6274
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200021_122120, 200020_138013]; Swiss Initiative for Systems
   Biology, SystemsX.ch
FX We thank F. David and S. Ho for technical assistance, G. Knot and D.
   Demurtas for help with EM, M. Grutter for testing of crystals, C.
   Schulze-Briese for assistance in collecting the data and M. Schiltz for
   support with X-ray crystallography. EM computation was performed at the
   Vital-IT (Swiss Institute of Bioinformatics). This work was supported by
   the Swiss National Science Foundation with grants to M.D.P.
   (200021_122120 and 200020_138013) and to F.G.v.d.G. and by the Swiss
   Initiative for Systems Biology, SystemsX.ch to EG.v.d.G. and H.S.
CR Abrami L, 2002, FEBS LETT, V512, P249, DOI 10.1016/S0014-5793(02)02274-3
   Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525
   Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005
   Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003
   De Colibus L, 2012, STRUCTURE, V20, P1498, DOI 10.1016/j.str.2012.06.011
   De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108
   Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014
   Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398
   Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508
   Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959
   Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135
   Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013
   Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109
   Lesieur C, 1999, J BIOL CHEM, V274, P36722, DOI 10.1074/jbc.274.51.36722
   MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604
   Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200
   Melton-Witt JA, 2006, BIOCHEMISTRY-US, V45, P14347, DOI 10.1021/bi061334p
   Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026
   Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170
   PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0
   Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8
   Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662
   Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349
   Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005
   TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088
   Tsitrin Y, 2002, NAT STRUCT BIOL, V9, P729, DOI 10.1038/nsb839
   WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x
   Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162
NR 32
TC 119
Z9 124
U1 3
U2 66
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1552-4450
EI 1552-4469
J9 NAT CHEM BIOL
JI Nat. Chem. Biol.
PD OCT
PY 2013
VL 9
IS 10
BP 623
EP 629
DI 10.1038/NCHEMBIO.1312
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 226MZ
UT WOS:000325041800009
PM 23912165
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Nielsen, G
   Jonker, HRA
   Vajpai, N
   Grzesiek, S
   Schwalbe, H
AF Nielsen, Gerd
   Jonker, Hendrik R. A.
   Vajpai, Navratna
   Grzesiek, Stephan
   Schwalbe, Harald
TI Kinase in Motion: Insights into the Dynamic Nature of p38 alpha by
   High-Pressure NMR Spectroscopic Studies
SO CHEMBIOCHEM
LA English
DT Article
DE DFG loop; high-pressure chemistry; NMR spectroscopy; p38alpha;
   relaxation
ID MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; P38 MAP KINASES;
   CHEMICAL-SHIFTS; PROTEIN-KINASE; MACROMOLECULES; DOMAIN; STATES; N-15
AB Protein kinases are highly dynamic and complex molecules. Here we present high-pressure and relaxation studies of the activated p38 alpha mitogen-activated protein kinase (MAPK). p38 alpha plays a central role in inflammatory diseases such as rheumatoid arthritis and is therefore a highly attractive pharmaceutical target. The combination of high pressure and NMR spectroscopy allowed for a detailed per-residue based assessment of the structural plasticity of p38 alpha and the accessibility of low-lying excited-energy conformations throughout the kinase structure. Such information is uniquely accessible through the combination of liquid-state NMR and high pressure and is of considerable value for the drug discovery process. The interactions of p38 alpha and DFG-in and DFG-out ligands were studied under the application of high pressure, and we demonstrate how we can alter kinase dynamics by pressure in a similar way to what has previously only been observed by ligand binding. Pressure is shown to be a mild and efficient tool for manipulation of intermediate-timescale dynamics.
C1 [Nielsen, Gerd; Jonker, Hendrik R. A.; Schwalbe, Harald] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany.
   [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Schwalbe, H (corresponding author), Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Ctr Biomol Magnet Resonance, Max von Laue Str 7, D-60438 Frankfurt, Germany.
EM schwalbe@nmr.uni-frankfurt.de
RI Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010
OI Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald
   J/0000-0001-5693-7909; Grzesiek, Stephan/0000-0003-1998-4225
FU State of Hessen (BMRZ); DFGGerman Research Foundation (DFG); EUEuropean
   Union (EU)
FX We thank Dr. Hamid Nasiri for the synthesis of the DFG-out ligand. This
   work was funded by the State of Hessen (BMRZ). H. S. is a member of the
   DFG-funded cluster of excellence: macromolecular complexes. The work was
   financially supported by EU projects: WeNMR and Bio-NMR.
CR Akasaka K, 2001, BIOCHEMISTRY-US, V40, P8665, DOI 10.1021/bi010312u
   Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z
   [Anonymous], PYMOL MOL GRAPHICS S
   Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2
   de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170
   Fu YN, 2012, J AM CHEM SOC, V134, P8543, DOI 10.1021/ja3004655
   Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4
   Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007
   Hass MAS, 2008, PROTEINS, V72, P333, DOI 10.1002/prot.21929
   Inoue K, 2001, FEBS LETT, V506, P180, DOI 10.1016/S0014-5793(01)02809-5
   Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16
   Kalbitzer HR, 2009, J AM CHEM SOC, V131, P16714, DOI 10.1021/ja904314q
   Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177
   Kuwata K, 2001, J MOL BIOL, V305, P1073, DOI 10.1006/jmbi.2000.4350
   Langer T, 2004, CHEMBIOCHEM, V5, P1508, DOI 10.1002/cbic.200400129
   LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383
   Mitra L, 2007, J AM CHEM SOC, V129, P14108, DOI 10.1021/ja073576y
   Nielsen G, 2011, CHEMBIOCHEM, V12, P2599, DOI 10.1002/cbic.201100527
   Nisius L, 2012, NAT CHEM, V4, P711, DOI [10.1038/NCHEM.1396, 10.1038/nchem.1396]
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109
   Tomlinson JH, 2010, PROTEINS, V78, P3000, DOI 10.1002/prot.22825
   Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770
   Wilton DJ, 2009, BIOPHYS J, V97, P1482, DOI 10.1016/j.bpj.2009.06.022
   Wishart DS, 2001, METHOD ENZYMOL, V338, P3
   Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276
NR 29
TC 9
Z9 9
U1 0
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD SEP 23
PY 2013
VL 14
IS 14
BP 1799
EP 1806
DI 10.1002/cbic.201300170
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 237ER
UT WOS:000325851800015
PM 23843149
DA 2021-01-25
ER

PT J
AU Quebatte, G
   Kitas, E
   Seelig, J
AF Quebatte, Gabriela
   Kitas, Eric
   Seelig, Joachim
TI riDOM, a Cell-Penetrating Peptide. Interaction with DNA and Heparan
   Sulfate
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID TITRATION CALORIMETRY; THERMODYNAMICS; CONDENSATION; BINDING
AB DNA condensation in the presence of polycationic molecules is a well-known phenomenon exploited in gene delivery. riDOM (retro-inverso dioleoylmelittin) is a cell-penetrating peptide with excellent transporter properties for DNA. It is a chimeric molecule where ri-melittin is fused to dioleoylphosphoethanolamine. The physical-chemical properties of riDOM in solution and in the presence of DNA and heparan sulfate were investigated with spectroscopic and thermodynamic methods. Dynamic light scattering shows that riDOM in solution aggregates to well-defined nanoparticles with a diameter of similar to 13 nm and a xi-potential of 22 mV, composed of about 220-270 molecules. Binding of riDOM to DNA was studied with dynamic light scattering, xi-potential measurements, and isothermal titration calorimetry and was compared with microscopic binding constant of S X 10(7) M-1 and a stoichiometry of 12 riDOM per 10 DNA base pairs. In the complex the DNA double strand is completely shielded by the more hydrophobic riDOM molecules. Authentic melittin binds to DNA with a much lower binding constant of 5 X 10(6) M-1 and lower stoichiometry of 5 melittin per 10 DNA base pairs. The binding enthalpies for riDOM and melittin are small and the binding reactions are entropy-driven. Sulfated glycosaminoglycans such as heparan sulfate are also linear molecules with a negative charge. riDOM binding to heparan sulfate on cell surfaces can therefore interfere with DNA-riDOM binding. riDOM-heparan sulfate complex formation was characterized by isothermal titration calorimetry and spectroscopic methods. The binding constant of riDOM for heparan sulfate is K approximate to 2 X 10(6) M-1. Authentic melittin has a similar binding constant but riDOM shows a 3-fold higher packing density on heparan sulfate than the distinctly smaller melittin.
C1 [Quebatte, Gabriela; Seelig, Joachim] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Kitas, Eric] F Hoffmann LaRoche Ltd, pRED, Div Pharmaceut, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
OI Quebatte, Gabriela/0000-0002-2530-5527
CR BERGETHON PR, 1990, BIOPHYSICAL CHEM MOL
   Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2
   Ehtezazi T, 2003, LANGMUIR, V19, P9387, DOI 10.1021/la0268799
   Estevez-Torres A, 2011, SOFT MATTER, V7, P6746, DOI 10.1039/c1sm05373f
   Goncalves E, 2006, BIOCHEMISTRY-US, V45, P3086, DOI 10.1021/bi052221t
   Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754
   Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
NR 11
TC 7
Z9 7
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD SEP 19
PY 2013
VL 117
IS 37
BP 10807
EP 10817
DI 10.1021/jp404979y
PG 11
WC Chemistry, Physical
SC Chemistry
GA 287CD
UT WOS:000329515200015
PM 24016043
DA 2021-01-25
ER

PT J
AU Duran, RV
   MacKenzie, ED
   Boulahbel, H
   Frezza, C
   Heiserich, L
   Tardito, S
   Bussolati, O
   Rocha, S
   Hall, MN
   Gottlieb, E
AF Duran, R. V.
   MacKenzie, E. D.
   Boulahbel, H.
   Frezza, C.
   Heiserich, L.
   Tardito, S.
   Bussolati, O.
   Rocha, S.
   Hall, M. N.
   Gottlieb, E.
TI HIF-independent role of prolyl hydroxylases in the cellular response to
   amino acids
SO ONCOGENE
LA English
DT Article
DE prolyl hydroxylases; PHD; alpha-ketoglutarate; amino acids; HIF; mTOR
ID FISSION YEAST; HYPOXIA; GROWTH; MTOR; 4-HYDROXYLASES; DEFICIENCY;
   EXPRESSION; AUTOPHAGY; PATHWAY; FAMILY
AB Hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs) are alpha-ketoglutarate (alpha KG)-dependent dioxygenases that function as cellular oxygen sensors. However, PHD activity also depends on factors other than oxygen, especially aKG, a key metabolic compound closely linked to amino-acid metabolism. We examined the connection between amino-acid availability and PHD activity. We found that amino-acid starvation leads to alpha KG depletion and to PHD inactivation but not to HIF stabilization. Furthermore, pharmacologic or genetic inhibition of PHDs induced autophagy and prevented mammalian target of rapamycin complex 1 (mTORC1) activation by amino acids in a HIF-independent manner. Therefore, PHDs sense not only oxygen but also respond to amino acids, constituting a broad intracellular nutrient-sensing network.
C1 [Duran, R. V.; MacKenzie, E. D.; Boulahbel, H.; Frezza, C.; Heiserich, L.; Tardito, S.; Gottlieb, E.] Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Metab Lab, Glasgow G61 1BD, Lanark, Scotland.
   [Duran, R. V.; Hall, M. N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Tardito, S.; Bussolati, O.] Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, I-43100 Parma, Italy.
   [Rocha, S.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland.
RP Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Metab Lab, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.
EM e.gottlieb@beatson.gla.ac.uk
RI Bussolati, Ovidio/B-7589-2013; Frezza, Christian/G-2174-2010; Gottlieb,
   Eyal/G-6450-2010; Tardito, Saverio/AAJ-7727-2020; Duran, Raul
   V./E-4764-2011
OI Bussolati, Ovidio/0000-0002-4301-2939; Frezza,
   Christian/0000-0002-3293-7397; Gottlieb, Eyal/0000-0002-9770-0956;
   Tardito, Saverio/0000-0002-5294-8683; Duran, Raul V./0000-0002-2249-9215
FU Cancer Research UKCancer Research UK; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Cancer Research
   UKCancer Research UK [12918] Funding Source: researchfish
FX PHD2 and PHD3 antibodies were provided by Kevin Gatter. We thank David
   Sabatini and Fuyuhiko Tamanoi for kindly providing Rag and Rheb
   plasmids. We thank David Kwiatkowski for TSC2<SUP>+/+</SUP> and
   TSC2<SUP>-/-</SUP> mouse embryonic fibroblasts. This work was supported
   by the Cancer Research UK and by the Swiss National Science Foundation.
CR Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62
   Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598
   Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804
   Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103
   DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865
   Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4
   Frei C, 2004, DEV CELL, V6, P241, DOI 10.1016/S1534-5807(03)00409-X
   Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200
   Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002
   Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83
   Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044
   Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06
   Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366
   Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0
   Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3
   Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   Zhong H, 2000, CANCER RES, V60, P1541
NR 36
TC 61
Z9 62
U1 0
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD SEP 19
PY 2013
VL 32
IS 38
BP 4549
EP 4556
DI 10.1038/onc.2012.465
PG 8
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 223SW
UT WOS:000324831300010
PM 23085753
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Bircher, BA
   Duempelmann, L
   Renggli, K
   Lang, HP
   Gerber, C
   Bruns, N
   Braun, T
AF Bircher, Benjamin A.
   Duempelmann, Luc
   Renggli, Kasper
   Lang, Hans Peter
   Gerber, Christoph
   Bruns, Nico
   Braun, Thomas
TI Real-Time Viscosity and Mass Density Sensors Requiring Microliter Sample
   Volume Based on Nanomechanical Resonators
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPE; FREQUENCY-RESPONSE; VISCOUS FLUIDS; RADICAL
   POLYMERIZATION; LIQUID ENVIRONMENT; TUNING FORK; CANTILEVER; BEAMS;
   MICROCANTILEVERS; EXCITATION
AB A microcantilever based method for fluid viscosity and mass density measurements with high temporal resolution and microliter sample consumption is presented. Nanomechanical cantilever vibration is driven by photothermal excitation and detected by an optical beam deflection system using two laser beams of different wavelengths. The theoretical framework relating cantilever response to the viscosity and mass density of the surrounding fluid was extended to consider higher flexural modes vibrating at high Reynolds numbers. The performance of the developed sensor and extended theory was validated over a viscosity range of 1-20 mPa.s and a corresponding mass density range of 998-1176 kg/m(3) using reference fluids. Separating sample plugs from the carrier fluid by a two-phase configuration in combination with a microfluidic flow cell, allowed samples of 5 mu L to be sequentially measured under continuous flow, opening the method to fast and reliable screening applications. To demonstrate the study of dynamic processes, the viscosity and mass density changes occurring during the free radical polymerization of acrylamide were monitored and compared to published data. Shear-thinning was observed in the viscosity data at higher flexural modes, which vibrate at elevated frequencies. Rheokinetic models allowed the monomer-to-polymer conversion to be tracked in spite of the shear-thinning behavior, and could be applied to study the kinetics of unknown processes.
C1 [Bircher, Benjamin A.; Duempelmann, Luc; Braun, Thomas] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
   [Renggli, Kasper; Bruns, Nico] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Lang, Hans Peter; Gerber, Christoph] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Braun, T (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, Mattenstr 26, CH-4058 Basel, Switzerland.
EM thomas.braun@unibas.ch
RI Duempelmann, Luc/M-4046-2017; Bruns, Nico/C-6485-2009; Duempelmann,
   Luc/P-6061-2019; Renggli, Kasper/AAU-1831-2020; Bircher,
   Benjamin/AAW-2668-2020
OI Duempelmann, Luc/0000-0002-7552-543X; Bruns, Nico/0000-0001-6199-9995;
   Duempelmann, Luc/0000-0002-7552-543X; Bircher,
   Benjamin/0000-0002-1494-6732; Gerber, Christoph/0000-0001-7035-3838;
   /0000-0001-6865-4084; Lang, Hans Peter/0000-0002-0012-2564
FU SNF [200021/130594]; NCCR Nano; ARGOVIA project NoViDeMo
FX The authors gratefully acknowledge Henning Stahlberg (C-CINA, University
   of Basel) for providing infrastructure and facilities; Shirley A. Muller
   (C-CINA, Univ. Basel) for critically reading the manuscript; Bernd Rinn
   (CISD, D-BSSE, ETHZ) and Patrick Vogt (URZ, Univ. Basel) for support
   with numerical calculations; Francois Huber and Natalija Backmann (SNI,
   Univ. Basel) for help with the sensor passivation; Andreas Hierlemann
   and Alexander Stettler (BEL, D-BSSE, ETHZ) for assistance on PDMS
   fabrication; Andreas Tonin (Electronics Workshop, Dept. Physics, Univ.
   Basel) and Raymond Strittmatter (Mechanical Workshop, Biozentrum, Univ.
   Basel) for helping to design the instrument and for its manufacture;
   Michel Despont and Ute Drechsler (IBM Research GmbH, Ruschlikon,
   Switzerland) for providing cantilever arrays; Thomas Pfohl (Department
   of Chemistry, Univ. Basel) and Ernst Meyer (Dept. Physics, Univ. Basel)
   for fruitful discussions. This work was supported by SNF grant
   200021/130594, NCCR Nano, and ARGOVIA project NoViDeMo.
CR Ahmed N, 2001, REV SCI INSTRUM, V72, P2731, DOI 10.1063/1.1368856
   Aureli M, 2012, J SOUND VIB, V331, P1624, DOI 10.1016/j.jsv.2011.12.007
   Batchelor G.K., 1967, INTRO FLUID DYNAMICS
   Bergaud C, 2000, REV SCI INSTRUM, V71, P2487, DOI 10.1063/1.1150640
   Bhangale AS, 2012, MACROMOLECULES, V45, P7000, DOI 10.1021/ma301178k
   Bosart LW, 1928, IND ENG CHEM, V20, P1377, DOI 10.1021/ie50228a032
   Boskovic S, 2002, J RHEOL, V46, P891, DOI 10.1122/1.1475978
   Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907
   Cheng NS, 2008, IND ENG CHEM RES, V47, P3285, DOI 10.1021/ie071349z
   Chon JWM, 2000, J APPL PHYS, V87, P3978, DOI 10.1063/1.372455
   Doy N, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3353379
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Fukuma T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3086418
   Ghatkesar MK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838295
   Ghatkesar MK, 2008, SENSOR ACTUAT B-CHEM, V135, P133, DOI 10.1016/j.snb.2008.08.012
   Ghatkesar MK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445502
   Green CP, 2005, J APPL PHYS, V98, DOI 10.1063/1.2136418
   Hennemeyer M, 2008, SENSORS-BASEL, V8, P10, DOI 10.3390/s8010010
   JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370
   Kim S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240737
   Kim S, 2010, EXP FLUIDS, V48, P721, DOI 10.1007/s00348-010-0830-3
   Kokavecz J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.172101
   Kulichikhin SG, 1997, POLYM ENG SCI, V37, P1331, DOI 10.1002/pen.11779
   Kulicke WM, 1982, PROGR POLYM SCI, V8, P373, DOI 10.1016/0079-6700(82)90004-1.
   Lee J, 2005, ANAL CHEM, V77, P7137, DOI 10.1021/ac050932r
   Liu Y, 2011, SENSOR ACTUAT A-PHYS, V167, P347, DOI 10.1016/j.sna.2011.03.017
   Lochon F, 2006, SENSOR ACTUAT B-CHEM, V118, P292, DOI 10.1016/j.snb.2006.04.034
   Maali A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1873060
   McLoughlin N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2374867
   McLoughlin N, 2007, LAB CHIP, V7, P1057, DOI 10.1039/b705787c
   Nishida S, 2009, J VAC SCI TECHNOL B, V27, P964, DOI 10.1116/1.3077487
   Paxman R, 2012, SENSORS-BASEL, V12, P6497, DOI 10.3390/s120506497
   Pipe CJ, 2009, MECH RES COMMUN, V36, P110, DOI 10.1016/j.mechrescom.2008.08.009
   Ramos D, 2006, J APPL PHYS, V99, DOI 10.1063/1.2205409
   Ricciardi C, 2010, BIOSENS BIOELECTRON, V26, P1565, DOI 10.1016/j.bios.2010.07.114
   RICCO AJ, 1987, APPL PHYS LETT, V50, P1474, DOI 10.1063/1.97804
   Riesch C, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/075010
   Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002
   Seemann R, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016601
   Sigg SJ, 2011, MACROMOL RAPID COMM, V32, P1710, DOI 10.1002/marc.201100349
   Sparks D, 2003, LAB CHIP, V3, P19, DOI 10.1039/b211429a
   Sparks D, 2009, SENSOR ACTUAT A-PHYS, V149, P38, DOI 10.1016/j.sna.2008.09.013
   Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977
   Van Eysden CA, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2395967
   Van Eysden CA, 2006, J APPL PHYS, V100, DOI 10.1063/1.2401053
   Van Eysden CA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3254191
   Van Eysden CA, 2007, J APPL PHYS, V101, DOI 10.1063/1.2654274
   Vancura C, 2008, SENSOR ACTUAT A-PHYS, V141, P43, DOI 10.1016/j.sna.2007.07.010
   Wilson TL, 2007, SENSOR ACTUAT A-PHYS, V138, P44, DOI 10.1016/j.sna.2007.04.050
   Youssry M, 2011, SENSOR ACTUAT A-PHYS, V172, P40, DOI 10.1016/j.sna.2011.02.025
   Youssry M, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/12/125306
   Zhang J, 2002, SENSOR ACTUAT B-CHEM, V84, P123, DOI 10.1016/S0925-4005(02)00012-6
NR 52
TC 38
Z9 39
U1 0
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 17
PY 2013
VL 85
IS 18
BP 8676
EP 8683
DI 10.1021/ac4014918
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 294BM
UT WOS:000330017400029
PM 23905589
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Davis, NJ
   Cohen, Y
   Sanselicio, S
   Fumeaux, C
   Ozaki, S
   Luciano, J
   Guerrero-Ferreira, RC
   Wright, ER
   Jenal, U
   Viollier, PH
AF Davis, Nicole J.
   Cohen, Yaniv
   Sanselicio, Stefano
   Fumeaux, Coralie
   Ozaki, Shogo
   Luciano, Jennifer
   Guerrero-Ferreira, Ricardo C.
   Wright, Elizabeth R.
   Jenal, Urs
   Viollier, Patrick H.
TI De- and repolarization mechanism of flagellar morphogenesis during a
   bacterial cell cycle
SO GENES & DEVELOPMENT
LA English
DT Article
DE asymmetric division; c-di-GMP; Caulobacter; cell cycle; flagellum;
   morphogenesis; polarity
ID C-DI-GMP; CAULOBACTER-CRESCENTUS; CHROMOSOME SEGREGATION; RESPONSE
   REGULATOR; POLAR LOCALIZATION; G-PROTEIN; MOTILITY; MOTOR;
   VISUALIZATION; CHEMOTAXIS
AB Eukaryotic morphogenesis is seeded with the establishment and subsequent amplification of polarity cues at key times during the cell cycle, often using (cyclic) nucleotide signals. We discovered that flagellum de-and repolarization in the model prokaryote Caulobacter crescentus is precisely orchestrated through at least three spatiotemporal mechanisms integrated at TipF. We show that TipF is a cell cycle-regulated receptor for the second messenger-bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP)-that perceives and transduces this signal through the degenerate c-di-GMP phosphodiesterase (EAL) domain to nucleate polar flagellum biogenesis. Once c-di-GMP levels rise at the G1 -> S transition, TipF is activated, stabilized, and polarized, enabling the recruitment of downstream effectors, including flagellar switch proteins and the PflI positioning factor, at a preselected pole harboring the TipN landmark. These c-di-GMP-dependent events are coordinated with the onset of tipF transcription in early S phase and together enable the correct establishment and robust amplification of TipF-dependent polarization early in the cell cycle. Importantly, these mechanisms also govern the timely removal of TipF at cell division coincident with the drop in c-di-GMP levels, thereby resetting the flagellar polarization state in the next cell cycle after a preprogrammed period during which motility must be suspended.
C1 [Davis, Nicole J.; Viollier, Patrick H.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
   [Cohen, Yaniv; Ozaki, Shogo; Luciano, Jennifer; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sanselicio, Stefano; Fumeaux, Coralie; Viollier, Patrick H.] Univ Geneva, Ctr Med Univ, Dept Microbiol & Mol Med, Inst Genet & Genom Geneva iGE3,Fac Med, CH-1211 Geneva 4, Switzerland.
   [Guerrero-Ferreira, Ricardo C.; Wright, Elizabeth R.] Emory Univ, Childrens Healthcare Atlanta, Sch Med, Div Pediat Infect Dis,Dept Pediat, Atlanta, GA 30322 USA.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch; patrick.viollier@unige.ch
OI Guerrero-Ferreira, Ricardo/0000-0002-3664-8277; Viollier,
   Patrick/0000-0002-5249-9910; Fumeaux, Coralie/0000-0002-6969-3111
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [127287, 130469]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [GM104540]; Human Frontier Science ProgramHuman Frontier Science
   Program [RGP0051/2010]; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM104540, R01GM104540, R01GM104540,
   R01GM104540, R01GM104540, R01GM104540, R01GM104540] Funding Source: NIH
   RePORTER
FX We thank Lucy Shapiro and Jim Gober for providing antibodies. Funding
   support is from Swiss National Science Foundation (no. 127287 to P. H.
   V. and no. 130469 to U.J.), National Institutes of Health (GM104540 to
   E. R. W), and Human Frontier Science Program (RGP0051/2010 to P.H.V and
   E.R.W).
CR Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018
   ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825
   Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678
   Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09
   Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966
   Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705
   Brown MT, 2011, CURR OPIN MICROBIOL, V14, P734, DOI 10.1016/j.mib.2011.09.009
   Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017
   Charest PG, 2010, DEV CELL, V19, P795, DOI 10.1016/j.devcel.2010.11.017
   Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887
   Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658
   Davis NJ, 2011, FEMS MICROBIOL LETT, V319, P146, DOI 10.1111/j.1574-6968.2011.02275.x
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x
   Green JCD, 2009, J MOL BIOL, V391, P679, DOI 10.1016/j.jmb.2009.05.075
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019
   IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993
   Ji YBA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1759
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kusumoto A, 2009, J BIOCHEM, V146, P643, DOI 10.1093/jb/mvp109
   Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114
   McAdams HH, 2011, J MOL BIOL, V409, P28, DOI 10.1016/j.jmb.2011.02.041
   Obuchowski PL, 2008, J BACTERIOL, V190, P1718, DOI 10.1128/JB.01706-07
   Osteras M, 1999, J BACTERIOL, V181, P3039
   Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x
   Paul K, 2011, J BACTERIOL, V193, P5914, DOI 10.1128/JB.05458-11
   Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732
   Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384
   St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011
   Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038
   Thompson SR, 2006, P NATL ACAD SCI USA, V103, P8209, DOI 10.1073/pnas.0600919103
   Tsokos CG, 2012, CURR OPIN MICROBIOL, V15, P744, DOI 10.1016/j.mib.2012.10.011
   Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454
   Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07
   Yamaichi Y, 2012, GENE DEV, V26, P2348, DOI 10.1101/gad.199869.112
   Zarbiv G, 2012, J MOL BIOL, V416, P192, DOI 10.1016/j.jmb.2011.12.027
   Zhang Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000430
   Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005
NR 54
TC 34
Z9 34
U1 0
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
J9 GENE DEV
JI Genes Dev.
PD SEP 15
PY 2013
VL 27
IS 18
BP 2049
EP 2062
DI 10.1101/gad.222679.113
PG 14
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 224GW
UT WOS:000324872100009
PM 24065770
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Biebricher, A
   Hirano, S
   Enzlin, JH
   Wiechens, N
   Streicher, WW
   Huttner, D
   Wang, LHC
   Nigg, EA
   Owen-Hughes, T
   Liu, Y
   Peterman, E
   Wuite, GJL
   Hickson, ID
AF Biebricher, Andreas
   Hirano, Seiki
   Enzlin, Jacqueline H.
   Wiechens, Nicola
   Streicher, Werner W.
   Huttner, Diana
   Wang, Lily H. -C.
   Nigg, Erich A.
   Owen-Hughes, Tom
   Liu, Ying
   Peterman, Erwin
   Wuite, Gijs J. L.
   Hickson, Ian D.
TI PICH: A DNA Translocase Specially Adapted for Processing Anaphase Bridge
   DNA
SO MOLECULAR CELL
LA English
DT Article
ID PROTEIN; RAD54; PLK1; BLM; THREADS; MOTOR
AB The Plk1-interacting checkpoint helicase (PICH) protein localizes to ultrafine anaphase bridges (UFBs) in mitosis alongside a complex of DNA repair proteins, including the Bloom's syndrome protein (BLM). However, very little is known about the function of PICH or how it is recruited to UFBs. Using a combination of microfluidics, fluorescence microscopy, and optical tweezers, we have defined the properties of PICH in an in vitro model of an anaphase bridge. We show that PICH binds with a remarkably high affinity to duplex DNA, resulting in ATP-dependent protein translocation and extension of the DNA. Most strikingly, the affinity of PICH for binding DNA increases with tension-induced DNA stretching, which mimics the effect of the mitotic spindle on a UFB. PICH binding also appears to diminish force-induced DNA melting. We propose a model in which PICH recognizes and stabilizes DNA under tension during anaphase, thereby facilitating the resolution of entangled sister chromatids.
C1 [Biebricher, Andreas; Peterman, Erwin; Wuite, Gijs J. L.] Vrije Univ Amsterdam, LaserLaB Amsterdam, NL-1081 HV Amsterdam, Netherlands.
   [Biebricher, Andreas; Peterman, Erwin; Wuite, Gijs J. L.] Vrije Univ Amsterdam, Dept Phys, NL-1081 HV Amsterdam, Netherlands.
   [Hirano, Seiki; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.
   [Enzlin, Jacqueline H.; Huttner, Diana; Liu, Ying; Hickson, Ian D.] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Nordea Ctr Hlth Aging, DK-2200 Copenhagen N, Denmark.
   [Streicher, Werner W.; Huttner, Diana] Univ Copenhagen, Panum Inst, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen N, Denmark.
   [Wiechens, Nicola; Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.
   [Wang, Lily H. -C.; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hickson, ID (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.
EM iandh@sund.ku.dk
RI Hickson, Ian/AAJ-7548-2020; Peterman, Erwin JG/G-5529-2010
OI Peterman, Erwin JG/0000-0003-1058-249X; Huttner,
   Diana/0000-0003-3233-9108; Streicher, Werner/0000-0002-2425-5839;
   Owen-Hughes, Tom/0000-0002-0618-8185; nigg, erich/0000-0003-4835-5719;
   wuite, gijs/0000-0002-5706-043X
FU Cancer Research (UK)Cancer Research UK; Nordea Foundation (Denmark);
   Association for International Cancer Research (UK); Danish Cancer
   SocietyDanish Cancer Society; Novo Nordisk Foundation (Denmark)Novo
   Nordisk Foundation; LaserLab Europe; University of Basel (Switzerland);
   VICI of NWO; ERCEuropean Research Council (ERC); Worldwide Cancer
   Research [10-0500] Funding Source: researchfish
FX We would like to thank members of the Hickson, Nigg, Peterman, and Wuite
   groups for helpful discussions. Work in the authors' laboratories is
   supported by Cancer Research (UK), The Nordea Foundation (Denmark), The
   Association for International Cancer Research (UK), The Danish Cancer
   Society, The Novo Nordisk Foundation (Denmark), LaserLab Europe, and the
   University of Basel (Switzerland). This work is also part of a research
   program of the Foundation for Fundamental Research on Matter (FOM),
   which is part of the Netherlands Organisation for Scientific Research
   (NWO). Finally, we acknowledge support by VICI of NWO, as well as an ERC
   Starting Grant.
CR Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Bianco PR, 2007, J MOL BIOL, V374, P618, DOI 10.1016/j.jmb.2007.09.052
   Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766
   Candelli A, 2011, PHYS CHEM CHEM PHYS, V13, P7263, DOI 10.1039/c0cp02844d
   Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006
   Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001
   Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882
   Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777
   Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128
   Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682
   Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900
   Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007
   Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001
   Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059
   Flaus A, 2004, EMBO J, V23, P343, DOI 10.1038/sj.emboj.7600047
   GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003
   Gisselsson D, 2003, ADV CANCER RES, V87, P1
   Gross P, 2011, NAT PHYS, V7, P731, DOI [10.1038/NPHYS2002, 10.1038/nphys2002]
   Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2
   Kaulich M, 2012, CHROMOSOMA, V121, P395, DOI 10.1007/s00412-012-0370-0
   Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226
   Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590
   Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950
   Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951
   Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292
   Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006
   Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883
   Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200
   ODIJK T, 1995, MACROMOLECULES, V28, P7016, DOI 10.1021/ma00124a044
   Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2
   Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005
   Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3
   van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106
   van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581
   Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7
   Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255
   Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729
   Ying SM, 2011, INT J HEMATOL, V93, P440, DOI 10.1007/s12185-011-0818-7
NR 39
TC 55
Z9 55
U1 0
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD SEP 12
PY 2013
VL 51
IS 5
BP 691
EP 701
DI 10.1016/j.molcel.2013.07.016
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 296MP
UT WOS:000330189500014
PM 23973328
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Schwede, T
AF Schwede, Torsten
TI Protein Modeling: What Happened to the "Protein Structure Gap"?
SO STRUCTURE
LA English
DT Review
ID X-RAY-SCATTERING; BINDING-SITE PREDICTION; COMPUTATIONAL DESIGN; QUALITY
   ASSESSMENT; SWISS-MODEL; MACROMOLECULAR ASSEMBLIES; 3-DIMENSIONAL
   STRUCTURES; HOMOLOGOUS PROTEINS; MOLECULAR DOCKING; CRYSTAL-STRUCTURE
AB Computational modeling of three-dimensional macromolecular structures and complexes from their sequence has been a long-standing vision in structural biology. Over the last 2 decades, a paradigm shift has occurred: starting from a large "structure knowledge gap" between the huge number of protein sequences and small number of known structures, today, some form of structural information, either experimental or template-based models, is available for the majority of amino acids encoded by common model organism genomes. With the scientific focus of interest moving toward larger macromolecular complexes and dynamic networks of interactions, the integration of computational modeling methods with low-resolution experimental techniques allows the study of large and complex molecular machines. One of the open challenges for computational modeling and prediction techniques is to convey the underlying assumptions, as well as the expected accuracy and structural variability of a specific model, which is crucial to understanding its limitations.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schwede, Torsten] SIB Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU National Institute of General Medical Science of the National Institutes
   of Health [U01 GM093324]; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324,
   U01GM093324, U01GM093324, U01GM093324, U01GM093324, U01GM093324] Funding
   Source: NIH RePORTER
FX Special thanks to Andrej Sail (University of California, San Francisco)
   for providing the image of the NPC, Damien Lariviere (Fondation
   Fourmentin) for the screen shot of Life Explorer, and Jurgen Haas and
   Stefan Bienert for help with the template coverage plot. Model Archive
   was supported by the National Institute of General Medical Science of
   the National Institutes of Health as a subaward to Rutgers University
   under award number U01 GM093324 and the SIB Swiss Institute of
   Bioinformatics.
CR Al-Amoudi A, 2011, P NATL ACAD SCI USA, V108, P6480, DOI 10.1073/pnas.1019469108
   Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Aviran S, 2011, P NATL ACAD SCI USA, V108, P11069, DOI 10.1073/pnas.1106541108
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Berman HM, 2006, STRUCTURE, V14, P1211, DOI 10.1016/j.str.2006.06.005
   Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5
   Box GEP, 1987, EMPIRICAL MODEL BUIL
   Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003
   Buljan M, 2013, CURR OPIN STRUC BIOL, V23, P443, DOI 10.1016/j.sbi.2013.03.006
   Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633
   Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662
   Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Colak R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003030
   Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626
   Costanzi S, 2013, CURR OPIN STRUC BIOL, V23, P185, DOI 10.1016/j.sbi.2013.01.008
   Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111
   Damm-Ganamet KL, 2013, J CHEM INF MODEL, V53, P1853, DOI 10.1021/ci400025f
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656
   de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414
   Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454
   DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964
   Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022
   Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973
   Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617
   Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666
   Graewert MA, 2013, CURR OPIN STRUC BIOL, V23, P748, DOI 10.1016/j.sbi.2013.06.007
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Haas J, 2013, DATABASE, V2013, P31, DOI DOI 10.1093/DATABASE/BAT031
   Hennig J, 2013, J BIOMOL NMR, V56, P17, DOI 10.1007/s10858-013-9719-9
   Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012
   Hornus S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053609
   Janin Joel, 2013, F1000 Biol Rep, V5, P2, DOI 10.3410/B5-2
   Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c
   Javadi Y, 2013, CURR OPIN STRUC BIOL, V23, P622, DOI 10.1016/j.sbi.2013.06.011
   Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c
   Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/NMETH.2222, 10.1038/nmeth.2222]
   Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kimura H, 2013, J BIOCHEM, V154, P137, DOI 10.1093/jb/mvt033
   Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181
   King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364
   Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009
   Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kryshtafovych A., 2013, PROTEINS, DOI DOI 10.1002/PR0T.24347
   Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012
   Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109
   Lapedes A., 2002, ARXIV12072484
   Larsson P, 2011, BIOINFORMATICS, V27, P426, DOI 10.1093/bioinformatics/btq664
   Lasker Keren, 2012, Methods Mol Biol, V857, P331, DOI 10.1007/978-1-61779-588-6_15
   Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181
   Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106
   Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002
   MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330
   McGuffin LJ, 2013, NUCLEIC ACIDS RES, V41, pW368, DOI 10.1093/nar/gkt294
   Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108
   Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200
   Nakashima R, 2013, NATURE, V500, P102, DOI 10.1038/nature12300
   Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109
   Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008
   Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012
   Oshiro C, 2004, J MED CHEM, V47, P764, DOI 10.1021/jm0300781
   Peitsch M. C., 1995, NAT BIOTECHNOL, V13, P658, DOI DOI 10.1038/NBT0795-658
   Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091
   Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540
   Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301
   Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224
   Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
   Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428
   Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z
   Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523
   Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184
   Rother M, 2011, BRIEF BIOINFORM, V12, P601, DOI 10.1093/bib/bbr050
   Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244
   Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805
   Safi M, 2012, J CHEM INF MODEL, V52, P1529, DOI 10.1021/ci200626m
   SAMPL, 2010, J COMPUT AID MOL DES, V24, P257
   Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597
   Schneidman-Duhovny D, 2012, BIOINFORMATICS, V28, P3282, DOI 10.1093/bioinformatics/bts628
   Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17
   Schneidman-Duhovny D, 2011, J STRUCT BIOL, V173, P461, DOI 10.1016/j.jsb.2010.09.023
   Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5
   Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154
   Sim AYL, 2012, CURR OPIN STRUC BIOL, V22, P273, DOI 10.1016/j.sbi.2012.03.012
   Skolnick J, 2013, CURR OPIN STRUC BIOL, V23, P191, DOI 10.1016/j.sbi.2013.01.009
   Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005
   SUTCLIFFE MJ, 1987, PROTEIN ENG, V1, P377, DOI 10.1093/protein/1.5.377
   Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7
   Terwilliger Thomas C., 2011, Journal of Structural and Functional Genomics, V12, P43, DOI 10.1007/s10969-011-9114-2
   Trewhella J, 2013, STRUCTURE, V21, P875, DOI 10.1016/j.str.2013.04.020
   Unwalla RJ, 2010, J COMPUT AID MOL DES, V24, P237, DOI 10.1007/s10822-010-9336-6
   Uversky Vladimir N, 2013, F1000 Biol Rep, V5, P1, DOI 10.3410/B5-1
   Vakser IA, 2013, CURR OPIN STRUC BIOL, V23, P198, DOI 10.1016/j.sbi.2012.12.003
   Velazquez-Muriel J, 2012, P NATL ACAD SCI USA, V109, P18821, DOI 10.1073/pnas.1216549109
   Vendeville A, 2011, FEMS MICROBIOL REV, V35, P395, DOI 10.1111/j.1574-6976.2010.00254.x
   Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016
   Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008
   Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb B, 2011, METHODS MOL BIOL, V781, P377, DOI 10.1007/978-1-61779-276-2_19
   Wei Q, 2013, PROTEINS, V81, P199, DOI 10.1002/prot.24176
   Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109
   Whitehead TA, 2013, METHOD ENZYMOL, V523, P1, DOI 10.1016/B978-0-12-394292-0.00001-1
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
   Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503
   ZHANG Y, 2013, INTERPLAY I TASSER Q
   Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671
   Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162
NR 135
TC 61
Z9 63
U1 1
U2 32
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD SEP 3
PY 2013
VL 21
IS 9
BP 1531
EP 1540
DI 10.1016/j.str.2013.08.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 297PY
UT WOS:000330268600009
PM 24010712
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Walter, D
   Matter, A
AF Fahrenkrog, Birthe
   Walter, David
   Matter, Anja
TI Loss of histone H3 methylation at lysine 4 triggers apoptosis in S.
   cerevisiae
SO YEAST
LA English
DT Meeting Abstract
CT 26th International Conference on Yeast Genetics and Molecular Biology
CY AUG 29-SEP 03, 2013
CL Frankfurt Main, GERMANY
SP Wiley Blackwell, Lesaffre, Singer Instruments, Federat European Microbiol Soc, Sci Res & Dev GmbH, VAAM, Cluster Excellence Frankfurt, Carlsberg Lab, Butalco, SFB 902, DSM, ARTES
C1 [Fahrenkrog, Birthe] Univ Libre Brussels, Inst Mol Biol & Med, Charleroi, Belgium.
   [Walter, David] BRIC Copenhagen, Copenhagen, Denmark.
   [Matter, Anja] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-503X
EI 1097-0061
J9 YEAST
JI Yeast
PD SEP
PY 2013
VL 30
SU 1
BP 95
EP 95
PG 1
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Microbiology; Mycology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Microbiology; Mycology
GA 265CN
UT WOS:000327927400140
DA 2021-01-25
ER

PT J
AU Abel, S
   Bucher, T
   Nicollier, M
   Hug, I
   Kaever, V
   Wiesch, PAZ
   Jenal, U
AF Abel, Soeren
   Bucher, Tabitha
   Nicollier, Micaeel
   Hug, Isabelle
   Kaever, Volkhard
   Wiesch, Pia Abel Zur
   Jenal, Urs
TI Bi-modal Distribution of the Second Messenger c-di-GMP Controls Cell
   Fate and Asymmetry during the Caulobacter Cell Cycle
SO PLOS GENETICS
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; RESPONSE REGULATOR; SIGNAL-TRANSDUCTION; PILZ
   DOMAIN; CRESCENTUS; MOTILITY; PROTEIN; IDENTIFICATION; SALMONELLA;
   BACTERIA
AB Many bacteria mediate important life-style decisions by varying levels of the second messenger c-di-GMP. Behavioral transitions result from the coordination of complex cellular processes such as motility, surface adherence or the production of virulence factors and toxins. While the regulatory mechanisms responsible for these processes have been elucidated in some cases, the global pleiotropic effects of c-di-GMP are poorly understood, primarily because c-di-GMP networks are inherently complex in most bacteria. Moreover, the quantitative relationships between cellular c-di-GMP levels and c-di-GMP dependent phenotypes are largely unknown. Here, we dissect the c-di-GMP network of Caulobacter crescentus to establish a global and quantitative view of c-di-GMP dependent processes in this organism. A genetic approach that gradually reduced the number of diguanylate cyclases identified novel c-di-GMP dependent cellular processes and unraveled c-di-GMP as an essential component of C. crescentus cell polarity and its bimodal life cycle. By varying cellular c-di-GMP concentrations, we determined dose response curves for individual c-di-GMP-dependent processes. Relating these values to c-di-GMP levels modeled for single cells progressing through the cell cycle sets a quantitative frame for the successive activation of c-di-GMP dependent processes during the C. crescentus life cycle. By reconstructing a simplified c-di-GMP network in a strain devoid of c-di-GMP we defined the minimal requirements for the oscillation of c-di-GMP levels during the C. crescentus cell cycle. Finally, we show that although all c-di-GMP dependent cellular processes were qualitatively restored by artificially adjusting c-di-GMP levels with a heterologous diguanylate cyclase, much higher levels of the second messenger are required under these conditions as compared to the contribution of homologous c-di-GMP metabolizing enzymes. These experiments suggest that a common c-di-GMP pool cannot fully explain spatiotemporal regulation by c-di-GMP in C. crescentus and that individual enzymes preferentially regulate specific phenotypes during the cell cycle.
C1 [Abel, Soeren; Bucher, Tabitha; Nicollier, Micaeel; Hug, Isabelle; Jenal, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kaever, Volkhard] Leibniz Univ Hannover, Sch Med, Inst Pharmacol, D-30167 Hannover, Germany.
   [Wiesch, Pia Abel Zur] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA.
RP Abel, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM sabel1@partners.org; urs.jenal@unibas.ch
RI Kaever, Volkhard/G-3280-2013; Wiesch, Pia Abel zur/M-1980-2019
OI Wiesch, Pia Abel zur/0000-0001-9420-9005; Hug,
   Isabelle/0000-0002-4524-9569; Abel, Soren/0000-0002-4041-6989
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_130469]
FX This work was supported by Swiss National Science Foundation
   (www.snf.ch) grant 31003A_130469 to UJ. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abel S, 2010, 2 MESSENGER CYCLIC D, P120
   Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018
   Ackermann M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-126
   Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   Bodenmiller D, 2004, J BACTERIOL, V186, P1438, DOI 10.1128/JB.186.5.1438-1447.2004
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Charbon G, 2009, GENE DEV, V23, P1131, DOI 10.1101/gad.1795509
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658
   Cole JL, 2003, MOL MICROBIOL, V49, P1671, DOI 10.1046/j.1365-2958.2003.03664.x
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   EDWARDS P, 1991, J BACTERIOL, V173, P5568, DOI 10.1128/jb.173.17.5568-5572.1991
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x
   Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Guerrero-Ferreira RC, 2011, P NATL ACAD SCI USA, V108, P9963, DOI 10.1073/pnas.1012388108
   Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08
   Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05
   Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x
   Lindenberg S, 2013, EMBO J, DOI DOI 10.1038/EMB0J.2013.120.ACCESSED
   Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10
   Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/nmeth.1286, 10.1038/NMETH.1286]
   Parkinson JS, 2007, METHOD ENZYMOL, V423, P432, DOI 10.1016/S0076-6879(07)23020-4
   Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066
   R Development Core Team, 2012, R LANG ENV STAT COMP
   RAVENSCROFT N, 1991, J BACTERIOL, V173, P5677, DOI 10.1128/jb.173.18.5677-5684.1991
   Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x
   Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106
   Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008
   Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038
   Wagner JK, 2007, MOL MICROBIOL, V64, P28, DOI 10.1111/j.1365-2958.2007.05633.x
   West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002
   Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07
NR 61
TC 71
Z9 71
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD SEP
PY 2013
VL 9
IS 9
AR e1003744
DI 10.1371/journal.pgen.1003744
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA 226ZM
UT WOS:000325076600016
PM 24039597
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kemmerling, S
   Arnold, SA
   Bircher, BA
   Sauter, N
   Escobedo, C
   Dernick, G
   Hierlemann, A
   Stahlberg, H
   Braun, T
AF Kemmerling, Simon
   Arnold, Stefan A.
   Bircher, Benjamin A.
   Sauter, Nora
   Escobedo, Carlos
   Dernick, Gregor
   Hierlemann, Andreas
   Stahlberg, Henning
   Braun, Thomas
TI Single-cell lysis for visual analysis by electron microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Electron microscopy; Microfluidics; Single-cell analysis; Single-cell
   lysis; Systems biology
ID GENE-EXPRESSION; MASS-SPECTROMETRY; SYSTEMS BIOLOGY; PROTEOMICS;
   TOMOGRAPHY; FORM
AB The stochastic nature of biological systems makes the study of individual cells a necessity in systems biology. Yet, handling and disruption of single cells and the analysis of the relatively low concentrations of their protein components still challenges available techniques. Transmission electron microscopy (TEM) allows for the analysis of proteins at the single-molecule level. Here, we present a system for single-cell lysis under light microscopy observation, followed by rapid uptake of the cell lysate. Eukaryotic cells were grown on conductively coated glass slides and observed by light microscopy. A custom-designed microcapillary electrode was used to target and lyse individual cells with electrical pulses. Nanoliter volumes were subsequently aspirated into the microcapillary and dispensed onto an electron microscopy grid for TEM inspection. We show, that the cell lysis and preparation method conserves protein structures well and is suitable for visual analysis by TEM. (C) 2013 Elsevier Inc.. Published by Elsevier Inc. All rights reserved.
C1 [Kemmerling, Simon; Arnold, Stefan A.; Bircher, Benjamin A.; Sauter, Nora; Stahlberg, Henning; Braun, Thomas] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Escobedo, Carlos; Hierlemann, Andreas] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, BEL, Basel, Switzerland.
   [Dernick, Gregor] F Hoffmann La Roche & Cie AG, Discovery Technol Pharma Res & Early Dev pRED, Basel, Switzerland.
RP Braun, T (corresponding author), C CINA, Mattenstr 26, CH-4058 Basel, Switzerland.
EM thomas.braun@unibas.ch
RI Stahlberg, Henning/H-1868-2011; Bircher, Benjamin/AAW-2668-2020;
   Hierlemann, Andreas/A-7046-2008
OI Stahlberg, Henning/0000-0002-1185-4592; Bircher,
   Benjamin/0000-0002-1494-6732; Hierlemann, Andreas/0000-0002-3838-2468
FU SNF [NSX1003]; SystemsX.ch (CINA); NCCR NanoscienceSwiss National
   Science Foundation (SNSF)
FX We thank Andreas Engel for his inspiring ideas and support, the workshop
   of the Biozentrum of the University Basel for their aid and Shirley
   Muller for carefully reading the manuscript and expert discussions. The
   project was financially supported by the SNF (NSX1003, granted to T.B.),
   SystemsX.ch (CINA, granted to H.S., co-PI is A.H.) and the NCCR
   Nanoscience.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x
   Amantonico A., 2008, ANGEW CHEM INT EDIT, V120, P5462, DOI DOI 10.1002/ANGE.200705923
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Beck M, 2011, J STRUCT BIOL, V173, P483, DOI 10.1016/j.jsb.2010.11.011
   Beck M, 2009, NAT METHODS, V6, P817, DOI [10.1038/NMETH.1390, 10.1038/nmeth.1390]
   Best C, 2007, METHOD CELL BIOL, V79, P615, DOI 10.1016/S0091-679X(06)79025-2
   Brown RB, 2008, J R SOC INTERFACE, V5, pS131, DOI 10.1098/rsif.2008.0009.focus
   Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636
   Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o
   De Carlo S, 2008, MICRON, V39, P934, DOI 10.1016/j.micron.2007.11.003
   Dernick G, 2011, J LIPID RES, V52, P2323, DOI 10.1194/jlr.D016824
   Diebolder CA, 2012, J MICROSC-OXFORD, V248, P1, DOI 10.1111/j.1365-2818.2012.03627.x
   Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326
   Engel A, 2010, SPRINGER SERIES CHEM, V96, P417, DOI 10.1007/978-3-642-02597-6_21
   Engel A, 2009, ADV IMAG ELECT PHYS, V159, P357, DOI 10.1016/S1076-5670(09)59009-X
   Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82
   Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108
   Fox MB, 2006, ANAL BIOANAL CHEM, V385, P474, DOI 10.1007/s00216-006-0327-3
   Han FT, 2003, ANAL CHEM, V75, P3688, DOI 10.1021/ac0341970
   Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749
   Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607
   KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895
   Kemmerling S, 2012, J STRUCT BIOL, V177, P128, DOI 10.1016/j.jsb.2011.11.001
   Luo W, 2008, LANGMUIR, V24, P13096, DOI 10.1021/la802775v
   Mader A, 2010, METHOD ENZYMOL, V483, P245, DOI 10.1016/S0076-6879(10)83012-5
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Movahed S, 2011, MICROFLUID NANOFLUID, V10, P703, DOI 10.1007/s10404-010-0716-y
   Nashimoto Y, 2007, ANAL CHEM, V79, P6823, DOI 10.1021/ac071050q
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050
   Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563
   Shah SS, 2009, ACS APPL MATER INTER, V1, P2592, DOI 10.1021/am900508m
   Souchelnytskyi S, 2005, PROTEOMICS, V5, P4123, DOI 10.1002/pmic.200500135
   Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002
   Westerhoff HV, 2011, METHOD ENZYMOL, V500, P3, DOI 10.1016/B978-0-12-385118-5.00001-3
   Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164
NR 39
TC 19
Z9 20
U1 1
U2 32
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD SEP
PY 2013
VL 183
IS 3
BP 467
EP 473
DI 10.1016/j.jsb.2013.06.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 217GO
UT WOS:000324347900018
PM 23816812
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Renggli, S
   Keck, W
   Jenal, U
   Ritz, D
AF Renggli, Sabine
   Keck, Wolfgang
   Jenal, Urs
   Ritz, Daniel
TI Role of Autofluorescence in Flow Cytometric Analysis of Escherichia coli
   Treated with Bactericidal Antibiotics
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MEDIATED CELL-DEATH; HYDROXYL RADICALS; CYCLE KINETICS; SOS RESPONSE;
   DNA GYRASE; DIVISION; INHIBITION; RESISTANCE; INDUCTION; BINDING
AB Bactericidal antibiotics kill by different mechanisms as a result of a specific interaction with their cellular targets. Over the past few years, alternative explanations for cidality have been proposed based on a postulated common pathway, depending on the intracellular production of reactive oxygen species. Detection of hydroxyl radicals relies on staining with specific fluorescent dyes that can penetrate the cell and are detected using flow cytometry. Flow cytometry has become an important tool in microbiology to study characteristics of individual cells within large heterogeneous cellular populations. We show here that Escherichia coli treated with different bactericidal antibiotics exhibits increased autofluorescence when analyzed by flow cytometry. We present evidence suggesting that this change in autofluorescence is caused by altered cell morphology upon antibiotic treatment. Consistent with this view, mutant cells that fail to elongate upon norfloxacin treatment show no increased auto-fluorescence response. Finally, we present data demonstrating that changes in autofluorescence can impact the results with fluorescent probes when using flow cytometry and confound the findings obtained with specific dyes. In summary, recent findings that correlate the exposure to cidal antibiotics with the production of reactive oxygen species need to be reconsidered in light of such changes in autofluorescence. Conclusive evidence for an increase of hydroxyl radicals after treatment with such drugs is still missing.
C1 [Renggli, Sabine; Keck, Wolfgang; Ritz, Daniel] Actel Pharmaceut Ltd, Allschwil, Switzerland.
   [Renggli, Sabine; Jenal, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
RP Ritz, D (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.
EM daniel.ritz@actelion.com
RI Renggli, Sabine/AAO-2686-2020
OI Renggli, Sabine/0000-0001-8233-6154
CR Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069
   BOYE E, 1983, J GEN MICROBIOL, V129, P973
   BURTON P, 1983, MOL GEN GENET, V190, P309, DOI 10.1007/BF00330656
   Chen CR, 1996, J MOL BIOL, V258, P627, DOI 10.1006/jmbi.1996.0274
   Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024
   DURODIE J, 1995, CYTOMETRY, V21, P374, DOI 10.1002/cyto.990210409
   Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135
   Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027
   Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018
   Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192
   GANT VA, 1993, J MED MICROBIOL, V39, P147, DOI 10.1099/00222615-39-2-147
   Gottfredsson M, 1998, ANTIMICROB AGENTS CH, V42, P1005, DOI 10.1128/AAC.42.5.1005
   Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109
   Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607
   Hassett DJ, 2007, ACS CHEM BIOL, V2, P708, DOI 10.1021/cb700232k
   Hill TM, 1997, J BACTERIOL, V179, P1931, DOI 10.1128/jb.179.6.1931-1939.1997
   Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056
   HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490
   Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688
   Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333
   Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003
   Liu IF, 2009, J BACTERIOL, V191, P5315, DOI 10.1128/JB.00559-09
   Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12
   Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751
   Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12
   Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885
   PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631
   PIDDOCK LJV, 1992, ANTIMICROB AGENTS CH, V36, P819, DOI 10.1128/AAC.36.4.819
   Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12
   Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200
   SHEN LL, 1989, J BIOL CHEM, V264, P2973
   SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999
   STEEN HB, 1986, ANN NY ACAD SCI, V468, P329, DOI 10.1111/j.1749-6632.1986.tb42050.x
   STEEN HB, 1982, CYTOMETRY, V2, P249
   STEEN HB, 1980, CYTOMETRY, V1, P32, DOI 10.1002/cyto.990010108
   Steen HB, 2000, J MICROBIOL METH, V42, P65, DOI 10.1016/S0167-7012(00)00177-9
   Tracy BP, 2010, CURR OPIN BIOTECH, V21, P85, DOI 10.1016/j.copbio.2010.02.006
   Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x
   Walberg M, 1996, J ANTIMICROB CHEMOTH, V37, P1063, DOI 10.1093/jac/37.6.1063
   Wickens HJ, 2000, ANTIMICROB AGENTS CH, V44, P682, DOI 10.1128/AAC.44.3.682-687.2000
   Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456
NR 47
TC 51
Z9 52
U1 0
U2 25
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD SEP
PY 2013
VL 195
IS 18
BP 4067
EP 4073
DI 10.1128/JB.00393-13
PG 7
WC Microbiology
SC Microbiology
GA 208BD
UT WOS:000323649300006
PM 23836867
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Han, YY
   Mrsic-Flogel, T
AF Han, Yunyun
   Mrsic-Flogel, Thomas
TI A finely tuned cortical amplifier
SO NATURE NEUROSCIENCE
LA English
DT Editorial Material
ID LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; ORIENTATION SELECTIVITY;
   THALAMIC INPUT; SIMPLE CELLS; SPECIFICITY; CONNECTIONS; EMERGENCE
AB Three studies in visual and auditory cortex show that intracortical excitatory inputs amplify incoming sensory signals, as their sensory tuning is closely matched to that arriving from the sensory thalamus.
C1 [Han, Yunyun; Mrsic-Flogel, Thomas] Univ Basel, Biozentrum, Basel, Switzerland.
RP Han, YY (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM thomas.mrsic-flogel@unibas.ch
RI Han, Yunyun/O-2092-2013
OI Han, Yunyun/0000-0003-2336-167X; Mrsic-Flogel, Tom/0000-0002-8947-408X
CR Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5
   Da Costa NM, 2009, J COMP NEUROL, V516, P264, DOI 10.1002/cne.22133
   DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624
   Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0
   GILBERT CD, 1989, J NEUROSCI, V9, P2432
   Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729
   Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015
   Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880
   Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493
   Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494
   Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488
   Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021
   Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013
   REID RC, 1995, NATURE, V378, P281
   Scholl B, 2013, J NEUROSCI, V33, P10616, DOI 10.1523/JNEUROSCI.0404-13.2013
NR 15
TC 2
Z9 2
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD SEP
PY 2013
VL 16
IS 9
BP 1166
EP 1168
DI 10.1038/nn.3507
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 207KN
UT WOS:000323597500003
PM 23982448
DA 2021-01-25
ER

PT J
AU Bhattacharya, I
   Dragert, K
   Albert, V
   Contassot, E
   Damjanovic, M
   Hagiwara, A
   Zimmerli, L
   Humar, R
   Hall, MN
   Battegay, EJ
   Haas, E
AF Bhattacharya, Indranil
   Draegert, Katja
   Albert, Verena
   Contassot, Emmanuel
   Damjanovic, Marlen
   Hagiwara, Asami
   Zimmerli, Lukas
   Humar, Rok
   Hall, Michael N.
   Battegay, Edouard J.
   Haas, Elvira
TI Rictor in Perivascular Adipose Tissue Controls Vascular Function by
   Regulating Inflammatory Molecule Expression
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE adipose tissue; inflammation; nitric oxide synthase type II;
   perivascular adipose tissue; mammalian target of rapamycin complex 2;
   thoracic aorta
ID NITRIC-OXIDE SYNTHASE; MTOR COMPLEX 2; GENE-EXPRESSION; SMOOTH-MUSCLE;
   FAT; ENDOTHELIUM; DYSFUNCTION; CELL; PHOSPHORYLATION; MODULATION
AB Objective-Perivascular adipose tissue (PVAT) wraps blood vessels and modulates vasoreactivity by secretion of vasoactive molecules. Mammalian target of rapamycin complex 2 (mTORC2) has been shown to control inflammation and is expressed in adipose tissue. In this study, we investigated whether adipose-specific deletion of rictor and thereby inactivation of mTORC2 in PVAT may modulate vascular function by increasing inflammation in PVAT.
   Approach and Results-Rictor, an essential mTORC2 component, was deleted specifically in mouse adipose tissue (rictor(ad-/-)). Phosphorylation of mTORC2 downstream target Akt at Serine 473 was reduced in PVAT from rictor(ad-/-) mice but unaffected in aortic tissue. Ex vivo functional analysis of thoracic aortae revealed increased contractions and impaired dilation in rings with PVAT from rictor(ad-/-) mice. Adipose rictor knockout increased gene expression and protein release of interleukin-6, macrophage inflammatory protein-1 alpha, and tumor necrosis factor-alpha in PVAT as shown by quantitative real-time polymerase chain reaction and Bioplex analysis for the cytokines in the conditioned media, respectively. Moreover, gene and protein expression of inducible nitric oxide synthase was upregulated without affecting macrophage infiltration in PVAT from rictor(ad-/-) mice. Inhibition of inducible nitric oxide synthase normalized vascular reactivity in aortic rings from rictor(ad-/-) mice with no effect in rictor(fl/fl) mice. Interestingly, in perivascular and epididymal adipose depots, high-fat diet feeding induced downregulation of rictor gene expression.
   Conclusions-Here, we identify mTORC2 as a critical regulator of PVAT-directed protection of normal vascular tone. Modulation of mTORC2 activity in adipose tissue may be a potential therapeutic approach for inflammation-related vascular damage.
C1 [Bhattacharya, Indranil; Draegert, Katja; Damjanovic, Marlen; Zimmerli, Lukas; Humar, Rok; Battegay, Edouard J.; Haas, Elvira] Univ Zurich Hosp, Div Internal Med, Res Unit, CH-8091 Zurich, Switzerland.
   [Contassot, Emmanuel] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland.
   [Albert, Verena; Hagiwara, Asami; Hall, Michael N.] Univ Basel, Growth & Dev Biozentrum, Basel, Switzerland.
   [Humar, Rok; Battegay, Edouard J.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Haas, E (corresponding author), Univ Zurich Hosp, Div Internal Med, Res Unit, Gloriastr 30, CH-8091 Zurich, Switzerland.
EM Elvira.haas@usz.ch
OI Contassot, Emmanuel/0000-0002-3060-4644
FU University of Zurich; University Hospital of Zurich; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
FX This work was supported by funding from University of Zurich, University
   Hospital of Zurich, and Swiss National Science Foundation.
CR Aghamohammadzadeh R, 2012, BRIT J PHARMACOL, V165, P670, DOI 10.1111/j.1476-5381.2011.01479.x
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008
   Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053
   Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003
   Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Fesus G, 2007, CARDIOVASC RES, V75, P719, DOI 10.1016/j.cardiores.2007.05.025
   Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011
   Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218
   Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228
   Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013
   Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959
   Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025
   Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181
   Gunnett CA, 2001, ARTERIOSCL THROM VAS, V21, P1281, DOI 10.1161/hq0801.093509
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Hassan M, 2012, NAT REV CARDIOL, V9, P689, DOI 10.1038/nrcardio.2012.148
   Jabs A, 2008, J AM COLL CARDIOL, V51, P2130, DOI 10.1016/j.jacc.2008.01.058
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Juan CC, 2008, OBESITY, V16, P1219, DOI 10.1038/oby.2008.200
   Ketonen J, 2010, CIRC J, V74, P1479, DOI 10.1253/circj.CJ-09-0661
   Kohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041951
   KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651
   Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061
   Lee RMKW, 2009, J HYPERTENS, V27, P782, DOI 10.1097/HJH.0b013e328324ed86
   Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com
   Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419
   Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305
   Meijer RI, 2013, DIABETES, V62, P590, DOI 10.2337/db11-1603
   Naureckiene Saule, 2007, Journal of Pharmacological and Toxicological Methods, V55, P303, DOI 10.1016/j.vascn.2006.08.002
   Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586
   Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930
   SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063
   Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151
   Takaoka M, 2010, ARTERIOSCL THROM VAS, V30, P1576, DOI 10.1161/ATVBAHA.110.207175
   Takaoka M, 2009, CIRC RES, V105, P906, DOI 10.1161/CIRCRESAHA.109.199653
   Tian J, 2010, ACTA PHARMACOL SIN, V31, P1324, DOI 10.1038/aps.2010.111
   Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479
   Withers SB, 2011, ARTERIOSCL THROM VAS, V31, P908, DOI 10.1161/ATVBAHA.110.221705
   Yudkin JS, 2005, LANCET, V365, P1817, DOI 10.1016/S0140-6736(05)66585-3
NR 50
TC 27
Z9 27
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1079-5642
EI 1524-4636
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD SEP
PY 2013
VL 33
IS 9
BP 2105
EP 2111
DI 10.1161/ATVBAHA.112.301001
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 203UY
UT WOS:000323320700011
PM 23868942
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Hanssen, E
   Dekiwadia, C
   Riglar, DT
   Rug, M
   Lemgruber, L
   Cowman, AF
   Cyrklaff, M
   Kudryashev, M
   Frischknecht, F
   Baum, J
   Ralph, SA
AF Hanssen, Eric
   Dekiwadia, Chaitali
   Riglar, David T.
   Rug, Melanie
   Lemgruber, Leandro
   Cowman, Alan F.
   Cyrklaff, Marek
   Kudryashev, Mikhail
   Frischknecht, Friedrich
   Baum, Jake
   Ralph, Stuart A.
TI Electron tomography of Plasmodium falciparum merozoites reveals core
   cellular events that underpin erythrocyte invasion
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID RED-BLOOD-CELLS; MALARIA PARASITE INVASION; TOXOPLASMA-GONDII;
   APICOMPLEXAN PARASITES; INFECTED ERYTHROCYTES; FINE STRUCTURE;
   SUBPELLICULAR MICROTUBULES; RHOPTRY PROTEINS; SURFACE-ANTIGEN; DENSE
   GRANULES
AB Erythrocyte invasion by merozoites forms of the malaria parasite is a key step in the establishment of human malaria disease. To date, efforts to understand cellular events underpinning entry have been limited to insights from non-human parasites, with no studies at sub-micrometer resolution undertaken using the most virulent human malaria parasite, Plasmodium falciparum. This leaves our understanding of the dynamics of merozoite sub-cellular compartments during infection incomplete, in particular that of the secretory organelles. Using advances in P. falciparum merozoite isolation and new imaging techniques we present a three-dimensional study of invasion using electron microscopy, cryo-electron tomography and cryo-X-ray tomography. We describe the core architectural features of invasion and identify fusion between rhoptries at the commencement of invasion as a hitherto overlooked event that likely provides a critical step that initiates entry. Given the centrality of merozoite organelle proteins to vaccine development, these insights provide a mechanistic framework to understand therapeutic strategies targeted towards the cellular events of invasion.
C1 [Hanssen, Eric] Univ Melbourne, Adv Microscopy Facil, Parkville, Vic 3010, Australia.
   [Hanssen, Eric] Univ Melbourne, Ctr Excellence Coherent Xray Sci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   [Riglar, David T.; Rug, Melanie; Cowman, Alan F.; Baum, Jake] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.
   [Riglar, David T.; Rug, Melanie; Cowman, Alan F.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.
   [Lemgruber, Leandro; Cyrklaff, Marek; Frischknecht, Friedrich] Heidelberg Univ, Sch Med, D-69120 Heidelberg, Germany.
   [Kudryashev, Mikhail] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt C CINA, CH-4058 Basel, Switzerland.
RP Baum, J (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.
EM jake@wehi.edu.au; saralph@unimelb.edu.au
RI Rug, Melanie/B-5417-2015; Hanssen, Eric/A-7217-2013; Ralph,
   Stuart/C-8590-2014
OI Hanssen, Eric/0000-0002-4064-1844; Lemgruber,
   Leandro/0000-0003-2832-6806; Ralph, Stuart/0000-0003-0114-7808; Riglar,
   David/0000-0002-5004-4373; Frischknecht, Friedrich/0000-0002-8332-6668;
   Baum, Jake/0000-0002-0275-352X; Kudryashev, Misha/0000-0003-3550-6274
FU National Center for Research ResourcesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [5P41RR019664-08]; National
   Institute of General Medical Sciences from the National Institutes of
   Health [8 P41 GM103445-08]; National Health and Medical Research Council
   of Australia (NHMRC)National Health and Medical Research Council of
   Australia [637340, APP1047085]; Australian Research CouncilAustralian
   Research Council [DP120103161]; Human Frontier Science Organisation
   (HFSP YI Program) [RGY0071/2011]; Australian Synchrotron; Australian
   Academy of Science; US Department of Energy, Office of Biological and
   Environmental ResearchUnited States Department of Energy (DOE)
   [DE-AC02-05CH11231]; National Center for Research Resources of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [RR019664]; US Department of Energy, Office of
   ScienceUnited States Department of Energy (DOE); Pratt Foundation
   through the University of Melbourne; OzeMalaR Network; University of
   Heidelberg cluster of excellence CellNetworks; CINA grant from
   SystemX.ch; Henning Stahlberg (University of Basel); Australian Research
   Council (ARC)Australian Research Council [FT100100112, FT0990350];
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664, P41RR019664, P41RR019664, P41RR019664, P41RR019664,
   P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445, P41GM103445, P41GM103445, P41GM103445,
   P41GM103445, P41GM103445] Funding Source: NIH RePORTER
FX The authors thank Carolyn Larabell, and Mark A. Le Gros (University of
   California, San Francisco) and Christian Knoechel (Lawrence Berkeley
   National Laboratory) for assistance and advice with X-ray tomography.
   X-ray tomography was conducted at the National Center for X-ray
   Tomography, supported by grants from the National Center for Research
   Resources (5P41RR019664-08) and the National Institute of General
   Medical Sciences (8 P41 GM103445-08) from the National Institutes of
   Health. Human erythrocytes were kindly provided by the Red Cross Blood
   Bank (Melbourne). This work was made possible through Victorian State
   Government Operational Infrastructure Support and Australian Government
   NHMRC IRIISS. Funding for the research came from the National Health and
   Medical Research Council of Australia (NHMRC Project Grants 637340 and
   APP1047085 JB & SAR), The Australian Research Council (Discovery Project
   Grant DP120103161), and Human Frontier Science Organisation (HFSP YI
   Program Grant RGY0071/2011 J.B. and F. F.), the Australian Synchrotron
   and the Australian Academy of Science, the US Department of Energy,
   Office of Biological and Environmental Research (DE-AC02-05CH11231), the
   National Center for Research Resources of the National Institutes of
   Health (RR019664). Use of the Advanced Light Source was supported by the
   US Department of Energy, Office of Science. D. T. R. is supported by a
   Pratt Foundation PhD scholarship through the University of Melbourne; M.
   R. was supported by the Australian Academy of Science and a grant from
   the OzeMalaR Network. L. L. was supported by a Postdoctoral fellowship
   from the University of Heidelberg cluster of excellence CellNetworks. M.
   K. acknowledges support of the CINA grant from SystemX.ch and from
   Henning Stahlberg (University of Basel). J.B. and S. A. R. are supported
   by Australian Research Council (ARC) Future Fellowships (FT100100112 and
   FT0990350). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   authors have declared that no conflict of interest exists.
CR Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499
   Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029
   Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270
   AIKAW M, 1967, J CELL BIOL, V35, P103, DOI 10.1083/jcb.35.1.103
   AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72
   AIKAWA M, 1966, AM J TROP MED HYG, V15, P449, DOI 10.4269/ajtmh.1966.15.449
   Bannister L H, 1993, Methods Mol Biol, V21, P415
   BANNISTER LH, 1975, PARASITOLOGY, V71, P483, DOI 10.1017/S0031182000047247
   Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320
   Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5
   BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064
   Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665
   BANNISTER LH, 1977, B WORLD HEALTH ORGAN, V55, P163
   Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200
   Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194
   Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0
   BLOOM FE, 1966, SCIENCE, V154, P1575, DOI 10.1126/science.154.3756.1575
   Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107
   Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591
   Carruthers VB, 1997, EUR J CELL BIOL, V73, P114
   CHOI JW, 1989, APPL ENVIRON MICROB, V55, P1761, DOI 10.1128/AEM.55.7.1761-1765.1989
   Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006
   Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112
   CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991
   Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405
   Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5
   Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096
   DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007
   Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067
   Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070
   Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x
   Hanssen E, 2012, J STRUCT BIOL, V177, P224, DOI 10.1016/j.jsb.2011.09.003
   Hanssen E, 2011, J STRUCT BIOL, V173, P161, DOI 10.1016/j.jsb.2010.08.013
   Hanssen E, 2010, INT J PARASITOL, V40, P1127, DOI 10.1016/j.ijpara.2010.04.012
   Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002
   HEPLER PK, 1966, J CELL BIOL, V30, P333, DOI 10.1083/jcb.30.2.333
   Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1
   Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068
   Kono M, 2012, MOL BIOL EVOL, V29, P2113, DOI 10.1093/molbev/mss081
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x
   Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037
   LADDA R, 1969, J PARASITOL, V55, P633, DOI 10.2307/3277308
   Lee JJ, 2000, ILLUSTRATED GUIDE PR
   Lemgruber L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-25
   Lemgruber L, 2011, MICROSC RES TECHNIQ, V74, P812, DOI 10.1002/jemt.20960
   Lingelbach K, 1998, J CELL SCI, V111, P1467
   LUTHER PK, 1988, ULTRAMICROSCOPY, V24, P7, DOI 10.1016/0304-3991(88)90322-1
   Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919
   MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9
   MICHEL R, 1980, INT J PARASITOL, V10, P309, DOI 10.1016/0020-7519(80)90012-0
   MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172
   Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104
   MITCHELL GH, 1988, CRIT REV ONCOL HEMAT, V8, P255, DOI 10.1016/S1040-8428(88)80011-8
   Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002
   NICHOLS BA, 1983, J ULTRA MOL STRUCT R, V83, P85, DOI 10.1016/S0022-5320(83)90067-9
   Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x
   Paredes-Santos TC, 2012, J STRUCT BIOL, V177, P420, DOI 10.1016/j.jsb.2011.11.028
   Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919
   Pinder JC, 1998, J CELL SCI, V111, P1831
   PRENSIER G, 1986, J PARASITOL, V72, P731, DOI 10.2307/3281465
   Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007
   Ravindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008143
   Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770
   Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449
   Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003
   SADAK A, 1988, MOL BIOCHEM PARASIT, V29, P203, DOI 10.1016/0166-6851(88)90075-8
   SAMYELLOWE TY, 1995, J EUKARYOT MICROBIOL, V42, P224, DOI 10.1111/j.1550-7408.1995.tb01570.x
   SCHOLTYSECK E, 1970, Z PARASITENK, V34, P68, DOI 10.1007/BF00629180
   SCHOLTYSECK E, 1970, Z PARASITENK, V34, P97
   Schrevel J, 2008, PARASITOLOGY, V135, P1, DOI 10.1017/S0031182007003629
   SELIGMAN AM, 1966, J CELL BIOL, V30, P424, DOI 10.1083/jcb.30.2.424
   SIM BKL, 1992, MOL BIOCHEM PARASIT, V51, P157, DOI 10.1016/0166-6851(92)90211-2
   Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746
   Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104
   Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1
   TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989
   Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200
   Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794
   Weiner A, 2011, CELL MICROBIOL, V13, P967, DOI 10.1111/j.1462-5822.2011.01592.x
   WILLINGHAM MC, 1984, J HISTOCHEM CYTOCHEM, V32, P455, DOI 10.1177/32.4.6323574
   Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10
   Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200
   Zuccala ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046160
NR 86
TC 36
Z9 36
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD SEP
PY 2013
VL 15
IS 9
BP 1457
EP 1472
DI 10.1111/cmi.12132
PG 16
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 197XE
UT WOS:000322885000002
PM 23461734
OA Bronze
DA 2021-01-25
ER

PT J
AU Castets, P
   Ruegg, MA
AF Castets, Perrine
   Rueegg, Markus A.
TI MTORC1 determines autophagy through ULK1 regulation in skeletal muscle
SO AUTOPHAGY
LA English
DT Editorial Material
DE MTORC1; FOXO; skeletal muscle; autophagy; ULK1; atrophy; myopathy
AB Autophagy impairment has been implicated in several muscle disorders and in age-related dysfunction. Although previous reports pointed to FOXO as a positive regulator of autophagy in skeletal muscle, it remained unclear what is triggering autophagy. We found that TSC muscle knockout (TSCmKO) mice, characterized by specific depletion of TSC1 in skeletal muscle, and thus constant activation of MTORC1, develop a late-onset myopathy marked by the accumulation of autophagic substrates. In those mice, autophagy induction is blocked despite FOXO activation because of constant MTORC1-dependent inhibition of ULK1. Treatment of TSCmKO mice with rapamycin is sufficient to restore autophagy and to alleviate, at least in part, the myopathy. Inversely, inactivation of the MTORC1 pathway in RPTOR-depleted muscles triggers LC3B lipidation in spite of FOXO inhibition. In conclusion, MTORC1 constitutes the master regulator of autophagy induction in skeletal muscle and its deregulation leads to pathologic alterations of muscle homeostasis.
C1 [Castets, Perrine; Rueegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Castets, Perrine] Univ Basel Hosp, Pharmazentrum, Dept Neurol, Neuromuscular Res Ctr, CH-4031 Basel, Switzerland.
   [Castets, Perrine] Univ Basel Hosp, Pharmazentrum, Dept Biomed, CH-4031 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [145505] Funding Source: Medline
NR 0
TC 34
Z9 36
U1 0
U2 7
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD SEP 1
PY 2013
VL 9
IS 9
BP 1435
EP 1437
DI 10.4161/auto.25722
PG 3
WC Cell Biology
SC Cell Biology
GA 260FD
UT WOS:000327579500015
PM 23896646
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Nair, IS
   Rodrigues, V
   Reichert, H
   VijayRaghavan, K
AF Nair, Indu S.
   Rodrigues, Veronica
   Reichert, Heinrich
   VijayRaghavan, K.
TI The zinc finger transcription factor Jing is required for
   dendrite/axonal targeting in Drosophila antennal lobe development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE jing; Olfactory system; Dendrite targeting; Axonal targeting
ID OLFACTORY PROJECTION NEURONS; EMPTY-SPIRACLES GENE; WIRING SPECIFICITY;
   NEUROBLAST LINEAGE; RECEPTOR NEURONS; EMX2 COOPERATE; N-CADHERIN;
   SYSTEM; MELANOGASTER; MAP
AB An important role in olfactory system development is played by transcription factors which act in sensory neurons or in their interneuron targets as cell autonomous regulators of downstream effectors such as cell surface molecules and signalling systems that control neuronal identity and process guidance. Some of these transcriptional regulators have been characterized in detail in the development of the neural elements that innervate the antennal lobe in the olfactory system of Drosophila. Here we identify the zinc finger transcription factor Jing as a cell autonomously acting transcriptional regulator that is required both for dendrite targeting of projection neurons and local interneurons as well as for axonal targeting of olfactory sensory neurons in Drosophila olfactory system development. Immunocytochemical analysis shows that Jing is widely expressed in the neural cells during postembryonic development. MARCM-based clonal analysis of projection neuron and local intemeuron lineages reveals a requirement for Jing in dendrite targeting; Jing loss-of-function results in loss of innervation in specific glomeruli, ectopic innervation of inappropriate glomeruli, aberrant profuse dendrite arborisation throughout the antennal lobe, as well as mistargeting to other parts of the CNS. ey-FLP-based MARCM analysis of olfactory sensory neurons reveals an additional requirement for ling in axonal targeting; mutational inactivation of Jing causes specific mistargeting of some olfactory sensory neuron axons to the DA1 glomerulus, reduction of targeting to other glomeruli, as well as aberrant stalling of axons in the antennal lobe. Taken together, these findings indicate that Jing acts as a key transcriptional control element in wiring of the circuitry in the developing olfactory sensory system in Drosophila. (C) 2013 Published by Elsevier Inc.
C1 [Nair, Indu S.; Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.
   [Nair, Indu S.; Rodrigues, Veronica; VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
RP VijayRaghavan, K (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
EM vijay@ncbs.res.in
FU TIFR; Department of Biotechnololgy, Government of India; Swiss NSFSwiss
   National Science Foundation (SNSF); Indo-Swiss Joint Research Program
FX We dedicate this paper to the memory of our co-author, Veronica
   Rodrigues. This work was supported by core funding from TIFR and the
   Department of Biotechnololgy, Government of India; the Swiss NSF and the
   Indo-Swiss Joint Research Program. We are grateful to Denise Montell,
   Joaquim Cull and Tzumin Lee; the Bloomington Drosophila Stock Centre,
   DSHB for fly stocks and reagents. We thank Greeshma Ray for technical
   help with the deficiency mapping crosses. We are thankful to Ajeet
   Pratap Singh and Sonia Sen for comments on the manuscript. We thank the
   Department of Science and Technology, Government of India for the
   Olympus FV1000 confocal microscopes in the Central Imaging and Flow
   Cytometry Facility (CIFF) at NCBS.
CR Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Brochtrup A, 2011, CURR OPIN NEUROBIOL, V21, P85, DOI 10.1016/j.conb.2010.11.001
   Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020
   Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997
   Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005
   Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034
   Culi J, 2006, GENETICS, V173, P255, DOI 10.1534/genetics.106.056341
   Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33
   Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808
   Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066
   Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595
   Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442
   Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8
   Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2
   Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083
   Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025174
   Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149
   Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284
   Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002
   Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8
   Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028
   Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Liu YR, 2001, DEVELOPMENT, V128, P321
   LUO L, 2007, NEURON, V56, P84300
   McClure KD, 2008, MECH DEVELOP, V125, P67, DOI 10.1016/j.mod.2007.10.003
   Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003
   Sedaghat Y, 2002, DEV GENES EVOL, V212, P277, DOI 10.1007/s00427-002-0240-5
   Sedaghat Y, 2002, DEVELOPMENT, V129, P2591
   Sen S, 2010, DEVELOPMENT, V137, P3687, DOI 10.1242/dev.052407
   Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013
   Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14
   Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5
   Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022
   Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008
   Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306
   Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336
   Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652
   Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4
NR 48
TC 2
Z9 2
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD SEP 1
PY 2013
VL 381
IS 1
BP 17
EP 27
DI 10.1016/j.ydbio.2013.06.023
PG 11
WC Developmental Biology
SC Developmental Biology
GA 204WL
UT WOS:000323401900004
PM 23810656
OA Bronze
DA 2021-01-25
ER

PT J
AU Peralta, B
   Gil-Carton, D
   Castano-Diez, D
   Bertin, A
   Boulogne, C
   Oksanen, HM
   Bamford, DH
   Abrescia, NGA
AF Peralta, Bibiana
   Gil-Carton, David
   Castano-Diez, Daniel
   Bertin, Aurelie
   Boulogne, Claire
   Oksanen, Hanna M.
   Bamford, Dennis H.
   Abrescia, Nicola G. A.
TI Mechanism of Membranous Tunnelling Nanotube Formation in Viral Genome
   Delivery
SO PLOS BIOLOGY
LA English
DT Article
ID MAJOR CAPSID PROTEIN; BACTERIOPHAGE PRD1; UNIQUE VERTEX; 3-DIMENSIONAL
   STRUCTURE; VIRUS EVOLUTION; CELL BIOLOGY; DNA ENTRY; WILD-TYPE;
   CURVATURE; INSIGHTS
AB In internal membrane-containing viruses, a lipid vesicle enclosed by the icosahedral capsid protects the genome. It has been postulated that this internal membrane is the genome delivery device of the virus. Viruses built with this architectural principle infect hosts in all three domains of cellular life. Here, using a combination of electron microscopy techniques, we investigate bacteriophage PRD1, the best understood model for such viruses, to unveil the mechanism behind the genome translocation across the cell envelope. To deliver its double-stranded DNA, the icosahedral protein-rich virus membrane transforms into a tubular structure protruding from one of the 12 vertices of the capsid. We suggest that this viral nanotube exits from the same vertex used for DNA packaging, which is biochemically distinct from the other 11. The tube crosses the capsid through an aperture corresponding to the loss of the peripentonal P3 major capsid protein trimers, penton protein P31 and membrane protein P16. The remodeling of the internal viral membrane is nucleated by changes in osmolarity and loss of capsid-membrane interactions as consequence of the de-capping of the vertices. This engages the polymerization of the tail tube, which is structured by membrane-associated proteins. We have observed that the proteo-lipidic tube in vivo can pierce the gram-negative bacterial cell envelope allowing the viral genome to be shuttled to the host cell. The internal diameter of the tube allows one double-stranded DNA chain to be translocated. We conclude that the assembly principles of the viral tunneling nanotube take advantage of proteo-lipid interactions that confer to the tail tube elastic, mechanical and functional properties employed also in other protein-membrane systems.
C1 [Peralta, Bibiana; Gil-Carton, David; Abrescia, Nicola G. A.] CIBERehd, CIC BioGUNE, Struct Biol Unit, Derio, Spain.
   [Castano-Diez, Daniel] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Bertin, Aurelie; Boulogne, Claire] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.
   [Oksanen, Hanna M.; Bamford, Dennis H.] Univ Helsinki, Viikki Bioctr, Inst Biotechnol, FIN-00014 Helsinki, Finland.
   [Oksanen, Hanna M.; Bamford, Dennis H.] Univ Helsinki, Viikki Bioctr, Dept Biosci, FIN-00014 Helsinki, Finland.
   [Abrescia, Nicola G. A.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.
RP Peralta, B (corresponding author), CIBERehd, CIC BioGUNE, Struct Biol Unit, Derio, Spain.
EM nabrescia@cicbiogune.es
RI Carton, David Gil/M-9332-2019; Abrescia, Nicola GA/F-5898-2011; Oksanen,
   Hanna M/Y-7379-2019; Abrescia, Nicola Gerardo/AAY-2323-2020; Carton,
   David Gil/G-2404-2011
OI Carton, David Gil/0000-0003-4241-1302; Oksanen, Hanna
   M/0000-0003-3047-8294; Abrescia, Nicola Gerardo/0000-0001-5559-1918;
   Carton, David Gil/0000-0003-4241-1302; Bamford,
   Dennis/0000-0002-6438-8118; Bertin, Aurelie/0000-0002-3400-6887;
   Castano-Diez, daniel/0000-0002-0197-163X
FU Spanish Ministerio de Economia y Competitividad [BFU2012-33947]; Academy
   Professor (Academy of Finland)Academy of Finland [255342, 256518,
   271413]; Agence Nationale pour la RechercheFrench National Research
   Agency (ANR) [ANR-09-RPDOC-026-01]; FP7 Marie Curie actions
   "International Reintegration Grant'' [PIRG7-GA-2010-268151]; University
   of Helsinki
FX This investigation was supported by the Spanish Ministerio de Economia y
   Competitividad BFU2012-33947 to NGAA, by the Academy Professor (Academy
   of Finland) funding grants 255342 and 256518 to DHB, and by the Agence
   Nationale pour la Recherche ANR-09-RPDOC-026-01 and FP7 Marie Curie
   actions "International Reintegration Grant'' PIRG7-GA-2010-268151 to AB.
   We are indebted to the Academy of Finland (grant 271413) and to the
   University of Helsinki for the support to EU ESFRI Instruct Centre for
   Virus Production and Purification used in this study. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aalto AP, 2012, P NATL ACAD SCI USA, V109, P7079, DOI 10.1073/pnas.1120174109
   Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056
   Abrescia NGA, 2008, MOL CELL, V31, P749, DOI 10.1016/j.molcel.2008.06.026
   Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130
   Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692
   Bahar MW, 2011, STRUCTURE, V19, P1011, DOI 10.1016/j.str.2011.03.023
   BAMFORD D, 1982, J VIROL, V44, P1031, DOI 10.1128/JVI.44.3.1031-1038.1982
   Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591
   Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0
   Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086
   Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017
   Cherrier MV, 2009, P NATL ACAD SCI USA, V106, P11085, DOI 10.1073/pnas.0904716106
   Cockburn JJB, 2004, NATURE, V432, P122, DOI 10.1038/nature03053
   Daugelavicius R, 1997, J BACTERIOL, V179, P5203, DOI 10.1128/jb.179.16.5203-5210.1997
   Derenyi I, 2007, LECT NOTES PHYS, V711, P141
   Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010
   Fu CY, 2012, CURR OPIN VIROL, V2, P122, DOI 10.1016/j.coviro.2012.01.007
   Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003
   Grahn AM, 2002, MOL MICROBIOL, V46, P1199, DOI 10.1046/j.1365-2958.2002.03250.x
   Grahn AM, 2002, J VIROL, V76, P4866, DOI 10.1128/JVI.76.10.4866-4872.2002
   Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0
   Happonen LJ, 2013, J VIROL, V87, P8388, DOI 10.1128/JVI.00831-13
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887
   Huiskonen JT, 2007, P NATL ACAD SCI USA, V104, P6666, DOI 10.1073/pnas.0608625104
   Jaakkola ST, 2012, J VIROL, V86, P4734, DOI 10.1128/JVI.06666-11
   Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105
   Jaatinen ST, 2008, VIROLOGY, V379, P10, DOI 10.1016/j.virol.2008.06.023
   Jaatinen ST, 2004, J VIROL, V78, P9790, DOI 10.1128/JVI.78.18.9790-9797.2004
   Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484
   Karhu NJ, 2007, J VIROL, V81, P2970, DOI 10.1128/JVI.02211-06
   Khayat R, 2005, P NATL ACAD SCI USA, V102, P18944, DOI 10.1073/pnas.0506383102
   Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022
   Li YH, 2011, P NATL ACAD SCI USA, V108, P4731, DOI 10.1073/pnas.1015892108
   Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299
   Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226
   MINDICH L, 1982, J VIROL, V44, P1021, DOI 10.1128/JVI.44.3.1021-1030.1982
   Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699
   Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023
   Oliveira L, 2010, J BIOL CHEM, V285, P7366, DOI 10.1074/jbc.M109.061010
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642
   Sakashita A, 2012, SOFT MATTER, V8, P8569, DOI 10.1039/c2sm25759a
   Salas ML, 2013, VIRUS RES, V173, P29, DOI 10.1016/j.virusres.2012.09.016
   San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107
   Stromsten NJ, 2003, J VIROL, V77, P6314, DOI 10.1128/JVI.77.11.6314-6321.2003
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Xu L, 2003, STRUCTURE, V11, P309, DOI 10.1016/S0969-2126(03)00023-6
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
   Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18431, DOI 10.1073/pnas.1211702109
   Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108
   Ziedaite G, 2009, J MOL BIOL, V386, P637, DOI 10.1016/j.jmb.2008.12.068
   Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784
NR 59
TC 48
Z9 49
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD SEP
PY 2013
VL 11
IS 9
AR e1001667
DI 10.1371/journal.pbio.1001667
PG 15
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 224SU
UT WOS:000324910500023
PM 24086111
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Ahrne, E
   Molzahn, L
   Glatter, T
   Schmidt, A
AF Ahrne, Erik
   Molzahn, Lars
   Glatter, Timo
   Schmidt, Alexander
TI Critical assessment of proteome-wide label-free absolute abundance
   estimation strategies
SO PROTEOMICS
LA English
DT Article
DE Absolute protein quantification; APEX; Bioinformatics; emPAI; iBAQ; MS;
   Top3
ID MASS-SPECTROMETRY; QUANTITATIVE PROTEOMICS; QUANTIFICATION; PEPTIDES;
   PROTEINS; EMPAI; MS/MS; MODEL; RNA
AB There is a great interest in reliable ways to obtain absolute protein abundances at a proteome-wide scale. To this end, label-free LC-MS/MS quantification methods have been proposed where all identified proteins are assigned an estimated abundance. Several variants of this quantification approach have been presented, based on either the number of spectral counts per protein or MS1 peak intensities. Equipped with several datasets representing real biological environments, containing a high number of accurately quantified reference proteins, we evaluate five popular low-cost and easily implemented quantification methods (Absolute Protein Expression, Exponentially Modified Protein Abundance Index, Intensity-Based Absolute Quantification Index, Top3, and MeanInt). Our results demonstrate considerably improved abundance estimates upon implementing accurately quantified reference proteins; that is, using spiked in stable isotope labeled standard peptides or a standard protein mix, to generate a properly calibrated quantification model. We show that only the Top3 method is directly proportional to protein abundance over the full quantification range and is the preferred method in the absence of reference protein measurements. Additionally, we demonstrate that spectral count based quantification methods are associated with higher errors than MS1 peak intensity based methods. Furthermore, we investigate the impact of miscleaved, modified, and shared peptides as well as protein size and the number of employed reference proteins on quantification accuracy.
C1 [Ahrne, Erik; Molzahn, Lars; Glatter, Timo; Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland.
RP Schmidt, A (corresponding author), Univ Basel, Prote Core Facil, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM alex.schmidt@unibas.ch
OI Glatter, Timo/0000-0001-8716-8516
CR Anderle M, 2004, BIOINFORMATICS, V20, P3575, DOI 10.1093/bioinformatics/bth446
   Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82
   Blein-Nicolas M, 2012, PROTEOMICS, V12, P2797, DOI 10.1002/pmic.201100660
   Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529
   CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050
   Glatter T., 2012, J PROTEOME RES
   Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79
   Grossmann J, 2010, J PROTEOMICS, V73, P1740, DOI 10.1016/j.jprot.2010.05.011
   Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200
   Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kito K, 2008, CURR GENOMICS, V9, P263, DOI 10.2174/138920208784533647
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270
   Ludwig C., 2011, MOL CELL PROTEOMICS, V11, P1
   Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019
   Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553
   Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x
   Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200
   Podwojski K, 2010, EXPERT REV PROTEOMIC, V7, P249, DOI 10.1586/EPR.09.107
   Qi D, 2012, OMICS, V16, P489, DOI 10.1089/omi.2012.0042
   Ryu SY, 2008, CANCER INFORM, V6, P243
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800
   Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44
   Zeiler M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.009613
   ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V
NR 41
TC 106
Z9 107
U1 0
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD SEP
PY 2013
VL 13
IS 17
BP 2567
EP 2578
DI 10.1002/pmic.201300135
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 252MK
UT WOS:000327009000008
PM 23794183
DA 2021-01-25
ER

PT J
AU Schweizer, K
   Romkes, J
   Brunner, R
AF Schweizer, Katrin
   Romkes, Jacqueline
   Brunner, Reinald
TI The association between premature plantarflexor muscle activity, muscle
   strength, and equinus gait in patients with various pathologies
SO RESEARCH IN DEVELOPMENTAL DISABILITIES
LA English
DT Article
DE Gait deviation; Dynamic electromyography; Premature plantarflexor
   activity; Muscle weakness; Equinus gait
ID TOE-WALKING; CEREBRAL-PALSY; ELECTROMYOGRAPHIC ANALYSIS; CHILDREN;
   INVOLVEMENT; DEMANDS; ANKLE; KNEE
AB This study provides an overview on the association between premature plantarflexor muscle activity (PPF), muscle strength, and equinus gait in patients with various pathologies. The purpose was to evaluate whether muscular weakness and biomechanical alterations are aetiological factors for PPF during walking, independent of the underlying pathology. In a retrospective design, 716 patients from our clinical database with 46 different pathologies (orthopaedic and neurologic) were evaluated. Gait analysis data of the patients included kinematics, kinetics, electromyographic activity (EMG) data, and manual muscle strength testing. All patients were clustered three times. First, patients were grouped according to their primary pathology. Second, all patients were again clustered, this time according to their impaired joints. Third, groups of patients with normal EMG or PPF, and equinus or normal foot contact were formed to evaluate the association between PPF and equinus gait. The patient groups derived by the first two cluster methods were further subdivided into patients with normal or reduced muscle strength. Additionally, the phi correlation coefficient was calculated between PPF and equinus gait. Independent of the clustering, PPF was present in all patient groups. Weak patients revealed PPF more frequently. The correlations of PPF and equinus gait were lower than expected, due to patients with normal EMG during loading response and equinus. These patients, however, showed higher gastrocnemius activity prior to foot strike together with lower peak tibialis anterior muscle activity in loading response. Patients with PPF and a normal foot contact possibly apply the plantarflexion knee extension couple during loading response. While increased gastrocnemius activity around foot strike seems essential for equinus gait, premature gastrocnemius activity does not necessarily produce an equinus gait. We conclude that premature gastrocnemius activity is strongly associated with muscle weakness. It helps to control the knee joint under load independent from the underlying disease, and it is therefore a secondary deviation. If treated as primary target, caution should be exercised. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Schweizer, Katrin; Romkes, Jacqueline; Brunner, Reinald] Univ Childrens Hosp Basel UKBB, Lab Movement Anal, CH-4031 Basel, Switzerland.
   [Schweizer, Katrin] Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   [Brunner, Reinald] Univ Childrens Hosp Basel UKBB, Neuroorthopaed Unit, CH-4031 Basel, Switzerland.
RP Brunner, R (corresponding author), Univ Childrens Hosp Basel UKBB, Spitalstr 33, CH-4031 Basel, Switzerland.
EM reinaldbrunner@sunrise.ch
CR Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020
   Brunner R, 2008, GAIT POSTURE, V27, P399, DOI 10.1016/j.gaitpost.2007.05.009
   BRUNT D, 1988, ARCH PHYS MED REHAB, V69, P115
   Clancy EA, 2002, J ELECTROMYOGR KINES, V12, P1, DOI 10.1016/S1050-6411(01)00033-5
   Davids JR, 1999, J PEDIATR ORTHOPED, V19, P461, DOI 10.1097/00004694-199907000-00008
   Davis RB, 1997, J ELECTROMYOGR KINES, V7, P251, DOI 10.1016/S1050-6411(97)00008-4
   Gage JR., 1991, GAIT ANAL CEREBRAL P
   Goldberg EJ, 2007, GAIT POSTURE, V25, P360, DOI 10.1016/j.gaitpost.2006.04.009
   Goodman MJ, 2004, GAIT POSTURE, V20, P238, DOI 10.1016/j.gaitpost.2003.09.005
   Hermens HJ, 1999, EUROPEAN RECOMMENDAT
   Higginson JS, 2006, GAIT POSTURE, V23, P32, DOI 10.1016/j.gaitpost.2004.11.011
   Hislop H.J., 1999, MANUELLE MUSKELTESTS
   HOF AL, 1996, GAIT POSTURE, V4, P222
   Kadaba M., 1987, J ORTHOPAED RES, V7, P849
   Katrin S, 2012, J BIOMECH, V45, P2306, DOI 10.1016/j.jbiomech.2012.06.012
   Moritz CT, 2004, J APPL PHYSIOL, V96, P1996, DOI 10.1152/japplphysiol.00983.2003
   Neptune RR, 2007, J BIOMECH, V40, P1293, DOI 10.1016/j.jbiomech.2006.05.022
   Nigg B.M., 2007, **DROPPED REF**
   Perry J, 2003, ARCH PHYS MED REHAB, V84, P7, DOI 10.1053/apmr.2003.50057
   Perry J, 1992, GAIT ANAL NORMAL PAT
   Romkes J, 2007, GAIT POSTURE, V26, P577, DOI 10.1016/j.gaitpost.2006.12.010
   Schmid S, 2013, GAIT POSTURE, V37, P480, DOI 10.1016/j.gaitpost.2012.09.006
   Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015
   Stebbins J, 2010, GAIT POSTURE, V32, P226, DOI 10.1016/j.gaitpost.2010.05.006
   THOMAS SS, 1996, GAIT POSTURE, V4, P100
NR 25
TC 11
Z9 11
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-4222
J9 RES DEV DISABIL
JI Res. Dev. Disabil.
PD SEP
PY 2013
VL 34
IS 9
BP 2676
EP 2683
DI 10.1016/j.ridd.2013.05.025
PG 8
WC Education, Special; Rehabilitation
SC Education & Educational Research; Rehabilitation
GA 191OT
UT WOS:000322423200027
PM 23764825
DA 2021-01-25
ER

PT J
AU Bhogaraju, S
   Cajanek, L
   Fort, C
   Blisnick, T
   Weber, K
   Taschner, M
   Mizuno, N
   Lamla, S
   Bastin, P
   Nigg, EA
   Lorentzen, E
AF Bhogaraju, Sagar
   Cajanek, Lukas
   Fort, Cecile
   Blisnick, Thierry
   Weber, Kristina
   Taschner, Michael
   Mizuno, Naoko
   Lamla, Stefan
   Bastin, Philippe
   Nigg, Erich A.
   Lorentzen, Esben
TI Molecular Basis of Tubulin Transport Within the Cilium by IFT74 and
   IFT81
SO SCIENCE
LA English
DT Article
ID FLAGELLAR LENGTH CONTROL; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS;
   PROTEIN; COMPLEX; TURNOVER; CILIOGENESIS; MOTILITY; DYNEIN; CELLS
AB Intraflagellar transport (IFT) of ciliary precursors such as tubulin from the cytoplasm to the ciliary tip is involved in the construction of the cilium, a hairlike organelle found on most eukaryotic cells. However, the molecular mechanisms of IFT are poorly understood. Here, we found that the two core IFT proteins IFT74 and IFT81 form a tubulin-binding module and mapped the interaction to a calponin homology domain of IFT81 and a highly basic domain in IFT74. Knockdown of IFT81 and rescue experiments with point mutants showed that tubulin binding by IFT81 was required for ciliogenesis in human cells.
C1 [Bhogaraju, Sagar; Weber, Kristina; Taschner, Michael; Mizuno, Naoko; Lorentzen, Esben] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany.
   [Cajanek, Lukas; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France.
   [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] CNRS, URA2581, F-75015 Paris, France.
   [Lamla, Stefan] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
RP Lorentzen, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM lorentze@biochem.mpg.de
RI Cajanek, Lukas/ABG-6559-2020; Lorentzen, Esben/AAX-8077-2020; Bastin,
   Philippe/B-1402-2014; Bastin, Philippe/O-4230-2019; Bastin,
   Philippe/E-6688-2017
OI Cajanek, Lukas/0000-0003-2914-8589; Bastin,
   Philippe/0000-0002-3042-8679; Bhogaraju, Sagar/0000-0001-9998-5927;
   Taschner, Michael/0000-0002-8881-3705; Taschner,
   Michael/0000-0002-3789-5077; nigg, erich/0000-0003-4835-5719; Lorentzen,
   Esben/0000-0001-6493-7220
FU DGFGerman Research Foundation (DFG) [LO1627/1-1]; European Research
   Council (ERC)European Research Council (ERC) [310343]; European
   Molecular Biology OrganizationEuropean Molecular Biology Organization
   (EMBO); Agence Nationale de la RechercheFrench National Research Agency
   (ANR) [ANR-11-BSV8-016]; Ministere de l'Enseignement et de la Recherche
   [ED387]; University of Basel; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [31003A_132428/1]; Austrian Science
   FundAustrian Science Fund (FWF) [J3148-B12]; International Max Planck
   Research School for Molecular and Cellular Life Sciences (IMPRS); FEBS
   long-term fellowship
FX We thank the staff at SLS for help with x-ray diffraction data
   collection; the crystallization facility of the Max Planck Institute of
   Biochemistry (Munich) for access to crystallization screening; the staff
   at Biozentrum Imaging Core Facility for assistance; C. Basquin for
   static light-scattering experiments; C. Jung for help with microscale
   thermophoresis; and S. Chakrabarti, A. Cook, and B. D. Engel for
   carefully reading and correcting the manuscript. B. D. Engel is
   additionally acknowledged for assistance with Fig. 4 and for many
   valuable discussions concerning ciliary length control. We thank the
   Plateforme d'Imagerie Dynamique for providing access to their equipment
   and Jean-Yves Tinevez for technical advice. We acknowledge M. Morawetz
   and M. Stiegler for technical assistance with molecular biology. This
   work was funded by an Emmy Noether grant (DGF; LO1627/1-1), the European
   Research Council (ERC grant 310343), and the European Molecular Biology
   Organization Young Investigator program. Work at the Institut Pasteur
   was funded by Agence Nationale de la Recherche grant ANR-11-BSV8-016. C.
   F. is funded by a fellowship from the Ministere de l'Enseignement et de
   la Recherche (ED387). E.A.N. acknowledges support from the University of
   Basel and the Swiss National Science Foundation (31003A_132428/1). M. T.
   is the recipient of an Erwin Schroedinger stipend granted by the
   Austrian Science Fund J3148-B12, S. B was supported by the International
   Max Planck Research School for Molecular and Cellular Life Sciences
   (IMPRS), and L. C. was supported by the FEBS long-term fellowship. The
   authors declare that they have no conflict of interest. The data
   presented in this paper are tabulated in the main paper and the
   supplementary materials. Structural coordinates have been deposited at
   the Protein DataBank, accession nos. 4LVP and 4LVR.
CR Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069
   Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020
   Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993
   Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977
   Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268
   HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5
   Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041
   Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085
   JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605
   Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895
   KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517
   KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519
   Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200
   Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586
   Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141
   Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473
   Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008
   Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457
   Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132
   Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952
   Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269
   Song L, 2001, J BIOL CHEM, V276, P29754, DOI 10.1074/jbc.M103184200
   STEPHENS RE, 1977, DEV BIOL, V61, P311, DOI 10.1016/0012-1606(77)90301-3
NR 23
TC 161
Z9 168
U1 0
U2 27
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 30
PY 2013
VL 341
IS 6149
BP 1009
EP 1012
DI 10.1126/science.1240985
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 208BZ
UT WOS:000323652300045
PM 23990561
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Terranova, R
   Luisier, R
   Lempiainen, H
   Mueller, A
   Marcellin, M
   Couttet, P
   Bolognani, F
   Dubost, V
   Unterberger, E
   Scherbichler, N
   Vitry, V
   Del Espinola, A
   Thomson, J
   Braeuning, A
   Goodman, J
   Grenet, O
   Stiehl, D
   Chibout, SD
   Moulin, P
   Schwarz, M
   Meehan, R
   van Nimwegen, E
   Moggs, J
AF Terranova, R.
   Luisier, R.
   Lempiainen, H.
   Mueller, A.
   Marcellin, M.
   Couttet, P.
   Bolognani, F.
   Dubost, V.
   Unterberger, E.
   Scherbichler, N.
   Vitry, V.
   Del Espinola, A.
   Thomson, J.
   Braeuning, A.
   Goodman, J.
   Grenet, O.
   Stiehl, D.
   Chibout, S-D.
   Moulin, P.
   Schwarz, M.
   Meehan, R.
   van Nimwegen, E.
   Moggs, J.
TI Preclinical (epi)genomics - identifying safety biomarkers for the
   prediction of non-genotoxic carcinogenesis
SO TOXICOLOGY LETTERS
LA English
DT Meeting Abstract
CT 49th Congress of the European-Societies-of-Toxicology (EUROTOX)
CY SEP 01-04, 2013
CL Interlaken, SWITZERLAND
SP European Soc Toxicol (EUROTOX), ECETOC, Roche, Syngenta, AstraZeneca, Sanofi, Basilea Pharmaceutica, ACEA Biosciences Inc, European Crop Protect, Bioservice Sci Labs GmbH, Oekotoxzentrum Ctr Ecotox, Swiss Confederat, Fed Dept Home Affairs, Fed Off Publ Hlth (FOPH), BASF, SCAHT, Johnson & Johnson, Janssen Pharmaceut Co, Natl Ctr Replacement, Refinement & Reduct Anim Res, ILSI, SERVIER, RCC, Nestle, Suva Pro, Interpharma, Covance, Novartis, Merck, BioReliance
C1 [Terranova, R.; Luisier, R.; Lempiainen, H.; Mueller, A.; Marcellin, M.; Couttet, P.; Bolognani, F.; Dubost, V.; Scherbichler, N.; Vitry, V.; Del Espinola, A.; Grenet, O.; Stiehl, D.; Chibout, S-D.; Moulin, P.; Moggs, J.] Novartis Inst Biomed Res, Basel, Switzerland.
   [Unterberger, E.; Braeuning, A.; Schwarz, M.] Univ Tubingen, Dept Toxicol, Tubingen, Germany.
   [Thomson, J.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland.
   [Goodman, J.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA.
   [van Nimwegen, E.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Couttet, Philippe/AAH-5489-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
J9 TOXICOL LETT
JI Toxicol. Lett.
PD AUG 28
PY 2013
VL 221
SU S
BP S43
EP S43
DI 10.1016/j.toxlet.2013.06.157
PG 1
WC Toxicology
SC Toxicology
GA 210WO
UT WOS:000323865800133
DA 2021-01-25
ER

PT J
AU Yang, L
   Munck, M
   Swaminathan, K
   Kapinos, LE
   Noegel, AA
   Neumann, S
AF Yang, Liu
   Munck, Martina
   Swaminathan, Karthic
   Kapinos, Larisa E.
   Noegel, Angelika A.
   Neumann, Sascha
TI Mutations in LMNA Modulate the Lamin A - Nesprin-2 Interaction and Cause
   LINC Complex Alterations
SO PLOS ONE
LA English
DT Article
ID FAMILIAL PARTIAL LIPODYSTROPHY; STEROL REGULATORY ELEMENT; DREIFUSS
   MUSCULAR-DYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; A-TYPE LAMINS; DILATED
   CARDIOMYOPATHY; METABOLIC SYNDROME; BINDING-SITE; HELA-CELLS; A/C GENE
AB Background: In eukaryotes the genetic material is enclosed by a continuous membrane system, the nuclear envelope (NE). Along the NE specific proteins assemble to form meshworks and mutations in these proteins have been described in a group of human diseases called laminopathies. Laminopathies include lipodystrophies, muscle and cardiac diseases as well as metabolic or progeroid syndromes. Most laminopathies are caused by mutations in the LMNAgene encoding lamins A/C. Together with Nesprins (Nuclear Envelope Spectrin Repeat Proteins) they are core components of the LINC complex (Linker of Nucleoskeleton and Cytoskeleton). The LINC complex connects the nucleoskeleton and the cytoskeleton and plays a role in the transfer of mechanically induced signals along the NE into the nucleus, and its components have been attributed functions in maintaining nuclear and cellular organization as well as signal transduction.
   Results: Here we narrowed down the interaction sites between lamin A and Nesprin-2 to aa 403-425 in lamin A and aa 6146-6347 in Nesprin-2. Laminopathic mutations in and around the involved region of lamin A (R401C, G411D, G413C, V415I, R419C, L421P, R427G, Q432X) modulate the interaction with Nesprin-2 and this may contribute to the disease phenotype. The most notable mutation is the lamin A mutation Q432X that alters LINC complex protein assemblies and causes chromosomal and transcription factor rearrangements.
   Conclusion: Mutations in Nesprin-2 and lamin A are characterised by complex genotype phenotype relations. Our data show that each mutation in LMNAanalysed here has a distinct impact on the interaction among both proteins that substantially explains how distinct mutations in widely expressed genes lead to the formation of phenotypically different diseases.
C1 [Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany.
   [Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
   [Yang, Liu; Munck, Martina; Swaminathan, Karthic; Noegel, Angelika A.; Neumann, Sascha] Univ Cologne, Fac Med, Cologne Cluster Cellular Stress Responses Aging A, D-50931 Cologne, Germany.
   [Kapinos, Larisa E.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kapinos, Larisa E.] Univ Basel, Nanosci Inst, Basel, Switzerland.
RP Noegel, AA (corresponding author), Univ Cologne, Fac Med, Inst Biochem 1, D-50931 Cologne, Germany.
EM noegel@uni-koeln.de; neumanns@uni-koeln.de
OI Swaminathan, Karthic/0000-0002-0981-7549
FU Center for Molecular Medicine, University of Cologne; Cologne Excellence
   Cluster on Cellular Stress Responses in Aging-associated Diseases; China
   Scholarship Council (CSC)China Scholarship Council
FX The work was supported by the Center for Molecular Medicine, University
   of Cologne, the Cologne Excellence Cluster on Cellular Stress Responses
   in Aging-associated Diseases. LY is supported by a fellowship from the
   China Scholarship Council (CSC). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122
   Bechert K, 2003, EXP CELL RES, V286, P75, DOI 10.1016/S0014-4827(03)00104-6
   Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Brauch KM, 2009, AM J CARDIOL, V103, P1426, DOI 10.1016/j.amjcard.2009.01.354
   Broers JLV, 1999, J CELL SCI, V112, P3463
   Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158
   Capanni C, 2003, EXP CELL RES, V291, P122, DOI 10.1016/S0014-4827(03)00395-1
   Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197
   Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087
   Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023
   Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Decaudain A, 2007, J CLIN ENDOCR METAB, V92, P4835, DOI 10.1210/jc.2007-0654
   Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222
   Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722
   Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006
   Haque WA, 2003, DIABETES CARE, V26, P1350, DOI 10.2337/diacare.26.5.1350
   Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100
   Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075
   Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186
   Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791
   Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506
   Kandert S, 2007, HUM MOL GENET, V16, P2944, DOI 10.1093/hmg/ddm255
   Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001
   Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106
   Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09
   Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009
   Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769
   Lu W, 2012, CELL MOL LIFE SCI
   Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001
   Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008
   Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992
   Mariappan I, 2007, BIOCHEM BIOPH RES CO, V355, P981, DOI 10.1016/j.bbrc.2007.02.060
   Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006
   Moller DV, 2009, EUR J HEART FAIL, V11, P1031, DOI 10.1093/eurjhf/hfp134
   Neumann S, 2010, J BIOL CHEM, V285, P34932, DOI 10.1074/jbc.M110.119651
   Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27
   Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098
   Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090
   Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008
   Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106
   Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359
   Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g
   Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017
   TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33
   Taranum Surayya, 2012, Int J Cell Biol, V2012, P736524, DOI 10.1155/2012/736524
   Taranum S, 2012, EUR J CELL BIOL, V91, P614, DOI 10.1016/j.ejcb.2012.03.003
   Vigouroux C, 2001, J CELL SCI, V114, P4459
   Vytopil M, 2002, NEUROMUSCULAR DISORD, V12, P958, DOI 10.1016/S0960-8966(02)00178-5
   WANG XD, 1993, J BIOL CHEM, V268, P14497
   WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8
   Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058
   Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083
   Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   Zaremba-Czogalla M, 2011, CELL MOL BIOL LETT, V16, P114, DOI 10.2478/s11658-010-0038-9
   Zhen YY, 2002, J CELL SCI, V115, P3207
NR 68
TC 24
Z9 26
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 20
PY 2013
VL 8
IS 8
AR e71850
DI 10.1371/journal.pone.0071850
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219RU
UT WOS:000324527300045
PM 23977161
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Bastos, RN
   Gandhi, SR
   Baron, RD
   Gruneberg, U
   Nigg, EA
   Barr, FA
AF Bastos, Ricardo Nunes
   Gandhi, Sapan R.
   Baron, Ryan D.
   Gruneberg, Ulrike
   Nigg, Erich A.
   Barr, Francis A.
TI Aurora B suppresses microtubule dynamics and limits central spindle size
   by locally activating KIF4A
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID CHROMOSOMAL PASSENGER COMPLEX; MITOTIC KINESIN MKLP2; POLO-LIKE
   KINASE-1; MIDZONE FORMATION; CELL-CYCLE; CYTOKINESIS; PROTEIN;
   PHOSPHORYLATION; PRC1; PLK1
AB Anaphase central spindle formation is controlled by the microtubule-stabilizing factor PRC1 and the kinesin KIF4A. We show that an MKlp2-dependent pool of Aurora B at the central spindle, rather than global Aurora B activity, regulates KIF4A accumulation at the central spindle. KIF4A phosphorylation by Aurora B stimulates the maximal microtubule-dependent ATPase activity of KIF4A and promotes its interaction with PRC1. In the presence of phosphorylated KIF4A, microtubules grew more slowly and showed long pauses in growth, resulting in the generation of shorter PRC1-stabilized microtubule overlaps in vitro. Cells expressing only mutant forms of KIF4A lacking the Aurora B phosphorylation site overextended the anaphase central spindle, demonstrating that this regulation is crucial for microtubule length control in vivo. Aurora B therefore ensures that suppression of microtubule dynamic instability by KIF4A is restricted to a specific subset of microtubules and thereby contributes to central spindle size control in anaphase.
C1 [Bastos, Ricardo Nunes; Gandhi, Sapan R.; Baron, Ryan D.; Gruneberg, Ulrike; Barr, Francis A.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
   [Baron, Ryan D.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Barr, FA (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
EM francis.barr@bioch.ox.ac.uk
RI Gruneberg, Ulrike/AAY-2351-2020
OI Gruneberg, Ulrike/0000-0001-8344-0500; Nunes Bastos,
   Ricardo/0000-0002-7328-0977; Barr, Francis/0000-0001-7518-253X; nigg,
   erich/0000-0003-4835-5719
FU Cancer Research UK program award [C20079/A9473]; Cancer Research UK
   career development fellowshipCancer Research UK [C24085/A8296]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   Swiss Cancer League; Royal College of Surgeons/Freemasons Research
   Fellowship; Liverpool CRUK center; Max Planck SocietyMax Planck Society;
   Cancer Research UKCancer Research UK [15940] Funding Source:
   researchfish
FX This study was funded by a Cancer Research UK program award
   (C20079/A9473) to F.A. Barr. U. Gruneberg was supported by a Cancer
   Research UK career development fellowship (C24085/A8296). E.A. Nigg
   acknowledges supports from the Swiss National Science Foundation and the
   Swiss Cancer League. A Royal College of Surgeons/Freemasons Research
   Fellowship and the Liverpool CRUK center support R.D. Baron. Parts of
   this work originated when the authors were located at the Max Planck
   Institute of Biochemistry, Martinsried, Germany and supported by the Max
   Planck Society.
CR Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369
   Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414
   Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796
   Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5
   Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107
   Bastos RN, 2010, J CELL BIOL, V191, P751, DOI 10.1083/jcb.201008108
   Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7
   Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033
   Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6
   Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838
   Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3
   Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83
   Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055
   Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425
   Elad N, 2011, J CELL SCI, V124, P207, DOI 10.1242/jcs.073486
   Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003
   Friel CT, 2012, J MUSCLE RES CELL M, V33, P377, DOI 10.1007/s10974-012-9289-6
   Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923
   Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9
   Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609
   Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084
   Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061
   Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041
   Hackney DD, 2007, J CELL BIOL, V176, P7, DOI 10.1083/jcb.200611082
   Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713
   Hu CK, 2012, MOL BIOL CELL, V23, P2702, DOI 10.1091/mbc.E12-01-0058
   Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019
   Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046
   Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0
   Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824
   Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497
   Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133
   Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347
   Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055
   Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095
   Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13
   Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023
   Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767
   Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1
   Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052
   Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030
   Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009
   Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557
   Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124
   NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0
   Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082
   Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200
   Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468
   Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013
   Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289
   SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187
   SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431
   Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031
   Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012
   Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017
   Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036
   Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5
   Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7
   Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060
   Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0
   Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669
   Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110
   Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102
   Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103
   Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167
NR 69
TC 64
Z9 65
U1 1
U2 22
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD AUG 19
PY 2013
VL 202
IS 4
BP 605
EP 621
DI 10.1083/jcb.201301094
PG 17
WC Cell Biology
SC Cell Biology
GA 203US
UT WOS:000323319900003
PM 23940115
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Thedieck, K
   Holzwarth, B
   Prentzell, MT
   Boehlke, C
   Klasener, K
   Ruf, S
   Sonntag, AG
   Maerz, L
   Grellscheid, SN
   Kremmer, E
   Nitschke, R
   Kuehn, EW
   Jonker, JW
   Groen, AK
   Reth, M
   Hall, MN
   Baumeister, R
AF Thedieck, Kathrin
   Holzwarth, Birgit
   Prentzell, Mirja Tamara
   Boehlke, Christopher
   Klaesener, Kathrin
   Ruf, Stefanie
   Sonntag, Annika Gwendolin
   Maerz, Lars
   Grellscheid, Sushma-Nagaraja
   Kremmer, Elisabeth
   Nitschke, Roland
   Kuehn, E. Wolfgang
   Jonker, Johan W.
   Groen, Albert K.
   Reth, Michael
   Hall, Michael N.
   Baumeister, Ralf
TI Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in
   Cancer Cells
SO CELL
LA English
DT Article
ID MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; HYDROGEN-PEROXIDE; COMPLEX
   1; SIGNALING PATHWAY; RAPAMYCIN; PROTEIN; ACTIVATION; INITIATION; KINASE
AB Mammalian target of rapamycin complex 1 (mTORC1) controls growth and survival in response to metabolic cues. Oxidative stress affects mTORC1 via inhibitory and stimulatory inputs. Whereas downregulation of TSC1-TSC2 activates mTORC1 upon oxidative stress, the molecular mechanism of mTORC1 inhibition remains unknown. Here, we identify astrin as an essential negative mTORC1 regulator in the cellular stress response. Upon stress, astrin inhibits mTORC1 association and recruits the mTORC1 component raptor to stress granules (SGs), thereby preventing mTORC1-hyperactivation-induced apoptosis. In turn, balanced mTORC1 activity enables expression of stress factors. By identifying astrin as a direct molecular link between mTORC1, SG assembly, and the stress response, we establish a unifying model of mTORC1 inhibition and activation upon stress. Importantly, we show that in cancer cells, apoptosis suppression during stress depends on astrin. Being frequently upregulated in tumors, astrin is a potential clinically relevant target to sensitize tumors to apoptosis.
C1 [Thedieck, Kathrin; Holzwarth, Birgit; Prentzell, Mirja Tamara; Klaesener, Kathrin; Ruf, Stefanie; Sonntag, Annika Gwendolin; Maerz, Lars; Nitschke, Roland; Reth, Michael; Baumeister, Ralf] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
   [Thedieck, Kathrin; Klaesener, Kathrin; Ruf, Stefanie; Nitschke, Roland; Kuehn, E. Wolfgang; Reth, Michael; Baumeister, Ralf] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.
   [Thedieck, Kathrin; Nitschke, Roland; Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany.
   [Prentzell, Mirja Tamara] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany.
   [Ruf, Stefanie] Univ Freiburg, Res Training Grp RTG 1104, D-79104 Freiburg, Germany.
   [Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ Ctr Biochem & Mol Cell Res, D-79104 Freiburg, Germany.
   [Thedieck, Kathrin; Boehlke, Christopher; Kuehn, E. Wolfgang] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany.
   [Klaesener, Kathrin; Reth, Michael] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.
   [Grellscheid, Sushma-Nagaraja] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.
   [Kremmer, Elisabeth] Inst Mol Immunol, Helmholtz Zentrum Munchen, D-81377 Munich, Germany.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jonker, Johan W.; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9713 GZ Groningen, Netherlands.
RP Thedieck, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM k.thedieck@umcg.nl
RI Jonker, Johan W./ABE-6853-2020; Nitschke, Roland/F-9525-2010
OI Jonker, Johan W./0000-0002-3919-5437; Nitschke,
   Roland/0000-0002-9397-8475; Prentzell, Mirja Tamara/0000-0002-9659-9825;
   Boehlke, Christopher/0000-0002-6985-0201; Thedieck,
   Kathrin/0000-0002-9069-2930
FU EC 6th FP NoE LifeSpan [LSHG-CT-2007-036894]; Schlieben-Lange-Programm;
   Excellence Initiative of the German Research FoundationGerman Research
   Foundation (DFG) [EXC 294, GSC-4]; Excellence Initiative of the German
   Research Foundation (Spemann Graduate School); DFG Research Training
   Group RTGGerman Research Foundation (DFG) [1104]; DFGGerman Research
   Foundation (DFG) [KU 1504, CRC746, CRC850]; BMBF Gerontosys
   II-NephAgeFederal Ministry of Education & Research (BMBF) [031 5896A];
   Freiburg Institute for Advanced Studies, FRIASFonds de la Recherche
   Scientifique - FNRS; Peter und Traudl Engelhorn Stiftung zur Forderung
   der Biotechnologie und Gentechnik; Addison Wheeler Fellowship; European
   Research CouncilEuropean Research Council (ERC) [IRG-277169]; Human
   Frontier Science ProgramHuman Frontier Science Program
   [CDA00013/2011-C]; Netherlands Organization for Scientific Research
   (VIDI)Netherlands Organization for Scientific Research (NWO)
   [016.126.338]; Dutch Digestive Foundation [WO 11-67]; Dutch Diabetes
   Foundation [2012.00.1537]
FX We thank Daryl P. Shanley (Newcastle University, UK) and Anna Johann for
   helpful discussions and critical reading of the manuscript. We thank
   Jerry Pelletier, McGill University, Montreal, Quebec, Canada for kindly
   providing hippuristanol. We thank our reviewers for excellent feedback
   and helpful experimental suggestions. Special thanks go to the staff of
   the Life Imaging Center (LIC) in the Center for Systems Biology,
   Albert-Ludwigs-University Freiburg for excellent confocal and widefield
   microscopy resources and the support in image analysis. This study was
   supported in part by the EC 6th FP NoE LifeSpan (LSHG-CT-2007-036894, to
   K. T. and R. B.), the Schlieben-Lange-Programm (K. T.), the Excellence
   Initiative of the German Research Foundation (EXC 294 to K. T., R. B.,
   M. R., E. W. K., and R.N.; GSC-4, Spemann Graduate School to M. T. P.),
   the DFG Research Training Group RTG 1104 (S. R.), DFG grant KU 1504 (E.
   W. K.), BMBF Gerontosys II-NephAge (031 5896A) (K. T. and R. B.), the
   DFG grants CRC746 (M. R. and R. B.) and CRC850 (R. B.), the Freiburg
   Institute for Advanced Studies, FRIAS (K. T.), and the Peter und Traudl
   Engelhorn Stiftung zur Forderung der Biotechnologie und Gentechnik (K.
   T.). SNG is supported by an Addison Wheeler Fellowship. J.W.J. is
   supported by grants from the European Research Council (IRG-277169),
   Human Frontier Science Program (CDA00013/2011-C), the Netherlands
   Organization for Scientific Research (VIDI grant 016.126.338), the Dutch
   Digestive Foundation (grant WO 11-67), and the Dutch Diabetes Foundation
   (grant 2012.00.1537). A part of this work is the basis for a pending
   European patent application, filed on January 11, 2013 (Application no.
   EP13151022.4).
CR Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006
   Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791
   Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243
   Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554
   Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679
   Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311
   Dennis MD, 2013, J BIOL CHEM, V288, P10, DOI 10.1074/jbc.M112.402461
   Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033
   Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009
   Fournier MJ, 2013, MOL CELL BIOL, V33, P2285, DOI 10.1128/MCB.01517-12
   Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082
   Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011
   Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088
   Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026
   Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197
   Halim VA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003664
   Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618
   Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912
   Huang CS, 2002, CANCER RES, V62, P5689
   Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107
   Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900
   Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015
   Luo XA, 2011, RNA BIOL, V8, P14, DOI 10.4161/rna.8.1.13483
   Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298
   Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223
   Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Pour NK, 2011, BIOCHEMISTRY-US, V50, P6942, DOI 10.1021/bi200711v
   Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215
   Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09
   Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449
   Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shao XP, 2001, MOL REPROD DEV, V59, P410, DOI 10.1002/mrd.1047
   Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014
   Sonntag AG, 2012, FEBS J, V279, P3314, DOI 10.1111/j.1742-4658.2012.08582.x
   Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004
   Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019
   Talarek N, 2010, MOL CELL, V38, P345, DOI 10.1016/j.molcel.2010.02.039
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128
   Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116
   Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101
   Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273
   Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25
   Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033
   Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013
   Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014
NR 66
TC 128
Z9 136
U1 1
U2 45
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 15
PY 2013
VL 154
IS 4
BP 859
EP 874
DI 10.1016/j.cell.2013.07.031
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 202GQ
UT WOS:000323202500016
PM 23953116
OA Bronze
DA 2021-01-25
ER

PT J
AU Kagoshima, H
   Cassata, G
   Tong, YG
   Pujol, N
   Niklaus, G
   Burglin, TR
AF Kagoshima, Hiroshi
   Cassata, Giuseppe
   Tong, Yong Guang
   Pujol, Nathalie
   Niklaus, Gisela
   Burglin, Thomas R.
TI The LIM homeobox gene ceh-14 is required for phasmid function and
   neurite outgrowth
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Homeobox gene; LIM domain; ceh-14; Caenorhabditis elegans; Neurite
   outgrowth; Neural development; Phasmids
ID C-ELEGANS; HOMEODOMAIN PROTEINS; NERVOUS-SYSTEM; CELL LINEAGE; MOTOR
   AXONS; NEURON; EXPRESSION; DOMAINS; BINDING; PATHWAY
AB Transcription factors play key roles in cell fate specification and cell differentiation. Previously, we showed that the LIM homeodomain factor CEH-14 is expressed in the AFD neurons where it is required for thermotaxis behavior in Caenorhabditis elegans. Here, we show that ceh-14 is expressed in the phasmid sensory neurons, PHA and PHB, a number of neurons in the tail, i.e., PHC, DVC, PVC, PVN, PVQ PVT, PVW and PVR, as well as the touch neurons. Analysis of the promoter region shows that important regulatory elements for the expression in most neurons reside from -4 kb to -1.65 kb upstream of the start codon. Further, within the first introns are elements for expression in the hypodermis. Phylogenetic footprinting revealed numerous conserved motifs in these regions. In addition to the existing deletion mutation ceh-14(ch3), we isolated a new allele, ceh-14(ch2), in which only one LIM domain is disrupted. The latter mutant allele is partially defective for thermosensation. Analysis of both mutant alleles showed that they are defective in phasmid dye-filling. However, the cell body, dendritic outgrowth and ciliated endings of PHA and PHB appear normal, indicating that ceh-14 is not required for growth. The loss of a LIM domain in the ceh-14(ch2) allele causes a partial loss-of-function phenotype. Examination of the neurites of ALA and tail neurons using a ceh-14::GFP reporter shows abnormal axonal outgrowth and pathfinding. (c) 2013 Elsevier Inc. All rights reserved.
C1 [Kagoshima, Hiroshi; Cassata, Giuseppe; Niklaus, Gisela; Burglin, Thomas R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kagoshima, Hiroshi] Res Org Informat & Syst, Ctr Genet Resources Informat, Genome Biol Lab, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.
   [Kagoshima, Hiroshi] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Minato Ku, Tokyo 1050001, Japan.
   [Tong, Yong Guang; Burglin, Thomas R.] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.
   [Tong, Yong Guang; Burglin, Thomas R.] Sodertorn Univ, Sch Life Sci, SE-14189 Huddinge, Sweden.
   [Pujol, Nathalie] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France.
   [Pujol, Nathalie] INSERM, U1104, F-13288 Marseille, France.
   [Pujol, Nathalie] CNRS, UMR7280, F-13288 Marseille, France.
RP Burglin, TR (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14183 Huddinge, Sweden.
EM thomas.burglin@ki.se
RI Pujol, Nathalie/K-3880-2012
OI Pujol, Nathalie/0000-0001-8889-3197
FU NIH National Center for Research Resources (NCRR)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR); Novartis
   FoundationNovartis; JSPS Postdoctoral Fellowship for Research
   AbroadMinistry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT)Japan Society for the Promotion of Science; JSPSMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of Science [23510239]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [NF. 3100-040843.94,
   NF. 31-50839.97]; Kanton Basel-Stadt; START Fellowship [NF.
   3130-038786.93]; Swedish Foundation for Strategic ResearchSwedish
   Foundation for Strategic Research; Center of Biosciences and Sodertorn
   University; Grants-in-Aid for Scientific ResearchMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [23510239] Funding Source: KAKEN
FX We would like to thank I. Mori and her group for critical advice in
   identification of neurons and performing thermotaxis assays. Further we
   thank C. Van Buskirk and P. Sternberg for sharing of unpublished
   information. We thank A. Fire for providing vectors and G. Jansen for
   the gpa-13::GFP reporter plasmid, Y. Andachi and Y. Kohara for providing
   the Tc1 insertion strain YK11, M. Koga for some strains and markers, M.
   Nonet for prabGFPim3', and G. Aspock, C. Dozier, J. Ewbank and Y. Ohsima
   for helpful advice and discussion. Nematode strains used in this work
   were provided by the Caenorhabditis Genetics Center, which is funded by
   the NIH National Center for Research Resources (NCRR). This work and
   H.K. was supported by the Novartis Foundation. H.K. was and is supported
   by a JSPS Postdoctoral Fellowship for Research Abroad, and Grant-in-Aid
   for Scientific Research (Kakenhi) (C) (No. 23510239) from JSPS. This
   work was supported by grants NF. 3100-040843.94 and NF. 31-50839.97 from
   the Swiss National Science Foundation and the Kanton Basel-Stadt. T.R.B.
   was supported by a START Fellowship (NF. 3130-038786.93) and grants from
   the Swedish Foundation for Strategic Research. We acknowledge the
   support of the Center of Biosciences and Sodertorn University.
CR Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0
   Aurelio O, 2003, DEVELOPMENT, V130, P599, DOI 10.1242/dev.00277
   Ausubel F.M., 1987, CURRENT PROTOCOLS MO
   Bando T, 2005, J MOL BIOL, V348, P101, DOI 10.1016/j.jmb.2005.01.045
   Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5
   Cassata G, 2000, DEV BIOL, V226, P45, DOI 10.1006/dbio.2000.9846
   Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1
   Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4
   CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0
   Cheah SS, 2000, GENESIS, V27, P12, DOI 10.1002/1526-968X(200005)27:1<12::AID-GENE30>3.0.CO;2-X
   Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Epstein H.F., 1995, METHODS CELL BIOL, V48
   Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708
   Feng HY, 2012, GENE, V494, P73, DOI 10.1016/j.gene.2011.11.042
   FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F
   Fire A., 1992, GENETIC ANAL TECHNIQ, V9, P5
   FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0
   Fukushige T, 1999, J CELL SCI, V112, P395
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914
   HAN M, 1991, GENE DEV, V5, P2188, DOI 10.1101/gad.5.12a.2188
   HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9
   HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061
   Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8
   Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1
   Hobert O, 1999, DEVELOPMENT, V126, P1547
   Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7
   Hobert O, 1998, J NEUROSCI, V18, P2084
   Hope I. A., 1999, C ELEGANS PRACTICAL
   Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499
   Kagoshima H, 2000, DEV GENES EVOL, V210, P564, DOI 10.1007/s004270000099
   Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2
   KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0
   Koch BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033261
   Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7
   LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0
   Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110
   O'Keefe DD, 1998, DEVELOPMENT, V125, P3915
   Ohkura K, 2011, BIOCHEM BIOPH RES CO, V406, P188, DOI 10.1016/j.bbrc.2011.02.003
   Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697
   PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3
   Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X
   Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950
   Pujol N, 2000, DEVELOPMENT, V127, P3361
   Sambrook J., 2001, MOL CLONING LAB MANU
   SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x
   Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7
   Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078
   Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3
   Srivastava M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-4
   SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4
   Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0
   Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003
   Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806
   Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1
   Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X
   Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275
   Tong YG, 2010, J NEUROSCI METH, V188, P58, DOI 10.1016/j.jneumeth.2010.02.003
   Van Buskirk C, 2010, DEVELOPMENT, V137, P2065, DOI 10.1242/dev.040881
   WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2
   WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056
   Wood WB, 1988, NEMATODE CAENORHABDI
   Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126
NR 66
TC 7
Z9 8
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD AUG 15
PY 2013
VL 380
IS 2
BP 314
EP 323
DI 10.1016/j.ydbio.2013.04.009
PG 10
WC Developmental Biology
SC Developmental Biology
GA 189WB
UT WOS:000322297900015
PM 23608457
OA Bronze
DA 2021-01-25
ER

PT J
AU Farhan, M
   Ruusuvuori, P
   Emmenlauer, M
   Ramo, P
   Dehio, C
   Yli-Harja, O
AF Farhan, Muhammad
   Ruusuvuori, Pekka
   Emmenlauer, Mario
   Raemoe, Pauli
   Dehio, Christoph
   Yli-Harja, Olli
TI Multi-scale Gaussian representation and outline-learning based cell
   image segmentation
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 10th International Workshop on Computational Systems Biology
CY JUN 10-12, 2013
CL Tampere, FINLAND
ID AUTOMATIC SEGMENTATION; FLUORESCENCE; CLASSIFICATION; MICROSCOPY; NUCLEI
AB Background: High-throughput genome-wide screening to study gene-specific functions, e. g. for drug discovery, demands fast automated image analysis methods to assist in unraveling the full potential of such studies. Image segmentation is typically at the forefront of such analysis as the performance of the subsequent steps, for example, cell classification, cell tracking etc., often relies on the results of segmentation.
   Methods: We present a cell cytoplasm segmentation framework which first separates cell cytoplasm from image background using novel approach of image enhancement and coefficient of variation of multi-scale Gaussian scale-space representation. A novel outline-learning based classification method is developed using regularized logistic regression with embedded feature selection which classifies image pixels as outline/non-outline to give cytoplasm outlines. Refinement of the detected outlines to separate cells from each other is performed in a post-processing step where the nuclei segmentation is used as contextual information.
   Results and conclusions: We evaluate the proposed segmentation methodology using two challenging test cases, presenting images with completely different characteristics, with cells of varying size, shape, texture and degrees of overlap. The feature selection and classification framework for outline detection produces very simple sparse models which use only a small subset of the large, generic feature set, that is, only 7 and 5 features for the two cases. Quantitative comparison of the results for the two test cases against state-of-the-art methods show that our methodology outperforms them with an increase of 4-9% in segmentation accuracy with maximum accuracy of 93%. Finally, the results obtained for diverse datasets demonstrate that our framework not only produces accurate segmentation but also generalizes well to different segmentation tasks.
C1 [Farhan, Muhammad; Ruusuvuori, Pekka; Yli-Harja, Olli] Tampere Univ Technol, Dept Signal Proc, Tampere 33720, Finland.
   [Emmenlauer, Mario; Raemoe, Pauli; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Farhan, M (corresponding author), Tampere Univ Technol, Dept Signal Proc, Tampere 33720, Finland.
EM muhammad.farhan@tut.fi
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Yli-Harja, Olli/0000-0001-8581-4414
CR Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Allalou A, 2007, LECT NOTES COMPUT SC, V4522, P631
   Brejl M, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P814, DOI 10.1109/IJCNN.1998.685872
   Brejl M, 2000, IEEE T MED IMAGING, V19, P973, DOI 10.1109/42.887613
   Brox T, 2004, LECT NOTES COMPUT SC, V3175, P415
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Chen C, 2008, J MICROSC-OXFORD, V230, P177, DOI 10.1111/j.1365-2818.2008.01974.x
   Danek O, 2009, LECT NOTES COMPUT SC, V5575, P410
   Farhan M, 2013, P SPIE, V8655
   Farhan M, 2013, PATTERN RECOGN, V46, P741, DOI 10.1016/j.patcog.2012.09.008
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Garrido A, 2000, PATTERN RECOGN, V33, P821, DOI 10.1016/S0031-3203(99)00091-6
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Hastie T, 1996, J ROY STAT SOC B MET, V58, P155
   Held C, 2011, CYTOM PART A, V79A, P933, DOI 10.1002/cyto.a.21122
   JAIN AK, 1990, 1990 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS, P14, DOI 10.1109/ICSMC.1990.142050
   Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535
   Keuper M, 2010, LECT NOTES COMPUT SC, V6376, P462
   Lesko Milan, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1485, DOI 10.1109/ICPR.2010.367
   Lindblad J, 2004, CYTOM PART A, V57A, P22, DOI 10.1002/cyto.a.10107
   Lindeberg T., 1994, J APPL STAT, V21, P225, DOI DOI 10.1080/757582976
   Mocellin S, 2004, J TRANSLATIONAL MED, V2
   Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Prasad M, 2006, LECT NOTES COMPUT SC, V4338, P94
   Quelhas P, 2010, IEEE T MED IMAGING, V29, P1463, DOI 10.1109/TMI.2010.2048253
   Russ J.C., 1999, IMAGE PROCESSING HDB
   Russell Christopher, 2007, P IEEE 11 INT C COMP, P1
   Ruusuvuori P, 2012, EUR SIGNAL PR CONF, P2253
   Selinummi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007497
   Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076
   Wahlby C, 2002, ANAL CELL PATHOL, V24, P101
   Wollman R, 2007, J CELL SCI, V120, P3715, DOI 10.1242/jcs.013623
   Xiong GL, 2006, IEEE IMAGE PROC, P73, DOI 10.1109/ICIP.2006.312365
   Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006
   Zuiderveld K, 1994, CONTRAST LTD ADAPTIV
NR 36
TC 3
Z9 3
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD AUG 12
PY 2013
VL 14
SU 10
AR S6
DI 10.1186/1471-2105-14-S10-S6
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 215YV
UT WOS:000324248300006
PM 24267488
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Leppanen, VM
   Tvorogov, D
   Kisko, K
   Prota, AE
   Jeltsch, M
   Anisimov, A
   Markovic-Mueller, S
   Stuttfeld, E
   Goldie, KN
   Ballmer-Hofer, K
   Alitalo, K
AF Leppanen, Veli-Matti
   Tvorogov, Denis
   Kisko, Kaisa
   Prota, Andrea E.
   Jeltsch, Michael
   Anisimov, Andrey
   Markovic-Mueller, Sandra
   Stuttfeld, Edward
   Goldie, Kenneth N.
   Ballmer-Hofer, Kurt
   Alitalo, Kari
TI Structural and mechanistic insights into VEGF receptor 3 ligand binding
   and activation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE signal transduction; receptor tyrosine kinase
ID ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE;
   X-RAY; COMPLEX; SITES; DETERMINANTS; RECOGNITION; SPECIFICITY; CONTACTS
AB Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are key drivers of blood and lymph vessel formation in development, but also in several pathological processes. VEGF-C signaling through VEGFR-3 promotes lymphangiogenesis, which is a clinically relevant target for treating lymphatic insufficiency and for blocking tumor angiogenesis and metastasis. The extracellular domain of VEGFRs consists of seven Ig homology domains; domains 1-3 (D1-3) are responsible for ligand binding, and the membrane-proximal domains 4-7 (D4-7) are involved in structural rearrangements essential for receptor dimerization and activation. Here we analyzed the crystal structures of VEGF-C in complex with VEGFR-3 domains D1-2 and of the VEGFR-3 D4-5 homodimer. The structures revealed a conserved ligand-binding interface in D2 and a unique mechanism for VEGFR dimerization and activation, with homotypic interactions in D5. Mutation of the conserved residues mediating the D5 interaction (Thr446 and Lys516) and the D7 interaction (Arg737) compromised VEGF-C induced VEGFR-3 activation. A thermodynamic analysis of VEGFR-3 deletion mutants showed that D3, D4-5, and D6-7 all contribute to ligand binding. A structural model of the VEGF-C/VEGFR-3 D1-7 complex derived from small-angle X-ray scattering data is consistent with the homotypic interactions in D5 and D7. Taken together, our data show that ligand-dependent homotypic interactions in D5 and D7 are essential for VEGFR activation, opening promising possibilities for the design of VEGFR-specific drugs.
C1 [Leppanen, Veli-Matti; Tvorogov, Denis; Jeltsch, Michael; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Wihuri Res Inst, FIN-00014 Helsinki, Finland.
   [Leppanen, Veli-Matti; Tvorogov, Denis; Jeltsch, Michael; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Translat Canc Biol Program, Inst Mol Med Finland, FIN-00014 Helsinki, Finland.
   [Leppanen, Veli-Matti; Tvorogov, Denis; Jeltsch, Michael; Anisimov, Andrey; Alitalo, Kari] Univ Helsinki, Cent Hosp, Biomedicum Helsinki, Helsinki 00014, Finland.
   [Kisko, Kaisa; Prota, Andrea E.; Markovic-Mueller, Sandra; Stuttfeld, Edward; Ballmer-Hofer, Kurt] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland.
   [Stuttfeld, Edward] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4056 Basel, Switzerland.
RP Alitalo, K (corresponding author), Univ Helsinki, Wihuri Res Inst, FIN-00014 Helsinki, Finland.
EM Kari.Alitalo@helsinki.fi
RI Alitalo, Kari K/J-5013-2014; Jeltsch, Michael/I-5340-2012; Prota, Andrea
   Enrico/R-9526-2019
OI Alitalo, Kari K/0000-0002-7331-0902; Jeltsch,
   Michael/0000-0003-2890-7790; Prota, Andrea Enrico/0000-0003-0875-5339;
   Ballmer-Hofer, Kurt/0000-0002-3800-9129; Leppanen,
   Veli-Matti/0000-0001-7100-965X
FU Academy of FinlandAcademy of Finland; Sigrid Juselius FoundationSigrid
   Juselius Foundation; Louis-Jeantet Foundation; European Research
   CouncilEuropean Research Council (ERC) [ERC-2010-AdG-268804-TX-FACTORS];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-130463]; Oncosuisse [OC2 01200-08-2007]; NOVARTIS
   Stiftung fur medizinisch-biologische Forschung [10C61]; Swiss Initiative
   for Systems Biology (SystemsX.ch; grant CINA)
FX We thank Tapio Tainola and Seppo Kaijalainen for excellent technical
   assistance, Dr. John H. Missimer for SAXS data evalution, and the staff
   at European Synchrotron Radiation Facility beamline ID29 and staff at
   Swiss Light Source beamlines X06SA, X06DA, and cSAXS for assistance and
   access to their facilities. This work was supported by grants from the
   Academy of Finland, the Sigrid Juselius Foundation, the Louis-Jeantet
   Foundation, the European Research Council
   (ERC-2010-AdG-268804-TX-FACTORS), Swiss National Science Foundation
   (Grant 31003A-130463), Oncosuisse (Grant OC2 01200-08-2007), NOVARTIS
   Stiftung fur medizinisch-biologische Forschung (Grant 10C61), and the
   Swiss Initiative for Systems Biology (SystemsX.ch; grant CINA).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545
   Barleon B, 1997, J BIOL CHEM, V272, P10382
   Brozzo MS, 2012, BLOOD, V119, P1781, DOI 10.1182/blood-2011-11-390922
   Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698
   Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105
   Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200
   Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977
   Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946
   Elegheert J, 2011, STRUCTURE, V19, P1762, DOI 10.1016/j.str.2011.10.012
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197
   Hyde CAC, 2012, MOL CELL BIOL, V32, P3802, DOI 10.1128/MCB.06787-11
   Iyer S, 2010, J BIOL CHEM, V285, P23779, DOI 10.1074/jbc.M110.130658
   Jeltsch M, 2006, J BIOL CHEM, V281, P12187, DOI 10.1074/jbc.M511593200
   Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997
   Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013
   Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com
   Kendrew J, 2011, MOL CANCER THER, V10, P770, DOI 10.1158/1535-7163.MCT-10-0876
   Kisko K, 2011, FASEB J, V25, P2980, DOI 10.1096/fj.11-185397
   Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301
   Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549
   Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107
   Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010
   Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30
   PAJUSOLA K, 1994, ONCOGENE, V9, P3545
   Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009
   Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202
   Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107
   Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283
   Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X
   Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083
   Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331
   Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045
   Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001
   Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532
   Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215
   Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0
   Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105
   Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107
   Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055
NR 44
TC 46
Z9 47
U1 0
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 6
PY 2013
VL 110
IS 32
BP 12960
EP 12965
DI 10.1073/pnas.1301415110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 196JQ
UT WOS:000322771100038
PM 23878260
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Brunner, R
   Ng, CL
   Aissaoui, H
   Akabas, MH
   Boss, C
   Brun, R
   Callaghan, PS
   Corminboeuf, O
   Fidock, DA
   Frame, IJ
   Heidmann, B
   Le Bihan, A
   Jeno, P
   Mattheis, C
   Moes, S
   Muller, IB
   Paguio, M
   Roepe, PD
   Siegrist, R
   Voss, T
   Welford, RWD
   Wittlin, S
   Binkert, C
AF Brunner, Ralf
   Ng, Caroline L.
   Aissaoui, Hamed
   Akabas, Myles H.
   Boss, Christoph
   Brun, Reto
   Callaghan, Paul S.
   Corminboeuf, Olivier
   Fidock, David A.
   Frame, Ithiel J.
   Heidmann, Bibia
   Le Bihan, Amelie
   Jenoe, Paul
   Mattheis, Corinna
   Moes, Suzette
   Mueller, Ingrid B.
   Paguio, Michelle
   Roepe, Paul D.
   Siegrist, Romain
   Voss, Till
   Welford, Richard W. D.
   Wittlin, Sergio
   Binkert, Christoph
TI UV-triggered Affinity Capture Identifies Interactions between the
   Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and
   Antimalarial Agents in Live Parasitized Cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DIHYDROOROTATE DEHYDROGENASE; ARTEMISININ RESISTANCE; MALARIA; TARGET;
   MEFLOQUINE; TRANSPORTER; SENSITIVITY; INHIBITORS; QUININE; GENE
AB A representative of a new class of potent antimalarials with an unknown mode of action was recently described. To identify the molecular target of this class of antimalarials, we employed a photo-reactive affinity capture method to find parasite proteins specifically interacting with the capture compound in living parasitized cells. The capture reagent retained the antimalarial properties of the parent molecule (ACT-213615) and accumulated within parasites. We identified several proteins interacting with the capture compound and established a functional interaction between ACT-213615 and PfMDR1. We surmise that PfMDR1 may play a role in the antimalarial activity of the piperazine-containing compound ACT-213615.
C1 [Brunner, Ralf; Brun, Reto; Voss, Till; Wittlin, Sergio] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland.
   [Brunner, Ralf; Brun, Reto; Voss, Till; Wittlin, Sergio] Univ Basel, CH-4003 Basel, Switzerland.
   [Ng, Caroline L.; Fidock, David A.; Mattheis, Corinna] Columbia Univ, Med Ctr, Hammer Hlth Sci Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.
   [Aissaoui, Hamed; Boss, Christoph; Corminboeuf, Olivier; Heidmann, Bibia; Le Bihan, Amelie; Siegrist, Romain; Welford, Richard W. D.; Binkert, Christoph] Actel Pharmaceut Ltd, Drug Discovery Biol, CH-4123 Allschwil, Switzerland.
   [Akabas, Myles H.; Frame, Ithiel J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.
   [Callaghan, Paul S.; Paguio, Michelle; Roepe, Paul D.] Georgetown Univ, Dept Chem Biochem & Cellular & Mol Biol, Washington, DC 20057 USA.
   [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
   [Mueller, Ingrid B.] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
RP Binkert, C (corresponding author), Actel Pharmaceut Ltd, Drug Discovery Biol, CH-4123 Allschwil, Switzerland.
EM christoph.binkert@ext.actelion.com
OI Frame, I.J./0000-0002-7560-7427; Akabas, Myles/0000-0001-8781-7846;
   Fidock, David/0000-0001-6753-8938
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI079709, RO1
   AI056312, T32-GM007288]; Medicines for Malaria Venture; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI056312, R01AI056312, R01AI079709, R01AI056312, R01AI056312,
   R01AI056312, R01AI079709, R01AI056312, R01AI056312, R01AI056312,
   R01AI056312, R01AI056312, R01AI079709, R01AI056312, R01AI079709,
   R01AI056312, R01AI056312, R01AI056312] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288] Funding Source: NIH RePORTER
FX This work was supported in part by National Institutes of Health Grant
   R01 AI079709 (to D. A. F.) and RO1 AI056312 (to P. D. R.). I. J. F. was
   supported in part by National Institutes of Health Grant T32-GM007288.
   This work was also supported by the Medicines for Malaria Venture (to D.
   A. F.). H. Aissaoui, C. Binkert, C. Boss, O. Corminboeuf, B. Heidmann,
   A. Le Bihan, R. Siegrist, and R. Welford are or were Actelion employees.
CR Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845
   Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081
   Brunner R, 2012, J INFECT DIS, V206, P735, DOI 10.1093/infdis/jis418
   Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683
   Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108
   Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f
   DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710
   Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331
   Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859
   Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08
   Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008
   Durdagi S, 2011, CURR MED CHEM, V18, P2601, DOI 10.2174/092986711795933641
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Ferreira PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023875
   Frame IJ, 2012, BIOCHEM J, V446, P179, DOI 10.1042/BJ20112220
   Hofer S, 2008, J ANTIMICROB CHEMOTH, V62, P1061, DOI 10.1093/jac/dkn315
   Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039
   LIBBY PR, 1978, J BIOL CHEM, V253, P233
   Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007
   Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936
   Muller IB, 2010, CELL MICROBIOL, V12, P677, DOI 10.1111/j.1462-5822.2010.01426.x
   Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Pleeter P, 2010, MOL BIOCHEM PARASIT, V173, P158, DOI 10.1016/j.molbiopara.2010.05.012
   Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615
   Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216
   Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225
   Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x
   Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x
   Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301
   Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601
NR 35
TC 10
Z9 10
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 2
PY 2013
VL 288
IS 31
BP 22576
EP 22583
DI 10.1074/jbc.M113.453159
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 302HY
UT WOS:000330596300038
PM 23754276
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Ozonov, EA
   van Nimwegen, E
AF Ozonov, Evgeniy A.
   van Nimwegen, Erik
TI Nucleosome Free Regions in Yeast Promoters Result from Competitive
   Binding of Transcription Factors That Interact with Chromatin Modifiers
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID HIGH-RESOLUTION; ORGANIZATION; POSITIONS; REVEALS; SITES; LANDSCAPE;
   MECHANISM; ELEMENTS; MOTIFS; MODEL
AB Because DNA packaging in nucleosomes modulates its accessibility to transcription factors (TFs), unraveling the causal determinants of nucleosome positioning is of great importance to understanding gene regulation. Although there is evidence that intrinsic sequence specificity contributes to nucleosome positioning, the extent to which other factors contribute to nucleosome positioning is currently highly debated. Here we obtained both in vivo and in vitro reference maps of positions that are either consistently covered or free of nucleosomes across multiple experimental data-sets in Saccharomyces cerevisiae. We then systematically quantified the contribution of TF binding to nucleosome positiong using a rigorous statistical mechanics model in which TFs compete with nucleosomes for binding DNA. Our results reconcile previous seemingly conflicting results on the determinants of nucleosome positioning and provide a quantitative explanation for the difference between in vivo and in vitro positioning. On a genome-wide scale, nucleosome positioning is dominated by the phasing of nucleosome arrays over gene bodies, and their positioning is mainly determined by the intrinsic sequence preferences of nucleosomes. In contrast, larger nucleosome free regions in promoters, which likely have a much more significant impact on gene expression, are determined mainly by TF binding. Interestingly, of the 158 yeast TFs included in our modeling, we find that only 10-20 significantly contribute to inducing nucleosome-free regions, and these TFs are highly enriched for having direct interations with chromatin remodelers. Together our results imply that nucleosome free regions in yeast promoters results from the binding of a specific class of TFs that recruit chromatin remodelers.
C1 [Ozonov, Evgeniy A.] Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Ozonov, EA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
FU SystemsX.ch through the CellPlasticity project
FX Part of the the work presented here was supported by SystemsX.ch through
   the CellPlasticity project. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119
   Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020
   Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018
   BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8
   Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397
   Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054
   Chevereau G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.188103
   Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754
   Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107
   Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216
   Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048
   Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Jansen A, 2011, MICROBIOL MOL BIOL R, V75, P301, DOI 10.1128/MMBR.00046-10
   Jaynes E. T., 2003, PROBABILITY THEORY L
   Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109
   Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806
   Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140
   Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667
   Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011
   KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677
   KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868
   Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867
   Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117
   Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551
   Locke G, 2010, P NATL ACAD SCI USA, V107, P20998, DOI 10.1073/pnas.1003838107
   Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494
   Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108
   Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929
   Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107
   Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891
   Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441
   Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108
   Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022
   Schwab DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228105
   Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979
   Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002
   Shannon C. E., 1948, BELL SYS TECH J, V27
   Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51
   Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888
   Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043
   STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419
   Tolkunov D, 2011, MOL BIOL CELL, V22, P2106, DOI 10.1091/mbc.E10-10-0826
   Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108
   Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730
   Wang X, 2011, TRENDS GENET, V27, P487, DOI 10.1016/j.tig.2011.09.001
   Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109
   Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391
   Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636
   Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508
NR 60
TC 16
Z9 16
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD AUG
PY 2013
VL 9
IS 8
AR e1003181
DI 10.1371/journal.pcbi.1003181
PG 16
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 211DQ
UT WOS:000323885400019
PM 23990766
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schmidt, FI
   Bleck, CKE
   Reh, L
   Novy, K
   Wollscheid, B
   Helenius, A
   Stahlberg, H
   Mercer, J
AF Schmidt, Florian Ingo
   Bleck, Christopher Karl Ernst
   Reh, Lucia
   Novy, Karel
   Wollscheid, Bernd
   Helenius, Ari
   Stahlberg, Henning
   Mercer, Jason
TI Vaccinia Virus Entry Is Followed by Core Activation and
   Proteasome-Mediated Release of the Immunomodulatory Effector VH1 from
   Lateral Bodies
SO CELL REPORTS
LA English
DT Article
ID INTRACELLULAR MATURE VIRIONS; CELL ENTRY; CRYOELECTRON TOMOGRAPHY;
   INTERFERON-GAMMA; POXVIRUS DNA; LATE GENES; PROTEIN; MEMBRANE; FUSION;
   MORPHOGENESIS
AB Host cell entry of vaccinia virus, the prototypic poxvirus, involves a membrane fusion event delivering the viral core and two proteinaceous lateral bodies (LBs) into the cytosol. Uncoating of viral cores is poorly characterized, and the composition and function of LBs remains enigmatic. We found that cytosolic cores rapidly dissociated from LBs and expanded in volume, which coincided with reduction of disulfide-bonded core proteins. We identified the abundant phosphoprotein F17, the dual-specificity phosphatase VH1, and the oxidoreductase G4 as bona fide LB components. After reaching the cytosol, F17 was degraded in a proteasome-dependent manner. Proteasome activity, and presumably LB disassembly, was required for the immediate immunomodulatory activity of VH1: dephosphorylation of STAT1 to prevent interferon-gamma-mediated antiviral responses. These results reveal a mechanism used by poxviruses to deliver viral enzymes to the host cell cytosol and are likely to facilitate the identification of additional LB-resident viral effectors.
C1 [Schmidt, Florian Ingo; Reh, Lucia; Helenius, Ari; Mercer, Jason] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Novy, Karel; Wollscheid, Bernd] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Bleck, Christopher Karl Ernst; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
RP Mercer, J (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
EM jason.mercer@bc.biol.ethz.ch
RI Stahlberg, Henning/H-1868-2011; Schmidt, Florian/H-7372-2012;
   Wollscheid, Bernd/E-8909-2010; Schmidt, Florian Ingo/J-1672-2019
OI Stahlberg, Henning/0000-0002-1185-4592; Schmidt,
   Florian/0000-0002-9979-9769; Wollscheid, Bernd/0000-0002-3923-1610;
   Schmidt, Florian Ingo/0000-0002-9979-9769; Bleck,
   Christopher/0000-0003-1029-3444
FU European Research CouncilEuropean Research Council (ERC); Swiss National
   Foundation: SystemsX CINA; Swiss National Foundation: InfectX; Swiss
   National Foundation: AmbizioneSwiss National Science Foundation (SNSF);
   Swiss National Foundation: Sinergia
FX We thank Paula Traktman for helpful discussions, Daniel Castano-Diez for
   help with Dynamo software, Mirko Sobotta for help with redox 2D
   SDS-PAGE, and Kenneth N. Goldie and Samuel N. Kilcher for critical
   reading of the manuscript. This work was in part funded by grants from
   the European Research Council (to A.H.) and the Swiss National
   Foundation: SystemsX CINA (to C.K.E.B. and H.S.) and InfectX (to A.H.),
   Ambizione (to J.M.), and Sinergia (to H.S.). F.I.S., A.H., and J.M.
   conceived the study; F.I.S., C.K.E.B., L.R, and K.N. designed and
   carried out the experiments; F.I.S., C.K.E.B., and J.M. analyzed the
   data; B.W. and H.S. gave technical support; and F.I.S., C.K.E.B., A.H.,
   and J.M. wrote the paper.
CR BANHAM AH, 1992, VIROLOGY, V191, P803, DOI 10.1016/0042-6822(92)90256-O
   Bengali Z, 2012, VIROLOGY, V433, P506, DOI 10.1016/j.virol.2012.08.044
   Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x
   Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017
   CHANG A, 1976, J GEN VIROL, V32, P275, DOI 10.1099/0022-1317-32-2-275
   Chang SJ, 2010, J VIROL, V84, P8422, DOI 10.1128/JVI.00599-10
   Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006
   Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8
   Cyrklaff M, 2005, P NATL ACAD SCI USA, V102, P2772, DOI 10.1073/pnas.0409825102
   Cyrklaff M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000420
   DALES S, 1963, J CELL BIOL, V18, P51, DOI 10.1083/jcb.18.1.51
   DAMON IK, 2007, FIELDS VIROLOGY, P2947
   Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999
   EASTERBROOK KB, 1966, J ULTRA MOL STRUCT R, V14, P484, DOI 10.1016/S0022-5320(66)80077-1
   GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z
   Griffiths G., 1993, FINE STRUCTURE IMMUN
   Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999
   HUANG C, 1988, J VIROL, V62, P3855, DOI 10.1128/JVI.62.10.3855-3861.1988
   Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08
   ICHIHASHI Y, 1984, J VIROL, V50, P929, DOI 10.1128/JVI.50.3.929-938.1984
   Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009
   JOKLIK WK, 1964, J MOL BIOL, V8, P263, DOI 10.1016/S0022-2836(64)80136-4
   JOKLIK WK, 1964, J MOL BIOL, V8, P277, DOI 10.1016/S0022-2836(64)80137-6
   KAO SY, 1987, VIROLOGY, V159, P399, DOI 10.1016/0042-6822(87)90479-X
   KAO SY, 1981, VIROLOGY, V111, P500, DOI 10.1016/0042-6822(81)90352-4
   Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357
   Laliberte JP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002446
   Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103
   Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4
   LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995
   Locker JK, 1999, J CELL BIOL, V144, P267, DOI 10.1083/jcb.144.2.267
   MACCALLUM F O, 1957, Bull World Health Organ, V16, P441
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mann BA, 2008, J INTERF CYTOK RES, V28, P367, DOI 10.1089/jir.2007.0113
   MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9
   Mercer J, 2005, J VIROL, V79, P7146, DOI 10.1128/JVI.79.11.7146-7161.2005
   Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003
   Moss B, 2012, VIRUSES-BASEL, V4, P688, DOI 10.3390/v4050688
   MUNYON W, 1967, P NATL ACAD SCI USA, V58, P2280, DOI 10.1073/pnas.58.6.2280
   Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000
   Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986
   SAROV I, 1972, VIROLOGY, V50, P579, DOI 10.1016/0042-6822(72)90409-6
   Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08
   SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037
   Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007
   Schmidt FI, 2011, EMBO J, V30, P3647, DOI 10.1038/emboj.2011.245
   Schulz K. R., 2012, CURR PROTOC IMMUNOL
   Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102
   Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799
   Senkevich TG, 2000, VIROLOGY, V278, P244, DOI 10.1006/viro.2000.0656
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004
   SOMMER A, 1974, P NATL ACAD SCI USA, V71, P3946, DOI 10.1073/pnas.71.10.3946
   Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08
   Terajima M, 2005, VIRAL IMMUNOL, V18, P722, DOI 10.1089/vim.2005.18.722
   TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   Traktman P, 2000, J VIROL, V74, P3682, DOI 10.1128/JVI.74.8.3682-3695.2000
   Trilling M, 2009, J VIROL, V83, P3684, DOI 10.1128/JVI.02042-08
   White CL, 2000, J VIROL, V74, P9175, DOI 10.1128/JVI.74.19.9175-9183.2000
   White CL, 2002, J VIROL, V76, P467, DOI 10.1128/JVI.76.2.467-472.2002
   Wickramasekera NT, 2010, J VIROL, V84, P6846, DOI 10.1128/JVI.00399-10
   WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378
   YANG WP, 1988, VIROLOGY, V167, P585, DOI 10.1016/0042-6822(88)90121-3
   Yang ZL, 2009, J VIROL, V83, P12018, DOI 10.1128/JVI.01653-09
NR 67
TC 42
Z9 42
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD AUG
PY 2013
VL 4
IS 3
BP 464
EP 476
DI 10.1016/j.celrep.2013.06.028
PG 13
WC Cell Biology
SC Cell Biology
GA 206SH
UT WOS:000323542200008
PM 23891003
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Dietrich, FS
   Voegeli, S
   Kuo, S
   Philippsen, P
AF Dietrich, Fred S.
   Voegeli, Sylvia
   Kuo, Sidney
   Philippsen, Peter
TI Genomes of Ashbya Fungi Isolated from Insects Reveal Four Mating-Type
   Loci, Numerous Translocations, Lack of Transposons, and Distinct Gene
   Duplications
SO G3-GENES GENOMES GENETICS
LA English
DT Article
DE fungal ecology; tandem duplications; intron evolution; mating type
ID YEAST-SPOT DISEASE; CYTOPLASMIC MICROTUBULES; GOSSYPII REVEALS;
   EVOLUTION; HYPHAE; CELL; ALIGNMENT; PROTEINS; GROWTH; IDENTIFICATION
AB The filamentous fungus Ashbya gossypii is a cotton pathogen transmitted by insects. It is readily grown and manipulated in the laboratory and is commercially exploited as a natural overproducer of vitamin B2. Our previous genome analysis of A. gossypii isolate ATCC10895, collected in Trinidad nearly 100 years ago, revealed extensive synteny with the Saccharomyces cerevisiae genome, leading us to use it as a model organism to understand the evolution of filamentous growth. To further develop Ashbya as a model system, we have investigated the ecological niche of A. gossypii and isolated additional strains and a sibling species, both useful in comparative analysis. We isolated fungi morphologically similar to A. gossypii from different plant-feeding insects of the suborder Heteroptera, generated a phylogenetic tree based on rDNA-ITS sequences, and performed high coverage short read sequencing with one A. gossypii isolate from Florida, a new species, Ashbya aceri, isolated in North Carolina, and a genetically marked derivative of ATCC10895 intensively used for functional studies. In contrast to S. cerevisiae, all strains carry four not three mating type loci, adding a new puzzle in the evolution of Ashbya species. Another surprise was the genome identity of 99.9% between the Florida strain and ATCC10895, isolated in Trinidad. The A. aceri and A. gossypii genomes show conserved gene orders rearranged by eight translocations, 90% overall sequence identity, and fewer tandem duplications in the A. aceri genome. Both species lack transposable elements. Finally, our work identifies plant-feeding insects of the suborder Heteroptera as the most likely natural reservoir of Ashbya, and that infection of cotton and other plants may be incidental to the growth of the fungus in its insect host.
C1 [Dietrich, Fred S.; Kuo, Sidney] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA.
   [Dietrich, Fred S.; Kuo, Sidney] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [Voegeli, Sylvia; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dietrich, FS (corresponding author), 289 CARL Bldg,Res Dr, Durham, NC 27710 USA.
EM fred.dietrich@duke.edu
FU University of Basel; Duke University
FX We acknowledge the assistance of Jennifer, Jane, and Riley Tenor in the
   collection of insects for this project. This work was supported by
   funding from the University of Basel (to P.P.) and Duke University (to
   F.S.D.).
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Ashby S. F., 1916, ANN REPORT MICROBIOL, P29
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Astrom SU, 2000, GENETICS, V156, P81
   Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153
   Batra L. R., 1973, USDA TECHNICAL B, V1469
   Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009
   Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   BURGESS L, 1983, CAN ENTOMOL, V115, P25, DOI 10.4039/Ent11525-1
   BURGESS L, 1986, CAN ENTOMOL, V118, P1059, DOI 10.4039/Ent1181059-10
   BURGESS L, 1991, CAN PLANT DIS SURV, V71, P37
   Cashman JR, 1996, ENVIRON HEALTH PERSP, V104, P23, DOI 10.2307/3432694
   CLARKE RG, 1970, J ECON ENTOMOL, V63, P355, DOI 10.1093/jee/63.2.355
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579
   EVERIST SL, 1981, POISONOUS PLANTS AUS
   Farries EHM, 1930, ANN BOT-LONDON, V44, P423, DOI 10.1093/oxfordjournals.aob.a090228
   FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X
   Finlayson MR, 2011, MOL BIOL CELL, V22, P3081, DOI 10.1091/mbc.E10-12-1006
   Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400
   FOSTER JE, 1969, J ECON ENTOMOL, V62, P424, DOI 10.1093/jee/62.2.424
   Frazer HL, 1944, ANN APPL BIOL, V31, P271, DOI 10.1111/j.1744-7348.1944.tb06738.x
   Gibeaux R, 2013, GENE DEV, V27, P335, DOI 10.1101/gad.206318.112
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485
   Grava S, 2010, MOL BIOL CELL, V21, P3680, DOI 10.1091/mbc.E10-06-0527
   Grunler A, 2010, FUNGAL GENET BIOL, V47, P619, DOI 10.1016/j.fgb.2010.04.001
   GUILLIERMOND A., 1928, REV GEN BOT, V40, P328
   Guilliermond A, 1928, REV GEN BOT, V40, P397
   Guilliermond A, 1928, REV GEN BOT, V40, P555
   Guilliermond A, 1928, REV GEN BOT, V40, P606
   Guilliermond A, 1928, REV GEN BOT, V40, P690
   Guilliermond A, 1928, REV GEN BOT, V40, P474
   Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271
   Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338
   Jorde S, 2011, MICROBIOL RES, V166, P137, DOI 10.1016/j.micres.2010.09.003
   Kato T, 2012, BIOTECHNOL LETT, V34, P611, DOI 10.1007/s10529-011-0833-z
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x
   Knechtle P, 2006, EUKARYOT CELL, V5, P1635, DOI 10.1128/EC.00210-06
   Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   LAI CY, 1992, GENE, V113, P175, DOI 10.1016/0378-1119(92)90393-4
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Langel D, 2011, PHYTOCHEMISTRY, V72, P1576, DOI 10.1016/j.phytochem.2010.12.014
   Lewis W. H., 1986, MED BOT PLANTS AFFEC
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426
   Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166
   Maruyama R, 2002, J BIOTECHNOL, V94, P157, DOI 10.1016/S0168-1656(01)00426-6
   MIRANDA CL, 1991, BIOCHEM BIOPH RES CO, V178, P546, DOI 10.1016/0006-291X(91)90142-T
   Nair DR, 2010, CELL CYCLE, V9, P3771, DOI 10.4161/cc.9.18.12999
   NOWELL W, 1916, Agric. News, V15, P126
   Nowell W, 1915, AGR NEWS BARBADOS, V14, P234
   Nowell W., 1915, AGR NEWS BARBADOS, V14, p[238, 222, 234]
   Nowell W, 1916, AGR NEWS BARBADOS, V15, P182
   Nowell W, 1916, AGR NEWS BARBADOS, V15, P214
   Nowell W, 1915, NEWS, V14, P238
   PEARSON E. 0, 1934, BULL ENT RES, V25, P383, DOI 10.1017/S000748530001275X
   Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   ROBBINS WILLIAM J., 1939, BULL TORREY BOT CLUB, V66, P139, DOI 10.2307/2481224
   Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547
   Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104
   Schmitz HP, 2011, FUNGAL BIOL-UK, V115, P557, DOI 10.1016/j.funbio.2011.02.015
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sehlmeyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010435
   Seret ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-459
   SHERMAN F, 1987, METHODS YEAST GENETI
   Slater J.A., 1982, P417
   Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109
   Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649
   Stajich JE, 2006, EUKARYOT CELL, V5, P789, DOI 10.1128/EC.5.5.789-793.2006
   Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602
   STEINER S, 1995, GENETICS, V140, P973
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000
   Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2011, G3-GENES GENOM GENET, V1, P539, DOI 10.1534/g3.111.001032
   WILLIAMS C. B., 1934, EMPIRE COTTON GROWING REV, V11, P99
   Wong S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r10
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 91
TC 22
Z9 949
U1 0
U2 46
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 2160-1836
J9 G3-GENES GENOM GENET
JI G3-Genes Genomes Genet.
PD AUG 1
PY 2013
VL 3
IS 8
BP 1225
EP 1239
DI 10.1534/g3.112.002881
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA 197BJ
UT WOS:000322822300006
PM 23749448
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Bonkat, G
   Wirz, D
   Rieken, M
   Gasser, TC
   Bachmann, A
   Braissant, O
AF Bonkat, G.
   Wirz, D.
   Rieken, M.
   Gasser, T. C.
   Bachmann, A.
   Braissant, O.
TI Areas of application of isothermal microcalorimetry in urology. An
   overview
SO UROLOGE
LA German
DT Review
DE Heat flow curves; Tumours, urogenital; Urinary tract infection; Urinary
   tract pathogens
ID TRACT
AB Isothermal microcalorimetry (IMC) is a nonspecific analytical tool for measurement of heat. With sensitivity in the order of 0.2 mu W, IMC can detect very small amounts of heat produced by only a small number of microorganisms or eukaryotic cells. This report is intended to introduce IMC to the urological audience and to give an overview about the past, present and future of this cutting edge technology in the urological context.
C1 [Bonkat, G.; Rieken, M.; Gasser, T. C.; Bachmann, A.; Braissant, O.] Urol Univ Klin Basel Liestal, CH-4031 Basel, Switzerland.
   [Bonkat, G.; Wirz, D.; Braissant, O.] Univ Basel, BCCB, Biozentrum Pharmazentrum, Basel, Switzerland.
RP Bonkat, G (corresponding author), Urol Univ Klin Basel Liestal, Spitalstr 21, CH-4031 Basel, Switzerland.
EM bonkatg@uhbs.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Baldoni D, 2010, ANTIMICROB AGENTS CH, V54, P157, DOI 10.1128/AAC.00700-09
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   Beezer A. E., 1974, SCI TOOLS, V21, P13
   Beezer A. E., 1978, SCI TOOLS, V25, P2510
   Bonkat G, 2012, WORLD J UROL
   Bonkat G, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.04.050
   Bonkat G, 2012, BJU INT, V110, P892, DOI 10.1111/j.1464-410X.2011.10902.x
   Braissant O, 2011, METHODS MOL BIOL, V740, P191, DOI 10.1007/978-1-61779-108-6_20
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   Buchholz F, 2010, ANTIMICROB AGENTS CH, V54, P312, DOI 10.1128/AAC.00583-09
   Figueiredo AA, 2008, INT J UROL, V15, P827, DOI 10.1111/j.1442-2042.2008.02099.x
   Furustrand U, 2011, MYCOSES, V54, P168
   Hemmiger W, 1986, PHYS UNSERER ZEIT, V17, P11
   Herwaarden S van, 2000, CALORIMETRY MEASUREM
   Kallerhoff M, 1996, UROL RES, V24, P83, DOI 10.1007/BF00431084
   KARNEBOGEN M, 1993, THERMOCHIM ACTA, V229, P147, DOI 10.1016/0040-6031(93)80322-2
   Lavoisier A, 1780, MEMOIRES ACAD SCI, P355
   Maiolo E, 2011, MYCOSES, V54, P171
   Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243
   Segal R, 2012, BJU INT, V109, P1026, DOI 10.1111/j.1464-410X.2011.10462.x
   Tafin UF, 2012, CLIN MICROBIOL INFEC, V18, pE241, DOI 10.1111/j.1469-0691.2012.03854.x
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wadso I, 1997, CHEM SOC REV, V26, P79, DOI 10.1039/cs9972600079
   Wadso I, 2012, PURE APPL CHEM, V73, P1625
   Wadso L, 2001, J CHEM EDUC, V78, P1080
   Wadso L, 2009, FOOD CONTROL, V20, P956, DOI 10.1016/j.foodcont.2008.11.008
   Wenzler T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001668
NR 29
TC 2
Z9 2
U1 0
U2 16
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-2592
EI 1433-0563
J9 UROLOGE
JI Urologe
PD AUG
PY 2013
VL 52
IS 8
BP 1092
EP 1096
DI 10.1007/s00120-013-3169-6
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 202NY
UT WOS:000323225600010
PM 23699913
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, Michael N.
TI On mTOR nomenclature
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE cell growth; mammalian target of rapamycin (mTOR); nomenclature;
   rapamycin; regulatory associated protein of mammalian target of
   rapamycin (raptor); signalling
ID MAMMALIAN PROTEIN; RAPAMYCIN; YEAST; COMPLEX; TOR; CYTOSKELETON;
   HOMOLOG; TARGET; FKBP12
AB In the present article, I discuss recent developments in the naming of the TOR (target of rapamycin) protein. In particular, I address the issue of mammalian target of rapamycin (mTOR) versus the newer mechanistic target of rapamycin (MTOR). mTOR is the name given by the TOR community almost two decades ago and widely used ever since. MTOR is a name recently imposed on the TOR community by database curators and used mainly by newcomers. I argue that MTOR is causing needless confusion in the field, and conclude that one should use the name mTOR.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
CR BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 9
TC 16
Z9 17
U1 0
U2 2
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD AUG
PY 2013
VL 41
BP 887
EP 888
DI 10.1042/BST20130092
PN 4
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 193LU
UT WOS:000322562100014
PM 23863150
DA 2021-01-25
ER

PT J
AU Sauer, E
   Imseng, S
   Maier, T
   Hall, MN
AF Sauer, Evelyn
   Imseng, Stefan
   Maier, Timm
   Hall, Michael N.
TI Conserved sequence motifs and the structure of the mTOR kinase domain
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE mammalian target of rapamycin (mTOR)
ID PROTEIN-KINASES; BINDING PARTNER; GROWTH-CONTROL; RAPTOR;
   PHOSPHORYLATION; ACTIVATION; ALIGNMENT; TARGET; IDENTIFICATION;
   MECHANISMS
AB The atypical serine/threonine kinase mTOR (mammalian target of rapamycin) is a central regulator of cell growth and metabolism. mTOR is part of two multisubunit signalling complexes, mTORC1 and mTORC2. Although many aspects of mTOR signalling are understood, the lack of high-resolution structures impairs a detailed understanding of complex assembly, function and regulation. The structure of the kinase domain is of special interest for the development of mTOR inhibitors as anti-cancer agents. A homology model of the mTOR kinase domain was derived from the structure of PI3Ks (phosphoinositide 3-kinases). More recently, the crystal structure of the catalytic domain of human mTOR was determined, providing long-awaited structural insight into the architecture of mTOR. Interestingly, the homology model predicted several aspects of the crystal structure. In the present paper, we revisit the homology model in the context of the now available crystal structure of the mTOR kinase domain.
C1 [Sauer, Evelyn; Imseng, Stefan; Maier, Timm; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Maier, Timm/A-8835-2016
OI Maier, Timm/0000-0002-7459-1363
FU People Program (Marie Curie Actions, European Union Framework Programme
   7) [REA] [328159]; Louis Jeantet Foundation; Canton of Basel; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX E.S. receives funding from the People Program (Marie Curie Actions,
   European Union Framework Programme 7 2007-2013) [REA grant agreement
   number 328159]. T.M. and M.N.H. acknowledge support from the Louis
   Jeantet Foundation, the Canton of Basel and the Swiss National Science
   Foundation.
CR Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w
   Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392
   Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   HANKS SK, 1995, FASEB J, V9, P576
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771
   Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136
   Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200
   John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281
   Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762
   Nowak P, 2009, J MED CHEM, V52, P7081, DOI 10.1021/jm9012642
   Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3
   Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4
   Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5
   Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e
   Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 42
TC 8
Z9 8
U1 2
U2 19
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD AUG
PY 2013
VL 41
BP 889
EP 895
DI 10.1042/BST20130113
PN 4
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 193LU
UT WOS:000322562100015
PM 23863151
DA 2021-01-25
ER

PT J
AU Saldivia, M
   Barquilla, A
   Bart, JM
   Diaz-Gonzalez, R
   Hall, MN
   Navarro, M
AF Saldivia, Manuel
   Barquilla, Antonio
   Bart, Jean-Mathieu
   Diaz-Gonzalez, Rosario
   Hall, Michael N.
   Navarro, Miguel
TI Target of rapamycin (TOR) kinase in Trypanosoma brucei: an extended
   family
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE differentiation; quiescence; rapamycin; target of rapamycin complex 4
   (TORC4); trypanosome
ID CELL-GROWTH; DIFFERENTIATION; MTOR; AUTOPHAGY; PATHWAY; EXPRESSION;
   BIOLOGY
AB The complex life cycle of Trypanosoma brucei provides an excellent model system to understand signalling pathways that regulate development. We described previously the classical functions of TOR (target of rapamycin) 1 and TOR2 in T. brucei. In a more recent study, we described a novel TOR kinase, named TOR4, which regulates differentiation from the proliferative infective form to the quiescent form. In contrast with TOR1 loss-of-function, down-regulation of TOR4 triggers an irreversible differentiation process through the development of the insect pre-adapted quiescent form. TOR4 governs a signalling pathway distinct from those controlled by the conventional TOR complexes TORC1 and TORC2. Depletion of TOR4 induces all well-known characteristics of the quiescent developmental stage in trypanosomes, including expression of the PAD (proteins associated with differentiation) surface proteins and transcriptional down-regulation of the VSG (variant surface glycoprotein) gene. TOR4 kinase forms a structurally and functionally distinct complex named TORC4. TOR4 associates with LST8 (lethal with sec-13 protein 8) and other factors including an armadillo-domain-containing protein and the major vault protein, which probably serves as a scaffold for this kinase. Research in T. brucei, a protozoan parasite that diverged from the eukaryotic tree early in evolution, may help to uncover new functions of TOR kinases.
C1 [Saldivia, Manuel; Barquilla, Antonio; Bart, Jean-Mathieu; Diaz-Gonzalez, Rosario; Navarro, Miguel] IPBLN, Consejo Super Invest Cient, Granada 18100, Spain.
   [Bart, Jean-Mathieu] ISCIII, Ctr Nacl Med Trop, Madrid 28019, Spain.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Navarro, M (corresponding author), IPBLN, Consejo Super Invest Cient, Granada 18100, Spain.
EM miguel.navarro@ipb.csic.es
RI Bart, Jean-Mathieu/N-2598-2014; Navarro, Miguel/C-3685-2009
OI Bart, Jean-Mathieu/0000-0001-5707-3778; Navarro,
   Miguel/0000-0003-2301-2699; Diaz Gonzalez, Rosario/0000-0002-3187-2704;
   Saldivia, Manuel/0000-0001-6204-0460
FU Miguel Servet fellowship [CP09/00300]; Spanish Ministerio de Ciencia e
   Innovacion, Plan Nacional [SAF2012-40029]; Junta de AndaluciaJunta de
   Andalucia [CTS-5841]; Red de Investigacion Cooperativa en Enfermedades
   Tropicales (RICET) [RD06/0001/0010]
FX J.-M.B. is supported by a Miguel Servet fellowship [grant number
   CP09/00300]. This work was supported by the Spanish Ministerio de
   Ciencia e Innovacion, Plan Nacional [grant number SAF2012-40029], Junta
   de Andalucia [grant number CTS-5841] and Red de Investigacion
   Cooperativa en Enfermedades Tropicales (RICET) [grant number
   RD06/0001/0010].
CR Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002
   Aksoy S, 2003, ADV PARASIT, V53, P1, DOI 10.1016/S0065-308X(03)53002-0
   Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Barquilla A, 2012, P NATL ACAD SCI USA, V109, P14399, DOI 10.1073/pnas.1210465109
   Barquilla A, 2009, AUTOPHAGY, V5, P256, DOI 10.4161/auto.5.2.7591
   Barquilla A, 2009, CELL CYCLE, V8, P697, DOI 10.4161/cc.8.5.7808
   Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200
   da Silva LM, 2010, P NATL ACAD SCI USA, V107, P11965, DOI 10.1073/pnas.1004599107
   Diaz-Gonzalez R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001297
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310
   Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310
   Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014
   Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018
   Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443
   Hong S. M., CLIN EXP METASTASIS, V30, P177
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   de Jesus TCL, 2010, J BIOL CHEM, V285, P24131, DOI 10.1074/jbc.M110.120212
   Lippman SI, 2010, ENZYMES, V28, P317, DOI 10.1016/S1874-6047(10)28016-2
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Markman B, 2010, ONCOTARGET, V1, P530, DOI 10.18632/oncotarget.188
   Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019
   Miranda-Saavedra D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-309
   Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a
   Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586
   Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127
   Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510
   Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9
   WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x
NR 40
TC 13
Z9 13
U1 0
U2 22
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0300-5127
EI 1470-8752
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD AUG
PY 2013
VL 41
BP 934
EP 938
DI 10.1042/BST20130052
PN 4
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 193LU
UT WOS:000322562100023
PM 23863159
DA 2021-01-25
ER

PT J
AU Ben-Tekaya, H
   Gorvel, JP
   Dehio, C
AF Ben-Tekaya, Houchaima
   Gorvel, Jean-Pierre
   Dehio, Christoph
TI Bartonella and Brucella-Weapons and Strategies for Stealth Attack
SO COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
LA English
DT Article
ID IV SECRETION SYSTEMS; INTRACELLULAR LIFE-STYLE; HUMAN ENDOTHELIAL-CELLS;
   TOLL-LIKE-RECEPTOR; MEMBRANE AUTOTRANSPORTER PROTEIN;
   AGROBACTERIUM-TUMEFACIENS VIRB; MARINE MAMMAL BRUCELLA; CELLULAR PRION
   PROTEIN; CAT-SCRATCH DISEASE; ABORTUS LIPOPOLYSACCHARIDE
AB Bartonella spp. and Brucella spp. are closely related alpha-proteobacterial pathogens that by distinct stealth-attack strategies cause chronic infections in mammals including humans. Human infections manifest by a broad spectrum of clinical symptoms, ranging from mild to fatal disease. Both pathogens establish intracellular replication niches and subvert diverse pathways of the host's immune system. Several virulence factors allow them to adhere to, invade, proliferate, and persist within various host-cell types. In particular, type IV secretion systems (T4SS) represent essential virulence factors that transfer effector proteins tailored to recruit host components and modulate cellular processes to the benefit of the bacterial intruders. This article puts the remarkable features of these two pathogens into perspective, highlighting the mechanisms they use to hijack signaling and trafficking pathways of the host as the basis for their stealthy infection strategies.
C1 [Ben-Tekaya, Houchaima; Dehio, Christoph] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4052 Basel, Switzerland.
   [Gorvel, Jean-Pierre] Aix Marseille Univ, Fac Sci Luminy, Ctr Immunol Marseille Luminy, UM 2, Marseille, France.
   [Gorvel, Jean-Pierre] INSERM, U 1104, F-13258 Marseille, France.
   [Gorvel, Jean-Pierre] CNRS, UMR 7280, Marseille, France.
RP Dehio, C (corresponding author), Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4052 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Gorvel, Jean-Pierre/O-1332-2018; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016
OI Gorvel, Jean-Pierre/0000-0002-2829-9804; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052
FU Swiss National Sciences FoundationSwiss National Science Foundation
   (SNSF) [31003A-132979]; SystemX.ch [51RT-0-126008]; Fondation Recherche
   Medicale, FRMFondation pour la Recherche Medicale
FX We thank Dr. Philipp Engel for providing the phylogenetic tree of Figure
   1. This study is supported by grant 31003A-132979 from the Swiss
   National Sciences Foundation and grant 51RT-0-126008 from SystemX.ch (to
   C.D.) and by The Fondation Recherche Medicale, FRM (to J.-P.G.).
CR Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102
   ANDERSON TD, 1986, VET PATHOL, V23, P219, DOI 10.1177/030098588602300301
   Andersson SGE, 2004, INT J MED MICROBIOL, V293, P463, DOI 10.1078/1438-4221-00304
   Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202
   Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000
   Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317
   Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008
   Bandara AB, 2005, VET MICROBIOL, V109, P95, DOI 10.1016/j.vetmic.2005.05.012
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994
   Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x
   Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299
   Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381
   Byam W, 1920, Proc R Soc Med, V13, P1
   Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010
   Castaneda-Roldan EI, 2006, CELL MICROBIOL, V8, P1877, DOI 10.1111/j.1462-5822.2006.00754.x
   Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102
   Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088
   Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8
   Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104
   Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734
   Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x
   Conde-Alvarez R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002675
   Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219
   COTELL SL, 1994, ARCH INTERN MED, V154, P524, DOI 10.1001/archinte.154.5.524
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003
   Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   de Barsy M, 2012, MICROBIOL-SGM, V158, P2610, DOI 10.1099/mic.0.060509-0
   de Barsy M, 2011, CELL MICROBIOL, V13, P1044, DOI 10.1111/j.1462-5822.2011.01601.x
   de Jong MF, 2012, FUTURE MICROBIOL, V7, P47, DOI [10.2217/FMB.11.136, 10.2217/fmb.11.136]
   de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Dehio C, 2012, FEMS MICROBIOL REV, V36, P513, DOI 10.1111/j.1574-6976.2012.00336.x
   Delpino AV, 2006, MICROBES INFECT, V8, P1203, DOI 10.1016/j.micinf.2005.11.008
   Deng HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041447
   Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475
   Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x
   Engel P, 2009, GENOME DYNAM, V6, P158, DOI 10.1159/000235769
   Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Eskra L, 2003, INFECT IMMUN, V71, P1125, DOI 10.1128/IAI.71.3.1125-1133.2003
   Ficht TA, 2003, VET MICROBIOL, V92, P213, DOI 10.1016/S0378-1135(02)00367-X
   Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608
   Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202
   Forestier C, 1999, INFECT IMMUN, V67, P4048, DOI 10.1128/IAI.67.8.4048-4054.1999
   Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0
   Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08
   Franco MP, 2007, T ROY SOC TROP MED H, V101, P854, DOI 10.1016/j.trstmh.2007.05.016
   Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4
   Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x
   Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487
   Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11
   Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000
   Guzman-Verri C, 2001, J BIOL CHEM, V276, P44435, DOI 10.1074/jbc.M105606200
   Haag AF, 2010, INT J MICROBIOL, V2010, DOI DOI 10.1155/2010/124509
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05
   HIGNETT PG, 1966, VET REC, V79, P886, DOI 10.1136/vr.79.27.886
   HILL EM, 1992, INFECT IMMUN, V60, P4051, DOI 10.1128/IAI.60.10.4051-4058.1992
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Hwang HH, 2004, PLANT CELL, V16, P3148, DOI 10.1105/tpc.104.026476
   Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x
   Iriarte M, 2004, BRUCELLA MOL CELLULA, P152
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Khan MY, 2001, CLIN INFECT DIS, V32, P1172, DOI 10.1086/319758
   Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Kirov SM, 2003, FEMS MICROBIOL LETT, V224, P151, DOI 10.1016/S0378-1097(03)00445-2
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   KOSTIANOVSKY M, 1994, ULTRASTRUCT PATHOL, V18, P349, DOI 10.3109/01913129409023203
   Kunz S, 2008, AM J PATHOL, V172, P1005, DOI 10.2353/ajpath.2008.070591
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Lacerda TLS, 2013, CURR OPIN MICROBIOL, V16, P45, DOI 10.1016/j.mib.2012.11.005
   Lamps Laura W, 2004, Am J Clin Pathol, V121 Suppl, pS71
   Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x
   Lavigne JP, 2005, INFECT IMMUN, V73, P5524, DOI 10.1128/IAI.73.9.5524-5529.2005
   Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005
   Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x
   Lu YY, 2013, CELL MICROBIOL, V15, P759, DOI 10.1111/cmi.12070
   Maguina C, 2001, CLIN INFECT DIS, V33, P772, DOI 10.1086/322614
   Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006
   Manders SM, 1996, CLIN DERMATOL, V14, P295, DOI 10.1016/0738-081X(96)00015-6
   Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103
   Marignac G, 2010, COMP IMMUNOL MICROB, V33, P95, DOI 10.1016/j.cimid.2008.07.011
   Martinez-Nunez C, 2010, J BACTERIOL, V192, P5603, DOI 10.1128/JB.00567-10
   Martirosyan A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002983
   Matera G, 2003, INT IMMUNOPHARMACOL, V3, P853, DOI 10.1016/S1567-5769(03)00059-6
   Matera G, 2008, EUR CYTOKINE NETW, V19, P113, DOI 10.1684/ecn.2008.0128
   McCord AM, 2006, INFECT IMMUN, V74, P5185, DOI 10.1128/IAI.00622-06
   Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551
   MERNAUGH G, 1992, INFECT IMMUN, V60, P937, DOI 10.1128/IAI.60.3.937-943.1992
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   MORENO E, 1981, INFECT IMMUN, V31, P214, DOI 10.1128/IAI.31.1.214-222.1981
   Moreno E., 2004, Brucella: molecular and cellular biology, P287
   Moreno E, 2002, VET MICROBIOL, V90, P209, DOI 10.1016/S0378-1135(02)00210-9
   Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   Nakato G, 2012, J IMMUNOL, V189, P1540, DOI 10.4049/jimmunol.1103332
   O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x
   O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4
   Ohl ME, 2000, CLIN INFECT DIS, V31, P131, DOI 10.1086/313890
   Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581
   Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6
   Pappas G, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/j.ijantimicag.2010.06.013
   Parrow NL, 2009, INFECT IMMUN, V77, P307, DOI 10.1128/IAI.01194-08
   Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099
   Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711
   Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07
   Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999
   Posadas DM, 2012, CELL MICROBIOL, V14, P965, DOI 10.1111/j.1462-5822.2012.01771.x
   Pulliainen AT, 2012, P NATL ACAD SCI USA, V109, P9581, DOI 10.1073/pnas.1117651109
   Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577
   Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200
   Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002
   RASOOL O, 1992, INFECT IMMUN, V60, P1699, DOI 10.1128/IAI.60.4.1699-1702.1992
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   RICKETTS WE, 1948, BLOOD, V3, P1025, DOI 10.1182/blood.V3.9.1025.1025
   Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278
   Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8
   Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x
   Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003
   Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Salcedo SP, 2013, J INFECT DIS, V207, P1075, DOI 10.1093/infdis/jit007
   SAMARTINO LE, 1993, COMP IMMUNOL MICROB, V16, P95, DOI 10.1016/0147-9571(93)90001-L
   Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0
   Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06
   Schwartzman W, 1996, ANNU REV MED, V47, P355, DOI 10.1146/annurev.med.47.1.355
   Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004
   Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000
   Silva TMA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/518323
   Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576
   Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x
   Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002
   Tiller RV, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-23
   Tolomeo M, 2003, CLIN INFECT DIS, V36, P1533, DOI 10.1086/375223
   Truttmann MC, 2011, J CELL SCI, V124, P3591, DOI 10.1242/jcs.084459
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005
   Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599
   Ugalde RA, 1999, MICROBES INFECT, V1, P1211, DOI 10.1016/S1286-4579(99)00240-3
   van Ulsen P, 2011, ADV EXP MED BIOL, V715, P125, DOI 10.1007/978-94-007-0940-9_8
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Velho Paulo Eduardo Neves Ferreira, 2003, Braz J Infect Dis, V7, P01, DOI 10.1590/S1413-86702003000100001
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342
   Viadas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010216
   von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x
   WALKER TS, 1981, INFECT IMMUN, V31, P480, DOI 10.1128/IAI.31.1.480-486.1981
   Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x
   Watanabe K, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-95
   Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x
   Watarai MH, 2003, J EXP MED, V198, P5, DOI 10.1084/jem.20021980
   Wattam AR, 2009, J BACTERIOL, V191, P3569, DOI 10.1128/JB.01767-08
   Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829
   Williams-Bouyer NM, 1999, FEMS MICROBIOL LETT, V171, P191, DOI 10.1111/j.1574-6968.1999.tb13432.x
   Young EJ, 2005, PRINCIPLES PRACTICE, V2, P2669
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zygmunt MS, 2006, MICROBES INFECT, V8, P2849, DOI 10.1016/j.micinf.2006.09.002
NR 204
TC 16
Z9 16
U1 0
U2 13
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 2157-1422
J9 CSH PERSPECT MED
JI Cold Spring Harb. Perspect. Med.
PD AUG
PY 2013
VL 3
IS 8
AR a010231
DI 10.1101/cshperspect.a010231
PG 19
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 211WB
UT WOS:000323941200006
PM 23906880
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Easton, AC
   Lourdusamy, A
   Loth, E
   Torro, R
   Giese, KP
   Kornhuber, J
   de Quervain, DJF
   Papassotiropoulos, A
   Fernandes, C
   Muller, CP
   Schumann, G
AF Easton, A. C.
   Lourdusamy, A.
   Loth, E.
   Torro, R.
   Giese, K. P.
   Kornhuber, J.
   de Quervain, D. J-F
   Papassotiropoulos, A.
   Fernandes, C.
   Mueller, C. P.
   Schumann, G.
CA IMAGEN Consortium
TI CAMK2A polymorphisms predict working memory performance in humans
SO MOLECULAR PSYCHIATRY
LA English
DT Editorial Material
ID CALMODULIN KINASE-II; ALPHA; AUTOPHOSPHORYLATION
C1 [Easton, A. C.; Lourdusamy, A.; Loth, E.; Fernandes, C.; Mueller, C. P.; Schumann, G.] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London, England.
   [Torro, R.] Inst Pasteur, CNRS, Paris, France.
   [Giese, K. P.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, Ctr Cellular Basis Behav, London, England.
   [Giese, K. P.] James Black Ctr, London, England.
   [Kornhuber, J.; Mueller, C. P.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.
   [de Quervain, D. J-F] Univ Basel, Dept Psychol, Div Cognit Neurosci, Basel, Switzerland.
   [de Quervain, D. J-F; Papassotiropoulos, A.] Univ Basel, Univ Psychiat Clin, Basel, Switzerland.
   [Papassotiropoulos, A.] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland.
   [Papassotiropoulos, A.] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.
RP Easton, AC (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, De Crespigny Pk, London, England.
EM Christian.Mueller@uk-erlangen.de
RI Lourdusamy, Anbarasu/P-6606-2014; Giese, Karl P/A-3112-2011; Easton,
   Alanna/C-1538-2012; Kornhuber, Johannes/B-9613-2014
OI Giese, Karl P/0000-0003-4503-7344; Kornhuber,
   Johannes/0000-0002-8096-3987; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Toro, Roberto/0000-0002-6671-858X;
   Fernandes, Cathy/0000-0001-7318-3352; Loth, Eva/0000-0001-9458-9167;
   Lourdusamy, Anbarasu/0000-0002-1978-6301; de Quervain,
   Dominique/0000-0001-7131-2464; Muller, Christian/0000-0002-5325-9900
FU Medical Research CouncilMedical Research Council UK (MRC) [G0901858]
   Funding Source: Medline
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Cathomas F, 2010, INT J NEUROPSYCHOPH, V13, P975, DOI 10.1017/S1461145710000519
   Easton AC, 2011, NEUROPHARMACOLOGY, V61, P1424, DOI 10.1016/j.neuropharm.2011.08.036
   Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870
   Harms MP, 2013, BRAIN STRUCT FUNCT, V218, P173, DOI 10.1007/s00429-012-0391-8
   Irvine EE, 2005, NAT NEUROSCI, V8, P411, DOI 10.1038/nn1431
   Kang SS, 2011, NEUROPSYCHOLOGIA, V49, P2836, DOI 10.1016/j.neuropsychologia.2011.06.009
   Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4
   SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648
   Wang YJ, 2005, BRAIN RES, V1031, P101, DOI 10.1016/j.brainres.2004.10.061
NR 10
TC 15
Z9 15
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD AUG
PY 2013
VL 18
IS 8
BP 850
EP 852
DI 10.1038/mp.2012.114
PG 4
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 191XM
UT WOS:000322448400003
PM 22824813
OA Bronze
DA 2021-01-25
ER

PT J
AU Broz, P
   Monack, DM
AF Broz, Petr
   Monack, Denise M.
TI Newly described pattern recognition receptors team up against
   intracellular pathogens
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID CYCLIC DI-GMP; TOLL-LIKE RECEPTORS; INNATE IMMUNE RECOGNITION; CYTOSOLIC
   DNA SENSOR; RIG-I; INFLAMMASOME ACTIVATION; CUTTING EDGE; RNA HELICASE;
   CELL-DEATH; BACTERIAL FLAGELLIN
AB Recognizing the presence of invading pathogens is key to mounting an effective innate immune response. Mammalian cells express different classes of germline-encoded pattern recognition receptors that monitor the extracellular and intracellular compartments of host cells for signs of infection and that activate several conserved signalling pathways. An efficient immune response often requires the sequential detection of a pathogen by different receptors in different subcellular compartments, which results in a complex interplay of downstream signalling pathways. In this Review, we discuss the recent identification of previously unknown pattern recognition receptors and how they complement the repertoire of established receptors.
C1 [Broz, Petr] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Monack, Denise M.] Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
RP Monack, DM (corresponding author), Stanford Univ, Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM dmonack@stanford.edu
RI poinssot, benoit/B-2569-2009; Broz, Petr/AAC-7940-2019
OI poinssot, benoit/0000-0001-5890-4318; Broz, Petr/0000-0002-2334-7790
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3_139120/1]; US National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI095396, AI08972]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI095396, R01AI095396, R01AI095396, R01AI095396, F32AI008972,
   F32AI008972, R01AI095396, R01AI095396, R01AI095396, F32AI008972,
   R01AI095396] Funding Source: NIH RePORTER
FX This work was supported by the following grants: PP00P3_139120/1 from
   the Swiss National Science Foundation to P.B., and AI095396 and AI08972
   to D.M.M. from the US National Institute of Allergy and Infectious
   Diseases. We apologize to investigators whose contributions were not
   cited more extensively because of space limitations.
CR Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783
   Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779
   Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012
   Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200
   Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340
   Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009
   Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419
   Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429
   Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110
   Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38
   Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412
   Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015
   Debierre-Grockiego F, 2006, INFECT IMMUN, V74, P5487, DOI 10.1128/IAI.01934-05
   Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189
   Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247
   Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012
   Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022
   Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011
   Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710
   Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346
   Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460
   Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498
   Gavrilin MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00011
   Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200
   Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222
   Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665
   Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898
   Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732
   Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725
   Hu DL, 2009, VACCINE, V27, P4867, DOI 10.1016/j.vaccine.2009.04.053
   Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333
   Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107
   Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199
   Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517
   Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001
   Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107
   Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726
   Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016
   Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394
   Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303
   Li XJ, 2012, INT IMMUNOPHARMACOL, V13, P1, DOI 10.1016/j.intimp.2012.02.011
   Lich JD, 2007, MICROBES INFECT, V9, P672, DOI 10.1016/j.micinf.2007.01.018
   Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646
   Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042
   McGuinness DH, 2003, TRENDS PARASITOL, V19, P312, DOI 10.1016/S1471-4922(03)00123-5
   Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107
   Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10
   Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131
   Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108
   O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079
   Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363
   Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109
   Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203
   Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019
   Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51
   Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025
   Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429
   Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007
   Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397
   Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260
   Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782
   Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104
   Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072
   Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107
   Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10
   Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332
   Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331
   Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006
   Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362
   Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932
   Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI 10.1016/j.chom.2012.01.016
   Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006
   Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012
   Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006
   Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030
   Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801
   Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963
   Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876
   Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893
   Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003
   Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351
   Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389
   Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091
   Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027
   Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510
   Zheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036019
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
NR 113
TC 248
Z9 257
U1 2
U2 82
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD AUG
PY 2013
VL 13
IS 8
BP 551
EP 565
DI 10.1038/nri3479
PG 15
WC Immunology
SC Immunology
GA 188TS
UT WOS:000322217500010
PM 23846113
DA 2021-01-25
ER

PT J
AU Zund, D
   Gruber, AR
   Zavolan, M
   Muhlemann, O
AF Zuend, David
   Gruber, Andreas R.
   Zavolan, Mihaela
   Muehlemann, Oliver
TI Translation-dependent displacement of UPF1 from coding sequences causes
   its enrichment in 3 ' UTRs
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID MESSENGER-RNA DECAY; EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY;
   POLY(A)-BINDING PROTEIN; MAMMALIAN TRANSCRIPTS; NUCLEOTIDE-RESOLUTION;
   TERMINATION CODON; DIVERSE CLASSES; HUMAN-CELLS; SURVEILLANCE
AB Recruitment of the UPF1 nonsense-mediated mRNA decay (NMD) factor to target mRNAs was initially proposed to occur through interaction with release factors at terminating ribosomes. However, recently emerging evidence points toward translation-independent interaction with the 3' untranslated region (UTR) of mRNAs. We mapped transcriptome-wide UPF1-binding sites by individual-nucleotide-resolution UV cross-linking and immunoprecipitation in human cells and found that UPF1 preferentially associated with 3' UTRs in translationally active cells but underwent significant redistribution toward coding regions (CDS) upon translation inhibition, thus indicating that UPF1 binds RNA before translation and gets displaced from the CDS by translating ribosomes. Corroborated by RNA immunoprecipitation and by UPF1 cross-linking to long noncoding RNAs, our evidence for translation-independent UPF1-RNA interaction suggests that the triggering of NMD occurs after UPF1 binding to mRNA, presumably through activation of RNA-bound UPF1 by aberrant translation termination.
C1 [Zuend, David; Muehlemann, Oliver] Univ Bern, Dept Chem & Biochem, Bern, Switzerland.
   [Zuend, David] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
   [Gruber, Andreas R.; Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gruber, Andreas R.; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland.
RP Muhlemann, O (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.
EM oliver.muehlemann@dcb.unibe.ch
RI Zavolan, Mihaela/S-3888-2016
OI Muhlemann, Oliver/0000-0003-0657-1368; Zavolan,
   Mihaela/0000-0002-8832-2041; Gruber, Andreas/0000-0003-1219-4239
FU European Research CouncilEuropean Research Council (ERC) [StG 207419];
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-127614, 31003A-143717]; canton of BernJapanese Urological
   Association; University of Basel
FX We thank R. Bruggmann and S. Neuenschwander (Institute of Cell Biology,
   University of Bern, Bern, Switzerland) for initial bioinformatics
   support, H. le Hir (Institut de Biologie, Ecole Normale Superieure,
   Paris, France) for technical hints with the CLIP and for providing their
   eIF4AIII CLIP data, L. Maquat (University of Rochester, Rochester, New
   York, USA) for providing their protocol for RIP coupled with RNase-H
   cleavage, S. Rufener (Department of Chemistry and Biochemistry,
   University of Bern, Bern, Switzerland) for help with the RIPs and S.
   Kishore and N. Mittal (Biozentrum, University of Basel, Basel,
   Switzerland) for sharing the HeLa mRNA-seq data before publication. This
   work was supported by grants to O.M. from the European Research Council
   (StG 207419), the Swiss National Science Foundation (31003A-127614 and
   31003A-143717) and the canton of Bern. The work of A. R. G. and M.Z. was
   supported by the University of Basel.
CR Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060
   Arias-Palomo E, 2011, GENE DEV, V25, P153, DOI 10.1101/gad.606911
   Avery P, 2011, RNA, V17, P624, DOI 10.1261/rna.2404211
   Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018
   Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588
   Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546
   Buhler M, 2004, NUCLEIC ACIDS RES, V32, P3304, DOI 10.1093/nar/gkh651
   Chakrabarti S, 2011, MOL CELL, V41, P693, DOI 10.1016/j.molcel.2011.02.010
   Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330
   Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280
   Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464
   Cho H, 2013, NUCLEIC ACIDS RES, V41, P1319, DOI 10.1093/nar/gks1222
   Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022
   Clerici M, 2009, EMBO J, V28, P2293, DOI 10.1038/emboj.2009.175
   Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665
   Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8
   Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092
   Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530
   Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305
   Fiorini F, 2013, NUCLEIC ACIDS RES, V41, P2404, DOI 10.1093/nar/gks1320
   Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043
   FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x
   Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010
   Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502
   Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005
   Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677
   Huang LL, 2011, MOL CELL, V43, P950, DOI 10.1016/j.molcel.2011.06.031
   Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208
   Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39
   Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5
   Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17
   Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Jonas S, 2013, GENE DEV, V27, P211, DOI 10.1101/gad.206672.112
   Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006
   Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972
   Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050
   Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Kurosaki T, 2013, P NATL ACAD SCI USA, V110, P3357, DOI 10.1073/pnas.1219908110
   Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2
   Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99
   Melero R, 2012, NAT STRUCT MOL BIOL, V19, P498, DOI 10.1038/nsmb.2287
   Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428
   Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1
   Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791
   Page MF, 1999, MOL CELL BIOL, V19, P5943
   Riehs-Kearnan N, 2012, NUCLEIC ACIDS RES, V40, P5615, DOI 10.1093/nar/gks195
   Sauliere J, 2012, NAT STRUCT MOL BIOL, V19, P1124, DOI 10.1038/nsmb.2420
   Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108
   Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111
   Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005
   Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67
   Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360
   Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013
   Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461
   Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09
   Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002
   Yepiskoposyan H, 2011, RNA, V17, P2108, DOI 10.1261/rna.030247.111
NR 65
TC 93
Z9 93
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD AUG
PY 2013
VL 20
IS 8
BP 936
EP +
DI 10.1038/nsmb.2635
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 195PH
UT WOS:000322715300006
PM 23832275
DA 2021-01-25
ER

PT J
AU Song, J
   Lokmic, Z
   Lammermann, T
   Rolf, J
   Wu, C
   Zhang, XL
   Hallmann, R
   Hannocks, MJ
   Horn, N
   Ruegg, MA
   Sonnenberg, A
   Georges-Labouesse, E
   Winkler, TH
   Kearney, JF
   Cardell, S
   Sorokin, L
AF Song, Jian
   Lokmic, Zerina
   Laemmermann, Tim
   Rolf, Julia
   Wu, Chuan
   Zhang, Xueli
   Hallmann, Rupert
   Hannocks, Melanie-Jane
   Horn, Nathalie
   Ruegg, Markus A.
   Sonnenberg, Arnoud
   Georges-Labouesse, Elisabeth
   Winkler, Thomas H.
   Kearney, John F.
   Cardell, Susanna
   Sorokin, Lydia
TI Extracellular matrix of secondary lymphoid organs impacts on B-cell fate
   and survival
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE B-cell development; immunology
ID T-CELL; LAMININ; MICE; MOLECULES; GROWTH; ENTRY; LYMPHOCYTES;
   CHEMOKINES; EXPRESSION; DEPENDENCE
AB We describe a unique extracellular matrix (ECM) niche in the spleen, the marginal zone (MZ), characterized by the basement membrane glycoproteins, laminin alpha 5 and agrin, that promotes formation of a specialized population of MZ B lymphocytes that respond rapidly to blood-borne antigens. Mice with reduced laminin alpha 5 expression show reduced MZ B cells and increased numbers of newly formed (NF) transitional B cells that migrate from the bone marrow, without changes in other immune or stromal cell compartments. Transient integrin alpha 6 beta 1-mediated interaction of NF B cells with laminin alpha 5 in the MZ supports the MZ B-cell population, their long-term survival, and antibody response. Data suggest that the unique 3D structure and biochemical composition of the ECM of lymphoid organs impacts on immune cell fate.
C1 [Song, Jian; Lokmic, Zerina; Laemmermann, Tim; Wu, Chuan; Zhang, Xueli; Hallmann, Rupert; Hannocks, Melanie-Jane; Horn, Nathalie; Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany.
   [Rolf, Julia; Cardell, Susanna] Univ Gothenburg, Dept Microbiol & Immunobiol, S-40530 Gothenburg, Sweden.
   [Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sonnenberg, Arnoud] Netherlands Canc Inst, NL-90203 Amsterdam, Netherlands.
   [Georges-Labouesse, Elisabeth] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.
   [Winkler, Thomas H.] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany.
   [Kearney, John F.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.
RP Sorokin, L (corresponding author), Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany.
EM sorokin@uni-muenster.de
RI Ruegg, Markus/X-7256-2019; Wu, Chuan/H-6379-2013
OI Ruegg, Markus/0000-0002-4974-9384; , Jian/0000-0003-2159-9190; Tomkins
   (nee lokmic), Zerina/0000-0003-0266-9536; Song,
   Jian/0000-0002-2459-7046; Zhang, Xueli/0000-0001-8306-0639; Wu,
   Chuan/0000-0003-2288-353X
FU Swedish Research Foundations [K2005-06X-14184-04A, 621-2001-2142];
   Alfred Osterlunds; Knut and Alice Wallenbergs (KAW) [2002.0056];
   National Insitutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI01478-33]; 
   [Sonderforschungsbereich (SFB) 492 A19]; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI014782, R01AI014782,
   R01AI014782, R01AI014782, R01AI014782, R01AI014782, R01AI014782,
   R01AI014782, R01AI014782, R01AI014782, R01AI014782, R01AI014782,
   R01AI014782, R01AI014782, R01AI014782, R01AI014782, R01AI014782,
   K08AI001478, K08AI001478, K08AI001478, R01AI014782, R01AI014782,
   R01AI014782, R01AI014782, R01AI014782, R01AI014782, R01AI014782,
   R01AI014782, R01AI014782, R01AI014782, R01AI014782, R01AI014782,
   K08AI001478, R01AI014782, R01AI014782, K08AI001478, R01AI014782,
   R01AI014782] Funding Source: NIH RePORTER
FX We thank A. Ljubimov, R. Nischt, J.-E. Mansson, and D. Vestweber for
   generous gifts of antibodies; Pascal Schneider, Fabienne Mackay, and
   Biogen Idec Inc. for the TACI<SUP>-/-</SUP> mice; S. Budny for preparing
   laminins 511/521, 411, and laminin fragments; Adele De Arcangelis for
   preparation of the integrin alpha 6<SUP>-/-</SUP> fetal livers; and Nina
   Gerigk for Fig. 7. This work was supported by the German
   [Sonderforschungsbereich (SFB) 492 A19] and Swedish Research Foundations
   (K2005-06X-14184-04A, 621-2001-2142), Alfred Osterlunds, Knut and Alice
   Wallenbergs (KAW 2002.0056) and National Insitutes of Health Grant
   AI01478-33.
CR Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834
   Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014
   AUFDERHEIDE E, 1988, J CELL BIOL, V107, P2341, DOI 10.1083/jcb.107.6.2341
   Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947
   Cancro MP, 2004, J IMMUNOL, V173, P15, DOI 10.4049/jimmunol.173.1.15
   Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083
   Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542
   Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112
   Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2
   ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4
   Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1
   FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370
   Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425
   Guinamard R, 2000, NAT IMMUNOL, V1, P31
   He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914
   Henderson RB, 2010, J EXP MED, V207, P837, DOI 10.1084/jem.20091489
   Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0
   Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200
   Kikkawa Y, 2000, J CELL SCI, V113, P869
   Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106
   Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004
   Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014
   LEITER EH, 1987, AM J PATHOL, V128, P380
   Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098
   Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Lokmic Z, 2008, SEMIN IMMUNOL, V20, P4, DOI 10.1016/j.smim.2007.12.009
   Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632
   Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807
   Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801
   Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73
   Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656
   RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0
   Rolf J, 2005, J IMMUNOL, V174, P4821, DOI 10.4049/jimmunol.174.8.4821
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0
   Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2
   Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013
   Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933
   Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200
   Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016
NR 49
TC 48
Z9 49
U1 0
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 30
PY 2013
VL 110
IS 31
BP E2915
EP E2924
DI 10.1073/pnas.1218131110
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 191VH
UT WOS:000322441500012
PM 23847204
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kudryashev, M
   Stenta, M
   Schmelz, S
   Amstutz, M
   Wiesand, U
   Castano-Diez, D
   Degiacomi, MT
   Munnich, S
   Bleck, CKE
   Kowal, J
   Diepold, A
   Heinz, DW
   Dal Peraro, M
   Cornelis, GR
   Stahlberg, H
AF Kudryashev, Mikhail
   Stenta, Marco
   Schmelz, Stefan
   Amstutz, Marlise
   Wiesand, Ulrich
   Castano-Diez, Daniel
   Degiacomi, Matteo T.
   Muennich, Stefan
   Bleck, Christopher K. E.
   Kowal, Julia
   Diepold, Andreas
   Heinz, Dirk W.
   Dal Peraro, Matteo
   Cornelis, Guy R.
   Stahlberg, Henning
TI In situ structural analysis of the Yersinia enterocolitica injectisome
SO ELIFE
LA English
DT Article
ID III SECRETION SYSTEM; NUCLEAR-PORE COMPLEX; CRYOELECTRON TOMOGRAPHY;
   NEEDLE COMPLEX; MOLECULAR-DYNAMICS; CYTOPLASMIC DOMAIN;
   ESCHERICHIA-COLI; PROTEIN; ARCHITECTURE; RESOLUTION
AB Injectisomes are multi-protein transmembrane machines allowing pathogenic bacteria to inject effector proteins into eukaryotic host cells, a process called type III secretion. Here we present the first three-dimensional structure of Yersinia enterocolitica and Shigella flexneri injectisomes in situ and the first structural analysis of the Yersinia injectisome. Unexpectedly, basal bodies of injectisomes inside the bacterial cells showed length variations of 20%. The in situ structures of the Y. enterocolitica and S. flexneri injectisomes had similar dimensions and were significantly longer than the isolated structures of related injectisomes. The crystal structure of the inner membrane injectisome component YscD appeared elongated compared to a homologous protein, and molecular dynamics simulations documented its elongation elasticity. The ring-shaped secretin YscC at the outer membrane was stretched by 30-40% in situ, compared to its isolated liposome-embedded conformation. We suggest that elasticity is critical for some two-membrane spanning protein complexes to cope with variations in the intermembrane distance.
C1 [Kudryashev, Mikhail; Castano-Diez, Daniel; Bleck, Christopher K. E.; Kowal, Julia; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, Basel, Switzerland.
   [Stenta, Marco; Degiacomi, Matteo T.; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   [Schmelz, Stefan; Wiesand, Ulrich; Muennich, Stefan; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany.
   [Amstutz, Marlise; Wiesand, Ulrich; Diepold, Andreas; Cornelis, Guy R.] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Dal Peraro, Matteo] SIB, Lausanne, Switzerland.
RP Heinz, DW (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany.
EM Dirk.Heinz@Helmholtz-HZI.de; Matteo.Dalperaro@epfl.ch;
   Guy.Cornelis@fundp.ac.be; Henning.Stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011; Degiacomi, Matteo/M-4342-2017
OI Stahlberg, Henning/0000-0002-1185-4592; Degiacomi,
   Matteo/0000-0003-4672-471X; Kowal, Julia/0000-0003-4694-1896;
   Kudryashev, Misha/0000-0003-3550-6274; Diepold,
   Andreas/0000-0002-4475-3923; Bleck, Christopher/0000-0003-1029-3444
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AOB-128659, CRSII3_125110, NCCR Nano, NCCR Struct.Biol.,
   NCCR TransCure, 00021_122120, 200020_138013]; SystemsX.ch [CINA]; Swiss
   National Supercomputing Center (CSCS) [s274]
FX Swiss National Science Foundation 3100AOB-128659 Stefan Munnich, Andreas
   Diepold, Guy R Cornelis; SystemsX.ch CINA Mikhail Kudryashev, Daniel
   Castano-Dez, Christopher KE Bleck, Julia Kowal, Henning Stahlberg; Swiss
   National Science Foundation CRSII3_125110 Mikhail Kudryashev, Marco
   Stenta, Stefan Schmelz, Marlise Amstutz, Ulrich Wiesand, Daniel
   Castano-Diez, Matteo T Degiacomi, Stefan Munnich, Christopher KE Bleck,
   Julia Kowal, Andreas Diepold, Dirk W Heinz, Matteo Dal Peraro, Guy R
   Cornelis, Henning Stahlberg; Swiss National Science Foundation NCCR Nano
   Mikhail Kudryashev, Christopher KE Bleck, Julia Kowal, Henning
   Stahlberg; Swiss National Science Foundation NCCR Struct.Biol. Julia
   Kowal; Swiss National Science Foundation NCCR TransCure Henning
   Stahlberg; Swiss National Science Foundation 00021_122120 Matteo T
   Degiacomi, Matteo Dal Peraro; Swiss National Science Foundation
   200020_138013 Matteo T Degiacomi, Matteo Dal Peraro; Swiss National
   Supercomputing Center (CSCS) projectID s274 Mikhail Kudryashev, Daniel
   Castano-Diez, Henning Stahlberg
CR Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452
   AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   ALLAOUI A, 1995, J BACTERIOL, V177, P4230, DOI 10.1128/jb.177.15.4230-4237.1995
   AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408
   Astumian RD, 2011, ANNU REV BIOPHYS, V40, P289, DOI 10.1146/annurev-biophys-042910-155355
   Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258
   Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168
   Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Bleck CKE, 2010, J MICROSC-OXFORD, V237, P23, DOI 10.1111/j.1365-2818.2009.03299.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Castano-Diez D, 2012, J STRUCT BIOL, V178, P139, DOI 10.1016/j.jsb.2011.12.017
   Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x
   Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352
   Degiacomi M.T., 2013, NAT CHEM BIOL, DOI DOI 10.1038/NCHEMBI0.1312
   Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014
   Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84
   Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299
   Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Fujii T, 2012, P NATL ACAD SCI USA, V109, P4461, DOI 10.1073/pnas.1116126109
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464
   Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599
   Howitt RLJ, 2006, ARCH VIROL, V151, P563, DOI 10.1007/s00705-005-0621-y
   Hsin J, 2011, BIOPHYS J, V100, pL22, DOI 10.1016/j.bpj.2011.01.019
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Koch AL, 1998, CRIT REV MICROBIOL, V24, P23, DOI 10.1080/10408419891294172
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Kudryashev M, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207002
   Kudryashev M, 2012, J STRUCT BIOL, V178, P88, DOI 10.1016/j.jsb.2011.10.004
   Kudryashev M, 2010, J STRUCT BIOL, V169, P54, DOI 10.1016/j.jsb.2009.08.008
   Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109
   Lilic M, 2010, ACTA CRYSTALLOGR D, V66, P709, DOI 10.1107/S0907444910010796
   Liu J, 2011, VIROLOGY, V417, P304, DOI 10.1016/j.virol.2011.06.005
   Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09
   Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079
   Lountos GT, 2012, ACTA CRYSTALLOGR D, V68, P201, DOI 10.1107/S0907444911054308
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Ohgita T, 2013, FASEB J, V27, P2862, DOI 10.1096/fj.13-229054
   Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001
   Panjikar S, 2009, ACTA CRYSTALLOGR D, V65, P1089, DOI 10.1107/S0907444909029643
   Pantelic RS, 2011, NANO LETT, V11, P4319, DOI 10.1021/nl202386p
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716
   Ross JA, 2011, J BACTERIOL, V193, P2276, DOI 10.1128/JB.01137-10
   Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10
   SANSONETTI PJ, 1991, REV INFECT DIS, V13, pS285
   Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115
   Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358
   Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824
   Silva-Herzog E, 2008, MICROBIOL-SGM, V154, P593, DOI 10.1099/mic.0.2007/013045-0
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716
   Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005
   van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009
   Wang K, 2012, J STRUCT BIOL, V180, P318, DOI 10.1016/j.jsb.2012.07.003
   Worrall LJ, 2011, CURR OPIN MICROBIOL, V14, P3, DOI 10.1016/j.mib.2010.10.009
   Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554
NR 82
TC 65
Z9 66
U1 1
U2 9
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JUL 30
PY 2013
VL 2
AR e00792
DI 10.7554/eLife.00792
PG 23
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 274QX
UT WOS:000328622300003
PM 23908767
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Betz, C
   Stracka, D
   Prescianotto-Baschong, C
   Frieden, M
   Demaurex, N
   Hall, MN
AF Betz, Charles
   Stracka, Daniele
   Prescianotto-Baschong, Cristina
   Frieden, Maud
   Demaurex, Nicolas
   Hall, Michael N.
TI mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic
   reticulum membranes (MAM) regulates mitochondrial physiology
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID RAT-LIVER; PROTEOMIC ANALYSIS; CA2+ RELEASE; AKT; PHOSPHORYLATION;
   RAPAMYCIN; KINASE; GLYCOLYSIS; CALNEXIN; FRACTION
AB The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here we report that mTORC2 is localized to the endoplasmic reticulum (ER) subcompartment termed mitochondria-associated ER membrane (MAM). mTORC2 localization to MAM was growth factor-stimulated, and mTORC2 at MAM interacted with the IP3 receptor (IP3R)-Grp75-voltage-dependent anion-selective channel 1 ER-mitochondrial tethering complex. mTORC2 deficiency disrupted MAM, causing mitochondrial defects including increases in mitochondrial membrane potential, ATP production, and calcium uptake. mTORC2 controlled MAM integrity and mitochondrial function via Akt mediated phosphorylation of the MAM associated proteins IP3R, Hexokinase 2, and phosphofurin acidic cluster sorting protein 2. Thus, mTORC2 is at the core of a MAM signaling hub that controls growth and metabolism.
C1 [Betz, Charles; Stracka, Daniele; Prescianotto-Baschong, Cristina; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Frieden, Maud; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Betz, Charles/B-7444-2008
OI Betz, Charles/0000-0002-9837-6916; Demaurex,
   Nicolas/0000-0002-9933-6772; Frieden, Maud/0000-0001-7135-0874
FU Leslie Misrock Foundation; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); SystemsX.ch; Swiss Cancer League;
   Louis Jeantet Foundation; Canton of Basel
FX We thank Asami Hagiwara, Marion Cornu, Cyril Castelbou, Estela Jacinto,
   and Don Benjamin for assistance or reagents. Immunofluorescent images
   were acquired at the Imaging Core Facility, Biozentrum Basel. This work
   was supported in part by the Leslie Misrock Foundation (C.B.), the Swiss
   National Science Foundation, SystemsX.ch, the Swiss Cancer League, the
   Louis Jeantet Foundation, and the Canton of Basel.
CR ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206
   Ando Masaru, 2010, Journal of Nippon Medical School, V77, P97
   Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523
   Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006
   Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834
   Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204
   Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x
   Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819
   Bononi A, 2012, ADV EXP MED BIOL, V740, P411, DOI 10.1007/978-94-007-2888-2_17
   Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034
   Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584
   Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731
   Clippinger AJ, 2011, J VIROL, V85, P3930, DOI 10.1128/JVI.01913-10
   Colombi M, 2011, ONCOGENE, V30, P1551, DOI 10.1038/onc.2010.539
   Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96
   Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177
   Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698
   Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157
   Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Khan MT, 2006, J BIOL CHEM, V281, P3731, DOI 10.1074/jbc.M509262200
   Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017
   Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384
   Marchi S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.45
   Marriott KSC, 2012, J PHARMACOL EXP THER, V343, P578, DOI 10.1124/jpet.112.198168
   Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285
   Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390
   Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995
   Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Pawlikowska P, 2007, CELL TISSUE RES, V327, P571, DOI 10.1007/s00441-006-0320-3
   Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011
   Poston CN, 2013, J PROTEOMICS, V79, P219, DOI 10.1016/j.jprot.2012.12.018
   Poston CN, 2011, BIOCHEM BIOPH RES CO, V415, P355, DOI 10.1016/j.bbrc.2011.10.072
   Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106
   Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   RUBY JR, 1969, Z ZELLFORSCH MIK ANA, V97, P30, DOI 10.1007/BF00331868
   RUSINOL AE, 1994, J BIOL CHEM, V269, P27494
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14
   Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017
   Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   VANCE JE, 1990, J BIOL CHEM, V265, P7248
   Wang YB, 2010, J BIOL CHEM, V285, P15611, DOI 10.1074/jbc.M109.095778
   Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151
   Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Zhang AP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009936
   Zhao LQ, 2013, CANCER RES, V73, P1946, DOI 10.1158/0008-5472.CAN-12-3710
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 73
TC 274
Z9 281
U1 1
U2 35
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 30
PY 2013
VL 110
IS 31
BP 12526
EP 12534
DI 10.1073/pnas.1302455110
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 191VH
UT WOS:000322441500022
PM 23852728
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Jenal, U
AF Jenal, Urs
TI Think globally, act locally: How bacteria integrate local decisions with
   their global cellular programme
SO EMBO JOURNAL
LA English
DT Editorial Material
ID C-DI-GMP; ESCHERICHIA-COLI; PROTEINS
AB It has long been speculated that the bacterial second messenger c-di-GMP, a key molecular switch of bacterial community behaviour and persistence, can trigger specific cellular processes both on a global level as well as through some local action that prevents crosstalk originating from rapid diffusion of the signalling molecule. In this issue, Lindenberg et al (2013) report on a mechanism that not only helps to explain how spatial sequestration of c-di-GMP signalling components could be organized within bacterial cells, but also demonstrates how global and local command levels are interconnected.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM urs.jenal@unibas.ch
CR Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
NR 11
TC 2
Z9 3
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUL 17
PY 2013
VL 32
IS 14
BP 1972
EP 1974
DI 10.1038/emboj.2013.140
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 184ME
UT WOS:000321893200003
PM 23749210
OA Green Published
DA 2021-01-25
ER

PT J
AU De Zorzi, R
   Nicholson, WV
   Guigner, JM
   Erne-Brand, F
   Stahlberg, H
   Venien-Bryan, C
AF De Zorzi, Rita
   Nicholson, William V.
   Guigner, Jean-Michel
   Erne-Brand, Francoise
   Stahlberg, Henning
   Venien-Bryan, Catherine
TI Growth of Large and Highly Ordered 20 Crystals of a K+ Channel,
   Structural Role of Lipidic Environment
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID 2-DIMENSIONAL CRYSTALLIZATION; POTASSIUM CHANNEL; MEMBRANE-PROTEIN;
   ELECTRON CRYSTALLOGRAPHY; 2D CRYSTALLIZATION; DETERGENTS; MECHANISM; ART
AB 2D crystallography has proven to be an excellent technique to determine the 3D structure of membrane proteins. Compared to 3D crystallography, it has the advantage of visualizing the protein in an environment closer to the native one. However, producing good 2D crystals is still a challenge and little statistical knowledge can be gained from literature. Here, we present a thorough screening of 2D crystallization conditions for a prokaryotic inwardly rectifying potassium channel (>130 different conditions). Key parameters leading to very large and well-organized 2D crystals are discussed. In addition, the problem of formation of multilayers during the growth of 2D crystals is also addressed. An intermediate resolution projection map of KirBac3.1 at 6 A is presented, which sheds (to our knowledge) new light on the structure of this channel in a lipid environment.
C1 [De Zorzi, Rita; Nicholson, William V.; Venien-Bryan, Catherine] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England.
   [Guigner, Jean-Michel; Venien-Bryan, Catherine] Univ Paris 06, IMPMC, F-75252 Paris, France.
   [Erne-Brand, Francoise; Stahlberg, Henning] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
RP Venien-Bryan, C (corresponding author), Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England.
EM catherine.venien@impmc.upmc.fr
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Nicholson,
   William/0000-0001-6614-0194; DE ZORZI, Rita/0000-0001-7001-7498;
   Venien-Bryan, Catherine/0000-0002-7328-3764
FU Biotechnology and Biological Sciences Research Council
   (BBSRC)Biotechnology and Biological Sciences Research Council (BBSRC);
   Wellcome TrustWellcome Trust; Marie Curie Intra-European
   FellowshipEuropean Union (EU)
FX This work was supported by grants from the Biotechnology and Biological
   Sciences Research Council (BBSRC) and the Wellcome Trust. R.D.Z. was
   supported by a Marie Curie Intra-European Fellowship. All authors
   declare that there is no conflict of interest.
CR Abeyrathne PD, 2010, METHOD ENZYMOL, V481, P25, DOI 10.1016/S0076-6879(10)81001-8
   Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208
   Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244
   Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012
   Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68
   Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Jaroslawski S, 2007, J MOL BIOL, V374, P500, DOI 10.1016/j.jmb.2007.09.043
   Jonic S, 2009, CURR OPIN PHARMACOL, V9, P636, DOI 10.1016/j.coph.2009.04.006
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011
   Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028
   MICHEL H, 1980, P NATL ACAD SCI-BIOL, V77, P338, DOI 10.1073/pnas.77.1.338
   Mosser G, 2001, MICRON, V32, P517, DOI 10.1016/S0968-4328(00)00047-0
   Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828
   Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687
   RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V
   Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2
   Schenk AD, 2010, METHOD ENZYMOL, V483, P91, DOI 10.1016/S0076-6879(10)83005-8
   Schmidt-Krey I, 2007, METHODS, V41, P417, DOI 10.1016/j.ymeth.2006.07.011
   Schmidt-Krey I, 2007, J STRUCT BIOL, V157, P437, DOI 10.1016/j.jsb.2006.08.002
   Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307
   Stahlberg H, 2008, ACS CHEM BIOL, V3, P268, DOI 10.1021/cb800037d
   Stuart MCA, 2004, BBA-BIOMEMBRANES, V1663, P108, DOI 10.1016/j.bbamem.2004.02.008
   Tsai CJ, 2007, J STRUCT BIOL, V160, P275, DOI 10.1016/j.jsb.2007.09.008
   Tsai CJ, 2010, CURR OPIN STRUC BIOL, V20, P448, DOI 10.1016/j.sbi.2010.06.005
   Wang HB, 2011, MICRON, V42, P132, DOI 10.1016/j.micron.2010.05.003
   Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046
   Zhao G, 2010, J STRUCT BIOL, V169, P450, DOI 10.1016/j.jsb.2009.11.002
NR 39
TC 5
Z9 5
U1 0
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JUL 16
PY 2013
VL 105
IS 2
BP 398
EP 408
DI 10.1016/j.bpj.2013.05.054
PG 11
WC Biophysics
SC Biophysics
GA 185CB
UT WOS:000321941700013
PM 23870261
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Sonnen, KF
   Gabryjonczyk, AM
   Anselm, E
   Stierhof, YD
   Nigg, EA
AF Sonnen, Katharina F.
   Gabryjonczyk, Anna-Maria
   Anselm, Eduard
   Stierhof, York-Dieter
   Nigg, Erich A.
TI Human Cep192 and Cep152 cooperate in Plk4 recruitment and centriole
   duplication
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Cep152; Cep192; Plk4; Centriole duplication; Centrosome
ID CENTROSOME DUPLICATION; C. ELEGANS; CAENORHABDITIS-ELEGANS; CELL-CYCLE;
   STRUCTURED ILLUMINATION; PROCENTRIOLE FORMATION; MITOTIC CENTROSOMES;
   PROTEIN SPD-2; POLO KINASE; DROSOPHILA
AB Polo-like kinase 4 (Plk4) is a key regulator of centriole duplication, but the mechanism underlying its recruitment to mammalian centrioles is not understood. In flies, Plk4 recruitment depends on Asterless, whereas nematodes rely on a distinct protein, Spd-2. Here, we have explored the roles of two homologous mammalian proteins, Cep152 and Cep192, in the centriole recruitment of human Plk4. We demonstrate that Cep192 plays a key role in centrosome recruitment of both Cep152 and Plk4. Double-depletion of Cep192 and Cep152 completely abolishes Plk4 binding to centrioles as well as centriole duplication, indicating that the two proteins cooperate. Most importantly, we show that Cep192 binds Plk4 through an N-terminal extension that is specific to the largest isoform. The Plk4 binding regions of Cep192 and Cep152 (residues 190-240 and 1-46, respectively) are rich in negatively charged amino acids, suggesting that Plk4 localization to centrioles depends on electrostatic interactions with the positively charged polo-box domain. We conclude that cooperation between Cep192 and Cep152 is crucial for centriole recruitment of Plk4 and centriole duplication during the cell cycle.
C1 [Sonnen, Katharina F.; Gabryjonczyk, Anna-Maria; Anselm, Eduard; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Stierhof, York-Dieter] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
RI Sonnen, Katharina F/R-7747-2018
OI Sonnen, Katharina F/0000-0002-2902-9419; nigg, erich/0000-0003-4835-5719
FU Boehringer Ingelheim FondsBoehringer Ingelheim; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31003A_132428/1]
FX K.F.S. was the recipient of a PhD fellowship from the Boehringer
   Ingelheim Fonds and a member of the International Max Planck Research
   School for Molecular and Cellular Life Sciences (Martinsried, Germany).
   This work was supported by a grant from the Swiss National Science
   Foundation [grant number 31003A_132428/1 to E.A.N.]
CR Azimzadeh J, 2012, SCIENCE, V335, P461, DOI 10.1126/science.1214457
   Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930
   Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004
   Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141
   Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751
   Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037
   Brownlee CW, 2011, J CELL BIOL, V195, P231, DOI 10.1083/jcb.201107086
   Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152
   Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931
   Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118
   Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023
   Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006
   Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059
   Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065
   Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224
   Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388
   Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373
   Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019
   Gomez-Ferreria MA, 2012, CELL CYCLE, V11, P3555, DOI 10.4161/cc.21574
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   Guichard P, 2012, SCIENCE, V337, P553, DOI 10.1126/science.1222789
   Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976
   Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049
   Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112
   Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102
   Joukov V, 2010, P NATL ACAD SCI USA, V107, P21022, DOI 10.1073/pnas.1014664107
   Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725
   Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8
   Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X
   Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008
   Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701
   Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220
   Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5
   Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100
   Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030
   Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007
   Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714
   O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5
   Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457
   Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Slevin LK, 2012, STRUCTURE, V20, P1905, DOI 10.1016/j.str.2012.08.025
   Song MH, 2011, DEV CELL, V20, P563, DOI 10.1016/j.devcel.2011.03.007
   Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325
   Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031
   WOLFF A, 1992, EUR J CELL BIOL, V59, P425
   Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810
   Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055
NR 76
TC 112
Z9 113
U1 0
U2 12
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 15
PY 2013
VL 126
IS 14
BP 3223
EP 3233
DI 10.1242/jcs.129502
PG 11
WC Cell Biology
SC Cell Biology
GA 182MQ
UT WOS:000321747400025
PM 23641073
OA Bronze
DA 2021-01-25
ER

PT J
AU Viktorin, G
   Riebli, N
   Reichert, H
AF Viktorin, Gudrun
   Riebli, Nadia
   Reichert, Heinrich
TI A multipotent transit-amplifying neuroblast lineage in the central brain
   gives rise to optic lobe glial cells in Drosophila
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Drosophila; Neuroglioblast; Type II neuroblast; Glia; Optic lobe
ID CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; POSTEMBRYONIC DEVELOPMENT;
   PROGENITOR CELLS; CENTRAL COMPLEX; RETINAL AXONS; MIGRATION; PROTEIN;
   DIFFERENTIATION; PROLIFERATION
AB The neurons and glial cells of the Drosophila brain are generated by neural stem cell-like progenitors during two developmental phases, one short embryonic phase and one more prolonged postembryonic phase. Like the bulk of the adult-specific neurons, most of glial cells found in the adult central brain are generated postembryonically. Five of the neural stem cell-like progenitors that give rise to glial cells during postembryonic brain development have been identified as type II neuroglioblasts that generate neural and glial progeny through transient amplifying INPs. Here we identify DL1 as a novel multipotent neuroglial progenitor in the central brain and show that this type II neuroblast not only gives rise to neurons that innervate the central complex but also to glial cells that contribute exclusively to the optic lobe. Immediately following their generation in the central brain during the second half of larval development, these DL1 lineage-derived glia migrate into the developing optic lobe, where they differentiate into three identified types of optic lobe glial cells, inner chiasm glia, outer chiasm glia and cortex glia. Taken together, these findings reveal an unexpected central brain origin of optic lobe glial cells and central complex interneurons from one and the same type II neuroglioblast. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Viktorin, Gudrun; Riebli, Nadia; Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
RP Viktorin, G (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM gudrun.viktorin@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF) [31003A 140607]
FX We thank Philipp Kuert and Susanne Flister for help with screening Ga14
   lines, Volker Hartenstein, Holger Apitz, and Iris Salecker for
   assistance in identifying lineages and glial cells and for discussions,
   as well as Bruno Bello, Angela Giangrande, Yanrui Jiang, Cheng-Yu Lee,
   Veronica Rodrigues, Iris Salecker, the Developmental Studies Hybridoma
   bank, and the Bloomington stock center for reagents and fly stocks, and
   an anonymous reviewer for useful suggestions on the manuscript. We thank
   Susanne Flister for excellent technical assistance. Supported by the
   Swiss NSF 31003A 140607.
CR Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740
   Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008
   Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Beckervordersandforth RM, 2008, MECH DEVELOP, V125, P542, DOI 10.1016/j.mod.2007.12.004
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Boyan GS, 2011, TRENDS NEUROSCI, V34, P247, DOI 10.1016/j.tins.2011.02.002
   Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016
   BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8
   CAMPBELL G, 1994, DEVELOPMENT, V120, P2957
   Chotard C, 2007, NEURON GLIA BIOL, V3, P17, DOI 10.1017/S1740925X07000592
   Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Edwards TN, 2012, J COMP NEUROL, V520, P2067, DOI 10.1002/cne.23071
   Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108
   Hartenstein V, 1998, J COMP NEUROL, V402, P32
   Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162
   Hofmeyer K, 2008, DEV BIOL, V315, P28, DOI 10.1016/j.ydbio.2007.10.011
   Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515
   HORTSCH M, 1990, DEVELOPMENT, V110, P1327
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Ito M, 2013, CURR BIOL, V23, P644, DOI 10.1016/j.cub.2013.03.015
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   JACOBS JR, 1989, NEURON, V2, P1625
   Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011
   Jiang YR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-3
   JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5
   Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720
   KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W
   KLAMBT C, 1991, ANN NY ACAD SCI, V633, P142
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Miyata T, 2010, CURR OPIN NEUROBIOL, V20, P22, DOI 10.1016/j.conb.2010.01.001
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Park Y, 2002, DEVELOPMENT, V129, P493
   PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9
   Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   Pignoni F, 1997, DEVELOPMENT, V124, P271
   Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0
   Saini N, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/486169
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660
   Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007
   Soustelle L, 2007, DEV DYNAM, V236, P2101, DOI 10.1002/dvdy.21232
   STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X
   Tix S, 1997, CELL TISSUE RES, V289, P397, DOI 10.1007/s004410050886
   Unhavaithaya Y, 2012, GENE DEV, V26, P31, DOI 10.1101/gad.177436.111
   Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   WINBERG ML, 1992, DEVELOPMENT, V115, P903
   XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981
   Yu HH, 2013, CURR BIOL, V23, P633, DOI 10.1016/j.cub.2013.02.057
NR 67
TC 21
Z9 21
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD JUL 15
PY 2013
VL 379
IS 2
BP 182
EP 194
DI 10.1016/j.ydbio.2013.04.020
PG 13
WC Developmental Biology
SC Developmental Biology
GA 164LT
UT WOS:000320412300005
PM 23628691
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Domingues, TM
   Mattei, B
   Seelig, J
   Perez, KR
   Miranda, A
   Riske, KA
AF Domingues, Tatiana M.
   Mattei, Bruno
   Seelig, Joachim
   Perez, Katia R.
   Miranda, Antonio
   Riske, Karin A.
TI Interaction of the Antimicrobial Peptide Gomesin with Model Membranes: A
   Calorimetric Study
SO LANGMUIR
LA English
DT Article
ID SPIDER ACANTHOSCURRIA-GOMESIANA; MAGAININ 2 AMIDE; PORE FORMATION;
   UNILAMELLAR VESICLES; LIPID-MEMBRANES; LYTIC PEPTIDES; BINDING;
   MECHANISM; LIPOSOMES; THERMODYNAMICS
AB Gomesin is a potent cationic antimicrobial peptide (z = +6) isolated from the Brazilian spider Acanthoscurria gomesiana. The interaction of gomesin with large unilamellar vesicles composed of a 1:1 mixture of zwitterionic (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and anionic (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) phospholipids is studied with isothermal titration calorimetry (ITC). In parallel, light scattering and optical microscopy are used to assess peptide-induced vesicle aggregation. The ability of gomesin to permeabilize the membrane is examined with fluorescence spectroscopy of the leakage of 5,6-carboxyfluorescein (CF). Vesicles coated with 3 mol % 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (PE-PEG) lipids are also investigated to assess the influence of peptide-induced vesicle aggregation in the activity of gomesin. The ITC and light scattering titrations are done in two ways: lipid into peptide and peptide into lipid injections. Although some differences arise between the two setups, the basic interaction of gomesin with anionic vesicles is preserved. A surface partition model combined with the Gouy-Chapman theory is put forward to fit the ITC results. The intrinsic binding constant of gomesin is found to be K approximate to 10(3) M-1. The interaction of gomesin with anionic membranes is highly exothermic and enthalpy-driven. Binding of gomesin is virtually always accompanied by vesicle aggregation and changes in membrane permeability, leading to CF leakage. Addition of PE-PEG to the membrane strongly attenuates vesicle aggregation but does not significantly change the mode of action of gomesin. The results point to a strong interaction of gomesin with the membrane surface, causing membrane rupture without a deep penetration into the bilayer core.
C1 [Domingues, Tatiana M.; Mattei, Bruno; Perez, Katia R.; Miranda, Antonio; Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   [Seelig, Joachim] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Riske, KA (corresponding author), Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
EM kariske@unifesp.br
RI Riske, Karin A/F-2314-2014; Perez, Katia/J-2312-2016; Miranda,
   Antonio/C-8855-2012
OI Perez, Katia Regina/0000-0001-9612-1816
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); INCT-FCx
FX We acknowledge financial support from FAPESP, CAPES, CNPq, and INCT-FCx.
CR Ambroggio EE, 2005, BIOPHYS J, V89, P1874, DOI 10.1529/biophysj.105.066589
   Barbosa FM, 2007, FEMS MICROBIOL LETT, V274, P279, DOI 10.1111/j.1574-6968.2007.00850.x
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   BLUME G, 1990, BIOCHIM BIOPHYS ACTA, V1029, P91, DOI 10.1016/0005-2736(90)90440-Y
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Chen R, 2011, EUR BIOPHYS J BIOPHY, V40, P545, DOI 10.1007/s00249-011-0677-4
   Cummings JE, 2007, BBA-BIOMEMBRANES, V1768, P1796, DOI 10.1016/j.bbamem.2007.04.016
   Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a
   Cabrera MPD, 2011, LANGMUIR, V27, P10805, DOI 10.1021/la202608r
   Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396
   Fazio MA, 2007, BIOPOLYMERS, V88, P386, DOI 10.1002/bip.20660
   Gehman JD, 2008, BIOCHEMISTRY-US, V47, P8557, DOI 10.1021/bi800320v
   Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i
   Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001
   Immordino ML, 2006, INT J NANOMED, V1, P297
   Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
   KENWORTHY AK, 1995, BIOPHYS J, V68, P1921, DOI 10.1016/S0006-3495(95)80369-3
   Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P55
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   Mandard N, 2002, EUR J BIOCHEM, V269, P1190, DOI 10.1046/j.0014-2956.2002.02760.x
   Marquette A, 2010, BIOPHYS J, V98, P2544, DOI 10.1016/j.bpj.2010.02.042
   Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v
   Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8
   Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y
   MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.bb.18.060189.000553
   Miranda A., 2009, ANIMAL TOXINS STATE, P323
   Moreira CK, 2007, EXP PARASITOL, V116, P346, DOI 10.1016/j.exppara.2007.01.022
   Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001
   Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846
   Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h
   Rodrigues EG, 2008, NEOPLASIA, V10, P61, DOI 10.1593/neo.07885
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Sacramento RS, 2009, PARASITOLOGY, V136, P813, DOI 10.1017/S0031182009006283
   Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200
   Stromstedt AA, 2010, CURR OPIN COLLOID IN, V15, P467, DOI 10.1016/j.cocis.2010.05.006
   Tamba Y, 2005, BIOCHEMISTRY-US, V44, P15823, DOI 10.1021/bi051684w
   Tamba Y, 2007, BIOPHYS J, V92, P3178, DOI 10.1529/biophysj.106.097105
   Tang M, 2006, BIOPHYS J, V90, P3616, DOI 10.1529/biophysj.105.062075
   Tirosh O, 1998, BIOPHYS J, V74, P1371, DOI 10.1016/S0006-3495(98)77849-X
   Verly RM, 2008, PEPTIDES, V29, P15, DOI 10.1016/j.peptides.2007.10.028
   Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115
   WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wieprecht T, 2000, BIOPHYS CHEM, V85, P187, DOI 10.1016/S0301-4622(00)00120-4
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200
NR 54
TC 30
Z9 30
U1 2
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 9
PY 2013
VL 29
IS 27
BP 8609
EP 8618
DI 10.1021/la401596s
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 183DE
UT WOS:000321793400019
PM 23755822
DA 2021-01-25
ER

PT J
AU Zahringer, F
   Lacanna, E
   Jenal, U
   Schirmer, T
   Boehm, A
AF Zaehringer, Franziska
   Lacanna, Egidio
   Jenal, Urs
   Schirmer, Tilman
   Boehm, Alex
TI Structure and Signaling Mechanism of a Zinc-Sensory Diguanylate Cyclase
SO STRUCTURE
LA English
DT Article
ID C-DI-GMP; POLYSACCHARIDE ADHESIN; ALLOSTERIC CONTROL; ACTIVATION;
   BINDING; CSRA; DETERMINANTS; EXPRESSION; PGAABCD; DOMAIN
AB Diguanylate cyclases synthesize the second messenger c-di-GMP, which in turn governs a plethora of physiological processes in bacteria. Although most diguanylate cyclases harbor sensory domains, their input signals are largely unknown. Here, we demonstrate that diguanylate cyclase DgcZ (YdeH) from Escherichia coli is regulated allosterically by zinc. Crystal structures show that the zinc ion is bound to the 3His/1 Cys motif of the regulatory chemoreceptor zinc-binding domain, which mediates subunit contact within the dimeric enzyme. In vitro, zinc reversibly inhibits DgcZ with a subfemtomolar K-i constant. In vivo, bacterial biofilnn formation is modulated by externally applied zinc in a DgcZ- and c-di-GMP-dependent fashion. The study outlines the structural principles of this zinc sensor. Zinc binding seems to regulate the activity of the catalytic GGDEF domains by impeding their mobility and thus preventing productive encounter of the two GTP substrates.
C1 [Zaehringer, Franziska; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Jenal, Urs; Boehm, Alex] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Lacanna, Egidio; Boehm, Alex] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany.
   [Boehm, Alex] Univ Marburg, LOEWE Zentrum Synthet Mikrobiol SYNMIKRO, D-35032 Marburg, Germany.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
RI Lacanna, Egidio/G-8050-2016
OI Lacanna, Egidio/0000-0002-6036-8558
FU DFGGerman Research Foundation (DFG) [BO3733/1-1]; LOEWE program of the
   state of Hesse; SNF [31003A_138414, 31003A_130469]
FX We thank Timm Maier for expert crystallographic assistance. This work
   was supported by DFG grant BO3733/1-1 and the LOEWE program of the state
   of Hesse (to A.B.) and by SNF grants 31003A_138414 (to T.S.) and
   31003A_130469 (to U.J.). A.B. gratefully acknowledges support from Jorg
   Vogel (IMIB, Wurzburg, Germany). F.Z., T.S., U.J., and A.B. designed the
   research. F.Z., E.L., and A.B. performed the research. T.S. analyzed the
   data. F.Z., T.S., U.J., and A.B. wrote the manuscript.
CR ANDEREGG G, 1977, CRITICAL SURVEY STAB
   Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030
   Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109
   Draper J, 2011, J BACTERIOL, V193, P4338, DOI 10.1128/JB.05140-11
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09
   Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9
   Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x
   Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512
   Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023
   ROMEO T, 1993, J BACTERIOL, V175, P5740, DOI 10.1128/JB.175.17.5740-5741.1993
   Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Schweinitzer T, 2008, J BACTERIOL, V190, P3244, DOI 10.1128/JB.01940-07
   Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382
   Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008
   Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315
   Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x
   VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x
   WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x
NR 32
TC 55
Z9 59
U1 2
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD JUL 2
PY 2013
VL 21
IS 7
BP 1149
EP 1157
DI 10.1016/j.str.2013.04.026
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 181PS
UT WOS:000321681600012
PM 23769666
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kebbel, F
   Kurz, M
   Arheit, M
   Grutter, MG
   Stahlberg, H
AF Kebbel, Fabian
   Kurz, Mareike
   Arheit, Marcel
   Gruetter, Markus G.
   Stahlberg, Henning
TI Structure and Substrate-Induced Conformational Changes of the Secondary
   Citrate/Sodium Symporter CitS Revealed by Electron Crystallography
SO STRUCTURE
LA English
DT Article
ID KLEBSIELLA-PNEUMONIAE; TRANSPORT PROTEINS; MEMBRANE TOPOLOGY; PROJECTION
   STRUCTURE; BACTERIAL HOMOLOG; NA+/H+ ANTIPORTER; CRYSTAL-STRUCTURE;
   MECHANISM; CLASSIFICATION; CARRIER
AB The secondary Na+/citrate symporter CitS of Klebsiella pneumoniae is the best-characterized member of the 2-hydroxycarboxylate transporter family. The recent projection structure gave insight into its overall structural organization. Here, we present the three-dimensional map of dimeric CitS obtained with electron crystallography. Each monomer has 13 alpha-helical transmembrane segments; six are organized in a distal helix cluster and seven in the central dimer interface domain. Based on structural analyses and comparison to VcINDY, we propose a molecular model for CitS, assign the helices, and demonstrate the internal structural symmetry. We also present projections of CitS in several conformational states induced by the presence and absence of sodium and citrate as substrates. Citrate binding induces a defined movement of alpha helices within the distal helical cluster. Based on this, we propose a substrate translocation site and conformational changes that are in agreement with the transport model of "alternating access".
C1 [Kebbel, Fabian; Arheit, Marcel; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
   [Kurz, Mareike; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.
RP Grutter, MG (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM gruetter@bioc.uzh.ch; henning.stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU Swiss National Science Foundation (National Centers for Competence in
   Research [NCCR] Structural Biology and TransCure) [SNF 315230_127545];
   Swiss Initiative for Systems Biology (SystemsX.ch)
FX We thank Thomas Huber and Andreas Pluckthun for fruitful discussion
   concerning CitS production and Mohamed Chami, Kenneth N. Goldie, and
   Bill Anderson for providing excellent support for the cryo-EM. We also
   thank Shirley A. Muller for her helpful comments on the manuscript. This
   work was supported by the Swiss National Science Foundation (SNF
   315230_127545, National Centers for Competence in Research [NCCR]
   Structural Biology and TransCure), and the Swiss Initiative for Systems
   Biology (SystemsX.ch).
CR Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002
   Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010
   Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455
   Dobrowolski A, 2010, BIOCHEMISTRY-US, V49, P4509, DOI 10.1021/bi100336s
   Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014
   Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321
   Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200
   Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692
   JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0
   Kebbel F, 2012, J MOL BIOL, V418, P117, DOI 10.1016/j.jmb.2012.02.016
   Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143
   Krupnik T, 2011, MOL MEMBR BIOL, V28, P243, DOI 10.3109/09687688.2011.581252
   Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g
   Lolkema JS, 2005, FEBS J, V272, P2334, DOI 10.1111/j.1742-4658.2005.04665.x
   LOLKEMA JS, 1994, EUR J BIOCHEM, V220, P469, DOI 10.1111/j.1432-1033.1994.tb18645.x
   Lolkema JS, 2003, J MOL BIOL, V327, P901, DOI 10.1016/S0022-2836(03)00214-6
   Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516
   Lolkema JS, 2006, J MOL MICROB BIOTECH, V11, P318, DOI 10.1159/000095634
   Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542
   Moscicka KB, 2009, BIOCHEMISTRY-US, V48, P6618, DOI 10.1021/bi900838d
   Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pos KM, 1996, BIOCHEMISTRY-US, V35, P1018, DOI 10.1021/bi951609t
   Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616
   Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000
   Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303
   Sobczak I, 2005, BIOCHEMISTRY-US, V44, P5461, DOI 10.1021/bi047759y
   Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005
   Sobczak T, 2005, MICROBIOL MOL BIOL R, V69, P665, DOI 10.1128/MMBR.69.4.665-695.2005
   Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524
   ter Horst R, 2012, BBA-BIOMEMBRANES, V1818, P72, DOI 10.1016/j.bbamem.2011.09.021
   Tsai CJ, 2010, CURR OPIN STRUC BIOL, V20, P448, DOI 10.1016/j.sbi.2010.06.005
   Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611
   van Geest M, 2000, BBA-BIOMEMBRANES, V1466, P328, DOI 10.1016/S0005-2736(00)00185-1
   VANDERREST ME, 1992, J BACTERIOL, V174, P4893, DOI 10.1128/JB.174.15.4893-4898.1992
   Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978
NR 38
TC 9
Z9 9
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD JUL 2
PY 2013
VL 21
IS 7
BP 1243
EP 1250
DI 10.1016/j.str.2013.05.011
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 181PS
UT WOS:000321681600021
PM 23810698
OA Bronze
DA 2021-01-25
ER

PT J
AU Domingues, TM
   Mattei, B
   Seelig, J
   Perez, KR
   Miranda, A
   Riske, KA
AF Domingues, T. M.
   Mattei, B.
   Seelig, J.
   Perez, K. R.
   Miranda, A.
   Riske, K. A.
TI Interaction of the antimicrobial peptide gomesin with model membranes
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Domingues, T. M.; Mattei, B.; Perez, K. R.; Miranda, A.; Riske, K. A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   [Seelig, J.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RI Miranda, Antonio/C-8855-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S149
EP S149
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300436
DA 2021-01-25
ER

PT J
AU Hochstetter, A
   Stellamanns, E
   Uppaluri, S
   Heddergott, N
   Engstler, M
   Pfohl, T
AF Hochstetter, A.
   Stellamanns, E.
   Uppaluri, S.
   Heddergott, N.
   Engstler, M.
   Pfohl, T.
TI Tracing the microscopic motility of unicellular parasites
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Hochstetter, A.; Pfohl, T.] Univ Basel, Dept Chem, Basel, Switzerland.
   [Stellamanns, E.; Uppaluri, S.] Max Planck Inst Dynam & Selbstorganisat, Gottingen, Germany.
   [Heddergott, N.; Engstler, M.] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany.
RI Hochstetter, Axel/N-5910-2014; Pfohl, Thomas/D-7296-2016
OI Hochstetter, Axel/0000-0002-2791-2400; Pfohl, Thomas/0000-0002-7879-5216
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S97
EP S97
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300237
DA 2021-01-25
ER

PT J
AU Kapinos, LE
   Schoch, RL
   Wagner, R
   Lim, RYH
AF Kapinos, L. E.
   Schoch, R. L.
   Wagner, R.
   Lim, R. Y. H.
TI Karyopherin binding induces conformational transitions in the
   intrinsically disordered FG domains
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
CR Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092
   Schoch RL, 2013, LANGMUIR, V29, P4068, DOI 10.1021/la3049289
   Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S186
EP S186
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300578
DA 2021-01-25
ER

PT J
AU Steimer, L
   Wurm, JP
   Linden, MH
   Rudolph, MG
   Wohnert, J
   Klostermeier, D
AF Steimer, L.
   Wurm, J. P.
   Linden, M. H.
   Rudolph, M. G.
   Woehnert, J.
   Klostermeier, D.
TI RNA binding and unwinding by the T. thermophilus DEAD-box helicase Hera
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Steimer, L.; Klostermeier, D.] Univ Munster, Inst Phys Chem, Munster, Germany.
   [Wurm, J. P.; Woehnert, J.] Goethe Univ Frankfurt, Inst Mol Biosci, D-60054 Frankfurt, Germany.
   [Linden, M. H.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Rudolph, M. G.] F Hoffmann La Roche & Cie AG, Pharma Res & Early Dev, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S133
EP S133
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300378
DA 2021-01-25
ER

PT J
AU Steimer, L
   Wurm, JP
   Linden, MH
   Rudolph, MG
   Wohnert, J
   Klostermeier, D
AF Steimer, Lenz
   Wurm, Jan Philip
   Linden, Martin H.
   Rudolph, Markus G.
   Woehnert, Jens
   Klostermeier, Dagmar
TI Recognition of two distinct elements in the RNA substrate by the
   RNA-binding domain of the T-thermophilus DEAD box helicase Hera
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID C-TERMINAL DOMAIN; NUCLEOPORIN NUP214; CRYSTAL-STRUCTURE; STRUCTURAL
   BASIS; PROTEIN; MOTIF; YXIN; NMR
AB DEAD box helicases catalyze the ATP-dependent destabilization of RNA duplexes. Whereas duplex separation is mediated by the helicase core shared by all members of the family, flanking domains often contribute to binding of the RNA substrate. The Thermus thermophilus DEAD-box helicase Hera (for "heat-resistant RNA-binding ATPase") contains a C-terminal RNA-binding domain (RBD). We have analyzed RNA binding to the Hera RBD by a combination of mutational analyses, nuclear magnetic resonance and X-ray crystallography, and identify residues on helix alpha 1 and the C-terminus as the main determinants for high-affinity RNA binding. A crystal structure of the RBD in complex with a single-stranded RNA resolves the RNA-protein interactions in the RBD core region around helix alpha 1. Differences in RNA binding to the Hera RBD and to the structurally similar RBD of the Bacillus subtilis DEAD box helicase YxiN illustrate the versatility of RNA recognition motifs as RNA-binding platforms. Comparison of chemical shift perturbation patterns elicited by different RNAs, and the effect of sequence changes in the RNA on binding and unwinding show that the RBD binds a single-stranded RNA region at the core and simultaneously contacts double-stranded RNA through its C-terminal tail. The helicase core then unwinds an adjacent RNA duplex. Overall, the mode of RNA binding by Hera is consistent with a possible function as a general RNA chaperone.
C1 [Steimer, Lenz; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany.
   [Wurm, Jan Philip; Woehnert, Jens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Mol Biosci, D-60438 Frankfurt, Germany.
   [Linden, Martin H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Rudolph, Markus G.] F Hoffmann La Roche & Cie AG, PRED, Pharma Res & Early Dev, Discovery Technol, CH-4070 Basel, Switzerland.
RP Wohnert, J (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.
EM woehnert@bio.uni-frankfurt.de; dagmar.klostermeier@uni-muenster.de
OI Rudolph, Markus/0000-0003-0447-1101
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Aventis Foundation professorship in Chemical Biology; University
   of Muenster;  [SFB 902]
FX Swiss National Science Foundation (to D. K.); Aventis Foundation
   professorship in Chemical Biology; SFB 902 'Molecular principles of
   RNA-based regulation' (to J.W.). Funding for open access charge:
   University of Muenster.
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006
   Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032
   Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814
   Duchardt-Ferner E, 2010, ANGEW CHEM INT EDIT, V49, P6216, DOI 10.1002/anie.201001339
   Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1
   Einspahr H.M., 2011, INT TABLES CRYSTAL F, VF, P64
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Hardin JW, 2010, J MOL BIOL, V402, P412, DOI 10.1016/j.jmb.2010.07.040
   Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Keller R, 2004, COMPUTER AIDED RESON
   Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154
   Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106
   OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0
   Pugh GE, 1999, J MOL BIOL, V292, P771, DOI 10.1006/jmbi.1999.3112
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Rudolph MG, 2009, RNA, V15, P1993, DOI 10.1261/rna.1820009
   Rudolph MG, 2009, ACTA CRYSTALLOGR F, V65, P248, DOI 10.1107/S1744309108043145
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Warkentin Matthew, 2007, Journal of Structural and Functional Genomics, V8, P141, DOI 10.1007/s10969-007-9029-0
   Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 42
TC 14
Z9 14
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL
PY 2013
VL 41
IS 12
BP 6259
EP 6272
DI 10.1093/nar/gkt323
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 173DA
UT WOS:000321057100032
PM 23625962
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Helker, CSM
   Schuermann, A
   Karpanen, T
   Zeuschner, D
   Belting, HG
   Affolter, M
   Schulte-Merker, S
   Herzog, W
AF Helker, Christian S. M.
   Schuermann, Annika
   Karpanen, Terhi
   Zeuschner, Dagmar
   Belting, Heinz-Georg
   Affolter, Markus
   Schulte-Merker, Stefan
   Herzog, Wiebke
TI The zebrafish common cardinal veins develop by a novel mechanism: lumen
   ensheathment
SO DEVELOPMENT
LA English
DT Article
DE Cadherin 5; Vegfc; Angioblast specification; Collective migration;
   Common cardinal vein; Lumen formation
ID MOLECULAR-MECHANISMS; VESSEL FUSION; VE-CADHERIN; LYMPHANGIOGENESIS;
   SPECIFICATION; GENE; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION;
   RECEPTORS
AB The formation and lumenization of blood vessels has been studied in some detail, but there is little understanding of the morphogenetic mechanisms by which endothelial cells (ECs) forming large caliber vessels aggregate, align themselves and finally form a lumen that can support blood flow. Here, we focus on the development of the zebrafish common cardinal veins (CCVs), which collect all the blood from the embryo and transport it back to the heart. We show that the angioblasts that eventually form the definitive CCVs become specified as a separate population distinct from the angioblasts that form the lateral dorsal aortae. The subsequent development of the CCVs represents a novel mechanism of vessel formation, during which the ECs delaminate and align along the inner surface of an existing luminal space. Thereby, the CCVs are initially established as open-ended endothelial tubes, which extend as single EC sheets along the flow routes of the circulating blood and eventually enclose the entire lumen in a process that we term 'lumen ensheathment'. Furthermore, we found that the initial delamination of the ECs as well as the directional migration within the EC sheet depend on Cadherin 5 function. By contrast, EC proliferation within the growing CCV is controlled by Vascular endothelial growth factor C, which is provided by circulating erythrocytes. Our findings not only identify a novel mechanism of vascular lumen formation, but also suggest a new form of developmental crosstalk between hematopoietic and endothelial cell lineages.
C1 [Helker, Christian S. M.; Schuermann, Annika; Herzog, Wiebke] Univ Munster, D-48149 Munster, Germany.
   [Karpanen, Terhi; Schulte-Merker, Stefan] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.
   [Helker, Christian S. M.; Schulte-Merker, Stefan] UMC, NL-3584 CT Utrecht, Netherlands.
   [Zeuschner, Dagmar; Herzog, Wiebke] Max Planck Inst Mol Biomed, D-48149 Munster, Germany.
   [Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schulte-Merker, Stefan] Wageningen Univ, EZO, NL-6700 AH Wageningen, Netherlands.
RP Herzog, W (corresponding author), Univ Munster, D-48149 Munster, Germany.
EM wiebke.herzog@mpi-muenster.mpg.de
OI Affolter, Markus/0000-0002-5171-0016; Helker,
   Christian/0000-0003-0427-5338; Belting, Heinz-Georg/0000-0002-1538-4364;
   Herzog, Wiebke/0000-0002-9843-3458
FU North Rhine Westphalia (NRW) 'return fellowship'; VENI grant from the
   Netherlands Organization for Scientific Research (NWO)Netherlands
   Organization for Scientific Research (NWO); KNAW; Kantons Basel-Stadt
   and Basel-Land; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF)
FX C.S.M.H., A.S. and W.H. were funded by the North Rhine Westphalia (NRW)
   'return fellowship'; T.K. was supported by a VENI grant from the
   Netherlands Organization for Scientific Research (NWO); S.S.-M. is
   supported by the KNAW; H.-G.B. and M.A. are supported by the Kantons
   Basel-Stadt and Basel-Land and by a grant from the Swiss National
   Science Foundation to M.A.
CR Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599
   Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105
   Atkins GB, 2011, ARTERIOSCL THROM VAS, V31, P1476, DOI 10.1161/ATVBAHA.111.228999
   Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408
   Chung WS, 2008, DEV CELL, V14, P582, DOI 10.1016/j.devcel.2008.02.012
   Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144
   Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103
   David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530
   Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183
   Dupin I, 2009, J CELL BIOL, V185, P779, DOI 10.1083/jcb.200812034
   Dyer LA, 2010, SEMIN THROMB HEMOST, V36, P227, DOI 10.1055/s-0030-1253446
   Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035
   Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001
   Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78
   Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021
   Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96
   Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Herzog W, 2009, CIRC RES, V104, P1260, DOI 10.1161/CIRCRESAHA.108.191718
   Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990
   Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321
   Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Joukov V, 1996, EMBO J, V15, P290
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kingsley PD, 2004, BLOOD, V104, P19, DOI 10.1182/blood-2003-12-4162
   Krens SFG, 2011, P NATL ACAD SCI USA, V108, pE9, DOI 10.1073/pnas.1010767108
   Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026
   Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102
   Lawson ND, 2001, DEVELOPMENT, V128, P3675
   Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651
   McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581
   Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19
   Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951
   Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036
   Pyrgaki C, 2010, DEV BIOL, V344, P941, DOI 10.1016/j.ydbio.2010.06.010
   Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014
   Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220
   Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3
   Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078
   Sakaguchi T, 2001, MECH DEVELOP, V107, P25, DOI 10.1016/S0925-4773(01)00453-1
   Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8
   Schieber NL, 2010, METHOD CELL BIOL, V96, P425, DOI 10.1016/S0091-679X(10)96018-4
   Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012
   Schulte-Merker Stefan, 2002, P39
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Strilic B, 2010, CELL MOL LIFE SCI, V67, P3209, DOI 10.1007/s00018-010-0400-0
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805
   Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887
   Torres-Vaazquez J, 2003, CELL TISSUE RES, V314, P43, DOI 10.1007/s00441-003-0771-8
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091
   Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785
   Westerfield M., 1993, ZEBRAFISH BOOK
   Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232
   Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427
   Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599
NR 71
TC 59
Z9 61
U1 0
U2 13
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JUL 1
PY 2013
VL 140
IS 13
BP 2776
EP 2786
DI 10.1242/dev.091876
PG 11
WC Developmental Biology
SC Developmental Biology
GA 161CH
UT WOS:000320168300015
PM 23698350
OA Bronze
DA 2021-01-25
ER

PT J
AU Pieters, J
   Muller, P
   Jayachandran, R
AF Pieters, Jean
   Mueller, Philipp
   Jayachandran, Rajesh
TI On guard: coronin proteins in innate and adaptive immunity
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID ACTIN-BINDING-PROTEIN; CALCINEURIN-A-BETA; T-CELL SURVIVAL;
   MYCOBACTERIUM-TUBERCULOSIS; ARP2/3 COMPLEX; FUNCTIONAL-CHARACTERIZATION;
   F-ACTIN; CALCIUM; MACROPHAGES; ACTIVATION
AB Recent work has implicated members of the evolutionarily conserved family of coronin proteins-in particular coronin 1-in immune homeostasis. Coronins are involved in processes as diverse as pathogen survival in phagocytes and homeostatic T cell signalling. Notably, in both mice and humans, coronin mutations are associated with immune deficiencies and resistance to autoimmunity. In this article, we review what is currently known about these conserved molecules and discuss a potential common mechanism that underlies their diverse activities, which seem to involve cytoskeletal interactions as well as calcium-calcineurin signalling.
C1 [Pieters, Jean; Jayachandran, Rajesh] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mueller, Philipp] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland.
   [Mueller, Philipp] Univ Basel Hosp, CH-4031 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Canton of Basel; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF)
FX The authors thank D. Moshous, K. Siegmund, M. Stiess and A. Vinet for
   critical reading and comments, A. Roulier for illustrations and members
   of the laboratory for discussions. R.J. is a Max Cloetta medical
   research fellow. Work in the laboratory of J.P. is financed by the
   Canton of Basel and the Swiss National Science Foundation.
CR Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115
   Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013
   Arandjelovic S, 2010, J LEUKOCYTE BIOL, V88, P737, DOI 10.1189/jlb.0310131
   ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1
   Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345
   Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06
   Brandborg L. L., 1990, HEPATOLOGY TXB LIVER, P1086
   Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399
   Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054
   Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641
   Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031
   Carrithers LM, 2011, FEMS IMMUNOL MED MIC, V63, P319, DOI 10.1111/j.1574-695X.2011.00853.x
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133
   Eckert C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-268
   Falkow S, 2006, CELL, V124, P699, DOI 10.1016/j.cell.2006.02.004
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757
   Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007
   Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5
   Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022
   Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   Hogquist KA, 2008, NAT IMMUNOL, V9, P1207, DOI 10.1038/ni1108-1207
   Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018
   Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102
   Kerstan A, 2006, J IMMUNOL, V177, P7689, DOI 10.4049/jimmunol.177.11.7689
   Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269
   KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270
   Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012
   Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964
   MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   Manicassamy S, 2008, J IMMUNOL, V180, P106, DOI 10.4049/jimmunol.180.1.106
   Marshall TW, 2009, J CELL SCI, V122, P3061, DOI 10.1242/jcs.051482
   Mendez-Samperio P, 2006, J INFECTION, V52, P147, DOI 10.1016/j.jinf.2005.02.027
   Mendez-Samperio P, 2004, MEDIAT INFLAMM, V13, P45, DOI 10.1080/09629350410001664743
   Mendez-Samperio P, 2007, J INFECTION, V54, P469, DOI 10.1016/j.jinf.2006.08.009
   Montoya D, 2010, ADV IMMUNOL, V105, P1, DOI 10.1016/S0065-2776(10)05001-7
   Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312
   Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042
   MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467
   Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377
   Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322
   NORTH RJ, 1974, INFECT IMMUN, V10, P66, DOI 10.1128/IAI.10.1.66-71.1974
   Okumura M, 1998, DNA CELL BIOL, V17, P779, DOI 10.1089/dna.1998.17.779
   Pareek TK, 2010, J EXP MED, V207, P2507, DOI 10.1084/jem.20100876
   Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898
   Robinson DN, 2000, J CELL BIOL, V150, P823, DOI 10.1083/jcb.150.4.823
   Rojas M, 2000, J INFECT DIS, V182, P240, DOI 10.1086/315676
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066
   Santiago-Raber ML, 2007, J IMMUNOL, V178, P8195, DOI 10.4049/jimmunol.178.12.8195
   Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x
   Shina MC, 2011, CELL MOL LIFE SCI, V68, P303, DOI 10.1007/s00018-010-0455-y
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002
   SIBLEY LD, 1987, INFECT IMMUN, V55, P680, DOI 10.1128/IAI.55.3.680-685.1987
   Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491
   STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0
   Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Suzuki K, 2006, ACTA HISTOCHEM CYTOC, V39, P107, DOI 10.1267/ahc.06010
   Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581
   Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9
   Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057
   Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   WARDLE EN, 1987, LIVER, V7, P63
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557
   Westritschnig K, 2013, MOL IMMUNOL, V53, P379, DOI 10.1016/j.molimm.2012.09.002
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
   Yagi H, 1996, J IMMUNOL, V157, P3412
   Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769
   Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120
   Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x
NR 100
TC 54
Z9 56
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD JUL
PY 2013
VL 13
IS 7
BP 510
EP 518
DI 10.1038/nri3465
PG 9
WC Immunology
SC Immunology
GA 170LT
UT WOS:000320853100011
PM 23765056
DA 2021-01-25
ER

PT J
AU McCann, HC
   Rikkerink, EHA
   Bertels, F
   Fiers, M
   Lu, A
   Rees-George, J
   Andersen, MT
   Gleave, AP
   Haubold, B
   Wohlers, MW
   Guttman, DS
   Wang, PW
   Straub, C
   Vanneste, J
   Rainey, PB
   Templeton, MD
AF McCann, Honour C.
   Rikkerink, Erik H. A.
   Bertels, Frederic
   Fiers, Mark
   Lu, Ashley
   Rees-George, Jonathan
   Andersen, Mark T.
   Gleave, Andrew P.
   Haubold, Bernhard
   Wohlers, Mark W.
   Guttman, David S.
   Wang, Pauline W.
   Straub, Christina
   Vanneste, Joel
   Rainey, Paul B.
   Templeton, Matthew D.
TI Genomic Analysis of the Kiwifruit Pathogen Pseudomonas syringae pv.
   actinidiae Provides Insight into the Origins of an Emergent Plant
   Disease
SO PLOS PATHOGENS
LA English
DT Article
ID III SECRETION SYSTEM; BACTERIAL CANKER; PHYLOGENETIC ANALYSIS;
   MYCOSPHAERELLA-GRAMINICOLA; INNATE IMMUNITY; 1ST REPORT; SEQUENCE;
   VIRULENCE; EFFECTOR; POPULATIONS
AB The origins of crop diseases are linked to domestication of plants. Most crops were domesticated centuries - even millennia - ago, thus limiting opportunity to understand the concomitant emergence of disease. Kiwifruit (Actinidia spp.) is an exception: domestication began in the 1930s with outbreaks of canker disease caused by P. syringae pv. actinidiae (Psa) first recorded in the 1980s. Based on SNP analyses of two circularized and 34 draft genomes, we show that Psa is comprised of distinct clades exhibiting negligible within-clade diversity, consistent with disease arising by independent samplings from a source population. Three clades correspond to their geographical source of isolation; a fourth, encompassing the Psa-V lineage responsible for the 2008 outbreak, is now globally distributed. Psa has an overall clonal population structure, however, genomes carry a marked signature of within-pathovar recombination. SNP analysis of Psa-V reveals hundreds of polymorphisms; however, most reside within PPHGI-1-like conjugative elements whose evolution is unlinked to the core genome. Removal of SNPs due to recombination yields an uninformative (star-like) phylogeny consistent with diversification of Psa-V from a single clone within the last ten years. Growth assays provide evidence of cultivar specificity, with rapid systemic movement of Psa-V in Actinidia chinensis. Genomic comparisons show a dynamic genome with evidence of positive selection on type III effectors and other candidate virulence genes. Each clade has highly varied complements of accessory genes encoding effectors and toxins with evidence of gain and loss via multiple genetic routes. Genes with orthologs in vascular pathogens were found exclusively within Psa-V. Our analyses capture a pathogen in the early stages of emergence from a predicted source population associated with wild Actinidia species. In addition to candidate genes as targets for resistance breeding programs, our findings highlight the importance of the source population as a reservoir of new disease.
C1 [McCann, Honour C.; Bertels, Frederic; Straub, Christina; Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.
   [McCann, Honour C.; Bertels, Frederic; Straub, Christina; Rainey, Paul B.] Massey Univ, Allan Wilson Ctr, Auckland, New Zealand.
   [McCann, Honour C.; Guttman, David S.; Wang, Pauline W.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada.
   [Rikkerink, Erik H. A.; Rees-George, Jonathan; Andersen, Mark T.; Gleave, Andrew P.; Wohlers, Mark W.; Templeton, Matthew D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.
   [Bertels, Frederic] Univ Basel, Biozentrum, Basel, Switzerland.
   [Bertels, Frederic] Swiss Inst Bioinformat, Basel, Switzerland.
   [Fiers, Mark; Lu, Ashley] New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand.
   [Haubold, Bernhard; Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany.
   [Vanneste, Joel] New Zealand Inst Plant & Food Res Ltd, Hamilton, New Zealand.
   [Templeton, Matthew D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
RP Rainey, PB (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.
EM rainey@evolbio.mpg.de; matt.templeton@plantandfood.co.nz
RI Wohlers, Mark/L-1225-2017; Rainey, Paul/A-3207-2008; Fiers, Mark
   WEJ/E-6755-2010; Templeton, Matthew D./J-6966-2017; Rikkerink, Erik H
   A/B-5752-2011; Guttman, David/A-7839-2011; Vanneste, Joel L/L-8636-2016;
   Vanneste, Joel/H-2784-2019
OI Wohlers, Mark/0000-0001-6077-8672; Rainey, Paul/0000-0003-0879-5795;
   Fiers, Mark WEJ/0000-0001-5694-2409; Templeton, Matthew
   D./0000-0003-0192-9041; Rikkerink, Erik H A/0000-0003-4682-5078;
   Guttman, David/0000-0001-8479-3869; Vanneste, Joel
   L/0000-0002-4877-0667; Vanneste, Joel/0000-0002-4877-0667; Straub,
   Christina/0000-0002-1047-1362; Gleave, Andrew/0000-0002-0105-1737;
   Bertels, Frederic/0000-0001-6222-4139
FU New Zealand Ministry for Business, Innovation and EmploymentNew Zealand
   Ministry of Business, Innovation and Employment (MBIE) [C06X0812]; Allan
   Wilson Centre for Molecular Ecology and Evolution; Zespri International,
   Mt Maunganui, New Zealand
FX This work was funded in part by the New Zealand Ministry for Business,
   Innovation and Employment (www.mbie.govt.nz) contract C06X0812 (to MDT
   and EHAR), and Allan Wilson Centre for Molecular Ecology and Evolution
   (http://www.allanwilsoncentre.ac.nz/) (to PBR). PBR is grateful for
   support from Zespri International, Mt Maunganui, New Zealand
   (http://www.Zespri.com). The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856
   Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376
   Balestra GM, 2013, PLANT DIS, V97, P472, DOI 10.1094/PDIS-06-12-0590-RE
   Balestra GM, 2009, PHYTOPATHOL MEDITERR, V48, P299
   Baltrus DA, 2012, MOL PLANT MICROBE IN, V25, P877, DOI 10.1094/MPMI-08-11-0218
   Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132
   Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8
   Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58
   Bielawski JP, 2005, STAT BIOL HEALTH, P103, DOI 10.1007/0-387-27733-1_5
   Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683
   Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647
   Brook PJ, 1990, KIWIFRUIT SCI MANAGE, P420
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x
   Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100
   Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464
   Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130
   Campos A, 2009, EUR J PLANT PATHOL, V125, P603, DOI 10.1007/s10658-009-9509-0
   Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R
   Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123
   Ciraulo MB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/781365
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   Domazet-Loso M, 2011, BIOINFORMATICS, V27, P1466, DOI 10.1093/bioinformatics/btr176
   Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9
   Fang Y, 1990, SICHUAN FRUIT SCI TE, V18, P28
   Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561
   Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102
   Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x
   Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1
   Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x
   Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388
   Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224
   Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069
   Guo W, 2012, APPL ENVIRON MICROB, V78, P5672, DOI 10.1128/AEM.07997-11
   Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Jackson Robert W, 2011, Mob Genet Elements, V1, P55
   Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654
   KING EO, 1954, J LAB CLIN MED, V44, P301
   Kniskern JM, 2011, EVOLUTION, V65, P818, DOI 10.1111/j.1558-5646.2010.01157.x
   Koh YJ, 2010, NEW ZEAL J CROP HORT, V38, P275, DOI 10.1080/01140671.2010.512624
   Koh YJ, 1994, PLANT PATHOL, V10, P68
   Korber B., 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102
   Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350
   Lee AHY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002523
   Li X., 2008, FRONT BIOL CHINA, V4, P55, DOI [10.1007/s11515-008-0110-2, DOI 10.1007/S11515-008-0110-2]
   Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151
   Loytynoja A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-579
   Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106
   Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102
   Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395
   Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297
   Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10
   Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518
   McCann HC, 2012, P NATL ACAD SCI USA, V109, P4215, DOI 10.1073/pnas.1113893109
   Mellgren EM, 2009, J BACTERIOL, V191, P3132, DOI 10.1128/JB.01570-08
   Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705
   Morris CE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000693
   Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867
   Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392
   Nathanson N, 1997, AM J EPIDEMIOL, V145, P959, DOI 10.1093/oxfordjournals.aje.a009064
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108
   Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423
   Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110
   Payne R.W., 2011, INTRO GENSTAT WINDOW
   Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074
   Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11
   Rees-George J, 2010, PLANT PATHOL, V59, P453, DOI 10.1111/j.1365-3059.2010.02259.x
   ROOS IMM, 1987, PHYTOPATHOLOGY, V77, P1253, DOI 10.1094/Phyto-77-1253
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004
   SAWYER S, 1989, MOL BIOL EVOL, V6, P526
   Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004
   SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x
   Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x
   Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11
   SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427
   Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51
   Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31
   Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839
   Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114
   Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398
   Stukenbrock EH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002893
   Stukenbrock EH, 2011, GENOME RES, V21, P2157, DOI 10.1101/gr.118851.110
   Stukenbrock EH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001189
   Stukenbrock EH, 2012, P NATL ACAD SCI USA, V109, P10954, DOI 10.1073/pnas.1201403109
   Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104
   Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE
   Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195
   Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212
   WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9
   Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249
   Zhou HB, 2011, CELL HOST MICROBE, V9, P177, DOI 10.1016/j.chom.2011.02.007
NR 96
TC 138
Z9 151
U1 2
U2 140
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2013
VL 9
IS 7
AR e1003503
DI 10.1371/journal.ppat.1003503
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 190CX
UT WOS:000322316700043
PM 23935484
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Ackermann, S
   Heck, A
   Rasch, B
   Papassotiropoulos, A
   de Quervain, DJF
AF Ackermann, Sandra
   Heck, Angela
   Rasch, Bjoern
   Papassotiropoulos, Andreas
   de Quervain, Dominique J. -F.
TI The BclI polymorphism of the glucocorticoid receptor gene is associated
   with emotional memory performance in healthy individuals
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Glucocorticoid receptor gene polymorphism; BclI; Memory; Emotion
ID POSTTRAUMATIC-STRESS-DISORDER; SENSITIVITY; SYSTEM
AB Glucocorticoids, stress hormones released from the adrenal cortex, are important players in the regulation of emotional memory. Specifically, in animals and in humans, glucocorticoids enhance memory consolidation of emotionally arousing experiences, but impair memory retrieval. These glucocorticoid actions are partly mediated by glucocorticoid receptors in the hippocampus, amygdala and prefrontal cortex, key brain regions for emotional memory. In a recent study in patients who underwent cardiac surgery, the BclI polymorphism of the glucocorticoid receptor gene (NR3C1) was associated with traumatic memories and posttraumatic stress disorder symptoms after intensive care therapy. Based on this finding, we investigated if the BclI polymorphism is also associated with emotional memory in healthy young subjects (N = 841). We used a picture-learning task consisting of learning and recalling neutral and emotional photographs on two consecutive days. The BclI variant was associated with short-delay recall of emotional pictures on both days, with GG carriers showing increased emotional memory performance as compared to GC and CC carriers. We did not detect a genotype-dependent difference in recall performance for neutral pictures. These findings suggest that the BclI polymorphism contributes to inter-individual differences in emotional memory also in healthy humans. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Ackermann, Sandra; Heck, Angela; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Rasch, Bjoern] Univ Zurich, Dept Psychol, Div Biopsychol, Zurich, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
RP Ackermann, S (corresponding author), Univ Basel, Dept Psychol, Div Mol Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM sandra.ackermann@unibas.ch
RI Rasch, Bjorn/A-3119-2015
OI Rasch, Bjorn/0000-0001-7607-3415; de Quervain,
   Dominique/0000-0001-7131-2464; Heck, Angela/0000-0002-1543-3197;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSIK0_122691, CRSI33_130080]; 7th Framework Programme of the
   European Union (ADAMS project) [HEALTH-F4-2009-242257]
FX This work was funded by the Swiss National Science Foundation (Sinergia
   grants CRSIK0_122691, CRSI33_130080 to D.Q. and A.P.) and by the 7th
   Framework Programme of the European Union (ADAMS project,
   HEALTH-F4-2009-242257).
CR Bachmann AW, 2005, PSYCHONEUROENDOCRINO, V30, P297, DOI 10.1016/j.psyneuen.2004.08.006
   de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542
   de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002
   DeRijk R, 2005, ENDOCRINE, V28, P263, DOI 10.1385/ENDO:28:3:263
   Hauer D, 2011, CRIT CARE MED, V39, P643, DOI 10.1097/CCM.0b013e318206bae6
   Kumsta R, 2010, NEUROPSYCHOBIOLOGY, V61, P49, DOI 10.1159/000262180
   Lang P. J., 1988, INT AFFECTIVE PICTUR
   MCEWEN BS, 1986, PHYSIOL REV, V66, P1121
   OITZL MS, 1992, BEHAV NEUROSCI, V106, P62, DOI 10.1037/0735-7044.106.1.62
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765
   Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X
   Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932
   van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007
   van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x
   Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034
NR 16
TC 16
Z9 16
U1 1
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD JUL
PY 2013
VL 38
IS 7
BP 1203
EP 1207
DI 10.1016/j.psyneuen.2012.10.009
PG 5
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA 164LU
UT WOS:000320412400025
PM 23148886
DA 2021-01-25
ER

PT J
AU Mizuno, K
   Boudko, S
   Engel, J
   Bachinger, HP
AF Mizuno, Kazunori
   Boudko, Sergei
   Engel, Juergen
   Baechinger, Hans Peter
TI Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen
   Differently Stall the Triple Helical Folding
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CRYSTAL-STRUCTURE; OSTEOGENESIS IMPERFECTA; TRIMERIZATION DOMAIN;
   CONNECTIVE-TISSUE; NC2 DOMAIN; CHAIN; DISORDER; FIBRILS; PEPTIDE;
   HAPLOINSUFFICIENCY
AB Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen. Aslower folding of the collagen helix is a potential cause for over-modifications. However, little is known about the rate of folding of type III collagen in patients with EDS. To understand the molecular mechanism of the effect of mutations, a system was developed for bacterial production of homotrimeric model polypeptides. The C-terminal quarter, 252 residues, of the natural human type III collagen was attached to (GPP)(7) with the type XIX collagen trimerization domain (NC2). The natural collagen domain forms a triple helical structure without 4-hydroxylation of proline at a low temperature. At 33 degrees C, the natural collagenous part is denatured, but the C-terminal (GPP)(7)-NC2 remains intact. Switching to a low temperature triggers the folding of the type III collagen domain in a zipper-like fashion that resembles the natural process. We used this system for the two known EDS mutations (Gly-to-Val) in the middle at Gly-910 and at the C terminus at Gly-1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is much more severe compared with Gly-to-Ala. This is the first report on the folding of collagen with EDS mutations, which demonstrates local delays in the triple helix propagation around the mutated residue.
C1 [Mizuno, Kazunori; Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland Res Ctr, Portland, OR 97239 USA.
   [Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Portland Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hpb@shcc.org
OI Mizuno, Kazunori/0000-0003-3354-6264
FU Shriners Hospitals for Children
FX This work was supported by a grant from Shriners Hospitals for Children
   (to H. P. B.).
CR Aebi U., 2006, CELL BIOL LAB HDB, P241
   BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204
   BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059
   Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko S. P., 2012, INT J BIOCH CELL BIO, V44
   Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200
   Boudko SP, 2012, J BIOL CHEM, V287, P44536, DOI 10.1074/jbc.M112.417543
   Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405
   Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104
   Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x
   Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200
   Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842
   Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253
   Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181
   De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874
   KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393
   Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852
   Malfait F, 2005, AM J MED GENET C, V139C, P17, DOI 10.1002/ajmg.c.30070
   Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019
   MORRIS NP, 1986, J BIOL CHEM, V261, P5638
   Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381
   Okuyama K, 2009, ACTA CRYSTALLOGR D, V65, P1007, DOI 10.1107/S0907444909023051
   PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901
   RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458
   Royce P. M., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9
   Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004
   Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243
   Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123
   Smith LB, 2011, CARDIOVASC RES, V90, P182, DOI 10.1093/cvr/cvq356
   Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441
   Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228
   Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200
   Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005
   Wu JJ, 2010, J BIOL CHEM, V285, P18537, DOI 10.1074/jbc.M110.112904
   Yoshizumi A, 2011, J BIOL CHEM, V286, P17512, DOI 10.1074/jbc.M110.217364
   Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356
NR 50
TC 16
Z9 16
U1 0
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 28
PY 2013
VL 288
IS 26
BP 19166
EP 19176
DI 10.1074/jbc.M113.462002
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 176WB
UT WOS:000321335800050
PM 23645670
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Satoh, D
   Arber, S
AF Satoh, Daisuke
   Arber, Silvia
TI Carving Axon Arbors to Fit: Master Directs One Kinase at a Time
SO CELL
LA English
DT Editorial Material
ID SAD KINASES; PATHWAY; LKB1
C1 [Satoh, Daisuke; Arber, Silvia] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Satoh, Daisuke; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Satoh, Daisuke/0000-0002-4039-1670; Arber, Silvia/0000-0002-6261-250X
CR Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025
   Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021
   Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2
   Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441
   Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024
   Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403
   Lilley BN, 2013, NEURON, V79, P39, DOI 10.1016/j.neuron.2013.05.017
   Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110
   Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008
   Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012
   Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010
NR 11
TC 0
Z9 0
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUN 20
PY 2013
VL 153
IS 7
BP 1425
EP 1426
DI 10.1016/j.cell.2013.05.047
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 168RA
UT WOS:000320722000009
PM 23791171
OA Bronze
DA 2021-01-25
ER

PT J
AU Ackema, KB
   Sauder, U
   Solinger, JA
   Spang, A
AF Ackema, Karin B.
   Sauder, Ursula
   Solinger, Jachen A.
   Spang, Anne
TI The ArfGEF GBF-1 Is Required for ER Structure, Secretion and Endocytic
   Transport in C. elegans
SO PLOS ONE
LA English
DT Article
ID NUCLEOTIDE EXCHANGE FACTORS; CAENORHABDITIS-ELEGANS; RETROGRADE
   TRANSPORT; DISTINCT FUNCTIONS; PICHIA-PASTORIS; GOLGI STRUCTURE; FACTORS
   GEA1P; CIS-GOLGI; GERM-LINE; PROTEIN
AB Small GTPases of the Sar/Arf family are essential to generate transport containers that mediate communication between organelles of the secretory pathway. Guanine nucleotide exchange factor (GEFs) activate the small GTPases and help their anchorage in the membrane. Thus, GEFs in a way temporally and spatially control Sar1/Arf1 GTPase activation. We investigated the role of the ArfGEF GBF-1 in C. elegans oocytes and intestinal epithelial cells. GBF-1 localizes to the cis-Golgi and is part of the t-ER-Golgi elements. GBF-1 is required for secretion and Golgi integrity. In addition, gbf-1(RNAi) causes the ER reticular structure to become dispersed, without destroying ER exit sites (ERES) because the ERES protein SEC-16 was still localized in distinct punctae at t-ER-Golgi units. Moreover, GBF-1 plays a role in receptor-mediated endocytosis in oocytes, without affecting recycling pathways. We find that both the yolk receptor RME-2 and the recycling endosome-associated RAB-11 localize similarly in control and gbf-1(RNAi) oocytes. While RAB5-positive early endosomes appear to be less prominent and the RAB-5 levels are reduced by gbf-1(RNAi) in the intestine, RAB-7-positive late endosomes were more abundant and formed aggregates and tubular structures. Our data suggest a role for GBF-1 in ER structure and endosomal traffic.
C1 [Ackema, Karin B.; Solinger, Jachen A.; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
   [Sauder, Ursula] Univ Basel, Biozentrum, Microscopy Ctr, Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX Funding provided by the Swiss National Science Foundation and the
   University of Basel. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711
   Ahringer J., 2006, C ELEGANS RES COMMUN, DOI 10.1895/wormbook.1.47.1
   Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493
   Armbruster K, 2012, J CELL SCI, V125, P1318, DOI 10.1242/jcs.096263
   Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627
   Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361
   Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022
   Bianchi L, 2006, C ELEGANS RES COMMUN
   BRENNER S, 1974, GENETICS, V77, P71
   Esaki M, 2006, FEBS LETT, V580, P5215, DOI 10.1016/j.febslet.2006.08.058
   Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021
   FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27
   Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100
   Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730
   Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311
   Grant Barth D, 2006, WormBook, P1
   Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154
   Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768
   Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161
   Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398
   Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9
   Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874
   Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048
   Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666
   Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394
   Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856
   Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989
   Page Antony P, 2007, WormBook, P1
   Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0
   Peyroche A, 2001, J CELL SCI, V114, P2241
   Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726
   Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011
   Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162
   Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69
   Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144
   Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211
   Sato M, 2008, J CELL SCI, V121, P3177, DOI 10.1242/jcs.034678
   SCHIERENBERG E, 1992, ROUX ARCH DEV BIOL, V202, P10, DOI 10.1007/BF00364592
   Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802
   Shaham S, 2006, WORMBOOK
   Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272
   Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035
   Szul Tomasz, 2011, Cell Logist, V1, P69
   Tang LC, 2012, BBA-GEN SUBJECTS, V1820, P829, DOI 10.1016/j.bbagen.2012.03.004
   Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wang SS, 2012, J CELL SCI, V125, P461, DOI 10.1242/jcs.092551
   Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225
   Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014
   Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420
   Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173
NR 53
TC 13
Z9 19
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2013
VL 8
IS 6
AR e67076
DI 10.1371/journal.pone.0067076
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 190ST
UT WOS:000322361200119
PM 23840591
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Wentzel, C
   Sommer, JE
   Nair, R
   Stiefvater, A
   Sibarita, JB
   Scheiffele, P
AF Wentzel, Corinna
   Sommer, Julia E.
   Nair, Ramya
   Stiefvater, Adeline
   Sibarita, Jean-Baptiste
   Scheiffele, Peter
TI mSYD1A, a Mammalian Synapse-Defective-1 Protein, Regulates Synaptogenic
   Signaling and Vesicle Docking
SO NEURON
LA English
DT Article
ID LIPRIN-ALPHA FAMILY; ACTIVE ZONE; MOLECULAR-MECHANISMS; PTP-SIGMA;
   EXPRESSION; RECEPTOR; DYNAMICS; SYD-1; LOCALIZATION; MEMBRANE
AB Structure and function of presynaptic terminals are critical for the transmission and processing of neuronal signals. Trans-synaptic signaling systems instruct the differentiation and function of presynaptic release sites, but their downstream mediators are only beginning to be understood. Here, we identify the intracellular mSYD1A (mouse Synapse-Defective-1A) as a regulator of presynaptic function in mice. mSYD1A forms a complex with presynaptic receptor tyrosine phosphatases and controls tethering of synaptic vesicles at synapses. mSYD1A function relies on an intrinsically disordered domain that interacts with multiple structurally unrelated binding partners, including the active zone protein liprin-alpha 2 and nsec1/munc18-1. In mSYD1A knockout mice, synapses assemble in normal numbers but there is a significant reduction in synaptic vesicle docking at the active zone and an impairment of synaptic transmission. Thus, mSYD1A is a regulator of presynaptic release sites at central synapses.
C1 [Wentzel, Corinna; Sommer, Julia E.; Nair, Ramya; Stiefvater, Adeline; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sibarita, Jean-Baptiste] Univ Bordeaux, Interdisciplinary Inst Neurosci, F-33400 Bordeaux, France.
   [Sibarita, Jean-Baptiste] CNRS, UMR 5297, F-33000 Bordeaux, France.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
OI Sibarita, Jean-Baptiste/0000-0002-9920-7700
FU Werner-Siemens Foundation; Boehringer Ingelheim FundBoehringer
   Ingelheim; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); F. Hoffmann La RocheHoffmann-La Roche; National
   Institute on Drug AbuseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA); Kanton Basel-Stadt; NATIONAL INSTITUTE ON DRUG
   ABUSEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [R01DA020844, R01DA020844, R01DA020844, R01DA020844, R01DA020844]
   Funding Source: NIH RePORTER
FX We thank Yves Barde, Casper Hoogenraad, Eunjoon Kim, Thi-Minh Nguyen,
   Olivier Pertz, Susanne Schoch, Dietmar Schreiner, Tim Sharpe, Stephan
   Sigrist, Matthijs Verhage, and Mingjie Zhang for valuable reagents and
   advice. We thank Ursula Sauder and the Zentrum fur Mikroskopie for
   excellent support with the electron microscopy and Daniela
   Klewe-Nebenius and the Transgenic Mouse Core Facility for help in
   generating the mSYD1A<SUP>KO</SUP> mice. This work was supported by a
   fellowship from the Werner-Siemens Foundation to C.W., an award from the
   Boehringer Ingelheim Fund to J.E.S., funds to P.S. from the Swiss
   National Science Foundation, F. Hoffmann La Roche, the National
   Institute on Drug Abuse, and the Kanton Basel-Stadt.
CR Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005
   Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001
   Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Cheadle L, 2012, J CELL BIOL, V199, P985, DOI 10.1083/jcb.201205041
   Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808
   de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x
   Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028
   Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c
   Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023
   Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770
   Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005
   Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959
   Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014
   Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195
   Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002
   Izeddin I, 2012, OPT EXPRESS, V20, P2081, DOI 10.1364/OE.20.002081
   Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417
   Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002
   Johnson EL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000193
   Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200
   Kwon SK, 2010, J BIOL CHEM, V285, P13966, DOI 10.1074/jbc.M109.061127
   Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042
   Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010
   Owald D, 2012, NAT NEUROSCI, V15, P1219, DOI 10.1038/nn.3183
   Owald D, 2010, J CELL BIOL, V188, P565, DOI 10.1083/jcb.200908055
   Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806
   Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665
   Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x
   Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042
   Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302
   Sigrist SJ, 2011, CURR OPIN NEUROBIOL, V21, P144, DOI 10.1016/j.conb.2010.08.012
   Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x
   Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163
   Spangler SA, 2011, J COMP NEUROL, V519, P3040, DOI 10.1002/cne.22665
   Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127
   Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012
   Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011
   Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024
   Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007
   Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004
   Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103
   Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x
   Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021
   Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279
   Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011
   Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004
   Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370
   Zurner M, 2011, J COMP NEUROL, V519, P3019, DOI 10.1002/cne.22664
   Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007
NR 52
TC 31
Z9 31
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD JUN 19
PY 2013
VL 78
IS 6
BP 1012
EP 1023
DI 10.1016/j.neuron.2013.05.010
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 172TD
UT WOS:000321026900008
PM 23791195
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Berkemeier, C
   Hall, M
   Hollander, G
AF Berkemeier, Caroline
   Hall, Mike
   Hollander, Georg
TI The Role of the mTOR pathway for the development and function of the
   mouse thymic epithelium
SO SWISS MEDICAL WEEKLY
LA English
DT Meeting Abstract
C1 [Berkemeier, Caroline; Hollander, Georg] Univ Kinderspital Beider Basel, Basel, Switzerland.
   [Hall, Mike] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD JUN 14
PY 2013
VL 143
SU 197
MA P 129
BP 46S
EP 46S
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA VG6CO
UT WOS:000447695000170
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Liang, CW
   Jansen, TLC
AF Liang, Chungwen
   Jansen, Thomas L. C.
TI Simulation of Two-Dimensional Sum-Frequency Generation Response
   Functions: Application to Amide I in Proteins
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID VIBRATIONAL SPECTROSCOPY; 2D IR; INFRARED-SPECTROSCOPY;
   N-METHYLACETAMIDE; HYDROGEN-BOND; SECONDARY STRUCTURES; GATING
   MECHANISM; WATER; DYNAMICS; PEPTIDES
AB We present the implementation of an approach to simulate the two-dimensional sum frequency generation response functions of systems with numerous coupled chromophores using a quantum-classical simulation scheme that was previously applied successfully to simulate two-dimensional infrared spectra. We apply the simulation to the amide I band of a mechanosensitive channel protein. By examining the signal generated from different segments of the protein, we find that the overall signal is impossible to interpret without the aid of simulations due to the interference of the response generated on different segments of the protein. We do not find significant cross-peaks in the spectra, even when the waiting time is increased. The spectra are thus not sensitive to coupling between different structural elements. Despite this, we conclude that two-dimensional sum frequency generation spectroscopy will be a powerful tool to investigate membrane bound proteins.
C1 [Liang, Chungwen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jansen, Thomas L. C.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
RP Jansen, TLC (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM t.l.c.jansen@rug.nl
RI Jansen, T.L.C./A-1911-2010; Institute, Zernike/W-7033-2019
OI Jansen, T.L.C./0000-0001-6066-6080; 
CR Auer BM, 2009, J PHYS CHEM B, V113, P4125, DOI 10.1021/jp806644x
   Auer BM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012568
   Backus EHG, 2012, J PHYS CHEM C, V116, P23351, DOI 10.1021/jp306273d
   Baiz CR, 2012, ANALYST, V137, P1793, DOI 10.1039/c2an16031e
   Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   BLOEMBERGEN N, 1962, PHYS REV, V128, P606, DOI 10.1103/PhysRev.128.606
   Bour P, 2003, J CHEM PHYS, V119, P11253, DOI 10.1063/1.1622384
   Bredenbeck J, 2008, J AM CHEM SOC, V130, P2152, DOI 10.1021/ja710099c
   Bredenbeck J, 2007, P NATL ACAD SCI USA, V104, P14243, DOI 10.1073/pnas.0607758104
   Bredenbeck J, 2009, ACCOUNTS CHEM RES, V42, P1332, DOI 10.1021/ar900016c
   Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429
   Cahoon JF, 2008, SCIENCE, V319, P1820, DOI 10.1126/science.1154041
   Carter JA, 2009, ACCOUNTS CHEM RES, V42, P1343, DOI 10.1021/ar9000197
   Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220
   Cheatum CM, 2004, J CHEM PHYS, V120, P8201, DOI 10.1063/1.1689637
   Demirdoven N, 2004, J AM CHEM SOC, V126, P7981, DOI 10.1021/ja049811j
   Eisenthal KB, 1996, CHEM REV, V96, P1343, DOI 10.1021/cr9502211
   Fang C, 2003, CHEM PHYS LETT, V382, P586, DOI 10.1016/j.cplett.2003.10.111
   Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251
   Golonzka O, 2001, J CHEM PHYS, V115, P10814, DOI 10.1063/1.1417504
   Gorbunov RD, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1898215
   Gorbunov RD, 2007, CHEM PHYS LETT, V437, P272, DOI 10.1016/j.cplett.2007.02.033
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   Ham S, 2003, J CHEM PHYS, V118, P6915, DOI 10.1063/1.1559681
   Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286
   Hamm P., 2011, CONCEPTS METHODS 2D
   Hayashi T, 2007, J PHYS CHEM B, V111, P11032, DOI 10.1021/jp070369b
   Huang R, 2007, J AM CHEM SOC, V129, P13592, DOI 10.1021/ja0736414
   Hybl JD, 1998, CHEM PHYS LETT, V297, P307, DOI 10.1016/S0009-2614(98)01140-3
   Jansen TLC, 2009, ACCOUNTS CHEM RES, V42, P1405, DOI 10.1021/ar900025a
   Jansen TLC, 2009, J PHYS CHEM A, V113, P6260, DOI 10.1021/jp900480r
   Jansen TLC, 2008, BIOPHYS J, V94, P1818, DOI 10.1529/biophysj.107.118851
   Jansen TL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218516
   Jansen TL, 2006, J PHYS CHEM B, V110, P22910, DOI 10.1021/jp064795t
   Jansen TL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2148409
   Karjalainen EL, 2012, J PHYS CHEM B, V116, P4448, DOI 10.1021/jp300329k
   Kim YS, 2005, P NATL ACAD SCI USA, V102, P11185, DOI 10.1073/pnas.0504865102
   King JT, 2010, J PHYS CHEM A, V114, P10590, DOI 10.1021/jp106142u
   Kobus M, 2008, CHEM PHYS, V347, P208, DOI 10.1016/j.chemphys.2007.10.034
   Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   KRIMM S, 1972, P NATL ACAD SCI USA, V69, P2788, DOI 10.1073/pnas.69.10.2788
   Kwac K, 2003, J CHEM PHYS, V119, P2247, DOI 10.1063/1.1580807
   Laaser JE, 2013, J PHYS CHEM A, V117, P5875, DOI 10.1021/jp307721y
   Larsen OFA, 2005, P NATL ACAD SCI USA, V102, P13378, DOI 10.1073/pnas.0505313102
   Lessing J, 2012, J AM CHEM SOC, V134, P5032, DOI 10.1021/ja2114135
   Liang CW, 2013, J PHYS CHEM LETT, V4, P448, DOI 10.1021/jz3019258
   Liang CW, 2012, J CHEM THEORY COMPUT, V8, P1706, DOI 10.1021/ct300045c
   Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107
   Manor J, 2009, STRUCTURE, V17, P247, DOI 10.1016/j.str.2008.12.015
   Moran SD, 2012, P NATL ACAD SCI USA, V109, P3329, DOI 10.1073/pnas.1117704109
   Mukamel S., 1995, PRINCIPLES NONLINEAR
   Nguyen KT, 2009, J PHYS CHEM B, V113, P12169, DOI 10.1021/jp904153z
   Ni YC, 2013, P NATL ACAD SCI USA, V110, P1992, DOI 10.1073/pnas.1222017110
   Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992
   Petersen PB, 2006, ANNU REV PHYS CHEM, V57, P333, DOI 10.1146/annurev.physchem.57.032905.104609
   Roy S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3665417
   Rubtsov IV, 2009, ACCOUNTS CHEM RES, V42, P1385, DOI 10.1021/ar900008p
   Schmidt JR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1961472
   Schmidt JR, 2004, J CHEM PHYS, V121, P8887, DOI 10.1063/1.1791632
   Shen Y.R., 1984, PRINCIPLES NONLINEAR
   SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0
   Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106
   Singh PC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747828
   Smith AW, 2010, J PHYS CHEM B, V114, P10913, DOI 10.1021/jp104017h
   Torii H, 2006, J PHYS CHEM A, V110, P4822, DOI 10.1021/jp060014c
   Tsuboi M, 1997, APPL SPECTROSC REV, V32, P263, DOI 10.1080/05704929708003316
   UNGER R, 1993, J MOL BIOL, V231, P75, DOI 10.1006/jmbi.1993.1258
   Wang J, 2003, J AM CHEM SOC, V125, P9914, DOI 10.1021/ja036373s
   Woutersen S, 2001, J CHEM PHYS, V114, P2727, DOI 10.1063/1.1336807
   Woutersen S, 2001, J CHEM PHYS, V115, P7737, DOI 10.1063/1.1407842
   Xiong W, 2011, P NATL ACAD SCI USA, V108, P20902, DOI 10.1073/pnas.1115055108
   Ye SJ, 2012, J AM CHEM SOC, V134, P6237, DOI 10.1021/ja2110784
   Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966
   Zhang Z, 2011, NAT CHEM, V3, P888, DOI [10.1038/nchem.1158, 10.1038/NCHEM.1158]
NR 75
TC 13
Z9 13
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 13
PY 2013
VL 117
IS 23
BP 6937
EP 6945
DI 10.1021/jp403111j
PG 9
WC Chemistry, Physical
SC Chemistry
GA 167OF
UT WOS:000320640600009
PM 23656353
DA 2021-01-25
ER

PT J
AU Tiwari, N
   Tiwari, VK
   Waldmeier, L
   Balwierz, PJ
   Arnold, P
   Pachkov, M
   Meyer-Schaller, N
   Schubeler, D
   van Nimwegen, E
   Christofori, G
AF Tiwari, Neha
   Tiwari, Vijay K.
   Waldmeier, Lorenz
   Balwierz, Piotr J.
   Arnold, Phil
   Pachkov, Mikhail
   Meyer-Schaller, Nathalie
   Schuebeler, Dirk
   van Nimwegen, Erik
   Christofori, Gerhard
TI Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by
   Controlling Ezh2 Expression and Epigenetic Reprogramming
SO CANCER CELL
LA English
DT Article
ID CARDIAC OUTFLOW TRACT; CANCER STEM-CELLS; BREAST-CANCER; TRANSCRIPTION
   FACTORS; GENE-EXPRESSION; E-CADHERIN; POLYCOMB; REPRESSION;
   OVEREXPRESSION; CARCINOMA
AB Gene expression profiling has uncovered the transcription factor Sox4 with upregulated activity during TGF-beta-induced epithelial-mesenchymal transition (EMT) in normal and cancerous breast epithelial cells. Sox4 is indispensable for EMT and cell survival in vitro and for primary tumor growth and metastasis in vivo. Among several EMT-relevant genes, Sox4 directly regulates the expression of Ezh2, encoding the Polycomb group histone methyltransferase that trimethylates histone 3 lysine 27 (H3K27me3) for gene repression. Ablation of Ezh2 expression prevents EMT, whereas forced expression of Ezh2 restores EMT in Sox4-deficient cells. Ezh2-mediated H3K27me3 marks associate with key EMT genes, representing an epigenetic EMT signature that predicts patient survival. Our results identify Sox4 as a master regulator of EMT by governing the expression of the epigenetic modifier Ezh2.
C1 [Tiwari, Neha; Waldmeier, Lorenz; Meyer-Schaller, Nathalie; Christofori, Gerhard] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
   [Tiwari, Vijay K.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Balwierz, Piotr J.; Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Balwierz, Piotr J.; Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Christofori, G (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
EM gerhard.christofori@unibas.ch
OI Balwierz, Piotr Jan/0000-0002-1548-4605; Tiwari,
   Neha/0000-0001-7931-4085; van Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss Initiative for Systems Biology (RTD Cellplasticity);
   EU-FP7 framework program TuMIC [2008-201662]; Swiss Cancer League;
   Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [TI 799/1-1]; EpiGeneSys RISE1 program; Marie Curie CIGEuropean Union
   (EU) [322210]; Wilhelm Sander Stiftung [2012.009.1]; Novartis Research
   Foundation; European Union (NoE "EpiGeneSys" FP7) [HEALTH-2010-257082];
   "Blueprint" consortium [FP7-282510]; European Research Council
   (EpiGePlas); SNF Sinergia program
FX We are grateful to H. Antoniadis, I. Galm, and P. Schmidt for technical
   support and A. Fantozzi for critical comments. We thank I. Nissen
   (Laboratory of Quantitative Genomics at D-BSSE, ETH Zurich) and S.
   Dessus-Babus (FMI, Basel) for Illumina sequencing. We thank A.P. Tsou
   (National Yang-Ming University, Taipei), A.H. Peters (FMI, Basel), N.
   Goldfinger and V. Rotter (Weizmann Institute, Rehovot), and G. Berx
   (VIB, Ghent) for providing important reagents and P. Demougin for gene
   expression profiling. This research has been supported by the Swiss
   National Science Foundation, the Swiss Initiative for Systems Biology
   (RTD Cellplasticity), the EU-FP7 framework program TuMIC 2008-201662,
   and the Swiss Cancer League. Research in the laboratory of V.K.T. is
   supported by Deutsche Forschungsgemeinschaft (DFG) grant TI 799/1-1,
   EpiGeneSys RISE1 program, Marie Curie CIG 322210, and Wilhelm Sander
   Stiftung 2012.009.1. Research in the laboratory of D.S. is supported by
   the Novartis Research Foundation, the European Union (NoE "EpiGeneSys"
   FP7- HEALTH-2010-257082 and the "Blueprint" consortium FP7-282510), the
   European Research Council (EpiGePlas), and the SNF Sinergia program.
CR Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456
   Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005
   Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34
   Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036
   Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694
   Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333
   Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156
   Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200
   Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1
   Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128
   Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872
   Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40
   Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043
   Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175
   Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08
   Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005
   Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001
   Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072
   Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675
   Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011
   Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100
   Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178
   Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168
   Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311
   Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055
   Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931
   Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100
   Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799
   Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888
   Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566
   Restivo A, 2006, ANAT REC PART A, V288A, P936, DOI 10.1002/ar.a.20367
   Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661
   Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002
   Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415
   Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0
   Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534
   Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206
   Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121
   Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885
   Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06
   Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991
   Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487
   Thiery JP, 2004, NAT MED, V10, P777, DOI 10.1038/nm0804-777
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254
   VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x
   Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395
   Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651
   Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598
   Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402
   Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148
   Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045
NR 65
TC 272
Z9 275
U1 0
U2 42
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1535-6108
EI 1878-3686
J9 CANCER CELL
JI Cancer Cell
PD JUN 10
PY 2013
VL 23
IS 6
BP 768
EP 783
DI 10.1016/j.ccr.2013.04.020
PG 16
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 163QB
UT WOS:000320350900010
PM 23764001
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Lenard, A
   Ellertsdottir, E
   Herwig, L
   Krudewig, A
   Sauteur, L
   Belting, HG
   Affolter, M
AF Lenard, Anna
   Ellertsdottir, Elin
   Herwig, Lukas
   Krudewig, Alice
   Sauteur, Loic
   Belting, Heinz-Georg
   Affolter, Markus
TI In Vivo Analysis Reveals a Highly Stereotypic Morphogenetic Pathway of
   Vascular Anastomosis
SO DEVELOPMENTAL CELL
LA English
DT Article
ID EMBRYONIC-DEVELOPMENT; ENDOTHELIAL-CADHERIN; NETWORK FORMATION;
   MOLECULAR CONTROL; ZEBRAFISH EMBRYO; VESSEL FUSION; VE-CADHERIN; LUMEN;
   ANGIOGENESIS; TUBULOGENESIS
AB Organ formation and growth requires cells to organize into properly patterned three-dimensional architectures. Network formation within the vertebrate vascular system is driven by fusion events between nascent sprouts or between sprouts and pre-existing blood vessels. Here, we describe the cellular activities that occur during blood vessel anastomosis in the cranial vasculature of the zebrafish embryo. We show that the early steps of the fusion process involve endothelial cell recognition, de novo polarization of endothelial cells, and apical membrane invagination and fusion. These processes generate a unicellular tube, which is then transformed into a multicellular tube via cell rearrangements and cell splitting. This stereotypic series of morphogenetic events is typical for anastomosis in perfused sprouts. Vascular endothelial-cadherin plays an important role early in the anastomosis process and is required for filopodial tip cell interactions and efficient formation of a single contact site.
C1 [Lenard, Anna; Ellertsdottir, Elin; Herwig, Lukas; Krudewig, Alice; Sauteur, Loic; Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM heinz-georg.belting@unibas.ch; markus.affolter@unibas.ch
OI Belting, Heinz-Georg/0000-0002-1538-4364; Affolter,
   Markus/0000-0002-5171-0016
FU Werner-Siemens-Foundation (Zug); Kantons Basel-Stadt and Basel-Land;
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We thank the Imaging Core Facility of the Biozentrum for generous
   support, Kumuthini Kulendra for fish care, J.J. Essner for the
   VE-cadherin plasmid, Amanda Ochoa-Espinosa for critically reading the
   manuscript, and members of the Affolter laboratory for scientific
   support. A.L. performed the experiments and analyzed the data, E.E.
   supervised A.L., L.H. generated the VE-cadherin-EGFP transgenic line,
   A.K. and H.-G.B. provided the VE-cadherin mutant, L.S. provided the ESAM
   antibody, and A.L., H.-G.B., and M.A. wrote the manuscript. A.L. and
   A.K. were supported by a fellowship from the Werner-Siemens-Foundation
   (Zug). This work has been supported by the Kantons Basel-Stadt and
   Basel-Land and by a grant from the Swiss National Science Foundation to
   M.A.
CR Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057
   Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106
   Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Chen CT, 2012, NAT REV MOL CELL BIO, V13, P483, DOI 10.1038/nrm3395
   Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374
   Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c
   Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027
   Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482
   Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Khan LA, 2013, NAT CELL BIOL, V15, P143, DOI 10.1038/ncb2656
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080
   Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329
   Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772
   Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008
   Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012674
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   Totong R, 2011, DEVELOPMENT, V138, P4199, DOI 10.1242/dev.064261
   Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002
   Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785
   Westerfield M., 2000, ZEBRAFISH BOOK GUIDE
   Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001
   Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010
   Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033
NR 38
TC 90
Z9 92
U1 0
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JUN 10
PY 2013
VL 25
IS 5
BP 492
EP 506
DI 10.1016/j.devcel.2013.05.010
PG 15
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 163OX
UT WOS:000320347900007
PM 23763948
OA Bronze
DA 2021-01-25
ER

PT J
AU Scheiffele, P
AF Scheiffele, Peter
TI Preparing for Your Future as You Grow
SO NEURON
LA English
DT Editorial Material
AB Commissural axons cross the nervous system rnidline and connect to targets in the contralateral hemisphere. In this issue of Neuron, Michalski et al. (2013) demonstrate that synapses formed by ipsilaterally misrouted commissural axons exhibit defects in synapse maturation. Thus, midline crossing primes axons for subsequent synaptogenesis.
C1 Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Scheiffele, P (corresponding author), Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
CR Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055
   Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014
   Kolodkin AL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001727
   Michalski N, 2013, NEURON, V78, P855, DOI 10.1016/j.neuron.2013.04.006
   Renier N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000325
   Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4
NR 6
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD JUN 5
PY 2013
VL 78
IS 5
BP 751
EP 752
DI 10.1016/j.neuron.2013.05.031
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA 168YH
UT WOS:000320743400001
PM 23764279
OA Bronze
DA 2021-01-25
ER

PT J
AU Leuppi, JD
   Schuetz, P
   Bingisser, R
   Bodmer, M
   Briel, M
   Drescher, T
   Duerring, U
   Henzen, C
   Leibbrandt, Y
   Maier, S
   Miedinger, D
   Muller, B
   Scherr, A
   Schindler, C
   Stoeckli, R
   Viatte, S
   von Garnier, C
   Tamm, M
   Rutishauser, J
AF Leuppi, Joerg D.
   Schuetz, Philipp
   Bingisser, Roland
   Bodmer, Michael
   Briel, Matthias
   Drescher, Tilman
   Duerring, Ursula
   Henzen, Christoph
   Leibbrandt, Yolanda
   Maier, Sabrina
   Miedinger, David
   Mueller, Beat
   Scherr, Andreas
   Schindler, Christian
   Stoeckli, Rolf
   Viatte, Sebastien
   von Garnier, Christophe
   Tamm, Michael
   Rutishauser, Jonas
TI Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations
   of Chronic Obstructive Pulmonary Disease The REDUCE Randomized Clinical
   Trial
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Article
ID SYSTEMIC GLUCOCORTICOIDS; ORAL PREDNISONE; COPD; MORTALITY
AB Importance International guidelines advocate a 7- to 14-day course of systemic glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD). However, the optimal dose and duration are unknown.
   Objective To investigate whether a short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation is noninferior to conventional (14 days) treatment in clinical outcome and whether it decreases the exposure to steroids.
   Design, Setting, and Patients REDUCE (Reduction in the Use of Corticosteroids in Exacerbated COPD), a randomized, noninferiority multicenter trial in 5 Swiss teaching hospitals, enrolling 314 patients presenting to the emergency department with acute COPD exacerbation, past or present smokers (>= 20 pack-years) without a history of asthma, from March 2006 through February 2011.
   Interventions Treatment with 40 mg of prednisone daily for either 5 or 14 days in a placebo-controlled, double-blind fashion. The predefined noninferiority criterion was an absolute increase in exacerbations of at most 15%, translating to a critical hazard ratio of 1.515 for a reference event rate of 50%.
   Main Outcome and Measure Time to next exacerbation within 180 days.
   Results Of 314 randomized patients, 289 (92%) of whom were admitted to the hospital, 311 were included in the intention-to-treat analysis and 296 in the per-protocol analysis. Hazard ratios for the short-term vs conventional treatment group were 0.95 (90% CI, 0.70 to 1.29; P=.006 for noninferiority) in the intention-to-treat analysis and 0.93 (90% CI, 0.68 to 1.26; P=.005 for noninferiority) in the per-protocol analysis, meeting our noninferiority criterion. In the short-term group, 56 patients (35.9%) reached the primary end point; 57 (36.8%) in the conventional group. Estimates of reexacerbation rates within 180 days were 37.2% (95% CI, 29.5% to 44.9%) in the short-term; 38.4% (95% CI, 30.6% to 46.3%) in the conventional, with a difference of -1.2% (95% CI, -12.2% to 9.8%) between the short-term and the conventional. Among patients with a reexacerbation, the median time to event was 43.5 days (interquartile range [IQR], 13 to 118) in the short-term and 29 days (IQR, 16 to 85) in the conventional. There was no difference between groups in time to death, the combined end point of exacerbation, death, or both and recovery of lung function. In the conventional group, mean cumulative prednisone dose was significantly higher (793 mg [95% CI, 710 to 876 mg] vs 379 mg [95% CI, 311 to 446 mg], P<.001), but treatment-associated adverse reactions, including hyperglycemia and hypertension, did not occur more frequently.
   Conclusions and Relevance In patients presenting to the emergency department with acute exacerbations of COPD, 5-day treatment with systemic glucocorticoids was noninferior to 14-day treatment with regard to reexacerbation within 6 months of follow-up but significantly reduced glucocorticoid exposure. These findings support the use of a 5-day glucocorticoid treatment in acute exacerbations of COPD.
C1 [Leuppi, Joerg D.; Drescher, Tilman; Maier, Sabrina; Miedinger, David; Scherr, Andreas] Univ Basel Hosp, Clin Internal Med, Basel, Switzerland.
   [Bingisser, Roland; Bodmer, Michael] Univ Basel Hosp, Interdisciplinary Emergency Dept, Basel, Switzerland.
   [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland.
   [Drescher, Tilman; Duerring, Ursula; Stoeckli, Rolf] Univ Basel Hosp, Clin Endocrinol Diabetol & Metab, Basel, Switzerland.
   [Scherr, Andreas; Tamm, Michael] Univ Basel Hosp, Clin Pneumol, Basel, Switzerland.
   [Schuetz, Philipp; Mueller, Beat] Kantonsspital, Med Univ Clin, Aarau, Switzerland.
   [Henzen, Christoph] Kantonsspital, Dept Internal Med, Luzern, Switzerland.
   [Rutishauser, Jonas] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Schindler, Christian] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4003 Basel, Switzerland.
   [Viatte, Sebastien] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.
   [von Garnier, Christophe] Inselspital Bern, Univ Hosp Bern, Resp Med Clin, Bern, Switzerland.
   [Leibbrandt, Yolanda; Viatte, Sebastien; Rutishauser, Jonas] Hosp Ctr Biel Bienne, Clin Internal Med, Dept Med, Biel, Switzerland.
RP Rutishauser, J (corresponding author), Ctr Hosp, Clin Internal Med, Dept Med, Vogelsang 84, CH-2501 Biel, Switzerland.
EM j.rutishauser@unibas.ch
RI Mueller, Beat/G-2662-2012; Bodmer, Michael/K-1873-2013; Schindler,
   Christian/D-3472-2015; Viatte, Sebastien/B-4253-2015; Leuppi,
   Jorg/W-6798-2019; Reid, David W/B-3263-2011
OI Viatte, Sebastien/0000-0001-6471-3358; Bingisser,
   Roland/0000-0001-8223-9792; Briel, Matthias/0000-0002-2070-5230
FU Department of Medicine, University Hospital Basel; Clinic of Internal
   Medicine, Hospital Center of Biel-Bienne; Freie Akademische
   Gesellschaft; Fonds fur Lehre und Forschung; AstraZenecaAstraZeneca;
   Viollier Laboratory; Gottfried und Julia Bangerter-Rhyner-Stiftung fur
   Medizinische Forschung
FX The REDUCE trial was an investigator-initiated study supported by the
   Department of Medicine, University Hospital Basel; the Clinic of
   Internal Medicine, Hospital Center of Biel-Bienne; Freie Akademische
   Gesellschaft; Fonds fur Lehre und Forschung; AstraZeneca; Viollier
   Laboratory; Gottfried und Julia Bangerter-Rhyner-Stiftung fur
   Medizinische Forschung.
CR Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161
   ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196
   Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581
   Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110
   Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304
   Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8
   Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0
   Evans AT, 2002, LANCET, V359, P1648, DOI 10.1016/S0140-6736(02)08597-5
   Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN
   Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459
   Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8
   Jochmann A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13567
   Jochmann A, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13053
   Lindenauer PK, 2010, JAMA-J AM MED ASSOC, V303, P2359, DOI 10.1001/jama.2010.796
   Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502
   Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256
   Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802
   Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S
   Sayiner A, 2001, CHEST, V119, P726, DOI 10.1378/chest.119.3.726
   Schuetz P, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13109
   Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527
   Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500
   Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814
   Walters JAE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006897.pub2
   Wouters EFM, 2004, LANCET, V364, P883, DOI 10.1016/S0140-6736(04)16984-5
NR 25
TC 208
Z9 219
U1 0
U2 28
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JUN 5
PY 2013
VL 309
IS 21
BP 2223
EP 2231
DI 10.1001/jama.2013.5023
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 156YC
UT WOS:000319859200026
PM 23695200
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Trewhella, J
   Hendrickson, WA
   Kleywegt, GJ
   Sali, A
   Sato, M
   Schwede, T
   Svergun, DI
   Tainer, JA
   Westbrook, J
   Berman, HM
AF Trewhella, Jill
   Hendrickson, Wayne A.
   Kleywegt, Gerard J.
   Sali, Andrej
   Sato, Mamoru
   Schwede, Torsten
   Svergun, Dmitri I.
   Tainer, John A.
   Westbrook, John
   Berman, Helen M.
TI Report of the wwPDB Small-Angle Scattering Task Force: Data Requirements
   for Biomolecular Modeling and the PDB
SO STRUCTURE
LA English
DT News Item
ID X-RAY-SCATTERING; COMPLEXES; SAXS; ASSEMBLIES; VALIDATION; INHIBITOR;
   BINDING; NMR
AB This report presents the conclusions of the July 12-13, 2012 meeting of the Small-Angle Scattering Task Force of the worldwide Protein Data Bank (wwPDB; Berman et al., 2003) at Rutgers University in New Brunswick, New Jersey. The task force includes experts in small-angle scattering (SAS), crystallography, data archiving, and molecular modeling who met to consider questions regarding the contributions of SAS to modern structural biology. Recognizing there is a rapidly growing community of structural biology researchers acquiring and interpreting SAS data in terms of increasingly sophisticated molecular models, the task force recommends that (1) a global repository is needed that holds standard format X-ray and neutron SAS data that is searchable and freely accessible for download; (2) a standard dictionary is required for definitions of terms for data collection and for managing the SAS data repository; (3) options should be provided for including in the repository SAS-derived shape and atomistic models based on rigid-body refinement against SAS data along with specific information regarding the uniqueness and uncertainty of the model, and the protocol used to obtain it; (4) criteria need to be agreed upon for assessment of the quality of deposited SAS data and the accuracy of SAS-derived models, and the extent to which a given model fits the SAS data; (5) with the increasing diversity of structural biology data and models being generated, archiving options for models derived from diverse data will be required; and (6) thought leaders from the various structural biology disciplines should jointly define what to archive in the PDB and what complementary archives might be needed, taking into account both scientific needs and funding.
C1 [Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
   [Kleywegt, Gerard J.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England.
   [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn, San Francisco, CA 94143 USA.
   [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Therapeut Sci, San Francisco, CA 94143 USA.
   [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.
   [Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2360027, Japan.
   [Schwede, Torsten] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Schwede, Torsten] SIB, CH-4056 Basel, Switzerland.
   [Svergun, Dmitri I.] DESY, European Mol Biol Lab, D-22603 Hamburg, Germany.
   [Tainer, John A.] Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94704 USA.
   [Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
   [Westbrook, John; Berman, Helen M.] Rutgers State Univ, Dept Chem & Chem Biol, Newark, NJ 07102 USA.
RP Trewhella, J (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM jill.trewhella@sydney.edu.au
RI Classen, Scott/AAY-8176-2020; Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Kleywegt, Gerard
   J./0000-0002-4670-0331; Westbrook, John/0000-0002-6686-5475; Svergun,
   Dmitri/0000-0003-0830-5696; Trewhella, Jill/0000-0002-8555-6766; Berman,
   Helen/0000-0002-3337-0660; Tainer, John/0000-0003-1659-2429
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [21113001] Funding Source: KAKEN; Div Of Biological
   InfrastructureNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [0829586] Funding Source: National Science
   Foundation; NATIONAL CANCER INSTITUTEUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584, P01CA092584,
   P01CA092584, P01CA092584, P01CA092584, P01CA092584] Funding Source: NIH
   RePORTER; NCI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01 CA092584] Funding Source: Medline; Wellcome
   TrustWellcome Trust [088944] Funding Source: Medline
CR Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556
   Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091
   Glatter O, 1982, SMALL ANGLE XRAY SCA
   Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m
   Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5
   Guinier A., 1955, STRUCTURE MATTER SER
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353
   Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073
   Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047
   Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351
   Jacques DA, 2008, J MOL BIOL, V384, P422, DOI 10.1016/j.jmb.2008.09.017
   Karaca E., 2012, ADV INTEGRATIVE MODE
   Kleywegt GJ, 2009, ACTA CRYSTALLOGR D, V65, P134, DOI 10.1107/S090744490900081X
   Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364
   KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3
   Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109
   Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]
   Malfois M, 2000, J APPL CRYSTALLOGR, V33, P812, DOI 10.1107/S0021889800001357
   Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012
   Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018
   Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430
   Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635
   Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015
   Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078
   Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244
   Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108
   Schneidman-Duhovny D, 2012, BIOINFORMATICS, V28, P3282, DOI 10.1093/bioinformatics/bts628
   Shannon CE, 1949, MATH THEORY COMMUNIC
   Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105
   Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033
NR 35
TC 50
Z9 50
U1 0
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0969-2126
J9 STRUCTURE
JI Structure
PD JUN 4
PY 2013
VL 21
IS 6
BP 875
EP 881
DI 10.1016/j.str.2013.04.020
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 168WY
UT WOS:000320739800004
PM 23747111
OA Bronze
DA 2021-01-25
ER

PT J
AU Siegmund, K
   Lee, WY
   Tchang, VS
   Stiess, M
   Terracciano, L
   Kubes, P
   Pieters, J
AF Siegmund, Kerstin
   Lee, Woo-Yong
   Tchang, Vincent S.
   Stiess, Michael
   Terracciano, Luigi
   Kubes, Paul
   Pieters, Jean
TI Coronin 1 is dispensable for leukocyte recruitment and liver injury in
   concanavalin A-induced hepatitis
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE Coronin 1; Leukocytes; Hepatitis; Concanavalin A
ID T-CELLS; SURVIVAL; ADHESION; MICE; MYCOBACTERIA; MACROPHAGES;
   NEUTROPHILS; IMMUNODEFICIENCY; MOBILIZATION; INFLAMMATION
AB Coronin 1, a member of the evolutionary conserved coronin protein family, is highly expressed in all leukocytes. In mice and human, genetic inactivation of coronin 1 results in immuno-deficiencies that are linked to a strong reduction of naive T cell numbers in peripheral organs, while memory/effector T cells, B cells, monocytes and neutrophils are less or not at all affected. Whether or not coronin 1 is important for leukocyte functions such as migration and phagocytosis has been a matter of debate. The current work addresses coronin 1-dependent leukocyte function by analyzing the response of coronin 1-deficient mice in a model of concanavalin A (Con A)-induced liver injury. Histological evaluation and determination of serum liver enzyme levels showed that coronin 1-deficient mice develop signs of acute hepatitis similar to Con A-treated wild type mice despite a reduced activation of T cells in the absence of coronin 1. Furthermore, analysis by intravital microscopy following Con A stimulation revealed that Gr-1(+) neutrophils and CD4(+) T cell adhesion in the post-sinusoidal venules increased in wild type as well as in coronin 1-deficient mice. These results suggest that coronin 1, while important for naive T cell survival, is dispensable for other leukocyte function under inflammatory conditions in vivo. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Siegmund, Kerstin; Tchang, Vincent S.; Stiess, Michael; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Terracciano, Luigi] Univ Hosp, Inst Pathol, Mol Pathol Div, CH-4003 Basel, Switzerland.
   [Siegmund, Kerstin; Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada.
RP Siegmund, K (corresponding author), Med Univ Innsbruck, Div Translat Cell Genet, Dept Med Genet Mol & Clin Pharmacol, Peter Mayr Str 1A, A-6020 Innsbruck, Austria.
EM Kerstin.siegmund@i-med.ac.at; jean.pieters@unibas.ch
RI Bellaire-Siegmund, Kerstin/AAA-9702-2021; Stiess, Michael/ABF-9835-2020;
   Bellaire-Siegmund, Kerstin/D-4774-2018
OI Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Stiess,
   Michael/0000-0001-5363-0389; Bellaire-Siegmund,
   Kerstin/0000-0002-3654-1170; Pieters, Jean/0000-0002-5284-9757
FU Canton of Basel; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); EMBOEuropean Molecular Biology Organization (EMBO)
   [1151-2011, 415-2010]; Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR); Canada Foundation for Innovantion
FX This work was supported by the Canton of Basel, the Swiss National
   Science Foundation [to J.P.], EMBO [ALTF 1151-2011 to M.S. and ASTF No.
   415-2010 to K.S] and the Canadian Institutes of Health Research [to
   P.K.].; We thank Fausta Chiaverio from the laboratory medicine of the
   University Hospital of Basel for coordinating the AST/ALT measurements
   in murine blood samples. We thank the animal care unit at the
   Biozentrum, University of Basel, and at the University of Calgary for
   help with all mice related issues, especially Carla Badick in the
   laboratory of Paul Kubes for the coordination of the mouse import to
   Calgary. We thank The Live Cell Imaging Facility at the University of
   Calgary funded by the Canada Foundation for Innovantion for support
   concerning all microscopy related issues.
CR Bonder CS, 2004, J IMMUNOL, V172, P45, DOI 10.4049/jimmunol.172.1.45
   Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589
   Chan KT, 2011, TRENDS CELL BIOL, V21, P481, DOI 10.1016/j.tcb.2011.04.004
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   Hatada S, 2005, CELL IMMUNOL, V233, P23, DOI 10.1016/j.cellimm.2005.03.003
   Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018
   Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Miyazawa Y, 1998, HEPATOLOGY, V27, P497, DOI 10.1002/hep.510270225
   Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604
   Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312
   Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465
   Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11
   Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   SHIOW LR, 2008, CLIN IMMUNOL
   Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491
   SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143
   Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697
   Tchang V, 2013, MOL IMMUNOL IN PRESS
   TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836
   Westritschnig K, 2013, MOL IMMUNOL, V53, P379, DOI 10.1016/j.molimm.2012.09.002
   Wimer BM, 2002, CANCER BIOTHER RADIO, V17, P569, DOI 10.1089/108497802760804808
   Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468
NR 36
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUN
PY 2013
VL 153
IS 1-2
BP 62
EP 70
DI 10.1016/j.imlet.2013.06.005
PG 9
WC Immunology
SC Immunology
GA 223DD
UT WOS:000324783400011
PM 23856257
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI Retrograde Traffic from the Golgi to the Endoplasmic Reticulum
SO COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
LA English
DT Article
ID GTPASE-ACTIVATING PROTEIN; STRUCTURE-BASED MECHANISM; EXCHANGE FACTORS
   GEA1P; COPI-COATED VESICLES; NUCLEOTIDE-EXCHANGE; TRANSPORT VESICLES;
   MEMBRANE CURVATURE; TETHERING COMPLEX; CHOLERA-TOXIN; KDEL RECEPTOR
AB Proteins to be secreted are transported from the endoplasmic reticulum (ER) to the Golgi apparatus. The transport of these proteins requires the localization and activity of proteins that create ER exit sites, coat proteins to collect cargo and to reshape the membrane into a transport container, and address labels-SNARE proteins-to target the vesicles specifically to the Golgi apparatus. In addition some proteins may need export chaperones or export receptors to enable their exit into transport vesicles. ER export factors, SNAREs, and misfolded Golgi-resident proteins must all be retrieved from the Golgi to the ER again. This retrieval is also part of the organellar homeostasis pathway essential to maintaining the identity of the ER and of the Golgi apparatus. In this review, I will discuss the different processes in retrograde transport from the Golgi to the ER and highlight the mechanistic insights we have obtained in the last couple of years.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National Science Foundation, EMBO; University of Basel
FX The work on the early secretory pathway in the Spang lab is funded by
   the Swiss National Science Foundation, EMBO, and the University of
   Basel. Fred Hughson is acknowledged for critical comments on the
   manuscript.
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Alpadi K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001243
   Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29
   Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812
   Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305
   Ballensiefen W, 1998, J CELL SCI, V111, P1507
   Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097
   BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0
   Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105
   Beck R, 2011, J CELL BIOL, V194, P765, DOI 10.1083/jcb.201011027
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095
   Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527
   Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55
   Chen A, 2003, J CELL SCI, V116, P3503, DOI 10.1242/jcs.00641
   Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157
   Cohen M, 2003, J BIOL CHEM, V278, P51989, DOI 10.1074/jbc.C300451200
   Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065
   Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909
   Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657
   Dumaresq-Doiron K, 2010, J CELL SCI, V123, P2273, DOI 10.1242/jcs.055798
   Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942
   Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443
   Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136
   Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x
   Gallegos KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030368
   Girod A, 1999, NAT CELL BIOL, V1, P423
   Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X
   Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183
   HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883
   Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489
   HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0
   Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138
   HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0
   Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kamena F, 2008, J CELL SCI, V121, P1293, DOI 10.1242/jcs.016998
   Kartberg F, 2010, J BIOL CHEM, V285, P36709, DOI 10.1074/jbc.M110.180380
   Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136
   Kondylis V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017173
   Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935
   Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017
   Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030
   Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Levi SK, 2010, TRAFFIC, V11, P1168, DOI 10.1111/j.1600-0854.2010.01089.x
   LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969
   Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601
   Majoul IV, 1996, J CELL BIOL, V133, P777, DOI 10.1083/jcb.133.4.777
   Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514
   Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327
   OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425
   Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899
   Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0
   Peyroche A, 2001, J CELL SCI, V114, P2241
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002
   ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U
   Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69
   Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.E03-11-0837
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756
   Schindler C, 2009, TRAFFIC, V10, P1362, DOI 10.1111/j.1600-0854.2009.00952.x
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E
   Shiba K, 2010, FEBS J, V277, P5006, DOI 10.1111/j.1742-4658.2010.07933.x
   SMITH R, 2009, CONSUM REP, V74, P6
   Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y
   Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589
   Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   Spang A, 2012, TRAFFIC, V13, P908, DOI 10.1111/j.1600-0854.2012.01362.x
   Spang A, 2009, CURR OPIN CELL BIOL, V21, P531, DOI 10.1016/j.ceb.2009.03.003
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024
   Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x
   TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0
   TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365
   Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397
   Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548
   Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108
   VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553
   VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x
   WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0
   Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140
   WHITNEY JA, 1995, CELL, V83, P703
   Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225
   Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
   Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015
   Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173
   Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012
   Zong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029995
NR 104
TC 40
Z9 40
U1 0
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1943-0264
J9 CSH PERSPECT BIOL
JI Cold Spring Harbor Perspect. Biol.
PD JUN
PY 2013
VL 5
IS 6
AR a013391
DI 10.1101/cshperspect.a013391
PG 10
WC Cell Biology
SC Cell Biology
GA 169GS
UT WOS:000320768600006
PM 23732476
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Marzolini, C
   Mueller, R
   Li-Blatter, X
   Battegay, M
   Seelig, A
AF Marzolini, Catia
   Mueller, Rita
   Li-Blatter, Xiaochun
   Battegay, Manuel
   Seelig, Anna
TI The Brain Entry of HIV-1 Protease Inhibitors Is Facilitated When Used in
   Combination
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE HIV; brain permeation; antiretroviral drugs; P-glycoprotein; BCRP;
   neurocognitive disorders
ID CEREBROSPINAL-FLUID CONCENTRATIONS; BARRIER PERMEATION; DRUGS; BLOOD;
   MODULATION; RITONAVIR; MEMBRANE; KINETICS; PHARMACOKINETICS; PENETRATION
AB One hypothesis for persisting HIV-associated neurocognitive disorders (HAND) in effectively treated individuals is the limited permeation of antiretroviral agents (ARV) across the blood-brain barrier (BBB). However, the physicochemical factors limiting the brain entry of a given ARV and the mutual interactions of combined drugs on their brain entry have not been properly characterized. Using transporter kinetic measurements, we show that large lipophilic drugs such as protease inhibitors (PI) have strong binding affinities to drug efflux transporters expressed at the BBB and thus are prevented from entering the brain. However, when combined, the PI with the highest binding affinity (i.e., boosting ritonavir) will occupy a large proportion of the transporter binding sites and thus slow down the efflux rate of the coadministered PI thereby facilitating its brain entry. Furthermore, using thermodynamic measurements and computational modeling, we show that ARV with small cross-sectional areas (A(D) < 70 angstrom(2)) and octanol water distribution coefficients (-1 < log D <5) such as most nucleoside analogues have a high passive influx and cross the BBB despite interactions with drug transporters These data indicate that HIV therapies combining small diffusing molecules with large lipophilic molecules are better suited for brain entry and should be preferred for HAND. This work highlights the role of PI as modulators of drugs brain entry.
C1 [Marzolini, Catia; Battegay, Manuel] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.
   [Mueller, Rita; Li-Blatter, Xiaochun; Seelig, Anna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Marzolini, C (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Petersgraben 4, CH-4031 Basel, Switzerland.
EM MarzoliniC@uhbs.ch
RI Marzolini, Catia/C-8253-2019
FU Janssen-Cilag AG Switzerland
FX The study was funded by an unrestricted research grant from
   Janssen-Cilag AG Switzerland. The funder had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript.
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   [Anonymous], 2006, EMTRIVA EMTRICITABIN
   Best BM, 2012, JAIDS-J ACQ IMM DEF, V59, P376, DOI 10.1097/QAI.0b013e318247ec54
   Best BM, 2011, J ANTIMICROB CHEMOTH, V66, P354, DOI 10.1093/jac/dkq434
   Best BM, 2009, AIDS, V23, P83, DOI 10.1097/QAD.0b013e328317a702
   Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033
   Brady KA, 2005, PHARMACOTHERAPY, V25, P10, DOI 10.1592/phco.25.1.10.55625
   BURGER DM, 1995, PHARM WORLD SCI, V17, P218, DOI 10.1007/BF01870615
   Calcagno A, 2012, AIDS, V26, P1529, DOI 10.1097/QAD.0b013e3283553619
   Calcagno A, 2010, AIDS, V24, P931, DOI 10.1097/QAD.0b013e3283319954
   Capparelli EV, 2005, AIDS, V19, P949, DOI 10.1097/01.aids.0000171409.38490.48
   Capparelli EV, 2005, ANTIMICROB AGENTS CH, V49, P2504, DOI 10.1128/AAC.49.6.2504-2506.2005
   Croteau D, 2012, ANTIMICROB AGENTS CH, V56, P1985, DOI 10.1128/AAC.05098-11
   Croteau D, 2010, ANTIMICROB AGENTS CH, V54, P5156, DOI 10.1128/AAC.00507-10
   est B, 2009, 16 C RETR OPP INF MO
   Eyal S, 2009, PHARMACOL THERAPEUT, V123, P80, DOI 10.1016/j.pharmthera.2009.03.017
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Frenkel YV, 2005, J MED CHEM, V48, P1974, DOI 10.1021/jm049439i
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   Glavinas Hristos, 2007, Drug Metab Dispos, V35, P1533, DOI 10.1124/dmd.106.014605
   Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342
   Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1
   Haas DW, 2000, AIDS RES HUM RETROV, V16, P1491, DOI 10.1089/088922200750006010
   Haas DW, 2003, ANTIMICROB AGENTS CH, V47, P2131, DOI 10.1128/AAC.47.7.2131-2137.2003
   Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Kashuba ADM, 1999, ANTIMICROB AGENTS CH, V43, P1817, DOI 10.1128/AAC.43.8.1817
   Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20
   Kis O, 2010, J PHARMACOL EXP THER, V334, P1009, DOI 10.1124/jpet.110.166314
   Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001
   Kravcik S, 1999, J ACQ IMMUN DEF SYND, V21, P371
   Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018
   Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Moss DM, 2012, ANTIMICROB AGENTS CH, V56, P3020, DOI 10.1128/AAC.06407-11
   Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022
   Polli JW, 2001, J PHARMACOL EXP THER, V299, P620
   Rolinski B, 1997, J ACQ IMMUN DEF SYND, V15, P192, DOI 10.1097/00042560-199707010-00002
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003
   Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5
   Storch CH, 2007, BIOCHEM PHARMACOL, V73, P1573, DOI 10.1016/j.bcp.2007.01.027
   Stormer E, 2002, PHARMACEUT RES, V19, P1038, DOI 10.1023/A:1016430825740
   Tiraboschi JM, 2012, J ANTIMICROB CHEMOTH, V67, P1446, DOI 10.1093/jac/dks048
   Toteva MM, 2008, J PHARM SCI-US, V97, P3810, DOI 10.1002/jps.21259
   Truvada (tenofovir/emtricitabine), 2004, TRUV TEN EMTR PACK I
   Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8
   Vernazza P, 2007, AIDS, V21, P1309, DOI 10.1097/QAD.0b013e32814e6b1c
   Walker DK, 2005, DRUG METAB DISPOS, V33, P587, DOI 10.1124/dmd.104.002626
   Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474
   YARCHOAN R, 1988, LANCET, V1, P76
   Yilmaz Aylin, 2009, AIDS, V23, P2537, DOI 10.1097/QAD.0b013e328333ae0e
   Zembruski NCL, 2011, J ANTIMICROB CHEMOTH, V66, P802, DOI 10.1093/jac/dkq501
   Zembruski NCL, 2011, ANTIMICROB AGENTS CH, V55, P1282, DOI 10.1128/AAC.01527-10
NR 59
TC 11
Z9 11
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD JUN
PY 2013
VL 10
IS 6
BP 2340
EP 2349
DI 10.1021/mp300712a
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 159AE
UT WOS:000320015600025
PM 23617680
DA 2021-01-25
ER

PT J
AU Andreasen, SO
   Chong, SF
   Kryger, MBL
   Jensen, BEB
   Postma, A
   Alves, MH
   Stadler, B
   Goldie, KN
   Zelikin, AN
AF Andreasen, Sidsel O.
   Chong, Siow-Feng
   Kryger, Mille B. L.
   Jensen, Bettina E. B.
   Postma, Almar
   Alves, Marie-Helene
   Stadler, Brigitte
   Goldie, Kenneth N.
   Zelikin, Alexander N.
TI Liposomal Templating, Association with Mammalian Cells, and Cytotoxicity
   of Poly(vinyl alcohol) Physical Hydrogel Nanoparticles
SO PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
LA English
DT Article
DE biomaterials; hydrogels; liposomal templating; nanoparticles; poly(vinyl
   alcohol)
ID BIODEGRADABLE DEXTRAN NANOGELS; DRUG-DELIVERY SYSTEMS; POLYACRYLAMIDE
   NANOPARTICLES; ENZYMATIC MICROREACTORS; ENDOTHELIAL-CELLS;
   MOLECULAR-WEIGHT; CROSS-LINKING; IN-VITRO; SURFACE; MICROCAPSULES
AB The assembly, cellular internalization, and cytotoxicity of nanoparticles based on physical hydrogels of poly(vinyl alcohol) (PVA) are reported. PVA nanoparticles are assembled using a liposomal templating technique followed by removal of the lipids using isopropanol, a process that requires the presence of a custom-made block copolymer, poly(vinyl alcohol-b-vinyl pyrrolidone), to avoid aggregation of the nanoparticles. Polymer hydrogelation is induced via incubation in aqueous isopropyl alcohol solution, which results in PVA hydrogel nanoparticles (PVA HNP) with excellent colloidal stability and stability towards disintegration over at least 24 h. Pristine PVA HNP are found to be remarkably stealth-like and exhibit negligible cellular internalization. This feature is likely inherent with the low fouling nature of PVA and makes PVA HNP attractive for targeted drug delivery with a low level of association with non-targeted cells and tissues. Blending PVA with varied amounts of collagen results in colloidal hydrogel particles with a well pronounced tendency towards association with mammalian cells, specifically hepatocytes and endothelial cells. The association of PVA HNP elicits minimal changes in cellular proliferation, making these novel hydrogel particles convenient tools for drug delivery applications and creation of implantable artificial organelles and sensors.
C1 [Andreasen, Sidsel O.; Chong, Siow-Feng; Kryger, Mille B. L.; Jensen, Bettina E. B.; Alves, Marie-Helene; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark.
   [Kryger, Mille B. L.; Stadler, Brigitte; Zelikin, Alexander N.] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
   [Postma, Almar] CSIRO Mat Sci & Engn, Clayton, Vic, Australia.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
RP Andreasen, SO (corresponding author), Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark.
EM zelikin@chem.au.dk
RI Postma, Almar/B-6749-2008; Stadler, Brigitte/I-2661-2013; Postma,
   Almar/Q-9890-2019; Zelikin, Alexander/J-3659-2012
OI Postma, Almar/0000-0001-7343-7236; Zelikin,
   Alexander/0000-0002-9864-321X; Stadler, Brigitte/0000-0002-7335-3945
FU Lundbeck FoundationLundbeckfonden; Danish Council for Independent
   Research, Technology and Production Sciences, DenmarkDet Frie
   Forskningsrad (DFF)
FX This work was financed by grants from the Lundbeck Foundation and Sapere
   Aude Starting Grants from the Danish Council for Independent Research,
   Technology and Production Sciences, Denmark. The authors thank Dr.
   Francesca Ercole for GPC and NMR analysis.
CR Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Bachtsi AR, 1996, J APPL POLYM SCI, V60, P9, DOI 10.1002/(SICI)1097-4628(19960404)60:1<9::AID-APP2>3.0.CO;2-T
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   Cavalieri F, 2008, BIOMACROMOLECULES, V9, P1967, DOI 10.1021/bm800225v
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Dash BC, 2010, BIOMATERIALS, V31, P8188, DOI 10.1016/j.biomaterials.2010.07.067
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Fejerskov B, 2013, LANGMUIR, V29, P344, DOI 10.1021/la3040903
   Fejerskov B, 2012, ACS APPL MATER INTER, V4, P4981, DOI 10.1021/am3013467
   Galbiati A, 2011, BIOCONJUGATE CHEM, V22, P1066, DOI 10.1021/bc100546s
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hendrickson GR, 2010, ANGEW CHEM INT EDIT, V49, P2193, DOI 10.1002/anie.200906606
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong JS, 2008, LANGMUIR, V24, P4092, DOI 10.1021/la7031219
   Ito A, 2007, J BIOSCI BIOENG, V104, P371, DOI 10.1263/jbb.104.371
   Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h
   Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e
   Kazakov S, 2002, MACROMOLECULES, V35, P1911, DOI 10.1021/ma011644+
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kimura T, 2007, J ARTIF ORGANS, V10, P104, DOI 10.1007/s10047-006-0367-7
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kozlov M, 2004, LANGMUIR, V20, P9170, DOI 10.1021/la0492299
   Kozlov M, 2003, MACROMOLECULES, V36, P6054, DOI 10.1021/ma021681g
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Lima AC, 2012, EXPERT OPIN DRUG DEL, V9, P231, DOI 10.1517/17425247.2012.652614
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Madlova M, 2009, EUR J PHARM BIOPHARM, V72, P438, DOI 10.1016/j.ejpb.2009.01.009
   Mathews DT, 2008, J BIOMED MATER RES B, V84B, P531, DOI 10.1002/jbm.b.30901
   Moretto A., 2004, Farmaco (Lausanne), V59, P1, DOI 10.1016/j.farmac.2003.11.003
   Mutsuo S, 2008, J POLYM SCI POL PHYS, V46, P743, DOI 10.1002/polb.21407
   Negishi J, 2010, EUR J PHARM SCI, V41, P617, DOI 10.1016/j.ejps.2010.09.001
   Nielsen LJ, 2010, ACS NANO, V4, P4361, DOI 10.1021/nn100635j
   Osaka T, 2009, COLLOID SURFACE B, V71, P325, DOI 10.1016/j.colsurfb.2009.03.004
   Postma A, 2006, MACROMOLECULES, V39, P5307, DOI 10.1021/ma0604338
   Schillemans JP, 2006, MACROMOLECULES, V39, P5885, DOI 10.1021/ma060727t
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h
   Sun HH, 2008, ACS NANO, V2, P19, DOI 10.1021/nn700166x
   TADAVARTHY SM, 1975, AM J ROENTGENOL, V125, P609, DOI 10.2214/ajr.125.3.609
   Valentin JL, 2009, MACROMOLECULES, V42, P263, DOI 10.1021/ma802172g
   Van Thienen TG, 2007, LANGMUIR, V23, P9794, DOI 10.1021/la700736v
   Van Thienen TG, 2005, MACROMOLECULES, V38, P8503, DOI 10.1021/ma050822m
   Wang MY, 2005, ARTIF CELL BLOOD SUB, V33, P257, DOI 10.1081/BIO-200066606
   YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316
   Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8
   Zelikin AN, 2007, BIOMACROMOLECULES, V8, P2950, DOI 10.1021/bm700498j
   Zelikin AN, 2010, BIOMACROMOLECULES, V11, P2123, DOI 10.1021/bm100500v
NR 51
TC 5
Z9 5
U1 0
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0934-0866
J9 PART PART SYST CHAR
JI Part. Part. Syst. Charact.
PD JUN
PY 2013
VL 30
IS 6
BP 514
EP 522
DI 10.1002/ppsc.201200134
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 167HJ
UT WOS:000320621800005
DA 2021-01-25
ER

PT J
AU Bonkat, G
   Braissant, O
   Rieken, M
   Solokhina, A
   Widmer, AF
   Frei, R
   van der Merwe, A
   Wyler, S
   Gasser, TC
   Bachmann, A
AF Bonkat, Gernot
   Braissant, Olivier
   Rieken, Malte
   Solokhina, Anna
   Widmer, Andreas F.
   Frei, Reno
   van der Merwe, Andre
   Wyler, Stephen
   Gasser, Thomas C.
   Bachmann, Alexander
TI Standardization of isothermal microcalorimetry in urinary tract
   infection detection by using artificial urine
SO WORLD JOURNAL OF UROLOGY
LA English
DT Article
DE Artificial urine; Diagnosis of urinary tract infection; Isothermal
   microcalorimetry; Heat flow curves; Urinary tract infection
ID DIAGNOSIS; GROWTH; BACTERIURIA; TESTS
AB Isothermal microcalorimetry (IMC) has recently been reported as a new method to rapidly detect urinary tract pathogens (UTP). However, further application of microcalorimetry in the clinical setting requires a standardized procedure. An important step toward such standardization is to use a reproducible growth medium. In this study, we investigated the potential of artificial urine in combination with microcalorimetry for detection of common UTP.
   A microcalorimeter equipped with 48 channels was used. Detection was accomplished, and growth was monitored for four bacterial strains in artificial urine at 37 A degrees C by measuring metabolic heat flow (mu W = mu J/s) as a function of time. The strains were Escherichia coli, Proteus mirabilis, Enterococcus faecalis, and Staphylococcus aureus.
   Bacterial growth was detected after 3-32 h with decreasing inoculums down to 1 CFU. The gram-negative strains grew and were detected faster than their gram-positive counterparts. The growth rates the different strains were 0.75 +/- A 0.11 for E. coli, 0.74 +/- A 0.10 for E. faecalis, 1.31 +/- A 0.04 for P. mirabilis, and 0.56 +/- A 0.20 for S. aureus. The shape of individual heat flow curves was characteristic for each species independent of its initial concentration.
   IMC allows rapid detection of UTP in artificial urine. Clearly, different heat flow patterns enable accurate pathogen differentiation. UTP detection after only 4 h is realistic. The rapid detection of UTP tested in standardized artificial urine proves the diagnostic potential of IMC and warrants further microcalorimetric studies in the clinical setting of urinary tract infections.
C1 [Bonkat, Gernot; Braissant, Olivier; Rieken, Malte; Wyler, Stephen; Gasser, Thomas C.; Bachmann, Alexander] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Bonkat, Gernot; Braissant, Olivier; Solokhina, Anna] Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, Biozentrum,Pharmazentrum, CH-4056 Basel, Switzerland.
   [Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.
   [Frei, Reno] Univ Basel Hosp, Clin Microbiol Lab, CH-4031 Basel, Switzerland.
   [van der Merwe, Andre] Univ Stellenbosch, Fac Hlth Sci, Dept Urol, ZA-7505 Tygerberg, South Africa.
RP Bonkat, G (corresponding author), Univ Basel Hosp, Dept Urol, Spitalstr 21, CH-4031 Basel, Switzerland.
EM bonkatg@uhbs.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124
   BERMUDEZ J, 1988, CAN J MICROBIOL, V34, P1058, DOI 10.1139/m88-186
   BOLING EA, 1973, NATURE, V241, P472, DOI 10.1038/241472a0
   Bonkat G, 2012, BJU INT, V110, P892, DOI 10.1111/j.1464-410X.2011.10902.x
   Brilha S, 2010, CLIN CHEM LAB MED, V48, P289, DOI 10.1515/CCLM.2010.047
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x
   BUNKER JC, 1986, MICROBIOS, V47, P177
   Eisner BH, 2010, UROLOGY, V75, P1289, DOI 10.1016/j.urology.2009.09.024
   GORDON DM, 1992, MOL MICROBIOL, V6, P555, DOI 10.1111/j.1365-2958.1992.tb01500.x
   HESSE A, 1986, CLIN CHIM ACTA, V160, P79, DOI 10.1016/0009-8981(86)90126-9
   Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429
   Keating Karen N, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P457, DOI 10.1586/14737167.5.4.457
   LOPEZ D, 1987, CAN J MICROBIOL, V33, P6, DOI 10.1139/m87-002
   Okada H, 2000, J CLIN MICROBIOL, V38, P2870, DOI 10.1128/JCM.38.8.2870-2872.2000
   Pieretti B, 2010, J CLIN MICROBIOL, V48, P3990, DOI 10.1128/JCM.00975-10
   Raynor MC, 2011, MED CLIN N AM, V95, P43, DOI 10.1016/j.mcna.2010.08.015
   Shawe-Taylor J, 2000, INTRO SUPPORT VECTOR, P93
   Sosa V, 2006, MICROBIOL-SGM, V152, P2149, DOI 10.1099/mic.0.28846-0
   St John A, 2006, AM J CLIN PATHOL, V126, P428, DOI 10.1309/C69RW1BT7E4QAFPV
   STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802
   Taylor EN, 2007, J AM SOC NEPHROL, V18, P654, DOI 10.1681/ASN.2006080854
   Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1
   Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029
   YOUNG DS, 1970, CLIN CHEM, V16, P954
NR 26
TC 15
Z9 17
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-4983
EI 1433-8726
J9 WORLD J UROL
JI World J. Urol.
PD JUN
PY 2013
VL 31
IS 3
BP 553
EP 557
DI 10.1007/s00345-012-0913-2
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 149YM
UT WOS:000319357300019
PM 22832589
DA 2021-01-25
ER

PT J
AU Jiang, YR
   Reichert, H
AF Jiang, Yanrui
   Reichert, Heinrich
TI Analysis of neural stem cell self-renewal and differentiation by
   transgenic RNAi in Drosophila
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Neural stem cell; Neuroblast; Self-renewal; Differentiation; RNAi;
   Drosophila
ID NEUROBLAST ASYMMETRIC DIVISIONS; REGULATES SPINDLE ORIENTATION;
   GENOME-WIDE ANALYSIS; DOUBLE-STRANDED-RNA; BRAIN-DEVELOPMENT; G-PROTEIN;
   POSTEMBRYONIC NEUROBLASTS; BACTERIAL-INFECTION; TUMOR SUPPRESSORS;
   CORTICAL POLARITY
AB The fruit fly, Drosophila melanogaster, has proved to be a useful model organism for studying the biology of neural stem cells. Notably, significant progress has been made in identifying the molecular mechanisms that regulate the asymmetric cell divisions of the neural stem cell-like neuroblasts during brain development. Recently, the emerging technology of genome-wide transgenic RNA interference (RNAi), which makes it possible to analyze complicated developmental processes in a targeted, tissue-specific way, has been used for the analysis of gene function in Drosophila neuroblasts. Here, we review the key molecular mechanisms that regulate the asymmetric cell divisions of neuroblasts during brain development in Drosophila. We then summarize recent genome-wide transgenic RNAi screens in Drosophila and report on the identification of new regulators and gene networks that are required in balancing neuroblast self-renewal and differentiation. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Jiang, Yanrui; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jiang, YR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yanrui.jiang@unibas.ch; heinrich.reichert@unibas.ch
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF);  [SNSF-NFP63]
FX This work is supported by the Swiss National Science Foundation (SNSF)
   and SNSF-NFP63 "Stem cells and regenerative medicine".
CR Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016
   Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005
   Camey T. D., 2012, DEV BIOL, V361, P137
   Campos-Ortega Jose A., 1993, P1091
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164
   DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Frank DJ, 2002, DEVELOPMENT, V129, P399
   GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525
   Goodman Corey S., 1993, P1131
   HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0
   HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162
   Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409
   Jiang YR, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-3
   KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008
   Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949
   Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936
   Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640
   Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079
   Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013
   Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2
   Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9
   Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799
   Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   SPANA EP, 1995, DEVELOPMENT, V121, P3187
   SPANA EP, 1995, DEVELOPMENT, V121, P3489
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506
   Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005
   Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361
   Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128
   Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090
   Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505
   Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5
   Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174
   Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0
NR 75
TC 6
Z9 6
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN
PY 2013
VL 534
IS 1-2
SI SI
BP 38
EP 43
DI 10.1016/j.abb.2012.08.003
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 139MT
UT WOS:000318587500006
PM 22906721
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Abu Kwaik, Y
   Bumann, D
AF Abu Kwaik, Yousef
   Bumann, Dirk
TI Microbial quest for food in vivo: "Nutritional virulence' as an emerging
   paradigm
SO CELLULAR MICROBIOLOGY
LA English
DT Review
ID BACTERIAL PATHOGENS; METABOLISM; AUTOPHAGY; GROWTH; EXPLOITATION;
   SUBVERSION
AB Microbial access to host nutrients is a fundamental aspect of infectious diseases. Pathogens face complex dynamic nutritional host microenvironments that change with increasing inflammation and local hypoxia. Since the host can actively limit microbial access to nutrient supply, pathogens have evolved various metabolic adaptations to successfully exploit available host nutrients for proliferation. Recent studies have unraveled an emerging paradigm that we propose to designate as nutritional virulence'. This paradigm is based on specific virulence mechanisms that target major host biosynthetic and degradation pathways (proteasomes, autophagy and lysosomes) or nutrient-rich sources, such as glutathione, to enhance host supply of limiting nutrients, such as cysteine. Although Cys is the most limiting cellular amino acid, it is a metabolically favourable source of carbon and energy for various pathogens that are auxotrophic for Cys but utilize idiosyncratic nutritional virulence strategies to generate a gratuitous supply of host Cys. Therefore, proliferation of some intracellular pathogens is restricted by a host nutritional rheostat regulated by certain limiting amino acids, and pathogens have evolved idiosyncratic strategies to short circuit the host nutritional rheostat. Deciphering mechanisms of microbial nutritional virulence' and metabolism in vivo will facilitate identification of novel microbialand host targets for treatment and prevention of infectious diseases. Hostpathogen synchronization of amino acid auxotrophy indicates that this nutritional synchronization has been a major driving force in the evolution of many intracellular bacterial pathogens.
C1 [Abu Kwaik, Yousef] Univ Louisville, Dept Microbiol & Immunol, Coll Med, Louisville, KY 40202 USA.
   [Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
RP Abu Kwaik, Y (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Coll Med, Louisville, KY 40202 USA.
EM abukwaik@louisville.edu; Dirk.Bumann@unibas.ch
FU Public Health Service from NIAID [R01AI43965, R01AI069321]; commonwealth
   of Kentucky Research Challenge Trust Fund; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); SystemsX.ch
   ('BattleX'); EU IMIEuropean Union (EU); NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI043965, R01AI043965,
   R01AI069321, R01AI069321, R01AI043965, R01AI043965, R01AI043965,
   R01AI069321, R01AI043965, R01AI069321, R01AI069321] Funding Source: NIH
   RePORTER
FX Y.A.K. is supported by Public Health Service Awards R01AI43965 and
   R01AI069321 from NIAID and by the commonwealth of Kentucky Research
   Challenge Trust Fund. D.B. is supported by Swiss National Science
   Foundation, SystemsX.ch ('BattleX'), and EU IMI 'New drugs for bad
   bugs'. We thank Dr Christopher T. Price for help with the figure design.
CR Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005
   Al-Quadan T, 2011, TRENDS MICROBIOL, V19, P573, DOI 10.1016/j.tim.2011.08.003
   Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284
   Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386
   Bliven KA, 2012, INFECT IMMUN, V80, P4061, DOI 10.1128/IAI.00740-12
   Cerda-Maira F, 2009, MICROBES INFECT, V11, P1150, DOI 10.1016/j.micinf.2009.08.003
   Chavali AK, 2012, TRENDS MICROBIOL, V20, P113, DOI 10.1016/j.tim.2011.12.004
   Christian JG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002283
   Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037
   Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006
   Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351
   Elwell C. A., 2011, PLOS PATHOG, V7
   Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198
   Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x
   Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005
   Gutierrez MG, 2005, AUTOPHAGY, V1, P179, DOI 10.4161/auto.1.3.2063
   Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948
   Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Meibom KL, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00140
   Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x
   Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109
   Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607
   Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109
   Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106
   Ouellette SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016783
   Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868
   Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771
   Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0
   Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011
   Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003
   Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002
   Steeb B., 2013, PLOS PATHOG IN PRESS
   Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003
   Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012
   Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551
   Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   YOUNG VR, 1994, J NUTR, V124, pS1517
   Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263
NR 40
TC 112
Z9 114
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JUN
PY 2013
VL 15
IS 6
BP 882
EP 890
DI 10.1111/cmi.12138
PG 9
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 144IB
UT WOS:000318931800004
PM 23490329
OA Bronze
DA 2021-01-25
ER

PT J
AU Solinger, JA
   Spang, A
AF Solinger, Jachen A.
   Spang, Anne
TI Tethering complexes in the endocytic pathway: CORVET and HOPS
SO FEBS JOURNAL
LA English
DT Review
DE CORVET; endocytosis; endosomes; HOPS; lysosome; membrane fusion;
   membranes; Rab GTPases; sorting; Tether
ID VACUOLE MEMBRANE-FUSION; TRANS-SNARE COMPLEX; CAENORHABDITIS-ELEGANS;
   SACCHAROMYCES-CEREVISIAE; EARLY ENDOSOMES; YEAST VACUOLES; DEEP-ORANGE;
   LYSOSOMAL TRAFFICKING; ALKALINE-PHOSPHATASE; HOMOTYPIC FUSION
AB Endocytosis describes the processes by which proteins, peptides and solutes, and also pathogens, enter the cell. Endocytosed material progresses to endosomes. Genetic studies in yeast, worms, flies and mammals have identified a set of universally conserved proteins that are essential for early-to-late endosome transition and lysosome biogenesis, and for endolysosomal trafficking pathways, including autophagy. The two Vps-C complexes CORVET (classC core vacuole/endosome tethering) and HOPS (homotypic fusion and vacuole protein sorting) perform diverse biochemical functions in endocytosis: they tether membranes, interact with Rab GTPases, activate and proof-read SNARE assembly to drive membrane fusion, and possibly attach endosomes to the cytoskeleton. In addition, several of the CORVET and HOPS subunits have diversified in metazoans, and probably form additional specialized complexes to accomodate the higher complexity of trafficking pathways in these cells. Recent studies offer new insights into the complex relationships between CORVET and HOPS complexes and other factors of the endolysosomal pathway. Interactions with V-ATPase, the ESCRT machinery, phosphoinositides, the cytoskeleton and the Rab switch suggest an intricate cooperative network for endosome maturation. Accumulating evidence supports the view that endosomal tethering complexes implement a regulatory logic that governs endomembrane identity and dynamics.
C1 [Solinger, Jachen A.; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119
   Akbar MA, 2011, J CELL BIOL, V192, P383, DOI 10.1083/jcb.201008119
   Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272
   BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075
   BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369
   Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004
   Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009
   Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103
   Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716
   Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109
   Bryant NJ, 1998, EUR J CELL BIOL, V76, P43, DOI 10.1016/S0171-9335(98)80016-2
   Bugnicourt A, 2004, MOL BIOL CELL, V15, P4203, DOI 10.1091/mbc.E04-05-0420
   Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092
   Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683
   Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142
   Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000
   Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947
   Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104
   Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37
   Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950
   Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437
   Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089
   Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068
   Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106
   Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009
   Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882
   Gissen P, 2005, HUM MOL GENET, V14, P1261, DOI 10.1093/hmg/ddi137
   GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0
   Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012
   Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060
   Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439
   Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077
   Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200
   Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029
   Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718
   Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853
   Kjeken R, 2004, MOL BIOL CELL, V15, P345
   Kucharczyk R, 2009, FEMS YEAST RES, V9, P565, DOI 10.1111/j.1567-1364.2009.00515.x
   Lachman J., 2011, SMALL GTPASES, V2, P182, DOI DOI 10.4161/SGTP.2.3.16701
   Lee SK, 2010, BBA-BIOENERGETICS, V1797, P1687, DOI 10.1016/j.bbabio.2010.07.004
   Lees JA, 2010, NAT STRUCT MOL BIOL, V17, P1292, DOI 10.1038/nsmb.1917
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20
   LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7
   Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002
   Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x
   Loubery S, 2012, TRAFFIC, V13, P665, DOI 10.1111/j.1600-0854.2012.01342.x
   Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245
   Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x
   Markgraf DF, 2009, MOL BIOL CELL, V20, P5276, DOI 10.1091/mbc.E09-06-0521
   MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8
   Messller S, 2011, IMMUNOBIOLOGY, V216, P343, DOI 10.1016/j.imbio.2010.07.006
   Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097
   Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004
   Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007
   Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002
   Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1
   Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x
   Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109
   PASTAN IH, 1981, SCIENCE, V214, P504, DOI 10.1126/science.6170111
   Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006
   Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500
   Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075
   Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809
   Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531
   Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260
   Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498
   Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011
   Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040
   Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301
   Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022
   Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502
   Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016
   RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389
   Rehling P, 1999, NAT CELL BIOL, V1, P346
   Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002
   Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001
   ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6
   Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098
   Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9
   Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016
   Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166
   Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077
   Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21
   Strasser B, 2011, EMBO J, V30, P4126, DOI 10.1038/emboj.2011.335
   Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051
   Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748
   Takeda K, 2008, FEBS LETT, V582, P1558, DOI 10.1016/j.febslet.2008.03.055
   TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635
   Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003
   WADA Y, 1992, J BIOL CHEM, V267, P18665
   Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071
   Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064
   Whyte JRC, 2002, J CELL SCI, V115, P2627
   Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131
   Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441
   Xu H, 2010, J BIOL CHEM, V285, P39359, DOI 10.1074/jbc.M110.183111
   Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327
   Zhu GD, 2003, GENETICS, V165, P145
   Zhu GD, 2009, MOL BIOL CELL, V20, P1223, DOI 10.1091/mbc.E08-07-0728
   Zieger M, 2012, MOL BIOL CELL, V23, P3438, DOI 10.1091/mbc.E12-05-0347
   Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467
NR 106
TC 97
Z9 102
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD JUN
PY 2013
VL 280
IS 12
BP 2743
EP 2757
DI 10.1111/febs.12151
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 159IA
UT WOS:000320037900003
PM 23351085
OA Bronze
DA 2021-01-25
ER

PT J
AU Gunaratne, J
   Schmidt, A
   Quandt, A
   Neo, SP
   Sarac, OS
   Gracia, T
   Loguercio, S
   Ahrne, E
   Xia, RLH
   Tan, KH
   Lossner, C
   Baehler, J
   Beyer, A
   Blackstock, W
   Aebersold, R
AF Gunaratne, Jayantha
   Schmidt, Alexander
   Quandt, Andreas
   Neo, Suat Peng
   Sarac, Oemer Sinan
   Gracia, Tannia
   Loguercio, Salvatore
   Ahrne, Erik
   Xia, Rachel Li Hai
   Tan, Keng Hwa
   Loessner, Christopher
   Baehler, Juerg
   Beyer, Andreas
   Blackstock, Walter
   Aebersold, Ruedi
TI Extensive Mass Spectrometry-based Analysis of the Fission Yeast Proteome
   THE SCHIZOSACCHAROMYCES POMBE PEPTIDEATLAS
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID MESSENGER-RNA; GENE-EXPRESSION; ABUNDANCE; IDENTIFICATION;
   TRANSCRIPTOME; PROTEINS; SEQUENCE; SCALE; QUANTIFICATION; RESOURCE
AB We report a high quality and system-wide proteome catalogue covering 71% (3,542 proteins) of the predicted genes of fission yeast, Schizosaccharomyces pombe, presenting the largest protein dataset to date for this important model organism. We obtained this high proteome and peptide (11.4 peptides/protein) coverage by a combination of extensive sample fractionation, high resolution Orbitrap mass spectrometry, and combined database searching using the iProphet software as part of the Trans-Proteomics Pipeline. All raw and processed data are made accessible in the S. pombe PeptideAtlas. The identified proteins showed no biases in functional properties and allowed global estimation of protein abundances. The high coverage of the PeptideAtlas allowed correlation with transcriptomic data in a system-wide manner indicating that post-transcriptional processes control the levels of at least half of all identified proteins. Interestingly, the correlation was not equally tight for all functional categories ranging from r(s) >0.80 for proteins involved in translation to r(s) <0.45 for signal transduction proteins. Moreover, many proteins involved in DNA damage repair could not be detected in the PeptideAtlas despite their high mRNA levels, strengthening the translation-on-demand hypothesis for members of this protein class. In summary, the extensive and publicly available S. pombe PeptideAtlas together with the generated proteotypic peptide spectral library will be a useful resource for future targeted, in-depth, and quantitative proteomic studies on this microorganism.
C1 [Gunaratne, Jayantha; Neo, Suat Peng; Xia, Rachel Li Hai; Tan, Keng Hwa; Loessner, Christopher; Blackstock, Walter] Agcy Sci Technol & Res, Quantitat Prote Grp, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Schmidt, Alexander; Ahrne, Erik] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
   [Quandt, Andreas; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.
   [Sarac, Oemer Sinan; Loguercio, Salvatore; Beyer, Andreas] Tech Univ Dresden, Biotechnol Ctr, D-01069 Dresden, Germany.
   [Gracia, Tannia; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Gracia, Tannia; Baehler, Juerg] UCL, UCL Canc Inst, London WC1E 6BT, England.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
RP Schmidt, A (corresponding author), Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
EM alex.schmidt@unibas.ch; aebersold@imsb.biol.ethz.ch
RI Beyer, Andreas/AAQ-5519-2020; Beyer, Andreas/A-3352-2009; Bahler,
   Jurg/B-4572-2009
OI Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123;
   Bahler, Jurg/0000-0003-4036-1532
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/I012451/1] Funding
   Source: researchfish; Wellcome TrustWellcome Trust [095598/Z/11/Z]
   Funding Source: researchfish; Wellcome TrustWellcome Trust [095598]
   Funding Source: Medline
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140
   Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956
   Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200
   Bitton DA, 2011, GENETICS, V187, P1207, DOI 10.1534/genetics.110.123497
   Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057
   Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300
   Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499
   Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092
   Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   de Graaf EL, 2011, J PROTEOME RES, V10, P4334, DOI 10.1021/pr200156b
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   Humphrey T, 2000, MUTAT RES-FUND MOL M, V451, P211, DOI 10.1016/S0027-5107(00)00051-8
   Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001
   Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200
   Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102
   Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024
   Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683
   Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002
   Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25
   Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254
   Lam H, 2007, PROTEOMICS, V7, P655, DOI 10.1002/pmic.200600625
   Lam H, 2011, NAT METHODS, V8, P546, DOI 10.1038/nmeth.1633
   Lam H, 2010, J PROTEOME RES, V9, P605, DOI 10.1021/pr900947u
   Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019
   Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217
   Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81
   Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200
   Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722
   Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387
   Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Sherwood CA, 2009, J PROTEOME RES, V8, P3746, DOI 10.1021/pr801122b
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Shteynberg D, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007690
   Sipiczki M, 2000, GENOME BIOL, V1, P1011, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011
   Vizcaino JA, 2010, J PROTEOMICS, V73, P2136, DOI 10.1016/j.jprot.2010.06.008
   Warringer J, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-61
   Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002
   Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724
   Wood V, 2006, TOP CURR GENET, V15, P233, DOI 10.1007/4735_97
   Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853
   Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230
   ZHANG JA, 2011, DATABASE, V28, DOI DOI 10.1088/0256-307X/28/3/038901
NR 58
TC 17
Z9 18
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD JUN
PY 2013
VL 12
IS 6
BP 1741
EP 1751
DI 10.1074/mcp.M112.023754
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 156ZS
UT WOS:000319865000021
PM 23462206
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Goepfert, A
   Stanger, FV
   Dehio, C
   Schirmer, T
AF Goepfert, Arnaud
   Stanger, Frederic V.
   Dehio, Christoph
   Schirmer, Tilman
TI Conserved Inhibitory Mechanism and Competent ATP Binding Mode for
   Adenylyltransferases with Fic Fold
SO PLOS ONE
LA English
DT Article
ID CRYSTAL-STRUCTURE; AMPYLATION; COMPLEX; KINASE; SITE
AB The ubiquitous FIC domain is evolutionarily conserved from bacteria to human and has been shown to catalyze AMP transfer onto protein side-chain hydroxyl groups. Recently, it was predicted that most catalytically competent Fic proteins are inhibited by the presence of an inhibitory helix alpha(inh) that is provided by a cognate anti-toxin (class I), or is part of the Nor C-terminal part of the Fic protein itself (classes II and III). In vitro, inhibition is relieved by mutation of a conserved glutamate of alpha(inh) to glycine. For the class III bacterial Fic protein NmFic from Neisseria meningitidis, the inhibitory mechanism has been elucidated. Here, we extend above study by including bacterial class I and II Fic proteins VbhT from Bartonella schoenbuchensis and SoFic from Shewanella oneidensis, respectively, and the respective E-> G mutants. Comparative enzymatic and crystallographic analyses show that, in all three classes, the ATP substrate binds to the wildtype FIC domains, but with the alpha-phosphate in disparate and non-competent orientations. In the E-> G mutants, however, the tri-phosphate moiety is found reorganized to the same tightly bound structure through a unique set of hydrogen bonds with Fic signature motif residues. The gamma-phosphate adopts the location that is taken by the inhibitory glutamate in wild-type resulting in an alpha-phosphate orientation that can be attacked in-line by a target side-chain hydroxyl group. The latter is properly registered to the Fic active center by main-chain beta-interactions with the beta-hairpin flap. These data indicate that the active site motif and the exposed edge of the flap are both required to form an adenylylation-competent Fic protein.
C1 [Goepfert, Arnaud; Stanger, Frederic V.; Dehio, Christoph; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Goepfert, Arnaud; Stanger, Frederic V.; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM christoph.dehio@unibas.ch; tilman.schirmer@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Stanger, Frederic/0000-0002-9847-5084
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A 312979, 3100 138414]; SystemsX.ch Swiss Initiative for
   Systems Biology [51RT 0_126008]
FX This work was supported by grants 31003A 312979 and 3100 138414 from the
   Swiss National Science Foundation (to CD and TS, respectively) and grant
   51RT 0_126008 (InfectX) in the frame of the SystemsX.ch Swiss Initiative
   for Systems Biology (to CD). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338
   Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729
   HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422
   Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818
   Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0
   Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227
   Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456
   Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008
   Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867
   Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870
   Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382
NR 23
TC 19
Z9 22
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 30
PY 2013
VL 8
IS 5
AR e64901
DI 10.1371/journal.pone.0064901
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 177SC
UT WOS:000321394700070
PM 23738009
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Santos, G
   Perez-Schindler, J
   Handschin, C
AF Summermatter, Serge
   Santos, Gesa
   Perez-Schindler, Joaquin
   Handschin, Christoph
TI Skeletal muscle PGC-1 alpha controls whole-body lactate homeostasis
   through estrogen-related receptor alpha-dependent activation of LDH B
   and repression of LDH A
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE transcriptional regulation; mitochondria; oxidative metabolism;
   metabolic reprogramming; muscle plasticity
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; C-MYC; EXERCISE PERFORMANCE;
   GLUCOSE-UPTAKE; METABOLISM; DEHYDROGENASE; EXPRESSION; MCT1; INDUCTION;
   RESPONSES
AB The peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) controls metabolic adaptations. We now show that PGC-1 alpha in skeletal muscle drives the expression of lactate dehydrogenase (LDH) B in an estrogen-related receptor-alpha-dependent manner. Concomitantly, PGC-1 alpha reduces the expression of LDH A and one of its regulators, the transcription factor myelocytomatosis oncogene. PGC-1 alpha thereby coordinately alters the composition of the LDH complex and prevents the increase in blood lactate during exercise. Our results show how PGC-1 alpha actively coordinates lactate homeostasis and provide a unique molecular explanation for PGC-1 alpha-mediated muscle adaptations to training that ultimately enhance exercise performance and improve metabolic health.
C1 [Summermatter, Serge; Santos, Gesa; Perez-Schindler, Joaquin; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097; Perez-Schindler,
   Joaquin/0000-0003-3141-8859
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy AssociationMuscular
   Dystrophy Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit
   und Medizinische Forschung"; Swiss Society for Research on Muscle
   Diseases; Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation; Association Francaise Contre les
   MyopathiesAssociation Francaise contre les Myopathies; University of
   Basel
FX This project was funded by Swiss National Science Foundation Grant SNF
   PP00A-110746, the Muscular Dystrophy Association, the SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und Medizinische Forschung," the
   Swiss Society for Research on Muscle Diseases, Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation, the Association Francaise Contre les Myopathies, and
   the University of Basel.
CR AHLBORG G, 1994, J APPL PHYSIOL, V76, P1037
   APPLE FS, 1989, J APPL PHYSIOL, V66, P2717
   APPLE FS, 1986, J APPL PHYSIOL, V61, P477
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e
   Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008
   Cairns SP, 2006, SPORTS MED, V36, P279, DOI 10.2165/00007256-200636040-00001
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610
   DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929
   DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032
   Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724
   Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11
   Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111
   GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822
   HAGBERG JM, 1988, J APPL PHYSIOL, V65, P900
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2010, J RECEPT SIG TRANSD, V30, P376, DOI 10.3109/10799891003641074
   Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005
   HOWELL BF, 1979, CLIN CHEM, V25, P269
   JORFELDT L, 1970, SCAND J CLIN LAB INV, V26, P73, DOI 10.3109/00365517009049217
   Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x
   Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100
   Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Mortensen OH, 2007, J APPL PHYSIOL, V103, P1536, DOI 10.1152/japplphysiol.00575.2007
   Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854
   OMACHI A, 1956, AM J PHYSIOL, V185, P35
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   Park EJ, 2012, J NAT PROD, V75, P378, DOI 10.1021/np200791j
   Park EJ, 2011, CANCER PREV RES, V4, P592, DOI 10.1158/1940-6207.CAPR-10-0004
   Py G, 2001, AM J PHYSIOL-ENDOC M, V281, pE1308
   RICHTER EA, 1988, AM J PHYSIOL, V254, pE555
   Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539
   SIMONEAU JA, 1989, PFLUG ARCH EUR J PHY, V413, P679, DOI 10.1007/BF00581821
   Summermatter S, 2012, INT J OBESITY, V36, P1428, DOI 10.1038/ijo.2012.12
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793
   Van Hall G, 2000, ACTA PHYSIOL SCAND, V168, P643, DOI 10.1046/j.1365-201x.2000.00716.x
   van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x
   Veal EA, 1998, INT J BIOCHEM CELL B, V30, P811, DOI 10.1016/S1357-2725(98)00032-6
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x
NR 48
TC 66
Z9 70
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 21
PY 2013
VL 110
IS 21
BP 8738
EP 8743
DI 10.1073/pnas.1212976110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 163IE
UT WOS:000320328700089
PM 23650363
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Siekmann, AF
   Affolter, M
   Belting, HG
AF Siekmann, Arndt F.
   Affolter, Markus
   Belting, Heinz-Georg
TI The tip cell concept 10 years after: New players tune in for a common
   theme
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE Angiogenesis; Tip cell; VEGF; Notch; Mouse; Embryo; Zebrafish
ID VASCULAR SPROUT FORMATION; BLOOD-VESSEL FUSION; ENDOTHELIAL-CELLS;
   ZEBRAFISH EMBRYO; BRANCHING MORPHOGENESIS; NEGATIVE REGULATOR; NETWORK
   FORMATION; UP-REGULATION; NOTCH; ANGIOGENESIS
C1 [Siekmann, Arndt F.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany.
   [Affolter, Markus; Belting, Heinz-Georg] Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Biozentrum Univ Basel, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM arndt.siekmann@mpi-muenster.mpg.de; markus.affolter@unibas.ch;
   heinz-georg.belting@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Belting,
   Heinz-Georg/0000-0002-1538-4364
FU Max Planck SocietyMax Planck Society; DFGGerman Research Foundation
   (DFG) [SI-1374/3-1]; ERCEuropean Research Council (ERC)
   [260794-ZebrafishAngio]; DFG special priority program 629; Kantons
   Basel-Stadt and Basel-Land; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX We thank Dr. Anna Lenard for help with illustrations and critically
   reading the manuscript. This work has been supported by the Max Planck
   Society (AFS), a DFG Grant (SI-1374/3-1) (AFS), an ERC starting Grant
   (260794-ZebrafishAngio) (AFS), the DFG special priority program 629
   (AFS), by the Kantons Basel-Stadt and Basel-Land and by a grant from the
   Swiss National Science Foundation to M.A.
CR Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716
   Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908
   Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Bussmann J, 2011, DEVELOPMENT, V138, P1717, DOI 10.1242/dev.059881
   Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311
   Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011
   Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103
   del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819
   Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Funahashi Yasuhiro, 2010, J Angiogenes Res, V2, P3, DOI 10.1186/2040-2384-2-3
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002
   Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037
   Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349
   Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990
   Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103
   Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233
   Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315
   KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705
   Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011
   Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933
   Kurz H, 1996, DEV BIOL, V173, P133, DOI 10.1006/dbio.1996.0012
   Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005
   Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144
   Lawson N. D., 2009, GENE DEV, V23, P2272
   Lawson ND, 2001, DEVELOPMENT, V128, P3675
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266
   Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104
   Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007
   Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Outtz HH, 2011, BLOOD, V118, P3436, DOI 10.1182/blood-2010-12-327015
   Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313
   Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096
   Ruhrberg C., BLOOD IN PRESS
   Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012674
   Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284
   Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104
   Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083
   Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331
   Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008
   Weinstein BM, 2005, CELL, V120, P299, DOI 10.1016/j.cell.2005.01.010
   Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232
   Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000
NR 61
TC 49
Z9 52
U1 0
U2 15
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAY 15
PY 2013
VL 319
IS 9
SI SI
BP 1255
EP 1263
DI 10.1016/j.yexcr.2013.01.019
PG 9
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 150DD
UT WOS:000319369500004
PM 23419245
DA 2021-01-25
ER

PT J
AU Beck, A
   Aanismaa, P
   Li-Blatter, X
   Dawson, R
   Locher, K
   Seelig, A
AF Beck, Andreas
   Aeaenismaa, Paeivi
   Li-Blatter, Xiaochun
   Dawson, Roger
   Locher, Kaspar
   Seelig, Anna
TI Sav1866 from Staphylococcus aureus and P-Glycoprotein: Similarities and
   Differences in ATPase Activity Assessed with Detergents as Allocrites
SO BIOCHEMISTRY
LA English
DT Article
ID MULTIDRUG ABC TRANSPORTER; BRAIN-BARRIER PERMEATION;
   FUNCTIONAL-CHARACTERIZATION; NUCLEOTIDE-BINDING; ESCHERICHIA-COLI;
   LIPID-MEMBRANES; CATALYTIC CYCLE; DRUG TRANSPORT; LIVING CELLS; PRESSURE
AB The ATP-binding cassette exporters Sav1866 from Staphylococcus aureus and P-glycoprotein are known to share a certain sequence similarity and disposition for cationic allocrites. Conversely, the two ATPases react very differently to neutral detergents that have previously been shown to be inhibitory allocrites for P-glycoprotein. To gain insight into the functional differences of the two proteins, we compared their basal and detergent-stimulated ATPase activity. P-Glycoprotein was investigated in NIH-MDR1-G185 plasma membrane vesicles and Sav1866 in lipid vesicles exhibiting a membrane packing density and a surface potential similar to those of the plasma membrane vesicles. Under basal conditions, Sav1866 revealed a lower catalytic efficiency and concomitantly a more pronounced sodium chloride and pH dependence than P-glycoprotein. As expected, the cationic allocrites (alkyltrimethylammonium chlorides) induced similar bell-shaped activity curves as a function of concentration for both exporters, suggesting stimulation upon binding of the first and inhibition upon binding of the second allocrite molecule. However, the neutral allocrites (n-alkyl-beta-D-maltosides and n-ethylene glycol monododecyl ethers) reduced P-glycoprotein's ATPase activity at concentrations well below their critical micelle concentration (CMC) but strongly enhanced Sav1866's ATPase activity even at concentrations above their CMC. The lack of ATPase inhibition at high concentrations of neutral of detergents could be explained by their comparatively low binding affinity for the transmembrane domains of Sav1866, which seems to prevent binding of a second inhibitory molecule. The high ATPase activity in the presence of hydrophobic, long chain detergents moreover revealed that Sav1866, despite its lower basal catalytic efficiency, is a more efficient floppase for lipidlike amphiphiles than P-glycoprotein.
C1 [Beck, Andreas; Aeaenismaa, Paeivi; Li-Blatter, Xiaochun; Seelig, Anna] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Dawson, Roger; Locher, Kaspar] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM anna.seelig@unibas.ch
OI Dawson, Roger/0000-0003-2161-5883
FU Swiss National Science Foundation GrantSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX This work was supported by Swiss National Science Foundation Grant
   31003A-129701.
CR Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h
   Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
   Beck A, 2010, J PHYS CHEM B, V114, P15862, DOI 10.1021/jp107088d
   Benabdelhak H, 2005, BIOCHEM J, V386, P489, DOI 10.1042/BJ20041282
   Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073
   Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155
   Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445
   DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2
   Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Ernst R, 2006, J BIOL CHEM, V281, P27471, DOI 10.1074/jbc.M601131200
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   GORDON JA, 1991, METHOD ENZYMOL, V201, P477
   GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Hoffman AD, 2010, PROTEIN J, V29, P373, DOI 10.1007/s10930-010-9262-4
   Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267
   ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8
   JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0
   Kamaraju K, 2008, BIOCHEMISTRY-US, V47, P10540, DOI 10.1021/bi801092g
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Li-Blatter XC, 2012, BIOPHYS J, V102, P1383, DOI 10.1016/j.bpj.2012.02.018
   Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Nebel S, 1997, BIOCHEMISTRY-US, V36, P2853, DOI 10.1021/bi961839n
   Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022
   O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069
   Orlowski S, 1998, Cancer Biochem Biophys, V16, P85
   SCHWYZER R, 1987, EMBO J, V6, P2255, DOI 10.1002/j.1460-2075.1987.tb02498.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+
   SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381
   SHAROM FJ, 1993, J BIOL CHEM, V268, P24197
   URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956
   Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737
   Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
   Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122
   Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com
   Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/BSE0500043, 10.1042/bse0500043]
NR 54
TC 10
Z9 10
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 14
PY 2013
VL 52
IS 19
BP 3297
EP 3309
DI 10.1021/bi400203d
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 147RS
UT WOS:000319185300011
PM 23600489
DA 2021-01-25
ER

PT J
AU Stevens, J
   Spang, A
AF Stevens, Julia
   Spang, Anne
TI N-Glycosylation Is Required for Secretion and Mitosis in C. elegans
SO PLOS ONE
LA English
DT Article
ID CAENORHABDITIS-ELEGANS; CELL-DEATH; PROTEINS; OLIGOSACCHARYLTRANSFERASE;
   INTERFERENCE; DYNAMICS; ISOFORMS; EMBRYOS
AB N-glycosylation of proteins is an essential process, and N-glucans serve as important beacons in protein folding and ER associated degradation. More importantly, N-glycosylation increases the structural repertoire of proteins because the addition of the N-glucan on proteins will serve as a base for further sugar additions in the Golgi apparatus, and hence complex three-dimensional structures can be build. N-glycosylation is mediated by the ER-resident OST complex, which is essential throughout eukaryotes. Partial knockdown of conserved OST complex members, such as C. elegans RIBO-1, led to an embryonic lethal phenotype. Although the ER morphology was not grossly altered in ribo-1(RNAi) oocytes and embryos, secretion of yolk and of the yolk receptor RME-2 was perturbed in those worms. Perhaps as a consequence of reduced arrival of N-glycosylated proteins at the plasma membrane, cytokinesis occurred less efficiently leading to multinuclear cells. Unexpectedly, we detected a chromosome segregation defect in ribo-1(RNAi) embryos suggesting an essential role of at least one N-glycosylated protein in metaphase-anaphase transition.
C1 [Stevens, Julia; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Max Planck SocietyMax Planck Society; University of Basel; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX Funding provided by the Max Planck Society, University of Basel, The
   Swiss National Science Foundation. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267
   Badtke M, 2012, BREAST CANCER RES TR, V131, P75, DOI 10.1007/s10549-011-1399-0
   Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627
   BRENNER S, 1974, GENETICS, V77, P71
   Edgar LG, 2012, METHOD CELL BIOL, V107, P153, DOI 10.1016/B978-0-12-394620-1.00005-9
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237
   Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927
   Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311
   Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002
   Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0
   Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994
   Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f
   Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1
   Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880
   Parry H, 2005, J CELL BIOL, V171, P47, DOI 10.1083/jcb.200503139
   Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726
   Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498
   Praitis V, 2001, GENETICS, V157, P1217
   Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047
   Schmutz C, 2005, EUR J CELL BIOL, V84, P75, DOI 10.1016/j.ejcb.2004.10.004
   Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802
   SHARROCK WJ, 1983, DEV BIOL, V96, P182, DOI 10.1016/0012-1606(83)90321-4
   Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012
   Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353
   Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751
   Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5
   Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6
   Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729
NR 29
TC 8
Z9 15
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 14
PY 2013
VL 8
IS 5
AR e63687
DI 10.1371/journal.pone.0063687
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 146RE
UT WOS:000319107400073
PM 23691084
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, Gottfried
TI Getting mitochondria to center stage
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; INTRAMITOCHONDRIAL FIBERS;
   SACCHAROMYCES-CEREVISIAE; DNA CHARACTERISTICS; RESPIRATORY-CHAIN;
   PROTEIN SYNTHESIS; MEMBRANE SYSTEM; BAKERS-YEAST; MUTANTS;
   PHOSPHORYLATION
AB The question of how eukaryotic cells assemble their mitochondria was long considered to be inaccessible to biochemical investigation. This attitude changed about fifty years ago when the powerful tools of yeast genetics, electron microscopy and molecular biology were brought to bear on this problem. The rising interest in mitochondrial biogenesis thus paralleled and assisted in the birth of modern biology. This brief recollection recounts the days when research on mitochondrial biogenesis was an exotic effort limited to a small group of outsiders. (C) 2013 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM gottfried.schatz@unibas.ch
CR Altmann R., 1890, ELEMENTARORGANISMEN
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   ATTARDI G, 1986, COLD SPRING HARB SYM, V51, P103, DOI 10.1101/SQB.1986.051.01.013
   BARRELL BG, 1980, P NATL ACAD SCI-BIOL, V77, P3164, DOI 10.1073/pnas.77.6.3164
   Bonner John Tyler, 1998, Integrative Biology, V1, P27
   CABRAL F, 1978, J BIOL CHEM, V253, P297
   Ephrussi Boris, 1953, NUCLEOCYTOPLASMIC RE
   ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s
   KOVACOVA V, 1968, BIOCHIM BIOPHYS ACTA, V162, P157, DOI 10.1016/0005-2728(68)90097-2
   KUZELA S, 1969, EXPERIENTIA, V25, P1042, DOI 10.1007/BF01901416
   LEHNINGER A. L., 1964, The mitochondrion. Molecular basis of structure and function.
   MASON TL, 1973, J BIOL CHEM, V248, P1355
   MASON TL, 1973, J BIOL CHEM, V248, P1346
   Mason TL, 1972, MITOCHONDRIA BIOGENE, P53
   MCLEAN JR, 1958, J BIOL CHEM, V233, P657
   Mereschkowsky C., 1905, BIOL CENTRALBL, V25, P593
   MERESCHKOWSKY C, 1905, BIOL CENTRALBL, V25, P689
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   MOUNOLOU JC, 1966, BIOCHEM BIOPH RES CO, V24, P218, DOI 10.1016/0006-291X(66)90723-6
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   NASS S, 1963, J CELL BIOL, V19, P613, DOI 10.1083/jcb.19.3.613
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   RIS H, 1962, J CELL BIOL, V13, P383, DOI 10.1083/jcb.13.3.383
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   SCHATZ G, 1969, BIOCHEM BIOPH RES CO, V37, P996, DOI 10.1016/0006-291X(69)90230-7
   SCHATZ G, 1963, Z NATURFORSCH PT B, VB 18, P145
   SCHATZ G, 1964, BIOCHEM BIOPH RES CO, V15, P127, DOI 10.1016/0006-291X(64)90311-0
   Schatz G, 2000, COMPREHENSIVE BIOCH, V41, P449
   Schatz G., 1964, MONATSH CHEM, V95, P1135
   Schatz G., 1996, PROTEIN SCI, V6, P728
   Schatz G, 2012, ANNU REV BIOCHEM, V81, P35, DOI 10.1146/annurev-biochem-081009-125448
   Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1
   Schimper A.F.W., 1883, BOT Z, V41
   Schimper A.F.W., 1883, BOT Z, V41
   Schimper A.F.W., 1883, BOT Z, V41
   Schimper ATW, 1883, BOT ZTG, V41, P105
   SLONIMSKI P, 1953, FORMATION ENZYMES RE
   TZAGOLOFF A, 1979, ANNU REV BIOCHEM, V48, P419, DOI 10.1146/annurev.bi.48.070179.002223
   TZAGOLOFF A, 1971, J BIOL CHEM, V246, P3050
   TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8236
   Wallin IE, 1923, AM NAT, V57, P255, DOI 10.1086/279919
   YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819
NR 44
TC 4
Z9 4
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 10
PY 2013
VL 434
IS 3
BP 407
EP 410
DI 10.1016/j.bbrc.2013.03.081
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 151SW
UT WOS:000319481500001
PM 23562480
DA 2021-01-25
ER

PT J
AU Castets, P
   Lin, S
   Rion, N
   Di Fulvio, S
   Romanino, K
   Guridi, M
   Frank, S
   Tintignac, LA
   Sinnreich, M
   Ruegg, MA
AF Castets, Perrine
   Lin, Shuo
   Rion, Nathalie
   Di Fulvio, Sabrina
   Romanino, Klaas
   Guridi, Maitea
   Frank, Stephan
   Tintignac, Lionel A.
   Sinnreich, Michael
   Rueegg, Markus A.
TI Sustained Activation of mTORC1 in Skeletal Muscle Inhibits Constitutive
   and Starvation-Induced Autophagy and Causes a Severe, Late-Onset
   Myopathy
SO CELL METABOLISM
LA English
DT Article
ID AMINO-ACIDS; MOUSE MODEL; IN-VIVO; CELLS; MICE; ULK1; HYPERTROPHY;
   DYSTROPHY; RAPAMYCIN; ABLATION
AB Autophagy is a catabolic process that ensures homeostatic cell clearance and is deregulated in a growing number of myopathological conditions. Although FoxO3 was shown to promote the expression of autophagy-related genes in skeletal muscle, the mechanisms triggering autophagy are unclear. We show that TSC1-deficient mice (TSCmKO), characterized by sustained activation of mTORC1, develop a late-onset myopathy related to impaired autophagy. In young TSCmKO mice, constitutive and starvation-induced autophagy is blocked at the induction steps via mTORC1-mediated inhibition of Ulk1, despite FoxO3 activation. Rapamycin is sufficient to restore autophagy in TSCmKO mice and improves the muscle phenotype of old mutant mice. Inversely, abrogation of mTORC1 signaling by depletion of raptor induces autophagy regardless of FoxO inhibition. Thus, mTORC1 is the dominant regulator of autophagy induction in skeletal muscle and ensures a tight coordination of metabolic pathways. These findings may open interesting avenues for therapeutic strategies directed toward autophagy-related muscle diseases.
C1 [Castets, Perrine; Lin, Shuo; Rion, Nathalie; Romanino, Klaas; Guridi, Maitea; Tintignac, Lionel A.; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Castets, Perrine; Di Fulvio, Sabrina; Sinnreich, Michael] Univ Basel Hosp, Dept Neurol, Neuromuscular Res Ctr, CH-4056 Basel, Switzerland.
   [Castets, Perrine; Di Fulvio, Sabrina; Sinnreich, Michael] Univ Basel Hosp, Dept Biomed, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Frank, Stephan] Univ Basel Hosp, Inst Pathol, Div Neuropathol, CH-4056 Basel, Switzerland.
   [Tintignac, Lionel A.] Univ Montpellier 2, Univ Montpellier 1, INRA, UMR866, F-34060 Montpellier, France.
RP Sinnreich, M (corresponding author), Univ Basel Hosp, Dept Neurol, Neuromuscular Res Ctr, CH-4056 Basel, Switzerland.
EM msinnreich@uhbs.ch; markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Canton of Basel-Stadt; Canton of Baselland; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Swiss Foundation for
   Research on Muscle Disease, Swiss Life; Association Francaise contre les
   MyopathiesAssociation Francaise contre les Myopathies; University of
   Basel; Myosuisse
FX We thank Dr. V. Allamand for her remarks on the manuscript and Drs. T.
   Wiktorowicz, A. Bertrand, A. S. Arnold, R. M. Lustenberger as well as B.
   Erne, F. Oliveri, B. Kupr, and U. Sauder for technical assistance. MHC
   and Lamp antibodies, developed by H. M. Blau and J.T. August,
   respectively, were obtained from DSHB (Iowa, USA). We acknowledge
   Professor Muramatsu for the Ulk1 plasmid deposited at Addgene. This work
   was supported by the Cantons of Basel-Stadt and Baselland, grants from
   the Swiss National Science Foundation, the Swiss Foundation for Research
   on Muscle Disease, Swiss Life, the Association Francaise contre les
   Myopathies, the University of Basel, and Myosuisse.
CR Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   DEBLEECKER JL, 1993, AM J PATHOL, V143, P1200
   Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660
   Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Ogata T, 2010, BIOCHEM BIOPH RES CO, V394, P136, DOI 10.1016/j.bbrc.2010.02.130
   ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773
   Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200
   Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77
   Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
NR 34
TC 126
Z9 128
U1 1
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAY 7
PY 2013
VL 17
IS 5
BP 731
EP 744
DI 10.1016/j.cmet.2013.03.015
PG 14
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 242TU
UT WOS:000326266000014
PM 23602450
OA Bronze
DA 2021-01-25
ER

PT J
AU Chen, PH
   Chou, PC
   Oh, WJ
   Wu, CC
   Hall, M
   Jacinto, E
   Werlen, G
AF Chen, Po-Hao
   Chou, Po-Chien
   Oh, Won Jun
   Wu, Chang-Chih
   Hall, Michael
   Jacinto, Estela
   Werlen, Guy
TI mTORC2 modulates alpha beta T-cell receptor processing and surface
   expression during thymocyte development
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 100th Annual Meeting of the American-Association-of-Immunologists
CY MAY 03-07, 2013
CL Honolulu, HI
SP Amer Assoc Immunologists
C1 [Chen, Po-Hao; Chou, Po-Chien; Oh, Won Jun; Wu, Chang-Chih; Jacinto, Estela] UMDNJ, Piscataway, NJ USA.
   [Werlen, Guy] Rutgers State Univ, Piscataway, NJ USA.
   [Hall, Michael] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2013
VL 190
MA P4414
PG 1
WC Immunology
SC Immunology
GA 199ID
UT WOS:000322987105228
DA 2021-01-25
ER

PT J
AU Kasahara, K
   Goto, H
   Izawa, I
   Kiyono, T
   Watanabe, N
   Elowe, S
   Nigg, EA
   Inagaki, M
AF Kasahara, Kousuke
   Goto, Hidemasa
   Izawa, Ichiro
   Kiyono, Tohru
   Watanabe, Nobumoto
   Elowe, Sabine
   Nigg, Erich A.
   Inagaki, Masaki
TI PI 3-kinase-dependent phosphorylation of Plk1-Ser99 promotes association
   with 14-3-3 gamma and is required for metaphase-anaphase transition
SO NATURE COMMUNICATIONS
LA English
DT Article
ID POLO-LIKE KINASES; SPINDLE-ASSEMBLY CHECKPOINT; TRCP-DEPENDENT
   DEGRADATION; MITOTIC ENTRY; AURORA-A; VIMENTIN PHOSPHORYLATION;
   ANTITUMOR-ACTIVITY; CELL-DIVISION; CANCER-CELLS; PLK1
AB Polo-like kinase 1 (Plk1) controls multiple aspects of mitosis and is activated through its phosphorylation at Thr210. Here we identify Ser99 on Plk1 as a novel mitosis-specific phosphorylation site, which operates independently of Plk1-Thr210 phosphorylation. Plk1-Ser99 phosphorylation creates a docking site for 14-3-3 gamma, and this interaction stimulates the catalytic activity of Plk1. Knockdown of 14-3-3 gamma or replacement of wild-type (WT) Plk1 by a Ser99-phospho-blocking mutant leads to a prometaphase/metaphase-like arrest due to the activation of the spindle assembly checkpoint. Inhibition of phosphatidylinositol 3-kinase (PI3K) and Akt significantly reduces the level of Plk1-Ser99 phosphorylation and delays metaphase to anaphase transition. Plk1-Ser99 phosphorylation requires not only Akt activity but also protein(s) associated with Plk1 in a mitosis-specific manner. Therefore, mitotic Plk1 activity is regulated not only by Plk1-Thr210 phosphorylation, but also by Plk1 binding to 14-3-3 gamma following Plk1-Ser99 phosphorylation downstream of the PI3K-Akt signalling pathway. This novel Plk1 activation pathway controls proper progression from metaphase to anaphase.
C1 [Kasahara, Kousuke; Goto, Hidemasa; Izawa, Ichiro; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan.
   [Kasahara, Kousuke] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Nagoya, Aichi 4678603, Japan.
   [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan.
   [Kiyono, Tohru] Natl Canc Ctr, Div Virol, Chou Ku, Tokyo 1040045, Japan.
   [Watanabe, Nobumoto] RIKEN, Adv Sci Inst, Dept Biol Chem, Chem Lib Validat Team, Wako, Saitama 3510198, Japan.
   [Elowe, Sabine] Ctr Rech CHUQ, Quebec City, PQ G1V 4G2, Canada.
   [Elowe, Sabine] Univ Laval, Fac Med, Dept Pediat, Quebec City, PQ G1V 4G2, Canada.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan.
EM minagaki@aichi-cc.jp
RI Watanabe, Nobumoto/N-6959-2015; Inagaki, Masaki/B-9920-2016
OI Watanabe, Nobumoto/0000-0002-2130-1334; nigg, erich/0000-0003-4835-5719;
   Goto, Hidemasa/0000-0002-6796-4467
FU Japan Society for the Promotion of Science and from the Ministry of
   Education, Science, Technology, Sports and Culture of Japan; Ministry of
   Health and Welfare, JapanMinistry of Health, Labour and Welfare, Japan;
   Uehara Memorial FoundationUehara Memorial Foundation; Astellas
   Foundation for Research on Metabolic Disorders; Naito FoundationNaito
   Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; Takeda
   Science FoundationTakeda Science Foundation (TSF); Grants-in-Aid for
   Scientific ResearchMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24113005,
   24113001, 24590396, 24510320, 25460089, 24659659, 23247035] Funding
   Source: KAKEN
FX We thank S. Matsuura (Hiroshima Univ.) for providing human BubR1 cDNA;
   T. Kanda (Aichi Cancer Ctr. Res. Inst.) and T. Hirota (Cancer Inst.,
   JFCR) for H2B-GFP-expressing HeLa cell line. We are indebted to Y.
   Tomono (Shigei Med. Res. Inst.) and M. Kuhara and all his group members
   (Medical & Biological Laboratories Co., Ltd.) for the antibody
   production. We are grateful to E. Kawamoto, K. Kobori, Y. Hayashi and C.
   Yuhara for technical assistance and Y. Takada for secretarial expertise.
   This work was supported in part by Grants-in-Aid for Scientific Research
   from the Japan Society for the Promotion of Science and from the
   Ministry of Education, Science, Technology, Sports and Culture of Japan;
   by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for
   Cancer Control from the Ministry of Health and Welfare, Japan; by the
   Uehara Memorial Foundation; the Astellas Foundation for Research on
   Metabolic Disorders; the Naito Foundation; the Daiichi-Sankyo Foundation
   of Life Science; and the Takeda Science Foundation. S.E. is a Canadian
   Institute of Health Sciences New Investigator.
CR Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250
   Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008
   Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540
   Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350
   Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543
   Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374
   Goto H, 2012, CANCER SCI, V103, P1195, DOI 10.1111/j.1349-7006.2012.02280.x
   Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801
   Hermeking H., NAT REV CANCER, V3, P931
   Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1
   Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101
   Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200
   Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3
   Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157
   Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5
   Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964
   Li P, 2012, MOL BIOL CELL, V23, P1582, DOI 10.1091/mbc.E11-10-0883
   Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602
   Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200
   Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185
   Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200
   Meuillet EJ, 2010, MOL CANCER THER, V9, P706, DOI 10.1158/1535-7163.MCT-09-0985
   Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096
   NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074
   Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/BJ20031797
   Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781
   Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425
   Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027
   Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x
   Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6
   Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262
   Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008
   Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200
   TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097
   Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832
   Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102
   Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091
   Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343
NR 46
TC 34
Z9 35
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY
PY 2013
VL 4
AR 1882
DI 10.1038/ncomms2879
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 166WI
UT WOS:000320589900078
PM 23695676
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Sen, S
   Reichert, H
   VijayRaghavan, K
AF Sen, Sonia
   Reichert, Heinrich
   VijayRaghavan, K.
TI Conserved roles of ems/Emx and otd/Otx genes in olfactory and visual
   system development in Drosophila and mouse
SO OPEN BIOLOGY
LA English
DT Review
DE evolutionary conservation; sensory systems; empty spiracles;
   orthodenticle; Emx1/2; Otx1/2
ID EMPTY-SPIRACLES GENE; DEVELOPING CEREBRAL-CORTEX; HEAD DEVELOPMENT;
   NERVOUS-SYSTEM; HOMEOBOX GENE; ORTHODENTICLE GENE; ANTERIOR
   NEUROECTODERM; NEUROBLAST LINEAGE; BRAIN-DEVELOPMENT; NEURAL ELEMENTS
AB The regional specialization of brain function has been well documented in the mouse and fruitfly. The expression of regulatory factors in specific regions of the brain during development suggests that they function to establish or maintain this specialization. Here, we focus on two such factors-the Drosophila cephalic gap genes empty spiracles (ems) and orthodenticle (otd), and their vertebrate homologues Emx1/2 and Otx1/2-and review novel insight into their multiple crucial roles in the formation of complex sensory systems. While the early requirement of these genes in specification of the neuroectoderm has been discussed previously, here we consider more recent studies that elucidate the later functions of these genes in sensory system formation in vertebrates and invertebrates. These new studies show that the ems and Emx genes in both flies and mice are essential for the development of the peripheral and central neurons of their respective olfactory systems. Moreover, they demonstrate that the otd and Otx genes in both flies and mice are essential for the development of the peripheral and central neurons of their respective visual systems. Based on these recent experimental findings, we discuss the possibility that the olfactory and visual systems of flies and mice share a common evolutionary origin, in that the conserved visual and olfactory circuit elements derive from conserved domains of otd/Otx and ems/Emx action in the urbilaterian ancestor.
C1 [Sen, Sonia; VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Sen, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, UAS GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.
EM sonia@ncbs.res.in; vijay@ncbs.res.in
RI Sen, Sonia/H-6681-2019
OI Sen, Sonia/0000-0003-4693-3378
FU NCBS-TIFR, Department of Biotechnology, Government of India; Indo Swiss
   Bilateral Research Initiative; Swiss NSFSwiss National Science
   Foundation (SNSF)
FX This work was supported by grants from NCBS-TIFR, Department of
   Biotechnology, Government of India, the Indo Swiss Bilateral Research
   Initiative and the Swiss NSF. We thank the Department of Science and
   Technology, Government of India-Centre for Nanotechnology (no.
   SR/S5/NM-36/2005) and Central Imaging and Flow Cytometry Facility.
CR ACAMPORA D, 1995, DEVELOPMENT, V121, P3279
   Acampora D, 1998, DEVELOPMENT, V125, P1691
   Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3
   Ang SL, 1996, DEVELOPMENT, V122, P243
   Arendt D, 1999, DEVELOPMENT, V126, P2309
   Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Bolwig N., 1946, SENSES SENSE ORGANS
   Bovolenta P, 1997, J NEUROSCI, V17, P4243
   Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8
   Cajal S.R., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839
   Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8
   Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33
   Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040
   Fichelson P, 2012, P NATL ACAD SCI USA, V109, P7893, DOI 10.1073/pnas.1120276109
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0
   FRANTZ GD, 1994, J NEUROSCI, V14, P5725
   Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0
   Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591
   Gao Q, 1998, DEVELOPMENT, V125, P4185
   GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712
   HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159
   Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255
   Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003
   Jurgens G., 1993, DEV DROSOPHILA MELAN, V1, P687
   Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Lichtneckert R, 2008, ADV EXP MED BIOL, V628, P32, DOI 10.1007/978-0-387-78261-4_2
   Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1
   Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5
   Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614
   Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019
   MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646
   McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016
   McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061
   MEINERTZHAGEN IA, 1973, DEV NEUROBIOLOGY ART, P51
   Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722
   Morrow EM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-5
   Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155
   Pellegrini M, 1996, DEVELOPMENT, V122, P3893
   Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101
   Ranade SS, 2008, DEV BIOL, V315, P521, DOI 10.1016/j.ydbio.2007.12.017
   Reichert H, 2001, PHILOS T R SOC B, V356, P1533, DOI 10.1098/rstb.2001.0972
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   ROYET J, 1995, DEVELOPMENT, V121, P3561
   Royet J, 1997, DEVELOPMENT, V124, P4793
   Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018
   SCHMIDTOTT U, 1995, ROUX ARCH DEV BIOL, V205, P31, DOI 10.1007/BF00188841
   SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363
   Sen S, 2010, DEVELOPMENT, V137, P3687, DOI 10.1242/dev.052407
   Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013
   SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Soto F, 2012, J NEUROSCI, V32, P5426, DOI 10.1523/JNEUROSCI.0194-12.2012
   Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407
   STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2
   Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5
   Sweeney LB, 2010, CELL, V142, P679, DOI 10.1016/j.cell.2010.08.024
   Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9
   Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043
   Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2
   WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5
   Wolff Tanya, 1993, P1277
   Yoshida M, 1997, DEVELOPMENT, V124, P101
   YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891
NR 78
TC 13
Z9 13
U1 3
U2 25
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2046-2441
J9 OPEN BIOL
JI Open Biol
PD MAY
PY 2013
VL 3
AR 120177
DI 10.1098/rsob.120177
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 159DH
UT WOS:000320023900007
PM 23635521
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Biasini, M
   Schmidt, T
   Bienert, S
   Mariani, V
   Studer, G
   Haas, J
   Johner, N
   Schenk, AD
   Philippsen, A
   Schwede, T
AF Biasini, M.
   Schmidt, T.
   Bienert, S.
   Mariani, V.
   Studer, G.
   Haas, J.
   Johner, N.
   Schenk, A. D.
   Philippsen, A.
   Schwede, T.
TI OpenStructure: an integrated software framework for computational
   structural biology
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID IMAGE-PROCESSING LIBRARY; PROTEIN STRUCTURES; CROSS-LINKING;
   IDENTIFICATION; PREDICTIONS; ALIGNMENT; SEARCH; MODEL; SIMILARITIES;
   QUALITY
AB Research projects in structural biology increasingly rely on combinations of heterogeneous sources of information, e. g. evolutionary information from multiple sequence alignments, experimental evidence in the form of density maps and proximity constraints from proteomics experiments. The OpenStructure software framework, which allows the seamless integration of information of different origin, has previously been introduced. The software consists of C++ libraries which are fully accessible from the Python programming language. Additionally, the framework provides a sophisticated graphics module that interactively displays molecular structures and density maps in three dimensions. In this work, the latest developments in the OpenStructure framework are outlined. The extensive capabilities of the framework will be illustrated using short code examples that show how information from molecular-structure coordinates can be combined with sequence data and/or density maps. The framework has been released under the LGPL version 3 license and is available for download from http://www.openstructure.org.
C1 [Biasini, M.; Schmidt, T.; Bienert, S.; Mariani, V.; Studer, G.; Haas, J.; Philippsen, A.; Schwede, T.] Univ Basel, Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
   [Biasini, M.; Schmidt, T.; Bienert, S.; Mariani, V.; Studer, G.; Haas, J.; Schwede, T.] Swiss Inst Bioinformat, Basel, Switzerland.
   [Johner, N.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.
   [Schenk, A. D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum Univ Basel, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Studer,
   Gabriel/0000-0003-0462-1456; Johner, Niklaus/0000-0003-2257-7508;
   Schenk, Andreas/0000-0001-9214-2505
CR Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Amrein B, 2012, METALLOMICS, V4, P379, DOI 10.1039/c2mt20010d
   Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Biasini M, 2010, BIOINFORMATICS, V26, P2626, DOI 10.1093/bioinformatics/btq481
   Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007
   DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008
   Dubois P. F., 1996, Computers in Physics, V10, P262
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301
   Gamma E., 1995, DESIGN PATTERNS
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hinsen K, 2000, J COMPUT CHEM, V21, P79, DOI 10.1002/(SICI)1096-987X(20000130)21:2<79::AID-JCC1>3.0.CO;2-B
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348
   Kohlbacher O, 2000, BIOINFORMATICS, V16, P815, DOI 10.1093/bioinformatics/16.9.815
   Kryshtafovych A, 2011, PROTEINS, V79, P91, DOI 10.1002/prot.23180
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]
   Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177
   Mariani V, 2011, J STRUCT BIOL, V174, P259, DOI 10.1016/j.jsb.2011.02.008
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Olechnovic K, 2013, PROTEINS, V81, P149, DOI 10.1002/prot.24172
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Rigden DJ, 2008, ACTA CRYSTALLOGR D, V64, P1288, DOI 10.1107/S0907444908033192
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Schmidt T, 2011, PROTEINS, V79, P126, DOI 10.1002/prot.23174
   Schroeder W, 2004, VTK VISUALIZATION TO
   Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063
   SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228
   Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005
   Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
NR 51
TC 32
Z9 32
U1 0
U2 8
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD MAY
PY 2013
VL 69
SI SI
BP 701
EP 709
DI 10.1107/S0907444913007051
PN 5
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 134UK
UT WOS:000318240200004
PM 23633579
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Stolting, MNL
   Ferrari, S
   Handschin, C
   Becskei, A
   Provenzano, M
   Sulser, T
   Eberli, D
AF Stoelting, Meline Nogueira Lucena
   Ferrari, Stefano
   Handschin, Christoph
   Becskei, Attila
   Provenzano, Maurizio
   Sulser, Tullio
   Eberli, Daniel
TI Myoblasts Inhibit Prostate Cancer Growth by Paracrine Secretion of Tumor
   Necrosis Factor-alpha
SO JOURNAL OF UROLOGY
LA English
DT Article
DE prostate; prostatic neoplasms; neoplasm metastasis; tumor necrosis
   factor-alpha; myoblasts
ID SKELETAL-MUSCLE; TNF-ALPHA; RADICAL PROSTATECTOMY; SOFT-TISSUE; CELLS;
   REGENERATION; INCONTINENCE; ACTIVATION
AB Purpose: Myoblasts can form muscle fibers after transplantation. Therefore, they are envisioned as a treatment for urinary incontinence after radical prostatectomy. However, to our knowledge the safety of this treatment and the interaction of myoblasts with any remaining neighboring cancer are unknown. We investigated the interactions between myoblasts and prostate carcinoma cells in vitro and in vivo.
   Materials and Methods: Myoblasts isolated from the rectus abdominis were used in a series of co-culture experiments with prostate cancer cells and subcutaneously co-injected in vivo. Cell proliferation, cell cycle arrest and apoptosis of cancer in co-culture with myoblasts were assessed. Tumor volume and metastasis formation were evaluated in a mouse model. Tissue specific markers were assessed by immunohistochemistry, fluorescence activated cell sorting analysis, Western blot and real-time quantitative polymerase chain reaction.
   Results: Myoblasts in proximity to tumor provided paracrine tumor necrosis factor-alpha to their microenvironment, decreasing the tumor growth of all prostate cancer cell lines examined. Co-culture experiments revealed induction of cell cycle arrest, tumor death by apoptosis and increased myoblast differentiation. This effect was largely blocked by tumor necrosis factor-alpha inhibition. The same outcome was noted in a mouse model, in which co-injected human myoblasts also inhibited the tumor growth and metastasis formation of all prostate cancer cell lines evaluated.
   Conclusions: Myoblasts restrict prostate cancer growth and limit metastasis formation by paracrine tumor necrosis factor-alpha secretion in vitro and in vivo.
C1 [Stoelting, Meline Nogueira Lucena; Provenzano, Maurizio; Sulser, Tullio; Eberli, Daniel] Univ Zurich, Lab Urol Tissue Engn & Stem Cell Therapy, Div Urol, Zurich, Switzerland.
   [Ferrari, Stefano] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland.
   [Becskei, Attila] Univ Zurich, Inst Mol Biol, Zurich, Switzerland.
   [Handschin, Christoph] Univ Basel, Biozentrum, Focal Area Growth & Dev, Basel, Switzerland.
RP Eberli, D (corresponding author), Univ Zurich Hosp, Lab Urol Tissue Engn & Stem Cell Therapy, Urol Clin, Frauenklin Str 10, CH-8091 Zurich, Switzerland.
EM Daniel.Eberli@usz.ch
RI Handschin, Christoph/E-6886-2015; Ferrari, Stefano/I-7357-2016
OI Handschin, Christoph/0000-0003-0603-1097; Ferrari,
   Stefano/0000-0002-6607-215X; Eberli, Daniel/0000-0001-8866-8010;
   Becskei, Attila/0000-0002-9462-0934
CR Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.3.CO;2-X
   Carducci MA, 2006, CLIN CANCER RES, V12, p6296S, DOI 10.1158/1078-0432.CCR-06-0929
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Eberli D, 2012, CELL TRANSPLANT, V21, P2089, DOI 10.3727/096368911X623835
   Eberli D, 2009, METHODS, V47, P98, DOI 10.1016/j.ymeth.2008.10.016
   Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x
   Klingler HC, 2006, CURR OPIN UROL, V16, P60
   Leventis AK, 2001, RADIOLOGY, V219, P432, DOI 10.1148/radiology.219.2.r01ma20432
   Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006
   Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252
   Nunez C, 2008, HISTOPATHOLOGY, V53, P166, DOI 10.1111/j.1365-2559.2008.03092.x
   Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013
   Parlakian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009299
   Plaza JA, 2008, CANCER-AM CANCER SOC, V112, P193, DOI 10.1002/cncr.23151
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Taeger G, 2008, INT J HYPERTHER, V24, P193, DOI 10.1080/02656730701868387
   van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397
   Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x
   Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372
NR 20
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2013
VL 189
IS 5
BP 1952
EP 1959
DI 10.1016/j.juro.2012.10.071
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 148QZ
UT WOS:000319262900110
PM 23123370
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Artunc, F
   Azaz, A
   Haenisch, N
   Roerden, M
   Cordts, T
   Arnold, F
   Kerjaschki, D
   Ruegg, M
   Hall, M
   Huber, T
   Grahammer, F
AF Artunc, Ferruh
   Azaz, Ahmed
   Haenisch, Nora
   Roerden, Malte
   Cordts, Tomke
   Arnold, Frederic
   Kerjaschki, Dontscho
   Ruegg, Markus
   Hall, Michael
   Huber, Tobias
   Grahammer, Florian
TI DIVERSE ROLES OF mTOR COMPLEXES IN TUBULAR FUNCTION
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Meeting Abstract
CT 50th European-Renal-Association -
   European-Dialysis-and-Transplant-Association Congress
CY MAY 18-21, 2013
CL Istanbul, TURKEY
SP European Renal Assoc (ERA), European Dialysis & Transplant Assoc (EDTA)
C1 [Artunc, Ferruh; Azaz, Ahmed; Haenisch, Nora; Roerden, Malte] Univ Tubingen Hosp, Div Renal, Tubingen, Germany.
   [Cordts, Tomke; Arnold, Frederic; Huber, Tobias; Grahammer, Florian] Univ Hosp Freiburg, Freiburg, Germany.
   [Kerjaschki, Dontscho] Med Univ Vienna, Vienna, Austria.
   [Ruegg, Markus; Hall, Michael] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD MAY
PY 2013
VL 28
SU 1
BP 61
EP 61
PG 1
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA 151ZF
UT WOS:000319498200147
DA 2021-01-25
ER

PT J
AU Andreasen, SO
   Chong, SF
   Wohl, BM
   Goldie, KN
   Zelikin, AN
AF Andreasen, Sidsel O.
   Chong, Siow-Feng
   Wohl, Benjamin M.
   Goldie, Kenneth N.
   Zelikin, Alexander N.
TI Poly(vinyl alcohol) Physical Hydrogel Nanoparticles, Not Polymer
   Solutions, Exert Inhibition of Nitric Oxide Synthesis in Cultured
   Macrophages
SO BIOMACROMOLECULES
LA English
DT Article
ID MULTIFUNCTIONAL NANOPARTICLES; RELEASE; MICROGELS; DESIGN; DNA
AB Hydrogel nanoparticles (HNP) are an emerging tool of biomedicine with unique materials characteristics, scope, and utility. These hydrated, soft colloidal carriers can penetrate through voids with dimensions narrower than the size of the particle, provide stabilization for fragile biological cargo and allow diffusion and exchange of solutes with external phase. However, techniques to assemble HNP are few; solitary examples exist of biocompatible polymers being formulated into HNP; and knowledge on the biomedical properties of HNP remains rather cursory. In this work, we investigate assembly of HNP based on a polymer with decades of prominence in the biomedical field, poly(vinyl alcohol), PVA. We develop a novel method for production of PVA HNP through nanoprecipitation-based assembly of polymer nanoparticles and subsequent physical hydrogelation of the polymer. Polymer nanoparticles and HNP were visualized using scanning electron microscopy and fluorescence imaging, and characterized using dynamic light scattering and zeta potential measurements. Interaction of PVA HNP with mammalian cells was investigated using flow cytometry, viability screening, and measurements of nitric oxide production by cultured macrophages. The latter analyses revealed that PVA administered as a polymer solution or in the form of HNP resulted in no measurable increase in production of the inflammation marker. Unexpectedly, PVA HNP exerted a pronounced inhibition of NO synthesis by stimulated macrophages, that is, had an anti-inflammatory activity. This effect was accomplished with a negligible change in the cell viability and was not observed when PVA was administered as a polymer solution. To the best of our knowledge, this is the first observation of inhibition of NO synthesis in macrophages by administered nanoparticles and specifically hydrogel nanoparticles. Taken together, our results present PVA HNP as promising colloidal hydrogel nanocarriers for biomedical applications, specifically drug delivery and assembly of intracellular biosensors.
C1 [Andreasen, Sidsel O.; Chong, Siow-Feng; Wohl, Benjamin M.; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark.
   [Wohl, Benjamin M.; Zelikin, Alexander N.] Aarhus Univ, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
RP Zelikin, AN (corresponding author), Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark.
EM zelikin@chem.au.dk
RI Zelikin, Alexander/J-3659-2012
OI Zelikin, Alexander/0000-0002-9864-321X
FU Lundbeck FoundationLundbeckfonden; Sapere Aude Starting Grant from the
   Danish Council for Independent Research, Technology and Production
   Sciences, Denmark; SystemsX.ch
FX This work is financed by a grant from the Lundbeck Foundation and Sapere
   Aude Starting Grant from the Danish Council for Independent Research,
   Technology and Production Sciences, Denmark. Electron microscopy was in
   part supported by the SystemsX.ch http://SystemsX.ch, grant CINA.
CR Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Andreasen SO, 2013, PART PART SYST CHAR, V30, P514, DOI 10.1002/ppsc.201200134
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Carter S, 2009, HPB, V11, P541, DOI 10.1111/j.1477-2574.2009.00071.x
   Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
   Chin SF, 2011, CARBOHYD POLYM, V86, P1817, DOI 10.1016/j.carbpol.2011.07.012
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   de Mel A, 2011, CHEM REV, V111, P5742, DOI 10.1021/cr200008n
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Fejerskov B, 2013, LANGMUIR, V29, P344, DOI 10.1021/la3040903
   Felley-Bosco E, 1998, CANCER METAST REV, V17, P25, DOI 10.1023/A:1005948420548
   Fessi H., 1992, US patent, Patent No. [US5118528A1, 5118528]
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hendrickson GR, 2010, ANGEW CHEM INT EDIT, V49, P2193, DOI 10.1002/anie.200906606
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h
   Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e
   Kabanov AV, 2006, ADV POLYM SCI, V193, P173, DOI 10.1007/12_028
   Kazakov S, 2002, MACROMOLECULES, V35, P1911, DOI 10.1021/ma011644+
   Kimura T, 2004, MAT SCI ENG C-BIO S, V24, P797, DOI 10.1016/j.msec.2004.08.046
   Kimura T, 2007, J ARTIF ORGANS, V10, P104, DOI 10.1007/s10047-006-0367-7
   Klinger D, 2012, POLYMER, V53, P5209, DOI 10.1016/j.polymer.2012.08.053
   Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520
   Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d
   Lee EJ, 2012, BIOPROC BIOSYST ENG, V35, P297, DOI 10.1007/s00449-011-0591-2
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Lima AC, 2012, EXPERT OPIN DRUG DEL, V9, P231, DOI 10.1517/17425247.2012.652614
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Madlova M, 2009, EUR J PHARM BIOPHARM, V72, P438, DOI 10.1016/j.ejpb.2009.01.009
   Moorcroft MJ, 2001, TALANTA, V54, P785, DOI 10.1016/S0039-9140(01)00323-X
   Mutsuo S, 2008, J POLYM SCI POL PHYS, V46, P743, DOI 10.1002/polb.21407
   Perfezou M, 2012, CHEM SOC REV, V41, P2606, DOI 10.1039/c1cs15134g
   Rauch J, 2013, CHEM REV, V113, P3391, DOI 10.1021/cr3002627
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h
   Sun HH, 2008, ACS NANO, V2, P19, DOI 10.1021/nn700166x
   Tang C, 2010, STEM CELLS, V28, P1686, DOI 10.1002/stem.473
   Van Thienen TG, 2005, MACROMOLECULES, V38, P8503, DOI 10.1021/ma050822m
   YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316
   Zhang H, 2006, BIOMACROMOLECULES, V7, P1568, DOI 10.1021/bm050912z
NR 46
TC 9
Z9 9
U1 0
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2013
VL 14
IS 5
BP 1687
EP 1695
DI 10.1021/bm400369u
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 145RN
UT WOS:000319034600051
PM 23560438
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Jastrzebska, B
   Ringler, P
   Palczewski, K
   Engel, A
AF Jastrzebska, Beata
   Ringler, Philippe
   Palczewski, Krzysztof
   Engel, Andreas
TI The rhodopsin-transducin complex houses two distinct rhodopsin molecules
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE G protein-coupled receptor; Heterotrimeric G protein; Photoactivated
   rhodopsin dimer; Transmission electron microscopy; Transducin
ID PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; VISUAL CYCLE; DIMERS;
   DIMERIZATION; ACTIVATION; MONOMERS; AGONIST; OPSIN
AB Upon illumination the visual receptor rhodopsin (Rho) transitions to the activated form Rho*, which binds the heterotrimeric G protein, transducin (G(t)) causing GDP to GTP exchange and G(t) dissociation. Using succinylated concanavalin A (sConA) as a probe, we visualized native Rho dimers solubilized in 1 mM n-dodecyl-beta-D-maltoside (DDM) and Rho monomers in 5 mM DDM. By nucleotide depletion and affinity chromatography together with crosslinking and size exclusion chromatography, we trapped and purified nucleotide-free Rho*.G(t) and sConA-Rho*.G(t) complexes kept in solution by either DDM or lauryl-maltose-neopentyl-glycol (LMNG). The 3 D envelope calculated from projections of negatively stained Rho*.G(t)-LMNG complexes accommodated two Rho molecules, one G(t) heterotrimer and a detergent belt. Visualization of triple sConA-Rho*.G(t) complexes unequivocally demonstrated a pentameric assembly of the Rho*.G(t) complex in which the photoactivated Rho* dimer serves as a platform for binding the G(t) heterotrimer. Importantly, individual monomers of the Rho* dimer in the heteropentameric complex exhibited different capabilities for regeneration with either 11-cis or 9-cis-retinal. (c) 2013 Elsevier Inc. All rights reserved.
C1 [Jastrzebska, Beata; Palczewski, Krzysztof; Engel, Andreas] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Ringler, Philippe; Engel, Andreas] Univ Basel, Biozentrum, C CINA, CH-4058 Basel, Switzerland.
RP Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM bxj27@case.edu; lap65@case.edu; andreas.engel@case.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [EY008061, EY019478];
   Swiss National FoundationSwiss National Science Foundation (SNSF)
   [3100A0-108299]; NIH Protein Structure InitiativeUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U54GM094598]; NATIONAL EYE INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R01EY008061, R01EY019478, R01EY008061,
   R01EY008061, R01EY008061, R29EY008061, R29EY008061, R01EY008061,
   R01EY008061, R01EY008061, R29EY008061, R29EY008061, R01EY008061,
   R01EY008061, R01EY008061, R01EY008061, R29EY008061, R01EY008061,
   R01EY008061, R01EY008061, R01EY008061, R29EY008061, R01EY019478,
   R01EY008061, R01EY008061, R01EY019478, R01EY008061, R01EY008061,
   R01EY008061, R01EY019478, R01EY019478, R01EY008061, R01EY008061,
   R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598, U54GM094598,
   U54GM094598, U54GM094598, U54GM094598, U54GM094598] Funding Source: NIH
   RePORTER
FX We thank Drs. Leslie T. Webster Jr., Phoebe L. Stewart, and members of
   the Palczewski laboratory for helpful comments on the manuscript, Dr.
   David Lodowski for his advice about building the model of the triple
   complex. This work was supported by National Institutes of Health grants
   EY008061 and EY019478, and the Swiss National Foundation grant
   3100A0-108299 to AE who belongs to the Transcontinental EM Initiative
   for Membrane Protein Structure (TEMIMPS), which is a center for membrane
   protein structure determination funded by the NIH Protein Structure
   Initiative under grant U54GM094598. KP is John Hord Professor of
   Pharmacology.
CR Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697
   Angers S, 2001, LIFE SCI, V68, P2243, DOI 10.1016/S0024-3205(01)01012-8
   Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021
   Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789
   Diaz-Avalos R, 1998, BIOPHYS J, V74, P595, DOI 10.1016/S0006-3495(98)77818-X
   El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   FUKUDA MN, 1982, METHOD ENZYMOL, V81, P214
   Garwin GG, 2000, METHOD ENZYMOL, V316, P313
   Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444
   Gonzalez-Maeso J, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-20
   GUNTHER GR, 1973, P NATL ACAD SCI USA, V70, P1012, DOI 10.1073/pnas.70.4.1012
   Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199
   Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200
   Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249
   Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005
   Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200
   Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200
   Jastrzebska B., 2013, FASEB J IN PRESS
   Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016
   Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Khelashvili G, 2010, BIOINFORMATICS, V26, P1804, DOI 10.1093/bioinformatics/btq264
   Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   LIS H, 1973, ANNU REV BIOCHEM, V42, P541, DOI 10.1146/annurev.bi.42.070173.002545
   Nemoto W, 2011, J RECEPT SIG TRANSD, V31, P199, DOI 10.3109/10799893.2011.563312
   Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044
   Orban T, 2012, STRUCTURE, V20, P826, DOI 10.1016/j.str.2012.03.017
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743
   Pandit SB, 2010, BIOINFORMATICS, V26, P687, DOI 10.1093/bioinformatics/btq006
   PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48
   Pellissier LP, 2011, J BIOL CHEM, V286, P9985, DOI 10.1074/jbc.M110.201939
   Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361
   Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106
   Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348
   Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103
   Salom D, 2012, BIOCHEMISTRY-US, V51, P214, DOI 10.1021/bi201707v
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330
   Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Vahedi-Faridi A, 2013, MICROSCOPY-JPN, V62, P95, DOI 10.1093/jmicro/dfs091
   Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108
   Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565
   WALD G, 1957, Bibl Ophthalmol, V12, P173
   Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108
   Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200
   Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104
NR 54
TC 36
Z9 36
U1 0
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAY
PY 2013
VL 182
IS 2
BP 164
EP 172
DI 10.1016/j.jsb.2013.02.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 136VI
UT WOS:000318391100012
PM 23458690
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Bailly, X
   Reichert, H
   Hartenstein, V
AF Bailly, Xavier
   Reichert, Heinrich
   Hartenstein, Volker
TI The urbilaterian brain revisited: novel insights into old questions from
   new flatworm clades
SO DEVELOPMENT GENES AND EVOLUTION
LA English
DT Article
DE Brain; Evolution; Acoel; Platyhelminth; Urbilateria
ID NERVOUS-SYSTEM CENTRALIZATION; EMBRYONIC-DEVELOPMENT;
   SYMSAGITTIFERA-ROSCOFFENSIS; ANIMAL PHYLOGENY; PLANARIAN; GLIA;
   BILATERIANS; ACOELA; CELLS; MODEL
AB Flatworms are classically considered to represent the simplest organizational form of all living bilaterians with a true central nervous system. Based on their simple body plans, all flatworms have been traditionally grouped together in a single phylum at the base of the bilaterians. Current molecular phylogenomic studies now split the flatworms into two widely separated clades, the acoelomorph flatworms and the platyhelminth flatworms, such that the last common ancestor of both clades corresponds to the urbilaterian ancestor of all bilaterian animals. Remarkably, recent comparative neuroanatomical analyses of acoelomorphs and platyhelminths show that both of these flatworm groups have complex anterior brains with surprisingly similar basic neuroarchitectures. Taken together, these findings imply that fundamental neuroanatomical features of the brain in the two separate flatworm groups are likely to be primitive and derived from the urbilaterian brain.
C1 [Bailly, Xavier] UPMC, CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France.
   [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
RP Hartenstein, V (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
EM xavier.bailly@sb-roscoff.fr; Heinrich.Reichert@unibas.ch;
   volkerh@mcdb.ucla.edu
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS054814] Funding Source: Medline;
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573, P41RR017573, P41RR017573,
   P41RR017573, P41RR017573, P41RR017573] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814] Funding Source: NIH RePORTER
CR Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453
   Adoutte A, 1999, TRENDS GENET, V15, P104, DOI 10.1016/S0168-9525(98)01671-0
   Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433
   Almuedo-Castillo M, 2012, INT J DEV BIOL, V56, P53, DOI 10.1387/ijdb.113451ma
   Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242
   BARNES RSK, 1993, INVERTEBRATES
   Bery A, 2010, DEV GENES EVOL, V220, P61, DOI 10.1007/s00427-010-0328-2
   Biserova NM, 2008, ACTA BIOL HUNG, V59, P209, DOI 10.1556/ABiol.59.2008.Suppl.30
   Biserova NM, 2000, ACTA BIOL HUNG, V51, P439
   Boyan G, 2011, DEV GENES EVOL, V221, P141, DOI 10.1007/s00427-011-0366-4
   Boyan GS, 2012, DEV GENES EVOL, V222, P125, DOI 10.1007/s00427-012-0394-8
   Brindley PJ, 2005, TRENDS PARASITOL, V21, P533, DOI 10.1016/j.pt.2005.08.015
   Brusca R.C., 1990, INVERTEBRATES
   Bullock TH, 1965, STRUCTURE FUNCTION N
   Cebria F, 2008, NEUROSCI RES, V61, P375, DOI 10.1016/j.neures.2008.04.005
   DELAGE Y, 1886, ARCH ZOOL EXP GEN, V4, P109
   Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040
   Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4
   Gaerber CW, 2007, ZOOMORPHOLOGY, V126, P73, DOI 10.1007/s00435-007-0039-z
   Gustafsson MKS, 2002, PEPTIDES, V23, P2053, DOI 10.1016/S0196-9781(02)00193-6
   HANSTROEM B, 1968, VERGLEICHENDE ANATOM
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162
   Hartline DK, 2011, GLIA, V59, P1215, DOI 10.1002/glia.21149
   Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239
   Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896
   Hickman C., 2004, INTEGRATED PRINCIPLE
   Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703
   Hyman L. H., 1940, INVERTEBRATES, P726
   KEENAN CL, 1981, J COMP NEUROL, V195, P697, DOI 10.1002/cne.901950412
   KOTIKOVA EA, 2008, J EVOL BIOCHEM PHYS, V44, P108
   LENTZ TL, 1967, J MORPHOL, V121, P323, DOI 10.1002/jmor.1051210406
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   LoVerde PT, 2007, EXP PARASITOL, V117, P304, DOI 10.1016/j.exppara.2007.06.002
   Martin-Duran JM, 2012, DEV GENES EVOL, V222, P45, DOI 10.1007/s00427-012-0389-5
   Morris J, 2007, DEV GENES EVOL, V217, P569, DOI 10.1007/s00427-007-0166-z
   Mwinyi A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-309
   Nauta W. J. H., 1986, FUNDAMENTAL NEUROANA
   Newmark PA, 2008, COLD SH Q B, V73, P573, DOI 10.1101/sqb.2008.73.022
   Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233
   Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x
   Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717
   Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676
   Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0
   Ramachandra NB, 2002, DEV GENES EVOL, V212, P55, DOI 10.1007/s00427-001-0207-y
   Reichert H, 2009, BIOL LETTERS, V5, P112, DOI 10.1098/rsbl.2008.0337
   Reisinger E., 1925, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V3, P197, DOI 10.1007/BF00408145
   Reuter M, 1998, TISSUE CELL, V30, P57, DOI 10.1016/S0040-8166(98)80006-2
   Reuter M., 1995, NERVOUS SYSTEM INVER
   Riddiford N, 2011, DEV GENES EVOL, V221, P187, DOI 10.1007/s00427-011-0370-8
   Semmler H, 2010, DEV GROWTH DIFFER, V52, P701, DOI 10.1111/j.1440-169X.2010.01207.x
   von Graff L, 1891, ORG TURBULLERIA ACOE
   Wada H, 2001, CURR OPIN NEUROBIOL, V11, P16, DOI 10.1016/S0959-4388(00)00168-9
   WOLPERT L, 1998, PRINCIPLES DEV
   Younossi-Hartenstein A, 2000, J COMP NEUROL, V416, P461, DOI 10.1002/(SICI)1096-9861(20000124)416:4<461::AID-CNE4>3.0.CO;2-A
   Younossi-Hartenstein A, 2001, CELL TISSUE RES, V304, P295, DOI 10.1007/s004410100376
NR 56
TC 19
Z9 19
U1 12
U2 66
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0949-944X
J9 DEV GENES EVOL
JI Dev. Genes Evol.
PD MAY
PY 2013
VL 223
IS 3
BP 149
EP 157
DI 10.1007/s00427-012-0423-7
PG 9
WC Cell Biology; Evolutionary Biology; Developmental Biology
SC Cell Biology; Evolutionary Biology; Developmental Biology
GA 127HO
UT WOS:000317689200001
PM 23143292
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Lu, YY
   Franz, B
   Truttmann, MC
   Riess, T
   Gay-Fraret, J
   Faustmann, M
   Kempf, VAJ
   Dehio, C
AF Lu, Yun-Yueh
   Franz, Bettina
   Truttmann, Matthias C.
   Riess, Tanja
   Gay-Fraret, Jeremie
   Faustmann, Marco
   Kempf, Volkhard A. J.
   Dehio, Christoph
TI Bartonella henselae trimeric autotransporter adhesin BadA expression
   interferes with effector translocation by the VirB/D4 type IV secretion
   system
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID BACILLARY ANGIOMATOSIS; ENDOTHELIAL-CELLS; SP-NOV; MACROPHAGES;
   ACTIVATION; ADHERENCE; PROTEINS; SIGMA(E); BACTERIA; SURFACE
AB The Gram-negative, zoonotic pathogen Bartonella henselae is the aetiological agent of cat scratch disease, bacillary angiomatosis and peliosis hepatis in humans. Two pathogenicity factors of B.henselae each displaying multiple functions in host cell interaction have been characterized in greater detail: the trimeric autotransporter Bartonella adhesin A (BadA) and the type IV secretion system VirB/D4 (VirB/D4 T4SS). BadA mediates, e.g. binding to fibronectin (Fn), adherence to endothelial cells (ECs) and secretion of vascular endothelial growth factor (VEGF). VirB/D4 translocates several Bartonella effector proteins (Beps) into the cytoplasm of infected ECs, resulting, e.g. in uptake of bacterial aggregates via the invasome structure, inhibition of apoptosis and activation of a proangiogenic phenotype. Despite this knowledge of the individual activities of BadA or VirB/D4 it is unknown whether these major virulence factors affect each other in their specific activities. In this study, expression and function of BadA and VirB/D4 were analysed in a variety of clinical B.henselae isolates. Data revealed that mostisolates have lost expression of either BadA or VirB/D4 during in vitro passages. However, the phenotypic effects of coexpression of both virulence factors was studied in one clinical isolate that was found to stably coexpress BadA and VirB/D4, as well as by ectopic expression of BadA in a strain expressing VirB/D4 but not BadA. BadA, which forms a dense layer on the bacterial surface, negatively affected VirB/D4-dependent Bep translocation and invasome formation by likely preventing close contact between the bacterial cell envelope and the host cell membrane. In contrast, BadA-dependent Fn binding, adhesion to ECs and VEGF secretion were not affected by a functional VirB/D4 T4SS. The obtained data imply that the essential virulence factors BadA and VirB/D4 are likely differentially expressed during different stages of the infection cycle of Bartonella.
C1 [Lu, Yun-Yueh; Truttmann, Matthias C.; Gay-Fraret, Jeremie; Faustmann, Marco; Dehio, Christoph] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Franz, Bettina; Riess, Tanja; Kempf, Volkhard A. J.] Goethe Univ Frankfurt, Univ Hosp, Inst Med Microbiol & Infect Control, D-60596 Frankfurt, Germany.
RP Dehio, C (corresponding author), Univ Basel, Focal Area Infect Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM volkhard.kempf@kgu.de; christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_132979]; InfectX [51RT-0-126008]; German Ministery of
   Education and ResearchFederal Ministry of Education & Research (BMBF)
   [031A012A]; Robert Koch-Institute, Berlin, Germany [1369-434]
FX Work in Christoph Dehio's laboratory is supported by Grant 31003A_132979
   from the Swiss National Science Foundation, Grant 51RT-0-126008
   (InfectX) in the frame of SystemsX.ch, the Swiss Initiative for Systems
   Biology. Work in Volkhard Kempf's laboratory was partially supported by
   grants from the German Ministery of Education and Research (031A012A)
   and the Robert Koch-Institute, Berlin, Germany (1369-434).
CR Anderson BE, 1997, CLIN MICROBIOL REV, V10, P203, DOI 10.1128/CMR.10.2.203
   Arvand M, 1998, CLIN INFECT DIS, V26, P1296, DOI 10.1086/516348
   Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x
   Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347
   Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Franz B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-54
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Gerlach RG, 2008, CELL MICROBIOL, V10, P2364, DOI 10.1111/j.1462-5822.2008.01218.x
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09
   Ishijima N, 2011, J BIOL CHEM, V286, P25256, DOI 10.1074/jbc.M111.233601
   Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kaiser PO, 2012, CELL MICROBIOL, V14, P198, DOI 10.1111/j.1462-5822.2011.01711.x
   Kaiser PO, 2011, INT J MED MICROBIOL, V301, P7, DOI 10.1016/j.ijmm.2010.06.004
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   Mainardi J. L., 1996, Clin Microbiol Infect, V1, P275
   MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618
   Miyake M, 2005, BIOCHEM BIOPH RES CO, V337, P922, DOI 10.1016/j.bbrc.2005.09.130
   Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   RELMAN DA, 1991, NEW ENGL J MED, V324, P1514
   RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   Rolain JM, 2001, J CLIN MICROBIOL, V39, P2978, DOI 10.1128/JCM.39.8.2978-2980.2001
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Scheidegger F, 2011, CELL MICROBIOL, V13, P419, DOI 10.1111/j.1462-5822.2010.01545.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534
   Truttmann MC, 2011, J CELL SCI, V124, P3591, DOI 10.1242/jcs.084459
   Truttmann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025106
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
   ZBINDEN R, 1995, CLIN DIAGN LAB IMMUN, V2, P693, DOI 10.1128/CDLI.2.6.693-695.1995
NR 57
TC 25
Z9 25
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD MAY
PY 2013
VL 15
IS 5
BP 759
EP 778
DI 10.1111/cmi.12070
PG 20
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 129TQ
UT WOS:000317865900007
PM 23163798
OA Bronze
DA 2021-01-25
ER

PT J
AU Cabrita, P
   Batista, S
   Machado, H
   Moes, S
   Jeno, P
   Manadas, B
   Trigo, MJ
   Monteiro, S
   Ferreira, RB
   Brito, L
AF Cabrita, Paula
   Batista, Sandra
   Machado, Henrique
   Moes, Suzette
   Jenoe, Paul
   Manadas, Bruno
   Trigo, Maria Joao
   Monteiro, Sara
   Ferreira, Ricardo Boavida
   Brito, Luisa
TI Comparative Analysis of the Exoproteomes of Listeria monocytogenes
   Strains Grown at Low Temperatures
SO FOODBORNE PATHOGENS AND DISEASE
LA English
DT Article
ID PROTEOMIC ANALYSIS; PROTEIN SECRETION; VIRULENCE; CHEESE; PATHOGENESIS;
   TOLERANCE
AB This article presents the major differences in the exoproteomes of Listeria monocytogenes strains grown at 11 degrees C and 20 degrees C, and their comparison to 37 degrees C, the optimal temperature of growth of this foodborne pathogenic bacteria. A set of four strains previously characterized and representing the genetic diversity of the species was used. Two were virulent, of which one was persistent, and two were low virulent strains. The proteins secreted by the strains grown in minimal medium were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by liquid chromatography tandem mass spectrometry. The heterogeneity among the four strains concerning the 15 major proteins detected was noticed. No clear association of exoproteome with virulence or genotype was found. Cluster analysis of the protein patterns of the strains suggests an increasing differentiation of strain response with low temperatures, highlighting the importance of the study of the exoproteomes. The main finding was the lack of some proteins in the exoproteome of the persistent strain, namely, flagellin (FlaA) and of OppA/oligopeptide ABC transporter, when compared to the other strains. In fact, these two proteins differ in abundance between strains grown at low temperature. Moreover, FlaA was the only glycoprotein identified in the exoproteomes. An attempt is made here to assess the relevance of the major exoproteins differentially detected. The investigation of the exoproteomes of other persistent and sporadic strains will allow identification of proteins involved in adaptation of particular L. monocytogenes strains to low temperatures in use throughout the food chain.
C1 [Cabrita, Paula; Batista, Sandra; Machado, Henrique; Monteiro, Sara; Ferreira, Ricardo Boavida; Brito, Luisa] Univ Tecn Lisboa, Inst Super Agron, CBAA DRAT Dept Recursos Nat Ambiente & Terr, P-1349017 Lisbon, Portugal.
   [Cabrita, Paula; Trigo, Maria Joao] Inst Nacl Invest Agr & Vet, IP, Oeiras, Portugal.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
   [Manadas, Bruno] Univ Coimbra, Ctr Neurosci & Cell Biol, Cantanhede, Portugal.
   [Ferreira, Ricardo Boavida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.
RP Brito, L (corresponding author), Univ Tecn Lisboa, Inst Super Agron, DRAT, Lab Microbiol, P-1349017 Lisbon, Portugal.
EM lbrito@isa.utl.pt
RI Manadas, Bruno/A-7667-2012; Manadas, Bruno/ABH-8490-2020; Brito, Luisa
   Castro/G-5744-2018; Cabrita, Paula/B-8174-2016; Manadas,
   Bruno/AAS-5973-2020
OI Manadas, Bruno/0000-0002-2087-4042; Manadas, Bruno/0000-0002-2087-4042;
   Brito, Luisa Castro/0000-0002-8614-5184; Cabrita,
   Paula/0000-0002-8838-9043; Monteiro, Sara/0000-0002-7069-0591; Machado,
   Henrique/0000-0003-0286-0605; Ferreira, Ricardo
   Boavida/0000-0002-5027-7564
FU Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science
   and Technology [REEQ/348/AGR/2005]; Fundacao Marques de Pombal
FX The authors thank Rui Fernandes (Institute for Molecular and Cell
   Biology, University of Porto, Portugal) for the TEM images, and INIAV,
   IP for allowing Paula Cabrita's stay at Laboratorio de Microbiologia
   (CBAA/DRAT), ISA. The authors also thank Fundacao para a Ciencia e a
   Tecnologia (Project REEQ/348/AGR/2005) and Fundacao Marques de Pombal
   for financial support.
CR Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000
   Cabrita P, 2004, SYST APPL MICROBIOL, V27, P454, DOI 10.1078/0723202041438518
   Cabrita P, 2010, TALANTA, V83, P457, DOI 10.1016/j.talanta.2010.09.039
   Cacace G, 2010, J PROTEOMICS, V73, P2021, DOI 10.1016/j.jprot.2010.06.011
   Conte MP, 2000, MICROB PATHOGENESIS, V29, P137, DOI 10.1006/mpat.2000.0379
   D'Amico DJ, 2008, J FOOD PROTECT, V71, P2239, DOI 10.4315/0362-028X-71.11.2239
   Desvaux M, 2006, FEMS MICROBIOL REV, V30, P774, DOI 10.1111/j.1574-6976.2006.00035.x
   Dumas E, 2008, APPL ENVIRON MICROB, V74, P7399, DOI 10.1128/AEM.00594-08
   Dumas E, 2009, PROTEOMICS, V9, P3136, DOI 10.1002/pmic.200800765
   European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597
   Glaser P, 2001, SCIENCE, V294, P849
   GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987
   Keto-Timonen R, 2007, J FOOD PROTECT, V70, P1866, DOI 10.4315/0362-028X-70.8.1866
   Lee VT, 2001, GENE DEV, V15, P1725, DOI 10.1101/gad.896801
   Leite P, 2006, INT J FOOD MICROBIOL, V106, P111, DOI 10.1016/j.ijfoodmicro.2005.05.017
   Midelet-Bourdin G, 2006, J APPL MICROBIOL, V101, P300, DOI 10.1111/j.1365-2672.2006.02925.x
   Neves E, 2008, J MED MICROBIOL, V57, P411, DOI 10.1099/jmm.0.47672-0
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Perrot M, 2007, PROTEOMICS, V7, P1117, DOI 10.1002/pmic.200600952
   PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991
   Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x
   Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r
   Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]
   Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Soni KA, 2011, FOODBORNE PATHOG DIS, V8, P843, DOI 10.1089/fpd.2010.0746
   Tasara T, 2006, J FOOD PROTECT, V69, P1473, DOI 10.4315/0362-028X-69.6.1473
   Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024
   Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001
   Waak E, 2002, APPL ENVIRON MICROB, V68, P3366, DOI 10.1128/AEM.68.7.3366-3370.2002
   Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08
   Wulff G, 2006, APPL ENVIRON MICROB, V72, P4313, DOI 10.1128/AEM.02288-05
NR 32
TC 7
Z9 7
U1 2
U2 33
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1535-3141
EI 1556-7125
J9 FOODBORNE PATHOG DIS
JI Foodborne Pathog. Dis.
PD MAY
PY 2013
VL 10
IS 5
BP 428
EP 434
DI 10.1089/fpd.2012.1385
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA 134OW
UT WOS:000318223100004
PM 23531123
DA 2021-01-25
ER

PT J
AU Stolting, MN
   Handschin, C
   Becskei, A
   Sulser, T
   Eberli, D
AF Stoelting, M. N.
   Handschin, C.
   Becskei, A.
   Sulser, T.
   Eberli, D.
TI MAGNETIC STIMULATION SUPPORTS MUSCLE REGENERATION AND FUNCTION AFTER
   CELL TRANSPLANTATION FOR SPHINCTER INSUFFICIENCY BY BOOSTING MUSCULAR
   METABOLISM AND STIMULATING NERVE INGROWTH
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Meeting Abstract
C1 [Stoelting, M. N.; Sulser, T.; Eberli, D.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland.
   [Handschin, C.; Becskei, A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2013
VL 24
SU 1
MA 096
BP S75
EP S75
PG 1
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA V41LP
UT WOS:000209548000097
DA 2021-01-25
ER

PT J
AU Stolting, MN
   Arnold, A
   Haralampieva, DGD
   Handschin, C
   Sulser, T
   Eberli, D
AF Stoelting, M. N.
   Arnold, A.
   Haralampieva, D. G. Deana
   Handschin, C.
   Sulser, T.
   Eberli, D.
TI MAGNETIC STIMULATION FOR THE TREATMENT OF URINARY SPHINCTER
   INSUFFICIENCY MODULATES NEUROMUSCULAR JUNCTION FORMATION, INDUCES NERVE
   INGROWTH AND SUPPORTS POST-TRAUMATIC MUSCLE REGENERATION
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Meeting Abstract
C1 [Stoelting, M. N.; Haralampieva, D. G. Deana; Sulser, T.; Eberli, D.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland.
   [Arnold, A.; Handschin, C.] Univ Basel, Biozentrum, Focal Area Growth & Dev, Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2013
VL 24
SU 1
MA 095
BP S71
EP S74
PG 4
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA V41LP
UT WOS:000209548000096
DA 2021-01-25
ER

PT J
AU Cloetta, D
   Thomanetz, V
   Baranek, C
   Lustenberger, RM
   Lin, S
   Oliveri, F
   Atanasoski, S
   Ruegg, MA
AF Cloetta, Dimitri
   Thomanetz, Venus
   Baranek, Constanze
   Lustenberger, Regula M.
   Lin, Shuo
   Oliveri, Filippo
   Atanasoski, Suzana
   Rueegg, Markus A.
TI Inactivation of mTORC1 in the Developing Brain Causes Microcephaly and
   Affects Gliogenesis
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID CELL-CYCLE PROGRESSION; MESSENGER-RNA TRANSLATION;
   CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; KINASE-B-GAMMA; SERINE
   PHOSPHORYLATION; MAXIMAL ACTIVATION; PROTEIN-SYNTHESIS; MAMMALIAN
   TARGET; RAPAMYCIN MTOR
AB The mammalian target of rapamycin (mTOR) regulates cell growth in response to various intracellular and extracellular signals. It assembles into two multiprotein complexes: the rapamycin-sensitive mTOR complex 1 (mTORC1) and the rapamycin-insensitive mTORC2. In this study, we inactivated mTORC1 in mice by deleting the gene encoding raptor in the progenitors of the developing CNS. Mice are born but never feed and die within a few hours. The brains deficient for raptor show a microcephaly starting at E17.5 that is the consequence of a reduced cell number and cell size. Changes in cell cycle length during late cortical development and increased cell death both contribute to the reduction in cell number. Neurospheres derived from raptor-deficient brains are smaller, and differentiation of neural progenitors into glia but not into neurons is inhibited. The differentiation defect is paralleled by decreased Stat3 signaling, which is a target of mTORC1 and has been implicated in gliogenesis. Together, our results show that postnatal survival, overall brain growth, and specific aspects of brain development critically depend on mTORC1 function.
C1 [Cloetta, Dimitri; Thomanetz, Venus; Lustenberger, Regula M.; Lin, Shuo; Oliveri, Filippo; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Baranek, Constanze; Atanasoski, Suzana] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
   [Baranek, Constanze; Atanasoski, Suzana] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM suzana.atanasoski@unibas.ch; markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Cantons of Basel-Stadt; Cantons of Basel-Landschaft; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF); Novartis
   FoundationNovartis; Botnar Foundation; Swiss Life
FX This work was supported by the Cantons of Basel-Stadt and
   Basel-Landschaft and the Swiss National Science Foundation (M. A. R.).
   The work in the laboratory of S. A. was supported by the Swiss National
   Science Foundation, the Novartis Foundation, the Botnar Foundation, and
   Swiss Life. We thank Drs. J. S. Tchorz and F. Schatzmann for providing a
   Cre-expressing adenovirus; Prof. M. Wegner (University of Erlangen) for
   the anti-Sox5 antibodies; Ludmilla Butenko for excellent technical
   assistance; and Prof. V. Taylor, Drs. M. Gassmann, and J. R. Reinhard
   for comments on the manuscript.
CR Baranek C, 2012, P NATL ACAD SCI USA, V109, P3546, DOI 10.1073/pnas.1108718109
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477
   Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7
   Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005
   Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11
   Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542
   Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Giachino Claudio, 2009, V482, P143, DOI 10.1007/978-1-59745-060-7_9
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003
   Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962
   He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440
   Hentges K, 1999, DEVELOPMENT, V126, P1601
   Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176
   Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005
   Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021
   Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09
   Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090
   SANCHOTELLO M, 1995, GLIA, V15, P157, DOI 10.1002/glia.440150208
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409
   Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066
   Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649
   Shu TZ, 2003, J NEUROBIOL, V57, P81, DOI 10.1002/neu.10252
   Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871
   Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864
   Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005
   Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856
   WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7
   Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6
   ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1
   Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020
NR 58
TC 69
Z9 70
U1 1
U2 10
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD MAY 1
PY 2013
VL 33
IS 18
BP 7799
EP 7810
DI 10.1523/JNEUROSCI.3294-12.2013
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 137FH
UT WOS:000318420400018
PM 23637172
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Riebli, N
   Viktorin, G
   Reichert, H
AF Riebli, Nadia
   Viktorin, Gudrun
   Reichert, Heinrich
TI Early-born neurons in type II neuroblast lineages establish a larval
   primordium and integrate into adult circuitry during central complex
   development in Drosophila
SO NEURAL DEVELOPMENT
LA English
DT Article
DE Neuroblast; Lineage; Fan-shaped body; Primordium; Metamorphosis
ID NEURAL STEM-CELLS; BALANCING SELF-RENEWAL; CENTRAL-NERVOUS-SYSTEM;
   BRAIN-DEVELOPMENT; LOCOMOTOR BEHAVIOR; TEMPORAL IDENTITY; TUMOR
   SUPPRESSORS; GENERATION; DIFFERENTIATION; MELANOGASTER
AB Background: The central complex is a multimodal information-processing center in the insect brain composed of thousands of neurons representing more than 50 neural types arranged in a stereotyped modular neuroarchitecture. In Drosophila, the development of the central complex begins in the larval stages when immature structures termed primordia are formed. However, the identity and origin of the neurons that form these primordia and, hence, the fate of these neurons during subsequent metamorphosis and in the adult brain, are unknown.
   Results: Here, we used two pointed-Gal4 lines to identify the neural cells that form the primordium of the fan-shaped body, a major component of the Drosophila central complex. We found that these early-born primordium neurons are generated by four identified type II neuroblasts that amplify neurogenesis through intermediate progenitors, and we demonstrate that these neurons generate the fan-shaped body primordium during larval development in a highly specific manner. Moreover, we characterize the extensive growth and differentiation that these early-born primordium neurons undergo during metamorphosis in pupal stages and show that these neurons persist in the adult central complex, where they manifest layer-specific innervation of the mature fan-shaped body.
   Conclusions: Taken together, these findings indicate that early-born neurons from type II neuroblast lineages have dual roles in the development of a complex brain neuropile. During larval stages they contribute to the formation of a specific central complex primordium; during subsequent pupal development they undergo extensive growth and differentiation and integrate into the modular circuitry of the adult brain central complex.
C1 [Riebli, Nadia; Viktorin, Gudrun; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF)
FX We thank Arnim Jenett, Bruno Bello, Yuh-Nung Jan, Veronica Rodrigues,
   Reinhard Stocker, Gerald Rubin, Barrett Pfeiffer, the Bloomington Stock
   Center and the DSHB for strains and antibodies. We also thank Susanne
   Flister for excellent technical help. This work was supported by the
   Swiss NSF.
CR Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Boyan GS, 2011, TRENDS NEUROSCI, V34, P247, DOI 10.1016/j.tins.2011.02.002
   Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090
   Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108
   HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   Izergina N, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-44
   Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011
   Jiang Y, ARCH BIOCH BIOPHYS
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kunz T, 2012, DEVELOPMENT, V139, P2510, DOI 10.1242/dev.077883
   Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381
   Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8
   Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471
   STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993
   Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9
   STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Viktorin G, 2011, LUXEMBOURG IMAGEJ US, V356, P553
   Viktorin G, 2011, DEV BIOL, V356, P553, DOI 10.1016/j.ydbio.2011.06.013
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9
   Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285
   Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284
   Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109
NR 48
TC 16
Z9 16
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD APR 23
PY 2013
VL 8
AR 6
DI 10.1186/1749-8104-8-6
PG 17
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 165XO
UT WOS:000320519100001
PM 23618231
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hiller, S
AF Hiller, Sebastian
TI The Functional Heart of the M2 Channel
SO BIOPHYSICAL JOURNAL
LA English
DT News Item
ID INFLUENZA-A VIRUS; SOLID-STATE NMR; SIDE-CHAIN CONFORMATION; PROTON
   CHANNEL; TRANSMEMBRANE PEPTIDE; AMANTADINE BINDING; LIPID-BILAYERS;
   MECHANISM; PROTEIN; INHIBITION
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM sebastian.hiller@unibas.ch
RI Hiller, Sebastian/B-3573-2008
OI Hiller, Sebastian/0000-0002-6709-4684
CR Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107
   Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722
   Cady SD, 2009, J MOL BIOL, V385, P1127, DOI 10.1016/j.jmb.2008.11.022
   Cross TA, 2012, CURR OPIN VIROL, V2, P128, DOI 10.1016/j.coviro.2012.01.005
   deAzevedo ER, 1999, J AM CHEM SOC, V121, P8411, DOI 10.1021/ja992022v
   Gullion T., 2011, J MAGN RESON, V81, P413
   HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3
   Hong M, 2009, J AM CHEM SOC, V131, P7806, DOI 10.1021/ja901550q
   Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185
   Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714
   Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183
   Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k
   Luo W, 2006, J AM CHEM SOC, V128, P7242, DOI 10.1021/ja0603406
   Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799
   Pielak RM, 2010, BIOCHEM BIOPH RES CO, V401, P58, DOI 10.1016/j.bbrc.2010.09.008
   Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106
   Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531
   Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750
   Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528
   Wang T, 2012, BIOPHYS J, V102, P787, DOI 10.1016/j.bpj.2012.01.010
   Williams JK, 2013, BIOPHYS J, V104, P1698, DOI 10.1016/j.bpj.2013.02.054
NR 21
TC 2
Z9 2
U1 0
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD APR 16
PY 2013
VL 104
IS 8
BP 1639
EP 1640
DI 10.1016/j.bpj.2013.03.020
PG 2
WC Biophysics
SC Biophysics
GA 135BZ
UT WOS:000318262300003
PM 23601309
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schonichen, A
   Mannherz, HG
   Behrmann, E
   Mazur, AJ
   Kuhn, S
   Silvan, U
   Schoenenberger, CA
   Fackler, OT
   Raunser, S
   Dehmelt, L
   Geyer, M
AF Schoenichen, Andre
   Mannherz, Hans Georg
   Behrmann, Elmar
   Mazur, Antonina J.
   Kuehn, Sonja
   Silvan, Unai
   Schoenenberger, Cora-Ann
   Fackler, Oliver T.
   Raunser, Stefan
   Dehmelt, Leif
   Geyer, Matthias
TI FHOD1 is a combined actin filament capping and bundling factor that
   selectively associates with actin arcs and stress fibers
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE FHOD1; Actin bundling; Actin arcs; Stress fibers; Retrograde flow
ID FORMIN FHOD1; MAMMALIAN FORMIN; CROSS-LINKING; LEADING-EDGE; F-ACTIN;
   CELLS; BINDING; PROTEIN; DOMAIN; MDIA1
AB Formins are actin polymerization factors that are known to nucleate and elongate actin filaments at the barbed end. In the present study we show that human FHOD1 lacks actin nucleation and elongation capacity, but acts as an actin bundling factor with capping activity toward the filament barbed end. Constitutively active FHOD1 associates with actin filaments in filopodia and lamellipodia at the leading edge, where it moves with the actin retrograde flow. At the base of lamellipodia, FHOD1 is enriched in nascent, bundled actin arcs as well as in more mature stress fibers. This function requires actin-binding domains located N-terminally to the canonical FH1-FH2 element. The bundling phenotype is maintained in the presence of tropomyosin, confirmed by electron microscopy showing assembly of 5 to 10 actin filaments into parallel, closely spaced filament bundles. Taken together, our data suggest a model in which FHOD1 stabilizes actin filaments by protecting barbed ends from depolymerization with its dimeric FH2 domain, whereas the region N-terminal to the FH1 domain mediates F-actin bundling by simultaneously binding to the sides of adjacent F-actin filaments.
C1 [Schoenichen, Andre; Mannherz, Hans Georg; Behrmann, Elmar; Kuehn, Sonja; Raunser, Stefan; Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.
   [Mannherz, Hans Georg; Mazur, Antonina J.] Ruhr Univ Bochum, Dept Anat & Mol Embryol, D-44801 Bochum, Germany.
   [Kuehn, Sonja; Geyer, Matthias] Res Ctr Caesar, D-53175 Bonn, Germany.
   [Silvan, Unai; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, INF 324, D-69120 Heidelberg, Germany.
   [Dehmelt, Leif] Max Planck Inst Mol Physiol, Dept Syst Biol, D-44227 Dortmund, Germany.
   [Dehmelt, Leif] TU Dortmund, Fac Chem, Dept Biol Chem, D-44227 Dortmund, Germany.
RP Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.
EM andre.schoenichen@gmail.com; matthias.geyer@caesar.de
RI Silvan, Unai/J-7376-2013; Mazur, Antonina/L-6504-2019; Mazur,
   Antonina/E-3379-2012; Behrmann, Elmar/I-5808-2015; Dehmelt,
   Leif/AAF-9616-2020
OI Mazur, Antonina/0000-0002-7561-9030; Behrmann,
   Elmar/0000-0001-6794-3669; Dehmelt, Leif/0000-0002-6559-6496; Raunser,
   Stefan/0000-0001-9373-3016; Fackler, Oliver/0000-0003-2982-4209; Geyer,
   Matthias/0000-0002-7718-5002; Mannherz, Hans Georg/0000-0001-8158-5722;
   Silvan, Unai/0000-0003-0757-3621
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [GE-976/4, FA-378/6, MA-807/19, RA-1781/1]; Fonds der Chemischen
   IndustrieFonds der Chemischen Industrie
FX This work was supported in part by the Deutsche Forschungsgemeinschaft
   [grant numbers GE-976/4 to M.G., FA-378/6 to O.T.F., MA-807/19 to
   H.G.M., and RA-1781/1 to S.R.]; and by the Fonds der Chemischen
   Industrie (stipend to E.B.).
CR Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200
   Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064
   Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062
   Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205
   Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816
   Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287
   Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052
   Danuser G, 2006, ANNU REV BIOPH BIOM, V35, P361, DOI 10.1146/annurev.biophys.35.040405.102114
   Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200
   Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049
   Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200
   Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200
   HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x
   Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060
   Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11
   KNIGHT P, 1978, BIOCHEM J, V175, P1023, DOI 10.1042/bj1751023
   Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101
   Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332
   Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053
   Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2
   Mannherz HG, 2007, J MOL BIOL, V366, P745, DOI 10.1016/j.jmb.2006.11.100
   Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176
   Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200
   Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621
   Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70
   Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016
   Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012
   Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196
   Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010
   Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039
   Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014
   Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200
   Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008
   Silvan U, 2012, J STRUCT BIOL, V177, P70, DOI 10.1016/j.jsb.2011.09.010
   Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634
   Staus DP, 2011, ARTERIOSCL THROM VAS, V31, P360, DOI 10.1161/ATVBAHA.110.212993
   Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769
   Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7
   Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303
   Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007
   Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8
   Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109
   Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200
   Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343
   Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057
NR 49
TC 47
Z9 47
U1 0
U2 5
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR 15
PY 2013
VL 126
IS 8
BP 1891
EP 1901
DI 10.1242/jcs.126706
PG 11
WC Cell Biology
SC Cell Biology
GA 144XP
UT WOS:000318975700017
PM 23444374
OA Bronze
DA 2021-01-25
ER

PT J
AU Neves, RC
   Bailly, X
   Leasi, F
   Reichert, H
   Sorensen, MV
   Kristensen, RM
AF Neves, Ricardo C.
   Bailly, Xavier
   Leasi, Francesca
   Reichert, Heinrich
   Sorensen, Martin V.
   Kristensen, Reinhardt M.
TI A complete three-dimensional reconstruction of the myoanatomy of
   Loricifera: comparative morphology of an adult and a Higgins larva stage
SO FRONTIERS IN ZOOLOGY
LA English
DT Article
DE Confocal microscopy; Phalloidin; Body plan; Phylogeny; Scalidophora;
   Cycloneuralia
ID DEEP-SEA; PRIAPULUS-CAUDATUS; ULTRASTRUCTURE; PLICILORICIDAE; GENUS;
   NANALORICIDAE; INTROVERT; TRENCH; PHYLUM; NORTH
AB Introduction: Loricifera is a group of small, marine animals, with undetermined phylogenetic relationships within Ecdysozoa (molting protostome animals). Despite their well-known external morphology, data on the internal anatomy of loriciferans are still incomplete. Aiming to increase the knowledge of this enigmatic phylum, we reconstruct for the first time the three-dimensional myoanatomy of loriciferans. Adult Nanaloricus sp. and the Higgins larva of Armorloricus elegans were investigated with cytochemical labeling techniques and CLSM. We discuss our findings with reference to other loriciferan species and recently established phylogenies.
   Results: The somatic musculature of both adult and larval stages is very complex and includes several muscles arranged in three orientations: circular, transverse and longitudinal. In adult Nanaloricus sp., the introvert is characterized by a net-like muscular arrangement, which is composed of five thin circular fibers crossed by several (up to 30) thin longitudinal fibers with bifurcated anterior ends. Two sets of muscles surround the pre-pharyngeal armature: 6 buccal tube retractors arranged 3 x 2 in a conical shaped structure, and 8 mouth cone retractors. Additionally, a thick, circular muscle marks the neck region and a putative anal sphincter is the posteriormost myoanatomical feature. In the Higgins larva of A. elegans, two circular muscles are distinguished anteriorly in the introvert: a dorsal semicircular fiber and a thin ring muscle. The posteriormost region of the body is characterized by an anal sphincter and a triangular muscle.
   Conclusions: Based on the currently available knowledge, the myoanatomical bodyplan of adult loriciferans includes: (i) 8 mouth cone retractors, (ii) a pharynx bulb composed of transversal fibers arranged radially, (iii) circular muscles of the head and neck, (iv) internal muscles of the spinoscalids, (v) longitudinal muscles spanning all body regions, and (vi) transverse (circular) muscles in the abdomen. Concerning the Higgins larva, the muscle subsets assigned to its myoanatomical ground pattern are the (i) longitudinal retractors of the mouth cone, introvert, and abdomen, (ii) abdominal transverse muscles, and (iii) a pharynx bulb composed of transverse, radial fibers. In a comparison with phyla traditionally regarded as phylogenetically close, our data show that the overall myoanatomy of Loricifera is more similar to Kinorhyncha and Nematomorpha than to Priapulida. However, the head musculature of all these groups is very similar, which supports homology of their introverts and head morphology.
C1 [Neves, Ricardo C.; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bailly, Xavier] UPMC, CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France.
   [Leasi, Francesca] Drexel Univ, Acad Nat Sci, Philadelphia, PA 19104 USA.
   [Sorensen, Martin V.; Kristensen, Reinhardt M.] Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark.
RP Neves, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM ricardon.6@gmail.com
RI Kristensen, Reinhardt M/A-8772-2013; Sorensen, Martin V/A-8852-2013;
   Leasi, Francesca/E-4361-2017
OI Kristensen, Reinhardt M/0000-0001-9549-1188; Sorensen, Martin
   V/0000-0002-0377-0276; Leasi, Francesca/0000-0001-6995-0934
FU EU programme ASSEMBLE [227799]
FX We are grateful to the technical support by the staff from the Marine
   Station of Roscoff, especially Gilles Maron and Sophie Le Panse for
   their crucial help during field collection and permission to use the
   CLSM, respectively. Funding to support the collection in Roscoff was
   provided by EU programme ASSEMBLE- grant agreement no. 227799. Fernando
   Pardos (Madrid), Iben Heiner (Copenhagen) and Andreas Schmidt-Rhaesa
   (Hamburg) are acknowledged for many discussions on the subject. The
   first author also greatly appreciated the generous support by the staff
   from the Imaging Core Facility of the Biozentrum - University of Basel.
CR Bang-Berthelsen IH, 2012, HDB ZOOLOGY GASTROTR, V1, P349
   Bang-Berthelsen IH, THESIS U COPENHAGEN
   Danovaro R., 2012, YB SCI TECHNOLOGY, P5
   Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30
   Gad G, 2005, ORG DIVERS EVOL, V5, P77, DOI 10.1016/j.ode.2004.10.006
   Gad G, 2005, MAR BIOL RES, V1, P313, DOI 10.1080/17451000500327455
   Gad G, 2004, HELGOLAND MAR RES, V58, P40, DOI 10.1007/s10152-003-0167-x
   Gad G, 2005, THESIS C VONOSSIETZK
   Gad G., 2005, BERICHTE POLAR MEERE, V507, P140
   Gad G, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2096.1.6
   Heiner I, 2005, ZOOL ANZ, V243, P121, DOI 10.1016/j.jcz.2004.05.002
   Heiner I, 2008, SYST BIODIVERS, V6, P225, DOI 10.1017/S147720000800265X
   Heiner I, 2007, HELGOLAND MAR RES, V61, P167, DOI 10.1007/s10152-007-0064-9
   Heiner I, 2009, MAR BIOL RES, V5, P529, DOI 10.1080/17451000902933009
   Heiner I, 2009, J MORPHOL, V270, P129, DOI 10.1002/jmor.10671
   Higgins R.P., 1986, SMITHSONIAN CONTRIB, V438, P1
   Kristensen R.M., 2003, P467
   Kristensen R.M., 1991, P351
   Kristensen R. M., 1995, BODY CAVITIES FUNCTI, V8, P41
   Kristensen Reinhardt M., 2002, P179
   Kristensen RM, 2013, CAH BIOL MAR, V54, P161
   KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163
   Kristensen RM, 2004, CAH BIOL MAR, V45, P121
   KRISTENSEN RM, 1988, ZOOL SCI, V5, P875
   Kristensen RM, 2002, INTEGR COMP BIOL, V42, P641, DOI 10.1093/icb/42.3.641
   KRISTENSEN RM, 1991, VERH DTSCH ZOOL GES, V84, P231
   Lemburg C, 1999, THESIS U GOTTINGEN
   MATTISSON A, 1974, ZOOL SCR, V3, P209, DOI 10.1111/j.1463-6409.1974.tb00818.x
   Muller MCM, 2004, ZOOMORPHOLOGY, V123, P45, DOI 10.1007/s00435-003-0088-x
   Muller MCM, 2003, J MORPHOL, V256, P103, DOI 10.1002/jmor.10058
   Neuhaus B, 2002, INTEGR COMP BIOL, V42, P619, DOI 10.1093/icb/42.3.619
   Pardos F, 2013, HELGOLAND MAR RES, V67, P623, DOI 10.1007/s10152-013-0349-0
   Rothe B. H., 2004, MEIOFAUNA MAR, V13, P21
   Rothe Birgen H., 2006, Meiofauna Marina, V15, P79
   Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x
   STORCH V, 1989, T AM MICROSC SOC, V108, P319, DOI 10.2307/3226262
   Storch V., 1991, P333
   STORCH V, 1990, J MORPHOL, V206, P163, DOI 10.1002/jmor.1052060203
   STORCH V, 1994, J MORPHOL, V220, P281, DOI 10.1002/jmor.1052200307
NR 39
TC 16
Z9 16
U1 0
U2 58
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-9994
J9 FRONT ZOOL
JI Front. Zool.
PD APR 15
PY 2013
VL 10
AR 19
DI 10.1186/1742-9994-10-19
PG 21
WC Zoology
SC Zoology
GA 132LX
UT WOS:000318070900001
PM 23587092
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Thomanetz, V
   Angliker, N
   Cloetta, D
   Lustenberger, RM
   Schweighauser, M
   Oliveri, F
   Suzuki, N
   Ruegg, MA
AF Thomanetz, Venus
   Angliker, Nico
   Cloetta, Dimitri
   Lustenberger, Regula M.
   Schweighauser, Manuel
   Oliveri, Filippo
   Suzuki, Noboru
   Rueegg, Markus A.
TI Ablation of the mTORC2 component rictor in brain or Purkinje cells
   affects size and neuron morphology
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID PROTEIN-KINASE-C; COMPLEX 2; MOTIF PHOSPHORYLATION; GROWTH-CONTROL; TOR
   COMPLEX-2; B-GAMMA; MICE; RAPTOR; AKT; PKC
AB The mammalian target of rapamycin (mTOR) assembles into two distinct multi-protein complexes called mTORC1 and mTORC2. Whereas mTORC1 is known to regulate cell and organismal growth, the role of mTORC2 is less understood. We describe two mouse lines that are devoid of the mTORC2 component rictor in the entire central nervous system or in Purkinje cells. In both lines neurons were smaller and their morphology and function were strongly affected. The phenotypes were accompanied by loss of activation of Akt, PKC, and SGK1 without effects on mTORC1 activity. The striking decrease in the activation and expression of several PKC isoforms, the subsequent loss of activation of GAP-43 and MARCKS, and the established role of PKCs in spinocerebellar ataxia and in shaping the actin cytoskeleton strongly suggest that the morphological deficits observed in rictor-deficient neurons are mediated by PKCs. Together our experiments show that mTORC2 has a particularly important role in the brain and that it affects size, morphology, and function of neurons.
C1 [Thomanetz, Venus; Angliker, Nico; Cloetta, Dimitri; Lustenberger, Regula M.; Schweighauser, Manuel; Oliveri, Filippo; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Suzuki, Noboru] Mie Univ, Dept Anim Genom, Funct Genom Inst, Life Sci Res Ctr, Tsu, Mie 5148507, Japan.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel-Stadt; Canton of Basel-Landschaft; Swiss Life
FX This work was supported by the Swiss National Science Foundation, the
   Cantons of Basel-Stadt and Basel-Landschaft, and Swiss Life.
CR Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Boukhtouche F, 2006, J NEUROSCI, V26, P1531, DOI 10.1523/JNEUROSCI.4636-05.2006
   Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027
   Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883
   Cole EH, 2008, CLIN J AM SOC NEPHRO, V3, P814, DOI 10.2215/CJN.04681107
   Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005
   Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005
   Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307
   Hisano S, 2002, MOL BRAIN RES, V107, P23, DOI 10.1016/S0169-328X(02)00442-4
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   LARSELL O, 1952, J COMP NEUROL, V97, P281, DOI 10.1002/cne.900970204
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012
   Metzger F, 2010, Curr Mol Pharmacol, V3, P1
   Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8
   Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230
   Saito H, 2005, BIOCHEM BIOPH RES CO, V331, P1216, DOI 10.1016/j.bbrc.2005.04.043
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Seki T, 2011, J PHARMACOL SCI, V116, P239, DOI 10.1254/jphs.11R04CP
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393
   Sucher NJ, 2000, CELL TISSUE RES, V302, P295, DOI 10.1007/s004410000289
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864
   WETTS R, 1982, BRAIN RES, V250, P358, DOI 10.1016/0006-8993(82)90431-0
   Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 54
TC 135
Z9 138
U1 0
U2 11
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD APR 15
PY 2013
VL 201
IS 2
BP 293
EP 308
DI 10.1083/jcb.201205030
PG 16
WC Cell Biology
SC Cell Biology
GA 126AM
UT WOS:000317583500012
PM 23569215
OA Other Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Stutzer, I
   Selevsek, N
   Esterhazy, D
   Schmidt, A
   Aebersold, R
   Stoffel, M
AF Stuetzer, Ina
   Selevsek, Nathalie
   Esterhazy, Daria
   Schmidt, Alexander
   Aebersold, Ruedi
   Stoffel, Markus
TI Systematic Proteomic Analysis Identifies beta-Site Amyloid Precursor
   Protein Cleaving Enzyme 2 and 1 (BACE2 and BACE1) Substrates in
   Pancreatic beta-Cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ABSOLUTE QUANTIFICATION; STATISTICAL-MODEL; IGF-II; INSULIN; GLUCOSE;
   EXPRESSION; SECRETASE; MEMBRANE; EXOCYTOSIS; RECEPTORS
AB Expansion of functional islet beta-cell mass is a physiological process to compensate for increased insulin demand. Deficiency or pharmacological inhibition of the plasma membrane protease BACE2 enhances pancreatic beta-cell function and proliferation, and therefore BACE2 is a putative target for the therapeutic intervention under conditions of beta-cell loss and dysfunction. To gain a molecular understanding of BACE2 function, we performed a systematic and quantitative proteomic analysis to map the natural substrate repertoire of BACE2 and its homologue BACE1 in beta-cells. Loss-and gain-of-function studies of in vitro and in vivo models identified specific and functionally heterogeneous targets. Our analysis revealed non-redundant roles of BACE1/2 in ectodomain shedding with BACE1 regulating a broader and BACE2 a more distinct set of beta-cell-enriched substrates including two proteins of the seizure 6 protein family (SEZ6L and SEZ6L2). Lastly, our study provides insights into the global beta-cell sheddome and secretome, an important prerequisite to uncover novel mechanisms contributing to beta-cell homeostasis and a resource for therapeutic target and biomarker discoveries.
C1 [Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.
   [Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Stuetzer, Ina; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
   [Stoffel, Markus] Univ Zurich, Fac Med, CH-8057 Zurich, Switzerland.
RP Stoffel, M (corresponding author), ETH, Inst Mol Hlth Sci, HPL H36,Schafmattstr 22, CH-8093 Zurich, Switzerland.
EM stoffel@biol.ethz.ch
FU Juvenile Diabetes Research FoundationJuvenile Diabetes Research
   Foundation; EUEuropean Union (EU) [CEED3]
FX This work was funded in part by a grant from the Juvenile Diabetes
   Research Foundation and EU Grant CEED3.
CR Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001
   Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8
   Beraud-Dufour S, 2010, INT J BIOCHEM CELL B, V42, P1681, DOI 10.1016/j.biocel.2010.06.018
   Blanton D, 2011, DIABETES, V60, P2566, DOI 10.2337/db11-0576
   Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004
   Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991
   Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0
   Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124
   Butler GS, 2007, CURR PHARM DESIGN, V13, P263, DOI 10.2174/138161207779313524
   Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945
   Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662
   Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895
   DOLAISKITABGI J, 1979, ENDOCRINOLOGY, V105, P256, DOI 10.1210/endo-105-1-256
   Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530
   Dowling P, 2008, ELECTROPHORESIS, V29, P4141, DOI 10.1002/elps.200800152
   Eberhard D, 2009, CURR OPIN GENET DEV, V19, P469, DOI 10.1016/j.gde.2009.07.003
   Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018
   Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405
   Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381
   Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050
   Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018
   Hald J, 2012, DIABETOLOGIA, V55, P154, DOI 10.1007/s00125-011-2295-1
   Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477
   Hill DJ, 1998, DIABETES CARE, V21, pB60
   Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hussain I, 2001, J BIOL CHEM, V276, P23322, DOI 10.1074/jbc.M101069200
   In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1
   KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173
   Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001
   MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126
   Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057
   Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120
   Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]
   Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103
   Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4
   Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756
   Selevsek N, 2011, PROTEOMICS, V11, P1135, DOI 10.1002/pmic.201000599
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3
   Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115
   Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970
   Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172
   Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478
   Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
   Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610
   Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232
   Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465
NR 59
TC 50
Z9 50
U1 2
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 12
PY 2013
VL 288
IS 15
BP 10536
EP 10547
DI 10.1074/jbc.M112.444703
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 125TU
UT WOS:000317565000033
PM 23430253
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Shortt, J
   Martin, BP
   Newbold, A
   Hannan, KM
   Devlin, JR
   Baker, AJ
   Ralli, R
   Cullinane, C
   Schmitt, CA
   Reimann, M
   Hall, MN
   Wall, M
   Hannan, RD
   Pearson, RB
   McArthur, GA
   Johnstone, RW
AF Shortt, Jake
   Martin, Benjamin P.
   Newbold, Andrea
   Hannan, Katherine M.
   Devlin, Jennifer R.
   Baker, Adele J.
   Ralli, Rachael
   Cullinane, Carleen
   Schmitt, Clemens A.
   Reimann, Maurice
   Hall, Michael N.
   Wall, Meaghan
   Hannan, Ross D.
   Pearson, Richard B.
   McArthur, Grant A.
   Johnstone, Ricky W.
TI Combined inhibition of PI3K-related DNA damage response kinases and
   mTORC1 induces apoptosis in MYC-driven B-cell lymphomas
SO BLOOD
LA English
DT Article
ID PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; DEPENDENT
   PROTEIN-KINASE; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; IN-VIVO; C-MYC;
   RAPAMYCIN INHIBITOR; HUMAN CANCER; BURKITTS-LYMPHOMA; MAMMALIAN TARGET;
   TUMOR-SUPPRESSOR
AB Pharmacological strategies capable of directly targeting MYC are elusive. Previous studies have shown that MYC-driven lymphomagenesis is associated with mammalian target of rapamycin (mTOR) activation and a MYC-evoked DNA damage response (DDR) transduced by phosphatidylinositol-3-kinase (PI3K)-related kinases (DNA-PK, ATM, and ATR). Here we report that BEZ235, a multitargeted pan-PI3K/dual-mTOR inhibitor, potently killed primary Myc-driven B-cell lymphomas and human cell lines bearing IGc-MYC translocations. Using pharmacologic and genetic dissection of PI3K/mTOR signaling, dual DDR/mTORC1 inhibition was identified as a key mediator of apoptosis. Moreover, apoptosis was initiated at drug concentrations insufficient to antagonize PI3K/mTORC2-regulated AKT phosphorylation. p53-independent induction of the proapoptotic BH3-only protein BMF was identified as a mechanism by which dual DDR/mTORC1 inhibition caused lymphoma cell death. BEZ235 treatment induced apoptotic tumor regressions in vivo that correlated with suppression of mTORC1-regulated substrates and reduced H2AX phosphorylation and also with feedback phosphorylation of AKT. These mechanistic studies hold important implications for the use of multitargeted PI3K inhibitors in the treatment of hematologic malignancies. In particular, the newly elucidated role of PI3K-related DDR kinases in response to PI3K inhibitors offers a novel therapeutic opportunity for the treatment of hematologic malignancies with an MYC-driven DDR.
C1 [Shortt, Jake; Martin, Benjamin P.; Newbold, Andrea; Baker, Adele J.; Ralli, Rachael; Johnstone, Ricky W.] Peter MacCallum Canc Ctr, Gene Regulat Lab, Canc Therapeut Program, Melbourne, Vic 8006, Australia.
   [Shortt, Jake; Martin, Benjamin P.; Newbold, Andrea; Hannan, Katherine M.; Devlin, Jennifer R.; Baker, Adele J.; Ralli, Rachael; Cullinane, Carleen; Wall, Meaghan; Hannan, Ross D.; Pearson, Richard B.; McArthur, Grant A.; Johnstone, Ricky W.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia.
   [Hannan, Katherine M.; Devlin, Jennifer R.; Wall, Meaghan; Hannan, Ross D.; Pearson, Richard B.; McArthur, Grant A.] Peter MacCallum Canc Ctr, Oncogen Signalling & Growth Control Program, Melbourne, Vic 8006, Australia.
   [Cullinane, Carleen; McArthur, Grant A.] Peter MacCallum Canc Ctr, Canc Therapeut Program, Translat Res Lab, Melbourne, Vic 8006, Australia.
   [Schmitt, Clemens A.; Reimann, Maurice] Charite, Mol Krebsforschungszentrum, D-13353 Berlin, Germany.
   [Schmitt, Clemens A.] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Johnstone, RW (corresponding author), Peter MacCallum Canc Ctr, Gene Regulat Lab, Locked Bag 1,A Beckett St, Melbourne, Vic 8006, Australia.
EM ricky.johnstone@petermac.org
RI Schmitt, Clemens A/S-9479-2017; Johnstone, Ricky w/H-3748-2014; Pearson,
   Richard Bruce/I-1451-2013
OI Schmitt, Clemens A/0000-0002-4731-2226; Johnstone, Ricky
   w/0000-0001-7053-9237; Pearson, Richard Bruce/0000-0001-5919-5090;
   Shortt, Jake/0000-0003-3185-6488; Hannan, Katherine/0000-0003-4186-8167;
   Hannan, Ross/0000-0002-2166-4493; Cullinane,
   Carleen/0000-0001-5833-6605; McArthur, Grant/0000-0001-8908-6071
FU Leukaemia Foundation of Australia; Co-operative Research Centre for
   Biomedical Imaging DevelopmentAustralian GovernmentDepartment of
   Industry, Innovation and ScienceCooperative Research Centres (CRC)
   Programme; NHMRCNational Health and Medical Research Council of
   Australia; Susan G. Komen Breast Cancer FoundationSusan G. Komen Breast
   Cancer Foundation; Cancer Council VictoriaCanadian Institutes of Health
   Research (CIHR)Cancer Council Victoria; The Leukaemia Foundation of
   Australia; Victorian Breast Cancer Research Consortium; Victorian Cancer
   Agency
FX J.S. was supported by funding from the Leukaemia Foundation of Australia
   and the Co-operative Research Centre for Biomedical Imaging Development.
   R.W.J. is a Principal Research Fellow of the National Health and Medical
   Research Council of Australia (NHMRC) and is supported by NHMRC Program
   and Project Grants, the Susan G. Komen Breast Cancer Foundation, Cancer
   Council Victoria, The Leukaemia Foundation of Australia, Victorian
   Breast Cancer Research Consortium, and the Victorian Cancer Agency. R.
   D. H. and R. B. P. are Senior Research Fellows of the NHMRC and are
   supported by NHMRC Project Grants and the Leukaemia Foundation of
   Australia.
CR ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0
   Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407
   Azad A, 2011, MOL CANCER RES, V9, P1696, DOI 10.1158/1541-7786.MCR-11-0312
   BEEBE SJ, 1984, J BIOL CHEM, V259, P3539
   Bhatt AP, 2010, BLOOD, V115, P4455, DOI 10.1182/blood-2009-10-251082
   Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]
   Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814
   Cullinane C, 2005, CANCER RES, V65, P9633, DOI 10.1158/0008-5472.CAN-05-2285
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101
   Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658
   Elliott SL, 2011, BRIT J HAEMATOL, V152, P61, DOI 10.1111/j.1365-2141.2010.08425.x
   FAN SJ, 1994, CANCER RES, V54, P5824
   Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489
   Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342
   Grespi F, 2010, CELL DEATH DIFFER, V17, P1672, DOI 10.1038/cdd.2010.97
   Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97
   Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977
   Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985
   Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x
   Kong D, 2009, BIOL PHARM BULL, V32, P297, DOI 10.1248/bpb.32.297
   Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189
   Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104
   Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017
   Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474
   McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285
   Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253
   Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231
   Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105
   Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512
   O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925
   Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257
   Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351
   Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614
   Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432
   Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8
   Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072
   Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015
   Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419
   Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369
   Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289
   Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254
   Witzig TE, 2010, HEMATOL-AM SOC HEMAT, P265, DOI 10.1182/asheducation-2010.1.265
   Yang DQ, 2000, NAT CELL BIOL, V2, P893
NR 50
TC 54
Z9 56
U1 0
U2 8
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD APR 11
PY 2013
VL 121
IS 15
BP 2964
EP 2974
DI 10.1182/blood-2012-08-446096
PG 11
WC Hematology
SC Hematology
GA 183OH
UT WOS:000321825700021
PM 23403624
OA Green Published
DA 2021-01-25
ER

PT J
AU Zimbron, JM
   Heinisch, T
   Schmid, M
   Hamels, D
   Nogueira, ES
   Schirmer, T
   Ward, TR
AF Zimbron, Jeremy M.
   Heinisch, Tillmann
   Schmid, Maurus
   Hamels, Didier
   Nogueira, Elisa S.
   Schirmer, Tilman
   Ward, Thomas R.
TI A Dual Anchoring Strategy for the Localization and Activation of
   Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID TRANSFER HYDROGENATION; MOLECULAR-DYNAMICS; DIRECTED EVOLUTION;
   COMPLEXES; CATALYST; PROTEIN; DESIGN; SITE; OPTIMIZATION; REDUCTION
AB Artificial metalloenzymes result from anchoring an active catalyst within a protein environment. Toward this goal, various localization strategies have been pursued: covalent, supramolecular, or dative anchoring. Herein we show that introduction of a suitably positioned histidine residue contributes to firmly anchor, via a dative bond, a biotinylated rhodium piano stool complex within streptavidin. The in silico design of the artificial metalloenzyme was confirmed by X-ray crystallography. The resulting artificial metalloenzyme displays significantly improved catalytic performance, both in terms of activity and selectivity in the transfer hydrogenation of imines. Depending on the position of the histidine residue, both enantiomers of the salsolidine product can be obtained.
C1 [Ward, Thomas R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Ward, TR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM thomas.ward@unibas.ch
RI Ward, Thomas R/K-6419-2012
OI Ward, Thomas R/0000-0001-8602-5468; Schmid, Maurus/0000-0002-4679-6919
FU Canton of Basel, SNF [200020-126366]
FX Generous support from the Canton of Basel, SNF (grant 200020-126366) as
   well as the Marie Curie training networks (BioChemLig FP7-ITN-238434 to
   T.H. and Biotrains FP7-ITN-238531 to E.N.) is gratefully acknowledged.
   T.R.W. thanks Umicore for a precious metal loan as well as Prof. C. R.
   Cantor for the Sav gene.
CR Abe S, 2007, INORG CHEM, V46, P5137, DOI 10.1021/ic070289m
   Amouri H. E., 2010, SYNTH REACT INORG M, V24, P395
   Canivet J, 2007, EUR J INORG CHEM, P4736, DOI 10.1002/ejic.200700505
   Carey JR, 2004, J AM CHEM SOC, V126, P10812, DOI 10.1021/ja046908x
   Collot J, 2003, J AM CHEM SOC, V125, P9030, DOI 10.1021/ja035545i
   Creus M, 2008, ANGEW CHEM INT EDIT, V47, P1400, DOI 10.1002/anie.200704865
   Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646
   Durrenberger M, 2011, ANGEW CHEM INT EDIT, V50, P3026, DOI 10.1002/anie.201007820
   Garner DK, 2011, ACS CATAL, V1, P1083, DOI 10.1021/cs200258e
   Himeda Y, 2003, J MOL CATAL A-CHEM, V195, P95, DOI 10.1016/S1381-1169(02)00576-9
   Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132
   Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0
   Kaufman TS, 2004, TETRAHEDRON-ASYMMETR, V15, P1203, DOI 10.1016/j.tetasy.2004.02.021
   Klein G, 2005, ANGEW CHEM INT EDIT, V44, P7764, DOI 10.1002/anie.200502000
   Kohler V, 2011, ANGEW CHEM INT EDIT, V50, P10863, DOI 10.1002/anie.201103632
   Lin CC, 1999, TETRAHEDRON-ASYMMETR, V10, P1887, DOI 10.1016/S0957-4166(99)00193-7
   Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304
   MacKerell A.J., 1998, CHARMM ENERGY FUNCTI, V1
   Ogo S, 1999, ORGANOMETALLICS, V18, P5470, DOI 10.1021/om9903689
   Ohashi M, 2003, ANGEW CHEM INT EDIT, V42, P1005, DOI 10.1002/anie.200390256
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Reetz MT, 2006, CHEM COMMUN, P4318, DOI 10.1039/b610461d
   Reetz MT, 2009, TOP ORGANOMETAL CHEM, V25, P63, DOI 10.1007/3418_2008_12
   Reiner T, 2009, J ORGANOMET CHEM, V694, P1934, DOI 10.1016/j.jorganchem.2009.01.056
   Rosati F, 2010, CHEMCATCHEM, V2, P916, DOI 10.1002/cctc.201000011
   Schmid M, 2012, CHEM SCI, V3, P690, DOI 10.1039/c1sc00628b
   van Leusen D, 2000, ORGANOMETALLICS, V19, P4084, DOI 10.1021/om000402f
   Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u
   WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064
   Zimbron JM, 2010, CHEM-EUR J, V16, P12883, DOI 10.1002/chem.201001573
NR 30
TC 63
Z9 64
U1 3
U2 135
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD APR 10
PY 2013
VL 135
IS 14
BP 5384
EP 5388
DI 10.1021/ja309974s
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 125OF
UT WOS:000317548400039
PM 23496309
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Dekkers, MPJ
   Barde, YA
AF Dekkers, Martijn P. J.
   Barde, Yves-Alain
TI Programmed Cell Death in Neuronal Development
SO SCIENCE
LA English
DT Editorial Material
ID NERVE GROWTH-FACTOR; RAT
C1 [Dekkers, Martijn P. J.; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dekkers, MPJ (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
OI Barde, Yves/0000-0002-7627-461X
CR Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800
   Gartner A., 2008, WORMBOOK, DOI 10.1895/wormbook.1.145.
   Gumienny TL, 1999, DEVELOPMENT, V126, P1011
   Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084
   KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513
   LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916
   MILLER MW, 1995, J COMP NEUROL, V355, P6, DOI 10.1002/cne.903550104
   Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Purves D., 1984, PRINCIPLES NEURAL DE, P131
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012
   Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523
   SULSTON J, 1988, NEMATODE CAENORHABDI, P123
NR 14
TC 30
Z9 30
U1 0
U2 24
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 5
PY 2013
VL 340
IS 6128
BP 39
EP 41
DI 10.1126/science.1236152
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 118XS
UT WOS:000317061100036
PM 23559240
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI Traffic COPs: rules of detection
SO EMBO JOURNAL
LA English
DT Editorial Material
ID RETROGRADE TRANSPORT; ALPHA-COP; COATOMER; MOTIFS; PROTEINS; VESICLES;
   DISTINCT; BINDING; SITE
AB How specific cargo recognition by coat proteins is achieved and how this recognition event may regulate vesicle formation are still under investigation. In two recent papers by the Owen and Goldberg labs, the binding mode of dilysine motifs to the coatomer of the COPI coat has been analysed. Collectively, their findings suggest that the dilysine motif containing cargo proteins may stabilize coat complexes on membranes and enhance the chance for coat polymerization and vesicle budding.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252
   Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724
   Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443
   Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017
   Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030
   Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004
   Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   Schroder-Kohne S, 1998, J CELL SCI, V111, P3459
   Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198
   Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012
NR 13
TC 4
Z9 4
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD APR 3
PY 2013
VL 32
IS 7
BP 915
EP 916
DI 10.1038/emboj.2013.57
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 118QN
UT WOS:000317040600001
PM 23481254
OA Green Published
DA 2021-01-25
ER

PT J
AU Sauer, E
AF Sauer, Evelyn
TI Special Focus Hfq
SO RNA BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Sauer, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr Basel, CH-4003 Basel, Switzerland.
EM evelyn.sauer@unibas.ch
CR Luisi BF, 2013, RNA BIOL, P10
   Mura C, 2013, RNA BIOL, V10, P636, DOI 10.4161/rna.24538
   Regnier P, 2013, RNA BIOL, V10, P602, DOI 10.4161/rna.23664
   Sauer E, 2013, RNA BIOL, DOI 1010.4161/rna.2420123535768
   Wagner EG, 2013, RNA BIOL, V10, DOI 10.4161/rna.2404423466677
   Wilusz CJ, 2013, RNA BIOL, V10, P592, DOI 10.4161/rna.23695
NR 6
TC 2
Z9 2
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1547-6286
EI 1555-8584
J9 RNA BIOL
JI RNA Biol.
PD APR 1
PY 2013
VL 10
IS 4
BP 590
EP 591
DI 10.4161/rna.24617
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 181WU
UT WOS:000321701600014
PM 23774896
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Sauer, E
AF Sauer, Evelyn
TI Structure and RNA-binding properties of the bacterial LSm protein Hfq
SO RNA BIOLOGY
LA English
DT Article
DE 3 end recognition; LSm ring; RNA chaperone; RNA degradation; crystal
   structure; gene regulation; non-coding RNAs; prokaryotes
ID ESCHERICHIA-COLI-HFQ; SM-LIKE PROTEIN; C-TERMINAL DOMAIN;
   Q-BETA-REPLICASE; MESSENGER-RNA; CRYSTAL-STRUCTURE; SOLUBLE-RNA; HOST
   FACTOR; REGULATORY RNAS; PSEUDOMONAS-AERUGINOSA
AB Over the past years, small non-coding RNAs (sRNAs) emerged as important modulators of gene expression in bacteria. Guided by partial sequence complementarity, these sRNAs interact with target mRNAs and eventually affect transcript stability and translation. The physiological function of sRNAs depends on the protein Hfq, which binds sRNAs in the cell and promotes the interaction with their mRNA targets. This important physiological function of Hfq as a central hub of sRNA-mediated regulation made it one of the most intensely studied proteins in bacteria. Recently, a new model for sRNA binding by Hfq has been proposed that involves the direct recognition of the sRNA 3 end and interactions of the sRNA body with the lateral RNA-binding surface of Hfq. This review summarizes the current understanding of the RNA binding properties of Hfq and its (s)RNA complexes. Moreover, the implications of the new binding model for sRNA-mediated regulation are discussed.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Sauer, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM evelyn.sauer@unibas.ch
FU German Research Foundation Priority Program SPP1258 "Sensory and
   Regulatory RNAs in Prokaryotes"; International PhD Program Tubingen
FX The author is very grateful to Oliver Weichenrieder, Steffen Schmidt and
   many other colleagues at the Max Planck Institute for Developmental
   Biology and the members of the German Research Foundation Priority
   Program SPP1258 "Sensory and Regulatory RNAs in Prokaryotes" for
   stimulating discussions about the biochemistry of Hfq and its RNA
   binding properties. During her work on the Hfq protein, the author was
   supported by a grant from the German Research Foundation Priority
   Program SPP1258 "Sensory and Regulatory RNAs in Prokaryotes" and a
   fellowship by the International PhD Program Tubingen.
CR Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998
   Arluison V, 2004, EUR J BIOCHEM, V271, P1258, DOI 10.1111/j.1432-1033.2004.04026.x
   Arluison W, 2006, J MOL BIOL, V356, P86, DOI 10.1016/j.jmb.2005.11.010
   Baba S, 2010, ACTA CRYSTALLOGR F, V66, P563, DOI 10.1107/S1744309110009942
   Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015
   BARRERA I, 1993, J MOL BIOL, V232, P512, DOI 10.1006/jmbi.1993.1407
   Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605
   Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346
   Beich-Frandsen M, 2011, ACTA CRYSTALLOGR F, V67, P536, DOI 10.1107/S174430911100786X
   Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217
   Boggild A, 2009, FEBS J, V276, P4328, DOI 10.1111/j.1742-4658.2009.07104.x
   Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015
   Brescia CC, 2003, RNA, V9, P33, DOI 10.1261/rna.2570803
   CARMICHAEL GG, 1975, J BIOL CHEM, V250, P6160
   Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693
   Das D, 2009, PROTEINS, V75, P296, DOI 10.1002/prot.22360
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310
   Folichon M, 2005, FEBS J, V272, P454, DOI 10.1111/j.1742-4658.2004.04485.x
   Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915
   Franze de Fernandez M T, 1972, J Biol Chem, V247, P824
   FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0
   Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798
   Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897
   Hajnsdorf E, 1999, J MOL BIOL, V286, P1033, DOI 10.1006/jmbi.1999.2547
   Hopkins JF, 2011, NUCLEIC ACIDS RES, V39, P5193, DOI 10.1093/nar/gkr062
   Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646
   HORI K, 1974, FEBS LETT, V43, P20, DOI 10.1016/0014-5793(74)81095-1
   Horstmann N, 2012, NUCLEIC ACIDS RES, V40, P11023, DOI 10.1093/nar/gks809
   Ishikawa H, 2012, RNA, V18, P1062, DOI 10.1261/rna.031575.111
   KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994
   Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4
   Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006
   Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22
   Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851
   Le Derout J, 2003, NUCLEIC ACIDS RES, V31, P4017, DOI 10.1093/nar/gkg456
   Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006
   Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956
   Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106
   Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032
   Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4
   Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858
   Miranda G, 1997, J MOL BIOL, V267, P1089, DOI 10.1006/jmbi.1997.0939
   Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x
   Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703
   Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x
   Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405
   Morita T, 2011, GENE DEV, V25, P294, DOI 10.1101/gad.2030311
   Muffler A, 1997, J BACTERIOL, V179, P445
   Mura C, 2001, P NATL ACAD SCI USA, V98, P5532, DOI 10.1073/pnas.091102298
   Naidoo N, 2008, J MOL BIOL, V377, P1357, DOI 10.1016/j.jmb.2008.01.007
   Nielsen JS, 2007, RNA, V13, P2213, DOI 10.1261/rna.689007
   Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008
   Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038
   Otaka H, 2011, P NATL ACAD SCI USA, V108, P13059, DOI 10.1073/pnas.1107050108
   Panja S, 2012, NUCLEIC ACIDS RES, V40, P8690, DOI 10.1093/nar/gks618
   Panja S, 2012, J MOL BIOL, V417, P406, DOI 10.1016/j.jmb.2012.02.009
   Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107
   Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004
   Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631
   Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711
   Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445
   Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103
   Salim NN, 2012, NUCLEIC ACIDS RES, V40, P8021, DOI 10.1093/nar/gks392
   Salim NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013028
   Santangelo TJ, 2011, NAT REV MICROBIOL, V9, P319, DOI 10.1038/nrmicro2560
   Sauer E, 2012, P NATL ACAD SCI USA, V109, P9396, DOI 10.1073/pnas.1202521109
   Sauer E, 2011, P NATL ACAD SCI USA, V108, P13065, DOI 10.1073/pnas.1103420108
   Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480
   Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322
   Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163
   Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x
   Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001
   Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892
   Sonnleitner E, 2002, MICROBIOL-SGM, V148, P883, DOI 10.1099/00221287-148-3-883
   Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608
   Soper TJ, 2011, RNA, V17, P1544, DOI 10.1261/rna.2767211
   Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022
   Sun XG, 2006, BIOCHEMISTRY-US, V45, P4875, DOI 10.1021/bi0523613
   Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293
   Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997
   TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x
   Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405
   Updegrove TB, 2011, BBA-GENE REGUL MECH, V1809, P532, DOI 10.1016/j.bbagrm.2011.08.006
   Updegrove TB, 2011, RNA, V17, P489, DOI 10.1261/rna.2452111
   Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985
   Vincent HA, 2012, NUCLEIC ACIDS RES, V40, P8698, DOI 10.1093/nar/gks582
   Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615
   Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x
   Vytvytska O, 2000, GENE DEV, V14, P1109
   Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043
   Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295
   Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8
   WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793
   Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037
   Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059
   Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043
NR 97
TC 54
Z9 57
U1 0
U2 17
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1547-6286
EI 1555-8584
J9 RNA BIOL
JI RNA Biol.
PD APR 1
PY 2013
VL 10
IS 4
BP 610
EP 618
DI 10.4161/rna.24201
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 181WU
UT WOS:000321701600017
PM 23535768
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Reckel, S
   Hiller, S
AF Reckel, Sina
   Hiller, Sebastian
TI Perspectives of solution NMR spectroscopy for structural and functional
   studies of integral membrane proteins
SO MOLECULAR PHYSICS
LA English
DT Article
DE membrane protein; NMR spectroscopy; structure determination; dynamics;
   structural restraints
ID PARAMAGNETIC RELAXATION ENHANCEMENT; KCSA POTASSIUM CHANNEL; CELL-FREE
   EXPRESSION; BACKBONE ASSIGNMENT; RECEPTOR; RHODOPSIN; DOMAIN; DYNAMICS;
   STRATEGIES; FRAGMENT
AB This article discusses future perspectives of solution NMR spectroscopy to study structures and functions of integral membrane proteins at atomic resolution, based on a review of recent progress in this area. Several selected examples of structure determinations, as well as functional studies of integral membrane proteins are highlighted. We expect NMR spectroscopy to make future key scientific contributions to understanding membrane protein function, in particular for large membrane protein systems with known three-dimensional structure. Such situations can benefit from the fact that functional NMR studies have substantially less limitations by molecular size than a full de novo structure determination. Therefore, the general potential for NMR spectroscopy to solve biologic key questions associated with integral membrane proteins is very promising.
C1 [Reckel, Sina; Hiller, Sebastian] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hiller, S (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland.
EM sebastian.hiller@unibas.ch
RI Hiller, Sebastian/B-3573-2008
OI Hiller, Sebastian/0000-0002-6709-4684
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); European Research CommissionEuropean CommissionEuropean
   Commission Joint Research Centre
FX This work was supported by the Swiss National Science Foundation and the
   European Research Commission.
CR Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003
   Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311
   Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257
   Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833
   Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650
   Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012
   Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706
   Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4
   Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104
   Edrington TC, 2011, J BIOL CHEM, V286, P39211, DOI 10.1074/jbc.M111.280933
   Esposito V, 2011, J BIOL CHEM, V286, P41767, DOI 10.1074/jbc.M111.289314
   Fernandez C, 2004, J MOL BIOL, V336, P1211, DOI 10.1016/j.jmb.2003.09.014
   Gautier A, 2008, ANGEW CHEM INT EDIT, V47, P7297, DOI 10.1002/anie.200802783
   Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807
   Gottstein D, 2012, STRUCTURE, V20, P1019, DOI 10.1016/j.str.2012.03.010
   Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Hiller S, 2010, BIOMOL NMR ASSIGN, V4, P29, DOI 10.1007/s12104-009-9194-0
   Hiller S, 2009, J AM CHEM SOC, V131, P12970, DOI 10.1021/ja902012x
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815
   Imai S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401265
   Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107
   Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a
   Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525
   Klammt C, 2012, NAT METHODS, V9, P834, DOI [10.1038/NMETH.2033, 10.1038/nmeth.2033]
   Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101
   Klein-Seetharaman J, 1999, P NATL ACAD SCI USA, V96, P13744, DOI 10.1073/pnas.96.24.13744
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825
   Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802
   Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107
   Morrison EA, 2012, NATURE, V481, P45, DOI 10.1038/nature10703
   Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009
   Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580
   Qureshi T, 2012, TOP CURR CHEM, V326, P123, DOI 10.1007/128_2011_306
   Reckel S, 2008, P NATL ACAD SCI USA, V105, P8262, DOI 10.1073/pnas.0710843105
   Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648
   Reckel S, 2010, METHODS MOL BIOL, V607, P187, DOI 10.1007/978-1-60327-331-2_16
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007
   Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107
   Tugarinov V, 2005, J AM CHEM SOC, V127, P2767, DOI 10.1021/ja044032o
   Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s
   Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101
   Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716
   Velyvis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043725
   Werner K, 2008, J BIOMOL NMR, V40, P49, DOI 10.1007/s10858-007-9205-3
   White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]
   Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028
NR 52
TC 3
Z9 3
U1 0
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0026-8976
EI 1362-3028
J9 MOL PHYS
JI Mol. Phys.
PD APR 1
PY 2013
VL 111
IS 7
BP 843
EP 849
DI 10.1080/00268976.2013.783639
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 171GX
UT WOS:000320914300003
DA 2021-01-25
ER

PT J
AU Pieles, K
   Harms, A
   Dehio, C
AF Pieles, Kathrin
   Harms, Alexander
   Dehio, Christoph
TI Manipulation of host cell signaling by bacterial FIC proteins
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Joint Annual Meeting of the ASPET/BPS at Experimental Biology (EB)
CY APR 20-24, 2013
CL Boston, MA
SP ASPET, British Pharmacol Soc (BPS)
C1 [Pieles, Kathrin; Harms, Alexander; Dehio, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2013
VL 27
MA 554.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 157GG
UT WOS:000319883503228
DA 2021-01-25
ER

PT J
AU Wojtas-Niziurski, W
   Meng, YL
   Roux, B
   Berneche, S
AF Wojtas-Niziurski, Wojciech
   Meng, Yilin
   Roux, Benoit
   Berneche, Simon
TI Self-Learning Adaptive Umbrella Sampling Method for the Determination of
   Free Energy Landscapes in Multiple Dimensions
SO JOURNAL OF CHEMICAL THEORY AND COMPUTATION
LA English
DT Article
ID ACCELERATED MOLECULAR-DYNAMICS; HISTOGRAM ANALYSIS METHOD; GUIDED
   LANGEVIN DYNAMICS; MONTE-CARLO; K+ CHANNEL; POTENTIAL FUNCTIONS;
   SIMULATION METHOD; ION CONDUCTION; BIOMOLECULES; ENKEPHALIN
AB The potential of mean force describing conformational changes of biomolecules is a central quantity for understanding the function of biomolecular systems. Calculating an energy landscape of a process that depends on three or more reaction coordinates requires extensive computational power, making some multidimensional calculations practically impossible. Here, we present an efficient automatized umbrella sampling strategy for calculating a multidimensional potential of mean force. The method progressively learns by itself, through a feedback mechanism, which regions of a multidimensional space are worth exploring and automatically generates a set of umbrella sampling windows that is adapted to the system. The self-learning adaptive umbrella sampling method is first explained with illustrative examples based on simplified reduced model systems and then applied to two nontrivial situations: the conformational equilibrium of the pentapeptide Met-enkephalin in solution and ion permeation in the KcsA potassium channel. With this method, it is demonstrated that a significant smaller number of umbrella windows needs to be employed to characterize the free energy landscape over the most relevant regions without any loss in accuracy.
C1 [Wojtas-Niziurski, Wojciech; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Wojtas-Niziurski, Wojciech; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Meng, Yilin; Roux, Benoit] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.
RP Roux, B (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.
EM roux@uchicago.edu; simon.berneche@unibas.ch
RI Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [118928]; National Science FoundationNational Science Foundation
   (NSF) [MCB-0920261, OCI-1053575]; Swiss National Supercomputing Center
   (CSCS) [s241]; Extreme Science and Engineering Discovery Environment
   (XSEDE); NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; NIH through Biological Sciences
   Division of the University of Chicago and Argonne National Laboratory
   [S10 RR029030-01]; NATIONAL CANCER INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [R01CA093577, R01CA093577, R01CA093577,
   R01CA093577, R01CA093577, R01CA093577, R01CA093577, R01CA093577,
   R01CA093577, R01CA093577, R01CA093577, R01CA093577, R01CA093577] Funding
   Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [S10RR029030] Funding Source: NIH RePORTER
FX S.B. is grateful to Guillaume Lamoureux for fruitful discussions in the
   early stage of development of the method. This work was supported by the
   Swiss National Science Foundation (SNF Professorship number 118928 to
   S.B.) and the National Science Foundation through grant MCB-0920261
   (Y.M. and BR). The computations were supported in part by a grant from
   the Swiss National Supercomputing Center (CSCS) under project ID s241,
   the Extreme Science and Engineering Discovery Environment (XSEDE), which
   is supported by National Science Foundation grant number OCI-1053575,
   and by NIH through resources provided by the Computation Institute and
   the Biological Sciences Division of the University of Chicago and
   Argonne National Laboratory, under grant S10 RR029030-01.
CR Bartels C, 1997, J COMPUT CHEM, V18, P1450, DOI 10.1002/(SICI)1096-987X(199709)18:12<1450::AID-JCC3>3.0.CO;2-I
   Bartels C, 2000, CHEM PHYS LETT, V331, P446, DOI 10.1016/S0009-2614(00)01215-X
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978
   Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Fajer M, 2008, J CHEM THEORY COMPUT, V4, P1565, DOI 10.1021/ct800250m
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195
   Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656
   Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432
   HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291
   HOOFT RWW, 1992, J CHEM PHYS, V97, P6690, DOI 10.1063/1.463947
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Konig G, 2011, EUR BIOPHYS J BIOPHY, V40, P108
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k
   Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942
   Maragliano L, 2006, CHEM PHYS LETT, V426, P168, DOI 10.1016/j.cplett.2006.05.062
   Maragliano L, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2907241
   MEZEI M, 1987, J COMPUT PHYS, V68, P237, DOI 10.1016/0021-9991(87)90054-4
   Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ren W., 2002, PHYS REV B, V66
   ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I
   Roux B, 2002, BIOPHYS J, V82, P1681, DOI 10.1016/S0006-3495(02)75520-3
   Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Sutto L, 2010, J CHEM THEORY COMPUT, V6, P3640, DOI 10.1021/ct100413b
   TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0
   VANDUIJNEVELDT JS, 1992, J CHEM PHYS, V96, P4655, DOI 10.1063/1.462802
   Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908
   Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013
   Zheng LQ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3153841
   Zheng LQ, 2008, P NATL ACAD SCI USA, V105, P20227, DOI 10.1073/pnas.0810631106
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
   Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989
NR 45
TC 54
Z9 54
U1 0
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9618
EI 1549-9626
J9 J CHEM THEORY COMPUT
JI J. Chem. Theory Comput.
PD APR
PY 2013
VL 9
IS 4
BP 1885
EP 1895
DI 10.1021/ct300978b
PG 11
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 124BF
UT WOS:000317438100004
PM 23814508
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Zschiedrich, S
   Eulenbruch, K
   Munder, S
   Godel, M
   Hartleben, B
   Herbach, N
   Rastaldi, M
   Cohen, C
   Hall, M
   Ruegg, M
   Walz, G
   Huber, T
AF Zschiedrich, S.
   Eulenbruch, K.
   Munder, S.
   Goedel, M.
   Hartleben, B.
   Herbach, N.
   Rastaldi, M.
   Cohen, C.
   Hall, M.
   Rueegg, M.
   Walz, G.
   Huber, T.
TI mTORC1 Signaling in Focal-Segmental Glomerulosclerosis
SO INTERNIST
LA German
DT Meeting Abstract
C1 [Zschiedrich, S.; Eulenbruch, K.; Munder, S.; Goedel, M.; Hartleben, B.; Walz, G.; Huber, T.] Univ Freiburg Klinikum, Freiburg, Germany.
   [Herbach, N.] LMU Munchen, Inst Tierpathol, Munich, Germany.
   [Rastaldi, M.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Renal Res Lab, Milan, Italy.
   [Cohen, C.] Univ Spital Zurich, Klin Nephrol, Zurich, Switzerland.
   [Hall, M.; Rueegg, M.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Zschiedrich, Stefan/ABE-9871-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0020-9554
J9 INTERNIST
JI Internist
PD APR
PY 2013
VL 54
SU 1
BP 111
EP 112
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA 122EK
UT WOS:000317299700254
DA 2021-01-25
ER

PT J
AU Hausser, J
   Syed, AP
   Bilen, B
   Zayolanl, M
AF Hausser, Jean
   Syed, Afzal Pasha
   Bilen, Biter
   Zayolanl, Mihaela
TI Analysis of CDS-located miRNA target sites suggests that they can
   effectively inhibit translation
SO GENOME RESEARCH
LA English
DT Article
ID RNA-BINDING PROTEINS; MESSENGER-RNA; MICRORNA TARGETS;
   POSTTRANSCRIPTIONAL REGULATION; CODING SEQUENCE; XENOPUS-LAEVIS;
   STEM-CELLS; C-ELEGANS; DEADENYLATION; WIDESPREAD
AB Most of what is presently known about how miRNAs regulate gene expression comes from studies that characterized the regulatory effect of miRNA binding sites located in the 3' untranslated regions (UTR) of mRNAs. In recent years, there has been increasing evidence that miRNAs also bind in the coding region (CDS), but the implication of these interactions remains obscure because they have a smaller impact on mRNA stability compared with miRNA-target interactions that involve 3' UTRs. Here we show that miRNA-complementary sites that are located in both CDS and 3'-UTRs are under selection pressure and share the same sequence and structure properties. Analyzing recently published data of ribosome-protected fragment profiles upon miRNA transfection from the perspective of the location of miRNA-complementary sites, we find that sites located in the CDS are most potent in inhibiting translation, while sites located in the 3' UTR are more efficient at triggering mRNA degradation. Our study suggests that miRNAs may combine targeting of CDS and 3' UTR to flexibly tune the time scale and magnitude of their post-transcriptional regulatory effects.
C1 [Hausser, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Hausser, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM jean.hausser@unibas.ch; mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Bilen, Biter/0000-0001-9452-3512; Hausser, Jean/0000-0002-3321-7199;
   Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_127307]; Werner Siemens fellowship
FX We thank Nitish Mittal for valuable input in the design and analysis of
   the reporter experiments as well as members of the Zavolan and
   Filipowicz lab for comments and discussions. We also thank Antonio
   Giraldez and Miler Lee for sharing the processed mRNAseq and RPF
   zebrafish sequencing data. Work on this project was supported by the
   Swiss National Science Foundation Grant #31003A_127307 to M.Z. B.B. was
   supported by a Werner Siemens fellowship.
CR Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565
   Audic Y, 1997, MOL CELL BIOL, V17, P209, DOI 10.1128/MCB.17.1.209
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Balatti V, 2011, J THORAC ONCOL, V6, P844, DOI 10.1097/JTO.0b013e31820db125
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704
   Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   David R, 2012, NAT REV MOL CELL BIO, V13, P340, DOI 10.1038/nrm3354
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105
   Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246
   Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Henrion G, 2000, MOL REPROD DEV, V56, P12, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;12::AID-MRD3&gt;3.0.CO;2-#
   Huang FWD, 2010, BIOINFORMATICS, V26, P175, DOI 10.1093/bioinformatics/btp635
   Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681
   Hurst LD, 2006, J MOL EVOL, V63, P174, DOI 10.1007/s00239-005-0273-2
   Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811
   Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512
   Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409
   Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250
   Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429
   Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111
   Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431
   Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426
   Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292
   Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019
   Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532
   TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113
   Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019
   Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
NR 64
TC 179
Z9 185
U1 0
U2 21
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
J9 GENOME RES
JI Genome Res.
PD APR
PY 2013
VL 23
IS 4
BP 604
EP 615
DI 10.1101/gr.139758.112
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 116YY
UT WOS:000316920500003
PM 23335364
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Ronken, S
   Wirz, D
   Daniels, AU
   Kurokawa, T
   Gong, JP
   Arnold, M
AF Ronken, S.
   Wirz, D.
   Daniels, A. U.
   Kurokawa, T.
   Gong, J. P.
   Arnold, M. P.
TI Double-network acrylamide hydrogel compositions adapted to achieve
   cartilage-like dynamic stiffness
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article
DE Double-network hydrogels; Modulus; Loss angle; Cartilage repair; Water
   content
ID ARTICULAR-CARTILAGE; CHONDROCYTE IMPLANTATION; KNEE; DEFECTS; LESIONS;
   REPAIR
AB Since articular cartilage has a limited potential for spontaneous healing, various techniques are employed to repair cartilage lesions. Acrylate-based double-network (DN) hydrogels containing similar to 90% water have shown promising properties as repair materials for skeletal system soft tissues. Although their mechanical properties approach those of native cartilage, the critical factor-stiffness-of DN-gels does not equal the stiffness of articular cartilage. This study investigated whether revised PAMPS/PAAm compositions with lower water content result in stiffness parameters closer to cartilage. DN-gels containing 61, 86 and 90% water were evaluated using two non-destructive, mm-scale indentation test modes: fast-impact (FI) and slow-sinusoidal (SS) deformation. Deformation resistance (dynamic modulus) and energy handling (loss angle) were determined. The dynamic modulus increased with decreasing water content in both testing modes. In the 61% water DN-gel, the modulus resembled that of cartilage (FI-mode: DN-gel = 12, cartilage = 17; SS-mode: DN-gel = 4, cartilage = 1.7 MPa). Loss angle increased with decreasing water content in fast-impact, but not in slow-sinusoidal deformation. However, loss angle was still much lower than cartilage (FI: DN-gel = 5, cartilage = 11; SS: DN-gel = 10, cartilage = 32A degrees), indicating somewhat less ability to dissipate energy. Overall, results show that it is possible to adapt DN-gel composition to produce dynamic stiffness properties close to normal articular cartilage.
C1 [Ronken, S.; Wirz, D.; Daniels, A. U.] Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, Biozentrum,Pharmazentrum, CH-4056 Basel, Switzerland.
   [Wirz, D.; Arnold, M. P.] Kantonsspital Bruderholz, Dept Orthoped Surg & Skeletal Traumatol, CH-4101 Bruderholz, Switzerland.
   [Kurokawa, T.; Gong, J. P.] Hokkaido Univ, Dept Biol Sci, Grad Sch Sci, Sapporo, Hokkaido, Japan.
   [Kurokawa, T.] Hokkaido Univ, Creat Res Inst Sousei, Sapporo, Hokkaido, Japan.
RP Ronken, S (corresponding author), Univ Basel, Fac Med, Lab Biomech & Biocalorimetry LOB2, Biozentrum,Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM sarah.ronken@gmail.com
RI Gong, Jian Ping/B-7019-2009; Kurokawa, Takayuki/B-7061-2009
OI Gong, Jian Ping/0000-0003-2228-2750; Kurokawa,
   Takayuki/0000-0001-6834-684X
FU Hardy and Otto Frey-Zund Stiftung; University Basel
FX Hardy and Otto Frey-Zund Stiftung for the support and H.J. Wyss for the
   funds donated to University Basel.
CR Arnold MP, 2011, CARTILAGE, V2, P374, DOI 10.1177/1947603511402320
   Azuma C, 2006, J BIOMED MATER RES A, DOI [10.1002/jbm.a, DOI 10.1002/JBM.A]
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hunter W, 1742, PHILOS T R SOC LOND, V42, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Kren AP, 2005, INT POLYM SCI TECH, V32, P19
   Lakes R.S., 1999, VISCOELASTIC SOLIDS
   Mandelbaum BR, 1998, AM J SPORT MED, V26, P853, DOI 10.1177/03635465980260062201
   Mankin H. J., 2000, ORTHOPAEDIC BASIC SC, VII, P443
   Minas T, 1999, Instr Course Lect, V48, P629
   Mithoefer Kai, 2007, Instr Course Lect, V56, P457
   Nakajima T, 2009, MACROMOLECULES, V42, P2184, DOI 10.1021/ma802148p
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Negrin L, 2012, INT ORTHOP, V36, P43, DOI 10.1007/s00264-011-1364-x
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Robert H, 2011, ORTHOP TRAUMATOL-SUR, V97, P418, DOI 10.1016/j.otsr.2011.04.001
   Ronken S, 2012, BIOMECH MODEL MECHAN, V11, P631, DOI 10.1007/s10237-011-0338-7
   Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009
   Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095
   Slauterbeck JR, 2009, J BONE JOINT SURG AM, V91A, P2094, DOI 10.2106/JBJS.H.00888
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
   Wirz Dieter, 2008, Journal of Biomechanics, DOI 10.1016/S0021-9290(08)70172-6
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
   Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223
NR 26
TC 12
Z9 13
U1 1
U2 169
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
EI 1617-7940
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD APR
PY 2013
VL 12
IS 2
BP 243
EP 248
DI 10.1007/s10237-012-0395-6
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 108HR
UT WOS:000316283900004
PM 22527368
DA 2021-01-25
ER

PT J
AU Boos, W
   Parkinson, JS
   Jenal, U
   Vogel, J
   Sogaard-Andersen, L
AF Boos, Winfried
   Parkinson, John S.
   Jenal, Urs
   Vogel, Joerg
   Sogaard-Andersen, Lotte
TI Alexander Bohm (1971-2012) Obituary
SO MOLECULAR MICROBIOLOGY
LA English
DT Biographical-Item
AB On November 28, 2012 Alexander (Alex) Bohm, a bacterial geneticist, died at age 41, only a few months after taking up a position as an assistant professor at the LOEWE Center for Synthetic Microbiology in Marburg, Germany. Earlier in 2012 Alex had been diagnosed with an aggressive form of thyroid cancer that left him little time to live his scientific and personal dreams.
C1 [Boos, Winfried] Univ Konstanz, Fachbereich Biol, Constance, Germany.
   [Parkinson, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.
   [Jenal, Urs] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany.
   [Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.
RP Boos, W (corresponding author), Univ Konstanz, Fachbereich Biol, Constance, Germany.
RI Vogel, Jorg/D-5574-2011
OI Vogel, Jorg/0000-0003-2220-1404; Sogaard-Andersen,
   Lotte/0000-0002-0674-0013
CR Bohm A, 2011, MOL MICROBIOL, V82, P797, DOI 10.1111/j.1365-2958.2011.07852.x
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200
   BOHM A, PUBLICATION LIST
   Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147
   Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315
NR 7
TC 2
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2013
VL 88
IS 2
BP 219
EP 221
DI 10.1111/mmi.12198
PG 3
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 126CG
UT WOS:000317588300001
PM 23574277
OA Bronze
DA 2021-01-25
ER

PT J
AU Hayashi, M
   Majumdar, A
   Li, X
   Adler, J
   Sun, Z
   Vertuani, S
   Hellberg, C
   Mellberg, S
   Koch, S
   Dimberg, A
   Koh, GY
   Dejana, E
   Belting, HG
   Affolter, M
   Thurston, G
   Holmgren, L
   Vestweber, D
   Claesson-Welsh, L
AF Hayashi, Makoto
   Majumdar, Arindam
   Li, Xiujuan
   Adler, Jeremy
   Sun, Zuyue
   Vertuani, Simona
   Hellberg, Carina
   Mellberg, Sofie
   Koch, Sina
   Dimberg, Anna
   Koh, Gou Young
   Dejana, Elisabetta
   Belting, Heinz-Georg
   Affolter, Markus
   Thurston, Gavin
   Holmgren, Lars
   Vestweber, Dietmar
   Claesson-Welsh, Lena
TI VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial
   cell polarity and lumen formation
SO NATURE COMMUNICATIONS
LA English
DT Article
ID RECEPTOR-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR-2; BLOOD-VESSEL
   DEVELOPMENT; TIE2 RECEPTOR; CADHERIN; ANGIOPOIETIN-1; PHOSPHATASE;
   EXPRESSION; VASCULOGENESIS; ACTIVATION
AB Vascular endothelial growth factor (VEGF) guides the path of new vessel sprouts by inducing VEGF receptor-2 activity in the sprout tip. In the stalk cells of the sprout, VEGF receptor-2 activity is downregulated. Here, we show that VEGF receptor-2 in stalk cells is dephosphorylated by the endothelium-specific vascular endothelial-phosphotyrosine phosphatase (VE-PTP). VE-PTP acts on VEGF receptor-2 located in endothelial junctions indirectly, via the Angiopoietin-1 receptor Tie2. VE-PTP inactivation in mouse embryoid bodies leads to excess VEGF receptor-2 activity in stalk cells, increased tyrosine phosphorylation of VE-cadherin and loss of cell polarity and lumen formation. Vessels in ve-ptp(-/-) teratomas also show increased VEGF receptor-2 activity and loss of endothelial polarization. Moreover, the zebrafish VE-PTP orthologue ptp-rb is essential for polarization and lumen formation in intersomitic vessels. We conclude that the role of Tie2 in maintenance of vascular quiescence involves VE-PTP-dependent dephosphorylation of VEGF receptor-2, and that VEGF receptor-2 activity regulates VE-cadherin tyrosine phosphorylation, endothelial cell polarity and lumen formation.
C1 [Hayashi, Makoto; Majumdar, Arindam; Li, Xiujuan; Adler, Jeremy; Sun, Zuyue; Mellberg, Sofie; Koch, Sina; Dimberg, Anna; Claesson-Welsh, Lena] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.
   [Majumdar, Arindam; Vertuani, Simona; Holmgren, Lars] Karolinska Inst, CCK, Dept Pathol & Oncol, S-17176 Stockholm, Sweden.
   [Hellberg, Carina] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea.
   [Dejana, Elisabetta] IFOM IEO Campus, I-20139 Milan, Italy.
   [Belting, Heinz-Georg; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA.
   [Vestweber, Dietmar] Max Planck Inst Mol Biomed, D-48149 Munster, Germany.
RP Claesson-Welsh, L (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Dag Hammarskjolds V 20, S-75185 Uppsala, Sweden.
EM lena.welsh@igp.uu.se
RI Koh, Gou Young/C-1615-2011; Dejana, Elisabetta/A-6274-2016
OI Affolter, Markus/0000-0002-5171-0016; Belting,
   Heinz-Georg/0000-0002-1538-4364; Dimberg, Anna/0000-0003-4422-9125;
   DEJANA, ELISABETTA/0000-0002-0007-0426; Vestweber,
   Dietmar/0000-0002-3517-732X
FU Knut and Alice Wallenberg foundation (Wallenberg Scholar Award); Swedish
   Science council; Swedish Cancer foundation
FX This study was supported by grants from the Knut and Alice Wallenberg
   foundation (Wallenberg Scholar Award), the Swedish Science council and
   the Swedish Cancer foundation, to L.C-.W. Services by the Karolinska
   Institutet zebra fish core facility and the Uppsala University BioVIs
   facility are gratefully acknowledged. S. Nystrom provided expert
   assistance with the zebra fish movies. We sincerely thank C. Welsh for
   critical reading of the manuscript and S. Hultin for help with the
   Imaris programme. We also gratefully acknowledge the gift of PAE/VEGFR3
   cells from Dr K. Alitalo, Helsinki University, Finland.
CR Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639
   Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226
   Dallabrida SM, 2008, FASEB J, V22, P3010, DOI 10.1096/fj.07-100966
   Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200
   Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104
   DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897
   Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680
   Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714
   Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007
   Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Hwang SJ, 2008, PROTEIN J, V27, P319, DOI 10.1007/s10930-008-9140-5
   Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521
   Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856
   Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018
   Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301
   Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080
   Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Li XJ, 2008, METHOD ENZYMOL, V443, P261, DOI 10.1016/S0076-6879(08)02013-2
   Li XJ, 2007, STEM CELLS, V25, P2987, DOI 10.1634/stemcells.2007-0397
   Li Z, 2009, P NATL ACAD SCI USA, V106, P22399, DOI 10.1073/pnas.0911189106
   Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200
   Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001
   Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709
   Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810
   Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129
   Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772
   Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z
   Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497
   Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406
   Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715
   SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   Tyler RC, 2010, BIOCHEMISTRY-US, V49, P951, DOI 10.1021/bi9017335
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822
   Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785
   Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159
   Zang GX, 2013, CELL SIGNAL, V25, P85, DOI 10.1016/j.cellsig.2012.09.018
   Zeeb M, 2010, CURR OPIN CELL BIOL, V22, P626, DOI 10.1016/j.ceb.2010.07.003
   Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006
NR 60
TC 79
Z9 83
U1 1
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR
PY 2013
VL 4
AR 1672
DI 10.1038/ncomms2683
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 143MR
UT WOS:000318872100029
PM 23575676
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Steeb, B
   Claudi, B
   Burton, NA
   Tienz, P
   Schmidt, A
   Farhan, H
   Maze, A
   Bumann, D
AF Steeb, Benjamin
   Claudi, Beatrice
   Burton, Neil A.
   Tienz, Petra
   Schmidt, Alexander
   Farhan, Hesso
   Maze, Alain
   Bumann, Dirk
TI Parallel Exploitation of Diverse Host Nutrients Enhances Salmonella
   Virulence
SO PLOS PATHOGENS
LA English
DT Article
ID ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CARBON METABOLISM;
   ABSOLUTE QUANTIFICATION; BACTERIAL PATHOGENS; VACCINE EFFICACY; OMIC
   DATA; TYPHIMURIUM; GROWTH; MODEL
AB Pathogen access to host nutrients in infected tissues is fundamental for pathogen growth and virulence, disease progression, and infection control. However, our understanding of this crucial process is still rather limited because of experimental and conceptual challenges. Here, we used proteomics, microbial genetics, competitive infections, and computational approaches to obtain a comprehensive overview of Salmonella nutrition and growth in a mouse typhoid fever model. The data revealed that Salmonella accessed an unexpectedly diverse set of at least 31 different host nutrients in infected tissues but the individual nutrients were available in only scarce amounts. Salmonella adapted to this situation by expressing versatile catabolic pathways to simultaneously exploit multiple host nutrients. A genome-scale computational model of Salmonella in vivo metabolism based on these data was fully consistent with independent large-scale experimental data on Salmonella enzyme quantities, and correctly predicted 92% of 738 reported experimental mutant virulence phenotypes, suggesting that our analysis provided a comprehensive overview of host nutrient supply, Salmonella metabolism, and Salmonella growth during infection. Comparison of metabolic networks of other pathogens suggested that complex host/pathogen nutritional interfaces are a common feature underlying many infectious diseases.
C1 [Steeb, Benjamin; Claudi, Beatrice; Burton, Neil A.; Tienz, Petra; Farhan, Hesso; Maze, Alain; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
RP Steeb, B (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM dirk.bumann@unibas.ch
RI Farhan, Hesso/C-7997-2012
OI Farhan, Hesso/0000-0002-0889-8463; Maze, Alain/0000-0003-0873-3690
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-121834]; SystemsX (RTD project BattleX); Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB641-A9,
   SPP1316 Bu971/6]
FX DB and co-workers were funded by the Swiss National Science Foundation
   (31003A-121834; www.snf.ch), SystemsX (RTD project BattleX;
   www.systemsx.ch) and Deutsche Forschungsgemeinschaft (SFB641-A9, SPP1316
   Bu971/6; www.dfg.de). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AbuOun M, 2009, J BIOL CHEM, V284, P29480, DOI 10.1074/jbc.M109.005868
   Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06
   Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780
   Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289
   Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448
   [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Barat S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002966
   BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bellamy R, 1999, MICROBES INFECT, V1, P23, DOI 10.1016/S1286-4579(99)80010-0
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   Bonde BK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002060
   Bordbar A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.21
   Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68
   Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09
   Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772
   Buchmeier NA, 1997, CAN J MICROBIOL, V43, P29, DOI 10.1139/m97-005
   Bumann D, 2010, J PROTEOMICS, V73, P2267, DOI 10.1016/j.jprot.2010.08.004
   Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305
   Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875
   Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101
   Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529
   Clark DP, 2005, ECOSAL
   COLLINS LV, 1991, INFECT IMMUN, V59, P1079, DOI 10.1128/IAI.59.3.1079-1085.1991
   Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164
   Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x
   Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351
   Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feist AM, 2008, NAT REV MICROBIOL, V31, P31
   FERENCI T, 1973, BIOCHEM J, V132, P341, DOI 10.1042/bj1320341
   Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x
   Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334
   Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d
   GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107
   Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000
   HONE D, 1987, J INFECT DIS, V156, P167, DOI 10.1093/infdis/156.1.167
   Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022
   Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143
   Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018
   Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107
   Kroger C, 2009, J BACTERIOL, V191, P545, DOI 10.1128/JB.01253-08
   Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928
   LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470
   Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47
   LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535
   Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103
   Livesey G, 2003, NUTR RES REV, V16, P163, DOI 10.1079/NRR200371
   Lobel L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002887
   Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107
   Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042
   Mendum TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r127
   Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x
   Nishikawa T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000236
   OCALLAGHAN D, 1988, INFECT IMMUN, V56, P419, DOI 10.1128/IAI.56.2.419-423.1988
   Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004
   Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Otto NM, 2008, CRIT CARE, V12, DOI 10.1186/cc6989
   Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060
   Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048
   Polonais V, 2010, BIOL CELL, V102, P435, DOI 10.1042/BC20100005
   Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374
   Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J
   Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38
   Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101
   Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477
   SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592
   Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Senaratne RH, 2007, J MED MICROBIOL, V56, P454, DOI 10.1099/jmm.0.46983-0
   Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09
   Smallwood HS, 2011, BIOCHEMISTRY-US, V50, P9911, DOI 10.1021/bi2011866
   Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001
   Stritzker J, 2004, INFECT IMMUN, V72, P5622, DOI 10.1128/IAI.72.10.5622-5629.2004
   Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8
   Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108
   Thierauf Anne, 2009, V501, P267, DOI 10.1007/978-1-60327-164-6_23
   Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007
   Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10
   VIRGILIO R, 1981, CAN J MICROBIOL, V27, P1272, DOI 10.1139/m81-195
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1786, DOI 10.1073/pnas.45.12.1786
NR 99
TC 99
Z9 99
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2013
VL 9
IS 4
AR e1003301
DI 10.1371/journal.ppat.1003301
PG 16
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 132MN
UT WOS:000318072700042
PM 23633950
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Westritschnig, K
   BoseDasgupta, S
   Tchang, V
   Siegmund, K
   Pieters, J
AF Westritschnig, Katrin
   BoseDasgupta, Somdeb
   Tchang, Vincent
   Siegmund, Kerstin
   Pieters, Jean
TI Antigen processing and presentation by dendritic cells is independent of
   coronin 1
SO MOLECULAR IMMUNOLOGY
LA English
DT Article
DE Coronin 1; Dendritic cells; Antigen processing and presentation; T cell
   stimulation
ID CD8 T-CELLS; CLASS-II; MANNOSE RECEPTOR; SURVIVAL; MEMORY; ACTIVATION;
   ALPHA; REQUIREMENTS; MYCOBACTERIA; MOBILIZATION
AB Coronin 1, which is a member of the evolutionary conserved coronin protein family that is highly expressed in all leukocytes is involved in the activation of the Ca2+/calcineurin signaling pathway following cell surface stimulation in T cells, B cells as well as macrophages. Mice deficient for coronin 1 have strongly reduced peripheral T cell numbers as a result of a lack of pro-survival signals for nave T cells. Whether or not impaired antigen processing and presentation in the absence of coronin 1 expression contributes to this reduction of T cell numbers is unknown. We here show that coronin 1-deficient bone marrow-derived dendritic cells develop normally, and that wild type and coronin 1-deficient dendritic cells were equally able to induce antigen-specific proliferation of T cells. Furthermore, upon immunization, in vivo proliferation of adoptively transferred antigen-specific T cells was comparable in wild type and coronin 1-deficient mice. Finally, infection of wild type and coronin 1-deficient dendritic cells with an ovalbumin-expressing Listeria monocytogenes strain induced comparable levels of ovalbumin-specific T cells responses. Together these results suggest that coronin 1 is dispensable for antigen processing and presentation by dendritic cells. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Westritschnig, Katrin; BoseDasgupta, Somdeb; Tchang, Vincent; Siegmund, Kerstin; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Siegmund, K (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM kerstin.siegmund@unibas.ch; jean.pieters@unibas.ch
RI Bellaire-Siegmund, Kerstin/AAA-9702-2021; Bellaire-Siegmund,
   Kerstin/D-4774-2018
OI Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Bellaire-Siegmund,
   Kerstin/0000-0002-3654-1170; Pieters, Jean/0000-0002-5284-9757
FU Kanton Basel-Stadt; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF)
FX We thank Helene Rossez for help with T cell transfer, Daniel Mathys for
   SEM analysis and Antonius Rolink and Ed Palmer (Department of
   Biomedicine, Basel, Switzerland) for ovalbumin peptides. We thank Dr.
   Sing Sing Way (Minneapolis, USA) for providing the Listeria strain. KW
   performed this work in the laboratory of JP as part of her master work.
   This work was supported by the Kanton Basel-Stadt and grants from the
   Swiss National Science Foundation.
CR Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Combaluzier B, 2009, J IMMUNOL, V182, P2745, DOI 10.4049/jimmunol.0801812
   Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528
   Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007
   Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018
   Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269
   Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173
   Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X
   Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352
   Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467
   Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377
   Nedela V, 2007, MICROSC RES TECHNIQ, V70, P95, DOI 10.1002/jemt.20390
   Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039
   Pieters J, 2000, ADV IMMUNOL, V75, P159, DOI 10.1016/S0065-2776(00)75004-8
   Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662
   Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491
   Singer AL, 2002, SCIENCE, V296, P1639, DOI 10.1126/science.1071551
   Skoberne M, 2002, J IMMUNOL, V169, P1410, DOI 10.4049/jimmunol.169.3.1410
   Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706
   STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415
   Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581
   Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090
   Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057
   Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x
   Zehn D, 2012, CELL MOL LIFE SCI, V69, P1565, DOI 10.1007/s00018-012-0965-x
NR 41
TC 12
Z9 12
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD APR
PY 2013
VL 53
IS 4
BP 379
EP 386
DI 10.1016/j.molimm.2012.09.002
PG 8
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 082FN
UT WOS:000314377800009
PM 23099476
DA 2021-01-25
ER

PT J
AU Schoch, RL
   Lim, RYH
AF Schoch, Rafael L.
   Lim, Roderick Y. H.
TI Non-Interacting Molecules as Innate Structural Probes in Surface Plasmon
   Resonance
SO LANGMUIR
LA English
DT Article
ID DIELECTRIC-CONSTANT; POLYMER BRUSHES; THIN-FILMS; PROTEIN; THICKNESS;
   GLYCOL); DENSITY; BEHAVIOR; SENSORS; GOLD
AB Determining the structural parameters of a molecular layer remains an unresolved problem in surface plasmon resonance (SPR). Given that molecular form and function are intimately coupled, a breakthrough in this area could be of considerable benefit to the study of protein and/or polymer-decorated material interfaces that are ubiquitous in biology and technology. Here, we describe how noninteracting molecules function as innate structural probes that "feel" the intrinsic exclusion volume of a surface-tethered molecular layer in SPR. Importantly, this is noninvasive and provides a means to bypass the refractive index (RI) constraint that convolutes and hinders SPR thickness measurements. To show proof-of-concept, we use BSA molecules in solution to measure the thicknesses of polyethylene glycol (PEG) molecular brushes as a function of molecular weight. The SPR-acquired brush thicknesses scale with PEG hydrodynamic diameter and are in good agreement with atomic force microscopy force-distance measurements. Theoretical treatments that account for changes in the evanescent field decay length at the metal-dielectric interface indicate that the method is most appropriate for low RI layers with an estimated maximal error of +/- 15% in the thickness due to the RI constraint. Such in situ thickness measurements can be easily incorporated into routine SPR binding assays for investigating mesoscopic structure function correlations of diverse molecular layers (i.e., biointerfaces).
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Schoch, Rafael/0000-0003-1799-2272; Lim, Roderick/0000-0001-5015-6087
FU National Center of Competence in Research "Nanoscale Science"
   (NCCR-Nano)Swiss National Science Foundation (SNSF); Biozentrum; Swiss
   Nanoscience Institute
FX We thank R. Wagner and J. Hyotyla for contributing the AFM force-curve
   evaluation software as well as T. Sharpe for assisting with the PEG
   polydispersity measurements. This work is supported by the National
   Center of Competence in Research "Nanoscale Science" (NCCR-Nano), the
   Biozentrum, and the Swiss Nanoscience Institute.
CR Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Arwin H, 2011, THIN SOLID FILMS, V519, P2589, DOI 10.1016/j.tsf.2010.11.082
   AUST EF, 1994, SCANNING, V16, P353
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   DEBRUIJN HE, 1991, OPT COMMUN, V82, P425, DOI 10.1016/0030-4018(91)90353-F
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Dunker AK, 2007, STRUCTURE, V15, P1026, DOI 10.1016/j.str.2007.08.001
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Eisele NB, 2012, BIOMACROMOLECULES, V13, P2322, DOI 10.1021/bm300577s
   Ekgasit S, 2004, ANAL CHEM, V76, P561, DOI 10.1021/ac035042v
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hyotyla JT, 2011, ACS NANO, V5, P5180, DOI 10.1021/nn201327y
   Jain PK, 2007, NANO LETT, V7, P2080, DOI 10.1021/nl071008a
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   KARIM A, 1994, PHYS REV LETT, V73, P3407, DOI 10.1103/PhysRevLett.73.3407
   Kim J. U., 2002, PHYS REV LETT, V89
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koutsioubas AG, 2007, J POLYM SCI POL PHYS, V45, P2060, DOI 10.1002/polb.21203
   Lee H, 2012, J PHYS CHEM LETT, V3, P1589, DOI 10.1021/jz3002772
   Lee HS, 2009, LANGMUIR, V25, P7983, DOI 10.1021/la900468n
   LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7
   LOFAS S, 1991, SENSOR ACTUAT B-CHEM, V5, P79, DOI 10.1016/0925-4005(91)80224-8
   Lukosz W, 1997, BIOSENS BIOELECTRON, V12, P175, DOI 10.1016/S0956-5663(97)85335-3
   Melzak KA, 2010, MICROSC RES TECHNIQ, V73, P959, DOI 10.1002/jemt.20851
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   Mock JJ, 2012, NANO LETT, V12, P1757, DOI 10.1021/nl204596h
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Peterlinz KA, 1997, J AM CHEM SOC, V119, P3401, DOI 10.1021/ja964326c
   Peterlinz KA, 1996, OPT COMMUN, V130, P260, DOI 10.1016/0030-4018(96)00238-6
   Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P117, DOI 10.1016/S0304-4157(97)00004-X
   Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109
   Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541
   SCHULZ LG, 1954, J OPT SOC AM, V44, P362, DOI 10.1364/JOSA.44.000362
   SCHULZ LG, 1954, J OPT SOC AM, V44, P357, DOI 10.1364/JOSA.44.000357
   Shalabney A, 2010, SENSOR ACTUAT A-PHYS, V159, P24, DOI 10.1016/j.sna.2010.02.005
   Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100
   Srinivasan N, 2012, WIRES NANOMED NANOBI, V4, P204, DOI 10.1002/wnan.1160
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   STUART MAC, 1984, MACROMOLECULES, V17, P1825, DOI 10.1021/ma00139a035
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tokareva I, 2004, J AM CHEM SOC, V126, P15950, DOI 10.1021/ja044575y
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
NR 49
TC 20
Z9 20
U1 1
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 26
PY 2013
VL 29
IS 12
BP 4068
EP 4076
DI 10.1021/la3049289
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 115YG
UT WOS:000316847200025
PM 23437874
DA 2021-01-25
ER

PT J
AU Eicher, SC
   Dehio, C
AF Eicher, Simone C.
   Dehio, Christoph
TI Systems-level analysis of host-pathogen interaction using RNA
   interference
SO NEW BIOTECHNOLOGY
LA English
DT Article
ID INFLUENZA-VIRUS REPLICATION; FUNCTIONAL GENOMIC SCREEN;
   CULTURED-MAMMALIAN-CELLS; NIEMANN-PICK C1; HIV-1 REPLICATION;
   GENE-EXPRESSION; CELLULAR COFACTORS; NEUROSPORA-CRASSA; DENGUE VIRUS;
   INFECTION
AB Hand-in-hand with the availability of full genome sequences for eukaryotic model organisms and humans the demand for analysis of gene function on a system level has grown. In a process called RNA interference (RNAi) specific mRNA species can be degraded by introduction of double-stranded small interfering RNAs (siRNAs) that are complementary to the targeted transcript sequence. This enables the selective impairment of gene function. During the past decade RNAi has been exploited in many different eukaryotic cell types and model organisms. Large-scale and eventually genome-wide RNAi screens ablating gene functions in a systematic manner have delivered an overwhelming amount of data on the requirement of distinct gene products for major cellular pathways. A large part of the RNAi field is dedicated to disease states such as cancer or infection with the prospect of discovering pathways suitable for new therapeutic interventions. Here some of the major steps in the development of the RNAi technology will be outlined and exemplified with a focus on the progress made in the field of mammalian host-pathogen interactions.
C1 [Eicher, Simone C.; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-132979]; (InfectX) in the frame of SystemsX.ch, the Swiss
   Initiative for Systems Biology [51RT 0_126008]
FX We are grateful for the current support of the host-pathogen screening
   projects in our laboratory by Grant 31003A-132979 from the Swiss
   National Science Foundation and Grant 51RT 0_126008 (InfectX) in the
   frame of SystemsX.ch, the Swiss Initiative for Systems Biology.
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Adelman ZN, 2002, J VIROL, V76, P12925, DOI 10.1128/JVI.76.24.12925-12933.2002
   Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782
   Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854
   Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1089/dna.1997.16.663
   Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798
   Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543
   Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102
   Chong R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023399
   Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380
   Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155
   Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708
   Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100
   Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007
   Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791
   Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a
   Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151
   Harborth J, 2001, J CELL SCI, V114, P4557
   Horn T, 2007, NUCLEIC ACIDS RES, V35, pD492, DOI 10.1093/nar/gkl906
   Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896
   Jia F, 2006, BIOTECHNOL LETT, V28, P1679, DOI 10.1007/s10529-006-9138-z
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020
   Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760
   Kim ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015371
   Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699
   Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78
   Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Mazur S, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas027
   Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169
   Meliopoulos VA, 2012, FASEB J, V26, P1372, DOI 10.1096/fj.11-193466
   Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7
   Ng TI, 2007, HEPATOLOGY, V45, P1413, DOI 10.1002/hep.21608
   Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009
   Pan QW, 2011, FEBS LETT, V585, P1025, DOI 10.1016/j.febslet.2011.02.035
   PANDIT NN, 1992, MOL GEN GENET, V234, P412, DOI 10.1007/BF00538700
   Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733
   Qin QM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002078
   Qiu S, 2005, NUCLEIC ACIDS RES, V33, P1834, DOI 10.1093/nar/gki324
   Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100
   Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104
   Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263
   Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0
   ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x
   Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109
   Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460
   Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018
   Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754
   Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Stroschein-Stevenson Shannon L., 2009, V470, P347, DOI 10.1007/978-1-59745-204-5_24
   Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48
   Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261
   VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033
   Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004
NR 84
TC 1
Z9 1
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD MAR 25
PY 2013
VL 30
IS 3
BP 308
EP 313
DI 10.1016/j.nbt.2013.01.008
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 121JR
UT WOS:000317240000009
PM 23395778
DA 2021-01-25
ER

PT J
AU von Schubert, C
   Nigg, EA
AF von Schubert, Conrad
   Nigg, Erich A.
TI Polo-like kinases
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID DROSOPHILA
C1 [von Schubert, Conrad; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP von Schubert, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Erich.Nigg@unibas.ch
OI nigg, erich/0000-0003-4835-5719
CR Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005
   LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184
   SUNKEL CE, 1988, J CELL SCI, V89, P25
NR 7
TC 4
Z9 4
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD MAR 18
PY 2013
VL 23
IS 6
BP R225
EP R227
DI 10.1016/j.cub.2013.01.066
PG 3
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 110GG
UT WOS:000316430000006
PM 23518048
OA Bronze
DA 2021-01-25
ER

PT J
AU Shimobayashi, M
   Oppliger, W
   Moes, S
   Jeno, P
   Hall, MN
AF Shimobayashi, Mitsugu
   Oppliger, Wolfgang
   Moes, Suzette
   Jenoe, Paul
   Hall, Michael N.
TI TORC1-regulated protein kinase Npr1 phosphorylates Orm to stimulate
   complex sphingolipid synthesis
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; SENSITIVE PHOSPHOPROTEOME REVEALS; HEAT-STRESS;
   SERINE PALMITOYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; CELL-GROWTH;
   INTRACELLULAR TRAFFICKING; TRANSLATION INITIATION; GAP1 PERMEASE; TOR
AB The evolutionarily conserved Orm1 and Orm2 proteins mediate sphingolipid homeostasis. However, the homologous Orm proteins and the signaling pathways modulating their phosphorylation and function are incompletely characterized. Here we demonstrate that inhibition of nutrient-sensitive target of rapamycin complex 1 (TORC1) stimulates Orm phosphorylation and synthesis of complex sphingolipids in Saccharomyces cerevisiae. TORC1 inhibition activates the kinase Npr1 that directly phosphorylates and activates the Orm proteins. Npr1-phosphorylated Orm1 and Orm2 stimulate de novo synthesis of complex sphingolipids downstream of serine palmitoyltransferase. Complex sphingolipids in turn stimulate plasma membrane localization and activity of the nutrient scavenging general amino acid permease 1. Thus activation of Orm and complex sphingolipid synthesis upon TORC1 inhibition is a physiological response to starvation.
C1 [Shimobayashi, Mitsugu; Oppliger, Wolfgang; Moes, Suzette; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Shimobayashi, Mitsugu/0000-0002-6936-0990
FU Canton of Basel; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); SystemsX.ch
FX We thank J. S. Weissman (University of California, San Francisco, San
   Francisco, CA) for yeast strains, B. Andre (Universite Libre de
   Bruxelles, Brussels, Belgium) for Gap1 antibody and plasmids, the
   Biozentrum Imaging Care Facility for the microscope, and A. Spang
   (Biozentrum, Basel, Switzerland) for antibodies and helpful discussion.
   The experiments described here were initiated in the laboratory of
   Yasunori Kozutsumi (Kyoto University, Kyoto, Japan). This work was
   supported by grants from the Canton of Basel, SystemsX.ch, and the Swiss
   National Science Foundation (M.N.H).
CR ARNDT KT, 1989, CELL, V56, P527, DOI 10.1016/0092-8674(89)90576-X
   Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480
   Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033
   Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787
   Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196
   Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597
   Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790
   Gelperin D, 2002, GENETICS, V161, P1453
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Helliwell SB, 1998, GENETICS, V148, P99
   Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109
   Iwaki S, 2007, J BIOL CHEM, V282, P28485, DOI 10.1074/jbc.M701607200
   Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566
   Kaiser CA, 2002, METHOD ENZYMOL, V351, P325
   Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200
   Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196
   Liu M, 2012, J CELL SCI, V23, P2388
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054
   McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549
   Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039
   Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12
   Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014
   NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899
   O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636
   Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469
   Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108
   Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999
   Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182
   Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209
   Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
   Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6
NR 55
TC 70
Z9 71
U1 0
U2 9
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR 15
PY 2013
VL 24
IS 6
BP 870
EP 881
DI 10.1091/mbc.E12-10-0753
PG 12
WC Cell Biology
SC Cell Biology
GA 173YV
UT WOS:000321120600028
PM 23363605
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Robitaille, AM
   Christen, S
   Shimobayashi, M
   Cornu, M
   Fava, LL
   Moes, S
   Prescianotto-Baschong, C
   Sauer, U
   Jenoe, P
   Hall, MN
AF Robitaille, Aaron M.
   Christen, Stefan
   Shimobayashi, Mitsugu
   Cornu, Marion
   Fava, Luca L.
   Moes, Suzette
   Prescianotto-Baschong, Cristina
   Sauer, Uwe
   Jenoe, Paul
   Hall, Michael N.
TI Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo
   Pyrimidine Synthesis
SO SCIENCE
LA English
DT Article
ID NUCLEOTIDE BIOSYNTHESIS; PHOSPHATE SYNTHETASE; GROWTH; KINASE;
   PHOSPHORYLATION; PROLIFERATION; ASSOCIATION; FIBROBLASTS; MECHANISM;
   RIBOSOME
AB The Ser-Thr kinase mammalian target of rapamycin (mTOR) controls cell growth and metabolism by stimulating glycolysis and synthesis of proteins and lipids. To further understand the central role of mTOR in cell physiology, we used quantitative phosphoproteomics to identify substrates or downstream effectors of the two mTOR complexes. mTOR controlled the phosphorylation of 335 proteins, including CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase). CAD catalyzes the first three steps in de novo pyrimidine synthesis. mTORC1 indirectly phosphorylated CAD-S1859 through S6 kinase (S6K). CAD-S1859 phosphorylation promoted CAD oligomerization and thereby stimulated de novo synthesis of pyrimidines and progression through S phase of the cell cycle in mammalian cells. Thus, mTORC1 also stimulates the synthesis of nucleotides to control cell proliferation.
C1 [Robitaille, Aaron M.; Shimobayashi, Mitsugu; Cornu, Marion; Fava, Luca L.; Moes, Suzette; Prescianotto-Baschong, Cristina; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Christen, Stefan; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Sauer, Uwe/Y-3556-2019; Fava, Luca/E-2876-2017
OI Fava, Luca/0000-0002-6741-1723; Robitaille, Aaron
   Mark/0000-0003-2774-2066; Shimobayashi, Mitsugu/0000-0002-6936-0990
FU Werner Siemens Foundation; Societe Francophone du Diabete-Association de
   Langue Francaise pour L'Etude du Diabete et des Maladies Metaboliques;
   Swiss Cancer League; Louis Jeantet Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); SystemsX.ch project
   YeastX
FX We acknowledge support from the Werner Siemens Foundation (A. M. R.),
   the Societe Francophone du Diabete-Association de Langue Francaise pour
   L'Etude du Diabete et des Maladies Metaboliques (M. C.), the Swiss
   Cancer League, the Louis Jeantet Foundation, the Swiss National Science
   Foundation, and the SystemsX.ch project YeastX. We declare no conflicts
   of interest. The phosphoproteomic data, including UniProt accession
   numbers reported in this paper, are deposited in the supplementary
   materials.
CR Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x
   Cybulski N, 2012, METHODS MOL BIOL, V821, P267, DOI 10.1007/978-1-61779-430-8_16
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203
   Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847
   Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111
   Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   LEE L, 1985, P NATL ACAD SCI USA, V82, P6802, DOI 10.1073/pnas.82.20.6802
   MITCHELL AD, 1975, EXP CELL RES, V93, P105, DOI 10.1016/0014-4827(75)90428-0
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Ramirez-Valle F, 2010, MOL CELL BIOL, V30, P3151, DOI 10.1128/MCB.00322-09
   Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344
   SMITH ML, 1979, J CELL PHYSIOL, V101, P293, DOI 10.1002/jcp.1041010210
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484
   Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 23
TC 263
Z9 270
U1 2
U2 55
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD MAR 15
PY 2013
VL 339
IS 6125
BP 1320
EP 1323
DI 10.1126/science.1228771
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 105GC
UT WOS:000316053400038
PM 23429704
DA 2021-01-25
ER

PT J
AU Braissant, O
   Bonkat, G
   Wirz, D
   Bachmann, A
AF Braissant, O.
   Bonkat, G.
   Wirz, D.
   Bachmann, A.
TI Microbial growth and isothermal microcalorimetry: Growth models and
   their application to microcalorimetric data
SO THERMOCHIMICA ACTA
LA English
DT Review
DE Isothermal microcalorimetry; Growth rate; Growth models; Microbiology
ID BACTERIAL-GROWTH; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; QUANTITATIVE
   RELATION; OPTICAL-DENSITY; HEAT-PRODUCTION; CALORIMETRY; BIOFILMS;
   COUNT; TIME
AB Over the last 10 years use of isothermal microcalorimetry in the biological and biomedical field has been a increasing. Several biomedical applications such as detection and characterization of pathogens, drug testing, parasitology, and tissue engineering have been investigated. Similarly in environmental science isothermal microcalorimetry has been shown to provide insight in soil science or in geomicrobiology. Often it is useful to convert the isothermal microcalorimetry data into biologically meaningful data such as growth rate, lag phase, or maximum growth. In this study we review not only the various approaches used for such conversion but we also carefully look at the advantages, the drawbacks and underlying assumption of each approach. Understanding of these assumptions is a critical point into applying the right model to the right portion of the microcalorimetric data. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Braissant, O.; Bonkat, G.; Bachmann, A.] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Braissant, O.; Bonkat, G.; Wirz, D.; Bachmann, A.] Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Olivier.braissant@unibas.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Alklint C, 2005, J SCI FOOD AGR, V85, P281, DOI 10.1002/jsfa.1942
   Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007
   Astasov-Frauenhoffer M, 2011, J MATER SCI-MATER M, V22, P2045, DOI 10.1007/s10856-011-4377-5
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0
   Battley EH, 2003, J THERM ANAL CALORIM, V74, P709, DOI 10.1023/B:JTAN.0000011003.43875.0d
   Baty F, 2002, APPL ENVIRON MICROB, V68, P5816, DOI 10.1128/AEM.68.12.5816-5825.2002
   Beezer A.E., 1980, BIOL MICROCALORIM, P195
   BERMUDEZ J, 1988, CAN J MICROBIOL, V34, P1058, DOI 10.1139/m88-186
   Braissant O, 2010, TUBERCULOSIS, V90, P57, DOI 10.1016/j.tube.2009.11.001
   Braissant O, 2010, SENSORS-BASEL, V10, P9369, DOI 10.3390/s101009369
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Chen HL, 2009, J ENVIRON SCI HEAL B, V44, P157, DOI 10.1080/03601230802599084
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cristianini N., 2006, INTRO SUPPORT VECTOR
   DALGAARD P, 1994, INT J FOOD MICROBIOL, V23, P391, DOI 10.1016/0168-1605(94)90165-1
   Fan DD, 2008, CHEM BIOCHEM ENG Q, V22, P363
   Francois K, 2005, J APPL MICROBIOL, V99, P1503, DOI 10.1111/j.1365-2672.2005.02727.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   HASHIMOTO M, 1982, AGR BIOL CHEM TOKYO, V46, P1559, DOI 10.1080/00021369.1982.10865296
   Howell M, 2012, J CLIN MICROBIOL, V50, P16, DOI 10.1128/JCM.05556-11
   Hrenovic J, 2009, EURASIA J BIOSCI, V3, P144, DOI DOI 10.5053/EJ0BI0S.2009.3.0.18
   Johansson P, 1999, THERMOCHIM ACTA, V342, P19, DOI 10.1016/S0040-6031(99)00299-3
   Kabanova N, 2012, FOOD MICROBIOL, V29, P67, DOI 10.1016/j.fm.2011.08.018
   Kabanova N, 2009, THERMOCHIM ACTA, V496, P87, DOI 10.1016/j.tca.2009.07.003
   Kahm M, 2010, J STAT SOFTW, V33, P1
   KIMURA T, 1985, J GEN MICROBIOL, V131, P3083
   Kong WJ, 2009, APPL MICROBIOL BIOT, V83, P1183, DOI 10.1007/s00253-009-2054-0
   Kong WJ, 2009, J HAZARD MATER, V168, P609, DOI 10.1016/j.jhazmat.2009.02.071
   Lamprecht I, 2003, THERMOCHIM ACTA, V405, P1, DOI 10.1016/S0040-6031(03)00123-0
   Lerchner J, 2006, THERMOCHIM ACTA, V445, P144, DOI 10.1016/j.tca.2005.07.011
   Liu GS, 2003, J VIROL METHODS, V112, P137, DOI 10.1016/S0166-0934(03)00214-3
   LJUNGHOLM K, 1976, J GEN MICROBIOL, V96, P283, DOI 10.1099/00221287-96-2-283
   LOPEZ D, 1987, CAN J MICROBIOL, V33, P6, DOI 10.1139/m87-002
   Madigan MT, 2000, BROCK BIOL MICROORGA
   Marison I, 1998, THERMOCHIM ACTA, V309, P157, DOI 10.1016/S0040-6031(97)00424-3
   MARISON IW, 1986, BIOTECHNOL BIOENG, V28, P1780, DOI 10.1002/bit.260281205
   Maskow T, 2006, ENG LIFE SCI, V6, P266, DOI 10.1002/elsc.200520123
   Maskow T, 2010, MICROB BIOTECHNOL, V3, P269, DOI 10.1111/j.1751-7915.2009.00121.x
   Mihhalevski A, 2011, J APPL MICROBIOL, V110, P529, DOI 10.1111/j.1365-2672.2010.04904.x
   MONK PR, 1978, J BACTERIOL, V135, P373, DOI 10.1128/JB.135.2.373-378.1978
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   ORIOL E, 1987, Biotechnology Techniques, V1, P79, DOI 10.1007/BF00159326
   Perni S, 2005, FOOD MICROBIOL, V22, P491, DOI 10.1016/j.fm.2004.11.014
   Przybylski D., 2012, INT SOC BIOL CAL M L
   R Core Team, 2017, R LANG ENV STAT COMP
   Reinders RD, 2001, APPL ENVIRON MICROB, V67, P2863, DOI 10.1128/AEM.67.6.2863-2866.2001
   Rodriguez D, 2011, J APPL MICROBIOL, V111, P1016, DOI 10.1111/j.1365-2672.2011.05117.x
   Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591
   RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995
   Santoro R, 2011, BIOTECHNOL BIOENG, V108, P3019, DOI 10.1002/bit.23268
   SCHAARSCHMIDT B, 1978, THERMOCHIM ACTA, V22, P333, DOI 10.1016/0040-6031(78)85099-0
   SCHIRALDI A, 1995, PURE APPL CHEM, V67, P1873, DOI 10.1351/pac199567111873
   Schuler MM, 2012, APPL MICROBIOL BIOT, V94, P1469, DOI 10.1007/s00253-012-4095-z
   Schuler MM, 2012, APPL MICROBIOL BIOT, V93, P575, DOI 10.1007/s00253-011-3507-9
   Sivaprakasam S, 2011, J THERM ANAL CALORIM, V104, P75, DOI 10.1007/s10973-010-1259-x
   Stulova I., 2009, AGRON RES, V9, P473
   Trampuz A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-116
   TRAORE AS, 1982, J BACTERIOL, V149, P606, DOI 10.1128/JB.149.2.606-611.1982
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   VONSTOCKAR U, 1989, BIOTECHNOL BIOENG, V34, P86, DOI 10.1002/bit.260340112
   VONSTOCKAR U, 1989, ADV BIOCHEM ENG BIOT, V40, P94
   Wadso I, 2005, J THERM ANAL CALORIM, V82, P553, DOI 10.1007/s10973-005-0933-x
   Wadso L, 2004, THERMOCHIM ACTA, V422, P63, DOI 10.1016/j.tca.2004.05.034
   Wenzler T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001668
   Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1
   Wirkner S, 2002, RADIAT PHYS CHEM, V63, P327, DOI 10.1016/S0969-806X(01)00521-7
   Xiaoyan L, 2005, J THERM ANAL CALORIM, V79, P649
   XIE CL, 1988, THERMOCHIM ACTA, V123, P33
   Yang LN, 2008, J THERM ANAL CALORIM, V93, P417, DOI 10.1007/s10973-007-8680-9
   Yao J, 2008, CHINESE J CHEM, V26, P101, DOI 10.1002/cjoc.200890000
   Yoon SI, 2008, J MICROELECTROMECH S, V17, P590, DOI 10.1109/JMEMS.2008.924846
   Yoon SI, 2008, BIOCHIP J, V2, P52
   Zhao YL, 2011, J THERM ANAL CALORIM, V104, P357, DOI 10.1007/s10973-010-1003-6
   ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875
NR 76
TC 82
Z9 87
U1 2
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD MAR 10
PY 2013
VL 555
BP 64
EP 71
DI 10.1016/j.tca.2012.12.005
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 104YW
UT WOS:000316033800011
DA 2021-01-25
ER

PT J
AU von Meyenn, F
   Porstmann, T
   Gasser, E
   Selevsek, N
   Schmidt, A
   Aebersold, R
   Stoffel, M
AF von Meyenn, Ferdinand
   Porstmann, Thomas
   Gasser, Emanuel
   Selevsek, Nathalie
   Schmidt, Alexander
   Aebersold, Ruedi
   Stoffel, Markus
TI Glucagon-Induced Acetylation of Foxa2 Regulates Hepatic Lipid Metabolism
SO CELL METABOLISM
LA English
DT Article
ID FATTY-ACID-METABOLISM; GLUCOSE-PRODUCTION; GENE-EXPRESSION; SIRT1;
   LIVER; GLUCONEOGENESIS; KETOGENESIS; INHIBITION; HEPATOCYTE; OXIDATION
AB Circulating levels of insulin and glucagon reflect the nutritional state of animals and elicit regulatory responses in the liver that maintain glucose and lipid homeostasis. The transcription factor Foxa2 activates lipid metabolism and ketogenesis during fasting and is inhibited via insulin-PI3K-Akt signaling-mediated phosphorylation at Thr156 and nuclear exclusion. Here we show that, in addition, Foxa2 is acetylated at the conserved residue Lys259 following inhibition of histone deacetylases (HDACs) class I-III and the cofactors p300 and SirT1 are involved in Foxa2 acetylation and deacetylation, respectively. Physiologically, fasting states and glucagon stimulation are sufficient to induce Foxa2 acetylation. Introduction of the acetylation-mimicking (K259Q) or -deficient (K259R) mutations promotes or inhibits Foxa2 activity, respectively, and adenoviral expression of Foxa2-K259Q augments expression of genes involved in fatty acid oxidation and ketogenesis. Our study reveals a molecular mechanism by which glucagon signaling activates a fasting response through acetylation of Foxa2.
C1 [von Meyenn, Ferdinand; Porstmann, Thomas; Gasser, Emanuel; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.
   [von Meyenn, Ferdinand; Porstmann, Thomas; Gasser, Emanuel; Aebersold, Ruedi; Stoffel, Markus] Swiss Fed Inst Technol, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Selevsek, Nathalie; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
RP Stoffel, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Schafmattstr 22, CH-8093 Zurich, Switzerland.
EM stoffel@biol.ethz.ch
RI von Meyenn, Ferdinand/O-4517-2017
OI von Meyenn, Ferdinand/0000-0001-9920-3075; Gasser,
   Emanuel/0000-0002-6792-8909
FU EMBO LTFEuropean Molecular Biology Organization (EMBO); SNSFSwiss
   National Science Foundation (SNSF) [310030_141209]
FX We thank Christian Wolfrum for helpful discussion and Bianca Kaps,
   Michele Muller, and Regina Kubsch for technical support. We would also
   like to thank Pere Puigserver for providing plasmids, Frank Gillardon
   (Bohringer-Ingelheim) for providing reagents, and Johan Auwerx for the
   Sirt1<SUP>fl/fl</SUP> mice. We acknowledge salary support from an EMBO
   LTF (to T. P.). This work was funded in part by the SNSF, grant number
   310030_141209 (to M.S.).
CR Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072
   Banerjee A, 2010, J VIROL, V84, P5936, DOI 10.1128/JVI.02344-09
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   DAVIDSON IWF, 1957, NATURE, V180, P1124, DOI 10.1038/1801124a0
   Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513
   GERICH JE, 1975, NEW ENGL J MED, V292, P985, DOI 10.1056/NEJM197505082921901
   Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   HOPPEL C, 1979, J BIOL CHEM, V254, P4164
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Kurose Y, 2009, ANIM SCI J, V80, P686, DOI 10.1111/j.1740-0929.2009.00685.x
   Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009
   LESAUTER J, 1991, AM J PHYSIOL, V261, pR154
   Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003
   Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349
   Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991
   Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008
   MARTIN JR, 1977, PHYSIOL BEHAV, V19, P461, DOI 10.1016/0031-9384(77)90218-9
   NAIR KS, 1987, J CLIN ENDOCR METAB, V64, P896, DOI 10.1210/jcem-64-5-896
   Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27
   Pandey AK, 2009, FEBS J, V276, P4181, DOI 10.1111/j.1742-4658.2009.07091.x
   PEGORIER JP, 1989, BIOCHEM J, V264, P93, DOI 10.1042/bj2640093
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024
   Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589
   Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027
   VONS C, 1991, HEPATOLOGY, V13, P1126, DOI 10.1016/0270-9139(91)92483-O
   Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010
   Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100
   Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001
   Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047
   Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200
   Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002
NR 46
TC 54
Z9 54
U1 1
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAR 5
PY 2013
VL 17
IS 3
BP 436
EP 447
DI 10.1016/j.cmet.2013.01.014
PG 12
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 242TP
UT WOS:000326265400014
PM 23416070
OA Bronze
DA 2021-01-25
ER

PT J
AU Peter, JC
   Rossez, H
   Weckering, M
   Zipfel, G
   Lecourt, AC
   Owen, JB
   Banks, WA
   Hofbauer, KG
AF Peter, Jean-Christophe
   Rossez, Helene
   Weckering, Marjorie
   Zipfel, Geraldine
   Lecourt, Anne-Catherine
   Owen, Joshua B.
   Banks, William A.
   Hofbauer, Karl G.
TI Protective effects of an anti-melanocortin-4 receptor scFv derivative in
   lipopolysaccharide-induced cachexia in rats
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Article
DE Monoclonal antibody; scFv derivative; Melanocortin-4 receptor; Cachexia;
   Anorexia; Lipopolysaccharide
ID BLOOD-BRAIN-BARRIER; BETA-PROTEIN ANTIBODY; ADSORPTIVE ENDOCYTOSIS;
   ALZHEIMERS-DISEASE; MOUSE MODEL; IN-VIVO; ANOREXIA; PASSAGE; EXPRESSION;
   MONOLAYERS
AB Background Cachexia is a complex syndrome defined by weight loss due to an ongoing loss of skeletal muscle mass with or without loss of body fat. It is often associated with anorexia. Numerous results from experimental studies suggest that blockade of the melanocortin-4 receptor (MC4R) could be an effective treatment for anorexia and cachexia. In a previous study, we reported the basic pharmacological properties of a blocking anti-MC4R mAb 1E8a and its scFv derivative in vitro and in vivo.
   Methods In the present study, we further characterized the mode of action of the 1E8a scFv, evaluated its pharmacokinetic properties in mice, and assessed its therapeutic potential in a lipopolysaccharide (LPS)-induced cachexia model in rats.
   Results In vitro, scFv enhanced the efficacy of the endogenous inverse agonist Agouti-related protein. After intravenous (i.v.) administration in mice, the scFv penetrated the blood-brain barrier (BBB) and reached its central sites of action: the scFv brain-serum concentration ratios increased up to 15-fold which suggests an active uptake into brain tissue. In telemetry experiments, i.v. administration of the scFv in rats was well tolerated and only induced slight cardiovascular effects consistent with MC4R blockade, i.e., a small decrease in mean arterial pressure and heart rate. In the model of LPS-induced anorexia, i.v. administration of scFv 1E8a prevented anorexia and loss of body weight. Moreover, it stimulated a myogenic response which may contribute to the preservation of muscle mass in cachexia.
   Conclusion The pharmacological profile of scFv 1E8a suggests its potential value in the treatment of cachexia or anorexia.
C1 [Peter, Jean-Christophe; Rossez, Helene; Weckering, Marjorie; Zipfel, Geraldine; Lecourt, Anne-Catherine; Hofbauer, Karl G.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Peter, Jean-Christophe; Hofbauer, Karl G.] Obexia AG, Biozentrum, CH-4056 Basel, Switzerland.
   [Owen, Joshua B.; Banks, William A.] Univ Washington, Sch Med, VAPSCHS, GRECC S182, Seattle, WA USA.
   [Owen, Joshua B.; Banks, William A.] Univ Washington, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Seattle, WA USA.
RP Hofbauer, KG (corresponding author), Obexia AG, Biozentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
RI Banks, William A/K-1330-2017
OI Banks, William A/0000-0002-0496-3619
FU Swiss Anorexia Nervosa Foundation
FX These studies were supported by a grant of the Swiss Anorexia Nervosa
   Foundation. The authors of this manuscript certify that they comply with
   the ethical guidelines for authorship and publishing in the Journal of
   Cachexia, Sarcopenia and Muscle [35].
CR Banks WA, 1998, J CELL SCI, V111, P533
   Banks WA, 2005, PEPTIDES, V26, P287, DOI 10.1016/j.peptides.2004.09.016
   Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9
   BANKS WA, 1989, METHOD ENZYMOL, V168, P652
   Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005
   BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2
   Blum D, 2011, CRIT REV ONCOL HEMAT, DOI [10.1016/j.critrevonc.2010.10.004, DOI 10.1016/J.CRITREV0NC.2010.10.004]
   BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059
   Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013
   Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7
   Garg A, 2009, AAPS J, V11, P553, DOI 10.1208/s12248-009-9129-9
   Gautron L, 2003, NEUROENDOCRINOLOGY, V77, P32, DOI 10.1159/000068336
   Hofbauer KG, 2008, NUTRITION, V24, P791, DOI 10.1016/j.nut.2008.06.001
   Jaeger LB, 2005, P NATL ACAD SCI USA, V102, P12495, DOI 10.1073/pnas.0504163102
   Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002
   Laviano A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1000, DOI 10.1152/ajpendo.90252.2008
   MacDonald L, 2011, AM J PHYSIOL-REG I, V301, pR172, DOI 10.1152/ajpregu.00057.2011
   Marks DL, 2003, ANN NY ACAD SCI, V994, P258, DOI 10.1111/j.1749-6632.2003.tb03188.x
   Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099
   Marks DL, 2001, RECENT PROG HORM RES, V56, P359, DOI 10.1210/rp.56.1.359
   Marks DL, 2001, CANCER RES, V61, P1432
   Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa
   Nicholson JR, 2006, J PHARMACOL EXP THER, V317, P771, DOI 10.1124/jpet.105.097725
   PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1
   Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006
   Peter JC, 2010, J PHARMACOL EXP THER, V333, P478, DOI 10.1124/jpet.109.163279
   RAUB TJ, 1990, J CELL SCI, V97, P127
   Schlachetzki F, 2002, J NEUROCHEM, V81, P203, DOI 10.1046/j.1471-4159.2002.00840.x
   Sergeyev V, 2001, MOL BRAIN RES, V90, P93, DOI 10.1016/S0169-328X(01)00088-2
   TERASAKI T, 1992, PHARMACEUT RES, V9, P529, DOI 10.1023/A:1015848531603
   Ueta Y, 2007, ENDOCR J, V54, P831, DOI 10.1507/endocrj.KR-111
   von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6
   Wisse BE, 2001, ENDOCRINOLOGY, V142, P3292, DOI 10.1210/en.142.8.3292
NR 33
TC 5
Z9 5
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Caxhexia Sarcopenia Muscle
PD MAR
PY 2013
VL 4
IS 1
BP 79
EP 88
DI 10.1007/s13539-012-0084-4
PG 10
WC Geriatrics & Gerontology; Medicine, General & Internal
SC Geriatrics & Gerontology; General & Internal Medicine
GA 218XN
UT WOS:000324466100009
PM 22911214
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Rolain, JM
   Vayssier-Taussat, M
   Saisongkorh, W
   Merhej, V
   Gimenez, G
   Robert, C
   Le Rhun, D
   Dehio, C
   Raoult, D
AF Rolain, Jean Marc
   Vayssier-Taussat, Muriel
   Saisongkorh, Watcharee
   Merhej, Vicky
   Gimenez, Gregory
   Robert, Catherine
   Le Rhun, Danielle
   Dehio, Christoph
   Raoult, Didier
TI Partial Disruption of Translational and Posttranslational Machinery
   Reshapes Growth Rates of Bartonella birtlesii
SO MBIO
LA English
DT Article
ID ESCHERICHIA-COLI; RNA GENES; EVOLUTION; BACTERIA; INSIGHTS; RICKETTSIA;
   APODEMUS; BIOLOGY; SPP.
AB Specialization of bacteria in a new niche is associated with genome repertoire changes, and speciation in bacterial specialists is associated with genome reduction. Here, we tested a signature-tagged mutant library of 3,456 Bartonella birtlesii clones to detect mutants that could grow rapidly in vitro. Overall, we found 124 mutants that grew faster than the parental wild-type strain in vitro. We sequenced the genomes of the four mutants with the most rapid growth (formed visible colonies in only 1 to 2 days compared with 5 days for the wild type) and compared them to the parental isolate genome. We found that the number of disrupted genes associated with translation in the 124 rapid-growth clones was significantly higher than the number of genes involved in translation in the full genome (P < 10(-6)). Analysis of transposon integration in the genome of the four most rapidly growing clones revealed that one clone lacked one of the two wild-type RNA ribosomal operons. Finally, one of the four clones did not induce bacteremia in our mouse model, whereas infection with the other three resulted in a significantly lower bacterial count in blood than that with the wild-type strain.
   IMPORTANCE Here, we show that specialization in a specific niche could be caused by the disruption of critical genes. Most of these genes were involved in translation, and we show that evolution of obligate parasitism bacteria was specifically associated with disruption of translation system-encoding genes.
C1 [Rolain, Jean Marc; Saisongkorh, Watcharee; Merhej, Vicky; Gimenez, Gregory; Robert, Catherine; Raoult, Didier] Aix Marseille Univ, URMITE CNRS IRD, URMITE 6236, Fac Med & Pharm, Marseille, France.
   [Vayssier-Taussat, Muriel; Le Rhun, Danielle] INRA, USC Bipar Bartonella & Tiques, Maison Alfort, France.
   [Dehio, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
RP Raoult, D (corresponding author), Aix Marseille Univ, URMITE CNRS IRD, URMITE 6236, Fac Med & Pharm, Marseille, France.
EM didier.raoult@gmail.com
RI Merhej, Vicky/J-4733-2015; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016; Rolain, Jean-Marc/Y-3788-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Rolain, Jean-Marc/0000-0002-2402-4467;
   raoult, didier/0000-0002-0633-5974
FU French Centre National de la Recherche Scientifique (CNRS)Centre
   National de la Recherche Scientifique (CNRS); INRA; Region Ile de
   FranceRegion Ile-de-France
FX This work was funded by the French Centre National de la Recherche
   Scientifique (CNRS), INRA, and Region Ile de France.
CR Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6
   Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226
   Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   Bliven KA, 2012, INFECT IMMUN, V80, P4061, DOI 10.1128/IAI.00740-12
   Feng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027754
   Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962
   Georgiades K, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-6
   Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103
   Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160
   Laland KN, 2011, SCIENCE, V334, P1512, DOI 10.1126/science.1210879
   Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152
   Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943
   MAYR E, 1961, SCIENCE, V134, P1501, DOI 10.1126/science.134.3489.1501
   Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13
   Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7
   Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9
   Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471
   Rolain JM, 2012, J BACTERIOL, V194, P4779, DOI 10.1128/JB.01044-12
   Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143
   Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
NR 24
TC 5
Z9 5
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2013
VL 4
IS 2
AR e00115-13
DI 10.1128/mBio.00115-13
PG 5
WC Microbiology
SC Microbiology
GA 137JI
UT WOS:000318431500020
PM 23611908
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Khorshid, M
   Hausser, J
   Zavolan, M
   van Nimwegen, E
AF Khorshid, Mohsen
   Hausser, Jean
   Zavolan, Mihaela
   van Nimwegen, Erik
TI A biophysical miRNA-mRNA interaction model infers canonical and
   noncanonical targets
SO NATURE METHODS
LA English
DT Article
ID BINDING-SITES; MICRORNA; RECOGNITION
AB We introduce a biophysical model of miRNA-target interaction and infer its parameters from Argonaute 2 cross-linking and immunoprecipitation data. We show that a substantial fraction of human miRNA target sites are noncanonical and that predicted target-site affinity correlates well with the extent of target destabilization. Our model provides a rigorous biophysical approach to miRNA target identification beyond ad hoc miRNA seed based methods.
C1 [Khorshid, Mohsen; Hausser, Jean; Zavolan, Mihaela; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Khorshid, Mohsen; Hausser, Jean; Zavolan, Mihaela; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch; erik.vannimwegen@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI van Nimwegen, Erik/0000-0001-6338-1312; Zavolan,
   Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PDFMP3_123123, 31003A_127307]
FX We are grateful to N. Beerenwinkel and S. Bergmann for comments in the
   initial stages of this work. We are also thankful to A.R. Gruber and the
   other members of the Zavolan group for providing input and feedback on
   the algorithm and the manuscript, A. Crippa for help with the code
   distribution and P.J. Balwierz for help converting the LaTeX manuscript
   to Word. M.K. was supported by Swiss National Science Foundation ProDoc
   grant PDFMP3_123123 to M.Z. and E.v.N. The work was additionally
   supported by Swiss National Science Foundation grant 31003A_127307 to
   M.Z.
CR Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020
   Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404
   Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056
NR 22
TC 92
Z9 92
U1 1
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD MAR
PY 2013
VL 10
IS 3
BP 253
EP 255
DI 10.1038/NMETH.2341
PG 3
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 113FB
UT WOS:000316650800023
PM 23334102
DA 2021-01-25
ER

PT J
AU Keiser, J
   Manneck, T
   Kirchhofer, C
   Braissant, O
AF Keiser, Jennifer
   Manneck, Theresia
   Kirchhofer, Carla
   Braissant, Olivier
TI Isothermal microcalorimetry to study the activity of triclabendazole and
   its metabolites on juvenile and adult Fasciola hepatica
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Fascioliasis; Triclabendazole; Triclabendazole sulphoxide;
   Triclabendazole sulphone; Isothermal microcalorimetry
ID IN-VITRO; LIVER FLUKE; VIVO; SENSITIVITY; OZ78
AB Isothermal microcalorimetry (IMC) is an analytical tool that continuously measures the heat flow generated by chemical, physical or biological processes. We have demonstrated that IMC is a useful tool to analyze drug effects on helminths, including adult Fasciola hepatica. Here, we used IMC to examine the activity of triclabendazole and its metabolites triclabendazole sulphone and triclabendazole sulphoxide on juvenile and adult F. hepatica. Worms (one adult or 2-3 juveniles) were placed in 4 or 20 ml glass ampoules containing RPMI 1640 and the test compound (25-100 mu g/ml) and the heat flow and motility of worms was examined with TAM48 and TAMIII isothermal microcalorimetry instruments. IMC was found to be precisely document drug effects on juvenile F. hepatica and confirmed the pronounced effect of the benzimidazole derivatives on the motor activity of F. hepatica. Juvenile F. hepatica incubated with 100 mu g/ml triclabendazole, triclabendazole sulphone and triclabendazole sulphoxide showed no movements 8.3, 35 and 6 h post-incubation (all p < 0.001). The metabolic heat of triclabendazole sulphoxide treated worms (100 mu g/ml) was reduced by 50% and 76% 24 and 120 h post-incubation, respectively. Limitations of calorimetric measurements were observed using adult F. hepatica as only three worms could be measured simultaneously and also control worms showed a considerable decrease in heat flow. Adult F. hepatica exposed to triclabendazole, triclabendazole sulphone and triclabendazole sulphoxide showed no movements after 31 (p = 0.009), 49 (p > 0.05) and 88 (p > 0.05) h. In conclusion, IMC is useful to document drug effects on juvenile F. hepatica and since rapid technological developments in this field are occurring IMC might also hold promise to study adult F. hepatica in the near future. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Keiser, Jennifer; Manneck, Theresia; Kirchhofer, Carla] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Keiser, Jennifer; Manneck, Theresia; Kirchhofer, Carla] Univ Basel, CH-4003 Basel, Switzerland.
   [Keiser, Jennifer; Manneck, Theresia; Kirchhofer, Carla] Univ Basel, Biozentrum, Pharmazentrum, Lab Biomech & Biocalorimetry, CH-4003 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
RP Keiser, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
RI Braissant, Olivier/AAO-2371-2020; Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU SNSF personal career development grant [PPOOA3-114941, PPOOP3_135170]
FX JK, TM and CK acknowledge funding through a SNSF personal career
   development grant to JK (Projects Nos. PPOOA3-114941 and PPOOP3_135170).
CR Ball V, 2009, INT J MOL SCI, V10, P3283, DOI 10.3390/ijms10083283
   BENNETT JL, 1987, EXP PARASITOL, V63, P49, DOI 10.1016/0014-4894(87)90077-4
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   Duthaler U, 2010, ANTIMICROB AGENTS CH, V54, P4596, DOI 10.1128/AAC.00828-10
   Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377
   Fairweather I, 2011, VET PARASITOL, V180, P133, DOI 10.1016/j.vetpar.2011.05.034
   Halferty L, 2009, VET PARASITOL, V159, P126, DOI 10.1016/j.vetpar.2008.10.007
   Keiser J, 2010, PARASITOLOGY, V137, P589, DOI 10.1017/S0031182009991739
   Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513
   Kirchhofer C, 2011, ACTA TROP, V118, P56, DOI 10.1016/j.actatropica.2011.02.003
   Lerchner J, 2006, THERMOCHIM ACTA, V445, P144, DOI 10.1016/j.tca.2005.07.011
   Lerchner J, 2008, CHEM ENG PROCESS, V47, P991, DOI 10.1016/j.cep.2007.02.014
   Manneck T, 2011, J CLIN MICROBIOL, V49, P1217, DOI 10.1128/JCM.02382-10
   Manneck T, 2011, EXP PARASITOL, V127, P260, DOI 10.1016/j.exppara.2010.08.011
   Phipps Mark A., 2000, Pharmaceutical Science and Technology Today, V3, P9, DOI 10.1016/S1461-5347(99)00227-8
   R Core Team, 2017, R LANG ENV STAT COMP
   Silbereisen A, 2011, J MICROBIOL METH, V87, P169, DOI 10.1016/j.mimet.2011.08.009
   Tritten L, 2012, PARASITOLOGY, V139, P348, DOI 10.1017/S0031182011001934
   van Herwaarden S., 2000, MECH VARIABLES MEASU, P1711
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wenzler T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001668
NR 21
TC 9
Z9 9
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD MAR
PY 2013
VL 133
IS 3
BP 265
EP 268
DI 10.1016/j.exppara.2012.11.020
PG 4
WC Parasitology
SC Parasitology
GA 105SP
UT WOS:000316093100006
PM 23206957
DA 2021-01-25
ER

PT J
AU Hee, CS
   Beerbaum, M
   Loll, B
   Ballaschk, M
   Schmieder, P
   Uchanska-Ziegler, B
   Ziegler, A
AF Hee, Chee-Seng
   Beerbaum, Monika
   Loll, Bernhard
   Ballaschk, Martin
   Schmieder, Peter
   Uchanska-Ziegler, Barbara
   Ziegler, Andreas
TI Dynamics of free versus complexed beta(2)-microglobulin and the
   evolution of interfaces in MHC class I molecules
SO IMMUNOGENETICS
LA English
DT Article
DE beta(2)m dynamics; beta(2)m-MHC class I heavy chain interface; MHC class
   I and class I-like molecules; MHC evolution; NMR spectroscopy
ID HUMAN BETA-2-MICROGLOBULIN REVEALS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS;
   HLA-B27 SUBTYPES; HLA-G; BINDING; RECOGNITION; ANTIGEN; RESOLUTION;
   INSIGHTS
AB In major histocompatibility complex (MHC) class I molecules, monomorphic beta(2)-microglobulin (beta(2)m) is non-covalently bound to a heavy chain (HC) exhibiting a variable degree of polymorphism. beta M-2 can stabilize a wide variety of complexes ranging from classical peptide binding to nonclassical lipid presenting MHC class I molecules as well as to MHC class I-like molecules that do not bind small ligands. Here we aim to assess the dynamics of individual regions in free as well as complexed beta(2)m and to understand the evolution of the interfaces between beta(2)m and different HC. Using human beta(2)m and the HLA-B*27:09 complex as a model system, a comparison of free and HC-bound beta(2)m by nuclear magnetic resonance spectroscopy was initially carried out. Although some regions retain their flexibility also after complex formation, these studies reveal that most parts of beta(2)m gain rigidity upon binding to the HC. Sequence analyses demonstrate that some of the residues exhibiting flexibility participate in evolutionarily conserved beta(2)m-HC contacts which are detectable in diverse vertebrate species or characterize a particular group of MHC class I complexes such as peptide-or lipid-binding molecules. Therefore, the spectroscopic experiments and the interface analyses demonstrate that beta(2)m fulfills its role of interacting with diverse MHC class I HC as well as effector cell receptors not only by engaging in conserved intermolecular contacts but also by falling back upon key interface residues that exhibit a high degree of flexibility.
C1 [Hee, Chee-Seng; Uchanska-Ziegler, Barbara; Ziegler, Andreas] Free Univ Berlin, Inst Immungenet, Charite Univ Med Berlin, D-14195 Berlin, Germany.
   [Beerbaum, Monika; Ballaschk, Martin; Schmieder, Peter] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany.
   [Loll, Bernhard] Free Univ Berlin, Inst Chem & Biochem, Abt Strukturbiochem, D-14195 Berlin, Germany.
   [Hee, Chee-Seng] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ziegler, A (corresponding author), Free Univ Berlin, Inst Immungenet, Charite Univ Med Berlin, Campus Benjamin Franklin Thielallee 73, D-14195 Berlin, Germany.
EM andreas.ziegler@charite.de
RI Loll, Bernhard/J-4815-2019
OI Loll, Bernhard/0000-0001-7928-4488; Schmieder, Peter/0000-0001-9968-9327
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [Na226/12-3, UC8/1-2, UC8/2-1, SCHM880/9-1, SFB 449/B6];
   VolkswagenStiftungVolkswagen [I/79 989]; Forschungskommission of the
   Freie Universitat Berlin; Fonds der Chemischen IndustrieFonds der
   Chemischen Industrie
FX We are grateful to Christina Schnick (Institut fur Immungenetik,
   Charite-Universitatsmedizin Berlin), Annette Diehl and Natalja Erdmann
   (Leibniz-Institut fur Molekulare Pharmakologie, Berlin) for excellent
   technical support. This work was supported by the Deutsche
   Forschungsgemeinschaft (grants Na226/12-3, UC8/1-2, UC8/2-1, SCHM880/9-1
   and SFB 449/B6). A. Ziegler thanks the VolkswagenStiftung for financial
   assistance (grant I/79 989). B. Loll is grateful for support by the
   Forschungskommission of the Freie Universitat Berlin and Fonds der
   Chemischen Industrie. C.-S. Hee thanks the Berliner Krebsgesellschaft
   (Ernst von Leyden Stipendium) and the Deutsche Forschungsgemeinschaft
   for support through UC8/2-1.
CR Achour A, 2006, J MOL BIOL, V356, P382, DOI 10.1016/j.jmb.2005.11.068
   Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225
   BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0
   Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x
   Cavanagh J., 1996, PROTEIN NMR SPECTROS
   Chen WH, 2010, J BIOL CHEM, V285, P22505, DOI 10.1074/jbc.M109.095000
   Chen Y, 2009, IUBMB LIFE, V61, P579, DOI 10.1002/iub.208
   Chu FL, 2007, J IMMUNOL, V178, P944, DOI 10.4049/jimmunol.178.2.944
   Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102
   Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006
   DELANO WL, 2002, PYMOL MOL GRAPHIC SY
   Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200
   Dvir H, 2010, J IMMUNOL, V184, P2504, DOI 10.4049/jimmunol.0903509
   Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028
   Esposito G, 2005, BBA-PROTEINS PROTEOM, V1753, P76, DOI 10.1016/j.bbapap.2005.07.003
   Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002
   Fabian H, 2011, FEBS J, V278, P1713, DOI 10.1111/j.1742-4658.2011.08097.x
   Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316
   Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113
   FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280
   Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009
   Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Gras S, 2011, IMMUNOL CELL BIOL, V89, P388, DOI 10.1038/icb.2010.150
   Hassan MI, 2011, ADV PROTEIN CHEM STR, V83, P223, DOI 10.1016/B978-0-12-381262-9.00006-9
   Hassan MI, 2008, J MOL BIOL, V384, P663, DOI 10.1016/j.jmb.2008.09.072
   Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952
   Hee CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000557
   Hee CS, 2012, BIOPHYS CHEM, V167, P26, DOI 10.1016/j.bpc.2012.04.001
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Holmes MA, 2002, J IMMUNOL, V169, P1395, DOI 10.4049/jimmunol.169.3.1395
   Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690
   Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200
   Iwata K, 2007, J BIOCHEM, V142, P413, DOI 10.1093/jb/mvm148
   Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017
   Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4
   Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007
   Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6
   Li X, 2011, J VIROL, V85, P6038, DOI 10.1128/JVI.00030-11
   Liu YW, 2003, IMMUNITY, V18, P205, DOI 10.1016/S1074-7613(03)00027-X
   MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H
   Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1
   McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791
   Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003
   Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021
   O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2
   OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035
   Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658
   Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914
   Shi Y, 2011, MOL IMMUNOL, V48, P2198, DOI 10.1016/j.molimm.2011.05.009
   Shields MJ, 1998, J BIOL CHEM, V273, P28010, DOI 10.1074/jbc.273.43.28010
   Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170
   Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399
   Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004
   Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002
   Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449
   Wang R, 2009, J IMMUNOL, V183, P2554, DOI 10.4049/jimmunol.0901276
   Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961
   Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105
   Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948
   Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339
NR 68
TC 17
Z9 17
U1 0
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0093-7711
EI 1432-1211
J9 IMMUNOGENETICS
JI Immunogenetics
PD MAR
PY 2013
VL 65
IS 3
BP 157
EP 172
DI 10.1007/s00251-012-0667-4
PG 16
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 109FH
UT WOS:000316351100001
PM 23229474
DA 2021-01-25
ER

PT J
AU Chalmel, F
   Lardenois, A
   Georg, I
   Barrionuevo, F
   Demougin, P
   Jegou, B
   Scherer, G
   Primig, M
AF Chalmel, F.
   Lardenois, A.
   Georg, I.
   Barrionuevo, F.
   Demougin, P.
   Jegou, B.
   Scherer, G.
   Primig, M.
TI Genome-wide identification of Sox8-, and Sox9-dependent genes during
   early post-natal testis development in the mouse
SO ANDROLOGY
LA English
DT Article
DE microarrays; Sertoli cells; Sox8; Sox9; spermatogenesis
ID TRANSCRIPTION FACTOR GENE; AUTOSOMAL SEX REVERSAL; MICE LACKING;
   IN-VIVO; CAMPOMELIC DYSPLASIA; SERTOLI-CELLS; TARGET GENES;
   UNDIFFERENTIATED SPERMATOGONIA; NONCODING RNAS; GERM-CELLS
AB The SOX8 and SOX9 transcription factors are involved in, among others, sex differentiation, male gonad development and adult maintenance of spermatogenesis. Sox8(-/-) mice lacking Sox9 in Sertoli cells fail to form testis cords and cannot establish spermatogenesis. Although genetic and histological data show an important role for these transcription factors in regulating spermatogenesis, it is not clear which genes depend upon them at a genome-wide level. To identify transcripts that respond to the absence of Sox8 in all cells and Sox9 in Sertoli cells we measured mRNA concentrations in testicular samples from mice at 0, 6 and 18 days post-partum. In total, 621 and 629 transcripts were found at decreased or increased levels, respectively, at different time points in the mutant as compared to the control samples. These mRNAs were categorized as preferentially expressed in Sertoli cells or germ cells using data obtained with male and female gonad samples and enriched testicular cell populations. Five candidate genes were validated at the protein level. Furthermore, we identified putative direct SOX8 and SOX9 target genes by integrating predicted SOX-binding sites present in potential regulatory regions upstream of the transcription start site. Finally, we used protein network data to gain insight into the effects on regulatory interactions that occur when Sox8 and Sox9 are absent in developing Sertoli cells. The integration of testicular samples with enriched Sertoli cells, germ cells and female gonads enabled us to broadly distinguish transcripts directly affected in Sertoli cells from others that respond to secondary events in testicular cell types. Thus, combined RNA profiling signals, motif predictions and network data identified putative SOX8/SOX9 target genes in Sertoli cells and yielded insight into regulatory interactions that depend upon these transcription factors. In addition, our results will facilitate the interpretation of genome-wide in vivo SOX8 and SOX9 DNA binding data.
C1 [Chalmel, F.; Lardenois, A.; Jegou, B.; Primig, M.] Univ Rennes 1, INSERM, Irset U1085, F-35042 Rennes, France.
   [Georg, I.; Barrionuevo, F.; Scherer, G.] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany.
   [Georg, I.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany.
   [Demougin, P.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Jegou, B.] EHESP Sch Publ Hlth Rennes Paris, Rennes, France.
   [Barrionuevo, F.] Univ Granada, Dept Genet, Armilla, Spain.
   [Barrionuevo, F.] Univ Granada, Inst Biotecnol, Armilla, Spain.
RP Primig, M (corresponding author), Univ Rennes 1, INSERM, Irset U1085, 263 Ave Gen Leclerc, F-35042 Rennes, France.
EM michael.primig@inserm.fr
RI Lardenois, Aurelie/AAA-8961-2020; Jegou, Bernard/I-4742-2015; Chalmel,
   Frederic/M-1297-2016; Georg, Ina/L-5018-2014; Barrionuevo,
   Francisco/AAA-7639-2019; Chalmel, Frederic/L-5360-2018; Primig,
   Michael/G-3175-2013
OI Georg, Ina/0000-0002-1256-5805; Barrionuevo,
   Francisco/0000-0003-2651-1530; Chalmel, Frederic/0000-0002-0535-3628;
   Primig, Michael/0000-0002-2061-0119; JEGOU, Bernard/0000-0003-0623-3609
FU INSERM Young Investigator fellowship; INERIS-STORM [10028NN]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [Sche 195/15, GRK
   1104]; INSERM Avenir grantInstitut National de la Sante et de la
   Recherche Medicale (Inserm) [R07216NS]
FX We thank J. Moore for stimulating discussions, and F. Petit and S. Jamin
   for critical reading of the manuscript and O. Collin (IRISA, Genouest)
   for MIMAS and GermOnline system administration. A. Lardenois received an
   INSERM Young Investigator fellowship and support from grant INERIS-STORM
   10028NN awarded to B. Jegou. Deutsche Forschungsgemeinschaft grants Sche
   195/15 and GRK 1104 awarded to G. Scherer and INSERM Avenir grant
   R07216NS awarded to M. Primig funded this work.
CR Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5
   Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930
   Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480
   Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001
   Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087
   Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86
   Chalmel F, 2007, ANN NY ACAD SCI, V1120, P1, DOI 10.1196/annals.1411.010
   Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104
   Chalmel F, 2012, HUM REPROD, V27, P3233, DOI 10.1093/humrep/des301
   Chan YF, 2008, BIOL REPROD, V78, P780, DOI 10.1095/biolreprod.107.060863
   Chang Y, 2008, OSTEOARTHR CARTILAGE, V16, P1403, DOI 10.1016/j.joca.2008.03.018
   Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950
   Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825
   Cocquet J, 2005, GENOMICS, V85, P531, DOI 10.1016/j.ygeno.2005.01.007
   Cost NG, 2009, J PEDIATR SURG, V44, P451, DOI 10.1016/j.jpedsurg.2008.10.003
   das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946
   De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653
   Dupont S, 2000, DEVELOPMENT, V127, P4277
   Edson MA, 2010, MOL ENDOCRINOL, V24, P1251, DOI 10.1210/me.2009-0461
   Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889
   FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0
   Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003
   Gattiker A, 2007, NUCLEIC ACIDS RES, V35, pD457, DOI 10.1093/nar/gkl957
   Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907
   Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795
   Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203
   Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887
   Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198
   Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025
   Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883
   Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501
   Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038
   Huang BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037702
   Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526
   Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756
   Jagarlamudi K, 2012, MOL CELL ENDOCRINOL, V356, P31, DOI 10.1016/j.mce.2011.07.049
   JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4
   Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Kennedy CRJ, 1999, NAT MED, V5, P217
   Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958
   Kimura F, 2011, ENDOCRINOLOGY, V152, P697, DOI 10.1210/en.2010-0950
   Kimura F, 2010, ENDOCRINOLOGY, V151, P1310, DOI 10.1210/en.2009-1176
   Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102
   Labelle-Dumais C, 2007, BIOL REPROD, V77, P217, DOI 10.1095/biolreprod.106.059121
   Lardenois A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-154
   Lavery R, 2011, DEV BIOL, V354, P111, DOI 10.1016/j.ydbio.2011.03.029
   Lee KE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-408
   Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168
   Lin SY, 2008, MOL ENDOCRINOL, V22, P415, DOI 10.1210/me.2006-0529
   Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412
   MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489
   Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631
   Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902
   Nakata H, 2012, ACTA HISTOCHEM CYTOC, V45, P47, DOI 10.1267/ahc.11057
   O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042
   Ohe K, 2009, DEV DYNAM, V238, P1595, DOI 10.1002/dvdy.21957
   Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889
   Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142
   Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104
   Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285
   Savitt J, 2012, STEM CELLS, V30, P732, DOI 10.1002/stem.1028
   Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200
   Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X
   Schepers GE, 2000, NUCLEIC ACIDS RES, V28, P1473, DOI 10.1093/nar/28.6.1473
   Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762
   Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242
   Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100
   Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880
   Singh AP, 2009, SEX DEV, V3, P16, DOI 10.1159/000200078
   Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Takada S, 2003, CYTOGENET GENOME RES, V101, P212, DOI 10.1159/000074339
   Thomas Kelwyn, 2011, Front Biosci (Elite Ed), V3, P1209
   Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370
   Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124
   Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025
   van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049
   WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8
   Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018
   Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614
   Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200
   Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105
   Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408
   Yazama F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019387
   Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391
NR 92
TC 11
Z9 11
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2047-2919
EI 2047-2927
J9 ANDROLOGY-US
JI Andrology
PD MAR
PY 2013
VL 1
IS 2
BP 281
EP 292
DI 10.1111/j.2047-2927.2012.00049.x
PG 12
WC Andrology
SC Endocrinology & Metabolism
GA 097GW
UT WOS:000315463000014
PM 23315995
OA Bronze
DA 2021-01-25
ER

PT J
AU Tiwari, N
   Meyer-Schaller, N
   Arnold, P
   Antoniadis, H
   Pachkov, M
   van Nimwegen, E
   Christofori, G
AF Tiwari, Neha
   Meyer-Schaller, Nathalie
   Arnold, Phil
   Antoniadis, Helena
   Pachkov, Mikhail
   van Nimwegen, Erik
   Christofori, Gerhard
TI Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including
   Jnk1 (Mapk8)
SO PLOS ONE
LA English
DT Article
ID KRUPPEL-LIKE FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER
   PATIENTS; TUMOR-SUPPRESSOR; STEM-CELLS; DOWN-REGULATION; PROGRESSION;
   EXPRESSION; GROWTH; DIFFERENTIATION
AB We have identified the zinc-finger transcription factor Kruppel-like factor 4 (Klf4) among the transcription factors that are significantly downregulated in their expression during epithelial-mesenchymal transition (EMT) in mammary epithelial cells and in breast cancer cells. Loss and gain of function experiments demonstrate that the down-regulation of Klf4 expression is required for the induction of EMT in vitro and for metastasis in vivo. In addition, reduced Klf4 expression correlates with shorter disease-free survival of subsets of breast cancer patients. Yet, reduced expression of Klf4 also induces apoptosis in cells undergoing TGF beta-induced EMT. Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct Klf4 target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), beta-catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8). Thereby, Klf4 acts as a transcriptional activator of epithelial genes and as a repressor of mesenchymal genes. Specifically, increased expression of Jnk1 (Mapk8) upon down-regulation of its transcriptional repressor Klf4 is required for EMT cell migration and for the induction of apoptosis. The data demonstrate a central role of Klf4 in the maintenance of epithelial cell differentiation and the prevention of EMT and metastasis.
C1 [Tiwari, Neha; Meyer-Schaller, Nathalie; Antoniadis, Helena; Christofori, Gerhard] Univ Basel, Dept Biomed, Basel, Switzerland.
   [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
RP Christofori, G (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.
EM Gerhard.christofori@unibas.ch
OI Tiwari, Neha/0000-0001-7931-4085; van Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); SystemsX.ch RTD project Cellplasticity; Swiss Cancer League
FX This work was supported by the Swiss National Science Foundation, the
   SystemsX.ch RTD project Cellplasticity, and the Swiss Cancer League. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151
   Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455
   BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029
   Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694
   Cellurale C, 2012, CANCER RES, V72, P472, DOI 10.1158/0008-5472.CAN-11-1628
   Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469
   Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443
   Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200
   Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872
   Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0
   Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560
   DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8
   Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765
   Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307
   Foster KW, 1999, CELL GROWTH DIFFER, V10, P423
   Foster KW, 2000, CANCER RES, V60, P6488
   Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175
   Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745
   Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001
   Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414
   Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022
   Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634
   Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314
   Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003
   Segre JA, 1999, NAT GENET, V22, P356
   Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806
   Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009
   Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048
   Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036
   Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8
   Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870
   Van der Velden JL, 2010, AM J RESP CELL MOL B, V47, P306
   Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319
   Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260
   Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546
   Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591
   Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067
NR 49
TC 57
Z9 60
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 25
PY 2013
VL 8
IS 2
AR e57329
DI 10.1371/journal.pone.0057329
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 115ZB
UT WOS:000316849500090
PM 23451207
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Tol, MB
   Deluz, C
   Hassaine, G
   Graff, A
   Stahlberg, H
   Vogel, H
AF Tol, Menno B.
   Deluz, Cedric
   Hassaine, Gherici
   Graff, Alexandra
   Stahlberg, Henning
   Vogel, Horst
TI Thermal Unfolding of a Mammalian Pentameric Ligand-gated Ion Channel
   Proceeds at Consecutive, Distinct Steps
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID NICOTINIC ACETYLCHOLINE-RECEPTOR; BLUE NATIVE ELECTROPHORESIS; SEROTONIN
   5-HT3 RECEPTOR; NONIONIC SURFACTANTS; CIRCULAR-DICHROISM;
   PROTEIN-STABILITY; MEMBRANE; BINDING; TORPEDO; THERMOSTABILITY
AB Pentameric ligand-gated ion channels (LGICs) play an important role in fast synaptic signal transduction. Binding of agonists to the beta-sheet-structured extracellular domain opens an ion channel in the transmembrane alpha-helical region of the LGIC. How the structurally distinct and distant domains are functionally coupled for such central transmembrane signaling processes remains an open question. To obtain detailed information about the stability of and the coupling between these different functional domains, we analyzed the thermal unfolding of a homopentameric LGIC, the 5-hydroxytryptamine receptor (ligand binding, secondary structure, accessibility of Trp and Cys residues, and aggregation), in plasma membranes as well as during detergent extraction, purification, and reconstitution into artificial lipid bilayers. We found a large loss in thermostability correlating with the loss of the lipid bilayer during membrane solubilization and purification. Thermal unfolding of the 5-hydroxytryptamine receptor occurred in consecutive steps at distinct protein locations. A loss of ligand binding was detected first, followed by formation of different transient low oligomeric states of receptor pentamers, followed by partial unfolding of helical parts of the protein, which finally lead to the formation receptor aggregates. Structural destabilization of the receptor in detergents could be partially reversed by reconstituting the receptor into lipid bilayers. Our results are important because they quantify the stability of LGICs during detergent extraction and purification and can be used to create stabilized receptor proteins for structural and functional studies.
C1 [Tol, Menno B.; Deluz, Cedric; Hassaine, Gherici; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland.
   [Graff, Alexandra; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4085 Basel, Switzerland.
RP Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol Lausanne, LCPPM, Stn 6, CH-1015 Lausanne, Switzerland.
EM horst.vogel@epfl.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU European Community's Seventh Framework ProgramEuropean Union (EU)
   [211800]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [31003A-118148]; Ecole Polytechnique Federale de
   Lausanne
FX This work was supported by the European Community's Seventh Framework
   Program FP7/2007-2013 under Grant 211800, the Swiss National Science
   Foundation (the SystemsX program and SNF Grant 31003A-118148), and
   internal funds of the Ecole Polytechnique Federale de Lausanne.
CR Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004
   ARTIGUES A, 1987, ARCH BIOCHEM BIOPHYS, V258, P33, DOI 10.1016/0003-9861(87)90319-5
   Asmar-Rovira GA, 2008, J MEMBRANE BIOL, V223, P13, DOI 10.1007/s00232-008-9107-7
   Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007
   Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003
   Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833
   Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462
   Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2
   Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200
   Chen ML, 2007, CHEM RES CHINESE U, V23, P715, DOI 10.1016/S1005-9040(07)60156-1
   daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200
   Dellisanti CD, 2011, J BIOL CHEM, V286, P3658, DOI 10.1074/jbc.M110.156851
   Derewenda ZS, 2010, ACTA CRYSTALLOGR D, V66, P604, DOI 10.1107/S090744491000644X
   Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103
   FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035
   Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560
   Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721
   HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W
   Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006
   Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   Heyden M, 2012, SOFT MATTER, V8, P7742, DOI 10.1039/c2sm25402f
   Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139
   Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101
   Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0
   Hovius R, 1998, J NEUROCHEM, V70, P824
   Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9
   Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315
   Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496
   Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003
   MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388
   Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105
   Maksay G, 1996, J NEUROCHEM, V67, P407
   Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008
   Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005
   Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023
   Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016
   O'Malley MA, 2010, BIOCHEMISTRY-US, V49, P9181, DOI 10.1021/bi101155r
   Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072
   PEREZRAMIREZ B, 1994, MOL CELL BIOCHEM, V132, P91, DOI 10.1007/BF00926917
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001
   Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384
   Quirk PL, 2004, J NEUROSCI RES, V77, P498, DOI 10.1002/jnr.20185
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schlinkmann KM, 2012, J MOL BIOL, V422, P414, DOI 10.1016/j.jmb.2012.05.039
   Schreiter C, 2003, J BIOL CHEM, V278, P22709, DOI 10.1074/jbc.M301801200
   Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105
   Sharma KS, 2003, COLLOID SURFACE A, V219, P67, DOI 10.1016/S0927-7757(03)00012-8
   Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001
   Tairi AP, 1998, BIOCHEMISTRY-US, V37, P15850, DOI 10.1021/bi981812z
   Tate CG, 2010, METHODS MOL BIOL, V601, P187, DOI 10.1007/978-1-60761-344-2_12
   Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004
   Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168
   Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x
   Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   VOGEL H, 1988, P NATL ACAD SCI USA, V85, P5067, DOI 10.1073/pnas.85.14.5067
   VOGEL H, 1987, BIOCHEMISTRY-US, V26, P4562, DOI 10.1021/bi00388a060
   Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001
   Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101
   White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319
   White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904
   Yeh AP, 2006, ACTA CRYSTALLOGR D, V62, P451, DOI 10.1107/S0907444906005233
   Zelent B, 1998, BIOPHYS CHEM, V73, P53, DOI 10.1016/S0301-4622(98)00137-9
NR 69
TC 14
Z9 14
U1 0
U2 17
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 22
PY 2013
VL 288
IS 8
BP 5756
EP 5769
DI 10.1074/jbc.M112.422287
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 095NY
UT WOS:000315342500047
PM 23275379
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Huser, S
   Suri, G
   Crottet, P
   Spiess, M
AF Huser, Sonja
   Suri, Gregor
   Crottet, Pascal
   Spiess, Martin
TI Interaction of amphiphysins with AP-1 clathrin adaptors at the membrane
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE adaptor protein 1 (AP-1); amphiphysin; clathrin; coated vesicle;
   liposome; membrane traffic
ID SYNAPTIC VESICLE ENDOCYTOSIS; TRANS-GOLGI NETWORK; MANNOSE 6-PHOSPHATE
   RECEPTORS; DOMAIN-CONTAINING PROTEIN; CARGO-SORTING SIGNALS; MEDIATED
   ENDOCYTOSIS; SPLICE VARIANTS; COATED VESICLES; BINDING; TRAFFICKING
AB The assembly of clathrin/AP (adaptor protein)-1-coated vesicles on the trans-Golgi network and endosomes is much less studied than that of clathrin/AP-2 vesicles at the plasma membrane for endocytosis. In vitro, the association of AP-1 with protein-free liposomes had been shown to require phosphoinositides, Arfl (ADP-ribosylation factor 1) GTP and additional cytosolic factor(s). We have purified an active fraction from brain cytosol and found it to contain amphiphysin 1 and 2 and endophilin A1, three proteins known to be involved in the formation of AP2/clathrin coats at the plasma membrane. Assays with bacterially expressed and purified proteins showed that AP-1 stabilization on liposomes depends on amphiphysin 2 or the amphiphysin 1/2 heterodimer. Activity is independent of the SH3 (Src homology 3) domain, but requires interaction of the WDLW motif with gamma-adaptin. Endogenous amphiphysin in neurons and transfected protein in cell lines co-localize perinuclearly with AP-1 at the trans-Golgi network. This localization depends on interaction of clathrin and the adaptor sequence in the amphiphysins and is sensitive to brefeldin A, which inhibits Arf1-dependent AP1 recruitment. Interaction between AP-1 and amphiphysin 1/2 in vivo was demonstrated by co-immunoprecipitation after cross-linking. These results suggest an involvement of amphiphysins not only with AP-2 at the plasma membrane, but also in AP-1/clathrin coat formation at the trans-Golgi network.
C1 [Huser, Sonja; Suri, Gregor; Crottet, Pascal; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-125423]
FX This work was supported by the Swiss National Science Foundation [grant
   number 31003A-125423 (to M.S.)].
CR Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006
   Bai HD, 2004, J BIOL CHEM, V279, P17411, DOI 10.1074/jbc.M401158200
   Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997
   Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309
   David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331
   Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257
   Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3
   Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200
   Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Farsad K, 2003, NEUROPHARMACOLOGY, V45, P787, DOI 10.1016/S0028-3908(03)00306-X
   Folsch H, 2005, TRENDS CELL BIOL, V15, P222, DOI 10.1016/j.tcb.2005.02.006
   Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010
   Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755
   Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050
   Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080
   Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004
   Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462
   Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028
   Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067
   Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200
   Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009
   Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699
   Lee I, 2008, ARCH BIOCHEM BIOPHYS, V479, P63, DOI 10.1016/j.abb.2008.08.009
   Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037
   Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403
   Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101
   Liang JO, 1997, J BIOL CHEM, V272, P4141, DOI 10.1074/jbc.272.7.4141
   McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151
   McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9
   McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0
   Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193
   Meyer DM, 2005, MOL BIOL CELL, V16, P4745, DOI 10.1091/mbc.E05-06-0568
   Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239
   Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8
   Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029
   Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600
   Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355
   Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993
   Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986
   Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266
   Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700
   Ramjaun AR, 1998, J NEUROCHEM, V70, P2369
   Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569
   Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4
   Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004
   Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031
   Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199
   Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821
   Suri Gregor, 2008, V457, P227, DOI 10.1007/978-1-59745-261-8_17
   Takei K, 1999, NAT CELL BIOL, V1, P33
   Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604
   Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751
   Tsutsui K, 1997, BIOCHEM BIOPH RES CO, V236, P178, DOI 10.1006/bbrc.1997.6927
   Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100
   Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003
   Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013
NR 59
TC 6
Z9 6
U1 0
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD FEB 15
PY 2013
VL 450
BP 73
EP 83
DI 10.1042/BJ20121373
PN 1
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 081LB
UT WOS:000314322600008
PM 23190214
DA 2021-01-25
ER

PT J
AU Picotti, P
   Clement-Ziza, M
   Lam, H
   Campbell, DS
   Schmidt, A
   Deutsch, EW
   Rost, H
   Sun, Z
   Rinner, O
   Reiter, L
   Shen, Q
   Michaelson, JJ
   Frei, A
   Alberti, S
   Kusebauch, U
   Wollscheid, B
   Moritz, RL
   Beyer, A
   Aebersold, R
AF Picotti, Paola
   Clement-Ziza, Mathieu
   Lam, Henry
   Campbell, David S.
   Schmidt, Alexander
   Deutsch, Eric W.
   Roest, Hannes
   Sun, Zhi
   Rinner, Oliver
   Reiter, Lukas
   Shen, Qin
   Michaelson, Jacob J.
   Frei, Andreas
   Alberti, Simon
   Kusebauch, Ulrike
   Wollscheid, Bernd
   Moritz, Robert L.
   Beyer, Andreas
   Aebersold, Ruedi
TI A complete mass-spectrometric map of the yeast proteome applied to
   quantitative trait analysis
SO NATURE
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; PEPTIDE IDENTIFICATION; BUDDING YEAST;
   EXPRESSION; PREDICTION; LIBRARIES; PROTEINS; SEQUENCE; TANDEM; ASSAYS
AB Experience from different fields of life sciences suggests that accessible, complete reference maps of the components of the system under study are highly beneficial research tools. Examples of such maps include libraries of the spectroscopic properties of molecules, or databases of drug structures in analytical or forensic chemistry. Such maps, and methods to navigate them, constitute reliable assays to probe any sample for the presence and amount of molecules contained in the map. So far, attempts to generate such maps for any proteome have failed to reach complete proteome coverage(1-3). Here we use a strategy based on high-throughput peptide synthesis and mass spectrometry to generate an almost complete reference map (97% of the genome-predicted proteins) of the Saccharomyces cerevisiae proteome. We generated two versions of this mass-spectrometric map, one supporting discovery-driven (shotgun)(3,4) and the other supporting hypothesis-driven (targeted)(5,6) proteomic measurements. Together, the two versions of the map constitute a complete set of proteomic assays to support most studies performed with contemporary proteomic technologies. To show the utility of the maps, we applied them to a protein quantitative trait locus (QTL) analysis(7), which requires precise measurement of the same set of peptides over a large number of samples. Protein measurements over 78 S. cerevisiae strains revealed a complex relationship between independent genetic loci, influencing the levels of related proteins. Our results suggest that selective pressure favours the acquisition of sets of polymorphisms that adapt protein levels but also maintain the stoichiometry of functionally related pathway members.
C1 [Picotti, Paola; Roest, Hannes; Rinner, Oliver; Reiter, Lukas; Shen, Qin; Frei, Andreas; Wollscheid, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.
   [Picotti, Paola] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland.
   [Clement-Ziza, Mathieu; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01069 Dresden, Germany.
   [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China.
   [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.
   [Campbell, David S.; Deutsch, Eric W.; Sun, Zhi; Kusebauch, Ulrike; Moritz, Robert L.] Inst Syst Biol, Seattle, WA 98103 USA.
   [Schmidt, Alexander] Univ Basel, Prote Core Facil Biozentrum, CH-4056 Basel, Switzerland.
   [Rinner, Oliver; Reiter, Lukas] Biognosys AG, CH-8093 Zurich, Switzerland.
   [Shen, Qin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China.
   [Alberti, Simon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
RP Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland.
EM paola.picotti@bc.biol.ethz.ch; andreas.beyer@biotec.tu-dresden.de;
   aebersold@imsb.biol.ethz.ch
RI Deutsch, Eric/AAF-5912-2020; Wollscheid, Bernd/E-8909-2010; Beyer,
   Andreas/AAQ-5519-2020; Beyer, Andreas/A-3352-2009; Rost,
   Hannes/L-2056-2019; Rost, Hannes L/E-9564-2013; Clement-Ziza,
   Mathieu/J-4146-2012; Alberti, Simon/B-2822-2017; Lam, Henry/D-8629-2011
OI Wollscheid, Bernd/0000-0002-3923-1610; Beyer,
   Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123; Rost,
   Hannes/0000-0003-0990-7488; Rost, Hannes L/0000-0003-0990-7488;
   Clement-Ziza, Mathieu/0000-0003-2763-249X; Alberti,
   Simon/0000-0003-4017-6505; Michaelson, Jacob/0000-0001-9713-0992; Lam,
   Henry/0000-0001-7928-0364; Deutsch, Eric/0000-0001-8732-0928
FU ETH ZurichETH Zurich; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [3100A0-107679]; National Heart, Lung and
   Blood Institute, National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [N01-HV-28179]; National
   Science Foundation MRINational Science Foundation (NSF) [0923536];
   Luxembourg Centre for Systems Biomedicine; University of Luxembourg;
   SystemsX.ch; Swiss initiative for systems biology; Foerderungsprofessur
   grant from the Swiss National Science Foundation [PP00P3_133670];
   European Union Seventh Framework Program Reintegration grant
   [FP7-PEOPLE-2010-RG-277147]; Promedica Stiftung [2-70669-11]; University
   Grant Council of the Hong Kong Special Administrative Region Government,
   China [HKUST DAG08/09.EG02]; Klaus Tschira Foundation; European Union
   FP7 HEALTH grant [HEALTH-F4-2008-223539]; European Research
   CouncilEuropean Research Council (ERC) [ERC-2008-AdG 233226];
   SystemsX.ch, the Swiss Initiative for Systems Biolod; DIVISION OF HEART
   AND VASCULAR DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [N01HV028179] Funding Source: NIH RePORTER;
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [RC2HG005805,
   RC2HG005805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547, P50GM076547,
   P50GM076547, P50GM076547, P50GM076547, P50GM076547] Funding Source: NIH
   RePORTER; Direct For Biological SciencesNational Science Foundation
   (NSF)NSF - Directorate for Biological Sciences (BIO) [0923536] Funding
   Source: National Science Foundation; Div Of Biological
   InfrastructureNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [0923536] Funding Source: National Science
   Foundation
FX This project has been funded in part by ETH Zurich, the Swiss National
   Science Foundation (3100A0-107679), the National Heart, Lung and Blood
   Institute, National Institutes of Health (N01-HV-28179), the National
   Science Foundation MRI (grant 0923536); the Luxembourg Centre for
   Systems Biomedicine and the University of Luxembourg, and by
   SystemsX.ch, the Swiss initiative for systems biology. PP. is supported
   by a Foerderungsprofessur grant from the Swiss National Science
   Foundation (PP00P3_133670), by a European Union Seventh Framework
   Program Reintegration grant (FP7-PEOPLE-2010-RG-277147) and by a
   Promedica Stiftung (2-70669-11), H. L is supported by the University
   Grant Council of the Hong Kong Special Administrative Region Government,
   China (HKUST DAG08/09.EG02). A.B. is supported by the Klaus Tschira
   Foundation and by a European Union FP7 HEALTH grant
   (HEALTH-F4-2008-223539). R.A. is supported by the European Research
   Council (ERC-2008-AdG 233226) and by SystemsX.ch, the Swiss Initiative
   for Systems Biolod.
CR Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916
   Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973
   Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200
   Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516
   Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099
   Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085
   Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   de Smidt O, 2012, FEMS YEAST RES, V12, P33, DOI 10.1111/j.1567-1364.2011.00760.x
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Deutsch EW, 2010, METHODS MOL BIOL, V604, P285, DOI 10.1007/978-1-60761-444-9_19
   Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22
   Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717
   Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w
   Lam H, 2008, NAT METHODS, V5, P873, DOI 10.1038/NMETH.1254
   Lam H, 2010, METHODS MOL BIOL, V604, P95, DOI 10.1007/978-1-60761-444-9_7
   Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275
   Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502
   Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/NMETH.1584, 10.1038/nmeth.1584]
   Rost H, 2012, MOL CELL PROTEOMICS, V11, P540, DOI 10.1074/mcp.M111.013045
   Taussig M. J., 2007, NATURE METHODS, V4, P187, DOI [10.1038/nmeth0207-187a, DOI 10.1038/NMETH0207-187A]
   YOUNG ET, 1985, MOL CELL BIOL, V5, P3024, DOI 10.1128/MCB.5.11.3024
   Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109
NR 30
TC 189
Z9 193
U1 1
U2 175
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 14
PY 2013
VL 494
IS 7436
BP 266
EP 270
DI 10.1038/nature11835
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 092QS
UT WOS:000315137700046
PM 23334424
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Steiner, S
   Lori, C
   Boehm, A
   Jenal, U
AF Steiner, Samuel
   Lori, Christian
   Boehm, Alex
   Jenal, Urs
TI Allosteric activation of exopolysaccharide synthesis through cyclic
   di-GMP-stimulated protein-protein interaction
SO EMBO JOURNAL
LA English
DT Article
DE biofilm; c-di-GMP; glycosyltransferase; poly-GlcNAc; signalling
ID DEPENDENT BIOFILM FORMATION; ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE;
   DIGUANYLATE CYCLASE; STAPHYLOCOCCUS-EPIDERMIDIS; POLYSACCHARIDE ADHESIN;
   HYALURONAN SYNTHASES; ACETOBACTER-XYLINUM; SIGNAL-TRANSDUCTION;
   CELLULOSE SYNTHASE
AB In many bacterial pathogens, the second messenger c-di-GMP stimulates the production of an exopolysaccharide (EPS) matrix to shield bacteria from assaults of the immune system. How c-di-GMP induces EPS biogenesis is largely unknown. Here, we show that c-di-GMP allosterically activates the synthesis of poly-beta-1,6-N-acetylglucosamine (poly-GlcNAc), a major extracellular matrix component of Escherichia coli biofilms. C-di-GMP binds directly to both PgaC and PgaD, the two inner membrane components of the poly-GlcNAc synthesis machinery to stimulate their glycosyltransferase activity. We demonstrate that the PgaCD machinery is a novel type c-di-GMP receptor, where ligand binding to two proteins stabilizes their interaction and promotes enzyme activity. This is the first example of a c-di-GMP-mediated process that relies on protein-protein interaction. At low c-di-GMP concentrations, PgaD fails to interact with PgaC and is rapidly degraded. Thus, when cells experience a c-di-GMP trough, PgaD turnover facilitates the irreversible inactivation of the Pga machinery, thereby temporarily uncoupling it from c-di-GMP signalling. These data uncover a mechanism of c-di-GMP-mediated EPS control and provide a frame for c-di-GMP signalling specificity in pathogenic bacteria.
C1 [Steiner, Samuel; Lori, Christian; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Boehm, Alex] Univ Marburg, LOEWE Zentrum Synthet Mikrobiol, Marburg, Germany.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_130469]; Werner Siemens Foundation
FX We thank Jacob G Malone for assistance with error-prone PCR; Alain
   Casanova for the construction of strain AB1313 and plasmid pAC551; Knut
   Ohlsen and Wilma Ziebuhr for the generous gift of antiserum against
   poly-GlcNAc; and Regis Hallez for helpful advice and discussions.
   C-di-GMP measurements were provided by Prof. Volkhard Kaever from the
   Medizinische Hochschule Hannover. This work was supported by Swiss
   National Science Foundation grant 31003A_130469 to UJ and a fellowship
   from the Werner Siemens Foundation (Zug) to SS.
CR ALONI Y, 1983, J BIOL CHEM, V258, P4419
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Becker S, 2009, GENET MOL BIOL, V32, P640, DOI 10.1590/S1415-47572009000300031
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x
   Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Ciocchini AE, 2006, GLYCOBIOLOGY, V16, P679, DOI 10.1093/glycob/cwj113
   Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Heldermon C, 2001, J BIOL CHEM, V276, P2037, DOI 10.1074/jbc.M002276200
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08
   Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07
   Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004
   Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004
   Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005
   Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550
   MENGINLECREULX D, 1989, J BACTERIOL, V171, P3282, DOI 10.1128/jb.171.6.3282-3287.1989
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x
   Namboori SC, 2008, ANAL BIOCHEM, V381, P94, DOI 10.1016/j.ab.2008.06.034
   Nesper J, 2012, J PROTEOMICS, V75, P4874, DOI 10.1016/j.jprot.2012.05.033
   Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Povolotsky TL, 2012, J BIOTECHNOL, V160, P10, DOI 10.1016/j.jbiotec.2011.12.024
   ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993
   Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103
   Saxena IM, 1997, CELLULOSE, V4, P33, DOI 10.1023/A:1018411101036
   Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Skurnik D, 2012, J INFECT DIS, V205, P1709, DOI 10.1093/infdis/jis254
   Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008
   Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175
   Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606
   Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0
   Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z
   Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100
   Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019
   VANDERHEIDEN GJ, 1970, APPL MICROBIOL, V19, P875, DOI 10.1128/AEM.19.5.875-877.1970
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x
   Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200
   Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378
   Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11
NR 77
TC 85
Z9 91
U1 6
U2 55
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD FEB 6
PY 2013
VL 32
IS 3
BP 354
EP 368
DI 10.1038/emboj.2012.315
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 110SE
UT WOS:000316465100006
PM 23202856
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Hofsteenge, N
   van Nimwegen, E
   Silander, OK
AF Hofsteenge, Niels
   van Nimwegen, Erik
   Silander, Olin K.
TI Quantitative analysis of persister fractions suggests different
   mechanisms of formation among environmental isolates of E-coli
SO BMC MICROBIOLOGY
LA English
DT Article
DE Persister; Antibiotic; Ampicillin; Ciprofloxacin; Nalidixic acid;
   Environmental isolates; E. coli
ID MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL PERSISTENCE; MULTIDRUG TOLERANCE;
   FREQUENCY; GROWTH; CELLS; HIPA; ANTIBIOTICS; QUINOLONES; RESISTANCE
AB Background: Bacterial persistence describes a phenomenon wherein a small subpopulation of cells is able to survive a challenge with high doses of an antibiotic (or other stressor) better than the majority of the population. Previous work has shown that cells that are in a dormant or slow-growing state are persistent to antibiotic treatment and that populations with higher fractions of dormant cells exhibit higher levels of persistence. These data suggest that a major determinant of the fraction of persisters within a population is the rate at which cells enter and exit from dormancy. However, it is not known whether there are physiological changes in addition to dormancy that influence persistence. Here, we use quantitative measurements of persister fractions in a set of environmental isolates of E. coli together with a mathematical model of persister formation to test whether a single general physiological change, such as cell dormancy, can explain the differences in persister phenotypes observed in different strains.
   Results: If a single physiological change (e. g. cell dormancy) underlies most persister phenotypes, then strains should exhibit characteristic fractions of persister cells: some strains will consistently have high fractions of persisters (dormant cells), whereas others will have low fractions. Although we found substantial variation in the fraction of persisters between different environmental isolates of E. coli, these fractions were not correlated across antibiotics. Some strains exhibited high persister fractions in one antibiotic, but low persister fractions in a second antibiotic. Surprisingly, no correlation in persister fractions was observed between any two drugs, even for antibiotics with nearly identical modes of action (ciprofloxacin and nalidixic acid).
   Conclusions: These data support the hypothesis that there is no single physiological change that determines the persistence level in a population of cells. Instead, the fraction of cells that survive antibiotic treatment (persist) depends critically on the specific antibiotic that is used, suggesting that physiological changes in addition to dormancy can underlie persister phenotypes.
C1 [Hofsteenge, Niels; van Nimwegen, Erik; Silander, Olin K.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Silander, OK (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM olinsilander@gmail.com
OI Silander, Olin/0000-0003-4105-8316; van Nimwegen,
   Erik/0000-0001-6338-1312
CR Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390
   Belenky P, 2011, SCIENCE, V334, P915, DOI 10.1126/science.1214823
   Bigger JW, 1944, LANCET, V2, P497
   Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247
   Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107
   Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760
   Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192
   Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105
   Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08
   HOOPER DC, 1991, EUR J CLIN MICROBIOL, V10, P223, DOI 10.1007/BF01966994
   Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006
   Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052
   Joers A, 2010, J BACTERIOL, V192, P3379, DOI 10.1128/JB.00056-10
   Johnson PJT, 2013, PLOS GENET IN PRESS
   Kashiwagi K, 1998, J BACTERIOL, V180, P5484, DOI 10.1128/JB.180.20.5484-5488.1998
   Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004
   Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11
   Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05
   Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11
   Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108
   Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108
   MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983
   Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09
   Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455
   Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004
   Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53
   Silander Olin K, 2009, BMC Res Notes, V2, P2, DOI 10.1186/1756-0500-2-2
   Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09
   Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06
   Stewart B, 2012, EVOLUTION, V66, P933, DOI 10.1111/j.1558-5646.2011.01467.x
   TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297
   Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006
   Wiuff C, 2007, J ANTIMICROB CHEMOTH, V59, P254, DOI 10.1093/jac/dkl469
   WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938
NR 38
TC 37
Z9 39
U1 0
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD FEB 4
PY 2013
VL 13
AR 25
DI 10.1186/1471-2180-13-25
PG 11
WC Microbiology
SC Microbiology
GA 164AT
UT WOS:000320381800001
PM 23379956
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Baudouin, SJ
AF Baudouin, Stephane J.
TI Mouse models of autism: a common basis for syndromic and non syndromic
   autisms?
SO M S-MEDECINE SCIENCES
LA French
DT News Item
ID FRAGILE-X; SYNAPTIC PATHOPHYSIOLOGY; MICE; MUTATIONS; BEHAVIOR
C1 Univ Basel, Biozentrum, Mech Format Neuronal Networks, Res Grp Peter Scheiffele, CH-4056 Basel, Switzerland.
RP Baudouin, SJ (corresponding author), Univ Basel, Biozentrum, Mech Format Neuronal Networks, Res Grp Peter Scheiffele, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM stephane.baudouin@unibas.ch
CR Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346
   Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Davidovic L, 2006, M S-MED SCI, V22, P41, DOI 10.1051/medsci/200622141
   Feliciano D, 2011, M S-MED SCI, V27, P328, DOI 10.1051/medsci/2011273328
   Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136
   Jamain S, 2003, MED SCI PARIS, V19, P181
   Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009
   Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x
   Roux JC, 2007, M S-MED SCI, V23, P805, DOI 10.1051/medsci/20072310805
   Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851
   Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310
   Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208
   Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071
NR 15
TC 4
Z9 4
U1 0
U2 3
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 0767-0974
J9 M S-MED SCI
JI M S-Med. Sci.
PD FEB
PY 2013
VL 29
IS 2
BP 121
EP 123
DI 10.1051/medsci/2013292002
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 101BH
UT WOS:000315749700002
PM 23452591
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Rutkowski, A
   Bonnemann, C
   Brown, S
   Thorsteinsdottir, S
   Dominov, J
   Ruegg, MA
   Matter, ML
   Guttridge, D
   Crosbie-Watson, RH
   Kardon, G
   Nagaraju, K
   Girgenrath, M
   Burkin, DJ
AF Rutkowski, Anne
   Boennemann, Carsten
   Brown, Susan
   Thorsteinsdottir, Solveig
   Dominov, Janice
   Ruegg, Markus A.
   Matter, Michelle L.
   Guttridge, Denis
   Crosbie-Watson, Rachelle H.
   Kardon, Gabrielle
   Nagaraju, Kanneboyina
   Girgenrath, Mahasweta
   Burkin, Dean J.
TI Report on the Myomatrix Conference April 22-24, 2012, University of
   Nevada, Reno, Nevada, USA
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE Conference report; Congenital muscular dystrophy; Translational Research
   Road Map; MDC1A; DMD; Dystroglycanopathy; Collagen VI related myopathy;
   Muscular dystrophy; Extracellular matrix; Fibrosis; Laminin; Integrin
AB The Myomatrix 2012 conference held April 22-24th, 2012 at the University of Nevada, Reno convened 73 international participants to discuss the dynamic relationship between muscle and its matrix in muscular dystrophy with a specific focus on congenital muscular dystrophy. Seven sessions over 2 1/2 days defined three central themes: (1) the role of extracellular matrix proteins and compartments in development and specifically in congenital muscular dystrophy (CMD) (2) the role of extracellular matrix signaling and adhesion to membrane receptors and (3) the balance and interplay between inflammation and fibrosis as drivers of altered matrix stiffness, impaired regeneration and progressive dystrophy. This report highlights major conference findings and the translational roadmap as defined by conference attendees. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Rutkowski, Anne] Cure CMD, Kaiser SCPMG, Olathe, KS 66051 USA.
   [Boennemann, Carsten] NINDS, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA.
   [Boennemann, Carsten] NINDS, Neurogenet Disorders Childhood Sect, Bethesda, MD 20892 USA.
   [Brown, Susan] Univ London, Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England.
   [Thorsteinsdottir, Solveig] Univ Lisbon, Dept Biol Anim, Ctr Biol Ambiental, P-1699 Lisbon, Portugal.
   [Dominov, Janice] Boston Biomed Res Inst, Watertown, MA 02472 USA.
   [Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Matter, Michelle L.] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Guttridge, Denis] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.
   [Crosbie-Watson, Rachelle H.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.
   [Kardon, Gabrielle] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.
   [Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.
   [Girgenrath, Mahasweta] Boston Univ, Coll Hlth & Rehabil Sci, Boston, MA 02215 USA.
   [Burkin, Dean J.] Univ Nevada, Sch Med, Dept Pharmacol, Ctr Mol Med, Reno, NV 89557 USA.
RP Burkin, DJ (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Ctr Mol Med, Reno, NV 89557 USA.
EM dburkin@medicine.nevada.edu
RI Thorsteinsdottir, Solveig/M-3561-2013; Ruegg, Markus/X-7256-2019
OI Thorsteinsdottir, Solveig/0000-0002-9018-3431; Ruegg,
   Markus/0000-0002-4974-9384; Brown, Sue/0000-0001-8112-933X; Dominov,
   Janice/0000-0002-5751-0955; Burkin, Dean/0000-0001-9228-5258
FU NIH/NIAMSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Arthritis &
   Musculoskeletal & Skin Diseases (NIAMS) [R13AR062995]; Muscular
   Dystrophy AssociationMuscular Dystrophy Association [MDA219240]; Genzyme
   SanofiGenzyme Corporation; AVIBioPharma; Cellular Dynamics; Cure
   Congenital Muscular Dystrophy (Cure CMD); LGMD2I Fund; PTC Therapeutics;
   Santhera Pharmaceuticals; Ultragenyx; NATIONAL INSTITUTE OF ARTHRITIS
   AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)
   [R13AR062995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003129,
   ZIANS003129, ZIANS003129, ZIANS003129, ZIANS003129, ZIANS003129,
   ZIANS003129, ZIANS003129] Funding Source: NIH RePORTER
FX This conference was supported by NIH/NIAMS (R13AR062995) and Muscular
   Dystrophy Association (MDA219240). Sponsorship for the conference was
   provided by Genzyme Sanofi, AVIBioPharma, Cellular Dynamics, Cure
   Congenital Muscular Dystrophy (Cure CMD), LGMD2I Fund, PTC Therapeutics,
   Santhera Pharmaceuticals and Ultragenyx. The conference organizers wish
   to thank the University of Nevada, Reno for hosting the Myomatrix
   conference within the Center for Molecular Medicine and all conference
   participants. To view the Myomatrix conference program and abstracts:
   www.curecmd.org/myomatrix.
NR 0
TC 4
Z9 4
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD FEB
PY 2013
VL 23
IS 2
BP 188
EP 191
DI 10.1016/j.nmd.2012.06.353
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 098IO
UT WOS:000315542900015
PM 22800409
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Wong, CCL
   Cociorva, D
   Miller, CA
   Schmidt, A
   Monell, C
   Aebersold, K
   Yates, JR
AF Wong, Catherine C. L.
   Cociorva, Daniel
   Miller, Christine A.
   Schmidt, Alexander
   Monell, Craig
   Aebersold, Kuedi
   Yates, John R., III
TI Proteomics of Pyrococcus furiosus (Pfu): Identification of Extracted
   Proteins by Three Independent Methods
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Pyrococcus furiosus (Pfu); proteomics; protein complex standard; MudPIT;
   OFFGEL electrophoresis; directed LC-MS/MS
ID AMINO-ACID-SEQUENCES; TANDEM MASS-SPECTRA; MIXTURES; PEPTIDES; MS/MS;
   MODEL
AB Pyrococcus furiosus (Pfu) is an excellent organism to generate reference samples for proteomics laboratories because of its moderately sized genome and very little sequence duplication within the genome. We demonstrated a stable and consistent method to prepare proteins in bulk that eliminates growth and preparation as a source of uncertainty in the standard. We performed several proteomic studies in different laboratories using each laboratory's specific workflow as well as separate and integrated data analysis. This study demonstrated that a Pfu whole cell lysate provides suitable protein sample complexity to not only validate proteomic methods, work flows, and benchmark new instruments but also to facilitate comparison of experimental data generated over time and across instruments or laboratories.
C1 [Wong, Catherine C. L.; Cociorva, Daniel; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.
   [Miller, Christine A.] Agilent Technol, Santa Clara, CA 95051 USA.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland.
   [Monell, Craig] Biolegend, San Diego, CA 92121 USA.
   [Aebersold, Kuedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
RP Yates, JR (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd,SR 11, La Jolla, CA 92037 USA.
EM jyates@scripps.edu
OI Wong, Catherine CL/0000-0001-7270-980X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P41
   RR011823/GM103533, R01 MH067880-09, P01 AG031097-03, R01 HL079442-07];
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823] Funding Source: NIH
   RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL079442,
   R01HL079442, R01HL079442, R01HL079442, R01HL079442, R01HL079442,
   R01HL079442, R01HL079442, R01HL079442, R01HL079442] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH067880, R01MH067880, R01MH067880, R01MH067880, R01MH067880,
   R01MH067880, R01MH067880, R01MH067880, R01MH067880, R01MH067880,
   R01MH067880, R01MH067880, R01MH067880, R01MH067880, R01MH067880] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097,
   P01AG031097, P01AG031097, P01AG031097, P01AG031097, P01AG031097] Funding
   Source: NIH RePORTER
FX C.C.L.W. and J.RY. acknowledge funding from the National Institutes of
   Health grants P41 RR011823/GM103533, R01 MH067880-09, P01 AG031097-03,
   and R01 HL079442-07.
CR Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]
   Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16
   Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200
   Holden JF, 2001, COMP FUNCT GENOM, V2, P275, DOI 10.1002/cfg.110
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805
   Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102
   Lee AM, 2009, J PROTEOME RES, V8, P3844, DOI 10.1021/pr801119h
   Lim H, 2003, J AM SOC MASS SPECTR, V14, P957, DOI 10.1016/S1044-0305(03)00144-2
   Link AJ, 1999, NAT BIOTECHNOL, V17, P676
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q
   McCormack Ashley L., 1994, Methods (Orlando), V6, P274, DOI 10.1006/meth.1994.1029
   McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603
   Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Ponnamma Kurian D. M. G., 2005, ELECTROPHORESIS, V2, P184
   Purvine S, 2004, OMICS, V8, P79, DOI 10.1089/153623104773547507
   Robb FT, 2001, METHOD ENZYMOL, V330, P134
   Schmidt A, 2008, MOL CELL PROTEOMICS, V7, P2138, DOI 10.1074/mcp.M700498-MCP200
   Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Yates JR, 2006, ANAL CHEM, V78, P493, DOI 10.1021/ac0514624
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
NR 28
TC 13
Z9 13
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD FEB
PY 2013
VL 12
IS 2
BP 763
EP 770
DI 10.1021/pr300840j
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 084SG
UT WOS:000314558800019
PM 23298259
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Burch, P
   Binaghi, M
   Scherer, M
   Wentzel, C
   Bossert, D
   Eberhardt, L
   Neuburger, M
   Scheiffele, P
   Gademann, K
AF Burch, Patrick
   Binaghi, Massimo
   Scherer, Manuel
   Wentzel, Corinna
   Bossert, David
   Eberhardt, Luc
   Neuburger, Markus
   Scheiffele, Peter
   Gademann, Karl
TI Total Synthesis of Gelsemiol
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE natural products; PC-12 cells; rearrangement; synthetic methods; total
   synthesis
ID ENANTIOSELECTIVE TOTAL-SYNTHESIS; FACTOR-POTENTIATING ACTIVITY;
   NATURAL-PRODUCTS; STEREOSELECTIVE-SYNTHESIS; SKELETAL REARRANGEMENTS;
   ORGANIC-SYNTHESIS; DRUG DISCOVERY; RANEY-NICKEL; ALCOHOLS; LACTONE
C1 [Burch, Patrick; Binaghi, Massimo; Scherer, Manuel; Bossert, David; Eberhardt, Luc; Neuburger, Markus; Gademann, Karl] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Wentzel, Corinna; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gademann, K (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
EM karl.gademann@unibas.ch
OI Gademann, Karl/0000-0003-3053-0689; Bossert, David/0000-0001-8997-7122
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200021-144028, PE0022-117136]; Latsis foundation
FX K.G. is a European Young Investigator (EURYI). We gratefully acknowledge
   the Swiss National Science Foundation (200021-144028 and PE0022-117136)
   and the Latsis foundation for financial support. We thank York Schramm
   (Univ. of Basel) for technical assistance with HPLC measurements.
CR Ashfeld BL, 2006, TETRAHEDRON, V62, P10497, DOI 10.1016/j.tet.2006.05.087
   Augustyns B, 2005, TETRAHEDRON LETT, V46, P3895, DOI 10.1016/j.tetlet.2005.03.204
   BOROS CA, 1990, J NAT PROD, V53, P1055, DOI 10.1021/np50071a001
   Buchwald S. L., 1998, ORG SYNTH COLL, V9, P162
   Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893
   CURRAN DP, 1985, TETRAHEDRON LETT, V26, P4991, DOI 10.1016/S0040-4039(01)80834-0
   CURRAN DP, 1986, J ORG CHEM, V51, P1612, DOI 10.1021/jo00359a048
   Cuzzupe AN, 2002, J ORG CHEM, V67, P4392, DOI 10.1021/jo016221k
   D'Alfonso A, 2010, ORG LETT, V12, P596, DOI 10.1021/ol902809v
   Danishefsky S, 2010, NAT PROD REP, V27, P1114, DOI 10.1039/c003211p
   Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   Elamparuthi E, 2012, ANGEW CHEM INT EDIT, V51, P4071, DOI 10.1002/anie.201200515
   FUJISAWA T, 1983, CHEM LETT, P835, DOI 10.1246/cl.1983.835
   GRIECO PA, 1980, J ORG CHEM, V45, P2247, DOI 10.1021/jo01299a042
   GRIECO PA, 1981, J ORG CHEM, V46, P2591, DOI 10.1021/jo00325a035
   Gross BH, 2001, APPL CATAL A-GEN, V219, P281, DOI 10.1016/S0926-860X(01)00700-1
   HART DW, 1974, J AM CHEM SOC, V96, P8115, DOI 10.1021/ja00833a048
   HORITA K, 1986, TETRAHEDRON, V42, P3021, DOI 10.1016/S0040-4020(01)90593-9
   Huang ZH, 2006, ORG LETT, V8, P3675, DOI 10.1021/ol061202o
   Jana C. K., 2011, ANGEW CHEM, V123, P8557
   Jana CK, 2011, ANGEW CHEM INT EDIT, V50, P8407, DOI 10.1002/anie.201101869
   JENSEN SR, 1987, PHYTOCHEMISTRY, V26, P1725, DOI 10.1016/S0031-9422(00)82277-3
   Jessen H. J., 2011, ANGEW CHEM, V123, P4308
   Jessen HJ, 2011, ORG LETT, V13, P4368, DOI 10.1021/ol201692h
   Jessen HJ, 2009, ORG LETT, V11, P3446, DOI 10.1021/ol901277q
   Jessen HJ, 2011, ANGEW CHEM INT EDIT, V50, P4222, DOI 10.1002/anie.201007671
   JOHNSTONE RAW, 1985, CHEM REV, V85, P129, DOI 10.1021/cr00066a003
   KLEIDERER EC, 1948, J ORG CHEM, V13, P455, DOI 10.1021/jo01161a022
   Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657
   KRAFFT ME, 1986, J ORG CHEM, V51, P5482, DOI 10.1021/jo00376a099
   KRAFFT ME, 1988, J ORG CHEM, V53, P3158, DOI 10.1021/jo00249a007
   Li YS, 2004, YAKUGAKU ZASSHI, V124, P417, DOI 10.1248/yakushi.124.417
   Li YS, 2003, CHEM PHARM BULL, V51, P1103, DOI 10.1248/cpb.51.1103
   Li YS, 2001, J PHARM PHARMACOL, V53, P915, DOI 10.1211/0022357011776108
   Liao JH, 2006, ORG BIOMOL CHEM, V4, P1464, DOI 10.1039/b518121f
   Makama B. Y., 2010, SCI WORLD J, V1, P26
   Mangion IK, 2005, J AM CHEM SOC, V127, P3696, DOI 10.1021/ja050064f
   Marko IE, 2000, ORG LETT, V2, P3123, DOI 10.1021/ol006324+
   Marko IE, 1997, TETRAHEDRON LETT, V38, P4269, DOI 10.1016/S0040-4039(97)00876-9
   Piccinini P, 2004, J AM CHEM SOC, V126, P5088, DOI 10.1021/ja0493796
   Qi J, 2011, MINI-REV MED CHEM, V11, P658, DOI 10.2174/138955711796268796
   Robertson J, 2004, SYNLETT, P2788, DOI 10.1055/s-2004-835637
   Schmid F, 2013, MEDCHEMCOMM, V4, P135, DOI 10.1039/c2md20181j
   SCHWARTZ J, 1976, ANGEW CHEM INT EDIT, V15, P333, DOI 10.1002/anie.197603331
   Schwartz J., 1976, ANGEW CHEM, V88, P402
   Szpilman A. M., 2010, ANGEW CHEM, V122, P9786
   Szpilman AM, 2010, ANGEW CHEM INT EDIT, V49, P9592, DOI 10.1002/anie.200904761
   Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384
   WEINMANN H, 1995, SYNTHESIS-STUTTGART, P1097
   Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b
   Zanoni G, 2002, J ORG CHEM, V67, P4346, DOI 10.1021/jo025652f
   ZANONI G, 1995, J ORG CHEM, V60, P5319, DOI 10.1021/jo00121a062
   Zhu LS, 1996, TETRAHEDRON, V52, P9819, DOI 10.1016/0040-4020(96)00513-3
NR 53
TC 21
Z9 21
U1 0
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD FEB
PY 2013
VL 19
IS 8
BP 2589
EP 2591
DI 10.1002/chem.201203746
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 089QY
UT WOS:000314926300003
PM 23307641
DA 2021-01-25
ER

PT J
AU Cornu, M
   Albert, V
   Hall, MN
AF Cornu, Marion
   Albert, Verena
   Hall, Michael N.
TI mTOR in aging, metabolism, and cancer
SO CURRENT OPINION IN GENETICS & DEVELOPMENT
LA English
DT Article
ID EXTENDS LIFE-SPAN; GENETICALLY HETEROGENEOUS MICE; INSULIN SIGNALING
   PATHWAY; MESSENGER-RNA TRANSLATION; CAENORHABDITIS-ELEGANS; COMPLEX 1;
   ADIPOCYTE DIFFERENTIATION; HEPATOCELLULAR-CARCINOMA; ADIPOSE-TISSUE;
   CELL-GROWTH
AB The target of rapamycin (TOR) is a highly conserved serine/threonine kinase that is part of two structurally and functionally distinct complexes, TORC1 and TORC2. In multicellular organisms, TOR regulates cell growth and metabolism in response to nutrients, growth factors and cellular energy. Deregulation of TOR signaling alters whole body metabolism and causes age-related disease. This review describes the most recent advances in TOR signaling with a particular focus on mammalian TOR (mTOR) in metabolic tissues vis-a-vis aging, obesity, type 2 diabetes, and cancer.
C1 [Cornu, Marion; Albert, Verena; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss Cancer League; Louis-Jeantet Foundation; SFD-ALFEDIAM;
   Werner Siemens Foundation; Canton of Basel
FX We acknowledge support from the Swiss National Science Foundation, the
   Swiss Cancer League, the Louis-Jeantet Foundation, the SFD-ALFEDIAM
   (MC), the Werner Siemens Foundation (VA) and the Canton of Basel.
CR Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006
   Anisimov VN, 2010, AM J PATHOL, V176, P2092, DOI 10.2353/ajpath.2010.091050
   Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29
   Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769
   Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Brown KA, 2010, BREAST CANCER RES TR, V123, P591, DOI 10.1007/s10549-010-0834-y
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021
   Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018
   Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486
   Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532
   Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   Duran RV, 2012, MOL CELL
   El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737
   Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922
   Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Hansen M, 2010, ENZYMES, V28, P279, DOI 10.1016/S1874-6047(10)28014-9
   Hansen M, 2007, WESTERN HUM REV, V61, P6
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444
   Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973
   Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513
   Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324
   Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912
   Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2
   Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107
   Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363
   Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013
   Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x
   Masoro Edward J, 2003, Sci Aging Knowledge Environ, V2003, pRE2, DOI 10.1126/sageke.2003.8.re2
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029
   Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412
   Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007
   Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010
   Romanino K, 2011, P NATL ACAD SCI USA, V108, P20808, DOI 10.1073/pnas.1111448109
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666
   Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097
   Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Syntichaki P, 2007, ANN NY ACAD SCI, V1119, P289, DOI 10.1196/annals.1404.001
   Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009
   Wang JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001048
   Wang T, 2012, MOL CELL BIOL, V32, P2203, DOI 10.1128/MCB.06474-11
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6
   Yuan M, 2012, J BIOL CHEM
   Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008
   Zhang HH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006189
   Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
NR 126
TC 296
Z9 308
U1 0
U2 74
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-437X
EI 1879-0380
J9 CURR OPIN GENET DEV
JI Curr. Opin. Genet. Dev.
PD FEB
PY 2013
VL 23
IS 1
BP 53
EP 62
DI 10.1016/j.gde.2012.12.005
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 127PG
UT WOS:000317710300008
PM 23317514
DA 2021-01-25
ER

PT J
AU Papassotiropoulos, A
   Stefanova, E
   Vogler, C
   Gschwind, L
   Ackermann, S
   Spalek, K
   Rasch, B
   Heck, A
   Aerni, A
   Hanser, E
   Demougin, P
   Huynh, KD
   Luechinger, R
   Klarhofer, M
   Novakovic, I
   Kostic, V
   Boesiger, P
   Scheffler, K
   de Quervain, DJF
AF Papassotiropoulos, A.
   Stefanova, E.
   Vogler, C.
   Gschwind, L.
   Ackermann, S.
   Spalek, K.
   Rasch, B.
   Heck, A.
   Aerni, A.
   Hanser, E.
   Demougin, P.
   Huynh, K-D
   Luechinger, R.
   Klarhoefer, M.
   Novakovic, I.
   Kostic, V.
   Boesiger, P.
   Scheffler, K.
   de Quervain, D. J-F
TI A genome-wide survey and functional brain imaging study identify CTNNBL1
   as a memory-related gene
SO MOLECULAR PSYCHIATRY
LA English
DT Article
DE beta-catenin-like; fMRI; GWAS; memory
ID EPISODIC MEMORY; BETA-CATENIN; ASSOCIATION; DISEASE; CONSOLIDATION;
   COGNITION; VARIANT
AB Unbiased genome-wide screens combined with imaging data on brain function may identify novel molecular pathways related to human cognition. Here we performed a dense genome-wide screen to identify episodic memory-related gene variants. A genomic locus encoding the brain-expressed beta-catenin-like protein 1 (CTNNBL1) was significantly (P = 7 x 10(-8)) associated with verbal memory performance in a cognitively healthy cohort from Switzerland (n = 1073) and was replicated in a second cohort from Serbia (n = 524; P = 0.003). Gene expression studies showed CTNNBL1 genotype-dependent differences in beta-catenin-like protein 1 mRNA levels in the human cortex. Functional magnetic resonance imaging in 322 subjects detected CTNNBL1 genotype-dependent differences in memory-related brain activations. Converging evidence from independent experiments and different methodological approaches suggests a role for CTNNBL1 in human memory. Molecular Psychiatry (2013) 18, 255-263; doi:10.1038/mp.2011.148; published online 22 November 2011
C1 [Papassotiropoulos, A.; Vogler, C.; Gschwind, L.; Ackermann, S.; Rasch, B.; Heck, A.; Hanser, E.; Demougin, P.; Huynh, K-D] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, A.; Aerni, A.; de Quervain, D. J-F] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, A.; Hanser, E.; Demougin, P.; Huynh, K-D] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   [Stefanova, E.] Univ Belgrade, Sch Med, CCS, Inst Neurol, Belgrade, Serbia.
   [Spalek, K.; Rasch, B.; Aerni, A.; de Quervain, D. J-F] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Luechinger, R.; Boesiger, P.] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.
   [Luechinger, R.; Boesiger, P.] ETH, Zurich, Switzerland.
   [Klarhoefer, M.] Univ Basel, Univ Basel Hosp, Div Radiol Phys, CH-4055 Basel, Switzerland.
   [Novakovic, I.] Univ Belgrade, Inst Biol, Sch Med, Belgrade, Serbia.
   [Scheffler, K.] MPI Biol Cybernet, MRC Dept, Tubingen, Germany.
   [Scheffler, K.] Univ Tubingen, Dept Neuroimaging & MR Phys, Tubingen, Germany.
RP Papassotiropoulos, A (corresponding author), Univ Basel, Dept Psychol, Div Mol Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM andreas.papas@unibas.ch; dominique.dequervain@unibas.ch
RI Luechinger, Roger/AAD-5192-2019; Rasch, Bjorn/A-3119-2015; Kostic,
   Vladimir S/Q-6998-2018
OI Luechinger, Roger/0000-0002-7365-0421; Rasch, Bjorn/0000-0001-7607-3415;
   de Quervain, Dominique/0000-0001-7131-2464; Heck,
   Angela/0000-0002-1543-3197; Vogler, Christian/0000-0003-3922-109X;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00B-106708, PP00B-68859, PP00B-114813]; European UnionEuropean
   Union (EU) [HEALTH-F4-2009-242257]; National Centre of Competence in
   Research Synapsy; Ministry of Science, Republic of SerbiaMinistry of
   Science, Serbia [145057D]
FX This work was funded by the Swiss National Science Foundation (grants
   PP00B-106708, PP00B-68859, PP00B-114813, Sinergia to DJ-FdeQ and AP), by
   the 7th framework programme of the European Union (ADAMS project,
   HEALTH-F4-2009-242257), by the National Centre of Competence in Research
   Synapsy and by the Ministry of Science, Republic of Serbia (project no.
   145057D).
CR BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9
   Brickenkamp R., 1998, D2 TEST ATTENTION
   Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585
   Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed.
   COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461
   Lang PJ, 2008, INT AFFECTIVE PICTUR
   Lezak M. D., 1983, NEUROPSYCHOLOGICAL A
   Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198
   Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241
   Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088
   Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16
   Pawlowski TL, 2011, METHODS MOL BIOL, V700, P261, DOI 10.1007/978-1-61737-954-3_17
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001
   SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9
   Wechsler D., 1987, WECHSLER MEMORY SCAL
   Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132
NR 22
TC 24
Z9 26
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1359-4184
J9 MOL PSYCHIATR
JI Mol. Psychiatr.
PD FEB
PY 2013
VL 18
IS 2
BP 255
EP 263
DI 10.1038/mp.2011.148
PG 9
WC Biochemistry & Molecular Biology; Neurosciences; Psychiatry
SC Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry
GA 112BW
UT WOS:000316567800018
PM 22105620
OA Other Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Broz, P
   Monack, DM
AF Broz, Petr
   Monack, Denise M.
TI Noncanonical Inflammasomes: Caspase-11 Activation and Effector
   Mechanisms
SO PLOS PATHOGENS
LA English
DT Article
ID BACTERIA; INFECTION; PROMOTES
C1 [Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.
RP Broz, P (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM dmonack@stanford.edu
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI095396, AI08972]; Stanford Digestive
   Disease Center (DDC); Human Frontiers in Science Program (HFSP)Human
   Frontier Science Program [LT000636/2009-L]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI089722,
   R01AI089722, R01AI095396, R01AI095396, R01AI095396, R01AI095396,
   R01AI095396, R01AI095396, R01AI095396, R01AI095396, R01AI089722,
   R01AI089722] Funding Source: NIH RePORTER
FX This work was supported by awards AI095396 and AI08972 from NIAID to DM,
   a Stanford Digestive Disease Center (DDC) pilot grant to PB, and a
   long-term fellowship (LT000636/2009-L) from the Human Frontiers in
   Science Program (HFSP) to PB. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001
   Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419
   Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007
   Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135
   Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040
   Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007
   Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397
   Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072
   Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200
   von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351
   Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5
   Yen JH, 2009, BLOOD, V114, P1344, DOI 10.1182/blood-2008-12-196592
NR 16
TC 52
Z9 52
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2013
VL 9
IS 2
AR e1003144
DI 10.1371/journal.ppat.1003144
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 099UU
UT WOS:000315648900006
PM 23468620
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Vajpai, N
   Nisius, L
   Wiktor, M
   Grzesiek, S
AF Vajpai, Navratna
   Nisius, Lydia
   Wiktor, Maciej
   Grzesiek, Stephan
TI High-pressure NMR reveals close similarity between cold and alcohol
   protein denaturation in ubiquitin
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE protein unfolding; thermodynamics; protein dynamics; heteronuclear NMR
ID HYDROGEN-BOND NETWORK; SUPERCOOLED WATER; HYDROPHOBIC INTERACTIONS;
   TEMPERATURE-DEPENDENCE; UNFOLDED UBIQUITIN; DIPOLAR COUPLINGS;
   CHEMICAL-SHIFTS; STATE; PERTURBATION; CONFORMATION
AB Proteins denature not only at high, but also at low temperature as well as high pressure. These denatured states are not easily accessible for experiment, because usually heat denaturation causes aggregation, whereas cold or pressure denaturation occurs at temperatures well below the freezing point of water or pressures above 5 kbar, respectively. Here we have obtained atomic details of the pressure-assisted, cold-denatured state of ubiquitin at 2,500 bar and 258 K by high-resolution NMR techniques. Under these conditions, a folded, native-like and a disordered state exist in slow exchange. Secondary chemical shifts show that the disordered state has structural propensities for a native-like N-terminal beta-hairpin and cc-helix and a nonnative C-terminal alpha-helix. These propensities are very similar to the previously described alcohol-denatured (A-)state. Similar to the A-state, N-15 relaxation data indicate that the secondary structure elements move as independent segments. The close similarity of pressure-assisted, cold-denatured, and alcohol-denatured states with native and nonnative secondary elements supports a hierarchical mechanism of folding and supports the notion that similar to alcohol, pressure and cold reduce the hydrophobic effect. Indeed, at nondenaturing concentrations of methanol, a complete transition from the native to the A-state can be achieved at ambient temperature by varying the pressure from 1 to 2,500 bar. The methanol-assisted pressure transition is completely reversible and can also be induced in protein G. This method should allow highly detailed studies of protein-folding transitions in a continuous and reversible manner.
C1 [Vajpai, Navratna; Nisius, Lydia; Wiktor, Maciej; Grzesiek, Stephan] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-132857]; Boehringer Ingelheim FondsBoehringer Ingelheim
FX We thank Marco Rogowski and Klara Rathgeb-Szabo for protein preparation
   and Florence Cordier as well as Shin Isogai for valuable discussions.
   This work was supported by SNF Grant 31-132857 (to S.G.) and by a
   stipend from the Boehringer Ingelheim Fonds (to L.N.).
CR Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   Cordier F, 2004, BIOCHEMISTRY-US, V43, P11295, DOI 10.1021/bi049314f
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Davidovic M, 2009, J AM CHEM SOC, V131, P1025, DOI 10.1021/ja8056419
   Day R, 2008, PROTEINS, V70, P1175, DOI 10.1002/prot.21562
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005
   Fu YN, 2012, J AM CHEM SOC, V134, P8543, DOI 10.1021/ja3004655
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Grigera JR, 2010, BIOPHYS J, V98, P1626, DOI 10.1016/j.bpj.2009.12.4298
   HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002
   Herberhold H, 2002, BIOCHEMISTRY-US, V41, P2396, DOI 10.1021/bi012023b
   Huang JR, 2012, J AM CHEM SOC, V134, P4429, DOI 10.1021/ja2118688
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   KAUZMANN W, 1987, NATURE, V325, P763, DOI 10.1038/325763a0
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   Kitahara R, 2005, J MOL BIOL, V347, P277, DOI 10.1016/j.jmb.2005.01.052
   Kitahara R, 2003, P NATL ACAD SCI USA, V100, P3167, DOI 10.1073/pnas.0630309100
   Kitahara R, 2001, BIOCHEMISTRY-US, V40, P13556, DOI 10.1021/bi010922u
   Kitahara R, 2006, MAGN RESON CHEM, V44, pS108, DOI 10.1002/mrc.1820
   Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2
   Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x
   Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Nisius L, 2012, NAT CHEM, V4, P711, DOI [10.1038/NCHEM.1396, 10.1038/nchem.1396]
   Paschek D, 2005, P NATL ACAD SCI USA, V102, P6765, DOI 10.1073/pnas.0408527102
   Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645
   PRIELMEIER FX, 1987, PHYS REV LETT, V59, P1128, DOI 10.1103/PhysRevLett.59.1128
   Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X
   PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3
   Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109
   Rouget JB, 2010, BIOPHYS J, V98, P2712, DOI 10.1016/j.bpj.2010.02.044
   Sarupria S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.037803
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Shan B, 2010, J AM CHEM SOC, V132, P4669, DOI 10.1021/ja908104s
   Skalicky JJ, 2000, J AM CHEM SOC, V122, P3230, DOI 10.1021/ja9938884
   Smeller L, 2002, BBA-PROTEIN STRUCT M, V1595, P11, DOI 10.1016/S0167-4838(01)00332-6
   Smolin N, 2006, BBA-PROTEINS PROTEOM, V1764, P522, DOI 10.1016/j.bbapap.2006.01.003
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382
   Szyperski T, 2006, EUR BIOPHYS J BIOPHY, V35, P363, DOI 10.1007/s00249-005-0028-4
   Szyperski Thomas, 2011, Journal of Structural and Functional Genomics, V12, P1, DOI 10.1007/s10969-011-9111-5
   Takekiyo T, 2006, BBA-PROTEINS PROTEOM, V1764, P355, DOI 10.1016/j.bbapap.2005.11.013
   TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009
   Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020
   Vajpai N, 2010, J AM CHEM SOC, V132, P3196, DOI 10.1021/ja910331t
   WILKINSON KD, 1986, ARCH BIOCHEM BIOPHYS, V250, P390, DOI 10.1016/0003-9861(86)90741-1
   Wirmer J, 2006, J BIOMOL NMR, V35, P175, DOI 10.1007/s10858-006-9026-9
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
NR 56
TC 37
Z9 38
U1 0
U2 54
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 29
PY 2013
VL 110
IS 5
BP E368
EP E376
DI 10.1073/pnas.1212222110
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 130VG
UT WOS:000317947600009
PM 23284170
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Baday, S
   Wang, SH
   Lamoureux, G
   Berneche, S
AF Baday, Sefer
   Wang, Shihao
   Lamoureux, Guillaume
   Berneche, Simon
TI Two Distinct Transport Mechanisms in AmtB and RhCG Proteins
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the Biophysical-Society
CY FEB 02-06, 2013
CL Philadelphia, PA
SP Biophys Soc
C1 [Baday, Sefer; Berneche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
   [Wang, Shihao; Lamoureux, Guillaume] Concordia Univ, Montreal, PQ, Canada.
RI baday, sefer/ABA-9111-2020
OI baday, sefer/0000-0002-2913-6687
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 29
PY 2013
VL 104
IS 2
SU 1
BP 285A
EP 285A
DI 10.1016/j.bpj.2012.11.1596
PG 1
WC Biophysics
SC Biophysics
GA 105MI
UT WOS:000316074302465
OA Bronze
DA 2021-01-25
ER

PT J
AU Eisele, PS
   Salatino, S
   Sobek, J
   Hottiger, MO
   Handschin, C
AF Eisele, Petra S.
   Salatino, Silvia
   Sobek, Jens
   Hottiger, Michael O.
   Handschin, Christoph
TI The Peroxisome Proliferator-activated Receptor gamma Coactivator 1
   alpha/beta (PGC-1) Coactivators Repress the Transcriptional Activity of
   NF-kappa B in Skeletal Muscle Cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AORTIC SMOOTH-MUSCLE; OXIDATIVE-METABOLISM; INSULIN-RESISTANCE; P65
   SUBUNIT; IKK-BETA; PGC-1-ALPHA; INFLAMMATION; EXERCISE; GENE; EXPRESSION
AB A persistent, low-grade inflammation accompanies many chronic diseases that are promoted by physical inactivity and improved by exercise. The beneficial effects of exercise are mediated in large part by peroxisome proliferator-activated receptor gamma coactivator (PGC) 1 alpha, whereas its loss correlates with propagation of local and systemic inflammatory markers. We examined the influence of PGC-1 alpha and the related PGC-1 beta on inflammatory cytokines upon stimulation of muscle cells with TNF alpha, Toll-like receptor agonists, and free fatty acids. PGC-1s differentially repressed expression of proinflammatory cytokines by targeting NF-kappa B signaling. Interestingly, PGC-1 alpha and PGC-1 beta both reduced phoshorylation of the NF-kappa B family member p65 and thereby its transcriptional activation potential. Taken together, the data presented here show that the PGC-1 coactivators are able to constrain inflammatory events in muscle cells and provide a molecular link between metabolic and immune pathways. The PGC-1s therefore represent attractive targets to not only improve metabolic health in diseases like type 2 diabetes but also to limit the detrimental, low-grade inflammation in these patients.
C1 [Eisele, Petra S.; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   [Eisele, Petra S.; Hottiger, Michael O.; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
   [Sobek, Jens] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland.
   [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Hottiger, Michael O./J-7747-2013; Handschin, Christoph/E-6886-2015
OI Hottiger, Michael O./0000-0002-7323-2270; Handschin,
   Christoph/0000-0003-0603-1097; Salatino, Silvia/0000-0003-1286-3076
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Muscular Dystrophy Association USA (MDA)Muscular Dystrophy
   Association; SwissLife "Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung"; Swiss Society for Research on Muscle Diseases
   (SSEM); Swiss Diabetes Association; Roche Research Foundation; United
   Mitochondrial Disease Foundation (UMDF); Association Francaise contre
   les Myopathies (AFM)Association Francaise contre les Myopathies;
   Gebert-Ruf Foundation "Rare Diseases" Program; University of Basel
FX This work was supported by grants from the Swiss National Science
   Foundation, Muscular Dystrophy Association USA (MDA), SwissLife
   "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung,"
   Swiss Society for Research on Muscle Diseases (SSEM), Swiss Diabetes
   Association, Roche Research Foundation, United Mitochondrial Disease
   Foundation (UMDF), Association Francaise contre les Myopathies (AFM),
   Gebert-Ruf Foundation "Rare Diseases" Program, and the University of
   Basel.
CR Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556
   Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185
   Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118
   Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262
   Blanquart C, 2004, MOL ENDOCRINOL, V18, P1906, DOI 10.1210/me.2003-0327
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200
   Creus KK, 2009, ANN NY ACAD SCI, V1173, P370, DOI 10.1111/j.1749-6632.2009.04874.x
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022
   Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423
   Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007
   Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Jayne S, 2009, J MOL BIOL, V394, P485, DOI 10.1016/j.jmb.2009.09.032
   Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456
   Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200
   Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324
   Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200
   Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007
   Spencer MJ, 1997, J CLIN INVEST, V99, P2745, DOI 10.1172/JCI119464
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Suliman HB, 2010, J CELL SCI, V123, P2565, DOI 10.1242/jcs.064089
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4
   TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211
   Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0
NR 59
TC 104
Z9 110
U1 0
U2 13
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 25
PY 2013
VL 288
IS 4
BP 2246
EP 2260
DI 10.1074/jbc.M112.375253
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 079ZS
UT WOS:000314211500015
PM 23223635
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Lemgruber, L
   Kudryashev, M
   Dekiwadia, C
   Riglar, DT
   Baum, J
   Stahlberg, H
   Ralph, SA
   Frischknecht, F
AF Lemgruber, Leandro
   Kudryashev, Mikhail
   Dekiwadia, Chaitali
   Riglar, David T.
   Baum, Jake
   Stahlberg, Henning
   Ralph, Stuart A.
   Frischknecht, Friedrich
TI Cryo-electron tomography reveals four-membrane architecture of the
   Plasmodium apicoplast
SO MALARIA JOURNAL
LA English
DT Article
DE Apicoplast; Cryo-electron tomography; Symbiosis; Organelle interaction;
   Malaria
ID ASEXUAL BLOOD STAGES; APICOMPLEXAN PARASITES; ELECTRON TOMOGRAPHY;
   PLASTID EVOLUTION; ALGAL ORIGIN; FALCIPARUM; PROTEIN; DINOFLAGELLATE;
   MICROSCOPY; ULTRASTRUCTURE
AB Background: The apicoplast is a plastid organelle derived from a secondary endosymbiosis, containing biosynthetic pathways essential for the survival of apicomplexan parasites. The Toxoplasma apicoplast clearly possesses four membranes but in related Plasmodium spp. the apicoplast has variably been reported to have either three or four membranes.
   Methods: Cryo-electron tomography was employed to image merozoites of Plasmodium falciparum and Plasmodium berghei frozen in their near-native state. Three-dimensional reconstructions revealed the number of apicoplast membranes and the association of the apicoplast with other organelles. Routine transmission electron microscopy of parasites preserved by high-pressure freezing followed by freeze substitution techniques was also used to analyse apicoplast morphology.
   Results: Cryo-preserved parasites showed clearly four membranes surrounding the apicoplast. A wider gap between the second and third apicoplast membranes was frequently observed. The apicoplast was found in close proximity to the nucleus and to the rhoptries. The apicoplast matrix showed ribosome-sized particles and membranous whorls.
   Conclusions: The Plasmodium apicoplast possesses four membranes, as do the apicoplasts of other apicomplexan parasites. This is consistent with a four-membraned secondary endosymbiotic plastid ancestor.
C1 [Lemgruber, Leandro; Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, D-69120 Heidelberg, Germany.
   [Kudryashev, Mikhail; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt C CINA, CH-4058 Basel, Switzerland.
   [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
   [Riglar, David T.; Baum, Jake] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.
   [Riglar, David T.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.
RP Ralph, SA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
EM saralph@unimelb.edu.au; freddy.frischknecht@med.uni-heidelberg.de
RI Stahlberg, Henning/H-1868-2011; Ralph, Stuart/C-8590-2014
OI Stahlberg, Henning/0000-0002-1185-4592; Baum, Jake/0000-0002-0275-352X;
   Frischknecht, Friedrich/0000-0002-8332-6668; Ralph,
   Stuart/0000-0003-0114-7808; Kudryashev, Misha/0000-0003-3550-6274;
   Lemgruber, Leandro/0000-0003-2832-6806; Riglar,
   David/0000-0002-5004-4373
FU Chica and Heinz Schaller Foundation; ERCEuropean Research Council (ERC);
   University of Heidelberg Cluster of Excellence CellNetworks; Swiss
   initiative for Systems Biology (SystemsX. ch, grant CINA); Pratt
   Foundation postgraduate scholarship through the University of Melbourne;
   Australian Society for Biochemistry and Molecular Biology; Harold
   Mitchell Travel Fellowship; OzeMalR travel award; ARC Future
   fellowshipAustralian Research Council [FT0990350]
FX We thank Marek Cyrklaff for discussions, Claudia Kuss for P. falciparum
   culture, Jessica Kehrer and Mirko Singer for help with P. berghei
   infections and Oliver Grunvogel for helping with the computational
   modelling. The work was funded by the Chica and Heinz Schaller
   Foundation and an ERC starting grant to FF, a postdoctoral fellowship of
   the University of Heidelberg Cluster of Excellence CellNetworks to LL,
   the Swiss initiative for Systems Biology (SystemsX. ch, grant CINA) to
   MK and HS, a Pratt Foundation postgraduate scholarship through the
   University of Melbourne to DTR. FF is a member of the European Network
   of Excellence EVIMalaR. DTR received a travel fellowship from the
   Australian Society for Biochemistry and Molecular Biology and a Harold
   Mitchell Travel Fellowship, and CD an OzeMalR travel award. SAR is
   supported by an ARC Future fellowship (FT0990350).
CR Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067
   Bannister L, 2005, MAKING HOME PLASMODI
   Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5
   Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107
   Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002
   Caballero MC, 2012, MOL BIOCHEM PARASIT, V181, P125, DOI 10.1016/j.molbiopara.2011.10.009
   Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x
   Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405
   Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775
   Diniz JAP, 2000, PARASITOL RES, V86, P971, DOI 10.1007/PL00008528
   DODGE J D, 1975, Phycologia, V14, P253, DOI 10.2216/i0031-8884-14-4-253.1
   Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818
   Ferguson DJP, 2007, INT J PARASITOL, V37, P33, DOI 10.1016/j.ijpara.2006.10.003
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   GIBBS SP, 1979, J CELL SCI, V35, P253
   Glaser S, 2012, ACTA CRYSTALLOGR F, V68, P351, DOI 10.1107/S1744309112004952
   Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915
   Henrich Philipp, 2009, Biotechnology Journal, V4, P888, DOI 10.1002/biot.200900058
   Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1
   Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107
   Kalanon M, 2009, EUKARYOT CELL, V8, P1146, DOI 10.1128/EC.00061-09
   Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x
   Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kudryashev M, 2012, CELL MICROBIOL, V14, P1757, DOI 10.1111/j.1462-5822.2012.01836.x
   Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6
   Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x
   Kuhni-Boghenbor K, 2012, CELL MICROBIOL, V14, P1867, DOI 10.1111/cmi.12006
   Leforestier A, 2012, P NATL ACAD SCI USA, V109, P8959, DOI 10.1073/pnas.1200881109
   Lepper S, 2010, J MICROSC-OXFORD, V238, P21, DOI 10.1111/j.1365-2818.2009.03327.x
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0
   Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635
   Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843
   Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7
   Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1
   Tomova C, 2006, BIOL CELL, V98, P535, DOI 10.1042/BC20060028
   Tomova C, 2009, TRAFFIC, V10, P1471, DOI 10.1111/j.1600-0854.2009.00954.x
   Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x
   van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105
   Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57
NR 41
TC 28
Z9 28
U1 0
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 19
PY 2013
VL 12
AR 25
DI 10.1186/1475-2875-12-25
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 151FX
UT WOS:000319447200001
PM 23331966
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Das, A
   Gupta, T
   Davla, S
   Prieto-Godino, LL
   Diegelmann, S
   Reddy, OV
   Raghavan, KV
   Reichert, H
   Lovick, J
   Hartenstein, V
AF Das, Abhijit
   Gupta, Tripti
   Davla, Sejal
   Prieto-Godino, Lucia L.
   Diegelmann, Soeren
   Reddy, O. Venkateswara
   Raghavan, K. Vijay
   Reichert, Heinrich
   Lovick, Jennifer
   Hartenstein, Volker
TI Neuroblast lineage-specific origin of the neurons of the Drosophila
   larval olfactory system
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Drosophila; Larval olfactory system; Local interneuron; Projection
   neuron; Olfactory lineage
ID ANTENNAL LOBE NEURONS; LOCAL INTERNEURONS; NEURAL LINEAGES;
   CONNECTIVITY; MELANOGASTER; BRAIN; REPRESENTATION; ARCHITECTURE;
   VARIABILITY; PROJECTION
AB The complete neuronal repertoire of the central brain of Drosophila originates from only approximately 100 pairs of neural stem cells, or neuroblasts. Each neuroblast produces a highly stereotyped lineage of neurons which innervate specific compartments of the brain. Neuroblasts undergo two rounds of mitotic activity: embryonic divisions produce lineages of primary neurons that build the larval nervous system; after a brief quiescence, the neuroblasts go through a second round of divisions in larval stage to produce secondary neurons which are integrated into the adult nervous system. Here we investigate the lineages that are associated with the larval antennal lobe, one of the most widely studied neuronal systems in fly. We find that the same five neuroblasts responsible for the adult antennal lobe also produce the antennal lobe of the larval brain. However, there are notable differences in the composition of larval (primary) lineages and their adult (secondary) counterparts. Significantly, in the adult, two lineages (INB/BAlc and adNB/BAmv3) produce uniglomerular projection neurons connecting the antennal lobe with the mushroom body and lateral horn; another lineage, vNB/BAla1, generates multiglomerular neurons reaching the lateral horn directly. INB/BAlc, as well as a fourth lineage, vINB/BAla2, generate a diversity of local interneurons. We describe a fifth, previously unknown lineage, BAlp4, which connects the posterior part of the antennal lobe and the neighboring tritocerebrum (gustatory center) with a higher brain center located adjacent to the mushroom body. In the larva, only one of these lineages, adNB/BAmv3, generates all uniglomerular projection neurons. Also as in the adult, INB/BAlc and vINB/BAla2 produce local interneurons which, in terms of diversity in architecture and transmitter expression, resemble their adult counterparts. In addition, lineages INB/BAlc and vNB/BAla1, as well as the newly described BAlp4, form numerous types of projection neurons which along the same major axon pathways (antennal tracts) used by the antenna( projection neurons, but which form connections that include regions outside the "classical" olfactory circuit triad antennal lobe-mushroom body-lateral horn. Our work will benefit functional studies of the larval olfactory circuit, and shed light on the relationship between larval and adult neurons. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Das, Abhijit; Gupta, Tripti; Davla, Sejal; Reddy, O. Venkateswara; Raghavan, K. Vijay] TIFR, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lovick, Jennifer; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
   [Prieto-Godino, Lucia L.; Diegelmann, Soeren] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England.
RP Hartenstein, V (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, 610 Charles E Young Dr,5009 Terasaki Life Sci Bld, Los Angeles, CA 90095 USA.
EM volkerh@mcdb.ucla.edu
RI Lovick, Jennifer/Q-3886-2019
OI Davla, Sejal/0000-0003-3201-1970; Prieto-Godino, Lucia
   L/0000-0002-2980-362X; Das, Abhijit/0000-0001-5880-996X
FU TIFRTata Institute of Fundamental Research (TIFR); Indo-Swiss Joint
   Research Program; Fundacion Caja Madrid; BBSRC (Biothecnology and
   Biological Sciences Research Council); Balfour Fund; Cambridge European
   Trust; Fundacion Mutua MadrilenaInstituto de Salud Carlos III;
   Department of Science and Technology, Government of India (Center for
   Nanotechnology) [SR/S5/NM-36/2005]; NATIONAL INSTITUTE OF NEUROLOGICAL
   DISORDERS AND STROKEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814] Funding Source: NIH RePORTER
FX We thank Cahir O'Kane, Hermann Aberle, Reinhard Stocker, Tzumin Lee,
   Liqun Luo, Kirti Rathore, and the Bloomington Drosophila Stock Center
   for fly stocks, and the Developmental Studies Hybridoma Bank (Iowa, USA)
   for antibodies. We are grateful to late Prof. Veronica Rodrigues for her
   support, encouragement and valuable suggestions during this work. This
   work was supported by grants from TIFR and the Indo-Swiss Joint Research
   Program. Prieto Godino LL was supported by grants from Fundacion Caja
   Madrid, BBSRC (Biothecnology and Biological Sciences Research Council),
   Balfour Fund, Cambridge European Trust, and Fundacion Mutua Madrilena.
   We thank the Department of Science and Technology, Government of India
   (Center for Nanotechnology No. SR/S5/NM-36/2005), for the Olympus FV1000
   confocal microscopes in the Central Imaging and Flow Cytometry Facility
   (CIFF), NCBS.
CR AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154
   Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199
   Brochtrup A., 2010, CURR OPIN NEUROBIOL
   Cardona A, 2010, J NEUROSCI, V30, P7538, DOI 10.1523/JNEUROSCI.0186-10.2010
   Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405
   Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489
   Das Abhijit, 2011, Neural Syst Circuits, V1, P4, DOI 10.1186/2042-1001-1-4
   Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Heimbeck G, 1999, J NEUROSCI, V19, P6599
   Huang J, 2010, NEURON, V67, P1021, DOI 10.1016/j.neuron.2010.08.025
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516
   Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614
   Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106
   Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376
   Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188
   Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20
   Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034
   SIEGLER MVS, 1979, J COMP NEUROL, V183, P121, DOI 10.1002/cne.901830110
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   Thum AS, 2011, J COMP NEUROL, V519, P3415, DOI 10.1002/cne.22713
   Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3
   Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2
   Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306
   Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9
   Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041
   Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483
   Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461
NR 37
TC 22
Z9 22
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD JAN 15
PY 2013
VL 373
IS 2
BP 322
EP 337
DI 10.1016/j.ydbio.2012.11.003
PG 16
WC Developmental Biology
SC Developmental Biology
GA 068QL
UT WOS:000313381200009
PM 23149077
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Petrinovic, MM
   Hourez, R
   Aloy, EM
   Dewarrat, G
   Gall, D
   Weinmann, O
   Gaudias, J
   Bachmann, LC
   Schiffmann, SN
   Vogt, KE
   Schwab, ME
AF Petrinovic, Marija M.
   Hourez, Raphael
   Aloy, Elisabeth M.
   Dewarrat, Gregoire
   Gall, David
   Weinmann, Oliver
   Gaudias, Julien
   Bachmann, Lukas C.
   Schiffmann, Serge N.
   Vogt, Kaspar E.
   Schwab, Martin E.
TI Neuronal Nogo-A negatively regulates dendritic morphology and synaptic
   transmission in the cerebellum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID NEURITE OUTGROWTH INHIBITOR; CLIMBING FIBER; PURKINJE-CELLS;
   MESSENGER-RNA; MICE LACKING; MYELIN; ELIMINATION; RAT; GLUR-DELTA-2;
   MECHANISMS
AB Neuronal signal integration as well as synaptic transmission and plasticity highly depend on the morphology of dendrites and their spines. Nogo-A is a membrane protein enriched in the adult central nervous system (CNS) myelin, where it restricts the capacity of axons to grow and regenerate after injury. Nogo-A is also expressed by certain neurons, in particular during development, but its physiological function in this cell type is less well understood. We addressed this question in the cerebellum, where Nogo-A is transitorily highly expressed in the Purkinje cells (PCs) during early postnatal development. We used general genetic ablation (KO) as well as selective overexpression of Nogo-A in PCs to analyze its effect on dendritogenesis and on the formation of their main input synapses from parallel (PFs) and climbing fibers (CFs). PC dendritic trees were larger and more complex in Nogo-A KO mice and smaller than in wild-type in Nogo-A overexpressing PCs. Nogo-A KO resulted in premature soma-to-dendrite translocation of CFs and an enlargement of the CF territory in the molecular layer during development. Although spine density was not influenced by Nogo-A, the size of postsynaptic densities of PF-PC synapses was negatively correlated with the Nogo-A expression level. Electrophysiological studies revealed that Nogo-A negatively regulates the strength of synaptic transmission at the PF-PC synapse. Thus, Nogo-A appears as a negative regulator of PC input synapses, which orchestrates cerebellar connectivity through regulation of synapse morphology and the size of the PC dendritic tree.
C1 [Petrinovic, Marija M.; Aloy, Elisabeth M.; Dewarrat, Gregoire; Weinmann, Oliver; Bachmann, Lukas C.; Schwab, Martin E.] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland.
   [Petrinovic, Marija M.; Aloy, Elisabeth M.; Dewarrat, Gregoire; Weinmann, Oliver; Bachmann, Lukas C.; Schwab, Martin E.] ETH, Det Hlth Sci & Technol, CH-8057 Zurich, Switzerland.
   [Hourez, Raphael; Gall, David; Schiffmann, Serge N.] Univ Libre Bruxelles, Lab Neurophysiol, B-1070 Brussels, Belgium.
   [Gaudias, Julien; Vogt, Kaspar E.] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Petrinovic, MM (corresponding author), F Hoffmann La Roche & Cie AG, DTA Neurosci, Pharma Res & Early Dev, pRED, CH-4070 Basel, Switzerland.
EM marija-magdalena.petrinovic@roche.com; schwab@hifo.uzh.ch
RI Schwab, Martin/B-6818-2016; Petrinovic, Marija/T-2349-2019
OI Vogt, Kaspar/0000-0002-0859-876X; Schiffmann, Serge/0000-0002-0118-9816;
   Petrinovic, Marija/0000-0002-0894-8424
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [3100A0-122527/1]; National Center of Competence in
   Research (NCCR)Swiss National Science Foundation (SNSF); Christopher and
   Dana Reeve Foundation; European Union Sixth Framework Programme Network
   of Excellence NeuroNEEuropean Union (EU); Queen Elisabeth Medical
   Foundation (Belgium); Fonds National de la Recherche Scinetifique
   (FNS-FNRS) (Belgium)Fonds de la Recherche Scientifique - FNRS; Action de
   Recherche Concertee from the Communaute Francaise de Belgique (CFWB)
FX We thank C. Orlando for help with confocal microscopy. This work was
   supported by the Swiss National Science Foundation (SNSF)
   (3100A0-122527/1), the National Center of Competence in Research (NCCR)
   "Neural Plasticity and Repair," the Christopher and Dana Reeve
   Foundation, the European Union Sixth Framework Programme Network of
   Excellence NeuroNE, the Queen Elisabeth Medical Foundation (Belgium),
   Fonds National de la Recherche Scinetifique (FNS-FNRS) (Belgium), and
   Action de Recherche Concertee from the Communaute Francaise de Belgique
   (CFWB).
CR Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3
   ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305
   CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7
   Cesa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019160
   CHEDOTAL A, 1992, EUR J NEUROSCI, V4, P1159, DOI 10.1111/j.1460-9568.1992.tb00142.x
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Da Silva JS, 2004, MOL CELL NEUROSCI, V27, P1, DOI 10.1016/j.men.2004.03.008
   Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108
   Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200
   Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978
   Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5
   Foscarin S, 2009, EUR J NEUROSCI, V30, P1837, DOI 10.1111/j.1460-9568.2009.06985.x
   Gianola S, 2003, J NEUROSCI, V23, P4613
   Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8
   Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001
   Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008
   Huber AB, 2002, J NEUROSCI, V22, P3553
   Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002
   Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7
   Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408
   Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7
   Kano M, 2009, CURR OPIN NEUROBIOL, V19, P154, DOI 10.1016/j.conb.2009.05.002
   Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008
   Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9
   Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204
   Maeder CI, 2011, CURR OPIN NEUROBIOL, V21, P93, DOI 10.1016/j.conb.2010.10.004
   Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923
   Mandolesi G, 2009, NEUROSCIENCE, V164, P1084, DOI 10.1016/j.neuroscience.2009.08.067
   Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243
   Margeta MA, 2010, MOL CELL NEUROSCI, V43, P261, DOI 10.1016/j.mcn.2009.11.009
   Metzger F, 2000, EUR J NEUROSCI, V12, P1993, DOI 10.1046/j.1460-9568.2000.00086.x
   Miyazaki T, 2006, FEBS LETT, V580, P4057, DOI 10.1016/j.febslet.2006.06.043
   Montani L, 2009, J BIOL CHEM, V284, P10793, DOI 10.1074/jbc.M808297200
   Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570
   Niederost B, 2002, J NEUROSCI, V22, P10368
   Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008
   Nishida K, 2002, DEVELOPMENT, V129, P5647, DOI 10.1242/dev.00162
   Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004
   O'Connor TP, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-18
   Oertle T, 2003, J NEUROSCI, V23, P5393
   Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010
   Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567
   Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936
   Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5
   Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193
   SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052
   Smith SL, 2003, J NEUROSCI, V23, P367
   Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035
   Vanderhaeghen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001859
   Wang XX, 2002, J NEUROSCI, V22, P5505
   Watanabe F, 2008, EUR J NEUROSCI, V27, P836, DOI 10.1111/j.1460-9568.2008.06069.x
   Watanabe M, 2008, TOHOKU J EXP MED, V214, P175, DOI 10.1620/tjem.214.175
   Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x
   Willi R, 2009, GENES BRAIN BEHAV, V8, P181, DOI 10.1111/j.1601-183X.2008.00460.x
   Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010
NR 59
TC 42
Z9 45
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 15
PY 2013
VL 110
IS 3
BP 1083
EP 1088
DI 10.1073/pnas.1214255110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 075TI
UT WOS:000313909100063
PM 23277570
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kochanowski, K
   Volkmer, B
   Gerosa, L
   van Rijsewijk, BRH
   Schmidt, A
   Heinemann, M
AF Kochanowski, Karl
   Volkmer, Benjamin
   Gerosa, Luca
   van Rijsewijk, Bart R. Haverkorn
   Schmidt, Alexander
   Heinemann, Matthias
TI Functioning of a metabolic flux sensor in Escherichia coli
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CENTRAL CARBON METABOLISM; PYRUVATE-KINASE; GROWTH-RATE; TRANSCRIPTIONAL
   REGULATION; CATABOLITE REPRESSION; GLUCOSE-METABOLISM; GENE-EXPRESSION;
   BINDING; RESPIRATION; ACTIVATION
AB Regulation of metabolic operation in response to extracellular cues is crucial for cells' survival. Next to the canonical nutrient sensors, which measure the concentration of nutrients, recently intracellular "metabolic flux" was proposed as a novel impetus for metabolic regulation. According to this concept, cells would have molecular systems ("flux sensors") in place that regulate metabolism as a function of the actually occurring metabolic fluxes. Although this resembles an appealing concept, we have not had any experimental evidence for the existence of flux sensors and also we have not known how these flux sensors would work in detail. Here, we show experimental evidence that supports the hypothesis that Escherichia coli is indeed able to measure its glycolytic flux and uses this signal for metabolic regulation. Combining experiment and theory, we show how this flux-sensing function could emerge from an aggregate of several molecular mechanisms: First, the system of reactions of lower glycolysis and the feedforward activation of fructose-1,6-bisphosphate on pyruvate kinase translate flux information into the concentration of the metabolite fructose-1,6-bisphosphate. The interaction of this "flux-signaling metabolite" with the transcription factor Cra then leads to flux-dependent regulation. By responding to glycolytic flux, rather than to the concentration of individual carbon sources, the cell may minimize sensing and regulatory expenses.
C1 [Kochanowski, Karl; Volkmer, Benjamin; Gerosa, Luca; van Rijsewijk, Bart R. Haverkorn; Heinemann, Matthias] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Kochanowski, Karl] Life Sci Zurich, PhD Program Syst Biol, CH-8057 Zurich, Switzerland.
   [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland.
   [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands.
RP Heinemann, M (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
EM m.heinemann@rug.nl
RI Heinemann, Matthias/B-9421-2008
OI Heinemann, Matthias/0000-0002-5512-9077; Volkmer,
   Benjamin/0000-0002-9945-9772; Gerosa, Luca/0000-0001-6805-9410
FU Roche Research Foundation; VIDI grant by the Nederlandse Organisatie
   voor Wetenschappelijk Onderzoek (NWO)
FX We thank Stefan Christen for technical assistance on the <SUP>13</SUP>C
   flux analysis, and we thank Hannes Link, Bastian Niebel, and Victor
   Chubukov for helpful comments on the manuscript. Financial support from
   the Roche Research Foundation (to M. H.) and from a VIDI grant by the
   Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (to M. H.)
   is acknowledged.
CR Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   BABUL J, 1993, BIOCHEMISTRY-US, V32, P4685, DOI 10.1021/bi00068a029
   Bali M, 2001, CR ACAD SCI III-VIE, V324, P185, DOI 10.1016/S0764-4469(00)01295-6
   Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186
   Bettenbrock K, 2006, J BIOL CHEM, V281, P2578, DOI 10.1074/jbc.M508090200
   Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007
   Bledig SA, 1996, J BACTERIOL, V178, P280, DOI 10.1128/jb.178.1.280-283.1996
   Boles E, 1997, J BACTERIOL, V179, P2987, DOI 10.1128/jb.179.9.2987-2993.1997
   Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d
   Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288
   Christen S, 2011, FEMS YEAST RES, V11, P263, DOI 10.1111/j.1567-1364.2010.00713.x
   Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12
   Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x
   Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036
   Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508
   Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016
   Hao JJ, 2004, PROTEIN ENG DES SEL, V17, P689, DOI 10.1093/protein/gzh081
   Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x
   Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010
   Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x
   Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001
   Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10
   Kremling A, 2008, BIOINFORMATICS, V24, P704, DOI 10.1093/bioinformatics/btn010
   Kremling A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-42
   Krishna S, 2009, J MOL BIOL, V391, P671, DOI 10.1016/j.jmb.2009.06.043
   LOWRY OH, 1971, J BIOL CHEM, V246, P6511
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Martinez-Antonio A, 2006, TRENDS MICROBIOL, V14, P22, DOI 10.1016/j.tim.2005.11.002
   MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6
   Miller J.H., 1992, SHORT COURSE BACTERI
   Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006
   Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07
   Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65
   Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051
   Raab F. H., 2003, HIGH FREQUENCY E NOV, P38
   RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561
   Ramseier TM, 1996, RES MICROBIOL, V147, P489, DOI 10.1016/0923-2508(96)84003-4
   Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63
   Schaub J, 2008, BIOTECHNOL PROGR, V24, P1402, DOI 10.1002/btpr.59
   Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007
   Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x
   Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10
   Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200
   van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9
   van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393
   Voit E, 2006, P NATL ACAD SCI USA, V103, P9452, DOI 10.1073/pnas.0603337103
   Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126
   Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209
   Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58
   Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895
   Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x
NR 53
TC 113
Z9 114
U1 2
U2 64
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 15
PY 2013
VL 110
IS 3
BP 1130
EP 1135
DI 10.1073/pnas.1202582110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 075TI
UT WOS:000313909100071
PM 23277571
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Budreck, EC
   Kwon, OB
   Jung, JH
   Baudouin, S
   Thommen, A
   Kim, HS
   Fukazawa, Y
   Harada, H
   Tabuchi, K
   Shigemoto, R
   Scheiffele, P
   Kim, JH
AF Budreck, Elaine C.
   Kwon, Oh-Bin
   Jung, Jung Hoon
   Baudouin, Stephane
   Thommen, Albert
   Kim, Hye-Sun
   Fukazawa, Yugo
   Harada, Harumi
   Tabuchi, Katsuhiko
   Shigemoto, Ryuichi
   Scheiffele, Peter
   Kim, Joung-Hun
TI Neuroligin-1 controls synaptic abundance of NMDA-type glutamate
   receptors through extracellular coupling
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE synapse; neurotranmitter receptor; neurexin
ID CELL-ADHESION MOLECULE; INHIBITORY SYNAPSES; AMPA RECEPTORS;
   TRAFFICKING; PLASTICITY; PROTEIN; PSD-95; EXPRESSION; MATURATION;
   SUBUNITS
AB Despite the pivotal functions of the NMDA receptor (NMDAR) for neural circuit development and synaptic plasticity, the molecular mechanisms underlying the dynamics of NMDAR trafficking are poorly understood. The cell adhesion molecule neuroligin-1 (NL1) modifies NMDAR-dependent synaptic transmission and synaptic plasticity, but it is unclear whether NL1 controls synaptic accumulation or function of the receptors. Here, we provide evidence that NL1 regulates the abundance of NMDARs at postsynaptic sites. This function relies on extracellular, NL1 isoform-specific sequences that facilitate biochemical interactions between NL1 and the NMDAR GluN1 subunit. Our work uncovers NL1 isoform-specific cis-interactions with ionotropic glutamate receptors as a key mechanism for controlling synaptic properties.
C1 [Budreck, Elaine C.; Baudouin, Stephane; Thommen, Albert; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kwon, Oh-Bin; Jung, Jung Hoon; Kim, Joung-Hun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 790784, Gyungbuk, South Korea.
   [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 110799, South Korea.
   [Fukazawa, Yugo; Harada, Harumi; Tabuchi, Katsuhiko; Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan.
   [Fukazawa, Yugo; Harada, Harumi; Tabuchi, Katsuhiko; Shigemoto, Ryuichi] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan.
   [Tabuchi, Katsuhiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.
   [Shigemoto, Ryuichi] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3330012, Japan.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch; joungkim@postech.ac.kr
RI Fukazawa, Yugo/H-9899-2012; Shigemoto, Ryuichi/E-3628-2013
OI Fukazawa, Yugo/0000-0001-7436-8797; Shigemoto,
   Ryuichi/0000-0001-8761-9444; baudouin, stephane/0000-0001-6902-6071;
   Thommen, Albert/0000-0002-2285-0714; Harada, Harumi/0000-0001-7429-7896
FU National Research Service AwardUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [MH083473];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NS045014]; Biozentrum
   of the University of Basel; European Autism Interventions: A Multicentre
   Study for Developing New Medications (EU-AIMS); Innovative Medicines
   Initiative Joint Undertaking; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); National Research Foundation of
   KoreaNational Research Foundation of Korea [2009K001247, 2010-0029402,
   2010-0007293]; Ministry of Education, Science and Technology, Republic
   of KoreaMinistry of Education, Science and Technology, Republic of
   Korea; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [F30MH083473, F30MH083473,
   F30MH083473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01NS045014,
   R01NS045014, R01NS045014, R01NS045014, R01NS045014, R01NS045014] Funding
   Source: NIH RePORTER; Grants-in-Aid for Scientific ResearchMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [24650183, 23390156, 23650180] Funding Source: KAKEN
FX We thank Yun-Beom Choi, Craig Bailey, Eric Kandel, Ralf Schneggenburger,
   Kaspar Vogt, and members of our laboratories for discussions and
   critical comments on the manuscript; Laetitia Hatstatt, Caroline
   Bornmann, Hye-sung Hwang, and Shin-Eun Ryeo for excellent assistance;
   Drs. Roberto Malinow, Nathalie Sans, Stefano Vicini, and Dietmar
   Schreiner for sharing reagents; and Dr. Nils Brose for generously making
   NL1 KO mice available. E. C. B. was supported by National Research
   Service Award MH083473. This work was supported by National Institutes
   of Health Grant NS045014; funds from the Biozentrum of the University of
   Basel; European Autism Interventions: A Multicentre Study for Developing
   New Medications (EU-AIMS), which receives support from the Innovative
   Medicines Initiative Joint Undertaking; an award from the Swiss National
   Science Foundation (to P. S.); and National Research Foundation of Korea
   Grants 2009K001247, 2010-0029402, and 2010-0007293 (to J.-H.K.) awarded
   by the Ministry of Education, Science and Technology, Republic of Korea.
CR Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6
   Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17
   Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159
   Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447
   Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035
   Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x
   Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010
   Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470
   Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029
   Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458
   Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5
   Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473
   Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023
   Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106
   Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108
   Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008
   Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200
   Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3
   Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511
   Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107
   Kasugai Y, 2010, EUR J NEUROSCI, V32, P1868, DOI 10.1111/j.1460-9568.2010.07473.x
   Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012
   Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256
   Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153
   Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015
   Lu KT, 1999, NEUROSCIENCE, V88, P69, DOI 10.1016/S0306-4522(98)00200-0
   MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7
   Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006
   Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023
   Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302
   Shipman SL, 2012, NEURON, V76, P309, DOI 10.1016/j.neuron.2012.07.024
   Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825
   Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947
   Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108
   Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100
   Tovar KR, 2002, NEURON, V34, P253
   Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208
NR 43
TC 95
Z9 97
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 8
PY 2013
VL 110
IS 2
BP 725
EP 730
DI 10.1073/pnas.1214718110
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 075SK
UT WOS:000313906600069
PM 23269831
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Perez-Schindler, J
   Philp, A
   Hernandez-Cascales, J
AF Perez-Schindler, Joaquin
   Philp, Andrew
   Hernandez-Cascales, Jesus
TI Pathophysiological relevance of the cardiac beta(2)-adrenergic receptor
   and its potential as a therapeutic target to improve cardiac function
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Review
DE Beta-adrenoceptors; Cardiac contractility; Cardiac arrhythmias; Cardiac
   metabolism; Cardiac apoptosis
ID MYOCARDIAL SUBSTRATE METABOLISM; BETA-ADRENOCEPTOR SUBTYPES; PGC-1-ALPHA
   MESSENGER-RNA; SKELETAL-MUSCLE; HEART-FAILURE; SIGNALING PATHWAY; RAT;
   ACTIVATION; AGONISTS; APOPTOSIS
AB beta-adrenoceptors are members of the G protein-coupled receptor superfamily which play a key role in the regulation of myocardial function. Their activation increases cardiac performance but can also induce deleterious effects such as cardiac arrhythmias or myocardial apoptosis. In fact, inhibition of beta-adrenoceptors exerts a protective effect in patients with sympathetic over-stimulation during heart failure. Although beta(2)-adrenoceptor is not the predominant subtype in the heart, it seems to importantly contribute to the cardiac effects of adrenergic stimulation; however, the mechanism by which this occurs is not fully understood. This review summarizes the current knowledge on the role of beta(2)-adrenoceptors in the regulation of cardiac contractility, metabolism, cardiomyocyte survival and cardiac arrhythmias. In addition, therapeutic considerations relating to stimulation of the beta(2)-adrenoceptor such as an increase in cardiac contractility with low arrythmogenic effect, protection of the myocardium again apoptosis or positive regulation of heart metabolism are discussed. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Perez-Schindler, Joaquin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Philp, Andrew] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.
   [Hernandez-Cascales, Jesus] Univ Murcia, Dept Pharmacol, Fac Med, E-30100 Murcia, Spain.
RP Hernandez-Cascales, J (corresponding author), Univ Murcia, Dept Pharmacol, Fac Med, E-30100 Murcia, Spain.
EM jehernca@um.es
OI Philp, Andrew/0000-0003-3860-4136; Perez-Schindler,
   Joaquin/0000-0003-3141-8859
CR Abramson Michael J, 2003, Am J Respir Med, V2, P287
   Ahmet I, 2005, HEART FAIL REV, V10, P289, DOI 10.1007/s10741-005-7543-3
   Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335
   ALHILLAWI AH, 1984, BRIT MED J, V288, P367, DOI 10.1136/bmj.288.6414.367
   Altschuld RA, 2000, PHARMACOL THERAPEUT, V88, P1, DOI 10.1016/S0163-7258(00)00075-9
   Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173
   Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048
   Bartel S, 2003, CARDIOVASC RES, V57, P694, DOI 10.1016/S0008-6363(02)00720-4
   Baruscotti M, 2010, J MOL CELL CARDIOL, V48, P55, DOI 10.1016/j.yjmcc.2009.06.019
   Bassiakou E, 2008, AM J EMERG MED, V26, P578, DOI 10.1016/j.ajem.2007.09.010
   Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5
   Billman GE, 1997, CIRCULATION, V96, P1914, DOI 10.1161/01.CIR.96.6.1914
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7
   Boer DC, 2011, BRIT J PHARMACOL, V162, P1314, DOI 10.1111/j.1476-5381.2010.01121.x
   BOHM M, 1989, J CARDIOVASC PHARM, V14, P549, DOI 10.1097/00005344-198910000-00006
   BOHM M, 1992, J CARDIOVASC PHARM, V20, P479
   Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X
   Brown DA, 2009, CARDIOVASC RES, V84, P343, DOI 10.1093/cvr/cvp330
   Cammarata Gianluca, 2004, Crit Care Med, V32, pS440, DOI 10.1097/01.CCM.0000134263.32657.34
   Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Carceles MD, 2007, CLIN THER, V29, P1718, DOI 10.1016/j.clinthera.2007.08.009
   Cazzola M, 1998, CHEST, V114, P411, DOI 10.1378/chest.114.2.411
   CERBAI E, 1990, J MOL CELL CARDIOL, V22, P859, DOI 10.1016/0022-2828(90)90117-K
   Cerbai E, 1999, CARDIOVASC RES, V42, P121, DOI 10.1016/S0008-6363(98)00291-0
   Chakraborti S, 2007, MOL CELL BIOCHEM, V298, P1, DOI 10.1007/s11010-006-9355-8
   CHARPENTIER F, 1994, AM J PHYSIOL, V266, pH2310
   Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Collis LP, 2007, AM J PHYSIOL-HEART C, V293, pH2826, DOI 10.1152/ajpheart.00101.2007
   Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210
   Dorian P, 2005, J CARDIOVASC PHARM T, V10, pS15, DOI 10.1177/10742484050100i403
   Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056
   Felker GM, 2003, J AM COLL CARDIOL, V41, P997, DOI 10.1016/S0735-1097(02)02968-6
   FREYSSBEGUIN M, 1983, BRIT J PHARMACOL, V78, P717, DOI 10.1111/j.1476-5381.1983.tb09425.x
   Fujita T, 2011, CIRC J, V75, P1811, DOI 10.1253/circj.CJ-11-0025
   Gonzalez-Mufioz C., 2008, CYCLIC NUCLEOTIDE PH
   Gonzalez-Munoz C, 2009, EUR J PHARMACOL, V607, P151, DOI 10.1016/j.ejphar.2009.02.029
   Gonzalez-Munoz C, 2011, LIFE SCI, V88, P1095, DOI 10.1016/j.lfs.2011.04.015
   Grimm M, 1998, J MOL CELL CARDIOL, V30, P1917, DOI 10.1006/jmcc.1998.0769
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   HAYASHI Y, 1992, CAN J ANAESTH, V39, P873, DOI 10.1007/BF03008299
   Hjalmarson A, 1999, LANCET, V353, P2001
   Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217
   Huerta C, 2005, EPIDEMIOLOGY, V16, P360, DOI 10.1097/01.ede.0000158743.90664.a7
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54
   Johnson WB, 2012, LIFE SCI, V90, P328, DOI 10.1016/j.lfs.2011.11.016
   JUBERG EN, 1985, N-S ARCH PHARMACOL, V330, P193, DOI 10.1007/BF00572434
   Khoynezhad A, 2007, TEX HEART I J, V34, P352
   Kikkawa H, 1997, BRIT J PHARMACOL, V121, P1059, DOI 10.1038/sj.bjp.0701229
   Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005
   Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561
   LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765
   Lemaitre RN, 2002, AM J MED, V113, P711, DOI 10.1016/S0002-9343(02)01384-0
   Li J, 2010, J PHYSIOL-LONDON, V588, P2987, DOI 10.1113/jphysiol.2010.190900
   Lonardo G, 2005, J MOL CELL CARDIOL, V38, P453, DOI 10.1016/j.yjmcc.2004.12.010
   Maarbjerg SJ, 2011, ACTA PHYSIOL, V202, P323, DOI 10.1111/j.1748-1716.2011.02267.x
   MCPHERSON GA, 1985, J PHARM PHARMACOL, V37, P499, DOI 10.1111/j.2042-7158.1985.tb03051.x
   Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009
   Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466
   Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646
   Muller JE, 1997, CIRCULATION, V96, P3233, DOI 10.1161/01.CIR.96.9.3233
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Nevzorova J, 2006, BRIT J PHARMACOL, V147, P446, DOI 10.1038/sj.bjp.0706626
   Nevzorova J, 2002, BRIT J PHARMACOL, V137, P9, DOI 10.1038/sj.bjp.0704845
   Newton GE, 1999, CIRCULATION, V99, P2402, DOI 10.1161/01.CIR.99.18.2402
   Ngala RA, 2008, BRIT J PHARMACOL, V155, P395, DOI 10.1038/bjp.2008.244
   OLSSON G, 1992, EUR HEART J, V13, P28, DOI 10.1093/oxfordjournals.eurheartj.a060043
   Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007
   Perez-Schindler J, 2011, LIFE SCI, V88, P892, DOI 10.1016/j.lfs.2011.03.020
   Philipson L. H., 2002, Journal of Allergy and Clinical Immunology, V110, pS313, DOI 10.1067/mai.2002.129702
   Ponicke K, 2006, BRIT J PHARMACOL, V147, P714, DOI 10.1038/sj.bjp.0706674
   Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e
   Roux FJ, 1996, AM J RESP CRIT CARE, V153, P1489, DOI 10.1164/ajrccm.153.5.8630591
   RYDEN L, 1990, LANCET, V336, P1
   Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008
   SCHAFERS RF, 1994, J AM COLL CARDIOL, V23, P1224, DOI 10.1016/0735-1097(94)90615-7
   SCHWINGER RHG, 1993, J PHARMACOL EXP THER, V265, P346
   Singh BN, 2005, J CARDIOVASC PHARM T, V10, pS3, DOI 10.1177/10742484050100i402
   Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004
   Sosunov EA, 2000, CARDIOVASC RES, V48, P211, DOI 10.1016/S0008-6363(00)00171-1
   SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Steinberg SF, 1999, CIRC RES, V85, P1101
   Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341
   Talan MI, 2011, J MOL CELL CARDIOL, V51, P529, DOI 10.1016/j.yjmcc.2010.09.019
   Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506
   Wang W, 2010, AM J PHYSIOL-HEART C, V299, pH322, DOI 10.1152/ajpheart.00392.2010
   Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201
   Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103
   Xiao RP, 1999, CIRC RES, V84, P43
   XIAO RP, 1995, MOL PHARMACOL, V47, P322
   Xydas S, 2006, J PHARMACOL EXP THER, V317, P553, DOI 10.1124/JPET.105.099432
   Yamamoto DL, 2007, DIABETOLOGIA, V50, P158, DOI 10.1007/s00125-006-0484-0
   ZERKOWSKI HR, 1986, N-S ARCH PHARMACOL, V332, P142, DOI 10.1007/BF00511404
   Zhang W., 2011, PLOS ONE
   Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006
   Zheng Ming, 2004, Shengli Xuebao, V56, P1
   Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200
   Zhu WZ, 2005, CIRC RES, V97, P507, DOI 10.1161/01.RES.0000184615.56822.bd
   Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607
NR 102
TC 13
Z9 14
U1 0
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD JAN 5
PY 2013
VL 698
IS 1-3
BP 39
EP 47
DI 10.1016/j.ejphar.2012.11.001
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 085LL
UT WOS:000314616200005
PM 23183106
DA 2021-01-25
ER

PT S
AU Hilge, M
AF Hilge, Mark
BE Annunziato, L
TI Ca2+ Regulation in the Na+/Ca2+ Exchanger Features a Dual Electrostatic
   Switch Mechanism
SO SODIUM CALCIUM EXCHANGE: A GROWING SPECTRUM OF PATHOPHYSIOLOGICAL
   IMPLICATIONS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Sodium Calcium Exchange
CY OCT 01-05, 2011
CL Lacco Ameno, ITALY
DE Na+/Ca2+ exchanger; Ca2+-binding domain; Ca2+ sensor; Ca2+ regulation;
   Electrostatic switch; Alternative splicing
ID SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGER; DYNAMIC PROPERTIES;
   CRYSTAL-STRUCTURES; SPLICE VARIANTS; STEADY-STATE; DOMAIN; NCX1; SENSOR;
   CALX
AB Ion transport performed by the Na+/Ca2+ exchanger (NCX) is regulated via its cytosolic Ca2+-binding domains, CBD1 and CBD2, which act as sensors for intracellular Ca2+. Striking differences in the electrostatic potential of the Ca2+-bound and Ca2+-free forms turn the CBD1 and CBD2 Ca2+-binding sites into electrostatic switches similar to those of C-2 domains. Binding of Ca2+ with high affinity to CBD1 induces a conformational change that is relayed to the transmembrane domain and thereby initiates Na+/Ca2+ exchange. The Ca2+ concentration at which this conformational change occurs is determined by the Ca2+ affinities of the strictly conserved CBD1 Ca2+-binding sites that are modulated by an adjacent, variable region of CBD2. In contrast, the Ca2+-binding properties of CBD2 depend on the isoform and the type of residues in the Ca2+-binding sites, encoded by a mutually exclusive exon. This second electrostatic switch, formed by CBD2, appears to be required for sustained Na+/Ca2+ exchange and may allow tailored, tissue-specific exchange activities.
C1 Univ Basel, Ctr Cellular Imaging & Nano Analyt C CINA, Biozentrum, CH-4058 Basel, Switzerland.
RP Hilge, M (corresponding author), Univ Basel, Ctr Cellular Imaging & Nano Analyt C CINA, Biozentrum, Mattenstr 26, CH-4058 Basel, Switzerland.
EM mark.hilge@unibas.ch
FU Netherlands Organisation for Scientific Research (NWO)Netherlands
   Organization for Scientific Research (NWO) [700.55.443, 700.57.101];
   Swiss National Science Foundation (NCCRs Struct. Biol. and TransCure);
   Swiss Initiative for Systems Biology (SystemsX.ch)
FX I thank Jan Aelen, Drs. Anastassis Perrakis and Geerten W. Vuister for
   their help in the lab and NMR measurements. I would like to thank Dr.
   Shirley A. Muller for critically reading the manuscript. This work was
   supported by grants of the Netherlands Organisation for Scientific
   Research (NWO; grants # 700.55.443 and # 700.57.101), the Swiss National
   Science Foundation (NCCRs Struct. Biol. and TransCure) and the Swiss
   Initiative for Systems Biology (SystemsX.ch).
CR Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104
   Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701
   Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005
   Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008
   Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106
   HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905
   HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933
   Hurtado C, 2006, AM J PHYSIOL-HEART C, V290, pH2155, DOI 10.1152/ajpheart.00958.2005
   Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200
   Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250
   Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0
   Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008
   Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162
   Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045
NR 14
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
BN 978-1-4614-4756-6
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2013
VL 961
BP 27
EP 33
DI 10.1007/978-1-4614-4756-6_3
PG 7
WC Medicine, Research & Experimental; Physiology
SC Research & Experimental Medicine; Physiology
GA BA3PQ
UT WOS:000334582100004
PM 23224867
OA Green Published
DA 2021-01-25
ER

PT J
AU Meier-Abt, F
   Milani, E
   Roloff, T
   Brinkhaus, H
   Duss, S
   Meyer, DS
   Klebba, I
   Balwierz, PJ
   van Nimwegen, E
   Bentires-Alj, M
AF Meier-Abt, Fabienne
   Milani, Emanuela
   Roloff, Tim
   Brinkhaus, Heike
   Duss, Stephan
   Meyer, Dominique S.
   Klebba, Ina
   Balwierz, Piotr J.
   van Nimwegen, Erik
   Bentires-Alj, Mohamed
TI Parity induces differentiation and reduces Wnt/Notch signaling ratio and
   proliferation potential of basal stem/progenitor cells isolated from
   mouse mammary epithelium
SO BREAST CANCER RESEARCH
LA English
DT Article
ID BREAST-CANCER RISK; PREGNANCY-INDUCED PROTECTION; HORMONE-INDUCED
   PROTECTION; STEM-CELLS; PROGENITOR CELLS; PERSISTENT DECREASE; GLAND
   DEVELOPMENT; GENE-EXPRESSION; SELF-RENEWAL; WNT
AB Introduction: Early pregnancy has a strong protective effect against breast cancer in humans and rodents, but the underlying mechanism is unknown. Because breast cancers are thought to arise from specific cell subpopulations of mammary epithelia, we studied the effect of parity on the transcriptome and the differentiation/proliferation potential of specific luminal and basal mammary cells in mice.
   Methods: Mammary epithelial cell subpopulations (luminal Sca1(-), luminal Sca1(+), basal stem/progenitor, and basal myoepithelial cells) were isolated by flow cytometry from parous and age-matched virgin mice and examined by using a combination of unbiased genomics, bioinformatics, in vitro colony formation, and in vivo limiting dilution transplantation assays. Specific findings were further investigated with immunohistochemistry in entire glands of parous and age-matched virgin mice.
   Results: Transcriptome analysis revealed an upregulation of differentiation genes and a marked decrease in the Wnt/Notch signaling ratio in basal stem/progenitor cells of parous mice. Separate bioinformatics analyses showed reduced activity for the canonical Wnt transcription factor LEF1/TCF7 and increased activity for the Wnt repressor TCF3. This finding was specific for basal stem/progenitor cells and was associated with downregulation of potentially carcinogenic pathways and a reduction in the proliferation potential of this cell subpopulation in vitro and in vivo. As a possible mechanism for decreased Wnt signaling in basal stem/progenitor cells, we found a more than threefold reduction in the expression of the secreted Wnt ligand Wnt4 in total mammary cells from parous mice, which corresponded to a similar decrease in the proportion of Wnt4-secreting and estrogen/progesterone receptor-positive cells. Because recombinant Wnt4 rescued the proliferation defect of basal stem/progenitor cells in vitro, reduced Wnt4 secretion appears to be causally related to parity-induced alterations of basal stem/progenitor cell properties in mice.
   Conclusions: By revealing that parity induces differentiation and downregulates the Wnt/Notch signaling ratio and the in vitro and in vivo proliferation potential of basal stem/progenitor cells in mice, our study sheds light on the long-term consequences of an early pregnancy. Furthermore, it opens the door to future studies assessing whether inhibitors of the Wnt pathway may be used to mimic the parity-induced protective effect against breast cancer.
C1 [Meier-Abt, Fabienne; Milani, Emanuela; Roloff, Tim; Brinkhaus, Heike; Duss, Stephan; Meyer, Dominique S.; Klebba, Ina; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res FMI, CH-4058 Basel, Switzerland.
   [Meier-Abt, Fabienne; Milani, Emanuela; Meyer, Dominique S.] Univ Basel, CH-4056 Basel, Switzerland.
   [Balwierz, Piotr J.; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM bentires@fmi.ch
RI Mohamed, Bentires-Alj/F-4484-2015; Balwierz, Piotr J/AAG-4187-2020
OI Mohamed, Bentires-Alj/0000-0001-6344-1127; Balwierz, Piotr
   J/0000-0002-1548-4605; van Nimwegen, Erik/0000-0001-6338-1312
FU Novartis Research Foundation; European Research Council (ERC)European
   Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer League; Krebsliga
   Beider Basel; SNF fellowship
FX We thank S. Gasser, N. Hynes, M. Smalley, and P. Meier-Abt for helpful
   comments on the manuscript, C. Rochlitz, D. Schuebeler and D. Medina for
   helpful discussions, M. Stadler for bioinformatics support, and U.
   Mueller, S. Bichet, and R. Thierry for technical assistance, as well as
   further members of the Bentires-Alj lab for advice and discussions.
   Research in the lab of MB-A is supported by the Novartis Research
   Foundation, the European Research Council (ERC starting grant
   243211-PTPsBDC), the Swiss Cancer League, and the Krebsliga Beider
   Basel. FM-A is supported by an SNF fellowship.
CR Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302
   Blakely CM, 2006, CANCER RES, V66, P6421, DOI 10.1158/0008-5472.CAN-05-4235
   Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7
   Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001
   Brisken C, 2000, GENE DEV, V14, P650
   Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245
   Bruno RD, 2011, STEM CELL REV REP, V7, P238, DOI 10.1007/s12015-010-9191-9
   Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025
   Cowling VH, 2007, CELL CYCLE, V6, P2625, DOI 10.4161/cc.6.21.4880
   D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073
   DEOME KB, 1959, CANCER RES, V19, P515
   Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828
   Dunphy KA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2094
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11
   Gonzalez R.C., 2009, DIGITAL IMAGE PROCES
   Guzman RC, 1999, P NATL ACAD SCI USA, V96, P2520, DOI 10.1073/pnas.96.5.2520
   Han LQ, 2010, GENET MOL RES, V9, P449, DOI 10.4238/vol9-1gmr724
   Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100
   Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x
   MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209
   Many AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2631
   Medina D, 2005, ENDOCR-RELAT CANCER, V12, P483, DOI 10.1677/erc.1.00804
   Medina D, 2003, CANCER RES, V63, P6140
   Munoz-Descalzo S, 2012, BIOESSAYS, V34, P110, DOI 10.1002/bies.201100102
   Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282
   Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483
   Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017
   Rajaram RD, 2009, THESIS ECOLE POLYTEC
   Rajkumar L, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1645
   Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018
   Roarty K, 2010, CURR OPIN PHARMACOL, V10, P643, DOI 10.1016/j.coph.2010.07.004
   Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029
   Russo J, 2008, CANCER EPIDEM BIOMAR, V17, P51, DOI 10.1158/1055-9965.EPI-07-0678
   Schedin P, 2004, MOL CARCINOGEN, V41, P207, DOI 10.1002/mc.20058
   Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372
   Sivaraman L, 2001, P NATL ACAD SCI USA, V98, P12379, DOI 10.1073/pnas.221459098
   Siwko SK, 2008, STEM CELLS, V26, P3205, DOI 10.1634/stemcells.2008-0103
   Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065
   Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371
   Smalley MJ, 2012, J MAMMARY GLAND BIOL, V17, P91, DOI 10.1007/s10911-012-9257-1
   Smalley MJ, 2010, METHODS MOL BIOL, V633, P139, DOI 10.1007/978-1-59745-019-5_11
   Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711
   Smith GH, 2009, STEM CELLS, V27, P1223, DOI 10.1002/stem.19
   Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301
   Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Taylor D, 2009, BREAST CANCER RES TR, V118, P161, DOI 10.1007/s10549-009-0322-4
   THORDARSON G, 1995, CARCINOGENESIS, V16, P2847, DOI 10.1093/carcin/16.11.2847
   van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023
   Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573
   Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007
   Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879
   Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509
   Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8
   Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067
   Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042
   Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283
   Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020
NR 60
TC 64
Z9 64
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1465-542X
EI 1465-5411
J9 BREAST CANCER RES
JI Breast Cancer Res.
PY 2013
VL 15
IS 2
AR R36
DI 10.1186/bcr3419
PG 17
WC Oncology
SC Oncology
GA 302NU
UT WOS:000330612000019
PM 23621987
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT B
AU Riezman, H
   Conzelmann, A
AF Riezman, Howard
   Conzelmann, Andreas
BE Rawlings, ND
   Salvesen, GS
TI Glycosylphosphatidylinositol: Protein Transamidase
SO HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION
LA English
DT Article; Book Chapter
ID VARIANT SURFACE GLYCOPROTEIN; MEMBRANE ANCHOR ATTACHMENT;
   SACCHAROMYCES-CEREVISIAE; GPI TRANSAMIDASE; THY-1 GLYCOPROTEIN;
   PARASITIC PROTOZOA; TERMINAL SIGNAL; PI-G; PHOSPHATIDYLINOSITOL;
   BIOSYNTHESIS
C1 [Riezman, Howard] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Conzelmann, Andreas] Univ Fribourg, Div Biochim, CH-1700 Fribourg, Switzerland.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Howard.Riezman@unibas.ch; andreas.conzelmann@unifr.ch
OI Riezman, Howard/0000-0003-4680-9422
CR BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207
   Benghezal M, 1996, EMBO J, V15, P6575, DOI 10.1002/j.1460-2075.1996.tb01048.x
   CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389
   Chen R, 1996, P NATL ACAD SCI USA, V93, P2280, DOI 10.1073/pnas.93.6.2280
   CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x
   CONZELMANN A, 1987, BIOCHEM J, V246, P605, DOI 10.1042/bj2460605
   Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155
   FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365
   Ferguson MAJ, 1999, J CELL SCI, V112, P2799
   FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856
   Fraering P, 2001, MOL BIOL CELL, V12, P3295, DOI 10.1091/mbc.12.10.3295
   GERBER LD, 1992, J BIOL CHEM, V267, P12168
   HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629
   HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0
   HYMAN R, 1988, TRENDS GENET, V4, P5, DOI 10.1016/0168-9525(88)90120-5
   Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4
   KODUKULA K, 1992, P NATL ACAD SCI USA, V89, P4982, DOI 10.1073/pnas.89.11.4982
   MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3
   MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6
   MAXWELL SE, 1995, P NATL ACAD SCI USA, V92, P1550, DOI 10.1073/pnas.92.5.1550
   MAXWELL SE, 1995, J BIOL CHEM, V270, P19576, DOI 10.1074/jbc.270.33.19576
   MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305
   MENON AK, 1990, J BIOL CHEM, V265, P9033
   Meyer U, 2000, BIOCHEMISTRY-US, V39, P3461, DOI 10.1021/bi992186o
   MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157
   MORAN P, 1991, J CELL BIOL, V115, P1595, DOI 10.1083/jcb.115.6.1595
   MORAN P, 1991, J BIOL CHEM, V266, P1250
   MORAN P, 1994, J CELL BIOL, V125, P333, DOI 10.1083/jcb.125.2.333
   NUOFFER C, 1993, J BIOL CHEM, V268, P10558
   Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523
   Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088
   SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x
   Wang JY, 1999, J MOL BIOL, V286, P1303, DOI 10.1006/jmbi.1999.2584
   Yu JL, 1997, P NATL ACAD SCI USA, V94, P12580, DOI 10.1073/pnas.94.23.12580
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 978-0-12-382220-8; 978-0-12-382219-2
PY 2013
BP 2320
EP 2323
DI 10.1016/B978-0-12-382219-2.00518-4
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BJJ95
UT WOS:000328545103086
DA 2021-01-25
ER

PT J
AU Erhard, F
   Dolken, L
   Jaskiewicz, L
   Zimmer, R
AF Erhard, Florian
   Doelken, Lars
   Jaskiewicz, Lukasz
   Zimmer, Ralf
TI PARma: identification of microRNA target sites in AGO-PAR-CLIP data
SO GENOME BIOLOGY
LA English
DT Article
DE PAR-CLIP; microRNA; generative model; EM algorithm
ID WIDE IDENTIFICATION; CELLULAR MICRORNA; BINDING-SITES; SMALL RNAS;
   BIOGENESIS; VERTEBRATE; REVEALS; PATHWAY; PROTEIN
AB PARma is a complete data analysis software for AGO-PAR-CLIP experiments to identify target sites of microRNAs as well as the microRNA binding to these sites. It integrates specific characteristics of the experiments into a generative model. The model and a novel pattern discovery tool are iteratively applied to data to estimate seed activity probabilities, cluster confidence scores and to assign the most probable microRNA. Based on differential PAR-CLIP analysis and comparison to RIP-Chip data, we show that PARma is more accurate than existing approaches. PARma is available from http://www.bio.ifi.lmu.de/PARma
C1 [Erhard, Florian; Zimmer, Ralf] Univ Munich, Inst Informat, D-80333 Munich, Germany.
   [Doelken, Lars] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England.
   [Jaskiewicz, Lukasz] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jaskiewicz, Lukasz] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Erhard, F (corresponding author), Univ Munich, Inst Informat, Amalienstr 17, D-80333 Munich, Germany.
EM Florian.Erhard@bio.ifi.lmu.de
RI Zimmer, Ralf/L-9295-2019
FU BMBF (NGFN-Plus)Federal Ministry of Education & Research (BMBF)
   [0IGS080I]; MRCMedical Research Council UK (MRC) [GI002523]; NHSBT
   [WPII-05]; Swiss Cancer League [KFS 02477-08-2009]
FX FE and RZ were supported in this work by the BMBF (NGFN-Plus #0IGS080I).
   LD was supported by MRC fellowship grant GI002523 and NHSBT grant
   WPII-05. LJ was supported by the Swiss Cancer League (grant #KFS
   02477-08-2009).
CR Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809
   Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79
   Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138
   Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008
   Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   Erhard F, 2013, BIOINFORMATICS, V29, P77, DOI 10.1093/bioinformatics/bts631
   Erhard F, 2010, BIOINFORMATICS, V26, pi426, DOI 10.1093/bioinformatics/btq363
   Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810
   Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126
   Jaskiewicz L, 2012, METHODS, V58, P106, DOI 10.1016/j.ymeth.2012.09.006
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Kozak M, 2008, GENE, V423, P108, DOI 10.1016/j.gene.2008.07.013
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474
   Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311
   Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110
   Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109
   Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916
   PACE CN, 1991, ANGEW CHEM INT EDIT, V30, P343, DOI 10.1002/anie.199103433
   Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109
   Raabe CA, 2011, RNA, V17, P1357, DOI 10.1261/rna.2682311
   Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397
   Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808
   Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484
   Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909
   Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330
   Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036
   Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107
NR 49
TC 33
Z9 33
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2013
VL 14
IS 7
AR R79
DI 10.1186/gb-2013-14-7-r79
PG 19
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 268UA
UT WOS:000328194900011
PM 23895117
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Kishore, S
   Gruber, AR
   Jedlinski, DJ
   Syed, AP
   Jorjani, H
   Zavolan, M
AF Kishore, Shivendra
   Gruber, Andreas R.
   Jedlinski, Dominik J.
   Syed, Afzal P.
   Jorjani, Hadi
   Zavolan, Mihaela
TI Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA
   core proteins and small RNA sequencing
SO GENOME BIOLOGY
LA English
DT Article
ID SMALL NUCLEOLAR RNAS; EFFICIENT TARGET PREDICTION; C/D BOX SNORNAS;
   RIBOSOMAL-RNA; PRERIBOSOMAL RNA; REGULATORY RNAS; NONCODING RNAS;
   CELL-CYCLE; IDENTIFICATION; METHYLATION
AB Background: In recent years, a variety of small RNAs derived from other RNAs with well-known functions such as tRNAs and snoRNAs, have been identified. The functional relevance of these RNAs is largely unknown. To gain insight into the complexity of snoRNA processing and the functional relevance of snoRNA-derived small RNAs, we sequence long and short RNAs, small RNAs that co-precipitate with the Argonaute 2 protein and RNA fragments obtained in photoreactive nucleotide-enhanced crosslinking and immunoprecipitation (PAR-CLIP) of core snoRNA-associated proteins.
   Results: Analysis of these data sets reveals that many loci in the human genome reproducibly give rise to C/D box-like snoRNAs, whose expression and evolutionary conservation are typically less pronounced relative to the snoRNAs that are currently cataloged. We further find that virtually all C/D box snoRNAs are specifically processed inside the regions of terminal complementarity, retaining in the mature form only 4-5 nucleotides upstream of the C box and 2-5 nucleotides downstream of the D box. Sequencing of the total and Argonaute 2-associated populations of small RNAs reveals that despite their cellular abundance, C/D box-derived small RNAs are not efficiently incorporated into the Ago2 protein.
   Conclusions: We conclude that the human genome encodes a large number of snoRNAs that are processed along the canonical pathway and expressed at relatively low levels. Generation of snoRNA-derived processing products with alternative, particularly miRNA-like, functions appears to be uncommon.
C1 [Kishore, Shivendra; Gruber, Andreas R.; Jedlinski, Dominik J.; Syed, Afzal P.; Jorjani, Hadi; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Gruber,
   Andreas/0000-0003-1219-4239
FU University of Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31003A 127307]; Gebert Ruf Foundation Rare
   Diseases Program [GRS-046/11]
FX The authors thank Erich Nigg (Biozentrum) for providing the HeLa cells
   in which the histone H2B gene is fused to green fluorescent protein and
   for advice on the isolation of mitotic cells. We are grateful to Gunter
   Meister for the anti-Ago2 antibody and Ina Nissen and Christian Beisel
   from the Quantitative Genomics Facility of the D-BSSE of ETH Zurich, for
   help with deep sequencing. All computations were carried out on the
   [BC]2 HPC infrastructure at the University of Basel. Work in the Zavolan
   lab is supported by the University of Basel and the Swiss National
   Science Foundation (grant #31003A 127307). SK acknowledges the support
   of the Gebert Ruf Foundation Rare Diseases Program (grant GRS-046/11).
CR Bernhart Stephan H., 2009, Briefings in Functional Genomics & Proteomics, V8, P461, DOI 10.1093/bfgp/elp043
   Berninger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-46
   Bortolin ML, 1999, EMBO J, V18, P457, DOI 10.1093/emboj/18.2.457
   Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776
   Brown JWS, 2003, TRENDS PLANT SCI, V8, P42, DOI 10.1016/S1360-1385(02)00007-9
   Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005
   Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0
   Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409
   d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518
   Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746
   Darzacq X, 2000, MOL CELL BIOL, V20, P4522, DOI 10.1128/MCB.20.13.4522-4531.2000
   Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   ELVIN P, 1983, BIOL CELL, V48, P1
   Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017
   Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810
   Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464
   Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502
   Jung CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-77
   Karijolich J, 2010, RNA BIOL, V7, P192, DOI 10.4161/rna.7.2.11207
   Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157
   Kehr S, 2011, BIOINFORMATICS, V27, P279, DOI 10.1093/bioinformatics/btq642
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585
   Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617
   Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032
   KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2
   Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527
   Langenberger D, 2012, BIOINFORMATICS, V28, P17, DOI 10.1093/bioinformatics/btr598
   Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609
   Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002
   Li W, 2012, CELL MICROBIOL, V14, P1455, DOI 10.1111/j.1462-5822.2012.01811.x
   Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307
   Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563
   MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4
   Maden BEH, 2001, METHODS, V25, P374, DOI 10.1006/meth.2001.1250
   Marz M, 2011, RNA BIOL, V8, P938, DOI 10.4161/rna.8.6.16603
   McKeegan KS, 2007, MOL CELL BIOL, V27, P6782, DOI 10.1128/MCB.01097-07
   MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7
   Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157
   Nicolas FE, 2012, FEBS LETT, V586, P1226, DOI 10.1016/j.febslet.2012.03.026
   Nicoloso M, 1996, J MOL BIOL, V260, P178, DOI 10.1006/jmbi.1996.0391
   Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249
   Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972
   PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7
   Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394
   Schattner P, 2006, RNA, V12, P15, DOI 10.1261/rna.2210406
   Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021
   Scott MS, 2012, NUCLEIC ACIDS RES, V40, P3676, DOI 10.1093/nar/gkr1233
   Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026
   Shen ML, 2011, NUCLEIC ACIDS RES, V39, P9720, DOI 10.1093/nar/gkr684
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Tafer H, 2010, BIOINFORMATICS, V26, P610, DOI 10.1093/bioinformatics/btp680
   Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909
   TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F
   Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1
   Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610
   Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091
   Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106
   Yan DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021652
   Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672
   Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P6562, DOI 10.1093/nar/gkp704
   Zywicki M, 2012, NUCLEIC ACIDS RES, V40, P4013, DOI 10.1093/nar/gks020
NR 68
TC 66
Z9 67
U1 0
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2013
VL 14
IS 5
AR R45
DI 10.1186/gb-2013-14-5-r45
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 234YK
UT WOS:000325680100005
PM 23706177
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Bhattacharya, I
   Dragert, K
   Ruegg, MA
   Hall, MN
   Battegay, E
   Haas, E
   Humar, R
AF Bhattacharya, Indranil
   Draegert, Katja
   Rueegg, Markus A.
   Hall, Michael N.
   Battegay, Edouard
   Haas, Elvira
   Humar, Rok
TI RAPTOR DEFICIENCY IN ENDOTHELIUM AMPLIFIES CYCLOOXYGENASE-DEPENDENT
   ENDOTHELIUM-DERIVED CONTRACTIONS
SO JOURNAL OF VASCULAR RESEARCH
LA English
DT Meeting Abstract
CT 11th International Symposium on Mechanisms of Vasodilatation
CY OCT 04-06, 2013
CL Univ Hosp Zurich, Zurich, SWITZERLAND
SP Zurich Heart House, Univ Zurich, Servier, Actelion, Bayer HealthCare, Biotronik, Boston Sci, Cardiorentis, Medtronic, Novartis
HO Univ Hosp Zurich
C1 [Bhattacharya, Indranil; Draegert, Katja; Battegay, Edouard; Haas, Elvira; Humar, Rok] Univ Zurich Hosp, Div Internal Med, Zurich, Switzerland.
   [Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Battegay, Edouard; Humar, Rok] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-1172
EI 1423-0135
J9 J VASC RES
JI J. Vasc. Res.
PY 2013
VL 50
SU 1
BP 55
EP 55
PG 1
WC Physiology; Peripheral Vascular Disease
SC Physiology; Cardiovascular System & Cardiology
GA 235FN
UT WOS:000325702300075
DA 2021-01-25
ER

PT S
AU Meyer, UA
   Zanger, UM
   Schwab, M
AF Meyer, Urs A.
   Zanger, Ulrich M.
   Schwab, Matthias
BE Insel, PA
TI Omics and Drug Response
SO ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013
SE Annual Review of Pharmacology and Toxicology
LA English
DT Review; Book Chapter
DE genomic medicine; personalized medicine; pharmacogenetics;
   pharmacogenomics; biomarkers; genotype-phenotype
ID GENOME-WIDE ASSOCIATION; IMPLEMENTATION CONSORTIUM GUIDELINES; ACUTE
   LYMPHOBLASTIC-LEUKEMIA; SYSTEMS BIOLOGY APPROACH; BREAST-CANCER
   PATIENTS; COLORECTAL-CANCER; HYPERSENSITIVITY REACTIONS; MISSING
   HERITABILITY; CLINICAL DEVELOPMENT; GENETIC-VARIATION
AB A new generation of technologies commonly named omics permits assessment of the entirety of the components of biological systems and produces an explosion of data and a major shift in our concepts of disease. These technologies will likely shape the future of health care. One aspect of these advances is that the data generated document the uniqueness of each human being in regard to disease risk and treatment response. These developments have reemphasized the concept of personalized medicine. Here we review the impact of omics technologies on one key aspect of personalized medicine: the individual drug response. We describe how knowledge of different omics may affect treatment decisions, namely drug choice and drug dose, and how it can be used to improve clinical outcomes.
C1 [Meyer, Urs A.] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Zanger, Ulrich M.; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.
   [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, D-72076 Tubingen, Germany.
RP Meyer, UA (corresponding author), Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch; uli.zanger@ikp-stuttgart.de;
   matthias.schwab@ikp-stuttgart.de
RI Schwab, Matthias/ABH-7449-2020; Zanger, Ulrich M./A-9364-2012
OI Zanger, Ulrich M./0000-0002-5276-2002
CR Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920
   [Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a
   Antoine DJ, 2012, J HEPATOL, V56, P1070, DOI 10.1016/j.jhep.2011.12.019
   Argiles G, 2012, FUTURE ONCOL, V8, P373, DOI [10.2217/FON.12.20, 10.2217/fon.12.20]
   Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177
   Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7
   Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989
   Barnadas A, 2011, ADV THER, V28, P1045, DOI 10.1007/s12325-011-0075-4
   Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Barrie ES, 2012, MOL PHARMACOL, V81, P620, DOI 10.1124/mol.111.076604
   Bassingthwaighte J, 2009, EXP PHYSIOL, V94, P597, DOI 10.1113/expphysiol.2008.044099
   Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166
   Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424
   Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba
   Blay JY, 2011, SEMIN ONCOL, V38, pS3, DOI 10.1053/j.seminoncol.2011.01.016
   Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053
   Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717
   Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009
   Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385
   Chung YL, 2008, ERNST SCHERING FOUND, V4, P55, DOI 10.1007/2789_2008_089
   Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247
   Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143
   Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216
   Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287
   Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497
   Croxtall JD, 2011, DRUGS, V71, P363, DOI 10.2165/11204810-000000000-00000
   Curran MP, 2012, DRUGS, V72, P99, DOI 10.2165/11207680-000000000-00000
   Daly AK, 2012, DRUG METAB REV, V44, P116, DOI 10.3109/03602532.2011.605790
   Daly AK, 2012, ANNU REV PHARMACOL, V52, P21, DOI 10.1146/annurev-pharmtox-010611-134743
   Daly AK, 2010, BIOCHEM J, V429, P435, DOI 10.1042/BJ20100522
   Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751
   Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013
   Deeks ED, 2009, DRUGS, V69, P889, DOI 10.2165/00003495-200969070-00007
   del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010
   Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221
   Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280
   Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Druker BJ, 2006, NEW ENGL J MED, V354, P2594, DOI 10.1056/NEJMe068073
   Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149
   Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940
   Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004
   Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009
   Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695
   Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067
   Eur. Med. Agency, 2012, QUAL NOV METH MED DE
   Fareed J, 2012, ANNU REV PHARMACOL, V52, P79, DOI 10.1146/annurev-pharmtox-010611-134633
   Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175
   Finkelman BS, 2011, J AM COLL CARDIOL, V57, P612, DOI 10.1016/j.jacc.2010.08.643
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Gamazon ER, 2012, PHARMACOGENET GENOM, V22, P261, DOI 10.1097/FPC.0b013e328350ca5f
   Garay JP, 2012, MOL ONCOL, V6, P128, DOI 10.1016/j.molonc.2012.02.009
   Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005
   Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641
   Gong IY, 2011, BLOOD, V118, P3163, DOI 10.1182/blood-2011-03-345173
   Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644
   Hanash S, 2004, J PROTEOME RES, V3, P197, DOI 10.1021/pr034126h
   Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8
   Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513
   Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158
   Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118
   Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897
   Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987
   Hunter P, 2010, PHILOS T R SOC A, V368, P2595, DOI 10.1098/rsta.2010.0048
   Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300
   Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93
   Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208
   Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282
   Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250
   Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002
   Johnson JA, 2012, CLIN PHARMACOL THER, V91, P774, DOI 10.1038/clpt.2012.21
   Johnson JA, 2011, CLIN PHARMACOL THER, V90, P519, DOI 10.1038/clpt.2011.179
   Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185
   Jordan VC, 2008, EUR J CANCER, V44, P30, DOI 10.1016/j.ejca.2007.11.002
   Kacevska M, 2011, CLIN PHARMACOL THER, V89, P902, DOI 10.1038/clpt.2011.21
   Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715
   Kelleher FC, 2012, J PERS MED, V2, P35, DOI 10.3390/jpm2020035
   Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651
   Kim MJ, 2009, J CLIN PHARMACOL, V49, P138, DOI 10.1177/0091270008328098
   Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195
   Kiyotani K, 2012, HUM MOL GENET, V21, P1665, DOI 10.1093/hmg/ddr597
   Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329
   Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999
   Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92
   Koturbash I, 2012, EXPERT OPIN DRUG MET, V8, P597, DOI 10.1517/17425255.2012.673587
   Lamond AI, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O112.017731
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906
   Lindon JC, 2008, ANNU REV ANAL CHEM, V1, P45, DOI 10.1146/annurev.anchem.1.031207.113026
   Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936
   MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040
   Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006
   Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X
   Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135
   Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   Mardis ER, 2010, GENOME MED, V2, DOI 10.1186/gm205
   Martin MA, 2012, CLIN PHARMACOL THER, V91, P734, DOI 10.1038/clpt.2011.355
   McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297
   McCormack PL, 2011, DRUGS, V71, P1771, DOI 10.2165/11207580-000000000-00000
   McDonagh EM, 2012, PHARMACOGENET GENOM, V22, P219, DOI 10.1097/FPC.0b013e32834eb313
   Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005
   Meyer UA, 2012, CLIN PHARMACOL THER, V91, P373, DOI 10.1038/clpt.2011.238
   Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428
   Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104
   Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144
   Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903
   Mook S, 2010, ANN ONCOL, V21, P717, DOI 10.1093/annonc/mdp388
   Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027
   National Research Council, 2011, PREC MED BUILD KNOWL
   Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a
   Nicholson JK, 2012, EXPERT OPIN DRUG MET, V8, P135, DOI 10.1517/17425255.2012.646987
   Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857
   O'Connell TM, 2010, CLIN PHARMACOL THER, V88, P394, DOI 10.1038/clpt.2010.151
   Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537
   Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934
   Pal SK, 2010, MOL CANCER THER, V9, P1931, DOI 10.1158/1535-7163.MCT-10-0239
   Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228
   Pegram MD, 1998, BREAST CANCER RES TR, V52, P65, DOI 10.1023/A:1006111117877
   Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000
   Philips EJ, 2010, PHARMACOGENOMICS, V11, P973, DOI 10.2217/PGS.10.77
   Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15
   Pirmohamed M, 2011, DRUG DISCOV TODAY, V16, P852, DOI 10.1016/j.drudis.2011.08.006
   Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113
   Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000
   Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]
   Ramsey LB, 2012, GENOME RES, V22, P1, DOI 10.1101/gr.129668.111
   Ramsey SA, 2010, EMBO MOL MED, V2, P79, DOI 10.1002/emmm.201000063
   Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50
   Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320
   Rhea J. M., 2011, MLO MED LAB OBS, V43, P22
   Rhea J. M., 2011, MLO MED LAB OBS, V43, P16
   Rhea J. M., 2011, MLO MED LAB OBS, V43, P18
   Rhea Jeanne M, 2011, MLO Med Lab Obs, V43, P24
   Rhea Jeanne M, 2011, MLO Med Lab Obs, V43, P10
   Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570
   Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503
   Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003
   Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380
   Roden DM, 2012, CLIN PHARMACOL THER, V91, P1083, DOI 10.1038/clpt.2012.42
   Roden DM, 2006, ANN INTERN MED, V145, P749, DOI 10.7326/0003-4819-145-10-200611210-00007
   Rodriguez B, 2010, CLIN PHARMACOL THER, V88, P130, DOI 10.1038/clpt.2010.95
   Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305
   Rostami-Hodjegan A, 2007, NAT REV DRUG DISCOV, V6, P140, DOI 10.1038/nrd2173
   Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161
   Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003
   Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382
   Sadee W, 2011, CLIN PHARMACOL THER, V89, P355, DOI 10.1038/clpt.2010.314
   Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008
   Schaeffeler E, 2011, GENOME MED, V3, DOI 10.1186/gm298
   Scott CT, 2012, NAT BIOTECHNOL, V30, P141, DOI 10.1038/nbt.2116
   Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132
   Scott SA, 2011, GENET MED, V13, P987, DOI 10.1097/GIM.0b013e318238b38c
   Shen Y, 2012, PHARMACOGENOMICS J, V12, P96, DOI 10.1038/tpj.2010.84
   Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232
   Sim SC, 2011, TRENDS PHARMACOL SCI, V32, P72, DOI 10.1016/j.tips.2010.11.008
   Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302
   Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4
   Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354
   Suhre K, 2011, NAT GENET, V43, P565, DOI 10.1038/ng.837
   Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314
   Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447
   Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34
   Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433
   Tan YM, 2011, INT J ENV RES PUB HE, V8, P1613, DOI 10.3390/ijerph8051613
   Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449
   Teichert M, 2011, PHARMACOGENET GENOM, V21, P26, DOI 10.1097/FPC.0b013e32834154fb
   Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309
   Thorisson GA, 2003, NUCLEIC ACIDS RES, V31, P124, DOI 10.1093/nar/gkg052
   Topol EJ, 2012, CREATIVE DESTRUCTION
   Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156
   US Dep. Health Hum. Serv. US Food Drug Admin. Cent. Drug Eval. Res, 2010, GUID IND QUAL PROC D
   US Food Drug Admin, 2012, TABL PHARM BIOM DRUG
   Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029
   Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164
   Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197
   Wells QS, 2012, CURR OPIN CARDIOL, V27, P253, DOI 10.1097/HCO.0b013e32835220e3
   Willmann S, 2009, CLIN PHARMACOL THER, V86, P634, DOI 10.1038/clpt.2009.151
   Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240
   Yap TA, 2012, ANNU REV PHARMACOL, V52, P549, DOI 10.1146/annurev-pharmtox-010611-134532
   Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934
   Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6
   Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338
   Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309
   Zhang W, 2010, CURR OPIN MOL THER, V12, P695
   Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735
   Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109
NR 198
TC 91
Z9 95
U1 3
U2 52
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0362-1642
EI 1545-4304
BN 978-0-8243-0453-9
J9 ANNU REV PHARMACOL
JI Annu. Rev. Pharmacol. Toxicol.
PY 2013
VL 53
BP 475
EP 502
DI 10.1146/annurev-pharmtox-010510-100502
PG 28
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA BGH79
UT WOS:000323040100023
PM 23140244
DA 2021-01-25
ER

PT J
AU Henrich, PB
   Monnier, CA
   Loparic, M
   Cattin, PC
AF Henrich, Paul B.
   Monnier, Christophe A.
   Loparic, Marko
   Cattin, Philippe C.
CA Int Chromovitrectomy Collaboration
TI Material Properties of the Internal Limiting Membrane and Their
   Significance in Chromovitrectomy
SO OPHTHALMOLOGICA
LA English
DT Article
DE Atomic force microscopy; Color contrast; Chromaticity analysis;
   Chromovitrectomy; Internal limiting membrane; Material properties
ID MACULAR HOLE SURGERY; BRILLIANT BLUE-G; VITREOMACULAR TRACTION SYNDROME;
   OPTICAL COHERENCE TOMOGRAPHY; TRYPAN BLUE; INDOCYANINE GREEN; EPIRETINAL
   MEMBRANE; BASEMENT-MEMBRANE; CLINICOPATHOLOGICAL CORRELATION;
   VITREORETINAL SURGERY
AB Intraoperative visualization of the internal limiting membrane (ILM), the choice of a point of vantage for lifting an initial flap, the precision with which the ILM is grasped, adhesion between the forceps and the ILM, thickness, stiffness and elasticity of the ILM as well as monitoring of the completeness of ILM removal are all important factors for safety and efficacy of a chromovitrectonny intervention. The understanding of the underlying physical features of the ILM, such as contrast behavior and bioanatomical and biomechanical properties represent, thus, useful prerequisites for successful macular surgery. New analytical tools, such as atomic force microscopy and chromaticity analysis, allow new in-sights into ILM material characteristics, permitting a systematic approach to refinement of surgical technique. (C) 2013 S. Karger AG, Basel
C1 [Henrich, Paul B.] Univ Basel Hosp, Dept Ophthalmol, CH-4012 Basel, Switzerland.
   [Monnier, Christophe A.; Loparic, Marko] Univ Basel, Biozentrum, Basel, Switzerland.
   [Monnier, Christophe A.; Loparic, Marko] Univ Basel, Swiss Nanosci Inst, Basel, Switzerland.
   [Cattin, Philippe C.] Univ Basel, Med Image Anal Ctr, Basel, Switzerland.
RP Henrich, PB (corresponding author), Univ Basel Hosp, Dept Ophthalmol, CH-4012 Basel, Switzerland.
EM Henrichp@uhbs.ch
OI Monnier, Christophe/0000-0002-0071-7269
CR Ando F, 2004, GRAEF ARCH CLIN EXP, V242, P995, DOI 10.1007/s00417-004-0864-4
   Balaiya S, 2011, RETINA-J RET VIT DIS, V31, P1128, DOI 10.1097/IAE.0b013e3181fe543a
   Balasubramani M, 2010, MATRIX BIOL, V29, P471, DOI 10.1016/j.matbio.2010.04.002
   Banker AS, 1997, OPHTHALMOLOGY, V104, P1442, DOI 10.1016/S0161-6420(97)30118-3
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bottos Juliana, 2012, J Ophthalmic Vis Res, V7, P148
   Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900
   Burk SE, 2000, OPHTHALMOLOGY, V107, P2010, DOI 10.1016/S0161-6420(00)00375-4
   Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004
   Dib E, 2009, ARQ BRAS OFTALMOL, V72, P845, DOI 10.1590/S0004-27492009000600022
   Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006
   Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007
   Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001
   Farah Michel E, 2008, Dev Ophthalmol, V42, P91, DOI 10.1159/000138980
   FINE BS, 1961, ARCH OPHTHALMOL-CHIC, V66, P847, DOI 10.1001/archopht.1961.00960010849012
   FOOS RY, 1972, INVEST OPHTH VISUAL, V11, P801
   Gandorfer A, 2003, INVEST OPHTH VIS SCI, V44, P316, DOI 10.1167/iovs.02-0545
   Gandorfer A, 2002, BRIT J OPHTHALMOL, V86, P902, DOI 10.1136/bjo.86.8.902
   Gandorfer A, 2009, DEV OPHTHALMOL, V44, P1, DOI 10.1159/000223938
   Gerding H, 2011, KLIN MONATSBL AUGENH, V228, P298, DOI 10.1055/s-0031-1273213
   Gregor ZJ, 1996, EYE, V10, P685, DOI 10.1038/eye.1996.161
   Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480
   Halfter W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067660
   Haritoglou C, 2002, AM J OPHTHALMOL, V134, P836, DOI 10.1016/S0002-9394(02)01816-0
   Haritoglou C, 2001, BRIT J OPHTHALMOL, V85, P231, DOI 10.1136/bjo.85.2.231
   Haritoglou C, J CATARACT IN PRESS
   Haritoglou C, 2011, RETINA-J RET VIT DIS, V31, P405, DOI 10.1097/IAE.0b013e3181feccd7
   Haritoglou C, 2009, RETINA-J RET VIT DIS, V29, P1266, DOI 10.1097/IAE.0b013e3181b8626f
   Henrich PB, 2013, RETINA-J RET VIT DIS, V33, P818, DOI 10.1097/IAE.0b013e318271f250
   Henrich Paul B, 2012, Invest Ophthalmol Vis Sci, V53, P2561, DOI 10.1167/iovs.11-8502
   Henrich PB, 2011, INVEST OPHTH VIS SCI, V52, P4345, DOI 10.1167/iovs.10-6972
   Henrich PB, 2013, GRAEFES ARC IN PRESS
   Henrich PB, 2012, ACTA OPHTHALMOL, V20, P12005
   Henrich PB, 2009, ACTA OPHTHALMOL, V23, P23
   HIKICHI T, 1995, AM J OPHTHALMOL, V119, P55, DOI 10.1016/S0002-9394(14)73813-9
   Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P514, DOI 10.1001/archopht.124.4.514
   HOGAN MJ, 1963, INVEST OPHTH VISUAL, V2, P418
   Iriyama A, 2004, INVEST OPHTH VIS SCI, V45, P943, DOI 10.1167/iovs.03-1026
   Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116, DOI 10.1001/archopht.118.8.1116
   Kadonosono K, 2013, RETINA, V11, P11
   KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031
   Koerner F, 1999, DOC OPHTHALMOL, V97, P449, DOI 10.1023/A:1002412323399
   KRAUSHAR MF, 1989, OPHTHALMIC SURG LAS, V20, P508
   Kushner DJ, 1999, CAN J PHYSIOL PHARM, V77, P79, DOI 10.1139/cjpp-77-2-79
   Last JA, 2010, INVEST OPHTH VIS SCI, V51, P6083, DOI 10.1167/iovs.10-5470
   Lee KL, 2005, BRIT J OPHTHALMOL, V89, P420, DOI 10.1136/bjo.2004.049684
   Lewis JM, 1997, AM J OPHTHALMOL, V124, P552, DOI 10.1016/S0002-9394(14)70874-8
   Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216
   Li KKW, 2010, CLIN EXP OPHTHALMOL, V38, P664, DOI 10.1111/j.1442-9071.2010.02333.x
   Livingstone BI, 1999, AUST NZ J OPHTHALMOL, V27, P331, DOI 10.1046/j.1440-1606.1999.00221.x
   Logvinenko AD, 2009, J VISION, V9, DOI 10.1167/9.11.5
   Luke C, 2006, GRAEF ARCH CLIN EXP, V244, P1188, DOI 10.1007/s00417-005-0239-5
   MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247
   MAGUIRE AM, 1990, RETINA-J RET VIT DIS, V10, P213, DOI 10.1097/00006982-199010030-00011
   Maia M, 2004, RETINA-J RET VIT DIS, V24, P80, DOI 10.1097/00006982-200402000-00012
   Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2
   Meyer CH, 2004, AM J OPHTHALMOL, V137, P207, DOI 10.1016/j.ajo.2003.09.014
   Park DW, 1999, OPHTHALMOLOGY, V106, P1392, DOI 10.1016/S0161-6420(99)00730-7
   Perrier M, 2003, AM J OPHTHALMOL, V135, P903, DOI 10.1016/S0002-9394(02)02239-0
   Perrier M, 2003, AM J OPHTHALMOL, V135, P909, DOI 10.1016/S0002-9394(02)02256-0
   Plodinec M, 2010, LIVE CELL IMAGING LA
   Plodinec M, 2010, COLD SPRING HARB PRO, V2010
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   Rodrigues EB, 2005, GRAEF ARCH CLIN EXP, V243, P291, DOI 10.1007/s00417-004-0992-x
   Rodrigues EB, 2003, BRIT J OPHTHALMOL, V87, P1431, DOI 10.1136/bjo.87.11.1431-a
   Rosenblum YZ, 2000, OPHTHAL PHYSL OPT, V20, P335, DOI 10.1046/j.1475-1313.2000.00545.x
   Sato Y, 2006, OPHTHALMOLOGICA, V220, P153, DOI 10.1159/000091757
   Sayegh RG, 2010, OPHTHALMOLOGY, V117, P2010, DOI 10.1016/j.ophtha.2010.01.041
   Schmidt-Erfurth U, 2005, INVEST OPHTH VIS SCI, V46, P3393, DOI 10.1167/iovs.05-0370
   Schumann RG, 2010, BRIT J OPHTHALMOL, V94, P1369, DOI 10.1136/bjo.2010.183210
   Schwartz SD, 1996, OPHTHALMOLOGY, V103, P323
   Simpson ARH, 2012, SURV OPHTHALMOL, V57, P498, DOI 10.1016/j.survophthal.2012.01.011
   SMIDDY WE, 1988, ARCH OPHTHALMOL-CHIC, V106, P624
   Teba FA, 2003, OPHTHALMOLOGY, V110, P2409, DOI 10.1016/S0161-6420(03)00716-4
   TRESE MT, 1983, GRAEF ARCH CLIN EXP, V221, P12, DOI 10.1007/BF02171725
   van den Biesen PR, 2000, BRIT J OPHTHALMOL, V84, P1372, DOI 10.1136/bjo.84.12.1372
   Wollensak G, 2004, J CATARACT REFR SURG, V30, P1526, DOI 10.1016/j.jcrs.2003.11.031
   Wollensak G, 2004, OPHTHALMOLOGICA, V218, P278, DOI 10.1159/000078621
   Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766
   Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087
NR 80
TC 2
Z9 2
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3755
J9 OPHTHALMOLOGICA
JI Ophthalmologica
PY 2013
VL 230
SU 2
BP 11
EP 20
DI 10.1159/000353866
PG 10
WC Ophthalmology
SC Ophthalmology
GA 218PM
UT WOS:000324444600003
PM 24022714
DA 2021-01-25
ER

PT S
AU Silvan, U
   Jockusch, BM
   Schoenenberger, CA
AF Silvan, Unai
   Jockusch, Brigitte M.
   Schoenenberger, Cora-Ann
BE Donev, R
TI Unconventional Actin Configurations Step into the Limelight
SO ORGANISATION OF CHROMOSOMES
SE Advances in Protein Chemistry and Structural Biology
LA English
DT Review; Book Chapter
ID F-ACTIN; NUCLEAR ACTIN; CRYSTAL-STRUCTURE; BETA-ACTIN;
   MONOCLONAL-ANTIBODY; TOXOPLASMA-GONDII; CYTOPLASMIC ACTIN;
   TRANSCRIPTIONAL COACTIVATOR; CONTRACTILE PROTEINS; INTERPHASE NUCLEUS
AB The existence of a cellular machinery that is based on the reversible polymerization of globular nucleotide-bound protomers into polar microfilaments is a persistent feature from prokaryotes to higher vertebrates. However, while in bacteria, actin-like proteins with such properties have evolved into a large family with divergent sequences and polymeric structures, eukaryotes express only a small number of highly conserved actins. Indeed, the sequence of actin is one of the best conserved among eukaryotes and yet actin carries out many different functions at distinct cellular sites. Because of the notorious conservation and lack of suitable tools to examine structural plasticity, the vast majority of studies on cellular actin functions consider mainly two structural states, G-actin and F-actin. However, there is more to the structural plasticity of actin than first meets the eye. On one hand, more than 200 actin-binding proteins shape the conformation of actin and thereby regulate functional diversity. On the other hand, unconventional actin conformations that differ from monomeric G-actin are stepping into the limelight. In addition, supramolecular actin structures that extend beyond classical F-actin are emerging. Herein, we recapitulate the current knowledge on the structure and conformations of monomeric actin and its polymerization into higher order structures, paying special attention to less known forms and their involvement in actin function.
C1 [Silvan, Unai; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, Basel, Switzerland.
   [Jockusch, Brigitte M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Braunschweig, Germany.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM cora-ann.schoenenberger@unibas.ch
RI Silvan, Unai/J-7376-2013
OI Silvan, Unai/0000-0003-0757-3621
CR AEBI U, 1980, NATURE, V288, P296, DOI 10.1038/288296a0
   AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340
   AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x
   Andrin C, 2012, NUCLEUS-PHILA, V3, P384, DOI 10.4161/nucl.21055
   Ballestrem C, 1998, J CELL SCI, V111, P1649
   Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29
   Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357
   BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290
   BREMER A, 1992, Current Opinion in Cell Biology, V4, P20, DOI 10.1016/0955-0674(92)90054-G
   BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003
   Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689
   Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602
   CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0
   CLARK TG, 1979, CELL, V18, P1101, DOI 10.1016/0092-8674(79)90223-X
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726
   Dawson JF, 2003, J BIOL CHEM, V278, P1229, DOI 10.1074/jbc.M209160200
   De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390
   de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364
   dos Remedios C G, 1978, Nature, V276, P731, DOI 10.1038/276731a0
   Durer ZAO, 2010, J MOL BIOL, V395, P544, DOI 10.1016/j.jmb.2009.11.001
   Fan J, 2012, BIOPHYS J, V103, P1334, DOI 10.1016/j.bpj.2012.08.029
   Feng ZQ, 2005, BIOMATERIALS, V26, P5348, DOI 10.1016/j.biomaterials.2005.01.069
   FOWLER WE, 1982, J CELL BIOL, V93, P452, DOI 10.1083/jcb.93.2.452
   FRANCIS NR, 1990, BIOPHYS J, V58, P771, DOI 10.1016/S0006-3495(90)82419-X
   Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372
   FUKUI Y, 1978, J CELL BIOL, V76, P146, DOI 10.1083/jcb.76.1.146
   Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930
   GALLWITZ D, 1980, NUCLEIC ACIDS RES, V8, P1043, DOI 10.1093/nar/8.5.1043
   Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133
   GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203
   Gonsior SM, 1999, J CELL SCI, V112, P797
   GOUNON P, 1981, J CELL BIOL, V88, P410, DOI 10.1083/jcb.88.2.410
   Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200
   HANSON J, 1973, PROC R SOC SER B-BIO, V183, P39, DOI 10.1098/rspb.1973.0003
   HANSON J, 1967, NATURE, V213, P353, DOI 10.1038/213353a0
   HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467
   HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S
   JOCKUSCH BM, 1974, EXP CELL RES, V89, P241, DOI 10.1016/0014-4827(74)90787-3
   Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2
   KABSCH W, 1995, FASEB J, V9, P167
   KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0
   KINDLE KL, 1978, CELL, V15, P763, DOI 10.1016/0092-8674(78)90262-3
   Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001
   LANE NJ, 1969, J CELL BIOL, V40, P286, DOI 10.1083/jcb.40.1.286
   Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056
   LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268
   Lee SH, 2007, P NATL ACAD SCI USA, V104, P16122, DOI 10.1073/pnas.0705794104
   LESTOURGEON WM, 1975, BIOCHIM BIOPHYS ACTA, V379, P529, DOI 10.1016/0005-2795(75)90160-9
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101
   McGough A, 1999, J MOL BIOL, V291, P513, DOI 10.1006/jmbi.1999.2968
   McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Minehardt TJ, 2006, BIOPHYS J, V90, P2445, DOI 10.1529/biophysj.105.072900
   Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2
   MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296
   Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211
   Morton WM, 2000, NAT CELL BIOL, V2, P376
   Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750
   Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235
   Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181
   Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317
   NAKAYASU H, 1983, EXP CELL RES, V143, P55, DOI 10.1016/0014-4827(83)90108-8
   NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262
   Obrdlik A, 2011, NUCLEUS-PHILA, V2, P72, DOI 10.4161/nucl.2.1.14508
   Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753
   Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685
   Oosawa F., 1975, THERMODYNAMICS POLYM
   ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x
   Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700
   Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216
   Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2
   Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545
   Popp D, 2012, J BIOL CHEM, V287, P21121, DOI 10.1074/jbc.M112.341016
   Popp D, 2011, MOL MICROBIOL, V80, P300, DOI 10.1111/j.1365-2958.2011.07599.x
   Poupel O, 2000, MOL BIOL CELL, V11, P355, DOI 10.1091/mbc.11.1.355
   Rebowski G, 2008, P NATL ACAD SCI USA, V105, P10785, DOI 10.1073/pnas.0801650105
   Reutzel R, 2004, J STRUCT BIOL, V146, P291, DOI 10.1016/j.jsb.2003.12.006
   Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220
   Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092
   Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200
   Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512
   SANGER JW, 1980, P NATL ACAD SCI-BIOL, V77, P5268, DOI 10.1073/pnas.77.9.5268
   Saunders MG, 2012, STRUCTURE, V20, P641, DOI 10.1016/j.str.2012.02.008
   Sawaya MR, 2008, ACTA CRYSTALLOGR D, V64, P454, DOI 10.1107/S0907444908003351
   SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X
   Schoenenberger CA, 2002, FEBS LETT, V529, P27, DOI 10.1016/S0014-5793(02)03267-2
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   Schoenenberger CA, 2011, EUR J CELL BIOL, V90, P797, DOI 10.1016/j.ejcb.2011.05.002
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
   Scoville D, 2006, BIOCHEMISTRY-US, V45, P13576, DOI 10.1021/bi061229f
   Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1
   Silvan U, 2012, J STRUCT BIOL, V177, P70, DOI 10.1016/j.jsb.2011.09.010
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873
   STRAUB F B, 1950, Kiserl Orvostud, V2, P141
   Straub F. B., 1942, STUDIES I MED CHEM U, V2, P3
   Svitkina TM, 1999, TRENDS BIOCHEM SCI, V24, P432, DOI 10.1016/S0968-0004(99)01461-9
   Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5
   TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207
   van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500
   van der Honing HS, 2011, CYTOSKELETON, V68, P578, DOI 10.1002/cm.20534
   Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908
NR 113
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
BN 978-0-12-410523-2
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PY 2013
VL 90
BP 151
EP 177
PG 27
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BFG37
UT WOS:000319779300006
PM 23582204
DA 2021-01-25
ER

PT J
AU Marot, L
   De Temmerman, G
   Doerner, RP
   Umstadter, K
   Wagner, RS
   Mathys, D
   Duggelin, M
   Meyer, E
AF Marot, L.
   De Temmerman, G.
   Doerner, R. P.
   Umstadter, K.
   Wagner, R. S.
   Mathys, D.
   Duggelin, M.
   Meyer, E.
TI Synergistic effects of hydrogen plasma exposure, pulsed laser heating
   and temperature on rhodium surfaces
SO JOURNAL OF NUCLEAR MATERIALS
LA English
DT Article
ID EROSION; TUNGSTEN; MIRRORS; IRRADIATION; DEPENDENCE; SIMULATION; SOLIDS;
   PISCES; ENERGY
AB The combined effect of hydrogen plasma exposure and surface heating, either continuous or by short laser pulses (5 ns), on the surface morphology of rhodium layers has been studied. Investigations were performed by reflectivity measurements, scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS) and atomic force microscope (AFM). While surfaces exposed at room temperature exhibit little modifications, strong surface changes are observed for surface temperatures higher than 250 degrees C. At 500 degrees C, the plasma exposed surface exhibits a nanoscale structure (50-100 nm) with a high level of porosity and a low reflectivity. Additional laser irradiation of the surface strongly enhances the observed surface damage. Localized surface melting is observed with craters extending deep into the substrate together with a dense network of voids. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Marot, L.; Wagner, R. S.; Meyer, E.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   [De Temmerman, G.] EURATOM, FOM Inst DIFFER, Ducth Inst Fundamental Energy Res, NL-3430 BE Nieuwegein, Netherlands.
   [Doerner, R. P.; Umstadter, K.] Univ Calif San Diego, Energy Res Ctr, La Jolla, CA 92093 USA.
   [Wagner, R. S.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Wagner, R. S.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Mathys, D.; Duggelin, M.] Univ Basel, Ctr Microscopy, CH-4056 Basel, Switzerland.
RP Marot, L (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM laurent.marot@unibas.ch
RI Meyer, Ernst/L-3873-2016; Marot, Laurent/A-5834-2008
OI Meyer, Ernst/0000-0001-6385-3412; Marot, Laurent/0000-0002-1529-9362
FU Swiss Federal Office of Energy; Federal Office for Education and Science
FX The financial support of the Swiss Federal Office of Energy and of the
   Federal Office for Education and Science is gratefully acknowledged. Mrs
   Verena Thommen and Mrs Monica Schonenberger are thanked for the AFM
   measurements.
CR Abe Y., 2001, Surface Science Spectra, V8, P117, DOI 10.1116/11.20010801
   Balden M, 2004, J NUCL MATER, V329, P1515, DOI 10.1016/j.jnucmat.2004.04.240
   Baldwin MJ, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035001
   Baldwin MJ, 2009, J NUCL MATER, V390-91, P886, DOI 10.1016/j.jnucmat.2009.01.247
   Brindley G.W., 1980, CRYSTAL STRUCTURES C, P131
   Brooks JN, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/4/045003
   Costley AE, 2010, IEEE T PLASMA SCI, V38, P2934, DOI 10.1109/TPS.2010.2064182
   De Temmerman G, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798389
   Eren B, 2011, FUSION ENG DES, V86, P2593, DOI 10.1016/j.fusengdes.2010.12.038
   GOEBEL DM, 1984, J NUCL MATER, V121, P277, DOI 10.1016/0022-3115(84)90135-1
   Joanny M, 2012, IEEE T PLASMA SCI, V40, P692, DOI 10.1109/TPS.2011.2181539
   Litnovsky A, 2007, J NUCL MATER, V363, P1395, DOI 10.1016/j.jnucmat.2007.01.281
   Litnovsky A, 2007, FUSION ENG DES, V82, P123, DOI 10.1016/j.fusengdes.2006.07.095
   Litnovsky A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075014
   Marot L, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2800779
   Marot L, 2008, SURF COAT TECH, V202, P2837, DOI 10.1016/j.surfcoat.2007.10.014
   Marot L, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/36/365707
   Marot L., 2008, 14 ITPA TG DIAGN LAU
   Marot L, 2008, SURF SCI, V602, P3375, DOI 10.1016/j.susc.2008.09.012
   Marot L, 2009, J NUCL MATER, V390-91, P1135, DOI 10.1016/j.jnucmat.2009.01.266
   Matveeva M., 2010, 37 EPS C PLASM PHYS
   Matveeva M., J NUCL MAT UNPUB
   MOLLER W, 1988, COMPUT PHYS COMMUN, V51, P355, DOI 10.1016/0010-4655(88)90148-8
   Naylor GA, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/C03043
   Ohno N, 2007, J NUCL MATER, V363, P1153, DOI 10.1016/j.jnucmat.2007.01.148
   Passoni M, 2010, J NUCL MATER, V404, P1, DOI 10.1016/j.jnucmat.2010.06.015
   SCHMITZ L, 1990, J NUCL MATER, V176, P522, DOI 10.1016/0022-3115(90)90100-2
   Ueda Y, 2007, FUSION ENG DES, V82, P1904, DOI 10.1016/j.fusengdes.2006.12.002
   Umstadter KR, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/5/053014
   Umstadter KR, 2009, J NUCL MATER, V386-88, P751, DOI 10.1016/j.jnucmat.2008.12.209
   Voitsenya V, 2001, REV SCI INSTRUM, V72, P475, DOI 10.1063/1.1310580
   Walsh MJ, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336473
   WEISSENRIEDER KS, 1997, THIN SOLID FILMS, V30, P300
   Yamamura Y, 1996, ATOM DATA NUCL DATA, V62, P149, DOI 10.1006/adnd.1996.0005
   Yoshida N., IRRADIATION EFFECTS
NR 35
TC 2
Z9 2
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3115
J9 J NUCL MATER
JI J. Nucl. Mater.
PD JAN
PY 2013
VL 432
IS 1-3
BP 388
EP 394
DI 10.1016/j.jnucmat.2012.08.013
PG 7
WC Materials Science, Multidisciplinary; Nuclear Science & Technology
SC Materials Science; Nuclear Science & Technology
GA 128XB
UT WOS:000317801900051
DA 2021-01-25
ER

PT J
AU Jagoda, A
   Zinn, M
   Bieler, E
   Meier, W
   Kita-Tokarczyk, K
AF Jagoda, Agnieszka
   Zinn, Manfred
   Bieler, Eva
   Meier, Wolfgang
   Kita-Tokarczyk, Katarzyna
TI Biodegradable polymer-lipid monolayers as templates for calcium
   phosphate mineralization
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID MACROPOROUS POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) MATRICES;
   DIRECTED INORGANIC CRYSTALLIZATION; 3-DIMENSIONAL SCAFFOLDS;
   POLYCATIONIC MONOLAYER; ORIENTED NUCLEATION; OSTEOBLAST RESPONSE;
   MOLECULAR PACKING; APATITE FORMATION; SURFACE PRESSURE; IONIC STRUCTURE
AB A combination of poly([R]-3-hydroxy-10-undecenoate) (PHUE), a biodegradable polymer from the group of polyhydroxyalkanoates (PHAs), and lipids of different head groups was used to support the growth of calcium phosphate, the main component of mammalian bones. Crystallization took place under two-dimensional films (Langmuir monolayers). The addition of a negatively charged lipid, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine, to a PHUE film led to the formation of lipid domains (rich in negative charge), and resulted in excellent mineralization control: crystals with uniform size and morphology were formed. The results show that carefully optimized combinations of materials can lead to better control of calcium phosphate crystallization compared to one-component organic scaffolds.
C1 [Jagoda, Agnieszka; Meier, Wolfgang; Kita-Tokarczyk, Katarzyna] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Zinn, Manfred] Univ Appl Sci Western Switzerland HES SO Valais, Inst Life Technol, CH-1950 Sion, Switzerland.
   [Bieler, Eva] Univ Basel, Ctr Microscopy ZMB, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Jagoda, A (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM katarzyna.kita@mail.com
RI Kita-Tokarczyk, Katarzyna/A-5614-2009; Kita-Tokarczyk,
   Katarzyna/V-4285-2019
OI Kita-Tokarczyk, Katarzyna/0000-0003-0741-134X; Zinn,
   Manfred/0000-0003-3565-3872
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); NCCR NanoscienceSwiss National Science Foundation (SNSF); Swiss
   Nanoscience Institute
FX We thank the Swiss National Science Foundation, NCCR Nanoscience and
   Swiss Nanoscience Institute for financial support, and Gianni Morson
   (ZMB, Uni Basel) for help with TEM. A.J. is grateful to A. Spielhofer
   and B. Banusch (Nanoscience students, Uni Basel) for help with the
   experiments.
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   [Anonymous], 2011, HLTH GLANCE 2011 OEC
   Bosetti M, 2007, J MATER SCI-MATER M, V18, P611, DOI 10.1007/s10856-007-2309-1
   Bosetti M, 2005, BIOMATERIALS, V26, P7572, DOI 10.1016/j.biomaterials.2005.05.033
   Casse O, 2008, FARADAY DISCUSS, V139, P179, DOI 10.1039/b716353c
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen YJ, 2009, LANGMUIR, V25, P1054, DOI 10.1021/la8029424
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   DiMasi E, 2002, LANGMUIR, V18, P8902, DOI 10.1021/la0260032
   Dynarowicz-Latka P, 2000, THIN SOLID FILMS, V360, P261, DOI 10.1016/S0040-6090(99)00889-5
   EANES ED, 1992, GLYCOBIOLOGY, V2, P571, DOI 10.1093/glycob/2.6.571
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartmann R, 2004, MACROMOLECULES, V37, P6780, DOI 10.1021/ma040035+
   HAUSER H, 1976, EUR J BIOCHEM, V62, P335, DOI 10.1111/j.1432-1033.1976.tb10165.x
   HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   HEYWOOD BR, 1992, ADV MATER, V4, P278, DOI 10.1002/adma.19920040407
   HEYWOOD BR, 1992, J AM CHEM SOC, V114, P4681, DOI 10.1021/ja00038a034
   HEYWOOD BR, 1992, LANGMUIR, V8, P1492, DOI 10.1021/la00041a041
   Jagoda A, 2012, MACROMOL CHEM PHYS, V213, P1922, DOI 10.1002/macp.201200232
   Jagoda A, 2011, LANGMUIR, V27, P10878, DOI 10.1021/la201654d
   JOOS P, 1969, BIOCHIM BIOPHYS ACTA, V183, P447, DOI 10.1016/0005-2736(69)90159-X
   Junginger M, 2010, NANOSCALE, V2, P2440, DOI 10.1039/c0nr00380h
   Junginger M, 2010, MACROMOL BIOSCI, V10, P1084, DOI 10.1002/mabi.201000093
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   LU HB, 1995, J CRYST GROWTH, V155, P120, DOI 10.1016/0022-0248(95)00229-4
   Ma CL, 1997, J CRYST GROWTH, V173, P141, DOI 10.1016/S0022-0248(96)00775-0
   Mann S., 2005, BIOMINERALIZATION PR
   Marcotte N, 1999, J PHYS CHEM A, V103, P3163, DOI 10.1021/jp9846328
   Maynadie J, 2004, INORG CHEM, V43, P2064, DOI 10.1021/ic0345828
   Merolli A, 2006, J MATER SCI-MATER M, V17, P789, DOI 10.1007/s10856-006-9836-z
   Merolli A, 2009, MOLECULES, V14, P5367, DOI 10.3390/molecules14125367
   MESTRES C, 1992, LANGMUIR, V8, P1388, DOI 10.1021/la00041a024
   PHILLIPS MC, 1972, BIOCHIM BIOPHYS ACTA, V290, P397, DOI 10.1016/0005-2736(72)90084-3
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   RAGGIO CL, 1986, J BONE MINER RES, V1, P409
   Reinstorf A, 2004, J MATER SCI-MATER M, V15, P451, DOI 10.1023/B:JMSM.0000021119.14870.3d
   SALZ E, 1981, J PHYS CHEM-US, V85, P3211, DOI 10.1021/j150622a002
   Santin M, 2006, J R SOC INTERFACE, V3, P277, DOI 10.1098/rsif.2005.0088
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Satsangi A, 2003, BIOMATERIALS, V24, P4585, DOI 10.1016/S0142-9612(03)00330-2
   Satsangi N, 2004, J MATER SCI-MATER M, V15, P693, DOI 10.1023/B:JMSM.0000030211.32655.80
   SCHROEDER LW, 1980, J BIOMED MATER RES, V14, P83, DOI 10.1002/jbm.820140109
   SEIMIYA T, 1987, CHEM PHYS LIPIDS, V43, P161, DOI 10.1016/0009-3084(87)90006-5
   SEIMIYA T, 1973, BIOCHIM BIOPHYS ACTA, V298, P546, DOI 10.1016/0005-2736(73)90073-4
   SHAH DO, 1967, J LIPID RES, V8, P227
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   STANDISH MM, 1968, T FARADAY SOC, V64, P1113, DOI 10.1039/tf9686401113
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Stripe B, 2012, LANGMUIR, V28, P572, DOI 10.1021/la2037422
   Sun JY, 2005, EUR POLYM J, V41, P2443, DOI 10.1016/j.eurpolymj.2005.04.039
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Toworfe GK, 2006, KEY ENG MATER, V309-311, P275, DOI 10.4028/www.scientific.net/KEM.309-311.275
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Walker HK, 1990, CLIN METHODS HIST PH
   Wang Y, 2008, BIOMATERIALS, V29, P2858, DOI 10.1016/j.biomaterials.2008.03.021
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   WUTHIER RE, 1975, CALC TISS RES, V19, P197, DOI 10.1007/BF02564004
   WUTHIER RE, 1985, CALCIFIED TISSUE INT, V37, P401, DOI 10.1007/BF02553710
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Zhang LJ, 2004, LANGMUIR, V20, P2243, DOI 10.1021/la035381j
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
   IMAGE J
NR 66
TC 4
Z9 4
U1 2
U2 41
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2013
VL 1
IS 3
BP 368
EP 378
DI 10.1039/c2tb00083k
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA 087TY
UT WOS:000314787400014
PM 32260761
DA 2021-01-25
ER

PT J
AU Rech, EL
   Arber, W
AF Rech, E. L.
   Arber, W.
TI Biodiversity as a source for synthetic domestication of useful specific
   traits
SO ANNALS OF APPLIED BIOLOGY
LA English
DT Review
DE Biodiversity traits; recombinant DNA; soybean fatty acids; synthetic
   domestication; synthetic spider-like fibre
ID SPIDER SILK; PROTEINS; SEQUENCE; BIOLOGY; DNA
AB Plant and animal domestication form the foundation of agriculture. Currently, there are considerable efforts and hypotheses to understand adaptation and regulatory processes involving domestication and biodiversity organisms. Here, we propose the use of recombinant DNA as a foundation for the synthetic domestication of biodiversity traits. For example, we commented on current studies involving synthetic spider-like fibres production in bacteria and mimicking oil seed species in genetically manipulated soybean. We suggest that this approach constitutes a sustainable and viable option for conservation and development of value-added processes and products from biodiversity.
C1 [Rech, E. L.] Embrapa Genet Resources & Biotechnol, Synthet Biol & Nanotechnol Grp, BR-70770917 Brasilia, DF, Brazil.
   [Arber, W.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Rech, EL (corresponding author), Embrapa Genet Resources & Biotechnol, Synthet Biol & Nanotechnol Grp, Parque Estacao Biol, BR-70770917 Brasilia, DF, Brazil.
EM elibio.rech@embrapa.br; w.arber@unibas.ch
CR Arber W., 2012, SYSTEMS BIOL ADV MOL, P145
   BERG P, 1975, SCIENCE, V188, P991, DOI 10.1126/science.1056638
   Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013
   Bittencourt D, 2010, COMP BIOCHEM PHYS B, V155, P419, DOI 10.1016/j.cbpb.2010.01.005
   Darwin C, 1876, ORIGIN SPECIES MEANS
   Darwin CR, 1868, VARIATION ANIMALS PL
   Drew E., 2005, NATURE, V438, P449
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Martin CH, 2009, CHEM BIOL, V16, P277, DOI 10.1016/j.chembiol.2009.01.010
   Murad AM, 2011, J MOL MODEL, V17, P1183, DOI 10.1007/s00894-010-0823-4
   Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634
   Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Shapiro J. A., 2011, EVOLUTION VIEW 21 CE
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
NR 22
TC 5
Z9 6
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-4746
EI 1744-7348
J9 ANN APPL BIOL
JI Ann. Appl. Biol.
PY 2013
VL 162
IS 2
BP 141
EP 144
DI 10.1111/aab.12013
PG 4
WC Agriculture, Multidisciplinary
SC Agriculture
GA 085CZ
UT WOS:000314591400001
DA 2021-01-25
ER

PT J
AU Kristensen, RM
   Neves, RC
   Gad, G
AF Kristensen, Reinhardt Mobjerg
   Neves, Ricardo Cardoso
   Gad, Gunnar
TI First report of Loricifera from the Indian Ocean: a new
   Rugiloricus-species represented by a hermaphrodite
SO CAHIERS DE BIOLOGIE MARINE
LA English
DT Article
DE Rugiloricus renaudae; Meiofauna; Hermaphroditism; Indian Ocean; Channel
   of Mozambique; BENTHEDI I expedition
ID ANGOLA BASIN; LIFE-CYCLE; DEEP-SEA; PLICILORICIDAE
AB A hermaphroditic adult of a new species of Rugiloricus was discovered in the deep sea of the Channel of Mozambique at 3,400 m water depth. This is the first report of Loricifera from the Indian Ocean. The adult of R. renaudae sp. nov. differs from similar species in having a mouth cone of medium size with a long, narrow, distally pointed first section; a mouth opening surrounded by four small denticle-like oral teeth; the long distal parts of the clavoscalids with a fine ventral serration; the proximal parts of the clavoscalids with a dorsal serration and stalked bases; a short, thin, transformed ventral pair of clavoscalids which Tartly looks like the spinoscalids of the second row; these spinoscalids divided into four segments, the three distal segments being laterally winged with serrated edges; the type B scalids of the fourth row end in indistinct hooks; the bristle-like scalids of the third to eighth rows with a fine serration; the trichoscalids differ slightly in length, but not in structure; the lorica plicae with double primary ridges and a single secondary ridge; a very small anal cone with a pair of narrow standing warts. The hermaphroditic adults have a single ovary and a single testis. These findings support earlier hypotheses regarding the life cycle of other Rugiloricus-species.
C1 [Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Zool Museum, Invertebrate Dept, DK-2100 Copenhagen O, Denmark.
   [Neves, Ricardo Cardoso] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gad, Gunnar] Carl von Ossietzky Univ Oldenburg, AG Zoosystemat & Morphol, Fak Math & Nat Wissensch 5, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.
RP Neves, RC (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM ricardon.6@gmail.com
RI Neves, Ricardo Cardoso/J-9822-2014; Kristensen, Reinhardt M/A-8772-2013
OI Neves, Ricardo Cardoso/0000-0002-9219-9066; Kristensen, Reinhardt
   M/0000-0001-9549-1188
FU European Union (EU)European Union (EU); Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHM-352/31-1];
   Danish Research CouncilDet Frie Forskningsrad (DFF) [FNU 272-08-0576];
   Carlsberg FoundationCarlsberg Foundation
FX We are grateful to Dr. Jeanne Renaud-Momant (Museum National d'Histoire
   Naturelle, Paris, France) for the material offered to the Zoological
   Museum of Copenhagen. Thanks are due to Prof. Dr. H. K. Schminke and
   Prof. Dr. Heinrich Reichert (Basel) for making helpful comments on this
   manuscript and to Dr. Anne-Sophie Laurenson (Basel) for translating the
   abstract into French. This publication is a result of the COBICE
   (Copenhagen Biosystematics Centre) project no. 212, which enabled G. Gad
   to use facilities at the Zoological Museum (ZMUC), Copenhagen. The
   COBICE project was financially supported by the European Union (EU).
   Furthermore, this work was supported by the Deutsche
   Forschungsgemeinschaft (grant no. SCHM-352/31-1), the Danish Research
   Council (grant no. FNU 272-08-0576) and the Carlsberg Foundation.
CR Danovaro R., 2012, YB SCI TECHNOLOGY, P5
   Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30
   Gad G, 2005, ORG DIVERS EVOL, V5, P77, DOI 10.1016/j.ode.2004.10.006
   Gad G, 2005, MAR BIOL RES, V1, P313, DOI 10.1080/17451000500327455
   Gad G, 2004, ARCH FISH MAR RES, V51, P9
   Gad G., 2005, BERICHTE POLAR MEERE, V507, P140
   Gad G., 2002, DEEP SEA NEWSLETTER, V32, P4
   Gad G, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2096.1.6
   Heiner I., 2010, NZ INVENTORY BIODIVE, V2, P472
   Heiner I, 2008, SYST BIODIVERS, V6, P225, DOI 10.1017/S147720000800265X
   Higgins R.P., 1986, SMITHSONIAN CONTRIB, V438, P1
   Higgins RP., 1988, INTRO STUDY MEIOFAUN
   Kristensen Reinhardt M., 2002, P179
   KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163
   KRISTENSEN RM, 1988, ZOOL SCI, V5, P875
   KRISTENSEN RM, 1991, VERH DTSCH ZOOL GES, V84, P231
   Kristensen RM, 2003, MITTELMEER FAUNA FLO, P638
   Neuhaus B, 1997, ACTA ZOOL-STOCKHOLM, V78, P215, DOI 10.1111/j.1463-6395.1997.tb01008.x
NR 18
TC 13
Z9 13
U1 0
U2 9
PU CAHIERS DE BIOLOGIE MARINE
PI ROSCOFF
PA STATION BIOLOGIQUE PLACE GEORGES TEISSIER, 29680 ROSCOFF, FRANCE
SN 0007-9723
EI 2262-3094
J9 CAH BIOL MAR
JI Cah. Biol. Mar.
PY 2013
VL 54
IS 1
BP 161
EP 171
PG 11
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA 081KA
UT WOS:000314319700015
DA 2021-01-25
ER

PT J
AU Wiktor, M
   Morin, S
   Sass, HJ
   Kebbel, F
   Grzesiek, S
AF Wiktor, Maciej
   Morin, Sebastien
   Sass, Hans-Juergen
   Kebbel, Fabian
   Grzesiek, Stephan
TI Biophysical and structural investigation of bacterially expressed and
   engineered CCR5, a G protein-coupled receptor
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE CCR5; G protein-coupled receptor; Expression in E. coli; NMR; Homology
   modeling
ID MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY;
   ESCHERICHIA-COLI; OPIOID RECEPTOR; BOVINE RHODOPSIN; HIV-1 INFECTION;
   SMALL-MOLECULE; GPCR; PURIFICATION
AB The chemokine receptor CCR5 belongs to the class of G protein-coupled receptors. Besides its role in leukocyte trafficking, it is also the major HIV-1 coreceptor and hence a target for HIV-1 entry inhibitors. Here, we report Escherichia coli expression and a broad range of biophysical studies on E. coli-produced CCR5. After systematic screening and optimization, we obtained 10 mg of purified, detergent-solubilized, folded CCR5 from 1L culture in a triply isotope-labeled (H-2/N-15/C-13) minimal medium. Thus the material is suitable for NMR spectroscopic studies. The expected alpha-helical secondary structure content is confirmed by circular dichroism spectroscopy. The solubilized CCR5 is monodisperse and homogeneous as judged by transmission electron microscopy. Interactions of CCR5 with its ligands, RANTES and MIP-1 beta were assessed by surface plasmon resonance yielding K-D values in the nanomolar range. Using size exclusion chromatography, stable monomeric CCR5 could be isolated. We show that cysteine residues affect both the yield and oligomer distribution of CCR5. HSQC spectra suggest that the transmembrane domains of CCR5 are in equilibrium between several conformations. In addition we present a model of CCR5 based on the crystal structure of CXCR4 as a starting point for protein engineering.
C1 [Wiktor, Maciej; Morin, Sebastien; Sass, Hans-Juergen; Grzesiek, Stephan] Univ Basel, Focal Area Struct Biol & Biophys, Biozentrum, CH-4056 Basel, Switzerland.
   [Kebbel, Fabian] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Focal Area Struct Biol & Biophys, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225; Morin,
   Sebastien/0000-0003-4426-326X
FU EUEuropean Union (EU); SNF [31-109,712]; SystemsX.ch (C-CINA)
FX We thank Prof. A. Arseniev for providing the plasmids pET28F10 and
   pMT10H10 and Prof. A. Spang for the plasmid pCA528, Dr. Paul Jeno and
   Suzanne Moes for mass spectrometry analysis as well as Dr. Marcel
   Blommers, Dr. Lukasz Skora and Prof. Sebastian Hiller for stimulating
   discussions. This work was supported by the EU FP7 Combined Highly
   Active Anti-Retroviral Microbicides (CHAARM), SNF Grant 31-109,712 and
   SystemsX.ch (C-CINA).
CR Abramoff D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Attrill H, 2009, PROTEIN EXPRES PURIF, V64, P32, DOI 10.1016/j.pep.2008.10.001
   Balistreri CR, 2007, ANN NY ACAD SCI, V1100, P162, DOI 10.1196/annals.1395.014
   Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8
   Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200
   Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902
   Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dodevski I, 2011, J MOL BIOL, V408, P599, DOI 10.1016/j.jmb.2011.02.051
   Duncan SR, 2005, J MED GENET, V42, P205, DOI 10.1136/jmg.2004.025346
   Filmore D., 2004, MOD DRUG DISCOV, V7, P24
   Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256
   Furukawa H, 2000, J BIOCHEM-TOKYO, V127, P151, DOI 10.1093/oxfordjournals.jbchem.a022577
   Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105
   Gautier A, 2008, ANGEW CHEM INT EDIT, V47, P7297, DOI 10.1002/anie.200802783
   Gottschalk G., 1986, BACTERIAL METABOLISM
   Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111
   Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753
   Hanson MA, 2012, SCIENCE, V335, P851, DOI 10.1126/science.1215904
   Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152
   Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772
   Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005
   Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101
   Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002
   Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867
   Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136
   Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288
   Lemay J, 2005, NAT IMMUNOL, V6, P535, DOI 10.1038/ni0605-535a
   Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5
   Lusso P, 2011, FASEB J, V25, P1230, DOI 10.1096/fj.10-167627
   Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954
   Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m
   Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653
   Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017
   Navratilova I, 2006, ANAL BIOCHEM, V353, P278, DOI 10.1016/j.ab.2006.03.049
   Navratilova I, 2011, ACS MED CHEM LETT, V2, P549, DOI 10.1021/ml2000017
   Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001
   Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007
   Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a
   Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580
   Park SH, 2011, BIOCHEMISTRY-US, V50, P2371, DOI 10.1021/bi101568j
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Petrovskaya LE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P881, DOI 10.1134/S0006297910070102
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648
   Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509
   Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226
   Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0
   Sastry M, 2011, J BIOMOL NMR, V50, P197, DOI 10.1007/s10858-011-9506-4
   Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068
   Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236
   Stenkamp RE, 2008, ACTA CRYSTALLOGR D, V64, P902, DOI 10.1107/S0907444908017162
   Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867
   Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8
   Tian CL, 2005, J AM CHEM SOC, V127, P8010, DOI 10.1021/ja051161b
   Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101
   Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x
   Werner K, 2008, J BIOMOL NMR, V40, P49, DOI 10.1007/s10858-007-9205-3
   White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004
   Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396
   Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939
NR 70
TC 12
Z9 12
U1 0
U2 26
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD JAN
PY 2013
VL 55
IS 1
BP 79
EP 95
DI 10.1007/s10858-012-9688-4
PG 17
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 077TK
UT WOS:000314050700008
PM 23229639
DA 2021-01-25
ER

PT J
AU Rudolph, MG
   Duany, YD
   Jungblut, SP
   Ganguly, A
   Klostermeier, D
AF Rudolph, Markus G.
   Duany, Yoandris del Toro
   Jungblut, Stefan P.
   Ganguly, Agneyo
   Klostermeier, Dagmar
TI Crystal structures of Thermotoga maritima reverse gyrase: inferences for
   the mechanism of positive DNA supercoiling
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HELICASE-LIKE DOMAIN; DEAD-BOX PROTEIN; TOPOISOMERASE-I; STRANDED-DNA;
   NUCLEOTIDE; ATP; LATCH; COMPLEX; BINDING; ENZYME
AB Reverse gyrase is an ATP-dependent topoisomerase that is unique to hyperthermophilic archaea and eubacteria. The only reverse gyrase structure determined to date has revealed the arrangement of the N-terminal helicase domain and the C-terminal topoisomerase domain that intimately cooperate to generate the unique function of positive DNA supercoiling. Although the structure has elicited hypotheses as to how supercoiling may be achieved, it lacks structural elements important for supercoiling and the molecular mechanism of positive supercoiling is still not clear. We present five structures of authentic Thermotoga maritima reverse gyrase that reveal a first view of two interacting zinc fingers that are crucial for positive DNA supercoiling. The so-called latch domain, which connects the helicase and the topoisomerase domains is required for their functional cooperation and presents a novel fold. Structural comparison defines mobile regions in parts of the helicase domain, including a helical insert and the latch that are likely important for DNA binding during catalysis. We show that the latch, the helical insert and the zinc fingers contribute to the binding of DNA to reverse gyrase and are uniquely placed within the reverse gyrase structure to bind and guide DNA during strand passage. A possible mechanism for positive supercoiling by reverse gyrases is presented.
C1 [Rudolph, Markus G.] Discovery Technol, Pharma Res & Early Dev, PRED, CH-4070 Basel, Switzerland.
   [Duany, Yoandris del Toro; Ganguly, Agneyo; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany.
   [Jungblut, Stefan P.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 28-30, D-48149 Munster, Germany.
EM dagmar.klostermeier@uni-muenster.de
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); DFGGerman Research Foundation (DFG) [SFB858]; European Union
   (Marie Curie Fellowship)European Union (EU); University of Muenster
FX The Swiss National Science Foundation (to D. K.); DFG [SFB858, to D.
   K.]; European Union (Marie Curie Fellowship, to A. G.). Funding for open
   access charge: University of Muenster.
CR Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Capp C, 2010, J BIOL CHEM, V285, P39637, DOI 10.1074/jbc.M110.173989
   Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   de la Tour CB, 2008, J BIOL CHEM, V283, P27395, DOI 10.1074/jbc.M800867200
   Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587
   Duany YD, 2011, BIOCHEMISTRY-US, V50, P5816, DOI 10.1021/bi200236a
   Duany YD, 2011, PHYS CHEM CHEM PHYS, V13, P10009, DOI 10.1039/c0cp02859b
   Einspahr H.M., 2011, INT TABLES CRYSTAL F, VF, P64
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1
   Ganguly A, 2013, J MOL BIOL, V425, P32, DOI 10.1016/j.jmb.2012.10.016
   Ganguly A, 2011, NUCLEIC ACIDS RES, V39, P1789, DOI 10.1093/nar/gkq1048
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Hansen G, 2006, J MOL BIOL, V358, P1328, DOI 10.1016/j.jmb.2006.03.012
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200
   Jaxel C, 1996, NUCLEIC ACIDS RES, V24, P4668, DOI 10.1093/nar/24.23.4668
   Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031
   KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903
   Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683
   Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]
   Krah R, 1996, P NATL ACAD SCI USA, V93, P106, DOI 10.1073/pnas.93.1.106
   Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Li J, 2011, EXTREMOPHILES, V15, P281, DOI 10.1007/s00792-011-0356-5
   LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   NAKASU S, 1985, EMBO J, V4, P2705, DOI 10.1002/j.1460-2075.1985.tb03990.x
   Perry K, 2003, STRUCTURE, V11, P1349, DOI 10.1016/j.str.2003.09.013
   Rodriguez AC, 2003, BIOCHEMISTRY-US, V42, P5993, DOI 10.1021/bi034188l
   Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418
   Viard T, 2004, J BIOL CHEM, V279, P30073, DOI 10.1074/jbc.M309692200
   Viard T, 2001, J BIOL CHEM, V276, P46495, DOI 10.1074/jbc.M107714200
   Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228
   Warkentin Matthew, 2007, Journal of Structural and Functional Genomics, V8, P141, DOI 10.1007/s10969-007-9029-0
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 48
TC 16
Z9 16
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2013
VL 41
IS 2
BP 1058
EP 1070
DI 10.1093/nar/gks1073
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 078SZ
UT WOS:000314121100038
PM 23209025
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Shui, GH
   Maag, D
   Santos, G
   Wenk, MR
   Handschin, C
AF Summermatter, Serge
   Shui, Guanghou
   Maag, Daniela
   Santos, Gesa
   Wenk, Markus R.
   Handschin, Christoph
TI PGC-1 alpha Improves Glucose Homeostasis in Skeletal Muscle in an
   Activity-Dependent Manner
SO DIABETES
LA English
DT Article
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; PROTEIN-KINASE-C;
   INSULIN-RESISTANCE; RAT ADIPOCYTES; OXIDATIVE-METABOLISM;
   PHYSICAL-ACTIVITY; HEXOSE-TRANSPORT; EXERCISE; DIET; DISEASE
AB Metabolic disorders are a major burden for public health systems globally. Regular exercise improves metabolic health. Pharmacological targeting of exercise mediators might facilitate physical activity or amplify the effects of exercise. The peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1 alpha) largely mediates musculoskeletal adaptations to exercise, including lipid refueling, and thus constitutes such a putative target. Paradoxically, forced expression of PGC-1 alpha in muscle promotes diet-induced insulin resistance in sedentary animals. We show that elevated PGC-1 alpha in combination with exercise preferentially improves glucose homeostasis, increases Krebs cycle activity, and reduces the levels of acylcarnitines and sphingosine. Moreover, patterns of lipid partitioning are altered in favor of enhanced insulin sensitivity in response to combined PGC-1 alpha and exercise. Our findings reveal how physical activity improves glucose homeostasis. Furthermore, our data suggest that the combination of elevated muscle PGC-1 alpha and exercise constitutes a promising approach for the treatment of metabolic disorders. Diabetes 62:85-95, 2013
C1 [Summermatter, Serge; Santos, Gesa; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
   [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.
   [Maag, Daniela] Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, Univ Childrens Hosp, Zurich, Switzerland.
   [Wenk, Markus R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015; Wenk, Markus/D-1441-2014
OI Handschin, Christoph/0000-0003-0603-1097; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy Association USA
   (MDA)Muscular Dystrophy Association; SwissLife "Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung"; Swiss Society for Research
   on Muscle Diseases (SSEM); Swiss Diabetes Association; Roche Research
   Foundation; United Mitochondrial Disease Foundation (UMDF); Association
   Francaise contre les Myopathies (AFM)Association Francaise contre les
   Myopathies; University of Basel; Singapore National Research Foundation
   (CRP)Singapore National Research Foundation [2007-04]; SystemsX.ch RTD
   project LipidX
FX This project was funded by the Swiss National Science Foundation (SNF
   PP00A-110746), the Muscular Dystrophy Association USA (MDA), the
   SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische
   Forschung," the Swiss Society for Research on Muscle Diseases (SSEM),
   the Swiss Diabetes Association, the Roche Research Foundation, the
   United Mitochondrial Disease Foundation (UMDF), the Association
   Francaise contre les Myopathies (AFM), and the University of Basel.
   M.R.W. has received grants from the Singapore National Research
   Foundation (CRP Award No. 2007-04) and the SystemsX.ch RTD project
   LipidX.
CR Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754
   Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Bogers RP, 2010, OBES REV, V11, P51, DOI 10.1111/j.1467-789X.2009.00606.x
   Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142
   Cheng B, 1997, PHYSIOL BEHAV, V61, P701, DOI 10.1016/S0031-9384(96)00522-7
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   FOLEY JE, 1980, DIABETOLOGIA, V19, P234, DOI 10.1007/BF00275275
   FRIED SK, 1981, J LIPID RES, V22, P753
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   GRIMDITCH GK, 1988, AM J CLIN NUTR, V48, P38
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Jakicic JM, 2009, OBESITY, V17, pS34, DOI 10.1038/oby.2009.386
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kopelman PG, 2000, NATURE, V404, P635
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409
   Lee JS, 2001, EXP PHYSIOL, V86, P499, DOI 10.1113/eph8602158
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004
   Matsakas A, 2010, CURR SPORT MED REP, V9, P227, DOI 10.1249/JSR.0b013e3181e93938
   MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   RICHARD D, 1982, J NUTR, V112, P1756
   ROBERTSON DG, 1989, J BIOL CHEM, V264, P6773
   Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d
   SMAL J, 1989, P NATL ACAD SCI USA, V86, P4705, DOI 10.1073/pnas.86.12.4705
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0, 10.1016/0076-6879(69)13005-0.]
   Summermatter S, 2012, INT J OBES LOND
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457
   TAKAGI A, 1971, BIOCHIM BIOPHYS ACTA, V248, P12, DOI 10.1016/0005-2760(71)90069-5
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhang JW, 2010, ENDOCRINE, V37, P157, DOI 10.1007/s12020-009-9283-y
NR 52
TC 70
Z9 77
U1 1
U2 27
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
J9 DIABETES
JI Diabetes
PD JAN
PY 2013
VL 62
IS 1
BP 85
EP 95
DI 10.2337/db12-0291
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 061CM
UT WOS:000312824700018
PM 23086035
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Pachkov, M
   Balwierz, PJ
   Arnold, P
   Ozonov, E
   van Nimwegen, E
AF Pachkov, Mikhail
   Balwierz, Piotr J.
   Arnold, Phil
   Ozonov, Evgeniy
   van Nimwegen, Erik
TI SwissRegulon, a database of genome-wide annotations of regulatory sites:
   recent updates
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID FACTOR-BINDING-SITES; TRANSCRIPTIONAL REGULATION; MULTIPLE ALIGNMENTS;
   MOUSE; IDENTIFICATION; CHROMATIN; PATTERNS; BROWSER; MOTIFS; ATLAS
AB Identification of genomic regulatory elements is essential for understanding the dynamics of cellular processes. This task has been substantially facilitated by the availability of genome sequences for many species and high-throughput data of transcripts and transcription factor (TF) binding. However, rigorous computational methods are necessary to derive accurate genome-wide annotations of regulatory sites from such data. SwissRegulon (http://swissregulon.unibas.ch) is a database containing genome-wide annotations of regulatory motifs, promoters and TF binding sites (TFBSs) in promoter regions across model organisms. Its binding site predictions were obtained with rigorous Bayesian probabilistic methods that operate on orthologous regions from related genomes, and use explicit evolutionary models to assess the evidence of purifying selection on each site. New in the current version of SwissRegulon is a curated collection of 190 mammalian regulatory motifs associated with similar to 340 TFs, and TFBS annotations across a curated set of similar to 35 000 promoters in both human and mouse. Predictions of TFBSs for Saccharomyces cerevisiae have also been significantly extended and now cover 158 of yeast's similar to 180 TFs. All data are accessible through both an easily navigable genome browser with search functions, and as flat files that can be downloaded for further analysis.
C1 [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Balwierz, Piotr J/AAG-4187-2020
OI Balwierz, Piotr J/0000-0002-1548-4605; van Nimwegen,
   Erik/0000-0001-6338-1312
FU Swiss Institute of Bioinformatics; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [31003A-118318];
   SystemsX.ch through the CellPlasticity project; University of Basel
FX Swiss Institute of Bioinformatics (to M. P.); Swiss National Science
   Foundation [31003A-118318, in part]; SystemsX.ch through the
   CellPlasticity project. Funding for open access charge: University of
   Basel.
CR Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014
   Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955
   Bulyk ML, 2007, ADV BIOCHEM ENG BIOT, V104, P65, DOI 10.1007/10_025
   Carmack CS, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-1
   Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054
   Davidson EH, 2001, GENOMIC REGULATORY S
   Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279
   Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963
   Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966
   Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488
   Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112
   Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507
   Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98
   Notredame C., 2010, CURR PROTOC BIOINFOR
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044
   Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964
NR 29
TC 60
Z9 60
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2013
VL 41
IS D1
BP D214
EP D220
DI 10.1093/nar/gks1145
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 062BE
UT WOS:000312893300029
PM 23180783
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Krudewig, A
   Sauteur, L
   Lenard, A
   Herwig, L
   Ellertsdottir, E
   Blum, Y
   Affolter, M
   Belting, HG
AF Krudewig, Alice
   Sauteur, Loic
   Lenard, Anna
   Herwig, Lukas
   Ellertsdottir, Elin
   Blum, Yannick
   Affolter, Markus
   Belting, Heinz-Georg
TI Distinct morphogenetic cell activities during sprouting angiogenesis and
   anastomosis require Ve-cadherin
SO ANGIOGENESIS
LA English
DT Meeting Abstract
C1 [Krudewig, Alice; Sauteur, Loic; Lenard, Anna; Herwig, Lukas; Ellertsdottir, Elin; Blum, Yannick; Affolter, Markus; Belting, Heinz-Georg] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
J9 ANGIOGENESIS
JI Angiogenesis
PD JAN
PY 2013
VL 16
IS 1
BP 258
EP 258
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 058UA
UT WOS:000312658800071
DA 2021-01-25
ER

PT J
AU Monnard, FW
   Nogueira, ES
   Heinisch, T
   Schirmer, T
   Ward, TR
AF Monnard, Fabien W.
   Nogueira, Elisa S.
   Heinisch, Tillmann
   Schirmer, Tilman
   Ward, Thomas R.
TI Human carbonic anhydrase II as host protein for the creation of
   artificial metalloenzymes: the asymmetric transfer hydrogenation of
   imines
SO CHEMICAL SCIENCE
LA English
DT Article
ID CATALYSTS; BINDING; INHIBITORS; COMPLEXES; REDUCTION; DESIGN;
   METALLOPROTEINS; ANCHOR; SITE
AB In the presence of human carbonic anhydrase II, aryl-sulfonamide-bearing IrCp* pianostool complexes catalyze the asymmetric transfer hydrogenation of imines. Critical cofactor-protein interactions revealed by the X-ray structure of [(eta(5)-Cp*)Ir(pico 4)CI] 9 subset of WT hCA II were genetically optimized to improve the catalytic performance of the artificial metalloenzyme (68% ee, k(cat)/K-M 6.11 x 10(-3) min(-1) mM(-1)).
C1 [Monnard, Fabien W.; Nogueira, Elisa S.; Heinisch, Tillmann; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Heinisch, Tillmann; Schirmer, Tilman] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ward, TR (corresponding author), Univ Basel, Dept Chem, Spitalstr 51, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; thomas.ward@unibas.ch
RI Ward, Thomas R/K-6419-2012
OI Ward, Thomas R/0000-0001-8602-5468
FU Novartis FoundationNovartis; Swiss Nanoscience Institute; Marie Curie
   ITN (Biotrains) [FP7-ITN-238531]; Marie Curie ITN (BioChemLig)
   [FP7-ITN-238434]
FX FWM thanks the Novartis Foundation and the Swiss Nanoscience Institute
   for financial support. EN thanks Marie Curie ITN (Biotrains
   FP7-ITN-238531). TH thanks the Marie Curie ITN (BioChemLig
   FP7-ITN-238434) TRW thanks C. Fierke for the hCA II plasmid and Umicore
   for a loan of Ir.
CR Abe S, 2009, TOP ORGANOMETAL CHEM, V25, P25, DOI 10.1007/3418_2008_4
   Baird TT, 1997, BIOCHEMISTRY-US, V36, P2669, DOI 10.1021/bi962663s
   Bos J, 2012, ANGEW CHEM INT EDIT, V51, P7472, DOI 10.1002/anie.201202070
   Bourdonnec B.L., 2000, J MED CHEM, V43, P2685
   Can D, 2012, ANGEW CHEM INT EDIT, V51, P3354, DOI 10.1002/anie.201107333
   Christopher JA, 2009, J MED CHEM, V52, P3098, DOI 10.1021/jm9000117
   Cordaro JG, 2002, CHEM COMMUN, P1496, DOI 10.1039/b203595b
   Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646
   Durrenberger M, 2011, ANGEW CHEM INT EDIT, V50, P3026, DOI 10.1002/anie.201007820
   Esmieu C, 2013, ANGEW CHEM INT EDIT, V52, P3922, DOI 10.1002/anie.201209021
   Fernandez-Gacio A, 2006, CHEMBIOCHEM, V7, P1013, DOI 10.1002/cbic.200600127
   Garner DK, 2011, ACS CATAL, V1, P1083, DOI 10.1021/cs200258e
   Gunnaz S, 2011, ORGANOMETALLICS, V30, P4165, DOI 10.1021/om200470p
   Ishida Y, 2009, CHEM COMMUN, P2848, DOI 10.1039/b905814a
   Iyer R, 2006, J BIOMOL SCREEN, V11, P782, DOI 10.1177/1087057106289403
   Jing Q, 2010, CHEMCATCHEM, V2, P953, DOI 10.1002/cctc.201000159
   Jing Q, 2009, CHEM-EUR J, V15, P1370, DOI 10.1002/chem.200801673
   Jones RC, 2009, TETRAHEDRON, V65, P7474, DOI 10.1016/j.tet.2009.07.013
   Kaufman TS, 2004, TETRAHEDRON-ASYMMETR, V15, P1203, DOI 10.1016/j.tetasy.2004.02.021
   Khanna IK, 2000, J MED CHEM, V43, P3168, DOI 10.1021/jm0000719
   Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p
   Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304
   Matsuo T, 2012, CHEM COMMUN, V48, P1662, DOI 10.1039/c2cc16898g
   Mayer C, 2011, CHEM COMMUN, V47, P12068, DOI 10.1039/c1cc15005g
   McCalmont WF, 2005, BIOORGAN MED CHEM, V13, P3821, DOI 10.1016/j.bmc.2005.03.004
   Monnard FW, 2011, CHEM COMMUN, V47, P8238, DOI 10.1039/c1cc10345h
   Mulcahy SP, 2010, TOP ORGANOMETAL CHEM, V32, P141, DOI 10.1007/978-3-642-13185-1_6
   Negi S, 1996, SYNTHESIS-STUTTGART, P991
   Ohashi M, 2003, ANGEW CHEM INT EDIT, V42, P1005, DOI 10.1002/anie.200390256
   Penso M, 2008, J ORG CHEM, V73, P6686, DOI 10.1021/jo800930g
   Qi DF, 2001, CHEM REV, V101, P3081, DOI 10.1021/cr000059o
   Qin L, 1998, BIOCHEMISTRY-US, V37, P3499, DOI 10.1021/bi9720585
   Reetz MT, 2009, TOP ORGANOMETAL CHEM, V25, P63, DOI 10.1007/3418_2008_12
   Rosati F, 2010, CHEMCATCHEM, V2, P916, DOI 10.1002/cctc.201000011
   Schmid M, 2012, CHEM SCI, V3, P690, DOI 10.1039/c1sc00628b
   Shaabani A, 2004, TETRAHEDRON, V60, P11415, DOI 10.1016/j.tet.2004.09.087
   Soltani O, 2010, ORG LETT, V12, P2893, DOI 10.1021/ol1008894
   Steinreiber J, 2008, COORDIN CHEM REV, V252, P751, DOI 10.1016/j.ccr.2007.09.016
   van den Heuvel M, 2004, J ORG CHEM, V69, P250, DOI 10.1021/jo035157z
   Wang C, 2011, CHEM COMMUN, V47, P9773, DOI 10.1039/c1cc12326b
   Wang SC, 2006, BIOCHEM MOL BIOL EDU, V34, P364, DOI 10.1002/bmb.2006.494034052656
   Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u
NR 42
TC 42
Z9 43
U1 2
U2 55
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
J9 CHEM SCI
JI Chem. Sci.
PY 2013
VL 4
IS 8
BP 3269
EP 3274
DI 10.1039/c3sc51065d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 176LV
UT WOS:000321307000038
OA Green Accepted
DA 2021-01-25
ER

PT B
AU van Driel, R
AF van Driel, Roel
BE VanSpeybroeck, L
   Braeckman, J
TI Biology comes of age: from gathering information to understanding
SO FASCINEREND LEVEN: MARKANTE FIGUREN EN IDEEEN UIT DE GESCHIEDENIS VAN DE
   BIOLOGIE
LA Dutch
DT Article; Book Chapter
C1 [van Driel, Roel] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [van Driel, Roel] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   [van Driel, Roel] Univ Amsterdam, Biochem, NL-1012 WX Amsterdam, Netherlands.
RP van Driel, R (corresponding author), Netherlands Consortium Syst Biol, Amsterdam, Netherlands.
EM r.vandriel@uva.nl
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIA PRESS
PI GHENT
PA GHENT, BELGIUM
BN 978-90-382-2037-6
PY 2013
BP 493
EP 504
PG 12
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA BC4TD
UT WOS:000352907100020
DA 2021-01-25
ER

PT J
AU Perspicace, S
   Rufer, AC
   Thoma, R
   Mueller, F
   Hennig, M
   Ceccarelli, S
   Schulz-Gasch, T
   Seelig, J
AF Perspicace, Samantha
   Rufer, Arne C.
   Thoma, Ralf
   Mueller, Francis
   Hennig, Michael
   Ceccarelli, Simona
   Schulz-Gasch, Tanja
   Seelig, Joachim
TI Isothermal titration calorimetry with micelles: Thermodynamics of
   inhibitor binding to carnitine palmitoyltransferase 2 membrane protein
SO FEBS OPEN BIO
LA English
DT Article
DE rCPT-2 (rat carnitine-palmitoyltransferase); CMC (critical micellar
   concentration); ITC (isothermal titration calorimetry); beta-OG
   (n-octyl-beta-D-glucopyranoside)
ID LIGAND INTERACTIONS; CRYSTAL-STRUCTURE; ACYLTRANSFERASES; PURIFICATION;
   FLUORESCENCE; TEMPERATURE; CINNAMYCIN; DETERGENTS; ANALOG
AB Carnitine palmitoyl transferase 2 (CPT-2) is a key enzyme in the mitochondrial fatty acid metabolism. The active site is comprised of a Y-shaped tunnel with distinct binding sites for the substrate acylcarnitine and the cofactor CoA. We investigated the thermodynamics of binding of four inhibitors directed against either the CoA or the acylcarnitine binding sites using isothermal titration calorimetry (ITC). CPT-2 is a monotopic membrane protein and was solubilized by beta-octylglucoside (beta-OG) above its critical micellar concentration (CMC) to perform inhibitor titrations in solutions containing detergent micelles. The CMC of beta-OG in the presence of inhibitors was measured with ITC and small variations were observed. The inhibitors bound to rat CPT-2 (rCPT-2) with 1:1 stoichiometry and the dissociation constants were in the range of K-D = 2-20 mu M. New X-ray structures and docking models of rCPT-2 in complex with inhibitors enable an analysis of the thermodynamic data in the context of the interaction observed for the individual binding sites of the ligands. For all ligands the binding enthalpy was exothermic, and enthalpy as well as entropy contributed to the binding reaction, with the exception of ST1326 for which binding was solely enthalpy-driven. The substrate analog ST1326 binds to the acylcarnitine binding site and a heat capacity change close to zero suggests a balance of electrostatic and hydrophobic interactions. An excellent correlation of the thermodynamic (ITC) and structural (X-ray crystallography, models) data was observed suggesting that ITC measurements provide valuable information for optimizing inhibitor binding in drug discovery. (C) 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies. All rights reserved.
C1 [Perspicace, Samantha; Seelig, Joachim] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Rufer, Arne C.; Thoma, Ralf; Mueller, Francis; Hennig, Michael] F Hoffmann La Roche & Cie AG, pRED, Pharma Res & Early Dev, Discovery Technol, CH-4070 Basel, Switzerland.
   [Ceccarelli, Simona; Schulz-Gasch, Tanja] F Hoffmann La Roche & Cie AG, pRED, Pharma Res & Early Dev, Discovery Chem, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-129701]
FX We thank M. Rudolph (crystal structure of the surrogate of inhibitors 1
   and 2), M. Stihle and J. Benz (crystallization and crystal structure
   refinement, respectively), E. Kusznir (fluorescence measurements), O.
   Chomienne and L. Hilfiger and C. Karrer (activity measurements) and P.
   Mattei (synthesis of sulfonamide series). The authors thank the staff at
   the SLS X10SA-PXII beamline for support with data collection. This work
   was supported by the Swiss National Science Foundation Grant
   #31003A-129701.
CR Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890
   Beck A, 2010, J PHYS CHEM B, V114, P15862, DOI 10.1021/jp107088d
   BHAIRD NNA, 1993, BIOCHEM J, V294, P645
   BIEBER LL, 1986, METHOD ENZYMOL, V123, P276
   BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401
   BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9
   Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004
   Ceccarelli SM, 2011, J MED CHEM, V54, P3109, DOI 10.1021/jm100809g
   DEGRIP WJ, 1979, CHEM PHYS LIPIDS, V23, P321, DOI 10.1016/0009-3084(79)90010-0
   Deschauer M, 2005, ARCH NEUROL-CHICAGO, V62, P37, DOI 10.1001/archneur.62.1.37
   deVries Y, 1997, BIOCHEMISTRY-US, V36, P5285, DOI 10.1021/bi962875p
   Eftink MR, 1997, METHOD ENZYMOL, V278, P221
   FIOL CJ, 1988, LIPIDS, V23, P120, DOI 10.1007/BF02535291
   Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118
   Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001
   Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902
   Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107
   Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006
   JOHNSON TM, 1995, BIOCHEM J, V309, P689, DOI 10.1042/bj3090689
   Machaidze G, 2003, BIOCHEMISTRY-US, V42, P12570, DOI 10.1021/bi035225b
   Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c
   Majhi PR, 2001, LANGMUIR, V17, P3844, DOI 10.1021/la001660k
   Milletti F, 2007, J CHEM INF MODEL, V47, P2172, DOI 10.1021/ci700018y
   Milletti F, 2010, EUR J MED CHEM, V45, P4270, DOI 10.1016/j.ejmech.2010.06.026
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   Rufer AC, 2006, STRUCTURE, V14, P713, DOI 10.1016/j.str.2006.01.008
   Rufer AC, 2007, FEBS LETT, V581, P3247, DOI 10.1016/j.febslet.2007.05.080
   Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247
   Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8
NR 29
TC 19
Z9 19
U1 0
U2 21
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 2211-5463
J9 FEBS OPEN BIO
JI FEBS Open Bio
PY 2013
VL 3
BP 204
EP 211
DI 10.1016/j.fob.2013.04.003
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AM0XA
UT WOS:000339569800033
PM 23772395
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Kiebler, MA
   Scheiffele, P
   Ule, J
AF Kiebler, Michael A.
   Scheiffele, Peter
   Ule, Jernej
TI What, where, and when: the importance of post-transcriptional regulation
   in the brain
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Editorial Material
DE alternative splicing; RNA editing; RNA methylation; translation; mRNA
   trafficking; axon guidance; synaptic plasticity; neurological disease
ID PROTEIN-RNA INTERACTIONS; MECHANISMS; TRANSLATION; BDNF
C1 [Kiebler, Michael A.] Ludwig Maximilians Univ Munchen, Dept Anatomy & Cell Biol, Munich, Germany.
   [Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
   [Ule, Jernej] Univ Coll London Inst Neurol, Dept Mol Neuroscience, London, England.
RP Kiebler, MA (corresponding author), Ludwig Maximilians Univ Munchen, Dept Anatomy & Cell Biol, Munich, Germany.
EM j.ule@ucl.ac.uk
RI Ule, Jernej/C-6315-2013
OI Ule, Jernej/0000-0002-2452-4277; Kiebler, Michael/0000-0002-8850-6297
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U105185858] Funding Source: Medline
CR Aparicio-Erriu IM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00167
   Baj G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00188
   Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036
   Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173
   Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322
   Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038
   Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278
   Fernandez E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00191
   Gascon E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00048
   Hornberg H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00081
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Kapeli K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00144
   Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141
   Kusek G, 2012, CELL STEM CELL, V11, P505, DOI 10.1016/j.stem.2012.06.006
   Modic M, 2013, MOL CELL NEUROSCI, V56, P429, DOI 10.1016/j.mcn.2013.04.002
   Norris AD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00122
   Penn AC, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00061
   Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038
   Tariq A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00099
   Trivedi MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00092
   Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238
   Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016
   Vessey JP, 2012, CELL STEM CELL, V11, P517, DOI 10.1016/j.stem.2012.06.010
NR 23
TC 9
Z9 9
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PY 2013
VL 7
AR 192
DI 10.3389/fnins.2013.00192
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA AW9HF
UT WOS:000346567300190
PM 24194693
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Arnold, P
   Scholer, A
   Pachkov, M
   Balwierz, PJ
   Jorgensen, H
   Stadler, MB
   van Nimwegen, E
   Schubeler, D
AF Arnold, Phil
   Schoeler, Anne
   Pachkov, Mikhail
   Balwierz, Piotr J.
   Jorgensen, Helle
   Stadler, Michael B.
   van Nimwegen, Erik
   Schuebeler, Dirk
TI Modeling of epigenome dynamics identifies transcription factors that
   mediate Polycomb targeting
SO GENOME RESEARCH
LA English
DT Article
ID EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; RNA-POLYMERASE-II; DNA
   METHYLATION; FACTOR-BINDING; DIFFERENTIATED CELLS; METHYLTRANSFERASE
   ACTIVITY; DEVELOPMENTAL REGULATORS; CHROMATIN STATE; GENE-EXPRESSION
AB Although changes in chromatin are integral to transcriptional reprogramming during cellular differentiation, it is currently unclear how chromatin modifications are targeted to specific loci. To systematically identify transcription factors (TFs) that can direct chromatin changes during cell fate decisions, we model the relationship between genomewide dynamics of chromatin marks and the local occurrence of computationally predicted TF binding sites. By applying this computational approach to a time course of Polycomb-mediated H3K27me3 marks during neuronal differentiation of murine stem cells, we identify several motifs that likely regulate the dynamics of this chromatin mark. Among these, the sites bound by REST and by the SNAIL family of TFs are predicted to transiently recruit H3K27me3 in neuronal progenitors. We validate these predictions experimentally and show that absence of REST indeed causes loss of H3K27me3 at target promoters in trans, specifically at the neuronal progenitor state. Moreover, using targeted transgenic insertion, we show that promoter fragments containing REST or SNAIL binding sites are sufficient to recruit H3K27me3 in cis, while deletion of these sites results in loss of H3K27me3. These findings illustrate that the occurrence of TF binding sites can determine chromatin dynamics. Local determination of Polycomb activity by REST and SNAIL motifs exemplifies such TF based regulation of chromatin. Furthermore, our results show that key TFs can be identified ab initio through computational modeling of epigenome data sets using a modeling approach that we make readily accessible.
C1 [Arnold, Phil; Pachkov, Mikhail; Balwierz, Piotr J.; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Arnold, Phil; Pachkov, Mikhail; Balwierz, Piotr J.; van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Schoeler, Anne; Stadler, Michael B.; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Schoeler, Anne; Stadler, Michael B.] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland.
   [Schoeler, Anne; Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland.
   [Jorgensen, Helle] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch; dirk@fmi.ch
RI Balwierz, Piotr J/AAG-4187-2020
OI Balwierz, Piotr J/0000-0002-1548-4605; Jorgensen,
   Helle/0000-0002-7909-2977; Scholer, Anne/0000-0001-6354-1689; van
   Nimwegen, Erik/0000-0001-6338-1312
FU Novartis Research Foundation; European UnionEuropean Union (EU)
   [FP7-HEALTH-2010-257082, LSHG-CT-2006-037415]; European Research
   CouncilEuropean Research Council (ERC) [ERC-204264]; Swiss National
   Science Foundation (Sinergia program); Swiss Institute of
   Bioinformatics; Swiss Systems Biology Initiative SystemsX.ch within the
   network "Cellplasticity."; EMBO Young Investigator programEuropean
   Molecular Biology Organization (EMBO)
FX We thank Robert Ivanek, Lukas Burger, and Nacho Molina for advice;
   Nicolas Thoma , Susan Gasser, and members of the Schubeler and van
   Nimwegen labs for comments on the manuscript; and the Laboratory for
   Quantitative Genomics of the ETH Zurich in Basel for next-generation
   sequencing. We also thank David Anderson for providing one of the used
   REST antibodies. Research in the laboratory of D. S. is supported by the
   Novartis Research Foundation, by the European Union (NoE "EpiGeneSys''
   FP7-HEALTH-2010-257082, LSHG-CT-2006-037415), the European Research
   Council (ERC-204264), the Swiss National Science Foundation (Sinergia
   program), and the EMBO Young Investigator program. E.v.N. acknowledges
   support by the Swiss National Science Foundation and the Swiss Institute
   of Bioinformatics. D. S. and E.v.N.are both supported by the Swiss
   Systems Biology Initiative SystemsX.ch within the network
   "Cellplasticity.''
CR Abbott A, 2011, NATURE, V477, P518, DOI 10.1038/477518a
   Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002
   Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6
   Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6
   Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733
   Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706
   Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017
   Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761
   Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   Chan HM, 2001, J CELL SCI, V114, P2363
   Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431
   Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3
   Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067
   de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802
   Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494
   Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113
   Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768
   Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08
   Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319
   Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256
   Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783
   Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242
   Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021
   Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946
   Liu YC, 2010, GENOMICS, V96, P17, DOI 10.1016/j.ygeno.2010.03.012
   Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047
   Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107
   Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684
   Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244
   Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008
   Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007
   Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5
   Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757
   O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001
   Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788
   Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013
   Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420
   Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391
   Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11
   Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723
   Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039
   SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435
   Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071
   Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902
   Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002
   Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994
   Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115
   Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315
   Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990
   Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238
   Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003
   Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248
   Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9
   Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905
NR 80
TC 78
Z9 80
U1 0
U2 16
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD JAN
PY 2013
VL 23
IS 1
BP 60
EP 73
DI 10.1101/gr.142661.112
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 062ZJ
UT WOS:000312963400006
PM 22964890
OA Green Published, Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Ritz, AM
   Trautwein, M
   Grassinger, F
   Spang, A
AF Ritz, A. M.
   Trautwein, M.
   Grassinger, F.
   Spang, A.
TI The prion domain in the exomer-dependent cargo Pin2p serves as
   trans-Golgi retention motif
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Ritz, A. M.; Trautwein, M.; Grassinger, F.; Spang, A.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2013
VL 24
MA 255
PG 1
WC Cell Biology
SC Cell Biology
GA V38MY
UT WOS:000209348705537
DA 2021-01-25
ER

PT J
AU Roubinet, C
   Cabernard, C
AF Roubinet, C.
   Cabernard, C.
TI Characterization of the polarity-dependent cleavage furrow positioning
   pathway required for asymmetric division of neuroblasts
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Roubinet, C.; Cabernard, C.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2013
VL 24
MA 1772
PG 1
WC Cell Biology
SC Cell Biology
GA V38MY
UT WOS:000209348703267
DA 2021-01-25
ER

PT J
AU Lehtinen, S
   Marsellach, FX
   Codlin, S
   Schmidt, A
   Clement-Ziza, M
   Beyer, A
   Bahler, J
   Orengo, C
   Pancaldi, V
AF Lehtinen, Sonja
   Marsellach, Francesc Xavier
   Codlin, Sandra
   Schmidt, Alexander
   Clement-Ziza, Mathieu
   Beyer, Andreas
   Baehler, Juerg
   Orengo, Christine
   Pancaldi, Vera
TI Stress induces remodelling of yeast interaction and co-expression
   networks
SO MOLECULAR BIOSYSTEMS
LA English
DT Article
ID OXIDATIVE STRESS; GENE-EXPRESSION; FISSION YEAST; RESPONSES; MODULARITY;
   EVOLUTION; DATABASE; MODULES
AB Network analysis provides a powerful framework for the interpretation of genome-wide data. While static network approaches have proved fruitful, there is increasing interest in the insights gained from the analysis of cellular networks under different conditions. In this work, we study the effect of stress on cellular networks in fission yeast. Stress elicits a sophisticated and large scale cellular response, involving a shift of resources from cell growth and metabolism towards protection and maintenance. Previous work has suggested that these changes can be appreciated at the network level. In this paper, we study two types of cellular networks: gene co-regulation networks and weighted protein interaction networks. We show that in response to oxidative stress, the co-regulation networks re-organize towards a more modularised structure: while sets of genes become more tightly co-regulated, co-regulation between these modules is decreased. This shift translates into longer average shortest path length, increased transitivity, and decreased modular overlap in these networks. We also find a similar change in structure in the weighted protein interaction network in response to both oxidative stress and nitrogen starvation, confirming and extending previous findings. These changes in network structure could represent an increase in network robustness and/or the emergence of more specialised functional modules. Additionally, we find stress induces tighter co-regulation of non-coding RNAs, decreased functional importance of splicing factors, as well as changes in the centrality of genes involved in chromatin organization, cytoskeleton organization, cell division, and protein turnover.
C1 [Lehtinen, Sonja] UCL, CoMPLEX, London WC1E 6BT, England.
   [Marsellach, Francesc Xavier; Codlin, Sandra; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Marsellach, Francesc Xavier; Codlin, Sandra; Baehler, Juerg] UCL, Inst Canc, London WC1E 6BT, England.
   [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, Basel, Switzerland.
   [Clement-Ziza, Mathieu; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany.
   [Orengo, Christine] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England.
   [Pancaldi, Vera] Spanish Natl Canc Res Ctr CNIO, Struct Biol & BioComp Program, Madrid 28029, Spain.
RP Orengo, C (corresponding author), UCL, Inst Struct & Mol Biol, Gower St, London WC1E 6BT, England.
EM c.orengo@ucl.ac.uk; v.pancaldi@cnio.es
RI Marsellach, Xavi/P-7835-2017; Beyer, Andreas/AAQ-5519-2020; Pancaldi,
   Vera/Y-5757-2019; Bahler, Jurg/B-4572-2009; Beyer, Andreas/A-3352-2009;
   Pancaldi, Vera/I-2555-2015; Clement-Ziza, Mathieu/J-4146-2012
OI Marsellach, Xavi/0000-0002-2435-6904; Beyer,
   Andreas/0000-0002-3891-2123; Pancaldi, Vera/0000-0002-7433-624X; Bahler,
   Jurg/0000-0003-4036-1532; Beyer, Andreas/0000-0002-3891-2123; Pancaldi,
   Vera/0000-0002-7433-624X; Clement-Ziza, Mathieu/0000-0003-2763-249X
FU PhenOxiGEn (an EU FP7 research project)European Union (EU); Wellcome
   Trust Senior Investigator AwardWellcome Trust; Engineering and Physical
   Sciences Research CouncilEngineering & Physical Sciences Research
   Council (EPSRC); Klaus Tschira Foundation; EU FP7 HEALTH grant
   [HEALTH-F4-2008-223539]; Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [974619] Funding Source: researchfish
FX The authors would like to thank two anonymous referees for suggesting
   interesting improvements to this work. This research was funded by
   PhenOxiGEn (an EU FP7 research project) and a Wellcome Trust Senior
   Investigator Award to JB. S.L. is supported by the Engineering and
   Physical Sciences Research Council.; A.B. is supported by the Klaus
   Tschira Foundation. A.B. and M.C.Z are supported by a EU FP7 HEALTH
   grant (HEALTH-F4-2008-223539).
CR Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817
   Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182
   Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154
   Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680
   Berry DB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002353
   Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735
   Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499
   de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055
   Gopalacharyulu PV, 2009, MOL BIOSYST, V5, P276, DOI 10.1039/b815347g
   Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555
   Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006
   Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528
   Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25
   Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035
   Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013
   Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019
   Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187
   Nadal-Ribelles M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r106
   Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271
   Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568
   Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p
   Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033
   Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851
   Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405
   Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863
   Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Vaggi F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002732
   Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
NR 33
TC 13
Z9 13
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1742-206X
EI 1742-2051
J9 MOL BIOSYST
JI Mol. Biosyst.
PY 2013
VL 9
IS 7
BP 1697
EP 1707
DI 10.1039/c3mb25548d
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 157FU
UT WOS:000319882200017
PM 23471351
OA Bronze
DA 2021-01-25
ER

PT J
AU Bentzinger, CF
   Lin, S
   Romanino, K
   Castets, P
   Guridi, M
   Summermatter, S
   Handschin, C
   Tintignac, LA
   Hall, MN
   Ruegg, MA
AF Bentzinger, C. Florian
   Lin, Shuo
   Romanino, Klaas
   Castets, Perrine
   Guridi, Maitea
   Summermatter, Serge
   Handschin, Christoph
   Tintignac, Lionel A.
   Hall, Michael N.
   Rueegg, Markus A.
TI Differential response of skeletal muscles to mTORC1 signaling during
   atrophy and hypertrophy
SO SKELETAL MUSCLE
LA English
DT Article
DE Skeletal muscle; Hypertrophy; Atrophy; Mammalian target of rapamycin
   complex 1 (mTORC1); Raptor; Tuberous sclerosis complex (TSC); PKB/Akt;
   FoxO; MuRF1; Atrogin-1/MAFbx
AB Background: Skeletal muscle mass is determined by the balance between protein synthesis and degradation. Mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of protein translation and has been implicated in the control of muscle mass. Inactivation of mTORC1 by skeletal muscle-specific deletion of its obligatory component raptor results in smaller muscles and a lethal dystrophy. Moreover, raptor-deficient muscles are less oxidative through changes in the expression PGC-1 alpha, a critical determinant of mitochondrial biogenesis. These results suggest that activation of mTORC1 might be beneficial to skeletal muscle by providing resistance to muscle atrophy and increasing oxidative function. Here, we tested this hypothesis by deletion of the mTORC1 inhibitor tuberous sclerosis complex (TSC) in muscle fibers.
   Method: Skeletal muscles of mice with an acute or a permanent deletion of raptor or TSC1 were examined using histological, biochemical and molecular biological methods. Response of the muscles to changes in mechanical load and nerve input was investigated by ablation of synergistic muscles or by denervation.
   Results: Genetic deletion or knockdown of raptor, causing inactivation of mTORC1, was sufficient to prevent muscle growth and enhance muscle atrophy. Conversely, short-term activation of mTORC1 by knockdown of TSC induced muscle fiber hypertrophy and atrophy-resistance upon denervation, in both fast tibialis anterior (TA) and slow soleus muscles. Surprisingly, however, sustained activation of mTORC1 by genetic deletion of Tsc1 caused muscle atrophy in all but soleus muscles. In contrast, oxidative capacity was increased in all muscles examined. Consistently, TSC1-deficient soleus muscle was atrophy-resistant whereas TA underwent normal atrophy upon denervation. Moreover, upon overloading, plantaris muscle did not display enhanced hypertrophy compared to controls. Biochemical analysis indicated that the atrophy response of muscles was based on the suppressed phosphorylation of PKB/Akt via feedback inhibition by mTORC1 and subsequent increased expression of the E3 ubiquitin ligases MuRF1 and atrogin-1/MAFbx. In contrast, expression of both E3 ligases was not increased in soleus muscle suggesting the presence of compensatory mechanisms in this muscle.
   Conclusions: Our study shows that the mTORC1- and the PKB/Akt-FoxO pathways are tightly interconnected and differentially regulated depending on the muscle type. These results indicate that long-term activation of the mTORC1 signaling axis is not a therapeutic option to promote muscle growth because of its strong feedback induction of the E3 ubiquitin ligases involved in protein degradation.
C1 [Bentzinger, C. Florian; Lin, Shuo; Romanino, Klaas; Castets, Perrine; Guridi, Maitea; Summermatter, Serge; Handschin, Christoph; Tintignac, Lionel A.; Hall, Michael N.; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Castets, Perrine] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland.
   [Tintignac, Lionel A.] Univ Montpellier 2, Univ Montpellier 1, INRA, UMR866, Montpellier, France.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019; Handschin, Christoph/E-6886-2015
OI Ruegg, Markus/0000-0002-4974-9384; Handschin,
   Christoph/0000-0003-0603-1097; Bentzinger, C.
   Florian/0000-0003-0422-9622
FU Canton of Basel-Stadt; Canton of Baselland; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Swiss Foundation for
   Research on Muscle Disease; Swiss Life; Association Francaise contres
   les Myopathies (AFM)Association Francaise contre les Myopathies
FX We thank Drs. Xian Chu Kong and Celine Costa for their help with the
   shRNA constructs. We thank Dr. Philippe Pierre (CIML Parc Scientifique
   de Luminy, Marseille, France) for providing us with the anti-puromycin
   antibody. This work was supported by the Cantons of Basel-Stadt and
   Baselland, grants from the Swiss National Science Foundation, the Swiss
   Foundation for Research on Muscle Disease, Swiss Life and the
   Association Francaise contres les Myopathies (AFM).
CR Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003
   BALDWIN KM, 1982, J APPL PHYSIOL, V52, P467
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1
   Dunn SE, 1997, AM J PHYSIOL-CELL PH, V273, pC371
   Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908
   Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774
   GOLDBERG AL, 1967, AM J PHYSIOL, V213, P1193
   Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454
   Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08
   Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Liu M, 2007, MUSCLE NERVE, V35, P649, DOI 10.1002/mus.20749
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007
   Mori H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1013, DOI 10.1152/ajpendo.00262.2009
   Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005
   Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599
   Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Romanino K, 2011, P NATL ACAD SCI USA, V108, P20808, DOI 10.1073/pnas.1111448109
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   Shavlakadze T, 2005, NEUROMUSCULAR DISORD, V15, P139, DOI 10.1016/j.nmd.2004.10.013
   Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Stockholm D, 2001, AM J PHYSIOL-CELL PH, V280, pC1561
   Tamaki T, 2009, HISTOCHEM CELL BIOL, V132, P59, DOI 10.1007/s00418-009-0585-1
   Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373
   TONGE DA, 1974, J PHYSIOL-LONDON, V241, P141, DOI 10.1113/jphysiol.1974.sp010645
   van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053
   Wan M, 2006, FEBS LETT, V580, P5621, DOI 10.1016/j.febslet.2006.09.008
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491
   Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004
NR 61
TC 72
Z9 74
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2044-5040
J9 SKELET MUSCLE
JI Skeletal Muscle
PY 2013
VL 3
AR 6
DI 10.1186/2044-5040-3-6
PG 16
WC Cell Biology
SC Cell Biology
GA V39PN
UT WOS:000209423000006
PM 23497627
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Gagne, D
   Charest, LA
   Morin, S
   Kovrigin, EL
   Doucet, N
AF Gagne, Donald
   Charest, Laurie-Anne
   Morin, Sebstien
   Kovrigin, Evgenii L.
   Doucet, Nicolas
TI Conservation of Flexible Residue Clusters among Structural and
   Functional Enzyme Homologues
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MAGNETIC-RESONANCE RELAXATION; EOSINOPHIL CATIONIC PROTEIN; MODEL-FREE
   APPROACH; RIBONUCLEASE-A; CRYSTAL-STRUCTURE; CHEMICAL-EXCHANGE; BACKBONE
   DYNAMICS; MOTIONS; RNASE; MACROMOLECULES
AB Conformational flexibility between structural ensembles is an essential component of enzyme function. Although the broad dynamical landscape of proteins is known to promote a number of functional events on multiple time scales, it is yet unknown whether structural and functional enzyme homologues rely on the same concerted residue motions to perform their catalytic function. It is hypothesized that networks of contiguous and flexible residue motions occurring on the biologically relevant millisecond time scale evolved to promote and/or preserve optimal enzyme catalysis. In this study, we use a combination of NMR relaxation dispersion, model-free analysis, and ligand titration experiments to successfully capture and compare the role of conformational flexibility between two structural homologues of the pancreatic ribonuclease family: RNaseA and eosinophil cationic protein (or RNase 3). In addition to conserving the same catalytic residues and structural fold, both homologues show similar yet functionally distinct clusters of millisecond dynamics, suggesting that conformational flexibility can be conserved among analogous protein folds displaying low sequence identity. Our work shows that the reduced conformational flexibility of eosinophil cationic protein can be dynamically and functionally reproduced in the RNase A scaffold upon creation of a chimeric hybrid between the two proteins. These results support the hypothesis that conformational flexibility is partly required for catalytic function in homologous enzyme folds, further highlighting the importance of dynamic residue sectors in the structural organization of proteins.
C1 [Gagne, Donald; Charest, Laurie-Anne; Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ H7V 1B7, Canada.
   [Morin, Sebstien] Univ Basel, Swiss Inst Bioinformat & Biozentrum, CH-4056 Basel, Switzerland.
   [Kovrigin, Evgenii L.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.
RP Doucet, N (corresponding author), Univ Quebec, INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada.
EM nicolas.doucet@iaf.inrs.ca
OI Morin, Sebastien/0000-0003-4426-326X
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of CanadaCGIAR [RGPIN
   402623-2011]; Fonds de Recherche du Quebec Sante Research Scholar-Junior
   1 career award; "Fondation Universitaire Armand-Frappier de l'INRS"
   Ph.D. scholarship; Fonds de Recherche du Quebec, Nature et Technologies,
   Strategic Cluster "Regroupement Quebecois de Recherche sur la Fonction,
   la Structure et l'Ingenierie des Proteines" (PROTEO); Fonds de Recherche
   du Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la
   Structure des Proteines" (GRASP)
FX This work was supported in part by Natural Sciences and Engineering
   Research Council of Canada Discovery Grant RGPIN 402623-2011 (to N. D.)
   and a Fonds de Recherche du Quebec Sante Research Scholar-Junior 1
   career award (to N. D.).; Recipient of a "Fondation Universitaire
   Armand-Frappier de l'INRS" Ph.D. scholarship.; Supported by the Fonds de
   Recherche du Quebec, Nature et Technologies, Strategic Cluster
   "Regroupement Quebecois de Recherche sur la Fonction, la Structure et
   l'Ingenierie des Proteines" (PROTEO) and the Fonds de Recherche du
   Quebec Sante (FRQS) Strategic Cluster "Groupe de Recherche Axe sur la
   Structure des Proteines" (GRASP).
CR Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092
   Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007
   Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481
   Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238
   Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145
   Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1
   Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a
   Branden C., 1999, INTRO PROTEIN STRUCT
   Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055
   Carnevale V, 2006, J AM CHEM SOC, V128, P9766, DOI 10.1021/ja060896t
   CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X
   Chatani E, 2002, BIOCHEMISTRY-US, V41, P4567, DOI 10.1021/bi011365e
   Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m
   Cuchillo CM, 2011, BIOCHEMISTRY-US, V50, P7835, DOI 10.1021/bi201075b
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3
   d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2
   Davey JA, 2012, PROTEIN SCI, V21, P1241, DOI 10.1002/pro.2128
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200
   Doucet N, 2011, PROTEIN PEPTIDE LETT, V18, P336, DOI 10.2174/092986611794653950
   Doucet N, 2011, BIOCHEMISTRY-US, V50, P1723, DOI 10.1021/bi1018539
   Doucet N, 2010, PROTEINS, V78, P2459, DOI 10.1002/prot.22754
   Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g
   Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2
   Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109
   Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s
   Goddard T. D., 2008, SPARKY VERSION 3
   Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164
   Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232
   Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407
   Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200
   Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p
   Kadonosono T, 2003, BIOCHEMISTRY-US, V42, P10651, DOI 10.1021/bi034499w
   KAPLAN JI, 1980, NMR CHEM EXCHANGING
   Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021
   Kovrigin EL, 2006, BIOCHEMISTRY-US, V45, P2636, DOI 10.1021/bi0525066
   Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010
   Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3
   Lassila JK, 2010, CURR OPIN CHEM BIOL, V14, P676, DOI 10.1016/j.cbpa.2010.08.010
   Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012
   Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939
   MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073
   Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023
   Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738
   Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845
   Merlino A, 2003, PROTEINS, V53, P101, DOI 10.1002/prot.10466
   Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225
   Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193
   RAO BDN, 1989, METHOD ENZYMOL, V176, P279
   Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049
   SELA M, 1957, BIOCHIM BIOPHYS ACTA, V24, P229, DOI 10.1016/0006-3002(57)90186-5
   Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239
   Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018
   Vila R, 2009, BIOPOLYMERS, V91, P1038, DOI 10.1002/bip.21204
   Vitagliano L, 2002, PROTEINS, V46, P97, DOI 10.1002/prot.10033
   Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104
   Watt ED, 2011, BIOPHYS J, V101, P411, DOI 10.1016/j.bpj.2011.05.039
NR 68
TC 26
Z9 26
U1 0
U2 16
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 28
PY 2012
VL 287
IS 53
BP 44289
EP 44300
DI 10.1074/jbc.M112.394866
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 062RI
UT WOS:000312938600027
PM 23135272
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mary, C
   Duek, P
   Salleron, L
   Tienz, P
   Bumann, D
   Bairoch, A
   Lane, L
AF Mary, Camille
   Duek, Paula
   Salleron, Lisa
   Tienz, Petra
   Bumann, Dirk
   Bairoch, Amos
   Lane, Lydie
TI Functional Identification of APIP as Human mtnB, a Key Enzyme in the
   Methionine Salvage Pathway
SO PLOS ONE
LA English
DT Article
ID ESCHERICHIA-COLI; METHYLTHIOADENOSINE PHOSPHORYLASE;
   ORNITHINE-DECARBOXYLASE; L-RIBULOSE-5-PHOSPHATE 4-EPIMERASE; CELL-LINES;
   BACILLUS-SUBTILIS; ABC TRANSPORTER; CANCER-CELLS; GENE; DEPENDENCY
AB The methionine salvage pathway is widely distributed among some eubacteria, yeast, plants and animals and recycles the sulfur-containing metabolite 5-methylthioadenosine (MTA) to methionine. In eukaryotic cells, the methionine salvage pathway takes place in the cytosol and usually involves six enzymatic activities: MTA phosphorylase (MTAP, EC 2.4.2.28), 5'-methylthioribose-1-phosphate isomerase (mtnA, EC 5.3.1.23), 5'-methylthioribulose-1-phosphate dehydratase (mtnB, EC: 4.2.1.109), 2,3-dioxomethiopentane-1-phosphate enolase/phosphatase (mtnC, EC 3.1.3.77), aci-reductone dioxygenase (mtnD, EC 1.13.11.54) and 4-methylthio-2-oxo-butanoate (MTOB) transaminase (EC 2.6.1.-). The aim of this study was to complete the available information on the methionine salvage pathway in human by identifying the enzyme responsible for the dehydratase step. Using a bioinformatics approach, we propose that a protein called APIP could perform this role. The involvement of this protein in the methionine salvage pathway was investigated directly in HeLa cells by transient and stable short hairpin RNA interference. We show that APIP depletion specifically impaired the capacity of cells to grow in media where methionine is replaced by MTA. Using a Shigella mutant auxotroph for methionine, we confirm that the knockdown of APIP specifically affects the recycling of methionine. We also show that mutation of three potential phosphorylation sites does not affect APIP activity whereas mutation of the potential zinc binding site completely abrogates it. Finally, we show that the N-terminal region of APIP that is missing in the short isoform is required for activity. Together, these results confirm the involvement of APIP in the methionine salvage pathway, which plays a key role in many biological functions like cancer, apoptosis, microbial proliferation and inflammation.
C1 [Mary, Camille; Duek, Paula; Bairoch, Amos; Lane, Lydie] Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland.
   [Salleron, Lisa; Bairoch, Amos; Lane, Lydie] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland.
   [Tienz, Petra; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland.
RP Mary, C (corresponding author), Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland.
EM camille.mary@isb-sib.ch
RI Bairoch, Amos/X-7411-2019; Duek, Paula/AAV-2308-2020
OI Bairoch, Amos/0000-0003-2826-6444; Lane, Lydie/0000-0002-9818-3030
FU Swiss SystemsX.ch initiative (BattleX)
FX This project was financed with a grant from the Swiss SystemsX.ch
   initiative (BattleX), evaluated by the Swiss National Science
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m
   Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278
   Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1
   [Anonymous], INT J ONCOLOGY, V40, P2111
   Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981
   Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651
   BACKLUND PS, 1982, J BIOL CHEM, V257, P4196
   Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200
   Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651
   Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4
   Cavuoto P, 2012, CANCER TREAT REV, V38, P726, DOI 10.1016/j.ctrv.2012.01.004
   Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X
   Chattopadhyay MK, 2005, P NATL ACAD SCI USA, V102, P16158, DOI 10.1073/pnas.0507299102
   Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080
   Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200
   Chow WA, 2006, CANCER GENET CYTOGEN, V166, P95, DOI 10.1016/j.cancergencyto.2005.10.009
   Collins CC, 2012, MOL CANCER THER, V11, P775, DOI 10.1158/1535-7163.MCT-11-0826
   Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002
   Cooper AJL, 2012, COMP BIOCHEM PHYS B, V163, P108, DOI 10.1016/j.cbpb.2012.05.010
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   DellaRagione F, 1996, BIOCHEM BIOPH RES CO, V223, P514, DOI 10.1006/bbrc.1996.0926
   DELLARAGIONE F, 1992, BIOCHEM J, V281, P533, DOI 10.1042/bj2810533
   DREYER MK, 1993, J MOL BIOL, V231, P549, DOI 10.1006/jmbi.1993.1307
   Durando X, 2008, B CANCER, V95, P69, DOI 10.1684/bdc.2008.0550
   Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002
   Hirano W, 2005, GENES CELLS, V10, P565, DOI 10.1111/j.1365-2443.2005.00859.x
   Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551
   Johnson AE, 1998, BIOCHEMISTRY-US, V37, P5746, DOI 10.1021/bi972984j
   Kabuyama Y, 2009, MOL CELL PROTEOMICS, V8, P2308, DOI 10.1074/mcp.M900178-MCP200
   KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974
   Ko DC, 2012, P NATL ACAD SCI US
   Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005
   KREIS W, 1991, J NATL CANCER I, V83, P725, DOI 10.1093/jnci/83.10.725
   Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266
   Lee LV, 2000, BIOCHEMISTRY-US, V39, P4821, DOI 10.1021/bi9928952
   Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661
   Luo Y, 2001, BIOCHEMISTRY-US, V40, P14763, DOI 10.1021/bi0112513
   Mantis N, 1996, INFECT IMMUN, V64, P2474, DOI 10.1128/IAI.64.7.2474-2482.1996
   MECHAM JO, 1983, BIOCHEM BIOPH RES CO, V117, P429, DOI 10.1016/0006-291X(83)91218-4
   Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002
   Miki K, 2000, CANCER RES, V60, P2696
   Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11
   Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475
   Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x
   Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570
   Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701
   Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9
   Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   SODA K, 1987, METHOD ENZYMOL, V143, P453
   Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x
   Subhi AL, 2004, CLIN CANCER RES, V10, P7290, DOI 10.1158/1078-0432.CCR-04-0972
   Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200
   Tang BQ, 2006, BIOCHEM PHARMACOL, V72, P806, DOI 10.1016/j.bcp.2006.06.018
   Tang BQ, 2000, CANCER RES, V60, P5543
   Thivat E, ANTICANCER RES, V27, P2779
   TRACKMAN PC, 1983, J BIOL CHEM, V258, P6717
   Wang H, 2005, J MOL BIOL, V348, P917, DOI 10.1016/j.jmb.2005.01.072
   Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838
   Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4
NR 60
TC 19
Z9 20
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2012
VL 7
IS 12
AR e52877
DI 10.1371/journal.pone.0052877
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 064DQ
UT WOS:000313051500075
PM 23285211
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Secchi, M
   Longhi, R
   Vassena, L
   Sironi, F
   Grzesiek, S
   Lusso, P
   Vangelista, L
AF Secchi, Massimiliano
   Longhi, Renato
   Vassena, Lia
   Sironi, Francesca
   Grzesiek, Stephan
   Lusso, Paolo
   Vangelista, Luca
TI Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of
   RANTES-Derived Peptides
SO CHEMISTRY & BIOLOGY
LA English
DT Article
ID HIV-1; CCR5; RECOGNITION; ACTIVATION; CHEMOKINES; INHIBITORS; RECEPTOR;
   REGION; POTENT
AB CCR5, the major HIV-1 coreceptor, is a primary target for HIV-1 entry inhibition strategies. CCL5/RANTES, a natural CCR5 ligand, is one of the most potent HIV-1 entry inhibitors and, therefore, an ideal candidate to derive HIV-1 blockers. Peptides spanning the RANTES N-loop/beta 1-strand region act as specific CCR5 antagonists, with their hydrophobic N- and C termini playing a crucial role in virus blockade. Here, hydrophobic surfaces were enhanced by tryptophan substitution of aromatic residues, highlighting position 27 as a critical hot spot for HIV-1 blockade. In a further molecular evolution step, C-terminal engraftment of RANTES 40' loop produced a peptide with the highest solubility and anti-HIV-1 activity. These modified peptides represent leads for the development of effective HIV-1 inhibitors and microbicides.
C1 [Secchi, Massimiliano; Vassena, Lia; Sironi, Francesca; Lusso, Paolo; Vangelista, Luca] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.
   [Longhi, Renato] Ist Chim Riconoscimento Mol, Consiglio Nazl Ric, I-20131 Milan, Italy.
   [Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lusso, Paolo] Univ Cagliari, Dept Biomed Sci, I-09124 Cagliari, Italy.
RP Vangelista, L (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Via Olgettina 58, I-20132 Milan, Italy.
EM vangelista.luca@hsr.it
RI Secchi, Massimiliano/AAN-5461-2020; Sironi, Francesca/ABH-7705-2020
OI Secchi, Massimiliano/0000-0002-4570-1885; Sironi,
   Francesca/0000-0003-0908-6683; Vangelista, Luca/0000-0003-0764-5031;
   Grzesiek, Stephan/0000-0003-1998-4225
FU European Microbicides Project (FP6) [LSHP-CT-2003-503558]; Combined
   Highly Active Anti-Retroviral Microbicides Project (FP7), Brussels,
   Belgium, European Union [242135]
FX We thank Sebastien Morin for stimulating discussion and critical reading
   of the manuscript, Gabriella Scarlatti for providing pediatric HIV-1
   isolates, and the NIH AIDS Research and Reference Reagent Program for
   providing primary HIV-1 isolates. This work was supported in part by the
   European Microbicides Project (FP6 Grant LSHP-CT-2003-503558) and the
   Combined Highly Active Anti-Retroviral Microbicides Project
   (FP7/2007-2013 Grant 242135), Brussels, Belgium, European Union.
CR Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040
   Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105
   Garman SC, 2000, NATURE, V406, P259
   Gilliam BL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S9
   Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400
   Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240
   Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801
   Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293
   Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947
   LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995
   Lusso P, 2011, FASEB J, V25, P1230, DOI 10.1096/fj.10-167627
   Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653
   Nedellec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022020
   Nedellec R, 2010, J VIROL, V84, P5842, DOI 10.1128/JVI.01907-09
   NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994
   Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E
   Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018
   Vangelista L, 2006, BIOCHEM BIOPH RES CO, V351, P664, DOI 10.1016/j.bbrc.2006.10.090
   Vangelista L, 2010, ANTIMICROB AGENTS CH, V54, P2994, DOI 10.1128/AAC.01492-09
   Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001
NR 22
TC 9
Z9 9
U1 0
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1074-5521
J9 CHEM BIOL
JI Chem. Biol.
PD DEC 21
PY 2012
VL 19
IS 12
BP 1579
EP 1588
DI 10.1016/j.chembiol.2012.10.007
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 064PG
UT WOS:000313087300011
PM 23261601
OA Bronze
DA 2021-01-25
ER

PT J
AU Baer, MM
   Palm, W
   Eaton, S
   Leptin, M
   Affolter, M
AF Baer, Magdalena M.
   Palm, Wilhelm
   Eaton, Suzanne
   Leptin, Maria
   Affolter, Markus
TI Microsomal triacylglycerol transfer protein (MTP) is required to expand
   tracheal lumen in Drosophila in a cell-autonomous manner
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Tubulogenesis; Trachea; Lumen expansion; Unicellular tubes
ID TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER ACTIVITY;
   APOLIPOPROTEIN-B; BRANCHING MORPHOGENESIS; TUBE MORPHOGENESIS;
   SECRETION; LIPOPROTEIN; TRANSPORT; INSIGHTS; BINDING
AB The Drosophila tracheal system is a useful model for dissecting the molecular mechanisms controlling the assembly and expansion of tubular organs. We have identified microsomal triacylglycerol transfer protein (MTP) as a new player involved in the lumen expansion in unicellular tubes. MTP is an endoplasmic reticulum resident protein that can transfer triglycerides and phospholipids between membranes in vitro. MTP lipid transfer activity is crucial for the assembly and secretion of apoB family lipoproteins, which are carriers of lipids between different tissues. Here we describe an unexpected role of MTP in tracheal development, which we postulate to be independent of its known function in lipoprotein secretion. We propose that, in tracheal cells, MTP is involved in regulation of de novo apical membrane delivery to the existing lumen and thus promotes proper expansion of the larval tracheal system.
C1 [Baer, Magdalena M.; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Baer, Magdalena M.; Leptin, Maria] Univ Cologne, Inst Genet, D-50674 Cologne, Germany.
   [Palm, Wilhelm; Eaton, Suzanne] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   [Leptin, Maria] European Mol Biol Lab, D-67112 Heidelberg, Germany.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
RI Eaton, Suzanne/D-7698-2017
OI Eaton, Suzanne/0000-0002-8319-284X; Baer, Magdalena/0000-0003-3315-0921;
   Affolter, Markus/0000-0002-5171-0016
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Cantons Basel-Stadt and Basel-Land; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [LE546/3-1,
   LE546/3-2, NV EA24]; NRW Graduate School for Genetics and Functional
   Genomics; Max Planck GesellschaftMax Planck Society; European Science
   FoundationEuropean Science Foundation (ESF) [EA4/5-1]
FX This work was supported by grants from the Swiss National Science
   Foundation and from Cantons Basel-Stadt and Basel-Land to M.A.; Deutsche
   Forschungsgemeinschaft [grant numbers LE546/3-1 and LE546/3-2 to M. L.];
   M.M.B. had a fellowship from the NRW Graduate School for Genetics and
   Functional Genomics; W.P. and S.E. were supported by the Max Planck
   Gesellschaft, the Deutsche Forschungsgemeinschaft [grant number NV
   EA24], and the European Science Foundation (Euromembranes) [grant number
   EA4/5-1].
CR Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797
   Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024
   Armbruster K, 2012, J CELL SCI, V125, P1318, DOI 10.1242/jcs.096263
   ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021
   ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019
   Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088
   Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6
   Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043
   Chen J, 2012, DEVELOPMENT, V139, P2170, DOI 10.1242/dev.073817
   Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049
   Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183
   Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019
   Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062
   Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087
   Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047
   Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241
   Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200
   Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071
   Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102
   Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504
   Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Norum M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010802
   Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008
   Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828
   Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504
   Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576
   Rava P, 2006, J BIOL CHEM, V281, P11019, DOI 10.1074/jbc.M512823200
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Sagiv Y, 2007, J EXP MED, V204, P921, DOI 10.1084/jem.20061568
   Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016
   Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200
   Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200
   Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Wang SS, 2012, J CELL SCI, V125, P461, DOI 10.1242/jcs.092551
   Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703
   Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040
NR 47
TC 12
Z9 12
U1 0
U2 9
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD DEC 15
PY 2012
VL 125
IS 24
BP 6038
EP 6048
DI 10.1242/jcs.110452
PG 11
WC Cell Biology
SC Cell Biology
GA 099AH
UT WOS:000315590300015
PM 23132924
OA Bronze
DA 2021-01-25
ER

PT J
AU Holland, AJ
   Fachinetti, D
   Zhu, Q
   Bauer, M
   Verma, IM
   Nigg, EA
   Cleveland, DW
AF Holland, Andrew J.
   Fachinetti, Daniele
   Zhu, Quan
   Bauer, Manuel
   Verma, Inder M.
   Nigg, Erich A.
   Cleveland, Don W.
TI The autoregulated instability of Polo-like kinase 4 limits centrosome
   duplication to once per cell cycle
SO GENES & DEVELOPMENT
LA English
DT Article
DE mitosis; aneuploidy; SCF; centrosome; centriole; genome instability; p53
ID CENTRIOLE DUPLICATION; PLK4; OVERDUPLICATION; PROTEINS; NUMBER
AB Centrioles organize the centrosome, and accurate control of their number is critical for the maintenance of genomic integrity. Centriole duplication occurs once per cell cycle and is controlled by Polo-like kinase 4 (Plk4). We showed previously that Plk4 phosphorylates itself to promote its degradation by the proteasome. Here we demonstrate that this autoregulated instability controls the abundance of endogenous Plk4. Preventing Plk4 autoregulation causes centrosome amplification, stabilization of p53, and loss of cell proliferation; moreover, suppression of p53 allows growth of cells carrying amplified centrosomes. Plk4 autoregulation thus guards against genome instability by limiting centrosome duplication to once per cell cycle.
C1 [Holland, Andrew J.; Fachinetti, Daniele; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Zhu, Quan; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.
   [Bauer, Manuel; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Holland, AJ (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
EM a1holland@ucsd.edu
OI Fachinetti, Daniele/0000-0002-8795-6771; Cleveland,
   Don/0000-0002-1934-3682; nigg, erich/0000-0003-4835-5719
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM29513]; Ludwig
   Institute for Cancer Research; Leukemia and Lymphoma SocietyLeukemia and
   Lymphoma Society; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [31003A_132428/1]; Cancer Center Core Grant
   [P30 CA014195-38]; Department of DefenseUnited States Department of
   Defense [W81XWH-10-1-0963]; European Molecular Biology Organization
   (EMBO)European Molecular Biology Organization (EMBO); NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195, P30CA014195, P30CA014195, P30CA014195, P30CA014195,
   P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R37GM029513, R37GM029513,
   R01GM029513, R01GM029513, R01GM029513, R01GM029513, R37GM029513,
   R01GM029513, R01GM029513, R01GM029513, R01GM029513, R01GM029513,
   R01GM029513, R37GM029513, R01GM029513, R01GM029513, R01GM029513,
   R37GM029513, R01GM029513, R01GM029513, R37GM029513, R01GM029513,
   R37GM029513, R01GM029513, R01GM029513, R37GM029513, R01GM029513,
   R01GM029513, R37GM029513, R37GM029513, R37GM029513, R01GM029513,
   R01GM029513, R01GM029513] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [P30NS047101, P30NS047101, P30NS047101, P30NS047101, P30NS047101,
   P30NS047101, P30NS047101, P30NS047101, P30NS047101, P30NS047101,
   P30NS047101, P30NS047101, P30NS047101, P30NS047101, P30NS047101,
   P30NS047101, P30NS047101, P30NS047101, P30NS047101, P30NS047101,
   P30NS047101, P30NS047101, P30NS047101, P30NS047101, P30NS047101,
   P30NS047101, P30NS047101, P30NS047101] Funding Source: NIH RePORTER
FX We thank Jeffrey Salisbury (Mayo Clinic Foundation, Minnesota) for
   providing the anti-Centrin antibody, Karen Oegema and Arshad Desai
   (Ludwig Institute for Cancer Research, California) for providing the
   human anti-SPD2 and anti-SAS6 antibody, Prasad Jallepalli (Memorial
   Sloan-Kettering Cancer Center, New York) for providing reagents for
   AAV-mediated gene targeting, Pierre Gonczy (Swiss Federal Institute of
   Technology, Switzerland) for providing the human SAS6 clone, and Bryan
   Tsou (Memorial Sloan-Kettering Cancer Center, New York) for providing
   the doxycycline-inducible Plk4<SUP>WT</SUP> and Plk4<SUP>AA</SUP> RPE1
   cell lines. We thank Timo Meerloo and Ying Jones of the University of
   California at San Diego Cellular and Molecular Medicine Electron
   Microscopy Core Facility for their generous help with electron
   microscopy, and the University of California at San Diego Neuroscience
   Microscopy Shared Facility (P30 NS047101). This work was supported by a
   grant (GM29513) from the National Institutes of Health to D. W. C., who
   receives salary support from the Ludwig Institute for Cancer Research.
   A. J. H. is supported by a Leukemia and Lymphoma Society special
   fellowship. E. A. N. and M. B. gratefully acknowledge support by the
   Swiss National Science Foundation (31003A_132428/1). I. M. V. is an
   American Cancer Society Professor of Molecular Biology and holds the
   Irwin and Joan Jacobs Chair in Exemplary Life Science. This work was
   supported in part by a Cancer Center Core Grant (P30 CA014195-38). Q. Z.
   was supported by a Department of Defense Idea Expansion Award
   (W81XWH-10-1-0963). D. F. was supported by a European Molecular Biology
   Organization (EMBO) long-term fellowship.
CR Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Brownlee CW, 2011, J CELL BIOL, V195, P231, DOI 10.1083/jcb.201107086
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100
   Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373
   Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55
   Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043
   Holland AJ, 2010, CELL CYCLE, V9, P2731, DOI 10.4161/cc.9.14.12184
   Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605
   Liu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041293
   Macmillan JC, 2001, ANN SURG ONCOL, V8, P729, DOI 10.1007/s10434-001-0729-6
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564
   Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008
   Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109
NR 25
TC 89
Z9 89
U1 0
U2 18
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD DEC 15
PY 2012
VL 26
IS 24
BP 2684
EP 2689
DI 10.1101/gad.207027.112
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 060KF
UT WOS:000312775700003
PM 23249732
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kocik, L
   Junne, T
   Spiess, M
AF Kocik, Lucyna
   Junne, Tina
   Spiess, Martin
TI Orientation of Internal Signal-Anchor Sequences at the Sec61 Translocon
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE hydrophobicity; membrane insertion; membrane protein; topology
ID ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; TRANSMEMBRANE ORIENTATION;
   CHARGED RESIDUES; CHANNEL; COMPLEX; TOPOGENESIS; RECOGNITION; RIBOSOME;
   DETERMINANTS
AB Trans location and insertion of secretory and membrane proteins at the endoplasmic reticulum are mediated by the Sec61 translocon. Evidence from in vivo as well as in vitro experiments indicates that N-terminal signal-anchor sequences initially insert N-first before they invert their orientation to translocate the C-terminus. Inversion is driven by flanking charges according to the positive-inside rule and inhibited by increased signal hydrophobicity. Here, we show that upon extending the N-terminal hydrophilic domain preceding the signal core to more than similar to 20 residues, the insertion behavior changes. Apparent signal inversion and the effect of hydrophobicity are largely lost, suggesting that N-first insertion is limited to N-terminal signal anchors. Extended N-domains sterically hinder N-translocation in a length-dependent manner also for reverse signal anchors with inverted flanking charges. The results indicate a mechanistic difference in the insertion process of N-terminal and internal signal sequences. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Kocik, Lucyna; Junne, Tina; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-125423]
FX This work was supported by grant 31003A-125423 from the Swiss National
   Science Foundation.
CR Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570
   Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535
   BELTZER JP, 1991, J BIOL CHEM, V266, P973
   Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108
   Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657
   Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004
   Egea P. F., 2010, P NATL ACAD SCI US
   Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026
   Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387
   Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m
   Higy M, 2005, BIOCHEMISTRY-US, V44, P2039, DOI 10.1021/bi047976z
   Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200
   Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060
   Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050
   Kida Y, 2009, J BIOL CHEM, V284, P2861, DOI 10.1074/jbc.M808020200
   Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117
   Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118
   Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010
   Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214
   Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014
   Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005
   Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693
   Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335
NR 36
TC 17
Z9 17
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 14
PY 2012
VL 424
IS 5
BP 368
EP 378
DI 10.1016/j.jmb.2012.10.010
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 068US
UT WOS:000313392300013
PM 23084973
DA 2021-01-25
ER

PT J
AU Kasmapour, B
   Gronow, A
   Bleck, CKE
   Hong, WJ
   Gutierrez, MG
AF Kasmapour, Bahram
   Gronow, Achim
   Bleck, Christopher K. E.
   Hong, Wanjin
   Gutierrez, Maximiliano Gabriel
TI Size-dependent mechanism of cargo sorting during lysosome-phagosome
   fusion is controlled by Rab34
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE LAMP-1; LAMP-2; phagocytosis
ID MYCOBACTERIUM-TUBERCULOSIS; MATURATION; ENDOSOMES; ACQUISITION;
   PROTEOME; GTPASES; PHAGOCYTOSIS; EFFECTOR; DELIVERY; MUNC13-4
AB Phagosome maturation is an essential part of the innate and adaptive immune response. Although it is well established that several Ras-related proteins in brain (Rab) proteins become associated to phagosomes, little is known about how these phagosomal Rab proteins influence phagosome maturation. Here, we show a specific role for Rab34 and mammalian uncoordinated 13-2 (Munc13-2) in phagolysosome biogenesis and cargo delivery. Rab34 knockdown impaired the fusion of phagosomes with late endosomes/lysosomes and high levels of active Rab34 promoted this process. We demonstrate that Rab34 enhances phagosome maturation independently of Rab7 and coordinates phagolysosome biogenesis through size-selective transfer of late endosomal/lysosomal cargo into phagosomes. More importantly, we show that Rab34 mediates phagosome maturation through the recruitment of the protein Munc13-2. Finally, we report that the alternative maturation pathway controlled by Rab34 is critical for mycobacterial killing because Rab34 silencing resulted in mycobacterial survival, and Rab34 expression led to mycobacterial killing. Altogether, our studies uncover Rab34/Munc13-2 as a critical part of an alternative Rab7-independent phagosome maturation machinery and lysosome-mediated killing of mycobacteria.
C1 [Kasmapour, Bahram; Gronow, Achim; Gutierrez, Maximiliano Gabriel] Helmholtz Ctr Infect Res, Res Grp Phagosome Biol, D-38124 Braunschweig, Germany.
   [Bleck, Christopher K. E.] Univ Basel, Ctr Cellular Imaging & Nanoanalyt Struct Biol & B, Biozentrum, CH-4058 Basel, Switzerland.
   [Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore.
   [Gutierrez, Maximiliano Gabriel] Natl Inst Med Res, MRC, Ridgeway, Div Mycobacterial Res, London NW7 1AA, England.
RP Gutierrez, MG (corresponding author), Helmholtz Ctr Infect Res, Res Grp Phagosome Biol, D-38124 Braunschweig, Germany.
EM mgutier@nimr.mrc.ac.uk
RI HONG, Wanjin/E-9927-2010
OI Gutierrez, Maximiliano/0000-0003-3199-0337; Bleck,
   Christopher/0000-0003-1029-3444
FU Helmholtz Young Investigator grant (Initiative and Networking funds of
   the Helmholtz Association)
FX We thank Dr. Brose and Dr. Reim (Max Planck Institute of Experimental
   Medicine) for providing the Munc13-2<SUP>-/-</SUP> mice and Munc13-2
   plasmids. We also thank Gareth Griffiths, Marisa Colombo, Luis Mayorga,
   and members of the Phagosome Biology Laboratory for critical reading of
   the manuscript. M.G.G. is supported by a Helmholtz Young Investigator
   grant (Initiative and Networking funds of the Helmholtz Association).
CR Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x
   BERTHIAUME EP, 1995, J CELL BIOL, V129, P989, DOI 10.1083/jcb.129.4.989
   Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6
   Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049
   Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467
   Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x
   Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842
   Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000
   Desjardins M, 1997, J CELL SCI, V110, P2303
   DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8
   Duclos S, 2000, J CELL SCI, V113, P3531
   Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006
   Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9
   Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128
   Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165
   Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991
   Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651
   Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003
   Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755
   KIELIAN MC, 1981, J EXP MED, V154, P101, DOI 10.1084/jem.154.1.101
   Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407
   Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923
   Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008
   Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417
   Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104
   Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x
   Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8
   Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x
   Seto S, 2009, BIOCHEM BIOPH RES CO, V387, P272, DOI 10.1016/j.bbrc.2009.06.152
   Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056
   Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x
   Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728
   Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002
   Terebiznik MR, 2006, INFECT IMMUN, V74, P6599, DOI 10.1128/IAI.01085-06
   Trivedi V, 2006, P NATL ACAD SCI USA, V103, P18226, DOI 10.1073/pnas.0609182103
   Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006
   Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003
   Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
   Wahe A, 2010, J CELL SCI, V123, P2502, DOI 10.1242/jcs.067686
   Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280
   WANG YL, 1987, J CELL BIOL, V104, P1749, DOI 10.1083/jcb.104.6.1749
NR 41
TC 36
Z9 36
U1 0
U2 25
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 11
PY 2012
VL 109
IS 50
BP 20485
EP 20490
DI 10.1073/pnas.1206811109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 058AF
UT WOS:000312605600073
PM 23197834
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Thiyagarajan, N
   Pham, TTK
   Stinson, B
   Sundriyal, A
   Tumbale, P
   Lizotte-Waniewski, M
   Brew, K
   Acharya, KR
AF Thiyagarajan, Nethaji
   Pham, Tram T. K.
   Stinson, Brittany
   Sundriyal, Amit
   Tumbale, Percy
   Lizotte-Waniewski, Michelle
   Brew, Keith
   Acharya, K. Ravi
TI Structure of a metal-independent bacterial glycosyltransferase that
   catalyzes the synthesis of histo-blood group A antigen
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DIFFERENTIAL RECOGNITION; ALPHA-1,3-GALACTOSYLTRANSFERASE; BINDING;
   SPECIFICITY; EVOLUTION; SUBSTRATE; FAMILIES; SYNTHASE; REVEALS; COMPLEX
AB Histo-blood group antigens (HBGAs) are a source of antigenic variation between individuals that modulates resistance and susceptibility to pathogens and is a barrier to the spread of enveloped viruses. HBGAs are also produced by a few prokaryotes where they are synthesized by glycosyltransferases (GTs) related to human HBGA synthases. Here we report the first structure of a bacterial GT of this family, from an intestinal resident, Bacteroides ovatus. Unlike its mammalian homologues and other GTs with similar folds, this protein lacks a metal-binding Asp-X-Asp motif and is fully active in the absence of divalent metal ions, yet is strikingly similar in structure and in its interactions with substrates to structurally characterized mammalian metal-dependent mammalian homologues. This shows how an apparently major divergence in catalytic properties can be accommodated by minor structural adjustments and illustrates the structural underpinnings of horizontal transfer of a functional gene from prokaryotes to vertebrates.
C1 [Stinson, Brittany; Tumbale, Percy; Lizotte-Waniewski, Michelle; Brew, Keith] Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.
   [Thiyagarajan, Nethaji; Pham, Tram T. K.; Sundriyal, Amit; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
   [Sundriyal, Amit] Univ Basel, Dept Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Tumbale, Percy] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA.
RP Brew, K (corresponding author), Florida Atlantic Univ, Dept Biomed Sci, Charles E Schmidt Coll Med, 777 Glades Rd, Boca Raton, FL 33431 USA.
EM kbrew@fau.edu; bsskra@bath.ac.uk
RI Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019
OI Brew, Keith/0000-0003-1306-1032; Acharya, K. Ravi/0000-0002-3009-4058
FU Wellcome Trust (UK) equipment grantWellcome Trust [088464]; University
   of Bath; NIH (USA)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AR40994]; National
   Science Foundation (USA)National Science Foundation (NSF) [GK-12];
   NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Arthritis &
   Musculoskeletal & Skin Diseases (NIAMS) [R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994] Funding Source: NIH RePORTER
FX This work was supported by a Wellcome Trust (UK) equipment grant (number
   088464) to K.R.A. We thank Professor Eleanor Dodson (University of York,
   UK) for help with 'molecular replacement' used in the structure
   determination of apo BoGT6a and the scientists at Diamond Light Source,
   Didcot, Oxon (UK) for their support during X-ray diffraction data
   collection. T.T.K.P. wishes to thank Biotechnology Center of Ho Chi Minh
   City, Vietnam and University of Bath for a post-graduate studentship.
   K.B. was supported by NIH (USA) grant AR40994 and P.T. and B.S. were
   partly funded by the National Science Foundation (USA) GK-12 Program.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200
   Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200
   Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200
   Brew K, 2010, J BIOL CHEM, V285, P37121, DOI 10.1074/jbc.R110.176248
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cochrane FC, 2009, J MOL BIOL, V390, P646, DOI 10.1016/j.jmb.2009.05.014
   Duewel HS, 2000, J BIOL CHEM, V275, P22824, DOI 10.1074/jbc.M000133200
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638
   Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429
   Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100
   Indyk L, 1998, METHOD ENZYMOL, V295, P350
   Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012
   Jamaluddin H, 2009, BIOCHEM BIOPH RES CO, V385, P601, DOI 10.1016/j.bbrc.2009.05.111
   Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195
   Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322
   Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91
   Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200
   Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]
   Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200
   Li JJ, 2004, J AM CHEM SOC, V126, P7448, DOI 10.1021/ja0480872
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Nguyen HP, 2003, J BIOL CHEM, V278, P49191, DOI 10.1074/jbc.M308770200
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pak JE, 2011, J MOL BIOL, V414, P798, DOI 10.1016/j.jmb.2011.10.039
   Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832
   Persson M, 2007, J BIOL CHEM, V282, P9564, DOI 10.1074/jbc.M610998200
   Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685
   Shulami S, 2004, J BIOL CHEM, V279, P45110, DOI 10.1074/jbc.M404561200
   Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985
   Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a
   Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878
   Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
   Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r
   Zhang YN, 2001, J BIOL CHEM, V276, P11567, DOI 10.1074/jbc.M006530200
NR 44
TC 10
Z9 10
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 7
PY 2012
VL 2
AR 940
DI 10.1038/srep00940
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 049MZ
UT WOS:000311988400002
PM 23230506
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Katayama, T
   Ozaki, S
   Noguchi, Y
   Miyazaki, E
AF Katayama, Tsutomu
   Ozaki, Shogo
   Noguchi, Yasunori
   Miyazaki, Erika
TI Molecular anatomy of higher-order complexes constructed on the E. coli
   chromosomal replication origin
SO GENES & GENETIC SYSTEMS
LA English
DT Meeting Abstract
C1 [Katayama, Tsutomu; Ozaki, Shogo; Noguchi, Yasunori; Miyazaki, Erika] Kyushu Univ, Grad Sch Pharm Scis, Dept Mol Biol, Fukuoka 812, Japan.
   [Ozaki, Shogo] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOC JAPAN
PI SHIZUOKA-KEN
PA NATIONAL INST GENETICS YATA 1111, MISHIMA, SHIZUOKA-KEN, 411-8540, JAPAN
SN 1341-7568
EI 1880-5779
J9 GENES GENET SYST
JI Genes Genet. Syst.
PD DEC
PY 2012
VL 87
IS 6
BP 385
EP 385
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 206PX
UT WOS:000323535700054
DA 2021-01-25
ER

PT J
AU Yusuke, A
   Shogo, O
   Tsutomu, K
AF Yusuke, Akama
   Shogo, Ozaki
   Tsutomu, Katayama
TI Analysis on mechanisms for DnaB progress on the oriC region complexed
   with DnaA multimers
SO GENES & GENETIC SYSTEMS
LA English
DT Meeting Abstract
C1 [Yusuke, Akama; Shogo, Ozaki; Tsutomu, Katayama] Kyushu Univ, Dept Mol Biol, Grad Sch Pharm Sci, Fukuoka 812, Japan.
   [Shogo, Ozaki] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOC JAPAN
PI SHIZUOKA-KEN
PA NATIONAL INST GENETICS YATA 1111, MISHIMA, SHIZUOKA-KEN, 411-8540, JAPAN
SN 1341-7568
EI 1880-5779
J9 GENES GENET SYST
JI Genes Genet. Syst.
PD DEC
PY 2012
VL 87
IS 6
BP 435
EP 435
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 206PX
UT WOS:000323535700250
DA 2021-01-25
ER

PT J
AU Gibeaux, R
   Lang, C
   Politi, AZ
   Jaspersen, SL
   Philippsen, P
   Antony, C
AF Gibeaux, Romain
   Lang, Claudia
   Politi, Antonio Z.
   Jaspersen, Sue L.
   Philippsen, Peter
   Antony, Claude
TI Electron tomography of the microtubule cytoskeleton in multinucleated
   hyphae of Ashbya gossypii
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Filamentous fungus; Nuclear migration; Microtubule ends; Spindle pole
   body; Mitotic spindle
ID SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC DYNEIN; NUCLEAR
   MIGRATION; ASPERGILLUS-NIDULANS; DYNAMICS; MORPHOGENESIS; FUNGI; CELLS;
   ENDS
AB We report the mechanistic basis guiding the migration pattern of multiple nuclei in hyphae of Ashbya gossypii. Using electron tomography, we reconstructed the cytoplasmic microtubule (cMT) cytoskeleton in three tip regions with a total of 13 nuclei and also the spindle microtubules of four mitotic nuclei. Each spindle pole body (SPB) nucleates three cMTs and most cMTs above a certain length grow according to their plus-end structure. Long cMTs closely align for several microns along the cortex, presumably marking regions where dynein generates pulling forces on nuclei. Close proximity between cMTs emanating from adjacent nuclei was not observed. The majority of nuclei carry duplicated side-by-side SPBs, which together emanate an average of six cMTs, in most cases in opposite orientation with respect to the hyphal growth axis. Such cMT arrays explain why many nuclei undergo short-range back and forth movements. Only occasionally do all six cMTs orient in one direction, a precondition for long-range nuclear bypassing. Following mitosis, daughter nuclei carry a single SPB with three cMTs. The increased probability that all three cMTs orient in one direction explains the high rate of nuclear bypassing observed in these nuclei. The A. gossypii mitotic spindle was found to be structurally similar to that of Saccharomyces cerevisiae in terms of nuclear microtubule (nMT) number, length distribution and three-dimensional organization even though the two organisms differ significantly in chromosome number. Our results suggest that two nMTs attach to each kinetochore in A. gossypii and not only one nMT like in S. cerevisiae.
C1 [Gibeaux, Romain; Politi, Antonio Z.; Antony, Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany.
   [Lang, Claudia; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA.
   [Jaspersen, Sue L.] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
RI antony, claude/K-5342-2013; Gibeaux, Romain/E-2920-2019
OI Gibeaux, Romain/0000-0001-5081-1985; Politi, Antonio/0000-0003-4788-0933
FU BIOMS (Center for Modelling and Simulation in the Biosciences); Stowers
   Institute for Medical Research; American Cancer SocietyAmerican Cancer
   Society [RSG-11-030-01-CSM]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [3100A0-112688]
FX This work is supported by a postdoctoral grant from BIOMS (Center for
   Modelling and Simulation in the Biosciences) to A. Z. P.; and the
   Stowers Institute for Medical Research and the American Cancer Society
   [grant number RSG-11-030-01-CSM to S. L. J.]. Part of the work was
   supported by the Swiss National Science Foundation [grant number
   3100A0-112688 to P.P.].
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0
   BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056
   BYERS B, 1973, COLD SPRING HARB SYM, V38, P123
   COTTAREL G, 1989, MOL CELL BIOL, V9, P3342, DOI 10.1128/MCB.9.8.3342
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Finlayson MR, 2011, MOL BIOL CELL, V22, P3081, DOI 10.1091/mbc.E10-12-1006
   Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485
   Grava S, 2011, EUKARYOT CELL, V10, P902, DOI 10.1128/EC.05095-11
   Grava S, 2010, MOL BIOL CELL, V21, P3680, DOI 10.1091/mbc.E10-06-0527
   Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7
   Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215
   Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9
   Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020
   Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106
   Koehli M, 2008, J CELL SCI, V121, P3878, DOI 10.1242/jcs.033852
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Lang C, 2010, MOL BIOL CELL, V21, P753, DOI 10.1091/mbc.E09-07-0555
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305
   McDonald K, 1999, METH MOL B, V117, P77
   Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23
   Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x
   Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097
   Nair DR, 2010, CELL CYCLE, V9, P3771, DOI 10.4161/cc.9.18.12999
   O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035
   O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017
   Roper M, 2011, CURR BIOL, V21, pR786, DOI 10.1016/j.cub.2011.06.042
   Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108
   Seiler S, 1999, CURR BIOL, V9, P779, DOI 10.1016/S0960-9822(99)80360-1
   Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475
   WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601
   Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010
   XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100
   Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685
   Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516
NR 38
TC 7
Z9 7
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD DEC 1
PY 2012
VL 125
IS 23
BP 5830
EP 5839
DI 10.1242/jcs.111005
PG 10
WC Cell Biology
SC Cell Biology
GA 093AN
UT WOS:000315164200024
PM 23015595
OA Bronze
DA 2021-01-25
ER

PT J
AU Gruber, AR
   Martin, G
   Keller, W
   Zavolan, M
AF Gruber, Andreas R.
   Martin, Georges
   Keller, Walter
   Zavolan, Mihaela
TI Cleavage factor I-m is a key regulator of 3 ' UTR length
SO RNA BIOLOGY
LA English
DT Article
DE cleavage factor I-m; CF I-m; CPSF5; CPSF6; CPSF7; alternative
   polyadenylation; 3 ' end processing; mRNA processing
ID MESSENGER-RNA CLEAVAGE; MICRORNA TARGET SITES; ALTERNATIVE
   POLYADENYLATION; NUCLEOTIDE RESOLUTION; UNTRANSLATED REGIONS; POLY(A)
   POLYMERASE; PROCESSING COMPLEX; STRUCTURAL BASIS; BINDING PROTEIN; CLIP
AB In eukaryotes, the 3' ends of RNA polymerase II-transcribed RNAs are generated in the majority of cases by site-specific endonucleolytic cleavage, followed by the addition of a poly(A) tail. Through alternative polyadenylation, a gene can give rise to multiple mRNA iso-forms that differ in the length of their 3' UTRs and hence in their susceptibility to post-transcriptional regulatory factors such as microRNAs. A series of recently conducted high-throughput studies of poly(A) site usage revealed an extensive tissue-specific control and drastic changes in the length of mRNA 3' UTRs upon induction of proliferation in resting cells. To understand the dynamics of poly(A) site choice, we recently identified binding sites of the major pre-mRNA 3' end processing factors - cleavage and polyadenylation specificity factor (CPSF), cleavage stimulation factor (CstF), and cleavage factor I-m (CF I-m)-and mapped polyadenylation sites in HEK293 cells. Our present study extends previous findings on the role of CF I-m in alternative polyadenylation and reveals that subunits of the CF I-m complex generally control 3' UTR length. More specifically, we demonstrate that the loss-of-function of CF I-m 68 and CF I-m 25 but not of CF I-m 59 leads to a transcriptome-wide increase in the use of proximal polyadenylation sites in HEK293 cells.
C1 [Zavolan, Mihaela] Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Gruber,
   Andreas/0000-0003-1219-4239
FU University of Basel; Louis-Jeantet Foundation for Medicine; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [31003A_133145]
FX The work was supported by the University of Basel, the Louis-Jeantet
   Foundation for Medicine and the Swiss National Science Foundation (grant
   31003A_133145 to W.K.). We acknowledge the technical support of Beatrice
   Dimitriades.
CR Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768
   Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54
   Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003
   Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110
   Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616
   Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022
   Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106
   Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479
   Kim S, 2010, GENES CELLS, V15, P1003, DOI 10.1111/j.1365-2443.2010.01436.x
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Li H, 2011, CELL RES, V21, P1039, DOI 10.1038/cr.2011.67
   Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3
   Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003
   Martin G, 2010, RNA, V16, P1646, DOI 10.1261/rna.2164210
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176
   Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002
   Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020
   Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8
   Ryan K, 2007, RNA BIOL, V4, P26, DOI 10.4161/rna.4.1.4365
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711
   Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028
   Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200
   Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040
   Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021
   Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107
   Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873
   Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100
NR 42
TC 73
Z9 77
U1 0
U2 15
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6286
J9 RNA BIOL
JI RNA Biol.
PD DEC
PY 2012
VL 9
IS 12
BP 1405
EP 1412
DI 10.4161/rna.22570
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 083GQ
UT WOS:000314451400003
PM 23187700
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Kuert, P
   Bello, B
   Reichert, H
AF Kuert, P.
   Bello, B.
   Reichert, H.
TI The labial gene is required to terminate proliferation of identified
   neuroblasts in postembryonic development of the Drosophila brain
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Kuert, P.; Bello, B.; Reichert, H.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2012
VL 26
SU 1
BP 29
EP 30
PG 2
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 090JK
UT WOS:000314975100070
DA 2021-01-25
ER

PT J
AU Laurenson, AS
   Saini, N
   Jiang, Y
   Fischer, A
   Knoblich, J
   Reichert, H
AF Laurenson, A. S.
   Saini, N.
   Jiang, Y.
   Fischer, A.
   Knoblich, J.
   Reichert, H.
TI From neural stem cells to brain tumors: a genetic analysis
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Laurenson, A. S.; Saini, N.; Jiang, Y.; Reichert, H.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Fischer, A.; Knoblich, J.] Austrian Acad Sci, Imba, A-1010 Vienna, Austria.
RI Knoblich, Juergen A/C-2974-2015
OI Knoblich, Juergen A/0000-0002-6751-3404
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2012
VL 26
SU 1
BP 30
EP 30
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 090JK
UT WOS:000314975100072
DA 2021-01-25
ER

PT J
AU Jiang, Y
   Reichert, H
AF Jiang, Y.
   Reichert, H.
TI Formation and suppression of neural stem cell-derived brain tumors by
   targeted transgenic RNAI in Drosophila
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Jiang, Y.; Reichert, H.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD DEC
PY 2012
VL 26
SU 1
BP 75
EP 75
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 090JK
UT WOS:000314975100191
DA 2021-01-25
ER

PT J
AU Milnik, A
   Heck, A
   Vogler, C
   Heinze, HJ
   de Quervain, DJF
   Papassotiropoulos, A
AF Milnik, Annette
   Heck, Angela
   Vogler, Christian
   Heinze, Hans-Jochen
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
TI Association of KIBRA With Episodic and Working Memory: A Meta-Analysis
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
LA English
DT Article
DE WWC1; rs17070145; single nucleotide polymorphism; common variant; human
ID ALZHEIMERS-DISEASE; GENETIC INFLUENCES; MESSENGER-RNA; POLYMORPHISM;
   SCHIZOPHRENIA; HERITABILITY; PERFORMANCE; VARIANTS; FAMILIES; HEIGHT
AB WWC1 was first implicated in human cognition through a genome wide association study in 2006 that reported an association of the intronic single nucleotide polymorphism (SNP) rs17070145 with episodic memory performance. WWC1 encodes the protein KIBRA, which is almost ubiquitously expressed. Together with its binding partners, KIBRA is assumed to play a role in synaptic plasticity. T-allele carriers of SNP rs17070145 have been reported to outperform individuals that are homozygous for the C-allele in episodic memory tasks. Here we report two random effects meta-analyses testing the association of rs17070145 with episodic and working memory. All currently available population-based association studies that investigated effects of rs17070145 on episodic or working memory were included in the analyses. Where performance measures for multiple domain-specific tasks were available for a given study population, averaged effect size estimates were calculated. The performed meta-analyses relied on 17 samples that were tested for episodic memory performance (N = 8,909) and 9 samples that had performed working memory tasks (N = 4,696). We report a significant association of rs17070145 with both episodic (r = 0.068, P = 0.001) and working memory (r = 0.035, P = 0.018). In summary, our findings indicate that SNP rs17070145 located within KIBRA explains 0.5% of the variance for episodic memory tasks and 0.1% of the variance for working memory tasks in samples of primarily Caucasian background. (C) 2012 Wiley Periodicals, Inc.
C1 [Milnik, Annette; Heck, Angela; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
   [Milnik, Annette; Heinze, Hans-Jochen] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.
   [Heck, Angela; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, CH-4055 Basel, Switzerland.
   [Heck, Angela; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Univ Psychiat Clin, CH-4055 Basel, Switzerland.
   [Heinze, Hans-Jochen] Leibniz Inst Neurobiol, Magdeburg, Germany.
   [Heinze, Hans-Jochen] Helmholtz Ctr Neurodegenerat Dis, Magdeburg, Germany.
   [de Quervain, Dominique J. -F.] Univ Basel, Div Cognit Neurosci, Dept Psychol, CH-4055 Basel, Switzerland.
RP Milnik, A (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM annette.milnik@med.ovgu.de
OI de Quervain, Dominique/0000-0001-7131-2464; Milnik,
   Annette/0000-0002-3933-3289; Vogler, Christian/0000-0003-3922-109X;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Heck,
   Angela/0000-0002-1543-3197
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [CRSIK0_122691, CRSI33_130080]; European UnionEuropean Union (EU)
   [HEALTH-F4-2009-242257]
FX Grant sponsor: The Swiss National Science Foundation (Sinergia Grants);
   Grant numbers: CRSIK0_122691, CRSI33_130080; Grant sponsor: The 7th
   framework programme of the European Union (ADAMS Project); Grant number:
   HEALTH-F4-2009-242257.
CR Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410
   Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x
   Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591
   Andreano JM, 2009, LEARN MEMORY, V16, P248, DOI 10.1101/lm.918309
   Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050
   Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335
   Burgess JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.004
   Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107
   Calkins ME, 2010, AM J PSYCHIAT, V167, P459, DOI 10.1176/appi.ajp.2009.08091351
   Champely S., 2009, PWR BASIC FUNCTIONS
   Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x
   Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916
   Finkel D, 1998, INT J AGING HUM DEV, V47, P217, DOI 10.2190/JEPX-G60A-6QK3-9DR3
   FINKEL D, 1995, PSYCHOL AGING, V10, P437, DOI 10.1037/0882-7974.10.3.437
   Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558
   Galecki P, 2010, NEUROENDOCRINOL LETT, V31, P97
   Greenwood TA, 2011, J ALZHEIMERS DIS, V27, P897, DOI 10.3233/JAD-2011-110782
   Hayashi N, 2010, DEMENT GERIATR COGN, V30, P302, DOI 10.1159/000320482
   Hedges LV, 1985, STAT MED, V20, P825
   Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594
   Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7
   Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841
   Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749
   Jacobsen LK, 2009, BIOL PSYCHIAT, V65, P671, DOI 10.1016/j.biopsych.2008.10.024
   Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054
   Johansson B, 1999, J GERONTOL B-PSYCHOL, V54, pP173, DOI 10.1093/geronb/54B.3.P173
   Kauppi K, 2011, J NEUROSCI, V31, P14218, DOI 10.1523/JNEUROSCI.3292-11.2011
   Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x
   Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865
   Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x
   Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5
   Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017
   Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046
   Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708
   Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105
   Nacmias B, 2008, NEUROSCI LETT, V436, P145, DOI 10.1016/j.neulet.2008.03.008
   Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x
   Need AC, 2008, AM J MED GENET B, V147B, P667, DOI 10.1002/ajmg.b.30658
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299
   Pfeiffer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018362
   Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852
   Read S, 2006, J GERONTOL B-PSYCHOL, V61, pP137, DOI 10.1093/geronb/61.3.P137
   Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003
   Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346
   Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74
   Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001
   Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010
   Sedille-Mostafaie N, 2012, J NEURAL TRANSM, V119, P77, DOI 10.1007/s00702-011-0667-9
   Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516
   Van Snellenberg JX, 2009, PSYCHIAT RES-NEUROIM, V174, P89, DOI 10.1016/j.pscychresns.2009.04.001
   Vassos E, 2010, J PSYCHIATR RES, V44, P795, DOI 10.1016/j.jpsychires.2010.01.012
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489
   Volk HE, 2006, TWIN RES HUM GENET, V9, P623, DOI 10.1375/183242706778553462
   Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121
   Wersching H, 2011, NEUROPSYCHOPHARMACOL, V36, P1296, DOI 10.1038/npp.2011.16
   Wilson RS, 2011, J ALZHEIMERS DIS, V23, P249, DOI 10.3233/JAD-2010-101515
   Yasuda Y, 2010, WORLD J BIOL PSYCHIA, V11, P852, DOI 10.3109/15622971003797258
   Zhang HP, 2009, NEUROPSYCHOPHARMACOL, V34, P2508, DOI 10.1038/npp.2009.80
NR 64
TC 52
Z9 54
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4841
EI 1552-485X
J9 AM J MED GENET B
JI Am. J. Med. Genet. B
PD DEC
PY 2012
VL 159B
IS 8
BP 958
EP 969
DI 10.1002/ajmg.b.32101
PG 12
WC Genetics & Heredity; Psychiatry
SC Genetics & Heredity; Psychiatry
GA 059SI
UT WOS:000312725200007
PM 23065961
DA 2021-01-25
ER

PT J
AU Itel, F
   Al-Samir, S
   Oberg, F
   Chami, M
   Kumar, M
   Supuran, CT
   Deen, PMT
   Meier, W
   Hedfalk, K
   Gros, G
   Endeward, V
AF Itel, Fabian
   Al-Samir, Samer
   Oberg, Fredrik
   Chami, Mohamed
   Kumar, Manish
   Supuran, Claudiu T.
   Deen, Peter M. T.
   Meier, Wolfgang
   Hedfalk, Kristina
   Gros, Gerolf
   Endeward, Volker
TI CO2 permeability of cell membranes is regulated by membrane cholesterol
   and protein gas channels
SO FASEB JOURNAL
LA English
DT Article
DE aquaporin 1; aquaporin Z; phospholipid vesicles; MDCK cells
ID CARBON-DIOXIDE PERMEABILITY; LIPID BILAYER-MEMBRANES; WATER CHANNEL;
   EPITHELIAL MEMBRANE; TRANSPORT; AQUAPORIN-1; LIPOSOMES; ANHYDRASE;
   AMMONIA; BLOOD
AB Recent observations that some membrane proteins act as gas channels seem surprising in view of the classical concept that membranes generally are highly permeable to gases. Here, we study the gas permeability of membranes for the case of CO2, using a previously established mass spectrometric technique. We first show that biological membranes lacking protein gas channels but containing normal amounts of cholesterol (30-50 mol% of total lipid), e.g., MDCK and tsA201 cells, in fact possess an unexpectedly low CO2 permeability (PCO2) of similar to 0.01 cm/s, which is 2 orders of magnitude lower than the PCO2 of pure planar phospholipid bilayers (similar to 1 cm/s). Phospholipid vesicles enriched with similar amounts of cholesterol also exhibit PCO2 approximate to 0.01 cm/s, identifying cholesterol as the major determinant of membrane PCO2. This is confirmed by the demonstration that MDCK cells depleted of or enriched with membrane cholesterol show dramatic increases or decreases in PCO2, respectively. We demonstrate, furthermore, that reconstitution of human AQP-1 into cholesterol-containing vesicles, as well as expression of human AQP-1 in MDCK cells, leads to drastic increases in PCO2, indicating that gas channels are of high functional significance for gas transfer across membranes of low intrinsic gas permeability.-Itel, F., Al-Samir, S., Oberg, F., Chami, M., Kumar, M., Supuran, C. T., Deen, P. M. T., Meier, W., Hedfalk, K., Gros, G., Endeward, V. CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels. FASEB J. 26, 5182-5191 (2012). www.fasebj.org
C1 [Al-Samir, Samer; Gros, Gerolf; Endeward, Volker] Hannover Med Sch, Zentrum Physiol, Dept Vegetat Physiol, D-30625 Hannover, Germany.
   [Itel, Fabian; Meier, Wolfgang] Univ Basel, Dept Chem, Basel, Switzerland.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt C CINA, Basel, Switzerland.
   [Oberg, Fredrik; Hedfalk, Kristina] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.
   [Kumar, Manish] Penn State Univ, Dept Chem Engn, State Coll, PA USA.
   [Supuran, Claudiu T.] Univ Florence, Dipartimento Chim, Lab Chim Bioinorgan, I-50144 Florence, Italy.
   [Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands.
RP Gros, G (corresponding author), Hannover Med Sch, Zentrum Physiol, Dept Vegetat Physiol, D-30625 Hannover, Germany.
EM gros.gerolf@mh-hannover.de
RI Kumar, Manish/C-2346-2008; Supuran, Claudiu T/A-5151-2008; Deen,
   P.M.T./H-8023-2014; Oberg, Fredrik Kryh/B-1241-2011; Hedfalk,
   Kristina/A-8244-2010; Deen, Peter/B-9854-2013; Gros, Gerolf/K-8421-2012
OI Deen, P.M.T./0000-0002-7868-4655; Oberg, Fredrik
   Kryh/0000-0002-7089-2118; Deen, Peter/0000-0002-7868-4655; Itel,
   Fabian/0000-0002-4161-2383; Supuran, Claudiu/0000-0003-4262-0323
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [EN
   908/1-1]; National Center of Competence in Nanoscale Science;
   Netherlands Organization for Scientific research (NWO)Netherlands
   Organization for Scientific Research (NWO); VICINetherlands Organization
   for Scientific Research (NWO) [865.07.002]
FX The authors thank Prof. Ernst Ungewickell (Medizinische Hochschule
   Hannover) and Dawid Krenc (Universitat Kiel, Kiel, Germany) for helpful
   discussions, and Mr. Mark Inglin (University of Basel) for
   language-editing the manuscript. The authors are indebted to Dr.
   Aleksandra Rojek (University of Aarhus, Aarhus, Denmark) for the kind
   gift of the AQP-1 antibody RA3391/2353AP. This work was supported by the
   Deutsche Forschungsgemeinschaft through grant EN 908/1-1 to V. E., S.
   A.-S., and G. G.. F. I., W. M., and M. C. gratefully acknowledge the
   National Center of Competence in Nanoscale Science for financial support
   and Prof. Henning Stahlberg (University of Basel) for access to the
   electron microscopy facility. P. M. T. D. is a recipient of a VICI grant
   of the Netherlands Organization for Scientific research (NWO) and
   acknowledges VICI grant 865.07.002. Author contributions: V. E. and G.
   G. conceived the study; V. E. designed the research and performed all
   mass spectrometric <SUP>18</SUP>O exchange experiments; F. I. and W. M.
   prepared liposomes and proteoliposomes, as well as AqpZ; S.A.-S.
   performed all experiments with MDCK and tsA201 cells; F. O. and K. H.
   contributed hAQP-1 protein; M. C. performed the freeze-fracture studies;
   P. T. M. D. contributed the pCB6-hAQP-1 expression construct; C. T. S.
   contributed the extracellular carbonic anhydrase inhibitor; M. K.
   contributed to lipo- and proteoliposome preparation; G. G. and V. E.
   wrote the paper; all authors critically commented on the manuscript. The
   authors declare no conflicts of interest.
CR AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Antonenko YN, 1997, BIOPHYS J, V72, P2187, DOI 10.1016/S0006-3495(97)78862-3
   BATTINO R, 1984, J PHYS CHEM REF DATA, V13, P563, DOI 10.1063/1.555713
   Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113
   Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032
   Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034
   BREWER CB, 1994, METHOD CELL BIOL, V43, P233
   BUNCE AS, 1974, BIOCHIM BIOPHYS ACTA, V363, P423, DOI 10.1016/0005-2736(74)90081-9
   Christian AE, 1997, J LIPID RES, V38, P2264
   CORVERA E, 1992, BIOCHIM BIOPHYS ACTA, V1107, P261, DOI 10.1016/0005-2736(92)90413-G
   de Groot Bert L, 2011, Chemphyschem, V12, P1021, DOI 10.1002/cphc.201000974
   Duttingdorf HDMZ, 1999, ANAL BIOCHEM, V269, P45, DOI 10.1006/abio.1998.3075
   Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com
   Endeward V, 2005, J PHYSIOL-LONDON, V567, P253, DOI 10.1113/jphysiol.2005.085761
   Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com
   Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027
   Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394
   FINKELSTEIN A, 1976, J GEN PHYSIOL, V68, P127, DOI 10.1085/jgp.68.2.127
   Forster RE, 1969, NASA, P275
   Francis SA, 1999, EUR J CELL BIOL, V78, P473, DOI 10.1016/S0171-9335(99)80074-0
   Geers C, 2000, PHYSIOL REV, V80, P681
   GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779
   HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x
   Hasselblatt P, 2000, PFLUG ARCH EUR J PHY, V441, P118, DOI 10.1007/s004240000377
   Hill WG, 2000, J BIOL CHEM, V275, P30176, DOI 10.1074/jbc.M003494200
   HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121
   Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406
   Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x
   ITADA N, 1977, J BIOL CHEM, V252, P3881
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   KIKERI D, 1989, NATURE, V339, P478, DOI 10.1038/339478a0
   KORN ED, 1969, ANNU REV BIOCHEM, V38, P263, DOI 10.1146/annurev.bi.38.070169.001403
   Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104
   LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67
   Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106
   Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200
   Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270
   Moller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200
   Musa-Aziz R., 2011, FASEB J S, V25, P10405
   Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106
   Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543
   Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099
   Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007
   OBRIEN JS, 1967, J THEOR BIOL, V15, P307, DOI 10.1016/0022-5193(67)90140-3
   Overton E, 1901, STUDIEN NARKOSE
   Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868
   Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123
   SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8
   SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4
   Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x
   Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467
   Trandum C, 2000, BIOPHYS J, V78, P2486, DOI 10.1016/S0006-3495(00)76793-2
   Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027
   van Beest M, 2006, BBA-BIOMEMBRANES, V1758, P1126, DOI 10.1016/j.bbamem.2006.03.007
   Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467
   Verkman AS, 2002, J PHYSIOL-LONDON, V542, P31, DOI 10.1113/jphysiol.2002.024398
   WAISBREN SJ, 1994, NATURE, V368, P332, DOI 10.1038/368332a0
   Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008
   WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373
   WILCOCK RJ, 1978, J CHEM THERMODYN, V10, P817, DOI 10.1016/0021-9614(78)90154-4
   Yang BX, 2000, J BIOL CHEM, V275, P2686, DOI 10.1074/jbc.275.4.2686
NR 61
TC 56
Z9 56
U1 5
U2 62
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD DEC
PY 2012
VL 26
IS 12
BP 5182
EP 5191
DI 10.1096/fj.12-209916
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 047KD
UT WOS:000311838300038
PM 22964306
DA 2021-01-25
ER

PT J
AU Astasov-Frauenhoffer, M
   Braissant, O
   Hauser-Gerspach, I
   Daniels, AU
   Weiger, R
   Waltimo, T
AF Astasov-Frauenhoffer, Monika
   Braissant, Olivier
   Hauser-Gerspach, Irmgard
   Daniels, Alma U.
   Weiger, Roland
   Waltimo, Tuomas
TI Isothermal microcalorimetry provides new insights into biofilm
   variability and dynamics
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Article
DE oral biofilm; metabolic activity; heat flow; scanning electron
   microscopy; fluorescence in situ hybridization; isothermal
   microcalorimetry
ID MATERIALS IN-VITRO; STREPTOCOCCUS-SANGUINIS; BACTERIAL-COLONIZATION;
   RESTORATIVE MATERIALS; FUSOBACTERIUM-NUCLEATUM; DENTAL IMPLANT;
   ADHESION; POCKETS; SYSTEM; CELLS
AB The purpose of this study was to investigate a three-species in vitro biofilm with peri-implantitis-related bacteria for its variability and metabolic activity. Streptococcus sanguinis, Fusobacterium nucleatum, and Porphyromonas gingivalis were suspended in simulated body fluid containing 0.2% glucose to form biofilms on polished, protein-coated implant-grade titanium disks over 72 h using a flow chamber system. Thereafter, biofilm-coated disks were characterized by scanning electron microscopy and fluorescence in situ hybridization/confocal laser scanning microscopy. To assess metabolic activity within the biofilms, their heat flow was recorded for 480 h at 37 degrees C by IMC. The microscopic methods revealed that the total number of bacteria in the biofilms varied slightly among specimens (2.59 x 104 +/- 0.67 x 104 cells mm-2), whereas all three species were found constantly with unchanged proportions (S. sanguinis 41.3 +/- 4.8%, F. nucleatum 17.7 +/- 2.1%, and P. gingivalis 41.0 +/- 4.9%). IMC revealed minor differences in time-to-peak heat flow (20.6 +/- 4.5 h), a trend consistent with the small variation in bacterial species proportions as shown by microscopy. Peak heat flow (35.8 +/- 42.6 mu W), mean heat flow (13.1 +/- 22.0 mu W), and total heat over 480 h (23.5 +/- 37.2 J) showed very high variation. These IMC results may be attributed to differences in the initial cell counts and relative proportions of the three species, their distribution and embedment in exopolysaccharide matrix on the test specimens. The present results provide new insights into variability and dynamics of biofilms on titanium disks, aspects that should be explored in future studies of dental surfaces.
C1 [Astasov-Frauenhoffer, Monika; Hauser-Gerspach, Irmgard; Waltimo, Tuomas] Univ Basel, Sch Dent Med, Inst Prevent Dent & Oral Microbiol, CH-4056 Basel, Switzerland.
   [Braissant, Olivier; Daniels, Alma U.] Univ Basel, Biozentrum Pharmazentrum, Lab Biomech & Biocalorimetry, CH-4056 Basel, Switzerland.
   [Braissant, Olivier] Univ Basel Hosp, Dept Urol, CH-4031 Basel, Switzerland.
   [Weiger, Roland] Univ Basel, Clin Periodontol Endodontol & Cariol, CH-4056 Basel, Switzerland.
RP Astasov-Frauenhoffer, M (corresponding author), Univ Basel, Sch Dent Med, Inst Prevent Dent & Oral Microbiol, Hebelstr 3, CH-4056 Basel, Switzerland.
EM m.astasov-frauenhoffer@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X; Astasov-Frauenhoffer,
   Monika/0000-0001-9638-3939
CR Al-Ahmad A, 2009, J MED MICROBIOL, V58, P1359, DOI 10.1099/jmm.0.011213-0
   Amann R. I., 1995, MOL MICROBIAL ECOLOG, P1
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Decker EM, 2003, EUR J ORAL SCI, V111, P144, DOI 10.1034/j.1600-0722.2003.00025.x
   Decker EM, 2008, QUINTESSENCE INT, V39, P17
   Decker Eva-Maria, 2003, Clin Oral Investig, V7, P98, DOI 10.1007/s00784-003-0202-y
   Dige I, 2009, ORAL MICROBIOL IMMUN, V24, P69, DOI 10.1111/j.1399-302X.2008.00482.x
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Filoche SK, 2007, ORAL MICROBIOL IMMUN, V22, P73, DOI 10.1111/j.1399-302X.2007.00323.x
   Furst MM, 2007, CLIN ORAL IMPLAN RES, V18, P501, DOI 10.1111/j.1600-0501.2007.01381.x
   Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280
   Hauser-Gerspach I, 2007, DENT MATER J, V26, P361, DOI 10.4012/dmj.26.361
   Heuer W, 2007, J ORAL REHABIL, V34, P377, DOI 10.1111/j.1365-2842.2007.01725.x
   Howell M, 2012, J CLIN MICROBIOL, V50, P16, DOI 10.1128/JCM.05556-11
   James AM., 1987, THERMAL ENERGETIC ST, P147
   Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x
   Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478
   LANCY P, 1983, INFECT IMMUN, V40, P303, DOI 10.1128/IAI.40.1.303-309.1983
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   Meier R, 2008, J MATER SCI-MATER M, V19, P3249, DOI 10.1007/s10856-008-3457-7
   Merritt J, 2009, APPL ENVIRON MICROB, V75, P7725, DOI 10.1128/AEM.00916-09
   Mombelli A, 2011, J CLIN PERIODONTOL, V38, P203, DOI 10.1111/j.1600-051X.2010.01666.x
   Paquette David W, 2006, Dent Clin North Am, V50, P361, DOI 10.1016/j.cden.2006.05.002
   Paster Bruce J., 1998, Methods in Cell Science, V20, P223, DOI 10.1023/A:1009715710555
   Postollec F, 2003, J MICROBIOL METH, V55, P241, DOI 10.1016/S0167-7012(03)00145-3
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Quirynen M, 2006, CLIN ORAL IMPLAN RES, V17, P25, DOI 10.1111/j.1600-0501.2005.01194.x
   Salvi GE, 2008, CLIN ORAL IMPLAN RES, V19, P242, DOI 10.1111/j.1600-0501.2007.01470.x
   Schaudinn C, 2009, J MICROSC-OXFORD, V235, P124, DOI 10.1111/j.1365-2818.2009.03201.x
   Schwartz T, 2003, J APPL MICROBIOL, V95, P591, DOI 10.1046/j.1365-2672.2003.02019.x
   Slenters TV, 2008, J MATER CHEM, V18, P5359, DOI 10.1039/b813026d
   Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838
   Tenuta LMA, 2006, CARIES RES, V40, P546, DOI 10.1159/000095656
   Thurnheer T, 2004, J MICROBIOL METH, V56, P37, DOI 10.1016/j.mimet.2003.09.003
   WEBSTER P, 2004, BIOFILMS, V1, P165, DOI DOI 10.1017/S1479050504001425
   Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1
   Weiger R, 1999, ARCH ORAL BIOL, V44, P621, DOI 10.1016/S0003-9969(99)00061-8
NR 39
TC 32
Z9 32
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD DEC
PY 2012
VL 337
IS 1
BP 31
EP 37
DI 10.1111/1574-6968.12007
PG 7
WC Microbiology
SC Microbiology
GA 035XK
UT WOS:000310986300005
PM 22967269
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Zeth, K
AF Zeth, Kornelius
TI Structure and uptake mechanism of bacteriocins targeting peptidoglycan
   renewal
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE bacteriocin; colicin; peptidoglycan; periplasmic space; pesticin
ID HIGHLY PATHOGENIC YERSINIA; COLICIN-M; PESTICIN RECEPTOR;
   CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CATALYTIC DOMAIN; ENTEROCOLITICA;
   PROTEIN; PERIPLASM; VIRULENCE
AB Bacteriocins are narrow-spectrum protein antibiotics released to kill related bacteria of the same niche. Uptake of bacteriocins depends critically on the presence of an uptake receptor in the outer membrane, a translocation pore and an energy-dependent activating system of the inner membrane. Most bacteriocins act on the inner membrane as pore-forming toxins or they target cytoplasmic DNA/RNA and ribosomal synthesis respectively. Only two bacteriocins are known to become activated in the periplasmic space and to inhibit the renewal process of the peptidoglycan structure. In Escherichia coli, the Cma (colicin M) phosphatase is activated in the periplasmic space by the FkpA chaperone and subsequently degrades the C55-PP precursor unit of the peptidoglycan. Pst (pesticin) from Yersinia pestis carries a lysozyme homology domain to degrade peptidoglycan. Import of Pst is only achieved if the N-terminal translocation domain can span the outer membrane and if extensive unfolding of the protein during membrane passage is permitted. There is considerable plasticity in the import pathway since a chimaera comprising the activity domain replaced by T4 lysozyme is also translocated and active in killing those bacteria carrying the FyuA receptor.
C1 Univ Basel, Biozentrum, CH-4053 Basel, Switzerland.
RP Zeth, K (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4053 Basel, Switzerland.
EM kornelius.zeth@googlemail.com
FU German Science FoundationGerman Research Foundation (DFG) [ZE522/4-1];
   Max Planck SocietyMax Planck Society; Human Frontier Science
   ProgrammeHuman Frontier Science Program [RGP61/2007]
FX My research is supported by the German Science Foundation [grant number
   ZE522/4-1], the Max Planck Society and the Human Frontier Science
   Programme [grant number RGP61/2007].
CR Barneoud-Arnoulet A, 2010, J BACTERIOL, V192, P5212, DOI 10.1128/JB.00431-10
   Barreteau H, 2012, MICROB DRUG RESIST, V18, P222, DOI 10.1089/mdr.2011.0230
   Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583
   BAUMLER A, 1993, ZBL BAKT-INT J MED M, V278, P416
   Braun M, 2002, EUR J BIOCHEM, V269, P4948, DOI 10.1046/j.1432-1033.2002.03195.x
   Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06
   Ferber D M, 1979, Contrib Microbiol Immunol, V5, P366
   FERBER DM, 1979, J BACTERIOL, V139, P495, DOI 10.1128/JB.139.2.495-501.1979
   GRAMOTINA LI, 1977, ANTIBIOT MED BIOTEK, V22, P704
   Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033
   HALL PJ, 1978, J BACTERIOL, V136, P786, DOI 10.1128/JB.136.2.786-789.1978
   HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x
   Helbig S, 2011, J BIOL CHEM, V286, P6280, DOI 10.1074/jbc.M110.165274
   Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10
   Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x
   Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454
   KOEBNIK R, 1993, MOL GEN GENET, V237, P152, DOI 10.1007/BF00282796
   Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109
   Patzer SI, 2012, J BIOL CHEM, V287, P23381, DOI 10.1074/jbc.M112.362913
   Pilsl H, 1996, J BACTERIOL, V178, P2431, DOI 10.1128/jb.178.8.2431-2435.1996
   Rakin A, 1996, MICROBIOL-UK, V142, P3415, DOI 10.1099/13500872-142-12-3415
   RAKIN A, 1995, J BACTERIOL, V177, P2292, DOI 10.1128/jb.177.9.2292-2298.1995
   RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x
   Rakin A, 1995, CONTRIB TO MICROBIOL, V13, P244
   Uson I, 2012, J STRUCT BIOL, V178, P45, DOI 10.1016/j.jsb.2012.02.004
   Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997
   Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200
NR 27
TC 2
Z9 2
U1 0
U2 18
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD DEC
PY 2012
VL 40
BP 1560
EP U441
DI 10.1042/BST20120194
PN 6
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 051AR
UT WOS:000312096800070
PM 23176517
DA 2021-01-25
ER

PT J
AU van der Westen, R
   Hosta-Rigau, L
   Sutherland, DS
   Goldie, KN
   Albericio, F
   Postma, A
   Stadler, B
AF van der Westen, Rebecca
   Hosta-Rigau, Leticia
   Sutherland, Duncan S.
   Goldie, Kenneth N.
   Albericio, Fernando
   Postma, Almar
   Stadler, Brigitte
TI Myoblast Cell Interaction with Polydopamine Coated Liposomes
SO BIOINTERPHASES
LA English
DT Article
ID ANTITUMOR-ACTIVITY; POLYMER CAPSULES; DRUG CARRIERS; THIOCORALINE;
   RELEASE; ROUTE
AB Liposomes are widely used, from biosensing to drug delivery. Their coating with polymers for stability and functionalization purposes further broadens their set of relevant properties. Poly(dopamine) (PDA), a eumelanin-like material deposited via the "self"-oxidative polymerization of dopamine at mildly basic pH, has attracted considerable interest in the past few years due to its simplicity, flexibility yet fascinating properties. Herein, we characterize the coating of different types of liposomes with PDA depending on the presence of oleoyldopamine in the lipid bilayer and the dopamine hydrochloride concentration. Further, the interaction of these coated liposomes in comparison to their uncoated counterparts with myoblast cells is assessed. Their uptake/association efficiency with these cells is determined. Further, their dose-dependent cytotoxicity with and without entrapped hydrophobic cargo (thiocoraline) is characterized. Taken together, the reported results demonstrate the potential of PDA coated liposomes as a tool in biomedical applications.
C1 [van der Westen, Rebecca; Hosta-Rigau, Leticia; Sutherland, Duncan S.; Stadler, Brigitte] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, Basel, Switzerland.
   [Albericio, Fernando] Univ Barcelona, Dept Organ Chem, Inst Res Biomed, Barcelona, Spain.
   [Albericio, Fernando] Networking Ctr Bioengn Biomat & Nanomed, CIBER BBN, Barcelona, Spain.
   [Postma, Almar] CSIRO, Mat Sci & Engn, Clayton, Vic 3168, Australia.
RP Stadler, B (corresponding author), Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, Aarhus, Denmark.
EM bstadler@inano.au.dk
RI Sutherland, Duncan S/E-4385-2010; Postma, Almar/B-6749-2008; Stadler,
   Brigitte/I-2661-2013; Postma, Almar/Q-9890-2019; Albericio,
   Fernando/B-4383-2013; Hosta-Rigau, Leticia/C-4346-2016
OI Sutherland, Duncan S/0000-0002-5045-9915; Postma,
   Almar/0000-0001-7343-7236; Albericio, Fernando/0000-0002-8946-0462;
   Hosta-Rigau, Leticia/0000-0001-8177-4806; Stadler,
   Brigitte/0000-0002-7335-3945
FU Lundbeckfonden, DenmarkLundbeckfonden; Danish Council for Independent
   Research, Technology and Production Sciences, DenmarkDet Frie
   Forskningsrad (DFF)
FX This work was supported by a Grant from Lundbeckfonden, Denmark and a
   Sapere Aude Starting Grant from the Danish Council for Independent
   Research, Technology and Production Sciences, Denmark (B. S). The
   authors thank Assistant Prof. Alexander N. Zelikin (Aarhus University)
   for the use of his equipment. We gratefully acknowledge Pharma Mar S. A.
   for providing the compound thiocoraline and Irena Krodkiewska
   (CSIRO-Materials Science and Engineering) for providing the compound
   oleoyldopamine.
CR Ali SI, 2010, LANGMUIR, V26, P7848, DOI 10.1021/la904709c
   Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644
   Bally M, 2009, NANOMEDICINE-UK, V4, P447, DOI 10.2217/NNM.09.16
   Chu ZL, 2010, MOL ENDOCRINOL, V24, P161, DOI 10.1210/me.2009-0239
   Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209
   Dang HT, 2011, BIOORGAN MED CHEM, V19, P1520, DOI 10.1016/j.bmc.2010.12.046
   Daubert BF, 1943, J AM CHEM SOC, V65, P2142, DOI 10.1021/ja01251a035
   Fujimoto K, 2007, MACROMOLECULES, V40, P5122, DOI 10.1021/ma070477w
   Graf N, 2011, ADV FUNCT MATER, V21, P1666, DOI 10.1002/adfm.201002283
   Hosta-Rigau L, 2010, BIOMACROMOLECULES, V11, P3548, DOI 10.1021/bm101020e
   Hosta-Rigau L, 2010, ADV FUNCT MATER, V20, P59, DOI 10.1002/adfm.200901297
   Immordino ML, 2006, INT J NANOMED, V1, P297
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Liu QZ, 2011, MACROMOL BIOSCI, V11, P1227, DOI 10.1002/mabi.201100061
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Negri A, 2007, J MED CHEM, V50, P3322, DOI 10.1021/jm070381s
   Ouyang RZ, 2007, ADV FUNCT MATER, V17, P3223, DOI 10.1002/adfm.200700143
   Postma A, 2009, CHEM MATER, V21, P3042, DOI 10.1021/cm901293e
   Qu WG, 2010, J PHYS CHEM C, V114, P13010, DOI 10.1021/jp104492f
   Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734
   Sawant RR, 2010, SOFT MATTER, V6, P4026, DOI 10.1039/b923535n
   Sofou S, 2007, NANOMEDICINE-UK, V2, P711, DOI 10.2217/17435889.2.5.711
   Stadler B, 2011, ADV FUNCT MATER, V21, P14, DOI 10.1002/adfm.201001676
   Stadler B, 2009, NANOSCALE, V1, P68, DOI 10.1039/b9nr00143c
   Takeuchi H, 2010, YAKUGAKU ZASSHI, V130, P1135, DOI 10.1248/yakushi.130.1135
   Woodle MC, 1998, ADV DRUG DELIVER REV, V32, P139, DOI 10.1016/S0169-409X(97)00136-1
   Xie CQ, 2009, HYPERTENSION, V54, P1298, DOI 10.1161/HYPERTENSIONAHA.109.132167
   Yang SH, 2011, J AM CHEM SOC, V133, P2795, DOI 10.1021/ja1100189
   Yu B., 2009, CHEM COMMUN, P6789
   Zelikin AN, 2010, SMALL, V6, P2201, DOI 10.1002/smll.201000765
NR 32
TC 28
Z9 28
U1 2
U2 57
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD DEC
PY 2012
VL 7
IS 1-4
AR 8
DI 10.1007/s13758-011-0008-4
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 987UD
UT WOS:000307442400008
PM 22589051
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Perez-Schindler, J
   Summermatter, S
   Salatino, S
   Zorzato, F
   Beer, M
   Balwierz, PJ
   van Nimwegen, E
   Feige, JN
   Auwerx, J
   Handschin, C
AF Perez-Schindler, Joaqun
   Summermatter, Serge
   Salatino, Silvia
   Zorzato, Francesco
   Beer, Markus
   Balwierz, Piotr J.
   van Nimwegen, Erik
   Feige, Jerome N.
   Auwerx, Johan
   Handschin, Christoph
TI The Corepressor NCoR1 Antagonizes PGC-1 alpha and Estrogen-Related
   Receptor alpha in the Regulation of Skeletal Muscle Function and
   Oxidative Metabolism
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID THYROID-HORMONE RECEPTOR; NUCLEAR RECEPTOR; FIBER-TYPE; INSULIN
   SENSITIVITY; ENERGY HOMEOSTASIS; CHRONIC DISEASE; CO-REPRESSOR;
   ERR-ALPHA; EXERCISE; DIFFERENTIATION
AB Skeletal muscle exhibits a high plasticity and accordingly can quickly adapt to different physiological and pathological stimuli by changing its phenotype largely through diverse epigenetic mechanisms. The nuclear receptor corepressor 1 (NCoR1) has the ability to mediate gene repression; however, its role in regulating biological programs in skeletal muscle is still poorly understood. We therefore studied the mechanistic and functional aspects of NCoR1 function in this tissue. NCoR1 muscle-specific knockout mice exhibited a 7.2% higher peak oxygen consumption (VO2peak), a 11% reduction in maximal isometric force, and increased ex vivo fatigue resistance during maximal stimulation. Interestingly, global gene expression analysis revealed a high overlap between the effects of NCoR1 deletion and peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator 1 alpha (PGC-1 alpha) overexpression on oxidative metabolism in muscle. Importantly, PPAR beta/delta and estrogen-related receptor alpha (ERR alpha) were identified as common targets of NCoR1 and PGC-1 alpha with opposing effects on the transcriptional activity of these nuclear receptors. In fact, the repressive effect of NCoR1 on oxidative phosphorylation gene expression specifically antagonizes PGC-1 alpha-mediated coactivation of ERR alpha. We therefore delineated the molecular mechanism by which a transcriptional network controlled by corepressor and coactivator proteins determines the metabolic properties of skeletal muscle, thus representing a potential therapeutic target for metabolic diseases.
C1 [Perez-Schindler, Joaqun; Summermatter, Serge; Salatino, Silvia; Beer, Markus; Balwierz, Piotr J.; van Nimwegen, Erik; Handschin, Christoph] Univ Basel, Biozentrum, Basel, Switzerland.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland.
   [Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Zorzato, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy.
   [Balwierz, Piotr J.; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
   [Feige, Jerome N.] Novartis Inst Biomed Res, Basel, Switzerland.
   [Feige, Jerome N.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Balwierz, Piotr J/AAG-4187-2020; Handschin, Christoph/E-6886-2015
OI Balwierz, Piotr J/0000-0002-1548-4605; Handschin,
   Christoph/0000-0003-0603-1097; Perez-Schindler,
   Joaquin/0000-0003-3141-8859; Salatino, Silvia/0000-0003-1286-3076; van
   Nimwegen, Erik/0000-0001-6338-1312
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF 310030 132900]; Muscular Dystrophy Association USAMuscular
   Dystrophy Association; SwissLife Jubilaumsstiftung fur Volksgesundheit
   und medizinische Forschung; Swiss Society for Research on Muscle
   Diseases (SSEM); Swiss Diabetes Association; Roche Research Foundation;
   United Mitochondrial Disease Foundation; Association Francaise contre
   les MyopathiesAssociation Francaise contre les Myopathies; Ecole
   Polytechnique Federale de Lausanne; European Research CouncilEuropean
   Research Council (ERC); University of Basel
FX This project was funded by the Swiss National Science Foundation (SNF
   310030 132900), the Muscular Dystrophy Association USA, the SwissLife
   Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung, the
   Swiss Society for Research on Muscle Diseases (SSEM), the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation, the Association Francaise contre les Myopathies, the
   Ecole Polytechnique Federale de Lausanne, the European Research Council,
   and the University of Basel.
CR Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455
   Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Baar K, 2010, ACTA PHYSIOL, V199, P477, DOI 10.1111/j.1748-1716.2010.02121.x
   Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155
   Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Booth FW, 2008, BRIT J SPORT MED, V42, P950, DOI 10.1136/bjsm.2008.052589
   Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006
   Busson M, 2005, ONCOGENE, V24, P1698, DOI 10.1038/sj.onc.1208373
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610
   Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560
   Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4
   Furuya F, 2007, MOL CELL BIOL, V27, P6116, DOI 10.1128/MCB.00900-07
   Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017
   Glass CK, 2000, GENE DEV, V14, P121
   Gonzalez E, 2001, MECH AGEING DEV, V122, P1019, DOI 10.1016/S0047-6374(01)00229-9
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327
   HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0
   Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009
   Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054
   Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010
   McKenna NJ, 2010, CELL, V143, P172, DOI 10.1016/j.cell.2010.09.032
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   NUUTILA P, 1994, J CLIN INVEST, V93, P2267, DOI 10.1172/JCI117226
   Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001
   Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960
   Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007
   Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004
   Schuler MJ, 1999, EUR J BIOCHEM, V264, P982, DOI 10.1046/j.1432-1327.1999.00706.x
   Schuler MJ, 1998, EUR J BIOCHEM, V257, P607, DOI 10.1046/j.1432-1327.1998.2570607.x
   Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101
   Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017
   Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120
NR 49
TC 52
Z9 53
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD DEC
PY 2012
VL 32
IS 24
BP 4913
EP 4924
DI 10.1128/MCB.00877-12
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 042SV
UT WOS:000311492200003
PM 23028049
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Feltrin, D
   Fusco, L
   Witte, H
   Moretti, F
   Martin, K
   Letzelter, M
   Fluri, E
   Scheiffele, P
   Pertz, O
AF Feltrin, Daniel
   Fusco, Ludovico
   Witte, Harald
   Moretti, Francesca
   Martin, Katrin
   Letzelter, Michel
   Fluri, Erika
   Scheiffele, Peter
   Pertz, Olivier
TI Growth Cone MKK7 mRNA Targeting Regulates MAP1b-Dependent Microtubule
   Bundling to Control Neurite Elongation
SO PLOS BIOLOGY
LA English
DT Article
ID N-TERMINAL KINASE; DEVELOPING CEREBRAL-CORTEX; LOCAL PROTEIN-SYNTHESIS;
   HIPPOCAMPAL-NEURONS; PERIPHERAL-NERVE; AXON FORMATION; ACTIN; REVEALS;
   PHOSPHORYLATION; LOCALIZATION
AB Local mRNA translation in neurons has been mostly studied during axon guidance and synapse formation but not during initial neurite outgrowth. We performed a genome-wide screen for neurite-enriched mRNAs and identified an mRNA that encodes mitogen-activated protein kinase kinase 7 (MKK7), a MAP kinase kinase (MAPKK) for Jun kinase (JNK). We show that MKK7 mRNA localizes to the growth cone where it has the potential to be translated. MKK7 is then specifically phosphorylated in the neurite shaft, where it is part of a MAP kinase signaling module consisting of dual leucine zipper kinase (DLK), MKK7, and JNK1. This triggers Map1b phosphorylation to regulate microtubule bundling leading to neurite elongation. We propose a model in which MKK7 mRNA localization and translation in the growth cone allows for a mechanism to position JNK signaling in the neurite shaft and to specifically link it to regulation of microtubule bundling. At the same time, this uncouples activated JNK from its functions relevant to nuclear translocation and transcriptional activation.
C1 [Feltrin, Daniel; Fusco, Ludovico; Moretti, Francesca; Martin, Katrin; Letzelter, Michel; Fluri, Erika; Pertz, Olivier] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland.
   [Witte, Harald; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
RP Feltrin, D (corresponding author), Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland.
EM olivier.pertz@unibas.ch
OI pertz, olivier/0000-0001-8579-4919
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); International Research Foundation for Paraplegy
FX Swiss National Science Foundation (http://www.snf.ch) International
   Research Foundation for Paraplegy (http://www.irp.ch). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001
   Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885
   Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494
   Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028
   Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036
   Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7
   Chicurel ME, 1998, NATURE, V392, P730
   Chong KWY, 2006, J NEUROSCI METH, V158, P56, DOI 10.1016/j.jneumeth.2006.05.017
   Coffey ET, 2000, J NEUROSCI, V20, P7602
   Condeelis J, 2005, BIOL CELL, V97, P97
   Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677
   Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025
   de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8
   Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284
   Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580
   Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Eng H, 1999, J NEUROSCI, V19, P1
   Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2
   Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145
   Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107
   Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906
   Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079
   Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111
   Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008
   Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006
   Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011
   Hodgson L, 2008, METHOD CELL BIOL, V85, P63, DOI 10.1016/S0091-679X(08)85004-2
   Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488
   Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115
   Jung H, 2011, CURR OPIN GENET DEV, V21, P458, DOI 10.1016/j.gde.2011.04.004
   Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021
   Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006
   Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195
   Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888
   Ng DCH, 2010, J BIOL CHEM, V285, P29001, DOI 10.1074/jbc.M110.128454
   Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006
   Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105
   Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220
   Takahashi S, 2011, CELL DEATH DIFFER, V18, P645, DOI 10.1038/cdd.2010.137
   Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009
   TORRE ER, 1992, J NEUROSCI, V12, P762
   Tournier C, 1999, MOL CELL BIOL, V19, P1569
   Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105
   Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002
   Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011
   Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001
   Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885
   Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011
   Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029
   Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010
NR 53
TC 37
Z9 36
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD DEC
PY 2012
VL 10
IS 12
AR e1001439
DI 10.1371/journal.pbio.1001439
PG 23
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 062FS
UT WOS:000312905300003
PM 23226105
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Roos, C
   Zocher, M
   Muller, D
   Munch, D
   Schneider, T
   Sahl, HG
   Scholz, F
   Wachtveitl, J
   Ma, Y
   Proverbio, D
   Henrich, E
   Dotsch, V
   Bernhard, F
AF Roos, Christian
   Zocher, Michael
   Mueller, Daniel
   Muench, Daniela
   Schneider, Tanja
   Sahl, Hans-Georg
   Scholz, Frank
   Wachtveitl, Josef
   Ma, Yi
   Proverbio, Davide
   Henrich, Erik
   Doetsch, Volker
   Bernhard, Frank
TI Characterization of co-translationally formed nanodisc complexes with
   small multidrug transporters, proteorhodopsin and with the E. coli MraY
   translocase
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Cell-free expression; Proteorhodopsin; Nanodiscs; Lipid screening;
   Membrane integration; MraY translocase
ID CELL-FREE SYNTHESIS; GREEN FLUORESCENT PROTEIN; NATIVE
   MEMBRANE-PROTEINS; PHOTOCHEMICAL-REACTION CYCLE; MOLECULE FORCE
   SPECTROSCOPY; ESCHERICHIA-COLI; IN-VITRO; PENTAPEPTIDE TRANSLOCASE;
   COUPLED RECEPTOR; FREE SYSTEMS
AB Nanodiscs (NDs) enable the analysis of membrane proteins (MP) in natural lipid bilayer environments. In combination with cell-free (CF) expression, they could be used for the co-translational insertion of MPs into defined membranes. This new approach allows the characterization of MPs without detergent contact and it could help to identify effects of particular lipids on catalytic activities. Association of MPs with different ND types, quality of the resulting MP/ND complexes as well as optimization parameters are still poorly analyzed. This study describes procedures to systematically improve CF expression protocols for the production of high quality MP/ND complexes. In order to reveal target dependent variations, the co-translational ND complex formation with the bacterial proton pump proteorhodopsin (PR), with the small multidrug resistance transporters SugE and EmrE, as well as with the Escherichia coli MraY translocase was studied. Parameters which modulate the efficiency of MP/ND complex formation have been identified and in particular effects of different lipid compositions of the ND membranes have been analyzed. Recorded force distance pattern as well as characteristic photocycle dynamics indicated the integration of functionally folded PR into NDs. Efficient complex formation of the E. coli MraY translocase was dependent on the ND size and on the lipid composition of the ND membranes. Active MraY protein could only be obtained with ND containing anionic lipids, thus providing new details for the in vitro analysis of this pharmaceutically important protein. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Roos, Christian; Ma, Yi; Proverbio, Davide; Henrich, Erik; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany.
   [Zocher, Michael; Mueller, Daniel] Swiss Fed Inst Technol, Biosyst Sci & Engn BSSE, Basel, Switzerland.
   [Zocher, Michael] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   [Muench, Daniela; Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Sect, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.
   [Scholz, Frank; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-6000 Frankfurt, Germany.
   [Ma, Yi] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.
RP Bernhard, F (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany.
EM fbern@bpc.uni-frankfurt.de
RI Schneider, Tanja/L-8049-2013; Muller, Daniel J/A-5967-2010; Wachtveitl,
   Josef/A-7590-2017
OI Muller, Daniel J/0000-0003-3075-0665; Wachtveitl,
   Josef/0000-0002-8496-8240; Schneider, Tanja/0000-0001-7269-4716; Rausch,
   Daniela/0000-0003-3211-5745; Dotsch, Volker/0000-0001-5720-212X;
   Bernhard, Frank/0000-0002-4860-1783; Proverbio,
   Davide/0000-0001-6660-9298
FU European Drug Initiative on Channels and Transporters (EDICT)
   [HEALTH-F4-2007-201924]; European Initiative on Structural Biology of
   Membrane Proteins (SBMP) [PITN-GA-2008-211800];  [SFB 807]
FX This work was financially supported by the European Drug Initiative on
   Channels and Transporters (EDICT) grant HEALTH-F4-2007-201924 and the
   European Initiative on Structural Biology of Membrane Proteins (SBMP)
   grant PITN-GA-2008-211800. We are also grateful for financial support
   from the SFB 807.
CR Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024
   Bazzacco P, 2012, BIOCHEMISTRY-US, V51, P1416, DOI 10.1021/bi201862v
   Berrier C, 2011, BBA-BIOMEMBRANES, V1808, P41, DOI 10.1016/j.bbamem.2010.09.018
   Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091
   Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014
   CHATTOPADHYAY A, 1990, CHEM PHYS LIPIDS, V53, P1, DOI 10.1016/0009-3084(90)90128-E
   Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574
   Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199
   Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303
   Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000
   Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4
   Fyfe PK, 2001, TRENDS BIOCHEM SCI, V26, P106, DOI 10.1016/S0968-0004(00)01746-1
   GEIS A, 1978, BIOCHIM BIOPHYS ACTA, V527, P414, DOI 10.1016/0005-2744(78)90355-8
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18
   Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3
   Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002
   Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004
   Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972
   Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087
   Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Klyszejko AL, 2008, J MOL BIOL, V376, P35, DOI 10.1016/j.jmb.2007.11.030
   Lakatos M, 2003, BIOPHYS J, V84, P3252, DOI 10.1016/S0006-3495(03)70049-6
   Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7
   Liguori L, 2008, J CONTROL RELEASE, V126, P217, DOI 10.1016/j.jconrel.2007.12.004
   Lyukmanova EN, 2012, BBA-BIOMEMBRANES, V1818, P349, DOI 10.1016/j.bbamem.2011.10.020
   Ma Y, 2011, J BIOL CHEM, V286, P38844, DOI 10.1074/jbc.M111.301085
   Marques B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000856
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012
   Park KH, 2007, BIOCHEM J, V403, P183, DOI 10.1042/BJ20061473
   PLESS DD, 1973, J BIOL CHEM, V248, P1568
   Ranaghan MJ, 2011, J AM CHEM SOC, V133, P18318, DOI 10.1021/ja2070957
   Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648
   Roos C., 2012, MOL MEMBR BIOL
   Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11
   Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426
   Schwarz D, 2010, PROTEOMICS, V10, P1762, DOI 10.1002/pmic.200900485
   Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585
   Umakoshi H, 2009, J BIOSCI BIOENG, V108, P450, DOI 10.1016/j.jbiosc.2009.05.012
   UMBREIT JN, 1972, P NATL ACAD SCI USA, V69, P1972, DOI 10.1073/pnas.69.7.1972
   van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2
   Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0
   Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181
   Wuu JJ, 2008, BBA-BIOMEMBRANES, V1778, P1237, DOI 10.1016/j.bbamem.2008.01.023
   Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57
   Zocher M, 2012, ACS NANO, V6, P961, DOI 10.1021/nn204624p
NR 48
TC 54
Z9 54
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD DEC
PY 2012
VL 1818
IS 12
BP 3098
EP 3106
DI 10.1016/j.bbamem.2012.08.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 020IF
UT WOS:000309801500022
PM 22960287
OA Bronze
DA 2021-01-25
ER

PT J
AU Faure, E
   Starek, G
   McGuire, H
   Berneche, S
   Blunck, R
AF Faure, Elise
   Starek, Greg
   McGuire, Hugo
   Berneche, Simon
   Blunck, Rikard
TI A Limited 4 angstrom Radial Displacement of the S4-S5 Linker Is
   Sufficient for Internal Gate Closing in Kv Channels
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID POLYUNSATURATED FATTY-ACIDS; SHAKER POTASSIUM CHANNEL; VOLTAGE-SENSING
   RESIDUES; DEPENDENT K+ CHANNEL; GATING CHARGE; STRUCTURAL BASIS;
   LIPID-MEMBRANE; RESTING STATE; CLOSED-STATE; SENSOR
AB Voltage-gated ion channels are responsible for the generation of action potentials in our nervous system. Conformational rearrangements in their voltage sensor domains in response to changes of the membrane potential control pore opening and thus ion conduction. Crystal structures of the open channel in combination with a wealth of biophysical data and molecular dynamics simulations led to a consensus on the voltage sensor movement. However, the coupling between voltage sensor movement and pore opening, the electromechanical coupling, occurs at the cytosolic face of the channel, from where no structural information is available yet. In particular, the question how far the cytosolic pore gate has to close to prevent ion conduction remains controversial. In cells, spectroscopic methods are hindered because labeling of internal sites remains difficult, whereas liposomes or detergent solutions containing purified ion channels lack voltage control. Here, to overcome these problems, we controlled the state of the channel by varying the lipid environment. This way, we directly measured the position of the S4-S5 linker in both the open and the closed state of a prokaryotic Kv channel (KvAP) in a lipid environment using Lanthanide-based resonance energy transfer. We were able to reconstruct the movement of the covalent link between the voltage sensor and the pore domain and used this information as restraints for molecular dynamics simulations of the closed state structure. We found that a small decrease of the pore radius of about 3-4 angstrom is sufficient to prevent ion permeation through the pore.
C1 [McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada.
   [Faure, Elise; McGuire, Hugo; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ H3C 3J7, Canada.
   [Faure, Elise; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada.
   [Starek, Greg; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Starek, Greg; Berneche, Simon] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Starek, Greg] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.
RP Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.
EM rikard.blunck@umontreal.ca
RI Blunck, Rikard/L-4226-2013; Berneche, Simon/L-6389-2013; Blunck,
   Rikard/AAM-3078-2020
OI Blunck, Rikard/0000-0003-4484-2907; Berneche, Simon/0000-0002-6274-4094;
   Blunck, Rikard/0000-0003-4484-2907
FU Canadian Institutes for Health Research GrantCanadian Institutes of
   Health Research (CIHR) [MOP-102689]; Canadian Foundation for
   InnovationCanada Foundation for Innovation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [118928]; Fonds de
   recherche du Quebec - Nature et technologies (FRQNT); Fonds de la
   recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du
   Quebec
FX This work was funded by the Canadian Institutes for Health Research
   Grant MOP-102689 (to R. B.), the Canadian Foundation for Innovation (to
   R. B.), and the Swiss National Science Foundation (SNF-Professorship
   Number 118928) (to S. B).; Recipients of student fellowships of Fonds de
   recherche du Quebec - Nature et technologies (FRQNT).; We thank Mireille
   Marsolais and Michel Brunette for technical assistance and Drs. William
   Skene and Matthieu Starck for help in synthesizing terbium chelate. The
   molecular dynamics simulations were performed at the Swiss National
   Super-computing Center (CSCS). GEPROM is a research group funded by the
   Fonds de la recherche en sante du Quebec (FRSQ).
CR Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9
   Ashcroft F., 1999, ION CHANNELS DIS, P97
   Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073
   Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717
   Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289
   Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512
   Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009
   Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166
   Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106
   Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757
   Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104
   Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552
   Chapman ML, 2005, J GEN PHYSIOL, V126, P87, DOI 10.1085/jgp.200509253
   Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w
   Ge PH, 2003, BIOCONJUGATE CHEM, V14, P870, DOI 10.1021/bc034029e
   Haddad GA, 2011, J GEN PHYSIOL, V137, P455, DOI 10.1085/jgp.201010573
   Hille B., 2001, ION CHANNELS EXCITAB
   Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2
   Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056
   Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048
   LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0
   Lin MCA, 2010, J GEN PHYSIOL, V135, P415, DOI 10.1085/jgp.200910320
   Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883
   Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269
   Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270
   Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265
   Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535
   Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819
   Ramu Y, 2007, P NATL ACAD SCI USA, V104, P6448, DOI 10.1073/pnas.0701354104
   Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880
   Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103
   Sandtner W, 2007, BIOPHYS J, V93, pL45, DOI 10.1529/biophysj.107.119073
   Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416
   Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062
   Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105
   Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927
   Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7
   Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024
   Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105
   Xu XP, 2008, EPILEPSY RES, V80, P57, DOI 10.1016/j.eplepsyres.2008.03.013
   Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618
   Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109
   ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321
   Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254
   Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7
NR 53
TC 16
Z9 16
U1 0
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 16
PY 2012
VL 287
IS 47
DI 10.1074/jbc.M112.415497
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 039GY
UT WOS:000311233800076
PM 23019337
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Seddik, R
   Jungblut, SP
   Silander, OK
   Rajalu, M
   Fritzius, T
   Besseyrias, V
   Jacquier, V
   Fakler, B
   Gassmann, M
   Bettler, B
AF Seddik, Riad
   Jungblut, Stefan P.
   Silander, Olin K.
   Rajalu, Mathieu
   Fritzius, Thorsten
   Besseyrias, Valerie
   Jacquier, Valerie
   Fakler, Bernd
   Gassmann, Martin
   Bettler, Bernhard
TI Opposite Effects of KCTD Subunit Domains on GABA(B) Receptor-mediated
   Desensitization
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; ACID(B) RECEPTORS; GIRK CURRENTS; RGS
   PROTEINS; K+ CHANNELS; B RECEPTOR; NEURONS; PHOSPHORYLATION; ACTIVATION;
   INHIBITION
AB GABA(B) receptors assemble from principle and auxiliary subunits. The principle subunits GABA(B1) and GABA(B2) form functional heteromeric GABA(B(1,2)) receptors that associate with homotetramers of auxiliary KCTD8, -12, -12b, or -16 (named after their K+ channel tetramerization domain) subunits. These auxiliary subunits constitute receptor subtypes with distinct functional properties. KCTD12 and -12b generate desensitizing receptor responses while KCTD8 and -16 generate largely non-desensitizing receptor responses. The structural elements of the KCTDs underlying these differences in desensitization are unknown. KCTDs are modular proteins comprising a T1 tetramerization domain, which binds to GABA(B2), and a H1 homology domain. KCTD8 and -16 contain an additional C-terminal H2 homology domain that is not sequence-related to the H1 domains. No functions are known for the H1 and H2 domains. Here we addressed which domains and sequence motifs in KCTD proteins regulate desensitization of the receptor response. We found that the H1 domains in KCTD12 and -12b mediate desensitization through a particular sequence motif, T/NFLEQ, which is not present in the H1 domains of KCTD8 and -16. In addition, the H2 domains in KCTD8 and -16 inhibit desensitization when expressed C-terminal to the H1 domains but not when expressed as a separate protein in trans. Intriguingly, the inhibitory effect of the H2 domain is sequence-independent, suggesting that the H2 domain sterically hinders desensitization by the H1 domain. Evolutionary analysis supports that KCTD12 and -12b evolved desensitizing properties by liberating their H1 domains from antagonistic H2 domains and acquisition of the T/NFLEQ motif.
C1 [Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Silander, Olin K.] Univ Basel, Core Program Computat & Syst Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany.
   [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany.
RP Gassmann, M (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM martin.gassmann@unibas.ch; bernhard.bettler@unibas.ch
RI bettler, bernhard/AAO-8018-2020
OI Gassmann, Martin/0000-0001-6201-3032; Silander,
   Olin/0000-0003-4105-8316; Bettler, Bernhard/0000-0003-0842-8207
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-117816]; National Center for Competence in Research
   (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease"; European
   Community's Seventh Framework Programme (FP7)European Union (EU)
   [201714]; Ambizione fellowship from the Swiss National Science
   Foundation; Marie Heim-Vogtlin fellowship from the Swiss National
   Science Foundation
FX This work was supported by grants from the Swiss National Science
   Foundation (3100A0-117816), the National Center for Competence in
   Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease" (to
   B. B.), the European Community's Seventh Framework Programme
   (FP7/2007-2013) under Grant Agreement 201714 (to B. B.), an Ambizione
   fellowship from the Swiss National Science Foundation (to O. K. S.), and
   a Marie Heim-Vogtlin fellowship from the Swiss National Science
   Foundation (to V. J.).
CR Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700
   Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x
   Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003
   Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010
   Bixby KA, 1999, NAT STRUCT BIOL, V6, P38
   Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004
   Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908
   Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833
   Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181
   Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008
   Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200
   Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152
   Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046
   Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249
   Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798
   HORTON RM, 1990, BIOTECHNIQUES, V8, P528
   Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007
   Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5
   Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270
   Kusunoki H, 1998, BIOCHEMISTRY-US, V37, P4782, DOI 10.1021/bi972756p
   Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006
   Maity B, 2012, J BIOL CHEM, V287, P4972, DOI 10.1074/jbc.M111.297218
   Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610
   Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x
   Mutneja M, 2005, PFLUG ARCH EUR J PHY, V450, P61, DOI 10.1007/s00424-004-1367-1
   Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200
   Pennock RL, 2012, J NEUROSCI, V32, P10192, DOI 10.1523/JNEUROSCI.1227-12.2012
   Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383
   Robbins MJ, 2001, J NEUROSCI, V21, P8043
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Schultheis C, 2011, J NEUROPHYSIOL, V106, P817, DOI 10.1152/jn.00578.2010
   Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964
   Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003
   Sodickson DL, 1996, J NEUROSCI, V16, P6374
   Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82
   Taylor RW, 2011, J NEUROSCI, V31, P9869, DOI 10.1523/JNEUROSCI.0435-11.2011
   Urwyler S, 2001, MOL PHARMACOL, V60, P963
   Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019
   Wetherington JP, 2002, J PHYSIOL-LONDON, V544, P459, DOI 10.1113/jphysiol.2002.023093
   Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005
   Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614
   Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549
NR 46
TC 29
Z9 30
U1 0
U2 13
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 16
PY 2012
VL 287
IS 47
DI 10.1074/jbc.M112.412767
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 039GY
UT WOS:000311233800055
PM 23035119
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kleylein-Sohn, J
   Pollinger, B
   Ohmer, M
   Hofmann, F
   Nigg, EA
   Hemmings, BA
   Wartmann, M
AF Kleylein-Sohn, Julia
   Poellinger, Bernadette
   Ohmer, Michaela
   Hofmann, Francesco
   Nigg, Erich A.
   Hemmings, Brian A.
   Wartmann, Markus
TI Acentrosomal spindle organization renders cancer cells dependent on the
   kinesin HSET
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE HSET; Acentrosomal microtubule nucleation; Acentrosomal MTOCs;
   HAUS-complex; Cancer; DNA damage
ID MICROTUBULE MOTOR PROTEIN; CROSS-LINKS MICROTUBULES; GAMMA-TUBULIN
   COMPLEXES; DNA-DAMAGE RESPONSE; MITOTIC SPINDLE; CENTROSOME
   AMPLIFICATION; CYCLE PROGRESSION; IMPORTIN-BETA; HUMAN TUMORIGENESIS;
   EXTRA CENTROSOMES
AB Centrosomes represent the major microtubule organizing centers (MTOCs) of animal somatic cells and orchestrate bipolar spindle assembly during mitotic cell division. In meiotic cells, the kinesin HSET compensates for the lack of centrosomes by focusing acentrosomal MTOCs into two spindle poles. By clustering multiple centrosomes into two spindle poles, HSET also mediates bipolar mitosis in cancer cells with supernumerary centrosomes. However, although dispensable in non-transformed human cells, the role of HSET in cancer cells with two centrosomes has remained elusive. In this study, we demonstrate that HSET is required for proper spindle assembly, stable pole-focusing and survival of cancer cells irrespective of normal or supernumerary centrosome number. Strikingly, we detected pronounced acentrosomal MTOC structures in untreated mitotic cancer cells. While in most cancer cells these acentrosomal MTOCs were rapidly incorporated into the assembling bipolar spindle, some cells eventually established bipolar spindles with acentrosomal poles and free centrosomes. These observations demonstrate that acentrosomal MTOCs were functional and that both centrosomal and acentrosomal mechanisms were required for bipolar spindle organization. Our study shows that HSET is critical for clustering acentrosomal and centrosomal MTOCs during spindle formation in human cancer cells with two bona fide centrosomes. Furthermore, we show that in checkpoint-defective cancer cells, acentrosomal spindle formation and HSET-dependence are partially mediated by a constitutive activation of the DNA damage response. In summary, we propose that acentrosomal spindle assembly mechanisms are hyperactive in cancer cells and promote HSET, a key driver of acentrosomal spindle organization, as an attractive target for cancer therapy.
C1 [Kleylein-Sohn, Julia; Ohmer, Michaela; Hofmann, Francesco; Wartmann, Markus] Novartis Pharma AG, NIBR Oncol Dis Area, CH-4002 Basel, Switzerland.
   [Poellinger, Bernadette] Novartis Pharma AG, NIBR Autoimmun, Inflammat & Transplantat Dis Area, CH-4002 Basel, Switzerland.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kleylein-Sohn, Julia; Hemmings, Brian A.] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Kleylein-Sohn, J (corresponding author), Novartis Pharma AG, NIBR Oncol Dis Area, CH-4002 Basel, Switzerland.
EM Julia.Kleylein-Sohn@fmi.ch
OI nigg, erich/0000-0003-4835-5719
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_132428/1]; Novartis Institutes of BioMedical Research
FX This work was supported by the Swiss National Science Foundation [grant
   number 31003A_132428/1 to E.A.N.]; and the Novartis Institutes of
   BioMedical Research (postdoctoral fellow grant of J. K.-S.).
CR Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962
   Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497
   Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971
   Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410
   Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393
   DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5
   Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454
   ENDOW SA, 1994, J CELL SCI, V107, P859
   Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371
   Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021
   Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779
   Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6
   Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019
   Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107
   Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053
   Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248
   Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3
   Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976
   HATSUMI M, 1992, J CELL SCI, V101, P547
   Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866
   Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510
   Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959
   Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056
   Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908
   Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033
   Leber B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000915
   Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950
   Loughlin R, 2008, CELL, V134, P548, DOI 10.1016/j.cell.2008.07.038
   Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054
   Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040
   Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351
   Moutinho-Pereira S, 2009, MOL BIOL CELL, V20, P2796, DOI 10.1091/mbc.E09-01-0011
   Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442
   Pihan GA, 1998, CANCER RES, V58, P3974
   Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025
   Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304
   Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835
   Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038
   Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005
   Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2
   Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178
   Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073
   Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782
   Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004
   Wainman A, 2009, GENE DEV, V23, P1876, DOI 10.1101/gad.532209
   Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859
   Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661
   Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018
   Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279
   Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738
   Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055
   Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796
   Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001
NR 67
TC 54
Z9 54
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 15
PY 2012
VL 125
IS 22
BP 5391
EP 5402
DI 10.1242/jcs.107474
PG 12
WC Cell Biology
SC Cell Biology
GA 084BU
UT WOS:000314511900014
PM 22946058
OA Bronze
DA 2021-01-25
ER

PT J
AU Rockenbauch, U
   Ritz, AM
   Sacristan, C
   Roncero, C
   Spang, A
AF Rockenbauch, Uli
   Ritz, Alicja M.
   Sacristan, Carlos
   Roncero, Cesar
   Spang, Anne
TI The complex interactions of Chs5p, the ChAPs, and the cargo Chs3p
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; TETRATRICOPEPTIDE REPEAT;
   ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; CELL-SURFACE; PROTEIN; YEAST;
   SUBUNIT; RECEPTOR
AB The exomer complex is a putative vesicle coat required for the direct transport of a subset of cargoes from the trans-Golgi network (TGN) to the plasma membrane. Exomer comprises Chs5p and the ChAPs family of proteins (Chs6p, Bud7p, Bch1p, and Bch2p), which are believed to act as cargo receptors. In particular, Chs6p is required for the transport of the chitin synthase Chs3p to the bud neck. However, how the ChAPs associate with Chs5p and recognize cargo is not well understood. Using domain-switch chimeras of Chs6p and Bch2p, we show that four tetratricopeptide repeats (TPRs) are involved in interaction with Chs5p. Because these roles are conserved among the ChAPs, the TPRs are interchangeable among different ChAP proteins. In contrast, the N-terminal and the central parts of the ChAPs contribute to cargo specificity. Although the entire N-terminal domain of Chs6p is required for Chs3p export at all cell cycle stages, the central part seems to predominantly favor Chs3p export in small-budded cells. The cargo Chs3p probably also uses a complex motif for the interaction with Chs6, as the C-terminus of Chs3p interacts with Chs6p and is necessary, but not sufficient, for TGN export.
C1 [Rockenbauch, Uli; Ritz, Alicja M.; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sacristan, Carlos; Roncero, Cesar] Univ Salamanca, Consejo Super Invest Cient, Inst Biol Func, E-37008 Salamanca, Spain.
   [Sacristan, Carlos; Roncero, Cesar] Univ Salamanca, Consejo Super Invest Cient, Dept Microbiol & Genet, E-37008 Salamanca, Spain.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Roncero, Cesar/M-9028-2019; Spang,
   Anne/A-7029-2008; Roncero, Cesar/B-5200-2017
OI Spang, Anne/0000-0002-2387-6203; Roncero, Cesar/0000-0001-5964-3252;
   Spang, Anne/0000-0002-2387-6203; Roncero, Cesar/0000-0001-5964-3252;
   Sacristan, Carlos/0000-0003-1312-2341
FU Werner Siemens Foundation; University of Basel; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX We thank B. Zanolari and M. Trautwein for their initial observation of
   the lithium-sensitivity phenotype and M. Spiess and S. Munro for the
   anti-Sec61p and anti-Anp1p sera, respectively. We also thank all members
   of the Spang lab for technical advice and helpful discussion. This work
   was supported by a graduate student fellowship of the Werner Siemens
   Foundation to U. R., the University of Basel (A. S.), and the Swiss
   National Science Foundation (A.S.).
CR Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126
   Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324
   Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217
   Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E
   Cos T, 1998, EUR J BIOCHEM, V256, P419, DOI 10.1046/j.1432-1327.1998.2560419.x
   D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007
   Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x
   HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297
   Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077
   Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107
   Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0
   Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1
   Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983
   Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049
   Lord M, 2002, METHOD ENZYMOL, V350, P131, DOI 10.1016/S0076-6879(02)50960-5
   Magliery TJ, 2004, J MOL BIOL, V343, P731, DOI 10.1016/j.jmb.2004.08.026
   Meissner D, 2010, MOL BIOL CELL, V21, P2425, DOI 10.1091/mbc.E10-01-0080
   Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605
   Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849
   Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102
   Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124
   Sacristan C, 2012, MOL MICROBIOL, V83, P1124, DOI 10.1111/j.1365-2958.2012.07995.x
   Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210
   Santos B, 2003, EUKARYOT CELL, V2, P821, DOI 10.1128/EC.2.4.821-825.2003
   Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1
   Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007
   Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100
   Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106
   Zanolari B, 2011, J CELL SCI, V124, P1055, DOI 10.1242/jcs.072371
   Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006
   Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200
   Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247
   Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565
NR 43
TC 14
Z9 14
U1 0
U2 5
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV 15
PY 2012
VL 23
IS 22
BP 4402
EP 4415
DI 10.1091/mbc.E11-12-1015
PG 14
WC Cell Biology
SC Cell Biology
GA 082PP
UT WOS:000314404700007
PM 23015758
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Duran, RV
   Hall, MN
AF Duran, Raul V.
   Hall, Michael N.
TI Glutaminolysis feeds mTORC1
SO CELL CYCLE
LA English
DT Editorial Material
ID MUTANT IDH1; GROWTH; METABOLISM; DISEASE
C1 [Duran, Raul V.; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM m.hall@unibas.ch
RI Duran, Raul/E-4764-2011
OI Duran, Raul/0000-0002-2249-9215
CR Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003
   Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Duran RV, 2012, ONCOGENE IN PRESS, DOI http://dx.doi.org/10.1038/onc.2012.465
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112
   Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666
   van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536
   Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016
NR 10
TC 39
Z9 39
U1 0
U2 11
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1538-4101
J9 CELL CYCLE
JI Cell Cycle
PD NOV 15
PY 2012
VL 11
IS 22
BP 4107
EP 4108
DI 10.4161/cc.22632
PG 2
WC Cell Biology
SC Cell Biology
GA 038FT
UT WOS:000311161300006
PM 23095634
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Scheiffele, P
   Iijima, T
AF Scheiffele, Peter
   Iijima, Takatoshi
TI Choreographing the Axo-Dendritic Dance
SO DEVELOPMENTAL CELL
LA English
DT Editorial Material
ID GLUR-DELTA-2; NEUREXINS; SYNAPSES
AB The assembly of neuronal synapses in the brain relies on a sophisticated bidirectional signal exchange between synaptic partners. In a recent issue of Neuron, Ito-Ishida and colleagues (2012) uncover a morphogenetic program underlying the formation of presynaptic terminals.
C1 [Scheiffele, Peter; Iijima, Takatoshi] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.scheiffele@unibas.ch
CR Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008
   Lee SJ, 2012, J NEUROSCI, V32, P4688, DOI 10.1523/JNEUROSCI.5584-11.2012
   Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302
   Sotelo C., 1982, EXP BRAIN RES S6, P50
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035
   Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180
   Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300
NR 9
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD NOV 13
PY 2012
VL 23
IS 5
BP 923
EP 924
DI 10.1016/j.devcel.2012.10.020
PG 2
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 037VH
UT WOS:000311134100009
PM 23153491
OA Bronze
DA 2021-01-25
ER

PT J
AU Summermatter, S
   Handschin, C
AF Summermatter, S.
   Handschin, C.
TI PGC-1 alpha and exercise in the control of body weight
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
DE PGC-1 alpha; thermogenesis; energy expenditure; exercise; weight control
ID HUMAN SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA;
   ACTIVATED PROTEIN-KINASE; DE-NOVO LIPOGENESIS; PPAR-GAMMA
   COACTIVATOR-1-ALPHA; FATTY-ACID OXIDATION; GLUT4 MESSENGER-RNA; CATCH-UP
   GROWTH; INSULIN-RESISTANCE; MITOCHONDRIAL BIOGENESIS
AB The increasing prevalence of obesity and its comorbidities represents a major threat to human health globally. Pharmacological treatments exist to achieve weight loss, but the subsequent weight maintenance is prone to fail in the long run. Accordingly, efficient new strategies to persistently control body weight need to be elaborated. Exercise and dietary interventions constitute classical approaches to reduce and maintain body weight, yet people suffering from metabolic diseases are often unwilling or unable to move adequately. The administration of drugs that partially mimic exercise adaptation might circumvent this problem by easing and supporting physical activity. The thermogenic peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) largely mediates the adaptive response of skeletal muscle to endurance exercise and is a potential target for such interventions. Here, we review the role of PGC-1 alpha in mediating exercise adaptation, coordinating metabolic circuits and enhancing thermogenic capacity in skeletal muscle. We suggest a combination of elevated muscle PGC-1 alpha and exercise as a modified approach for the efficient long-term control of body weight and the treatment of the metabolic syndrome. International Journal of Obesity (2012) 36, 1428-1435; doi:10.1038/ijo.2012.12; published online 31 January 2012
C1 [Summermatter, S.; Handschin, C.] Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy Association USA
   (MDA)Muscular Dystrophy Association; SwissLife 'Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung'; Swiss Society for Research
   on Muscle Diseases (SSEM); Swiss Diabetes Association; Roche Research
   Foundation; United Mitochondrial Disease Foundation (UMDF); Association
   Francaise contre les Myopathies (AFM)Association Francaise contre les
   Myopathies; University of Basel
FX Our research is supported by grants from the Swiss National Science
   Foundation (SNF PP00A-110746), the Muscular Dystrophy Association USA
   (MDA), the SwissLife 'Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung', the Swiss Society for Research on Muscle
   Diseases (SSEM), the Swiss Diabetes Association, the Roche Research
   Foundation, the United Mitochondrial Disease Foundation (UMDF), the
   Association Francaise contre les Myopathies (AFM), and the University of
   Basel. The funders had no role in the preparation of the manuscript.
CR An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Austin S, 2011, FREE RADICAL BIO MED, V51, P2243, DOI 10.1016/j.freeradbiomed.2011.08.036
   Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
   Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9
   Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011
   Bogers RP, 2010, OBES REV, V11, P51, DOI 10.1111/j.1467-789X.2009.00606.x
   Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5
   Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015
   Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cettour-Rose P, 2005, DIABETES, V54, P751, DOI 10.2337/diabetes.54.3.751
   Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003
   Chambers MA, 2009, J PHYSIOL-LONDON, V587, P3363, DOI 10.1113/jphysiol.2008.165639
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005
   Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516
   Dulloo AG, 2006, HORM RES, V65, P90, DOI 10.1159/000091512
   Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028
   Dyson PA, 2010, DIABETES OBES METAB, V12, P941, DOI 10.1111/j.1463-1326.2010.01256.x
   Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011
   Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397
   Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005
   Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008
   Gurd BJ, 2011, APPL PHYSIOL NUTR ME, V36, P589, DOI [10.1139/h11-070, 10.1139/H11-070]
   Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2010, J RECEPT SIG TRANSD, V30, P376, DOI 10.3109/10799891003641074
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Horton ES, 2009, OBESITY, V17, pS43, DOI 10.1038/oby.2009.388
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   IVY JL, 1991, SPORTS MED, V11, P6, DOI 10.2165/00007256-199111010-00002
   Janiszewski PM, 2007, APPL PHYSIOL NUTR ME, V32, P512, DOI 10.1139/H07-018
   Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942
   Kopelman PG, 2000, NATURE, V404, P635
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200
   Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409
   Lefort N, 2008, AM J PHYSIOL-ENDOC M, V295, pE1447, DOI 10.1152/ajpendo.90362.2008
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561
   Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1111/j.1753-4887.2004.tb00094.x
   Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009
   Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/h11-076, 10.1139/H11-076]
   MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343
   Matsakas A, 2010, CURR SPORT MED REP, V9, P227, DOI 10.1249/JSR.0b013e3181e93938
   McCarty MF, 2005, MED HYPOTHESES, V64, P399, DOI 10.1016/j.mehy.2004.03.034
   Merry TL, 2010, AM J PHYSIOL-REG I, V299, pR1656, DOI 10.1152/ajpregu.00433.2010
   Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510
   Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200
   Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512
   Musi N, 2005, FEBS LETT, V579, P2045, DOI 10.1016/j.febslet.2005.02.052
   Nabben M, 2011, BBA-BIOENERGETICS, V1807, P1095, DOI 10.1016/j.bbabio.2011.04.003
   Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502
   Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011
   O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106
   O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074
   Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685
   Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qi ZT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021140
   Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184
   Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB
   Solinas G, 2006, ENDOCRINOLOGY, V147, P31, DOI 10.1210/en.2005-1033
   Solinas G, 2004, FEBS LETT, V577, P539, DOI 10.1016/j.febslet.2004.10.066
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011
   Summermatter S, 2011, BIOCHEM BIOPH RES CO, V408, P180, DOI 10.1016/j.bbrc.2011.04.012
   Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995
   Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793
   Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017
   Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010
   Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005
   Weyer C, 2000, AM J CLIN NUTR, V72, P946
   Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284
   Zhang SJ, 2010, EXP PHYSIOL, V95, P892, DOI 10.1113/expphysiol.2010.053405
   ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857
NR 99
TC 23
Z9 23
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
J9 INT J OBESITY
JI Int. J. Obes.
PD NOV
PY 2012
VL 36
IS 11
BP 1428
EP 1435
DI 10.1038/ijo.2012.12
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 037KR
UT WOS:000311103500009
PM 22290535
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Crosson, S
   Mckee, K
   Ruegg, M
   Yurchenco, P
AF Crosson, Stephanie
   Mckee, Karen
   Ruegg, Markus
   Yurchenco, Peter
TI Restoring laminin polymerization by transgenic expression of alpha LNNd
   in skeletal muscle improves muscle integrity of laminin-alpha
   2-deficient mice
SO GLYCOBIOLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the Society-for-Glycobiology and
   American-Society-for-Matrix-Biology
CY NOV 11-14, 2012
CL San Diego, CA
SP Soc Glycobiol, Amer Soc Matrix Biol
C1 [Crosson, Stephanie; Mckee, Karen; Yurchenco, Peter] Robert Wood Johnson Med Sch, Piscataway, NJ USA.
   [Ruegg, Markus] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0959-6658
J9 GLYCOBIOLOGY
JI Glycobiology
PD NOV
PY 2012
VL 22
IS 11
BP 1536
EP 1536
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 027QS
UT WOS:000310368700060
DA 2021-01-25
ER

PT J
AU Gutnick, A
   Blechman, J
   Kaslin, J
   Herwig, L
   Belting, HG
   Affolter, M
   Bonkowsky, JL
   Levkowitz, G
AF Gutnick, A.
   Blechman, J.
   Kaslin, J.
   Herwig, L.
   Belting, H. G.
   Affolter, M.
   Bonkowsky, J. L.
   Levkowitz, G.
TI The hypothalamic neuropeptide oxytocin is required for formation of the
   neuro-vascular interface of the pituitary
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Meeting Abstract
CT 20th Annual Meeting of the Israel-Society-for-Neuroscience
CY DEC 11-13, 2011
CL Eilat, ISRAEL
SP Israel Soc Neurosci
C1 [Gutnick, A.; Blechman, J.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
   [Kaslin, J.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.
   [Herwig, L.; Belting, H. G.; Affolter, M.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Bonkowsky, J. L.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.
   [Bonkowsky, J. L.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.
RI Levkowitz, Gil/AAB-9441-2019
OI Levkowitz, Gil/0000-0002-3896-1881
NR 0
TC 0
Z9 0
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0895-8696
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PD NOV
PY 2012
VL 48
SU 1
BP S46
EP S46
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 030BC
UT WOS:000310541600115
DA 2021-01-25
ER

PT J
AU Buhler, M
   Hiller, S
AF Buehler, Marc
   Hiller, Sebastian
TI Dynamic nature of heterochromatin highlighted by a HP1(Swi6)-dependent
   gene silencing mechanism
SO CELL CYCLE
LA English
DT Editorial Material
ID RECOGNITION; BINDING
C1 [Buehler, Marc] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Hiller, Sebastian] Univ Basel, Biozentrum, Basel, Switzerland.
RP Buhler, M (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
EM marc.buehler@fmi.ch; sebastian.hiller@unibas.ch
RI Hiller, Sebastian/B-3573-2008; Buehler, Marc/S-5866-2019
OI Hiller, Sebastian/0000-0002-6709-4684; Buehler, Marc/0000-0001-6661-9795
CR Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932
   Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038
   Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025
   Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572
   Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004
   Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008
   Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411
   Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009
   Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024
   Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973
NR 10
TC 4
Z9 5
U1 0
U2 10
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1538-4101
J9 CELL CYCLE
JI Cell Cycle
PD NOV 1
PY 2012
VL 11
IS 21
BP 3907
EP 3908
DI 10.4161/cc.22234
PG 2
WC Cell Biology
SC Cell Biology
GA 030PV
UT WOS:000310583500003
PM 23032265
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kudryashev, M
   Munter, S
   Lemgruber, L
   Montagna, G
   Stahlberg, H
   Matuschewski, K
   Meissner, M
   Cyrklaff, M
   Frischknecht, F
AF Kudryashev, Mikhail
   Muenter, Sylvia
   Lemgruber, Leandro
   Montagna, Georgina
   Stahlberg, Henning
   Matuschewski, Kai
   Meissner, Markus
   Cyrklaff, Marek
   Frischknecht, Friedrich
TI Structural basis for chirality and directional motility of Plasmodium
   sporozoites
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID TOXOPLASMA-GONDII; MALARIA PARASITES; CRYOELECTRON TOMOGRAPHY; GLIDING
   MOTILITY; CONOID EXTRUSION; TRANSMISSION; INFECTIVITY; REVEALS; PROTEIN;
   CELLS
AB Plasmodium sporozoites can move at high speed for several tens of minutes, which is essential for the initial stage of a malaria infection. The crescent-shaped sporozoites move on 2D substrates preferably in the same direction on circular paths giving raise to helical paths in 3D matrices. Here we determined the structural basis that underlies this type of movement. Immature, non-motile sporozoites were found to lack the subpellicular network required for obtaining the crescent parasite shape. In vitro, parasites moving in the favoured direction move faster and more persistent than the few parasites that move in the opposite direction. Photobleaching experiments showed that sporozoites flip their ventral side up when switching the direction of migration. Cryo-electron tomography revealed a polarized arrangement of microtubules and polar rings towards the substrate in Plasmodium sporozoites, but not in the related parasite Toxoplasma gondii. As aconsequence, secretory vesicles, which release proteins involved in adhesion, migration and invasion at the front end of the parasite, are delivered towards the substrate. The resulting chiral structure of the parasite appears to determine the unique directionality of movement and could explain how the sporozoite achieves rapid and sustained directional motility in the absence of external stimuli.
C1 [Kudryashev, Mikhail; Muenter, Sylvia; Lemgruber, Leandro; Cyrklaff, Marek; Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, D-69120 Heidelberg, Germany.
   [Kudryashev, Mikhail; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland.
   [Montagna, Georgina; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany.
   [Meissner, Markus] Welcome Trust, Glasgow G12 8QQ, Lanark, Scotland.
   [Meissner, Markus] Univ Glasgow, Glasgow Biomed Res Ctr, Off B613, Glasgow G12 8QQ, Lanark, Scotland.
RP Frischknecht, F (corresponding author), Heidelberg Univ, Sch Med, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
EM marek.cyrklaff@med.uni-heidelberg.de;
   freddy.frischknecht@med.uni-heidelberg.de
RI Montagna, Georgina/D-1202-2013; Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Lemgruber,
   Leandro/0000-0003-2832-6806; Montagna, Georgina/0000-0003-0283-8977;
   Matuschewski, Kai/0000-0001-6147-8591; Kudryashev,
   Misha/0000-0003-3550-6274; Frischknecht, Friedrich/0000-0002-8332-6668
FU German Federal Ministry for Education and Research (BMBF,
   BioFuture)Federal Ministry of Education & Research (BMBF); German
   Research Foundation (DFG)German Research Foundation (DFG) [SPP 1128, SFB
   544]; Frontier Program of the University of Heidelberg; Swiss initiative
   for Systems Biology (SystemsX.ch); Medical School and the Cluster of
   Excellence CellNetworks at the University of Heidelberg; Chica and Heinz
   Schaller Foundation
FX We thank I. Arnold and D. Scheppan for mosquito infections, S. Hegge for
   help with quantification, C. Kuss for P. falciparum culture, M. Breinich
   for Toxoplasma culture, F. Hentzschel and J.K. Hellmann for
   determination of sporozoite pitch, J. Baum, P. Chlanda, M. Ganter, A.
   Leis, S. Lepper and U. Schwarz for discussions and comments on the
   manuscript, J. Pieroth for help with tracking parasites in vivo, W.
   Baumeister and M. Lanzer for generous support, U. Engel and the Nikon
   Imaging Center at the University of Heidelberg for access to their
   microscopes. The work was funded by grants from the German Federal
   Ministry for Education and Research (BMBF, BioFuture), the German
   Research Foundation (DFG, SPP 1128, SFB 544) and the Frontier Program of
   the University of Heidelberg. MK and HS are supported by the Swiss
   initiative for Systems Biology (SystemsX.ch, Grant CINA). FF, KM and MM
   are members of the European Union Network of Excellence EVIMalaR. We
   gratefully acknowledge support from the Medical School and the Cluster
   of Excellence CellNetworks at the University of Heidelberg and the Chica
   and Heinz Schaller Foundation.
CR Akaki M, 2005, J EXP BIOL, V208, P3211, DOI 10.1242/jeb.01756
   Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350
   Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019
   Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007
   Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1
   Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006
   Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405
   Ejigiri I, 2009, CURR OPIN MICROBIOL, V12, P401, DOI 10.1016/j.mib.2009.06.006
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x
   Frischknecht F, 2007, CELL MICROBIOL, V9, P1630, DOI 10.1111/j.1462-5822.2007.00955.x
   Frixione E, 1996, CELL MOTIL CYTOSKEL, V34, P152, DOI 10.1002/(SICI)1097-0169(1996)34:2&lt;152::AID-CM6&gt;3.0.CO;2-D
   Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539
   Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700
   Hegge Stephan, 2009, Biotechnology Journal, V4, P903, DOI 10.1002/biot.200900007
   Heintzelman MB, 2006, INT REV CYTOL, V251, P79, DOI 10.1016/S0074-7696(06)51003-4
   Hellmann JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002080
   Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084
   Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004
   Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935
   Khater EI, 2004, J CELL BIOL, V167, P425, DOI 10.1083/jcb.200406068
   KIMSEY RB, 1990, J INFECT DIS, V162, P1205, DOI 10.1093/infdis/162.5.1205
   Kudryashev Mikhail, 2010, PMC Biophys, V3, P6, DOI 10.1186/1757-5036-3-6
   Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x
   Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x
   Lemgruber L, 2009, MEM I OSWALDO CRUZ, V104, P706, DOI 10.1590/S0074-02762009000500007
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4
   Matuschewski K, 2002, EMBO J, V21, P1597, DOI 10.1093/emboj/21.7.1597
   McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009
   Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x
   Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109
   Monteiro VG, 2001, J STRUCT BIOL, V136, P181, DOI 10.1006/jsbi.2002.4444
   Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002
   Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Schrevel J, 2008, PARASITOLOGY, V135, P1, DOI 10.1017/S0031182007003629
   Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5
   Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200
   Tremp AZ, 2011, J BIOL CHEM, V286, P5383, DOI 10.1074/jbc.M110.187195
   VANDERBERG J, 1967, J PROTOZOOL, V14, P82, DOI 10.1111/j.1550-7408.1967.tb01452.x
   VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x
NR 44
TC 27
Z9 27
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD NOV
PY 2012
VL 14
IS 11
BP 1757
EP 1768
DI 10.1111/j.1462-5822.2012.01836.x
PG 12
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 023XY
UT WOS:000310072400009
PM 22776715
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Hosta-Rigau, L
   Jensen, BEB
   Fjeldso, KS
   Postma, A
   Li, GX
   Goldie, KN
   Albericio, F
   Zelikin, AN
   Stadler, B
AF Hosta-Rigau, Leticia
   Jensen, Bettina E. B.
   Fjeldso, Kit S.
   Postma, Almar
   Li, Guoxin
   Goldie, Kenneth N.
   Albericio, Fernando
   Zelikin, Alexander N.
   Stadler, Brigitte
TI Surface-Adhered Composite Poly(Vinyl Alcohol) Physical Hydrogels:
   Polymersome-Aided Delivery of Therapeutic Small Molecules
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID DRUG-RELEASE; LIPOSOMES; ATTACHMENT; PACLITAXEL; VESICLES; MICELLES;
   GROWTH; CELLS; FILMS; GEL
C1 [Hosta-Rigau, Leticia; Fjeldso, Kit S.; Zelikin, Alexander N.; Stadler, Brigitte] Aarhus Univ, Interdisciplinary Nanoscience Ctr iNANO, DK-8000 Aarhus, Denmark.
   [Jensen, Bettina E. B.; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
   [Postma, Almar; Li, Guoxin] CSIRO, Mat Sci & Engn, Clayton, Vic 3168, Australia.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt, CH-4058 Basel, Switzerland.
   [Albericio, Fernando] Univ Barcelona, Inst Res Biomed, Dept Organ Chem, CIBER BBN,Networking Ctr Bioengn Biomat & Nanomed, E-08028 Barcelona, Spain.
RP Stadler, B (corresponding author), Aarhus Univ, Interdisciplinary Nanoscience Ctr iNANO, DK-8000 Aarhus, Denmark.
EM bstadler@inano.au.dk
RI Stadler, Brigitte/I-2661-2013; Hosta-Rigau, Leticia/C-4346-2016;
   Albericio, Fernando/B-4383-2013; Zelikin, Alexander/J-3659-2012; Postma,
   Almar/Q-9890-2019; Postma, Almar/B-6749-2008
OI Hosta-Rigau, Leticia/0000-0001-8177-4806; Albericio,
   Fernando/0000-0002-8946-0462; Zelikin, Alexander/0000-0002-9864-321X;
   Postma, Almar/0000-0001-7343-7236; Stadler, Brigitte/0000-0002-7335-3945
FU Lundbeckfonden, DenmarkLundbeckfonden; Danish Council for Independent
   Research, Technology and Production Sciences, DenmarkDet Frie
   Forskningsrad (DFF)
FX This work was supported by grants from Lundbeckfonden, Denmark (A.N.Z.,
   B.S.) and a Sapere Aude Starting Grants from the Danish Council for
   Independent Research, Technology and Production Sciences, Denmark
   (A.N.Z., B.S.). We gratefully acknowledge PharmaMar S.A. for providing
   the compound thiocoraline.
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Ben-Haim N, 2008, NANO LETT, V8, P1368, DOI 10.1021/nl080105g
   Blacklock J, 2009, BIOMATERIALS, V30, P939, DOI 10.1016/j.biomaterials.2008.10.012
   Broz P, 2008, J CARDIOVASC PHARM, V51, P246, DOI 10.1097/FJC.0b013e3181624aed
   Caliceti P, 2001, BIOCONJUGATE CHEM, V12, P515, DOI 10.1021/bc000119x
   Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012
   Chandrawati R, 2009, BIOMATERIALS, V30, P5988, DOI 10.1016/j.biomaterials.2009.07.040
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Crosignani PG, 2008, HUM REPROD UPDATE, V14, P197, DOI 10.1093/humupd/dmn003
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Ercole F, 2011, SOFT MATTER, V7, P2687, DOI 10.1039/c0sm00746c
   Galeska I, 2005, AAPS J, V7, pE231, DOI 10.1208/aapsj070122
   Graf N, 2011, ADV FUNCT MATER, V21, P1666, DOI 10.1002/adfm.201002283
   Gulsen D, 2005, CURR EYE RES, V30, P1071, DOI 10.1080/02713680500346633
   He SJ, 2009, EUR POLYM J, V45, P2395, DOI 10.1016/j.eurpolymj.2009.04.030
   Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037
   Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h
   Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e
   Jo YS, 2008, MACROMOLECULES, V41, P1140, DOI 10.1021/ma071710t
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Leonard S., 2011, MED PRODUCT MANUF NE, V27
   Lethaby AE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002126.pub2
   Li SL, 2007, BIOTECHNOL PROGR, V23, P278, DOI 10.1021/bp060208+
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Litvinchuk S, 2009, PHARM RES-DORDR, V26, P1711, DOI 10.1007/s11095-009-9881-7
   LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Mourtas S, 2007, COLLOID SURFACE B, V55, P212, DOI 10.1016/j.colsurfb.2006.12.005
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248
   Ooya T, 2005, SCI TECHNOL ADV MAT, V6, P452, DOI 10.1016/j.stam.2005.01.006
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]
   Popescu MT, 2011, BIOMACROMOLECULES, V12, P3023, DOI 10.1021/bm2006483
   Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Sartore L, 1997, J BIOMAT SCI-POLYM E, V8, P741, DOI 10.1163/156856297X00281
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h
   Smith RC, 2009, ANGEW CHEM INT EDIT, V48, P8974, DOI 10.1002/anie.200902782
   Suri A, 2011, SOFT MATTER, V7, P7071, DOI 10.1039/c1sm05530e
   Svedhem S, 2003, CHEMBIOCHEM, V4, P339, DOI 10.1002/cbic.200390055
   Thid D, 2007, LANGMUIR, V23, P11693, DOI 10.1021/la701159u
   TORCHILIN VP, 1995, J PHARM SCI, V84, P1049, DOI 10.1002/jps.2600840904
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   van der Westen R, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0008-4
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Xu JT, 2011, MACROMOLECULES, V44, P299, DOI 10.1021/ma102386j
   Xu XD, 2007, J BIOMED MATER RES A, V81A, P418, DOI 10.1002/jbm.a.31063
   Yan H, 2005, COLLOID SURFACE B, V46, P142, DOI 10.1016/j.colsurfb.2005.10.007
   Yusa S, 2012, INT J POLYM SCI, V2012, DOI 10.1155/2012/609767
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhou YX, 2009, MATERIALS, V2, P636, DOI 10.3390/ma2020636
NR 58
TC 33
Z9 34
U1 3
U2 88
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD NOV
PY 2012
VL 1
IS 6
BP 791
EP 795
DI 10.1002/adhm.201200092
PG 5
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA 092KR
UT WOS:000315120500015
PM 23184834
DA 2021-01-25
ER

PT J
AU Chalmel, F
   Lardenois, A
   Evrard, B
   Mathieu, R
   Feig, C
   Demougin, P
   Gattiker, A
   Schulze, W
   Jegou, B
   Kirchhoff, C
   Primig, M
AF Chalmel, Frederic
   Lardenois, Aurelie
   Evrard, Bertrand
   Mathieu, Romain
   Feig, Caroline
   Demougin, Philippe
   Gattiker, Alexandre
   Schulze, Wolfgang
   Jegou, Bernard
   Kirchhoff, Christiane
   Primig, Michael
TI Global human tissue profiling and protein network analysis reveals
   distinct levels of transcriptional germline-specificity and identifies
   target genes for male infertility
SO HUMAN REPRODUCTION
LA English
DT Article
DE spermatogenesis; transcriptome; regulatory motifs; interactome
ID CELL NUCLEAR FACTOR; TESTICULAR SPERM EXTRACTION; SPERMATOGENIC CELLS;
   CANDIDATE GENES; ADULT TESTES; MICE LACKING; EXPRESSION; CREM; RECEPTOR;
   DATABASE
AB Mammalian spermatogenesis is a process that involves a complex expression program in both somatic and germ cells present in the male gonad. A number of studies have attempted to define the transcriptome of male meiosis and gametogenesis in rodents and primates. Few human transcripts, however, have been associated with testicular somatic cells and germ cells at different post-natal developmental stages and little is known about their level of germline-specificity compared with non-testicular tissues.
   We quantified human transcripts using GeneChips and a total of 47 biopsies from prepubertal children diagnosed with undescended testis, infertile adult patients whose spermatogenesis is arrested at consecutive stages and fertile control individuals. These results were integrated with data from enriched normal germ cells, non-testicular expression data, phenotype information, predicted regulatory DNA-binding motifs and interactome data.
   Among 3580 genes for which we found differential transcript concentrations in somatic and germ cells present in human testis, 933 were undetectable in 45 embryonic and adult non-testicular tissues, including many that were corroborated at protein level by published gene annotation data and histological high-throughput protein immunodetection assays. Using motif enrichment analyses, we identified regulatory promoter elements likely involved in germline development. Finally, we constructed a regulatory disease network for human fertility by integrating expression signals, interactome information, phenotypes and functional annotation data.
   Our results provide broad insight into the post-natal human testicular transcriptome at the level of cell populations and in a global somatic tissular context. Furthermore, they yield clues for genetic causes of male infertility and will facilitate the identification of novel cancer/testis genes as targets for cancer immunotherapies.
C1 [Chalmel, Frederic; Lardenois, Aurelie; Evrard, Bertrand; Mathieu, Romain; Jegou, Bernard; Primig, Michael] Univ Rennes 1, EHESP Sch Publ Hlth, Inserm Unit IRSET 1085, F-35042 Rennes, France.
   [Feig, Caroline; Schulze, Wolfgang; Kirchhoff, Christiane] Univ Hosp Hamburg Eppendorf, Dept Androl, D-20246 Hamburg, Germany.
   [Demougin, Philippe] Univ Basel, Biozentrum, CH-4046 Basel, Switzerland.
   [Gattiker, Alexandre] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.
RP Primig, M (corresponding author), Univ Rennes 1, EHESP Sch Publ Hlth, Inserm Unit IRSET 1085, F-35042 Rennes, France.
EM michael.primig@inserm.fr
RI Jegou, Bernard/I-4742-2015; Chalmel, Frederic/L-5360-2018; Primig,
   Michael/G-3175-2013; Chalmel, Frederic/M-1297-2016; Lardenois,
   Aurelie/AAA-8961-2020
OI Chalmel, Frederic/0000-0002-0535-3628; Primig,
   Michael/0000-0002-2061-0119; JEGOU, Bernard/0000-0003-0623-3609
FU Inserm AvenirInstitut National de la Sante et de la Recherche Medicale
   (Inserm) [R07216NS]; ARCAustralian Research Council [7985]; Region
   Bretagne CREATE [R11016NN]; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [SCH 587/3-1]; INERIS-STORM [N 10028NN]
FX This work was supported by the grants Inserm Avenir R07216NS, ARC No7985
   and Region Bretagne CREATE R11016NN awarded to M. P., SCH 587/3-1 from
   the Deutsche Forschungsgemeinschaft awarded to C. K. and W. S. and
   INERIS-STORM N 10028NN awarded to B.J.
CR Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105
   Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261
   Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184
   Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196
   Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008
   Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0
   Bolcun-Filas E, 2011, DEVELOPMENT, V138, P3319, DOI 10.1242/dev.067645
   Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x
   Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200
   Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86
   Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104
   Chaudhary J, 2000, ENDOCRINOLOGY, V141, P2758, DOI 10.1210/en.141.8.2758
   Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x
   Cheng CY, 2010, PHILOS T R SOC B, V365, P1459, DOI 10.1098/rstb.2010.0024
   Chizaki R, 2012, J ANDROL, V33, P277, DOI 10.2164/jandrol.110.012294
   Choudhury DR, 2010, BIOL REPROD, V83, P663, DOI 10.1095/biolreprod.110.084889
   CLERMONT Y, 1966, AM J ANAT, V118, P509, DOI 10.1002/aja.1001180211
   De Kretser D, 1976, HUMAN SEMEN FERTILIT
   Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399
   Ding B, 2004, TECHNICAL REPORT, P379
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ellis PJI, 2007, J MED GENET, V44, P498, DOI 10.1136/jmg.2007.049650
   Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097
   Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299
   Giatzakis C, 2007, BIOCHEMISTRY-US, V46, P4763, DOI 10.1021/bi062208o
   Guerrero-Bosagna CM, 2009, SEMIN REPROD MED, V27, P403, DOI 10.1055/s-0029-1237428
   Hadziselimovic F, 2009, SEX DEV, V3, P253, DOI 10.1159/000249147
   Hadziselimovic F, 2008, INT BRAZ J UROL, V34, P319, DOI 10.1590/S1677-55382008000300009
   He ZP, 2006, REPRODUCTION, V132, P11, DOI 10.1530/rep.1.01070
   Hermann BP, 2010, REPRODUCTION, V139, P479, DOI 10.1530/REP-09-0255
   Herrada G, 1997, J CELL SCI, V110, P1543
   Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107
   Hummelke GC, 2004, MOL REPROD DEV, V68, P394, DOI 10.1002/mrd.20092
   Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101
   JEGOU B, 1992, BAILLIERE CLIN ENDOC, V6, P273, DOI 10.1016/S0950-351X(05)80151-X
   Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524
   Jezek D, 1998, HUM REPROD, V13, P1230, DOI 10.1093/humrep/13.5.1230
   Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105
   Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200
   Kerr N, 2010, MOL CELL NEUROSCI, V44, P165, DOI 10.1016/j.mcn.2010.03.005
   Kerrien S, 2012, NUCL ACIDS RES
   Kimmins S, 2004, REPRODUCTION, V128, P5, DOI 10.1530/rep.1.00170
   Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093
   Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035
   Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193
   Kooistra SM, 2009, STEM CELL RES, V2, P211, DOI 10.1016/j.scr.2009.02.001
   Kosova G, 2012, AM J HUM GENET, V90, P950, DOI 10.1016/j.ajhg.2012.04.016
   Krallinger M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S8
   Kristensen DM, 2008, HUM REPROD, V23, P775, DOI 10.1093/humrep/den010
   Kristensen DM, 2011, HUM REPROD, V26, P235, DOI 10.1093/humrep/deq323
   Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066
   Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065
   Lan ZJ, 2003, EMBO J, V22, P4070, DOI 10.1093/emboj/cdg405
   Lan ZJ, 2003, BIOL REPROD, V68, P282, DOI 10.1095/biolreprod.102.008151
   Lardenois A, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq030
   Lardenois A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-154
   Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380
   Licata L, 2012, NUCL ACIDS RES
   Liu J, 2003, MOL REPROD DEV, V66, P81, DOI 10.1002/mrd.10323
   Lui WY, 2007, J CELL PHYSIOL, V211, P638, DOI 10.1002/jcp.20970
   Lysiak JJ, 2003, BIOL REPROD, V69, P202, DOI 10.1095/biolreprod.102.013318
   Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125
   Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530
   Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   McDonald SW, 2000, INT REV CYTOL, V199, P295, DOI 10.1016/S0074-7696(00)99006-5
   McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165
   Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200
   Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004
   Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0
   Naz RK, 2009, FRONT BIOSCI-LANDMRK, V14, P3994, DOI 10.2741/3507
   Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355
   Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37
   Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9
   Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641
   Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x
   Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Rajkovic M, 2010, NUCLEIC ACIDS RES, V38, P2268, DOI 10.1093/nar/gkp1220
   Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116
   Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172
   Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184
   Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762
   Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100
   Schulze W, 1999, HUM REPROD, V14, P82, DOI 10.1093/humrep/14.suppl_1.82
   Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481
   Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206
   Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669
   Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X
   Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696
   Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011
   Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116
   Teplyuk NM, 2009, MOL ENDOCRINOL, V23, P849, DOI 10.1210/me.2008-0270
   Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707
   Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0
   Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061
   van Bragt MPA, 2008, REPRODUCTION, V136, P33, DOI 10.1530/REP-07-0536
   Vanwert JM, 2008, J CELL BIOCHEM, V104, P1087, DOI 10.1002/jcb.21694
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Varela E, 2010, GENETICS, V185, P841, DOI 10.1534/genetics.109.113746
   Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016
   Virtanen HE, 2011, INT J ANDROL
   von Kopylow K, 2012, REPRODUCTION, V143, P45, DOI 10.1530/REP-11-0290
   von Kopylow K, 2010, HUM REPROD, V25, P1104, DOI 10.1093/humrep/deq053
   Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005
   Wang P, 2010, AM J CLIN PATHOL, V134, P604, DOI 10.1309/AJCPB44HBKINJNYU
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847
   Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903
   Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016
   Winnenburg R, 2008, BRIEF BIOINFORM, V9, P466, DOI 10.1093/bib/bbn043
   Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408
   Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106
   Zechel C, 2005, MOL REPROD DEV, V72, P550, DOI 10.1002/mrd.20377
NR 118
TC 50
Z9 50
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD NOV
PY 2012
VL 27
IS 11
BP 3233
EP 3248
DI 10.1093/humrep/des301
PG 16
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 025TT
UT WOS:000310218300013
PM 22926843
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Glatter, T
   Ludwig, C
   Ahrne, E
   Aebersold, R
   Heck, AJR
   Schmidt, A
AF Glatter, Timo
   Ludwig, Christina
   Ahrne, Erik
   Aebersold, Ruedi
   Heck, Albert J. R.
   Schmidt, Alexander
TI Large-Scale Quantitative Assessment of Different In-Solution Protein
   Digestion Protocols Reveals Superior Cleavage Efficiency of Tandem
   Lys-C/Trypsin Proteolysis over Trypsin Digestion
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE mass spectrometry; Lys-C; trypsin; in-solution digestion; label-free
   quantification; statistical data validation; SRM; endoprotease
   specificity; miscleaved peptides; SafeQuant
ID SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; ABSOLUTE
   QUANTIFICATION; IDENTIFICATION; PEPTIDEATLAS; SURFACTANTS; MIXTURES;
   STRATEGY; BIOLOGY; AGENTS
AB The complete and specific proteolytic cleavage of protein samples into peptides is crucial for the success of every shotgun LC-MS/MS experiment. In particular, popular peptide-based label-free and targeted mass spectrometry approaches rely on efficient generation of fully cleaved peptides to ensure accurate and sensitive protein quantification. In contrast to previous studies, we globally and quantitatively assessed the efficiency of different digestion strategies using a yeast cell lysate, label-free quantification, and statistical analysis. Digestion conditions include double tryptic, surfactant-assisted, and tandem-combinatorial Lys-C/trypsin digestion. In comparison to tryptic digests, Lys-C/trypsin digests were found most efficient to yield fully cleaved peptides while reducing the abundance of miscleaved peptides. Subsequent sequence context analysis revealed improved digestion performances of Lys-C/trypsin for miscleaved sequence stretches flanked by charged basic and particulary acidic residues. Furthermore, targeted MS analysis demonstrated a more comprehensive protein cleavage only after Lys-C/trypsin digestion, resulting in a more accurrate absolute protein quantification and extending the number of peptides suitable for SRM assay development Therefore, we conclude that a serial Lys-C/trypsin digestion is highly attractive for most applications in quantitative MS-based proteomics building on in-solution digestion schemes.
C1 [Glatter, Timo; Ahrne, Erik; Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
   [Ludwig, Christina; Aebersold, Ruedi; Heck, Albert J. R.] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland.
   [Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Utrecht, Netherlands.
   [Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland.
   [Aebersold, Ruedi] Ctr Syst Physiol & Metab Dis, Zurich, Switzerland.
RP Schmidt, A (corresponding author), Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
EM alex.schmidt@unibas.ch
RI Heck, Albert/D-7098-2011
OI Heck, Albert/0000-0002-2405-4404; Glatter, Timo/0000-0001-8716-8516
FU Department of Biology of the ETH Zurich; Distinguished Visiting
   Scientist Stipend of The Netherlands Genomics Initiative; The
   Netherlands Proteomics Centre
FX A.J.R.H. acknowledges the support of the Department of Biology of the
   ETH Zurich, enabling his sabbatical residence at the Institute for
   Molecular Systems Biology (Aebersold group), which was further supported
   by a Distinguished Visiting Scientist Stipend of The Netherlands
   Genomics Initiative. A.J.R.H. is also supported by The Netherlands
   Proteomics Centre.
CR Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a
   Choudhary G, 2003, J PROTEOME RES, V2, P59, DOI 10.1021/pr025557n
   Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Deutsch EW, 2005, PROTEOMICS, V5, P3497, DOI 10.1002/pmic.200500160
   Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619
   Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661
   Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100
   GORDON JA, 1963, BIOCHEMISTRY-US, V2, P47, DOI 10.1021/bi00901a011
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633
   Hervey WJ, 2007, J PROTEOME RES, V6, P3054, DOI 10.1021/pr070159b
   Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200
   Klammer AA, 2006, J PROTEOME RES, V5, P695, DOI 10.1021/pr050315j
   Link AJ, 1999, NAT BIOTECHNOL, V17, P676
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275
   Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104
   Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j
   Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681
   Proc JL, 2010, J PROTEOME RES, V9, P5422, DOI 10.1021/pr100656u
   Raijmakers R, 2010, CHEM COMMUN, V46, P8827, DOI 10.1039/c0cc02523b
   Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u
   Thiede B, 2000, RAPID COMMUN MASS SP, V14, P496, DOI 10.1002/(SICI)1097-0231(20000331)14:6<496::AID-RCM899>3.0.CO;2-1
   Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052
   Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
NR 29
TC 174
Z9 176
U1 0
U2 95
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
J9 J PROTEOME RES
JI J. Proteome Res.
PD NOV
PY 2012
VL 11
IS 11
BP 5145
EP 5156
DI 10.1021/pr300273g
PG 12
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 038RA
UT WOS:000311190600004
PM 23017020
DA 2021-01-25
ER

PT J
AU Plodinec, M
   Loparic, M
   Monnier, CA
   Obermann, EC
   Zanetti-Dallenbach, R
   Oertle, P
   Hyotyla, JT
   Aebi, U
   Bentires-Alj, M
   Lim, RYH
   Schoenenberger, CA
AF Plodinec, Marija
   Loparic, Marko
   Monnier, Christophe A.
   Obermann, Ellen C.
   Zanetti-Dallenbach, Rosanna
   Oertle, Philipp
   Hyotyla, Janne T.
   Aebi, Ueli
   Bentires-Alj, Mohamed
   Lim, Roderick Y. H.
   Schoenenberger, Cora-Ann
TI The nanomechanical signature of breast cancer
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX; FORCE MICROSCOPY; EPITHELIAL-CELL; LYSYL OXIDASE;
   METASTASIS; ELASTOGRAPHY; BIOMECHANICS; PROGRESSION; BIOPHYSICS;
   MALIGNANCY
AB Cancer initiation and progression follow complex molecular and structural changes in the extracellular matrix and cellular architecture of living tissue. However, it remains poorly understood how the transformation from health to malignancy alters the mechanical properties of cells within the tumour microenvironment. Here, we show using an indentation-type atomic force microscope (IT-AFM) that unadulterated human breast biopsies display distinct stiffness profiles. Correlative stiffness maps obtained on normal and benign tissues show uniform stiffness profiles that are characterized by a single distinct peak. In contrast, malignant tissues have a broad distribution resulting from tissue heterogeneity, with a prominent low-stiffness peak representative of cancer cells. Similar findings are seen in specific stages of breast cancer in MMTV-PyMT transgenic mice. Further evidence obtained from the lungs of mice with late-stage tumours shows that migration and metastatic spreading is correlated to the low stiffness of hypoxia-associated cancer cells. Overall, nanomechanical profiling by IT-AFM provides quantitative indicators in the clinical diagnostics of breast cancer with translational significance.
C1 [Plodinec, Marija; Loparic, Marko; Aebi, Ueli; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Plodinec, Marija; Loparic, Marko; Monnier, Christophe A.; Oertle, Philipp; Hyotyla, Janne T.; Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Obermann, Ellen C.] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.
   [Zanetti-Dallenbach, Rosanna] Univ Basel Hosp, Dept Gynecol & Gynecol Oncol, CH-4031 Basel, Switzerland.
   [Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Plodinec, M (corresponding author), Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
RI , /ABE-1619-2020; Mohamed, Bentires-Alj/F-4484-2015; Hyotyla,
   Janne/C-5640-2008; Obermann, Ellen/E-2656-2013
OI Mohamed, Bentires-Alj/0000-0001-6344-1127; Hyotyla,
   Janne/0000-0002-4323-5817; Monnier, Christophe/0000-0002-0071-7269; Lim,
   Roderick/0000-0001-5015-6087
FU National Centre of Competence in Research 'Nanoscale Science'; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   Commission for Technology and Innovation (CTI) supporting
   university-industry partnerships [11977.2 PFNM-NM]; Krebsliga Beider
   Basel [22-2010]; Novartis Research Foundation; European Research Council
   (ERC)European Research Council (ERC) [243211-PTPsBDC]; Swiss Cancer
   League; Krebsliga Beider Basel
FX The authors thank U. Mueller for excising tissues from MMTV-PyMT mice,
   T. Nguyen and P. Hirschmann for technical assistance with histology and
   IHC, and R. Suetterlin for advice on IHC. B. Bircher is acknowledged for
   his contribution to AFM data analysis, T. Pfandler for logistic support
   concerning clinical samples and A. Roulier for help with the drawing in
   Fig. 1. The authors also thank U. Sauder for SEM sample preparation, D.
   Mathys for SEM imaging and P. Demougin for RNA extraction. This work is
   funded by the National Centre of Competence in Research 'Nanoscale
   Science', Swiss National Science Foundation (to C-A. S.), and the
   Commission for Technology and Innovation (CTI) supporting
   university-industry partnerships (Project 11977.2 PFNM-NM within the
   project ARTIDIS 'Automated and Reliable Tissue Diagnostics' awarded to
   R.Y.H.L in partnership with Nanosurf AG). R.Z.D. is supported by
   Krebsliga Beider Basel (grant no. 22-2010). The laboratory of M. B-A. is
   supported by the Novartis Research Foundation, the European Research
   Council (ERC starting grant no. 243211-PTPsBDC), the Swiss Cancer League
   and the Krebsliga Beider Basel.
CR ALBRECHTSEN R, 1981, CANCER RES, V41, P5076
   Alcaraz J, 2011, INTEGR BIOL-UK, V3, P1153, DOI 10.1039/c1ib00073j
   Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8
   Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695
   Erler JT, 2005, BREAST CANCER RES, V7, pS57, DOI 10.1186/bcr1186
   Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530
   Fritsch A, 2010, NAT PHYS, V6, P730, DOI 10.1038/nphys1800
   Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476
   Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9
   GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025
   Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4
   Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570
   Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213
   Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h
   Lundin M, 2004, J CLIN PATHOL, V57, P1288, DOI 10.1136/jcp.2004.018739
   NEEDHAM D, 1991, CELL BIOPHYS, V18, P99, DOI 10.1007/BF02989809
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Plodinec M., 2010, COLD SPRING HARB PRO
   Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011
   Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   Sedwick C, 2011, J CELL BIOL, V193, P802, DOI 10.1083/jcb.1935pi
   Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]
   Suresh S, 2007, ACTA MATER, V55, P3989, DOI 10.1016/j.actamat.2007.04.022
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Thomas A, 2006, ULTRASOUND OBST GYN, V28, P335, DOI 10.1002/uog.2823
   WARD KA, 1991, BIORHEOLOGY, V28, P301
   Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080
   Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108
   Xu HY, 2010, ULTRASOUND MED BIOL, V36, P1813, DOI 10.1016/j.ultrasmedbio.2010.07.008
NR 45
TC 474
Z9 485
U1 18
U2 400
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
EI 1748-3395
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD NOV
PY 2012
VL 7
IS 11
BP 757
EP 765
DI 10.1038/NNANO.2012.167
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 033JQ
UT WOS:000310791900017
PM 23085644
OA Green Published
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Steiner, E
   Enzmann, GU
   Lin, S
   Ghavampour, S
   Hannocks, MJ
   Zuber, B
   Ruegg, MA
   Sorokin, L
   Engelhardt, B
AF Steiner, Esther
   Enzmann, Gaby U.
   Lin, Shuo
   Ghavampour, Sharang
   Hannocks, Melanie-Jane
   Zuber, Benoit
   Rueegg, Markus A.
   Sorokin, Lydia
   Engelhardt, Britta
TI Loss of astrocyte polarization upon transient focal brain ischemia as a
   possible mechanism to counteract early edema formation
SO GLIA
LA English
DT Article
DE aquaporin-4 (AQP4); agrin; ss-dystroglycan; laminin; astrocyte
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DYSTROPHIN-ASSOCIATED
   GLYCOPROTEIN; AQUAPORIN-4 WATER CHANNEL; CEREBRAL-ISCHEMIA;
   ALPHA-SYNTROPHIN; RAT-BRAIN; POSTSYNAPTIC DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; LAMININ ISOFORMS; AGRIN RECEPTOR
AB Brain edema is the main cause of death from brain infarction. The polarized expression of the water channel protein aquaporin-4 (AQP4) on astroglial endfeet surrounding brain microvessels suggests a role in brain water balance. Loss of astrocyte foot process anchoring to the basement membrane (BM) accompanied by the loss of polarized localization of AQP4 to astrocytic endfeet has been shown to be associated with vasogenic/extracellular edema in neuroinflammation. Here, we asked if loss of astrocyte polarity is also observed in cytotoxic/intracellular edema following focal brain ischemia after transient middle cerebral artery occlusion (tMCAO). Upon mild focal brain ischemia, we observed diminished immunostaining for the BM components laminin alpha 4, laminin alpha 2, and the proteoglycan agrin, in the core of the lesion, but not in BMs in the surrounding penumbra. Staining for the astrocyte endfoot anchorage protein beta-dystroglycan (DG) was dramatically reduced in both the lesion core and the penumbra, and AQP4 and Kir4.1 showed a loss of polarized localization to astrocytic endfeet. Interestingly, we observed that mice deficient for agrin expression in the brain lack polarized localization of beta-DG and AQP4 at astrocytic endfeet and do not develop early cytotoxic/intracellular edema following tMCAO. Taken together, these data indicate that the binding of DG to agrin embedded in the subjacent BM promotes polarized localization of AQP4 to astrocyte endfeet. Reduced DG protein levels and redistribution of AQP4 as observed upon tMCAO might therefore counteract early edema formation and reflect a beneficial mechanism operating in the brain to minimize damage upon ischemia. (c) 2012 Wiley Periodicals, Inc.
C1 [Steiner, Esther; Enzmann, Gaby U.; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland.
   [Lin, Shuo; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Ghavampour, Sharang; Hannocks, Melanie-Jane; Sorokin, Lydia] Univ Munster, Inst Physiol Chem & Pathobiochem, D-4400 Munster, Germany.
   [Zuber, Benoit] Univ Bern, Inst Anat, CH-3012 Bern, Switzerland.
RP Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.
EM bengel@tki.unibe.ch
RI Engelhardt, Britta/K-7267-2014; Zuber, Benoit/U-1952-2019; Ruegg,
   Markus/X-7256-2019
OI Engelhardt, Britta/0000-0003-3059-9846; Zuber,
   Benoit/0000-0001-7725-5579; Ruegg, Markus/0000-0002-4974-9384
FU EU FP7 European Stroke Network [201024, 202213]
FX Grant sponsor: EU FP7 European Stroke Network; Grant numbers: 201024,
   202213.
CR Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342
   Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100
   BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200
   Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026
   Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002
   Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953
   Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1
   GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3
   GEE SH, 1993, J BIOL CHEM, V268, P14972
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004
   HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120
   Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9
   Iandiev I, 2006, NEUROSCI LETT, V396, P97, DOI 10.1016/j.neulet.2005.11.016
   IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0
   KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051
   Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Milner R, 2008, J CEREBR BLOOD F MET, V28, P812, DOI 10.1038/sj.jcbfm.9600585
   Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198
   Nico B, 2001, J CELL SCI, V114, P1297
   Nielsen S, 1997, J NEUROSCI, V17, P171
   Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x
   Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x
   Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8
   Papadopoulos MC, 2004, FASEB J, V18, P425, DOI 10.1096/fj.04-2834fje
   Puwarawuttipanit W, 2006, NEUROSCIENCE, V137, P165, DOI 10.1016/j.neuroscience.2005.08.051
   RANSOM BR, 1973, J NEUROPHYSIOL, V36, P855
   Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981
   Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244
   Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4
   Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7
   SCHULER F, 1995, J CELL SCI, V108, P3795
   Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933
   Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863
   Tian M, 1996, EUR J NEUROSCI, V8, P2739, DOI 10.1111/j.1460-9568.1996.tb01568.x
   TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392
   Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13
   Wang GM, 2009, BRAIN RES, V1294, P183, DOI 10.1016/j.brainres.2009.07.070
   Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0
   Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P219, DOI 10.1007/s00401-009-0558-4
   Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131
   YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907
   Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2
NR 49
TC 61
Z9 69
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-1491
EI 1098-1136
J9 GLIA
JI Glia
PD NOV
PY 2012
VL 60
IS 11
BP 1646
EP 1659
DI 10.1002/glia.22383
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 001EU
UT WOS:000308444000002
PM 22782669
DA 2021-01-25
ER

PT J
AU Bischoff, V
   Deogracias, R
   Poirier, F
   Barde, YA
AF Bischoff, Vincent
   Deogracias, Ruben
   Poirier, Francoise
   Barde, Yves-Alain
TI Seizure-Induced Neuronal Death Is Suppressed in the Absence of the
   Endogenous Lectin Galectin-1
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID HIPPOCAMPAL-NEURONS; IMMUNE-RESPONSE; STEM-CELLS; PROLIFERATION;
   NEUROGENESIS; DEGENERATION; ACTIVATION; MECHANISMS; EXPRESSION;
   RECEPTORS
AB Pilocarpine injection induces epileptic seizures in rodents, an experimental paradigm extensively used to model temporal lobe epilepsy in humans. It includes conspicuous neuronal death in the forebrain and previous work has demonstrated an involvement of the neurotrophin receptor p75(NTR) in this process. Following the identification of Galectin-1 (Gal-1) as a downstream effector of p75(NTR), we examine here the role of this endogenous lectin in pilocarpine-induced cell death in adult mice. We found that most somatostatin-positive neurons also express Gal-1 and that in mice lacking the corresponding gene Lgals1, pilocarpine-induced neuronal death was essentially abolished in the forebrain. We also found that the related lectin Galectin-3 (Gal-3) was strongly upregulated by pilocarpine in microglial cells. This upregulation was absent in Lgals1 mutants and our results with Lgals3-null animals show that Gal-3 is not required for neuronal death in the hippocampus. These findings provide new insights into the roles and regulation of endogenous lectins in the adult CNS and a surprisingly selective proapoptotic role of Gal-1 for a subpopulation of GABAergic interneurons.
C1 [Bischoff, Vincent; Deogracias, Ruben; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Poirier, Francoise] Univ Paris Diderot, Inst Jacques Monod, F-75205 Paris, France.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Deogracias, Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867; Barde, Yves/0000-0002-7627-461X
FU European Molecular Biology OrganizationEuropean Molecular Biology
   Organization (EMBO); Human Frontier Science Program fellowships
FX V.B. was supported by European Molecular Biology Organization and Human
   Frontier Science Program fellowships.
CR BARONDES SH, 1994, J BIOL CHEM, V269, P20807
   Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025
   Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019
   Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131
   Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024
   Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x
   Ishibashi S, 2007, EXP NEUROL, V207, P302, DOI 10.1016/j.expneurol.2007.06.024
   Kajitani K, 2009, CELL DEATH DIFFER, V16, P417, DOI 10.1038/cdd.2008.162
   Kobayashi M, 2003, J NEUROSCI, V23, P2440
   Lalancette-Hebert M, 2012, J NEUROSCI, V32, P10383, DOI 10.1523/JNEUROSCI.1498-12.2012
   McGraw J, 2005, PAIN, V114, P7, DOI 10.1016/j.pain.2004.10.009
   Morrison RS, 1996, J NEUROSCI, V16, P1337
   PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0
   Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897
   POIRIER F, 1993, DEVELOPMENT, V119, P1229
   Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257
   Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x
   Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109
   Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999
   Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5
   Sakaguchi M, 2012, DEV NEUROBIOL, V72, P1059, DOI 10.1002/dneu.22023
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778
   Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200
   Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2
   Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008
   Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0
NR 29
TC 15
Z9 15
U1 0
U2 5
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD OCT 31
PY 2012
VL 32
IS 44
BP 15590
EP 15600
DI 10.1523/JNEUROSCI.4983-11.2012
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 030LY
UT WOS:000310573400033
PM 23115194
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Sylwestrak, EL
   Ghosh, A
AF Sylwestrak, Emily L.
   Ghosh, Anirvan
TI Elfn1 Regulates Target-Specific Release Probability at CA1-Interneuron
   Synapses
SO SCIENCE
LA English
DT Article
ID DUAL INTRACELLULAR-RECORDINGS; SCHAFFER COLLATERAL SYNAPSES; EXCITATORY
   SYNAPSES; HIPPOCAMPAL SLICES; PYRAMIDAL CELLS; INTERNEURONS;
   FACILITATION; EXPRESSION; CIRCUITS; RAT
AB Although synaptic transmission may be unidirectional, the establishment of synaptic connections with specific properties can involve bidirectional signaling. Pyramidal neurons in the hippocampus form functionally distinct synapses onto two types of interneurons. Excitatory synapses onto oriens-lacunosum moleculare (O-LM) interneurons are facilitating and have a low release probability, whereas synapses onto parvalbumin interneurons are depressing and have a high release probability. Here, we show that the extracellular leucine-rich repeat fibronectin containing 1 (Elfn1) protein is selectively expressed by O-LM interneurons and regulates presynaptic release probability to direct the formation of highly facilitating pyramidal-O-LM synapses. Thus, postsynaptic expression of Elfn1 in O-LM interneurons regulates presynaptic release probability, which confers target-specific synaptic properties to pyramidal cell axons.
C1 [Sylwestrak, Emily L.; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.
   [Sylwestrak, Emily L.; Ghosh, Anirvan] F Hoffmann La Roche, CNS Discovery, CH-4070 Basel, Switzerland.
   [Sylwestrak, Emily L.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.
EM anirvan.ghosh@roche.com
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS067216]; Gatsby Charitable
   Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS067216, R01NS067216, R01NS067216,
   R01NS067216] Funding Source: NIH RePORTER
FX We thank M. Scanziani, P. Scheiffele, and members of the Ghosh lab for
   suggestions and comments on the manuscript; J. de Wit for generating the
   Elfn1-GFP construct; and M. Macias, C. Sanchez, and E. Kang for help
   with virus and protein production. This work was supported by NIH grant
   R01NS067216 and the Gatsby Charitable Foundation.
CR Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x
   Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x
   Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876
   Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005
   Buchanan KA, 2012, NEURON, V75, P451, DOI 10.1016/j.neuron.2012.06.017
   BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5
   de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111
   Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0
   KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469
   Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763
   Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374
   Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005
   Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815
   LACAILLE JC, 1987, J NEUROSCI, V7, P1979
   LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615
   Reyes A, 1998, NAT NEUROSCI, V1, P279
   ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909
   Sun HY, 2009, J NEUROPHYSIOL, V101, P1043, DOI 10.1152/jn.90286.2008
   Sun HY, 2006, J NEUROSCI, V26, P10796, DOI 10.1523/JNEUROSCI.2746-06.2006
   Sun HY, 2005, J PHYSIOL-LONDON, V568, P815, DOI 10.1113/jphysiol.2005.093948
   Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024
   Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026
   VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3
   Zhu JJ, 2000, NAT NEUROSCI, V3, P1098
NR 30
TC 69
Z9 71
U1 1
U2 12
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 26
PY 2012
VL 338
IS 6106
BP 536
EP 540
DI 10.1126/science.1222482
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 025NH
UT WOS:000310195800060
PM 23042292
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Marguerat, S
   Schmidt, A
   Codlin, S
   Chen, W
   Aebersold, R
   Bahler, J
AF Marguerat, Samuel
   Schmidt, Alexander
   Codlin, Sandra
   Chen, Wei
   Aebersold, Ruedi
   Baehler, Juerg
TI Quantitative Analysis of Fission Yeast Transcriptomes and Proteomes in
   Proliferating and Quiescent Cells
SO CELL
LA English
DT Article
ID GENE-EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA; ABSOLUTE
   QUANTIFICATION; SEXUAL-DIFFERENTIATION; PROTEIN; HETEROCHROMATIN;
   RESOLUTION; RESPONSES; DIVISION
AB Data on absolute molecule numbers will empower the modeling, understanding, and comparison of cellular functions and biological systems. We quantified transcriptomes and proteomes in fission yeast during cellular proliferation and quiescence. This rich resource provides the first comprehensive reference for all RNA and most protein concentrations in a eukaryote under two key physiological conditions. The integrated data set supports quantitative biology and affords unique insights into cell regulation. Although mRNAs are typically expressed in a narrow range above 1 copy/cell, most long, noncoding RNAs, except for a distinct subset, are tightly repressed below 1 copy/cell. Cell-cycle-regulated transcription tunes mRNA numbers to phase-specific requirements but can also bring about more switch-like expression. Proteins greatly exceed mRNAs in abundance and dynamic range, and concentrations are regulated to functional demands. Upon transition to quiescence, the proteome changes substantially, but, in stark contrast to mRNAs, proteins do not uniformly decrease but scale with cell volume.
C1 [Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland.
   [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England.
   [Marguerat, Samuel; Codlin, Sandra; Baehler, Juerg] UCL Canc Inst, London WC1E 6BT, England.
   [Schmidt, Alexander] Univ Basel, Proteom Core Facil, Biozentrum, CH-4056 Basel, Switzerland.
   [Chen, Wei] Max Delbruck Ctr Mol Med MDC, Berlin Inst Med Syst Biol, D-13092 Berlin, Germany.
RP Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
EM aebersold@imsb.biol.ethz.ch; j.bahler@ucl.ac.uk
RI Chen, Wei/C-1273-2011; Marguerat, Samuel/AAY-3792-2020; Bahler,
   Jurg/B-4572-2009
OI Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532;
   Chen, Wei/0000-0003-3263-1627
FU PhenOxiGEn (an EU FP7 research project)European Union (EU);
   BBSRCBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/I012451/1]; Wellcome TrustWellcome Trust; SystemsX.ch; ERCEuropean
   Research Council (ERC); Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BB/I012451/1] Funding Source: researchfish; Wellcome TrustWellcome
   Trust [095598/Z/11/Z] Funding Source: researchfish
FX We thank F. Bachand, D. Bitton, L. Foukas, A. Lock, D. Lovell, J. Mata,
   and V. Wood for comments on the manuscript, P. Gardner for advice on
   lncRNA sequences, and P. Oliveri for help with nCounter. This research
   was funded by PhenOxiGEn (an EU FP7 research project), a BBSRC Research
   Grant BB/I012451/1, and a Wellcome Trust Senior Investigator Award to J.
   B., and by SystemsX.ch and an ERC Advanced Grant to R.A.
CR Atkinson SR, 2012, SEMIN CELL DEV BIOL, V23, P200, DOI 10.1016/j.semcdb.2011.12.003
   BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717
   Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002
   Bhavsar Rital B., 2010, Human Genomics, V4, P327
   Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499
   Coller HA, 2011, SCIENCE, V334, P1074, DOI 10.1126/science.1216242
   Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031
   Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216
   de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002
   Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108
   Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404
   Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129
   Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003
   Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0
   Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28
   Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255
   Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4
   Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628
   Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002
   Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008
   Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019
   Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794
   Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398
   Lovell D, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P193
   MACLEAN N, 1965, NATURE, V207, P322, DOI 10.1038/207322a0
   Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38
   Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351
   Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951
   Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217
   Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103
   McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556
   Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574
   Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81
   Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X
   Pancaldi V, 2010, MOL BIOSYST, V6, P543, DOI 10.1039/b913876p
   Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x
   Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357
   Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x
   Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113
   Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002
   Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853
   Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230
   Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006
   Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514
   Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002
   Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651
NR 52
TC 306
Z9 307
U1 6
U2 62
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD OCT 26
PY 2012
VL 151
IS 3
BP 671
EP 683
DI 10.1016/j.cell.2012.09.019
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 029WY
UT WOS:000310529300021
PM 23101633
OA Other Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Schoch, RL
   Kapinos, LE
   Lim, RYH
AF Schoch, Rafael L.
   Kapinos, Larisa E.
   Lim, Roderick Y. H.
TI Nuclear transport receptor binding avidity triggers a self-healing
   collapse transition in FG-nucleoporin molecular brushes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biointerface; molecular crowding; multivalent binding; nucleocytoplasmic
   transport; polymer brush
ID SURFACE-PLASMON RESONANCE; INTRINSICALLY UNSTRUCTURED PROTEINS; PORE
   COMPLEX; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; DISORDERED
   PROTEINS; REPEAT REGIONS; PERMEABILITY; FILMS; TRANSLOCATION
AB Conformational changes at supramolecular interfaces are fundamentally coupled to binding activity, yet it remains a challenge to probe this relationship directly. Within the nuclear pore complex, this underlies how transport receptors known as karyopherins proceed through a tethered layer of intrinsically disordered nucleoporin domains containing Phe-Gly (FG)-rich repeats (FG domains) that otherwise hinder passive transport. Here, we use nonspecific proteins (i.e., BSA) as innate molecular probes to explore FG domain conformational changes by surface plasmon resonance. This mathematically diminishes the surface plasmon resonance refractive index constraint, thereby providing the means to acquire and correlate height changes in a surface-tethered FG domain layer to Kap binding affinities in situ with respect to their relative spatial arrangements. Stepwise measurements show that FG domain collapse is caused by karyopherin beta 1 (Kap beta 1) binding at low concentrations, but this gradually transitions into a reextension at higher Kap beta 1 concentrations. This ability to self-heal is intimately coupled to Kap beta 1-FG binding avidity that promotes the maximal incorporation of Kap beta 1 into the FG domain layer. Further increasing Kap beta 1 to physiological concentrations leads to a "pileup" of Kap beta 1 molecules that bind weakly to unoccupied FG repeats at the top of the layer. Therefore, binding avidity does not hinder fast transport per se. Revealing the biophysical basis underlying the form-function relationship of Kap beta 1-FG domain behavior results in a convergent picture in which transport and mechanistic aspects of nuclear pore complex functionality are reconciled.
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087; Schoch, Rafael/0000-0003-1799-2272
FU National Center of Competence in Research "Nanoscale Science"Swiss
   National Science Foundation (SNSF); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF)
FX We thank A. Zilman for helpful discussions. This work is supported by
   the National Center of Competence in Research "Nanoscale Science" and
   the Swiss National Science Foundation.
CR Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bright JN, 2001, PROG BIOPHYS MOL BIO, V76, P131, DOI 10.1016/S0079-6107(01)00012-8
   Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34
   Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318
   Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   Kim JU, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.238301
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koutsioubas AG, 2007, J POLYM SCI POL PHYS, V45, P2060, DOI 10.1002/polb.21203
   Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/NNANO.2011.88, 10.1038/nnano.2011.88]
   Levicky R, 1998, J AM CHEM SOC, V120, P9787, DOI 10.1021/ja981897r
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   LOFAS S, 1991, SENSOR ACTUAT B-CHEM, V5, P79, DOI 10.1016/0925-4005(91)80224-8
   Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760
   Lyman SK, 2002, J CELL BIOL, V159, P55, DOI 10.1083/jcb.200204163
   Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109
   Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092
   Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541
   Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034
   Srinivasan N, 2012, WIRES NANOMED NANOBI, V4, P204, DOI 10.1002/wnan.1160
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656
   Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171
   Tompa P., 2010, STRUCTURE FUNCTION I
   Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k
   Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
   Yang WD, 2011, NUCLEUS-AUSTIN, V2, P10, DOI 10.4161/nucl.2.1.13818
   Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125
NR 56
TC 71
Z9 71
U1 1
U2 57
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 16
PY 2012
VL 109
IS 42
BP 16911
EP 16916
DI 10.1073/pnas.1208440109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 029SK
UT WOS:000310515800039
PM 23043112
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Sonnen, KF
   Schermelleh, L
   Leonhardt, H
   Nigg, EA
AF Sonnen, Katharina F.
   Schermelleh, Lothar
   Leonhardt, Heinrich
   Nigg, Erich A.
TI 3D-structured illumination microscopy provides novel insight into
   architecture of human centrosomes
SO BIOLOGY OPEN
LA English
DT Article
DE 3D-SIM; Plk4; Centriole; Centrosome; Super-resolution microscopy
AB Centrioles are essential for the formation of cilia and flagella. They also form the core of the centrosome, which organizes microtubule arrays important for cell shape, polarity, motility and division. Here, we have used super-resolution 3D-structured illumination microscopy to analyse the spatial relationship of 18 centriole and pericentriolar matrix (PCM) components of human centrosomes at different cell cycle stages. During mitosis, PCM proteins formed extended networks with interspersed gamma-Tubulin. During interphase, most proteins were arranged at specific distances from the walls of centrioles, resulting in ring staining, often with discernible density masses. Through use of site-specific antibodies, we found the C-terminus of Cep152 to be closer to centrioles than the N-terminus, illustrating the power of 3D-SIM to study protein disposition. Appendage proteins showed rings with multiple density masses, and the number of these masses was strongly reduced during mitosis. At the proximal end of centrioles, Sas-6 formed a dot at the site of daughter centriole assembly, consistent with its role in cartwheel formation. Plk4 and STIL co-localized with Sas-6, but Cep135 was associated mostly with mother centrioles. Remarkably, Plk4 formed a dot on the surface of the mother centriole before Sas-6 staining became detectable, indicating that Plk4 constitutes an early marker for the site of nascent centriole formation. Our study provides novel insights into the architecture of human centrosomes and illustrates the power of super-resolution microscopy in revealing the relative localization of centriole and PCM proteins in unprecedented detail. (C) 2012. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).
C1 [Sonnen, Katharina F.; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Dept Biol, D-82152 Planegg Martinsried, Germany.
   [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, D-82152 Planegg Martinsried, Germany.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch
RI Schermelleh, Lothar/H-4588-2019; Leonhardt, Heinrich/B-2791-2014;
   Sonnen, Katharina F/R-7747-2018
OI Schermelleh, Lothar/0000-0002-1612-9699; Sonnen, Katharina
   F/0000-0002-2902-9419; nigg, erich/0000-0003-4835-5719
FU EMBO Short-term fellowshipEuropean Molecular Biology Organization
   (EMBO); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [31003A_132428/1]; Bioimaging Network Munich;
   Boehringer Ingelheim FondsBoehringer Ingelheim; International Max Planck
   Research School for Molecular and Cellular Life Sciences (Martinsried,
   Germany)
FX We thank Jurgen Neumann for technical help with the OMX, and Oliver
   Biehlmaier and all members of the Nigg laboratory for helpful
   discussions. This work was supported by an EMBO Short-term fellowship
   (to K.F.S.), the Swiss National Science Foundation [31003A_132428/1] to
   E.A.N., and the Bioimaging Network Munich to H.L. In addition, K.F.S.
   was supported by a PhD fellowship from the Boehringer Ingelheim Fonds
   and the International Max Planck Research School for Molecular and
   Cellular Life Sciences (Martinsried, Germany).
CR Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887
   Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004
   Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505
   Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5
   Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3
   Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037
   Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152
   Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X
   Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928
   Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107
   Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037
   D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140
   Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302
   Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163
   Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224
   Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418
   Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008
   Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563
   Fuller SD, 1995, CURR BIOL, V5, P1384, DOI 10.1016/S0960-9822(95)00276-4
   Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939
   Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502
   Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45
   Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Haren L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005976
   Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049
   Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395
   Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021
   Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102
   Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002
   Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085
   Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63
   Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018
   Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460
   Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349
   Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100
   Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022
   Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054
   Mogensen MM, 2000, J CELL SCI, V113, P3013
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X
   Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449
   Paoletti A, 1996, J CELL SCI, V109, P3089
   Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317
   Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049
   Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947
   Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536
   Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027
   Stevens NR, 2010, J CELL BIOL, V188, P313, DOI 10.1083/jcb.200910016
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378
   Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889
   Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163
   Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048
   van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325
   VOROBJEV IA, 1980, CELL BIOL INT REP, V4, P1037, DOI 10.1016/0309-1651(80)90177-0
   Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109
   Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109
   WOLFF A, 1992, EUR J CELL BIOL, V59, P425
   Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810
NR 78
TC 203
Z9 208
U1 0
U2 28
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD OCT 15
PY 2012
VL 1
IS 10
BP 965
EP 976
DI 10.1242/bio.20122337
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA V36IH
UT WOS:000209205500005
PM 23213374
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Kuert, PA
   Bello, BC
   Reichert, H
AF Kuert, Philipp A.
   Bello, Bruno C.
   Reichert, Heinrich
TI The labial gene is required to terminate proliferation of identified
   neuroblasts in postembryonic development of the Drosophila brain
SO BIOLOGY OPEN
LA English
DT Article
DE labial; Hox; Homeotic; Neuroblast; Neural stem cell; Programmed cell
   death; Lineage; Brain; Postembryonic; Drosophila
AB The developing brain of Drosophila has become a useful model for studying the molecular genetic mechanisms that give rise to the complex neuronal arrays that characterize higher brains in other animals including mammals. Brain development in Drosophila begins during embryogenesis and continues during a subsequent postembryonic phase. During embryogenesis, the Hox gene labial is expressed in the developing tritocerebrum, and labial loss-of-function has been shown to be associated with a loss of regional neuronal identity and severe patterning defects in this part of the brain. However, nothing is known about the expression and function of labial, or any other Hox gene, during the postembryonic phase of brain development, when the majority of the neurons in the adult brain are generated. Here we report the first analysis of Hox gene action during postembryonic brain development in Drosophila. We show that labial is expressed initially in six larval brain neuroblasts, of which only four give rise to the labial expressing neuroblast lineages present in the late larval brain. Although MARCM-based clonal mutation of labial in these four neuroblast lineages does not result in an obvious phenotype, a striking and unexpected effect of clonal labial loss-of-function does occur during postembryonic brain development, namely the formation of two ectopic neuroblast lineages that are not present in wildtype brains. The same two ectopic neuroblast lineages are also observed following cell death blockage and, significantly, in this case the resulting ectopic lineages are Labial-positive. These findings imply that labial is required in two specific neuroblast lineages of the wildtype brain for the appropriate termination of proliferation through programmed cell death. Our analysis of labial function reveals a novel cell autonomous role of this Hox gene in shaping the lineage architecture of the brain during postembryonic development. (C) 2012. Published by The Company of Biologists Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).
C1 [Kuert, Philipp A.; Bello, Bruno C.; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kuert, PA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM philipp.kuert@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF)
FX We thank Markus Affolter, Jan Pielage and Simon G. Sprecher for
   discussions, Volker Hartenstein for helping with lineage identification
   and Susanne Flister for technical help. Supported by the Swiss NSF.
CR ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Albertson R, 2004, J CELL SCI, V117, P6061, DOI 10.1242/jcs.01525
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C
   Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762
   Chell JM, 2008, CELL, V133, P769, DOI 10.1016/j.cell.2008.05.010
   Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007
   del Toro ED, 2001, J NEUROSCI, V21, P5637
   DIEDERICH RJ, 1989, GENE DEV, V3, P399, DOI 10.1101/gad.3.3.399
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115
   Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Hirth F, 2001, DEVELOPMENT, V128, P4781
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Lichtneckert R, 2008, ADV EXP MED BIOL, V628, P32, DOI 10.1007/978-0-387-78261-4_2
   Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109
   LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787
   Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034
   MERRILL VKL, 1989, DEV BIOL, V135, P376, DOI 10.1016/0012-1606(89)90187-5
   Miguel-Aliaga I, 2009, CURR OPIN NEUROBIOL, V19, P127, DOI 10.1016/j.conb.2009.04.002
   Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809
   Patel N. H, 1994, DROSOPHILA MELANOGAS
   Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Peterson C, 2002, DEVELOPMENT, V129, P1467
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21
   Reichert H, 2010, ADV EXP MED BIOL, V689, P145
   Rogulja-Ortmann A, 2008, FLY, V2, P316, DOI 10.4161/fly.7464
   San-Juan BP, 2011, DEV BIOL, V352, P70, DOI 10.1016/j.ydbio.2011.01.019
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867
   Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005
   Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2005, VITAM HORM, V73, P1, DOI 10.1016/S0083-6729(05)73001-6
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
NR 57
TC 13
Z9 13
U1 0
U2 2
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD OCT 15
PY 2012
VL 1
IS 10
BP 1006
EP 1015
DI 10.1242/bio.20121966
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA V36IH
UT WOS:000209205500009
PM 23213378
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Baudouin, SJ
   Gaudias, J
   Gerharz, S
   Hatstatt, L
   Zhou, KK
   Punnakkal, P
   Tanaka, KF
   Spooren, W
   Hen, R
   De Zeeuw, CI
   Vogt, K
   Scheiffele, P
AF Baudouin, Stephane J.
   Gaudias, Julien
   Gerharz, Stefan
   Hatstatt, Laetitia
   Zhou, Kuikui
   Punnakkal, Pradeep
   Tanaka, Kenji F.
   Spooren, Will
   Hen, Rene
   De Zeeuw, Chris I.
   Vogt, Kaspar
   Scheiffele, Peter
TI Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent
   Models of Autism
SO SCIENCE
LA English
DT Article
ID LONG-TERM DEPRESSION; RARE DE-NOVO; NEUROLIGIN-3; MUTATIONS; RECEPTOR;
   PROTEIN
AB The genetic heterogeneity of autism poses a major challenge for identifying mechanism-based treatments. A number of rare mutations are associated with autism, and it is unclear whether these result in common neuronal alterations. Monogenic syndromes, such as fragile X, include autism as one of their multifaceted symptoms and have revealed specific defects in synaptic plasticity. We discovered an unexpected convergence of synaptic pathophysiology in a nonsyndromic form of autism with those in fragile X syndrome. Neuroligin-3 knockout mice (a model for nonsyndromic autism) exhibited disrupted heterosynaptic competition and perturbed metabotropic glutamate receptor-dependent synaptic plasticity, a hallmark of fragile X. These phenotypes could be rescued by reexpression of neuroligin-3 in juvenile mice, highlighting the possibility of reverting neuronal circuit alterations in autism after the completion of development.
C1 [Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Punnakkal, Pradeep; Vogt, Kaspar; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland.
   [Zhou, Kuikui; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.
   [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA.
   [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.
   [Spooren, Will] Hoffmann La Roche AG, Basel, Switzerland.
   [De Zeeuw, Chris I.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.
RP Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM peter.scheiffele@unibas.ch
RI baudouin, stephane/I-4372-2012
OI baudouin, stephane/0000-0001-6902-6071; Vogt,
   Kaspar/0000-0002-0859-876X; Tanaka, Kenji/0000-0003-2511-0057
FU Dutch Organization for Medical Sciences (ZonMw)Netherlands Organization
   for Health Research and Development; Life Sciences (ALW); Senter
   (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European
   Community)European Research Council (ERC)European Community (EC);
   SystemsX grant; EU-AIMS (European Autism Interventions); Innovative
   Medicines Initiative [115300]; European UnionEuropean Union (EU);
   European Federation of Pharmaceutical Industries and Associations
   companies'; NCCR Synapsy; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Kanton Basel-Stadt
FX We are grateful to our colleagues Arber, Barde, Gosh, Sylwestrak, Witte,
   and Xiao for comments on the manuscript; to Ponti, Genoud, Sauder,
   Ahrne, Ehrenfeuchter, and Stiefvater for technical help; and Zeilhofer,
   Fritschy, Brose, and Sans for sharing reagents. C.D.Z. was supported by
   the Dutch Organization for Medical Sciences (ZonMw); Life Sciences
   (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; and the European
   Research Council-advanced, CEREBNET, and C7 programs (European
   Community). This work was supported by a SystemsX grant (P.S. and W.S.);
   by EU-AIMS (European Autism Interventions), which receives support from
   the Innovative Medicines Initiative Joint Undertaking under grant
   agreement no. 115300, the resources of which are composed of financial
   contributions from the European Union's Seventh Framework Programme
   (grant FP7/2007-2013), from the European Federation of Pharmaceutical
   Industries and Associations companies' in-kind contributions, and from
   Autism Speaks, resulting in a total of (sic)29.6 million; by NCCR
   Synapsy; the Swiss National Science Foundation; and Kanton Basel-Stadt.
CR American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT
   Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658
   Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x
   Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061
   Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22
   Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470
   Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158
   Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108
   Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021
   Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708
   Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136
   Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270
   Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005
   Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015
   Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016
   Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129
   Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088
   Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x
   Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002
   Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995
   Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044
   Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221
   Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020
   Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007
   Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310
   Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886
NR 30
TC 184
Z9 185
U1 0
U2 43
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 5
PY 2012
VL 338
IS 6103
BP 128
EP 132
DI 10.1126/science.1224159
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015PC
UT WOS:000309457400069
PM 22983708
DA 2021-01-25
ER

PT J
AU Jaskiewicz, L
   Bilen, B
   Hausser, J
   Zavolan, M
AF Jaskiewicz, Lukasz
   Bilen, Biter
   Hausser, Jean
   Zavolan, Mihaela
TI Argonaute CLIP - A method to identify in vivo targets of miRINAs
SO METHODS
LA English
DT Article
DE Argonaute; Ago; miRNA; microRNA; miRNA targets; CLIP; PAR-CLIP;
   Computational biology
ID BINDING-SITES; NUCLEOTIDE RESOLUTION; MONOCLONAL-ANTIBODY; WIDE
   IDENTIFICATION; HIGH-THROUGHPUT; PAR-CLIP; PROTEIN; GENOME; MICRORNAS;
   CELLS
AB microRNAs are important regulators of gene expression that guide translational repression and degradation of target mRNAs. Only relatively few miRNA targets have been characterized, and computational prediction is hampered by the relatively small number of nucleotides that seem to be involved in target recognition. Argonaute (Ago) crosslinking and immunoprecipitation (CLIP) in combination with next-generation sequencing proved to be a successful method for identifying targets of endogenous cellular miRNAs on a transcriptome-wide scale. Here we review various approaches to Ago CLIP, describe in detail the PAR-CLIP method and provide an outline of the necessary computational analysis for identification of in vivo miRNA binding sites. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Hausser, Jean/0000-0002-3321-7199; Bilen, Biter/0000-0001-9452-3512;
   Zavolan, Mihaela/0000-0002-8832-2041
CR Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79
   Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425
   Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940
   Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007
   Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216
   Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721
   Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808
   Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11
   Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018
   Urlaub H, 2002, METHODS, V26, P170, DOI 10.1016/S1046-2023(02)00020-8
   Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666
   Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021
   Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873
   Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745
NR 28
TC 26
Z9 26
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD OCT
PY 2012
VL 58
IS 2
BP 106
EP 112
DI 10.1016/j.ymeth.2012.09.006
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 107QH
UT WOS:000316235300005
PM 23022257
DA 2021-01-25
ER

PT J
AU Mercer, J
   Snijder, B
   Sacher, R
   Burkard, C
   Bleck, CKE
   Stahlberg, H
   Pelkmans, L
   Helenius, A
AF Mercer, Jason
   Snijder, Berend
   Sacher, Raphael
   Burkard, Christine
   Bleck, Christopher Karl Ernst
   Stahlberg, Henning
   Pelkmans, Lucas
   Helenius, Ari
TI RNAi Screening Reveals Proteasome- and Cullin3-Dependent Stages in
   Vaccinia Virus Infection
SO CELL REPORTS
LA English
DT Article
ID MURINE INTRADERMAL MODEL; HOST-CELL ENTRY; POXVIRUS DNA; PROTEIN;
   UBIQUITIN; MACROPINOCYTOSIS; ENTER; ACID; INFLAMMATION; REPLICATION
AB A two-step, automated, high-throughput RNAi silencing screen was used to identify host cell factors required during vaccinia virus infection. Validation and analysis of clustered hits revealed previously unknown processes during virus entry, including a mechanism for genome uncoating. Viral core proteins were found to be already ubiquitinated during virus assembly. After entering the cytosol of an uninfected cell, the viral DNA was released from the core through the activity of the cell's proteasomes. Next, a Cullin3-based ubiquitin ligase mediated a further round of ubiquitination and proteasome action. This was needed in order to initiate viral DNA replication. The results accentuate the value of large-scale RNAi screens in providing directions for detailed cell biological investigation of complex pathways. The list of cell functions required during poxvirus infection will, moreover, provide a resource for future virus-host cell interaction studies and for the discovery of antivirals.
C1 [Mercer, Jason; Burkard, Christine; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
   [Sacher, Raphael] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Snijder, Berend; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
   [Bleck, Christopher Karl Ernst; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland.
RP Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.
EM lucas.pelkmans@imls.uzh.ch; ari.helenius@bc.biol.ethz.ch
RI Stahlberg, Henning/H-1868-2011; Snijder, Berend/O-9206-2019; Snijder,
   Berend/M-2998-2017
OI Stahlberg, Henning/0000-0002-1185-4592; Snijder,
   Berend/0000-0003-3386-6583; Bleck, Christopher/0000-0003-1029-3444;
   Burkard, Christine/0000-0002-0471-3230; Pelkmans,
   Lucas/0000-0002-6754-9730
FU SNF Ambizione [PZ00P3_131988]; University of Zurich; SystemsX.ch RTD
   project InfectX; European UnionEuropean Union (EU); SNF Sinergia
   [CRSII3_125110]; SystemsX.ch RTD project C-CINA; ETH ZurichETH Zurich;
   InfectX; ERC advanced investigator grant; SNSFSwiss National Science
   Foundation (SNSF)
FX We thank T. Steiger and O. Byrde for data storage and cluster computing,
   Pauli Ramo for statistical and image analysis, Karin Mench for technical
   assistance, and Jacomine Krijnse-Locker for anti-I3L. J.M. is supported
   by an SNF Ambizione (PZ00P3_131988), L.P. by the University of Zurich,
   SNSF, SystemsX.ch (http://SystemsX.ch) RTD project InfectX, and the
   European Union, C.K.E.B by the SNF Sinergia CRSII3_125110 and the
   SystemsX.ch RTD project C-CINA, and A.H. by ETH Zurich, InfectX, and an
   ERC advanced investigator grant.
CR Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5
   Barry M, 2010, VIRUSES-BASEL, V2, P2356, DOI 10.3390/v2102356
   Beard PM, 2006, J GEN VIROL, V87, P1521, DOI 10.1099/vir.0.81854-0
   Bray MA, 2012, J BIOMOL SCREEN, V17, P266, DOI 10.1177/1087057111420292
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cherry S, 2009, CURR OPIN MICROBIOL, V12, P446, DOI 10.1016/j.mib.2009.06.002
   Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06
   Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037
   Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006
   Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012
   DALES S, 1963, J CELL BIOL, V18, P51, DOI 10.1083/jcb.18.1.51
   de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0
   Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9
   Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231
   EPPSTEIN DA, 1985, NATURE, V318, P663, DOI 10.1038/318663a0
   Essbauer S, 2007, ZOONOSES PUBLIC HLTH, V54, P118, DOI 10.1111/j.1863-2378.2007.01035.x
   Froggatt GC, 2007, J GEN VIROL, V88, P1917, DOI 10.1099/vir.0.82815-0
   Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101
   Honeychurch KM, 2007, J VIROL, V81, P7310, DOI 10.1128/JVI.00034-07
   Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   ICHIHASHI Y, 1984, J VIROL, V50, P929, DOI 10.1128/JVI.50.3.929-938.1984
   JOKLIK WK, 1964, J MOL BIOL, V8, P263, DOI 10.1016/S0022-2836(64)80136-4
   JOKLIK WK, 1964, J MOL BIOL, V8, P277, DOI 10.1016/S0022-2836(64)80137-6
   KATES J, 1970, J MOL BIOL, V50, P1, DOI 10.1016/0022-2836(70)90100-2
   Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937
   Laliberte JP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002446
   Li Y, 2008, EUR J CELL BIOL, V87, P893, DOI 10.1016/j.ejcb.2008.06.003
   Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497
   MACCALLUM F O, 1957, Bull World Health Organ, V16, P441
   MAGEE WE, 1968, J VIROL, V2, P678, DOI 10.1128/JVI.2.7.678-685.1968
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   McNulty S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010884
   Mercer J, 2003, J VIROL, V77, P8857, DOI 10.1128/JVI.77.16.8857-8871.2003
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107
   Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949
   Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954
   MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661
   Moss B, 2007, FIELDS VIROLOGY
   Nerenberg BTH, 2005, J VIROL, V79, P597, DOI 10.1128/JVI.79.1.597-601.2005
   Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524
   Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08
   Schmidt FI, 2012, CURR OPIN VIROL, V2, P20, DOI 10.1016/j.coviro.2011.11.007
   Schmidt FI, 2011, EMBO J, V30, P3647, DOI 10.1038/emboj.2011.245
   Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9
   Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08
   Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06
   Villa NY, 2010, VIROLOGY, V401, P266, DOI 10.1016/j.virol.2010.02.027
   Welsch S, 2003, J VIROL, V77, P6014, DOI 10.1128/JVI.77.10.6014-6028.2003
NR 54
TC 96
Z9 97
U1 0
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD OCT
PY 2012
VL 2
IS 4
BP 1036
EP 1047
DI 10.1016/j.celrep.2012.09.003
PG 12
WC Cell Biology
SC Cell Biology
GA 083IA
UT WOS:000314455600032
PM 23084750
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Ochoa-Espinosa, A
   Affolter, M
AF Ochoa-Espinosa, Amanda
   Affolter, Markus
TI Branching Morphogenesis: From Cells to Organs and Back
SO COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
LA English
DT Article
ID DROSOPHILA TRACHEAL SYSTEM; ESTROGEN-RECEPTOR-ALPHA; MAMMARY-GLAND
   DEVELOPMENT; ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC LUNG GROWTH;
   NERVOUS-SYSTEM; INTUSSUSCEPTIVE ANGIOGENESIS; VASCULAR DEVELOPMENT;
   CELLULAR MECHANISMS; EPITHELIAL-CELLS
AB Many animal organs, such as the lung, the kidney, the mammary gland, and the vasculature, consist of branched tubular structures that arise through a process known as "branching morphogenesis" that results from the remodeling of epithelial or endothelial sheaths into multicellular tubular networks. In recent years, the combination of molecular biology, forward and reverse genetic approaches, and their complementation by live imaging has started to unravel rules and mechanisms controlling branching processes in animals. Common patterns of branch formation spanning diverse model systems are beginning to emerge that might reflect unifying principles of tubular organ formation.
C1 [Ochoa-Espinosa, Amanda; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Ochoa-Espinosa, Amanda/0000-0003-1943-790X; Affolter,
   Markus/0000-0002-5171-0016
FU SystemsX.ch within WingX RTD; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Kanton of Basel-Stadt; Kanton of
   Basel-Land
FX We thank Ross Metzger, Magdalena Baer, and Dagmar Iber for critical
   reading of the manuscript. Funding is from SystemsX.ch within the
   framework of the WingX RTD, the Swiss National Science Foundation, the
   Kantons of Basel-Stadt and Basel-Land.
CR Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875
   Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797
   Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024
   Bellusci S, 1996, DEVELOPMENT, V122, P1693
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Bellusci S, 1997, DEVELOPMENT, V124, P53
   Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151
   Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982
   Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420
   Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076
   Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013
   Chung S, 2011, DEV BIOL, V360, P160, DOI 10.1016/j.ydbio.2011.09.014
   Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357
   Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x
   Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   De Moerlooze L, 2000, DEVELOPMENT, V127, P483
   Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003
   Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701
   Franch-Marro X, 2000, DEV BIOL, V227, P80, DOI 10.1006/dbio.2000.9890
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043
   Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441
   Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168
   Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063
   Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750
   Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306
   Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182
   Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016
   Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836
   Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400
   Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144
   Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723
   Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Lim AH, 2011, DEVELOPMENT, V138, P3847, DOI 10.1242/dev.068403
   Little SC, 2011, DEV CELL, V21, P2, DOI 10.1016/j.devcel.2011.06.003
   Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020
   Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003
   Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293
   Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104
   Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012
   Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783
   Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012
   Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6
   Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5
   Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103
   Maruyama R, 2012, DEV DYNAM, V241, P119, DOI 10.1002/dvdy.22775
   Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377
   Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005
   Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x
   Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809
   Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003
   Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797
   Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010
   Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200
   Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786
   Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025
   Schedin P, 2007, J MAMMARY GLAND BIOL, V12, P71, DOI 10.1007/s10911-007-9039-3
   Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016
   Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014
   Shutter JR, 2000, GENE DEV, V14, P1313
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805
   Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557
   Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831
   Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002
   Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074
   Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025
   Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712
   Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000
   Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681
   Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033
NR 107
TC 48
Z9 48
U1 0
U2 20
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1943-0264
J9 CSH PERSPECT BIOL
JI Cold Spring Harbor Perspect. Biol.
PD OCT
PY 2012
VL 4
IS 10
AR a008243
DI 10.1101/cshperspect.a008243
PG 14
WC Cell Biology
SC Cell Biology
GA 054MJ
UT WOS:000312347600006
PM 22798543
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Sengupta, S
   Kaufmann, A
   Chandra, TS
AF Sengupta, Sudeshna
   Kaufmann, Andreas
   Chandra, T. S.
TI Development of fluorescent reporter tagged RIB gene cassettes for
   replicative transformation, early expression, and enhanced riboflavin
   production in Eremothecium ashbyi
SO FUNGAL BIOLOGY
LA English
DT Article
DE E. ashbyi; mCherry; Replicative transformation; RIB1; RIB3; Riboflavin;
   yEGFP
ID GTP-CYCLOHYDROLASE II; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE;
   GOSSYPII; SUPPLEMENTATION; OVEREXPRESSION; BIOSYNTHESIS; TRANSPORT;
   MARKER; DNA
AB Eremothecium ashbyi is a riboflavin overproducing filamentous fungus in which the metabolic pathways have not been genetically characterized. Two genes of the riboflavin biosynthetic (RIB) pathway, RIB1 and RIB3, which encode GTP-cyclohydrolase II (GCH II) and 3,4-dihydroxy-2-butanone 4-phosphate (DHBP) synthase respectively, were selected for the present study. The two RIB genes under their native promoters were obtained from Ashbya gossypii genomic library. Yeast enhanced green fluorescent protein (yEGFP) and mCherry genes were tagged to the C-terminal ends of RIB1 and RIB3 genes to analyse the functionality of the RIB transgenes in E. ashbyi. Shuttle vectors with the reporter tagged RIB genes contained the Escherichia coli kan(R) gene and Saccharomyces cerevisiae ARS element. On transformation with these plasmids, the ARS element was found to be functional in E. ashbyi. The E. ashbyi transcription factors could recognize the Ashbya RIB gene promoters and express the reporter tagged RIB genes as cytoplasmic proteins, in early cell development. Replicative transformants carrying RIB1-mCherry plasmids showed 2.95 times more GCH II activity and 2.44 times more riboflavin production when compared to untransformed. This is the first report of genetic transformation of E. ashbyi and is of significance as the first step towards genetic engineering of this genus. (C) 2012 British Mycological Society. Published by Elsevier Ltd. All rights reserved.
C1 [Sengupta, Sudeshna; Chandra, T. S.] Indian Inst Technol Madras, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.
   [Kaufmann, Andreas] Univ Basel, Biozentrum, Inst Appl Microbiol, CH-4056 Basel, Switzerland.
RP Chandra, TS (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.
EM chandra@iitm.ac.in
OI TS, Chandra/0000-0003-2336-0271
FU Dept of Biotechnology (DBT) Govt of IndiaDepartment of Biotechnology
   (DBT) India; Indo-Swiss Joint Research Programme (ISJRP) (EPFL,
   Switzerland); ISJRP
FX We would like to acknowledge, Dept of Biotechnology (DBT) Govt of India,
   and Indo-Swiss Joint Research Programme (ISJRP) (EPFL, Switzerland) for
   funding this project. We thank Prof. Peter Philippsen, Biozentrum,
   Basel, for hosting Sudeshna under the ISJRP funding.
CR Abbas CA, 2011, MICROBIOL MOL BIOL R, V75, P321, DOI 10.1128/MMBR.00030-10
   DEMAIN AL, 1972, ANNU REV MICROBIOL, V26, P369, DOI 10.1146/annurev.mi.26.100172.002101
   Forster C, 2001, APPL MICROBIOL BIOT, V55, P85, DOI 10.1007/s002530000483
   Guillermond A, 1935, CR HEBD ACAD SCI, V201, P1077
   Humbelin M, 1999, J IND MICROBIOL BIOT, V22, P1, DOI 10.1038/sj.jim.2900590
   IS:5399, 1969, IS1350, P3
   KAPRALEK F, 1962, J GEN MICROBIOL, V29, P403, DOI 10.1099/00221287-29-3-403
   Karos M, 2004, J BIOTECHNOL, V113, P69, DOI 10.1016/j.jbiotec.2004.03.025
   Kato T, 2006, APPL MICROBIOL BIOT, V71, P46, DOI 10.1007/s00253-005-0124-5
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   Kavitha S, 2009, PROCESS BIOCHEM, V44, P934, DOI 10.1016/j.procbio.2009.04.001
   Kimura S, 2009, J GEN PLANT PATHOL, V75, P322, DOI 10.1007/s10327-009-0170-4
   Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marx H, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-23
   Monschau N, 1998, APPL ENVIRON MICROB, V64, P4283
   Omprakash A. V., 1996, Cheiron, V25, P18
   OZBAS T, 1986, ENZYME MICROB TECH, V8, P593, DOI 10.1016/0141-0229(86)90116-X
   Peckham GD, 2006, PROTEIN EXPRES PURIF, V49, P183, DOI 10.1016/j.pep.2006.03.011
   Perkins JB, 1999, J IND MICROBIOL BIOT, V22, P8, DOI 10.1038/sj.jim.2900587
   Pujari V, 2001, J MICROBIOL BIOTECHN, V11, P552
   Pujari V, 2001, THESIS IIT MADRAS IN
   REVUELTA DJL, 1995, Patent No. 9526406
   Revuelta JL, 1998, Patent, Patent No. [WO9526406, C12N15/52, 9526406]
   Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schade D, 2003, FUNGAL GENET BIOL, V40, P65, DOI 10.1016/S1087-1845(03)00064-1
   Schlosser T, 2001, MICROBIOL-SGM, V147, P3377, DOI 10.1099/00221287-147-12-3377
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sengupta S, 2011, INT J ADV BIOTECHNOL, V2, P457
   Sengupta S, 2011, MYCOPATHOLOGIA, V171, P123, DOI 10.1007/s11046-010-9357-7
   Sengupta S, 2010, FUNGAL BIOL-UK, V114, P731, DOI 10.1016/j.funbio.2010.06.006
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
NR 39
TC 5
Z9 5
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1878-6146
EI 1878-6162
J9 FUNGAL BIOL-UK
JI Fungal Biol.
PD OCT
PY 2012
VL 116
IS 10
BP 1042
EP 1051
DI 10.1016/j.funbio.2012.07.008
PG 10
WC Mycology
SC Mycology
GA 038NZ
UT WOS:000311182700003
PM 23063183
DA 2021-01-25
ER

PT J
AU Barat, S
   Willer, Y
   Rizos, K
   Claudi, B
   Maze, A
   Schemmer, AK
   Kirchhoff, D
   Schmidt, A
   Burton, N
   Bumann, D
AF Barat, Somedutta
   Willer, Yvonne
   Rizos, Konstantin
   Claudi, Beatrice
   Maze, Alain
   Schemmer, Anne K.
   Kirchhoff, Dennis
   Schmidt, Alexander
   Burton, Neil
   Bumann, Dirk
TI Immunity to Intracellular Salmonella Depends on Surface-associated
   Antigens
SO PLOS PATHOGENS
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; T-CELL RESPONSES; NONTYPHOIDAL SALMONELLA;
   OUTER-MEMBRANE; B-CELL; VACCINE DEVELOPMENT; PROTECTIVE ANTIGEN; PROTEIN
   ANTIGENS; GENE-EXPRESSION; DENDRITIC CELLS
AB Invasive Salmonella infection is an important health problem that is worsening because of rising antimicrobial resistance and changing Salmonella serovar spectrum. Novel vaccines with broad serovar coverage are needed, but suitable protective antigens remain largely unknown. Here, we tested 37 broadly conserved Salmonella antigens in a mouse typhoid fever model, and identified antigen candidates that conferred partial protection against lethal disease. Antigen properties such as high in vivo abundance or immunodominance in convalescent individuals were not required for protectivity, but all promising antigen candidates were associated with the Salmonella surface. Surprisingly, this was not due to superior immunogenicity of surface antigens compared to internal antigens as had been suggested by previous studies and novel findings for CD4 T cell responses to model antigens. Confocal microscopy of infected tissues revealed that many live Salmonella resided alone in infected host macrophages with no damaged Salmonella releasing internal antigens in their vicinity. In the absence of accessible internal antigens, detection of these infected cells might require CD4 T cell recognition of Salmonella surface-associated antigens that could be processed and presented even from intact Salmonella. In conclusion, our findings might pave the way for development of an efficacious Salmonella vaccine with broad serovar coverage, and suggest a similar crucial role of surface antigens for immunity to both extracellular and intracellular pathogens.
C1 [Barat, Somedutta; Claudi, Beatrice; Maze, Alain; Schemmer, Anne K.; Burton, Neil; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Willer, Yvonne; Bumann, Dirk] Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany.
   [Rizos, Konstantin; Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.
   [Kirchhoff, Dennis] Deutsch Rheuma Forschungszentrum Berlin, Immunomodulat Grp, Berlin, Germany.
   [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland.
RP Barat, S (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM dirk.bumann@unibas.ch
OI Maze, Alain/0000-0003-0873-3690
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A-121834]; SystemsX (RTD project BattleX); Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB641-A9,
   SPP1316 Bu971/6]
FX DB and co-workers are funded by the Swiss National Science Foundation
   (31003A-121834), SystemsX (RTD project BattleX) and Deutsche
   Forschungsgemeinschaft (SFB641-A9, SPP1316 Bu971/6). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06
   Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692
   Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780
   Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736
   AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984
   Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013
   [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49
   Baghal SML, 2010, INT J INFECT DIS, V14, pE166, DOI 10.1016/j.ijid.2009.12.009
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   BENJAMIN WH, 1990, J IMMUNOL, V144, P3143
   BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989
   Bergman MA, 2005, INFECT IMMUN, V73, P1350, DOI 10.1128/IAI.73.3.1350-1356.2005
   BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1
   Buchmeier NA, 1997, CAN J MICROBIOL, V43, P29, DOI 10.1139/m97-005
   Bumann D, 2003, FEMS IMMUNOL MED MIC, V37, P105, DOI 10.1016/S0928-8244(03)00064-6
   Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x
   Bumann D, 2001, INFECT IMMUN, V69, P7493, DOI 10.1128/IAI.69.12.7493-7500.2001
   Bumann D, 2001, INFECT IMMUN, V69, P4618, DOI 10.1128/IAI.69.7.4618-4626.2001
   Bumann D, 2007, NAT PROTOC, V2, P770, DOI 10.1038/nprot.2007.78
   Charles RC, 2010, CLIN VACCINE IMMUNOL, V17, P1188, DOI 10.1128/CVI.00104-10
   Chooneea D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-44
   Cookson BT, 1997, J IMMUNOL, V158, P4310
   Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541
   de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z
   Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x
   Dunstan SJ, 1998, INFECT IMMUN, V66, P732, DOI 10.1128/IAI.66.2.732-740.1998
   Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022
   El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2
   Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9
   Ferguson AD, 2000, STRUCTURE, V8, P585
   Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014
   Finco O, 2011, P NATL ACAD SCI USA, V108, P9969, DOI 10.1073/pnas.1101756108
   Galen JE, 2004, INFECT IMMUN, V72, P7096, DOI 10.1128/IAI.72.12.7096-7106.2004
   Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106
   Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915
   Goldszmid RS, 2010, CURR OPIN IMMUNOL, V22, P118, DOI 10.1016/j.coi.2010.01.017
   Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107
   Graham SM, 2010, CURR OPIN INFECT DIS, V23, P409, DOI 10.1097/QCO.0b013e32833dd25d
   Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074
   Harris JB, 2006, INFECT IMMUN, V74, P5161, DOI 10.1128/IAI.00488-06
   Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934
   Hess J, 1996, P NATL ACAD SCI USA, V93, P1458, DOI 10.1073/pnas.93.4.1458
   Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   HORMAECHE CE, 1980, IMMUNOLOGY, V41, P973
   Hu Y, 2009, SCI CHINA SER C, V52, P942, DOI 10.1007/s11427-009-0127-z
   Kaneshige T, 2009, AVIAN DIS, V53, P563, DOI 10.1637/8925-051309-Reg.1
   Kang HY, 2003, FEMS IMMUNOL MED MIC, V37, P99, DOI 10.1016/S0928-8244(03)00063-4
   Kaufmann SHE, 1999, IMMUNOL LETT, V65, P81, DOI 10.1016/S0165-2478(98)00128-X
   Khan MI, 2010, EXPERT REV VACCINES, V9, P485, DOI 10.1586/ERV.10.43
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kirchhoff D, 2007, EUR J IMMUNOL, V37, P2370, DOI 10.1002/eji.200737322
   Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x
   Kramer U, 2003, INFECT IMMUN, V71, P1944, DOI 10.1128/IAI.71.4.1944-1952.2003
   Lee JS, 2000, NAT BIOTECHNOL, V18, P645, DOI 10.1038/76494
   Lee SJ, 2012, P NATL ACAD SCI USA, V109, P4998, DOI 10.1073/pnas.1111413109
   Lee SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002499
   Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3
   MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   Maurer J, 1997, J BACTERIOL, V179, P794, DOI 10.1128/jb.179.3.794-804.1997
   Maybeno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043481
   McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986
   MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990
   MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367
   Panthel K, 2005, INFECT IMMUN, V73, P334, DOI 10.1128/IAI.73.1.334-341.2005
   Pape KA, 1997, IMMUNOL REV, V156, P67, DOI 10.1111/j.1600-065X.1997.tb00959.x
   Pepper M, 2004, INFECT IMMUN, V72, P7240, DOI 10.1128/IAI.72.12.7240-7246.2004
   Podda A, 2010, J INFECT DEV COUNTR, V4, P404, DOI 10.3855/jidc.1048
   Prickett SP, 2006, J IMMUNOL, V176, P4826, DOI 10.4049/jimmunol.176.8.4826
   Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7
   RIDLEY MJ, 1986, AM J PATHOL, V123, P79
   Rizos K, 2003, INFECT IMMUN, V71, P6320, DOI 10.1128/IAI.71.11.6320-6328.2003
   Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101
   Rollins SM, 2005, CELL MICROBIOL, V7, P1, DOI 10.1111/j.1462-5822.2004.00477.x
   Ruiz-Olvera P, 2003, PLASMID, V50, P12, DOI 10.1016/S0147-619X(03)00047-7
   Sable SB, 2007, VACCINE, V25, P1553, DOI 10.1016/j.vaccine.2006.11.014
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   SCHOLLE A, 1987, MOL GEN GENET, V208, P247, DOI 10.1007/BF00330450
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017
   Sheikh A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001193
   Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0
   Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003
   Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949
   Sood S, 2005, MOL CELL BIOCHEM, V273, P69, DOI 10.1007/s11010-005-7756-8
   Stober CB, 2006, VACCINE, V24, P2602, DOI 10.1016/j.vaccine.2005.12.012
   Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10
   WICK MJ, 1994, INFECT IMMUN, V62, P4542, DOI 10.1128/IAI.62.10.4542-4548.1994
   Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g
   Zenewicz LA, 2002, J IMMUNOL, V169, P5805, DOI 10.4049/jimmunol.169.10.5805
   ZHANG WY, 1992, J BIOL CHEM, V267, P19560
   Zhang X, 1997, INFECT IMMUN, V65, P5381, DOI 10.1128/IAI.65.12.5381-5387.1997
NR 93
TC 53
Z9 56
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD OCT
PY 2012
VL 8
IS 10
AR e1002966
DI 10.1371/journal.ppat.1002966
PG 16
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 029XH
UT WOS:000310530300029
PM 23093937
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Huang, JR
   Gentner, M
   Vajpai, N
   Grzesiek, S
   Blackledge, M
AF Huang, Jie-rong
   Gentner, Martin
   Vajpai, Navratna
   Grzesiek, Stephan
   Blackledge, Martin
TI Residual dipolar couplings measured in unfolded proteins are sensitive
   to amino-acid-specific geometries as well as local conformational
   sampling
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article
DE coil library; flexible-Meccano algorithm; intrinsically disordered
   protein (IDP); molecular dynamics simulation; residual dipolar coupling
   (RDC); statistical coil model
ID ANGLE X-RAY; INTRINSICALLY DISORDERED PROTEINS; PARTIALLY FOLDED
   PROTEINS; UREA-DENATURED UBIQUITIN; LONG-RANGE ORDER;
   STRUCTURAL-CHARACTERIZATION; NMR; SCATTERING; DYNAMICS; SIMULATION
AB Many functional proteins do not have well defined folded structures. In recent years, both experimental and computational approaches have been developed to study the conformational behaviour of this type of protein. It has been shown previously that experimental RDCs (residual dipolar couplings) can be used to study the backbone sampling of disordered proteins in some detail. In these studies, the backbone structure was modelled using a common geometry for all amino acids. In the present paper, we demonstrate that experimental RDCs are also sensitive to the specific geometry of each amino acid as defined by energy-minimized internal co-ordinates. We have modified the FM (flexible-Meccano) algorithm that constructs conformational ensembles on the basis of a statistical coil model, to account for these differences. The modified algorithm inherits the advantages of the FM algorithm to efficiently sample the potential energy landscape for coil conformations. The specific geometries incorporated in the new algorithm result in a better reproduction of experimental RDCs and are generally applicable for further studies to characterize the conformational properties of intrinsically disordered proteins. In addition, the internal-co-ordinate-based algorithm is an order of magnitude more efficient, and facilitates side-chain construction, surface osmolyte simulation, spin-label distribution sampling and proline cis/trans isomer simulation.
C1 [Huang, Jie-rong; Blackledge, Martin] CEA CNRS UJF UMR 5075, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
   [Gentner, Martin; Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Blackledge, M (corresponding author), CEA CNRS UJF UMR 5075, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.
EM martin.blackledge@ibs.fr
RI Huang, Jie-rong/O-3661-2019
OI Huang, Jie-rong/0000-0003-3674-2228; Grzesiek,
   Stephan/0000-0003-1998-4225
FU FINOVI; MALZ TAU-STRUCT grant from Agence Nationale de Recherche
   (France)French National Research Agency (ANR); National Science Council
   of TaiwanMinistry of Science and Technology, Taiwan
FX We acknowledge financial support from FINOVI, a MALZ TAU-STRUCT grant
   from the Agence Nationale de Recherche (France) and the National Science
   Council of Taiwan (to J.-r.H.)
CR Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044
   Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Gabel F, 2009, J AM CHEM SOC, V131, P8769, DOI 10.1021/ja9013248
   Huang JR, 2012, J AM CHEM SOC, V134, P4429, DOI 10.1021/ja2118688
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Hus JC, 2001, J AM CHEM SOC, V123, P1541, DOI 10.1021/ja005590f
   Jensen MR, 2008, J AM CHEM SOC, V130, P8055, DOI 10.1021/ja801332d
   Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108
   Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Kokubo H, 2011, J AM CHEM SOC, V133, P1849, DOI 10.1021/ja1078128
   LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8
   Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w
   Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351
   Marsh JA, 2010, STRUCTURE, V18, P1094, DOI 10.1016/j.str.2010.05.015
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024
   Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172
   Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g
   Schneider R, 2012, MOL BIOSYST, V8, P58, DOI 10.1039/c1mb05291h
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Vajpai N, 2010, J AM CHEM SOC, V132, P3196, DOI 10.1021/ja910331t
   van Lune F, 2002, J BIOMOL NMR, V23, P169, DOI 10.1023/A:1019877830921
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Xue Y, 2011, J AM CHEM SOC, V133, P14614, DOI 10.1021/ja201605c
   Yao LS, 2008, J AM CHEM SOC, V130, P16518, DOI 10.1021/ja805654f
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 44
TC 10
Z9 10
U1 0
U2 22
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD OCT
PY 2012
VL 40
BP 989
EP U338
DI 10.1042/BST20120187
PN 5
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 016JD
UT WOS:000309513200010
PM 22988852
DA 2021-01-25
ER

PT J
AU Maiorca, M
   Hanssen, E
   Kazmierczak, E
   Maco, B
   Kudryashev, M
   Hall, R
   Quiney, H
   Tilley, L
AF Maiorca, Mauro
   Hanssen, Eric
   Kazmierczak, Edmund
   Maco, Bohumil
   Kudryashev, Misha
   Hall, Richard
   Quiney, Harry
   Tilley, Leann
TI Improving the quality of electron tomography image volumes using
   pre-reconstruction filtering
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Electron tomography; Denoising; Plasmodium; Non-linear anisotropic
   diffusion filtering
ID CRYOELECTRON TOMOGRAPHY; NOISE-REDUCTION; SCALE-SPACE; BIOLOGICAL
   SPECIMENS; NONLINEAR DIFFUSION; MICROSCOPY; SEGMENTATION; CELLS; 3D;
   PERSPECTIVES
AB Electron tomography produces highly magnified 3D image volumes useful for investigating the structure and function of cellular components. Image quality is degraded by multiple scattering events and quantum noise, which depend on the angle at which individual tilt projections are collected. We have adapted a biomedical imaging approach to improve image quality by enhancing individual tilt projections prior to volumetric reconstruction. Specifically, we have developed a family of non-linear anisotropic diffusion (NAD) filters parameterized by the tilt angle. We give a quantitative and qualitative evaluation of our pre-processing approach and the NAD filter. We show an improvement in the reconstructed volumes for tomograms generated from both plastic-embedded and cryo-stabilized samples of malaria parasite-infected erythrocytes. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Maiorca, Mauro; Tilley, Leann] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
   [Maiorca, Mauro; Hanssen, Eric; Quiney, Harry; Tilley, Leann] Univ Melbourne, Ctr Excellence Coherent Xray Sci, Australian Res Council, Melbourne, Vic 3010, Australia.
   [Hanssen, Eric] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Electron Microscopy Unit, Melbourne, Vic 3010, Australia.
   [Kazmierczak, Edmund] Univ Melbourne, Dept Comp Sci & Software Engn, Melbourne, Vic 3010, Australia.
   [Maco, Bohumil] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.
   [Kudryashev, Misha] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4003 Basel, Switzerland.
   [Hall, Richard] Univ Melbourne, Melbourne Univ Virtual Environm Simulat, Melbourne, Vic 3010, Australia.
   [Quiney, Harry] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia.
RP Kazmierczak, E (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.
EM edmundak@unimelb.edu.au; quiney@unimelb.edu.au; ltilley@unimelb.edu.au
RI Tilley, Leann/AAU-5281-2020; Hanssen, Eric/A-7217-2013
OI Hanssen, Eric/0000-0002-4064-1844; Tilley, Leann/0000-0001-9910-0199;
   Maco, Bohumil/0000-0001-8444-313X; Kudryashev, Misha/0000-0003-3550-6274
FU Australian Research CouncilAustralian Research Council; Australian
   National HealthNational Health and Medical Research Council of
   Australia; Medical Research CouncilMedical Research Council UK (MRC);
   Freddy Frischknecht and Marek Cyrklaff (University of Heidelberg,
   Germany); Wolfgang Baumeister (Max Planck for Biochemistry, Munich,
   Germany)
FX The authors acknowledge support from the Australian Research Council and
   the Australian National Health and Medical Research Council. We thank
   Kenneth Downing, Lawrence Berkeley Laboratories, CA, USA and Carlos
   Oscar Sorzano, Centro Nacional Biotecnologia, Madrid, Spain, and Bernard
   Heymann, National Institutes of Health, MD, USA, and David Mastronarde,
   University of Colorado, CO, USA, and Ruben Dilanian, University of
   Melbourne, Australia, for helpful discussions. We thank Freddy
   Frischknecht and Marek Cyrklaff (University of Heidelberg, Germany) and
   Wolfgang Baumeister (Max Planck for Biochemistry, Munich, Germany) for
   support in cryo data acquisition. The photo of Marie Curie is from the
   nobelprize.org website.
CR Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499
   Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692
   Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010
   Ali RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033697
   Alrefaya M, 2009, LECT NOTES COMPUT SC, V5567, P212, DOI 10.1007/978-3-642-02256-2_18
   BABAUD J, 1986, IEEE T PATTERN ANAL, V8, P26, DOI 10.1109/TPAMI.1986.4767749
   Bartesaghi A, 2009, CURR OPIN STRUC BIOL, V19, P402, DOI 10.1016/j.sbi.2009.06.005
   Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8
   Bazan C, 2009, J STRUCT BIOL, V166, P144, DOI 10.1016/j.jsb.2009.02.009
   Bouwer JC, 2004, J STRUCT BIOL, V148, P297, DOI 10.1016/j.jsb.2004.08.005
   DEMIRKAYA O, 2001, P SOC PHOTO-OPT INS, V2, P917
   den Dekker AJ, 2005, ULTRAMICROSCOPY, V104, P83, DOI 10.1016/j.ultramic.2005.03.001
   Downing KH, 2007, ANAL CHEM, V79, P7949, DOI 10.1021/ac071982u
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108
   Elbakri IA, 2002, IEEE T MED IMAGING, V21, P89, DOI 10.1109/42.993128
   Elbakri LA, 2003, P SOC PHOTO-OPT INS, V5032, P1839, DOI 10.1117/12.480302
   Fernandez JJ, 2005, COMPUT SCI ENG, V7, P54, DOI 10.1109/MCSE.2005.89
   Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010
   Frangakis A.S., 2006, ELECT TOMOGRAPHY, P331
   Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406
   Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202
   Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Gan L, 2012, Q REV BIOPHYS, V45, P27, DOI 10.1017/S0033583511000102
   Gerig G., 2001, LNCS, V2208, P516, DOI DOI 10.1007/3-540-45468-3_62
   Grimm R, 1997, BIOPHYS J, V72, P482, DOI 10.1016/S0006-3495(97)78689-2
   Grunewald K, 2003, BIOPHYS CHEM, V100, P577, DOI 10.1016/S0301-4622(02)00307-1
   Han KF, 1996, J MICROSC-OXFORD, V183, P124, DOI 10.1046/j.1365-2818.1996.810640.x
   Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x
   Hanssen E, 2010, METHOD CELL BIOL, V96, P93, DOI 10.1016/S0091-679X(10)96005-6
   Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7
   Hoenger A, 2011, ADV PROTEIN CHEM STR, V82, P67, DOI 10.1016/B978-0-12-386507-6.00003-8
   Hurbain I, 2011, BIOL CELL, V103, P405, DOI 10.1042/BC20110015
   Ibanez L, 2003, ITK SOFTWARE GUIDE
   KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961
   Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kudryashev M, 2010, CELL MICROBIOL, V12, P362, DOI 10.1111/j.1462-5822.2009.01399.x
   Leis A., 2008, TRENDS BIOCH SCI
   Li TF, 2004, IEEE T NUCL SCI, V51, P2505, DOI 10.1109/TNS.2004.834824
   Lindeberg T., 1992, Journal of Mathematical Imaging and Vision, V1, P65, DOI 10.1007/BF00135225
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923
   Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   McDonald KL, 2006, BIOTECHNIQUES, V41, P137, DOI 10.2144/000112226
   McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009
   Mendrik AM, 2009, IEEE T MED IMAGING, V28, P1585, DOI 10.1109/TMI.2009.2022368
   Milne JLS, 2009, NAT REV MICROBIOL, V7, P666, DOI 10.1038/nrmicro2183
   Mrazek P, 2003, INT J COMPUT VISION, V52, P189, DOI 10.1023/A:1022908225256
   Mumcuoglu EU, 2012, J MICROSC-OXFORD, V246, P248, DOI 10.1111/j.1365-2818.2012.03614.x
   Narasimha R, 2008, J STRUCT BIOL, V164, P7, DOI 10.1016/j.jsb.2008.04.006
   Nguyen H, 2008, IEEE T MED IMAGING, V27, P616, DOI 10.1109/TMI.2007.912390
   Nielsen M, 1997, J MATH IMAGING VIS, V7, P291, DOI 10.1023/A:1008282127190
   PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X
   PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205
   Pierson J, 2011, J ELECTRON MICROSC, V60, pS93, DOI 10.1093/jmicro/dfr014
   Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   Steven AC, 2003, TRENDS CELL BIOL, V13, P107, DOI 10.1016/S0962-8924(03)00023-0
   Tocheva EI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003442
   Vanhecke D, 2011, J MICROSC-OXFORD, V242, P221, DOI 10.1111/j.1365-2818.2010.03478.x
   Wang J, 2005, PROC SPIE, V5747, P2058, DOI 10.1117/12.595662
   Weickert J, 1999, INT J COMPUT VISION, V31, P111, DOI 10.1023/A:1008009714131
   Whiting BR, 2002, PROC SPIE, V4682, P53, DOI 10.1117/12.465601
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
   Zhou J, 2007, COMPUT MED IMAG GRAP, V31, P447, DOI 10.1016/j.compmedimag.2007.04.003
NR 68
TC 7
Z9 7
U1 0
U2 25
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD OCT
PY 2012
VL 180
IS 1
BP 132
EP 142
DI 10.1016/j.jsb.2012.05.019
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 023PH
UT WOS:000310046400016
PM 22683346
DA 2021-01-25
ER

PT J
AU Matthies, MC
   Bienert, S
   Torda, AE
AF Matthies, Marco C.
   Bienert, Stefan
   Torda, Andrew E.
TI Dynamics in Sequence Space for RNA Secondary Structure Design
SO JOURNAL OF CHEMICAL THEORY AND COMPUTATION
LA English
DT Article
ID NOVO PROTEIN DESIGN; MONTE-CARLO APPROACH; ENERGY MINIMIZATION;
   MOLECULAR-DYNAMICS; LAMBDA-DYNAMICS; OPTIMIZATION; ALGORITHM; SEARCH;
   PREDICTION; POTENTIALS
AB We have implemented a method for the design of RNA sequences that should fold to arbitrary secondary structures. A popular energy model allows one to take the derivative with respect to composition, which can then be interpreted as a force and used for Newtonian dynamics in sequence space. Combined with a negative design term, one can rapidly sample sequences which are compatible with a desired secondary structure via simulated annealing. Results for 360 structures were compared with those from another nucleic acid design program using measures such as the probability of the target structure and an ensemble-weighted distance to the target structure.
C1 [Matthies, Marco C.; Bienert, Stefan; Torda, Andrew E.] Univ Hamburg, Ctr Bioinformat, D-20146 Hamburg, Germany.
   [Bienert, Stefan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Matthies, MC (corresponding author), Univ Hamburg, Ctr Bioinformat, Bundesstr 43, D-20146 Hamburg, Germany.
EM matthies@zbh.uni-hamburg.de; torda@zbh.uni-hamburg.de
CR Allen BD, 2006, J COMPUT CHEM, V27, P1071, DOI 10.1002/jcc.20420
   Andronescu M, 2004, J MOL BIOL, V336, P607, DOI 10.1016/j.jmb.2003.12.041
   Bhattacherjee A, 2009, J PHYS CHEM B, V113, P5520, DOI 10.1021/jp810515s
   Busch A, 2006, BIOINFORMATICS, V22, P1823, DOI 10.1093/bioinformatics/btl194
   Chiu TL, 1998, PROTEIN ENG, V11, P749, DOI 10.1093/protein/11.9.749
   Cootes AP, 2000, J CHEM PHYS, V113, P2489, DOI 10.1063/1.482067
   Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82
   Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0
   Desmet J, 2002, PROTEINS, V48, P31, DOI 10.1002/prot.10131
   Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701
   Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291
   Flamm C, 2008, MONATSH CHEM, V139, P447, DOI 10.1007/s00706-008-0895-3
   Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009
   Giegerich R, 2004, NUCLEIC ACIDS RES, V32, P4843, DOI 10.1093/nar/gkh779
   GODZIK A, 1995, PROTEIN ENG, V8, P409, DOI 10.1093/protein/8.5.409
   Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S
   HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803
   HOCKNEY RW, 1988, COMPUTER SIMULATION, P94
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   Hom GK, 2006, J COMPUT CHEM, V27, P375, DOI 10.1002/jcc.20346
   Hu XQ, 2010, J COMPUT CHEM, V31, P2164, DOI 10.1002/jcc.21506
   JONES DT, 1994, PROTEIN SCI, V3, P567
   Jose J. V., 1998, CLASSICAL DYNAMICS C, P251
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Knight JL, 2011, J COMPUT CHEM, V32, P3423, DOI 10.1002/jcc.21921
   Knight JL, 2009, J COMPUT CHEM, V30, P1692, DOI 10.1002/jcc.21295
   Koehl P, 1999, J MOL BIOL, V293, P1161, DOI 10.1006/jmbi.1999.3211
   Kong XJ, 1996, J CHEM PHYS, V105, P2414, DOI 10.1063/1.472109
   Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427
   Lafontaine I, 2000, BIOPHYS J, V79, P680, DOI 10.1016/S0006-3495(00)76326-0
   Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006
   Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509
   Seno F, 1996, PHYS REV LETT, V77, P1901, DOI 10.1103/PhysRevLett.77.1901
   SHAKHNOVICH EI, 1993, PROTEIN ENG, V6, P793, DOI 10.1093/protein/6.8.793
   TIDOR B, 1993, J PHYS CHEM-US, V97, P1069, DOI 10.1021/j100107a015
   Torda AE, 2004, SOFT MATER, V2, P1, DOI 10.1081/smts-120030139
   Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758
   Yang X, 2005, CHEM PHYS LETT, V401, P205, DOI 10.1016/j.cplett.2004.10.153
   Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633
   Zou JM, 2003, J CHEM PHYS, V118, P3843, DOI 10.1063/1.1539845
NR 46
TC 14
Z9 14
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9618
J9 J CHEM THEORY COMPUT
JI J. Chem. Theory Comput.
PD OCT
PY 2012
VL 8
IS 10
BP 3663
EP 3670
DI 10.1021/ct300267j
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 016GN
UT WOS:000309505600023
PM 26593011
DA 2021-01-25
ER

PT J
AU Yakushev, S
   Mihov, D
   Gassmann, M
   Bogdanova, A
AF Yakushev, S.
   Mihov, D.
   Gassmann, M.
   Bogdanova, A.
TI Myocardial Na,K-ATPase and its role in Epo-induced cardioprotection
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract
C1 [Yakushev, S.; Gassmann, M.; Bogdanova, A.] Univ Zurich, Inst Vet Physiol, CH-8006 Zurich, Switzerland.
   [Mihov, D.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RI Bogdanova, Anna Yu/M-1977-2017
OI Bogdanova, Anna Yu/0000-0003-0502-5381
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
J9 AM J HEMATOL
JI Am. J. Hematol.
PD OCT
PY 2012
VL 87
IS 10
BP E93
EP E93
PG 1
WC Hematology
SC Hematology
GA 010AB
UT WOS:000309065700028
DA 2021-01-25
ER

PT J
AU Yazdani, M
   Deogracias, R
   Guy, J
   Poot, RA
   Bird, A
   Barde, YA
AF Yazdani, Morteza
   Deogracias, Ruben
   Guy, Jacky
   Poot, Raymond A.
   Bird, Adrian
   Barde, Yves-Alain
TI Disease Modeling Using Embryonic Stem Cells: MeCP2 Regulates Nuclear
   Size and RNA Synthesis in Neurons
SO STEM CELLS
LA English
DT Article
DE Rett syndrome; Nuclear size; Transcription; Astrocytes; Brain-derived
   neurotrophic factor; Synaptophysin
ID CPG-BINDING PROTEIN-2; RETT-SYNDROME; GENE-EXPRESSION; CEREBRAL-CORTEX;
   DEFICIENCY; TRANSCRIPTION; MICE; PROGRESSION; MATURATION; MUTATIONS
AB Mutations in the gene encoding the methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome, an autism spectrum disorder mainly affecting young females. MeCP2 is an abundant chromatin-associated protein, but how and when its absence begins to alter brain function is still far from clear. Using a stem cell-based system allowing the synchronous differentiation of neuronal progenitors, we found that in the absence of MeCP2, the size of neuronal nuclei fails to increase at normal rates during differentiation. This is accompanied by a marked decrease in the rate of ribonucleotide incorporation, indicating an early role of MeCP2 in regulating total gene transcription, not restricted to selected mRNAs. We also found that the levels of brain-derived neurotrophic factor (BDNF) were decreased in mutant neurons, while those of the presynaptic protein synaptophysin increased at similar rates in wild-type and mutant neurons. By contrast, nuclear size, transcription rates, and BDNF levels remained unchanged in astrocytes lacking MeCP2. Re-expressing MeCP2 in mutant neurons rescued the nuclear size phenotype as well as BDNF levels. These results reveal a new role of MeCP2 in regulating overall RNA synthesis in neurons during the course of their maturation, in line with recent findings indicating a reduced nucleolar size in neurons of the developing brain of mice lacking Mecp2. STEM Cells2012;30:21282139
C1 [Yazdani, Morteza; Deogracias, Ruben; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Guy, Jacky; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.
   [Poot, Raymond A.] Erasmus Med Ctr MC, Dept Cell Biol, Rotterdam, Netherlands.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Deogracias, Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867; Barde, Yves/0000-0002-7627-461X;
   Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372
FU Rett Syndrome Research Foundation; Swiss National FoundationSwiss
   National Science Foundation (SNSF) [CRSI33_130441]; International Rett
   Syndrome Foundation
FX We would like to thank the Rett Syndrome Research Foundation for
   supporting the initial phase of this work, subsequently supported by a
   "Sinergia" program of the Swiss National Foundation, CRSI33_130441, and
   by the International Rett Syndrome Foundation.
CR Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255
   Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275
   Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027
   Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906
   Cheung Aaron Y L, 2012, Front Psychiatry, V3, P24, DOI 10.3389/fpsyt.2012.00024
   Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093
   Farra N, 2012, MOL PSYCHIAT
   Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023
   Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104
   Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899
   Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389
   Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145
   Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108
   Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349
   Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214
   Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010
   Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038
   Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014
   Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Rett A, 1966, Wien Med Wochenschr, V116, P723
   Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062
   SATO S, 1994, J NEUROCHEM, V63, P1609
   SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467
   SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9
   Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011
   Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030
   THOMAS JO, 1977, CELL, V10, P633, DOI 10.1016/0092-8674(77)90096-4
   THOMPSON RJ, 1973, J NEUROCHEM, V21, P19, DOI 10.1111/j.1471-4159.1973.tb04222.x
   Trinkle-Mulcahy L, 2008, FEBS LETT, V582, P1960, DOI 10.1016/j.febslet.2008.04.029
   Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430
NR 39
TC 55
Z9 56
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PD OCT
PY 2012
VL 30
IS 10
BP 2128
EP 2139
DI 10.1002/stem.1180
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 008AA
UT WOS:000308928300006
PM 22865604
OA Bronze
DA 2021-01-25
ER

PT J
AU Muller, M
   Mazur, AJ
   Behrmann, E
   Diensthuber, RP
   Radke, MB
   Qu, Z
   Littwitz, C
   Raunser, S
   Schoenenberger, CA
   Manstein, DJ
   Mannherz, HG
AF Mueller, Mirco
   Mazur, Antonina Joanna
   Behrmann, Elmar
   Diensthuber, Ralph P.
   Radke, Michael B.
   Qu, Zheng
   Littwitz, Christoph
   Raunser, Stefan
   Schoenenberger, Cora-Ann
   Manstein, Dietmar J.
   Mannherz, Hans Georg
TI Functional characterization of the human alpha-cardiac actin mutations
   Y166C and M305L involved in hypertrophic cardiomyopathy
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Article
DE Cardiac actin; Actin expression; Hypertrophic cardiomyopathy; Myosin;
   Tropomyosin
ID SKELETAL-MUSCLE ACTIN; DNASE-I COMPLEX; F-ACTIN; GENETIC-BASIS; DILATED
   CARDIOMYOPATHY; MYOPATHY MUTATIONS; ESCHERICHIA-COLI; STRIATED-MUSCLE;
   SEPTAL-DEFECTS; BINDING-SITES
AB Inherited cardiomyopathies are caused by point mutations in sarcomeric gene products, including alpha-cardiac muscle actin (ACTC1). We examined the biochemical and cell biological properties of the alpha-cardiac actin mutations Y166C and M305L identified in hypertrophic cardiomyopathy (HCM). Untagged wild-type (WT) cardiac actin, and the Y166C and M305L mutants were expressed by the baculovirus/Sf9-cell system and affinity purified by immobilized gelsolin G4-6. Their correct folding was verified by a number of assays. The mutant actins also displayed a disturbed intrinsic ATPase activity and an altered polymerization behavior in the presence of tropomyosin, gelsolin, and Arp2/3 complex. Both mutants stimulated the cardiac beta-myosin ATPase to only 50 % of WT cardiac F-actin. Copolymers of WT and increasing amounts of the mutant actins led to a reduced stimulation of the myosin ATPase. Transfection of established cell lines revealed incorporation of EGFP- and hemagglutinin (HA)-tagged WT and both mutant actins into cytoplasmic stress fibers. Adenoviral vectors of HA-tagged WT and Y166C actin were successfully used to infect adult and neonatal rat cardiomyocytes (NRCs). The expressed HA-tagged actins were incorporated into the minus-ends of NRC thin filaments, demonstrating the ability to form hybrid thin filaments with endogenous actin. In NRCs, the Y166C mutant led after 72 h to a shortening of the sarcomere length when compared to NRCs infected with WT actin. Thus our data demonstrate that a mutant actin can be integrated into cardiomyocyte thin filaments and by its reduced mode of myosin interaction might be the basis for the initiation of HCM.
C1 [Mazur, Antonina Joanna; Qu, Zheng; Mannherz, Hans Georg] Ruhr Univ Bochum, Dept Anat & Mol Embryol, D-44780 Bochum, Germany.
   [Mueller, Mirco; Diensthuber, Ralph P.; Radke, Michael B.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE 4350, D-30625 Hannover, Germany.
   [Behrmann, Elmar; Raunser, Stefan; Mannherz, Hans Georg] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.
   [Littwitz, Christoph] Loyola Univ, Dept Physiol, Stritch Sch Med, Chicago, IL 60611 USA.
   [Schoenenberger, Cora-Ann] Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4046 Basel, Switzerland.
RP Mannherz, HG (corresponding author), Ruhr Univ Bochum, Dept Anat & Mol Embryol, Univ Str 150, D-44780 Bochum, Germany.
EM hans.g.mannherz@rub.de
RI Manstein, Dietmar J./AAG-2640-2019; Mazur, Antonina/L-6504-2019;
   Behrmann, Elmar/I-5808-2015; Manstein, Dietmar J. J/M-1034-2013; Mazur,
   Antonina/E-3379-2012
OI Manstein, Dietmar J./0000-0003-0763-0147; Mazur,
   Antonina/0000-0002-7561-9030; Behrmann, Elmar/0000-0001-6794-3669;
   Manstein, Dietmar J. J/0000-0003-0763-0147; Mannherz, Hans
   Georg/0000-0001-8158-5722; Raunser, Stefan/0000-0001-9373-3016
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [MA
   807/17-2, MA 1081/11-2, RA 1781/1-1]; Fonds der Chemischen
   IndustrieFonds der Chemischen Industrie [684052]; Hannover Biomedical
   Research School; Deutsche Akademische Ausstauschdienst (DAAD); FoRUM der
   Ruhr-Universitat Bochum; Schweizer National Fond; Max-Planck SocietyMax
   Planck Society
FX The authors thank Prof. Pott (Bochum) for supplying ARCs and Dipl. Biol.
   S. Fister and Dr. H. Milting (Herzund Diabeteszentrum NRW, Bad
   Oeyenhausen) for the human cardiac actin clones, and Prof. Claycomb (New
   Orleans, Lousiana, USA) for supplying the HL-1 cells. Mass spectrometry
   analysis was kindly performed at the Hannover Medical School (MHH) Core
   Unit Mass Spectrometry/Proteomics by A. Pich. This work was supported by
   the 'Deutsche Forschungsgemeinschaft' Grant MA 807/17-2 (to H.G.M.), MA
   1081/11-2 (to D.J.M), RA 1781/1-1 (to S.R.), the 'Fonds der Chemischen
   Industrie' Grant 684052 (to E.B.), the Hannover Biomedical Research
   School (to M.B.R.), the Deutsche Akademische Ausstauschdienst (DAAD) and
   FoRUM der Ruhr-Universitat Bochum (to A.J.M.), the Schweizer National
   Fond (to C.A.S.), and the Max-Planck Society (to S.R. and E.B.).
CR AJTAI K, 1983, FEBS LETT, V151, P94, DOI 10.1016/0014-5793(83)80350-0
   Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x
   Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499
   ASPENSTROM P, 1991, EUR J BIOCHEM, V200, P35, DOI 10.1111/j.1432-1033.1991.tb21045.x
   Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020
   Bathe FS, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-2
   BECHEM M, 1983, EUR J CELL BIOL, V31, P366
   Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200
   Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e
   BRYAN J, 1984, J BIOL CHEM, V259, P7480
   Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172
   Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   DOSREMEDIOS CG, 1995, BBA-BIOENERGETICS, V1228, P99, DOI 10.1016/0005-2728(94)00169-6
   Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380
   Ehler E, 2008, ADV EXP MED BIOL, V642, P1
   Fister S, 2004, THESIS U BIELEFELD B
   FRANKEL S, 1990, J BIOL CHEM, V265, P17980
   Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518
   Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   HOUMEIDA A, 1995, BIOPHYS CHEM, V56, P201, DOI 10.1016/0301-4622(95)00038-Y
   Huxley HE, 2004, EUR J BIOCHEM, V271, P1403, DOI 10.1111/j.1432-1033.2004.04044.x
   Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200
   Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094
   JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046
   Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a
   JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127
   KABSCH W, 1995, FASEB J, V9, P167
   KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0
   KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385
   Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047
   KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33
   Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869
   Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795
   Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107
   Mannherz HG, 2007, J MOL BIOL, V366, P745, DOI 10.1016/j.jmb.2006.11.100
   MANNHERZ HG, 1975, EUR J BIOCHEM, V60, P109, DOI 10.1111/j.1432-1033.1975.tb20981.x
   MANNHERZ HG, 1980, EUR J BIOCHEM, V104, P367, DOI 10.1111/j.1432-1033.1980.tb04437.x
   MANNHERZ HG, 1975, FEBS LETT, V60, P34, DOI 10.1016/0014-5793(75)80412-1
   MARIAN AJ, 1995, CIRC RES, V77, P98, DOI 10.1161/01.RES.77.1.98
   Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340
   MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785
   Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8
   Matsson H, 2008, HUM MOL GENET, V17, P256, DOI 10.1093/hmg/ddm302
   Mazur AJ, 2010, EUR J CELL BIOL, V89, P402, DOI 10.1016/j.ejcb.2009.10.017
   Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   Miller BM, 2008, J BIOL CHEM, V283, P19379, DOI 10.1074/jbc.M801963200
   Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21
   Mogensen J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010447
   Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460
   Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239
   Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463
   Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200
   Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436
   Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144
   Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750
   Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204
   Pant K, 2009, FASEB J, V23, P3571, DOI 10.1096/fj.08-126672
   Pereira JS, 2001, J BIOL CHEM, V276, P4409, DOI 10.1074/jbc.M006441200
   Pfaendtner J, 2010, J MOL BIOL, V396, P252, DOI 10.1016/j.jmb.2009.11.034
   Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X
   POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769
   Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271
   Przygodzki T, 2005, BBA-MOL BASIS DIS, V1740, P481, DOI 10.1016/j.bbadis.2005.03.009
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5
   Schoenenberger CA, 2011, EUR J CELL BIOL, V90, P797, DOI 10.1016/j.ejcb.2011.05.002
   Schuler H, 2006, ADV MOL CEL, V37, P49, DOI 10.1016/S1569-2558(06)37003-8
   Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x
   SCHWARTZ K, 1995, CIRCULATION, V91, P2865, DOI 10.1161/01.CIR.91.12.2865
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2
   SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1
   Song WH, 2011, J BIOL CHEM, V286, P27582, DOI 10.1074/jbc.M111.252320
   Sussman MA, 1998, CIRC RES, V82, P94
   TAYLOR RS, 1976, BIOCHEM J, V159, P301, DOI 10.1042/bj1590301
   Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF
   van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879
   VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7
   Vang S, 2005, FEBS J, V272, P2037, DOI 10.1111/j.1742-4658.2005.04630.x
   Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709
   Watkins H, 1996, J CLIN INVEST, V98, P2456, DOI 10.1172/JCI119063
   WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593
   WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3
   WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89
   Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880
   Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0
   Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215
   Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286
NR 101
TC 33
Z9 33
U1 0
U2 14
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD OCT
PY 2012
VL 69
IS 20
BP 3457
EP 3479
DI 10.1007/s00018-012-1030-5
PG 23
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 008OK
UT WOS:000308966200007
PM 22643837
DA 2021-01-25
ER

PT J
AU Cabernard, C
AF Cabernard, Clemens
TI Cytokinesis in Drosophila melanogaster
SO CYTOSKELETON
LA English
DT Review
DE cytokinesis; Drosophila
ID ASYMMETRIC CELL-DIVISION; NONMUSCLE MYOSIN-II; REGULATORY LIGHT-CHAIN;
   HISTONE H3 PHOSPHORYLATION; CENTRAL-SPINDLE; CONTRACTILE RING;
   CLEAVAGE-FURROW; MALE MEIOSIS; AURORA-B; MEIOTIC CYTOKINESIS
AB Cytokinesis is the process that physically separates two sibling cells, ensuring the proper partitioning of the nuclear and cytoplasmic contents at the end of cell division. Cytokinesis requires a fine-tuned molecular machinery that has to be assembled with high spatiotemporal precision. Drosophila melanogaster is an ideal model system to investigate this cellular process. Genetic screens performed in spermatocytes, neuroblasts, and Schneider cells revealed numerous evolutionary conserved components. These genetically amenable systems have proven to be very useful to further elucidate the cellular and molecular mechanism of cytokinesis, significantly contributing to our current understanding of this important cellular process. As in other organisms, cytokinesis is largely dependent on the mitotic spindle, providing positional cues for cleavage furrow placement and progression. However, spindle-independent mechanisms could also be important during special cases of cytokinesis, such as asymmetric cell division. Thus, powerful fly genetics combined with single-cell analysis, live imaging, and biochemical assays will continue to provide important insights into the mechanism of cytokinesis. (c) 2012 Wiley Periodicals, Inc
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cabernard, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM clemens.cabernard@unibas.ch
OI Cabernard, Clemens/0000-0003-3706-6401
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX The author would like to thank all members of the Cabernard lab for
   fruitful discussions and helpful comments on the manuscript. This work
   was supported by grants from the Swiss National Science Foundation and
   the University of Basel.
CR Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865
   Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483
   Allen-Baume V, 2002, FEBS LETT, V531, P74, DOI 10.1016/S0014-5793(02)03412-9
   Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9
   Bassi ZI, 2011, J CELL BIOL, V195, P595, DOI 10.1083/jcb.201105136
   Basto R, 2000, NAT CELL BIOL, V2, P939
   Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13
   Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378
   Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   Brill JA, 2000, DEVELOPMENT, V127, P3855
   Bucciarelli E, 2003, J CELL BIOL, V160, P993, DOI 10.1083/jcb.200211029
   Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111
   Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334
   Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009
   Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659
   CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367
   CENCI G, 1994, J CELL SCI, V107, P3521
   Chang CJ, 2006, J CELL SCI, V119, P1144, DOI 10.1242/jcs.02834
   Connell M, 2011, MOL BIOL CELL, V22, P4220, DOI 10.1091/mbc.E11-02-0173
   COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y
   D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716
   D'Avino PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000572
   D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210
   D'Avino PP, 2004, J CELL BIOL, V166, P61, DOI 10.1083/jcb.200402157
   de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242
   Dean SO, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000131
   Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102
   Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055
   Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983
   Ebrahimi S, 2010, J BIOL CHEM, V285, P28667, DOI 10.1074/jbc.M110.103887
   Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063
   EDWARDS KA, 1995, J MUSCLE RES CELL M, V16, P491, DOI 10.1007/BF00126433
   Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379
   El Kadhi KB, 2011, CURR BIOL, V21, P1074, DOI 10.1016/j.cub.2011.05.030
   Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343
   Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482
   Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843
   Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605
   Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128
   Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227
   Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952
   Gao S, 2008, J CELL BIOL, V180, P521, DOI 10.1083/jcb.200708072
   Gatt MK, 2006, J CELL SCI, V119, P2225, DOI 10.1242/jcs.02933
   GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438
   Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415
   Giansanti MG, 2001, CELL STRUCT FUNCT, V26, P609, DOI 10.1247/csf.26.609
   Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011
   Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603
   Giansanti MG, 1999, J CELL SCI, V112, P2323
   Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396
   Giansanti MG, 2001, DEVELOPMENT, V128, P1137
   Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669
   Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055
   Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896
   Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714
   Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102
   Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718
   Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050
   Gregory SL, 2010, IUBMB LIFE, V62, P290, DOI 10.1002/iub.310
   GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243
   Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041
   Haglund K, 2010, CURR BIOL, V20, P944, DOI 10.1016/j.cub.2010.03.068
   Hanson KK, 2005, DEVELOPMENT, V132, P4777, DOI 10.1242/dev.02057
   Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005
   Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043
   HIME G, 1992, DEVELOPMENT, V114, P165
   Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052
   Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153
   Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409
   KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O
   KAWAMURA K, 1977, EXP CELL RES, V106, P127, DOI 10.1016/0014-4827(77)90249-X
   Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062
   KIEHART DP, 1989, EMBO J, V8, P913, DOI 10.1002/j.1460-2075.1989.tb03452.x
   Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27
   Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010
   Lattao R, 2012, J CELL SCI, V125, P584, DOI 10.1242/jcs.101469
   LEHNER CF, 1992, J CELL SCI, V103, P1021
   Liu SL, 2008, J BIOL CHEM, V283, P380, DOI 10.1074/jbc.M703924200
   LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153
   Megraw TL, 1999, DEVELOPMENT, V126, P2829
   Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214
   Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1
   Mizuno T, 1999, GENE, V238, P437, DOI 10.1016/S0378-1119(99)00351-0
   Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060
   MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672
   Naim V, 2004, MOL BIOL CELL, V15, P5053, DOI 10.1091/mbc.E04-06-0536
   Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030
   NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X
   O'Keefe L, 2001, CELL STRUCT FUNCT, V26, P619, DOI 10.1247/csf.26.619
   Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129
   Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112
   Pearson J, 2006, EXP CELL RES, V312, P770, DOI 10.1016/j.yexcr.2005.11.031
   Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006
   Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002
   Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015
   Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301
   RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107
   Rebollo E, 2000, EMBO REP, V1, P65, DOI 10.1093/embo-reports/kvd011
   Rebollo E, 2004, METH MOL B, V247, P77
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Reich A, 1999, DNA CELL BIOL, V18, P593, DOI 10.1089/104454999315141
   Robinett CC, 2009, J CELL SCI, V122, P4526, DOI 10.1242/jcs.054536
   Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.E04-08-0734
   Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023
   Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Saint R, 2003, J CELL SCI, V116, P4277, DOI 10.1242/jcs.00816
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412
   Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338
   SMITH DA, 1985, GENETICS, V110, P647
   Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1
   Somma MP, 2002, MOL BIOL CELL, V13, P2448, DOI 10.1091/mbc.01-12-0589
   Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758
   SUNKEL CE, 1988, J CELL SCI, V89, P25
   Szafer-Glusman E, 2011, MOL BIOL CELL, V22, P3779, DOI 10.1091/mbc.E11-06-0569
   Uehara R, 2010, CURR BIOL, V20, P1080, DOI 10.1016/j.cub.2010.04.058
   Vale RD, 2009, J CELL BIOL, V186, P727, DOI 10.1083/jcb.200902083
   Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031
   Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054
   Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786
   WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709
   Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7
   Wong R, 2010, IMAGING DEV BIOL LAB
   Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830
   Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427
   Yumura S, 2008, TRAFFIC, V9, P2089, DOI 10.1111/j.1600-0854.2008.00837.x
NR 128
TC 13
Z9 13
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1949-3584
EI 1949-3592
J9 CYTOSKELETON
JI Cytoskeleton
PD OCT
PY 2012
VL 69
IS 10
SI SI
BP 791
EP 809
DI 10.1002/cm.21060
PG 19
WC Cell Biology
SC Cell Biology
GA 023XR
UT WOS:000310071500011
PM 22888045
OA Bronze
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Insight into the natural potency to evolve, can indicate safe procedures
   for genetic engineering
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Arber, Werner] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP 23
PY 2012
VL 29
SU S
MA 1.0.3
BP S1
EP S2
DI 10.1016/j.nbt.2012.08.096
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA V45GR
UT WOS:000209805600004
DA 2021-01-25
ER

PT J
AU Lee, J
   Friese, A
   Mielich, M
   Sigrist, M
   Arber, S
AF Lee, Jun
   Friese, Andreas
   Mielich, Monika
   Sigrist, Markus
   Arber, Silvia
TI Scaling Proprioceptor Gene Transcription by Retrograde NT3 Signaling
SO PLOS ONE
LA English
DT Article
ID TARGET-DERIVED NEUROTROPHINS; MUSCLE SENSORY NEURONS; SPINAL-CORD;
   PRESYNAPTIC INHIBITION; MOTOR-NEURONS; PRIMARY AFFERENTS;
   NERVOUS-SYSTEM; DRG NEURONS; IN-VIVO; BRAIN
AB Cell-type specific intrinsic programs instruct neuronal subpopulations before target-derived factors influence later neuronal maturation. Retrograde neurotrophin signaling controls neuronal survival and maturation of dorsal root ganglion (DRG) sensory neurons, but how these potent signaling pathways intersect with transcriptional programs established at earlier developmental stages remains poorly understood. Here we determine the consequences of genetic alternation of NT3 signaling on genome-wide transcription programs in proprioceptors, an important sensory neuron subpopulation involved in motor reflex behavior. We find that the expression of many proprioceptor-enriched genes is dramatically altered by genetic NT3 elimination, independent of survival-related activities. Combinatorial analysis of gene expression profiles with proprioceptors isolated from mice expressing surplus muscular NT3 identifies an anticorrelated gene set with transcriptional levels scaled in opposite directions. Voluntary running experiments in adult mice further demonstrate the maintenance of transcriptional adjustability of genes expressed by DRG neurons, pointing to life-long gene expression plasticity in sensory neurons.
C1 [Lee, Jun; Friese, Andreas; Mielich, Monika; Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   [Lee, Jun; Friese, Andreas; Mielich, Monika; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
FU ERC Advanced Grant; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Kanton Basel-Stadt; EU Framework Program 7;
   Novartis Research Foundation
FX All authors were supported by an ERC Advanced Grant, the Swiss National
   Science Foundation, the Kanton Basel-Stadt, EU Framework Program 7 and
   the Novartis Research Foundation. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Bautista W, 2012, J PHYSIOL-LONDON, V590, P3821, DOI 10.1113/jphysiol.2011.225987
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735
   BROWN AG, 1981, ORG SPINAL CORD
   Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028
   Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128
   da Silva S, 2011, CURR OPIN NEUROBIOL, V21, P61, DOI 10.1016/j.conb.2010.07.007
   Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7
   ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P237, DOI 10.1113/jphysiol.1962.sp006884
   Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z
   Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5
   FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0
   FRANK K, 1957, FED PROC, V16, P39
   Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106
   FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111
   Gaspard Nicolas, 2011, F1000 Biol Rep, V3, P6, DOI 10.3410/B3-6
   Gong SC, 2010, NAT PROTOC, V5, P1678, DOI 10.1038/nprot.2010.131
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862
   Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x
   Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010
   Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629
   Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0
   Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027
   Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024
   Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057
   McIlwrath SL, 2007, EUR J NEUROSCI, V26, P1801, DOI 10.1111/j.1460-9568.2007.05821.x
   Mendell LM, 1999, J NEUROSCI, V19, P3162
   Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6
   MU XJ, 1993, J NEUROSCI, V13, P4029
   OAKLEY RA, 1995, DEVELOPMENT, V121, P1341
   Oakley RA, 1997, J NEUROSCI, V17, P4262
   Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011
   Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7
   Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009
   Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933
   Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297
   SCOTT SA, 1992, SENSORY NEURONS DIVE
   Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168
   SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5
   Taylor MD, 2001, J COMP NEUROL, V432, P244, DOI 10.1002/cne.1100
   TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wang R, 2008, NAT NEUROSCI, V11, P488, DOI 10.1038/nn2069
   Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007
   Wu MR, 2010, FRONT BIOSCI-LANDMRK, V15, P957, DOI 10.2741/3656
   Zelena J, 1994, NERVES MECHANORECEPT
   Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727
NR 58
TC 10
Z9 10
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 19
PY 2012
VL 7
IS 9
AR e45551
DI 10.1371/journal.pone.0045551
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 014PP
UT WOS:000309388400103
PM 23029089
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Uppaluri, S
   Heddergott, N
   Stellamanns, E
   Herminghaus, S
   Zottl, A
   Stark, H
   Engstler, M
   Pfohl, T
AF Uppaluri, Sravanti
   Heddergott, Niko
   Stellamanns, Eric
   Herminghaus, Stephan
   Zoettl, Andreas
   Stark, Holger
   Engstler, Markus
   Pfohl, Thomas
TI Flow Loading Induces Oscillatory Trajectories in a Bloodstream Parasite
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID AFRICAN TRYPANOSOMES; SHEAR-FLOW; MOTION; CELLS; MIGRATION; FORMS;
   POLYMERS; VESICLES; PROTEIN; BRAIN
AB The dynamics of isolated microswimmers are studied in bounded flow using the African trypanosome, a unicellular parasite, as the model organism. With the help of a microfluidics platform, cells are subjected to flow and found to follow an oscillatory path that is well fit by a sine wave. The frequency and amplitudes of the oscillatory trajectories are dependent on the flow velocity and cell orientation. When traveling in such a manner, trypanosomes orient upstream while downstream-facing cells tumble within the same streamline. A comparison with immotile trypanosomes demonstrates that self-propulsion is essential to the trajectories of trypanosomes even at flow velocities up to similar to 40 times higher than their own swimming speed. These studies reveal important swimming dynamics that may be generally pertinent to the transport of microswimmers in flow and may be relevant to microbial pathogenesis.
C1 [Uppaluri, Sravanti; Stellamanns, Eric; Herminghaus, Stephan; Pfohl, Thomas] Max Planck Inst Dynam & Self Org, Dept Complex Fluids, Gottingen, Germany.
   [Heddergott, Niko; Engstler, Markus] Univ Wurzburg, Dept Cell & Dev Biol, Biozentrum, Wurzburg, Germany.
   [Zoettl, Andreas; Stark, Holger] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany.
   [Pfohl, Thomas] Univ Basel, Dept Chem, Basel, Switzerland.
RP Uppaluri, S (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.
EM uppaluri@princeton.edu
RI Pfohl, Thomas/D-7296-2016
OI Pfohl, Thomas/0000-0002-7879-5216; Zottl, Andreas/0000-0002-1736-9619
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SPP
   1207]
FX This study was supported by the Deutsche Forschungsgemeinschaft (SPP
   1207).
CR Abkarian M, 2005, BIOPHYS J, V89, P1055, DOI 10.1529/biophysj.104.056036
   Abkarian M, 2008, SOFT MATTER, V4, P653, DOI 10.1039/b716612e
   Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078
   BRETHERTON F, 1961, PROC R SOC SER B-BIO, V153, P490, DOI 10.1098/rspb.1961.0014
   Dao M, 2006, MAT SCI ENG C-BIO S, V26, P1232, DOI 10.1016/j.msec.2005.08.020
   Downton MT, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/20/204101
   Enanga B, 2002, CELL MOL LIFE SCI, V59, P845, DOI 10.1007/s00018-002-8472-0
   Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046
   Esch MB, 2011, TISSUE ENG PT A, V17, P2965, DOI 10.1089/ten.tea.2010.0371
   Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P35, DOI 10.1073/pnas.1009492108
   Gebremichael Y, 2006, BIOPHYS J, V91, P3640, DOI 10.1529/biophysj.106.091314
   Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101
   HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883
   HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2
   Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078
   Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108
   Kwasny D, 2011, BIOMED MICRODEVICES, V13, P899, DOI 10.1007/s10544-011-9559-x
   Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401
   Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601
   Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045
   Nagai M, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3481777
   Neve N, 2010, CELL MOL BIOENG, V3, P213, DOI 10.1007/s12195-010-0113-3
   PARSONS M, 1990, MOL BIOCHEM PARASIT, V42, P197, DOI 10.1016/0166-6851(90)90162-F
   PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903
   Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861
   Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106
   Saintillan D, 2006, J FLUID MECH, V557, P297, DOI 10.1017/S0022112006000243
   SATIR P, 1981, CELL MOTIL CYTOSKEL, V1, P303, DOI 10.1002/cm.970010304
   Sokolov A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158102
   Steinhauser D, 2008, THESIS GEORG AUGUST
   Steinhauser D, 2012, ACS MACRO LETT, V1, P541, DOI 10.1021/mz3000539
   Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058
   WALKER PJ, 1961, NATURE, V189, P1017, DOI 10.1038/1891017a0
   Wang JB, 2010, LAB CHIP, V10, P235, DOI 10.1039/b914874d
   Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7
   Zaburdaev V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.208103
   Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107
   Zilman G, 2008, MAR BIOL, V154, P1, DOI 10.1007/s00227-007-0891-x
   Zottl A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218104
   Zottl A, 2012, ARXIV12071186
NR 40
TC 20
Z9 20
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD SEP 19
PY 2012
VL 103
IS 6
BP 1162
EP 1169
DI 10.1016/j.bpj.2012.08.020
PG 8
WC Biophysics
SC Biophysics
GA 009HV
UT WOS:000309017800008
PM 22995488
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schwede, T
   Iber, D
AF Schwede, Torsten
   Iber, Dagmar
TI ECCB 2012: The 11(th) European Conference on Computational Biology
SO BIOINFORMATICS
LA English
DT Editorial Material
C1 [Schwede, Torsten] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Schwede, Torsten/A-4650-2008; Iber, Dagmar/V-2846-2019
OI Schwede, Torsten/0000-0003-2715-335X; Iber, Dagmar/0000-0001-8051-1035
NR 0
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
J9 BIOINFORMATICS
JI Bioinformatics
PD SEP 15
PY 2012
VL 28
IS 18
BP I303
EP I305
DI 10.1093/bioinformatics/bts490
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 002LA
UT WOS:000308532300001
PM 22962444
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Nef, C
   Frederix, PLTM
   Brunner, J
   Schonenberger, C
   Calame, M
AF Nef, C.
   Frederix, P. L. T. M.
   Brunner, J.
   Schoenenberger, C.
   Calame, M.
TI Force-conductance correlation in individual molecular junctions
SO NANOTECHNOLOGY
LA English
DT Article
ID ELECTRICAL CONDUCTANCE; METALLIC CONTACTS; SINGLE; STABILITY; WIRES
AB Conducting atomic force microscopy is an attractive approach enabling the correlation of mechanical and electrical properties in individual molecular junctions. Here we report on measurements of gold-gold and gold-octanedithiol-gold junctions. We introduce two-dimensional histograms in the form of scatter plots to better analyze the correlation between force and conductance. In this representation, the junction-forming octanedithiol compounds lead to a very clear step in the force-conductance data, which is not observed for control monothiol compounds. The conductance found for octanedithiols is in agreement with the idea that junction conductance is dominated by a single molecule.
C1 [Nef, C.; Brunner, J.; Schoenenberger, C.; Calame, M.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   [Frederix, P. L. T. M.] Univ Basel, C CINA, Biozentrum, CH-4058 Basel, Switzerland.
RP Nef, C (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM Michel.Calame@unibas.ch
RI Calame, Michel/O-8818-2019; Schonenberger, Christian/N-3187-2017;
   Calame, Michel/A-5037-2008
OI Calame, Michel/0000-0001-7467-9915; Schonenberger,
   Christian/0000-0002-5652-460X; Calame, Michel/0000-0001-7467-9915
FU Swiss Nanoscience Institute (SNI); Swiss NSF via the Sinergia program
   [126969]; European Commission (EC)European CommissionEuropean Commission
   Joint Research CentreEuropean Community (EC) [212942]; EC FP7 FUNMOL
   project [213382]
FX We gratefully acknowledge Professors Andreas Engel and Henning Stahlberg
   for granting us access to their research facilities. For their support,
   we also acknowledge the Swiss Nanoscience Institute (SNI), the Swiss NSF
   via the Sinergia program no 126969, the European Commission (EC) FP7 ITN
   FUNMOLS project no 212942 and the EC FP7 FUNMOL project no 213382.
CR Agrait N, 2003, PHYS REP, V377, P81, DOI 10.1016/S0370-1573(02)00633-6
   AGRAIT N, 1993, PHYS REV B, V47, P12345, DOI 10.1103/PhysRevB.47.12345
   Akkerman HB, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/01/013001
   Arroyo CR, 2011, J AM CHEM SOC, V133, P14313, DOI 10.1021/ja201861k
   Bosshart PD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384014
   BRANDBYGE M, 1995, PHYS REV B, V52, P8499, DOI 10.1103/PhysRevB.52.8499
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   Chen F, 2010, IEEE SENS J, V10, P485, DOI 10.1109/JSEN.2009.2037796
   Chen F, 2007, ANNU REV PHYS CHEM, V58, P535, DOI 10.1146/annurev.physchem.58.032806.104523
   Cui XD, 2001, SCIENCE, V294, P571, DOI 10.1126/science.1064354
   Diez-Perez I, 2011, NAT NANOTECHNOL, V6, P226, DOI 10.1038/nnano.2011.20
   Franco I, 2011, J AM CHEM SOC, V133, P2242, DOI 10.1021/ja1095396
   Frei M, 2011, NANO LETT, V11, P1518, DOI 10.1021/nl1042903
   French WR, 2011, J PHYS CHEM C, V115, P18422, DOI 10.1021/jp203837r
   Gonzalez MT, 2006, NANO LETT, V6, P2238, DOI 10.1021/nl061581e
   Gonzalez MT, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/065018
   Haiss W, 2006, FARADAY DISCUSS, V131, P253, DOI 10.1039/b507520n
   Haiss W, 2004, PHYS CHEM CHEM PHYS, V6, P4330, DOI 10.1039/b404929b
   Haiss W, 2009, J PHYS CHEM C, V113, P5823, DOI 10.1021/jp811142d
   Huang ZF, 2007, J AM CHEM SOC, V129, P13225, DOI 10.1021/ja074456t
   Huber R, 2008, J AM CHEM SOC, V130, P1080, DOI 10.1021/ja0767940
   Huisman E, 2010, THESIS U GRONINGEN
   Huisman EH, 2008, NANO LETT, V8, P3381, DOI 10.1021/nl801983z
   Kruger D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.186402
   Li C, 2008, J AM CHEM SOC, V130, P318, DOI 10.1021/ja0762386
   Li XL, 2006, J AM CHEM SOC, V128, P2135, DOI 10.1021/ja057316x
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Magoga M, 1999, PHYS REV B, V59, P16011, DOI 10.1103/PhysRevB.59.16011
   Martin S, 2010, J AM CHEM SOC, V132, P9157, DOI 10.1021/ja103327f
   Nichols RJ, 2010, PHYS CHEM CHEM PHYS, V12, P2801, DOI 10.1039/b922000c
   Okamoto M, 1999, PHYS REV B, V60, P7808, DOI 10.1103/PhysRevB.60.7808
   Osorio EA, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/37/374121
   Rubio G, 1996, PHYS REV LETT, V76, P2302, DOI 10.1103/PhysRevLett.76.2302
   Rubio-Bollinger G, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.026101
   Sorensen MR, 1998, PHYS REV B, V57, P3283, DOI 10.1103/PhysRevB.57.3283
   Stalder A, 1996, J VAC SCI TECHNOL B, V14, P1259, DOI 10.1116/1.588527
   Gonzalez MT, 2011, J PHYS CHEM C, V115, P17973, DOI 10.1021/jp204005v
   Tsutsui M, 2009, J AM CHEM SOC, V131, P10552, DOI 10.1021/ja902871d
   von Wrochem F, 2010, NAT NANOTECHNOL, V5, P618, DOI [10.1038/nnano.2010.119, 10.1038/NNANO.2010.119]
   Wu SM, 2008, NAT NANOTECHNOL, V3, P569, DOI 10.1038/nnano.2008.237
   Xu BQ, 2003, J AM CHEM SOC, V125, P16164, DOI 10.1021/ja038949j
   Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481
   Zhou JF, 2010, J PHYS CHEM C, V114, P8587, DOI 10.1021/jp101257y
NR 43
TC 26
Z9 27
U1 1
U2 37
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 14
PY 2012
VL 23
IS 36
AR 365201
DI 10.1088/0957-4484/23/36/365201
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 992XD
UT WOS:000307812800003
PM 22909952
DA 2021-01-25
ER

PT J
AU Hilge, M
AF Hilge, Mark
TI Ca2+ Regulation of Ion Transport in the Na+/Ca2+ Exchanger
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Review
ID SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGER; MOLECULAR DETERMINANTS;
   CA2+-BINDING DOMAIN; DYNAMIC PROPERTIES; CRYSTAL-STRUCTURES; STRUCTURAL
   BASIS; SPLICE VARIANTS; BINDING DOMAINS; STEADY-STATE
AB The binding of Ca2+ to two adjacent Ca2+-binding domains, CBD1 and CBD2, regulates ion transport in the Na+/Ca2+ exchanger. As sensors for intracellular Ca2+, the CBDs form electrostatic switches that induce the conformational changes required to initiate and sustain Na+/Ca2+ exchange. Depending on the presence of a few key residues in the Ca2+-binding sites, zero to four Ca2+ ions can bind with affinities between 0.1 to 20 mu M. Importantly, variability in CBD2 as a consequence of alternative splicing modulates not only the number and affinities of the Ca2+-binding sites in CBD2 but also the Ca2+ affinities in CBD1.
C1 Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
RP Hilge, M (corresponding author), Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland.
EM mark.hilge@unibas.ch
FU Swiss National Science Foundation (National Centres of Competence for
   Research (NCCRs) Structural Biology and TransCure); Swiss Initiative for
   Systems Biology (SystemsX.ch); Engineering and Physical Sciences
   Research CouncilEngineering & Physical Sciences Research Council (EPSRC)
   [EP/D032210/1] Funding Source: researchfish
FX This work was supported by grants from the Swiss National Science
   Foundation (National Centres of Competence for Research (NCCRs)
   Structural Biology and TransCure) and the Swiss Initiative for Systems
   Biology (SystemsX.ch). This article is part of the Thematic Minireview
   Series on Ins and Outs of Calcium Transport.
CR Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745
   Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5
   Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001
   BAKER PF, 1968, BIOCHIM BIOPHYS ACTA, V150, P167, DOI 10.1016/0005-2736(68)90023-0
   Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104
   Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005
   Blaustein MP, 1999, PHYSIOL REV, V79, P763
   Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106
   Brini M, 2011, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspect.a004168, DOI 10.1101/CSHPERSPECT.A004168]
   Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200
   Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101
   DIPOLO R, 1979, J GEN PHYSIOL, V73, P91, DOI 10.1085/jgp.73.1.91
   DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481
   Doering AE, 1996, ANN NY ACAD SCI, V779, P182, DOI 10.1111/j.1749-6632.1996.tb44786.x
   Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200
   Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701
   Dyck C, 1998, J BIOL CHEM, V273, P12981, DOI 10.1074/jbc.273.21.12981
   Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502
   FernandezBusquets X, 1996, J BIOL CHEM, V271, P23558, DOI 10.1074/jbc.271.38.23558
   Garman EF, 2005, PROG BIOPHYS MOL BIO, V89, P173, DOI 10.1016/j.pbiomolbio.2004.09.005
   He ZP, 2000, AM J PHYSIOL-CELL PH, V278, pC661
   Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008
   Hilge M, 2007, ANN NY ACAD SCI, V1099, P7, DOI 10.1196/annals.1387.030
   Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106
   HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905
   HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0
   HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0
   HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933
   Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696
   Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67
   Hurtado C, 2006, AM J PHYSIOL-HEART C, V290, pH2155, DOI 10.1152/ajpheart.00958.2005
   Iwamoto T, 2000, J BIOL CHEM, V275, P38571, DOI 10.1074/jbc.M003788200
   Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118
   Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45
   Iwamoto T, 2004, MOL CELL BIOCHEM, V259, P157, DOI 10.1023/B:MCBI.0000021367.42752.54
   Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200
   Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5
   Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391
   Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6
   John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108
   Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271
   KOFUJI P, 1994, J BIOL CHEM, V269, P5145
   Lee C, 2005, CAN J CARDIOL, V21, P509
   LEE SL, 1994, J BIOL CHEM, V269, P14849
   LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847
   LI ZP, 1991, J BIOL CHEM, V266, P1014
   LI ZP, 1994, J BIOL CHEM, V269, P17434
   Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759
   Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619
   MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403
   McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200
   Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910
   Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385
   Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914
   NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476
   Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200
   NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0
   Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351
   Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471
   Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386
   Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434
   PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287
   Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111
   Pignataro G, 2004, STROKE, V35, P2566, DOI 10.1161/01.STR.0000143730.29964.93
   Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200
   Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250
   Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057
   Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897
   Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249
   Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0
   Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910
   Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008
   Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162
   Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045
NR 79
TC 19
Z9 19
U1 0
U2 17
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 14
PY 2012
VL 287
IS 38
BP 31641
EP 31649
DI 10.1074/jbc.R112.353573
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 009XT
UT WOS:000309059400005
PM 22822067
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Nitschke, M
   Aebischer, D
   Abadier, M
   Haener, S
   Lucic, M
   Vigl, B
   Luche, H
   Fehling, HJ
   Biehlmaier, O
   Lyck, R
   Halin, C
AF Nitschke, Maximilian
   Aebischer, David
   Abadier, Michael
   Haener, Simone
   Lucic, Matije
   Vigl, Benjamin
   Luche, Herve
   Fehling, Hans Joerg
   Biehlmaier, Oliver
   Lyck, Ruth
   Halin, Cornelia
TI Differential requirement for ROCK in dendritic cell migration within
   lymphatic capillaries in steady-state and inflammation
SO BLOOD
LA English
DT Article
ID IN-VIVO; ENDOTHELIAL-CELLS; TRANSGENIC MOUSE; LANGERHANS CELLS;
   MYOSIN-II; EXPRESSION; REPORTER; ADHESION; TRAFFICKING; VESSELS
AB Dendritic cell (DC) migration via lymphatic vessels to draining lymph nodes (dLNs) is crucial for the initiation of adaptive immunity. We imaged this process by intravital microscopy (IVM) in the ear skin of transgenic mice bearing red-fluorescent vasculature and yellow-fluorescent DCs. DCs within lymphatic capillaries were rarely transported by flow, but actively migrated within lymphatics and were significantly faster than in the interstitium. Pharmacologic blockade of the Rho-associated protein kinase (ROCK), which mediates nuclear contraction and de-adhesion from integrin ligands, significantly reduced DC migration from skin to dLNs in steady-state. IVM revealed that ROCK blockade strongly reduced the velocity of interstitial DC migration, but only marginally affected intralymphatic DC migration. By contrast, during tissue inflammation, ROCK blockade profoundly decreased both interstitial and intralymphatic DC migration. Inhibition of intralymphatic migration was paralleled by a strong up-regulation of ICAM-1 in lymphatic endothelium, suggesting that during inflammation ROCK mediates de-adhesion of DC-expressed integrins from lymphatic-expressed ICAM-1. Flow chamber assays confirmed an involvement of lymphatic-expressed ICAM-1 and DC-expressed ROCK in DC crawling on lymphatic endothelium. Overall, our findings further define the role of ROCK in DC migration to dLNs and reveal a differential requirement for ROCK in intralymphatic DC crawling during steady-state and inflammation. (Blood. 2012;120(11):2249-2258)
C1 [Nitschke, Maximilian; Aebischer, David; Haener, Simone; Lucic, Matije; Vigl, Benjamin; Halin, Cornelia] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
   [Abadier, Michael; Lyck, Ruth] Univ Bern, Theodor Kocher Inst, Bern, Switzerland.
   [Luche, Herve; Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany.
   [Biehlmaier, Oliver] Biozentrum Univ Basel, Basel, Switzerland.
RP Halin, C (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Wolfgang Pauli St 10,HCI H413, CH-8093 Zurich, Switzerland.
EM cornelia.halin@pharma.ethz.ch
OI LUCHE, Herve/0000-0003-4309-8338; Halin, Cornelia/0000-0002-7899-2850;
   Lyck, Ruth/0000-0002-6479-4837; Biehlmaier, Oliver/0000-0003-0825-8500
FU Professor Dr Max Cloetta Foundation, ETH Zurich (TH-grant) [05 07-3];
   Novartis Foundation of Medical and Biologic Research (Switzerland)
FX The authors thank Carlos Ochoa (ETH Zurich) and Mark Liebi (Theodor
   Kocher Institute, Bern) for excellent technical assistance and Peter
   Horvath (Light Microscopy Center of ETH Zurich) for precious help with
   image analysis. C. H. gratefully acknowledges financial support from the
   Professor Dr Max Cloetta Foundation, ETH Zurich (TH-grant no. 05 07-3)
   and the Novartis Foundation of Medical and Biologic Research
   (Switzerland).
CR Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017
   Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643
   Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006
   Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596
   Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050
   Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159
   Berk DA, 1996, AM J PHYSIOL-HEART C, V270, pH330
   Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334
   Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562
   Dixon JB, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2135791
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015
   Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682
   Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722
   Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759
   Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435
   Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004
   KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632
   Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887
   Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139
   Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745
   Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X
   Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211
   Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543
   Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382
   Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889
   Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739
   Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619
   Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Saeki H, 1999, J IMMUNOL, V162, P2472
   Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107
   Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018
   Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606
   Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935
   Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732
   Swartz MA, 1996, AM J PHYSIOL-HEART C, V270, pH324
   Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885
   Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392
   Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC
   Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026
   Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025
   Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786
   Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447
   Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210
NR 46
TC 54
Z9 54
U1 0
U2 7
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD SEP 13
PY 2012
VL 120
IS 11
BP 2249
EP 2258
DI 10.1182/blood-2012-03-417923
PG 10
WC Hematology
SC Hematology
GA 009RZ
UT WOS:000309044200017
PM 22855606
DA 2021-01-25
ER

PT J
AU Harsman, A
   Niemann, M
   Pusnik, M
   Schmidt, O
   Burmann, BM
   Hiller, S
   Meisinger, C
   Schneider, A
   Wagner, R
AF Harsman, Anke
   Niemann, Moritz
   Pusnik, Mascha
   Schmidt, Oliver
   Burmann, Bjoern M.
   Hiller, Sebastian
   Meisinger, Chris
   Schneider, Andre
   Wagner, Richard
TI Bacterial Origin of a Mitochondrial Outer Membrane Protein Translocase
   NEW PERSPECTIVES FROM COMPARATIVE SINGLE CHANNEL ELECTROPHYSIOLOGY
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRYPANOSOMA-BRUCEI; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; FUNCTIONAL
   DOMAINS; BROWNIAN DYNAMICS; CONDUCTING PORE; OMP85 FAMILY; TOM40 FORMS;
   IMPORT; TRANSPORTER
AB Mitochondria are of bacterial ancestry and have to import most of their proteins from the cytosol. This process is mediated by Tom40, an essential protein that forms the protein-translocating pore in the outer mitochondrial membrane. Tom40 is conserved in virtually all eukaryotes, but its evolutionary origin is unclear because bacterial orthologues have not been identified so far. Recently, it was shown that the parasitic protozoon Trypanosoma brucei lacks a conventional Tom40 and instead employs the archaic translocase of the outer mitochondrial membrane (ATOM), a protein that shows similarities to both eukaryotic Tom40 and bacterial protein translocases of the Omp85 family. Here we present electrophysiological single channel data showing that ATOM forms a hydrophilic pore of large conductance and high open probability. Moreover, ATOM channels exhibit a preference for the passage of cationic molecules consistent with the idea that it may translocate unfolded proteins targeted by positively charged N-terminal presequences. This is further supported by the fact that the addition of a presequence peptide induces transient pore closure. An in-depth comparison of these single channel properties with those of other protein translocases reveals that ATOM closely resembles bacterial-type protein export channels rather than eukaryotic Tom40. Our results support the idea that ATOM represents an evolutionary intermediate between a bacterial Omp85-like protein export machinery and the conventional Tom40 that is found in mitochondria of other eukaryotes.
C1 [Wagner, Richard] Univ Osnabruck, Fachbereich Biol Chem, D-49076 Osnabruck, Germany.
   [Niemann, Moritz; Pusnik, Mascha; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
   [Schmidt, Oliver; Meisinger, Chris] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.
   [Schmidt, Oliver; Meisinger, Chris] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany.
   [Burmann, Bjoern M.; Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Wagner, R (corresponding author), Barbarastr 13, D-49076 Osnabruck, Germany.
EM wagner@uos.de
RI Burmann, Bjorn/AAR-7399-2020; Meisinger, Chris/J-1110-2014; Burmann,
   Bjorn/M-8913-2015; Hiller, Sebastian/B-3573-2008
OI Meisinger, Chris/0000-0002-8326-3548; Burmann,
   Bjorn/0000-0002-3135-7964; Hiller, Sebastian/0000-0002-6709-4684;
   Schmidt, Oliver/0000-0002-7921-4663
FU Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [WA681/2-1, FOR967, ME1921]; Swiss National Science Foundation
   (SNSF)Swiss National Science Foundation (SNSF) [31003A_13855,
   PP00P3_128419]; European Research Council FP7 ContractEuropean Research
   Council (ERC) [MOMP 281764]
FX This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant
   WA681/2-1 (to R. W.) and DFG Grant FOR967 (to R. W.), by DFG Grant
   ME1921 (to C. M.), by Swiss National Science Foundation (SNSF) Grant
   31003A_13855 (to A. S.) as well as by Swiss National Science Foundation
   grant PP00P3_128419 and European Research Council FP7 Contract MOMP
   281764 (to S. H.).
CR Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926
   Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019
   Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977
   Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831
   Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200
   Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531
   Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948
   Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860
   DARGENT B, 1986, EMBO J, V5, P773, DOI 10.1002/j.1460-2075.1986.tb04280.x
   Delcour AH, 2002, J MOL MICROB BIOTECH, V4, P1
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200
   Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884
   ENGEL A, 1985, NATURE, V317, P643, DOI 10.1038/317643a0
   Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200
   Flinner N, 2012, BIOL LETTERS, V8, P446, DOI 10.1098/rsbl.2011.1121
   Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610
   Harsman A, 2011, EUR J CELL BIOL, V90, P721, DOI 10.1016/j.ejcb.2011.04.012
   Harsman A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454102
   Hauser R, 1996, J CELL SCI, V109, P517
   Hausler T, 1997, EUR J CELL BIOL, V73, P240
   Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1
   Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019
   Hill K, 1998, NATURE, V395, P516
   HILLE B, 1992, IONIC CHANNELS EXCIT, P291
   Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8
   Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7
   Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731
   Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629
   Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032
   Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4
   Mahendran KR, 2012, BIOPHYS J, V102, P39, DOI 10.1016/j.bpj.2011.11.4003
   MAURO A, 1988, P NATL ACAD SCI USA, V85, P1071, DOI 10.1073/pnas.85.4.1071
   MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537
   Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200
   Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106
   PATLAK JB, 1993, BIOPHYS J, V65, P29, DOI 10.1016/S0006-3495(93)81041-5
   Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288
   Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060
   Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326
   Schleiff E, 2003, J CELL BIOL, V160, P541, DOI 10.1083/jcb.200210060
   Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261
   Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109
   Shah TD, 2011, MOL BIOCHEM PARASIT, V179, P100, DOI 10.1016/j.molbiopara.2011.07.001
   Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5
   Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004
   Zarsky V, 2012, CURR BIOL, V22, pR479, DOI 10.1016/j.cub.2012.03.057
NR 47
TC 26
Z9 26
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 7
PY 2012
VL 287
IS 37
BP 31437
EP 31445
DI 10.1074/jbc.M112.392118
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 006AK
UT WOS:000308791300054
PM 22778261
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Janssen, S
   Jayachandran, R
   Khathi, L
   Zinsstag, J
   Grobusch, MP
   Pieters, J
AF Janssen, Saskia
   Jayachandran, Rajesh
   Khathi, Lulama
   Zinsstag, Jakob
   Grobusch, Martin P.
   Pieters, Jean
TI Exploring prospects of novel drugs for tuberculosis
SO DRUG DESIGN DEVELOPMENT AND THERAPY
LA English
DT Review
DE tuberculosis; treatment; drug-resistance; drug targets
ID PROTEIN-KINASE-G; MULTIDRUG-RESISTANT TUBERCULOSIS; EARLY BACTERICIDAL
   ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; PATHOGENIC
   MYCOBACTERIA; INTRACELLULAR SURVIVAL; MACROPHAGES; TOLERABILITY;
   INHIBITION
AB Tuberculosis remains a disease with an enormous impact on public health worldwide. With the continuously increasing epidemic of drug-resistant tuberculosis, new drugs are desperately needed. However, even for the treatment of drug-sensitive tuberculosis, new drugs are required to shorten the treatment duration and thereby prevent development of drug resistance. Within the past ten years, major advances in tuberculosis drug research have been made, leading to a considerable number of antimycobacterial compounds which are now in the pipeline. Here we discuss a number of these novel promising tuberculosis drugs, as well as the discovery of two new potential drug targets for the development of novel effective drugs to curb the tuberculosis pandemic, ie, the coronin 1 and protein kinase G pathways. Protein kinase G is secreted by mycobacteria and is responsible for blocking lysosomal delivery within the macrophage. Coronin 1 is responsible for activating the phosphatase, calcineurin, and thereby preventing phagosome-lysosome fusion within the macrophage. Blocking these two pathways may lead to rapid killing of mycobacteria.
C1 [Jayachandran, Rajesh; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Janssen, Saskia; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Infect Dis,Ctr Trop Med & Travel Med, NL-1105 AZ Amsterdam, Netherlands.
   [Janssen, Saskia; Grobusch, Martin P.] Univ Tubingen, Inst Trop Med, D-72074 Tubingen, Germany.
   [Khathi, Lulama] Natl Hlth Lab Serv, Natl Reference Lab TB, Johannesburg, South Africa.
   [Zinsstag, Jakob] Univ Basel, Associated Inst, Swiss Trop & Publ Hlth Inst, CH-4056 Basel, Switzerland.
   [Grobusch, Martin P.] Univ Witwatersrand, Fac Hlth Sci, Div Internal Med, Dept Infect Dis, Johannesburg, South Africa.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Zinsstag, Jakob/A-8317-2008
OI Zinsstag, Jakob/0000-0002-8899-6097; Pieters, Jean/0000-0002-5284-9757
FU UBS Optimus Foundation, Basel, Switzerland; Cloetta Medical Research
   Fellowship program; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Kanton Basel-Stadt
FX JP, JZ, and MPG received funding from the UBS Optimus Foundation, Basel,
   Switzerland, for drug target identification in drug-resistant
   tuberculosis. RJ is a recipient of the Cloetta Medical Research
   Fellowship program. Work in the laboratory of JP is further supported by
   the Swiss National Science Foundation and the Kanton Basel-Stadt.
   Patents related to this work have been filed (WO2007110385A2 and
   WO2009112542A1) by the University of Basel.
CR Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Barry CE, 1997, BIOCHEM PHARMACOL, V54, P1165, DOI 10.1016/S0006-2952(97)00163-9
   Bentrup KHZ, 1999, J BACTERIOL, V181, P7161
   Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759
   Bock NN, 2002, AM J RESP CRIT CARE, V165, P1526, DOI 10.1164/rccm.200201-047OC
   BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B
   Chan J, 1996, P NATL ACAD SCI USA, V93, P14857, DOI 10.1073/pnas.93.25.14857
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8
   Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11
   Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616
   Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x
   Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6
   Grobusch MP, 2010, CURR OPIN PULM MED, V16, P180, DOI 10.1097/MCP.0b013e3283378680
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   Harth G, 2003, INFECT IMMUN, V71, P456, DOI 10.1128/IAI.71.1.456-464.2003
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981
   Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002
   Jain A, 1999, SURG CLIN N AM, V79, P59, DOI 10.1016/S0039-6109(05)70007-4
   JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1016/0378-1097(94)90267-4
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jia J, 2005, BRIT J PHARMACOL, V144, P80, DOI 10.1038/sj.bjp.0705984
   Jiang JR, 2011, RESPIROLOGY, V16, P308, DOI 10.1111/j.1440-1843.2010.01902.x
   John MA, 2007, EMERG INFECT DIS, V13, P795, DOI 10.3201/eid1305.060908
   Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605
   KARIM SSA, 2009, J GERONTOL B-PSYCHOL, V374, P921, DOI DOI 10.1016/S0140-6736(09)60916-8
   Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012
   Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811
   Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Migliori GB, 2009, EUR RESPIR J, V34, P387, DOI 10.1183/09031936.00009509
   Nathan C, 2006, SCIENCE, V312, P1874
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Nunn P, 2007, J INFECT DIS, V196, pS5, DOI 10.1086/518660
   Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4
   Reece ST, 2012, CURR OPIN MICROBIOL, V15, P63, DOI 10.1016/j.mib.2011.10.006
   Rovira P, 2000, CURR MED CHEM, V7, P673, DOI 10.2174/0929867003374778
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Russell DG, 1996, J IMMUNOL, V156, P4764
   Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128
   Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002
   Santhi N, 2011, BIOINFORMATION, V7, P1
   Schecter GF, 2010, CLIN INFECT DIS, V50, P49, DOI 10.1086/648675
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09
   Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71
   Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   *WHO, 2010, GLOB TUB CONTR REP
   World Health Organization, M XDR TB MULT EXT DR
   Zinsstag J, 2006, TROP MED INT HEALTH, V11, P565, DOI 10.1111/j.1365-3156.2006.01615.x
NR 68
TC 13
Z9 14
U1 1
U2 28
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1177-8881
J9 DRUG DES DEV THER
JI Drug Des. Dev. Ther.
PD SEP 7
PY 2012
VL 6
BP 217
EP 224
DI 10.2147/DDDT.S34006
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 000WJ
UT WOS:000308420700001
PM 22973091
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Barquilla, A
   Saldivia, M
   Diaz, R
   Bart, JM
   Vidal, I
   Calvo, E
   Hall, MN
   Navarro, M
AF Barquilla, Antonio
   Saldivia, Manuel
   Diaz, Rosario
   Bart, Jean-Mathieu
   Vidal, Isabel
   Calvo, Enrique
   Hall, Michael N.
   Navarro, Miguel
TI Third target of rapamycin complex negatively regulates development of
   quiescence in Trypanosoma brucei
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE parasitology; cell biology; kinetoplastida
ID MAJOR VAULT PROTEIN; BLOOD-STREAM; AFRICAN TRYPANOSOMES; SIGNALING
   PATHWAYS; CELL-GROWTH; DIFFERENTIATION; KINASE; MTOR; EXPRESSION; RAPTOR
AB African trypanosomes are protozoan parasites transmitted by a tsetse fly vector to a mammalian host. The life cycle includes highly proliferative forms and quiescent forms, the latter being adapted to host transmission. The signaling pathways controlling the developmental switch between the two forms remain unknown. Trypanosoma brucei contains two target of rapamycin (TOR) kinases, TbTOR1 and TbTOR2, and two TOR complexes, TbTORC1 and TbTORC2. Surprisingly, two additional TOR kinases are encoded in the T. brucei genome. We report that TbTOR4 associates with an Armadillo domain-containing protein (TbArmtor), a major vault protein, and LST8 to form a unique TOR complex, TbTORC4. Depletion of TbTOR4 caused irreversible differentiation of the parasite into the quiescent form. AMP and hydrolysable analogs of cAMP inhibited TbTOR4 expression and induced the stumpy quiescent form. Our results reveal unexpected complexity in TOR signaling and show that TbTORC4 negatively regulates differentiation of the proliferative form into the quiescent form.
C1 [Barquilla, Antonio; Saldivia, Manuel; Diaz, Rosario; Bart, Jean-Mathieu; Vidal, Isabel; Navarro, Miguel] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain.
   [Bart, Jean-Mathieu] Inst Hlth Carlos III, Ctr Nacl Med Trop, Madrid 28029, Spain.
   [Calvo, Enrique] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Navarro, M (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain.
EM miguel.navarro@ipb.csic.es
RI Navarro, Miguel/C-3685-2009; Bart, Jean-Mathieu/N-2598-2014
OI Navarro, Miguel/0000-0003-2301-2699; Bart,
   Jean-Mathieu/0000-0001-5707-3778; Saldivia, Manuel/0000-0001-6204-0460;
   Diaz Gonzalez, Rosario/0000-0002-3187-2704
FU Spanish Ministerio de Ciencia e InnovacionInstituto de Salud Carlos
   IIISpanish Government [SAF2009-07587]; Junta de AndaluciaJunta de
   Andalucia [CTS-5841]; Red de Investigacion de Centros de Enfermedades
   Tropicales (RICET) [RD06/0001/0010]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute [HHMI-55005525]; Miguel Servet
   Fellowship [CP09/00300]
FX We thank Keith Matthews for supplying anti-PAD antibodies; A. Estevez
   for the control antibodies anti-CSM and anti-RRP44; J. Bangs for
   anti-TbBiP; S. Reed for anti-TcP0; D. Gonzalez Pacanowska for
   anti-LmMVAK antibodies; and Sabine Hilfiker for discussions. This work
   was supported by Grant SAF2009-07587 from the Spanish Ministerio de
   Ciencia e Innovacion, Grant CTS-5841 from the Junta de Andalucia, Grant
   RD06/0001/0010 from Red de Investigacion de Centros de Enfermedades
   Tropicales (RICET) and Howard Hughes Medical Institute Grant
   HHMI-55005525. J.-M.B. is supported by Miguel Servet Fellowship
   CP09/00300. M.N.H. acknowledges the Swiss National Science Foundation.
CR Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z
   Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z
   da Silva LM, 2010, P NATL ACAD SCI USA, V107, P11965, DOI 10.1073/pnas.1004599107
   Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997
   Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404
   Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831
   Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014
   Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200
   Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119
   Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103
   de Jesus TCL, 2010, J BIOL CHEM, V285, P24131, DOI 10.1074/jbc.M110.120212
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06
   Matthews KR, 1997, J CELL SCI, V110, P2609
   Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093
   Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a
   Nolan DP, 2000, EUR J BIOCHEM, V267, P18, DOI 10.1046/j.1432-1327.2000.00935.x
   Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042
   TURNER CMR, 1995, PARASITOLOGY, V111, P289, DOI 10.1017/S0031182000081841
   Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009
   Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6
   Vassella E, 1997, J CELL SCI, V110, P2661
   Vassella E, 2001, MOL MICROBIOL, V41, P33, DOI 10.1046/j.1365-2958.2001.02471.x
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
NR 31
TC 50
Z9 50
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 4
PY 2012
VL 109
IS 36
BP 14399
EP 14404
DI 10.1073/pnas.1210465109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 007TZ
UT WOS:000308912600029
PM 22908264
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Jayachandran, R
   Scherr, N
   Pieters, J
AF Jayachandran, Rajesh
   Scherr, Nicole
   Pieters, Jean
TI Elimination of intracellularly residing Mycobacterium tuberculosis
   through targeting of host and bacterial signaling mechanisms
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE inhibitory compounds; intramacrophage survival; Mycobacterium
   tuberculosis; signaling mechanisms; virulence factors
ID PROTEIN-KINASE-G; TYROSINE-PHOSPHATASE PTPA; SODIUM-CHANNEL NAV1.5;
   IFN-GAMMA; PHAGOSOME MATURATION; HUMAN NEUTROPHILS; IMMUNE-RESPONSES;
   VIRULENCE FACTOR; WD-REPEAT; IN-VIVO
AB With more than 2 billion latently infected people, TB continues to represent a serious threat to human health. According to the WHO, 1.1 million people died from TB in 2010, which is equal to approximately 3000 deaths per day. The causative agent of the disease, Mycobacterium tuberculosis, is a highly successful pathogen having evolved remarkable strategies to persist within the host. Although normally, upon phagocytosis by macrophages, bacteria are readily eliminated by lysosomes, pathogenic mycobacteria actively prevent destruction within macrophages. The strategies that pathogenic mycobacteria apply range from releasing virulence factors to manipulating host molecules resulting in the modulation of host signal transduction pathways in order to sustain their viability within the infected host. Here, we analyze the current status of how a better understanding of both the bacterial and host factors involved in virulence can be used to develop drugs that may be helpful to curb the TB epidemic.
C1 [Jayachandran, Rajesh; Scherr, Nicole; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Scherr, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Max Cloetta Foundation; Kanton Basel-Stadt; Optimus Foundation; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX Work in the authors laboratories is supported by the Max Cloetta
   Foundation, the Kanton Basel-Stadt, the Optimus Foundation and the Swiss
   National Science Foundation. Patents related to this work have been
   filed (WO2007110385A2 and WO2009112542A1) by the University of Basel.
   The authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123
   Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009
   ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727
   Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008
   Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478
   Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011
   Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7
   Beresford N, 2007, BIOCHEM J, V406, P13, DOI 10.1042/BJ20070670
   Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031
   Bermudez LE, 1999, CLIN EXP IMMUNOL, V116, P94
   Bermudez LE, 1999, INFECT IMMUN, V67, P4912, DOI 10.1128/IAI.67.9.4912-4916.1999
   Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552
   Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159
   Bitter W, 2009, TRENDS MICROBIOL, V17, P337, DOI 10.1016/j.tim.2009.05.007
   Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x
   Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006
   Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x
   Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007
   Carrithers LM, 2011, FEMS IMMUNOL MED MIC, V63, P319, DOI 10.1111/j.1574-695X.2011.00853.x
   Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822
   Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200
   Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
   Cerda-Maira F, 2009, MICROBES INFECT, V11, P1150, DOI 10.1016/j.micinf.2009.08.003
   Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x
   Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894
   Chapman TM, 2012, BIOORG MED CHEM LETT, V22, P3349, DOI 10.1016/j.bmcl.2012.02.107
   Cheng Y, 2010, J MOL CELL BIOL, V2, P173, DOI 10.1093/jmcb/mjp053
   Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062
   Chopra P, 2003, BIOCHEM BIOPH RES CO, V311, P112, DOI 10.1016/j.bbrc.2003.09.173
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703
   Corleis B, 2012, CELL MICROBIOL, V14, P1109, DOI 10.1111/j.1462-5822.2012.01783.x
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cougoule C, 2002, INFECT IMMUN, V70, P1591, DOI 10.1128/IAI.70.3.1591-1598.2002
   Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657
   Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0
   de Jong R, 1998, SCIENCE, V280, P1435
   Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221
   Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561
   Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI 10.2217/FMB.10.112
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2000, PROTOPLASMA, V210, P99, DOI 10.1007/BF01276849
   Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525
   Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x
   GILLY M, 1992, J IMMUNOL, V148, P3275
   Greenstein AE, 2007, J BIOL CHEM, V282, P11427, DOI 10.1074/jbc.M610193200
   Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x
   Grundner C, 2007, STRUCTURE, V15, P499, DOI 10.1016/j.str.2007.03.003
   Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834
   Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305
   Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Henderson RA, 1997, J IMMUNOL, V159, P635
   Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963
   Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07
   Hoppe HC, 1997, INFECT IMMUN, V65, P3896, DOI 10.1128/IAI.65.9.3896-3905.1997
   Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x
   Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100
   Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596
   Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x
   Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839
   Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294
   Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701
   Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7
   Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091
   Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105
   Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131
   Khanna KV, 1996, J LEUKOCYTE BIOL, V60, P214
   Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711
   Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310
   Koch MA, 2005, DRUG DISCOV TODAY, V10, P471, DOI 10.1016/S1359-6446(05)03419-7
   Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000
   Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012
   Kumar D, 2012, INFECT GENET EVOL, V12, P737, DOI 10.1016/j.meegid.2011.09.008
   Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200
   Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06
   Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000
   Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005
   Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Lougheed KEA, 2011, TUBERCULOSIS, V91, P277, DOI 10.1016/j.tube.2011.03.005
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Malhotra V, 2010, MICROBIOL-SGM, V156, P2829, DOI 10.1099/mic.0.040675-0
   Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287
   Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811
   Marjanovic O, 2010, TUBERCULOSIS, V90, P50, DOI 10.1016/j.tube.2009.10.004
   Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619
   Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097
   Mascarello A, 2010, BIOORGAN MED CHEM, V18, P3783, DOI 10.1016/j.bmc.2010.04.051
   Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182
   Molle V, 2008, BIOCHEM J, V410, P309, DOI 10.1042/BJ20071384
   Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252
   Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010
   NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Nguyen L, 2007, J BACTERIOL, V189, P7896, DOI 10.1128/JB.00726-07
   Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103
   Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006
   Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005
   Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031
   Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885
   Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959
   Persson A, 2009, MICROB PATHOGENESIS, V47, P143, DOI 10.1016/j.micpath.2009.05.006
   PETERSON PK, 1995, INFECT IMMUN, V63, P1598, DOI 10.1128/IAI.63.4.1598-1602.1995
   Petrofsky M, 1999, CLIN IMMUNOL, V91, P354, DOI 10.1006/clim.1999.4709
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105
   Pieters J, 2003, MICROBIAL SUBVERSION
   PIETERS J, 2008, HDB TUBERCULOSIS MOL
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016
   Rawls KA, 2009, BIOORG MED CHEM LETT, V19, P6851, DOI 10.1016/j.bmcl.2009.10.090
   ROECKLEIN JA, 1992, J LAB CLIN MED, V119, P772
   Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521
   Saikolappan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036198
   Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Sangari FJ, 1999, INFECT IMMUN, V67, P5069, DOI 10.1128/IAI.67.10.5069-5075.1999
   Santhi N, 2011, BIOINFORMATION, V7, P1
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09
   SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920
   Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846
   Seiler P, 2000, J INFECT DIS, V181, P671, DOI 10.1086/315278
   Senaratne RH, 2008, J MED MICROBIOL, V57, P164, DOI 10.1099/jmm.0.47454-0
   Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x
   Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498
   Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100
   Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004
   Smith CV, 2004, TUBERCULOSIS, V84, P45, DOI 10.1016/j.tube.2003.08.019
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   Soellner MB, 2007, J AM CHEM SOC, V129, P9613, DOI 10.1021/ja0727520
   SORACE JM, 1995, J LEUKOCYTE BIOL, V58, P477
   Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11
   Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Szekely R, 2008, IMMUNOL LETT, V116, P225, DOI 10.1016/j.imlet.2007.12.005
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234
   Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200
   Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095
   Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3
   Vankayalapati R, 2005, J IMMUNOL, V175, P4611, DOI 10.4049/jimmunol.175.7.4611
   Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189
   Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200
   Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200
   Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
   Warner DF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002785
   Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996
   WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982
   Wehenkel A, 2006, FEBS LETT, V580, P3018, DOI 10.1016/j.febslet.2006.04.046
   Wiener C, 2012, HARRISONS PRINCIPLES
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
   Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108
   Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13
   Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271
NR 190
TC 11
Z9 11
U1 0
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD SEP
PY 2012
VL 10
IS 9
BP 1007
EP 1022
DI 10.1586/ERI.12.95
PG 16
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 047YW
UT WOS:000311878400011
PM 23106276
DA 2021-01-25
ER

PT J
AU Franz, B
   Lu, YY
   Truttmann, M
   Riess, T
   Faustmann, M
   Kempf, VAJ
   Dehio, C
AF Franz, B.
   Lu, Y. -Y.
   Truttmann, M.
   Riess, T.
   Faustmann, M.
   Kempf, V. A. J.
   Dehio, C.
TI Bartonella henselae adhesin BadA expression interferes with effector
   translocation by the VirB/D4 type IV secretion system
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Meeting Abstract
CT 64th Annual Meeting of the German-Society-for-Hygiene-and-Microbiology
   (DGHM)
CY SEP 30-OCT 03, 2012
CL Hamburg, GERMANY
SP German Soc Hyg & Microbiol (DGHM)
C1 [Franz, B.; Riess, T.; Kempf, V. A. J.] Klinikum Johann Wolfgang Goethe Univ Frankfort On, Inst Med Mikrobiol & Krankenhaushyg, Frankfort On The Main, Germany.
   [Lu, Y. -Y.; Truttmann, M.; Faustmann, M.; Dehio, C.] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4221
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD SEP
PY 2012
VL 302
SU 1
BP 67
EP 67
PG 1
WC Microbiology; Virology
SC Microbiology; Virology
GA 044BB
UT WOS:000311593300237
DA 2021-01-25
ER

PT J
AU Meinen, S
   Lin, S
   Ruegg, MA
   Punga, AR
AF Meinen, S.
   Lin, S.
   Ruegg, M. A.
   Punga, A. R.
TI Dissociation of sarcolemmal nNOS: a novel fatigue mechanism in MG
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Meeting Abstract
CT 16th Congress of the European-Federation-of-Neurological-Societies
   (EFNS)
CY SEP 08-11, 2012
CL Stockholm, SWEDEN
SP European Federat Neurol Soc (EFNS)
C1 [Meinen, S.; Lin, S.; Ruegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Punga, A. R.] Uppsala Univ, Uppsala, Sweden.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD SEP
PY 2012
VL 19
SU 1
SI SI
BP 847
EP 847
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 014FD
UT WOS:000309359705305
DA 2021-01-25
ER

PT J
AU Domingues, T
   Mattei, B
   Seelig, J
   Perez, KR
   Riske, KA
   Miranda, A
AF Domingues, T.
   Mattei, B.
   Seelig, J.
   Perez, K. R.
   Riske, K. A.
   Miranda, A.
TI Interaction of the antimicrobial peptide gomesin with model membranes
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Meeting Abstract
C1 [Domingues, T.; Mattei, B.; Perez, K. R.; Riske, K. A.; Miranda, A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil.
   [Seelig, J.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
CR Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a
   Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396
   Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200
NR 3
TC 0
Z9 0
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
J9 J PEPT SCI
JI J. Pept. Sci.
PD SEP
PY 2012
VL 18
SU 1
BP S63
EP S63
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 996MC
UT WOS:000308091500125
DA 2021-01-25
ER

PT J
AU Nisius, L
   Grzesiek, S
AF Nisius, Lydia
   Grzesiek, Stephan
TI Key stabilizing elements of protein structure identified through
   pressure and temperature perturbation of its hydrogen bond network
SO NATURE CHEMISTRY
LA English
DT Article
ID SCALAR COUPLINGS; HYDROPHOBIC INTERACTIONS; CHEMICAL-SHIFTS; UBIQUITIN;
   DENATURATION; NMR; BINDING; DEPENDENCE; DOMAIN; SPECTROSCOPY
AB Hydrogen bonds are key constituents of biomolecular structures, and their response to external perturbations may reveal important insights about the most stable components of a structure. NMR spectroscopy can probe hydrogen bond deformations at very high resolution through hydrogen bond scalar couplings (HBCs). However, the small size of HBCs has so far prevented a comprehensive quantitative characterization of protein hydrogen bonds as a function of the basic thermodynamic parameters of pressure and temperature. Using a newly developed pressure cell, we have now mapped pressure-and temperature-dependent changes of 31 hydrogen bonds in ubiquitin by measuring HBCs with very high precision. Short-range hydrogen bonds are only moderately perturbed, but many hydrogen bonds with large sequence separations (high contact order) show greater changes. In contrast, other high-contact-order hydrogen bonds remain virtually unaffected. The specific stabilization of such topologically important connections may present a general principle with which to achieve protein stability and to preserve structural integrity during protein function.
C1 [Nisius, Lydia; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-132857]; Boehringer Ingelheim FondsBoehringer Ingelheim
FX The authors acknowledge H.-R. Kalbitzer for introducing them to
   high-pressure NMR technology and R. Peterson (Daedalus Innovations) for
   many helpful discussions. This work was supported by SNF grant 31-132857
   (to S. G.) and a stipend from the Boehringer Ingelheim Fonds (to L.N.).
   This article is dedicated to Anna and Joachim Seelig, celebrating their
   40 years of science and life at the Biozentrum Basel.
CR Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Day R, 2008, PROTEINS, V70, P1175, DOI 10.1002/prot.21562
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Desiraju GR, 2011, ANGEW CHEM INT EDIT, V50, P52, DOI 10.1002/anie.201002960
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Grigera JR, 2010, BIOPHYS J, V98, P1626, DOI 10.1016/j.bpj.2009.12.4298
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   HAWLEY SA, 1971, BIOCHEMISTRY-US, V10, P2436, DOI 10.1021/bi00789a002
   Herberhold H, 2002, BIOCHEMISTRY-US, V41, P2396, DOI 10.1021/bi012023b
   Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701
   Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552
   Inoue K, 2000, NAT STRUCT BIOL, V7, P547
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Kalbitzer HR, 2000, PROTEIN SCI, V9, P693
   Kang YK, 2000, J PHYS CHEM B, V104, P8321, DOI 10.1021/jp000772h
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   KAUZMANN W, 1987, NATURE, V325, P763, DOI 10.1038/325763a0
   Kawahara S, 2003, HELV CHIM ACTA, V86, P3265, DOI 10.1002/hlca.200390267
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010
   Kitahara R, 2005, J MOL BIOL, V347, P277, DOI 10.1016/j.jmb.2005.01.052
   Kitahara R, 2003, P NATL ACAD SCI USA, V100, P3167, DOI 10.1073/pnas.0630309100
   Kitahara R, 2002, J MOL BIOL, V320, P311, DOI 10.1016/S0022-2836(02)00449-7
   Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092
   Li H, 2000, J BIOMOL NMR, V18, P207, DOI 10.1023/A:1026537609584
   MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978
   Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318
   PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3
   Quinlan RJ, 2005, ANAL BIOCHEM, V341, P69, DOI 10.1016/j.ab.2005.03.002
   Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649
   Sass HJ, 2007, J AM CHEM SOC, V129, P5898, DOI 10.1021/ja068336h
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   Sheppard D, 2010, J AM CHEM SOC, V132, P7709, DOI 10.1021/ja101691s
   Smeller L, 2002, BBA-PROTEIN STRUCT M, V1595, P11, DOI 10.1016/S0167-4838(01)00332-6
   TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009
   VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6
   Wilkens SJ, 2002, J AM CHEM SOC, V124, P1190, DOI 10.1021/ja017169c
   Wilton DJ, 2008, PROTEINS, V71, P1432, DOI 10.1002/prot.21832
NR 50
TC 62
Z9 65
U1 0
U2 49
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1755-4330
J9 NAT CHEM
JI Nat. Chem.
PD SEP
PY 2012
VL 4
IS 9
BP 711
EP 717
DI 10.1038/NCHEM.1396
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 998CG
UT WOS:000308214200008
PM 22914191
DA 2021-01-25
ER

PT J
AU Bhattacharjee, M
   Miot, S
   Gorecka, A
   Singha, K
   Loparic, M
   Dickinson, S
   Das, A
   Bhavesh, NS
   Ray, AR
   Martin, I
   Ghosh, S
AF Bhattacharjee, Maumita
   Miot, Sylvie
   Gorecka, Agata
   Singha, Kunal
   Loparic, Marko
   Dickinson, Sally
   Das, Anup
   Bhavesh, Neel Sarovar
   Ray, Alok R.
   Martin, Ivan
   Ghosh, Sourabh
TI Oriented lamellar silk fibrous scaffolds to drive cartilage matrix
   orientation: Towards annulus fibrosus tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomimetic material; Intervertebral disc tissue engineering; Silk;
   Extracellular matrix; Fibrous scaffold
ID CHONDROITIN SULFATE; INTERVERTEBRAL-DISK; ARTICULAR-CARTILAGE; IN-VITRO;
   DIFFERENTIATION; ELECTROSPUN; COLLAGEN; PROTEOGLYCANS; POPULATIONS;
   DAMAGE
AB A novel design of silk-based scaffold is developed using a custom-made winding machine, with fiber alignment resembling the anatomical criss-cross lamellar fibrous orientation features of the annulus fibrosus of the intervertebral disc. Crosslinking of silk fibroin fibers with chondroitin sulphate (CS) was introduced to impart superior biological functionality. The scaffolds, with or without CS, instructed alignment of expanded human chondrocytes and of the deposited extracellular matrix while supporting their chondrogenic redifferentiation. The presence of CS crosslinking could not induce statistically significant changes in the measured collagen or glycosaminoglycan content, but resulted in an increased construct stiffness. By offering the combined effect of cell/matrix alignment and chondrogenic support, the silk fibroin scaffolds developed with precise fiber orientation in lamellar form represent a suitable substrate for tissue engineering of the annulus fibrosus part of the intervertebral disc. Crown Copyright (C) 2012 Published by Elsevier Ltd. on behalf of Acta Materialia Inc. All rights reserved.
C1 [Miot, Sylvie; Gorecka, Agata; Martin, Ivan] Univ Basel Hosp, Dept Surg, Basel, Switzerland.
   [Miot, Sylvie; Gorecka, Agata; Martin, Ivan] Univ Basel Hosp, Dept Biomed, Basel, Switzerland.
   [Bhattacharjee, Maumita; Singha, Kunal; Das, Anup; Ghosh, Sourabh] Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
   [Loparic, Marko] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Loparic, Marko] Univ Basel, Swiss Nanosci Inst, CH-4003 Basel, Switzerland.
   [Dickinson, Sally] Univ Bristol, Sch Med Sci, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.
   [Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India.
   [Bhattacharjee, Maumita; Ray, Alok R.] IIT Delhi, Ctr Biomed Engn, New Delhi, India.
   [Bhattacharjee, Maumita; Ray, Alok R.] All India Inst Med Sci, New Delhi, India.
RP Martin, I (corresponding author), Univ Basel Hosp, Dept Surg, Basel, Switzerland.
EM sghosh08@textile.iitd.ac.in
RI Bhavesh, Neel Sarovar/F-3127-2015; Ray, Alok/A-7791-2011; Martin,
   Ivan/K-9286-2016; ray, alok/N-9901-2019
OI Bhavesh, Neel Sarovar/0000-0002-7248-4978; Ray,
   Alok/0000-0002-2223-222X; Martin, Ivan/0000-0001-6493-0432
FU Indo-Swiss Joint Research Programme [ISJRP 123 003]; Indian Council of
   Medical Research project [09/NCD-1]; Department of Biotechnology,
   Government of IndiaDepartment of Biotechnology (DBT) India
FX This work was supported by the Indo-Swiss Joint Research Programme
   (ISJRP 123 003) and Indian Council of Medical Research project
   (09/NCD-1). We thank Department of Biotechnology, Government of India,
   for providing financial support for the 500 MHz and 700 MHz NMR
   spectrometers at the ICGEB, New Delhi and NIL New Delhi.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950
   Barbero A, 2006, J CELL BIOCHEM, V98, P1140, DOI 10.1002/jcb.20754
   BERNICK S, 1991, SPINE, V16, P520, DOI 10.1097/00007632-199105000-00006
   Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chou AI, 2008, TISSUE ENG PT A, V14, P2079, DOI 10.1089/ten.tea.2007.0337
   COVENTRY MB, 1945, J BONE JOINT SURG, V27, P105
   Fernandez C, 2003, CURR OPIN STRUC BIOL, V13, P570, DOI 10.1016/j.sbi.2003.09.009
   Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941
   Green T P, 1993, Eur Spine J, V2, P209, DOI 10.1007/BF00299448
   Guerin HL, 2007, J ORTHOP RES, V25, P508, DOI 10.1002/jor.20324
   Happey F, 1976, LUMBAR SPINE BACKACH, V3, P293
   Hayes AJ, 2011, EUR CELLS MATER, V21, P1
   Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Huber A, 2007, EUR CELLS MATER, V14, P56, DOI 10.22203/eCM.v014a06
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Iatridis JC, 2005, J BIOMECH, V38, P557, DOI 10.1016/j.jbiomech.2004.03.038
   INEROT S, 1991, CONNECT TISSUE RES, V26, P47, DOI 10.3109/03008209109152163
   Johnson WE, 2006, EUR SPINE J, V15, pS389, DOI 10.1007/s00586-006-0125-9
   Kafienah W, 2003, METH MOL B, V238, P217
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.209.08.005, 10.1016/j.lfs.2009.08.005]
   Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216
   Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013
   Nerurkar NL, 2011, ACTA BIOMATER, V7, P485, DOI 10.1016/j.actbio.2010.08.011
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Park SH, 2012, TISSUE ENG PT A, V18, P447, DOI [10.1089/ten.tea.2011.0195, 10.1089/ten.TEA.2011.0195]
   Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011
   Reyes JMG, 2005, INVEST OPHTH VIS SCI, V46, P1247, DOI 10.1167/iovs.04-1192
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   ROVETTA G, 1991, DRUG EXP CLIN RES, V17, P53
   RUFAI A, 1995, ANAT EMBRYOL, V192, P53
   Sato M, 2003, J BIOMED MATER RES A, V64A, P249, DOI 10.1002/jbm.a.10287
   Schroeder Y, 2008, J ORTHOP RES, V26, P1141, DOI 10.1002/jor.20632
   SCOTT JE, 1986, BIOSCIENCE REP, V6, P879, DOI 10.1007/BF01116241
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/jbm.a.31030
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   Wilda H, 2006, BIOMATERIALS, V27, P5220, DOI 10.1016/j.biomaterials.2006.06.008
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
NR 49
TC 54
Z9 57
U1 0
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2012
VL 8
IS 9
BP 3313
EP 3325
DI 10.1016/j.actbio.2012.05.023
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 990JD
UT WOS:000307625900013
PM 22641105
DA 2021-01-25
ER

PT J
AU Leasi, F
   Neves, RC
   Worsaae, K
   Sorensen, MV
AF Leasi, Francesca
   Neves, Ricardo Cardoso
   Worsaae, Katrine
   Sorensen, Martin Vinther
TI Musculature of Seison nebaliae Grube, 1861 and Paraseison annulatus
   (Claus, 1876) revealed with CLSM: a comparative study of the gnathiferan
   key taxon Seisonacea (Rotifera)
SO ZOOMORPHOLOGY
LA English
DT Article
DE Comparative morphology; Ecological adaptation; Functional morphology;
   Gnathifera; Muscular ground pattern; Seisonidae
ID FUNCTIONAL-MORPHOLOGY; MUSCLES; ORGANIZATION; ULTRASTRUCTURE;
   MONOGONONTA; HEXARTHRA; EVOLUTION; TROPHI; PLOIMA; GENE
AB The somatic muscular systems of two species of Seisonacea (Rotifera), Seison nebaliae and Paraseison annulatus, are described using fluorescently labelled phalloidin in combination with confocal laser scanning microscopy. Their overall muscular arrangement is similar and consists of segmentally organised longitudinal fibres that extend the length of the body and are surrounded by semi-circular (= incomplete) bands. However, differences in the musculature between the two species are present and possibly reflect specific adaptations in feeding strategy and locomotion related to the occupation of individual niches on their host, the leptostracan crustacean N. bipes. For example, S. nebaliae has semi-circular muscles in the head region only, while P. annulatus possesses incomplete circular muscles also in the trunk region; furthermore, there are also differences in the arrangements and number of longitudinal muscles. The muscular systems of all rotifer species examined so far are compared in order to establish the ground pattern of the last putative ancestor as well as to seek for traits of systematic importance. Results from both species corroborate earlier hypotheses on the arrangement of muscles in the putative common ancestor of Rotifera, which suggested an orthogonal arrangement consisting of a series of probably continuous (not segmental) inner longitudinal muscles, surrounded by semi-circular fibres, ventrally opened. However, significant morphological and ecological variations among taxa investigated so far show that a consistent correlation between muscular traits and specific ecological features and/or phylogeny is still far from being clear. Hence, musculature of additional taxa, representing the systematic width and occupying a diverse range of habitats, should be investigated.
C1 [Leasi, Francesca] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SL5 7PY, England.
   [Leasi, Francesca] Drexel Univ, Acad Nat Sci, Philadelphia, PA 19104 USA.
   [Neves, Ricardo Cardoso] Univ Basel, Biozentrum, Basel, Switzerland.
   [Neves, Ricardo Cardoso; Sorensen, Martin Vinther] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.
   [Worsaae, Katrine] Univ Copenhagen, Dept Biol, Marine Biol Sect, Copenhagen, Denmark.
RP Leasi, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, London SL5 7PY, England.
EM francesca.leasi@gmail.com
RI Worsaae, Katrine/L-8739-2014; Leasi, Francesca/E-4361-2017; Sorensen,
   Martin V/A-8852-2013; Neves, Ricardo Cardoso/J-9822-2014
OI Worsaae, Katrine/0000-0003-0443-4298; Leasi,
   Francesca/0000-0001-6995-0934; Sorensen, Martin V/0000-0002-0377-0276;
   Neves, Ricardo Cardoso/0000-0002-9219-9066
FU EUEuropean Union (EU) [227799]; Encyclopedia of Life; Systematics
   Association; Accademia Nazionale dei Lincei (Royal Society)
FX We are grateful to Gilles Maron and Andreas Hejnol for their crucial
   help during field collection. Significant and improving comments on an
   early version of the manuscript by A. Hejnol and Diego Fontaneto were
   very much appreciated. The authors would like to thank Birgen H. Rothe,
   other two anonymous reviewers and the editor Thomas Bartolomaeus for
   their valuable comments and suggestions to improve the quality of the
   paper. Funding to support the collection in Roscoff was provided by EU
   programme ASSEMBLE-grant agreement no. 227799, while Encyclopedia of
   Life (Rubenstein Fellow 2011), Systematics Association (Systematics
   Research Fund 2011) and Accademia Nazionale dei Lincei (Royal Society
   Fellowship 2011) supported FL for her research.
CR Ahlrichs WH, 1997, ZOOMORPHOLOGY, V117, P41, DOI 10.1007/s004350050028
   Ahlrichs WH, 1998, ZOOMORPHOLOGY, V118, P255, DOI 10.1007/s004350050074
   Ahlrichs WH, 1995, ULTRASTRUKTUR PHYLOG
   AHLRICHS WH, 1995, VERHANDLUNGEN DTSCH, V88, P155
   Fontaneto D, 2011, ZOOL ANZ, V250, P80, DOI 10.1016/j.jcz.2010.11.005
   Fussmann GF, 2011, HYDROBIOLOGIA, V662, P11, DOI 10.1007/s10750-010-0515-1
   Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010
   Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/PL00006088
   Hochberg R, 2000, HYDROBIOLOGIA, V432, P57, DOI 10.1023/A:1004003509017
   Hochberg R, 2001, HYDROBIOLOGIA, V452, P155, DOI 10.1023/A:1011940430507
   Hochberg R, 2008, ZOOL ANZ, V247, P233, DOI 10.1016/j.jcz.2008.01.002
   Hochberg R, 2007, ZOOL ANZ, V246, P11, DOI 10.1016/j.jcz.2006.10.002
   Hochberg R, 2010, INVERTEBR BIOL, V129, P210, DOI 10.1111/j.1744-7410.2010.00202.x
   Hochberg R, 2010, ZOOMORPHOLOGY, V129, P153, DOI 10.1007/s00435-010-0108-6
   Hyman LH, 1951, PSEUDOCOELOMATE BILA, V3
   Illgen Horst., 1916, Zoologischer Anzeiger Leipzig, V47
   Kajihara H, 2001, HYDROBIOLOGIA, V456, P187, DOI 10.1023/A:1013047207243
   Koste W., 1975, MIKROKOSMOS, V64, P341
   Kotikova EA, 2006, J EVOL BIOCHEM PHYS+, V42, P89, DOI 10.1134/S0022093006010121
   Kotikova EA, 2004, TISSUE CELL, V36, P189, DOI 10.1016/j.tice.2004.01.005
   Kotikova EA, 2001, ACTA ZOOL-STOCKHOLM, V82, P1, DOI 10.1046/j.1463-6395.2001.00060.x
   Leasi F, 2010, J ZOOL, V282, P109, DOI 10.1111/j.1469-7998.2010.00721.x
   Leasi F, 2012, J MAR BIOL ASSOC UK, V92, P959, DOI 10.1017/S0025315411000129
   Leasi F, 2010, J ZOOL SYST EVOL RES, V48, P33, DOI 10.1111/j.1439-0469.2009.00538.x
   Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4
   Miller D.M., 1985, P73
   Remane A., 1929, P1
   RICCI C, 1993, HYDROBIOLOGIA, V255, P495, DOI 10.1007/BF00025879
   Ricci C, 2009, ITAL J ZOOL, V76, P240, DOI 10.1080/11250000902773484
   Riemann O, 2008, ZOOL ANZ, V247, P133, DOI 10.1016/j.jcz.2007.09.004
   Santo N, 2005, HYDROBIOLOGIA, V546, P223, DOI 10.1007/s10750-005-4200-8
   Segers H, 1998, J ZOOL, V244, P201, DOI 10.1111/j.1469-7998.1998.tb00025.x
   Segers H, 2012, ZOOTAXA, P61
   Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001
   Sorensen MV, 2005, HYDROBIOLOGIA, V546, P231, DOI 10.1007/s10750-005-4202-6
   Sorensen MV, 2005, ZOOMORPHOLOGY, V124, P47, DOI 10.1007/s00435-005-0110-6
   Sorensen MV, 2005, ZOOL STUD, V44, P34
   Sorensen MV, 2003, INVERTEBR BIOL, V122, P223
   Sorensen MV, 2002, J ZOOL SYST EVOL RES, V40, P129, DOI 10.1046/j.1439-0469.2002.00188.x
   Welch DBM, 2000, INVERTEBR BIOL, V119, P17
   Wilts EF, 2009, ZOOL ANZ, V248, P161, DOI 10.1016/j.jcz.2009.08.001
   Zrzavy J, 2001, FOLIA PARASIT, V48, P81, DOI 10.14411/fp.2001.013
NR 42
TC 11
Z9 11
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0720-213X
EI 1432-234X
J9 ZOOMORPHOLOGY
JI Zoomorphology
PD SEP
PY 2012
VL 131
IS 3
BP 185
EP 195
DI 10.1007/s00435-012-0155-2
PG 11
WC Anatomy & Morphology; Zoology
SC Anatomy & Morphology; Zoology
GA 990NB
UT WOS:000307636600001
DA 2021-01-25
ER

PT J
AU Nickerson, NN
   Abby, SS
   Rocha, EPC
   Chami, M
   Pugsley, AP
AF Nickerson, Nicholas N.
   Abby, Sophie S.
   Rocha, Eduardo P. C.
   Chami, Mohamed
   Pugsley, Anthony P.
TI A Single Amino Acid Substitution Changes the Self-Assembly Status of a
   Type IV Piliation Secretin
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; FILAMENTOUS PHAGE; PILUS
   SECRETIN; NEISSERIA-MENINGITIDIS; CELL-ENVELOPE; PULD; LOCALIZATION;
   LIPOPROTEIN; MULTIMERIZATION
AB Secretins form large multimeric complexes in the outer membranes of many Gram-negative bacteria, where they function as dedicated gateways that allow proteins to access the extracellular environment. Despite their overall relatedness, different secretins use different specific and general mechanisms for their targeting, assembly, and membrane insertion. We report that all tested secretins from several type II secretion systems and from the filamentous bacteriophage f1 can spontaneously multimerize and insert into liposomes in an in vitro transcription-translation system. Phylogenetic analyses indicate that these secretins form a group distinct from the secretins of the type IV piliation and type III secretion systems, which do not autoassemble in vitro. A mutation causing a proline-to-leucine substitution allowed PilQ secretins from two different type IV piliation systems to assemble in vitro, albeit with very low efficiency, suggesting that autoassembly is an inherent property of all secretins.
C1 [Nickerson, Nicholas N.; Pugsley, Anthony P.] Inst Pasteur, Dept Microbiol, Mol Genet Unit, Paris, France.
   [Nickerson, Nicholas N.; Pugsley, Anthony P.] CNRS, ERA3526, Paris, France.
   [Abby, Sophie S.; Rocha, Eduardo P. C.] Inst Pasteur, Microbial Evolutionary Gen,Genomes & Genet Dept, Paris, France.
   [Abby, Sophie S.; Rocha, Eduardo P. C.] CNRS, UMR3525, Paris, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, Dept Microbiol, Mol Genet Unit, Paris, France.
EM max@pasteur.fr
RI Rocha, Eduardo/B-7009-2009; Abby, Sophie S/H-4817-2011
OI Rocha, Eduardo/0000-0001-7704-822X; Abby, Sophie S/0000-0002-5231-3346
FU Canadian Louis Pasteur Foundation;  [ANR-05-0307-01]; 
   [ANR-09-BLAN-0291]
FX This work was supported in part by grants ANR-05-0307-01 and
   ANR-09-BLAN-0291. N.N.N. was supported by a postdoctoral fellowship from
   the Canadian Louis Pasteur Foundation during part of this work.
CR Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x
   BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862
   Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200
   Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07
   Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x
   Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333
   DENFERT C, 1989, J BIOL CHEM, V264, P17462
   DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feng JN, 1999, MOL MICROBIOL, V34, P745, DOI 10.1046/j.1365-2958.1999.01636.x
   Frye SA, 2006, MICROBIOL-SGM, V152, P3751, DOI 10.1099/mic.0.2006/000315-0
   Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Hoang HH, 2011, PSEUDOMONAS, V2, DOI [10.1128/mBio.00246-11., DOI 10.1128/MBI0.00246-11]
   KAZMIERCZAK BI, 1994, J MOL BIOL, V238, P187, DOI 10.1006/jmbi.1994.1280
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08
   Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x
   Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228
   Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002
   Li G, 2010, MOL MICROBIOL, V76, P772, DOI 10.1111/j.1365-2958.2010.07138.x
   Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11
   Miller JH, 1972, EXPT MOL GENETICS
   Nickerson NN, 2011, J BIOL CHEM, V286, P38833, DOI 10.1074/jbc.M111.279851
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x
   Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006
   Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001
   Seo J, 2009, J BACTERIOL, V191, P898, DOI 10.1128/JB.01443-08
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Strozen TG, 2011, J BACTERIOL, V193, P2322, DOI 10.1128/JB.01413-10
   Tosi T, 2011, MOL MICROBIOL, V82, P1422, DOI 10.1111/j.1365-2958.2011.07896.x
   Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028
   Viarre V, 2009, J BIOL CHEM, V284, P33815, DOI 10.1074/jbc.M109.065938
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338
NR 46
TC 13
Z9 13
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD SEP
PY 2012
VL 194
IS 18
BP 4951
EP 4958
DI 10.1128/JB.00798-12
PG 8
WC Microbiology
SC Microbiology
GA 001FO
UT WOS:000308446100020
PM 22773793
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Diepold, A
   Wiesand, U
   Amstutz, M
   Cornelis, GR
AF Diepold, Andreas
   Wiesand, Ulrich
   Amstutz, Marlise
   Cornelis, Guy R.
TI Assembly of the Yersinia injectisome: the missing pieces
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID III SECRETION SYSTEM; ENTEROPATHOGENIC ESCHERICHIA-COLI; NEEDLE COMPLEX;
   YOP SECRETION; SALMONELLA-TYPHIMURIUM; EXPORT APPARATUS;
   SUBSTRATE-SPECIFICITY; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION;
   CYTOPLASMIC DOMAIN
AB The assembly of the type III secretion injectisome culminates in the formation of the needle. In Yersinia, this step requires not only the needle subunit (YscF), but also the small components YscI, YscO, YscX and YscY. We found that these elements act after the completion of the transmembrane export apparatus. YscX and YscY co-purified with the export apparatus protein YscV, even in the absence of any other protein. YscY-EGFP formed fluorescent spots, suggesting its presence in multiple copies. YscO and YscX were required for export of the early substrates YscF, YscI and YscP, but were only exported themselves after the substrate specificity switch had occurred. Unlike its flagellar homologue FliJ, YscO was not required for the assembly of the ATPase YscN. Finally, we investigated the role of the small proteins in export across the inner membrane. No export of the reporter substrate YscP1137-PhoA into the periplasm was observed in absence of YscI, YscO or YscX, confirming that these proteins are required for export of the first substrates. In contrast, YscP1137-PhoA accumulated in the periplasm in the absence of YscF, suggesting that YscF is not required for the function of the export apparatus, but that its polymerization opens the secretin YscC.
C1 [Diepold, Andreas; Wiesand, Ulrich; Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Diepold, Andreas/0000-0002-4475-3923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-128659]
FX This work was supported by the Swiss National Science Foundation (Grant
   3100A0-128659).
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x
   Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107
   Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2
   Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Burr SE, 2002, J BACTERIOL, V184, P5966, DOI 10.1128/JB.184.21.5966-5970.2002
   Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Day JB, 2000, INFECT IMMUN, V68, P6466, DOI 10.1128/IAI.68.11.6466-6471.2000
   Day JB, 2000, J BACTERIOL, V182, P1834, DOI 10.1128/JB.182.7.1834-1843.2000
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x
   Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84
   Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103
   Evans LDB, 2009, FEMS MICROBIOL LETT, V293, P292, DOI 10.1111/j.1574-6968.2009.01535.x
   Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x
   FIELDS KA, 1994, J BACTERIOL, V176, P569, DOI 10.1128/jb.176.3.569-579.1994
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977
   Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104
   Iriarte M, 1999, J BACTERIOL, V181, P675, DOI 10.1128/JB.181.2.675-680.1999
   Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476
   LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239
   Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x
   Lilic M, 2010, ACTA CRYSTALLOGR D, V66, P709, DOI 10.1107/S0907444910010796
   Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106
   Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1
   Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x
   MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   MICHAELIS S, 1983, J BACTERIOL, V154, P356, DOI 10.1128/JB.154.1.356-365.1983
   Minamino T, 1999, BIOSCI BIOTECH BIOCH, V63, P1301, DOI 10.1271/bbb.63.1301
   Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11
   Moore SA, 2010, J BIOL CHEM, V285, P21060, DOI 10.1074/jbc.M110.119412
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Ogino T, 2006, J BACTERIOL, V188, P2801, DOI 10.1128/JB.188.8.2801-2811.2006
   Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x
   Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6
   Payne PL, 1998, J BACTERIOL, V180, P3882, DOI 10.1128/JB.180.15.3882-3890.1998
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   PLANO GV, 1991, J BACTERIOL, V173, P7293, DOI 10.1128/jb.173.22.7293-7303.1991
   Ple S, 2010, J BACTERIOL, V192, P3801, DOI 10.1128/JB.00117-10
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200
   Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104
   Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620
   Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007
   SANMILLAN JL, 1989, J BACTERIOL, V171, P5536, DOI 10.1128/jb.171.10.5536-5541.1989
   Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358
   Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824
   Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603
   Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067
   Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107
   Waterfield NR, 2002, TRENDS MICROBIOL, V10, P541, DOI 10.1016/S0966-842X(02)02463-0
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08
   Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382
   Yang HJ, 2007, J BACTERIOL, V189, P2599, DOI 10.1128/JB.01680-06
   Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196
NR 95
TC 36
Z9 37
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD SEP
PY 2012
VL 85
IS 5
BP 878
EP 892
DI 10.1111/j.1365-2958.2012.08146.x
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 996LR
UT WOS:000308089900005
PM 22788867
DA 2021-01-25
ER

PT J
AU Ackermann, S
   Spalek, K
   Rasch, B
   Gschwind, L
   Coynel, D
   Fastenrath, M
   Papassotiropoulos, A
   de Quervain, DJF
AF Ackermann, Sandra
   Spalek, Klara
   Rasch, Bjoern
   Gschwind, Leo
   Coynel, David
   Fastenrath, Matthias
   Papassotiropoulos, Andreas
   de Quervain, Dominique J. -F.
TI Testosterone levels in healthy men are related to amygdala reactivity
   and memory performance
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Steroid hormones; Memory; Emotion; Amygdala
ID RECEPTOR MESSENGER-RNA; INTRACELLULAR ANDROGEN RECEPTORS; ADULT MALE
   RATS; ELDERLY-MEN; ADRENERGIC ACTIVATION; COGNITIVE PERFORMANCE;
   NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; EMOTIONAL EVENTS; NEURAL
   CIRCUITRY
AB Testosterone is a steroid hormone thought to influence both emotional and cognitive functions. It is unknown, however, if testosterone also affects the interaction between these two domains, such as the emotional arousal-induced enhancement of memory. Healthy subjects (N = 234) encoded pictures taken from the International Affective Picture System (IAPS) during functional magnetic resonance imaging (fMRI) and underwent a free recall test 10 min after memory encoding. We show that higher endogenous testosterone levels at encoding were associated with higher arousal ratings of neutral pictures in men. fMRI analysis revealed that higher testosterone levels were related to increased brain activation in the amygdala during encoding of neutral pictures. Moreover, endogenous testosterone levels were positively correlated with the number of freely recalled neutral pictures. No such relations were found in women. These findings point to a male-specific role for testosterone in enhancing memory by increasing the biological salience of incoming information. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Spalek, Klara; Coynel, David; Fastenrath, Matthias; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Ackermann, Sandra; Gschwind, Leo; Coynel, David; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland.
   [Rasch, Bjoern] Univ Zurich, Dept Psychol, Div Biopsychol, Zurich, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   [Papassotiropoulos, Andreas; de Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
RP de Quervain, DJF (corresponding author), Univ Basel, Dept Psychol, Div Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM dominique.dequervain@unibas.ch
RI Rasch, Bjorn/A-3119-2015; Coynel, David/H-9189-2019
OI Rasch, Bjorn/0000-0001-7607-3415; Coynel, David/0000-0001-5028-5807;
   Papassotiropoulos, Andreas/0000-0002-2210-9651; Spalek,
   Klara/0000-0002-4244-6495; de Quervain, Dominique/0000-0001-7131-2464
FU Swiss National Science Foundation (Sinergia)Swiss National Science
   Foundation (SNSF) [CRSIK0_122691, CRSI33_130080]; 7th Framework
   Programme of the European Union (ADAMS project) [HEALTH-F4-2009-242257];
   National Center for Competence in Research SYNAPSY
FX This work was funded by the Swiss National Science Foundation (Sinergia
   grants CRSIK0_122691, CRSI33_130080 to D.Q. and A.P.), by the 7th
   Framework Programme of the European Union (ADAMS project,
   HEALTH-F4-2009-242257) and by the National Center for Competence in
   Research SYNAPSY.
CR Abdelgadir SE, 1999, BIOL REPROD, V60, P1251, DOI 10.1095/biolreprod60.5.1251
   Ambar G, 2009, GENES BRAIN BEHAV, V8, P161, DOI 10.1111/j.1601-183X.2008.00458.x
   Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103
   Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681
   Beyenburg S, 2000, NEUROSCI LETT, V294, P25, DOI 10.1016/S0304-3940(00)01542-1
   Bliss-Moreau E, 2011, NEUROSCIENCE, V178, P123, DOI 10.1016/j.neuroscience.2010.12.038
   CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0
   Cahill L, 1996, P W PHARMACOL SOC, V39, P81
   Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909
   Cherrier MM, 2002, J CLIN ENDOCR METAB, V87, P3090, DOI 10.1210/jc.87.7.3090
   Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1
   Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520
   Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007
   Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352
   Ely D, 2011, CLIN EXP HYPERTENS, V33, P124, DOI 10.3109/10641963.2010.531840
   Ferris CF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-111
   Finley SK, 1999, J NEUROBIOL, V40, P446
   Fonda SJ, 2005, J GERONTOL A-BIOL, V60, P385, DOI 10.1093/gerona/60.3.385
   GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G
   Gray PB, 2004, PSYCHONEUROENDOCRINO, V29, P1153, DOI 10.1016/j.psyneuen.2004.01.008
   Harooni HE, 2008, BEHAV BRAIN RES, V188, P71, DOI 10.1016/j.bbr.2007.10.017
   Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013
   Hogervorst E, 2010, BBA-GEN SUBJECTS, V1800, P1145, DOI 10.1016/j.bbagen.2009.12.009
   Hurlemann R, 2005, J NEUROSCI, V25, P6343, DOI 10.1523/JNEUROSCI.0228-05.2005
   Ikebuchi M, 2009, BRAIN BEHAV EVOLUT, V74, P250, DOI 10.1159/000264660
   Janowsky JS, 2006, TRENDS COGN SCI, V10, P77, DOI 10.1016/j.tics.2005.12.010
   Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67
   Kritzer M, 2004, CEREB CORTEX, V14, P268, DOI 10.1093/cercor/bhg127
   Kritzer MF, 2001, HORM BEHAV, V39, P167, DOI 10.1006/hbeh.2001.1645
   LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Lang P. J., 1988, INT AFFECTIVE PICTUR
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   McGaugh J.L., 2003, MEMORY EMOTION MAKIN
   McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157
   McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082
   McIntyre CK, 2002, EUR J NEUROSCI, V16, P1223, DOI 10.1046/j.1460-9568.2002.02188.x
   Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419
   O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703
   Perry P J, 2001, Ann Clin Psychiatry, V13, P75, DOI 10.1023/A:1016663523579
   Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025
   Rasch B, 2009, P NATL ACAD SCI USA, V106, P19191, DOI 10.1073/pnas.0907425106
   Roselli CE, 2001, J COMP NEUROL, V439, P208, DOI 10.1002/cne.1343
   Sarkey S, 2008, HORM BEHAV, V53, P753, DOI 10.1016/j.yhbeh.2008.02.015
   SARRIEAU A, 1990, NEUROENDOCRINOLOGY, V51, P713, DOI 10.1159/000125415
   SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107
   Southwick SM, 2002, AM J PSYCHIAT, V159, P1420, DOI 10.1176/appi.ajp.159.8.1420
   SPSS, 2008, REL 17 0 1
   Stanton SJ, 2009, BIOL PSYCHOL, V81, P118, DOI 10.1016/j.biopsycho.2009.03.004
   Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101
   Thilers PP, 2006, PSYCHONEUROENDOCRINO, V31, P565, DOI 10.1016/j.psyneuen.2005.12.005
   van Wingen GA, 2011, NEUROSCIENCE, V191, P38, DOI 10.1016/j.neuroscience.2011.04.042
   Wolf OT, 2000, BIOL PSYCHIAT, V47, P650, DOI 10.1016/S0006-3223(99)00145-6
   Wolf OT, 2002, HORM BEHAV, V41, P259, DOI 10.1006/hbeh.2002.1770
   Yonker JE, 2006, CORTEX, V42, P376, DOI 10.1016/S0010-9452(08)70364-2
   Young LA, 2010, J CLIN ENDOCR METAB, V95, P280, DOI 10.1210/jc.2009-1346
NR 56
TC 24
Z9 24
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD SEP
PY 2012
VL 37
IS 9
BP 1417
EP 1424
DI 10.1016/j.psyneuen.2012.01.008
PG 8
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA 991CJ
UT WOS:000307678800005
PM 22341731
DA 2021-01-25
ER

PT J
AU Meinen, S
   Lin, S
   Ruegg, MA
   Punga, AR
AF Meinen, Sarina
   Lin, Shuo
   Rueegg, Markus A.
   Punga, Anna Rostedt
TI Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is
   Paralleled by Loss of Sarcolemmal nNOS
SO PLOS ONE
LA English
DT Article
ID NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY;
   ACETYLCHOLINE-RECEPTOR; NO PRODUCTION; NEURONAL NOS; MDX MICE; MUSK;
   ANTIBODIES; VASOMODULATION
AB Myasthenia Gravis (MG) patients suffer from chronic fatigue of skeletal muscles, even after initiation of proper immunosuppressive medication. Since the localization of neuronal nitric oxide synthase (nNOS) at the muscle membrane is important for sustained muscle contraction, we here study the localization of nNOS in muscles from mice with acetylcholine receptor antibody seropositive (AChR+) experimental autoimmune MG (EAMG). EAMG was induced in 8 week-old male mice by immunization with AChRs purified from torpedo californica. Sham-injected wild type mice and mdx mice, a model for Duchenne muscular dystrophy, were used for comparison. At EAMG disease grade 3 (severe myasthenic weakness), the triceps, sternomastoid and masseter muscles were collected for analysis. Unlike in mdx muscles, total nNOS expression as well as the presence of its binding partner syntrophin alpha-1, were not altered in EAMG. Immunohistological and biochemical analysis showed that nNOS was lost from the muscle membrane and accumulated in the cytosol, which is likely the consequence of blocked neuromuscular transmission. Atrophy of all examined EAMG muscles were supported by upregulated transcript levels of the atrogenes atrogin-1 and MuRF1, as well as MuRF1 protein, in combination with reduced muscle fiber diameters. We propose that loss of sarcolemmal nNOS provides an additional mechanism for the chronic muscle fatigue and secondary muscle atrophy in EAMG and MG.
C1 [Meinen, Sarina; Lin, Shuo; Rueegg, Markus A.; Punga, Anna Rostedt] Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.
RP Meinen, S (corresponding author), Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.
EM annarostedtpunga@gmail.com
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Punga, Anna/0000-0002-2178-9413
FU Canton of Basel-Stadt; Canton of Baselland; Swiss Foundation for
   Research on Muscle Disease; European UnionEuropean Union (EU) [242210]
FX The work was supported by the Cantons of Basel-Stadt and Baselland, The
   Swiss Foundation for Research on Muscle Disease and the European Union
   through FP7 project number 242210 "FIGHT-MG". The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aricha R, 2006, FASEB J, V20, P374, DOI 10.1096/fj.05-4909fje
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142
   Christadoss P, 2002, J NEUROIMMUNOL, V122, P186, DOI 10.1016/S0165-5728(01)00473-8
   Fadel PJ, 2003, J PHYSIOL-LONDON, V549, P243, DOI 10.1113/jphysiol.2003.038828
   Farrugia ME, 2007, CLIN NEUROPHYSIOL, V118, P269, DOI 10.1016/j.clinph.2006.10.004
   Figueroa XF, 2009, AM J PHYSIOL-HEART C, V297, pH134, DOI 10.1152/ajpheart.00023.2009
   Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183
   GRAVES J, 1993, BRIT J PHARMACOL, V108, P631, DOI 10.1111/j.1476-5381.1993.tb12853.x
   HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5
   HALVORSEN SW, 1987, J NEUROSCI, V7, P2547
   HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W
   Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149
   Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414
   KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0
   KOLTGEN D, 1994, NEUROSCI LETT, V173, P79, DOI 10.1016/0304-3940(94)90154-6
   Lau T, 2000, J CLIN INVEST, V105, P1217, DOI 10.1172/JCI7199
   Liewluck T, 2011, MUSCLE NERVE, V44, P789, DOI 10.1002/mus.22176
   Martignago S, 2009, NEUROPATH APPL NEURO, V35, P103, DOI 10.1111/j.1365-2990.2008.00965.x
   Matell G, 1998, ANN NY ACAD SCI, V841, P785, DOI 10.1111/j.1749-6632.1998.tb11019.x
   Mizrachi K, 2010, J NEUROIMMUNOL, V220, P43, DOI 10.1016/j.jneuroim.2009.12.012
   Nakayashiki N, 2000, J NEUROIMMUNOL, V105, P131, DOI 10.1016/S0165-5728(00)00199-5
   PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871
   Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387
   Punga AR, 2006, CLIN NEUROPHYSIOL, V117, P1434, DOI 10.1016/j.clinph.2006.03.028
   Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018
   SCHMID A, 1985, J BIOL CHEM, V260, P3041
   Soliven B, 2009, J NEUROL SCI, V277, P150, DOI 10.1016/j.jns.2008.09.033
   Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654
   Suzuki N, 2010, J NEUROL SCI, V294, P95, DOI 10.1016/j.jns.2010.03.022
   Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52
   VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246
NR 34
TC 18
Z9 18
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2012
VL 7
IS 8
AR e44148
DI 10.1371/journal.pone.0044148
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 998CA
UT WOS:000308213600083
PM 22952904
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Deogracias, R
   Yazdani, M
   Dekkers, MPJ
   Guy, J
   Ionescu, MCS
   Vogt, KE
   Barde, YA
AF Deogracias, Ruben
   Yazdani, Morteza
   Dekkers, Martijn P. J.
   Guy, Jacky
   Ionescu, Mihai Constantin S.
   Vogt, Kaspar E.
   Barde, Yves-Alain
TI Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF
   levels and improves symptoms of a mouse model of Rett syndrome
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE electrophysiology; transcription
ID CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; MULTIPLE-SCLEROSIS; MUTANT
   MICE; RESPIRATORY-FUNCTION; BRAIN; NEURONS; FTY720; EXPRESSION;
   PHOSPHORYLATION
AB The functional relevance of brain-derived neurotrophic factor (BDNF) is beginning to be well appreciated not only in mice, but also in humans. Because reduced levels typically correlate with impaired neuronal function, increasing BDNF levels with well-tolerated drugs diffusing into the central nervous system may help in ameliorating functional deficits. With this objective in mind, we used the sphingosine-1 phosphate receptor agonist fingolimod, a drug that crosses the blood-brain barrier. In addition, fingolimod has recently been introduced as the first oral treatment for multiple sclerosis. In cultured neurons, fingolimod increases BDNF levels and counteracts NMDA-induced neuronal death in a BDNF-dependent manner. Ongoing synaptic activity and MAPK signaling is required for fingolimod-induced BDNF increase, a pathway that can also be activated in vivo by systemic fingolimod administration. Mice lacking Mecp2, a gene frequently mutated in Rett syndrome, show decreased levels of BDNF, and fingolimod administration was found to partially rescue these levels as well as the size of the striatum, a volumetric sensor of BDNF signaling in rodents. These changes correlate with increased locomotor activity of the Mecp2-deficient animals, suggesting that fingolimod may improve the functional output of the nervous system, in addition to its well-documented effects on lymphocyte egress from lymph nodes.
C1 [Deogracias, Ruben; Yazdani, Morteza; Dekkers, Martijn P. J.; Ionescu, Mihai Constantin S.; Vogt, Kaspar E.; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Guy, Jacky] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Deogracias, Ruben/I-5751-2015
OI Deogracias, Ruben/0000-0002-9279-7867; Guy, Jacky/0000-0002-8440-5667;
   Vogt, Kaspar/0000-0002-0859-876X; Barde, Yves/0000-0002-7627-461X
FU Rett Syndrome Research Trust; International Rett Syndrome Foundation
   [2809]; Swiss National FoundationSwiss National Science Foundation
   (SNSF) [31003A_124902]
FX This work was supported by Rett Syndrome Research Trust and
   International Rett Syndrome Foundation Research Grant 2809 and by Swiss
   National Foundation Grant 31003A_124902.
CR Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997
   Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108
   Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004
   BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x
   BARKER JL, 1980, SCIENCE, V208, P1054, DOI 10.1126/science.7375918
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027
   Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582
   Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108
   Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005
   Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183
   Gascon S, 2005, J BIOL CHEM, V280, P35018, DOI 10.1074/jbc.M504108200
   Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109
   Gray J, 2006, DANCING TIMES, V96, P55
   Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002
   Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899
   Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0
   Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899
   Heyden A, 2011, CELL TISSUE RES, V346, P11, DOI 10.1007/s00441-011-1233-3
   HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x
   Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   Latham PE, 2000, J NEUROPHYSIOL, V83, P808
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8
   Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366
   Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912
   Norman E, 2010, J NEUROCHEM, V114, P430, DOI 10.1111/j.1471-4159.2010.06779.x
   Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007
   Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010
   Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184
   Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010
   Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276
   Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127
   Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012
   Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106
   Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009
   Tremblay R, 1999, J NEUROCHEM, V72, P102, DOI 10.1046/j.1471-4159.1999.0720102.x
   Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256
   West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298
   Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101
NR 45
TC 168
Z9 171
U1 1
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 28
PY 2012
VL 109
IS 35
BP 14230
EP 14235
DI 10.1073/pnas.1206093109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 002VP
UT WOS:000308565300071
PM 22891354
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Barde, YA
AF Barde, Yves-Alain
TI Hans Thoenen: A Tribute
SO NEURON
LA English
DT Biographical-Item
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
NR 0
TC 2
Z9 2
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD AUG 23
PY 2012
VL 75
IS 4
BP 553
EP 555
DI 10.1016/j.neuron.2012.08.007
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 994EU
UT WOS:000307914500005
OA Bronze
DA 2021-01-25
ER

PT J
AU Chernyatina, AA
   Nicolet, S
   Aebi, U
   Herrmann, H
   Strelkov, SV
AF Chernyatina, Anastasia A.
   Nicolet, Stefan
   Aebi, Ueli
   Herrmann, Harald
   Strelkov, Sergei V.
TI Atomic structure of the vimentin central alpha-helical domain and its
   implications for intermediate filament assembly
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE X-ray crystallography; cytoskeleton; coiled coil
ID COILED-COILS; MOLECULAR ARCHITECTURE; SECONDARY STRUCTURE; PROTEINS;
   MECHANISM; SEQUENCE; KERATIN; EXPRESSION; PREDICTION; DYNAMICS
AB Together with actin filaments and microtubules, intermediate filaments (IFs) are the basic cytoskeletal components of metazoan cells. Over 80 human diseases have been linked to mutations in various IF proteins to date. However, the filament structure is far from being resolved at the atomic level, which hampers rational understanding of IF pathologies. The elementary building block of all IF proteins is a dimer consisting of an alpha-helical coiled-coil (CC) "rod" domain flanked by the flexible head and tail domains. Here we present three crystal structures of overlapping human vimentin fragments that comprise the first half of its rod domain. Given the previously solved fragments, a nearly complete atomic structure of the vimentin rod has become available. It consists of three a-helical segments (coils 1A, 1B, and 2) interconnected by linkers (L1 and L12). Most of the CC structure has a left-handed twist with heptad repeats, but both coil 1B and coil 2 also exhibit untwisted, parallel stretches with hendecad repeats. In the crystal structure, linker L1 was found to be alpha-helical without being involved in the CC formation. The available data allow us to construct an atomic model of the antiparallel tetramer representing the second level of vimentin assembly. Although the presence of the nonhelical head domains is essential for proper tetramer stabilization, the precise alignment of the dimers forming the tetramer appears to depend on the complementarity of their surface charge distribution patterns, while the structural plasticity of linker L1 and coil 1A plays a role in the subsequent IF assembly process.
C1 [Chernyatina, Anastasia A.; Nicolet, Stefan; Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, Dept Pharmaceut & Pharmacol Sci, B-3000 Louvain, Belgium.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Grp Funct Architecture Cell, D-69120 Heidelberg, Germany.
RP Strelkov, SV (corresponding author), Katholieke Univ Leuven, Lab Biocrystallog, Dept Pharmaceut & Pharmacol Sci, Herestr 49, B-3000 Louvain, Belgium.
EM sergei.strelkov@pharm.kuleuven.be
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652; Chernyatina,
   Anastasia/0000-0001-7714-2988
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre; Katholieke Universiteit Leuven Onderzoekstoelage [07/071];
   Research Foundation - Flanders (FWO)FWO [G.0709.12]; German Research
   FoundationGerman Research Foundation (DFG) [DFG BA 2186/3-1]
FX Authors thank Dr. Stephen Weeks for providing the pETHSUL expression
   vector and for stimulating discussions, and Mr. Steven Beelen for
   technical assistance. We are also grateful to Prof. J. Rozensky for
   mass-spectrometry analysis, to Drs. Beatriz Guimaraes, Andrew W.
   Thompson, and Kristof Van Hecke for help with X-ray data collection, and
   to Dr. John F. Hunt and colleagues from the Northeast Structural
   Genomics Consortium for making their structure 3UF1 available in the PDB
   prior to publication. Measurements at the Soleil synchrotron (beamline
   Proxima1) and at the Swiss Light Source (beamline PXIII) were supported
   by the European Commission under the 7th Framework Programme. This work
   was supported by the Katholieke Universiteit Leuven Onderzoekstoelage
   Grant 07/071, by the Research Foundation - Flanders (FWO) Grant
   G.0709.12 (both to S.V.S.) and by the German Research Foundation, DFG BA
   2186/3-1 (to H.H.).
CR Aziz A, 2009, J BIOL CHEM, V284, P7330, DOI 10.1074/jbc.M809029200
   BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9
   Brown JH, 1996, PROTEINS, V26, P134
   Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   DeLano WL, 2002, PYMOL USERS MANUAL
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053
   Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200
   Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003
   Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5
   MCLACHLAN AD, 1982, J MOL BIOL, V162, P693, DOI 10.1016/0022-2836(82)90396-5
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012
   Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170
   PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X
   Parry DAD, 2010, J STRUCT BIOL, V170, P364, DOI 10.1016/j.jsb.2009.12.006
   Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51
   QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006
NR 39
TC 90
Z9 91
U1 0
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 21
PY 2012
VL 109
IS 34
BP 13620
EP 13625
DI 10.1073/pnas.1206836109
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 996KJ
UT WOS:000308085200040
PM 22869704
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Grimm, M
   Franosch, T
   Jeney, S
AF Grimm, Matthias
   Franosch, Thomas
   Jeney, Sylvia
TI High-resolution detection of Brownian motion for quantitative optical
   tweezers experiments
SO PHYSICAL REVIEW E
LA English
DT Article
ID POSITION DETECTOR; PARTICLE TRACKING; SINGLE-MOLECULE; MICRORHEOLOGY;
   CALIBRATION
AB We have developed an in situ method to calibrate optical tweezers experiments and simultaneously measure the size of the trapped particle or the viscosity of the surrounding fluid. The positional fluctuations of the trapped particle are recorded with a high-bandwidth photodetector. We compute the mean-square displacement, as well as the velocity autocorrelation function of the sphere, and compare it to the theory of Brownian motion including hydrodynamic memory effects. A careful measurement and analysis of the time scales characterizing the dynamics of the harmonically bound sphere fluctuating in a viscous medium directly yields all relevant parameters. Finally, we test the method for different optical trap strengths, with different bead sizes and in different fluids, and we find excellent agreement with the values provided by the manufacturers. The proposed approach overcomes the most commonly encountered limitations in precision when analyzing the power spectrum of position fluctuations in the region around the corner frequency. These low frequencies are usually prone to errors due to drift, limitations in the detection, and trap linearity as well as short acquisition times resulting in poor statistics. Furthermore, the strategy can be generalized to Brownian motion in more complex environments, provided the adequate theories are available.
C1 [Grimm, Matthias; Jeney, Sylvia] Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, CH-1015 Lausanne, Switzerland.
   [Grimm, Matthias] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Franosch, Thomas] Univ Erlangen Nurnberg, Inst Theoret Phys, D-91058 Erlangen, Germany.
RP Grimm, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, CH-1015 Lausanne, Switzerland.
EM sylvia.jeney@epfl.ch
FU National Center of Competence in Research Nanoscale ScienceSwiss
   National Science Foundation (SNSF); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [200021-113529,
   206021-121396]
FX M.G. was supported by National Center of Competence in Research
   Nanoscale Science. S.J. acknowledges the Swiss National Science
   Foundation (Grants No. 200021-113529 and No. 206021-121396). We thank
   Flavio M. Mor for discussions.
CR Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7
   Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654
   Buosciolo A, 2004, OPT COMMUN, V230, P357, DOI 10.1016/j.optcom.2003.11.062
   CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942
   Franosch T, 2011, NATURE, V478, P85, DOI 10.1038/nature10498
   Franosch T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031402
   Furst EM, 2005, CURR OPIN COLLOID IN, V10, P79, DOI 10.1016/j.cocis.2005.04.001
   Gisler T, 1998, CURR OPIN COLLOID IN, V3, P586, DOI 10.1016/S1359-0294(98)80084-8
   Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007
   Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451
   Grimm M, 2011, SOFT MATTER, V7, P2076, DOI 10.1039/c0sm00636j
   Guzman C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020713
   HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102
   Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/nphys1953, 10.1038/NPHYS1953]
   Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102
   Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604
   Kubo R., 1991, SPRINGER SERIES SOLI
   Landau LD., 1959, FLUID MECH
   Le Gall A, 2010, OPT EXPRESS, V18, P26469, DOI 10.1364/OE.18.026469
   Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225
   Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844
   Nieminen TA, 2007, J OPT A-PURE APPL OP, V9, pS196, DOI 10.1088/1464-4258/9/8/S12
   Ou-Yang HD, 2010, ANNU REV PHYS CHEM, V61, P421, DOI 10.1146/annurev.physchem.012809.103454
   Peterman EJG, 2003, REV SCI INSTRUM, V74, P3246, DOI 10.1063/1.1584085
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Rohrbach A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168102
   Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368
   SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0
   Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852
   Veigel C, 2011, NAT REV MOL CELL BIO, V12, P163, DOI 10.1038/nrm3062
   Vermeulen KC, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2165568
   Vladimirsky V., 1945, ZH EKSP TEOR FIZ, V15, P258
NR 34
TC 33
Z9 33
U1 0
U2 52
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
EI 1550-2376
J9 PHYS REV E
JI Phys. Rev. E
PD AUG 13
PY 2012
VL 86
IS 2
AR 021912
DI 10.1103/PhysRevE.86.021912
PN 1
PG 7
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 987UJ
UT WOS:000307443000004
PM 23005790
DA 2021-01-25
ER

PT J
AU Bongiovanni, MN
   Puri, D
   Goldie, KN
   Gras, SL
AF Bongiovanni, Marie N.
   Puri, Dhivya
   Goldie, Kenneth N.
   Gras, Sally L.
TI Noncore Residues Influence the Kinetics of Functional TTR105-115-Based
   Amyloid Fibril Assembly
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE fragmentation; seed; cross-seeding; cross-beta core; structure
ID MECHANICAL-PROPERTIES; PEPTIDE-FRAGMENTS; RAY-SCATTERING; AGGREGATION;
   BETA; SEQUENCE; PREDICTION; MORPHOLOGY; GROWTH; CONFORMATIONS
AB Mutations in the polypeptide sequence that forms the core structure of amyloid fibrils are known to impact on fibril assembly and stability but the effect of changes on noncore residues, particularly relating to functionalized fibrils where the fibril core is preserved, has not been systematically examined. In this study, the short peptide sequence TTR105-115 (also known as TTR1) and the functionalized variants TTR1-RGD and TTR1-RAD are used as a model system to investigate the effect of noncore residues on the kinetics of fibril assembly. The noncore residues in TTR1-RGD and TTR1-RAD influence the rate of fibril assembly in non-seeded samples with the glycine residue at position 15 increasing the rate of aggregation compared to alanine. Mature TTR1-RGD fibrils were also found to fragment more readily, indicating possible differences in mechanical properties. Fragments of each type of fibril are capable of self- and cross-seeding, generating fibrils with a highly similar cross-p core structure. The similar rates of assembly observed for self-seeded samples reflect the similar free energy of elongation calculated for these peptides, while the morphology of cross-seeded fibrils is determined by the properties of the monomeric peptide and its macromolecular arrangement within the protofilaments and fibrils. These findings illustrate that noncore residues impact on fibril formation and fibril properties and demonstrate that the influence of noncore residues should be considered when designing sequences for the production of self-assembling functional fibrillar materials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Bongiovanni, Marie N.; Puri, Dhivya; Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
   [Bongiovanni, Marie N.; Puri, Dhivya; Goldie, Kenneth N.; Gras, Sally L.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nano Analyt C CINA Struct, CH-4058 Basel, Switzerland.
RP Gras, SL (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
EM sgras@unimelb.edu.au
RI Gras, Sally L/G-2025-2014
OI Gras, Sally L/0000-0002-4660-1245
CR Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703
   Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200
   Bongiovanni MN, 2011, BIOMATERIALS, V32, P6099, DOI 10.1016/j.biomaterials.2011.05.021
   Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960
   Byrne N, 2011, EUR POLYM J, V47, P1279, DOI 10.1016/j.eurpolymj.2010.12.002
   Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009
   Caporini MA, 2010, J PHYS CHEM B, V114, P13555, DOI 10.1021/jp106675h
   Channon KJ, 2009, J AM CHEM SOC, V131, P12520, DOI 10.1021/ja902825j
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65
   Deng W, 2007, BIOCHEM BIOPH RES CO, V362, P689, DOI 10.1016/j.bbrc.2007.08.059
   Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dubois J, 1999, SCAND J IMMUNOL, V49, P376
   Fandrich M, 2007, J MOL BIOL, V365, P1266, DOI 10.1016/j.jmb.2006.11.009
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Garvey M, 2009, INT J NANOTECHNOL, V6, P258, DOI 10.1504/IJNT.2009.022918
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P52
   GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4
   Goossens K, 2003, BIOCHEM J, V370, P529, DOI 10.1042/BJ20020717
   Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Gras SL, 2007, AUST J CHEM, V60, P333, DOI 10.1071/CH06485
   Gras SL, 2011, METHODS MOL BIOL, V752, P147, DOI 10.1007/978-1-60327-223-0_10
   HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3
   Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]
   Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250
   Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Linse B, 2011, MOL BIOSYST, V7, P2296, DOI 10.1039/c0mb00321b
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]
   Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2
   McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170
   Meersman F, 2002, BIOPHYS J, V82, P2635, DOI 10.1016/S0006-3495(02)75605-1
   Meersman F, 2011, BIOPHYS J, V100, P193, DOI 10.1016/j.bpj.2010.11.052
   Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0
   Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c
   O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0
   Paci E, 2004, J MOL BIOL, V340, P555, DOI 10.1016/j.jmb.2004.05.009
   Paparcone R, 2010, BIOCHEMISTRY-US, V49, P8967, DOI 10.1021/bi100953t
   Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Raynes JK, 2011, BIOTECHNOL PROGR, V27, P360, DOI 10.1002/btpr.518
   Sabate R, 2010, J MOL BIOL, V404, P337, DOI 10.1016/j.jmb.2010.09.052
   Saiki M, 2005, J MOL BIOL, V348, P983, DOI 10.1016/j.jmb.2005.03.022
   Sawyer EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018839
   Schowen R. L, 2011, J CHEM EDUC, V70, pA223
   Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108
   Squires AM, 2006, J AM CHEM SOC, V128, P11738, DOI 10.1021/ja063751v
   Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922
   TANFORD C, 1957, J AM CHEM SOC, V79, P5333, DOI 10.1021/ja01577a001
   Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013
   Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034
   Wang YQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208934
   Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036
   Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008
   Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195
   Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105
   Yagi H, 2010, BBA-PROTEINS PROTEOM, V1804, P2077, DOI 10.1016/j.bbapap.2010.07.007
NR 68
TC 10
Z9 10
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 10
PY 2012
VL 421
IS 2-3
BP 256
EP 269
DI 10.1016/j.jmb.2011.12.020
PN 1
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 980HW
UT WOS:000306885200009
PM 22198409
DA 2021-01-25
ER

PT J
AU Duran, RV
   Oppliger, W
   Robitaille, AM
   Heiserich, L
   Skendaj, R
   Gottlieb, E
   Hall, MN
AF Duran, Raul V.
   Oppliger, Wolfgang
   Robitaille, Aaron M.
   Heiserich, Lisa
   Skendaj, Roswitha
   Gottlieb, Eyal
   Hall, Michael N.
TI Glutaminolysis Activates Rag-mTORC1 Signaling
SO MOLECULAR CELL
LA English
DT Article
ID AMINO-ACID SUFFICIENCY; CELL-GROWTH; GLUTAMATE-DEHYDROGENASE; PROLYL
   HYDROXYLASES; MAMMALIAN TARGET; BINDING PARTNER; RAG GTPASES; MTOR; TOR;
   METABOLISM
AB Amino acids control cell growth via activation of the highly conserved kinase TORC1. Glutamine is a particularly important amino acid in cell growth control and metabolism. However, the role of glutamine in TORC1 activation remains poorly defined. Glutamine is metabolized through glutaminolysis to produce alpha-ketoglutarate. We demonstrate that glutamine in combination with leucine activates mammalian TORC1 (mTORC1) by enhancing glutaminolysis and alpha-ketoglutarate production. Inhibition of glutaminolysis prevented GTP loading of RagB and lysosomal translocation and subsequent activation of mTORC1. Constitutively active Rag heterodimer activated mTORC1 in the absence of glutaminolysis. Conversely, enhanced glutaminolysis or a cell-permeable alpha-ketoglutarate analog stimulated lysosomal translocation and activation of mTORC1. Finally, cell growth and autophagy, two processes controlled by mTORC1, were regulated by glutaminolysis. Thus, mTORC1 senses and is activated by glutamine and leucine via glutaminolysis and alpha-ketoglutarate production upstream of Rag. This may provide an explanation for glutamine addiction in cancer cells.
C1 [Duran, Raul V.; Oppliger, Wolfgang; Robitaille, Aaron M.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Heiserich, Lisa; Gottlieb, Eyal] Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Metab Lab, Glasgow G61 1BD, Lanark, Scotland.
   [Skendaj, Roswitha] Univ Basel Hosp, Div Clin Chem, CH-4031 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Gottlieb, Eyal/G-6450-2010; Duran, Raul/E-4764-2011
OI Gottlieb, Eyal/0000-0002-9770-0956; Duran, Raul/0000-0002-2249-9215;
   Robitaille, Aaron Mark/0000-0003-2774-2066
FU Canton of Basel; Louis-Jeantet Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Cancer Research
   UKCancer Research UK
FX We thank Karla Kirkegaard, Fuyuhiko Tamanoi, David M. Sabatini, and Chi
   Dang for reagents. M.N.H. acknowledges support from the Canton of Basel,
   the Louis-Jeantet Foundation, and the Swiss National Science Foundation.
   E.G. acknowledges support from Cancer Research UK.
CR Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531
   Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291
   Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200
   Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038
   Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257
   Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   FISCHER JE, 1990, JPEN-PARENTER ENTER, V14, pS86, DOI 10.1177/0148607190014004101
   Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200
   Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200
   MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06
   Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068
   Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044
   Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996
   Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200
   Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666
   SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0
   Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026
   SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250
   Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070
   Todorova VK, 2011, CANCER CHEMOTH PHARM, V67, P285, DOI 10.1007/s00280-010-1316-y
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009
   WILLIS RC, 1977, J CELL PHYSIOL, V93, P375, DOI 10.1002/jcp.1040930308
   Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031
   Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014
   Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 61
TC 342
Z9 352
U1 0
U2 47
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD AUG 10
PY 2012
VL 47
IS 3
BP 349
EP 358
DI 10.1016/j.molcel.2012.05.043
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 988IT
UT WOS:000307484600005
PM 22749528
OA Bronze
DA 2021-01-25
ER

PT J
AU Zocher, M
   Fung, JJ
   Kobilka, BK
   Muller, DJ
AF Zocher, Michael
   Fung, Juan J.
   Kobilka, Brian K.
   Mueller, Daniel J.
TI Ligand-Specific Interactions Modulate Kinetic, Energetic, and Mechanical
   Properties of the Human beta(2) Adrenergic Receptor
SO STRUCTURE
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; MOLECULE FORCE SPECTROSCOPY; NATIVE
   MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR;
   STRUCTURAL INSIGHTS; BOVINE RHODOPSIN; BINDING; BACTERIORHODOPSIN;
   ACTIVATION
AB G protein-coupled receptors (GPCRs) are a class of versatile proteins that transduce signals across membranes. Extracellular stimuli induce inter- and intramolecular interactions that change the functional state of GPCRs and activate intracellular messenger molecules. How these interactions are established and how they modulate the functional state of GPCRs remain to be understood. We used dynamic single-molecule force spectroscopy to investigate how ligand binding modulates the energy landscape of the human beta(2) adrenergic receptor (beta(2)AR). Five different ligands representing either agonists, inverse agonists or neutral antagonists established a complex network of interactions that tuned the kinetic, energetic, and mechanical properties of functionally important structural regions of beta(2)AR. These interactions were specific to the efficacy profile of the ligands investigated and suggest that the functional modulation of GPCRs follows structurally well-defined interaction patterns.
C1 [Fung, Juan J.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA.
   [Zocher, Michael; Mueller, Daniel J.] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
   [Zocher, Michael] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Palo Alto, CA 94305 USA.
EM kobilka@stanford.edu; daniel.mueller@bsse.ethz.ch
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
FU European CommunityEuropean Community (EC) [211800]; DFGGerman Research
   Foundation (DFG); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS028471, R01NS028471, R01NS028471,
   R01NS028471, R01NS028471, R01NS028471, R01NS028471, R01NS028471,
   R01NS028471, R01NS028471, R01NS028471, R01NS028471, R01NS028471,
   R01NS028471, R01NS028471, R01NS028471, R01NS028471, R01NS028471,
   R01NS028471, R01NS028471, R01NS028471, R01NS028471] Funding Source: NIH
   RePORTER
FX Research leading to these results has received funding from the
   (European Community's) Seventh Framework Programme (FP7/2007-2013) under
   grant agreement No. 211800 and the DFG. We thank Ch. Bippes and K.T.
   Sapra for assistance and discussions.
CR BAI TR, 1992, LUNG, V170, P125
   Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200
   BARNES PJ, 1993, LIFE SCI, V52, P2101, DOI 10.1016/0024-3205(93)90725-I
   Bippes CA, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/086601
   Bippes CA, 2009, J BIOL CHEM, V284, P18651, DOI 10.1074/jbc.M109.004267
   Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   CARON MG, 1993, RECENT PROG HORM RES, V48, P277
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789
   Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010
   Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267
   Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108
   Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x
   Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198
   Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153
   Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772
   Janovjak H, 2004, STRUCTURE, V12, P871, DOI 10.1016/S0969-2126(04)00098-X
   Janovjak H, 2008, CHEMPHYSCHEM, V9, P954, DOI 10.1002/cphc.200700662
   Janovjak H, 2007, J AM CHEM SOC, V129, P246, DOI 10.1021/ja065684a
   Kawamura S, 2010, BIOCHEMISTRY-US, V49, P10412, DOI 10.1021/bi101345x
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2008, J MOL BIOL, V375, P1258, DOI 10.1016/j.jmb.2007.11.032
   Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kedrov A, 2010, STRUCTURE, V18, P39, DOI 10.1016/j.str.2009.11.009
   Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722
   Kenakin TP, 2008, BRIT J PHARMACOL, V153, P432, DOI 10.1038/sj.bjp.0707407
   Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003
   Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Kumar S, 2000, PROTEIN SCI, V9, P10
   Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200
   Motulsky H, 2004, FITTING MODELS BIOL
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648
   Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609
   Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665
   Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144
   Sapra KT, 2008, BIOPHYS J, V95, P3407, DOI 10.1529/biophysj.108.131904
   Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027
   Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z
   Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008
   Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080
   Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330
   Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795
   Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101
   Wess J, 1997, FASEB J, V11, P346
   Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106
   ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154
NR 59
TC 68
Z9 70
U1 0
U2 48
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD AUG 8
PY 2012
VL 20
IS 8
BP 1391
EP 1402
DI 10.1016/j.str.2012.05.010
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 987LT
UT WOS:000307419200015
PM 22748765
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Nesper, J
   Reinders, A
   Glatter, T
   Schmidt, A
   Jenal, U
AF Nesper, Jutta
   Reinders, Alberto
   Glatter, Timo
   Schmidt, Alexander
   Jenal, Urs
TI A novel capture compound for the identification and analysis of cyclic
   di-GMP binding proteins
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Caulobacter crescentus; Pseudomonas aeruginosa; Salmonella enterica
   serovar typhimurium; c-di-GMP effector; EAL GGDEF; Capture compound
   mass; spectrometry
ID PSEUDOMONAS-AERUGINOSA; CELL-CYCLE
AB The second messenger cyclic di-GMP is a near-ubiquitous signaling molecule that globally alters bacterial cell physiology to promote biofilm formation and community behavior. Much progress was made in recent years towards the identification and characterization of diguanylate cyclases and phosphodiersterases, enzymes involved in the synthesis and degradation of this signaling compound. In contrast, our knowledge of the nature and mechanistic details of c-di-GMP effector proteins lags behind, primarily because effective tools for their specific enrichment and rapid analysis are missing. In this report we demonstrate that a novel tri-functional c-di-GMP-specific Capture Compound (cdG-CC) can be effectively used to identify and validate c-di-GMP binding proteins. The cdG-CC was able to specifically and efficiently pull down bona fide c-di-GMP effector proteins. Furthermore, in combination with mass spectrometry (CCMS), this technology robustly identified a substantial fraction of the known c-di-GMP signaling components directly from cell extracts of different model organisms. Finally, we applied the CCMS technique to profile c-di-GMP binding proteins of Pseudomonas aeruginosa and Salmonella enterica serovar typhimurium. Our studies establish CCMS as a powerful and versatile tool to identify and analyze components of the cellular c-di-GMP pathway in a wide range of different organisms. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Glatter, Timo; Schmidt, Alexander; Jenal, Urs] Univ Basel, Biozentrum, Prote Core Facil, CH-4054 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Prote Core Facil, Klingelbergstr 50, CH-4054 Basel, Switzerland.
EM urs.jenal@unibas.ch
OI Glatter, Timo/0000-0001-8716-8516
FU Swiss National Science Foundation (SNF) SinergiaSwiss National Science
   Foundation (SNSF) [CRSII3_127433]
FX We thank Samuel Steiner for help in optimization of Capture Compound
   binding assays. We also thank Benoit-Joseph Laventie for the annotation
   of Pseudomonas aeruginosa proteins. This work was supported by the Swiss
   National Science Foundation (SNF) Sinergia grant CRSII3_127433.
CR Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Cline MR, 2007, BIOCHEMISTRY-US, V46, P1981, DOI 10.1021/bi061269j
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Duvel J, 2012, J MICROBIOL METH, V88, P229, DOI 10.1016/j.mimet.2011.11.015
   Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006
   Hengge R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3149pe44
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039
   Lenz T, 2011, J PROTEOMICS, V75, P100, DOI 10.1016/j.jprot.2011.07.017
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106
   Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047
NR 17
TC 32
Z9 32
U1 1
U2 25
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD AUG 3
PY 2012
VL 75
IS 15
BP 4874
EP 4878
DI 10.1016/j.jprot.2012.05.033
PG 5
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 990CV
UT WOS:000307609500028
PM 22652488
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Biallas, M
   Trajkovic, I
   Hagmann, C
   Scholkmann, F
   Jenny, C
   Holper, L
   Beck, A
   Wolf, M
AF Biallas, Martin
   Trajkovic, Ivo
   Hagmann, Cornelia
   Scholkmann, Felix
   Jenny, Carmen
   Holper, Lisa
   Beck, Andreas
   Wolf, Martin
TI Multimodal recording of brain activity in term newborns during photic
   stimulation by near-infrared spectroscopy and electroencephalography
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE biomedical optics; deoxygenated hemoglobin (HHb, deoxyHb, HbR);
   event-related optical signal; fast optical signal; near-infrared
   spectroscopy; image sensors; medical imaging; medicine; neonates;
   newborns; repeatability; reproducibility; visual stimulation; oxygenated
   hemoglobin (O(2)Hb, oxyHb, HbO(2)); spectroscopy
ID NONINVASIVE MEASUREMENT; HEMODYNAMIC-RESPONSES; VISUAL-STIMULATION;
   LIGHT-PROPAGATION; CHILDREN; PRETERM; ADULT
AB In this study 14 healthy term newborns (postnatal mean age 2.1 days) underwent photic stimulation during sleep on two different days. Near-infrared spectroscopy (NIRS) and electroencephalography (EEG) was acquired simultaneously. The aims of the study were: to determine (i) the sensitivity and (ii) the repeatability of NIRS to detect the hemodynamic response, (iii) the sensitivity and (iv) the repeatability of EEG to detect a visual evoked potential (VEP), (v) to analyze optical data for the optical neuronal signal, and (vi) to test whether inadequate stimulation could be reason for absent hemodynamic responses. The results of the study were as follows. (i) Sensitivity of NIRS was 61.5% to detect hemodynamic responses; (ii) their reproducibility was 41.7%. A VEP was detected (iii) in 96.3% of all subjects with (iv) a reproducibility of 92.3%. (v) In two measurements data met the criteria for an optical neuronal signal. The noise level was 9.6 . 10(-5)% change in optical density. (vi) Insufficient stimulation was excluded as reason for absent hemodynamic responses. We conclude that NIRS is an promising tool to study cognitive activation and development of the brain. For clinical application, however, the sensitivity and reproducibility on an individual level needs to be improved. (C) 2012 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.17.8.086011]
C1 [Biallas, Martin; Trajkovic, Ivo; Hagmann, Cornelia; Scholkmann, Felix; Jenny, Carmen; Holper, Lisa; Wolf, Martin] Univ Zurich Hosp, Biomed Opt Res Lab, Div Neonatol, CH-8091 Zurich, Switzerland.
   [Biallas, Martin; Trajkovic, Ivo] Univ Zurich, CH-8093 Zurich, Switzerland.
   [Biallas, Martin; Trajkovic, Ivo] Swiss Fed Inst Technol, Inst Biomed Engn, CH-8093 Zurich, Switzerland.
   [Holper, Lisa] Swiss Fed Inst Technol, Inst Neuroinformat, CH-8057 Zurich, Switzerland.
   [Holper, Lisa] Univ Zurich, CH-8057 Zurich, Switzerland.
   [Beck, Andreas] Univ Basel, Core Program Struct Biol & Biophys, Biozentrum, CH-4056 Basel, Switzerland.
RP Biallas, M (corresponding author), Univ Zurich Hosp, Biomed Opt Res Lab, Div Neonatol, Frauenklinikstr 10, CH-8091 Zurich, Switzerland.
EM martin.biallas@alumni.ethz.ch
OI Hagmann, Cornelia/0000-0003-2647-9809; Holper, Lisa/0000-0002-2599-3649;
   Scholkmann, Felix/0000-0002-1748-4852; Biallas,
   Martin/0000-0002-3888-6578
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX The authors gratefully acknowledge the funding from the Swiss National
   Science Foundation.
CR Benavente I, 2005, DOC OPHTHALMOL, V110, P255, DOI 10.1007/s10633-005-0818-0
   Biallas M, 2012, ADV EXP MED BIOL, V737, P111, DOI 10.1007/978-1-4614-1566-4_17
   Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674
   Cooper CE, 1996, PEDIATR RES, V39, P32, DOI 10.1203/00006450-199601000-00005
   Franceschini MA, 2004, NEUROIMAGE, V21, P372, DOI 10.1016/j.neuroimage.2003.09.040
   Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881
   GRATTON G, 1995, PSYCHOPHYSIOLOGY, V32, P292, DOI 10.1111/j.1469-8986.1995.tb02958.x
   Haensse D, 2005, OPT EXPRESS, V13, P4525, DOI 10.1364/OPEX.13.004525
   Hoshi Y, 2000, PEDIATR NEUROL, V23, P323, DOI 10.1016/S0887-8994(00)00195-8
   Jasper H. H., 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI [10.1016/0013-4694(58)90053-1, DOI 10.1016/0013-4694(58)90053-1]
   Karen T, 2008, HUM BRAIN MAPP, V29, P453, DOI 10.1002/hbm.20411
   Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02
   Kono T, 2007, NEUROSCI RES, V57, P504, DOI 10.1016/j.neures.2006.12.007
   Kubota M, 2008, BRAIN RES, V1226, P124, DOI 10.1016/j.brainres.2008.05.079
   Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019
   MUSHIN J, 1986, BEHAV BRAIN RES, V21, P79, DOI 10.1016/0166-4328(86)90085-9
   O'Reilly M, 2010, DEVELOPMENTAL SCI, V13, P692, DOI 10.1111/j.1467-7687.2009.00925.x
   Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021
   Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008
   Taga G., 2004, PATHOPHYSIOLOGY, V10, P277
   Torrioli MG, 2000, BRAIN DEV-JPN, V22, P163, DOI 10.1016/S0387-7604(00)00098-X
   Trajkovic Ivo, 2009, 2009 17th European Signal Processing Conference (EUSIPCO 2009), P632
   Trajkovic I., 2010, THESIS ETH ZURICH
   Trajkovic I, 2012, ADV EXP MED BIOL, V737, P307, DOI 10.1007/978-1-4614-1566-4_45
   van den Hout BM, 2000, DEV MED CHILD NEUROL, V42, P376, DOI 10.1017/S0012162200000694
   Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6
   Wolf M, 2008, OPTO-ELECTRON REV, V16, P413, DOI 10.2478/sll772-008-0042-z
   Wolf M, 2009, CLIN PERINATOL, V36, P807, DOI 10.1016/j.clp.2009.07.007
   WRAY S, 1988, BIOCHIM BIOPHYS ACTA, V933, P184, DOI 10.1016/0005-2728(88)90069-2
NR 29
TC 8
Z9 8
U1 0
U2 6
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
EI 1560-2281
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD AUG
PY 2012
VL 17
IS 8
AR 086011
DI 10.1117/1.JBO.17.8.086011
PG 8
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 018WF
UT WOS:000309696800047
PM 23224198
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Sugihara, K
   Chami, M
   Derenyi, I
   Voros, J
   Zambelli, T
AF Sugihara, Kaori
   Chami, Mohamed
   Derenyi, Imre
   Voeroes, Janos
   Zambelli, Tomaso
TI Directed Self-Assembly of Lipid Nanotubes from Inverted Hexagonal
   Structures
SO ACS NANO
LA English
DT Article
DE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE); inverted hexagonal
   structure; directed self-assembly; lipid nanotubes; polyelectrolytes;
   microfluidic systems; cryo-electron microscopy
ID PHASE-TRANSITIONS; MEMBRANE CURVATURE; VESICLES; TUBULES; CELLS;
   NETWORKS; PHOSPHOLIPIDS; EXTRUSION; SUPERSTRUCTURES; CHOLESTEROL
AB Conventional lipid-tube formation is based on either a tube phase of certain lipids or the shape transformation of lamellar structures by applying a point load. In the present study, lipid blocks in Inverted hexagonal phase made of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were shown to protrude lipid nanotubes upon a fluid-dynamic flow on polyelectrolyte-functionalized surfaces in physiological buffer solution. The outer diameter of the tubes is 19.1 +/- 4.5 nm and their lengths are up to several hundred micrometers. The method described enables the alignment and patterning of lipid nanotubes into various (including curvy) shapes with a microfluidic system.
C1 [Sugihara, Kaori; Voeroes, Janos; Zambelli, Tomaso] ETH, Inst Biomed Engn, Lab Biosensors & Bioelect, CH-8092 Zurich, Switzerland.
   [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland.
   [Derenyi, Imre] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary.
   [Derenyi, Imre] ELTE MTA Lendulet Biophys Res Grp, H-1117 Budapest, Hungary.
RP Sugihara, K (corresponding author), ETH, Inst Biomed Engn, Lab Biosensors & Bioelect, Gloriastr 35, CH-8092 Zurich, Switzerland.
EM sugihara@is.mpg.de
RI Sugihara, Kaori/C-7783-2012
OI Sugihara, Kaori/0000-0003-3512-6036; Voros, Janos/0000-0001-6054-6230
FU EUEuropean Union (EU); Swiss National Science FoundationSwiss National
   Science Foundation (SNSF)
FX This work was supported by EU Seventh Research Framework Program (FP7,
   ASMENA Project). We are grateful to Stephen Wheeler (LBB workshop),
   Martin Lanz (LBB workshop), and Michael Gabi (LBB) for the fabrication
   of the microfluidic cells, and to Prof. Henning Stahlberg (Director of
   C-CINA, Biozentrum, University of Basel) for his support and access to
   the electron microscopy facilities. The electron microscopy part is
   supported by the Swiss National Science Foundation (SystemsX.ch RTD
   CINA).
CR ARCHIBALD DD, 1993, BIOCHIM BIOPHYS ACTA, V1166, P154, DOI 10.1016/0005-2760(93)90091-M
   Barauskas J, 2005, NANO LETT, V5, P1615, DOI 10.1021/nl050678i
   Borghi N, 2007, BIOPHYS J, V93, P1369, DOI 10.1529/biophysj.106.087908
   CHAPPELL JS, 1992, J MATER SCI LETT, V11, P633, DOI 10.1007/BF00728888
   Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6
   Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984
   Dittrich PS, 2006, LAB CHIP, V6, P488, DOI 10.1039/b517670k
   Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015
   Dusseiller MR, 2005, LAB CHIP, V5, P1387, DOI 10.1039/b509957a
   Evans E, 1996, SCIENCE, V273, P933, DOI 10.1126/science.273.5277.933
   Frusawa H, 2003, ANGEW CHEM INT EDIT, V42, P72, DOI 10.1002/anie.200390056
   Hayes MA, 2007, J NANOSCI NANOTECHNO, V7, P2283, DOI 10.1166/jnn.2007.646
   Heinrich V, 2005, BIOPHYS J, V88, P2299, DOI 10.1529/biophysj.104.051706
   Heinrich V, 1999, BIOPHYS J, V76, P2056, DOI 10.1016/S0006-3495(99)77362-5
   Huetz P, 1997, CHEM PHYS LIPIDS, V89, P15, DOI 10.1016/S0009-3084(97)00055-8
   Ishida Y, 2006, J ANAL APPL PYROL, V77, P116, DOI 10.1016/j.jaap.2006.02.006
   Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106
   Karlsson A, 2001, NATURE, V409, P150, DOI 10.1038/35051656
   KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8
   KOZLOV MM, 1994, BIOPHYS J, V67, P1603, DOI 10.1016/S0006-3495(94)80633-2
   Leikin S, 1996, BIOPHYS J, V71, P2623, DOI 10.1016/S0006-3495(96)79454-7
   Lin YC, 2006, SENSOR ACTUAT B-CHEM, V117, P464, DOI 10.1016/j.snb.2005.12.054
   Mahajan N, 2005, LANGMUIR, V21, P3153, DOI 10.1021/la046928c
   Moya SE, 2006, J NANOSCI NANOTECHNO, V6, P2329, DOI 10.1166/jnn.2006.513
   NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043
   PAPAHADJOPOULOS D, 1973, BIOCHIM BIOPHYS ACTA, V311, P330, DOI 10.1016/0005-2736(73)90314-3
   Pascoal P, 2010, LAB CHIP, V10, P2235, DOI 10.1039/c004659k
   RAND RP, 1994, BIOPHYS J, V66, P2127, DOI 10.1016/S0006-3495(94)81008-2
   ROSENBLATT C, 1987, BIOPHYS J, V52, P295, DOI 10.1016/S0006-3495(87)83216-2
   Rossier O, 2003, LANGMUIR, V19, P575, DOI 10.1021/la026236t
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669
   SCHWARZ G, 1992, J PHYSIOL-LONDON, V458, P527, DOI 10.1113/jphysiol.1992.sp019432
   Shalaev EY, 1999, BBA-BIOMEMBRANES, V1419, P229, DOI 10.1016/S0005-2736(99)00068-1
   SIEGEL DP, 1994, BIOPHYS J, V66, P402, DOI 10.1016/S0006-3495(94)80790-8
   Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5
   STELZLE M, 1992, BIOPHYS J, V63, P1346, DOI 10.1016/S0006-3495(92)81712-5
   Tan YC, 2008, LAB CHIP, V8, P339, DOI 10.1039/b713930f
   TOCANNE JF, 1974, CHEM PHYS LIPIDS, V12, P201, DOI 10.1016/0009-3084(74)90075-9
   VANVENETIE R, 1981, BIOCHIM BIOPHYS ACTA, V645, P262, DOI 10.1016/0005-2736(81)90197-8
   West J, 2008, LANGMUIR, V24, P6754, DOI 10.1021/la8004823
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   YAGER P, 1984, MOL CRYST LIQ CRYST, V106, P371, DOI 10.1080/00268948408071454
   YAMADA K, 1984, CHEM LETT, P1713, DOI 10.1246/cl.1984.1713
   Zhu TF, 2009, J AM CHEM SOC, V131, P5705, DOI 10.1021/ja900919c
NR 47
TC 19
Z9 19
U1 1
U2 74
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2012
VL 6
IS 8
BP 6626
EP 6632
DI 10.1021/nn300557s
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 995DU
UT WOS:000307988900013
PM 22861494
DA 2021-01-25
ER

PT J
AU Casuso, I
   Khao, J
   Chami, M
   Paul-Gilloteaux, P
   Husain, M
   Duneau, JP
   Stahlberg, H
   Sturgis, JN
   Scheuring, S
AF Casuso, Ignacio
   Khao, Jonathan
   Chami, Mohamed
   Paul-Gilloteaux, Perrine
   Husain, Mohamed
   Duneau, Jean-Pierre
   Stahlberg, Henning
   Sturgis, James N.
   Scheuring, Simon
TI Characterization of the motion of membrane proteins using high-speed
   atomic force microscopy
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOLOGICAL-MEMBRANES;
   CRYSTAL-STRUCTURES; PARTICLE TRACKING; PLASMA-MEMBRANE; DIFFUSION;
   PORIN; OMPF; TRANSLOCON
AB For cells to function properly(1), membrane proteins must be able to diffuse within biological membranes. The functions of these membrane proteins depend on their position and also on protein-protein and protein-lipid interactions(2). However, so far, it has not been possible to study simultaneously the structure and dynamics of biological membranes. Here, we show that the motion of unlabelled membrane proteins can be characterized using high-speed atomic force microscopy(3). We find that the molecules of outer membrane protein F (OmpF) are widely distributed in the membrane as a result of diffusion-limited aggregation, and while the overall protein motion scales roughly with the local density of proteins in the membrane, individual protein molecules can also diffuse freely or become trapped by protein-protein interactions. Using these measurements, and the results of molecular dynamics simulations, we determine an interaction potential map and an interaction pathway for a membrane protein, which should provide new insights into the connection between the structures of individual proteins and the structures and dynamics of supramolecular membranes.
C1 [Casuso, Ignacio; Husain, Mohamed; Scheuring, Simon] Aix Marseille Univ, INSERM U1006, F-13009 Marseille, France.
   [Khao, Jonathan; Duneau, Jean-Pierre; Sturgis, James N.] Aix Marseille Univ, UPR LISM 9027, CNRS, F-13402 Marseille, France.
   [Chami, Mohamed; Stahlberg, Henning] Univ Basel, C CINA, Biozentrum, CH-4058 Basel, Switzerland.
   [Paul-Gilloteaux, Perrine] Inst Curie, Cell & Tissue Imaging Facil PICT IBiSA, CNRS UMR144, F-75248 Paris, France.
RP Scheuring, S (corresponding author), Aix Marseille Univ, INSERM U1006, Parc Sci & Technol Luminy,163 Ave Luminy, F-13009 Marseille, France.
EM simon.scheuring@inserm.fr
RI Stahlberg, Henning/H-1868-2011; Sturgis, James/F-6051-2011; Scheuring,
   Simon/L-9843-2018; Husain, Mohamed/B-5689-2011; Paul-Gilloteaux,
   Perrine/L-8287-2018; Sturgis, James/AAU-8103-2020; Casuso,
   Ignacio/E-5574-2016
OI Stahlberg, Henning/0000-0002-1185-4592; Scheuring,
   Simon/0000-0003-3534-069X; Paul-Gilloteaux, Perrine/0000-0002-4822-165X;
   Husain, Mohamed/0000-0002-5714-1037; Sturgis, James/0000-0001-5125-7699;
   Casuso, Ignacio/0000-0001-7192-0136
FU Institut Curie; Institut National de la Sante et Recherche Medicale
   (INSERM)Institut National de la Sante et de la Recherche Medicale
   (Inserm); Agence Nationale de la Recherche (ANR)French National Research
   Agency (ANR); City of ParisRegion Ile-de-France; Centre National de la
   Recherche Scientifique (CNRS)Centre National de la Recherche
   Scientifique (CNRS); Centre Informatique National de l'Enseignement
   Superieur (CINES); Aix-Marseille University; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [315230_127545];
   Swiss National Science Foundation (NCCRs Struct Biol and TransCure);
   Swiss Initiative for Systems Biology (SystemsX.ch)
FX The authors thank C. Nimigean and F. Rico for critical discussion of the
   manuscript. The authors also thank P. Abeyrathne for support with the
   lipopolysaccharide detection. Work in the Scheuring laboratory was
   supported by the Institut Curie, the Institut National de la Sante et
   Recherche Medicale (INSERM), the Agence Nationale de la Recherche (ANR)
   and the City of Paris. Work in the Sturgis laboratory was supported by
   the Centre National de la Recherche Scientifique (CNRS), the Agence
   Nationale de la Recherche (ANR), Centre Informatique National de
   l'Enseignement Superieur (CINES) and Aix-Marseille University. Work in
   the Stahlberg laboratory was supported by the Swiss National Science
   Foundation (grant no. 315230_127545, and NCCRs Struct Biol and
   TransCure) and the Swiss Initiative for Systems Biology (SystemsX.ch).
CR Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898
   ANNE P, 2004, CURRENT OPINION STRU, V14, P233
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   de Meyer FJM, 2008, BIOPHYS J, V95, P1851, DOI 10.1529/biophysj.107.124164
   Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824
   ENGEL A, 1985, NATURE, V317, P643, DOI 10.1038/317643a0
   Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394
   FOULDS J, 1978, J BACTERIOL, V133, P1478, DOI 10.1128/JB.133.3.1478-1483.1978
   Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103
   Garcia R, 2010, AMPLITUDE MODULATION, P77, DOI DOI 10.1002/9783527632183.CH6
   HOENGER A, 1993, J MOL BIOL, V233, P400, DOI 10.1006/jmbi.1993.1520
   Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102
   Husain M, 2012, J MOL RECOGNIT, V25, P292, DOI 10.1002/jmr.2187
   KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0
   Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637
   Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204
   Melo E, 2006, BIOPHYS CHEM, V123, P77, DOI 10.1016/j.bpc.2006.05.003
   Mika JT, 2011, CURR OPIN BIOTECH, V22, P117, DOI 10.1016/j.copbio.2010.09.009
   OSBORN MJ, 1980, ANNU REV MICROBIOL, V34, P369, DOI 10.1146/annurev.mi.34.100180.002101
   Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147
   Rosenbusch P., 1974, J BIOL CHEM, V249, P8019
   SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111
   SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948
   Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926
   Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233
   Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5
   Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029
   Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510
   WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400
   Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137
NR 30
TC 133
Z9 136
U1 3
U2 119
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD AUG
PY 2012
VL 7
IS 8
BP 525
EP 529
DI 10.1038/NNANO.2012.109
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 986QR
UT WOS:000307359600013
PM 22772862
OA Green Published
DA 2021-01-25
ER

PT J
AU Llosa, M
   Schroder, G
   Dehio, C
AF Llosa, Matxalen
   Schroeder, Gunnar
   Dehio, Christoph
TI New perspectives into bacterial DNA transfer to human cells
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
DE type IV secretion; bacterial conjugation; Bartonella; R388; gene
   therapy; DNA delivery
ID IV SECRETION SYSTEMS; NUCLEIC-ACID DELIVERY; ZINC-FINGER NUCLEASES;
   GENE-THERAPY; MAMMALIAN-CELLS; CONJUGATIVE RELAXASE;
   BARTONELLA-HENSELAE; SITE; VECTORS; BACTOFECTION
AB The type IV secretion system (T4SS) VirB/D4 of the facultative intracellular pathogen Bartonella henselae is known to translocate bacterial effector proteins into human cells. Two recent reports on DNA transfer into human cells have demonstrated the versatility of this bacterial secretion system for macromolecular substrate transfer. Moreover, these findings have opened the possibility for developing new tools for DNA delivery into specific human cell types. DNA can be introduced into these cells covalently attached to a site-specific integrase with potential target sequences in the human genome. This novel DNA delivery system is discussed in the context of existing methods for genetic modification of human cells.
C1 [Schroeder, Gunnar; Dehio, Christoph] Univ Basel, Biozentrum, Res Area Infect Biol, Basel, Switzerland.
   [Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.
   [Llosa, Matxalen] IBBTEC UC CSIC SODERCAN, Santander, Spain.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Res Area Infect Biol, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; , matxalen/ABG-5541-2020; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; , matxalen/0000-0002-4826-2240;
   Dehio, Christoph/0000-0001-7288-1052
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A_132979]; Swiss Initiative for Systems Biology; Spanish
   Ministry of Science and InnovationSpanish Government [BIO2010-11623-E]; 
   [51RT 0_126008]
FX Work in our laboratories is supported by grant 3100A_132979 from the
   Swiss National Science Foundation, grant 51RT 0_126008 (InfectX) in the
   frame of SystemsX.ch, the Swiss Initiative for Systems Biology, to C.D.,
   and BIO2010-11623-E from the Spanish Ministry of Science and Innovation
   to M.L.
CR Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047
   Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10
   Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09
   Cheung W, 2012, BIOENGINEERED, V3, P86, DOI 10.4161/bbug.18621
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102
   Ellis BL, 2012, GENE THER
   Elsabahy M, 2011, CURR DRUG DELIV, V8, P235, DOI 10.2174/156720111795256174
   Fernandez-Gonzalez E, 2011, J BACTERIOL, V193, P6257, DOI 10.1128/JB.05905-11
   Gonzalez-Perez Blanca, 2009, Biotechnology Journal, V4, P554, DOI 10.1002/biot.200800184
   Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862
   Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805
   Jafari M, 2012, CURR MED CHEM, V19, P197, DOI 10.2174/092986712803414141
   Le Provost F, 2010, TRENDS BIOTECHNOL, V28, P134, DOI 10.1016/j.tibtech.2009.11.007
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x
   MADZAK C, 1989, J MOL BIOL, V205, P501, DOI 10.1016/0022-2836(89)90221-0
   McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207
   Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976
   Moreno M, 2010, CURR GENE THER, V10, P56, DOI 10.2174/156652310790945566
   Muhammad A, 2012, EXPERT REV VACCINES, V11, P97, DOI [10.1586/erv.11.149, 10.1586/ERV.11.149]
   Palffy R, 2006, GENE THER, V13, P101, DOI 10.1038/sj.gt.3302635
   Pilgrim S, 2003, GENE THER, V10, P2036, DOI 10.1038/sj.gt.3302105
   Pontes DS, 2011, PROTEIN EXPRES PURIF, V79, P165, DOI 10.1016/j.pep.2011.06.005
   Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x
   Read ML, 2005, ADV GENET, V53, P19, DOI 10.1016/S0065-2660(05)53002-5
   Recchia A, 2006, REJUV RES, V9, P446, DOI 10.1089/rej.2006.9.446
   Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001
   Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003
   Tangney Mark, 2010, Bioeng Bugs, V1, P284, DOI 10.4161/bbug.1.4.11725
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865
   Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141
NR 35
TC 26
Z9 27
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD AUG
PY 2012
VL 20
IS 8
BP 355
EP 359
DI 10.1016/j.tim.2012.05.008
PG 5
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 992TN
UT WOS:000307802700002
PM 22748513
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Blattler, SM
   Verdeguer, F
   Liesa, M
   Cunningham, JT
   Vogel, RO
   Chim, H
   Liu, HF
   Romanino, K
   Shirihai, OS
   Vazquez, F
   Ruegg, MA
   Shi, Y
   Puigserver, P
AF Blaettler, Sharon M.
   Verdeguer, Francisco
   Liesa, Marc
   Cunningham, John T.
   Vogel, Rutger O.
   Chim, Helen
   Liu, Huifei
   Romanino, Klaas
   Shirihai, Orian S.
   Vazquez, Francisca
   Rueegg, Markus A.
   Shi, Yang
   Puigserver, Pere
TI Defective Mitochondrial Morphology and Bioenergetic Function in Mice
   Lacking the Transcription Factor Yin Yang 1 in Skeletal Muscle
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID FACTOR YY1; OXIDATIVE-PHOSPHORYLATION; PGC-1 COACTIVATORS; FACTOR
   YIN-YANG-1; GENE-EXPRESSION; ERR-ALPHA; IN-VIVO; BIOGENESIS; DISEASE;
   PGC-1-ALPHA
AB The formation, distribution, and maintenance of functional mitochondria are achieved through dynamic processes that depend strictly on the transcription of nuclear genes encoding mitochondrial proteins. A large number of these mitochondrial genes contain binding sites for the transcription factor Yin Yang 1 (YY1) in their proximal promoters, but the physiological relevance is unknown. We report here that skeletal-muscle-specific YY1 knockout (YY1mKO) mice have severely defective mitochondrial morphology and oxidative function associated with exercise intolerance, signs of mitochondrial myopathy, and short stature. Gene set enrichment analysis (GSEA) revealed that the top pathways downregulated in YY1mKO mice were assigned to key metabolic and regulatory mitochondrial genes. This analysis was consistent with a profound decrease in the level of mitochondrial proteins and oxidative phosphorylation (OXPHOS) bioenergetic function in these mice. In contrast to the finding for wild-type mice, inactivation of the mammalian target of rapamycin (mTOR) did not suppress mitochondrial genes in YY1mKO mice. Mechanistically, mTOR-dependent phosphorylation of YY1 resulted in a strong interaction between YY1 and the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator la (PGC1 alpha), a major regulator of mitochondrial function. These results underscore the important role of YY1 in the maintenance of mitochondrial function and explain how its inactivation might contribute to exercise intolerance and mitochondrial myopathies.
C1 [Blaettler, Sharon M.; Verdeguer, Francisco; Cunningham, John T.; Vogel, Rutger O.; Chim, Helen; Vazquez, Francisca; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   [Blaettler, Sharon M.; Verdeguer, Francisco; Cunningham, John T.; Vogel, Rutger O.; Chim, Helen; Liu, Huifei; Vazquez, Francisca; Shi, Yang; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA.
   [Liesa, Marc; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Mitochondria ARC,Evans Biomed Res Ctr, Boston, MA 02118 USA.
   [Romanino, Klaas; Rueegg, Markus A.] Univ Basel, Biozentrum, Dept Neurobiol, Basel, Switzerland.
RP Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
EM Pere_Puigserver@dfci.harvard.edu
RI Ruegg, Markus/X-7256-2019; Vazquez, Francisca/AAA-3751-2020; Verdeguer,
   Francisco/O-5486-2016; Liesa, Marc/K-8590-2019; Vazquez,
   Francisca/ABC-4620-2020
OI Ruegg, Markus/0000-0002-4974-9384; Vazquez,
   Francisca/0000-0002-2857-4685; Verdeguer, Francisco/0000-0002-5798-1503;
   Liesa, Marc/0000-0002-5909-8570; Cunningham, John/0000-0001-6490-4533;
   Shirihai, Orian/0000-0002-9502-2661
FU postdoctoral fellowship from the Swiss National Science Foundation;
   NIH/NIDDK grant [RO1 DK081418]; Muscular Dystrophy Association
   grantMuscular Dystrophy Association [MDA202237]; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01DK081418, R01DK081418, R01DK081418, R01DK074778, R01DK074778,
   R01DK074778, R01DK081418, R01DK081418, R01DK074778, R01DK074778,
   R01DK074778, R01DK081418, R01DK074778, R01DK074778, R01DK074778,
   R01DK081418, R01DK074778, R01DK081418, R01DK081418, R01DK081418,
   R01DK081418, R01DK081418] Funding Source: NIH RePORTER
FX These studies were supported by a postdoctoral fellowship from the Swiss
   National Science Foundation (to S.M.B.) and by NIH/NIDDK grant RO1
   DK081418 and Muscular Dystrophy Association grant MDA202237 (to P.P.).
CR Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006
   Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124
   Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008
   Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z
   CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008
   He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102
   Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418
   Liesa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003613
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/h11-076, 10.1139/H11-076]
   Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003
   Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9
   Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   Weill L, 2003, J VIROL, V77, P2903, DOI 10.1128/JVI.77.5.2903-2914.2003
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707
   Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
NR 52
TC 53
Z9 55
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD AUG
PY 2012
VL 32
IS 16
BP 3333
EP 3346
DI 10.1128/MCB.00337-12
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 984PM
UT WOS:000307203500012
PM 22711985
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Duran, RV
   Hall, MN
AF Duran, Raul V.
   Hall, Michael N.
TI Leucyl-tRNA synthetase: double duty in amino acid sensing
SO CELL RESEARCH
LA English
DT Editorial Material
ID CONTROLS TORC1; EGO COMPLEX; RAG GTPASES; MTORC1; ACTIVATION; REGULATOR;
   PATHWAY
AB The cellular response to amino acids is controlled at the molecular level by TORC1. While many of the elements that participate in TORC1 signaling are known, we still have no clear idea how cells sense amino acids. Two recent studies found that leucyl-tRNA synthetase (LRS) is a leucine sensor for TORC1, in both yeast and mammalian cells.
C1 [Duran, Raul V.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Duran, Raul/E-4764-2011
OI Duran, Raul/0000-0002-2249-9215
CR Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033
   Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038
   Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056
NR 16
TC 14
Z9 15
U1 0
U2 9
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYAND ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
J9 CELL RES
JI Cell Res.
PD AUG
PY 2012
VL 22
IS 8
BP 1207
EP 1209
DI 10.1038/cr.2012.68
PG 3
WC Cell Biology
SC Cell Biology
GA 983KZ
UT WOS:000307119500001
PM 22525334
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Pantelic, RS
   Meyer, JC
   Kaiser, U
   Stahlberg, H
AF Pantelic, Radosav S.
   Meyer, Jannik C.
   Kaiser, Ute
   Stahlberg, Henning
TI The application of graphene as a sample support in transmission electron
   microscopy
SO SOLID STATE COMMUNICATIONS
LA English
DT Article
DE Graphene; Graphene oxide; Transmission electron microscopy
ID CARBON NANOTUBES; LARGE-AREA; SPECIMEN PREPARATION; BIOLOGICAL
   MACROMOLECULES; CRYOELECTRON MICROSCOPY; ATOMIC-RESOLUTION; LAYER
   GRAPHENE; FILMS; SINGLE; OXIDE
AB Transmission electron microscopy has witnessed rampant development and surging point resolution over the past few years. The improved imaging performance of modern electron microscopes shifts the bottleneck for image contrast and resolution to sample preparation. Hence, it is increasingly being realized that the full potential of electron microscopy will only be realized with the optimization of current sample preparation techniques. Perhaps the most recognized issues are background signal and noise contributed by sample supports, sample charging and instability. Graphene provides supports of single atom thickness, extreme physical stability, periodic structure, and ballistic electrical conductivity. As an increasing number of applications adapting graphene to their benefit emerge, we discuss the unique capabilities afforded by the use of graphene as a sample support for electron microscopy. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Kaiser, Ute] Univ Ulm, Electron Microscopy Dept Mat Sci, Ulm, Germany.
   [Pantelic, Radosav S.; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland.
   [Meyer, Jannik C.] Univ Vienna, Dept Phys, A-1090 Vienna, Austria.
RP Kaiser, U (corresponding author), Univ Ulm, Electron Microscopy Dept Mat Sci, Ulm, Germany.
EM ute.kaiser@uni-ulm.de; Henning.Stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011; Meyer, Jannik C/H-8541-2012
OI Stahlberg, Henning/0000-0002-1185-4592; Meyer, Jannik
   C/0000-0003-4023-0778
FU German Research Foundation (DFG)German Research Foundation (DFG);
   Ministry of Science, Research and Arts (MWK) of the state
   Baden-Wurttemberg within the Sub-Angstrom Low-Voltage Electron
   Microscopy (SALVE) project; Swiss National Science Foundation (NCCRs
   Struct. Biol., Nano, and TransCure); Swiss Initiative for Systems
   Biology (SystemsX.ch)
FX "Prof. Jannik C. Meyer and Prof. Ute Kaiser gratefully acknowledge
   financial support from the German Research Foundation (DFG) and the
   Ministry of Science, Research and Arts (MWK) of the state
   Baden-Wurttemberg within the Sub-Angstrom Low-Voltage Electron
   Microscopy (SALVE) project. Radosav S. Pantelic and Prof. Henning
   Stahlberg gratefully acknowledge support from the Swiss National Science
   Foundation (NCCRs Struct. Biol., Nano, and TransCure), and the Swiss
   Initiative for Systems Biology (SystemsX.ch)."
CR Benesch JLP, 2010, J STRUCT BIOL, V172, P161, DOI 10.1016/j.jsb.2010.03.004
   Booth TJ, 2008, NANO LETT, V8, P2442, DOI 10.1021/nl801412y
   Brink J, 1998, J MICROSC-OXFORD, V191, P67
   Cerf A, 2011, NANO LETT, V11, P4232, DOI 10.1021/nl202219w
   Chamberlain TW, 2007, J AM CHEM SOC, V129, P8609, DOI 10.1021/ja071803q
   Chen JH, 2008, NAT PHYS, V4, P377, DOI 10.1038/nphys935
   Chen SS, 2011, NANO LETT, V11, P3519, DOI 10.1021/nl201699j
   Chuvilin A, 2011, NAT MATER, V10, P687, DOI [10.1038/nmat3082, 10.1038/NMAT3082]
   Chuvilin A, 2010, NAT CHEM, V2, P450, DOI [10.1038/NCHEM.644, 10.1038/nchem.644]
   Chuvilin A, 2010, ANGEW CHEM INT EDIT, V49, P193, DOI 10.1002/anie.200902243
   Chuvilin A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083019
   COLE R, 1990, J ELECTRON MICR TECH, V16, P167, DOI 10.1002/jemt.1060160207
   DOBELLE WH, 1968, J CELL BIOL, V39, P733, DOI 10.1083/jcb.39.3.733
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Erickson K, 2010, ADV MATER, V22, P4467, DOI 10.1002/adma.201000732
   Erni R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165443
   Gass MH, 2008, NAT NANOTECHNOL, V3, P676, DOI 10.1038/nnano.2008.280
   Glaeser RM, 2004, MICROSC MICROANAL, V10, P790, DOI 10.1017/S1431927604040668
   Glaeser RM, 2011, BIOPHYS J, V100, P2331, DOI 10.1016/j.bpj.2011.04.018
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Gomez-Navarro C, 2010, NANO LETT, V10, P1144, DOI 10.1021/nl9031617
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452
   Guan L., 2005, PHYS REV LETT, V94, P2
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823
   Haider M, 2010, MICROSC MICROANAL, V16, P393, DOI 10.1017/S1431927610013498
   Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817
   Heersche HB, 2007, NATURE, V446, P56, DOI 10.1038/nature05555
   Hettler S, 2012, MICROSC MICROANAL, V18, P1010, DOI 10.1017/S1431927612001560
   Huang JY, 2009, P NATL ACAD SCI USA, V106, P10103, DOI 10.1073/pnas.0905193106
   Huang P.Y., 2012, NANO LETT
   Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1977, OPTIK, V48, P193
   JAKUBOWSKI U, 1989, ULTRAMICROSCOPY, V31, P351, DOI 10.1016/0304-3991(89)90333-1
   Kaiser U., 2011, ULTRAMICROSCOPY
   Kelly DF, 2008, P NATL ACAD SCI USA, V105, P4703, DOI 10.1073/pnas.0800867105
   Kim K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245433
   Kim K, 2010, PHYS STATUS SOLIDI-R, V4, P302, DOI 10.1002/pssr.201000244
   Kotakoski J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105505
   Krivanek OL, 1999, ULTRAMICROSCOPY, V78, P1, DOI 10.1016/S0304-3991(99)00013-3
   Krueger M, 2011, ACS NANO, V5, P10047, DOI 10.1021/nn204287g
   Larson DM, 2011, J STRUCT BIOL, V174, P420, DOI 10.1016/j.jsb.2011.02.005
   Lechner L., 2011, MICROSC MICROANAL, V17, P628
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee Z, 2009, NANO LETT, V9, P3365, DOI 10.1021/nl901664k
   Li N, 2011, BIOMATERIALS, V32, P9374, DOI 10.1016/j.biomaterials.2011.08.065
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Lin YC, 2012, NANO LETT, V12, P414, DOI 10.1021/nl203733r
   Liu Z, 2007, NAT NANOTECHNOL, V2, P422, DOI 10.1038/nnano.2007.187
   Liu ZF, 2010, ADV FUNCT MATER, V20, P2857, DOI 10.1002/adfm.201000761
   Massover WH, 2011, MICRON, V42, P141, DOI 10.1016/j.micron.2010.05.006
   Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m
   Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094
   Meyer JC, 2009, MICROSC MICROANAL, V15, P126, DOI 10.1017/S1431927609096056
   Mitsuoka K, 2011, MICRON, V42, P100, DOI 10.1016/j.micron.2010.08.006
   Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721
   Mohanty N, 2011, NANO LETT, V11, P1270, DOI 10.1021/nl104292k
   Nottbohm CT, 2008, ULTRAMICROSCOPY, V108, P885, DOI 10.1016/j.ultramic.2008.02.008
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pantelic R.S., 2011, NANO LETT
   Pantelic RS, 2011, J STRUCT BIOL, V174, P234, DOI 10.1016/j.jsb.2010.10.002
   Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020
   Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v
   Rhinow D, 2008, ULTRAMICROSCOPY, V108, P698, DOI 10.1016/j.ultramic.2007.11.005
   Rhinow D, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3645010
   Rhinow D, 2011, ULTRAMICROSCOPY, V111, P342, DOI 10.1016/j.ultramic.2011.01.028
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   Schaeffel F., 2011, ACS NANO
   Schmidt-Krey I, 2011, MICRON, V42, P107, DOI 10.1016/j.micron.2010.07.004
   Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x
   Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141
   Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3
   Wang XB, 2009, CHEM VAPOR DEPOS, V15, P53, DOI 10.1002/cvde.200806737
   Warner JH, 2010, ACS NANO, V4, P470, DOI 10.1021/nn901371k
   Westenfelder B, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/5/055502
   Westenfelder B., 2011, NANO LETT
   Wilson NR, 2009, ACS NANO, V3, P2547, DOI 10.1021/nn900694t
   Wu Y., 2012, ACS NANO
   Young NP, 2010, ULTRAMICROSCOPY, V110, P506, DOI 10.1016/j.ultramic.2009.12.010
   Zakharchenko KV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046808
   Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004
   Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235
   Ziegler K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266802
   Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245402
   Zoberbier T., 2012, J AM CHEM SOC
NR 88
TC 47
Z9 47
U1 0
U2 73
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0038-1098
EI 1879-2766
J9 SOLID STATE COMMUN
JI Solid State Commun.
PD AUG
PY 2012
VL 152
IS 15
SI SI
BP 1375
EP 1382
DI 10.1016/j.ssc.2012.04.038
PG 8
WC Physics, Condensed Matter
SC Physics
GA 983ZV
UT WOS:000307158100015
DA 2021-01-25
ER

PT J
AU Kaulich, M
   Cubizolles, F
   Nigg, EA
AF Kaulich, Manuel
   Cubizolles, Fabien
   Nigg, Erich A.
TI On the regulation, function, and localization of the DNA-dependent
   ATPase PICH
SO CHROMOSOMA
LA English
DT Article
ID ANAPHASE BRIDGES; CHROMOSOME SEGREGATION; SPINDLE CHECKPOINT; PLK1;
   CELLS; RESOLUTION; THREADS; PROTEIN; MITOSIS; BLM
AB The putative chromatin remodeling enzyme Plk1-interacting checkpoint helicase (PICH) was discovered as an interaction partner and substrate of the mitotic kinase Plk1. During mitosis PICH associates with centromeres and kinetochores and, most interestingly, constitutes a robust marker for ultrafine DNA bridges (UFBs) that connect separating chromatids in anaphase cells. The precise roles of PICH remain to be clarified. Here, we have used antibody microinjection and siRNA-rescue experiments to study PICH function and localization during M phase progression, with particular emphasis on the role of the predicted ATPase domain and the regulation of PICH localization by Plk1. We show that interference with PICH function results in chromatin bridge formation and micronucleation and that ATPase activity is critical for PICH function. Interestingly, an intact ATPase domain of PICH is required for prevention of chromatin bridge formation but not for UFB resolution, and quantitative analyses of UFB and chromatin bridge frequencies suggest that these structures are of different etiologies. We also show that the ATPase activity of PICH is required for temporal and spatial control of PICH localization to chromatin and that Plk1 likely controls PICH localization through phosphorylation of proteins distinct from PICH itself. This work strengthens the view that PICH is an important, Plk1-regulated enzyme, whose ATPase activity is essential for maintenance of genome integrity. Although not required for the spindle assembly checkpoint, PICH is clearly important for faithful chromosome segregation.
C1 [Kaulich, Manuel; Cubizolles, Fabien; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4065 Basel, Switzerland.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4065 Basel, Switzerland.
EM erich.nigg@unibas.ch
RI Kaulich, Manuel/U-4523-2017
OI Kaulich, Manuel/0000-0002-9528-8822; Cubizolles,
   Fabien/0000-0002-9822-4074; nigg, erich/0000-0003-4835-5719
FU Max Planck SocietyMax Planck Society; University of Basel
FX We thank Elisabeth Burgelt and Alicja Baskaya for their help in
   producing the monoclonal PICH antibody and Ina Poser, Anthony Hyman, and
   Jan Ellenberg for the HeLaS3 cell line stably expressing histone
   2B-mCherry. Furthermore, we thank Ian Hickson for critical reading of
   the manuscript and Lily Wang, Nadja Hubner, and all members of the Nigg
   lab for helpful discussions. This work was supported by the Max Planck
   Society and the University of Basel.
CR Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001
   Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882
   Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777
   Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167
   Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801
   Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6
   HUANG TG, 1994, J BIOL CHEM, V269, P16493
   Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2
   Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348
   Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226
   Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950
   Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951
   Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092
   Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Spence JM, 2007, J CELL SCI, V120, P3952, DOI 10.1242/jcs.013730
   Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020
   Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
   Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7
   Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255
NR 29
TC 26
Z9 27
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-5915
J9 CHROMOSOMA
JI Chromosoma
PD AUG
PY 2012
VL 121
IS 4
BP 395
EP 408
DI 10.1007/s00412-012-0370-0
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 977WP
UT WOS:000306695800006
PM 22527115
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Haas, J
   Arnold, K
   Kiefer, F
   Bordoli, L
   Schwede, T
AF Haas, Juergen
   Arnold, Konstantin
   Kiefer, Florian
   Bordoli, Lorenza
   Schwede, Torsten
TI The ProteinModelPortal - continuously assessing Homology Modeling
   Servers with CAMEO
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 26th Annual Symposium of the Protein-Society
CY AUG 05-08, 2012
CL San Diego, CA
SP Prot Soc, Genentech, BioSilta, Aviv Biomed, Inc, Jasco, Purtein, Wyatt Technol Corp, Emerald Biosyst
C1 [Haas, Juergen; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Schwede, Torsten] Swiss Inst Bioinformat, Basel, Switzerland.
   [Haas, Juergen; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Biozentrum, Basel, Switzerland.
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD AUG
PY 2012
VL 21
SU 1
SI SI
BP 188
EP 189
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 982CR
UT WOS:000307019800339
DA 2021-01-25
ER

PT J
AU Paul, R
   Graff-Meyer, A
   Stahlberg, H
   Lauer, ME
   Rufer, AC
   Beck, H
   Briguet, A
   Schnaible, V
   Buckel, T
   Boeckle, S
AF Paul, Rajsekhar
   Graff-Meyer, Alexandra
   Stahlberg, Henning
   Lauer, Matthias E.
   Rufer, Arne C.
   Beck, Hermann
   Briguet, Alexandre
   Schnaible, Volker
   Buckel, Thomas
   Boeckle, Sabine
TI Structure and Function of Purified Monoclonal Antibody Dimers Induced by
   Different Stress Conditions
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE antibody dimer; function; monoclonal antibody; protein aggregation;
   structure
ID INDUCED AGGREGATION; SELF-ASSOCIATION; IGG1; STABILITY;
   PHOTODEGRADATION; IMMUNOGENICITY; IMMUNOGLOBULIN; FLEXIBILITY;
   MODULATION; MECHANISM
AB To investigate structure and function of different monoclonal antibody (MAb) dimers.
   MAb dimers were induced by process-related, low pH and UV light stress. Dimers were isolated and purified by chromatography and extensively characterized by biochemical, structural and functional methods.
   Highly purified dimer forms were obtained which enabled detailed characterization. Dimers induced by process stress were associated by a single non-covalent interaction site between two Fab domains in a characteristic "bone-like" structure observed in Transmission Electron Microscopy (TEM). These dimers showed reduced potency and antigen binding affinity. Low pH stress generated more stable but also non-covalently associated dimers without chemical alterations in a typical "closed" conformation according to TEM. These dimer species were more compact and more hydrophobic as dimers induced by process stress. They showed bioactivity and antigen binding affinity similar to the native monomer. Light-induced dimers, exhibiting various different conformations, were the most stable dimers with various chemical modifications leading to a broad range in size, charge and hydrophobicity. These dimers fully lost bioactivity and antigen binding affinity.
   The use of highly purified MAb dimers and a panel of characterizations methods enabled to obtain a clear picture about molecular architecture and function of dimers.
C1 [Paul, Rajsekhar; Beck, Hermann; Briguet, Alexandre; Schnaible, Volker; Buckel, Thomas; Boeckle, Sabine] F Hoffmann La Roche Ltd, Pharma Tech Dev Europe Biol Analyt, CH-4070 Basel, Switzerland.
   [Graff-Meyer, Alexandra; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4085 Basel, Switzerland.
   [Lauer, Matthias E.; Rufer, Arne C.] F Hoffmann Roche Ltd, Discovery Technol, CH-4070 Basel, Switzerland.
RP Boeckle, S (corresponding author), F Hoffmann La Roche Ltd, Pharma Tech Dev Europe Biol Analyt, CH-4070 Basel, Switzerland.
EM sabine.boeckle@roche.com
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Lauer,
   Matthias/0000-0003-3252-8718
FU Swiss initiative for systems biology (SystemsX.ch)
FX We thank Thomas von Hirschheydt, Marc Pompiati, Gordan Graf ( all Roche
   Penzberg) and Marco Sonderegger for their support in isolation of
   aggregates. We sincerely acknowledge Rita Grubel, Gaby Walch, Jurgen
   May, Bernd Moritz, Stephen Hyland, Philipp Metzger, Jorg Hoernschemeyer
   and Eric Kusznir for their contributions to analytical characterizations
   of the dimers. Thanks to Jochem Alsenz and Michael Hennig for supporting
   the TEM experiments. We acknowledge Thomas Schreitmueller for sponsoring
   and supporting the project. This work was in part supported by the Swiss
   initiative for systems biology (SystemsX.ch).
CR Bond MD, 2010, J PHARM SCI-US, V99, P2582, DOI 10.1002/jps.22034
   Bongini L, 2004, P NATL ACAD SCI USA, V101, P6466, DOI 10.1073/pnas.0400119101
   Brummitt RK, 2011, J PHARM SCI-US, V100, P2087, DOI 10.1002/jps.22448
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Cao S, 2009, Pharmeur Bio Sci Notes, V2009, P73
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366
   Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862
   Demeule B, 2009, MABS-AUSTIN, V1, P142, DOI 10.4161/mabs.1.2.7632
   den Engelsman J, 2011, PHARM RES-DORDR, V28, P920, DOI 10.1007/s11095-010-0297-1
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243
   Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777
   Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834
   Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u
   Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508
   Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001
   Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599
   Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6
   Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174
   Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457
   Kanai S, 2008, J PHARM SCI-US, V97, P4219, DOI 10.1002/jps.21322
   Kendall A, 2007, VIROLOGY, V369, P226, DOI 10.1016/j.virol.2007.08.013
   Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815
   Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328
   Kumar S, 2011, PHARM RES-DORDR, V28, P949, DOI 10.1007/s11095-011-0414-9
   Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003
   Lewis JD, 1997, J COLLOID INTERF SCI, V196, P170, DOI 10.1006/jcis.1997.5187
   Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566
   Mahler HC, 2005, EUR J PHARM BIOPHARM, V59, P407, DOI 10.1016/j.ejpb.2004.12.004
   Moore JMR, 1999, BIOCHEMISTRY-US, V38, P13960, DOI 10.1021/bi9905516
   Perico N, 2009, J PHARM SCI-US, V98, P3031, DOI 10.1002/jps.21539
   Philo JS, 2006, AAPS J, V8, pE564, DOI 10.1208/aapsj080365
   Qi P, 2009, J PHARM SCI-US, V98, P3117, DOI 10.1002/jps.21617
   Remmele RL, 2006, J PHARM SCI-US, V95, P126, DOI 10.1002/jps.20515
   Rosenberg AS, 2006, AAPS J, V8, pE501
   Roux KH, 1999, INT ARCH ALLERGY IMM, V120, P85, DOI 10.1159/000024226
   Roux KH, 1997, J IMMUNOL, V159, P3372
   Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6
   Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097
   Taschner N, 2001, J MOL BIOL, V310, P169, DOI 10.1006/jmbi.2001.4736
   van Beers MMC, 2010, PHARM RES-DORDR, V27, P1812, DOI 10.1007/s11095-010-0172-0
   Van Buren N, 2009, J PHARM SCI-US, V98, P3013, DOI 10.1002/jps.21514
   Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1
   Zhang A, 2012, PHARM RES-DORDR, V29, P236, DOI 10.1007/s11095-011-0538-y
NR 47
TC 40
Z9 41
U1 0
U2 32
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD AUG
PY 2012
VL 29
IS 8
BP 2047
EP 2059
DI 10.1007/s11095-012-0732-6
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 975YI
UT WOS:000306547300002
PM 22477068
DA 2021-01-25
ER

PT J
AU Neves, RC
   Kristensen, RM
   Funch, P
AF Neves, Ricardo Cardoso
   Kristensen, Reinhardt Mobjerg
   Funch, Peter
TI Ultrastructure and morphology of the cycliophoran female
SO JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Symbion; gonopore; body plan; evolution; Spiralia
ID SYMBION-PANDORA CYCLIOPHORA; LIFE-CYCLE; DWARF MALE; PHYLOGENETIC
   POSITION; CRYPTIC SPECIATION; ADHESIVE ORGANS; NERVOUS-SYSTEM;
   AMERICANUS; PHYLUM; LARVA
AB Knowledge on the morphology of the cycliophoran female has mostly been based on observations of immature females in brood chambers of feeding stages. With the use of light- and transmission electron microscopy, the morphology and ultrastructure of the free and fully mature female of Cycliophora is described now for the first time. The external morphology is characterized by a ciliation consisting of an anteroventral ciliated field, a posterior ciliated tuft, and four sensory structures extending anteriorly from the anteroventral ciliated field. In addition, a small ciliated structure in the midventral region is interpreted as a round-shaped gonopore. Internally, a bilateral cerebral ganglion is situated in the anterior region and a large oocyte is located medially in the body. Several glands are present anteriorly, while posteriorly a pair of glands is associated with the ciliated tuft. Dorsal and ventral longitudinal muscles, as well as, dorsoventral muscles are identified by electron microscopy. Muscle fibers attach to the endocuticle via the epidermis, by means of attachment fibers. An unknown endosymbiont is present throughout the body of the female. We discuss the functional implications of the morphological and ultrastructural aspects of the cycliophoran female. Finally, we compare this life cycle stage with that fromother phyla, suggested as phylogenetically close. J. Morphol. 2012. (C) 2012 Wiley Periodicals, Inc.
C1 [Funch, Peter] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark.
   [Neves, Ricardo Cardoso] Univ Aveiro, Ctr Estudos Ambiente & Mar, Dept Biol, P-3810193 Aveiro, Portugal.
   [Neves, Ricardo Cardoso; Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Nat Hist Museum Denmark, Zool Museum, DK-2100 Copenhagen O, Denmark.
   [Neves, Ricardo Cardoso] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Funch, P (corresponding author), Aarhus Univ, Dept Biosci, Munkegade 116, DK-8000 Aarhus, Denmark.
EM peter.funch@biology.au.dk
RI Funch, Peter/B-7437-2009; Kristensen, Reinhardt M/A-8772-2013; Neves,
   Ricardo Cardoso/J-9822-2014; Funch, Peter/H-7191-2019
OI Funch, Peter/0000-0002-0184-1552; Kristensen, Reinhardt
   M/0000-0001-9549-1188; Neves, Ricardo Cardoso/0000-0002-9219-9066;
   Funch, Peter/0000-0002-0184-1552
FU Fundacao para a Ciencia e a Tecnologia, PortugalPortuguese Foundation
   for Science and Technology [SFRH/BD/24436/2005]
FX Contract grant sponsor: Fundacao para a Ciencia e a Tecnologia,
   Portugal; Contract grant number: SFRH/BD/24436/2005 (to RCN).
CR Ahlrichs W.H., 1995, ULTRASTRUKTUR PHYLOG, P1
   Baker JM, 2007, MAR BIOL, V151, P2183, DOI 10.1007/s00227-007-0654-8
   Baker JM, 2007, ZOOL SCR, V36, P353, DOI 10.1111/j.1463-6409.2006.00288.x
   BICUDO CED, 1988, NOVA HEDWIGIA, V46, P407
   Clement P., 1991, P219
   Funch P, 1996, J MORPHOL, V230, P231, DOI 10.1002/(SICI)1097-4687(199612)230:3<231::AID-JMOR1>3.0.CO;2-H
   FUNCH P, 1995, NATURE, V378, P711, DOI 10.1038/378711a0
   Funch P, 2005, HYDROBIOLOGIA, V546, P11, DOI 10.1007/s10750-005-4093-6
   Funch P, 2008, VIE MILIEU, V58, P185
   Funch P., 1999, ENCY REPROD, V1, P800
   Funch Peter, 1997, P409
   Garcia-Cuetos L, 2010, HARMFUL ALGAE, V9, P25, DOI 10.1016/j.hal.2009.07.002
   GILBERT JJ, 1983, ANNU REV ECOL SYST, V14, P1, DOI 10.1146/annurev.es.14.110183.000245
   Gilbert JJ, 2003, EVOL DEV, V5, P19, DOI 10.1046/j.1525-142X.2003.03004.x
   Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x
   Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385
   Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896
   HILL DRA, 1991, PHYCOLOGIA, V30, P170, DOI 10.2216/i0031-8884-30-2-170.1
   Kristensen Reinhardt Mobjerg, 2002, P199
   Kristensen RM, 2002, INTEGR COMP BIOL, V42, P641, DOI 10.1093/icb/42.3.641
   Kristensen RM, 1979, THESIS U COPENHAGEN
   LAKE P S, 1973, Crustaceana (Leiden), V24, P244, DOI 10.1163/156854073X00425
   Mukai Hideo, 1997, P45
   Neves RC, 2010, J MORPHOL, V271, P596, DOI 10.1002/jmor.10819
   Neves RC, 2010, HELGOLAND MAR RES, V64, P257, DOI 10.1007/s10152-010-0204-5
   Neves RC, 2010, ZOOL ANZ, V249, P1, DOI 10.1016/j.jcz.2010.02.002
   Neves RC, 2009, J MORPHOL, V270, P257, DOI 10.1002/jmor.10681
   Nielsen Claus, 1997, P13
   Obst M, 2006, MAR BIOL, V148, P945, DOI 10.1007/s00227-005-0131-1
   Obst M, 2005, MOL ECOL, V14, P4427, DOI 10.1111/j.1365-294X.2005.02752.x
   Obst M, 2003, CLADISTICS, V19, P159
   Obst M, 2003, J MORPHOL, V255, P261, DOI 10.1002/jmor.10040
   Obst M, 2006, ORG DIVERS EVOL, V6, P83, DOI 10.1016/j.ode.2005.05.001
   Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574
   Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001
   Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x
   REED CG, 1988, ACTA ZOOL-STOCKHOLM, V69, P177, DOI 10.1111/j.1463-6395.1988.tb00915.x
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Sorensen MV, 2000, ZOOL ANZ, V239, P297
   TYLER S, 1980, ZOOMORPHOLOGIE, V95, P17, DOI 10.1007/BF01342231
   TYLER S, 1980, ZOOMORPHOLOGIE, V95, P1, DOI 10.1007/BF01342230
   Winnepenninckx BMH, 1998, NATURE, V393, P636, DOI 10.1038/31377
   Zrzavy J, 1998, CLADISTICS, V14, P249, DOI 10.1111/j.1096-0031.1998.tb00338.x
   Zrzavy J, 2003, ZOOL SCR, V32, P61, DOI 10.1046/j.1463-6409.2003.00104.x
   Zrzavy J, 2001, CLADISTICS, V17, P170, DOI 10.1006/clad.2000.0148
NR 45
TC 10
Z9 10
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0362-2525
EI 1097-4687
J9 J MORPHOL
JI J. Morphol.
PD AUG
PY 2012
VL 273
IS 8
BP 850
EP 869
DI 10.1002/jmor.20025
PG 20
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 973JW
UT WOS:000306357400004
PM 22505145
DA 2021-01-25
ER

PT J
AU Eicher, SC
   Dehio, C
AF Eicher, Simone C.
   Dehio, Christoph
TI Bartonella entry mechanisms into mammalian host cells
SO CELLULAR MICROBIOLOGY
LA English
DT Review
ID OUTER-MEMBRANE PROTEINS; HUMAN ENDOTHELIAL-CELLS; INVASION-ASSOCIATED
   LOCUS; HUMAN ERYTHROCYTES; PATHOGEN BARTONELLA; EPITHELIAL-CELLS;
   HEMIN-BINDING; HENSELAE; BACILLIFORMIS; QUINTANA
AB The Gram-negative genus Bartonella comprises arthropod-borne pathogens that typically infect mammals in a host-specific manner. Bartonella bacilliformis and Bartonella quintana are human-specific pathogens, while several zoonotic bartonellae specific for diverse animal hosts infect humans as an incidental host. Clinical manifestations of Bartonella infections range from mild symptoms to life-threatening disease. Following transmission by blood-sucking arthropods or traumatic contact with infected animals, bartonellae display sequential tropisms towards endothelial and possibly other nucleated cells and erythrocytes, the latter in a host-specific manner. Attachment to the extracellular matrix (ECM) and to nucleated cells is mediated by surface-exposed bacterial adhesins, in particular trimeric autotransporter adhesins (TAAs). The subsequent engulfment of the pathogen into a vacuolar structure follows a unique series of events whereby the pathogen avoids the endolysosomal compartments. For Bartonella henselae and assumingly most other species, the infection process is aided at different steps by Bartonella effector proteins (Beps). They are injected into host cells through the type IV secretion system (T4SS) VirB/D4 and subvert host cellular functions to favour pathogen uptake. Bacterial binding to erythrocytes is mediated by Trw, another T4SS, in a strictly host-specific manner, followed by pathogen-forced uptake involving the IalB invasin and subsequentreplication and persistence within a membrane-bound intra-erythrocytic compartment.
C1 [Eicher, Simone C.; Dehio, Christoph] Univ Basel, Biozentrum, Res Area Infect Biol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Res Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-061777]; Swiss Initiative for Systems Biology [51RT
   0_126008]
FX We are grateful to Alexander Harms for suggestions to and critical
   reading of the manuscript. We would like to thank for the current
   support of the subject-related investigations in our lab by Grant
   3100-061777 from the Swiss National Science Foundation and Grant 51RT
   0_126008 (InfectX) in the frame of SystemsX.ch, the Swiss Initiative for
   Systems Biology.
CR BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381
   Burgess AWO, 1998, MICROB PATHOGENESIS, V25, P157, DOI 10.1006/mpat.1998.0223
   Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000
   Cartwright JL, 1999, BIOCHEM BIOPH RES CO, V256, P474, DOI 10.1006/bbrc.1999.0354
   Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   Conyers GB, 1999, J BIOL CHEM, V274, P1203, DOI 10.1074/jbc.274.3.1203
   CUADRA M, 1969, BLOOD-J HEMATOL, V33, P708, DOI 10.1182/blood.V33.5.708.708
   Dabo SM, 2006, MICROB PATHOGENESIS, V41, P10, DOI 10.1016/j.micpath.2006.04.003
   Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006
   Dehio C, 1997, J CELL SCI, V110, P2141
   Engel P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001296
   Guptill L, 2010, VET MICROBIOL, V140, P347, DOI 10.1016/j.vetmic.2009.11.011
   Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11
   HILL EM, 1992, INFECT IMMUN, V60, P4051, DOI 10.1128/IAI.60.10.4051-4058.1992
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kaiser PO, 2012, CELL MICROBIOL, V14, P198, DOI 10.1111/j.1462-5822.2011.01711.x
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   Litwin CM, 2007, INFECT IMMUN, V75, P5255, DOI 10.1128/IAI.00533-07
   Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005
   Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006
   Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998
   MERNAUGH G, 1992, INFECT IMMUN, V60, P937, DOI 10.1128/IAI.60.3.937-943.1992
   MERRELL BR, 1978, J BACTERIOL, V135, P633, DOI 10.1128/JB.135.2.633-640.1978
   MINNICK MF, 1994, INFECT IMMUN, V62, P2644, DOI 10.1128/IAI.62.6.2644-2648.1994
   Minnick MF, 1996, TRENDS MICROBIOL, V4, P343, DOI 10.1016/0966-842X(96)10055-X
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Mitchell SJ, 1997, MICROBIOL-SGM, V143, P1221, DOI 10.1099/00221287-143-4-1221
   Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10
   Musso T, 2001, INFECT IMMUN, V69, P5974, DOI 10.1128/IAI.69.10.5974-5980.2001
   O'Rourke F, 2011, ADV EXP MED BIOL, V715, P51, DOI 10.1007/978-94-007-0940-9_4
   Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x
   Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   Truttmann MC, 2011, J CELL SCI, V124, P3591, DOI 10.1242/jcs.084459
   Truttmann MC, 2011, CELL MICROBIOL, V13, P284, DOI 10.1111/j.1462-5822.2010.01535.x
   van Putten JPM, 1998, MOL MICROBIOL, V29, P369, DOI 10.1046/j.1365-2958.1998.00951.x
   Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Vermi W, 2006, BLOOD, V107, P454, DOI 10.1182/blood-2005-04-1342
   Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447
   WALKER TS, 1981, INFECT IMMUN, V31, P480, DOI 10.1128/IAI.31.1.480-486.1981
   XU YH, 1995, BBA-BIOMEMBRANES, V1234, P173, DOI 10.1016/0005-2736(94)00271-P
   ZBINDEN R, 1995, CLIN DIAGN LAB IMMUN, V2, P693, DOI 10.1128/CDLI.2.6.693-695.1995
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zimmermann R, 2003, J BACTERIOL, V185, P1739, DOI 10.1128/JB.185.5.1739-1744.2003
NR 65
TC 40
Z9 40
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
J9 CELL MICROBIOL
JI Cell Microbiol.
PD AUG
PY 2012
VL 14
IS 8
BP 1166
EP 1173
DI 10.1111/j.1462-5822.2012.01806.x
PG 8
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 974BO
UT WOS:000306405000002
PM 22519749
OA Bronze
DA 2021-01-25
ER

PT J
AU Tripodi, M
   Arber, S
AF Tripodi, Marco
   Arber, Silvia
TI Regulation of motor circuit assembly by spatial and temporal mechanisms
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Review
ID SPINAL-CORD; SYNAPTIC CONNECTIONS; LATERAL POSITION; NERVOUS-SYSTEM;
   ROBO RECEPTORS; DROSOPHILA CNS; SENSORY AXONS; NEURONS; INTERNEURONS;
   ORGANIZATION
AB Precision of synaptic connections in neuronal circuits is the product of an orderly assembly process during development. Circuits controlling motor behavior have been studied extensively in many animal species, allowing an assessment of evolutionarily conserved organizational principles that underlie neuronal subtype specification, connectivity and function. Across phylogenetically distant species, motor circuit assembly is based on spatial organization of interconnected circuit elements. Developmental molecular coordinate systems demarcate dendritic and axonal targeting territories, thereby regulating convergence of synaptic partners. Additional mechanisms subsequently control fine synaptic connection specificity within these domains. Spatial organization often correlates with the orderly sequence of neurogenesis contributing to the generation of distinct postmitotic neuronal subpopulations, a developmental strategy implemented far beyond motor circuits.
C1 [Tripodi, Marco; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Tripodi, Marco; Arber, Silvia] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Tripodi, Marco/0000-0002-6827-6690; Arber, Silvia/0000-0002-6261-250X
FU EMBO long-term fellowshipEuropean Molecular Biology Organization (EMBO);
   ERG Advanced Grant; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Kanton Basel-Stadt; EUEuropean Union (EU);
   Novartis Research Foundation
FX We are grateful to Matthias Landgraf and Abdel El Manira for comments on
   the manuscript. M.T. was supported by an EMBO long-term fellowship, M.T.
   and S.A. by an ERG Advanced Grant, the Swiss National Science
   Foundation, the Kanton Basel-Stadt, EU Framework Program 7 and the
   Novartis Research Foundation.
CR Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711
   Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034
   Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009
   Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536
   Benito-Gonzalez A, 2012, J NEUROSCI, V32, P1156, DOI 10.1523/JNEUROSCI.3630-12.2012
   Brierley D, 2011, J COMP NEUROL
   Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199
   BROWN AG, 1981, ORG SPINAL CORD
   BURROWS M, 1975, J EXP BIOL, V62, P189
   Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019
   Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768
   Demireva EY, 2011, CELL, V147, P641, DOI 10.1016/j.cell.2011.09.037
   Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017
   Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704
   Gaspard Nicolas, 2011, F1000 Biol Rep, V3, P6, DOI 10.3410/B3-6
   Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608
   Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011
   Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666
   Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   JACKSON PC, 1987, J COMP NEUROL, V255, P538, DOI 10.1002/cne.902550406
   Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368
   Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004
   Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041
   Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547
   Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17
   Mauss A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000200
   McCrea DA, 1998, ANN NY ACAD SCI, V860, P216, DOI 10.1111/j.1749-6632.1998.tb09051.x
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588
   McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009
   McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225
   MERRITT DJ, 1995, J NEUROSCI, V15, P1755
   Ozaki S, 1997, J COMP NEUROL, V380, P215
   Palmesino E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000446
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5
   Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5
   Rickert C, 2011, J NEUROSCI, V31, P15870, DOI 10.1523/JNEUROSCI.4009-11.2011
   ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93
   Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026
   Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3
   Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134
   Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019
   Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012
   Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538
   Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003
   Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wu ZH, 2011, NEURON, V70, P281, DOI 10.1016/j.neuron.2011.02.050
   Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032
   Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5
   Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135
   Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012
NR 54
TC 24
Z9 24
U1 0
U2 11
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
EI 1873-6882
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD AUG
PY 2012
VL 22
IS 4
BP 615
EP 623
DI 10.1016/j.conb.2012.02.011
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 013UK
UT WOS:000309331200008
PM 22417941
DA 2021-01-25
ER

PT J
AU Arner, E
   Mejhert, N
   Kulyte, A
   Balwierz, PJ
   Pachkov, M
   Cormont, M
   Lorente-Cebrian, S
   Ehrlund, A
   Laurencikiene, J
   Heden, P
   Dahlman-Wright, K
   Tanti, JF
   Hayashizaki, Y
   Ryden, M
   Dahlman, I
   van Nimwegen, E
   Daub, CO
   Arner, P
AF Arner, Erik
   Mejhert, Niklas
   Kulyte, Agne
   Balwierz, Piotr J.
   Pachkov, Mikhail
   Cormont, Mireille
   Lorente-Cebrian, Silvia
   Ehrlund, Anna
   Laurencikiene, Jurga
   Heden, Per
   Dahlman-Wright, Karin
   Tanti, Jean-Francois
   Hayashizaki, Yoshihide
   Ryden, Mikael
   Dahlman, Ingrid
   van Nimwegen, Erik
   Daub, Carsten O.
   Arner, Peter
TI Adipose Tissue MicroRNAs as Regulators of CCL2 Production in Human
   Obesity
SO DIABETES
LA English
DT Article
ID INSULIN-RESISTANCE; SUBCUTANEOUS ADIPOSE; FAT; EXPRESSION; INFLAMMATION;
   GLUCOSE; CELLS; MCP-1
AB In obesity, white adipose tissue (WAT) inflammation is linked to insulin resistance. Increased adipocyte chemokine (C-C motif) ligand 2 (CCL2) secretion may initiate adipose inflammation by attracting the migration of inflammatory cells into the tissue. Using an unbiased approach, we identified adipose microRNAs (miRNAs) that are dysregulated in human obesity and assessed their possible role in controlling CCL2 production. In subcutaneous WAT obtained from 56 subjects, 11 miRNAs were present in all subjects and downregulated in obesity. Of these, 10 affected adipocyte CCL2 secretion in vitro and for 2 miRNAs (miR-126 and miR-193b), regulatory circuits were defined. While miR-126 bound directly to the 3'-untranslated region of CCL2 mRNA, miR-193b regulated CCL2 production indirectly through a network of transcription factors, many of which have been identified in other inflammatory conditions. In addition, overexpression of miR-193b and miR-126 in a human monocyte/macrophage cell line attenuated CCL2 production. The levels of the two miRNAs in subcutaneous WAT were significantly associated with CCL2 secretion (miR-193b) and expression of integrin, a-X, an inflammatory macrophage marker (miR-193b and miR-126). Taken together, our data suggest that miRNAs may be important regulators of adipose inflammation through their effects on CCL2 release from human adipocytes and macrophages. Diabetes 61:1986-1993, 2012
C1 [Arner, Erik; Mejhert, Niklas; Kulyte, Agne; Lorente-Cebrian, Silvia; Ehrlund, Anna; Laurencikiene, Jurga; Ryden, Mikael; Dahlman, Ingrid; Arner, Peter] Dept Med, Huddinge, Sweden.
   [Arner, Erik; Hayashizaki, Yoshihide; Daub, Carsten O.] RIKEN Yokohama Inst, RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan.
   [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
   [Balwierz, Piotr J.; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland.
   [Cormont, Mireille; Tanti, Jean-Francois] Fac Med Nice, INSERM, Team Mol & Cellular Physiopathol Obes & Diabet 7, Mediterranean Ctr Mol Med,U895, F-06034 Nice, France.
   [Cormont, Mireille; Tanti, Jean-Francois] Univ Nice Sophia Antipolis, Fac Med, Nice, France.
   [Heden, Per] Akad Kliniken, Stockholm, Sweden.
   [Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.
   [Arner, Erik; Mejhert, Niklas; Kulyte, Agne; Lorente-Cebrian, Silvia; Ehrlund, Anna; Laurencikiene, Jurga; Ryden, Mikael; Dahlman, Ingrid; Arner, Peter] Karolinska Inst, Lipid Lab, Stockholm, Sweden.
RP Arner, P (corresponding author), Dept Med, Huddinge, Sweden.
EM daub@gsc.riken.jp; peter.arner@ki.se
RI Lorente-Cebrian, Silvia/N-2578-2019; Daub, Carsten O/A-7436-2010;
   Balwierz, Piotr J/AAG-4187-2020; Arner, Erik/A-1895-2010; Hayashizaki,
   Yoshihide/N-6590-2015
OI Lorente-Cebrian, Silvia/0000-0002-1033-6152; Daub, Carsten
   O/0000-0002-3295-8729; Balwierz, Piotr J/0000-0002-1548-4605; Arner,
   Erik/0000-0003-1225-4908; , Jurga/0000-0002-7032-2924; van Nimwegen,
   Erik/0000-0001-6338-1312; CORMONT, Mireille/0000-0001-6918-2410; Tanti,
   Jean-Francois/0000-0003-1782-1318; Dahlman, Ingrid/0000-0003-3819-5977;
   Kulyte, Agne/0000-0001-7745-2767; Mejhert, Niklas/0000-0003-1785-833X
FU Magnus Bergvall; Gun and Bertil Stohne; Ake Wiberg and Ageing Research
   at Karolinska Institutet; Ministry of Education, Culture, Sports,
   Science, and Technology of JapanMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT); Swedish Research CouncilSwedish
   Research Council; Swedish Heart and Lung FoundationSwedish Heart-Lung
   Foundation; Swedish Diabetes Foundation; Strategic Research Programme in
   Diabetes at Karolinska Institutet; Novo Nordisk FoundationNovo Nordisk
   Foundation; European Foundation for the Study of Diabetes/Lilly
   Programme; European Union (ADAPT)European Union (EU)
   [HEALTH-F2-2008-201100]; NordForsk [SYSDIET-070014]; Novo Nordisk
   FondenNovo Nordisk Foundation [NNF12OC1016371] Funding Source:
   researchfish
FX This work was supported by grants from the foundations of Magnus
   Bergvall, Gun and Bertil Stohne, and Ake Wiberg and Ageing Research at
   Karolinska Institutet (to E.A.); the Ministry of Education, Culture,
   Sports, Science, and Technology of Japan for RIKEN Omics Science Center
   and Innovative Technology (Cell Innovation Program) (to Y.H.); and the
   Swedish Research Council, the Swedish Heart and Lung Foundation, the
   Swedish Diabetes Foundation, the Strategic Research Programme in
   Diabetes at Karolinska Institutet, the Novo Nordisk Foundation, the
   European Foundation for the Study of Diabetes/Lilly Programme, the
   European Union (ADAPT, HEALTH-F2-2008-201100), and NordForsk
   (SYSDIET-070014) (to P.A.).
CR Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867
   Arner P, 2005, CURR MOL MED, V5, P333, DOI 10.2174/1566524053766022
   Arvidsson E, 2004, DIABETES, V53, P1966, DOI 10.2337/diabetes.53.8.1966
   Balwierz PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r79
   Clement K, 2009, REV MED INTERNE, V30, P824, DOI 10.1016/j.revmed.2009.03.363
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699
   KOLACZYNSKI JW, 1994, INT J OBESITY, V18, P161
   Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6
   Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154
   Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Romania P, 2008, BRIT J HAEMATOL, V143, P570, DOI 10.1111/j.1365-2141.2008.07382.x
   Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200
   Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010
   Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454
   Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969
   Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499
   Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125
   Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033
NR 29
TC 174
Z9 179
U1 1
U2 29
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD AUG
PY 2012
VL 61
IS 8
BP 1986
EP 1993
DI 10.2337/db11-1508
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 980KC
UT WOS:000306891100014
PM 22688341
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Wang, XT
   Pemberton-Ross, P
   Schirmer, SG
AF Wang, Xiaoting
   Pemberton-Ross, Peter
   Schirmer, Sophie G.
TI Symmetry and Subspace Controllability for Spin Networks With a
   Single-Node Control
SO IEEE TRANSACTIONS ON AUTOMATIC CONTROL
LA English
DT Article
DE Controllability; nonlinear control; quantum systems; spin networks;
   symmetries
ID QUANTUM-SYSTEMS; DECOMPOSITION
AB We consider the relation of symmetries and subspace controllability for spin-1/2 networks with XXZ couplings, subject to perturbation of a single node by a local potential (Z-control). The Hamiltonians for such networks decompose into excitation subspaces. Focusing on the single excitation subspace, it is shown for single-node Z-controls that external symmetries are characterized by eigenstates of the system Hamiltonian which have zero overlap with the control node, and there are no internal symmetries. It is further shown that there are symmetries which persist even in the presence of random perturbations. For XXZ chains with uniform coupling strengths, a characterization of all possible symmetries is given which shows a strong dependence on the position of the node we control. We then show for Heisenberg and XX chains with uniform coupling strength subject to single-node Z-control that the lack of symmetry is both necessary and sufficient for subspace controllability. Finally, the latter approach is generalized to establish controllability results for simple branched networks.
C1 [Wang, Xiaoting] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA.
   [Pemberton-Ross, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schirmer, Sophie G.] Swansea Univ, Coll Sci Phys, Swansea SA2 8PP, W Glam, Wales.
RP Wang, XT (corresponding author), Univ Massachusetts, Dept Phys, Harbor Campus, Boston, MA 02125 USA.
EM x.wang@damtp.cam.ac.uk; peter.pemberton-ross@unibas.ch; sgs29@cam.ac.uk
OI Wang, Xiaoting/0000-0001-6503-9158; Pemberton-Ross,
   Peter/0000-0002-6739-1873
FU EPSRC ARFEngineering & Physical Sciences Research Council (EPSRC)
   [EP/D07192X/1]; Hitachi; Cambridge Overseas Trust; Hughes Hall;
   Cambridge Philosophical Society; Engineering and Physical Sciences
   Research CouncilEngineering & Physical Sciences Research Council (EPSRC)
   [EP/D07195X/1, EP/D07195X/2] Funding Source: researchfish
FX This work was supported by EPSRC ARF Grant EP/D07192X/1 and Hitachi, the
   Cambridge Overseas Trust, Hughes Hall and the Cambridge Philosophical
   Society. Recommended by Associate Editor C. Altafini.
CR Albertini F, 2003, IEEE T AUTOMAT CONTR, V48, P1399, DOI 10.1109/TAC.2003.815027
   Albertini F, 2002, LINEAR ALGEBRA APPL, V350, P213, DOI 10.1016/S0024-3795(02)00290-2
   Albertini F., 2010, CONTROLLABILITY QUAN
   Altafini C, 2002, J MATH PHYS, V43, P2051, DOI 10.1063/1.1467611
   BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457
   Benjamin SC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.247901
   Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708
   Bose S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.207901
   Burgarth D, 2007, EUR PHYS J-SPEC TOP, V151, P147, DOI 10.1140/epjst/e2007-00370-9
   Burgarth D, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.040303
   Burgarth D, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.060305
   Burgarth D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.100501
   Caruso F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223548
   Chihara T. S., 1978, INTRO ORTHOGONAL POL
   D'Alessandro D., 2008, INTRODUCTION QUANTUM
   DIVINCENZO DP, 1995, PHYS REV A, V51, P1015, DOI 10.1103/PhysRevA.51.1015
   Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678
   Fu H, 2001, J PHYS A-MATH GEN, V34, P1679, DOI 10.1088/0305-4470/34/8/313
   Garcia-Ripoll JJ, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/376
   Greiner W., 1989, QUANTUM MECH SYMMETR
   Heule R, 2011, EUR PHYS J D, V63, P41, DOI 10.1140/epjd/e2010-10623-y
   Heule R, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.052333
   Jacobson N., 1979, LIE ALGEBRAS
   JURDJEVIC V, 1972, J DIFFER EQUATIONS, V12, P313, DOI 10.1016/0022-0396(72)90035-6
   Karabach M, 1997, COMPUT PHYS, V11, P36
   Kay A, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/143
   Kay A, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.010301
   Khaneja N, 2001, CHEM PHYS, V267, P11, DOI 10.1016/S0301-0104(01)00318-4
   Lloyd S, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.012305
   Mohseni M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002335
   Nielsen M. A., 2000, QUANTUM COMPUTATION
   Pemberton-Ross PJ, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042322
   Polack T, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053403
   Sander U., 2009, CONTROLLABILITY OBSE
   Schirmer SG, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062339
   Schirmer S. G., 2009, PHYS REV A, V80
   Schirmer SG, 2005, J OPT B-QUANTUM S O, V7, pS293, DOI 10.1088/1464-4266/7/10/013
   Schirmer SG, 2003, IFAC WORK S, P281
   Schirmer SG, 2002, J PHYS A-MATH GEN, V35, P8551, DOI 10.1088/0305-4470/35/40/313
   Schirmer SG, 2002, J PHYS A-MATH GEN, V35, P4125, DOI 10.1088/0305-4470/35/18/309
   Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037
   Vollbrecht KGH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.010501
   Wang XT, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032312
   Zeier R, 2011, J MATH PHYS, V52, DOI 10.1063/1.3657939
NR 44
TC 17
Z9 17
U1 0
U2 8
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9286
EI 1558-2523
J9 IEEE T AUTOMAT CONTR
JI IEEE Trans. Autom. Control
PD AUG
PY 2012
VL 57
IS 8
SI SI
BP 1945
EP 1956
DI 10.1109/TAC.2012.2202057
PG 12
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA 980TR
UT WOS:000306916900005
DA 2021-01-25
ER

PT J
AU Holme, MN
   Fedotenko, IA
   Abegg, D
   Althaus, J
   Babel, L
   Favarger, F
   Reiter, R
   Tanasescu, R
   Zaffalon, PL
   Ziegler, A
   Muller, B
   Saxer, T
   Zumbuehl, A
AF Holme, Margaret N.
   Fedotenko, Illya A.
   Abegg, Daniel
   Althaus, Jasmin
   Babel, Lucille
   Favarger, France
   Reiter, Renate
   Tanasescu, Radu
   Zaffalon, Pierre-Leonard
   Ziegler, Andre
   Mueller, Bert
   Saxer, Till
   Zumbuehl, Andreas
TI Shear-stress sensitive lenticular vesicles for targeted drug delivery
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID CALCIUM-ION TRANSPORT; MONOLAYER CHARACTERISTICS; MOLECULAR PACKING;
   PHASE-TRANSITION; LIPOSOMES; PERMEABILITY; BEHAVIOR;
   PHOSPHATIDYLCHOLINES; THERMODYNAMICS; SPHINGOMYELIN
AB Atherosclerosis results in the narrowing of arterial blood vessels and this causes significant changes in the endogenous shear stress between healthy and constricted arteries. Nanocontainers that can release drugs locally with such rheological changes can be very useful. Here, we show that vesicles made from an artificial 1,3-diaminophospholipid are stable under static conditions but release their contents at elevated shear stress. These vesicles have a lenticular morphology, which potentially leads to instabilities along their equator. Using a model cardiovascular system based on polymer tubes and an external pump to represent shear stress in healthy and constricted vessels of the heart, we show that drugs preferentially release from the vesicles in constricted vessels that have high shear stress.
C1 [Holme, Margaret N.; Althaus, Jasmin; Mueller, Bert] Univ Basel, Biomat Sci Ctr BMC, Univ Spital, CH-4031 Basel, Switzerland.
   [Holme, Margaret N.; Fedotenko, Illya A.; Abegg, Daniel; Babel, Lucille; Favarger, France; Tanasescu, Radu; Zaffalon, Pierre-Leonard; Zumbuehl, Andreas] Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland.
   [Holme, Margaret N.; Saxer, Till] Univ Hosp Geneva, Div Cardiol, Dept Med, CH-1211 Geneva, Switzerland.
   [Reiter, Renate] Univ Freiburg, D-79104 Freiburg, Germany.
   [Ziegler, Andre] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Muller, B (corresponding author), Univ Basel, Biomat Sci Ctr BMC, Univ Spital, CH-4031 Basel, Switzerland.
EM bert.mueller@unibas.ch; till.saxer@unige.ch; andreas.zumbuehl@unige.ch
RI Muller, Bert/A-6838-2008; Saxer, Till/A-9106-2010; Zumbuehl,
   Andreas/C-5324-2008
OI Muller, Bert/0000-0003-4078-9109; Saxer, Till/0000-0003-2077-1083;
   Babel, Lucille/0000-0002-8071-5561; Fedotenko,
   Illya/0000-0002-5768-3872; Zumbuehl, Andreas/0000-0002-8003-4432; Holme,
   Margaret/0000-0002-7314-9493
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200020_132035]; University of Geneva; European Cooperation in
   Science and Technology Action [D43]
FX This work was supported by the Swiss National Science Foundation via
   Research Program 62 'Smart Materials' and the proof-of-principle fund of
   the University of Geneva. I. A. F., P.-L.Z. and A.Z. acknowledge support
   from the Swiss National Science Foundation (grant 200020_132035) and
   European Cooperation in Science and Technology Action D43. The authors
   thank the Electron Microscopy Center ETH Zurich and T. Ishikawa for
   cryo-TEM work, K. Peters for viability tests, and the Bioimaging, Mass
   Spectroscopy and Nuclear Magnetic Resonance facilities at the University
   of Geneva for analytical services, and the Critical Care Service at the
   University Hospitals of Geneva for the gift of the extracorporeal heart
   pump. The authors also appreciate scientific discussions with T. Fyles,
   A. Roux, F. Stellacci and T. Zemb.
CR BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6
   Bernard AL, 2005, J COLLOID INTERF SCI, V287, P298, DOI 10.1016/j.jcis.2004.12.019
   Berridge BR, 2009, AM HEART J, V158, P21, DOI 10.1016/j.ahj.2009.04.020
   BLAUROCK AE, 1979, J MEMBRANE BIOL, V50, P187, DOI 10.1007/BF01868948
   BLOK MC, 1976, BIOCHIM BIOPHYS ACTA, V433, P1, DOI 10.1016/0005-2736(76)90172-3
   Brezesinski G, 2011, J PHYS CHEM C, V115, P8206, DOI 10.1021/jp200847c
   CHAKRAVARTHY SR, 1992, BIOCHIM BIOPHYS ACTA, V1112, P197, DOI 10.1016/0005-2736(92)90392-Y
   Cheng C, 2007, ATHEROSCLEROSIS, V195, P225, DOI 10.1016/j.atherosclerosis.2006.11.019
   Clerc S, 1995, BBA-BIOMEMBRANES, V1240, P257, DOI 10.1016/0005-2736(95)00214-6
   Curtis JJ, 1999, ANN THORAC SURG, V68, P666, DOI 10.1016/S0003-4975(99)00583-4
   DEHAAS GH, 1990, BIOCHIM BIOPHYS ACTA, V1043, P75, DOI 10.1016/0005-2760(90)90112-B
   Dubois M, 2004, P NATL ACAD SCI USA, V101, P15082, DOI 10.1073/pnas.0400837101
   Dubois M, 2001, NATURE, V411, P672, DOI 10.1038/35079541
   Duncan SL, 2008, BIOPHYS J, V94, P2965, DOI 10.1529/biophysj.107.114215
   Fainerman VB, 1997, J CHEM PHYS, V107, P243, DOI 10.1063/1.474371
   Fedotenko IA, 2010, TETRAHEDRON LETT, V51, P5382, DOI 10.1016/j.tetlet.2010.07.140
   Gaines G L, 1966, INSOLUBLE MONOLAYERS
   GIORGIO TD, 1995, BBA-BIOMEMBRANES, V1239, P39, DOI 10.1016/0005-2736(95)00137-R
   GUPTA CM, 1981, BIOCHIM BIOPHYS ACTA, V663, P506, DOI 10.1016/0005-2760(81)90178-8
   Heimburg T, 1998, BBA-BIOMEMBRANES, V1415, P147, DOI 10.1016/S0005-2736(98)00189-8
   Holopainen JM, 2003, METHOD ENZYMOL, V367, P15
   HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003
   INOUE K, 1974, BIOCHIM BIOPHYS ACTA, V339, P390, DOI 10.1016/0005-2736(74)90166-7
   Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072
   Jia C., 1993, J CHEM SOC P2, V1, P2521
   Kantsler V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036001
   LICHTENBERG D, 1981, BIOCHEMISTRY-US, V20, P3462, DOI 10.1021/bi00515a024
   LICHTENBERG D, 1981, LIPIDS, V16, P555, DOI 10.1007/BF02535056
   Liu HP, 2010, CHEM-EUR J, V16, P3791, DOI 10.1002/chem.200901546
   LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044
   MAGIN RL, 1984, CHEM PHYS LIPIDS, V34, P245, DOI 10.1016/0009-3084(84)90059-8
   Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356
   McConnell HM, 1996, LANGMUIR, V12, P4897, DOI 10.1021/la960411m
   Muller B, 2001, SURF REV LETT, V8, P169, DOI 10.1016/S0218-625X(01)00085-9
   Muller B, 1998, PHYS REV LETT, V80, P2642, DOI 10.1103/PhysRevLett.80.2642
   Noguchi H, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041901
   OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3
   Paparella D, 2004, ASAIO J, V50, P473, DOI 10.1097/01.MAT.0000136514.53139.D0
   PHILLIPS MC, 1968, BIOCHIM BIOPHYS ACTA, V163, P301, DOI 10.1016/0005-2736(68)90115-6
   PHILLIPS MC, 1975, NATURE, V254, P154, DOI 10.1038/254154a0
   Pijls NHJ, 2009, AM J CARDIOL, V103, P1204, DOI 10.1016/j.amjcard.2009.01.027
   Prenner E, 2007, CHEM PHYS LIPIDS, V145, P106, DOI 10.1016/j.chemphyslip.2006.11.002
   SEELIG J, 1980, BIOCHEMISTRY-US, V19, P2215, DOI 10.1021/bi00551a034
   SLYSH S, 1985, AM HEART J, V109, P744, DOI 10.1016/0002-8703(85)90633-7
   SUNAMOTO J, 1990, BIOCHIM BIOPHYS ACTA, V1024, P209, DOI 10.1016/0005-2736(90)90346-P
   Szebeni J, 2012, NANOMED-NANOTECHNOL, V8, P176, DOI 10.1016/j.nano.2011.06.003
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Vance D. E., 1991, BIOCH LIPIDS LIPOPRO
   Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010
   WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007
NR 50
TC 169
Z9 174
U1 2
U2 156
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
EI 1748-3395
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD AUG
PY 2012
VL 7
IS 8
BP 536
EP 543
DI 10.1038/NNANO.2012.84
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 986QR
UT WOS:000307359600015
PM 22683843
DA 2021-01-25
ER

PT J
AU Ellertsdottir, E
   Berthold, PR
   Bouzaffour, M
   Dufourcq, P
   Trayer, V
   Gauron, C
   Vriz, S
   Affolter, M
   Rampon, C
AF Ellertsdottir, Elin
   Berthold, Peter R.
   Bouzaffour, Mohamed
   Dufourcq, Pascale
   Trayer, Vincent
   Gauron, Carole
   Vriz, Sophie
   Affolter, Markus
   Rampon, Christine
TI Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in
   the Cardio-Vascular System
SO PLOS ONE
LA English
DT Article
ID THROMBIN-RECEPTOR; VASCULAR DEVELOPMENT; DESENSITIZATION; HEMATOPOIESIS;
   INHIBITION; KINASE
AB Thrombin receptor, F2R or PAR1 is a G-protein coupled receptor, located in the membrane of endothelial cells. It has been initially found to transduce signals in hemostasis, but recently also known to act in cancer and in vascular development. Mouse embryos lacking PAR1 function die from hemorrhages with varying frequency at midgestation. We have performed a survey of potential PAR1 homologs in the zebrafish genome and identified a teleost ortholog of mammalian PAR1. Knockdown of par1 function in zebrafish embryos demonstrates a requirement for Par1 in cardio-vascular development. Furthermore, we show that function of Par1 requires the presence of a phylogenetically conserved proteolytic cleavage site and a second intracellular domain. Altogether our results demonstrate a high degree of conservation of PAR1 proteins in the vertebrate lineage in respect to amino acid sequence as well as protein function.
C1 [Ellertsdottir, Elin; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Berthold, Peter R.; Bouzaffour, Mohamed; Dufourcq, Pascale; Trayer, Vincent; Vriz, Sophie; Rampon, Christine] Univ Paris Diderot, Paris, France.
   [Gauron, Carole; Vriz, Sophie; Rampon, Christine] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France.
   [Gauron, Carole; Vriz, Sophie; Rampon, Christine] CNRS, UMR 7241, Paris, France.
   [Gauron, Carole; Vriz, Sophie; Rampon, Christine] INSERM, Paris, France.
RP Ellertsdottir, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM christine.rampon@college-de-france.fr
OI /0000-0003-2029-5750; Affolter, Markus/0000-0002-5171-0016;
   /0000-0002-9058-9378
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Network of Excellence grant "Cells into Organs" from the FP6 of
   the European Community; ANR ProteophaneFrench National Research Agency
   (ANR); Canton Basel-Stadt; Canton Basel-Land
FX This work has been supported by the Cantons Basel-Stadt and Basel-Land,
   the Swiss National Science Foundation, and by a Network of Excellence
   grant "Cells into Organs" from the FP6 of the European Community. Carole
   Gauron is supported by ANR Proteophane 2008. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018
   Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824
   Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789
   Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0
   Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985
   Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259
   Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577
   Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d
   Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211
   Iida A, 2010, CURR BIOL, V20, P1110, DOI 10.1016/j.cub.2010.04.052
   ISHII K, 1994, J BIOL CHEM, V269, P1125
   Jiang TR, 1998, J MOL CELL CARDIOL, V30, P2193, DOI 10.1006/jmcc.1998.0779
   Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087
   Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130
   Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403
   Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792
   Kwan TT, 2006, EXP HEMATOL, V34, P27, DOI 10.1016/j.exphem.2005.09.017
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Macfarlane SR, 2001, PHARMACOL REV, V53, P245
   McKinney MC, 2008, METHOD ENZYMOL, V444, P65, DOI 10.1016/S0076-6879(08)02804-8
   Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951
   Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200
   Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699
   Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109
   Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390
   Song M, 2007, BIOCHEM BIOPH RES CO, V357, P924, DOI 10.1016/j.bbrc.2007.04.033
   Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308
   Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007
   Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018
   VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0
   Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068
   Westerfield M., 1993, ZEBRAFISH BOOK GUIDE
   Xu H, 2011, DEV DYNAM, V240, P278, DOI 10.1002/dvdy.22517
   Yasutake M, 1996, CIRC RES, V79, P705, DOI 10.1161/01.RES.79.4.705
   Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025
NR 38
TC 8
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 30
PY 2012
VL 7
IS 7
AR e42131
DI 10.1371/journal.pone.0042131
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 981EY
UT WOS:000306950900070
PM 22860064
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Keller, C
   Adaixo, R
   Stunnenberg, R
   Woolcock, KJ
   Hiller, S
   Buhler, M
AF Keller, Claudia
   Adaixo, Ricardo
   Stunnenberg, Rieka
   Woolcock, Katrina J.
   Hiller, Sebastian
   Buehler, Marc
TI HP1(Swi6) Mediates the Recognition and Destruction of Heterochromatic
   RNA Transcripts
SO MOLECULAR CELL
LA English
DT Article
ID HP1 CHROMO DOMAIN; HISTONE H3; FISSION YEAST; PERICENTRIC
   HETEROCHROMATIN; MONOCLONAL-ANTIBODIES; SHADOW DOMAIN; LYSINE 9;
   PROTEINS; BINDING; MECHANISMS
AB HP1 proteins are major components of heterochromatin, which is generally perceived to be an inert and transcriptionally inactive chromatin structure. Yet, HP1 binding to chromatin is highly dynamic and robust silencing of heterochromatic genes can involve RNA processing. Here, we demonstrate by a combination of in vivo and in vitro experiments that the fission yeast HP1(Swi6) protein guarantees tight repression of heterochromatic genes through RNA sequestration and degradation. Stimulated by positively charged residues in the hinge region, RNA competes with methylated histone H3K9 for binding to the chromodomain of HP1(Swi6). Hence, HP1(Swi6) binding to RNA is incompatible with stable heterochromatin association. We propose a model in which an ensemble of HP1(Swi6) proteins functions as a heterochromatin-specific checkpoint, capturing and priming heterochromatic RNAs for the RNA degradation machinery. Sustaining a functional checkpoint requires continuous exchange of HP1(Swi6) within heterochromatin, which explains the dynamic localization of HP1 proteins on heterochromatin.
C1 [Adaixo, Ricardo; Hiller, Sebastian] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Keller, Claudia; Stunnenberg, Rieka; Woolcock, Katrina J.; Buehler, Marc] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Keller, Claudia; Stunnenberg, Rieka; Woolcock, Katrina J.; Buehler, Marc] Univ Basel, CH-4003 Basel, Switzerland.
RP Hiller, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sebastian.hiller@unibas.ch; marc.buehler@fmi.ch
RI Hiller, Sebastian/B-3573-2008; Buehler, Marc/S-5866-2019
OI Hiller, Sebastian/0000-0002-6709-4684; Buehler,
   Marc/0000-0001-6661-9795; Keller Valsecchi, Claudia/0000-0003-4135-5927
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); European Research CouncilEuropean Research Council (ERC); Gebert
   Ruf Stiftung; Novartis Research Foundation
FX We are grateful to Yukiko Shimada, Nathalie Laschet, Sebastien Morin,
   Larisa Kapinos, and Alvar Gossert for technical assistance and
   discussions; Ben Hurschler and Helge Grosshans for help with polysome
   profiling; Tessi Iida for sharing protocols; Antoine Peters for
   peptides; the Nicolas Thoma lab, i.e., Andrea Scrima, Eric Fischer, and
   Mahamadou Faty, for technical advice and sharing awesome equipment;
   Laurent Gelman for assistance with FRAP analysis; and Heinz Gut and
   Hans-Rudolf Hotz for help with domain mappings and bioinformatics.
   Research in the lab of M.B. is supported by the Swiss National Science
   Foundation, the European Research Council, and the Gebert Ruf Stiftung.
   The Friedrich Miescher Institute for Biomedical Research is supported by
   the Novartis Research Foundation. Research in the lab of S.H. is
   supported by the Swiss National Science Foundation. R.A. acknowledges
   the Werner-Siemens Foundation.
CR Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169
   Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138
   Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027
   Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038
   Buhler M, 2009, CHROMOSOMA, V118, P141, DOI 10.1007/s00412-008-0195-z
   Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025
   Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572
   Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004
   Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X
   EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126
   Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011
   Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694
   Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106
   Gossert AD, 2011, J AM CHEM SOC, V133, P210, DOI 10.1021/ja108383x
   Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008
   Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473
   Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232
   Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411
   Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035
   Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014
   Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132
   Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843
   Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765
   Mandell JG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r1
   Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026
   Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194
   Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118
   Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722
   Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739
   Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024
   Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2
   Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5
   Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000
   Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018
   Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07
   Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006
   WOODS A, 1989, J CELL SCI, V93, P491
   Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935
NR 41
TC 75
Z9 75
U1 0
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD JUL 27
PY 2012
VL 47
IS 2
BP 215
EP 227
DI 10.1016/j.molcel.2012.05.009
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 982YW
UT WOS:000307084000009
PM 22683269
OA Bronze
DA 2021-01-25
ER

PT J
AU Barat, S
   Steeb, B
   Maze, A
   Bumann, D
AF Barat, Somedutta
   Steeb, Benjamin
   Maze, Alain
   Bumann, Dirk
TI Extensive In Vivo Resilience of Persistent Salmonella
SO PLOS ONE
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS PERSISTENCE; ESCHERICHIA-COLI; TYPHIMURIUM;
   VIRULENCE; REPLICATION; INFECTION; METABOLISM; DYNAMICS; MUTANTS; DUBLIN
AB Chronic infections caused by persistent pathogens represent an important health problem. Here, we establish a simple practical mouse Salmonella infection model for identifying bacterial maintenance functions that are essential for persistency. In this model, a substantial fraction of Salmonella survived even several days of treatment with a potent fluoroquinolone antibiotic indicating stringency of the model. Evaluation of twelve metabolic defects revealed dramatically different requirements for Salmonella during persistency as compared to acute infections. Disrupted synthesis of unsaturated/cyclopropane fatty acids was the only defect that resulted in rapid Salmonella clearance suggesting that this pathway might contain suitable targets for antimicrobial chemotherapy of chronic infection.
C1 [Barat, Somedutta; Steeb, Benjamin; Maze, Alain; Bumann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
RP Barat, S (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM Dirk.Bumann@unibas.ch
OI Maze, Alain/0000-0003-0873-3690
FU Deutsche Forschungsgemeinschaft (European Research Training Group)
   [1273]; Schweizerischer NationalfondsSwiss National Science Foundation
   (SNSF) [31003A-121834]
FX This work was supported by Deutsche Forschungsgemeinschaft (European
   Research Training Group 1273) and Schweizerischer Nationalfonds
   (31003A-121834). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4
   Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06
   Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772
   Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003
   BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x
   Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427
   Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200
   Dubois-Brissonnet F, 2011, APPL ENVIRON MICROB, V77, P906, DOI 10.1128/AEM.01480-10
   ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824
   Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005
   Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0
   Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003
   Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074
   Griffin A, 2009, J IMMUNOL, V183, P1263, DOI 10.4049/jimmunol.0900772
   Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10
   Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474
   Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938
   John AK, 2011, ANTIMICROB AGENTS CH, V55, P3510, DOI 10.1128/AAC.00172-11
   Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413
   Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909
   MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4
   Meredith TC, 2005, J BACTERIOL, V187, P6936, DOI 10.1128/JB.187.20.6936-6942.2005
   MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411
   Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319
   Monack DM, 2011, CURR OPIN MICROBIOL, V2011, P30
   Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005
   Nath G, 2010, J INFECT DEV COUNTR, V4, P259, DOI 10.3855/jidc.820
   Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77
   Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105
   Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749
   Thiele I, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-8
   Thierauf Anne, 2009, V501, P267, DOI 10.1007/978-1-60327-164-6_23
   Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x
   Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007
   Turner AK, 2003, INFECT IMMUN, V71, P3392, DOI 10.1128/IAI.71.6.3392-3401.2003
   VANCUTSEM PM, 1990, CORNELL VET, V80, P173
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
NR 47
TC 12
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 24
PY 2012
VL 7
IS 7
AR e42007
DI 10.1371/journal.pone.0042007
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 978NX
UT WOS:000306751300089
PM 22911873
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Daniels, AU
AF Daniels, A. U.
TI Silicone breast implant materials
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE breast implants; silicone rubber; silicone gel; biocompatibility;
   biodurability; rupture rate; regulatory issues
ID CONNECTIVE-TISSUE DISEASES; WOMEN; RISK; BIODURABILITY; POPULATION;
   DISORDERS; PLATINUM; COHORT
AB This opinion article has been written on request because of the recent public controversy over silicone breast implants produced by a now-defunct company, Poly Implant Prosthese (PIP) in France. More than 300,000 PIP devices have been implanted. The purposes of my article are to (1.) provide a general overview of silicone breast implant materials, (2.) to describe the general safety of these materials as reported to date, and (3.) to summarise current publicly available information about these aspects of the PIP prostheses. The materials covered are the silicone rubber from which the implant shells are made and the silicone gel used to fill the shell. The materials safety issues are biocompatibility (especially of the gel) and biodurability of the shell. The literature reviewed indicates that biocompatibility is not an issue with other current generation implants. However, biodurability is. A rough estimate of implant shell rupture rate is similar to 10+% at 10 years. Information is still emerging about the PIP implants. Initial regulatory disclosures suggest the PIP implants may have both biocompatibility and biodurability problems. They also suggest that PIP implants may have been produced using silicone materials not certified as medical grade. Governmental health and regulatory agencies are just now in the process of deciding what actions should be taken to protect patients.
C1 Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum,Fac Med, CH-4056 Basel, Switzerland.
RP Daniels, AU (corresponding author), Univ Basel, Lab Biomech & Biocalorimetry, Biozentrum, Pharmazentrum,Fac Med, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM au.daniels@unibas.ch
CR [Anonymous], 2010, HIGH TEAR STRENGTH S
   [Anonymous], SILICONE RUBBER
   [Anonymous], 2012, X BERTRAND N BERR MI
   [Anonymous], BREAST IMPLANT
   [Anonymous], 2011, FDA UPDATE SAFETY SI
   [Anonymous], BLUESTAR SILICONES O
   [Anonymous], DEFECTIVE PIP SILICO
   [Anonymous], POLYDIMETHYLSILOXANE
   [Anonymous], 2012, BBC NEWS EUROPE 0102
   [Anonymous], 2012, SILICONE
   [Anonymous], 2012, PIP BREAST IMPLANTS
   [Anonymous], GEL
   [Anonymous], BAYER SILICONES BAYS
   [Anonymous], CROSSLINKING
   Banks HT, 1997, P 36 IEEE C DEC CONT
   Black J., 1992, BIOL PERFORMANCE MAT
   Brandon HJ, 2003, PLAST RECONSTR SURG, V111, P2295, DOI 10.1097/01.PRS.0000060795.16982.1C
   Breast implants with silicone based gel filling from Poly Implant Prothese company: Update of tests results, 2011, BREAST IMPLANTS SILI
   Brinton LA, 2000, CANCER CAUSE CONTROL, V11, P819, DOI 10.1023/A:1008941110816
   Brinton LA, 1996, PLAST RECONSTR SURG, V97, P269, DOI 10.1097/00006534-199602000-00001
   Brown SL, 2000, AM J ROENTGENOL, V175, P1057, DOI 10.2214/ajr.175.4.1751057
   Colas A, 2004, BIOMATERIALS SCI INT, P697
   Colas A, 2004, BIOMATERIALS SCI INT, V2, P80, DOI DOI 10.1016/B978-0-08-087780-8.00025-5
   Cronin TD, 1963, 3 T INT C PLAST SURG, P41
   Deapen DM, 1997, PLAST RECONSTR SURG, V99, P1346, DOI 10.1097/00006534-199704001-00022
   Edworthy SM, 1998, J RHEUMATOL, V25, P254
   Flassbeck D, 2003, ANAL BIOANAL CHEM, V375, P356, DOI 10.1007/s00216-002-1694-z
   GABRIEL SE, 1994, NEW ENGL J MED, V330, P1697, DOI 10.1056/NEJM199406163302401
   Heden P, 2006, PLAST RECONSTR SURG, V118, P303, DOI 10.1097/01.prs.0000233471.58039.30
   Hennekens CH, 1996, JAMA-J AM MED ASSOC, V275, P616, DOI 10.1001/jama.275.8.616
   Herdman RC, 2001, CANCER INVEST, V19, P821, DOI 10.1081/CNV-100107744
   Holmich LR, 2003, ARCH SURG-CHICAGO, V138, P801, DOI 10.1001/archsurg.138.7.801
   ISO materials biocompatibility matrix, 2007, ISO MAT BIOC MATR AS, V22, P2007
   Keough B, 2012, PIP BREAST IMPLANTS
   Kjoller K, 2001, ARCH INTERN MED, V161, P973, DOI 10.1001/archinte.161.7.973
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   McLaughlin JK, 1998, J NATL CANCER I, V90, P156, DOI 10.1093/jnci/90.2.156
   Mellemkjaer L, 2000, INT J CANCER, V88, P301, DOI 10.1002/1097-0215(20001015)88:2<301::AID-IJC24>3.0.CO;2-G
   Neuhann-Lorenz C, 2011, PLAST RECONSTR SURG, V127, P1368, DOI 10.1097/PRS.0b013e318206312e
   Nyren O, 1998, BRIT MED J, V316, P417, DOI 10.1136/bmj.316.7129.417
   Park AJ, 1998, BREAST, V7, P22, DOI 10.1016/S0960-9776(98)90047-9
   SANCHEZGUERRERO J, 1995, NEW ENGL J MED, V332, P1666, DOI 10.1056/NEJM199506223322502
   Taylor RB, 2008, J BIOMED MATER RES A, V85A, P684, DOI 10.1002/jbm.a.31589
   US Government Depts. of Health & Human Services and Labor, 1978, OCC HLTH GUID SOL PL
NR 45
TC 29
Z9 29
U1 1
U2 31
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD JUL 23
PY 2012
VL 142
AR w13614
DI 10.4414/smw.2012.13614
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 980XG
UT WOS:000306926900001
PM 22826101
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Fairley, JA
   Mitchell, LE
   Berg, T
   Kenneth, NS
   von Schubert, C
   Sillje, HHW
   Medema, RH
   Nigg, EA
   White, RJ
AF Fairley, Jennifer A.
   Mitchell, Louise E.
   Berg, Tracy
   Kenneth, Niall S.
   von Schubert, Conrad
   Sillje, Herman H. W.
   Medema, Rene H.
   Nigg, Erich A.
   White, Robert J.
TI Direct Regulation of tRNA and 5S rRNA Gene Transcription by Polo-like
   Kinase 1 (vol 45, pg 541, 2012)
SO MOLECULAR CELL
LA English
DT Correction
C1 [Fairley, Jennifer A.; Mitchell, Louise E.; Berg, Tracy; White, Robert J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.
   [Fairley, Jennifer A.; Mitchell, Louise E.; Kenneth, Niall S.; White, Robert J.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.
   [von Schubert, Conrad; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Sillje, Herman H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands.
   [Medema, Rene H.] Univ Med Ctr, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands.
RP White, RJ (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.
EM r.white@beatson.gla.ac.uk
OI Medema, Rene/0000-0002-6754-0381
CR JENNIFER A, 2012, MOL CELL, V45, P541
NR 1
TC 0
Z9 0
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD JUL 13
PY 2012
VL 47
IS 1
BP 148
EP 149
DI 10.1016/j.molcel.2012.06.022
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 975HH
UT WOS:000306500800016
OA Bronze
DA 2021-01-25
ER

PT J
AU Koberle, M
   Goppel, D
   Grandl, T
   Gaentzsch, P
   Manncke, B
   Berchtold, S
   Muller, S
   Luscher, B
   Asselin-Labat, ML
   Pallardy, M
   Sorg, I
   Langer, S
   Barth, H
   Zumbihl, R
   Autenrieth, IB
   Bohn, E
AF Koeberle, Martin
   Goeppel, David
   Grandl, Tanja
   Gaentzsch, Peer
   Manncke, Birgit
   Berchtold, Susanne
   Mueller, Steffen
   Luescher, Bernhard
   Asselin-Labat, Marie-Liesse
   Pallardy, Marc
   Sorg, Isabel
   Langer, Simon
   Barth, Holger
   Zumbihl, Robert
   Autenrieth, Ingo B.
   Bohn, Erwin
TI Yersinia enterocolitica YopT and Clostridium difficile Toxin B Induce
   Expression of GILZ in Epithelial Cells
SO PLOS ONE
LA English
DT Article
ID INDUCED LEUCINE-ZIPPER; NF-KAPPA-B; PROTECTS T-LYMPHOCYTES; GENE-PRODUCT
   RHOB; DENDRITIC CELLS; THYMOCYTE APOPTOSIS; VIRULENCE PLASMID; SIGNALING
   PATHWAY; BINDING PROTEINS; INVASIN PROTEIN
AB Glucocorticoid induced-leucine zipper (GILZ) has been shown to be induced in cells by different stimuli such as glucocorticoids, IL-10 or deprivation of IL-2. GILZ has anti-inflammatory properties and may be involved in signalling modulating apoptosis. Herein we demonstrate that wildtype Yersinia enterocolitica which carry the pYV plasmid upregulated GILZ mRNA levels and protein expression in epithelial cells. Infection of HeLa cells with different Yersinia mutant strains revealed that the protease activity of YopT, which cleaves the membrane-bound form of Rho GTPases was sufficient to induce GILZ expression. Similarly, Clostridium difficile toxin B, another bacterial inhibitor of Rho GTPases induced GILZ expression. YopT and toxin B both increased transcriptional activity of the GILZ promoter in HeLa cells. GILZ expression could not be linked to the inactivation of an individual Rho GTPase by these toxins. However, forced expression of RhoA and RhoB decreased basal GILZ promoter activity. Furthermore, MAPK activation proved necessary for profound GILZ induction by toxin B. Promoter studies and gel shift analyses defined binding of upstream stimulatory factor (USF) 1 and 2 to a canonical c-Myc binding site (E-box) in the GILZ promoter as a crucial step of its trans-activation. In addition we could show that USF-1 and USF-2 are essential for basal as well as toxin B induced GILZ expression. These findings define a novel way of GILZ promoter trans-activation mediated by bacterial toxins and differentiate it from those mediated by dexamethasone or deprivation of IL-2.
C1 [Koeberle, Martin; Goeppel, David; Grandl, Tanja; Gaentzsch, Peer; Manncke, Birgit; Berchtold, Susanne; Mueller, Steffen; Autenrieth, Ingo B.; Bohn, Erwin] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.
   [Luescher, Bernhard] Univ Klinikum RWTH Aachen, Inst Biochem & Mol Biol, Aachen, Germany.
   [Asselin-Labat, Marie-Liesse; Pallardy, Marc] Universud, INSERM, UMR S 996, Fac Pharm Paris Sud, Chatenay Malabry, France.
   [Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.
   [Sorg, Isabel] Univ Basel, Biozentrum, Basel, Switzerland.
   [Langer, Simon; Barth, Holger] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Ulm, Germany.
   [Zumbihl, Robert] INRA, UMR1333, Lab Diversite Genomes & Interact Microorganismes, F-34060 Montpellier, France.
   [Zumbihl, Robert] Univ Montpellier 2, Montpellier, France.
RP Koberle, M (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.
EM erwin.bohn@med.uni-tuebingen.de
RI Barth, Holger/E-7920-2013; Luscher, Bernhard/A-7330-2011
OI Koberle, Martin/0000-0001-6825-2667; Luscher,
   Bernhard/0000-0002-9622-8709; Langer, Simon/0000-0002-9660-8058
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
FX This work was supported by Deutsche Forschungsgemeinschaft. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adkins I, 2008, MICROBES INFECT, V10, P798, DOI 10.1016/j.micinf.2008.04.014
   Adkins I, 2007, INT J MED MICROBIOL, V297, P235, DOI 10.1016/j.ijmm.2007.02.005
   Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041
   Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206
   Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295
   Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686
   Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009
   Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002
   Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743
   Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724
   Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684
   Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998
   Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538
   Bohn E, 2004, CELL MICROBIOL, V6, P129, DOI 10.1046/j.1462-5822.2003.00346.x
   Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136
   Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183
   Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024
   Castagliuolo I, 2001, AM J PHYSIOL-GASTR L, V280, pG539
   Chen L, 2006, J BIOL CHEM, V281, P10849, DOI 10.1074/jbc.M511237200
   Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x
   COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2
   D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2
   Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09
   Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920
   Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447
   Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027
   FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x
   Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199
   Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014
   Gerhard R, 2005, J BIOL CHEM, V280, P1499, DOI 10.1074/jbc.M406014200
   Ghashghaeinia M, 2011, CELL PHYSIOL BIOCHEM, V27, P45, DOI 10.1159/000325204
   Godot V, 2006, ALLERGY, V61, P886, DOI 10.1111/j.1398-9995.2006.01065.x
   Grassl GA, 2003, CELL MICROBIOL, V5, P957, DOI 10.1046/j.1462-5822.2003.00339.x
   HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983
   Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081
   Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Jacobi CA, 1998, MOL MICROBIOL, V30, P865, DOI 10.1046/j.1365-2958.1998.01128.x
   JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0
   Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551
   Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237
   Lee JY, 2009, J MOL MED, V87, P169, DOI 10.1007/s00109-008-0415-2
   Matte I, 2009, INFECT IMMUN, V77, P5400, DOI 10.1128/IAI.00485-09
   Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200
   Mohammadi S, 2009, INFECT IMMUN, V77, P4771, DOI 10.1128/IAI.00850-09
   Na X, 2005, GASTROENTEROLOGY, V128, P1002, DOI 10.1053/j.gastro.2005.01.053
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x
   Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996
   Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8
   Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004
   Schulte R, 1998, MED MICROBIOL IMMUN, V187, P53, DOI 10.1007/s004300050074
   Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996
   Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471
   Schulte R, 1998, INFECT IMMUN, V66, P1216, DOI 10.1128/IAI.66.3.1216-1224.1998
   SELF AJ, 1995, METHOD ENZYMOL, V256, P3
   Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219
   Sorg I, 2003, INFECT IMMUN, V71, P4623, DOI 10.1128/IAI.71.8.4623-4632.2003
   Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001
   Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200
   Suarez PE, 2012, MOL ENDOCRINOLOGY
   Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251
   Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004
   Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x
   Vohra P, 2012, FEMS IMMUNOL MED MIC, V65, P96, DOI 10.1111/j.1574-695X.2012.00952.x
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001
   Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016
   Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 74
TC 6
Z9 6
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2012
VL 7
IS 7
AR e40730
DI 10.1371/journal.pone.0040730
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 973IV
UT WOS:000306354700065
PM 22792400
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Muhia, M
   Willadt, S
   Yee, BK
   Feldon, J
   Paterna, JC
   Schwendener, S
   Vogt, K
   Kennedy, MB
   Knuesel, I
AF Muhia, Mary
   Willadt, Silvia
   Yee, Benjamin K.
   Feldon, Joram
   Paterna, Jean-Charles
   Schwendener, Severin
   Vogt, Kaspar
   Kennedy, Mary B.
   Knuesel, Irene
TI Molecular and behavioral changes associated with adult
   hippocampus-specific SynGAP1 knockout
SO LEARNING & MEMORY
LA English
DT Article
ID GTPASE-ACTIVATING PROTEIN; SPATIAL REFERENCE MEMORY; CA3 NMDA RECEPTORS;
   SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; SIGNAL-TRANSDUCTION;
   COGNITIVE-PROCESSES; WORKING-MEMORY; VIRAL VECTOR; RAT-BRAIN
AB The synaptic Ras/Rap-GTPase-activating protein (SynGAP1) plays a unique role in regulating specific downstream intracellular events in response to N-methyl-D-aspartate receptor (NMDAR) activation. Constitutive heterozygous loss of SynGAP1 disrupts NMDAR-mediated physiological and behavioral processes, but the disruptions might be of developmental origin. Therefore, the precise role of SynGAP1 in the adult brain, including its relative functional significance within specific brain regions, remains unexplored. The present study constitutes the first attempt in achieving adult hippocampal-specific SynGAP1 knockout using the Cre/loxP approach. Here, we report that this manipulation led to a significant numerical increase in both small and large GluA1 and NR1 immunoreactive clusters, many of which were non-opposed to presynaptic terminals. In parallel, the observed marked decline in the amplitude of spontaneous excitatory currents (sEPSCs) and inter-event intervals supported the impression that SynGAP1 loss might facilitate the accumulation of extrasynaptic glutamatergic receptors. In addition, SynGAP1-mediated signaling appears to be critical for the proper integration and survival of newborn neurons. The manipulation impaired reversal learning in the probe test of the water maze and induced a delay-dependent impairment in spatial recognition memory. It did not significantly affect anxiety or reference memory acquisition but induced a substantial elevation in spontaneous locomotor activity in the open field test. Thus, the present study demonstrates the functional significance of SynGAP1 signaling in the adult brain by capturing several changes that are dependent on NMDAR and hippocampal integrity.
C1 [Knuesel, Irene] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
   [Muhia, Mary; Yee, Benjamin K.; Feldon, Joram; Paterna, Jean-Charles; Schwendener, Severin] Swiss Fed Inst Technol, Lab Behav Neurobiol, CH-8063 Schwerzenbach, Switzerland.
   [Willadt, Silvia; Vogt, Kaspar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kennedy, Mary B.] CALTECH, Div Biol, Pasadena, CA 91125 USA.
RP Knuesel, I (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
EM knuesel@pharma.uzh.ch
OI Kennedy, Mary/0000-0003-1369-0525; Vogt, Kaspar/0000-0002-0859-876X
FU Swiss Federal Institute of Technology ZurichETH Zurich [TH-22a/04-03];
   SNF [310000-117806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS028710, R01NS028710, R01NS028710,
   R01NS028710, R01NS028710, R01NS028710, R01NS028710, R01NS028710,
   R01NS028710, R01NS028710, R01NS028710, R01NS028710, R01NS028710,
   R01NS028710, R01NS028710, R01NS028710, R01NS028710, R01NS028710,
   R01NS028710] Funding Source: NIH RePORTER
FX This study was supported by the Swiss Federal Institute of Technology
   Zurich, Grant Nr TH-22a/04-03 and SNF Grant Nr 310000-117806 (IK). We
   thank Corinne Sidler (Institute of Pharmacology and Toxicology,
   University of Zurich) for her help with the immunohistochemical
   stainings. We also thank Dr. Oleg Georgiev (Institute of Molecular Life
   Sciences, University of Zurich) for providing the Klenow-blunted
   SalI-NLS Cre-XbaI fragment of pCMV-NLS Cre. We are grateful to Jean-Marc
   Fritschy for his invaluable advice and support. We also thank the Animal
   Services Department Schwerzenbach for animal husbandry and care and Dr.
   Frank Bootz for his veterinary expertise and supervision.
CR Ahmed BY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-4
   Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003
   Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008
   Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004
   Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1
   Barnett MW, 2006, J NEUROSCI, V26, P1355, DOI 10.1523/JNEUROSCI.3164-05.2006
   Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6
   Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008
   Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7
   Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x
   Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494
   Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929
   Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3
   FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111
   Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011
   Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464
   Glass MJ, 2008, EXP NEUROL, V213, P57, DOI 10.1016/j.expneurol.2008.04.045
   GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3
   Gray JA, 1982, NEUROPSYCHOLOGY ANXI
   Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223
   Hagenbuch N, 2006, BEHAV PHARMACOL, V17, P31, DOI 10.1097/01.fbp.0000189811.77049.3e
   HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983
   Hauser J, 2005, MOL PSYCHIATR, V10, P201, DOI 10.1038/sj.mp.4001554
   Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629
   Inturrisi C E, 2005, Minerva Anestesiol, V71, P401
   Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1
   Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699
   Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750
   Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8
   Kim JH, 2003, J NEUROSCI, V23, P1119
   Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9
   Knuesel I, 2005, EUR J NEUROSCI, V21, P611, DOI 10.1111/j.1460-9568.2005.03908.x
   Komiyama NH, 2002, J NEUROSCI, V22, P9721
   Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003
   Lee N, 2008, EUR J NEUROSCI, V27, P2830, DOI 10.1111/j.1460-9568.2008.06298.x
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0
   Muhia M, 2010, EUR J NEUROSCI, V31, P529, DOI 10.1111/j.1460-9568.2010.07079.x
   Muhia M, 2009, BEHAV NEUROSCI, V123, P1114, DOI 10.1037/a0017118
   Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795
   Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X
   Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x
   Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200
   Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221
   Paterna JC, 2002, METHODS, V28, P208, DOI 10.1016/S1046-2023(02)00225-6
   Paterna JC, 2004, J VIROL, V78, P6808, DOI 10.1128/JVI.78.13.6808-6817.2004
   Paterna JC, 2007, MOL THER, V15, P698, DOI 10.1038/sj.mt.6300067
   Paxinos G., 2001, MOUSE BRAIN STEREOTA
   Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20
   Pietropaolo S, 2007, BEHAV PHARMACOL, V18, P533, DOI 10.1097/FBP.0b013e3282da0bf6
   Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x
   Pouzet B, 1999, EUR J NEUROSCI, V11, P123, DOI 10.1046/j.1460-9568.1999.00413.x
   Rama S, 2008, MOL CELL NEUROSCI, V38, P183, DOI 10.1016/j.mcn.2008.02.007
   Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103
   Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72
   Sanderson DJ, 2007, BEHAV NEUROSCI, V121, P559, DOI 10.1037/0735-7044.121.3.559
   Scammell TE, 2003, J NEUROSCI, V23, P5762
   Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004
   von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039
   Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938
NR 60
TC 14
Z9 15
U1 0
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1072-0502
J9 LEARN MEMORY
JI Learn. Mem.
PD JUL
PY 2012
VL 19
IS 7
BP 268
EP 281
DI 10.1101/lm.026351.112
PG 14
WC Neurosciences; Psychology, Experimental
SC Neurosciences & Neurology; Psychology
GA 963SU
UT WOS:000305645400002
PM 22700469
OA Bronze, Green Accepted
DA 2021-01-25
ER

EF